PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, IK; McCutcheon, JN; Rao, GH; Liu, SV; Pommier, Y; Skrzypski, M; Zhang, YW; Giaccone, G				Kim, In-Kyu; McCutcheon, Justine N.; Rao, Guanhua; Liu, Stephen V.; Pommier, Yves; Skrzypski, Marcin; Zhang, Yu-Wen; Giaccone, Giuseppe			Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer	ONCOGENE			English	Article							ELEMENT-BINDING-PROTEIN; TUMOR-SUPPRESSOR GENE; MEK INHIBITOR; METHYLTRANSFERASE; IDENTIFICATION; CHEMOTHERAPY; TRANSCRIPTION; EXPRESSION; CARCINOMA; EVOLUTION	Resistance to chemotherapy remains a critical barrier to effective cancer treatment. Although cisplatin is one of the most commonly used chemotherapeutic agents in the treatment of non-small cell lung cancer (NSCLC), mechanisms of resistance to this drug are not fully understood. Here, we report a novel cisplatin-resistance mechanism involving SET Domain Containing 2 (SETD2), a histone H3 lysine 36 (H3K36) trimethyltransferase, and cAMP-responsive element-binding protein 1 (CREB1). A549 cells selected in vivo to give brain metastases exhibited cisplatin resistance and decreased expression of phosphorylated CREB1. Next-generation sequencing (NGS) analysis identified a missense mutation in SETD2 (p.T1171K), and we demonstrated that SETD2-mediated trimethylation of H3K36 (H3K36me3) and CREB1 phosphorylation are critical for cellular sensitivity to cisplatin. Moreover, we showed that suppression of SETD2 or CREB1 and ectopic expression of mutant SETD2 conferred cisplatin resistance through inhibition of H3K36me3 and ERK activation in NSCLC cells. Our results provide evidence that SETD2 and CREB1 contribute to cisplatin cytotoxicity via regulation of the ERK signaling pathway, and their inactivation may lead to cisplatin resistance.	[Kim, In-Kyu; McCutcheon, Justine N.; Rao, Guanhua; Liu, Stephen V.; Zhang, Yu-Wen; Giaccone, Giuseppe] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Pommier, Yves] NCI, Lab Mol Pharmacol, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Skrzypski, Marcin] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fahrenheit Universities; Medical University Gdansk	Zhang, YW; Giaccone, G (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	yz457@georgetown.edu; gg496@georgetown.edu	Liu, Stephen/E-5688-2019	Liu, Stephen/0000-0002-4852-3914; Kim, In-Kyu/0000-0002-8427-8311; Skrzypski, Marcin/0000-0002-4391-4318	NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC006150] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abol-Enein H, 2003, LANCET, V361, P1927; Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Choi EB, 2016, ONCOGENE, V35, P4569, DOI 10.1038/onc.2016.3; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Crans-Vargas HN, 2002, BLOOD, V99, P2617, DOI 10.1182/blood.V99.7.2617; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giaccone G, 2018, LANCET ONCOL, V19, P347, DOI 10.1016/S1470-2045(18)30062-7; Hainsworth JD, 2010, J THORAC ONCOL, V5, P1630, DOI 10.1097/JTO.0b013e3181e8b3a3; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kachnic LA, 2010, CANCER LETT, V292, P73, DOI 10.1016/j.canlet.2009.11.009; Kovach SJ, 2006, J CELL PHYSIOL, V206, P411, DOI 10.1002/jcp.20474; Maione P, 2015, THER ADV MED ONCOL, V7, P263, DOI 10.1177/1758834015595048; Mar BG, 2017, BLOOD, V130, P2631, DOI 10.1182/blood-2017-03-775569; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Mizumoto Y, 2007, CANCER SCI, V98, P652, DOI 10.1111/j.1349-7006.2007.00445.x; Moon YW, 2015, CELL DEATH DIFFER, V22, P1341, DOI 10.1038/cdd.2014.228; Nagao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049926; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Rao GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06128-9; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xiang W, 2015, ONCOTARGET, V6, P4066, DOI 10.18632/oncotarget.2926; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang R, 2008, CLIN CANCER RES, V14, P6396, DOI 10.1158/1078-0432.CCR-07-5113; Yu ZY, 2010, AM J PHYSIOL-RENAL, V298, pF617, DOI 10.1152/ajprenal.00636.2009; Zhang YL, 2014, CELL REP, V8, P1989, DOI 10.1016/j.celrep.2014.08.031; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	49	23	26	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2019	38	2					180	193		10.1038/s41388-018-0429-3	http://dx.doi.org/10.1038/s41388-018-0429-3			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HG9XX	30093630	Green Accepted			2022-12-26	WOS:000455366700003
J	Cunningham, KE; Novak, EA; Vincent, G; Siow, VS; Griffith, BD; Ranganathan, S; Rosengart, MR; Piganelli, JD; Mollen, KP				Cunningham, Kellie E.; Novak, Elizabeth A.; Vincent, Garret; Siow, Vei Shaun; Griffith, Brian D.; Ranganathan, Sarangarajan; Rosengart, Matthew R.; Piganelli, Jon D.; Mollen, Kevin P.			Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation	FASEB JOURNAL			English	Article						inflammatory bowel disease; CREB; intracellular calcium signaling; intestinal epithelial barrier	ENDOPLASMIC-RETICULUM STRESS; INFLAMMATORY-BOWEL-DISEASE; ELEMENT-BINDING PROTEIN; DEXTRAN SULFATE SODIUM; CYCLE ARREST; OCCLUDING JUNCTIONS; TIGHT JUNCTIONS; CROHNS-DISEASE; STEM-CELLS; ER STRESS	The incidence and prevalence of inflammatory bowel disease (IBD) are increasing worldwide. IBD is known to be multifactorial, but inflammatory signaling within the intestinal epithelium and a subsequent failure of the intestinal epithelial barrier have been shown to play essential roles in disease pathogenesis. CaMKIV is a multifunctional protein kinase associated with inflammation and cell cycle regulation. CaMKIV has been extensively studied in autoimmune diseases, but a role in idiopathic intestinal inflammation has not been described. In this study, active CaMKIV was highly expressed within the intestinal epithelium of humans with ulcerative colitis and wild-type (WT) mice with experimental induced colitis. Clinical disease severity directly correlates with CaMKIV activation, as does expression of proinflammatory cytokines and histologic features of colitis. In WT mice, CaMKIV activation is associated with increases in expression of 2 cell cycle proarrest signals: p53 and p21. Cell cycle arrest inhibits proliferation of the intestinal epithelium and ultimately results in compromised intestinal epithelial barrier integrity, further perpetuating intestinal inflammation during experimental colitis. Using a CaMKIV null mutant mouse, we demonstrate that a loss of CaMKIV protects against murine DSS colitis. Small molecules targeting CaMKIV activation may provide therapeutic benefit for patients with IBD.Cunningham, K. E., Novak, E. A., Vincent, G., Siow, V. S., Griffith, B. D., Ranganathan, S., Rosengart, M. R., Piganelli, J. D., Mollen, K. P. Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation.	[Cunningham, Kellie E.; Novak, Elizabeth A.; Vincent, Garret; Siow, Vei Shaun; Griffith, Brian D.; Rosengart, Matthew R.; Piganelli, Jon D.; Mollen, Kevin P.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Novak, Elizabeth A.; Vincent, Garret; Mollen, Kevin P.] UPMC, Childrens Hosp Pittsburgh, Div Pediat Surg, Pittsburgh, PA USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mollen, KP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Sch Med, 4401 Penn Ave,Fac Pavil,Suite 7000, Pittsburgh, PA 15224 USA.	kevin.mollen@chp.edu		Ranganathan, Sarangarajan/0000-0001-6214-9167; Griffith, Brian/0000-0001-6580-7217	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants [K08DK101753, R03DK114464]; NIH National Institute of General Medical Sciences [R01GM082852]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK114464, K08DK101753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082852] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants K08DK101753 and R03DK114464 (to K.P.M.) and NIH National Institute of General Medical Sciences Grant R01GM082852 (to M.R.R.). The authors declare no conflicts of interest.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Al-Sadi R, 2013, AM J PATHOL, V183, P1871, DOI 10.1016/j.ajpath.2013.09.001; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Araki Y, 2006, ONCOL REP, V16, P1357; Araki Y, 2012, ONCOL REP, V28, P1597, DOI 10.3892/or.2012.1969; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Basaranoglu M., 2016, J GASTROINTEST DIG S, V6, P467; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099293; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cabral M, 2013, INT J BIOCHEM CELL B, V45, P1620, DOI 10.1016/j.biocel.2013.05.009; Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; CCFA, 2014, FACTS INFLAMMATORY B; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cintolo Marcello, 2016, World J Gastrointest Pathophysiol, V7, P1, DOI 10.4291/wjgp.v7.i1.1; Clem BF, 2005, ENDOCRINOLOGY, V146, P1348, DOI 10.1210/en.2004-0761; Cunningham KE, 2016, J BIOL CHEM, V291, P10184, DOI 10.1074/jbc.M115.688812; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Duronio Robert J, 2013, Cold Spring Harb Perspect Biol, V5, pa008904, DOI 10.1101/cshperspect.a008904; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; Evankovich J, 2012, AM J PHYSIOL-GASTR L, V303, pG189, DOI 10.1152/ajpgi.00051.2012; Ferrer R, 2010, BIOCHEM PHARMACOL, V80, P431, DOI 10.1016/j.bcp.2010.04.033; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; GALLI P, 1976, EXP CELL RES, V99, P178, DOI 10.1016/0014-4827(76)90694-7; Gersemann M, 2011, WORLD J GASTROENTERO, V17, P3198, DOI 10.3748/wjg.v17.i27.3198; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Greco CA, 2011, VOX SANG, V100, P336, DOI 10.1111/j.1423-0410.2010.01419.x; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Hamabata T, 2018, J LIPID RES, V59, P586, DOI 10.1194/jlr.M079095; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; HAYS RM, 1965, J CELL BIOL, V25, P195, DOI 10.1083/jcb.25.3.195; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hetz C, 2013, NAT REV MOL CELL BIO, V14, DOI 10.1038/nrm3606; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Holmberg FEO, 2018, J TISSUE ENG REGEN M, V12, P923, DOI 10.1002/term.2506; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krebs J, 1997, BIOCHEM BIOPH RES CO, V241, P383, DOI 10.1006/bbrc.1997.7823; Landy J, 2016, WORLD J GASTROENTERO, V22, P3117, DOI 10.3748/wjg.v22.i11.3117; Larmonier CB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504638; Luo QY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020066; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mao HZ, 2014, J BIOL CHEM, V289, P24417, DOI 10.1074/jbc.M114.588764; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; MELDOLESI J, 1978, J CELL BIOL, V79, P156, DOI 10.1083/jcb.79.1.156; Nagy Z, 2007, BBA-MOL BASIS DIS, V1772, P402, DOI 10.1016/j.bbadis.2006.11.001; Naz H, 2016, PROG BIOPHYS MOL BIO, V121, P54, DOI 10.1016/j.pbiomolbio.2015.12.016; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Okamoto R, 2016, J GASTROENTEROL, V51, P11, DOI 10.1007/s00535-015-1098-4; Orlando A, 2013, DIGEST LIVER DIS, V45, P986, DOI 10.1016/j.dld.2013.07.005; PALANT CE, 1983, AM J PHYSIOL, V245, pC203, DOI 10.1152/ajpcell.1983.245.3.C203; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Rigoli L, 2014, WORLD J GASTROENTERO, V20, P10262, DOI 10.3748/wjg.v20.i30.10262; Roda G, 2010, WORLD J GASTROENTERO, V16, P4264, DOI 10.3748/wjg.v16.i34.4264; Rolhion N, 2010, GUT, V59, P1355, DOI 10.1136/gut.2010.207456; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schuh RA, 2005, J NEUROCHEM, V92, P388, DOI 10.1111/j.1471-4159.2004.02873.x; SEDAR AW, 1964, J CELL BIOL, V22, P173, DOI 10.1083/jcb.22.1.173; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Shiomi R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13262; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Teshima CW, 2012, ANN NY ACAD SCI, V1258, P159, DOI 10.1111/j.1749-6632.2012.06612.x; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vaughn Byron P, 2014, Curr Treat Options Gastroenterol, V12, P103, DOI 10.1007/s11938-013-0008-1; Viazis N, 2010, INFLAMM BOWEL DIS, V16, P507, DOI 10.1002/ibd.21077; Wang H, 1997, BBA-GENE STRUCT EXPR, V1352, P325, DOI 10.1016/S0167-4781(97)00035-3; Zhang XH, 2017, FASEB J, V31, P4382, DOI 10.1096/fj.201601096RRR; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhou XY, 2014, IMMUNOLOGY, V143, P287, DOI 10.1111/imm.12309	102	7	8	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1330	1346		10.1096/fj.201800535R	http://dx.doi.org/10.1096/fj.201800535R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113881	Bronze, Green Published			2022-12-26	WOS:000457401500105
J	Hahn, J; Schauer, C; Czegley, C; Kling, L; Petru, L; Schmid, B; Weidner, D; Reinwald, C; Biermann, MHC; Blunder, S; Ernst, J; Lesner, A; Bauerle, T; Palmisano, R; Christiansen, S; Herrmann, M; Bozec, A; Gruber, R; Schett, G; Hoffmann, MH				Hahn, Jonas; Schauer, Christine; Czegley, Christine; Kling, Lasse; Petru, Lenka; Schmid, Benjamin; Weidner, Daniela; Reinwald, Christiane; Biermann, Mona H. C.; Blunder, Stefan; Ernst, Juergen; Lesner, Adam; Baeuerle, Tobias; Palmisano, Ralf; Christiansen, Silke; Herrmann, Martin; Bozec, Aline; Gruber, Robert; Schett, Georg; Hoffmann, Markus H.			Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases	FASEB JOURNAL			English	Article						neutrophil serine proteases; periodontal inflammation; eosinophils; immune regulation	PAPILLON-LEFEVRE-SYNDROME; NADPH OXIDASE; CELL-DEATH; RESOLUTION; PROTEASES; ELASTASE; LEADS; MYELOPEROXIDASE; REQUIREMENTS; DEFICIENCY	Papillon-Lefevre syndrome (PLS) is characterized by nonfunctional neutrophil serine proteases (NSPs) and fulminant periodontal inflammation of unknown cause. Here we investigated neutrophil extracellular trap (NET)-associated aggregation and cytokine/chemokine-release/degradation by normal and NSP-deficient human and mouse granulocytes. Stimulated with solid or soluble NET inducers, normal neutrophils formed aggregates and both released and degraded cytokines/chemokines. With increasing cell density, proteolytic degradation outweighed release. Maximum output of cytokines/chemokines occurred mostly at densities between 2 x 10(7) and 4 x 10(7) neutrophils/cm(3). Assessment of neutrophil density in vivo showed that these concentrations are surpassed during inflammation. Association with aggregated NETs conferred protection of neutrophil elastase against 1-antitrypsin. In contrast, eosinophils did not influence cytokine/chemokine concentrations. The proteolytic degradation of inflammatory mediators seen in NETs was abrogated in Papillon-Lefevre syndrome (PLS) neutrophils. In summary, neutrophil-driven proteolysis of inflammatory mediators works as a built-in safeguard for inflammation. The absence of this negative feedback mechanism might be responsible for the nonresolving periodontitis seen in PLS.Hahn, J., Schauer, C., Czegley, C., Kling, L., Petru, L., Schmid, B., Weidner, D., Reinwald, C., Biermann, M. H. C., Blunder, S., Ernst, J., Lesner, A., Bauerle, T., Palmisano, R., Christiansen, S., Herrmann, M., Bozec, A., Gruber, R., Schett, G., Hoffmann, M. H. Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases.	[Hahn, Jonas; Schauer, Christine; Czegley, Christine; Petru, Lenka; Weidner, Daniela; Reinwald, Christiane; Biermann, Mona H. C.; Herrmann, Martin; Bozec, Aline; Schett, Georg; Hoffmann, Markus H.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Med 3, Erlangen, Germany; [Baeuerle, Tobias] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Inst Radiol, Erlangen, Germany; [Kling, Lasse; Christiansen, Silke] Max Planck Inst Sci Light, Erlangen, Germany; [Petru, Lenka] Charles Univ Prague, Inst Rheumatol, Dept Rheumatol, Fac Med 1, Prague, Czech Republic; [Schmid, Benjamin; Palmisano, Ralf] Friedrich Alexander Univ Erlangen Nurnberg FAU, OICE, Erlangen, Germany; [Blunder, Stefan; Gruber, Robert] Med Univ Innsbruck, Dept Dermatol Venereol & Allergol, Innsbruck, Austria; [Ernst, Juergen] Fraunhofer Inst Integrated Circuits IIS, Erlangen, Germany; [Lesner, Adam] Univ Gdansk, Fac Chem, Gdansk, Poland; [Christiansen, Silke] Helmholtz Zentrum Berlin Mat & Energie, Berlin, Germany; [Christiansen, Silke] Free Univ Berlin, Phys Dept, Berlin, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Max Planck Society; Charles University Prague; Institute of Rheumatology; University of Erlangen Nuremberg; Medical University of Innsbruck; Fraunhofer Gesellschaft; Fahrenheit Universities; University of Gdansk; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Free University of Berlin	Hoffmann, MH (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Univ Str 25a, D-91054 Erlangen, Germany.	markus.hoffmann@uk-erlangen.de	herrmann, martin/AAT-9836-2020; christiansen, silke/R-1567-2019; Schmid, Benjamin/ABD-2017-2020; Herrmann, Martin/A-9597-2013; Hasikova, Lenka/ABI-4867-2020	christiansen, silke/0000-0002-4908-4087; Schmid, Benjamin/0000-0002-9327-2296; Herrmann, Martin/0000-0002-0258-2484; Hasikova, Lenka/0000-0002-4794-2252; Hahn, Jonas/0000-0003-3944-2108; Bauerle, Tobias/0000-0002-0206-6199; Hoffmann, Markus/0000-0001-9698-9922; Lesner, Adam/0000-0001-8335-3431; Kling, Lasse/0000-0003-1246-8228	German Research Council [DFG CRC1181, SCHA 2040/1-1]; Stadtler-Stiftung Nurnberg; European Union Project Research and Innovation Staff Exchange-Reactive Oxygen Species as Elixirs Against Chronic Disease: Oxidative Regulatory Mechanisms in T cells and Neutrophils (RISE-REDOXIT) (H2020-MSCA-RISE-2014) [644035]; Interdisziplinare Zentrum fur Klinische Forschung (IZKF) Anschubfinanzierung (ELAN) Fonds of the Faculty of Medicine of the Friedrich-Alexander University Erlangen-Nurnberg; Articulum Fellowship	German Research Council(German Research Foundation (DFG)); Stadtler-Stiftung Nurnberg; European Union Project Research and Innovation Staff Exchange-Reactive Oxygen Species as Elixirs Against Chronic Disease: Oxidative Regulatory Mechanisms in T cells and Neutrophils (RISE-REDOXIT) (H2020-MSCA-RISE-2014); Interdisziplinare Zentrum fur Klinische Forschung (IZKF) Anschubfinanzierung (ELAN) Fonds of the Faculty of Medicine of the Friedrich-Alexander University Erlangen-Nurnberg; Articulum Fellowship	The authors thank P. Tripal (Optical Imaging Centre Erlangen) for trouble-shooting with multiphoton imaging of aggNETs, D. Andreev for help with quantitative PCR, D. Kienhofer for biotinylation of proteins, and Z. E. Kilgus (all from Friedrich Alexander University of Erlangen-Nurnberg, Universitatsklinikum Erlangen) for help with the experiments showing temporal distribution of inflammatory mediators in neutrophil cultures. The authors also thank the PLS patients and control subjects enrolled in this study. This work was supported by the German Research Council (DFG CRC1181, Projects C03 and Z02, and SCHA 2040/1-1), the Stadtler-Stiftung Nurnberg, the European Union Project Research and Innovation Staff Exchange-Reactive Oxygen Species as Elixirs Against Chronic Disease: Oxidative Regulatory Mechanisms in T cells and Neutrophils (RISE-REDOXIT) (H2020-MSCA-RISE-2014, Project 644035), and the Interdisziplinare Zentrum fur Klinische Forschung (IZKF) Anschubfinanzierung (ELAN) Fonds of the Faculty of Medicine of the Friedrich-Alexander University Erlangen-Nurnberg (to C.S.). L.P. was a recipient of the Articulum Fellowship. The authors declare no conflicts of interest.	Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Chen Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11596; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Doring G, 1999, PEDIATR PULM, V28, P363, DOI 10.1002/(SICI)1099-0496(199911)28:5<363::AID-PPUL9>3.0.CO;2-#; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gordon RA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92926; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/elife.24437, 10.7554/eLife.24437]; Kienhofer D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92920; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Konig MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00461; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Maueroder C, 2015, J MOL MED, V93, P727, DOI 10.1007/s00109-015-1295-x; Munoz LE, 2017, IMMUNOL REV, V280, P26, DOI 10.1111/imr.12569; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; Nauseef WM, 2014, J CLIN INVEST, V124, P4237, DOI 10.1172/JCI77985; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pieterse E, 2017, ARTERIOSCL THROM VAS, V37, P1371, DOI 10.1161/ATVBAHA.117.309002; Popow-Stellmaszyk J, 2013, ANAL BIOCHEM, V442, P75, DOI 10.1016/j.ab.2013.07.028; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Reategui E, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0094; Reinwald C, 2016, NAT MED, V22, P1384, DOI 10.1038/nm.4217; Roberts H, 2016, J LEUKOCYTE BIOL, V100, P433, DOI 10.1189/jlb.5A1015-489R; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shah K, 2007, J EMERG MED, V32, P23, DOI 10.1016/j.jemermed.2006.07.019; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Toyama S, 2017, ALLERGOL INT, V66, P463, DOI 10.1016/j.alit.2017.01.001; Treffers LW, 2016, IMMUNOL REV, V273, P312, DOI 10.1111/imr.12444; Ueki S, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0634-5; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	49	64	67	0	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1401	1414		10.1096/fj.201800752R	http://dx.doi.org/10.1096/fj.201800752R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130433	Bronze, Green Published			2022-12-26	WOS:000457401500110
J	Whitley, SK; Balasubramani, A; Zindl, CL; Sen, R; Shibata, Y; Crawford, GE; Weathington, NM; Hatton, RD; Weaver, CT				Whitley, Sarah K.; Balasubramani, Anand; Zindl, Carlene L.; Sen, Ranjan; Shibata, Yoichiro; Crawford, Gregory E.; Weathington, Nathaniel M.; Hatton, Robin D.; Weaver, Casey T.			IL-1R signaling promotes STAT3 and NF-kappa B factor recruitment to distal cis-regulatory elements that regulate Il17a/f transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); DNA-protein interaction; NF-kappa B (NF-KB); STAT3; interleukin 17A (IL-17 or IL-17A); interleukin 1 (IL-1)	INTERFERON-GAMMA PRODUCTION; HYPER-IGE SYNDROME; CD4(+) T-CELLS; C-REL; LYMPHOCYTE-PROLIFERATION; GENE-EXPRESSION; T(H)17 CELLS; DIFFERENTIATION; CYTOKINE; GENERATION	Interleukin (IL)-1 beta plays a critical role in IL-6-beta- and transforming growth factor beta (TGF beta)-initiated Th17 differentiation and induction of Th17-mediated autoimmunity. However, the means by which IL-1 regulates various aspects of Th17 development remain poorly understood. We recently reported that IL-1 beta enhances STAT3 phosphorylation via NF-kappa B-mediated repression of SOCS3 to facilitate Il17 transcription and Th17 differentiation, identifying an effect of IL-1 signaling on proximal events of STAT3 signaling. Here, we show that IL-1 beta promotes STAT3 binding to key cis-elements that control IL-17 expression. Additionally, we demonstrate that the IL-1-induced NF-kappa B factor RelA directly regulates the Il17a/f loci in cooperation with STAT3. Our findings reveal that IL-1 impacts both proximal signaling events and downstream interactions between transcription factors and cis-regulatory elements to promote Il17a/f transcription and Th17 differentiation.	[Whitley, Sarah K.; Balasubramani, Anand; Weaver, Casey T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Zindl, Carlene L.; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sen, Ranjan] NIA, Lab Cellular & Mol Biol, NIH, Baltimore, MD 21224 USA; [Shibata, Yoichiro; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Weathington, Nathaniel M.] Univ Pittsburgh, Dept Med, Med Ctr, 930 Scaife Hall, Pittsburgh, PA 15213 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whitley, SK (corresponding author), Univ Pittsburgh, Med Ctr, Dept Dermatol, 200 Lothrop St,W1028 BST, Pittsburgh, PA 15261 USA.	whitleysk@upmc.edu		Zindl, Carlene/0000-0003-4841-3552; Hatton, Robin/0000-0002-4797-9899	National Institutes of Health [R01AI035783, R01DK103744, R01DK115172]; UAB Medical Scientist Training Program - National Institutes of Health [T32 GM008361]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL126135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115172, R01DK103744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Medical Scientist Training Program - National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01AI035783 and R01DK103744 (to C. T. W.) and R01DK115172 (to C. T. W. and R. D. H.), and the UAB Medical Scientist Training Program (to S. K. W.), supported by National Institutes of Health Grant T32 GM008361. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hwang ES, 2010, YONSEI MED J, V51, P484, DOI 10.3349/ymj.2010.51.4.484; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee YK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186351; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Molinero LL, 2012, P NATL ACAD SCI USA, V109, P18529, DOI 10.1073/pnas.1204557109; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Suzuki N, 2002, TRENDS IMMUNOL, V23, P503, DOI 10.1016/S1471-4906(02)02298-6; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	41	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15790	15800		10.1074/jbc.RA118.002721	http://dx.doi.org/10.1074/jbc.RA118.002721			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30093408	hybrid, Green Published			2022-12-26	WOS:000447256000004
J	Attia, ZI; Sugrue, A; Asirvatham, SJ; Ackerman, MJ; Kapa, S; Friedman, PA; Noseworthy, PA				Attia, Zachi, I; Sugrue, Alan; Asirvatham, Samuel J.; Ackerman, Michael J.; Kapa, Suraj; Friedman, Paul A.; Noseworthy, Peter A.			Noninvasive assessment of dofetilide plasma concentration using a deep learning (neural network) analysis of the surface electrocardiogram: A proof of concept study	PLOS ONE			English	Article							INTRAVENOUSLY ADMINISTERED DOFETILIDE; ATRIAL-FIBRILLATION; LONG-QT; ACUTE TERMINATION; ORAL DOFETILIDE; DOUBLE-BLIND; FLUTTER; EFFICACY; INTERVAL; MULTICENTER	Background Dofetilide is an effective antiarrhythmic medication for rhythm control in atrial fibrillation, but carries a significant risk of pro-arrhythmia and requires meticulous dosing and monitoring. The cornerstone of this monitoring, measurement of the QT/QTc interval, is an imperfect surrogate for plasma concentration, efficacy, and risk of pro-arrhythmic potential. Objective The aim of our study was to test the application of a deep learning approach (using a convolutional neural network) to assess morphological changes on the surface ECG (beyond the QT interval) in relation to dofetilide plasma concentrations. Methods We obtained publically available serial ECGs and plasma drug concentrations from 42 healthy subjects who received dofetilide or placebo in a placebo-controlled cross-over randomized controlled clinical trial. Three replicate 10-s ECGs were extracted at predefined time-points with simultaneous measurement of dofetilide plasma concentration We developed a deep learning algorithm to predict dofetilide plasma concentration in 30 subjects and then tested the model in the remaining 12 subjects. We compared the deep leaning approach to a linear model based only on QTc. Results Fourty two healthy subjects (21 females, 21 males) were studied with a mean age of 26.9 +/- 5.5 years. A linear model of the QTc correlated reasonably well with dofetilide drug levels (r = 0.64). The best correlation to dofetilide level was achieved with the deep learning model (r = 0.85). Conclusion This proof of concept study suggests that artificial intelligence (deep learning/neural network) applied to the surface ECG is superior to analysis of the QT interval alone in predicting plasma dofetilide concentration.	[Attia, Zachi, I; Sugrue, Alan; Asirvatham, Samuel J.; Kapa, Suraj; Friedman, Paul A.; Noseworthy, Peter A.] Mayo Clin, Dept Cardiovasc Dis, Div Heart Rhythm Serv, Rochester, MN 55905 USA; [Asirvatham, Samuel J.; Ackerman, Michael J.] Mayo Clin, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Noseworthy, PA (corresponding author), Mayo Clin, Dept Cardiovasc Dis, Div Heart Rhythm Serv, Rochester, MN 55905 USA.	noseworthy.peter@mayo.edu	Sugrue, Alan/AAN-8589-2021					Acharya UR, 2017, INFORM SCI; Al Rahhal MM, 2016, INFORM SCIENCES, V345, P340, DOI 10.1016/j.ins.2016.01.082; Allen MJ, 2000, BRIT J CLIN PHARMACO, V50, P247, DOI 10.1046/j.1365-2125.2000.00243.x; Anand Vidhu, 2016, JACC Clin Electrophysiol, V2, P777, DOI 10.1016/j.jacep.2016.05.007; [Anonymous], 2017, LANCET, V390, P2739, DOI 10.1016/S0140-6736(17)31540-4; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI [DOI 10.1001/JAMA.2017.18391, 10.1001/jama.2017.18391]; Bianconi L, 2000, EUR HEART J, V21, P1265, DOI 10.1053/euhj.1999.2039; Cho JH, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005333; Demolis JL, 1996, CIRCULATION, V94, P1592, DOI 10.1161/01.CIR.94.7.1592; FDA, NDA 20 931 TIKOSYN D; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Indik JH, 2006, HEART RHYTHM, V3, P1003, DOI 10.1016/j.hrthm.2006.05.023; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Johannesen L, 2016, CLIN PHARMACOL THER, V99, P214, DOI 10.1002/cpt.205; Johannesen L, 2014, CLIN PHARMACOL THER, V96, P549, DOI 10.1038/clpt.2014.155; Jonker DM, 2005, CLIN PHARMACOL THER, V77, P572, DOI 10.1016/j.clpt.2005.02.004; Kanters JK, 2004, HEART RHYTHM, V1, P285, DOI 10.1016/j.hrthm.2004.05.002; Kligfield P, 2014, AM HEART J, V167, P150, DOI 10.1016/j.ahj.2013.10.004; Krittanawong C, 2017, J AM COLL CARDIOL, V69, P1879, DOI 10.1016/j.jacc.2016.12.043; LECOZ F, 1995, CLIN PHARMACOL THER, V57, P533; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Malik M, 2004, J ELECTROCARDIOL, V37, P25, DOI 10.1016/j.jelectrocard.2004.08.005; McLaughlin NB, 1996, HEART, V76, P422, DOI 10.1136/hrt.76.5.422; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Narula S, 2016, J AM COLL CARDIOL, V68, P2287, DOI 10.1016/j.jacc.2016.08.062; Norgaard B L, 1999, Am Heart J, V137, P1062; ORTIZ J, 1995, J AM COLL CARDIOL, V26, P1356, DOI 10.1016/0735-1097(95)00300-2; Pedersen OD, 2001, CIRCULATION, V104, P292, DOI 10.1161/01.CIR.104.3.292; Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037; Rajpurkar Pranav, 2017, CARDIOLOGIST LEVEL A; SEDGWICK M, 1991, BRIT J CLIN PHARMACO, V31, P515, DOI 10.1111/j.1365-2125.1991.tb05572.x; SEDGWICK ML, 1992, AM J CARDIOL, V70, P1432, DOI 10.1016/0002-9149(92)90295-A; Sengupta PP, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004330; Singh S, 2000, CIRCULATION, V102, P2385, DOI 10.1161/01.CIR.102.19.2385; Sugrue A, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003830; Sugrue A, 2015, CARDIOVASC DRUG THER, V29, P433, DOI 10.1007/s10557-015-6619-0; Taggart NW, 2007, CIRCULATION, V115, P2613, DOI 10.1161/CIRCULATIONAHA.106.661082; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Vicente J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001615; Viskin S, 2005, HEART RHYTHM, V2, P569, DOI 10.1016/j.hrthm.2005.02.011; Yuan C, 2016, INF AUT ICIA 2016 IE	43	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201059	10.1371/journal.pone.0201059	http://dx.doi.org/10.1371/journal.pone.0201059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133452	Green Published, gold			2022-12-26	WOS:000442500400010
J	Grillova, L; Giacani, L; Mikalova, L; Strouhal, M; Strnadel, R; Marra, C; Centurion-Lara, A; Poveda, L; Russo, G; Cejkova, D; Vasku, V; Oppelt, J; Smajs, D				Grillova, Linda; Giacani, Lorenzo; Mikalova, Lenka; Strouhal, Michel; Strnadel, Radim; Marra, Christina; Centurion-Lara, Arturo; Poveda, Lucy; Russo, Giancarlo; Cejkova, Darina; Vasku, Vladimir; Oppelt, Jan; Smajs, David			Sequencing of Treponema pallidum subsp pallidum from isolate UZ1974 using Anti-Treponemal Antibodies Enrichment: First complete whole genome sequence obtained directly from human clinical material	PLOS ONE			English	Article							STRAIN TYPES; SYPHILIS; ASSOCIATION; ALIGNMENT	Treponema pallidum subsp. pallidum (TPA) is the infectious agent of syphilis, a disease that infects more than 5 million people annually. Since TPA is an uncultivable bacterium, most of the information on TPA genetics comes from genome sequencing and molecular typing studies. This study presents the first complete TPA genome (without sequencing gaps) of clinical isolate (UZ1974), which was obtained directly from clinical material, without multiplication in rabbits. Whole genome sequencing was performed using a newly developed Anti-Treponemal Antibody Enrichment technique combined with previously reported Pooled Segment Genome Sequencing. We identified the UW074B genome, isolated from a sample previously propagated in rabbits, to be the closest relative of the UZ1974 genome and calculated the TPA mutation rate as 2.8 x 10(-10) per site per generation.	[Grillova, Linda; Mikalova, Lenka; Strouhal, Michel; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Giacani, Lorenzo; Marra, Christina; Centurion-Lara, Arturo] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Strnadel, Radim] Univ Hosp Brno, Dept Dermatovenerol, Brno, Czech Republic; [Poveda, Lucy; Russo, Giancarlo] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Cejkova, Darina] Vet Res Inst, Dept Immunol, Brno, Czech Republic; [Vasku, Vladimir] Masaryk Univ, St Annes Univ Hosp Brno, Dermatovenereol Clin 1, Fac Med, Brno, Czech Republic; [Oppelt, Jan] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Oppelt, Jan] Masaryk Univ, Natl Ctr Biomol Res, Fac Sci, Brno, Czech Republic; [Grillova, Linda] Inst Pasteur, Biol Spirochetes Unit, Paris, France	Masaryk University Brno; University of Washington; University of Washington Seattle; University Hospital Brno; University of Zurich; Czech Veterinary Research Institute; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.muni.cz	Mikalová, Lenka/AAM-1068-2020; Russo, Giancarlo/GQY-5601-2022; Grillova, Linda/AAA-8557-2020; Oppelt, Jan/H-7388-2017; Cejkova, Darina/AAA-5820-2022	Oppelt, Jan/0000-0002-3076-4840; Cejkova, Darina/0000-0002-6989-6330; Grillova, Linda/0000-0003-2371-3161; Pastekova, Lenka/0000-0003-4266-9952; Poveda, Lucy/0000-0002-5291-5582	Grant Agency of the Czech Republic [GA17-25455S]; Ministry of Health of the Czech Republic [17-31333A]; CIISB - Ministry of Education, Youth and Sports of the Czech Republic [LM2015043]; Projects of Large Research, Development, and Innovations Infrastructures [CESNET LM2015042];  [R21AI094126]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); CIISB - Ministry of Education, Youth and Sports of the Czech Republic; Projects of Large Research, Development, and Innovations Infrastructures; 	This work was supported by the Grant Agency of the Czech Republic (GA17-25455S) and by the Ministry of Health of the Czech Republic (17-31333A) to DS. Sequencing of the UW074B strain was supported by grant R21AI094126 to LG. We acknowledge CF New Generation Sequencing Bioinformatics, supported by the CIISB research infrastructure (LM2015043 funded by the Ministry of Education, Youth and Sports of the Czech Republic), for their support with obtaining scientific data presented in this paper. Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum provided under the program "Projects of Large Research, Development, and Innovations Infrastructures" (CESNET LM2015042), is greatly appreciated.	Andrews S., 2010, FASTQC QUALITY CONTR; Arora N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.245; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Broad Institute, 2015, PIC TOOLK; Bushnell B., 2017, BBMAP SHORT READ ALI; Cejkova D, 2013, J MED MICROBIOL, V62, P196, DOI 10.1099/jmm.0.050658-0; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; CUMBERLAND MARY C, 1949, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V33, P201; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Giacani L, 2017, SEX TRANSM DIS; Giacani L, 2014, GENOME ANNOUNC, V2; Giacani L, 2010, J BACTERIOL, V192, P2645, DOI 10.1128/JB.00159-10; Gordon A.H., 2010, FASTX TOOLKIT; Grange PA, 2013, SEX TRANSM DIS, V40, P641, DOI 10.1097/OLQ.0000000000000006; Grillova A L, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0200773, DOI 10.1371/J0URNAL.P0NE.0200773]; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu H, 2001, J CLIN MICROBIOL, V39, P1941, DOI 10.1128/JCM.39.5.1941-1946.2001; Magnuson Harold J., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V32, P1; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Naqvi AAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124177; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Petrosova H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001832; Pinto M, 2017, MICROB PATHOGENESIS, V104, P296, DOI 10.1016/j.micpath.2017.01.059; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Read P, 2016, J CLIN MICROBIOL, V54, P2172, DOI 10.1128/JCM.00959-16; Salado-Rasmussen K, 2016, ACTA DERM-VENEREOL, V96, P202, DOI 10.2340/00015555-2190; Smajs D, 2016, WHY ARE 2 GENETICALL; Smajs D, 2018, INFECT GENET EVOL, V61, P92, DOI 10.1016/j.meegid.2018.03.015; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Staudova B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003261; Strouhal Michal, 2018, BMC Res Notes, V11, P16, DOI 10.1186/s13104-017-3106-7; Strouhal M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005894; Sun J, 2016, ONCOTARGET, V7, P42904, DOI 10.18632/oncotarget.10154; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182768; Weinstock GM, 2000, RES MICROBIOL, V151, P151, DOI 10.1016/S0923-2508(00)00115-7; World Health Organization, 2016, WHO GUIDELINES TREAT; Zobanikova M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002172; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838	51	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0202619	10.1371/journal.pone.0202619	http://dx.doi.org/10.1371/journal.pone.0202619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130365	gold, Green Published, Green Submitted			2022-12-26	WOS:000442284500011
J	Grindlay, K; Dako-Gyeke, P; Ngo, TD; Eva, G; Gobah, L; Reiger, ST; Chandrasekaran, S; Blanchard, K				Grindlay, Kate; Dako-Gyeke, Phyllis; Ngo, Thoai D.; Eva, Gillian; Gobah, Leonard; Reiger, Sarah T.; Chandrasekaran, Sruthi; Blanchard, Kelly			Contraceptive use and unintended pregnancy among young women and men in Accra, Ghana	PLOS ONE			English	Article								The objective of this study was to determine factors associated with modern contraceptive use and unintended pregnancy among young women and men in Accra, Ghana. From September-December 2013, we conducted a cross-sectional survey with 250 women and 100 men aged 18-24. We explored determinants of modern contraceptive use among males and females and unintended pregnancy among females. Descriptive statistics, chi-square tests, Fisher's exact tests, and multivariable logistic regression were used. Participants had an average of three lifetime sexual partners, and 91% had one current partner. Overall, 44% reported current modern contraceptive use. In multivariate modeling, modern contraceptive use was associated with higher education compared to primary (AORs 2.1-4.3); ever talking with someone about contraception (AOR 4.7); feeling unsupported by a healthcare provider for contraception (AOR 2.2); and not feeling at risk of unintended pregnancy (AOR 2.7). While >= 70% of participants recognized most contraceptive methods, awareness of some methods was lacking. Nearly all respondents (91%) felt at least one modern method was unsafe. Nearly half of all females (45%) reported their last pregnancy was unintended, and 63% of females and 58% of males felt at risk for future unintended pregnancy. Women were more likely to experience unintended pregnancy if they had ever given birth (AOR 6.7), their sexual debut was 8-14 years versus 20-24 years (AOR 3.4), or they had 3-4 lifetime sexual partners versus 1-2 (AOR 2.4). Targeted interventions are needed to improve understanding of the safety of modern contraceptive methods, increase awareness of long-acting methods, and consequently increase modern contraceptive access and use.	[Grindlay, Kate; Reiger, Sarah T.; Chandrasekaran, Sruthi; Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA 02140 USA; [Dako-Gyeke, Phyllis] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Accra, Ghana; [Ngo, Thoai D.] Populat Council, Poverty Gender & Youth Program, 1230 York Ave, New York, NY 10021 USA; [Eva, Gillian] Marie Stopes Int US, Washington, DC USA; [Gobah, Leonard] Marie Stopes Ghana, Accra, Ghana	University of Ghana; Population Council	Grindlay, K (corresponding author), Ibis Reprod Hlth, Cambridge, MA 02140 USA.	kgrindlay@ibisreproductivehealth.org		Ngo, Thoai/0000-0001-6683-2297	Marie Stopes International	Marie Stopes International	This study was funded by a grant from Marie Stopes International [grant: "Reproductive health decision making among urban youth in Accra, Ghana"]. The funder participated in discussions related to the study design; collection, analysis, and interpretation of the data; write-up of the data; and the decision to submit the article for publication.	Adanu R M, 2012, Ghana Med J, V46, P58; Adanu Richard M K, 2009, Afr J Reprod Health, V13, P123; Ahorlu CK, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0113-9; Aninanya GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125267; Aryeetey R, 2010, Afr J Reprod Health, V14, P26; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Challa S, 2017, WOMEN HLTH, P1; Chandra-Mouli V, 2015, J ADOLESCENT HEALTH, V56, pS1, DOI 10.1016/j.jadohealth.2014.09.015; Crissman HP, 2012, STUD FAMILY PLANN, V43, P201, DOI 10.1111/j.1728-4465.2012.00318.x; Darteh EKM, 2016, J COMMUN HEALTH, V41, P15, DOI 10.1007/s10900-015-0057-6; [Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF International], 2015, ICF INT GHAN DEM HLT; Ghana Statistical Service (GSS), 2014, 2010 POP HOUS CENS; Ghana Statistical Service (GSS) Noguchi Memorial Institute for Medical Research (NMIMR) and ORC Macro, 2004, GHAN DEM HLTH SURV 2; Guttmacher Institute, 2017, ADD IT INV CONTR MAT; Gyesaw NYK, 2013, INT J WOMENS HEALTH, V5, P773, DOI 10.2147/IJWH.S51528; Hindin MJ, 2014, J FAM PLAN REPROD H, V40, P30, DOI 10.1136/jfprhc-2012-100464; Konadu-Agyemang K, 2001, HABITAT INT, V25, P15, DOI 10.1016/S0197-3975(00)00016-3; Krugu JK, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0161-9; Machiyama K, 2014, STUD FAMILY PLANN, V45, P203, DOI 10.1111/j.1728-4465.2014.00385.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Singh S, 2012, ADDING IT COSTS BENE; Staveteig S, 2016, UNDERSTANDING UNMET; Sundaram A, 2015, HEALTH POLICY PLANN, V30, P1017, DOI 10.1093/heapol/czu105; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; United Nations Department of Economic and Social Affairs Population Division, 2014, STESASERA352	27	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0201663	10.1371/journal.pone.0201663	http://dx.doi.org/10.1371/journal.pone.0201663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR1HG	30118485	gold, Green Submitted, Green Published			2022-12-26	WOS:000442282700010
J	Jezzini, SH; Merced, A; Blagburn, JM				Jezzini, Sami H.; Merced, Amelia; Blagburn, Jonathan M.			Shaking-B misexpression increases the formation of gap junctions but not chemical synapses between auditory sensory neurons and the giant fiber of Drosophila melanogaster	PLOS ONE			English	Article							SYNAPTIC CONNECTIVITY; ELECTRICAL SYNAPSES; IMAGE-ANALYSIS; EXPRESSION; SYSTEM; BRAIN; GENE; NEUROTRANSMISSION; MATURATION; MUTATIONS	The synapse between auditory Johnston's Organ neurons (JONs) and the giant fiber (GF) of Drosophila is structurally mixed, being composed of cholinergic chemical synapses and Neurobiotin- (NB) permeable gap junctions, which consist of the innexin Shaking-B (ShakB). Previous observations showed that misexpression of one ShakB isoform, ShakB(N+16), in a subset of JONs that do not normally form gap junctions results in their de novo dye coupling to the GF. Misexpression of the transcription factor Engrailed (En) in these neurons also has this effect, and in addition causes the formation of new chemical synapses. These results, along with earlier studies suggesting that gap junctions are required for the development of some chemical synapses, led to the hypothesis that ShakB would, like En, have an instructive effect on the distribution of mixed chemical/electrical contacts. To test this, we first confirmed quantitatively that ShakB(N+16) misexpression increased the dye-coupling of JONs with the GF, indicating the formation of ectopic gap junctions. Conversely, expression of the 'incorrect' isoform, ShakB(N), abolished dye coupling. Immunocytochemistry of the ShakB protein showed that ShakB(N+16) increased gap junctional plaques in JON axons but ShakB(N) did not. To test our hypothesis, fluorescently-labeled presynaptic active zone protein (Brp) was expressed in JONs and the changes in its distribution on the GF dendrites was assayed with confocal microscopy in animals with misexpression of ShakB(N+16), ShakB(N) or, as a positive control, En. Using different methods of image analysis, we confirmed our previous result that En misexpression increased the chemical synapses with the GF and the amount of GF medial dendrite branching. However, contrary to our hypothesis, misexpression of ShakB did not increase these parameters. Immunostaining showed no association between presynaptic active zones and the new ShakB plaques, further evidence against the hypothesis. We conclude that both subsets of JON form chemical synapses onto the GF dendrites but only one population forms gap junctions, comprised of ShakB(N+16). Misexpression of this isoform in all JONs does not instruct the formation of new mixed chemical/electrical synapses, but results in the insertion of new gap junctions, presumably at the sites of existing chemical synaptic contacts with the GF.	[Jezzini, Sami H.; Merced, Amelia; Blagburn, Jonathan M.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Blagburn, JM (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	jonathan.blagburn@upr.edu	Merced, Amelia/P-3441-2019	Merced, Amelia/0000-0003-4649-8126; Blagburn, Jonathan/0000-0002-7681-2764	NINDS [SC1NS081726]; NIGMS [SC3GM121190]; NSF [DBI 0115825, DBI 1337284]; NIMHD [G12 MD007600, MD007600]; Bloomington Drosophila Stock Center [NIH P40OD018537]; NIH: Fluorender: An Imaging Tool for Visualization and Analysis of Confocal Data as Applied to Zebrafish Research [R01-GM098151-01]; DoD [52680-RT-ISP]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM121190, R01GM098151, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS081726] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600, U54MD007600] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Bloomington Drosophila Stock Center; NIH: Fluorender: An Imaging Tool for Visualization and Analysis of Confocal Data as Applied to Zebrafish Research; DoD(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors declare no competing financial interests. This work was supported by NINDS grant *SC1NS081726* and NIGMS grant SC3GM121190 to JMB. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The Nikon confocal microscope was funded by NSF DBI 1337284. The Institute Drosophila resource center was supported by NIMHD MD007600 (RCMI). Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. This work was made possible in part by software funded by the NIH: Fluorender: An Imaging Tool for Visualization and Analysis of Confocal Data as Applied to Zebrafish Research, R01-GM098151-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare no competing financial interests. This work was supported by NINDS grant SC1NS081726 and NIGMS grant SC3GM121190 to JMB. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The Nikon confocal microscope was funded by NSF DBI 1337284. The Institute Drosophila resource center was supported by NIMHD MD007600 (RCMI). We thank Jonathan Bacon for donating the ShakB antibody. We thank Pauline Phelan and Bruno Marie for donating fly stocks. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. This work was made possible in part by software funded by the NIH: Fluorender: An Imaging Tool for Visualization and Analysis of Confocal Data as Applied to Zebrafish Research, R01-GM098151-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, EUR J NEUROSCI, V26, P439, DOI 10.1111/j.1460-9568.2007.05686.x; Andreae LC, 2018, J NEUROSCI RES, V96, P354, DOI 10.1002/jnr.24154; Atwood HL, LEARN MEM, V6, P542; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Boekhoff-Falk G, 2014, WIRES DEV BIOL, V3, P179, DOI 10.1002/wdev.128; Card GM, 2012, CURR OPIN NEUROBIOL, V22, P180, DOI 10.1016/j.conb.2011.12.009; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Choi BJ, 2014, NEURON, V82, P618, DOI 10.1016/j.neuron.2014.03.012; Christiansen F, 2011, J NEUROSCI, V31, P9696, DOI 10.1523/JNEUROSCI.6542-10.2011; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Curtin KD, 2002, J NEUROSCI, V22, P7088; Feng LQ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0049-14.2014; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; Hammond S, 2007, J COMP PHYSIOL A, V193, P471, DOI 10.1007/s00359-006-0203-9; Harper DAT, 2001, PALAEONTOL ELECTRON, V4, DOI [10.1002/cne.21075, DOI 10.1002/CNE.21075]; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KRISHNAN SN, 1993, CELL, V73, P967, DOI 10.1016/0092-8674(93)90274-T; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Marks WD, 2014, J NEUROPHYSIOL, V111, P1383, DOI 10.1152/jn.00385.2013; Newman ZL, 2017, NEURON, V93, P1388, DOI 10.1016/j.neuron.2017.02.028; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Pereda AE, 2014, NAT REV NEUROSCI, V15, P250, DOI 10.1038/nrn3708; Personius KE, 2007, P NATL ACAD SCI USA, V104, P11808, DOI 10.1073/pnas.0703357104; Pezier A, 2014, J NEUROSCI, V34, P11691, DOI 10.1523/JNEUROSCI.1939-14.2014; Pezier AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152211; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; THOMAS JB, 1984, J NEUROSCI, V4, P530; Tobin WF, 2017, ELIFE, V6, DOI 10.7554/eLife.24838; Todd KL, 2010, J NEUROSCI, V30, P15277, DOI 10.1523/JNEUROSCI.2331-10.2010; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zhang Z, 1999, J NEUROBIOL, V40, P288, DOI 10.1002/(SICI)1097-4695(19990905)40:3<288::AID-NEU2>3.0.CO;2-O	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0198710	10.1371/journal.pone.0198710	http://dx.doi.org/10.1371/journal.pone.0198710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118493	gold, Green Published, Green Submitted			2022-12-26	WOS:000442282700001
J	Abu-Gharbieh, E; Shehab, NG; Almasri, IM; Bustanji, Y				Abu-Gharbieh, Eman; Shehab, Naglaa G.; Almasri, Ihab M.; Bustanji, Yasser			Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid: In vitro and in vivo investigation and docking simulations	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ALLOPURINOL; OXIDOREDUCTASE; MECHANISM; ANTITUMOR; COMPLEX; LEAVES	Background Hyperurecemia is usually associated with gout and various metabolic arthritis disorders. Limited medications are available to manage such conditions. This study aimed to isolate the triterpenes constituent of the plant and to assess xanthine oxidase (XO) inhibitory and antihyperuricemic activities of Tribulus arabicus ethanolic extract, its fractions and the isolated compound using in vitro and in vivo approaches. Methods The ethanolic extract, fractions; n-hexane, chloroform and n-butanol and the isolated compound (ursolic acid) were evaluated in vitro for their XO inhibitory activity. Those that demonstrated significant activity were further evaluated for their antihyperuricemic activity on potassium oxonate-induced hyperuricemia in mice. Results The ethanolic extract was found to be safe up to 5000 mg/kg. The extract and its n-hexane fraction exhibited significant inhibitory activity on XO, whilst only a modest reduction in the enzymatic activity was noticed with n-butanol and chloroform fractions. Furthermore, administration of the ethanolic extract at low and high doses significantly reduced serum urate levels in mice by 31.1 and 64.6% respectively. The isolated active constituent, ursolic acid, showed potent XO inhibition activity (Half maximal inhibitory concentration, IC50 = 10.3 mu g/mL), and significantly reduced uric acid level in vivo by 79.9%. Virtually, the binding mode of ursolic acid with XO was determined using molecular docking simulations. Conclusions The activity of the ethanolic extract of T. arabicus and its n-hexane fraction can be attributed to the isolated compound, ursolic acid. Ursolic acid has good hypouricemic activity and therefore has high potential to be used for the treatment of gout and hyperuricemia-related diseases.	[Abu-Gharbieh, Eman] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates; [Abu-Gharbieh, Eman] Dubai Pharm Coll, Dept Pharmacol & Toxicol, Dubai, U Arab Emirates; [Shehab, Naglaa G.] Dubai Pharm Coll, Dept Pharmaceut Chem & Nat Prod, Dubai, U Arab Emirates; [Shehab, Naglaa G.] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Almasri, Ihab M.] Al Azhar Univ, Fac Pharm, Dept Pharmaceut Chem & Pharmacognosy, Gaza, Palestine; [Bustanji, Yasser] Univ Jordan, Fac Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan; [Bustanji, Yasser] Univ Jordan, Hamdi Mango Ctr Sci Res, Amman, Jordan	University of Sharjah; Egyptian Knowledge Bank (EKB); Cairo University; University of Jordan; University of Jordan	Abu-Gharbieh, E (corresponding author), Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates.; Abu-Gharbieh, E (corresponding author), Dubai Pharm Coll, Dept Pharmacol & Toxicol, Dubai, U Arab Emirates.	eabugharbieh@sharjah.ac.ae	Almasri, Ihab/AAK-5245-2021; Abu-Gharbieh, Eman/F-3635-2010; Bustanji, Yasser/C-2626-2015	Abu-Gharbieh, Eman/0000-0002-5972-0681; shehab, naglaa/0000-0002-7514-4055; Bustanji, Yasser/0000-0003-1315-0609				Abu-Gharbieh E, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1729-9; Akhtari E, 2014, DARU, V22, DOI 10.1186/2008-2231-22-40; Al-Bayati FA, 2008, J ZHEJIANG UNIV-SC B, V9, P154, DOI 10.1631/jzus.B0720251; [Anonymous], 2014, MARVINSKETCH CALCULA; Berglund L, 1996, J DAIRY SCI, V79, P198, DOI 10.3168/jds.S0022-0302(96)76351-8; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Cao HN, 2014, J NAT PROD, V77, P1693, DOI 10.1021/np500320g; Chhatre Saurabh, 2014, Pharmacogn Rev, V8, P45, DOI 10.4103/0973-7847.125530; de Faria ELP, 2017, ACS SUSTAIN CHEM ENG, V5, P7344, DOI 10.1021/acssuschemeng.7b01616; Fried R. FLW., 1974, IMETHODS ENZYMATIC A, P644; Hille R, 1985, MOLYBDENUM ENZYMES; Hu XY, 2018, RSC ADV, V8, P6532, DOI 10.1039/c7ra11856b; Jongbloed M.V.D., 2003, COMPREHENSIVE GUIDE; Kamboj P, 2011, Indian J Nephrol, V21, P154, DOI 10.4103/0971-4065.83727; Kong LD, 2001, PHYTOCHEMISTRY, V58, P645, DOI 10.1016/S0031-9422(01)00176-5; Ksiksi Taoufik, 2017, Current Bioactive Compounds, V13, P82, DOI 10.2174/1573407212666161014130546; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Lewis CT, 1963, LATIN DICT BASED AND; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Lu J, 2010, FOOD SCI, V30, P250, DOI [10.7506/spkx1002-6630-200913057, DOI 10.7506/SPKX1002-6630-200913057]; Mohammad MK, 2010, PHARM BIOL, V48, P1376, DOI 10.3109/13880209.2010.483521; National Research Council, 2011, GUIDE CARE USE LAB A; Duong NT, 2017, ASIAN PAC J TROP MED, V10, P619, DOI 10.1016/j.apjtm.2017.06.002; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Okamoto K, 2008, NUCLEOS NUCLEOT NUCL, V27, P888, DOI 10.1080/15257770802146577; OMEGA, 2013, OMEGA2514; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pai PG, 2012, NEPHROPROTECTIVE EFF; Shan JZ, 2016, PROTEIN CELL, V7, P571, DOI 10.1007/s13238-016-0295-0; Sheng HM, 2011, NAT PROD REP, V28, P543, DOI 10.1039/c0np00059k; STAVRIC B, 1975, PHARMACOL RES COMMUN, V7, P117, DOI 10.1016/S0031-6989(75)80015-4; Sultana N, 2011, J ENZYM INHIB MED CH, V26, P616, DOI 10.3109/14756366.2010.546793; Tapsell LC, 2006, MED J AUSTRALIA, V185, pS4; Umpierrez A, 1998, J ALLERGY CLIN IMMUN, V101, P286, DOI 10.1016/S0091-6749(98)70396-3; Unno T, 2004, J ETHNOPHARMACOL, V93, P391, DOI 10.1016/j.jep.2004.04.012; Wallach SL, 1998, HOSP PRACT, V33, P22; Yang G, 2014, J AGR FOOD CHEM, V62, P2207, DOI 10.1021/jf405675g; Zhou XJ, 2009, DRUG DEV IND PHARM, V35, P305, DOI [10.1080/03639040802302165, 10.1080/03639040802302165 ]	38	21	21	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202572	10.1371/journal.pone.0202572	http://dx.doi.org/10.1371/journal.pone.0202572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114281	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400086
J	Huang, ZY; Liu, QY; Meng, HD; Liu, DP; Dobbs, D; Hyer, K; Conner, KO				Huang, Ziyue; Liu, Qingyue; Meng, Hongdao; Liu, Danping; Dobbs, Debra; Hyer, Kathryn; Conner, Kyaien O.			Factors associated with willingness to enter long-term care facilities among older adults in Chengdu, China	PLOS ONE			English	Article							ELDERLY CARE; MODEL	Objective To describe Chinese older adults' willingness to enter long-term care facilities and to examine individual factors associated with the willingness of using this growing model of long-term care in China. Methods A cross-sectional study involving a random sample of 670 adults aged 60+ in the Hezuo community in Chengdu, China in 2016. Respondents were interviewed by trained staff on socio-demographics, health status, quality of life, social support, and willingness to enter long-term care facilities. Results Only 11.9% of the respondents were willing to enter long-term care facilities for meeting their medical and social service needs. Multivariable logistic regression analysis showed that willingness to enter long-term care facilities was associated with higher household income (OR = 4.55, 95% CI: 1.72-12.00), insurance of Urban Resident Basic Medical Insurance (OR = 4.80, 95% CI: 1.17-19.67) and unemployment (OR = 0.48, 95% CI: 0.24-0.99). Among those who were willing to enter long-term care facilities, an overwhelming majority (81.2%) would prefer going to a facility within 30-minute walking distance from their current residence, 82.5% indicated the need of nursing care, and 90.0% expected a partnership between the long-term care facility and a large hospital. Conclusions A minority of older Chinese were willing to receive long-term care delivered at a facility within walking distance from their current residence. Recent policy aimed at increasing the supply of long-term care facilities may not be consistent with consumer preference for home and community-based care. Balancing investment between home and community-based care, and establishing long-term care insurance remain the top priorities for long-term care research and policy development in China.	[Huang, Ziyue; Liu, Qingyue; Liu, Danping] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China; [Meng, Hongdao; Dobbs, Debra; Hyer, Kathryn] Univ S Florida, Sch Aging Studies, Coll Behav & Community Sci, Tampa, FL USA; [Conner, Kyaien O.] Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL USA	Sichuan University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liu, DP (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China.	liudanping03@163.com	Conner, Kyaien/HHS-3575-2022; Meng, Hongdao/AAF-1866-2020	Dobbs, Debra/0000-0002-9282-7624; Liu, Danping/0000-0002-8017-7134	Community Health Foundation of Chengdu	Community Health Foundation of Chengdu	This work was supported by the Community Health Foundation of Chengdu.	[Anonymous], 2018, OP STAT COUNC INT BA; [Anonymous], 2018, BED SUPPLY ELDERLY I; Banister J., 1994, 73 CIR US BUR CENS C; Bartlett H, 1997, HEALTH PLACE, V3, P149, DOI 10.1016/S1353-8292(97)00008-7; Butler RN, 1997, BRIT MED J, V315, P1082, DOI 10.1136/bmj.315.7115.1082; Byrd M R, 2005, BEHAV INTEGRATIVE CA, P1; Chen L, 2016, J AGING SOC POLICY, V28, P292, DOI 10.1080/08959420.2016.1151310; Chen S., 1996, SOCIAL POLICY EC STA; Cheng Q X, 2016, CHINESE HLTH SERVICE, V5, P334; Cheng Q X, 2016, CHINESE HLTH SERVICE, V5, P380; Du J, 2016, CHINA CIVIL AFFAIRS, V14, P49; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; Eng C., 1996, CURR CONCEPTS GERIAT, V2, P4; Fang YY., 2016, J CHANGSHA SOC WORK, V23, P25; Feng ZL, 2011, J AM GERIATR SOC, V59, P738, DOI 10.1111/j.1532-5415.2011.03330.x; Goodwin Nick, 2015, Int J Integr Care, V15, pe037; Gu DN, 2007, SOC SCI MED, V64, P871, DOI 10.1016/j.socscimed.2006.10.026; Guo D., 2005, INT MED HLTH GUIDANC, V000, P43; [黄佳豪 Huang Jiahao], 2014, [中国卫生政策研究, Chinese Journal of Health Policy], V7, P63; Li R., 2016, UBLIC ADM LAW, V4, P42; Li T., 2015, PIONEER SCI TECHNOL, V28, P39; Lin WY, 2014, CHINA INT J, V12, P144; Liu DP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014510; Liu W J, 2016, CHINESE HLTH EC, V35, P35; MacAdam M, 2015, INT J INTEGR CARE, V15; Marek K D, 2000, Nurs Adm Q, V24, P1; Ministry of civil affairs of the people's repubic of China, 2013, OP STAT COUNC ACC DE; Mosqueda L, 2004, GERONTOLOGIST, V44, P703, DOI 10.1093/geront/44.5.703; Mui AC, 2002, J AGING SOC POLICY, V13, P53; National development and reform commission, 2013, OP STAT COUNC PROM D; Office of the national working committee on ageing, 2017, BBS INT IND PEAK AG; Office of the national working committee on aging, 2018, CHIN HAS 144 600 ELD; Ren L, 2017, CHINESE J GERONTOLOG, V37, P1782; Shen WW, 2015, CHINESE J GEN PRACTI, V6; Smith S M, 2007, COCHRANE DB SYST REV, V3, P10; Storch A, 2009, PARKINSONISM RELAT D, V15, pS41, DOI 10.1016/S1353-8020(09)70170-1; The state council of the people's repubic of China, 2015, GUID OP STAT COUNC P; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Tsutsui T, 2014, INT J INTEGR CARE, V14; van Bilsen PMA, 2008, HEALTH POLICY, V87, P285, DOI 10.1016/j.healthpol.2007.12.015; VICTOR CR, 1990, ARCH GERONTOL GERIAT, V10, P199, DOI 10.1016/0167-4943(90)90019-3; Wang D, 2018, HEALTH SOC CARE COMM, V26, pE164, DOI 10.1111/hsc.12490; Wang HF, 2011, HEALTH POLICY, V99, P37, DOI 10.1016/j.healthpol.2010.07.003; Wang LJ, 2016, INT J NURS PRACT, V22, P478, DOI 10.1111/ijn.12458; Wang Y., 2012, THESIS; Wang Y., 2016, STAT SCI PRACT, V8, P31; World Health Organization, 2003, WHO COLL LONG TERM C; Wu Bei, 2005, J Aging Soc Policy, V17, P37, DOI 10.1300/J031v17n04_03; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Xiao SY., 1987, J CHINESE PSYCHIAT, V1, P184; Xiu-Ming L I, 2016, CHINESE GEN PRACTICE, V10, P1199; Xu QW, 2011, INT SOC WORK, V54, P374, DOI 10.1177/0020872810396260; Yan N, 2015, J HUAZHONG AGR U, V4, P22; ZANG Shaomin, 2015, SCI RES AGING, V12, P42; Zhan HJ, 2013, GENERATIONS, V37, P53; Zhang XF, 2017, CHINESE PRIMARY HLTH, V1, P1; Zhang ZY, 2014, CLIN INTERV AGING, V9, P771, DOI 10.2147/CIA.S58771; Zhao X F, 2014, LANZHOU ACAD J, V9, P129	58	9	10	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202225	10.1371/journal.pone.0202225	http://dx.doi.org/10.1371/journal.pone.0202225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114274	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400051
J	Ongole, S; Sankaran, M; Karanth, KK				Ongole, Shasank; Sankaran, Mahesh; Karanth, Krithi K.			Responses of aerial insectivorous bats to local and landscape-level features of coffee agroforestry systems in Western Ghats, India	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; SPECIES RICHNESS; BIODIVERSITY CONSERVATION; PROTECTED AREA; FOREST; SCALE; PLANTATIONS; COMMUNITIES; DIVERSITY; BIRDS	Shade coffee has shown great promise in providing crucial habitats for biodiversity outside formal protected areas. Insectivorous bats have been understudied in coffee, although they may provide pest control services. We investigated the influence of local and landscapelevel features of coffee farms on aerial insectivorous bats in Chikmagalur district in the Western Ghats biodiversity hotspot, India. Bats were monitored in 20 farm sites using ultrasound detectors, and the response of bat species richness and activity to changes in tree density, proportion of built-up area in the neighborhood, and distance of farm from forest areas quantified. We examined if models built to explain the species richness and activity could also predict them in nine additional sites. We detected nine phonic types/species in the study area. The quantified predictors had no effect on assemblage-level species richness and activity of bats. Responses of edge-space and cluttered-space forager guilds mirrored those of the overall assemblage, but some species vulnerable to forest conversion like Rhinolophus beddomei were detected rarely. Best models explained up to 20% and 15% variation in assemblage-level species richness and activity respectively, and were poor predictors of both response variables. We conclude that coffee farms in our study area offer an important commuting space for insectivorous bats across a gradient of shade management. Further research should include species-specific responses to management decisions for at-risk species and quantification of ecosystem services like natural pest control to inform biodiversity conservation initiatives in the Western Ghats coffee landscapes.	[Ongole, Shasank] Tata Inst Fundamental Res, Wildlife Conservat Soc India Program, Postgrad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Ongole, Shasank; Sankaran, Mahesh] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Sankaran, Mahesh] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Karanth, Krithi K.] Wildlife Conservat Soc, New York, NY USA; [Karanth, Krithi K.] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Environm Sci & Policy, Durham, NC 27708 USA	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Leeds; Wildlife Conservation Society; Duke University	Ongole, S (corresponding author), Tata Inst Fundamental Res, Wildlife Conservat Soc India Program, Postgrad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India.; Ongole, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	ongoleshasank@gmail.com			Tata Trust; Department of Atomic Energy, Government of India; Oracle Corporation.; National Centre for Biological Sciences	Tata Trust; Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Oracle Corporation.; National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	In 2015-16, SO was funded by Tata Trust and core funding to the National Centre for Biological Sciences - TIFR from the Department of Atomic Energy, Government of India. In 2016-17, SO was supported by funding from Oracle Corporation. MS was supported by core funds from the National Centre for Biological Sciences during the study. KKK was funded by Oracle Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2013, ASSESSING ANAL BAT A, P176; Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; Anand MO, 2010, BIOL CONSERV, V143, P2363, DOI 10.1016/j.biocon.2010.01.013; Anand MO, 2008, ECOL APPL, V18, P1754, DOI 10.1890/07-1545.1; Bader E, 2015, BIOL CONSERV, V186, P97, DOI 10.1016/j.biocon.2015.02.028; Bali A, 2007, BIOL CONSERV, V139, P93, DOI 10.1016/j.biocon.2007.06.017; Beukema H, 2007, AGROFOREST SYST, V70, P217, DOI 10.1007/s10457-007-9037-x; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Blakey RV, 2016, J APPL ECOL, V53, P1694, DOI 10.1111/1365-2664.12691; Boreux V, 2013, P NATL ACAD SCI USA, V110, P8387, DOI 10.1073/pnas.1210590110; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Chambers CL, 2016, LANDSCAPE ECOL, V31, P1299, DOI 10.1007/s10980-016-0343-4; Chang C, 2018, NAT SCI REPORTS, V8, P3143; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Dolia J, 2008, ANIM CONSERV, V11, P26, DOI 10.1111/j.1469-1795.2007.00143.x; Eigenbrod F, 2011, BIOL CONSERV, V144, P298, DOI 10.1016/j.biocon.2010.09.007; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Fuentes-Montemayor E, 2017, ECOL APPL, V27, P1541, DOI 10.1002/eap.1546; Fuentes-Montemayor E, 2013, AGR ECOSYST ENVIRON, V172, P6, DOI 10.1016/j.agee.2013.03.019; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Graf S., 2010, DIVERSITY HABITAT US; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hanspach J, 2012, J APPL ECOL, V49, P842, DOI 10.1111/j.1365-2664.2012.02159.x; Harvey CA, 2007, BIODIVERS CONSERV, V16, P2257, DOI 10.1007/s10531-007-9194-2; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jha S, 2014, BIOSCIENCE, V64, P416, DOI 10.1093/biosci/biu038; KARANTH K U, 1982, Journal of the Bombay Natural History Society, V79, P79; Karanth KK, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00111; Karp DS, 2014, ECOLOGY, V95, P1065, DOI 10.1890/13-1012.1; Kingston Tigga, 2013, P169; Korad V., 2007, ZOOS PRINT J, V22, P2752, DOI [DOI 10.11609/JOTT.ZPJ.1563.2752-8, DOI 10.11609/J0TT.ZPJ.1563.2752-8]; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; Maas B, 2016, BIOL REV, V91, P1081, DOI 10.1111/brv.12211; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mendes ES, 2017, LANDSCAPE ECOL, V32, P295, DOI 10.1007/s10980-016-0444-0; Meyer Christoph F.J., 2016, P63; Muller J, 2012, OECOLOGIA, V169, P673, DOI 10.1007/s00442-011-2247-y; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Nichols JD, 1998, CONSERV BIOL, V12, P1390, DOI 10.1046/j.1523-1739.1998.97331.x; Numa C, 2005, BIOL CONSERV, V122, P151, DOI 10.1016/j.biocon.2004.07.013; Park KJ, 2015, MAMM BIOL, V80, P191, DOI 10.1016/j.mambio.2014.10.004; Perfecto I, 2002, CONSERV BIOL, V16, P174, DOI 10.1046/j.1523-1739.2002.99536.x; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; Pocock MJO, 2008, J APPL ECOL, V45, P151, DOI 10.1111/j.1365-2664.2007.01361.x; Quantum GIS Development Team, 2017, QUANT GIS GEOGR INF; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Raghuram H, 2014, CURR SCI INDIA, V107, P631; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Robbins P, 2015, CONSERV LETT, V8, P77, DOI 10.1111/conl.12169; Pedro ARS, 2015, LANDSCAPE ECOL, V30, P1561, DOI 10.1007/s10980-015-0213-5; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schroth G, 2007, BIODIVERS CONSERV, V16, P2237, DOI 10.1007/s10531-007-9195-1; Sheil D, 2003, J TROP FOR SCI, V15, P117; Skalak SL, 2012, METHODS ECOL EVOL, V3, P490, DOI 10.1111/j.2041-210X.2011.00177.x; Struebig MJ, 2008, BIOL CONSERV, V141, P2112, DOI 10.1016/j.biocon.2008.06.009; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Walsh A.L., 2004, BATECHOLOCATION RES, P157; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Williams-Guillen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016502; Williams-Guillen K, 2010, BIOTROPICA, V42, P605, DOI 10.1111/j.1744-7429.2010.00626.x; Wordley CFR, 2014, ECOLOGY CONSERVATION; Wordley CFR, 2018, ECOL EVOL, V8, P3883, DOI 10.1002/ece3.3942; Wordley CFR, 2017, BIOL CONSERV, V210, P48, DOI 10.1016/j.biocon.2017.03.026; Wordley CFR, 2015, BIOL CONSERV, V191, P529, DOI 10.1016/j.biocon.2015.08.005; Wordley CFR, 2014, ACTA CHIROPTEROL, V16, P213, DOI 10.3161/150811014X683408	72	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201648	10.1371/journal.pone.0201648	http://dx.doi.org/10.1371/journal.pone.0201648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114276	Green Published, gold			2022-12-26	WOS:000441850400021
J	Shakoor, A; Xu, YL; Wang, Q; Chen, NY; He, F; Zuo, HF; Yin, HX; Yang, XY; Ma, YH; Yang, SY				Shakoor, Awais; Xu, Yunlian; Wang, Qiang; Chen, Ningyi; He, Fei; Zuo, Huaifeng; Yin, Hanxun; Yang, Xiaoyuan; Ma, Youhua; Yang, Shuyun			Effects of fertilizer application schemes and soil environmental factors on nitrous oxide emission fluxes in a rice-wheat cropping system, east China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; VEGETABLE FIELDS; N2O EMISSIONS; METHANE; ROTATION; PADDY; AGRICULTURE; TEMPERATURE; INTENSITY; IMPACTS	Nitrous oxide (N2O) is a potent greenhouse gas (GHG) with agricultural soils representing its largest anthropogenic source. However, the mechanisms involved in the N2O emission and factors affecting N2O emission fluxes in response to various nitrogenous fertilizer applications remain uncertain. We conducted a four-year (2012-2015) field experiment to assess how fertilization scheme impacts N2O emissions from a rice-wheat cropping system in eastern China. The fertilizer treatments included Control (CK), Conventional fertilizer (CF), CF with shallow-irrigation (CF+SI), CF with deep-irrigation system (CF+DI), Optimized fertilizer (OF), OF with Urease inhibitor (OF+UI), OF with conservation tillage (OF+CT) and Slow-release fertilizer (SRF). N2O emissions were measured by a closed static chamber method. N2O emission fluxes ranged from 0.61 mu g m(-2) h(-1) to 1707 mu g m(-2) h(-1), indicating a significant impact of nitrogen fertilizer and cropping type on N2O emissions. The highest crop yields for wheat (3515-3667 kg ha(-1)) and rice (8633-8990 kg ha(-1)) were observed under the SRF and OF+UI treatments with significant reduction in N2O emissions by 16.94-21.20% and 5.55-7.93%, respectively. Our findings suggest that the SRF and OF+UI treatments can be effective in achieving maximum crop yield and lowering N2O emissions for the rice-wheat cropping system in eastern China.	[Shakoor, Awais; Xu, Yunlian; Wang, Qiang; Chen, Ningyi; He, Fei; Zuo, Huaifeng; Yin, Hanxun; Ma, Youhua; Yang, Shuyun] Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China; [Yang, Xiaoyuan] Chinese Acad Sci, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China	Anhui Agricultural University; Chinese Academy of Sciences; Institute of Soil Science, CAS	Ma, YH; Yang, SY (corresponding author), Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China.	yhma@ahau.edu.cn; yangshy@ahnu.edu.cn	Shakoor, Awais/ABC-6827-2020; Shakoor, Awais/AAA-2432-2022	Shakoor, Awais/0000-0001-9273-4500	Non-profit Research Foundation for Agriculture, China [201103039]; Non-profit Research Foundation	Non-profit Research Foundation for Agriculture, China; Non-profit Research Foundation	This work was financially supported by the Non-profit Research Foundation for Agriculture, China (201103039).; The authors are grateful to the Non-profit Research Foundation for providing the financial support, and Anhui Agro-ecological Environment Center is acknowledged for organizing the field work.	Adviento-Borbe MAA, 2006, J ENVIRON QUAL, V35, P1999, DOI 10.2134/jeq2006.0109; Arevalo-Martinez DL, 2015, NAT GEOSCI, V8, P530, DOI [10.1038/NGEO2469, 10.1038/ngeo2469]; Aulakh MS, 2001, BIOL FERT SOILS, V34, P375, DOI 10.1007/s003740100420; Bateman E M, 2005, ORIGINAL PAPER CONTR, P379, DOI [10.1007/s00374-005-0858-3, DOI 10.1007/S00374-005-0858-3]; Carter CA, CHINAS AGR ACHIEVEME, P30; Chadwick DR, 2014, EUR J SOIL SCI, V65, P295, DOI 10.1111/ejss.12117; Chang SC, 2008, AGR FOREST METEOROL, V148, P788, DOI 10.1016/j.agrformet.2008.01.003; Charles A, 2017, AGR ECOSYST ENVIRON, V236, P88, DOI 10.1016/j.agee.2016.11.021; Chen Q, 2004, NUTR CYCL AGROECOSYS, V69, P51, DOI 10.1023/B:FRES.0000025293.99199.ff; Dalal RC, 2003, AUST J SOIL RES, V41, P165, DOI 10.1071/SR02064; del Prado A, 2006, NUTR CYCL AGROECOSYS, V74, P229, DOI 10.1007/s10705-006-9001-6; Deng J, 2013, ATMOS ENVIRON, V81, P642, DOI 10.1016/j.atmosenv.2013.09.046; Deng Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125406; Diao TT, 2013, ATMOS ENVIRON, V72, P70, DOI 10.1016/j.atmosenv.2013.02.040; Ding WXX, 2011, BIOL FERT SOILS, V47, P91, DOI 10.1007/s00374-010-0504-6; Galloway JN, 2013, TRANSFORMATION NITRO, P889, DOI [10.1126/science.1136674, DOI 10.1126/SCIENCE.1136674]; Ghose B, 2014, FOOD ENERGY SECUR, V3, P86, DOI 10.1002/fes3.48; Grassini P, 2012, P NATL ACAD SCI USA, V109, DOI 10.1073/pnas.1201296109; Gupta DK, 2015, INDIAN J AGR SCI, V85, P63; Halvorson AD, 2014, AGRON J, V106, P715, DOI 10.2134/agronj2013.0081; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Hou Y, 2017, ENVIRON SCI TECHNOL, V51, P375, DOI 10.1021/acs.est.6b04524; Hu H, 2015, IEEE GLOB COMM CONF, DOI 10.1109/GLOCOM.2015.7417027; Hu NJ, 2016, AGR ECOSYST ENVIRON, V223, P115, DOI 10.1016/j.agee.2016.02.027; Hu XK, 2013, ENVIRON POLLUT, V176, P198, DOI 10.1016/j.envpol.2013.01.040; Huang T, 2013, BIOGEOSCIENCES, V10, P7897, DOI 10.5194/bg-10-7897-2013; Jiang YP, 2017, SOFT COMPUT, V21, P5489, DOI 10.1007/s00500-016-2139-5; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Ju XT, 2011, ENVIRON POLLUT, V159, P1007, DOI 10.1016/j.envpol.2010.10.040; Liu C, 2012, BIOGEOSCIENCES, V9, P839, DOI 10.5194/bg-9-839-2012; Liu CY, 2011, AGR ECOSYST ENVIRON, V140, P226, DOI 10.1016/j.agee.2010.12.009; Liu CY, 2010, PLANT SOIL, V332, P123, DOI 10.1007/s11104-009-0278-5; Liu R, 2017, BIOL FERT SOILS, V53, P141, DOI 10.1007/s00374-016-1167-8; Liu SW, 2014, PLANT SOIL, V374, P285, DOI 10.1007/s11104-013-1878-7; Ludwig Jorg, 2016, SOIL AIR EXCHANGE NI, V52, P225; Luo SS, 2016, EUR J AGRON, V81, P78, DOI 10.1016/j.eja.2016.09.002; Ma YC, 2013, AGR ECOSYST ENVIRON, V164, P209, DOI 10.1016/j.agee.2012.11.003; Maljanen M, 2017, SOIL BIOL BIOCHEM, V109, P70, DOI 10.1016/j.soilbio.2017.01.021; Mathieu O, 2006, ENVIRON POLLUT, V144, P933, DOI 10.1016/j.envpol.2006.02.005; Molodovskaya M, 2011, SOIL SCI SOC AM J, V75, P1829, DOI 10.2136/sssaj2010.0415; Parkin TB, 2013, ENHANCED EFFICIENCY, DOI [10.2134/agronj2013.0219, DOI 10.2134/AGRONJ2013.0219]; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Roche L, 2016, AGR ECOSYST ENVIRON, V233, P229, DOI 10.1016/j.agee.2016.08.031; Saarenheimo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121201; Shakoor Awais, 2016, Environ Sci Pollut Res Int; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Shi C, 2008, ATMOS ENVIRON, V42, P8484, DOI 10.1016/j.atmosenv.2008.08.002; Shurpali NJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25739; Smith KA, 1997, SOIL USE MANAGE, V13, P296, DOI 10.1111/j.1475-2743.1997.tb00601.x; Solomon S, 2013, J CHEM INF MODEL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Sun HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28255; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Yan GX, 2013, AGR ECOSYST ENVIRON, V178, P39, DOI 10.1016/j.agee.2013.06.016; Yao ZS, 2013, ATMOS ENVIRON, V79, P641, DOI 10.1016/j.atmosenv.2013.07.006; Yao ZS, 2012, AGR ECOSYST ENVIRON, V152, P1, DOI 10.1016/j.agee.2012.02.004; Yu JB, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000576; Zhang AF, 2012, FIELD CROP RES, V127, P153, DOI 10.1016/j.fcr.2011.11.020; Zhang WJ, 2010, BIOGEOSCIENCES, V7, P409, DOI 10.5194/bg-7-409-2010; Zhang XX, 2014, SCI TOTAL ENVIRON, V472, P381, DOI 10.1016/j.scitotenv.2013.11.014; Zhang X, 2015, ACTA BIOMATER, V14, P11, DOI 10.1016/j.actbio.2014.11.042; Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20700; Zhu XZ, 2013, ADV MECH ENG, DOI 10.1155/2013/236389	62	24	26	17	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202016	10.1371/journal.pone.0202016	http://dx.doi.org/10.1371/journal.pone.0202016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30107005	gold, Green Published, Green Submitted			2022-12-26	WOS:000441662800023
J	Moyo, S; Young, PW; Gouws, E; Naidoo, I; Wamicwe, J; Mukui, I; Marsh, K; Igumbor, EU; Kim, AA; Rehle, T				Moyo, Sizulu; Young, Peter W.; Gouws, Eleanor; Naidoo, Inbarani; Wamicwe, Joyce; Mukui, Irene; Marsh, Kimberly; Igumbor, Ehimario U.; Kim, Andrea A.; Rehle, Thomas			Equity of antiretroviral treatment use in high HIV burden countries: Analyses of data from nationally-representative surveys in Kenya and South Africa	PLOS ONE			English	Article								Objective To assess changes and equity in antiretroviral therapy (ART) use in Kenya and South Africa. Methods We analysed national population-based household surveys conducted in Kenya and South Africa between 2007 and 2012 for factors associated with lack of ART use among people living with HIV (PLHIV) aged 15-64 years. We considered ART use to be inequitable if significant differences in use were found between groups of PLHIV (e.g. by sex). Findings ART use among PLHIV increased from 29.3% (95% confidence interval [CI]: 22.8-35.8) to 42.5% (95% CI: 37.4-47.7) from 2007 to 2012 in Kenya and 17.4% (95% CI: 14.2-20.9) to 30.3% (95% CI: 27.2-33.6) from 2008 to 2012 in South Africa. In 2012, factors independently associated with lack of ART use among adult Kenyan PLHIV were rural residency (adjusted odds ratio [aOR] 1.98, 95% CI: 1.23-3.18), younger age (15-24 years: aOR 4.25, 95% CI: 1.7-10.63, and 25-34 years: aOR 5.16, 95% CI: 2.73-9.74 versus 50-64 years), nondisclosure of HIV status to most recent sex partner (aOR 2.41, 95% CI: 1.27-4.57) and recent recreational drug use (aOR 2.50, 95% CI: 1.09-5.77). Among South African PLHIV in 2012, lack of ART use was significantly associated with younger age (15-24 years: aOR 4.23, 95% CI: 2.56-6.70, and 25-34 years: aOR 2.84, 95% CI: 1.73-4.67, versus 50-64 years), employment status (aOR 1.61, 95%CI: 1.16-2.23 in students versus unemployed), and recent recreational drug use (aOR 4.56, 95%CI: 1.79-11.57). Conclusion Although we found substantial increases in ART use in both countries over time, we identified areas needing improvement including among rural Kenyans, students in South Africa, and among young people and drug users in both countries.	[Moyo, Sizulu] Human Sci Res Council, HIV AIDS STIs & TB Programme, Cape Town, South Africa; [Moyo, Sizulu; Naidoo, Inbarani; Rehle, Thomas] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Young, Peter W.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Nairobi, Kenya; [Gouws, Eleanor; Marsh, Kimberly] Joint United Nations Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Wamicwe, Joyce; Mukui, Irene] Natl AIDS & STI Control Programme, Minist Hlth, Nairobi, Kenya; [Igumbor, Ehimario U.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Pretoria, South Africa; [Kim, Andrea A.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA	Human Sciences Research Council-South Africa; University of Cape Town; UNAIDS; Centers for Disease Control & Prevention - USA	Young, PW (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Nairobi, Kenya.	pyoung1@cdc.gov	Igumbor, Ehimario U/B-2652-2012; Mukui, Irene/GYE-0151-2022	Igumbor, Ehimario U/0000-0002-6313-6031; Naidoo, Inbarani/0000-0001-7590-0618	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV TB (DGHT) [PS001805, GH000069, PS001814]; Global Fund; World Bank; Joint United Nations Programme on HIV/AIDS; PEPFAR through the CDC [3U2GGH000570]; United Nations Children's Fund; South African National AIDS Council; Bill and Melinda Gates Foundation	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV TB (DGHT); Global Fund; World Bank(The World Bank India); Joint United Nations Programme on HIV/AIDS; PEPFAR through the CDC; United Nations Children's Fund; South African National AIDS Council; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors did not receive specific funding to support the analyses described in this manuscript; however, the surveys described were supported by various donors/institutions. The Kenya surveys were made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreements [#PS001805, GH000069, and PS001814] through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV & TB (DGHT). This work was also funded in part by support from the Global Fund, World Bank, and the Joint United Nations Programme on HIV/AIDS. The South Africa surveys were funded by PEPFAR through the CDC under the terms of Cooperative Agreement Number 3U2GGH000570 (for the 2012 survey), with additional financial support from the United Nations Children's Fund, the South African National AIDS Council, and the Bill and Melinda Gates Foundation.	Akullian AN, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20171; Cleary S, HLTH POLICY, V99, P261, DOI [10.1016/j.healthpol.2010.10.016, DOI 10.1016/J.HEALTHP0L.2010.10.016]; Department of Health, 2004, HIV AIDS POL GUID; Department of Health, 2014, NAT CONS GUID PREV M; Department of Health, 2010, S AFR ANT TREATM GUI; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Greenacre M.J., 2006, CHAPMAN HALL CRC STA; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 15 15 GLOB TARG ACH; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; Kim AA, 2016, UNDISCLOSED HIV INFE, P1, DOI [10.1097/QAD.0000000000001227, DOI 10.1097/QAD.0000000000001227]; Loubiere S, 2009, HLTH POLICY, DOI [10.1016/j.healthpol.2009.03.006, DOI 10.1016/J.HEALTHP0L.2009.03.006]; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; Ministry of Health; National AIDS Control Council (NACC) National AIDS and STI Control Programme (NASCOP), 2014, GUID US ANT DRUGS TR; Ministry of Health National AIDS & STI Control Programme, 2016, GUIDELINES USE ANTIR; Mooney AC, 2017, AIDS EDUC PREV, V29, P274, DOI 10.1521/aeap.2017.29.3.274; Mukui IN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167465; National AIDS Control Council (NACC) National AIDS and STI Control Programme (NASCOP), 2011, GUID ANT THER KEN; National AIDS Control Council (NACC) National AIDS and STI Control Programme (NASCOP), 2013, KEN HIV EST; NEPHAK GNP+, 2011, GNP PLHIV STIGM IND; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Nyamhanga TM, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21812; Phelps BR, 2013, AIDS, V27, pS207, DOI 10.1097/QAD.0000000000000095; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Shisana O, 2014, S AFRICAN NATL HIV P; South African National AIDS Council, 2015, PEOPL LIV HIV STIGM; Tromp N, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0060-z; UNAIDS, 2014, E SO AFR HIV EP PROF; Waruiru W, 2014, JAIDS-J ACQ IMM DEF, V66, pS3, DOI 10.1097/QAI.0000000000000114; World Health Organization, 2015, GUID START ANT THER	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201899	10.1371/journal.pone.0201899	http://dx.doi.org/10.1371/journal.pone.0201899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096199	Green Submitted, gold, Green Published			2022-12-26	WOS:000441308500035
J	Swamy, BPM; Descalsota, GIL; Nha, CT; Amparado, A; Inabangan-Asilo, MA; Manito, C; Tesoro, F; Reinke, R				Swamy, B. P. Mallikarjuna; Descalsota, Gwen Iris L.; Chau Thanh Nha; Amparado, Amery; Inabangan-Asilo, Mary Ann; Manito, Christine; Tesoro, Frances; Reinke, Russell			Identification of genomic regions associated with agronomic and biofortification traits in DH populations of rice	PLOS ONE			English	Article							GRAIN ZINC; LOCI; GENE; IRON	Rice provides energy and nutrition to more than half of the world's population. Breeding rice varieties with the increased levels of bioavailable micronutrients is one of the most sustainable approaches to tackle micronutrient malnutrition. So, high zinc and iron content in the grain are primary targets in rice biofortification breeding. In this study, we conducted QTL mapping using doubled haploid (DH) populations, PSBRc82 x Joryeongbyeo and PSBRc82 x IR69428, phenotyped for agronomic traits and micronutrients during two growing seasons and using genotypic information from analysis with the 6K SNP chip. A number of DH lines were identified as having high grain Zn and Fe content in polished rice. Importantly, we identified 20 QTLs for agronomic traits and 59 QTLs for a number of biofortification traits. Of the 79 QTLs, 12 were large-effect QTLs (>25% PVE), nine QTLs were consistent across seasons in either population, and one QTL was identified in both populations. Moreover, at least two QTLs were clustered in defined regions of chromosomes 1, 2, 3,4, 5, 7 and 9. Eight epistatic interactions were detected for Cu, Mg, Na, and Zn in population 1. Furthermore, we identified several candidate genes near QTLs for grain Zn (OsNRAMP, OsNAS, OsZIP, OsYSL, OsFER, and OsZIFLfamily) and grainyield (OsSPL14and OsSPL16). These new QTLs and candidate genes help to further elucidate the genetic basis for grain micronutrient concentration, and may prove useful for marker assisted breeding for this important trait.	[Swamy, B. P. Mallikarjuna; Descalsota, Gwen Iris L.; Amparado, Amery; Inabangan-Asilo, Mary Ann; Manito, Christine; Tesoro, Frances; Reinke, Russell] IRRI, Plant Breeding Platform, Manila, Philippines; [Descalsota, Gwen Iris L.] Univ Southern Mindanao, Kabacan, Cotabato, Philippines; [Chau Thanh Nha] Cuu Long Delta Rice Res Inst CLRRI, Can Tho, Vietnam	CGIAR; International Rice Research Institute (IRRI)	Reinke, R (corresponding author), IRRI, Plant Breeding Platform, Manila, Philippines.	r.reinke@irri.org	Descalsota-Empleo, Gwen Iris/AAE-5249-2019	Descalsota-Empleo, Gwen Iris/0000-0003-0043-9040; Tesoro, Frances/0000-0001-5616-2365	HarvestPlus grant [HP5302]	HarvestPlus grant	This work was financially supported by HarvestPlus grant no. HP5302.; The authors would like thank HarvestPlus for funding the Rice Zinc Biofortification project. We thank Dr. George Kotch, former head of the Plant Breeding Division at IRRI, for all the advices and encouragement during the study. We thank Drs. Deepinder Grewal and Jessica Rey for their contributions in the initial development of the DH populations.	Abhyankar LN, 2012, ENVIRON HEALTH PERSP, V120, P494, DOI 10.1289/ehp.1103988; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Biradar Hanamareddy, 2007, Indian Journal of Genetics & Plant Breeding, V67, P105; Black R, 2003, B WORLD HEALTH ORGAN, V81, P79; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Chang LW, 1996, TOXICOLOGY METALS; Doust AN, 2014, P NATL ACAD SCI USA, V111, P6178, DOI 10.1073/pnas.1308940110; Gande NK, 2014, AFRICAN J BIOTECHNOL, V13; Gangashetty P. I., 2013, Molecular Plant Breeding, V2013, P31; GRiSP (Global Rice Science Partnership). (, 2013, RICE ALMANAC, V4th edition; Hu BL, 2016, CEREAL RES COMMUN, V44, P57, DOI 10.1556/0806.43.2015.044; Institute of Medicine Food and Nutrition Board, 2001, DIET REF INT VIT A V; Ishimaru Y, 2007, J EXP BOT, V58, P2909, DOI 10.1093/jxb/erm147; Jiang W, 2008, ANN APPL BIOL, V153, P135, DOI 10.1111/j.1744-7348.2008.00243.x; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Li H, 2017, AGRO BIOFORTIFICATIO, V6, DOI [10.15406/apar.2017.06.00210, DOI 10.15406/APAR.2017.06.00210]; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Martinez C., 2010, PAPER READ 28 INT RI; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Murovec J, 2011, PLANT BREEDING, P87; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Paltridge NG, 2012, PLANT SOIL, V361, P251, DOI 10.1007/s11104-011-1104-4; Perez-de-Castro AM, 2012, CURR GENOMICS, V13, P179, DOI 10.2174/138920212800543084; Ramesh SA, 2003, PLANT PHYSIOL, V133, P126, DOI 10.1104/pp.103.026815; Rao D. S, 2014, J RICE RES, V7, P45; Ricachenevsky FK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-20; Sathisha T. N., 2013, KARNATAKA J AGR SCI, V26, P474; Suwarto, 2011, RICE SCI, V18, P75, DOI 10.1016/S1672-6308(11)60011-5; Swamy BPM, 2018, RICE SCI, V25, P197, DOI 10.1016/j.rsci.2018.06.003; Swamy BPM, 2016, RICE, V9, DOI 10.1186/s12284-016-0122-5; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; Widodo, 2010, NEW PHYTOL, V186, P400, DOI 10.1111/j.1469-8137.2009.03177.x; Wissuwa M, 2007, PLANT SOIL, V30, P637; Yun BW, 2012, AM J PLANT SCI, V5, P1125; Zargar SM, 2015, CURRENT TRENDS BIOTE, V9, P181	50	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201756	10.1371/journal.pone.0201756	http://dx.doi.org/10.1371/journal.pone.0201756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096168	Green Submitted, Green Published, gold			2022-12-26	WOS:000441308500027
J	Kapesa, A; Kweka, EJ; Atieli, H; Afrane, YA; Kamugisha, E; Lee, MC; Zhou, GF; Githeko, AK; Yan, GY				Kapesa, Anthony; Kweka, Eliningaya J.; Atieli, Harrysone; Afrane, Yaw A.; Kamugisha, Erasmus; Lee, Ming-Chieh; Zhou, Guofa; Githeko, Andrew K.; Yan, Guiyun			The current malaria morbidity and mortality in different transmission settings in Western Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; CHILDREN; HIGHLANDS	Background Passive surveillance of malaria in health facilities remains vital for implementation of control and elimination programs. It is therefore essential understanding current age profile of clinical malaria morbidity, mortality and presentations in areas with variant infection susceptibility. This study aimed at understanding the current malaria morbidity and mortality in Western Kenya. Methods Surveillance of clinical and asymptomatic parasitological positivity rates of all malaria suspected patients and school children were respectively determined from June 2015 to August 2016. From 2014 to 2016, register books in hospitals were referred and the confirmed malaria cases in conjunction with total number of monthly outpatient visits (OPD) counted. All registered malaria admissions were counted together with other causes of admissions. Moreover, outcome of malaria admissions in terms of discharge or death was recorded using inpatient charts within the same time frame. Prospective surveillance of severe malaria collected information on clinical features of the disease. Giemsa stained blood slides confirmed existence of malaria parasitemia. Chi-square and analysis of variance tests were used, respectively, to compute proportions and means; then a comparison was made between different age groups, periods, and study areas. Results During the survey of asymptomatic infections among school children, overall blood slide positivity ranged from 6.4% at the epidemic prone site to 38.3% at the hyperendemic site. During the clinical malaria survey, school age children (5-14) presented with overall the highest (45%) blood slide positivity rate among those suspected to have the infection at the epidemic prone study site. The survey of all malaria confirmed and registered cases at OPD found 17% to 27% of all consultations among <5 children and 9.9% to 20.7% of all OPD visits among the >5 patients were due to malaria. Moreover, survey of all registered causes of admission in hospitals found 47% of admissions were due to malaria. The disease was a major cause of admission in epidemic prone setting where 63.4% of the <5 children and 62.8% of the >5 patients were admitted due to malaria (p>0.05) and 40% of all malaria admissions were school age children. Malaria related death rate was highest among <5 years at the hyperendemic site, that is 60.9 death per 1000 malaria <5 admissions. Conversely, the epidemic prone setting experienced highest malaria related death among >15 years (18.6 death per 1000 admissions) than the < 15 years (5.7 death per 1000 admissions of the <15 years) (p<0.001). Surveillance of severe form of the disease found that hyperpyrexia, hyperparastemia, prostration and convulsions as common presentations of severe disease. Conclusion Malaria is still the major cause of hospital consultations in Western Kenya with an alarming number of severe forms of the disease among the school aged children at the epidemic prone setting. Mortalities were higher among <5 children years in high infection transmission setting and among >15 years in low and moderate transmission settings. Surveillance of asymptomatic and symptomatic malaria along with evaluation of current interventions in different age groups should be implemented in Kenya.	[Kapesa, Anthony; Atieli, Harrysone; Afrane, Yaw A.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Climate & Hlth Lab, Kisumu, Kenya; [Kapesa, Anthony] Catholic Univ Hlth & Allied Sci, Dept Community Med, Sch Publ Hlth, Mwanza, Tanzania; [Kweka, Eliningaya J.] Catholic Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, Sch Med, Mwanza, Tanzania; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Hlth Dis Vector Control, Arusha, Tanzania; [Afrane, Yaw A.] Univ Ghana, Coll Hlth Sci, Dept Med Microbiol, Accra, Ghana; [Kamugisha, Erasmus] Catholic Univ Hlth & Allied Sci, Dept Biochem & Mol Biol, Sch Med, Mwanza, Tanzania; [Lee, Ming-Chieh; Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA	Kenya Medical Research Institute; University of Ghana; University of California System; University of California Irvine	Kapesa, A (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Climate & Hlth Lab, Kisumu, Kenya.; Kapesa, A (corresponding author), Catholic Univ Hlth & Allied Sci, Dept Community Med, Sch Publ Hlth, Mwanza, Tanzania.; Yan, GY (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.	anthony1kapesa@gmail.com; guiyuny@uci.edu	Lee, Ming-Chieh/ABE-8421-2021	Lee, Ming-Chieh/0000-0002-2462-6089; Afrane, Yaw/0000-0001-5653-5993; Kweka, Eliningaya/0000-0002-8891-758X	National Institutes of Health [R01 AI050243, U19 AI129326, D43 TW001505]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI129326, R01AI050243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funders had no any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by the National Institutes of Health through grant number R01 AI050243, U19 AI129326 and D43 TW001505. Dr. Guiyun Yan was a recipient.	Afrane YA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-405; [Anonymous], 2016, KEN MAL IND SURV 201; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Centre for disease control (CDC) Department of state health and human service, 2016, PRES MAL IN KEN MAL; Degefa T, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2098-z; Esamai F, 1999, E AFR MED J, V76, P89; Ferede G, 2013, MALARIA RES TREATMEN; Florey L, 2012, ANEMIA IMPACT MEASUR; Frosch AEP, 2014, AM J CLIN NUTR, V100, P968, DOI 10.3945/ajcn.114.087114; Gitonga CW, 2012, TROP MED INT HEALTH, V17, P858, DOI 10.1111/j.1365-3156.2012.03001.x; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kapesa A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2145-9; Kenya Ministry of Health, 2014, KEN MAL STRAT 2009 2; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Machini B, 2016, E AFR MED J, V93, P10; Malakooti MA, 1998, EMERG INFECT DIS, V4, P671, DOI 10.3201/eid0404.980422; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-3; Ministry of Public Health and Sanitation M.o.M.S., 2010, GUID DET REG PROC GE; Mogeni P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002047; Mutsigiri F, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.30.11130; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oguttu DW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1871-3; Okach D, 2014, SKY J MED MED SCI, V2; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Ototo EN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2119-y; Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7; Smithson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141112; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Ursing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101167; Wanjala CL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00055; WHO, 2013, METH ACH UN COV LON; WHO, 2017, WORLD MALARIA REPORT; Zhou GF, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00153; Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318	40	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202031	10.1371/journal.pone.0202031	http://dx.doi.org/10.1371/journal.pone.0202031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092043	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600080
J	Deng, B; Shen, WJ; Dong, DC; Azhar, S; Kraemer, FB				Deng, Bing; Shen, Wen-Jun; Dong, Dachuan; Azhar, Salman; Kraemer, Fredric B.			Plasma membrane cholesterol trafficking in steroidogenesis	FASEB JOURNAL			English	Article						adrenal gland; mitochondria; SNARE proteins	ENDOPLASMIC-RETICULUM; ACTH REGULATION; PROTEIN; CELLS; TRANSPORT; STEROL; ACCUMULATION; SUBSTRATE; IMPORT; LIPIDS	Cholesterol is an important component of plasma membranes (PMs) and the precursor of all steroid hormones. In steroidogenic tissues, upon hormone stimulation, there is a rapid transfer of cholesterol to the mitochondria, which is the site of the initial step in steroidogenesis. In the current study, we examined PM cholesterol trafficking for steroidogenesis. In a mitochondrial reconstitution assay, adrenal PMs supported steroidogenesis in the absence of additional transport proteins. Depletion of cholesterol in PMs by 50% eliminated the membranes' ability to support steroidogenesis in vitro and reduced steroid production in intact Y1 adrenocortical cells. Syntaxin (STX)-5 and -soluble N-ethylmaleimide-sensitive factor attachment protein (-SNAP) are enriched in adrenal PMs, and adrenocorticotropic hormone treatment of rats recruited STX5 and -SNAP to adrenal PMs and mitochondria. Immunodepletion of STX5 and -SNAP from PMs decreased steroidogenesis supported by PMs in vitro. Protease digestion of PMs decreased, whereas recombinant STX5 or -SNAP restored, the PMs' ability to support steroidogenesis. Knockdown of either STX5 or -SNAP in Y1 cells decreased stimulated steroidogenesis. These results indicate that STX5 and -SNAP facilitate cholesterol trafficking from PMs to mitochondria for adrenal steroid synthesis and underscore the importance of vesicular trafficking of PM cholesterol for steroidogenesis.Deng, B., Shen, W.-J., Dong, D., Azhar, S., Kraemer, F. B. Plasma membrane cholesterol trafficking in steroidogenesis.	[Deng, Bing; Shen, Wen-Jun; Dong, Dachuan; Azhar, Salman; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol Gerontol & Metab, Palo Alto, CA 94304 USA; [Deng, Bing; Shen, Wen-Jun; Dong, Dachuan; Azhar, Salman; Kraemer, Fredric B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Deng, Bing] Wuhan Acad Agr Sci, Wuhan, Hubei, Peoples R China	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kraemer, FB (corresponding author), Stanford Univ, Med Ctr, Div Endocrinol Gerontol & Metab, S025, Stanford, CA 94305 USA.	fbk@stanford.edu	Kraemer, Fredric/AAC-3633-2019	Deng, Bing/0000-0002-7391-7018; Kraemer, Fredric/0000-0003-2468-7807; Dong, Dachuan/0000-0002-5443-5304	Merit Review Awards from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program [I01BX001923, I01BX000398]; U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program [IK6B004200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK116074] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398, I01BX001923] Funding Source: NIH RePORTER	Merit Review Awards from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program; U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Awards I01BX001923 (to S.A.) and I01BX000398 (to F.B.K.); and Senior Research Career Scientist Award IK6B004200 (to S.A.) from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research Development Program. The authors declare no conflicts of interest.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; CARR BR, 1981, ENDOCR REV, V2, P306, DOI 10.1210/edrv-2-3-306; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Enrich C, 2015, J CELL SCI, V128, P1071, DOI 10.1242/jcs.164459; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREEMAN DA, 1989, ENDOCRINOLOGY, V124, P2527, DOI 10.1210/endo-124-5-2527; GOCZE PM, 1993, EXP CELL RES, V209, P21, DOI 10.1006/excr.1993.1279; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Grosse J, 2000, BIOL REPROD, V63, P643, DOI 10.1095/biolreprod63.2.643; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Lange Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098482; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lin Y, 2016, MOL ENDOCRINOL, V30, P234, DOI 10.1210/me.2015-1281; Lindzey Jonathan, 1997, P47; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Ostrom Rennolds S., 2007, V400, P459; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PON LA, 1988, ENDOCRINOLOGY, V123, P1942, DOI 10.1210/endo-123-4-1942; PON LA, 1986, J BIOL CHEM, V261, P3309; Purdy PH, 2004, BIOL REPROD, V71, P522, DOI 10.1095/biolreprod.103.025577; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; ROTHMAN JE, 1984, J CELL BIOL, V99, P248, DOI 10.1083/jcb.99.1.248; Shen WJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00042; Steegmaier M, 2000, MOL BIOL CELL, V11, P2719, DOI 10.1091/mbc.11.8.2719; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Venugopal S, 2016, J BIOL CHEM, V291, P26109, DOI 10.1074/jbc.M116.740928; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x	38	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1389	1400		10.1096/fj.201800697RRR	http://dx.doi.org/10.1096/fj.201800697RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133326	Green Published			2022-12-26	WOS:000457401500109
J	Kawagoe, S; Nakagawa, H; Kumeta, H; Ishimori, K; Saio, T				Kawagoe, Soichiro; Nakagawa, Hiroshi; Kumeta, Hiroyuki; Ishimori, Koichiro; Saio, Tomohide			Structural insight into proline cis/trans isomerization of unfolded proteins catalyzed by the trigger factor chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; prolyl isomerase; molecular dynamics; protein folding; structure-function; nuclear magnetic resonance (NMR); hydrophobic interaction; peptidyl-prolyl isomerase domain; trigger factor	ESCHERICHIA-COLI; PROLYL ISOMERIZATION; ENZYMATIC CATALYSIS; SUBSTRATE-BINDING; HYDROGEN-BONDS; ISOMERASE; DYNAMICS; DOMAIN; IDENTIFICATION; SPECIFICITY	Molecular chaperones often possess functional modules that are specialized in assisting the formation of specific structural elements, such as a disulfide bridges and peptidyl-prolyl bonds in cis form, in the client protein. A ribosome-associated molecular chaperone trigger factor (TF), which has a peptidyl-prolyl cis/trans isomerase (PPIase) domain, acts as a highly efficient catalyst in the folding process limited by peptidyl-prolyl isomerization. Herein we report a study on the mechanism through which TF recognizes the proline residue in the unfolded client protein during the cis/trans isomerization process. The solution structure of TF in complex with the client protein showed that TF recognizes the proline-aromatic motif located in the hydrophobic stretch of the unfolded client protein through its conserved hydrophobic cleft, which suggests that TF preferentially accelerates the isomerization of the peptidyl-prolyl bond that is eventually folded into the core of the protein in its native fold. Molecular dynamics simulation revealed that TF exploits the backbone amide group of Ile(195) to form an intermolecular hydrogen bond with the carbonyl oxygen of the amino acid residue preceding the proline residue at the transition state, which presumably stabilizes the transition state and thus accelerates the isomerization. The importance of such intermolecular hydrogen-bond formation during the catalysis was further corroborated by the activity assay and NMR relaxation analysis.	[Kawagoe, Soichiro; Ishimori, Koichiro; Saio, Tomohide] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Nakagawa, Hiroshi] Japan Atom Energy Agcy, Mat Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Kumeta, Hiroyuki] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0110021, Japan; [Ishimori, Koichiro; Saio, Tomohide] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan; [Saio, Tomohide] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020076, Japan	Hokkaido University; Japan Atomic Energy Agency; Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Ishimori, K; Saio, T (corresponding author), Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan.	koichiro@sci.hokudai.ac.jp; saio@sci.hokudai.ac.jp	Ishimori, Koichiro/S-1247-2016; Ishimori, Koichiro/AAQ-4434-2021	Ishimori, Koichiro/0000-0002-5868-0462; Ishimori, Koichiro/0000-0002-5868-0462; Saio, Tomohide/0000-0003-3639-7399; Kumeta, Hiroyuki/0000-0003-3713-2122; Kawagoe, Soichiro/0000-0002-7158-4504	JSPS KAKENHI [17H05657, 17H05867, 18H05229]; PRESTO, Japan Science and Technology Agency	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by in part by JSPS KAKENHI Grants 17H05657, 17H05867, and 18H05229 and by PRESTO, Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Alag R, 2013, EUKARYOT CELL, V12, P627, DOI 10.1128/EC.00016-13; ALBERS MW, 1990, J ORG CHEM, V55, P4984, DOI 10.1021/jo00304a003; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bang N, 2000, EUR J BIOCHEM, V267, P3270, DOI 10.1046/j.1432-1327.2000.01355.x; Bieri M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-421; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Camilloni C, 2014, P NATL ACAD SCI USA, V111, P10203, DOI 10.1073/pnas.1404220111; Case D., 2015, AMBER, V14; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Hamelberg D, 2009, J AM CHEM SOC, V131, P147, DOI 10.1021/ja806146g; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Huang CD, 2016, NATURE, V537, P202, DOI 10.1038/nature18965; Ikura T, 2008, PROTEIN ENG DES SEL, V21, P83, DOI 10.1093/protein/gzm087; Ikura T, 2007, PROTEIN SCI, V16, P2618, DOI 10.1110/ps.073203707; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Liu CP, 2010, INT J BIOCHEM CELL B, V42, P890, DOI 10.1016/j.biocel.2010.01.019; Low C, 2010, J MOL BIOL, V398, P375, DOI 10.1016/j.jmb.2010.03.014; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Quistgaard EM, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0300-3; ROSEN MK, 1990, SCIENCE, V248, P863, DOI 10.1126/science.1693013; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saio T, 2018, ELIFE, V7, DOI 10.7554/eLife.35731; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Teilum K, 2017, PROTEIN SCI, V26, P436, DOI 10.1002/pro.3105; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	51	12	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15095	15106		10.1074/jbc.RA118.003579	http://dx.doi.org/10.1074/jbc.RA118.003579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30093407	hybrid, Green Published			2022-12-26	WOS:000445998400013
J	Acket, B; Amirova, L; Gerdelat, A; Cintas, P; Custaud, MA; Pavy-LeTraon, A				Acket, Blandine; Amirova, Liubov; Gerdelat, Angelique; Cintas, Pascal; Custaud, Marc-Antoine; Pavy-LeTraon, Anne			Dry immersion as a model of deafferentation: A neurophysiology study using somatosensory evoked potentials	PLOS ONE			English	Article							PHANTOM-LIMB PAIN; DURATION SPACE-FLIGHT; CORTICAL REORGANIZATION; SPATIAL ORIENTATION; PARABOLIC FLIGHT; WEIGHTLESSNESS; SENSITIVITY; ANESTHESIA; GRAVITY; MOTION	Introduction Dry immersion is a ground-based experiment simulating the effects of weightlessness, and it is a model of acute symmetrical bilateral deafferentation. This exploratory study aimed to investigate the effects of three days of dry immersion (DI) on sensory thresholds and the functioning of lemniscal pathways, assessed by somatosensory evoked potentials (SEPs). Methods Twelve healthy male volunteers (32+/-4.8 years) participated in the study. Sensory thresholds and SEPs of the tibial nerve of both limbs were recorded before (D-1) and on the third day of dry immersion (D3). Results Sensory thresholds significantly decreased on D3 (-20.75 +/-21.7%; z = -2.54; p = 0.0109 on the right side and -22.18+/-17.28%; z = -3.059; p = 0.002 on the left side). The amplitude of P40 responses did not differ between D-1 and D3. Latencies of all central responses until P30 were shortened on D3 (N21 right:-0.57+/-0.31; z = -3.06; p = 0.002; N21 left -0.83 +/-0.53; z = -2.94; p = 0.003; P30 right: -1.26+/-1.42; z = -3.059; p = 0.002; P30 left: -1.11 +/-1.55; z = -2.27; p = 0.02) Conclusion Three days of dry immersion can induce hyperexcitability of lemniscal pathways. Significance This may be explained by a change in the expression of membrane channels and/or medullar plasticity and/or hypersensitization of peripheral sensory receptors induced by this acute deafferentation. Additional studies are needed to further elucidate the mechanisms.	[Acket, Blandine; Gerdelat, Angelique; Cintas, Pascal; Pavy-LeTraon, Anne] CHU Toulouse, Hop Purpan, Neurol Dept, Toulouse, France; [Amirova, Liubov] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia; [Amirova, Liubov; Custaud, Marc-Antoine] Univ Angers, Med Fac, Mitovasc Lab, UMR CNRS 6015,INSERM, Angers, France; [Custaud, Marc-Antoine] CHU Angers, Clin Res Ctr, Angers, France; [Pavy-LeTraon, Anne] INSERM U1048, Equipe 8, Toulouse, France	CHU de Toulouse; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Acket, B (corresponding author), CHU Toulouse, Hop Purpan, Neurol Dept, Toulouse, France.	acket.b@chu-toulouse.fr	Amirova, Liubov/V-7924-2017	Amirova, Liubov/0000-0002-9464-6413; pascal, cintas/0000-0002-0242-4849	French Space Agency (Centre National d'Etudes Spatiales)	French Space Agency (Centre National d'Etudes Spatiales)(Centre National D'etudes Spatiales)	The whole dry immersion experiment was supported by the French Space Agency (Centre National d'Etudes Spatiales) and coordinated by MEDES (Institut de Medecine et de Physiologie Spatiales - www.medes.fr).	Baker JT NA, 1977, BIOMEDICAL RESULTS S, P131; Berger M., 1992, HLTH SPACE RES AUSTR, P119; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Bjorkman A, 2009, EUR J NEUROSCI, V29, P837, DOI 10.1111/j.1460-9568.2009.06629.x; Bretzner F, 2005, J NEUROPHYSIOL, V94, P2911, DOI 10.1152/jn.00254.2005; Clement G, 2008, NEUROSCIENCE SPACE, P101; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Grigor'ev A I, 2004, Ross Fiziol Zh Im I M Sechenova, V90, P508; Guerit JM, 1993, POTENTIELS EVOQUE, P156; GURFINKEL VS, 1993, EXP BRAIN RES, V95, P343, DOI 10.1007/BF00229792; Jiang YQ, 2016, J NEUROSCI, V36, P193, DOI 10.1523/JNEUROSCI.3441-15.2016; Kozlovskaia I B, 2008, Aviakosm Ekolog Med, V42, P3; Kozlovskaya I B, 1982, Physiologist, V25, pS49; LACKNER JR, 1981, EXP BRAIN RES, V44, P312; LACKNER JR, 1979, SCIENCE, V206, P1105; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; LESTIENNE FG, 1988, TRENDS NEUROSCI, V11, P359, DOI 10.1016/0166-2236(88)90058-6; Lowrey CR, 2014, J APPL PHYSIOL, V116, P683, DOI 10.1152/japplphysiol.01200.2013; Mauguiere F FC, 2007, POTENTIELS EVOQUES N; Navasiolava NM, 2011, EUR J APPL PHYSIOL, V111, P1235, DOI 10.1007/s00421-010-1750-x; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ren JC, 2012, MUSCLE NERVE, V45, P65, DOI 10.1002/mus.22234; RESCHKE MF, 1986, EXP BRAIN RES, V64, P367; Roll R, 1998, EXP BRAIN RES, V122, P393, DOI 10.1007/s002210050527; Roullet S, 2009, ANN FR ANESTH, V28, P460, DOI 10.1016/j.annfar.2009.03.012; Saradjian AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108636; Sens E, 2012, J NEUROSCI, V32, P11773, DOI 10.1523/JNEUROSCI.5912-11.2012; Silva S, 2010, BRIT J ANAESTH, V105, P208, DOI 10.1093/bja/aeq144; Strzalkowski NDJ, 2015, NEUROSCI LETT, V592, P94, DOI 10.1016/j.neulet.2015.02.046; Tahayori B, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/964843; Vorobyov Y GO, 1982, 33RD C INT ASTR FED, P2; Watt D G, 1985, Can Aeronaut Space J, V31, P215; Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140; Werhahn KJ, 2002, NAT NEUROSCI, V5, P936, DOI 10.1038/nn917; Wittwer M, 2002, FASEB J, V16, P884, DOI 10.1096/fj.01-0792fje; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; YOUNG LR, 1986, EXP BRAIN RES, V64, P299	37	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201704	10.1371/journal.pone.0201704	http://dx.doi.org/10.1371/journal.pone.0201704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133473	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400030
J	Mendes, J; Santos, A; Borges, N; Afonso, C; Moreira, P; Padrao, P; Negrao, R; Amaral, TF				Mendes, J.; Santos, A.; Borges, N.; Afonso, C.; Moreira, P.; Padrao, P.; Negrao, R.; Amaral, T. F.			Vitamin D status and functional parameters: A cross-sectional study in an older population	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; PHYSICAL PERFORMANCE; GAIT SPEED; MUSCLE STRENGTH; NUTRITIONAL-STATUS; WALKING SPEED; D DEFICIENCY; ASSOCIATION; FALLS; MORTALITY	The present study aims to clarify the association of vitamin D status with functionality, measured through gait speed and hand grip strength, in a sample of older adults, considering sex-specific characteristics and the potential confounding effect of lifestyle factors, disease, skin phenotype, season of blood collection and vitamin D supplementation. The Nutrition UP 65 cross-sectional study was conducted in a population-based sample of 1,425 older adults >= 65 years old. Serum levels of 25-hydroxyvitamin D were quantified through electro-chemiluminescence immunoassay. Multinomial logistic regressions were carried out using quartiles of gait speed and of hand grip strength as dependent variables. Participants at risk of vitamin D inadequacy (30.0-49.9 nmol/L) and deficiency (< 30.0 nmol/L) presented higher adjusted odds ratio of the lowest values of gait speed and hand grip strength than those with adequate vitamin D levels (>= 50.0 nmol/L). These associations were strongest among men at risk of vitamin D deficiency [adjusted odds ratio for the lowest quartile of gait speed = 3.24; 95% CI: 1.56-6.73 and for the lowest quartile of hand grip strength = 3.28; 95% CI: 1.47-7.31] than in women at risk of vitamin D deficiency [adjusted odds ratio for the lowest quartile of gait speed = 2.72; 95% CI: 1.37-5.41 and for the lowest quartile of hand grip strength = 1.56; 95% CI: 0.81-3.00]. In conclusion, in older adults, particularly in men, the risk of vitamin D deficiency was directly associated with the lowest values of gait speed and of hand grip strength. However, randomized controlled trials are needed to overcome the possibility of reverse causation and residual confounding. Present results emphasise the need for strategies to promote the reduction of the high prevalence of low vitamin D status among the Portuguese older adult population.	[Mendes, J.; Negrao, R.] Univ Porto, Fac Med, Dept Biomed, Biochem Unit, Porto, Portugal; [Mendes, J.; Santos, A.; Negrao, R.] Univ Porto, Inst Res & Innovat Hlth I3S, Porto, Portugal; [Santos, A.; Borges, N.; Afonso, C.; Moreira, P.; Padrao, P.; Amaral, T. F.] Univ Porto, Fac Nutr & Food Sci, Porto, Portugal; [Borges, N.] CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal; [Moreira, P.; Padrao, P.] Univ Porto, Inst Publ Hlth, EPIUnit, Porto, Portugal; [Moreira, P.] Univ Porto, Res Ctr Phys Act Hlth & Leisure, Porto, Portugal; [Amaral, T. F.] Univ Porto, Fac Engn, Mech Engn Inst IDMEC, Syst Integrat & Proc Automat Unit UISPA, Porto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Mendes, J (corresponding author), Univ Porto, Fac Med, Dept Biomed, Biochem Unit, Porto, Portugal.; Mendes, J (corresponding author), Univ Porto, Inst Res & Innovat Hlth I3S, Porto, Portugal.	joanamarmendes@gmail.com	Moreira, Pedro/K-5456-2012; Santos, Alejandro/L-2658-2013; Moreira, Pedro/U-3034-2019; Padrão, Patrícia/K-8230-2012; Moreira, Pedro/U-2581-2019; Afonso, Cláudia/C-1453-2018; Negrao, Rita/L-2982-2013	Moreira, Pedro/0000-0002-7035-7799; Santos, Alejandro/0000-0003-0706-5301; Moreira, Pedro/0000-0002-7035-7799; Padrão, Patrícia/0000-0001-6310-4956; Borges, Nuno/0000-0001-6357-0615; Mendes, Joana/0000-0002-7561-9954; Negrao, Rita/0000-0002-0733-4412; F Amaral, Teresa/0000-0002-3998-6730; Afonso, Claudia/0000-0002-3837-3481	Public Health Initiatives Programme [PT06]; European Economic Area (EEA) Grants Financial Mechanism; Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal; Fundacao para a Ciencia e a Tecnologia, Portuguese Government Organization [SFRH/BD/115665/2016]	Public Health Initiatives Programme; European Economic Area (EEA) Grants Financial Mechanism; Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal; Fundacao para a Ciencia e a Tecnologia, Portuguese Government Organization	The present project was 85% funded by the Public Health Initiatives Programme (PT06), financed by European Economic Area (EEA) Grants Financial Mechanism 2009-2014 and 15% funded by Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal. The EEA Grants are managed by "Administracao Central do Sistema de Saude" through the "Programa Iniciativas em Saude Publica". JM is receiving a scholarship from the "Fundacao para a Ciencia e a Tecnologia", Portuguese Government Organization (Project SFRH/BD/115665/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir H, 2012, INJURY, V43, P2065, DOI 10.1016/j.injury.2011.12.001; Amaral Teresa F, 2016, JMIR Res Protoc, V5, pe184, DOI 10.2196/resprot.6037; Annweiler C, 2009, J NUTR HEALTH AGING, V13, P893, DOI 10.1007/s12603-009-0248-x; Annweiler C, 2009, J NUTR HEALTH AGING, V13, P90, DOI 10.1007/s12603-009-0013-1; Annweiler C, 2017, MATURITAS, V106, P8, DOI 10.1016/j.maturitas.2017.07.012; Annweiler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087314; Annweiler C, 2010, J BONE MINER RES, V25, P1858, DOI 10.1002/jbmr.80; [Anonymous], 2005 2006 PORT NAT H; Beauchet O, 2015, AGE, V37, DOI 10.1007/s11357-015-9755-3; Bienertova-Vasku J, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0454-z; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Boersma D, 2012, J NUTR HEALTH AGING, V16, P270, DOI 10.1007/s12603-011-0345-5; Boxer RS, 2008, J AM GERIATR SOC, V56, P454, DOI 10.1111/j.1532-5415.2007.01601.x; Candari C., 2017, ASSESSING EC COSTS U; Carrasco M, 2014, REV MED CHILE, V142, P1385, DOI 10.4067/S0034-98872014001100004; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; Chainani V, 2016, INT J CARDIOL, V215, P487, DOI 10.1016/j.ijcard.2016.04.068; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crescioli C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/949730; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Espy DD, 2010, GAIT POSTURE, V32, P378, DOI 10.1016/j.gaitpost.2010.06.013; Faulkner KA, 2006, OSTEOPOROSIS INT, V17, P1318, DOI 10.1007/s00198-006-0071-8; Fess E. E., 1992, GRIP STRENGTH; Fitzpatrick T. B., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345; Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Gschwind YJ, 2014, GERONTOLOGY, V60, P123, DOI 10.1159/000355667; Guerreiro M, 2010, REV PORT MED GERAL F, V26, DOI DOI 10.32385/rpmgf.v26i1.10711; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hirani V, 2013, J GERONTOL A-BIOL, V68, P1112, DOI 10.1093/gerona/glt059; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Institute for Environment and Sustainability (IES), 2001, SOL RAD PV MAPS EUR; Iolascon G, 2015, AGING CLIN EXP RES, V27, pS23, DOI 10.1007/s40520-015-0405-5; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Jenkins NDM, 2014, EXP GERONTOL, V58, P47, DOI 10.1016/j.exger.2014.07.007; Kositsawat J, 2013, J AM GERIATR SOC, V61, P1574, DOI 10.1111/jgs.12403; Kung SM, 2018, HUM MOVEMENT SCI, V57, P1, DOI 10.1016/j.humov.2017.10.023; Kwon J, 2007, GERONTOLOGY, V53, P322, DOI 10.1159/000103257; Lagari V, 2013, J BONE MINER RES, V28, P2194, DOI 10.1002/jbmr.1949; Mastaglia SR, 2011, J NUTR HEALTH AGING, V15, P349, DOI 10.1007/s12603-010-0287-3; Mathei C, 2013, AGE AGEING, V42, P186, DOI 10.1093/ageing/afs186; Mendes J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22584-3; Mendes J, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0590-5; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Minneci C, 2015, J AM GERIATR SOC, V63, P136, DOI 10.1111/jgs.13195; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Montero-Odasso Manuel, 2005, Molecular Aspects of Medicine, V26, P203, DOI 10.1016/j.mam.2005.01.005; Moreland JD, 2004, J AM GERIATR SOC, V52, P1121, DOI 10.1111/j.1532-5415.2004.52310.x; Nascimento CD, 2018, ARCH GERONTOL GERIAT, V74, P112, DOI 10.1016/j.archger.2017.10.011; Pike JW, 2017, ENDOCRIN METAB CLIN, V46, P815, DOI 10.1016/j.ecl.2017.07.001; Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508; Roomi MA, 2015, PAK J MED SCI, V31, P1236, DOI 10.12669/pjms.315.7196; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Santos A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016123; Shahar D, 2009, ANN NUTR METAB, V54, P59, DOI 10.1159/000207356; Shardell M, 2015, J GERONTOL A-BIOL, V70, P1156, DOI 10.1093/gerona/glv017; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4; Suzuki T, 2008, J BONE MINER RES, V23, P1309, DOI 10.1359/JBMR.080328; ter Borg S, 2015, BRIT J NUTR, V113, P1195, DOI 10.1017/S0007114515000203; Toffanello ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034950; Uusi-Rasi K, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-12; van Driel M, 2004, CURR PHARM DESIGN, V10, P2535; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Verreault R, 2002, J AM GERIATR SOC, V50, P912, DOI 10.1046/j.1532-5415.2002.50219.x; Vogt S, 2015, PREV MED, V73, P40, DOI 10.1016/j.ypmed.2015.01.010; von Berens A, 2018, J NUTR HEALTH AGING, V22, P1, DOI 10.1007/s12603-016-0849-0; Wang CY, 2012, PERCEPT MOTOR SKILL, V114, P469, DOI 10.2466/10.25.26.PMS.114.2.469-478; Wielders JPM, 2015, J CLIN LAB ANAL, V29, P451, DOI 10.1002/jcla.21793; World Health Organization, 2006, BMI CLASSIFICATION; Yumrutepe T, 2015, REV ASSOC MED BRAS, V61, P132, DOI 10.1590/1806-9282.61.02.132	72	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0201840	10.1371/journal.pone.0201840	http://dx.doi.org/10.1371/journal.pone.0201840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR1HU	30130370	gold, Green Published			2022-12-26	WOS:000442284500007
J	Goncalves, GL; Maestri, R; Moreira, GRP; Jacobi, MAM; Freitas, TRO; Hoekstra, HE				Goncalves, Gislene L.; Maestri, Renan; Moreira, Gilson R. P.; Jacobi, Marly A. M.; Freitas, Thales R. O.; Hoekstra, Hopi E.			Divergent genetic mechanism leads to spiny hair in rodents	PLOS ONE			English	Article							ECTODERMAL DYSPLASIA; ECTODYSPLASIN-A; KAPPA-B; EDAR; THICKNESS; MOUSE; DIVERSIFICATION; HYSTRICOMORPHA; INDUCTION; FEATURES	Spines, or modified hairs, have evolved multiple times in mammals, particularly in rodents. In this study, we investigated the evolution of spines in six rodent families. We first measured and compared the morphology and physical properties of hairs between paired spiny and non-spiny sister lineages. We found two distinct hair morphologies had evolved repeatedly in spiny rodents: hairs with a grooved cross-section and a second near cylindrical form. Compared to the ancestral elliptical-shaped hairs, spiny hairs had higher tension and stiffness, and overall, hairs with similar morphology had similar functional properties. To examine the genetic basis of this convergent evolution, we tested whether a single amino acid change (V370A) in the Ectodysplasin A receptor (Edar) gene is associated with spiny hair, as this substitution causes thicker and straighter hair in East Asian human populations. We found that most mammals have the common amino acid valine at position 370, but two species, the kangaroo rat (non-spiny) and spiny pocket mouse (spiny), have an isoleucine. Importantly, none of the variants we identified are associated with differences in rodent hair morphology. Thus, the specific Edar mutation associated with variation in human hair does not seem to play a role in modifying hairs in wild rodents, suggesting that different mutations in Edarand/or other genes are responsible for variation in the spiny hair phenotypes we observed within rodents.	[Goncalves, Gislene L.; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Goncalves, Gislene L.] Univ Tarapaca, Fac Ciencias Agron, Dept Recursos Ambientales, Arica, Chile; [Maestri, Renan; Moreira, Gilson R. P.; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Zool, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Maestri, Renan] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Ecol, Porto Alegre, RS, Brazil; [Jacobi, Marly A. M.] Univ Fed Rio Grande do Sul, Dept Quim, Porto Alegre, RS, Brazil; [Hoekstra, Hopi E.] Harvard Univ, Howard Hughes Med Inst, Dept Organism & Evolutionary Biol, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Universidade Federal do Rio Grande do Sul; Universidad de Tarapaca; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Harvard University; Howard Hughes Medical Institute	Goncalves, GL (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Goncalves, GL (corresponding author), Univ Tarapaca, Fac Ciencias Agron, Dept Recursos Ambientales, Arica, Chile.	lopes.goncalves@ufrgs.br	Moreira, Gilson R P/D-2209-2013; Jacobi, Marly A M/N-2766-2013; Maestri, Renan/L-2637-2015; Goncalves, Gislene Lopes/D-3567-2013; Hoekstra, Hopi/I-6690-2012	Jacobi, Marly A M/0000-0002-6424-4288; Maestri, Renan/0000-0001-9134-2943; Goncalves, Gislene Lopes/0000-0002-1459-4888; Hoekstra, Hopi/0000-0003-1431-1769	American Society of Mammalogists; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Science Foundation [DEB-0919190]; CNPq [500745/2011-0, 150391/2017-0]	American Society of Mammalogists; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the American Society of Mammalogists (Grant-in-Aid to G.L.G.), the Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the National Science Foundation (DEB-0919190 to H.E.H.). G.L.G. and R.M. received a postdoctoral fellowship from CNPq (processes 500745/2011-0 and 150391/2017-0, respectively). H.E.H. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Botchkarev VA, 2005, J INVEST DERM SYMP P, V10, P247, DOI 10.1111/j.1087-0024.2005.10129.x; Chernova OF, 2006, BIOL BULL+, V33, P43, DOI 10.1134/S1062359006010067; Chernova OF, 2001, BIOL BULL+, V28, P371, DOI 10.1023/A:1016623123957; Cluzeau C, 2012, BRIT J DERMATOL, V166, P678, DOI 10.1111/j.1365-2133.2011.10620.x; Courtois G, 2006, CELL DEATH DIFFER, V13, P843, DOI 10.1038/sj.cdd.4401841; Deshmukh Seema, 2012, Int J Clin Pediatr Dent, V5, P197, DOI 10.5005/jp-journals-10005-1165; Duarte TS, 2013, THESIS; Duverger O, 2009, BIRTH DEFECTS RES C, V87, P263, DOI 10.1002/bdrc.20158; FINDLAY GH, 1977, Z SAUGETIERKD, V42, P231; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Fujimoto A, 2009, J HUM GENET, V54, P461, DOI 10.1038/jhg.2009.61; Garcin CL, 2016, J INVEST DERMATOL, V136, P1022, DOI 10.1016/j.jid.2015.09.002; Hausman LA, 1920, AM NAT, V54, P496, DOI 10.1086/279782; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hoey KA, 2004, J ZOOL, V263, P307, DOI 10.1017/S0952836904005370; Kamberov YG, 2015, P NATL ACAD SCI USA, V112, P9932, DOI 10.1073/pnas.1511680112; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; KARAM GN, 1995, INT J SOLIDS STRUCT, V32, P1259, DOI 10.1016/0020-7683(94)00147-O; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Kuhn RA, 2010, ACTA THERIOL, V55, P211, DOI 10.4098/j.at.0001-7051.014.2009; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Montandon SA, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-33; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; Po-Chedley D. S., 1955, Journal of Mammalogy, V36, P84, DOI 10.2307/1375726; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rusu M, 2011, BIORESOURCES, V6, P641; SCHWARZ ERNST, 1939, JOUR MAMMAL, V20, P246, DOI 10.2307/1374385; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Sokolov VE, 1998, DOKL AKAD NAUK+, V363, P429; Sundberg JP, HDB MOUSE MUTATIONS; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; THESLEFF I, 2002, SCI STKE, V131; van Weers D.J., 1983, Zoologische Garten, V53, P226; Wilson D. E., 2005, MAMMAL SPECIES WORLD	40	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202219	10.1371/journal.pone.0202219	http://dx.doi.org/10.1371/journal.pone.0202219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118524	Green Submitted, Green Published, gold			2022-12-26	WOS:000442282700019
J	Silva, G; Marins, M; Chaichanasak, N; Yoon, Y; Fachin, AL; Pinhanelli, VC; Regasini, LO; dos Santos, MB; Ayusso, GM; Marques, BD; Wu, WW; Phue, JN; Shen, RF; Baek, SJ				Silva, Gabriel; Marins, Mozart; Chaichanasak, Nadda; Yoon, Yongdae; Fachin, Ana Lucia; Pinhanelli, Vitor Caressato; Regasini, Luis Octavio; dos Santos, Mariana Bastos; Ayusso, Gabriela Miranda; Marques, Beatriz de Carvalho; Wu, Wells W.; Phue, Je-Nie; Shen, Rong-Fong; Baek, Seung Joon			Trans-chalcone increases p53 activity via DNAJB1/HSP40 induction and CRM1 inhibition	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; COLORECTAL-CANCER CELLS; NUCLEAR EXPORT; IN-VITRO; MDM2; APOPTOSIS; RESTORATION; BLOCKING; GROWTH; UBIQUITINATION	Naturally-occurring chalcones and synthetic chalcone analogues have been demonstrated to have many biological effects, including anti-inflammatory, anti-malarial, anti-fungal, and anti-oxidant/anti-cancerous activities. Compared to other chalcones, trans-chalcone exhibits superior inhibitory activity in cancer cell growth as shown via in vitro assays, and exerts anti-cancerous effects via the activation of the p53 tumor suppressor protein. Thus, characterization of the specific mechanisms, by which trans-chalcone activates p53, can aid development of new chemotherapeutic drugs that can be used individually or synergistically with other drugs. In this report, we found that trans-chalcone modulates many p53 target genes, HSP40 being the most induced gene in the RNA-Seq data using trans-chalcone-treated cells. CRM1 is also inhibited by trans-chalcone, resulting in the accumulation of p53 and other tumor suppressor proteins in the nucleus. Similar effects were seen using trans-chalcone derivatives. Overall, trans-chalcone could provide a strong foundation for the development of chalcone-based anti-cancer drugs.	[Silva, Gabriel; Marins, Mozart; Fachin, Ana Lucia; Pinhanelli, Vitor Caressato] Univ Ribeirao Preto, Biotechnol Unit, Ribeirao Preto, SP, Brazil; [Marins, Mozart; Fachin, Ana Lucia] Univ Ribeirao Preto, Med Sch, Ribeirao Preto, SP, Brazil; [Chaichanasak, Nadda; Yoon, Yongdae; Baek, Seung Joon] Seoul Natl Univ, Coll Vet Med & Res Inst Vet Sci, Lab Signal Transduct, Seoul, South Korea; [Regasini, Luis Octavio; dos Santos, Mariana Bastos; Ayusso, Gabriela Miranda; Marques, Beatriz de Carvalho] Sao Paulo State Univ UNESP, Dept Chem & Environm Chem, Sao Paulo, Brazil; [Wu, Wells W.; Phue, Je-Nie; Shen, Rong-Fong] US FDA, Facil Biotechnol Resources, CBER, Silver Spring, MD USA	Universidade de Ribeirao Preto; Universidade de Ribeirao Preto; Seoul National University (SNU); Universidade Estadual Paulista; US Food & Drug Administration (FDA)	Marins, M (corresponding author), Univ Ribeirao Preto, Biotechnol Unit, Ribeirao Preto, SP, Brazil.; Marins, M (corresponding author), Univ Ribeirao Preto, Med Sch, Ribeirao Preto, SP, Brazil.; Baek, SJ (corresponding author), Seoul Natl Univ, Coll Vet Med & Res Inst Vet Sci, Lab Signal Transduct, Seoul, South Korea.	mmarins@gmb.bio.br; baeksj@snu.ac.kr	Marins, Mozart/U-7048-2017; Regasini, Luis O/B-1985-2012; Fachin, Ana L/B-7916-2012; dos Santos, Mariana Bastos/AAU-1364-2021; Silva, Gabriel/D-7731-2017	Fachin, Ana L/0000-0001-8755-9250; dos Santos, Mariana Bastos/0000-0003-3222-5696; Regasini, Luis Octavio/0000-0002-3705-0971; Miranda Ayusso, Gabriela/0000-0002-6008-634X; Phue, Je Nie/0000-0002-3502-3726; Silva, Gabriel/0000-0002-5660-9769	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [14/15307-7]; Research Resettlement Fund for the new faculty, the Research Institute for Veterinary Science; BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National University; National Research Foundation of Korea (NRF) grant - Korea government (MSIT) [2018R1A2B2002923]; CAPES Foundationan agency under the Ministry of Education of Brazil [BEX 3159/14-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Research Resettlement Fund for the new faculty, the Research Institute for Veterinary Science; BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National University; National Research Foundation of Korea (NRF) grant - Korea government (MSIT); CAPES Foundationan agency under the Ministry of Education of Brazil	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant no.: 14/15307-7). This work was also supported by the Research Resettlement Fund for the new faculty, the Research Institute for Veterinary Science, and BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National University, and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2018R1A2B2002923) to SJB. GS holds a scholarship via a grant from the CAPES Foundationan agency under the Ministry of Education of Brazil (grant no.: BEX 3159/14-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2006, MOL PHARMACOL, V70, P426, DOI 10.1124/mol.105.021311; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; Cai X, 2008, P NATL ACAD SCI USA, V105, P16958, DOI 10.1073/pnas.0804608105; Calderwood SK, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/217513; Chen D, 2014, BIOCHEM BIOPH RES CO, V443, P326, DOI 10.1016/j.bbrc.2013.11.122; Chen ZP, 2007, J BIOL CHEM, V282, P29284, DOI 10.1074/jbc.M705349200; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Cui X, 2015, CANCER LETT, V357, P307, DOI 10.1016/j.canlet.2014.11.041; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; De Cesare M, 2015, ONCOTARGET, V6, P13119; Dickmanns A, 2015, CELLS-BASEL, V4, P538, DOI 10.3390/cells4030538; Dickson J, 2006, J CHEM EDUC, V83, P934, DOI 10.1021/ed083p934; Hansen RK, 1997, BIOCHEM BIOPH RES CO, V239, P851, DOI 10.1006/bbrc.1997.7572; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hiraki M, 2015, CHEM BIOL, V22, P1206, DOI 10.1016/j.chembiol.2015.07.016; Kahyo T, 2008, J PHARMACOL SCI, V108, P364, DOI 10.1254/jphs.08203FP; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kandaswamy N., 2014, INDO AM J PHARM RES, V4, P3011; Kim JA, 2015, CARCINOGENESIS, V36, P696, DOI 10.1093/carcin/bgv045; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubo N, 2013, BIOCHEM BIOPH RES CO, V430, P1034, DOI 10.1016/j.bbrc.2012.11.121; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kwon SM, 2016, J NUTR BIOCHEM, V30, P24, DOI 10.1016/j.jnutbio.2015.11.013; Mahapatra DM, 2015, EUR J MED CHEM, V98, P69, DOI 10.1016/j.ejmech.2015.05.004; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Min KW, 2016, ONCOGENE, V35, P377, DOI 10.1038/onc.2015.95; Mitra A, 2009, CLIN EXP METASTAS, V26, P559, DOI 10.1007/s10585-009-9255-x; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nualsanit T, 2012, J NUTR BIOCHEM, V23, P915, DOI 10.1016/j.jnutbio.2011.04.017; Qi M, 2014, BBA-GENE REGUL MECH, V1839, P62, DOI 10.1016/j.bbagrm.2013.12.003; Silva G, 2016, MOL CARCINOGEN, V55, P1438, DOI 10.1002/mc.22386; Silva G, 2013, MOLECULES, V18, P15448, DOI 10.3390/molecules181215448; Stoll R, 2001, BIOCHEMISTRY-US, V40, P336, DOI 10.1021/bi000930v; Taylor-Kashton C, 2016, J CELL PHYSIOL, V231, P2711, DOI 10.1002/jcp.25378; Trinh DLN, 2010, ONCOTARGET, V1, P396, DOI 10.18632/oncotarget.174; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Wang Z., 2010, COMPREHENSIVE ORGANI, DOI DOI 10.1002/9780470638859.CONRR681; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamaguchi K, 2006, CANCER RES, V66, P2376, DOI 10.1158/0008-5472.CAN-05-1987; Zawacka-Pankau J, 2015, J INTERN MED, V277, P248, DOI 10.1111/joim.12336; Zhong Y, 2010, EUR J CANCER, V46, P3365, DOI 10.1016/j.ejca.2010.07.007; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	44	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202263	10.1371/journal.pone.0202263	http://dx.doi.org/10.1371/journal.pone.0202263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118500	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700020
J	Huang, LS; Mwebaza, N; Kajubi, R; Marzan, F; Forsman, C; Parikh, S; Aweeka, FT				Huang, Liusheng; Mwebaza, Norah; Kajubi, Richard; Marzan, Florence; Forsman, Camilla; Parikh, Sunil; Aweeka, Francesca T.			Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; PHARMACOKINETIC EXPOSURE; ARTEMETHER-LUMEFANTRINE; HEALTHY-VOLUNTEERS; UGANDAN CHILDREN; ARTEMETHER/LUMEFANTRINE	Background Lumefantrine is a long-acting antimalarial drug with an elimination half-life of over 3 days and protein binding of 99 percent. Correlation of lumefantrine concentrations from capillary plasma via fingerprick (C-c) versus venous plasma (C-v) remains to be defined. Methods Venous and capillary plasma samples were collected simultaneously from children, pregnant women, and non-pregnant adults at 2, 24, 120hr post last dose of a standard 3-day artemether-lumefantrine regimen they received for uncomplicated malaria. Some of the enrolled children and pregnant women were also HIV-infected. Samples were analyzed via liquid chromatography tandem mass spectrometry. Linear regression analysis was performed using the program Stata (R) SE12.1. Results In children, the linear regression equations for C-c vs C-v at 2, 24, and 120hr (day 7) post dose are [C-c] = 1.05*[C-v]+ 95.0 (n = 142, R-2 = 0.977), [C-c] = 0.995*[C-v]+ 56.7 (n = 147, R-2 = 0.990) and [C-c] = 0.958*[C-v]+ 18.6 (n = 139, R-2 = 0.994), respectively. For pregnant women, the equations are [C-c] = 1.04*[C-v]+ 68.1 (n = 43, R-2 = 0.990), [C-c] = 0.997*[C-v]+ 37.3 (n = 43, R-2 = 0.993) and [C-c] = 0.941*[C-v]+ 11.1 (n = 41, R-2 = 0.941), respectively. For non-pregnant adults, the equations are [C-c] = 1.05*[C-v]-117 (n = 32, R-2 = 0.958), [C-c] = 0.962*[C-v]+ 9.21 (n = 32, R-2 = 0.964) and [C-c] = 1.04*[C-v]-40.1 (n = 32, R-2 = 0.988), respectively. In summary, a linear relationship with a slope of similar to 1 was found for capillary and venous lumefantrine levels in children, pregnant women and non-pregnant adults at 2hr, 24hr and 120hr post last dose, representing absorption, distribution, and elimination phases. Conclusions Capillary and venous plasma concentration of lumefantrine can be used interchangeably at 1: 1 ratio. Capillary sampling method via finger prick is a suitable alternative for sample collection in clinical studies.	[Huang, Liusheng; Marzan, Florence; Forsman, Camilla; Aweeka, Francesca T.] Univ Calif San Francisco, Drug Res Unit, Dept Clin Pharm, San Francisco, CA 94143 USA; [Mwebaza, Norah] Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda; [Mwebaza, Norah; Kajubi, Richard] Infect Dis Res Collaborat, Kampala, Uganda; [Parikh, Sunil] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	University of California System; University of California San Francisco; Makerere University; Yale University	Huang, LS; Aweeka, FT (corresponding author), Univ Calif San Francisco, Drug Res Unit, Dept Clin Pharm, San Francisco, CA 94143 USA.	liusheng.huang@ucsf.edu; faweeka@sfghsom.ucsf.edu		KAJUBI, RICHARD/0000-0002-9179-9182	Eunice Kennedy Shriver National Institute of Child Health and Human Development of National Institutes of Healths [R01 HD068174]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068174] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of National Institutes of Healths; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work is supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development of National Institutes of Healths (Grant# R01 HD068174). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Ashley E, 2010, EUR J CLIN PHARMACOL, V66, P705, DOI 10.1007/s00228-010-0804-7; Bigira V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001689; Byakika-Kibwika P, 2012, J ANTIMICROB CHEMOTH, V67, P1217, DOI 10.1093/jac/dkr596; Colussi D, 1999, EUR J PHARM SCI, V9, P9, DOI 10.1016/S0928-0987(99)00037-8; Davis TME, 2016, EXPERT REV CLIN PHAR, V9, P341, DOI 10.1586/17512433.2016.1108190; Djimde A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S4; German P, 2009, JAIDS-J ACQ IMM DEF, V51, P424, DOI 10.1097/QAI.0b013e3181acb4ff; Huang LS, 2012, JAIDS-J ACQ IMM DEF, V61, P310, DOI 10.1097/QAI.0b013e31826ebb5c; Huang LS, 2012, BIOANALYSIS, V4, P157, DOI [10.4155/BIO.11.303, 10.4155/bio.11.303]; Huang LS, 2010, ANAL CHEM INSIGHTS, V5, P15; Kajubi Richard, 2016, Open Forum Infect Dis, V3, pofw217, DOI 10.1093/ofid/ofw217; Kloprogge F, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.59; Novartis Pharm. Co, COART FULL PRESCR IN; Nyunt MM, 2016, ANTIMICROB AGENTS CH, V60, P1274, DOI 10.1128/AAC.01605-15; Olliaro PL, 1995, B WORLD HEALTH ORGAN, V73, P565; Parikh S, 2016, CLIN INFECT DIS, V63, P414, DOI 10.1093/cid/ciw291; Simpson JA, 2001, T ROY SOC TROP MED H, V95, P347, DOI 10.1016/S0035-9203(01)90178-6; van Vugt M, 1998, T ROY SOC TROP MED H, V92, P564, DOI 10.1016/S0035-9203(98)90917-8; Wahajuddin, 2014, ANTIMICROB AGENTS CH, V58, P489, DOI 10.1128/AAC.01382-13; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; World Health Organization, 2015, GUID TREAT MAL D; Zongo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103200	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202082	10.1371/journal.pone.0202082	http://dx.doi.org/10.1371/journal.pone.0202082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114201	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400041
J	Rachinas-Lopes, P; Ribeiro, R; dos Santos, ME; Costa, RM				Rachinas-Lopes, Patricia; Ribeiro, Ricardo; dos Santos, Manuel E.; Costa, Rui M.			D-Track-A semi-automatic 3D video-tracking technique to analyse movements and routines of aquatic animals with application to captive dolphins	PLOS ONE			English	Article							LOCOMOTOR BEHAVIOR; SYSTEM; MICE; QUANTIFICATION; ETHOVISION; DROSOPHILA; PARADIGM	Scoring and tracking animal movements manually is a time consuming and subjective process, susceptible to errors due to fatigue. Automated and semi-automated video-based tracking methods have been developed to overcome the errors and biases of manual analyses. In this manuscript we present D-Track, an open-source semi-automatic tracking system able to quantify the 3D trajectories of dolphins, non-invasively, in the water. This software produces a three-dimensional reconstruction of the pool and tracks the animal at different depths, using standard cameras. D-Track allows the determination of spatial preferences of the animals, their speed and its variations, and the identification of behavioural routines. We tested the system with two captive dolphins during different periods of the day. Both animals spent around 85% of the time at the surface of the Deep Area of their pool (5 meters depth). Both dolphins showed a stable average speed throughout 31 sessions, with slow speeds predominant (maximum 1.7 ms(-1)). Circular swimming was highly variable, with significant differences in the size and duration of the "circles", between animals, within-animals and across sessions. The D-Track system is a novel tool to study the behaviour of aquatic animals, and it represents a convenient and inexpensive solution for laboratories and marine parks to monitor the preferences and routines of their animals.	[Rachinas-Lopes, Patricia; Ribeiro, Ricardo; Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Rachinas-Lopes, Patricia; dos Santos, Manuel E.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal	Fundacao Champalimaud; Instituto Superior Psicologia Aplicada (ISPA)	Rachinas-Lopes, P (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.; Rachinas-Lopes, P (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.	plopes@ispa.pt	Rachinas-Lopes, Patricia/H-6823-2019	Rachinas-Lopes, Patricia/0000-0001-6795-2610; dos Santos, Manuel/0000-0001-8225-9398	Fundacao para a Ciencia e Tecnologia [UID/MAR/04292/2013, SFRH/BD/73886/2010]; Howard Hughes Medical Institute [IEC 55007415]; Scientific Office of Zoomarine Algarve (Portugal)	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Scientific Office of Zoomarine Algarve (Portugal)	This study had the support of Fundacao para a Ciencia e Tecnologia (https://www.fct.pt/), through the strategic project UID/MAR/04292/2013 granted to MARE, a fellowship awarded to P.R-L. (SFRH/BD/73886/2010), and Howard Hughes Medical Institute (http://www.hhmi.org/) to R.M.C. (IEC 55007415).; The authors would like to thank the Administration and the Scientific Office of Zoomarine Algarve (Portugal), as well as all trainers involved in this study for their effort and support.	Ahrendt P, 2011, COMPUT ELECTRON AGR, V76, P169, DOI 10.1016/j.compag.2011.01.011; Ballestaa S, 2014, J NEUROSCI METH, V234, P147, DOI 10.1016/j.jneumeth.2014.05.022; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; CARSTENSEN JM, 2001, IMAGE ANAL VISION CO; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Defran RH., 1980, CETACEAN BEHAV MECH, P319; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; FISH FE, 1991, MAMMAL REV, V21, P181, DOI 10.1111/j.1365-2907.1991.tb00292.x; Giancardo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074557; Goforth H.W. Jr, 1990, P559; Hashimoto T, 1999, J NEUROSCI METH, V91, P115, DOI 10.1016/S0165-0270(99)00082-5; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Kato S, 2004, J NEUROSCI METH, V134, P1, DOI 10.1016/j.jneumeth.2003.09.028; Khan Z, 2005, BEHAV RES METHODS, V37, P453, DOI 10.3758/BF03192714; Lind NM, 2005, J NEUROSCI METH, V143, P123, DOI 10.1016/j.jneumeth.2004.09.019; Machino K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00202; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Mirat O, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00107; Noldus LPJJ, 2002, COMPUT ELECTRON AGR, V35, P201, DOI 10.1016/S0168-1699(02)00019-4; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Ohayon S, 2013, J NEUROSCI METH, V219, P10, DOI 10.1016/j.jneumeth.2013.05.013; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Shyan Melissa R., 2002, Journal of Applied Animal Welfare Science, V5, P215, DOI 10.1207/S15327604JAWS0503_05; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201614	10.1371/journal.pone.0201614	http://dx.doi.org/10.1371/journal.pone.0201614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114265	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400017
J	Reynolds, HM; Parameswaran, BK; Finnegan, ME; Roettger, D; Lau, E; Kron, T; Shaw, M; Chander, S; Siva, S				Reynolds, Hayley M.; Parameswaran, Bimal K.; Finnegan, Mary E.; Roettger, Diana; Lau, Eddie; Kron, Tomas; Shaw, Mark; Chander, Sarat; Siva, Shankar			Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma	PLOS ONE			English	Article							PRIMARY KIDNEY CANCER; TARGETED THERAPIES; MOTION; TUMOR	Purpose To explore the utility of diffusion and perfusion changes in primary renal cell carcinoma (RCC) after stereotactic ablative body radiotherapy (SABR) as an early biomarker of treatment response, using diffusion weighted (DWI) and dynamic contrast enhanced (DCE) MRI. Methods Patients enrolled in a prospective pilot clinical trial received SABR for primary RCC, and had DWI and DCE MRI scheduled at baseline, 14 days and 70 days after SABR. Tumours <5cm diameter received a single fraction of 26 Gy and larger tumours received three fractions of 14 Gy. Apparent diffusion coefficient (ADC) maps were computed from DWI data and parametric and pharmacokinetic maps were fitted to the DCE data. Tumour volumes were contoured and statistics extracted. Spearman's rank correlation coefficients were computed between MRI parameter changes versus the percentage tumour volume change from CT at 6, 12 and 24 months and the last follow-up relative to baseline CT. Results Twelve patients were eligible for DWI analysis, and a subset of ten patients for DCE MRI analysis. DCE MRI from the second follow-up MRI scan showed correlations between the change in percentage voxels with washout contrast enhancement behaviour and the change in tumour volume (rho = 0.84, p = 0.004 at 12 month CT, rho = 0.81, p = 0.02 at 24 month CT, and rho = 0.89, p = 0.001 at last follow-up CT). The change in mean initial rate of enhancement and mean Ktrans at the second follow-up MRI scan were positively correlated with percent tumour volume change at the 12 month CT onwards (rho = 0.65, p = 0.05 and rho = 0.66, p = 0.04 at 12 month CT respectively). Changes in ADC kurtosis from histogram analysis at the first follow-up MRI scan also showed positive correlations with the percentage tumour volume change (rho = 0.66, p = 0.02 at 12 month CT, rho = 0.69, p = 0.02 at last follow-up CT), but these results are possibly confounded by inflammation. Conclusion DWI and DCE MRI parameters show potential as early response biomarkers after SABR for primary RCC. Further prospective validation using larger patient cohorts is warranted.	[Reynolds, Hayley M.; Kron, Tomas] Peter MacCallum Canc Ctr, Dept Phys Sci, Melbourne, Vic, Australia; [Reynolds, Hayley M.; Kron, Tomas; Chander, Sarat; Siva, Shankar] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Parameswaran, Bimal K.; Lau, Eddie] Peter MacCallum Canc Ctr, Canc Imaging, Melbourne, Vic, Australia; [Finnegan, Mary E.] Imperial Coll Healthcare NHS Trust, Dept Imaging, London, England; [Finnegan, Mary E.] Imperial Coll London, Dept Bioengn, London, England; [Roettger, Diana] Image Anal Grp, London, England; [Shaw, Mark; Chander, Sarat; Siva, Shankar] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Imperial College London; Imperial College London; Peter Maccallum Cancer Center	Reynolds, HM (corresponding author), Peter MacCallum Canc Ctr, Dept Phys Sci, Melbourne, Vic, Australia.; Reynolds, HM (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.	Hayley.Reynolds@petermac.org	Reynolds, Hayley/AAK-5924-2020; Kron, Tomas/A-7217-2010; Chander, Sarat/AAP-7835-2020	Reynolds, Hayley/0000-0001-8146-1113; Kron, Tomas/0000-0002-5189-4046; Chander, Sarat/0000-0002-1803-049X; Lau, Eddie/0000-0002-1261-7775	Contributing to Australia Scholarship and Science (CASS) Science and Medicine [SM/11/3784]; Ferring Pharmaceutical Fellowship Award from the Royal Australia and New Zealand College of Radiation Oncology; CASS Science and Medicine [SM/11/3784]; Royal Australia and New Zealand College of Radiation Oncology / Ferring Pharmaceutical Fellowship Award; Image Analysis Group	Contributing to Australia Scholarship and Science (CASS) Science and Medicine; Ferring Pharmaceutical Fellowship Award from the Royal Australia and New Zealand College of Radiation Oncology(Ferring Pharmaceuticals); CASS Science and Medicine; Royal Australia and New Zealand College of Radiation Oncology / Ferring Pharmaceutical Fellowship Award(Ferring Pharmaceuticals); Image Analysis Group	This study was supported by a Contributing to Australia Scholarship and Science (CASS) Science and Medicine grant SM/11/3784 to SS (http://www.cassfoundation.org/) and a Ferring Pharmaceutical Fellowship Award from the Royal Australia and New Zealand College of Radiation Oncology (https://www.ranzcr.com/). Image Analysis Group provided support in the form of a salary for author Diana Roettger. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by a CASS Science and Medicine grant SM/11/3784, and the Royal Australia and New Zealand College of Radiation Oncology / Ferring Pharmaceutical Fellowship Award. The authors would like to gratefully acknowledge Noelene Bergen for assisting development of the MRI protocol, Price Jackson for imaging expertise and manuscript feedback, Mathias Bressel for providing statistical consultation and Teng Han Tan for carrying out CT tumour measurements.	American College of Radiology, 2013, POSTTR FOLL UP REN C; [Anonymous], DYN, DOI [10.1097/01.rli.0000184756.66360.d3, DOI 10.1097/01.RLI.0000184756.66360.D3]; Bex A, 2014, EUR UROL, V65, P766, DOI 10.1016/j.eururo.2013.11.031; Bokacheva L, 2008, MAGN RESON IMAGING C, V16, P597, DOI 10.1016/j.mric.2008.07.001; Cao Y, 2011, SEMIN RADIAT ONCOL, V21, P147, DOI 10.1016/j.semradonc.2010.11.001; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Choi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122019; Chu S, 2013, SPINE, V38, pE1418, DOI 10.1097/BRS.0b013e3182a40838; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Huang YS, 2018, J MAGN RESON IMAGING, V47, P191, DOI 10.1002/jmri.25758; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Jackson P, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0253-z; Kelly-Morland C, 2017, BMC CANCER, V17, P1, DOI [10.1186/s12885-016-3022-6, DOI 10.1186/S12885-016-3022-6]; Lassel EA, 2014, EUR RADIOL, V24, P241, DOI 10.1007/s00330-013-3004-x; Lis E, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.9.FOCUS16378; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; MOERLAND MA, 1994, RADIOTHER ONCOL, V30, P150, DOI 10.1016/0167-8140(94)90045-0; Notohamiprodjo M, 2013, ACAD RADIOL, V20, P685, DOI 10.1016/j.acra.2013.01.015; Pedrosa I, 2009, CANCER-AM CANCER SOC, V115, P2334, DOI 10.1002/cncr.24237; Pham D, 2015, TECHNOL CANCER RES T, V14, P149, DOI 10.7785/tcrt.2012.500410; Pham D, 2014, INT J RADIAT ONCOL, V90, P1061, DOI 10.1016/j.ijrobp.2014.07.043; Ponsky L, 2015, RADIOTHER ONCOL, V117, P183, DOI 10.1016/j.radonc.2015.08.030; Prestidge BR, 1997, INT J RADIAT ONCOL, V37, P31, DOI 10.1016/S0360-3016(96)00390-2; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Rosen MA, 2007, CLIN CANCER RES, V13, p770S, DOI 10.1158/1078-0432.CCR-06-1921; Sankineni S, 2016, UROL ONCOL-SEMIN ORI, V34, P147, DOI 10.1016/j.urolonc.2015.05.020; Siva S, 2017, BJU INT, V120, P623, DOI 10.1111/bju.13811; Siva S, 2016, RADIOTHER ONCOL, V118, P540, DOI 10.1016/j.radonc.2016.01.027; Siva S, 2015, ACTA ONCOL, V54, P1105, DOI 10.3109/0284186X.2015.1027409; Siva S, 2012, BJU INT, V110, pE737, DOI 10.1111/j.1464-410X.2012.11550.x; Spratt DE, 2016, SPINE J, V16, P291, DOI 10.1016/j.spinee.2015.08.041; Sun MRM, 2016, AM J ROENTGENOL, V206, P544, DOI 10.2214/AJR.14.14099; Team RC, 2014, R LANG ENV STAT COMP; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wang HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29146; Wang HY, 2011, EXPERT REV ANTICANC, V11, P1017, DOI [10.1586/ERA.11.77, 10.1586/era.11.77]; Wu Y, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/648495; Young JR, 2013, RADIOLOGY, V267, P444, DOI 10.1148/radiol.13112617; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202387	10.1371/journal.pone.0202387	http://dx.doi.org/10.1371/journal.pone.0202387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114235	Green Published, gold			2022-12-26	WOS:000441850400066
J	Zulfarina, MS; Sharif, R; Syarifah-Noratiqah, SB; Sharkawi, AM; Aqilah-SM, ZS; Mokhtar, SA; Nazrun, SA; Naina-Mohamed, I				Zulfarina, Mohamed S.; Sharif, Razinah; Syarifah-Noratiqah, Syed-Badrul; Sharkawi, Ahmad M.; Aqilah-SM, Zaris-SM; Mokhtar, Sabarul-Afian; Nazrun, Shuid A.; Naina-Mohamed, Isa		MALBONES Res Grp	Modifiable factors associated with bone health in Malaysian adolescents utilising calcaneus quantitative ultrasound	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; PHYSICAL-ACTIVITY; BODY-COMPOSITION; FAT MASS; SCHOOL-CHILDREN; GROWTH SPURT; OSTEOPOROSIS; ACQUISITION; FRACTURES; DENSITY	Maximizing bone mineral accrual to attain an optimal peak bone mass (PBM), particularly during adolescence, appears to be an effective protective strategy in the prevention of osteoporosis. This study aimed to evaluate the influence of physical activity (PA), fat mass (FM), lean mass (LM), body mass index (BMI), calcium, or combination of vitamin D supplement intake, smoking and alcohol drinking status on bone health assessed by calcaneus quantitative ultrasound (QUS) in a healthy adolescent population. The participants comprised of 920 male and female secondary school adolescents aged 15-17 years old. Quantitative ultrasound measurements of the left heel were performed using Lunar Achilles EX II, which included results of broadband ultrasound attenuation (BUA), speed of sound (SOS), and a calculated stiffness index (SI). Multivariable linear regression analyses revealed that-PA was positively associated with all three QUS indices in both genders; BMI was positively associated with SI and SOS in females; LM was positively associated with BUA in both genders; and FM was negatively associated with SI in females. These variables accounted for 32.1%, 21.2% and 29.4% of females' SOS, BUA and SI variances (p<0.001), respectively and 23.6%, 15.4% and 17.2% of males' SOS, BUA and SI variances (p<0.001), respectively. Promoting health benefits from physical activity could influence bone status and consequently improve PBM, which is a potent protective determinant against osteoporosis in adulthood.	[Zulfarina, Mohamed S.; Syarifah-Noratiqah, Syed-Badrul; Sharkawi, Ahmad M.; Nazrun, Shuid A.; Naina-Mohamed, Isa] Univ Kebangsaan Malaysia, Pharmacoepidemiol & Drug Safety Unit, Dept Pharmacol, Fac Med,UKM Med Ctr, Kuala Lumpur, Malaysia; [Sharif, Razinah] Univ Kebangsaan Malaysia, Fac Hlth Sci, Nutr Sci Programme, Kuala Lumpur, Malaysia; [Aqilah-SM, Zaris-SM; Mokhtar, Sabarul-Afian] Univ Kebangsaan Malaysia, Fac Med, UKM Med Ctr, Dept Orthopaed, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Naina-Mohamed, I (corresponding author), Univ Kebangsaan Malaysia, Pharmacoepidemiol & Drug Safety Unit, Dept Pharmacol, Fac Med,UKM Med Ctr, Kuala Lumpur, Malaysia.	isanaina@ppukm.ukm.edu.my	Zulfarina, Mohamed S/EZB-0645-2022; Mohamed, Zulfarina/ABA-4699-2021; Mokhtar, Sabarul/ABE-9158-2020	Zulfarina, Mohamed S/0000-0002-5954-6943; Mohamed, Zulfarina/0000-0002-5954-6943; Sharif, Razinah/0000-0001-7174-7353	Dana Impak Perdana (Premier Impact Grant) [DIP-2013-002]; Universiti Kebangsaan Malaysia	Dana Impak Perdana (Premier Impact Grant); Universiti Kebangsaan Malaysia	This study was supported by Dana Impak Perdana (Premier Impact Grant) DIP-2013-002, http://research.ukm.my/, Universiti Kebangsaan Malaysia, to Isa NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Babatunde OO, 2013, BONE, V53, P311, DOI 10.1016/j.bone.2012.12.011; Bachrach LK, 2005, ENDOCRIN METAB CLIN, V34, P521, DOI 10.1016/j.ecl.2005.04.001; Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Baharudin A, 2014, ASIA-PAC J PUBLIC HE, V26, p27S, DOI 10.1177/1010539514543682; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Baxter-Jones ADG, 2011, J BONE MINER RES, V26, P1729, DOI 10.1002/jbmr.412; Binkley TL, 2008, REV ENDOCR METAB DIS, V9, P95, DOI 10.1007/s11154-008-9073-5; Blanchet C, 2003, CALCIFIED TISSUE INT, V73, P339, DOI 10.1007/s00223-002-1091-9; Bonjour Jean-Philippe, 2007, Med Sport Sci, V51, P64, DOI 10.1159/000103005; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Clark EM, 2006, J CLIN ENDOCR METAB, V91, P2534, DOI 10.1210/jc.2006-0332; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cvijetic S, 2003, J CLIN EPIDEMIOL, V56, P591, DOI 10.1016/S0895-4356(03)00054-4; Davies JH, 2005, ARCH DIS CHILD, V90, P373, DOI 10.1136/adc.2004.053553; Dib L, 2005, BONE, V36, P736, DOI 10.1016/j.bone.2005.01.009; Fadhli Y., 2013, MALAYS J MED HLTH SC, V9, P25; Farr JN, 2015, NAT REV ENDOCRINOL, V11, P513, DOI 10.1038/nrendo.2015.89; Gluer CC, 1997, J BONE MINER RES, V12, P1280, DOI 10.1359/jbmr.1997.12.8.1280; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Ka K, 2013, HORM RES PAEDIAT, V80, P154, DOI 10.1159/000354043; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Krieg MA, 2008, J CLIN DENSITOM, V11, P163, DOI 10.1016/j.jocd.2007.12.011; KUSHNER RF, 1992, J AM COLL NUTR, V11, P199; Lavado-Garcia JM, 2012, J BONE MINER METAB, V30, P193, DOI 10.1007/s00774-011-0301-9; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; Lucas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046940; Mora S, 2003, ENDOCRIN METAB CLIN, V32, P39, DOI 10.1016/S0889-8529(02)00058-0; Novotny R, 2004, PREV MED, V39, P355, DOI 10.1016/j.ypmed.2004.01.031; Oden A, 2015, OSTEOPOROSIS INT, V26, P2243, DOI 10.1007/s00198-015-3154-6; Official Portal Ministry of Education Malaysia (MOE), NUMB SCH TYP GROUP S; Ondrak KS, 2007, SPORTS MED, V37, P587, DOI 10.2165/00007256-200737070-00003; Perez-Lopez FR, 2010, CURR MED CHEM, V17, P453, DOI 10.2174/092986710790226138; Petit M. A., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P213; Pietrobelli A, 2002, OBES RES, V10, P56, DOI 10.1038/oby.2002.8; Pollock NK, 2007, AM J CLIN NUTR, V86, P1530, DOI 10.1093/ajcn/86.5.1530; Prins SH, 1998, CLIN PHYSIOL, V18, P3; Rauch F, 2004, BONE, V34, P771, DOI 10.1016/j.bone.2004.01.022; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Sharif R, 2016, J PHYS ACT HEALTH, V13, pS201, DOI 10.1123/jpah.2016-0404; Specker BL, 2005, J PEDIATR-US, V146, P726, DOI 10.1016/j.jpeds.2005.02.002; Talma H, 2013, OBES REV, V14, P895, DOI 10.1111/obr.12061; Tamura Y, 2013, ENVIRON HEALTH PREV, V18, P313, DOI 10.1007/s12199-012-0322-6; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Whiting SJ, 2004, J NUTR, V134, p696S, DOI 10.1093/jn/134.3.696S; Winzenberg T, 2006, BMJ-BRIT MED J, V333, P775, DOI 10.1136/bmj.38950.561400.55; Wunsche K, 2000, CALCIFIED TISSUE INT, V67, P349, DOI 10.1007/s002230001143; Xu Y, 2014, J BONE MINER METAB, V32, P159, DOI 10.1007/s00774-013-0474-5; Zulfarina MS, 2016, IRAN J PUBLIC HEALTH, V45, P1545	52	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202321	10.1371/journal.pone.0202321	http://dx.doi.org/10.1371/journal.pone.0202321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106982	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800039
J	Bisognin, F; Lombardi, G; Lombardo, D; Re, MC; Dal Monte, P				Bisognin, Francesco; Lombardi, Giulia; Lombardo, Donatella; Re, Maria Carla; Dal Monte, Paola			Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples	PLOS ONE			English	Article							ASSAY; DIAGNOSIS; RESISTANCE	Background The new Xpert MTB/RIF Ultra assay (Ultra, Cepheid, Sunnyvale, USA) is a cartridge-based automated diagnostic test that can simultaneously identify Mycobacterium tuberculosis complex (MTB) and resistance to Rifampicin (RIF). With respect to the previous version Xpert MTB/RIF assay (Xpert), IS6110/1S1081 repetitive elements probes have been added allowing the detection of lower MTB load, defined by the new semi-quantitative category "trace" with indeterminate RIF resistance. The aim of this study was to evaluate performance of the new version Ultra on Xpert-negative, but TB culture-positive clinical samples. Methods The de-identified frozen samples (-20 degrees C) collected over a 4-year period (February 2014-October 2017), which had previously resulted smear-negative, Xpert-negative but MTB culture-positive, were analyzed with Ultra. The de-frosted samples were loaded into the cartridge using the same process as the previous version, according to manufacturer's instruction. Results During the study period 382 MTB culture-positive samples were archived: 314 resulted Xpert-positive and 68 Xpert-negative. Thirty-one of the 68 Xpert-negative samples resulted positive with Ultra, with an overall improvement in MTB detection of 45.6%. Out of 36 Xpert-negative respiratory samples, 18 resulted Ultra-positive with the following semi-quantitative loads: "low"(n = 1), "very low"(n = 11), "trace"(n = 6), with an improvement in MTB detection of 50%. The best performance was achieved on bronchoalveolar lavage specimens (53.8%). Out of 32 Xpert-negative non-respiratory samples, 13 resulted Ultra-positive with the following semi-quantitative loads: "very low"(n = 7), "trace"(n = 6), with an improvement in MTB detection of 40.6%. The best performance was achieved on biopsies (55.6%) and lymph nodes (50%). The new category "trace" detected 12 out of the 31 Ultra-positive MTB samples; in the remaining 19 samples RIF susceptibility was determined with 100% concordance with the phenotypic susceptibility test. The mean time to positivity of samples found negative by Ultra was significantly longer in comparison to positive samples in liquid culture. Conclusions Our results are consistent with the few studies published so far and confirm the better performance of Ultra compared to the previous version in both respiratory and non-respiratory smear-negative samples, with an overall improvement of 45.6%.	[Bisognin, Francesco; Lombardi, Giulia; Lombardo, Donatella; Re, Maria Carla; Dal Monte, Paola] Alma Mater Studiorum Univ Bologna, S Orsola Malpighi Univ Hosp, Unit Microbiol, Dept Expt Diagnost & Specialty Med, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Lombardi, G (corresponding author), Alma Mater Studiorum Univ Bologna, S Orsola Malpighi Univ Hosp, Unit Microbiol, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	g.lombardi@unibo.it	LOMBARDI, GIULIA/HGC-4356-2022; Lombardo, Donatella/GZL-5851-2022	LOMBARDI, GIULIA/0000-0001-6423-8358; Lombardo, Donatella/0000-0003-0730-742X; DAL MONTE, PAOLA/0000-0003-2326-7464; BISOGNIN, FRANCESCO/0000-0002-3254-9239	Fondazione Del Monte of Bologna and Ravenna [FdM/6243, ROL FdM/6243]	Fondazione Del Monte of Bologna and Ravenna	Fondazione Del Monte of Bologna and Ravenna (grant number: FdM/6243), http://fondazionedelmonte.it/. PDM received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by the contribution of the "Fondazione Del Monte of Bologna and Ravenna" (ID ROL FdM/6243). The authors thank Dr. Paola Monari and Dr. Sonia Bonora for technical support and Jackie Leeder BSc, for English language editing.	Cepheid, 2017, XPERT MTB RIF ULTR B; Chakravorty S, 2017, MBIO, V8, DOI [10.1128/mBio.00812-17, 10.1128/mbio.00812-17]; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Foundation for Innovative New Diagnostics, 2017, REP WHO MULT NON DIA; Lombardi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176186; Rufai SB, 2014, J CLIN MICROBIOL, V52, P1846, DOI 10.1128/JCM.03005-13; Singh S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0528-z; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05658; WHO, 2017, GLOB TUB REP 2017; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	12	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201934	10.1371/journal.pone.0201934	http://dx.doi.org/10.1371/journal.pone.0201934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102737	Green Published, Green Submitted, gold			2022-12-26	WOS:000441452200023
J	da Silva, NB; Taus, NS; Johnson, WC; Mira, A; Schnittger, L; Valente, JDM; Vidotto, O; Masterson, HE; Vieira, TSWJ; Ueti, MW; Vieira, RFC				da Silva, Nayara B.; Taus, Naomi S.; Johnson, Wendell C.; Mira, Anabela; Schnittger, Leonhard; Valente, Jessica D. M.; Vidotto, Odilon; Masterson, Hayley E.; Vieira, Thallitha S. W. J.; Ueti, Massaro W.; Vieira, Rafael F. C.			First report of Anaplasma marginale infection in goats, Brazil	PLOS ONE			English	Article							STRAINS; CATTLE; OVIS; IXODIDAE; SHEEP	Anaplasma marginale, the causative agent of bovine anaplasmosis, is a tick-borne bacterium that causes significant economic losses for cattle industries and is increasingly being detected in other animal species. Rhipicephalus microplus is the main vector of this bacterium and may be found parasitizing small ruminants. In northeastern Brazil, multispecies grazing is a common family subsistence practice on smallholder farms possibly facilitating interspecies transmission of pathogens. Considering that A. marginale infection has been previously molecularly described in sheep, this study has aimed to estimate the prevalence of A. marginale and factors associated with the infection in goats from northeastern Brazil. A total of 403 goat blood samples were included in the study. An epidemiological questionnaire was applied to each farm owner addressing age, gender, presence of ticks and multispecies grazing. All samples were screened for A. marginale- and A. ovis-infection using primers targeting the Anaplasma spp. msp4 gene. The identity of A. marginale in the blood was confirmed by PCR amplification of msp5 followed by sequencing. Anaplasma spp. were differentiated by sequencing of the repeat region of the msp1 alpha gene. For the statistical analysis the Chi-square or the Fisher's exact test was used to verify association of the individual factors (age, gender, presence of ticks, and multispecies grazing) with Anaplasma spp. infection. We report the first molecular detection of A. marginale in goats from northeastern Brazil, based on msp1 alpha, msp4 and msp5 gene sequencing analysis. Sequencing of the detected A. marginale msp1 alpha gene revealed the F repeat. Amblyomma parvum and R. microplus were found feeding on animals.	[da Silva, Nayara B.; Valente, Jessica D. M.; Vieira, Thallitha S. W. J.; Vieira, Rafael F. C.] Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil; [Taus, Naomi S.; Johnson, Wendell C.; Ueti, Massaro W.] ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA; [Taus, Naomi S.; Masterson, Hayley E.; Ueti, Massaro W.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mira, Anabela; Schnittger, Leonhard] INTA Castelar, Inst Pathobiol, Ctr Res Vet & Agron Sci, Castelar, Argentina; [Vidotto, Odilon] Univ Estadual Londrina, Dept Prevent Vet Med, Londrina, Parana, Brazil	Universidade Federal do Parana; United States Department of Agriculture (USDA); Washington State University; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidade Estadual de Londrina	Vieira, RFC (corresponding author), Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil.; Ueti, MW (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA.; Ueti, MW (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	massaro_ueti@wsu.edu; rvieira@ufpr.br	Vieira, Thallitha/AAY-3838-2021; Vieira, Rafael F.C./AAY-3827-2021; Schnittger, Leonhard/ABE-8453-2020	Vieira, Thallitha/0000-0002-8631-2712; Vieira, Rafael F.C./0000-0001-6613-0287; Schnittger, Leonhard/0000-0003-3484-5370	Agricultural Research Service [2090-32000-038-00D]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq	Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Agricultural Research Service (2090-32000-038-00D to Dr. Massaro W. Ueti), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (fellowship to MSc Nayara B. da Silva), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (fellowship to Jessica D.M. Valente). CNPq also provided an academic scholarship to Dr. Rafael Vieira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenheuer AJ, 2003, J CLIN MICROBIOL, V41, P4172, DOI 10.1128/JCM.41.9.4172-4177.2003; Brito D. R. B, 2005, Revista Brasileira de Parasitologia Veterinaria, V14, P59; Cabezas-Cruz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065243; Castaneda-Ortiz EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120748; da Silva JB, 2015, INFECT GENET EVOL, V35, P38, DOI 10.1016/j.meegid.2015.07.027; Dantas-Torres Filipe, 2009, Systematic and Applied Acarology, V14, P30; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Estrada-Pena A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-57; Grisi L, 2014, REV BRAS PARASITOL V, V23, P150, DOI 10.1590/S1984-29612014042; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Ma ML, 2016, KOREAN J PARASITOL, V54, P301, DOI 10.3347/kjp.2016.54.3.301; Machado CAL, 2017, COMP IMMUNOL MICROB, V55, P1, DOI 10.1016/j.cimid.2017.08.004; Machado RZ, 2015, REV BRAS PARASITOL V, V24, P438, DOI 10.1590/S1984-29612015078; Palmer GH, 2004, J CLIN MICROBIOL, V42, P5381, DOI 10.1128/JCM.42.11.5381-5384.2004; Pohl AE, 2013, REV BRAS PARASITOL V, V22, P129, DOI 10.1590/S1984-29612013000100024; Ramos RAN, 2008, REV BRAS PARASITOL V, V17, P115, DOI 10.1590/S1984-29612008000200011; Silva JB, 2014, VET PARASITOL, V205, P730, DOI 10.1016/j.vetpar.2014.09.009; Yousefi A, 2017, ASIAN PAC J TROP BIO, V7, P455, DOI 10.1016/j.apjtb.2017.01.017	18	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202140	10.1371/journal.pone.0202140	http://dx.doi.org/10.1371/journal.pone.0202140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102734	gold, Green Published, Green Submitted			2022-12-26	WOS:000441452200033
J	Lawson, G; Ogwu, J; Tanna, S				Lawson, Graham; Ogwu, John; Tanna, Sangeeta			Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy	PLOS ONE			English	Article							ATR-FTIR SPECTROSCOPY; RAMAN-SPECTROSCOPY; COUNTERFEIT MEDICINES; QUALITY-CONTROL; DRUGS; PARACETAMOL; CHEMOMETRICS; QUANTIFICATION; FORMULATIONS; DISCRIMINATE	The World Health Organization suggests that approximately 10% of medicines worldwide are either falsified or substandard with higher figures in low and middle income countries. Such poor quality medicines can seriously harm patients and pose a threat to the economy worldwide. This study investigates attenuated total reflectance-fourier transform infrared (ATR-FTIR) spectroscopy as a simple and rapid method for determination of drug content in tablet dosage forms. Paracetamol was used as the model pharmaceutical ingredient. Spectra of standard mixtures of paracetamol with different excipients formed the basis for multi-variate PLS based quantitative analysis of simulated tablet content using different selected infrared absorbance bands. Calibration methods using ATR-FTIR were compared with the ATR-FTIR and conventional ultraviolet spectroscopic analyses of real tablet samples and showed that the paracetamol/microcrystalline cellulose mixtures gave optimum results for all spectral bands tested. The quantitative data for band 1524-1493cm(-1) was linear (R-2 > 0.98; LOQ >= 10%w/w tablet). Global examples of paracetamol tablets were tested using this protocol and 12% of the tablet samples examined was identified as substandard. Each sample analysis was completed in just a few minutes. ATR-FTIR can therefore be used in the rapid screening of tablet formulations. The simplicity of the proposed method makes it appropriate for use in low and middle income countries where analytical facilities are not available.	[Lawson, Graham; Ogwu, John; Tanna, Sangeeta] De Montfort Univ, Leicester Sch Pharm, Fac Hlth & Life Sci, Leicester, Leics, England	De Montfort University	Tanna, S (corresponding author), De Montfort Univ, Leicester Sch Pharm, Fac Hlth & Life Sci, Leicester, Leics, England.	stanna@dmu.ac.uk		Tanna, Sangeeta/0000-0001-5246-3603				Alghannam AFA, 2014, INTEGR PHARM RES PRA, V3, P71, DOI 10.2147/IPRP.S63690; Amado AM, 2017, SPECTROCHIM ACTA A, V183, P431, DOI 10.1016/j.saa.2017.04.076; Anzanello MJ, 2014, FORENSIC SCI INT, V235, P1, DOI 10.1016/j.forsciint.2013.12.005; Banerjee, 2012, J ANAL BIOANAL TECHN, V3, P1, DOI [10.4172/2155-9872.1000151, DOI 10.4172/2155-9872.1000151]; Barry F., MEDLINE RECALLS MISL; Bosch ME, 2006, J PHARMACEUT BIOMED, V42, P291, DOI 10.1016/j.jpba.2006.04.007; Clark F, 2015, LANCET, V386, P1327, DOI 10.1016/S0140-6736(15)00394-3; Custers D, 2015, J PHARMACEUT BIOMED, V112, P181, DOI 10.1016/j.jpba.2014.11.007; Custers D, 2014, TALANTA, V123, P78, DOI 10.1016/j.talanta.2014.01.020; Davison M., 2011, PHARM ANTICOUNTERFEI, V1; de Veij M, 2008, J PHARMACEUT BIOMED, V46, P303, DOI 10.1016/j.jpba.2007.10.021; de Veij M, 2007, J RAMAN SPECTROSC, V38, P181, DOI 10.1002/jrs.1621; Degardin K, 2015, FORENSIC SCI INT, V248, P15, DOI 10.1016/j.forsciint.2014.11.015; Degardin K, 2014, J PHARMACEUT BIOMED, V87, P167, DOI 10.1016/j.jpba.2013.01.009; Degardin K, 2011, ANAL CHIM ACTA, V705, P334, DOI 10.1016/j.aca.2011.07.043; Dumarey M, 2009, ANAL CHIM ACTA, V655, P43, DOI 10.1016/j.aca.2009.09.050; Farouk F, 2011, SPECTROSC-BIOMED APP, V26, P297, DOI 10.1155/2011/975284; Fernandez FM, 2008, IND ENG CHEM RES, V47, P585, DOI 10.1021/ie0703787; Glass BD, 2014, RES REP TROP MED, V5, P11, DOI 10.2147/RRTM.S39354; Gorog S, 2015, TRAC-TREND ANAL CHEM, V69, P114, DOI 10.1016/j.trac.2014.11.020; Haywood A, 2011, AUST PRESCR, V34, P112; Hollein L, 2016, TRAC-TREND ANAL CHEM, V76, P60, DOI 10.1016/j.trac.2015.11.009; Hoellein L, 2014, J PHARMACEUT BIOMED, V98, P434, DOI 10.1016/j.jpba.2014.06.013; Jackson G, 2012, INT J CLIN PRACT, V66, P241, DOI 10.1111/j.1742-1241.2011.02826.x; Koczwara A, 2017, J PHARM SCI-US, V106, P2921, DOI 10.1016/j.xphs.2017.05.018; Koesdjojo MT, 2014, TALANTA, V130, P122, DOI 10.1016/j.talanta.2014.05.050; Kovacs S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090601; Kwok K, 2012, VIB SPECTROSC, V61, P176, DOI 10.1016/j.vibspec.2012.02.018; Lawson G., 2014, J ANAL BIOANAL TECH, V5, P214, DOI [10.4172/2155-9872.1000214, DOI 10.4172/2155-9872.1000214]; Lebel P, 2014, J CHROMATOGR A, V1343, P143, DOI 10.1016/j.chroma.2014.03.078; Lyndgaard LB, 2013, CHEMOMETR INTELL LAB, V125, P58, DOI 10.1016/j.chemolab.2013.03.014; Mallah MA, 2015, SPECTROCHIM ACTA A, V141, P64, DOI 10.1016/j.saa.2015.01.036; Nanda M., 2014, AUSTIN J CHEM ENG, V1, P1004; Neuberger S, 2015, J PHARMACEUT BIOMED, V112, P70, DOI 10.1016/j.jpba.2015.04.001; Ortiz RS, 2013, FORENSIC SCI INT, V226, P282, DOI 10.1016/j.forsciint.2013.01.043; Panusa A, 2007, J PHARMACEUT BIOMED, V43, P1221, DOI 10.1016/j.jpba.2006.10.012; Ranieri N, 2014, AM J TROP MED HYG, V91, P920, DOI 10.4269/ajtmh.13-0644; Roggo Y, 2007, J PHARMACEUT BIOMED, V44, P683, DOI 10.1016/j.jpba.2007.03.023; Rowe R.C., 2012, HDB PHARM EXCIPIENTS; Russo G, 2016, J PHARMACEUT BIOMED, V117, P436, DOI 10.1016/j.jpba.2015.09.027; Sacre PY, 2010, J PHARMACEUT BIOMED, V53, P445, DOI 10.1016/j.jpba.2010.05.012; Sammons HM, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000007; Silvestre V, 2009, J PHARMACEUT BIOMED, V50, P336, DOI 10.1016/j.jpba.2009.04.030; Sukkar E., 2014, PHARM J, V292, P570, DOI DOI 10.1211/PJ.2014.11138907; Vredenbregt MJ, 2006, J PHARMACEUT BIOMED, V40, P840, DOI 10.1016/j.jpba.2005.07.048; Wilczynski S, 2015, INT J PHARMACEUT, V490, P16, DOI 10.1016/j.ijpharm.2015.04.077; World Health Organization, 2018, SUBST SPUR FALS LAB	47	28	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202059	10.1371/journal.pone.0202059	http://dx.doi.org/10.1371/journal.pone.0202059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096202	gold, Green Submitted, Green Published			2022-12-26	WOS:000441308500047
J	Nichols, KS; Homayoun, T; Eckles, J; Blair, RB				Nichols, K. Samantha; Homayoun, Tania; Eckles, Joanna; Blair, Robert B.			Bird-building collision risk: An assessment of the collision risk of birds with buildings by phylogeny and behavior using two citizen-science datasets	PLOS ONE			English	Article							WINDOW COLLISIONS; MORTALITY; LANDSCAPE	Bird collisions with buildings are the second largest anthropogenic source of direct mortality for birds (365-988 million birds killed annually in the United States). Recent research suggests that this mortality occurs disproportionately across species. However, previous work had relied on regional and annual measures of relative species abundance. Our research identifies which species experience higher or lower collision rates than expected from local abundances using two sets of citizen science data: Minnesota Project BirdSafe and the Mississippi River Twin Cities Important Bird Area Landbird Monitoring Program. Our analysis used a measure of relative species abundance that spatially overlaps the area monitored for building collisions and was measured weekly, allowing for a temporally and spatially more specific analysis than most previous analyses. Abundance and collision data were used to model phylogenetic and behavioral traits associated with increased collision risk. Behavioral traits included diurnal/nocturnal migration timing, length of migration, and foraging strategies. Our analysis shows that birds that predominately migrate during the day have a decreased risk of building collisions despite peak collision numbers occurring during early morning; this result suggests that more nuanced behavioral or physiological differences between diurnal and nocturnal migrants could contribute to bird-building collision risk. Additionally, for many species, local abundance is the predominant determining factor for collision risk. However, for similar to 20% of species studied, the family, genus, and/or species of a bird may affect the collision risk.	[Nichols, K. Samantha; Homayoun, Tania] Univ Minnesota, Conservat Sci Grad Program, St Paul, MN 55108 USA; [Eckles, Joanna] Audubon Minnesota, St Paul, MN USA; [Blair, Robert B.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nichols, KS (corresponding author), Univ Minnesota, Conservat Sci Grad Program, St Paul, MN 55108 USA.	nicho561@umn.edu	Blair, Robert Brown/GYQ-5874-2022					Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; [Anonymous], 2013, POP EST DAT VERS 201; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Banks R. C., 1976, BIOSCIENCE, V26, P414, DOI [10.2307/1297184, DOI 10.2307/1297184]; Bayne EM, 2012, WILDLIFE RES, V39, P583, DOI 10.1071/WR11179; Birdlife International, 2012, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2012-1.RLTS.T22721618A39860643.en, DOI 10.2305/IUCN.UK.2012-1.RLTS.T22721618A39860643.EN]; Bolker B, 2012, R PACKAG VER 20 8, P12; Borden W. Calvin, 2010, Ohio Journal of Science, V110, P44; Burgess HK, 2017, BIOL CONSERV, V208, P113, DOI 10.1016/j.biocon.2016.05.014; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cusa M, 2015, URBAN ECOSYST, V18, P1427, DOI 10.1007/s11252-015-0459-3; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; DUNN EH, 1993, J FIELD ORNITHOL, V64, P302; Fischer D., 2013, INTRO R, P2; Fuchs T, 2006, ANIM BEHAV, V72, P951, DOI 10.1016/j.anbehav.2006.03.008; Gelb Yigal, 2006, Kingbird, V56, P190; Grubb Jr. T., 2008, BIRDS N AM; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Hager SB, 2017, BIOL CONSERV, V212, P209, DOI 10.1016/j.biocon.2017.06.014; Hager SB, 2014, PEERJ, V2, DOI 10.7717/peerj.460; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Homayoun T.Z., 2015, URBAN ECOSYST; Homayoun TZ, 2011, CITIZEN SCI MONITORI; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kahle LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144600; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; KLEM D, 1989, WILSON BULL, V101, P606; Klem D, 2014, LAND-BASEL, V3, P351, DOI 10.3390/land3010351; Klem D, 2009, WILSON J ORNITHOL, V121, P126, DOI 10.1676/08-068.1; Klem DJ, 2012, PLOS ONE; Kummer JA, 2016, CONDOR, V118, P624, DOI 10.1650/CONDOR-16-26.1; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; Matsuoka SM, 2014, CONDOR, V116, P599, DOI 10.1650/CONDOR-14-108.1; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Ricotta C, 2012, OECOLOGIA, V170, P501, DOI 10.1007/s00442-012-2318-8; Rodewald P., 2015, BIRDS N AM ONLINE; RStudio Team, 2015, RSTUDIO INT DEV R; Sauer John R., 2013, North American Fauna, V79, P2, DOI 10.3996/nafa.79.0001; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Schaub M, 2011, PLOS ONE, DOI [10.1371/journal.pone.0024708, DOI 10.1371/JOURNAL.PONE.0024708]; Schmidt JH, 2013, BIOL CONSERV, V160, P130, DOI 10.1016/j.biocon.2013.01.007; Sigwart JD, 2017, ZOOL J LINN SOC-LOND; Veech JA, 2012, AUK, V129, P259, DOI 10.1525/auk.2012.11242; Veltri CJ, 2005, J FIELD ORNITHOL, V76, P127, DOI 10.1648/0273-8570-76.2.127; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wittig TW, 2017, AVIAN CONSERV ECOL, V12, DOI [10.5751/ACE-01014-120117, 10.5751/ace-01014-120117]; Zink Robert M., 2010, Loon, V82, P34	52	14	18	13	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201558	10.1371/journal.pone.0201558	http://dx.doi.org/10.1371/journal.pone.0201558			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092094	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600036
J	Quintana, MD; Ch'ng, JH; Zandian, A; Imam, M; Hultenby, K; Theisen, M; Nilsson, P; Qundos, U; Moll, K; Chan, S; Wahlgren, M				Quintana, Maria del Pilar; Ch'ng, Jun-Hong; Zandian, Arash; Imam, Maryam; Hultenby, Kjell; Theisen, Michael; Nilsson, Peter; Qundos, Ulrika; Moll, Kirsten; Chan, Sherwin; Wahlgren, Mats			SURGE complex of Plasmodium falciparum in the rhoptry-neck (SURFIN4.2-RON4-GLURP) contributes to merozoite invasion	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; MALARIA PARASITE INVASION; RED-BLOOD-CELL; ERYTHROCYTE-MEMBRANE PROTEIN-1; GROWTH IN-VITRO; INFECTED ERYTHROCYTES; INHIBITORY ANTIBODIES; SURFACE-PROTEINS; GLURP; VACCINE	Plasmodium falciparum invasion into red blood cells (RBCs) is a complex process engaging proteins on the merozoite surface and those contained and sequentially released from the apical organelles (micronemes and rhoptries). Fundamental to invasion is the formation of a moving junction (MJ), a region of close apposition of the merozoite and the RBC plasma membranes, through which the merozoite draws itself before settling into a newly formed parasitophorous vacuole (PV). SURFIN4.2 was identified at the surface of the parasitized RBCs (pRBCs) but was also found apically associated with the merozoite. Using antibodies against the N-terminus of the protein we show the presence of SURFIN4.2 in the neck of the rhoptries, its secretion into the PV and shedding into the culture supernatant upon schizont rupture. Using immunoprecipitation followed by mass spectrometry we describe here a novel protein complex we have named SURGE where SURFIN4.2 forms interacts with the rhoptry neck protein 4 (RON4) and the Glutamate Rich Protein (GLURP). The N-terminal cysteine-rich domain (CRD) of SURFIN4.2 mediates binding to the RBC membrane and its interaction with RON4 suggests its involvement in the contact between the merozoite apex and the RBC at the MJ. Supporting this suggestion, we also found that polyclonal antibodies to the extracellular domain (including the CRD) of SURFIN4.2 partially inhibit merozoite invasion. We propose that the formation of the SURGE complex participates in the establishment of parasite infection within the PV and the RBCs.	[Quintana, Maria del Pilar; Ch'ng, Jun-Hong; Imam, Maryam; Moll, Kirsten; Chan, Sherwin; Wahlgren, Mats] Karolinska Inst, Biomedicum, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Ch'ng, Jun-Hong] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore, Singapore; [Zandian, Arash; Nilsson, Peter; Qundos, Ulrika] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Affin Prote, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Div Clin Res Ctr, Huddinge, Sweden; [Theisen, Michael] Statens Serum Inst, Dept Congenital Disorders, Copenhagen, Denmark; [Theisen, Michael] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark	Karolinska Institutet; National University of Singapore; Royal Institute of Technology; Karolinska Institutet; Statens Serum Institut; University of Copenhagen	Wahlgren, M (corresponding author), Karolinska Inst, Biomedicum, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se	Ch'ng, Jun Hong/V-7150-2019; Nilsson, Peter/E-4547-2010	Nilsson, Peter/0000-0002-4657-8532; Quintana, Maria del Pilar/0000-0001-6190-3324; Theisen, Michael/0000-0003-4412-1392; Zandian, Arash/0000-0003-1242-0873	Swedish Research Council [VR/2012-2014/521-2011-3377]; Royal Swedish Academy of Sciences (KVA); European Commission (ERACOL-Erasmus Columbus 2013); Administrative Department of Science, Technology and Innovation (Colciencias, Becas Francisco JoseA de Caldas)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences (KVA); European Commission (ERACOL-Erasmus Columbus 2013)(European Commission); Administrative Department of Science, Technology and Innovation (Colciencias, Becas Francisco JoseA de Caldas)	This study was funded by the Swedish Research Council (VR/2012-2014/521-2011-3377) to MW, https://vr.se/2.5b24e27d107949d9e3880000.html; the Royal Swedish Academy of Sciences (KVA) to MW, http://kva.se/sv/startsida; the European Commission (ERACOL-Erasmus Columbus 2013) to MPQ, http://nihes.com/eracol/index.html; and the Administrative Department of Science, Technology and Innovation (Colciencias, Becas Francisco JoseA de Caldas) to MPQ, http://www.colciencias.gov.co/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1146-4; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Beeson JG, 2016, FEMS MICROBIOL REV, V40, P343, DOI 10.1093/femsre/fuw001; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Chen L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002199; Cooper Roland A, 2002, Methods Mol Med, V72, P177, DOI 10.1385/1-59259-271-6:177; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; Esen M, 2009, VACCINE, V27, P6862, DOI 10.1016/j.vaccine.2009.09.011; Everberg H, 2006, J CHROMATOGR A, V1122, P35, DOI 10.1016/j.chroma.2006.04.020; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Forsstrom B, 2014, MOL CELL PROTEOMICS, V13, P1585, DOI 10.1074/mcp.M113.033308; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; Galaway F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14333; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Jepsen MPG, 2013, J INFECT DIS, V208, P479, DOI 10.1093/infdis/jit185; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kana IH, 2017, J INFECT DIS, V215, P623, DOI 10.1093/infdis/jiw617; Kauth CW, 2003, J BIOL CHEM, V278, P22257, DOI 10.1074/jbc.M302299200; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lin CS, 2016, J BIOL CHEM, V291, P7703, DOI 10.1074/jbc.M115.698282; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; Mphande FA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-116; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Petersen B., MOL BIOCH PARASITOL; Reddy K. S., 2015, P NATL ACAD SCI USA, V112; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Straub KW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002007; THEISEN M, 1994, INFECT IMMUN, V62, P3270, DOI 10.1128/IAI.62.8.3270-3275.1994; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Waller KL, 2010, BBA-BIOMEMBRANES, V1798, P861, DOI 10.1016/j.bbamem.2010.01.018; Weiss GE, 2015, PLOS PATHOG, V11; Weiss GE, 2016, TRENDS PARASITOL, V32, P284, DOI 10.1016/j.pt.2015.12.007; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; World Health Organization, 2017, DEPRESSION; Zandian A, 2017, J PROTEOME RES, V16, P1300, DOI 10.1021/acs.jproteome.6b00916; Zhu X, 2017, MALARIA J, P1, DOI [10.1186/s12936-016-1650-6, DOI 10.1186/S12936-016-1650-6]	56	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201669	10.1371/journal.pone.0201669	http://dx.doi.org/10.1371/journal.pone.0201669			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092030	Green Published, gold			2022-12-26	WOS:000441232600043
J	Sharma, D; Tiwari, A; Sood, S; Jamra, G; Singh, NK; Meher, PK; Kumar, A				Sharma, Divya; Tiwari, Apoorv; Sood, Salej; Jamra, Gautam; Singh, N. K.; Meher, Prabina Kumar; Kumar, Anil			Genome wide association mapping of agro-morphological traits among a diverse collection of finger millet (Eleusine coracana L.) genotypes using SNP markers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MIXED-MODEL APPROACH; FACILITATED INVESTIGATIONS; QUANTITATIVE TRAITS; MENDELIAN FACTORS; LOCI; MAIZE; IDENTIFICATION; TOMATO; PLANT	Finger millet (Eleusine coracana L.) is an important dry-land cereal in Asia and Africa because of its ability to provide assured harvest under extreme dry conditions and excellent nutritional properties. However, the genetic improvement of the crop is lacking in the absence of suitable genomic resources for reliable genotype-phenotype associations. Keeping this in view, a diverse global finger millet germplasm collection of 113 accessions was evaluated for 14 agro-morphological characters in two environments viz. ICAR-Vivekananda Institute of Hill Agriculture, Almora (E1) and Crop Research Centre (CRC), GBPUA&T, Pantnagar (E2), India. Principal component analysis and cluster analysis of phenotypic data separated the Indian and exotic accessions into two separate groups. Previously generated SNPs through genotyping by sequencing (GBS) were used for association mapping to identify reliable marker(s) linked to grain yield and its component traits. The marker trait associations were determined using single locus single trait (SLST), multi-locus mixed model (MLMM) and multi-trait mixed model (MTMM) approaches. SLST led to the identification of 20 marker-trait associations (MTAs) (p value<0.01 and <0.001) for 5 traits. While advanced models, MLMM and MTMM resulted in additional 36 and 53 MTAs, respectively. Nine MTAs were common out of total 109 associations in all the three mapping approaches (SLST, MLMM and MTMM). Among these nine SNPs, five SNP sequences showed homology to candidate genes of Oryza sativa (Rice) and Setaria italica (Foxtail millet), which play an important role in flowering, maturity and grain yield. In addition, 67 and 14 epistatic interactions were identified for 10 and 7 traits at El and E2 locations, respectively. Hence, the 109 novel SNPs associated with important agro-morphological traits, reported for the first time in this study could be precisely utilized in finger millet genetic improvement after validation.	[Sharma, Divya; Tiwari, Apoorv; Jamra, Gautam; Kumar, Anil] GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India; [Tiwari, Apoorv] Sam Higginbottom Univ Agr Technol & Sci, Allahabad, Uttar Pradesh, India; [Sood, Salej] ICAR Vivekananda Inst Hill Agr, Almora, Uttarakhand, India; [Singh, N. K.] GB Pant Univ Agr & Technol, Coll Agr, Dept Genet & Plant Breeding, Pantnagar, Uttarakhand, India; [Meher, Prabina Kumar] ICAR Indian Agr Stat Res Inst, Div Stat Genet, New Delhi, India; [Sood, Salej] ICAR Cent Potato Res Inst, Shimla, Himachal Prades, India	Govind Ballabh Pant University of Agriculture Technology; Sam Higginbottom University of Agriculture, Technology & Sciences; Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan; Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Potato Research Institute	Kumar, A (corresponding author), GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India.; Sood, S (corresponding author), ICAR Vivekananda Inst Hill Agr, Almora, Uttarakhand, India.; Sood, S (corresponding author), ICAR Cent Potato Res Inst, Shimla, Himachal Prades, India.	salej1plp@gmail.com; anilkumar.mbge@gmail.com	singh, Narendra Kumar/AAC-5386-2020; Boothapati, Anil Kumar/HHS-1813-2022; Sood, Salej/AAR-3504-2020; Meher, Prabina Kumar/V-9439-2019; KUMAR, ANIL/ACD-8340-2022	Meher, Prabina Kumar/0000-0002-7098-8785; TIWARI, APOORV/0000-0003-2294-0688; singh, narendra kumar/0000-0001-7404-5162	Department of Biotechnology, Govt. of India; DBT, India; Sub-DIC Bioinformatics - DBT	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); DBT, India(Department of Biotechnology (DBT) India); Sub-DIC Bioinformatics - DBT	DS and AT are supported by a fellowship from the Department of Biotechnology, Govt. of India. NexGenBio Life Sciences provided GBS sequencing services and analysis. No additional external funding was received for this study.; The authors wish to acknowledge Department of Biotechnology, Govt. of India for providing financial support and NXGenBio Life Sciences (New Delhi) for their valuable support. One of the authors is supported by fellowship from DBT, India and other from Sub-DIC Bioinformatics, supported by DBT during the project program.	[Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 1951, ANN EUGENIC, V15, P323, DOI [10.1111/j.1469-1809.1949.tb02451.x, DOI 10.1111/J.1469-1809.1949.TB02451.X]; Babu BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099182; Babu BK, 2014, MOL BIOL REP, V41, P3081, DOI 10.1007/s11033-014-3168-8; Barreto H., 1996, DROUGHT AND LOW N TO, P544; Bharathi A., 2011, THESIS; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Clevenger JP, 2015, G3-GENES GENOM GENET, V5, P1797, DOI 10.1534/g3.115.019703; Cockerham CC, 1996, GENETICS, V143, P1437; DEVICENTE MC, 1993, GENETICS, V134, P585; Dida M. M., 2008, Tropical Plant Biology, V1, P131, DOI 10.1007/s12042-008-9012-3; DOEBLEY J, 1995, GENETICS, V141, P333; EDWARDS MD, 1987, GENETICS, V116, P113; EDWARDS MD, 1992, THEOR APPL GENET, V83, P765, DOI 10.1007/BF00226696; FATOKUN CA, 1992, GENETICS, V132, P841; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Furlotte NA, 2015, GENETICS, V200, P59, DOI 10.1534/genetics.114.171447; Gao H, 2014, HEREDITY, V113, P526, DOI 10.1038/hdy.2014.57; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Gimode D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159437; Gonzalez JR, 2009, R PACKAGE SNPASSOC; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta PK, 2001, CURR SCI INDIA, V80, P524; HUANG YC, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PONE.0102448; Hulse-Kemp AM, 2015, G3-GENES GENOM GENET, V5, P1095, DOI 10.1534/g3.115.017749; Jaiswal V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159343; JOHNSON HERBERT W., 1955, AGRON JOUR, V47, P314; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KINOSHITA T, 1982, JPN J BREED, V32, P219; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kumar A, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.07.0058; Lai KT, 2012, PLANT BIOTECHNOL J, V10, P743, DOI 10.1111/j.1467-7652.2012.00718.x; LARK KG, 1995, P NATL ACAD SCI USA, V92, P4656, DOI 10.1073/pnas.92.10.4656; LI ZK, 1995, THEOR APPL GENET, V91, P374, DOI 10.1007/BF00220902; Li ZK, 1988, THEOR APPL GENET, V75, P811, DOI [10.1007/BF00265610, DOI 10.1007/BF00265610]; Mnyenyembe P. H., 1998, African Crop Science Journal, V6, P317; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; PATERSON AH, 1991, GENETICS, V127, P181; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rott M, 2011, PLANT CELL, V23, P304, DOI 10.1105/tpc.110.079111; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Sivagurunathan M, 2004, THESIS; Sood S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01634; SPASSKY B, 1965, GENETICS, V52, P653; STUBER CW, 1992, GENETICS, V132, P823; TANKSLEY SD, 1988, THEOR APPL GENET, V75, P811, DOI 10.1007/BF00265610; Wolie A, 2011, AFR J AGR RES, V6, P5099; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou XP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-573	55	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0199444	10.1371/journal.pone.0199444	http://dx.doi.org/10.1371/journal.pone.0199444			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092057	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600002
J	Qin, Y; Vasilatos, SN; Chen, L; Wu, H; Cao, ZS; Fu, YM; Huang, M; Vlad, AM; Lu, BF; Oesterreich, S; Davidson, NE; Huang, Y				Qin, Ye; Vasilatos, Shauna N.; Chen, Lin; Wu, Hao; Cao, Zhishen; Fu, Yumei; Huang, Min; Vlad, Anda M.; Lu, Binfeng; Oesterreich, Steffi; Davidson, Nancy E.; Huang, Yi			Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade	ONCOGENE			English	Article							INFILTRATING LYMPHOCYTES; PROGNOSTIC VALUE; CANCER; LSD1; EXPRESSION; CHEMOKINES; MICROENVIRONMENT; PEMBROLIZUMAB; REEXPRESSION; MPDL3280A	Immunotherapy strategies have been emerging as powerful weapons against cancer. Early clinical trials reveal that overall response to immunotherapy is low in breast cancer patients, suggesting that effective strategies to overcome resistance to immunotherapy are urgently needed. In this study, we investigated whether epigenetic reprograming by modulating histone methylation could enhance effector T lymphocyte trafficking and improve therapeutic efficacy of immune checkpoint blockade in breast cancer with focus on triple-negative breast cancer (TNBC) subtype. In silico analysis of The Cancer Genome Atlas (TCGA) data shows that expression of histone lysine-specific demethylase 1 (LSD1) is inversely associated with the levels of cytotoxic T cell-attracting chemokines (C-C motif chemokine ligand 5 (CCL5), C-X-C motif chemokine ligand 9 and 10 (CXCL9, CXCL10)) and programmed death-ligand 1 (PD-L1) in clinical TNBC specimens. Tiling chromatin immunoprecipitation study showed that re-expression of chemokines by LSD1 inhibition is associated with increased H3K4me2 levels at proximal promoter regions. Rescue experiments using concurrent treatment with small interfering RNA or inhibitor of chemokine receptors blocked LSD1 inhibitor-enhanced CD8+ T cell migration, indicating a critical role of key T cell chemokines in LSD1-mediated CD8+ lymphocyte trafficking to the tumor microenvironment. In mice bearing TNBC xenograft tumors, anti-PD-1 antibody alone failed to elicit obvious therapeutic effect. However, combining LSD1 inhibitors with PD-1 antibody significantly suppressed tumor growth and pulmonary metastasis, which was associated with reduced Ki-67 level and augmented CD8+ T cell infiltration in xenograft tumors. Overall, these results suggest that LSD1 inhibition may be an effective adjuvant treatment with immunotherapy as a novel management strategy for poorly immunogenic breast tumors.	[Qin, Ye; Vasilatos, Shauna N.; Chen, Lin; Wu, Hao; Oesterreich, Steffi; Huang, Yi] Univ Pittsburgh, UPMC Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15260 USA; [Qin, Ye; Huang, Min; Oesterreich, Steffi; Huang, Yi] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Cao, Zhishen; Vlad, Anda M.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Fu, Yumei] Allegheny Gen Hosp Pathol, Pittsburgh, PA USA; [Vlad, Anda M.; Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Davidson, Nancy E.] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Davidson, Nancy E.] Univ Washington, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle	Huang, Y (corresponding author), Univ Pittsburgh, UPMC Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15260 USA.; Huang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	yih26@pitt.edu	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Chen, Lin/0000-0002-8126-3333	US Army Breast Cancer Research Program [W81XWH-14-1-0237, W81XWH-14-1-0238]; Breast Cancer Research Foundation; NIH/NCI [P30CA047904]; Natural Science Foundation of China [81502366]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	US Army Breast Cancer Research Program(United States Department of Defense); Breast Cancer Research Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by US Army Breast Cancer Research Program (W81XWH-14-1-0237 to YH; W81XWH-14-1-0238 to NED/SO), Breast Cancer Research Foundation (to NED and SO), NIH/NCI P30CA047904 and Natural Science Foundation of China (81502366 to YQ).	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Akahori T, 2006, TRANSPLANT P, V38, P3366, DOI 10.1016/j.transproceed.2006.10.115; Ali HR, 2015, ANN ONCOL, V26, P1488, DOI 10.1093/annonc/mdv192; Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bhatti S, 2017, JCO PRECIS ONCOL, V1, P1; Cao C, 2017, ONCOGENE, V36, P133, DOI 10.1038/onc.2016.186; Cao CY, 2018, INT J CANCER, V143, P1388, DOI 10.1002/ijc.31419; Culhane JC, 2007, CURR OPIN CHEM BIOL, V11, P561, DOI 10.1016/j.cbpa.2007.07.014; Cunnick GH, 2002, HISTOL HISTOPATHOL, V17, P863, DOI 10.14670/HH-17.863; Deken MA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238557; Dirix L, 2016, CANC RES S, V76, pS1; Dong HD, 1999, NAT MED, V5, P1365; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hopewell EL, 2013, J CLIN INVEST, V123, P2509, DOI 10.1172/JCI67250; Huang Y, 2012, ROYAL SOC CHEM DRUG, V17, P238; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; Huang Y, 2009, ESSAYS BIOCHEM, V46, P95, DOI [10.1042/BSE0460007, 10.1042/bse0460007]; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Janzer A, 2012, J BIOL CHEM, V287, P30984, DOI 10.1074/jbc.M112.341040; Katz TA, 2014, ANN MED, V46, P397, DOI 10.3109/07853890.2014.923740; Kim JM, 2016, ANN ONCOL, V27, P1492, DOI 10.1093/annonc/mdw217; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Muthuswamy R, 2012, CANCER RES, V72, P3735, DOI 10.1158/0008-5472.CAN-11-4136; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Nishino M, 2017, NAT REV CLIN ONCOL, V14, P655, DOI 10.1038/nrclinonc.2017.88; Ostrand-Rosenberg S, 2014, J IMMUNOL, V193, P3835, DOI 10.4049/jimmunol.1401572; Pasculli B, 2018, SEMIN CANCER BIOL, V51, P22, DOI 10.1016/j.semcancer.2018.01.007; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ran S, 2010, PATHOPHYSIOLOGY, V17, P229, DOI DOI 10.1016/J.PATH0PHYS.2009.11.003; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rugo HS, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-S5-07; Sandhu R, 2015, AM J PATHOL, V185, P282, DOI 10.1016/j.ajpath.2014.12.003; Shayan G, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1261779; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Solinas C, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2017-000255; Terranova-Barberio M, 2017, ONCOTARGET, V8; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Wang K, 2017, HUM PATHOL, V69, P110, DOI 10.1016/j.humpath.2017.09.012; Wimberly H, 2015, CANCER IMMUNOL RES, V3, P326, DOI 10.1158/2326-6066.CIR-14-0133; Zheng H, 2016, CLIN CANCER RES, V22, P4119, DOI 10.1158/1078-0432.CCR-15-2584	55	90	93	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					390	405		10.1038/s41388-018-0451-5	http://dx.doi.org/10.1038/s41388-018-0451-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30111819	Green Accepted			2022-12-26	WOS:000455851200007
J	Lee, HS; Yoon, JS; Park, KJ; Hwang, JS				Lee, Hae Sang; Yoon, Jong Seo; Park, Kyu Jung; Hwang, Jin Soon			Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty	PLOS ONE			English	Article							LONG-TERM TREATMENT; REPRODUCTIVE FUNCTION; GNRH AGONIST; THERAPY; ANALOGS; EXPERIENCE; CESSATION; HEALTH	Objective Gonadotropin-releasing hormone agonists (GnRHa) are the treatment of choice for central precocious puberty (CPP) and have been widely used for several decades. We determined the effect of GnRHa treatment on the auxological outcomes of girls with idiopathic CPP. Methods This study included 84 girls treated monthly with depot leuprolide acetate who had reached adult height. We compared their final adult height (FAH) with their initial predicted adult height (PAH). We performed a multivariate analysis of the factors associated with FAH on all girls diagnosed with CPP. Results We performed the final evaluations at a mean age of 14.1 +/- 0.8 years after a mean treatment duration of 2.98 +/- 0.73 years (ranging from 1.5-4.8 years). Menarche had occurred at 12.6 +/- 0.6 years of age, which was 16.5 +/- 6.1 months after discontinuation of GnRHa therapy. Mean FAH was 160.1 +/- 5.0 cm, which was significantly higher than the initial PAH (156.1 +/- 5.7 cm; P < 0.001). To investigate whether growth outcomes were influenced by the age at initial treatment, we divided all patients into two groups, those treated between 6 and 8 years (n = 23) and those treated after 8 years (n = 61); no significant differences were observed in FAH between the two groups. FAH was significantly and positively correlated with the height standard deviation score (SDS) at the end of treatment and with the target height, whereas the difference between bone age and chronological age at the start and end of treatment was negatively correlated with FAH. Conclusion FAH was significantly higher than the initial PAH in girls with CPP who were treated with GnRHa. Also, GnRHa treatment was still effective even after 8 years of age in girls with CPP.	[Lee, Hae Sang; Yoon, Jong Seo; Park, Kyu Jung; Hwang, Jin Soon] Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon, South Korea	Ajou University; Ajou University Hospital	Hwang, JS (corresponding author), Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon, South Korea.	pedhwang@ajou.ac.kr	lee, haesang/AAG-6951-2022; lee, Hae Sang/AFL-6833-2022	lee, Hae Sang/0000-0002-9684-4042; Yoon, Jong Seo/0000-0003-2331-1680	Ajou University School of Medicine [M-2016-C0460-00033]; Ajou University School of Medicine	Ajou University School of Medicine; Ajou University School of Medicine	This study was supported by the 2016 new faculty Research Fund from Ajou University School of Medicine, URL: http://medicine.ajou.ac. kr/, Grant number M-2016-C0460-00033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the 2016 new faculty Research Fund from Ajou University School of Medicine.	Antoniazzi Franco, 2004, Paediatr Drugs, V6, P211, DOI 10.2165/00148581-200406040-00002; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Bhatia S, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e30; Brito VN, 2008, J CLIN ENDOCR METAB, V93, P2662, DOI 10.1210/jc.2007-2183; Carel JC, 1999, J CLIN ENDOCR METAB, V84, P1973; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Greulich WW, 1959, RADIOLOGIC ATLAS SKE, V2nd; Guaraldi F, 2016, EUR J ENDOCRINOL, V174, pR79, DOI 10.1530/EJE-15-0590; Heger S, 1999, J CLIN ENDOCR METAB, V84, P4583, DOI 10.1210/jc.84.12.4583; Klein KO, 2001, J CLIN ENDOCR METAB, V86, P4711, DOI 10.1210/jc.86.10.4711; Lazar L, 2007, J CLIN ENDOCR METAB, V92, P3483, DOI 10.1210/jc.2007-0321; Lazar L, 2015, J CLIN ENDOCR METAB, V100, P1445, DOI 10.1210/jc.2014-3748; Lee PA, 2011, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2011-7; Lin YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185080; Magiakou MA, 2010, J CLIN ENDOCR METAB, V95, P109, DOI 10.1210/jc.2009-0793; Micillo M, 2000, J PEDIATR ENDOCR MET, V13, P787; Mul D, 2000, J PEDIATR ENDOCR MET, V13, P765, DOI 10.1515/JPEM.2000.13.S1.765; Nabhan ZM, 2009, J PEDIATR ENDOCR MET, V22, P309; Oostdijk W, 1996, ARCH DIS CHILD, V75, P292, DOI 10.1136/adc.75.4.292; Park J, 2018, ANN PEDIATR ENDOCRIN, V23, P14, DOI 10.6065/apem.2018.23.1.14; Pasquino AM, 2008, J CLIN ENDOCR METAB, V93, P190, DOI 10.1210/jc.2007-1216; Poomthavorn P, 2011, GYNECOL ENDOCRINOL, V27, P524, DOI 10.3109/09513590.2010.507289; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; Thornton P, 2014, PEDIATR ENDOCR REV P, V11, P306; Willemsen RH, 2014, NAT REV ENDOCRINOL, V10, P352, DOI 10.1038/nrendo.2014.40; XhrouetHeinrichs D, 1997, ACTA PAEDIATR, V86, P808; Ying YQ, 2017, ONCOTARGET, V8, P109061, DOI 10.18632/oncotarget.22568; 문진수, 2008, Clinical and Experimental Pediatrics, V51, P1	29	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201906	10.1371/journal.pone.0201906	http://dx.doi.org/10.1371/journal.pone.0201906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133462	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400046
J	Lin, YS; Yeh, CC; Huang, SF; Chou, YS; Kuo, LT; Sung, FC; Muo, CH; Su, CT; Su, FH				Lin, Yu-Shan; Yeh, Chih-Ching; Huang, Shiang-Fu; Chou, Yi-Sheng; Kuo, Li-Tang; Sung, Fung-Chang; Muo, Chih-Hsin; Su, Chien-Tien; Su, Fu-Hsiung			Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; UPPER AERODIGESTIVE TRACT; COLORECTAL-CANCER; NATIONWIDE COHORT; CHEMOPREVENTION; PREVENTION; HEALTH; TRIAL	As reported by the Taiwan Cancer Registry in 2013 squamous cell carcinoma of head and neck cancer (HNSCC) was the sixth most frequently diagnosed cancer and the 5 th most common cause of cancer related death and its incidence and mortality rate is still rising. The co-occurrence of HNSCC and secondary primary cancer (SPC) and the chemopreventive effect of aspirin on certain malignancies had been reported. Therefore we conducted this national study to investigate the use of aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer in Taiwan. We searched the Registry for Catastrophic Illness in the National Health Insurance Research Database (NHIRD) for 18,234 patients (3,576 aspirin users and 14,667 non-aspirin users) diagnosed with HNSCC during 2000 +/- 2005. The SPC incidence density during follow-up in 2000 +/- 2011 was compared between the groups. For HNSCC patients, aspirin use after diagnosis was significantly associated with SPC risk reduction by 25% (adjusted HR, 0.75; 95% CI, 0.63 +/- 0.89; p = 0.001) after multivariate analysis. In the subgroup analysis, we found that esophageal cancer and stomach cancer incidence were significantly reduced after aspirin use (adjusted HR, 0.60; 95% CI, 0.41 +/- 0.90; p = 0.01 for esophageal cancer; adjusted HR, 0.27; 95% CI, 0.08 +/- 0.87; p = 0.03 for stomach cancer). Aspirin use for 1 +/- 3 years was associated with SPC risk reduction by 35% (adjusted HR, 0.65; 95% CI, 0.49 +/- 0.87; p = 0.003). SPC risk reduction extended continuously for more than 3 years of follow up (adjusted HR, 0.72; 95% CI, 0.53 +/- 0.98; p = 0.030). Our data shows aspirin use was associated with reduced SPC incidence for HNSCC patients, attributed mainly to reduced risk of esophageal and stomach cancer.	[Lin, Yu-Shan; Su, Chien-Tien] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Yeh, Chih-Ching; Su, Chien-Tien] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Huang, Shiang-Fu] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Linkou, Taiwan; [Huang, Shiang-Fu] Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan; [Chou, Yi-Sheng] Taipei City Hosp, Dept Med, Div Hematol & Oncol, Renai Branch, Taipei, Taiwan; [Chou, Yi-Sheng] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Kuo, Li-Tang] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Keelung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan; [Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Su, Fu-Hsiung] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Su, Fu-Hsiung] Fu Jen Catholic Univ, Div Family Med, Dept Community Med & Long Term Care, Fu Jen Catholic Univ Hosp, New Taipei, Taiwan; [Su, Fu-Hsiung] Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia; [Su, Fu-Hsiung] Fu Jen Catholic Univ, Cardinal Tien Hosp, Dept Family Med, New Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Taipei City Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Flinders University South Australia; Fu Jen Catholic University	Su, FH (corresponding author), Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan.; Su, FH (corresponding author), Fu Jen Catholic Univ, Div Family Med, Dept Community Med & Long Term Care, Fu Jen Catholic Univ Hosp, New Taipei, Taiwan.; Su, FH (corresponding author), Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia.; Su, FH (corresponding author), Fu Jen Catholic Univ, Cardinal Tien Hosp, Dept Family Med, New Taipei, Taiwan.	williamsufh1@yahoo.com.tw	Su, Fu-Hsiung/AAO-5468-2021	Su, Fu-Hsiung/0000-0002-9867-7655	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; Taiwan Ministry of Science and Technology [MOST105-2314-B-038-038]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Taiwan Ministry of Science and Technology; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium	This work was funded by: 1. Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); 2. Taiwan Ministry of Science and Technology (MOST105-2314-B-038-038); 3. China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); 4. NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza JAS, 2012, CURR MED RES OPIN, V28, P1899, DOI 10.1185/03007995.2012.746218; Bains SJ, 2016, J CLIN ONCOL, V34, P2501, DOI 10.1200/JCO.2015.65.3519; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Bosetti C, 2003, BRIT J CANCER, V88, P672, DOI 10.1038/sj.bjc.6600820; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Bosetti C, 2009, RECENT RESULTS CANC, V181, P231; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Carpenter Janette M, 2005, Pac Health Dialog, V12, P158; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Elwood PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152402; Fanchiang C, TAIWAN TODAY; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Freedman ND, 2007, BRIT J CANCER, V96, P1469, DOI 10.1038/sj.bjc.6603713; Friis S, 2003, BRIT J CANCER, V88, P684, DOI 10.1038/sj.bjc.6600760; Friis S, 2006, BRIT J CANCER, V95, P363, DOI 10.1038/sj.bjc.6603250; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Huang WK, 2013, ALIMENT PHARM THER, V38, P432, DOI 10.1111/apt.12388; Jayaprakash V, 2006, ARCH OTOLARYNGOL, V132, P1231, DOI 10.1001/archotol.132.11.1231; Kim YI, 2016, CANCER RES TREAT, V48, P798, DOI 10.4143/crt.2015.117; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Macfarlane TV, 2014, BRIT J CANCER, V111, P1852, DOI 10.1038/bjc.2014.473; Macfarlane TV, 2012, ANN ONCOL, V23, P1053, DOI 10.1093/annonc/mdr335; Macfarlane TV, 2015, CANCER EPIDEMIOL, V39, P1015, DOI 10.1016/j.canep.2015.10.030; Rachidi S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0065-5; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; Su FH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-495; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; Tang LH, 2016, ONCOTARGET, V7, P65196, DOI 10.18632/oncotarget.11239; Tiwana MS, 2014, LARYNGOSCOPE, V124, P2287, DOI 10.1002/lary.24719	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0199014	10.1371/journal.pone.0199014	http://dx.doi.org/10.1371/journal.pone.0199014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133455	gold, Green Submitted, Green Published			2022-12-26	WOS:000442500400003
J	Liu, YH; Wei, QG; Lu, ZW				Liu, Yonghui; Wei, Qingguo; Lu, Zongwu			A multi-target brain-computer interface based on code modulated visual evoked potentials	PLOS ONE			English	Article							FREQUENCY; COMMUNICATION; ORTHOSIS; BCI	The number of selectable targets is one of the main factors that affect the performance of a brain-computer interface (BCI). Most existing code modulated visual evoked potential (c-VEP) based BCIs use a single pseudorandom binary sequence and its circularly shifting sequences to modulate different stimulus targets, making the number of selectable targets limited by the length of modulation codes. This paper proposes a novel paradigm for c-VEP BCIs, which divides the stimulus targets into four target groups and each group of targets are modulated by a unique pseudorandom binary code and its circularly shifting codes. Based on the paradigm, a four-group c-VEP BCI with a total of 64 stimulus targets was developed and eight subjects were recruited to participate in the BCI experiment. Based on the experimental data, the characteristics of the c-VEP BCI were explored by the analyses of auto- and cross-correlation, frequency spectrum, signal to noise ratio and correlation coefficient. On the basis, single-trial data with the length of one stimulus cycle were classified and the attended target was recognized. The averaged classification accuracy across subjects was 88.36% and the corresponding information transfer rate was as high as 184.6 bit/min. These results suggested that the c-VEP BCI paradigm is both feasible and effective, and provides a new solution for BCI study to substantially increase the number of available targets.	[Liu, Yonghui; Wei, Qingguo; Lu, Zongwu] Nanchang Univ, Sch Informat Engn, Dept Elect Engn, Nanchang, Jiangxi, Peoples R China	Nanchang University	Wei, QG (corresponding author), Nanchang Univ, Sch Informat Engn, Dept Elect Engn, Nanchang, Jiangxi, Peoples R China.	wqg07@163.com	Liu, Yong/GWQ-6163-2022	Wei, Qingguo/0000-0002-2265-9821	National Natural Science Foundation of China [61663025, 61365013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (#61663025, # 61365013). http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Dawoud N. N., 2012, P INT MULTICONFENG C, V1, P700; Edelman BJ, 2018, IEEE T NEUR SYS REH, V26, P936, DOI 10.1109/TNSRE.2018.2817924; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Friman O, 2001, MAGNET RESON MED, V45, P323, DOI 10.1002/1522-2594(200102)45:2<323::AID-MRM1041>3.0.CO;2-#; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; GOLAY MJE, 1961, IRE T INFORM THEOR, V7, P82, DOI 10.1109/TIT.1961.1057620; Huang G, 2013, NEUROIMAGE, V81, P283, DOI 10.1016/j.neuroimage.2013.05.017; Jain AK, 1998, SIGNAL PROCESS, V71, P109, DOI 10.1016/S0165-1684(98)00139-X; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Jiang J, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aac605; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Meng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38565; Nezamfar H, 2011, INT J IMAG SYST TECH, V21, P139, DOI 10.1002/ima.20288; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Perelmouter J, 2000, IEEE T REHABIL ENG, V8, P227, DOI 10.1109/86.847824; Pfurtscheller G, 2010, IEEE T NEUR SYS REH, V18, P409, DOI 10.1109/TNSRE.2010.2040837; Riechmann H, 2016, IEEE T NEUR SYS REH, V24, P692, DOI 10.1109/TNSRE.2015.2490621; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Su HJ, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.11.111715; Sutter E. E., 1984, Proceedings of the Symposium on Biosensors (Cat. No. 84CH2068-5), P95; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Thielen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133797; Tu YH, 2014, CLIN NEUROPHYSIOL, V125, P2372, DOI 10.1016/j.clinph.2014.03.028; Wang Y, 2010, ELECTRON LETT, V46, P1057, DOI 10.1049/el.2010.0923; Waytowich NR, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/036006; Wei Q, 2018, IEEE T NEUR SYS REH, V26, P1; Wei QG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156416; Wittevrongel B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15373-x; WOLFMANN J, 1992, IEEE T INFORM THEORY, V38, P1412, DOI 10.1109/18.144729; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu MP, 2018, IEEE T BIO-MED ENG, V65, P1166, DOI 10.1109/TBME.2018.2799661; Zhang Y, 2012, PLOS ONE, V7	39	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202478	10.1371/journal.pone.0202478	http://dx.doi.org/10.1371/journal.pone.0202478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118504	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700030
J	Altan, E; Aiemjoy, K; Pha, TG; Deng, XT; Aragie, S; Tadesse, Z; Callahan, KE; Keenan, J; Delwart, E				Altan, Eda; Aiemjoy, Kristen; Pha, Tung G.; Deng, Xutao; Aragie, Solomon; Tadesse, Zerihun; Callahan, Kelly E.; Keenan, Jeremy; Delwart, Eric			Enteric virome of Ethiopian children participating in a clean water intervention trial	PLOS ONE			English	Article							DNA VIRAL GENOMES; FECAL VIROME; DIARRHEA; VIRUSES; DIVERSITY; IDENTIFICATION; PREVALENCE; MATTER; CLADE; FECES	Background The enteric viruses shed by different populations can be influenced by multiple factors including access to clean drinking water. We describe here the eukaryotic viral genomes in the feces of Ethiopian children participating in a clean water intervention trial. Methodology/principal findings Fecal samples from 269 children with a mean age of 2.7 years were collected from 14 villages in the Amhara region of Ethiopia, half of which received a new hand-dug water well. Feces from these villages were then analyzed in 29 sample pools using viral metagenomics. A total of 127 different viruses belonging to 3 RNA and 3 DNA viral families were detected. Picornaviridae family sequence reads were the most commonly found, originating from 14 enterovirus and 6 parechovirus genotypes plus multiple members of four other picornavirus genera (cosaviruses, saliviruses, kobuviruses, and hepatoviruses). Picornaviruses with nearly identical capsid VP1 were detected in different pools reflecting recent spread of these viral strains. Next in read frequencies and positive pools were sequences from the Caliciviridae family including noroviruses GI and GII and sapoviruses. DNA viruses from multiple genera of the Parvoviridae family were detected (bocaviruses 1 +/- 4, bufavirus 3, and dependoparvoviruses), together with four species of adenoviruses and common anelloviruses shedding. RNA in the order Picornavirales and CRESS-DNA viral genomes, possibly originating from intestinal parasites or dietary sources, were also characterized. No significant difference was observed between the number of mammalian viruses shed from children from villages with and without a new water well. Conclusions We describe an approach to estimate the efficacy of potentially virus transmission-reducing interventions and the first complete (DNA and RNA viruses) description of the enteric viromes of East African children. A wide diversity of human enteric viruses was found in both intervention and control groups. Mammalian enteric virome diversity was not reduced in children from villages with a new water well. This population-based sampling also provides a baseline of the enteric viruses present in Northern Ethiopia against which to compare future viromes.	[Altan, Eda; Pha, Tung G.; Deng, Xutao; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Altan, Eda; Pha, Tung G.; Deng, Xutao; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Aiemjoy, Kristen; Keenan, Jeremy] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Aiemjoy, Kristen] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Aragie, Solomon; Tadesse, Zerihun] Carter Ctr Ethiopia, Addis Ababa, Ethiopia; [Callahan, Kelly E.] Carter Ctr, Atlanta, GA USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Delwart, E (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.; Delwart, E (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	Eric.Delwart@ucsf.edu	Altan, Eda/W-4368-2017; Keenan, Jeremy David/AAO-5882-2020; Callahan, Kelly/GXV-2892-2022; Altan, Eda/AAK-3420-2021	Altan, Eda/0000-0001-7903-6986; Keenan, Jeremy David/0000-0002-7118-1457; Altan, Eda/0000-0001-7903-6986; Delwart, Eric/0000-0002-6296-4484; Phan, Tung/0000-0003-3517-3078; Aiemjoy, Kristen/0000-0003-1886-2699	Blood Systems Research Institute; National Institutes of Health [NEI U10 EY016214, NEI K23EY019071, NICHD F31 HD088070-01A1]; Sara & Evan Williams Foundation; Bernard Osher Foundation; That Man May See; Harper Inglis Trust; Bodri Foundation; Research to Prevent Blindness; Carter Center Ethiopia; South Asia Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD088070] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY019071, U10EY016214] Funding Source: NIH RePORTER	Blood Systems Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara & Evan Williams Foundation; Bernard Osher Foundation; That Man May See; Harper Inglis Trust; Bodri Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Carter Center Ethiopia; South Asia Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was entirely supported by funds from the Blood Systems Research Institute, the National Institutes of Health (NEI U10 EY016214, NEI K23EY019071, and NICHD F31 HD088070-01A1), the Sara & Evan Williams Foundation, the Bernard Osher Foundation, That Man May See, the Harper Inglis Trust, the Bodri Foundation, the South Asia Research Fund, Research to Prevent Blindness, and the Carter Center Ethiopia. There was no additional external funding received for this study.; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was entirely supported by funds from the Blood Systems Research Institute, the National Institutes of Health (NEI U10 EY016214, NEI K23EY019071, and NICHD F31 HD088070-01A1), the Sara & Evan Williams Foundation, the Bernard Osher Foundation, That Man May See, the Harper Inglis Trust, the Bodri Foundation, the South Asia Research Fund, Research to Prevent Blindness, and the Carter Center Ethiopia. There was no additional external funding received for this study.	Altan E, 2017, GENOME ANNOUNC, V5; Amimo JO, 2016, ARCH VIROL, V161, P887, DOI 10.1007/s00705-016-2819-6; Basu G, 2003, East Afr Med J, V80, P652; Blinkova O, 2010, J GEN VIROL, V91, P74, DOI 10.1099/vir.0.015446-0; Brazier L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185569; Breurec S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004283; Cheung AK, 2014, GENOME ANNOUNC, V2; Cheung AK, 2013, ARCH VIROL, V158, P2157, DOI 10.1007/s00705-013-1701-z; Deng X, 2015, NUCL ACIDS RES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gebre T, 2012, LANCET, V379, P143, DOI 10.1016/S0140-6736(11)61515-8; Hause BM, 2016, J GEN VIROL, V97, P1362, DOI 10.1099/jgv.0.000461; Kapusinszky B, 2017, J VIROL, V91, DOI 10.1128/JVI.00952-17; Kim HK, 2012, J GEN VIROL, V93, P635, DOI 10.1099/vir.0.037838-0; Kiulia NM, 2008, J TROP PEDIATRICS, V54, P401, DOI 10.1093/tropej/fmn052; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meyer CT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0299-z; Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011; Munnink BBO, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex022; Munnink BBO, 2015, J GEN VIROL, V96, P3440, DOI 10.1099/jgv.0.000279; Ng TFF, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev017; Operario DJ, 2017, J INFECT DIS, V216, P220, DOI 10.1093/infdis/jix294; Phan TG, 2016, ARCH VIROL, V161, P959, DOI 10.1007/s00705-016-2756-4; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Reuter G, 2015, ARCH VIROL, V160, P565, DOI 10.1007/s00705-014-2304-z; Reuter G, 2014, ARCH VIROL, V159, P2161, DOI 10.1007/s00705-014-2025-3; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Sano K, 2016, ARCH VIROL, V161, P3541, DOI 10.1007/s00705-016-3048-8; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shi M, 2016, NATURE; Shioda K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145943; Sikorski A, 2013, VIRUS RES, V177, P209, DOI 10.1016/j.virusres.2013.08.008; Sisay Z, 2016, ARCH VIROL, V161, P2169, DOI 10.1007/s00705-016-2887-7; Steel O, 2016, INFECT GENET EVOL, V43, P151, DOI 10.1016/j.meegid.2016.05.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATICHEFF S, 1994, ETHIOPIAN MED J, V32, P7; Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011; Weldegebriel G, 2017, VACCINE; WHO_ aho, 2017, ETH FACTSH HLTH STAT; WHO_ Ethiopia WHO, 2017, COUNTR HLTH TOP; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0	49	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202054	10.1371/journal.pone.0202054	http://dx.doi.org/10.1371/journal.pone.0202054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114205	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400039
J	Li, L; Wang, ZL; Liang, H; Yang, F; Yuan, W; Gelaye, B; Yu, YF; Miao, MH; Norgaard, M; Li, J				Li, Lin; Wang, Ziliang; Liang, Hong; Yang, Fen; Yuan, Wei; Gelaye, Bizu; Yu, Yongfu; Miao, Maohua; Norgaard, Mette; Li, Jiong			Risk of childhood cerebral palsy following prenatal exposure to beta 2-adrenergic receptor agonist: A nationwide cohort study	PLOS ONE			English	Article							MATERNAL ASTHMA; GENETIC POLYMORPHISMS; SEX-DIFFERENCES; PREGNANCY; TERBUTALINE; BRAIN; RAT; PREVALENCE; AUTISM; HEART	Background Cerebral palsy (CP) is the most common physical developmental disability in childhood with a prevalence of 2 to 3 per 1000 live births. beta 2-adrenoreceptor agonist (beta 2AA) are widely used for the treatment of asthma. Maternal use of beta 2AAs may increase the risk of adverse neuro-psychiatric health outcomes in the offspring. No study, however, has evaluated the effect of prenatal exposure to beta 2AAs on the risk of CP. Objective To examine the association between prenatal exposure to beta 2AAs and the risk of childhood cerebral palsy. Methods This population-based cohort study included all live singleton births in Denmark from January 1, 1997 to December 31, 2003. The information on outpatient prescriptions of beta 2AAs was extracted from Danish National Prescription Registry. Children born to mothers who used beta 2AAs from 30 days before pregnancy until delivery were categorized as the exposed. To differentiate the effect of beta 2AAs from the underlying indications, the exposure window was further extended to 2 years before pregnancy and the exposed groups were re-defined to represent different periods of exposure to maternal use of beta 2AAs (use only before pregnancy, use only during pregnancy, and use both before and during pregnancy). Cases of CP were identified from the Danish Cerebral Palsy Register. Logistic regression was used to estimate incidence odds ratio (OR) of CP. Results Among all the 442,278 singletons, 19,616 (4.44%) were exposed to beta 2AAs in utero (from 30 days before pregnancy until delivery). The risk of childhood CP was 0.21% in exposed and 0.19% in unexposed group, yielding an adjusted OR (aOR) 1.12 (95% confidence interval (CI): 0.82, 1.53). When extending the exposure time window to 2 years prior to pregnancy, no overall significant association was observed regardless of the exposure period. However, an increased risk of CP (aOR = 1.41, 95% CI: 0.92, 2.18) for maternal beta 2AAs use during pregnancy was observed in female offspring, especially in those born at term (aOR = 1.65, 95% CI: 1.02, 2.67). This increase was mainly attributed to an increased risk in those born to mothers who used beta 2AAs both before and during pregnancy (aOR = 1.81, 95% CI: 0.99, 3.33). Conclusions We observed an association between maternal beta 2AAs use during pregnancy and an increased risk of CP in female offspring, but we could not rule out confounding by the underlying indications for beta 2AAs.	[Li, Lin; Wang, Ziliang; Liang, Hong; Yang, Fen; Yuan, Wei; Miao, Maohua] Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai, Peoples R China; [Li, Lin; Yu, Yongfu; Norgaard, Mette; Li, Jiong] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Wang, Ziliang] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Gelaye, Bizu] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Fudan University; Aarhus University; Fudan University; Harvard University; Harvard T.H. Chan School of Public Health	Miao, MH (corresponding author), Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai, Peoples R China.	miaomaohua@163.com	Wang, Zhiquan/HHS-6768-2022; Yu, Yongfu/W-7557-2019; Yu, Yongfu/GLR-9881-2022	Yu, Yongfu/0000-0003-4208-9480; Li, Lin/0000-0002-7946-4574	National key research and development program [2016YFC1000505]; National Natural Science Foundation of China [81428011]; NPFPC Key Laboratory of Reproduction Regulation [CX2017-0X]; European Research Council [ERC-2010-StG-260242-PROGEURO]; Nordic Cancer Union [176673, 186200]; Danish Council for Independent Research [DFF-6110-00019]; Karen Elise Jensens Fond; Program for Clinical Research Infrastructure (PROCRIN); Novo Nordisk Foundation	National key research and development program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NPFPC Key Laboratory of Reproduction Regulation; European Research Council(European Research Council (ERC)European Commission); Nordic Cancer Union; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Karen Elise Jensens Fond; Program for Clinical Research Infrastructure (PROCRIN); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was supported by the National key research and development program (2016YFC1000505), the National Natural Science Foundation of China (81428011), the Innovation-oriented Science and Technology Grant from NPFPC Key Laboratory of Reproduction Regulation (CX2017-0X), the European Research Council (ERC-2010-StG-260242-PROGEURO), Nordic Cancer Union (176673, 186200), Danish Council for Independent Research (DFF-6110-00019), Karen Elise Jensens Fond (2016), and Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J ALLERGY CLIN IMMUN, V115, P34, DOI 10.1016/j.jaci.2004.10.023; BERGMAN B, 1984, EUR J RESPIR DIS, V65, P81; Blais L, 2010, BIRTH DEFECTS RES A, V88, P216, DOI 10.1002/bdra.20651; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Clifton VL, 2005, CELL TISSUE RES, V322, P63, DOI 10.1007/s00441-005-1117-5; Clifton VL, 2004, PLACENTA, V25, pS45, DOI 10.1016/j.placenta.2004.01.004; Connors SL, 2005, J CHILD NEUROL, V20, P876, DOI 10.1177/08830738050200110401; Croen LA, 2011, J NEURODEV DISORD, V3, P307, DOI 10.1007/s11689-011-9093-4; Denmark S., 1991, MAIN REPORT; ELMES MJ, 2009, BRIT J NUTR, V101, P725, DOI DOI 10.1017/S0007114508025075; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Froslev-Friis C, 2015, DAN MED J, V62; Garofolo MC, 2003, BRAIN RES BULL, V59, P319, DOI 10.1016/S0361-9230(02)00925-5; Gibson CS, 2008, PEDIATRICS, V122, P1079, DOI 10.1542/peds.2007-3758; Gidaya NB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1316; Golan H, 2004, J NEUROSCI RES, V78, P430, DOI 10.1002/jnr.20269; HADDERSALGRA M, 1986, BRIT J OBSTET GYNAEC, V93, P156, DOI 10.1111/j.1471-0528.1986.tb07880.x; Hansen C, 2013, MATERN CHILD HLTH J, V17, P1611, DOI 10.1007/s10995-012-1173-x; HSU CH, 1994, LIFE SCI, V54, P1465; Hvidtjorn D, 2010, HUM REPROD, V25, P2115, DOI 10.1093/humrep/deq070; Jensen LV, 2012, ACTA PAEDIATR, V101, pE80, DOI 10.1111/j.1651-2227.2011.02516.x; Johnston MV, 2007, DEV MED CHILD NEUROL, V49, P74, DOI 10.1017/S0012162207000199; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Koren G, 2002, TERATOLOGY, V65, P191, DOI 10.1002/tera.10038; KRIEG RJ, 1986, ENDOCRINOLOGY, V119, P1339, DOI 10.1210/endo-119-3-1339; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Liew Z, 2014, AM J EPIDEMIOL, V180, P574, DOI 10.1093/aje/kwu179; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marret S, 2013, HAND CLINIC, V111, P169, DOI 10.1016/B978-0-444-52891-9.00016-6; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Nelson KB, 2005, PEDIATR RES, V57, P494, DOI 10.1203/01.PDR.0000156477.00386.E7; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Osei-Kumah A, 2011, PLACENTA, V32, P570, DOI 10.1016/j.placenta.2011.05.005; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perna R., 2014, CHILD DEV RES, V2014, DOI [10.1155/2014/358608, DOI 10.1155/2014/358608]; Pitzer M, 2001, CHILD PSYCHIAT HUM D, V31, P165, DOI 10.1023/A:1026419720410; pregnancy WGoaa, 1993, REPORT NR PB96 14159, P1; Rhodes MC, 2004, J PHARMACOL EXP THER, V308, P529, DOI 10.1124/jpet.103.060095; SLOTKIN TA, 1994, TOXICOL APPL PHARM, V129, P223, DOI 10.1006/taap.1994.1247; Slotkin TA, 2001, DEV BRAIN RES, V131, P113, DOI 10.1016/S0165-3806(01)00282-6; Streja E, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.023; Uldall P, 2001, DAN MED BULL, V48, P161; Witter FR, 2009, AM J OBSTET GYNECOL, V201, P553, DOI 10.1016/j.ajog.2009.07.010; Zhu JL, 2010, HUM REPROD, V25, P3142, DOI 10.1093/humrep/deq206	51	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202078	10.1371/journal.pone.0202078	http://dx.doi.org/10.1371/journal.pone.0202078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114199	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400040
J	Supriya, R; Tam, BT; Yu, AP; Lee, PH; Lai, CW; Cheng, KK; Yau, SY; Chan, LW; Yung, BY; Sheridan, S; Siu, PM				Supriya, Rashmi; Tam, Bjorn T.; Yu, Angus P.; Lee, Paul H.; Lai, Christopher W.; Cheng, Kenneth K.; Yau, Sonata Y.; Chan, Lawrence W.; Yung, Benjamin Y.; Sheridan, Sinead; Siu, Parco M.			Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LOW HDL CHOLESTEROL; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FOLLOW-UP; SYSTEMIC INFLAMMATION; NUCLEAR RECEPTORS; OXIDATIVE STRESS; BLOOD-PRESSURE; NORMAL-WEIGHT	Objective Metabolic syndrome (MetS) or prediabetes is a complex disorder that is defined by a clustering of cardiometabolic risk factors, including obesity, hypertriglyceridemia, reduced high-density lipoprotein (HDL) cholesterol, hypertension, and insulin resistance. Among cardiometabolic risk factors, central obesity plays a key role in the development of MetS through alterations in the secretion of adipokines and interacts with other MetS risk factors to unfavorably influence overall cardiometabolic risk. Obesity has grasped epidemic proportions in Asia, which has the highest number of people with diabetes in the world. But, the importance of central obesity in the clustering of all four MetS risk factors or vice versa in predicting severity of MetS has not yet been investigated in Asian population. Therefore, the present study examined the influence of central obesity on circulating levels of adipokines through its interaction with the clustering of cardiometabolic risk factors of MetS including hypergly-cemia, hypertriglyceridemia, dyslipidemia and hypertension in Hong Kong Chinese adults. Subjects Blood samples from 83 Hong Kong Chinese adults, who were previously screened for MetS according to the guideline of the United States National Cholesterol Education Program Expert Panel Adult Treatment Panel III criteria were selected. Insulin and adipokines, including visfatin, chemerin, plasminogen activator inhibitor-1 (PAI-1), resistin, C-C motif chemokine ligand 2 (CCL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), tumour necrosis factor-alpha (TNF-alpha), leptin and adiponectin were assessed. Results The interacting effect of central obesity with all of the other four MetS risk factors increased the proinflammatory status of adipokines (TNF-alpha, leptin) and decreased the anti-inflammatory status of adipokine (adiponectin). Conclusion Our results indicate that the inflammatory status of MetS may be more severe in the presence of central obesity. Adipokines, as biomarkers for pathophysiological changes, may help to improve early patient identification and to predict MetS-associated morbidity and mortality.	[Supriya, Rashmi; Tam, Bjorn T.; Lai, Christopher W.; Cheng, Kenneth K.; Chan, Lawrence W.; Yung, Benjamin Y.] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China; [Yu, Angus P.; Sheridan, Sinead; Siu, Parco M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Lee, Paul H.] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Sch Nursing, Kowloon, Hong Kong, Peoples R China; [Yau, Sonata Y.] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Siu, PM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.	pmsiu@hku.hk	Lee, Paul H/F-2549-2010; Lai, Christopher Wai Keung/A-3852-2014	Lee, Paul H/0000-0002-5729-6450; Tam, Bjorn T./0000-0001-6740-8674; Chan, Lawrence/0000-0001-6451-2273; Lai, Christopher Wai Keung/0000-0002-8010-7232; Supriya, Rashmi/0000-0003-2995-1910; Yau, Sonata Suk Yu/0000-0002-7425-6741	Hong Kong Research Grants Council Hong Kong Ph.D. Fellowship Scheme [RTVX PF13-11753]; Hong Kong Polytechnic University Research Fund (RTAS); Hong Kong Polytechnic University Research Fund [1-ZE17]; University of Hong Kong Seed Fund for Basic Research; Hong Kong Research Grants Council General Research Fund [PolyU 5632/10M]	Hong Kong Research Grants Council Hong Kong Ph.D. Fellowship Scheme; Hong Kong Polytechnic University Research Fund (RTAS); Hong Kong Polytechnic University Research Fund(Hong Kong Polytechnic University); University of Hong Kong Seed Fund for Basic Research; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council)	We declare all the funding or sources of support received during this specific study as the following, and all the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Hong Kong Research Grants Council Hong Kong Ph.D. Fellowship Scheme (RTVX PF13-11753), the Hong Kong Polytechnic University Research Fund (RTAS and 1-ZE17), The University of Hong Kong Seed Fund for Basic Research, and the Hong Kong Research Grants Council General Research Fund (PolyU 5632/10M).	Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; Abu-Farha M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-76; Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Despres JP, 2006, EUR HEART J SUPPL, V8, pB4, DOI 10.1093/eurheartj/sul002; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gao WG, 2008, INT J OBESITY, V32, P757, DOI 10.1038/sj.ijo.0803797; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; Iida KT, 2001, J BIOL CHEM, V276, P32531, DOI 10.1074/jbc.M009894200; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Jeppesen J, 1997, ARTERIOSCL THROM VAS, V17, P1114, DOI 10.1161/01.ATV.17.6.1114; Jeppesen J, 2000, HYPERTENSION, V36, P226, DOI 10.1161/01.HYP.36.2.226; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Jonkers IJ, 2002, AM J MED, V112, P275, DOI 10.1016/S0002-9343(01)01123-8; Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971; Kendal CE, 2007, PLACENTA, V28, P305, DOI 10.1016/j.placenta.2006.03.011; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Lafontan M, 2006, CURR OPIN PHARMACOL, V6, P580, DOI 10.1016/j.coph.2006.08.002; Lee IT, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-43; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Lee JM, 2009, J INT MED RES, V37, P1803, DOI 10.1177/147323000903700616; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mailiana A, 2010, INDONES BIOMED J, V2, P118, DOI 10.18585/inabj.v2i3.125; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Marsland AL, 2010, METABOLISM, V59, P1801, DOI 10.1016/j.metabol.2010.05.015; Martins MD, 2012, REV PORT CARDIOL, V31, P711, DOI 10.1016/j.repc.2012.08.002; Masquio DCL, 2015, BRIT J NUTR, V113, P1920, DOI 10.1017/S0007114515001129; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Miyazaki Y, 2003, INT J OBESITY, V27, P88, DOI 10.1038/sj.ijo.0802187; Moreno LA, 2002, HORM METAB RES, V34, P394, DOI 10.1055/s-2002-33472; Nascimento H, 2014, PEDIATR RES, V76, P159, DOI 10.1038/pr.2014.73; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Nishikawa K, 2015, INTERNAL MED, V54, P375, DOI 10.2169/internalmedicine.54.3092; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patel HJ, 2016, LIFE SCI; Pausova Z, 2000, HYPERTENSION, V36, P14, DOI 10.1161/01.HYP.36.1.14; Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573; REAVEN GM, 1995, INT J OBESITY, V19, pS2; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Sakashita Y, 2015, J DIABETES INVEST, V6, P527, DOI 10.1111/jdi.12327; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Sethi JK, 2005, TRENDS MOL MED, V11, P344, DOI 10.1016/j.molmed.2005.06.010; Sidik Sherina Mohd, 2009, Asia Pac Fam Med, V8, P2, DOI 10.1186/1447-056X-8-2; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Supriya R, 2018, FRONT PHYSIOL, P9, DOI [10.3389fichys.2018.00294/fuIl, DOI 10.3389FICHYS.2018.00294/FUIL]; Tijerina Amanda J, 2004, Dimens Crit Care Nurs, V23, P237, DOI 10.1097/00003465-200411000-00001; Titov V N, 2014, Klin Lab Diagn, P27; Van Guilder GP, 2006, OBESITY, V14, P2127, DOI 10.1038/oby.2006.248; van Stijn CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086404; Weltman A, 2003, METABOLISM, V52, P73, DOI 10.1053/meta.2003.50007; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yu AP, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0108-2; Yun JE, 2010, METABOLISM, V59, P424, DOI 10.1016/j.metabol.2009.08.012	83	20	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201585	10.1371/journal.pone.0201585	http://dx.doi.org/10.1371/journal.pone.0201585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114249	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400016
J	Meissner, GW; Grimm, JB; Johnston, RM; Sutcliffe, B; Ng, J; Jefferis, GSXE; Cachero, S; Lavis, LD; Malkesman, O				Meissner, Geoffrey W.; Grimm, Jonathan B.; Johnston, Rebecca M.; Sutcliffe, Ben; Ng, Julian; Jefferis, Gregory S. X. E.; Cachero, Sebastian; Lavis, Luke D.; Malkesman, Oz			Optimization of fluorophores for chemical tagging and immunohistochemistry of Drosophila neurons	PLOS ONE			English	Article							GENERAL-METHOD; CELL; MICROSCOPY; EXPRESSION; PROTEINS; SYSTEM; TOOLS; TAGS	The use of genetically encoded 'self-labeling tags' with chemical fluorophore ligands enables rapid labeling of specific cells in neural tissue. To improve the chemical tagging of neurons, we synthesized and evaluated new fluorophore ligands based on Cy, Janelia Fluor, Alexa Fluor, and ATTO dyes and tested these with recently improved Drosophila melanogaster transgenes. We found that tissue clearing and mounting in DPX substantially improves signal quality when combined with specific non-cyanine fluorophores. We compared and combined this labeling technique with standard immunohistochemistry in the Drosophila brain.	[Meissner, Geoffrey W.; Grimm, Jonathan B.; Johnston, Rebecca M.; Lavis, Luke D.; Malkesman, Oz] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Sutcliffe, Ben; Ng, Julian; Jefferis, Gregory S. X. E.; Cachero, Sebastian] Med Res Council Lab Mol Biol, Div Neurobiol, Cambridge, England; [Johnston, Rebecca M.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	Howard Hughes Medical Institute; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Washington	Meissner, GW; Malkesman, O (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	meissnerg@janelia.hhmi.org; malkesmano@janelia.hhmi.org	Sutcliffe, Ben/R-3655-2019	Sutcliffe, Ben/0000-0003-3264-1649; Jefferis, Gregory/0000-0002-0587-9355; Meissner, Geoffrey/0000-0003-0369-9788; Cachero, Sebastian/0000-0002-6828-1211; Ng, Julian/0000-0002-1908-4414	Howard Hughes Medical Institute; Medical Research Council (MRC) [U105188491]; European Research Council Consolidator grant [649111]; Royal Society Dorothy Hodgkin Fellowship; MRC [MC_U105188491] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Consolidator grant(European Research Council (ERC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Howard Hughes Medical Institute (https://www.hhmi.org), the Medical Research Council (https://mrc.ukri.org; MRC file reference U105188491) and a European Research Council (https://erc.europa.eu) Consolidator grant (649111) to G.S.X.E.J., and a Royal Society (https://royalsociety.org) Dorothy Hodgkin Fellowship to S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Dickson BJ., 2017, 198648 BIORXIV, DOI [10.1101/198648, DOI 10.1101/198648]; ERICHSEN JT, 1982, NATURE, V295, P407, DOI 10.1038/295407a0; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim SH, 2003, J HISTOCHEM CYTOCHEM, V51, P129, DOI 10.1177/002215540305100116; Kohl J, 2014, P NATL ACAD SCI USA, V111, pE3805, DOI 10.1073/pnas.1411087111; LEDER L, 1994, EUR J BIOCHEM, V219, P73, DOI 10.1111/j.1432-1033.1994.tb19916.x; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; MAYERSBACH H. V., 1967, J ROY MICROSCOP SOC, V87, P295; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Stone MB, 2014, CHEMPHYSCHEM, V15, P2240, DOI 10.1002/cphc.201402002; Sutcliffe B, 2017, GENETICS, V205, P1399, DOI 10.1534/genetics.116.199281; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365	19	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0200759	10.1371/journal.pone.0200759	http://dx.doi.org/10.1371/journal.pone.0200759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110347	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000008
J	Turgimbayeva, A; Abeldenov, S; Zharkov, DO; Ishchenko, AA; Ramankulov, Y; Saparbaev, M; Khassenov, B				Turgimbayeva, Aigerim; Abeldenov, Sailau; Zharkov, Dmitry O.; Ishchenko, Alexander A.; Ramankulov, Yerlan; Saparbaev, Murat; Khassenov, Bekbolat			Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori	PLOS ONE			English	Article							NUCLEOTIDE INCISION REPAIR; OXIDATIVE DNA-DAMAGE; BASE EXCISION-REPAIR; ESCHERICHIA-COLI; AP ENDONUCLEASE; EXONUCLEASE-III; SUBSTRATE SPECIFICITIES; CRYSTAL-STRUCTURE; IV; PATHWAY	Apurinic/apyrimidinic (AP) endonucleases play critical roles in the repair of abasic sites and strand breaks in DNA. Complete genome sequences of Helicobacter pylori reveal that this bacterial specie has a single AP endonuclease. An H. pylori homolog of Xth (HpXth) is a member of exonuclease III family, which is represented by Escherichia coliXth. Currently, it remains unknown whether this single AP endonuclease has DNA repair activities similar to those of its counterpart in E. co/iand other bacteria. We report that HpXth possesses efficient AP site cleavage, 3'-repair phosphodiesterase, and 3'-phosphatase activities but not the nucleotide incision repair function. Optimal reaction conditions for HpXth's AP endonuclease activity are low ionic strength, high Mg2+ concentration, pH in the range 7-8, and temperature 30 degrees C. The kinetic parameters measured under steady-state conditions showed that HpXth removes the AP site, 3'-blocking sugar-phosphate, and 3'-terminal phosphate in DNA strand breaks with good efficiency (k(cat)/K-M = 1240, 44, and 5,4 mu M-1.min(-1), respectively), similar to that of E. coli Xth. As expected, the presence of HpXth protein in AP endonuclease-deficient E. coli xth nfo strain significantly reduced the sensitivity to an alkylating agent and H2O2. Mutation of active site residue D144 in HpXth predicted to be essential for catalysis resulted in a complete loss of enzyme activities. Several important structural features of HpXth were uncovered by homology modeling and phylogenetic analysis. Our data show the DNA substrate specificity of H. pylori AP endonuclease and suggest that HpXth counteracts the genotoxic effects of DNA damage generated by endogenous and host-imposed factors.	[Turgimbayeva, Aigerim; Abeldenov, Sailau; Ramankulov, Yerlan; Khassenov, Bekbolat] Natl Ctr Biotechnol, Astana, Kazakhstan; [Turgimbayeva, Aigerim] LN Gumilyov Eurasian Natl Univ, Astana, Kazakhstan; [Zharkov, Dmitry O.] SB RAS, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Zharkov, Dmitry O.] Novosibirsk State Univ, Novosibirsk, Russia; [Ishchenko, Alexander A.; Saparbaev, Murat] Univ Paris Sud, CNRS UMR8200, Equipe Labellisee Ligue Natl Canc, Grp Reparat ADN, Gustave Roussy Canc Campus, Villejuif, France; [Ramankulov, Yerlan] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan	National Center for Biotechnology (NCB); L.N. Gumilyov Eurasian National University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Nazarbayev University	Khassenov, B (corresponding author), Natl Ctr Biotechnol, Astana, Kazakhstan.; Saparbaev, M (corresponding author), Univ Paris Sud, CNRS UMR8200, Equipe Labellisee Ligue Natl Canc, Grp Reparat ADN, Gustave Roussy Canc Campus, Villejuif, France.	murat.saparbaev@gustaveroussy.fr; khassenov@biocenter.kz	Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat/AAC-5478-2020; Ramankulov, Yerlan/AAG-7450-2019; Zharkov, Dmitry/K-2158-2012; Khassenov, Bekbolat/AAM-8657-2020; Abeldenov, Sailau/F-5139-2015	Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat/0000-0002-4630-1074; Ramankulov, Yerlan/0000-0001-6786-3028; Zharkov, Dmitry/0000-0001-5013-0194; Khassenov, Bekbolat/0000-0003-4572-948X; Turgimbayeva, Aigerim/0000-0001-7263-1643; Ramanculov, Erlan/0000-0001-6791-4497	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [AP05130820]; la Ligue Nationale Francaise Contre le Cancer "Equipe Labellisee LIGUE 2016" [EL2016.LNCC/MuS]; Electricite de France RB 2017; ERA.Net RUS Plus [306]; French National Center for Scientific Research (PRC CNRS/RFBR) [1074 REDOBER]; Russian Ministry of Science and Education [6.5773.2017/6.7]; Russian Science Foundation [17-14-01190]; L.N. Gumilyov Eurasian National University, Kazakhstan	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); la Ligue Nationale Francaise Contre le Cancer "Equipe Labellisee LIGUE 2016"; Electricite de France RB 2017; ERA.Net RUS Plus; French National Center for Scientific Research (PRC CNRS/RFBR); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF)); L.N. Gumilyov Eurasian National University, Kazakhstan(L.N. Gumilyov Eurasian National University)	This work was supported by grants to S. A. from the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan AP05130820 (www.biocenter.kz), to M.S. from la Ligue Nationale Francaise Contre le Cancer "Equipe Labellisee LIGUE 2016" grant EL2016.LNCC/MuS and Electricite de France RB 2017 (http://www.edf.fr), to A.A.I. from ERA.Net RUS Plus (www.eranet-rus.eu) [#306] and French National Center for Scientific Research (PRC CNRS/RFBR n1074 REDOBER), and to D.O.Z. from the Russian Ministry of Science and Education (6.5773.2017/6.7) and Russian Science Foundation (17-14-01190). A.T. was supported by Ph.D. fellowships from L.N. Gumilyov Eurasian National University (www.enu.kz), Kazakhstan. The sponsors played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Abadi ATB, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00026; Abeldenov S, 2015, DNA REPAIR, V33, P1, DOI 10.1016/j.dnarep.2015.05.007; Akishev Z, 2016, DNA REPAIR, V48, P30, DOI 10.1016/j.dnarep.2016.10.009; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Burkovics P, 2006, NUCLEIC ACIDS RES, V34, P2508, DOI 10.1093/nar/gkl259; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Carpenter EP, 2007, EMBO J, V26, P1363, DOI 10.1038/sj.emboj.7601593; COUVEPRIVAT S, 2007, MOL B INT U, P54; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Daley JM, 2010, MUTAT RES-REV MUTAT, V705, P217, DOI 10.1016/j.mrrev.2010.07.003; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; He HZ, 2014, BIOCHEMISTRY-US, V53, P6520, DOI 10.1021/bi500676p; Huang S, 2006, J BACTERIOL, V188, P6224, DOI 10.1128/JB.00477-06; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Joldybayeva B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092963; Kulyyassov A, 2011, J PROTEOME RES, V10, P4416, DOI 10.1021/pr200189p; Lakomek K, 2010, J MOL BIOL, V399, P604, DOI 10.1016/j.jmb.2010.04.044; Lebedeva NA, 2013, DNA REPAIR, V12, P1037, DOI 10.1016/j.dnarep.2013.09.008; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lirussi L, 2012, MOL BIOL CELL, V23, P4079, DOI 10.1091/mbc.E12-04-0299; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Malfatti MC, 2017, NUCLEIC ACIDS RES, V45, P11193, DOI 10.1093/nar/gkx723; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mathieu A, 2006, J BACTERIOL, V188, P7464, DOI 10.1128/JB.00851-06; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Nagorska K, 2012, MOL MICROBIOL, V83, P1064, DOI 10.1111/j.1365-2958.2012.07989.x; Prorok P, 2013, P NATL ACAD SCI USA, V110, pE3695, DOI 10.1073/pnas.1305624110; Redrejo-Rodriguez M, 2016, BIOCHIMIE, V128, P20, DOI 10.1016/j.biochi.2016.06.011; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Schmiedel R, 2009, DNA REPAIR, V8, P219, DOI 10.1016/j.dnarep.2008.10.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; TAKEUCHI M, 1994, J BIOL CHEM, V269, P21907; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tsutakawa SE, 2013, J BIOL CHEM, V288, P8445, DOI 10.1074/jbc.M112.422774; van der Veen S, 2015, NAT REV MICROBIOL, V13, P83, DOI 10.1038/nrmicro3391; Vidal AE, 2007, J MOL BIOL, V373, P827, DOI 10.1016/j.jmb.2007.08.001; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wood E.J, 1983, BIOCHEM EDUC, V11, P82, DOI [10.1016/0307-4412(83)90068-7, DOI 10.1016/0307-4412(83)90068-7]; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yasui A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012617; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	63	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202232	10.1371/journal.pone.0202232	http://dx.doi.org/10.1371/journal.pone.0202232			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110394	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000057
J	Valledor, M; Myers, RS; Schiller, PC				Valledor, Melvys; Myers, Richard S.; Schiller, Paul C.			Herpes ICP8 protein stimulates homologous recombination in human cells	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; VIRUS REPLICATION COMPARTMENTS; GENE MODIFICATION; BINDING-PROTEIN; T-ANTIGEN; EXPRESSION; REPAIR; IDENTIFICATION; MUTAGENESIS; RAD52	Recombineering has transformed functional genomic analysis. Genome modification by recombineering using the phage lambda Red homologous recombination protein Beta in Escherichia coli has approached 100% efficiency. While highly efficient in E. coli, recombineering using the Red Synaptase/Exonuclease pair (SynExo) in other organisms declines in efficiency roughly correlating with phylogenetic distance from E. coll. SynExo recombinases are common to double-stranded DNA viruses infecting a variety of organisms, including humans. Human Herpes virus 1 (HHV1) encodes a SynExo comprised of ICP8 synaptase and UL12 exonuclease. In a previous study, the Herpes SynExo was reconstituted in vitro and shown to catalyze a model recombination reaction. Here we describe stimulation of gene targeting to edit a novel fluorescent protein gene in the human genome using ICP8 and compared its efficiency to that of a "humanized" version of Beta protein from phage lambda. ICP8 significantly enhanced gene targeting rates in HEK 293T cells while Beta was not only unable to catalyze recombineering but inhibited gene targeting using endogenous recombination functions, despite both synaptases being well-expressed and localized to the nucleus. This proof of concept encourages developing species-specific SynExo recombinases for genome engineering.	[Valledor, Melvys] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Myers, Richard S.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Schiller, Paul C.] Univ Miami, Miller Sch Med, Dept Orthopaed, Miami, FL 33136 USA; [Schiller, Paul C.] Bruce W Carter VAMC, Geriatr Res Educ & Clin Ctr, Miami, FL USA; [Schiller, Paul C.] Bruce W Carter VAMC, Res Serv, Miami, FL USA	University of Massachusetts System; University of Massachusetts Worcester; University of Miami; University of Miami; Geriatric Research Education & Clinical Center	Myers, RS (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.	rmyers@med.miami.edu			National Institutes of Health [F31-GM089125-01]; University of Miami Department of Biochemistry and Molecular Biology; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development) Merit Review award [BX000952]; Miami VA Geriatric Research, Education, and Clinical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM089125] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami Department of Biochemistry and Molecular Biology; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development) Merit Review award(US Department of Veterans Affairs); Miami VA Geriatric Research, Education, and Clinical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health [F31-GM089125-01] to MV, funds from the University of Miami Department of Biochemistry and Molecular Biology to RSM, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development) Merit Review award [BX000952] to PCS and funds from the Miami VA Geriatric Research, Education, and Clinical Center to PCS and MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI [10.1093/narigko589, DOI 10.1093/NARI/GK0589]; Aarts M, 2010, J CELL MOL MED, V14, P1657, DOI 10.1111/j.1582-4934.2009.00847.x; Andrieu-Soler C, 2005, NUCLEIC ACIDS RES, V33, P3733, DOI 10.1093/nar/gki686; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Dekker M, 2006, GENE THER, V13, P686, DOI 10.1038/sj.gt.3302689; DeWitt MA, 2017, METHODS, V121, P9, DOI 10.1016/j.ymeth.2017.04.003; Di Primio C, 2005, NUCLEIC ACIDS RES, V33, P4639, DOI 10.1093/nar/gki778; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FRIEDRICH TD, 1992, J VIROL, V66, P4576, DOI 10.1128/JVI.66.7.4576-4579.1992; Gourves AS, 2000, J BIOL CHEM, V275, P10864, DOI 10.1074/jbc.275.15.10864; Kalvala A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq486; KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9; Li XT, 2003, NUCLEIC ACIDS RES, V31, P6674, DOI 10.1093/nar/gkg844; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Murphy KC, 2012, ADV VIRUS RES, V83, P367, DOI 10.1016/B978-0-12-394438-2.00008-6; Myers R., 1998, PROC 1998 MIAMI NAT, V38, P49; Nickerson HD, 2003, GENE THER, V10, P1584, DOI 10.1038/sj.gt.3302049; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Perry MBA, 1998, CYTOMETRY, V31, P251; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; Poteete AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067440; Poteete AR, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-12; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; RIO DC, 1985, SCIENCE, V227, P23, DOI 10.1126/science.2981116; Rios X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036697; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takahashi N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni122; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; Taylor TJ, 2003, VIROLOGY, V309, P219, DOI 10.1016/S0042-6822(03)00108-9; Thomason L., 2005, PHAGES THEIR ROLE BA, P383, DOI DOI 10.1128/9781555816506.CH19; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Valledor M, 2012, IUBMB LIFE, V64, P684, DOI 10.1002/iub.1041; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Vellani TS, 2003, J BACTERIOL, V185, P2465, DOI 10.1128/JB.185.8.2465-2474.2003; Wang QY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03390-x; Xu K, 2015, MOL CELLS, V38, P33, DOI 10.14348/molcells.2015.2163; Yanez RJ, 2002, NUCLEIC ACIDS RES, V30, P740, DOI 10.1093/nar/30.3.740; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0200955	10.1371/journal.pone.0200955	http://dx.doi.org/10.1371/journal.pone.0200955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110337	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000010
J	Dai, S; Jin, Y; Li, T; Weng, YL; Xu, XL; Zhang, GL; Li, JL; Pang, RJ; Tian, B; Hua, YJ				Dai, Shang; Jin, Ye; Li, Tao; Weng, Yulan; Xu, Xiaolin; Zhang, Genlin; Li, Jiulong; Pang, Renjiang; Tian, Bing; Hua, Yuejin			DR1440 is a potential iron efflux protein involved in maintenance of iron homeostasis and resistance of Deinococcus radiodurans to oxidative stress	PLOS ONE			English	Article							RADIATION-RESISTANCE; ACCUMULATION; PERSPECTIVE; SURVIVAL; ATPASES; DAMAGE	Iron acquisition by bacteria is well studied, but iron export from bacteria is less understood. Herein, we identified dr1440 with a P-type ATPase motif as a potential exporter of iron from Deinococcus radiodurans, a bacterium known for its extreme resistance to radiation and oxidants. The DR1440 was located in cell membrane as demonstrated by fluorescence labelling analysis. Mutation of dr1440 resulted in cellular accumulation of iron ions, and expression level of dr1440 was up-regulated significantly under iron ion or hydrogen peroxide stress in the wild-type strain, implicating DR1440 as a potential iron efflux protein. The dr1440 mutant displayed higher sensitivity to iron ions and oxidative stresses including hydrogen peroxide, hypochlorous acid, and gamma-ray irradiation compared with the wildtype strain. The high amount of iron in the mutant strain resulted in severe protein carbonylation, suggesting that DR1440 might contribute to intracellular protein protection against reactive oxygen species (ROS) generated from ferrous ion-mediated Fenton-reaction. Mutations of S297A and C299A led to intracellular accumulation of iron, indicating that S297 and C299 might be important functional residues of DR1440. Thus, DR1440 is a potential iron efflux protein involved in iron homeostasis and oxidative stress-resistance of D. radiodurans.	[Dai, Shang; Jin, Ye; Li, Tao; Weng, Yulan; Li, Jiulong; Pang, Renjiang; Tian, Bing; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Key Lab Nucl Agr Sci, Chinese Minist Agr & Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaolin; Zhang, Genlin] Shihezi Univ, Sch Chem & Chem Engn, Key Lab Green Proc Chem Engn Xinjiang Bingtuan, Shihezi, Xinjiang, Peoples R China	Zhejiang University; Shihezi University	Tian, B (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Key Lab Nucl Agr Sci, Chinese Minist Agr & Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	tianbing@zju.edu.cn	Li, Jiulong/X-2367-2019; Li, Jiulong/AEN-0352-2022	Li, Jiulong/0000-0002-8816-7539; Chen, Xuanyi/0000-0001-7406-4806	National Natural Science Foundation of China [31670083, 31370119, 31210103904, 31370102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	T.B. received funding from the National Natural Science Foundation of China, grant numbers: 31670083, 31370119, 31210103904, 31370102, http://www.nsfc.gov.cn/.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Chen H, 2008, PLOS ONE, V3; Chen HA, 2010, BIOCHEM BIOPH RES CO, V396, P413, DOI 10.1016/j.bbrc.2010.04.106; Conrad ME, 2002, BLOOD CELL MOL DIS, V29, P336, DOI 10.1006/bcmd.2002.0564; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Lin L, 2016, MOL MICROBIOL, V100, P527, DOI 10.1111/mmi.13331; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pi HL, 2017, METALLOMICS, V9, P840, DOI 10.1039/c7mt00112f; Rainey FA, 1997, INT J SYST BACTERIOL, V47, P510, DOI 10.1099/00207713-47-2-510; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Schurig-Briccio LA, 2012, J BACTERIOL, V194, P4107, DOI 10.1128/JB.00849-12; Shah AMUH, 2014, PLOS ONE, V9; Sharma A, 2017, P NATL ACAD SCI USA, V114, pE9253, DOI 10.1073/pnas.1713608114; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Tian B, 2010, MOL BIOSYST, V6, P2068, DOI 10.1039/c004875e; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Yoshimizu T, 1998, BIOSCI BIOTECH BIOCH, V62, P1258, DOI 10.1271/bbb.62.1258	33	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202287	10.1371/journal.pone.0202287	http://dx.doi.org/10.1371/journal.pone.0202287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106993	Green Submitted, gold, Green Published			2022-12-26	WOS:000441662800036
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			Association between subclinical thyroid dysfunction and depressive symptoms in the Korean adult population: The 2014 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							NONTHYROIDAL ILLNESS SYNDROME; HYPOTHYROIDISM; DISORDERS; AUTOIMMUNITY; MOOD; RISK; AXIS	Background Clinical hyper and hypothyroidism are associated with a risk for depression. Objectives This study was performed to investigate the association between depressive symptoms and subclinical thyroid dysfunction. Methods Among the 7,550 subjects who participated in the 2014 Korea National Health and Nutrition Examination Survey, 1,763 participants without overt thyroid disease were included in this study. Serum thyroid stimulating hormone (TSH), serum free thyroxine (fT4), and depressive symptoms were analyzed based on the Patient Health Questionnaire (PHQ9). Results The percentages of subjects with subclinical hypothyroidism and subclinical hyperthyroidism were 3.3% and 2.6%, respectively. The percentages of subjects with moderate (10-14 points), moderately severe (15-19 points), and severe (>= 20 points) depression according to the distribution of PHQ-9 scores were 4.7%, 1.1%, and 0.3%, respectively. TSH, fT4, and the percentage of patients with subclinical hypothyroidism were not significantly associated with PHQ-9 score. However, the percentage of patients with subclinical hyperthyroidism increased significantly with PHQ9 score (P = 0.002). Subjects with subclinical hyperthyroidism had higher PHQ-9 scores than those with normal thyroid function (mean +/- standard error [SE], 4.2 +/- 0.5 vs. 2.7 +/- 0.1 points, P = 0.010). More subjects with subclinical hyperthyroidism had a PHQ9 score >= 10 than did those with normal thyroid function (mean +/- SE, 17.1 +/- 3.5 vs. 5.8 +/- 0.6%, P = 0.005). We performed logistic regression analyses for the presence of depressive symptoms, using age, sex, education, household income, alcohol drinking, smoking, diabetes, cerebrovascular disease history, subclinical hypothyroidism, and subclinical hyperthyroidism as variables. Subclinical hyperthyroidism was associated with the presence of clinically relevant depression (PHQ9 score >= 10), (odds ratio [OR], 4.04; 95% confidence interval [CI], 1.75-9.31; P = 0.001), and clinically significant depression (PHQ9 score >= 15), (OR, 7.05; 95% CI, 1.67-29.67; P = 0.008), respectively. However, subclinical hypothyroidism was not associated with the presence of clinically relevant depression (OR, 1.15; 95% CI, 0.39-3.38; P = 0.800), or clinically significant depression (OR, 3.35; 95% CI, 0.71-15.79; P = 0.127). Conclusions We demonstrated that subclinical hyperthyroidism was independently associated with depressive symptoms in the Korean general population using national cross-sectional data.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Adler SM, 2007, ENDOCRIN METAB CLIN, V36, P657, DOI 10.1016/j.ecl.2007.04.007; Almeida C, 2007, REV BRAS PSIQUIATR, V29, P157, DOI 10.1590/S1516-44462007000200013; Bauer M, 2002, MOL PSYCHIATR, V7, P140, DOI 10.1038/sj.mp.4000963; Blum MR, 2016, NEUROENDOCRINOLOGY, V103, P291, DOI 10.1159/000437387; Brownlie BEW, 2000, EUR J ENDOCRINOL, V142, P438, DOI 10.1530/eje.0.1420438; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Chueire VB, 2007, ARCH GERONTOL GERIAT, V44, P21, DOI 10.1016/j.archger.2006.02.001; Davis J D, 2007, Minerva Endocrinol, V32, P49; Davis Jennifer Duncan, 2003, Curr Psychiatry Rep, V5, P384, DOI 10.1007/s11920-003-0073-6; Demartini B, 2014, J NERV MENT DIS, V202, P603, DOI 10.1097/NMD.0000000000000168; Dickerman AL, 2012, AM J PSYCHIAT, V169, P127, DOI 10.1176/appi.ajp.2011.11040631; Engum A, 2002, ACTA PSYCHIAT SCAND, V106, P27, DOI 10.1034/j.1600-0447.2002.01250.x; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648; Hendrick V, 1998, PSYCHIAT CLIN N AM, V21, P277, DOI 10.1016/S0193-953X(05)70005-8; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Ittermann T, 2015, SOC PSYCH PSYCH EPID, V50, P1417, DOI 10.1007/s00127-015-1043-0; Jackson IMD, 1998, THYROID, V8, P951, DOI 10.1089/thy.1998.8.951; Kim WG, 2017, ENDOCRINOL METAB, V32, P106, DOI 10.3803/EnM.2017.32.1.106; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langton JE, 2002, ENDOCRIN METAB CLIN, V31, P159, DOI 10.1016/S0889-8529(01)00008-1; McIver B, 1997, THYROID, V7, P125, DOI 10.1089/thy.1997.7.125; Medici M, 2014, J CLIN ENDOCR METAB, V99, P1213, DOI 10.1210/jc.2013-3589; Park YJ, 2010, ARCH GERONTOL GERIAT, V50, pE68, DOI 10.1016/j.archger.2009.05.015; Roberts LM, 2006, ANN INTERN MED, V145, P573, DOI 10.7326/0003-4819-145-8-200610170-00006; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; van de Ven AC, 2012, ACTA PSYCHIAT SCAND, V126, P377, DOI 10.1111/j.1600-0447.2012.01870.x; Williams MD, 2009, CLIN ENDOCRINOL, V70, P484, DOI 10.1111/j.1365-2265.2008.03352.x; Yalcin MM, 2017, ENDOCR J, V64, P425, DOI 10.1507/endocrj.EJ16-0418	29	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202258	10.1371/journal.pone.0202258	http://dx.doi.org/10.1371/journal.pone.0202258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ4SC	30106989	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800033
J	Isidorov, V; Szoka, L; Nazaruk, J				Isidorov, Valery; Szoka, Lukasz; Nazaruk, Jolanta			Cytotoxicity of white birch bud extracts: Perspectives for therapy of tumours	PLOS ONE			English	Article							MEDICINAL-PLANTS; ANTICANCER; PRECURSORS; PROPOLIS	Birch buds (Gemmae Betulae) are widely used in Russian and Chinese traditional medicine mainly as a diuretic and diaphoretic agent but also as an antiseptic, anti-inflammatory and analgesic. Despite the long history of therapeutic use of birch buds in folk medicine, the existing information on their chemical composition and pharmacological effects is insufficient. This circumstance warrants further study of the chemistry and pharmacology of birch buds. The present study was designed to investigate (a) the chemical composition of buds from two species of white birch and (b) the in vitro cytotoxic effect of extracts from these sources on selected tumour cells. Extracts from Betula pubescens Ehrh. and Betula pendula Roth. buds were obtained using three different methods: carbon dioxide supercritical fluid extraction (SFE), washing of exudate covering whole buds, and extraction of milled buds with diethyl ether. The chemical composition of extracts was investigated by GC-MS. Cytotoxicity was determined by MTT assay, and cell proliferation was determined by [H-3]thymidine uptake in cancer cells and normal skin fibroblasts. The GC-MS investigation identified a total of 150 substances of different classes. The chemical composition of B. pubescens and B. pendula buds differed, with bud extracts from the former containing a relatively high quantity of sesquiterpenoids and flavonoids, while the main components of extracts from the latter were triterpenoids. The results of the biological assay indicated that birch bud extracts demonstrated time-and concentration-dependent and differential cytotoxicity. The highest cytotoxic activity demonstrated bud exudates and SFE extracts obtained from both Betula species. The rich chemical composition of birch buds suggests the possibility of a wider spectrum of biological activity than previously thought. Birch bud extracts could be a promising source of compounds with cytotoxic activity against various cancers.	[Isidorov, Valery] Bialystok Tech Univ, Forest Fac, Hajnowka, Poland; [Szoka, Lukasz] Med Univ Bialystok, Dept Med Chem, Bialystok, Poland; [Nazaruk, Jolanta] Med Univ Bialystok, Dept Pharmacognosy, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok	Isidorov, V (corresponding author), Bialystok Tech Univ, Forest Fac, Hajnowka, Poland.	isidorov@uwb.edu.pl	Szoka, Lukasz/S-7336-2018; Isidorov, Valery/B-3698-2018	Szoka, Lukasz/0000-0003-2822-1588; Isidorov, Valery/0000-0001-8185-3301	National Science Centre (Poland) [2016/23/B/NZ7/03360]; Bialystok University of Technology Program [S/ZWL/1/2017]	National Science Centre (Poland); Bialystok University of Technology Program	This work was supported by grant of National Science Centre (Poland) 2016/23/B/NZ7/03360 to V.I., as well as by Bialystok University of Technology Program S/ZWL/1/2017 to V.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Edward Roy and his staff (New Chemical Synthesis Institute, Pulawy) for SFE extraction of birch buds. This work was supported by grant of National Science Centre (Poland) 2016/23/B/NZ7/03360 and by Bialystok University of Technology Program S/ZWL/1/2017.	[Anonymous], 1990, STATE PHARMACOPOEIA, V2; Birch Raal A., 2010, RECENT PROGR MED PLA, V28, P123; Culpeper N., 1995, CULPEPERS COMPLETE H; Duric K., 2013, Journal of Plant Studies, V2, P61; Folkard C., 1995, ENCY HERBS THEIR USE; Galashkina N. G., 2004, Rastitel'nye Resursy, V40, P62; Goun EA, 2002, J ETHNOPHARMACOL, V81, P337, DOI 10.1016/S0378-8741(02)00116-2; HANSEL R., 1954, ARCH PHARM U BER DEUTSCH PHARM GES, V287, P117, DOI 10.1002/ardp.19542870303; Heywood VH, 1979, FLOWERING PLANTS WOR, P59; Isidorov V.A., 2015, 6 RUS KOR C CURR ISS, P189; Isidorov V.A., 2015, IDENTIFICATION BIOL, V1st ed.; Isidorov V, 2014, BIOCHEM SYST ECOL, V52, P41, DOI 10.1016/j.bse.2013.12.008; Isidorov VA, 2016, J CHEM ECOL, V42, P475, DOI 10.1007/s10886-016-0708-9; Isidorov VA, 2014, FOOD CHEM, V142, P101, DOI 10.1016/j.foodchem.2013.07.032; Isidorov VA, 2009, J CHROMATOGR A, V1216, P8998, DOI 10.1016/j.chroma.2009.10.079; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P5375, DOI 10.1021/jf060899p; Kuznicka B, 1986, HIST NATURAL REMEDIE, P217; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Legault J, 2007, J PHARM PHARMACOL, V59, P1643, DOI 10.1211/jpp.59.12.0005; Mashentseva A. A., 2011, Journal of Phytology, V3, P18; National Institute of Standards and Technology-NIST, 2013, NIST CHEM WEBBOOK; NIKOLAEVA V G, 1981, Rastitel'nye Resursy, V17, P410; Plochmann K, 2007, ARCH BIOCHEM BIOPHYS, V460, P1, DOI 10.1016/j.abb.2007.02.003; PLUMB JA, 1989, CANCER RES, V49, P4435; Prokof'eva NG, 2007, CHEM NAT COMPD+, V43, P72, DOI 10.1007/s10600-007-0035-z; Raal A, 2008, EMEAHMPC2600182006; Shikov AN, 2014, J ETHNOPHARMACOL, V154, P481, DOI 10.1016/j.jep.2014.04.007; Spiridonov NA, 2005, PHYTOTHER RES, V19, P428, DOI 10.1002/ptr.1616; Tolmacheva AA, 2014, ACTA PHARMACEUT, V64, P173, DOI 10.2478/acph-2014-0019; Uwai K, 2008, BIOORGAN MED CHEM, V16, P7795, DOI 10.1016/j.bmc.2008.07.006; Wichtl M., 1994, HERBAL DRUGS PHYTOPH, P106; Yakovlev GP, 1999, ENCY DICT HERBS PROD; Zemlinsky SE, 1958, MED PLANTS SSSR, P84	34	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201949	10.1371/journal.pone.0201949	http://dx.doi.org/10.1371/journal.pone.0201949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106978	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800019
J	Barnuevo, A; Asaeda, T				Barnuevo, Abner; Asaeda, Takashi			Integrating the ecophysiology and biochemical stress indicators into the paradigm of mangrove ecology and a rehabilitation blueprint	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; KANDELIA-CANDEL; GAS-EXCHANGE; GROWTH; SEEDLINGS; SALINITY; TOLERANCE; ZONE; ROOT; ACCUMULATION	The continuous degradation of mangrove habitats has encouraged governments and multilateral agencies to undertake rehabilitation initiatives to foster the recovery and biodiversity of these areas. However, some rehabilitation initiatives suffer high mortality because of incorrect species-site matching and failure to recognize the ecophysiology of mangrove species. This study investigated the effects of salinity, water depth and inundation on the growth, biochemical stress responses, and ecophysiology of Rhizophora stylosa in greenhouse conditions. Propagules were cultured in aquarium tanks and irrigated with low (0 ppt), moderate (20 ppt), and high (35 ppt) salinity treatments. In the first setup, the seedlings were cultured in aquarium tanks and arranged on the top of a platform at different elevations, subjecting the seedlings to flooding with low-water (3-5 cm), mid-water (10-13 cm) and high-water (30-33 cm) levels for ten months. In another setup, the seedlings were cultured for 15 months at the low-water level and subjected to inundation hydroperiods: semi-diurnal, diurnal and permanent inundation for one week. These microcosms simulated emerged and submerged conditions, mimicking intertidal inundation that seedlings would experience. The results showed that salinity significantly affected the early development of the cultured seedlings with higher growth rates and biomass at low and moderate salinity than those at high salinity. Levels of reactive oxygen species (ROS) and antioxidant activities (AOX) were significantly lower in the emerged condition than those in an inundated condition. Inundation imposed a higher-degree of stress than that of the salinity effect, with prolonged inundation caused sublethal damage (chlorotic leaves). Furthermore, inundation caused the reduction of photosynthetic pigments and fluorescence, dependent on salinity. Extrapolating the ecophysiology of R. stylosa, this species had low tolerance to inundation stress (high ROS and AOX, reduced pigments). Translating this low tolerance to field conditions, in the frequently inundated areas (i.e., seafront mangrove fringes) that are subjected to longer inundation at spring tides, this species may suffer from oxidative stress, stunted growth and consequently low survival.	[Barnuevo, Abner] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama, Japan; [Barnuevo, Abner] KGrp Philippines Inc, KP Ctr Mangrove Res, iMEZ Bldg,MEZ2, Lapulapu City, Cebu, Philippines; [Asaeda, Takashi] Saitama Univ, Dept Environm Sci, Sakura Ku, Saitama, Japan	Saitama University; Saitama University	Asaeda, T (corresponding author), Saitama Univ, Dept Environm Sci, Sakura Ku, Saitama, Japan.	asaeda@mail.saitama-u.ac.jp	Asaeda, Takashi/C-5278-2008	Barnuevo, Abner/0000-0002-7721-5355	APN Project [ARCP2012-02CMY-Fortes]; Takahashi Foundation; Japan Society for the Promotion of Science [15H05219]; KGroup Philippines, Inc.	APN Project; Takahashi Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KGroup Philippines, Inc.	This study was financially supported by the APN Project (Reference Number ARCP2012-02CMY-Fortes), by the Takahashi Foundation and by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (15H05219). KGroup Philippines, Inc. provided support in the form of salary for author (AB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Asaeda T, 2016, ESTUAR COAST SHELF S, V173, P57, DOI 10.1016/j.ecss.2016.02.017; Aziz I, 2001, AQUAT BOT, V70, P259, DOI 10.1016/S0304-3770(01)00160-7; Ball MC, 1988, TREES-STRUCT FUNCT, V2, P129, DOI 10.1007/BF00196018; Barnuevo A, 2017, ESTUAR COAST SHELF S, V198, P432, DOI 10.1016/j.ecss.2017.02.015; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chen LZ, 2005, ENVIRON EXP BOT, V54, P256, DOI 10.1016/j.envexpbot.2004.09.004; Chen LZ, 2004, ACTA OCEANOL SIN, V23, P149; Chen YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093337; CLOUGH BF, 1984, AUST J PLANT PHYSIOL, V11, P419, DOI 10.1071/PP9840419; Das SK, 2016, INT REV HYDROBIOL, V101, P3, DOI 10.1002/iroh.201401744; DeEll J. R., 2003, Practical applications of chlorophyll fluorescence in plant biology, P203; Ellison AM, 1997, OECOLOGIA, V112, P435, DOI 10.1007/s004420050330; FAO, 2007, 153 FAO; Friess DA, 2017, WETLANDS, V37, P603, DOI 10.1007/s13157-016-0747-6; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Garcia-Sanchez F, 2007, PHYSIOL PLANTARUM, V130, P532, DOI 10.1111/j.1399-3054.2007.00925.x; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; He B, 2009, FRONTIERS FORESTRY C, V4, P7, DOI DOI 10.1007/S11461-009-0001-Y; He BY, 2007, ESTUAR COAST SHELF S, V74, P254, DOI 10.1016/j.ecss.2007.04.018; Hoppe-Speer SCL, 2011, AQUAT BOT, V95, P71, DOI 10.1016/j.aquabot.2011.03.006; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; Jayatissa LP, 2008, INT REV HYDROBIOL, V93, P700, DOI 10.1002/iroh.200711017; Kodikara KAS, 2017, RESTOR ECOL, V25, P705, DOI 10.1111/rec.12492; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Krauss KW, 2006, TREE PHYSIOL, V26, P959, DOI 10.1093/treephys/26.7.959; Lewis RR, 2005, ECOL ENG, V24, P403, DOI 10.1016/j.ecoleng.2004.10.003; Lindeboom H., 2005, GLO CH IGBP, P1, DOI 10.1007/3-540-27851-6_1; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; MACADAM JW, 1992, PLANT PHYSIOL, V99, P879, DOI 10.1104/pp.99.3.879; Mangora MM, 2014, MAR FRESHWATER RES, V65, P497, DOI 10.1071/MF13167; McKee KL, 1996, TREE PHYSIOL, V16, P883; NAIDOO G, 1985, AQUAT BOT, V22, P133, DOI 10.1016/0304-3770(85)90042-7; Naidoo G, 1997, AS PAC C SCI MAN COA; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Oh RRY, 2017, ECOL ENG, V100, P325, DOI 10.1016/j.ecoleng.2016.12.021; PEZESHKI SR, 1990, CAN J FOREST RES, V20, P869, DOI 10.1139/x90-116; Primavera J. H., 2008, Wetlands Ecology and Management, V16, P345, DOI 10.1007/s11273-008-9101-y; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Samson MS, 2008, AMBIO, V37, P234, DOI 10.1579/0044-7447(2008)37[234:GPOPMI]2.0.CO;2; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Skelton NJ, 1996, AQUAT BOT, V54, P165, DOI 10.1016/0304-3770(96)01043-1; Sugimoto M, 2009, BIOSCI BIOTECH BIOCH, V73, P2762, DOI 10.1271/bbb.90456; Wang HM, 2014, BOT STUD, V55, DOI 10.1186/s40529-014-0057-3; Wang WQ, 2011, TREES-STRUCT FUNCT, V25, P953, DOI 10.1007/s00468-011-0570-x; Watson J. G., 1928, MALAYAN FOREST RECOR, V6, P275; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wolanski E., 2015, ESTUARINE ECOHYDROLO, P320; Ye Y, 2003, ENVIRON EXP BOT, V49, P209, DOI 10.1016/S0098-8472(02)00071-0; Ye Y, 2005, AQUAT BOT, V83, P193, DOI 10.1016/j.aquabot.2005.06.006; Youssef T, 1998, TREE PHYSIOL, V18, P317	51	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202227	10.1371/journal.pone.0202227	http://dx.doi.org/10.1371/journal.pone.0202227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102744	gold, Green Published, Green Submitted			2022-12-26	WOS:000441452200038
J	Deligianni, E; de Monerri, NCS; McMillan, PJ; Bertuccini, L; Superti, F; Manola, M; Spanos, L; Louis, C; Blackman, MJ; Tilley, L; Siden-Kiamos, I				Deligianni, Elena; de Monerri, Natalie C. Silmon; McMillan, Paul J.; Bertuccini, Lucia; Superti, Fabiana; Manola, Maria; Spanos, Lefteris; Louis, Christos; Blackman, Michael J.; Tilley, Leann; Siden-Kiamos, Inga			Essential role of Plasmodium perforin-like protein 4 in ookinete midgut passage	PLOS ONE			English	Article							MEMBRANE-ATTACK; ANOPHELES-STEPHENSI; HOST-CELLS; BERGHEI; INVASION; FALCIPARUM; INFECTION; GAMETOCYTES; PARASITE; EGRESS	Pore forming proteins such as those belonging to the membrane attack/perforin (MACPF) family have important functions in many organisms. Of the five MACPF proteins found in Plasmodium parasites, three have functions in cell passage and one in host cell egress. Here we report an analysis of the perforin-like protein 4, PPLP4, in the rodent parasite Plasmodium berghei. We found that the protein is expressed only in the ookinete, the invasive stage of the parasite formed in the mosquito midgut. Transcriptional analysis revealed that expression of the pplp4 gene commences during ookinete development. The protein was detected in retorts and mature ookinetes. Using two antibodies, the protein was found localized in a dotted pattern, and 3-D SIM super-resolution microcopy revealed the protein in the periphery of the cell. Analysis of a C-terminal mCherry fusion of the protein however showed mainly cytoplasmic label. A pplp4 null mutant formed motile ookinetes, but these were unable to invade and traverse the midgut epithelium resulting in severely impaired oocyst formation and no transmission to naive mice. However, when in vitro cultured ookinetes were injected into the thorax of the mosquito, thus by-passing midgut passage, sporozoites were formed and the mutant parasites were able to infect naive mice. Taken together, our data show that PPLP4 is required only for ookinete invasion of the mosquito midgut. Thus PPLP4 has a similar role to the previously studied PPLP3 and PPLP5, raising the question why three proteins with MACPF domains are needed for invasion by the ookinete of the mosquito midgut epithelium.	[Deligianni, Elena; Manola, Maria; Spanos, Lefteris; Louis, Christos; Siden-Kiamos, Inga] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [de Monerri, Natalie C. Silmon; Blackman, Michael J.] Francis Crick Inst, London, England; [McMillan, Paul J.; Tilley, Leann] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [McMillan, Paul J.; Tilley, Leann] Univ Melbourne, ARC Ctr Excellence Coherent Xray Sci, Melbourne, Vic, Australia; [McMillan, Paul J.; Tilley, Leann] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [McMillan, Paul J.] Univ Melbourne, Biol Opt Microcopy Platform, Melbourne, Vic, Australia; [Bertuccini, Lucia; Superti, Fabiana] Natl Inst Hlth, Natl Ctr Innovat Technol Publ Hlth, Rome, Italy; [Blackman, Michael J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [de Monerri, Natalie C. Silmon] Pfizer Inc, Pearl River, NY USA	Foundation for Research & Technology - Hellas (FORTH); Francis Crick Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Istituto Superiore di Sanita (ISS); University of London; London School of Hygiene & Tropical Medicine; Pfizer	Deligianni, E (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	delena@imbb.forth.gr	BERTUCCINI, LUCIA/F-2102-2015; Bertuccini, Lucia/AAI-6683-2021; Superti, Fabiana/F-2100-2015	Bertuccini, Lucia/0000-0002-4278-2376; Superti, Fabiana/0000-0003-4909-7598; Manola, Maria/0000-0002-6975-2812; McMillan, Paul/0000-0001-5629-1175	BIOSYS research project, Action KRIPIS - General Secretariat for Research and Technology, Ministry of Education, Greece [MIS-448301 (2013SE01380036)]; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF)/European Commission; Evimalar [242095]; Transmalaria bloc [GA223736]; UK Medical Research Council [U117532063]; OzMalNet; Medical Research Council	BIOSYS research project, Action KRIPIS - General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF)/European Commission; Evimalar; Transmalaria bloc; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); OzMalNet; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by BIOSYS research project, Action KRIPIS, project No MIS-448301 (2013SE01380036) funded by the General Secretariat for Research and Technology, Ministry of Education, Greece, and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission to ISK, http://www.gsrt.gr; Evimalar (Grant Agreement 242095) to CL, http://www.evimalar.org; Transmalaria bloc (contract nr GA223736) to CL, http://www.transmalariabloc.net/; UK Medical Research Council (U117532063) to MJB, https://www.mrc.ac.uk; Medical Research Council, PhD studentship to NCS, https://www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ISK is grateful for the hospitality provided by the group of Prof. G. McFadden, the excellent support of Ms Vanessa Mollard and the generous funding from OzMalNet. We acknowledge Prof. Gabriele Pradel and Christine Wirth for stimulating discussions, the exchange of unpublished results and a gift of PPLP4 antiserum. We thank Katerina Kallitsounaki, Katerina Dalakoura-Karagouni, and Ioannis Livadaras for valuable technical assistance and Dr Julian Rayner for kindly providing the GAP50 antibody. Dr Eric Hanssen assisted in interpreting the TEM images.	BILLINGSLEY PF, 1992, J PARASITOL, V78, P430, DOI 10.2307/3283640; Boysen KE, 2011, J BIOL CHEM, V286, P32661, DOI 10.1074/jbc.M111.269399; Deligianni E, 2013, CELL MICROBIOL, V15, P1438, DOI 10.1111/cmi.12131; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dinglasan RR, 2009, INSECT BIOCHEM MOLEC, V39, P125, DOI 10.1016/j.ibmb.2008.10.010; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Han YS, 2002, INSECT BIOCHEM MOLEC, V32, P1311, DOI 10.1016/S0965-1748(02)00093-0; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1989, EXP PARASITOL, V68, P274, DOI 10.1016/0014-4894(89)90109-4; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kaneko I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004905; Kondos SC, 2010, TISSUE ANTIGENS, V76, P341, DOI 10.1111/j.1399-0039.2010.01566.x; Kooij TWA, 2012, MOL BIOCHEM PARASIT, V185, P19, DOI 10.1016/j.molbiopara.2012.06.001; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; McMillan PJ, 2013, CELL MICROBIOL, V15, P1401, DOI 10.1111/cmi.12125; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; PERRY MM, 1979, J CELL SCI, V39, P257; Poulin B, 2013, BIOL OPEN, V2, P1160, DOI 10.1242/bio.20136163; Risco-Castillo V, 2015, CELL HOST MICROBE, V18, P593, DOI 10.1016/j.chom.2015.10.006; Rodriguez MC, 2002, EXP PARASITOL, V101, P73, DOI 10.1016/S0014-4894(02)00035-8; Roiko MS, 2013, J BIOL CHEM, V288, P8712, DOI 10.1074/jbc.M113.450932; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Siden-Kiamos I, 2006, MOL BIOCHEM PARASIT, V150, P308, DOI 10.1016/j.molbiopara.2006.09.003; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Wirth CC, 2015, MOL BIOCHEM PARASIT, V201, P90, DOI 10.1016/j.molbiopara.2015.06.005; Wirth CC, 2014, CELL MICROBIOL, V16, P709, DOI 10.1111/cmi.12288; Yang ASP, 2017, CELL REP, V18, P3105, DOI 10.1016/j.celrep.2017.03.017	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201651	10.1371/journal.pone.0201651	http://dx.doi.org/10.1371/journal.pone.0201651			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102727	Green Published, gold, Green Accepted			2022-12-26	WOS:000441452200015
J	Wang, Y; Wang, EF; Zhang, YB; Madamsetty, VS; Ji, BA; Radisky, DC; Grande, JP; Misra, S; Mukhopadhyay, D				Wang, Ying; Wang, Enfeng; Zhang, Yuebo; Madamsetty, Vijay S.; Ji, Baoan; Radisky, Derek C.; Grande, Joseph P.; Misra, Sanjay; Mukhopadhyay, Debabrata			Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension	FASEB JOURNAL			English	Article						endothelium; NO; high blood pressure; miRNA	NITRIC-OXIDE SYNTHESIS; ASYMMETRIC DIMETHYLARGININE; RISK-FACTOR; DYSFUNCTION; SEMAPHORIN; RECEPTOR; ADMA; ANGIOGENESIS; REGULATOR; PATHWAY	Dimethylarginine dimethylaminohydrolases (DDAHs) are known to degrade asymmetric dimethylarginine, an endogenous inhibitor of NOS, and maintain vascular homeostasis; however, the regulatory pathways of DDAHs remain unclear. In this study, we aimed to define the role of transmembrane glycoprotein neuropilin-1 (NRP1) in the expression of DDAHs and investigate the potential roles of NRP1 in regulation of blood pressure. Short hairpin RNA-mediated knockdown of NRP1 reduced the level and mRNA stability of DDAH1 but not DDAH2 in HUVECs, whereas overexpression of NRP1 increased the mRNA stability of DDAH1. Meanwhile, mesenteric arteries and lung vascular endothelial cells of tamoxifen-inducible endothelial cell-specific NRP1 knockout mice exhibited decreased expression of DDAH1 and slightly increased expression of DDAH2. Mechanistically, the regulation of NRP1 on DDAH1 expression is mediated by a posttranscriptional mechanism involving miR-219-5p in HUVECs. Although the endothelial cell-specific NRP1 knockout mice did not exhibit any significant change in blood pressure at the basal level, they were more sensitive to low-dose angiotensin II infusion-induced increases in blood pressure. Our results show that NRP1 is required for full expression of DDAH1 in endothelial cells and that NRP1 contributes to protection from low-dose angiotensin II-induced increases in blood pressure.Wang, Y., Wang, E., Zhang, Y., Madamsetty, V. S., Ji, B., Radisky, D. C., Grande, J. P., Misra, S., Mukhopadhyay, D. Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension.	[Wang, Ying; Wang, Enfeng; Madamsetty, Vijay S.; Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA; [Zhang, Yuebo; Ji, Baoan; Radisky, Derek C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Grande, Joseph P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Misra, Sanjay] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Mukhopadhyay, D (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.	mukhopadhyay.debabrata@mayo.edu	Madamsetty, Vijay Sagar/AAF-4804-2019; Grande, Joseph P./AAG-2128-2020	Madamsetty, Vijay Sagar/0000-0001-9883-190X; Grande, Joseph P./0000-0001-5674-1682; Wang, Ying/0000-0002-7852-386X	Microarray Core Facility at Mayo Clinic; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL140411]; NIH National Cancer Institute [CA78383-20]; Florida Department of Health Cancer Research Chair's Fund Florida Grant [3J-02]; American Heart Association [AHA-14POST20390029]; NATIONAL CANCER INSTITUTE [R01CA150190, R01CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140411] Funding Source: NIH RePORTER	Microarray Core Facility at Mayo Clinic; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Cancer Research Chair's Fund Florida Grant; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Alex Kolodkin (Johns Hopkins University, Baltimore, MD, USA) and Dr. Ralf H. Adams (Max Planck Institute, Munster, Germany) for the NRP1<SUP>flox/flox</SUP> mice and vascular endothelial-cadherin/Cre-ERT2 mice, respectively. They also thank Dr. Jordan D. Miller and Mr. Bruce E. Knudsen (Mayo Clinic) for assistance with the mouse blood pressure measurements. The authors thank the Microarray Core Facility at Mayo Clinic for their support and Brandy H. Edenfield (Mayo Clinic Jacksonville Histopathology Facility) for the kind help. The authors thank Dr. Luke H. Hoeppner (The Hormel Institute, University of Minnesota, Austin, MN, USA) for critically reviewing the manuscript, and Drs. DeLisa Fairweather and Katelyn A. Bruno (Mayo Clinic) for assistance with mouse lung endothelial cell isolation. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL140411, and NIH National Cancer Institute Grant CA78383-20 (both to D.M.), the Florida Department of Health Cancer Research Chair's Fund Florida Grant 3J-02 (to D.M.), and the American Heart Association Grant AHA-14POST20390029 (to Y.W.). The authors declare no conflicts of interest.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Dowsett L, 2015, CIRCULATION, V131, P2217, DOI 10.1161/CIRCULATIONAHA.114.015064; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hu XL, 2011, ARTERIOSCL THROM VAS, V31, P1540, DOI 10.1161/ATVBAHA.110.222638; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Iannone L, 2014, BIOCHEM J, V462, P103, DOI 10.1042/BJ20140486; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lambden S, 2015, ARTERIOSCL THROM VAS, V35, P1382, DOI 10.1161/ATVBAHA.115.305278; Leiper JM, 2005, THER DRUG MONIT, V27, P744, DOI 10.1097/01.ftd.0000179849.42395.11; Leong Xin-Fang, 2015, Biomed Res Int, V2015, P528757, DOI 10.1155/2015/528757; Liao JK, 2013, J CLIN INVEST, V123, P540, DOI 10.1172/JCI66843; Luo ZM, 2010, HYPERTENSION, V56, P498, DOI 10.1161/HYPERTENSIONAHA.110.152959; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; OGAWA T, 1987, BIOCHEM BIOPH RES CO, V148, P671, DOI 10.1016/0006-291X(87)90929-6; Onozato ML, 2008, DIABETES, V57, P172, DOI 10.2337/db06-1772; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; VALLANCE P, 1992, LANCET, V339, P572; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang Y, 2016, J CELL SCI, V129, P3911, DOI 10.1242/jcs.190702; Wang Y, 2015, ARTERIOSCL THROM VAS, V35, P1401, DOI 10.1161/ATVBAHA.115.305566; Willeit P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001833; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212	31	9	9	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					494	500		10.1096/fj.201800499R	http://dx.doi.org/10.1096/fj.201800499R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30118322	Green Published			2022-12-26	WOS:000457401500039
J	Lee, JS; Kim, YS; Kim, EY; Jin, W				Lee, Jong Soo; Kim, Young Saing; Kim, Eun Young; Jin, Wook			Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer	PLOS ONE			English	Article							SKELETAL-MUSCLE; NEOADJUVANT CHEMOTHERAPY; NUTRITIONAL-STATUS; BODY-COMPOSITION; NATIONAL-HEALTH; GASTRECTOMY; PREVALENCE; TOXICITY; PREDICTS; SURVIVAL	Background Sarcopenia, defined as decreased skeletal muscle mass, is prevalent and associated with poor prognosis in various solid tumors. This study aimed to determine the prognostic role of sarcopenia in patients with advanced gastric cancer (AGC). Methods This retrospective study consisted of 140 consecutive patients who underwent palliative chemotherapy for AGC. A cross-sectional area of muscle at the level of the third lumbar vertebra (L3) was measured using baseline computed tomography (CT) scans. Sarcopenia was defined as a L3 skeletal muscle index of <= 49 cm(2)/m(2) for men and <= 31 cm(2)/m(2) for women using Korean-specific cutoffs. We compared the overall survival (OS) and clinical characteristics of patients with and without sarcopenia. Results The median age was 67 years, and 133 (95%) patients had metastatic disease. Sarcopenia was present in 67 patients (47.9%) and was significantly related to male sex (p < 0.001) and low body mass index (p = 0.002). Patients with sarcopenia had a significantly shorter OS than those without sarcopenia (median, 6.8 months vs. 10.3 months, respectively; p = 0.033). In the multivariable analysis, sarcopenia was an independent prognostic factor of poor OS (hazard ratio, 1.51, p = 0.029); no response to chemotherapy (p < 0.001), no second-line chemotherapy (p < 0.001), metastatic sites >= 3 (p < 0.001), and low serum albumin level (p = 0.033) were also independent prognostic factors of poor OS. Conclusion Sarcopenia, as determined by baseline CT, can be used to predict poor prognosis in AGC patients treated with palliative chemotherapy.	[Lee, Jong Soo] Gachon Univ, Sch Med, Incheon, South Korea; [Kim, Young Saing] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Med Oncol, Incheon, South Korea; [Kim, Eun Young] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Jin, Wook] Gachon Univ, Sch Med, Lab Mol Dis & Cell Regulat, Dept Biochem, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Kim, EY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea.	oneshot0229@gmail.com		Lee, Jong Soo/0000-0002-1125-137X; Kim, Eun Young/0000-0002-2101-7982	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [HA17C0045]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (grant no. HA17C0045). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Blauwhoff-Buskermolen S, 2016, J CLIN ONCOL, V34, P1339, DOI 10.1200/JCO.2015.63.6043; Chen FF, 2016, LANGENBECK ARCH SURG, V401, P813, DOI 10.1007/s00423-016-1490-4; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dittus KL, 2017, PREV MED, V104, P124, DOI [10.1016/j.ypmed.2017.07.015, 10.1]; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fukushima H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115895; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Hayashi N, 2016, ONCOL REP, V35, P1727, DOI 10.3892/or.2015.4475; Heywood R, 2017, SUPPORT CARE CANCER, V25, P3031, DOI 10.1007/s00520-017-3827-0; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; Huang DD, 2017, SURGERY, V161, P680, DOI 10.1016/j.surg.2016.08.030; Huang DD, 2016, J CANCER RES CLIN, V142, P2347, DOI 10.1007/s00432-016-2230-4; Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Kim KM, 2014, IJC METAB ENDOCR, V4, P63, DOI 10.1016/j.ijcme.2014.06.001; Kim YS, 2012, J GERONTOL A-BIOL, V67, P1107, DOI 10.1093/gerona/gls071; Kudou K, 2017, ANN SURG ONCOL, V24, P1804, DOI 10.1245/s10434-017-5811-9; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; Miller BS, 2012, WORLD J SURG, V36, P1509, DOI 10.1007/s00268-012-1581-5; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Nishigori T, 2016, ANN SURG ONCOL, V23, P524, DOI 10.1245/s10434-016-5385-y; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Palmela C, 2017, J GASTRIC CANCER, V17, P74, DOI 10.5230/jgc.2017.17.e8; Peterson MD, 2011, MED SCI SPORT EXER, V43, P249, DOI 10.1249/MSS.0b013e3181eb6265; Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Sjoblom B, 2016, CLIN NUTR, V35, P1386, DOI 10.1016/j.clnu.2016.03.010; Solheim TS, 2018, BMJ SUPPORT PALLIAT, V8, P258, DOI 10.1136/bmjspcare-2017-001440; Song MY, 2004, AM J CLIN NUTR, V79, P874; Spira D, 2016, Z GERONTOL GERIATR, V49, P94, DOI 10.1007/s00391-015-0886-z; Tan BHL, 2015, EJSO-EUR J SURG ONC, V41, P333, DOI 10.1016/j.ejso.2014.11.040; Tegels JJW, 2015, J SURG ONCOL, V112, P403, DOI 10.1002/jso.24015; THRUMURTHY SG, 2013, BMJ CLIN RES ED, V347, DOI DOI 10.1136/BMJ.F6367; van Kan GA, 2012, CURR OPIN CLIN NUTR, V15, P436, DOI 10.1097/MCO.0b013e328356bbf4; Villasenor A, 2012, J CANCER SURVIV, V6, P398, DOI 10.1007/s11764-012-0234-x; Wang SL, 2016, ANN SURG ONCOL, V23, P556, DOI 10.1245/s10434-015-4887-3; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Zheng ZF, 2017, ANN SURG ONCOL, V24, P1795, DOI 10.1245/s10434-017-5813-7; Zhou CJ, 2017, J SURG RES, V211, P137, DOI 10.1016/j.jss.2016.12.014; Zhuang CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003164	47	72	75	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202700	10.1371/journal.pone.0202700	http://dx.doi.org/10.1371/journal.pone.0202700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR0JS	30125312	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100044
J	Posuwan, N; Vorayingyong, A; Jaroonvanichkul, V; Wasitthankasem, R; Wanlapakorn, N; Vongpunsawad, S; Poovorawan, Y				Posuwan, Nawarat; Vorayingyong, Arnond; Jaroonvanichkul, Vorapol; Wasitthankasem, Rujipat; Wanlapakorn, Nasamon; Vongpunsawad, Sompong; Poovorawan, Yong			Implementation of hepatitis B vaccine in high-risk young adults with waning immunity	PLOS ONE			English	Article							ANTIGEN-POSITIVE MOTHERS; LONG-TERM EFFICACY; ANTIBODY PERSISTENCE; INFANT VACCINATION; VIRUS INFECTION; CHILDREN; PROTECTION; BORN; IMMUNIZATION; THAILAND	Universal hepatitis B (HB) vaccination among Thai newborns was initiated in 1992. The first dose of the monovalent HB vaccine was given at birth, then at months 2 and 6 simultaneously with the diphtheria-tetanus-pertussis whole-cell (DTPw) vaccine. In 2008, Thailand replaced the monovalent HB vaccine at months 2 and 6 with a combined DTP-HB given at months 2, 4, and 6, with an added monovalent HB vaccine at month 1 for infants whose mothers were HBV carriers. Despite this rigorous HB vaccination schedule, vaccinated infants who are now adolescents do not possess a protective level of anti-HB surface antigen (anti-HBs) (>= 10 mIU/ml). Thus, many young adults may be rendered susceptible to HB infection. Our objective was to determine how HB booster vaccination may benefit high-risk adolescents. We evaluated the serological records of a cohort of medical students (n = 291), which showed that 271 students (93.1%) possessed anti-HBs less than the accepted protective level (< 10 mIU/ml) and subsequently received the HB vaccine booster prior to medical school enrollment. We then examined the anti-HB surface antibody (anti-HBs) in 216 individuals six weeks after they were immunized. We found that 61%, 88%, and 94% of individuals with pre-booster anti-HBs of < 1 mIU/ml, 1-< 3 mIU/ml, and 3-< 10 mIU/ml achieved protective anti-HBs, respectively. Post-booster geometric mean titers were 305, 513, and 1,929 mIU/ml in these groups and correlated with pre-booster anti-HBs titers. These data suggest that medical students with known anti-HBs < 1 mIU/ml will benefit from 3 doses of HB vaccine at 0, 1, and 6 months. Students with anti-HBs 1-< 10 mIU/ml would benefit from an HB vaccine booster without further anti-HBs evaluation.	[Posuwan, Nawarat; Wasitthankasem, Rujipat; Wanlapakorn, Nasamon; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand; [Vorayingyong, Arnond; Jaroonvanichkul, Vorapol] Chulalongkorn Univ, Acad Adm, Fac Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	Center of Excellence in Clinical Virology [GCE 58-014-30-004]; Research Chair Grant from NSTDA [P-15-50004]; Rachadapisek Sompote Fund of Chulalongkorn University	Center of Excellence in Clinical Virology; Research Chair Grant from NSTDA; Rachadapisek Sompote Fund of Chulalongkorn University	Funding was provided by The Center of Excellence in Clinical Virology (GCE 58-014-30-004) to YP, Research Chair Grant from NSTDA (P-15-50004) to YP, and the Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowships to Nawarat Posuwan and Rujipat Wasitthankasem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Banatvala J, 2000, VACCINE, V19, P877, DOI 10.1016/S0264-410X(00)00224-3; Bruce MG, 2016, J INFECT DIS, V214, P16, DOI 10.1093/infdis/jiv748; Center for Disease Control and Prevention, 2013, CDC GUID EV HLTH CAR; Chinchai T, 2009, VIRAL IMMUNOL, V22, P125, DOI 10.1089/vim.2008.0087; Chongsrisawat V, 2006, TROP MED INT HEALTH, V11, P1496, DOI 10.1111/j.1365-3156.2006.01709.x; Chunsuttiwat S, 2002, VACCINE, V21, P188, DOI 10.1016/S0264-410X(02)00461-9; DING LM, 1993, CLIN INFECT DIS, V17, P475; FitzSimons D, 2013, VACCINE, V31, P584, DOI 10.1016/j.vaccine.2012.10.101; Hepatitis B, 1991, MMWR RECOMM REP, V40, P1; Hepatitis B Foundation, 2018, HIST HEP B VACC; Hummel IB, 2016, PEDIATR INFECT DIS J, V35, P286, DOI 10.1097/INF.0000000000000994; LEE PI, 1995, J PEDIATR-US, V126, P716, DOI 10.1016/S0022-3476(95)70398-5; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; MARTIN CM, 1983, ORAL SURG ORAL MED O, V56, P455, DOI 10.1016/0030-4220(83)90363-8; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; POOVORAWAN Y, 1989, JAMA-J AM MED ASSOC, V261, P3278, DOI 10.1001/jama.261.22.3278; Poovorawan Y, 2011, J VIRAL HEPATITIS, V18, P369, DOI 10.1111/j.1365-2893.2010.01312.x; Poovorawan Y, 1997, ARCH DIS CHILD-FETAL, V77, pF47, DOI 10.1136/fn.77.1.F47; Poovorawan Y., 1994, VIRAL HEPATITIS LIVE, P526; Poovorawan Y, 2008, VACCINE, V26, P1535, DOI 10.1016/j.vaccine.2008.01.028; Poovorawan Y, 2013, HUM VACC IMMUNOTHER, V9, P1679, DOI 10.4161/hv.24844; Poovorawan Y, 2012, HUM VACC IMMUNOTHER, V8, P896, DOI 10.4161/hv.19989; Poovorawan Y, 2010, VACCINE, V28, P730, DOI 10.1016/j.vaccine.2009.10.074; Poovorawan Y, 2009, J INFECT DIS, V200, P33, DOI 10.1086/599331; Poovorawan Yong, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P496; Posuwan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150499; Tharmaphornpilas P, 2009, VACCINE, V27, P6110, DOI 10.1016/j.vaccine.2009.08.034; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; World Health Organization, 2017, GLOBAL HEPATITIS REP; World Health Organization (WHO), 2002, DEP COMM DIS SURV RE	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202637	10.1371/journal.pone.0202637	http://dx.doi.org/10.1371/journal.pone.0202637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125298	gold, Green Submitted, Green Published			2022-12-26	WOS:000442202100039
J	Regueiro, C; Ortiz, AM; Boveda, MD; Castaneda, S; Gonzalez-Alvaro, I; Gonzalez, A				Regueiro, Cristina; Ortiz, Ana M.; Boveda, Maria Dolores; Castaneda, Santos; Gonzalez-Alvaro, Isidoro; Gonzalez, Antonio			Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; RHEUMATOID-ARTHRITIS; CITRULLINATED PROTEIN; RADIOGRAPHIC PROGRESSION; CARP ANTIBODIES; PREDICT; ONSET; AUTOANTIBODIES; ARTHRALGIA; EROSIONS	Rheumatoid arthritis (RA) has a negative impact on bone that is partly mediated by anti-citrullinated proteins antibodies (ACPA). These antibodies are associated with erosions, and with juxta-articular and systemic bone loss. Other RA autoantibodies, the anti-carbamylated protein antibodies (anti-CarPA), are independently associated with erosions. However, we do not know if they are also associated with juxta-articular and systemic bone loss. Here, we have addressed this question with data from 548 early arthritis (EA) patients. Bone mineral density (BMD) was assessed by dual-energy x-ray absorptiometry at the lumbar spine (LS), total hip (TH) and metacarpophalangeal joints (MCP). The 25.9% anti-CarPA positive patients did not show significant differences in BMD Zscores with the negative patients. Nevertheless, this result was due to the similarity between negative and low-positive (below the median of the positive) patients, whereas the high-positive patients showed significant decrease of BMD at LS (beta = -0.39, p = 0.01) and TH (beta = -0.30, p = 0.02); but not at the juxta-articular bone of MCP. Given the overlap between anti-CarPA and ACPA, we included the two autoantibodies in an analysis that showed significantly lower BMD Z-scores at LS and TH (p< 0.01) only in the ACPA positive/anti-CarPA high-positive subgroup. However, the similar coefficients of regression between the ACPA positive/anti-CarPA high-positive and the ACPA negative/anti-CarPA high-positive subgroups (beta = -0.50 vs. -0.52 at LS, and (beta = -0.37 vs. -0.30 at TH) suggested an independent association. Overall, these results support a contribution of antiCarPA to systemic bone loss in EA patients.	[Regueiro, Cristina; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Expt & Observat Rheumatol, Santiago De Compostela, Spain; [Ortiz, Ana M.; Castaneda, Santos; Gonzalez-Alvaro, Isidoro] Inst Invest Hosp La Princesa IIS IP, Rheumatol Dept, Madrid, Spain; [Boveda, Maria Dolores] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Dept Pediat, Unit Diag & Treatment Congenital Metab Dis, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Inst Invest Sanitaria, Expt & Observat Rheumatol, Santiago De Compostela, Spain.	agmartinezp@ser.es	Expósito, Cristina Regueiro/AAC-1405-2021; Gonzalez, Antonio/C-4444-2008	Gonzalez, Antonio/0000-0002-2624-0606; Regueiro, Cristina/0000-0002-8567-6784	Instituto de Salud Carlos III (Spain) [PI14/01651, RD16/0012/0014, PI14/00442, RD16/0012/0011, PI12/01578]; European Regional Development Fund of the EU (FEDER); Ministerio de Educacion Cultura y Deporte (Spain) through a FPU [FPU15/03434]	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European Regional Development Fund of the EU (FEDER); Ministerio de Educacion Cultura y Deporte (Spain) through a FPU	This work was supported by the Instituto de Salud Carlos III (Spain) through grants [PI14/01651 and RD16/0012/0014 to AG; PI14/00442 and RD16/0012/0011 to IG-A and PI12/01578 to SC]. These grants are partially financed by the European Regional Development Fund of the EU (FEDER). CR was supported by Ministerio de Educacion Cultura y Deporte (Spain) through a FPU pre-doctoral fellowship [FPU15/03434]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajeganova S, 2017, ANN RHEUM DIS, V76, P112, DOI 10.1136/annrheumdis-2015-208870; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Boyesen P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2749; Brink M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0536-2; Bugatti S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1116-9; Castaneda S, 2007, J CLIN DENSITOM, V10, P298, DOI 10.1016/j.jocd.2007.04.003; Degboe Y, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000180; Deodhar A, 2010, ARTHRIT CARE RES, V62, P569, DOI 10.1002/acr.20004; Gan RW, 2015, J RHEUMATOL, V42, P572, DOI 10.3899/jrheum.140767; Gonzalez-Alvaro I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161727; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Guler-Yuksel M, 2009, ANN RHEUM DIS, V68, P330, DOI 10.1136/ard.2007.086348; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Hoff M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2280; Humphreys JH, 2015, ANN RHEUMATIC DIS; Jensen T, 2005, SCAND J RHEUMATOL, V34, P27, DOI 10.1080/03009740510017986; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3107; Kleyer A, 2014, ANN RHEUM DIS, V73, P854, DOI 10.1136/annrheumdis-2012-202958; Kleyer A, 2014, CURR OPIN RHEUMATOL, V26, P80, DOI 10.1097/BOR.0000000000000007; Kocijan R, 2014, ANN RHEUM DIS, V73, P2022, DOI 10.1136/annrheumdis-2013-203791; Krishnamurthy A, 2015, ANN RHEUM DIS, V74, P663, DOI 10.1136/annrheumdis-2015-eular.4943; Llorente I, 2017, RHEUMATOL INT, V37, P799, DOI 10.1007/s00296-017-3674-9; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; Mangnus L, 2017, SCAND J RHEUMATOL, V46, P364, DOI 10.1080/03009742.2017.1299217; Martinez-Calatrava MJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3884; Montes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161141; Nakabo S, 2017, RHEUMATOLOGY, V56, P1217, DOI 10.1093/rheumatology/kex088; Orsolini G, 2017, CALCIFIED TISSUE INT, V101, P17, DOI 10.1007/s00223-017-0253-8; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Smolen JS, 2016, LANCET, V388, P1984; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Syversen SW, 2010, ANN RHEUM DIS, V69, P345, DOI 10.1136/ard.2009.113092; Truchetet ME, 2017, ARTHRITIS RHEUMATOL, V69, P2292, DOI 10.1002/art.40237; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; Verheul MK, 2017, J AUTOIMMUN, V80, P77, DOI 10.1016/j.jaut.2017.02.008; Vidal-Bralo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180144; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421; Wysham KD, 2017, ARTHRITIS CARE RES H	44	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202583	10.1371/journal.pone.0202583	http://dx.doi.org/10.1371/journal.pone.0202583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118518	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700035
J	Bilkei-Gerzo, A; Albayram, O; Ativie, F; Chasan, S; Zimmer, T; Bach, K; Zimmer, A				Bilkei-Gerzo, Andras; Albayram, Onder; Ativie, Frank; Chasan, Safak; Zimmer, Till; Bach, Karsten; Zimmer, Andreas			Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain	PLOS ONE			English	Article							AGE-RELATED-CHANGES; ENDOCANNABINOID SYSTEM; 2-ARACHIDONOYLGLYCEROL PRODUCTION; GLUTAMATERGIC ACTIVITY; MICROGLIAL CELLS; MESSENGER-RNA; CB1; INJURY; MICE; RAT	Astrocytes, key regulators of brain homeostasis, interact with neighboring glial cells, neurons and the vasculature through complex processes involving different signaling pathways. It is not entirely clear how these interactions change in the ageing brain and which factors influence astrocyte ageing. Here, we investigate the role of endocannabinoid signaling, because it is an important modulator of neuron and astrocyte functions, as well as brain ageing. We demonstrate that mice with a specific deletion of CB1 receptors on GABAergic neurons (GABA-Cnr1(-/-) mice), which show a phenotype of accelerated brain ageing, affects age-related changes in the morphology of astrocytes in the hippocampus. Thus, GABA-Cnr1(-/-) mice showed a much more pronounced age-related and layer-specific increase in GFAP-positive areas in the hippocampus compared to wild-type animals. The number of astrocytes, in contrast, was similar between the two genotypes. Astrocytes in the hippocampus of old GABA-Cnr1(-/-) mice also showed a different morphology with enhanced GFAP-positive process branching and a less polarized intrahippocampal distribution. Furthermore, astrocytic TNF alpha levels were higher in GABA-Cnr1(-/-) mice, indicating that these morphological changes were accompanied by a more pro-inflammatory function. These findings demonstrate that the disruption of endocannabinoid signaling on GABAergic neurons is accompanied by functional changes in astrocyte activity, which are relevant to brain ageing.	[Bilkei-Gerzo, Andras; Albayram, Onder; Ativie, Frank; Chasan, Safak; Zimmer, Till; Bach, Karsten; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Med Fac, Bonn, Germany; [Albayram, Onder] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Translat Therapeut, Boston, MA USA; [Ativie, Frank] Univ Hosp Heidelberg, Dept Cardiol, Heidelberg, Germany; [Zimmer, Till] Univ Amsterdam, Dept NeuroPathol, Amsterdam, Netherlands; [Bach, Karsten] Univ Cambridge, Dept Pharmacol, Cambridge, England	University of Bonn; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ruprecht Karls University Heidelberg; University of Amsterdam; University of Cambridge	Bilkei-Gerzo, A (corresponding author), Univ Bonn, Inst Mol Psychiat, Med Fac, Bonn, Germany.	abilkei@uni-bonn.de	Chasan, Safak/GZH-0727-2022; Bilkei-Gorzo, Andras/F-8114-2010; Zimmer, Andreas/B-8357-2009	Chasan, Safak/0000-0001-7558-6032; Albayram, Onder/0000-0002-2028-1458; Zimmer, Till/0000-0002-6869-3697	German Research Council [FOR926 CP1, FOR926 SP2, BI-1227/5-1]; BONFOR program of the University of Bonn Medical Center; DFG	German Research Council(German Research Foundation (DFG)); BONFOR program of the University of Bonn Medical Center; DFG(German Research Foundation (DFG))	This work was financed by grants from the German Research Council (FOR926 CP1 to AZ, FOR926 SP2 and BI-1227/5-1 to ABG) and from the BONFOR program of the University of Bonn Medical Center (to OA). A.Z. is a member of the DFG-funded Excellence-Cluster ImmunoSensation.; A.Z. is a member of the DFG-funded Excellence-Cluster ImmunoSensation.	Albayram O, 2016, PFLUG ARCH EUR J PHY, V468, P727, DOI 10.1007/s00424-015-1782-5; Albayram O, 2011, P NATL ACAD SCI USA, V108, P11256, DOI 10.1073/pnas.1016442108; ANDERS JJ, 1990, GLIA, V3, P476, DOI 10.1002/glia.440030606; Ardel-Rahman A, 2004, GLIA, V47, P299, DOI 10.1002/glia.20047; Ativie F, 2015, LIFE SCI, V138, P52, DOI 10.1016/j.lfs.2014.12.016; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bilkei-Gorzo A, 2005, P NATL ACAD SCI USA, V102, P15670, DOI 10.1073/pnas.0504640102; Bilkei-Gorzo A, 2012, PHILOS T R SOC B, V367, P3326, DOI 10.1098/rstb.2011.0388; Bilkei-Gorzo A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.009; Bohme GA, 2000, NEUROSCIENCE, V95, P5; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Boscia F, 2016, GLIA, V64, P1677, DOI 10.1002/glia.23030; Bosier B, 2013, MOL METAB, V2, P393, DOI 10.1016/j.molmet.2013.08.001; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Campuzano O, 2009, J NEUROSCI RES, V87, P2484, DOI 10.1002/jnr.22074; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; CHANPALAY V, 1979, P NATL ACAD SCI USA, V76, P2067, DOI 10.1073/pnas.76.4.2067; Coiret G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037320; Cotrina ML, 2002, J NEUROSCI RES, V67, P1; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Dubreucq S, 2013, BIOL PSYCHIAT, V73, P895, DOI 10.1016/j.biopsych.2012.10.025; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Feliszek M, 2016, N-S ARCH PHARMACOL, V389, P603, DOI 10.1007/s00210-016-1226-6; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Genewsky AJ, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00201; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Grosche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069143; Hanbury R, 2003, J COMP NEUROL, V461, P307, DOI 10.1002/cne.10667; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hirayama Y, 2018, NEUROSCI RES, V126, P53, DOI 10.1016/j.neures.2017.11.013; Jinno S, 2011, NEUROSCIENCE, V180, P41, DOI 10.1016/j.neuroscience.2011.02.013; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Koizumi S, 2018, NEUROCHEM INT; Li Y, 2015, NEUROSCIENCE, V311, P253, DOI 10.1016/j.neuroscience.2015.10.041; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu BH, 2017, J NEUROSCI RES, V95, P2126, DOI 10.1002/jnr.24140; Long JM, 1998, J NEUROSCI METH, V84, P101, DOI 10.1016/S0165-0270(98)00100-9; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luongo L., 2010, OPEN PAIN J, V3, P29, DOI [10.2174/1876386301003010029, DOI 10.2174/1876386301003010029]; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Martin-Garcia E, 2016, NEUROPSYCHOPHARMACOL, V41, P2192, DOI 10.1038/npp.2015.351; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2015, J NEUROSCI, V35, P3842, DOI 10.1523/JNEUROSCI.3167-14.2015; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0599; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Ojo JO, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00057; Ortega-Gutierrez S, 2005, GLIA, V52, P163, DOI 10.1002/glia.20229; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Piyanoya A, 2015, MECH AGEING DEV, V150, P55, DOI 10.1016/j.mad.2015.08.005; Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3; Rodriguez JJ, 2014, NEUROBIOL AGING, V35, P15, DOI 10.1016/j.neurobiolaging.2013.07.002; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sidoryk-Wegrzynowicz M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0478-9; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P1165, DOI 10.1016/j.psyneuen.2008.06.004; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Teh DBL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13174-w; Terzian ALB, 2014, EUR J NEUROSCI, V40, P2293, DOI 10.1111/ejn.12561; Tham CS, 2007, FEBS LETT, V581, P2899, DOI 10.1016/j.febslet.2007.05.037; Tyzack GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01283-z; Ullrich O, 2007, J NEUROIMMUNOL, V184, P127, DOI 10.1016/j.jneuroim.2006.11.018; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Wolf SA, 2008, CURR PHARM DESIGN, V14, P2266, DOI 10.2174/138161208785740090; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Woodruff-Pak DS, 2010, P NATL ACAD SCI USA, V107, P1624, DOI 10.1073/pnas.0914207107; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	96	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202566	10.1371/journal.pone.0202566	http://dx.doi.org/10.1371/journal.pone.0202566			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114280	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400084
J	Chen, LC; Chen, MH; Su, TP; Tsai, SJ; Bai, YM; Li, CT; Yang, AC; Chang, WH; Chen, TJ				Chen, Li-Chi; Chen, Mu-Hong; Su, Tung-Ping; Tsai, Shih-Jen; Bai, Ya-Mei; Li, Cheng-Ta; Yang, Albert C.; Chang, Wen-Han; Chen, Tzeng-Ji			Atopic diseases/diathesis and subsequent ischemic stroke among patients with bipolar disorder: A nationwide longitudinal study	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; CO-MORBIDITY; RISK; ASTHMA; ASSOCIATION; ATHEROSCLEROSIS; INFLAMMATION; CYTOKINES	Introduction Previous studies have suggested that both bipolar disorder and atopy are associated with an increased risk of stroke. However, the role of atopic diseases/diathesis in the risk of stroke among patients with bipolar disorder remains unclear. Methods Using Taiwan's National Health Insurance Research Database, we selected 55,593 patients with bipolar disorder between 2002 and 2008, divided them into patients with atopic diseases/diathesis (n = 21,050) and patients without atopic diseases/diathesis (n = 34,543), and observed them until the end of 2011. Patients who experienced a stroke during the follow-up period were identified. Results Patients with bipolar disorder and atopic diseases/diathesis had an elevated risk of ischemic stroke (hazard ratio [HR]: 1.44, 95% confidence interval [CI]: 1.25 +/- 1.59) compared with patients with only bipolar disorder; a dose-dependent relationship was observed between the number of allergic comorbidities and the risk of ischemic stroke (1 atopic disease, HR: 1.30, 95% CI: 1.13 +/- 1.49; 2 atopic diseases, HR: 1.59, 95% CI: 1.33 +/- 1.91; >= 3 atopic diseases, HR: 2.09, 95% CI: 1.50 +/- 2.91). The role of atopic diseases in the risk of hemorrhagic stroke among patients with bipolar disorder was nonsignificant (HR: 0.84, 95% CI: 0.64 +/- 1.09). Conclusions Patients with bipolar disorder and atopic diseases/diathesis are more prone to ischemic stroke later in life than are those without atopic diseases/diathesis. Further study is required to investigate the underlying mechanism linking atopy, bipolar disorder, and stroke.	[Chen, Li-Chi; Chen, Mu-Hong; Su, Tung-Ping; Tsai, Shih-Jen; Bai, Ya-Mei; Li, Cheng-Ta; Yang, Albert C.; Chang, Wen-Han] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Li-Chi; Su, Tung-Ping; Yang, Albert C.] Cheng Hsin Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Mu-Hong; Su, Tung-Ping; Tsai, Shih-Jen; Bai, Ya-Mei; Li, Cheng-Ta] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan	Taipei Veterans General Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Su, TP; Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Su, TP (corresponding author), Cheng Hsin Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Su, TP; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan.	tpsu@vghtpe.gov.tw; tsai610913@gmail.com	Chen, TJ/AAH-8430-2021; Tsai, Shih-Jen/AAK-7944-2020; Li, Cheng-Ta/AAI-5759-2021; Chen, MuHong/ACJ-6131-2022	Tsai, Shih-Jen/0000-0002-9987-022X; Li, Cheng-Ta/0000-0002-0670-1153; Chen, MuHong/0000-0001-6516-1073	Taipei Veterans General Hospital [V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The study was supported by grant from Taipei Veterans General Hospital (V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181). The funding source had no role in any process of our study.	Aung T, 2010, CARDIOL J, V17, P443; Brietzke E, 2011, CNS SPECTRUMS, V16, P157, DOI 10.1017/S1092852912000338; Chen MH, 2014, J AM MED DIR ASSOC, V15, P763, DOI 10.1016/j.jamda.2014.06.003; Chen MH, 2014, SCHIZOPHR RES, V159, P171, DOI 10.1016/j.schres.2014.07.029; Chen MH, 2014, J AFFECT DISORDERS, V156, P232, DOI 10.1016/j.jad.2013.10.053; Chen MH, 2014, J PSYCHIATR RES, V49, P25, DOI 10.1016/j.jpsychires.2013.10.015; Chen MH, 2013, J CHILD PSYCHOL PSYC, V54, P1208, DOI 10.1111/jcpp.12087; Cui GL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-235; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Garmendia JV, 2014, RECENT PATENTS ENDOC, V8, P60, DOI 10.2174/1872214807666140107151023; Goodwin RD, 2012, CLIN EXP ALLERGY, V42, P1765, DOI 10.1111/j.1365-2222.2012.04042.x; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Gould TD, 2004, J CLIN PSYCHIAT, V65, P10; Gu L, 2013, AM J MED SCI, V345, P227, DOI 10.1097/MAJ.0b013e31825f92da; Heinrich J, 2004, J HYPERTENS, V22, P889, DOI 10.1097/00004872-200405000-00008; Husemoen LLN, 2008, ALLERGY, V63, P575, DOI 10.1111/j.1398-9995.2007.01613.x; Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kony S, 2003, AM J RESP CRIT CARE, V167, P538, DOI 10.1164/rccm.200208-851OC; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Li CT, 2016, CEREB CORTEX, V26, P202, DOI 10.1093/cercor/bhu191; Li XH, 2002, BIPOLAR DISORD, V4, P137, DOI 10.1034/j.1399-5618.2002.40201.x; Lin HC, 2007, J AFFECT DISORDERS, V100, P49, DOI 10.1016/j.jad.2006.09.016; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Matheson EM, 2008, J AM BOARD FAM MED, V21, P179, DOI 10.3122/jabfm.2008.03.070273; Munkholm K, 2013, J AFFECT DISORDERS, V144, P16, DOI 10.1016/j.jad.2012.06.010; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e; Prieto ML, 2014, ACTA PSYCHIAT SCAND, V130, P342, DOI 10.1111/acps.12293; Radinger M, 2011, J IMMUNOL, V187, P5587, DOI 10.4049/jimmunol.1101257; Radinger M, 2010, J IMMUNOL, V184, P564, DOI 10.4049/jimmunol.0902931; Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Roshanaei-Moghaddam B, 2009, PSYCHIAT SERV, V60, P147, DOI 10.1176/appi.ps.60.2.147; Schanen JG, 2005, THORAX, V60, P633, DOI 10.1136/thx.2004.026484; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Skaaby T, 2015, ENDOCRINE, V48, P541, DOI 10.1007/s12020-014-0321-z; Steppuhn H, 2014, PRIM CARE RESP J, V23, P22, DOI 10.4104/pcrj.2013.00107; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1388, DOI 10.1001/jama.288.11.1388; Su VYF, 2014, ANN MED, V46, P84, DOI 10.3109/07853890.2013.870018; Swartz HA, 2012, J CLIN PSYCHIAT, V73, P1563, DOI 10.4088/JCP.12ac08227; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yang X, 2014, GENE, V539, P258, DOI 10.1016/j.gene.2014.01.054	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0200682	10.1371/journal.pone.0200682	http://dx.doi.org/10.1371/journal.pone.0200682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114239	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400006
J	Martin, NA; Nawrocki, A; Molnar, V; Elkjaer, ML; Thygesen, EK; Palkovits, M; Acs, P; Sejbaek, T; Nielsen, HH; Hegedus, Z; Sellebjerg, F; Molnar, T; Barbosa, EGV; Alcaraz, N; Gallyas, F; Svenningsen, AF; Baumbach, J; Lassmann, H; Larsen, MR; Illes, Z				Martin, Nellie A.; Nawrocki, Arkadiusz; Molnar, Viktor; Elkjaer, Maria L.; Thygesen, Eva K.; Palkovits, Miklos; Acs, Peter; Sejbaek, Tobias; Nielsen, Helle H.; Hegedus, Zoltan; Sellebjerg, Finn; Molnar, Tihamer; Barbosa, Eudes G., V; Alcaraz, Nicolas; Gallyas, Ferenc, Jr.; Svenningsen, Asa F.; Baumbach, Jan; Lassmann, Hans; Larsen, Martin R.; Illes, Zsolt			Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes	PLOS ONE			English	Article							C-II ASSOCIATION; CEREBROSPINAL-FLUID; TISSUE INHIBITORS; AXONAL DAMAGE; TREM2; CUPRIZONE; DISEASE; DEFICIENCY; ACTIVATION; EXPRESSION	Objective Here, we applied a multi-omics approach (i) to examine molecular pathways related to de-and remyelination in multiple sclerosis (MS) lesions; and (ii) to translate these findings to the CSF proteome in order to identify molecules that are differentially expressed among MS subtypes. Methods To relate differentially expressed genes in MS lesions to de-and remyelination, we compared transcriptome of MS lesions to transcriptome of cuprizone (CPZ)-induced de-and remyelination. Protein products of the overlapping orthologous genes were measured within the CSF by quantitative proteomics, parallel reaction monitoring (PRM). Differentially regulated proteins were correlated with molecular markers of inflammation by using MesoScale multiplex immunoassay. Expression kinetics of differentially regulated orthologous genes and proteins were examined in the CPZ model. Results In the demyelinated and remyelinated corpus callosum, we detected 1239 differentially expressed genes; 91 orthologues were also differentially expressed in MS lesions. Pathway analysis of these orthologues suggested that the TYROBP (DAP12)-TREM2 pathway, TNF-receptor 1, CYBA and the proteasome subunit PSMB9 were related to de-and remyelination. We designed 129 peptides representing 51 orthologous proteins, measured them by PRM in 97 individual CSF, and compared their levels between relapsing (n = 40) and progressive MS (n = 57). Four proteins were differentially regulated among relapsing and progressive MS: tyrosine protein kinase receptor UFO (UFO), TIMP-1, apolipoprotein C-II (APOC2), and beta-2-microglobulin (B2M). The orthologous genes/proteins in the mouse brain peaked during acute remyelination. UFO, TIMP-1 and B2M levels correlated inversely with inflammation in the CSF (IL-6, MCP-1/CCL2, TARC/CCL17). APOC2 showed positive correlation with IL-2, IL-16 and eotaxin-3/CCL26. Conclusions Pathology-based multi-omics identified four CSF markers that were differentially expressed in MS subtypes. Upregulated TIMP-1, UFO and B2M orthologues in relapsing MS were associated with reduced inflammation and reflected reparatory processes, in contrast to the upregulated orthologue APOC2 in progressive MS that reflected changes in lipid metabolism associated with increased inflammation.	[Martin, Nellie A.; Nawrocki, Arkadiusz; Elkjaer, Maria L.; Thygesen, Eva K.; Sejbaek, Tobias; Nielsen, Helle H.; Illes, Zsolt] Odense Univ Hosp, Dept Neurol, Odense, Denmark; [Nawrocki, Arkadiusz; Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Molnar, Viktor] Semmelweis Univ, Dept Genet Cell & Immunobiol, Budapest, Hungary; [Palkovits, Miklos] Semmelweis Univ, Lab Neuromorphol, Budapest, Hungary; [Palkovits, Miklos] Semmelweis Univ, Human Brain Tissue Bank Microdissect Lab, Budapest, Hungary; [Acs, Peter; Illes, Zsolt] Univ Pecs, Dept Neurol, Pecs, Hungary; [Hegedus, Zoltan] Biol Res Ctr, Lab Bioinformat, Szeged, Hungary; [Sellebjerg, Finn] Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Copenhagen, Denmark; [Molnar, Tihamer] Univ Pecs, Dept Anaesthesiol & Intens Therapy, Pecs, Hungary; [Barbosa, Eudes G., V; Alcaraz, Nicolas; Baumbach, Jan] Univ Southern Denmark, Dept Math & Comp Sci, Computat Biol Grp, Odense, Denmark; [Alcaraz, Nicolas] Univ Copenhagen, Bioinformat Ctr, Dept Biol, Copenhagen, Denmark; [Gallyas, Ferenc, Jr.] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Gallyas, Ferenc, Jr.] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Gallyas, Ferenc, Jr.] Hungarian Acad Sci, Nucl Mitochondrial Interact Res Grp, Budapest, Hungary; [Svenningsen, Asa F.] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense, Denmark; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Illes, Zsolt] Univ Southern Denmark, Dept Clin Res, BRIDGE, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Semmelweis University; Semmelweis University; Semmelweis University; University of Pecs; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Rigshospitalet; University of Copenhagen; University of Pecs; University of Southern Denmark; University of Copenhagen; University of Pecs; University of Pecs; Hungarian Academy of Sciences; University of Southern Denmark; Medical University of Vienna; University of Southern Denmark	Illes, Z (corresponding author), Odense Univ Hosp, Dept Neurol, Odense, Denmark.; Illes, Z (corresponding author), Univ Pecs, Dept Neurol, Pecs, Hungary.; Illes, Z (corresponding author), Univ Southern Denmark, Dept Clin Res, BRIDGE, Odense, Denmark.	zsolt.illes@rsyd.dk	Alcaraz, Nicolas/K-2758-2019; Gallyas, Ferenc/AAY-5343-2020; Elkjaer, Maria Louise/AFV-8250-2022; Svenningsen, Åsa Fex/H-5443-2015; Sejbaek, Tobias/AAY-2476-2020; Molnar, Tihamer/AAY-4564-2020; Lassmann, Hans/Z-2269-2019; Gallyas, Ferenc/C-2272-2012; Palkovits, Miklos/F-2707-2013	Alcaraz, Nicolas/0000-0003-0839-8423; Svenningsen, Åsa Fex/0000-0002-5651-265X; Molnar, Tihamer/0000-0002-6149-9787; Lassmann, Hans/0000-0001-8617-5052; Palkovits, Miklos/0000-0003-0578-0387; Elkjaer, Maria Louise/0000-0002-8596-142X; Sellebjerg, Finn/0000-0002-1333-9623; Nielsen, Helle Hvilsted/0000-0002-7319-1368; Sejbaek, Tobias/0000-0002-7682-2188; Baumbach, Jan/0000-0002-0282-0462; Illes, Zsolt/0000-0001-9655-0450	Lundbeckfonden [R118-A11472, OTKA-K77892]; Scleroseforeningen [R431-A29926-B15690, R399-A28099-B15690]; Region of Southern Denmark [14/24200]; Jascha Fonden [5589]; Direktor Ejnar Jonasson kaldet Johnsen og hustrus mindelegat [5609]; Odense University Hospital (OUH) [A474, OTKA-NN109841, GINOP 2.3.2-15-2016-00049, GINOP 2.3.3-15-2016-00025]; Fonden for Lngevidenskabensfremme [13-267]; JB's VILLUM Young Investigator grant [13154]; JB's SDU2020 grant;  [KTIA_NAP_13-1-2013-0001]	Lundbeckfonden(Lundbeckfonden); Scleroseforeningen; Region of Southern Denmark; Jascha Fonden; Direktor Ejnar Jonasson kaldet Johnsen og hustrus mindelegat; Odense University Hospital (OUH); Fonden for Lngevidenskabensfremme; JB's VILLUM Young Investigator grant; JB's SDU2020 grant; 	The work was supported by Lundbeckfonden R118-A11472, OTKA-K77892, Scleroseforeningen R431-A29926-B15690 and R399-A28099-B15690, Region of Southern Denmark 14/24200, Jascha Fonden 5589, Direktor Ejnar Jonasson kaldet Johnsen og hustrus mindelegat 5609, Odense University Hospital (OUH) A474 (to ZI), OTKA-NN109841, GINOP 2.3.2-15-2016-00049, and GINOP 2.3.3-15-2016-00025 (to FG Jr), Fonden for Lngevidenskabensfremme 13-267 (to NAM). JB is grateful for financial support from JB's VILLUM Young Investigator grant nr. 13154. NA received funding from JB's SDU2020 grant. MP was supported by grant from KTIA_NAP_13-1-2013-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059367; Barcellos LF, 1997, JAMA-J AM MED ASSOC, V278, P1256, DOI 10.1001/jama.278.15.1256; Bastos P, 2017, CRIT REV CL LAB SCI, V54, P185, DOI 10.1080/10408363.2017.1299682; Bates D, 2011, NEUROLOGY, V76, pS14, DOI 10.1212/WNL.0b013e3182050388; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Bjerrum W, 1998, ACTA NEUROL SCAND, V78, P720; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Durrenberger PF, 2015, J NEURAL TRANSM, V122, P1055, DOI 10.1007/s00702-014-1293-0; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Fainardi E, 2006, MULT SCLER J, V12, P294, DOI 10.1191/135248506ms1274oa; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Fischer MT, 2013, BRAIN, V136, P1799, DOI 10.1093/brain/awt110; Gray E, 2008, J NEUROPATH EXP NEUR, V67, P888, DOI 10.1097/NEN.0b013e318183d003; Guldbrandsen A, 2017, MOL CELL PROTEOMICS, V16, P300, DOI 10.1074/mcp.O116.064477; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Han MH, 2012, J EXP MED, V209, P1325, DOI 10.1084/jem.20101974; Haure-Mirande JV, 2017, ACTA NEUROPATHOL, V134, P769, DOI 10.1007/s00401-017-1737-3; Hiremath MM, 2008, J NEUROIMMUNOL, V203, P23, DOI 10.1016/j.jneuroim.2008.06.034; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Illes Z, 2013, MULTIPLE SCLEROSIS I, P315; Jiang P, 2016, CELL REP, V15, P1303, DOI 10.1016/j.celrep.2016.04.011; Johnson KM, 2015, NEUROSCI LETT, V609, P165, DOI 10.1016/j.neulet.2015.10.038; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Kirk CW, 2000, MULT SCLER, V6, P291, DOI 10.1177/135245850000600412; Kivisakk P, 1998, CLIN EXP IMMUNOL, V111, P193; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kovacs KT, 2016, MULT SCLER J, V22, P1192, DOI 10.1177/1352458515613165; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kroksveen AC, 2013, J PROTEOMICS, V78, P312, DOI 10.1016/j.jprot.2012.09.037; Kroksveen AC, 2017, J PROTEOME RES, V16, P179, DOI 10.1021/acs.jproteome.6b00659; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Li ZY, 2013, NEURAL REGEN RES, V8, P156, DOI 10.3969/j.issn.1673-5374.2013.02.008; Lycke J, 2017, EXPERT REV CLIN IMMU, V13, P1143, DOI 10.1080/1744666X.2017.1400380; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Malekzadeh A, 2013, EXPERT REV NEUROTHER, V13, P1001, DOI 10.1586/14737175.2013.835602; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Opsahl JA, 2016, PROTEOMICS, V16, P1154, DOI 10.1002/pmic.201500284; Pavelek Z, 2016, BIOMED REP, V5, P35, DOI 10.3892/br.2016.668; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Ray AK, 2017, GLIA, V65, P2051, DOI 10.1002/glia.23214; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; Sand IK, 2014, MULT SCLER J, V20, P1654, DOI 10.1177/1352458514521517; Shankar SL, 2003, J NEUROSCI, V23, P4208; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Skuljec J, 2011, J NEUROPATH EXP NEUR, V70, P758, DOI 10.1097/NEN.0b013e3182294fad; Skundric DS, 2015, CYTOKINE, V75, P234, DOI 10.1016/j.cyto.2015.01.005; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Swarup V, 2012, NEUROSCI RES, V73, P161, DOI 10.1016/j.neures.2012.03.002; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Veto S, 2010, BRAIN, V133, P822, DOI 10.1093/brain/awp337; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Weber LW, 2004, WORLD J GASTROENTERO, V10, P3081, DOI 10.3748/wjg.v10.i21.3081; Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Wilson CJ, 2003, ANN NEUROL, V53, P807, DOI 10.1002/ana.10598; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008; Zouali H, 1999, MULT SCLER, V5, P134, DOI 10.1177/135245859900500211	69	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202530	10.1371/journal.pone.0202530	http://dx.doi.org/10.1371/journal.pone.0202530			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114292	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400083
J	Peixoto, L; Allen, GR; Ridenbaugh, RD; Quarrell, SR; Withers, TM; Sharanowski, BJ				Peixoto, Leanne; Allen, Geoff R.; Ridenbaugh, Ryan D.; Quarrell, Stephen R.; Withers, Toni M.; Sharanowski, Barbara J.			When taxonomy and biological control researchers unite: Species delimitation of Eadya parasitoids (Braconidae) and consequences for classical biological control of invasive paropsine pests of Eucalyptus	PLOS ONE			English	Article							AGRICOLA CHAPUIS COLEOPTERA; DNA BARCODING REVEALS; CONTROL AGENTS; CHRYSOMELIDAE; HYMENOPTERA; CHARYBDIS; MODEL; GENUS; PHYLOGENETICS; DIVERSITY	The invasive eucalyptus tortoise beetle, Paropsis charybdis, defoliates plantations of Eucalyptus nitens in New Zealand. Recent efforts to identify host specific biological control agents (parasitoids) from Tasmania, Australia, have focused on the larval parasitoid wasp, Eadya paropsidis (Braconidae), first described in 1978. In Tasmania, Eadya has been reared from Paropsisterna agricola (genus abbreviated Pst.), a smaller paropsine that feeds as a larva on juvenile rather than adult foliage of Eucalyptus nitens. To determine which of the many paropsine beetle hosts native to Tasmania are utilized by E. paropsidis, and to rule out the presence of cryptic species, a molecular phylogenetic approach was combined with host data from rearing experiments from multiple locations across six years. Sampling included 188 wasps and 94 beetles for molecular data alone. Two mitochondrial genes (CO/and Cytb) and one nuclear gene (28S) were analyzed to assess the species limits in the parasitoid wasps. The mitochondrial genes were congruent in delimiting four separate phylogenetic species, all supported by morphological examinations of Eadya specimens collected throughout Tasmania. Eadya paropsidis was true to the type description, and was almost exclusively associated with P. tasmanica. A new cryptic species similar to E. paropsidis, Eadya sp. 3, was readily reared from Pst. agricola and P. charybdis from all sites and all years. Eadya sp. 3 represents the best candidate for biological control of P. charybdis and was determined as the species undergoing host range testing in New Zealand for its potential as a biological control agent. Another new species, Eadya sp. 1, was morphologically distinctive and attacked multiple hosts. The most common host was Pst. variicollis, but was also reared from Pst. nobilitata and Pst. selmani. Eadya sp. 1 may have potential for control against Pst. variicollis, a new incursion in New Zealand, and possibly Pst. selmani in Ireland. Our molecular data suggests that Pst. variicollis is in need of taxonomic revision and the geographic source of the beetle in New Zealand may not be Tasmania. Eadya sp. 2 was rarely collected and attacked P. aegrota elliotti and P. charybdis. Most species of Eadya present in Tasmania are not host specific to one beetle species alone, but demonstrate some host plasticity across the genera Paropsisterna and Paropsis. This study is an excellent example of collaborative phylogenetic and biological control research prior to the release of prospective biological control agents, and has important implications for the Eucalyptus industry worldwide.	[Peixoto, Leanne; Ridenbaugh, Ryan D.; Sharanowski, Barbara J.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Peixoto, Leanne] Aarhus Univ, Dept Agroecol, Aarhus, Denmark; [Allen, Geoff R.; Quarrell, Stephen R.] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia; [Withers, Toni M.] Scion, Rotorua, New Zealand	State University System of Florida; University of Central Florida; Aarhus University; University of Tasmania; Scion	Sharanowski, BJ (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	barb.sharanowski@ucf.edu		Withers, Toni/0000-0001-8852-0622; Ridenbaugh, Ryan/0000-0003-2374-4646; Quarrell, Stephen/0000-0003-1112-4140; Peixoto, Leanne/0000-0002-8081-0569	New Zealand MPI Sustainable Farming Fund; NZ Farm Forestry Association; Southwood Export Ltd; Oji Fibre Solutions; Forest Owners Association; Scion MBIE core funding; National Science Engineering and Research Council (NSERC); Canada Discovery Grant; Department of Biology, College of Sciences, University of Central Florida	New Zealand MPI Sustainable Farming Fund; NZ Farm Forestry Association; Southwood Export Ltd; Oji Fibre Solutions; Forest Owners Association; Scion MBIE core funding(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Science Engineering and Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Discovery Grant; Department of Biology, College of Sciences, University of Central Florida	Co-funding of this project (to T. Withers) was provided by the New Zealand MPI Sustainable Farming Fund, NZ Farm Forestry Association, Southwood Export Ltd, Oji Fibre Solutions, the Forest Owners Association, and Scion MBIE core funding. Co-funding of this project (to B. Sharanowski) was provided by National Science Engineering and Research Council (NSERC), Canada Discovery Grant (http://www.nserc-crsng.gc.ca/Professors- Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) and start-up funds from the Department of Biology, College of Sciences, University of Central Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bain J, 1989, REV BIOL CONTROL INV, P281; Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; BAUM D, 1992, TRENDS ECOL EVOL, V7, P1, DOI 10.1016/0169-5347(92)90187-G; Belshaw R, 2002, SYST BIOL, V51, P450, DOI 10.1080/10635150290069896; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boring CA, 2011, SYST ENTOMOL, V36, P529, DOI 10.1111/j.1365-3113.2011.00579.x; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Chen R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20123; Cracraft J., 1983, Current Ornithology, V1, P159; Croft B. A., 1990, Arthropod biological control agents and pesticides.; de Little D.W., 1982, General and Applied Entomology, V14, P3; DEBACH P, 1974, P323; Elek J, 2013, AGR FOREST ENTOMOL, V15, P351, DOI 10.1111/afe.12021; Fanning PD, 2014, AGR FOREST ENTOMOL, V16, P45, DOI 10.1111/afe.12032; Fernandez-Triana JL, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.63.565; Forest Stewardship Council, 2007, FSC PEST POL GUID IM; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; Grossi AA, 2014, CAN ENTOMOL, V146, P598, DOI 10.4039/tce.2014.12; Hajek AE, 2016, BIOL INVASIONS, V18, P953, DOI 10.1007/s10530-016-1075-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Howlett BG, 2001, AGR FOREST ENTOMOL, V3, P121, DOI 10.1046/j.1461-9563.2001.00096.x; HUDDLESTON T, 1978, J AUST ENTOMOL SOC, V17, P317; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kay M., 1990, What's New in Forest Research; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Mansfield S, 2011, BIOL CONTROL, V56, P30, DOI 10.1016/j.biocontrol.2010.09.008; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Murphy B, 2006, THESIS; Murphy B. D., 2000, New Zealand Plant Protection Volume 53, 2000. Proceedings of a conference, Commodore Hotel, Christchurch, New Zealand, 8-10 August 2000, P334; Murray TJ, 2015, BIOL CONTROL, V91, P82, DOI 10.1016/j.biocontrol.2015.08.001; Murray T. J., 2008, New Zealand Plant Protection, V61, P185; Nahrung HF, 2008, FOREST ECOL MANAG, V255, P3515, DOI 10.1016/j.foreco.2008.02.033; Nahrung HF, 2004, AUST J ENTOMOL, V43, P177, DOI 10.1111/j.1440-6055.2004.00397.x; Namin HH, 2014, CAN ENTOMOL, V146, P26, DOI 10.4039/tce.2013.60; Paine TD, 2011, ANNU REV ENTOMOL, V56, P181, DOI 10.1146/annurev-ento-120709-144817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quicke DLJ, 2012, MOL ECOL RESOUR, V12, P676, DOI 10.1111/j.1755-0998.2012.03143.x; Reid Chris A.M., 2006, Zootaxa, V1292, P1; Reid CAM, 2013, ZOOTAXA, V3681, P395, DOI 10.11646/zootaxa.3681.4.4; Rice AD, 2005, AUST J ENTOMOL, V44, P400, DOI 10.1111/j.1440-6055.2005.00489.x; Rice AD, 2009, AUST J ENTOMOL, V48, P282, DOI 10.1111/j.1440-6055.2009.00717.x; Ridenbaugh RD, 2018, J HYMENOPT RES, V64, P141, DOI 10.3897/jhr.64.24282; Rosen D., 1973, Entomophaga, V18, P215, DOI 10.1007/BF02371468; ROSEN D, 1986, AGR ECOSYST ENVIRON, V15, P121, DOI 10.1016/0167-8809(86)90085-X; Rosen D, 1978, IMPORTANCE CRYPTIC S; Schauff M, 1998, PEST MAN FUT CHALL P; Seeman O, 2013, SYST PARASITOL, V86, P257, DOI 10.1007/s11230-013-9447-2; Sharanowski BJ, 2011, SYST ENTOMOL, V36, P549, DOI 10.1111/j.1365-3113.2011.00580.x; SHAW S R, 1985, Entomography, V3, P277; Shaw SR, 1997, SPECIAL PUBLICATION, P235; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Simberloff D, 1996, BIOL CONSERV, V78, P185, DOI 10.1016/0006-3207(96)00027-4; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Styles J. H., 1970, N. Z. Ent., V4, P103; TANTON MT, 1984, AUST J ZOOL, V32, P251, DOI 10.1071/ZO9840251; The New Zealand Forest Owners Association, 2016, EUC VAR BEETL PAR VA; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; WAAGE JK, 1982, PARASITOLOGY, V84, P241, DOI 10.1017/S003118200005366X; WHITE TCR, 1973, PAC INSECTS, V15, P59; Withers T. M., 2015, New Zealand Plant Protection, V68, P179; Withers T. M., 2013, New Zealand Plant Protection, V66, P138; Withers TM, 2012, NZ PLANT PROTECTION, V65, P292; Zhang YM, 2017, SYST ENTOMOL, V42, P596, DOI 10.1111/syen.12233	72	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201276	10.1371/journal.pone.0201276	http://dx.doi.org/10.1371/journal.pone.0201276			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114194	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000441850400012
J	Chen, YC; Xu, C; Zhang, JG; Zeng, CP; Wang, XF; Zhou, R; Lin, X; Ao, ZX; Lu, JM; Shen, J; Deng, HW				Chen, Yuan-Cheng; Xu, Chao; Zhang, Ji-Gang; Zeng, Chun-Ping; Wang, Xia-Fang; Zhou, Rou; Lin, Xu; Ao, Zeng-Xin; Lu, Jun-Min; Shen, Jie; Deng, Hong-Wen			Multivariate analysis of genomics data to identify potential pleiotropic genes for type 2 diabetes, obesity and dyslipidemia using Meta-CCA and gene-based approach	PLOS ONE			English	Article							WIDE ASSOCIATION; METABOLIC SYNDROME; PLASMA TRIGLYCERIDES; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; LIPID-LEVELS; RISK-FACTOR; MELLITUS; VARIANTS	Previous studies have demonstrated the genetic correlations between type 2 diabetes, obesity and dyslipidemia, and indicated that many genes have pleiotropic effects on them. However, these pleiotropic genes have not been well-defined. It is essential to identify pleiotropic genes using systematic approaches because systematically analyzing correlated traits is an effective way to enhance their statistical power. To identify potential pleiotropic genes for these three disorders, we performed a systematic analysis by incorporating GWAS (genome-wide associated study) datasets of six correlated traits related to type 2 diabetes, obesity and dyslipidemia using Meta-CCA (meta-analysis using canonical correlation analysis). Meta-CCA is an emerging method to systematically identify potential pleiotropic genes using GWAS summary statistics of multiple correlated traits. 2,720 genes were identified as significant genes after multiple testing (Bonferroni corrected p value < 0.05). Further, to refine the identified genes, we tested their relationship to the six correlated traits using VEGAS-2 (versatile gene-based association study-2). Only the genes significantly associated (Bonferroni corrected p value < 0.05) with more than one trait were kept. Finally, 25 genes (including two confirmed pleiotropic genes and eleven novel pleiotropic genes) were identified as potential pleiotropic genes. They were enriched in 5 pathways including the statin pathway and the PPAR (peroxisome proliferator-activated receptor) Alpha pathway. In summary, our study identified potential pleiotropic genes and pathways of type 2 diabetes, obesity and dyslipidemia, which may shed light on the common biological etiology and pathogenesis of these three disorders and provide promising insights for new therapies.	[Chen, Yuan-Cheng; Zeng, Chun-Ping; Wang, Xia-Fang; Zhou, Rou; Lin, Xu; Ao, Zeng-Xin; Lu, Jun-Min; Shen, Jie; Deng, Hong-Wen] Southern Med Univ, Affiliated Hosp 3, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China; [Chen, Yuan-Cheng; Xu, Chao; Zhang, Ji-Gang; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Bioinformat & Genom, Dept Global Biostat & Data Sci, New Orleans, LA 70118 USA; [Deng, Hong-Wen] Cent S Univ, Sch Basic Med Sci, Changsha, Hunan, Peoples R China	Southern Medical University - China; Tulane University; Central South University	Deng, HW (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China.; Deng, HW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Bioinformat & Genom, Dept Global Biostat & Data Sci, New Orleans, LA 70118 USA.; Deng, HW (corresponding author), Cent S Univ, Sch Basic Med Sci, Changsha, Hunan, Peoples R China.	hdeng2@tulane.edu	Xu, Chao/AAN-6427-2020	Xu, Chao/0000-0002-3821-6187	National Institutes of Health [AR069055, U19 AG055373, R01 MH104680, R01AR059781, P20GM109036]; Tulane University; Foundation from China Scholarship Council [20150322]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG055373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; Foundation from China Scholarship Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	HWD, CX, and JGZ were partially supported by grants from the National Institutes of Health [AR069055, U19 AG055373, R01 MH104680, R01AR059781 and P20GM109036], and startup funds from Tulane University. YCC was partially supported by the Foundation from China Scholarship Council (20150322).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Angin Y, 2016, EXPERIENTIA SUPPL, V107, P23, DOI 10.1007/978-3-319-43589-3_2; Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Benton MC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0569-x; Bjornson E, 2017, CURR OPIN LIPIDOL, V28, P11, DOI 10.1097/MOL.0000000000000375; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen ES, 2010, LIPIDS, V45, P511, DOI 10.1007/s11745-010-3426-z; Cho EY, 2002, DIABETES CARE, V25, P1142, DOI 10.2337/diacare.25.7.1142; Cichonska A, 2016, BIOINFORMATICS, V32, P1981, DOI 10.1093/bioinformatics/btw052; Cui RT, 2016, CLIN INTERV AGING, V11, P445, DOI 10.2147/CIA.S104803; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; el Yaagoubi FL, 2015, PATHOL BIOL, V63, P243, DOI 10.1016/j.patbio.2015.09.002; Fujita H, 2012, J HUM GENET, V57, P776, DOI 10.1038/jhg.2012.110; Gao KP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030260; Gao YQ, 2017, CELL REP, V20, P3034, DOI 10.1016/j.celrep.2017.09.008; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; GOMEZ JA, 1989, DIABETIC MED, V6, P127, DOI 10.1111/j.1464-5491.1989.tb02099.x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hasstedt SJ, 2011, J HUM GENET, V56, P491, DOI 10.1038/jhg.2011.46; Hasstedt SJ, 2010, ANN HUM GENET, V74, P308, DOI 10.1111/j.1469-1809.2010.00589.x; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Hotta K, 2011, J HUM GENET, V56, P647, DOI 10.1038/jhg.2011.74; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inouye M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002907; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Jung SY, 2016, GENET EPIDEMIOL, V40, P520, DOI 10.1002/gepi.21991; Kilpelainen TO, 2008, METABOLISM, V57, P428, DOI 10.1016/j.metabol.2007.10.022; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Marucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070159; Mercader JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003046; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Moreli JB, 2016, INT J BIOL SCI, V12, P466, DOI 10.7150/ijbs.12815; Palladino END, 2017, J LIPID RES, V58, P317, DOI 10.1194/jlr.M069740; Pardina E, 2016, BBA CLIN, V5, P54, DOI 10.1016/j.bbacli.2015.12.002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Read SH, 2018, DIABETIC MED, V35, P99, DOI 10.1111/dme.13528; Reiner Z, 2017, NAT REV CARDIOL, V14, P401, DOI 10.1038/nrcardio.2017.31; Sajuthi SP, 2016, HUM GENET, V135, P869, DOI 10.1007/s00439-016-1680-8; Sall J, 2017, DIABETOLOGIA, V60, P314, DOI 10.1007/s00125-016-4141-y; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Song YM, 2015, METAB SYNDR RELAT D, V13, P36, DOI 10.1089/met.2014.0087; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Temprano A, 2016, DIABETOLOGIA, V59, P1985, DOI 10.1007/s00125-016-4018-0; Thanopoulou AC, 2003, DIABETES CARE, V26, P302, DOI 10.2337/diacare.26.2.302; Tokoro F, 2015, BIOMED REP, V3, P88, DOI 10.3892/br.2014.379; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Wang Q, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0292-y; Wojcik GL, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0191-2; Wu X, 2017, J CLIN LIPIDOL, V11, P362, DOI 10.1016/j.jacl.2017.01.009; Yazici D, 2017, ADV EXP MED BIOL, V960, P277, DOI 10.1007/978-3-319-48382-5_12; Yin RX, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-123; Yin YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089167; Zhang S, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0621-z	61	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201173	10.1371/journal.pone.0201173	http://dx.doi.org/10.1371/journal.pone.0201173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110382	gold, Green Published, Green Submitted			2022-12-26	WOS:000441738000016
J	Fu, CP; Sheu, WHH; Lee, WL; Lee, WJ; Wang, JS; Lin, SY; Lee, IT				Fu, Chia-Po; Sheu, Wayne H-H; Lee, Wen-Lieng; Lee, Wen-Jane; Wang, Jun-Sing; Lin, Shih-Yi; Lee, I-Te			Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTOR; CARDIOVASCULAR-DISEASE; POSTPRANDIAL GLUCOSE; INSULIN-SECRETION; OXIDATIVE STRESS; OBESITY PARADOX; POOLED ANALYSIS; HEART-DISEASE; MORTALITY	Introduction Postprandial hyperglycemia plays a pivotal role in cardiovascular disease. However, few studies have investigated associations between the severity of coronary artery disease (CAD) and postprandial glucose levels in angina patients without known diabetes before coronary angiography. Methods Subjects who were admitted for coronary angiography due to angina and were in stable condition after discharge were recruited. A standard 75-g oral glucose tolerance test (OGTT) was performed at outpatient visits approximately 2-4 weeks after hospital discharge, and fasting and post-challenge blood glucose were measured. Twenty-six volunteers in our hospital staff served as the healthy group. CAD severity was graded using the SYNTAX and Jeopardy scoring systems. Results The subjects in the angina group had a higher body mass index, higher fasting glucose, and higher 2-h postprandial glucose than those in the healthy group. The SYNTAX and Jeopardy scores were significantly associated with 2-h postprandial blood glucose (correlation coefficients = 0.164 and 0.187, respectively) but not with fasting glucose. Linear regression analyses revealed that SYNTAX and Jeopardy scores were independently associated with glucose levels at 120 min after OGTT (SYNTAX 95%CI= 0.003-0.103; Jeopardy score 0.002-0.027) but not with fasting glucose. Conclusion CAD severity is associated with blood glucose levels after oral glucose challenge in patients without known diabetes before coronary angiography, suggesting that CAD patients should be routinely screened for post-challenge blood glucose.	[Fu, Chia-Po; Sheu, Wayne H-H; Wang, Jun-Sing; Lee, I-Te] Taichung Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taichung, Taiwan; [Fu, Chia-Po] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Sheu, Wayne H-H] Chung Sing Univ, Inst Biomed Sci, Taichung, Taiwan; [Sheu, Wayne H-H] Natl Def Med Ctr, Dept Med, Taipei, Taiwan; [Sheu, Wayne H-H; Wang, Jun-Sing; Lee, I-Te] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Wen-Lieng] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan; [Lee, Wen-Jane] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lee, Wen-Jane] Tunghai Univ, Taichung, Taiwan; [Lin, Shih-Yi] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Taichung, Taiwan; [Lee, I-Te] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Taichung Veterans General Hospital; National Taiwan University; National Defense Medical Center; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Tunghai University; Taichung Veterans General Hospital; Chung Shan Medical University	Lee, IT (corresponding author), Taichung Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taichung, Taiwan.; Lee, IT (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Lee, IT (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	itlee@vghtc.gov.tw		Fu, Chia-Po/0000-0001-5210-9444; Wang, Jun-Sing/0000-0002-0887-6432	National Science Council [NSC 101-2314-B-075A-006-MY3]; Taichung Veterans General Hospital, Taichung, Taiwan, ROC [TCVGH-973002D, TCVGH-993001C, VGHUST99-G2-1]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital, Taichung, Taiwan, ROC	This work received support from the National Science Council (NSC 101-2314-B-075A-006-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan, ROC (TCVGH-973002D, TCVGH-993001C, VGHUST99-G2-1.	Alva ML, 2015, DIABETIC MED, V32, P459, DOI 10.1111/dme.12647; CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055, DOI 10.1016/S0735-1097(85)80005-X; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Chen JY, 2016, ANGIOLOGY, V67, P820, DOI 10.1177/0003319715618803; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Chen YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123116; DeVries JH, 2013, DIABETES, V62, P1405, DOI 10.2337/db12-1610; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Gregory AB, 2017, CARDIOL RES PRACT, V2017, DOI 10.1155/2017/5481671; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; International Diabetes Federation, 2022, DIAB FACTS FIG; Kalantar-Zadeh K, 2012, AM J EPIDEMIOL, V175, P793, DOI 10.1093/aje/kwr384; Kuroda M, 2015, JACC-CARDIOVASC INTE, V8, P800, DOI 10.1016/j.jcin.2014.11.025; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Liang KW, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0209-1; Liu HH, 2018, HYPERTENSION, V71, P1039, DOI 10.1161/HYPERTENSIONAHA.118.11063; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Ma P, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0199-1; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Peter R, 2009, CURR VASC PHARMACOL, V7, P68, DOI 10.2174/157016109787354169; Service FJ, 2013, DIABETES, V62, P1398, DOI 10.2337/db12-1396; Sianos Georgios, 2005, EuroIntervention, V1, P219; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang JS, 2011, DIABETES-METAB RES, V27, P79, DOI 10.1002/dmrr.1149; Wang JS, 2013, DIABETES CARE, V36, P1138, DOI 10.2337/dc12-1434; Wang JS, 2011, CLIN THER, V33, P1932, DOI 10.1016/j.clinthera.2011.10.014; Watanabe M, 2017, J CARDIOL, V69, P625, DOI 10.1016/j.jjcc.2016.07.001	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202280	10.1371/journal.pone.0202280	http://dx.doi.org/10.1371/journal.pone.0202280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110378	gold, Green Published, Green Submitted			2022-12-26	WOS:000441738000060
J	Irmak, O; Orhan, EO; Gorgun, K; Yaman, BC				Irmak, Ozgur; Orhan, Ekim Onur; Gorgun, Kamuran; Yaman, Batu Can			Nuclear magnetic resonance spectroscopy and infrared spectroscopy analysis of precipitate formed after mixing sodium hypochlorite and QMix 2in1	PLOS ONE			English	Article							PARA-CHLOROANILINE; CHLORHEXIDINE GLUCONATE; ENDODONTIC IRRIGANTS; DISSOLUTION; TISSUE; DENTIN	Background Mixing sodium hypochlorite (NaOCl) with chlorhexidine (CHX) forms a brown precipitate. QMix-2in1 (QMix) was introduced as a final irrigant. Manufacturer recommends interim flushing with saline between the application of NaOCl and QMix to prevent formation of precipitation. This study assessed whether para-chloroaniline (PCA) is formed after mixing NaOCl with QMix. Methods Commercially available, 5.25% NaOCl solution, 2% CHX, QMix, 15% ethylenediaminetetra-acetic acid (EDTA) and 98% PCA in powder form were used. Groups were prepared at room temperature. Group 1, 98% PCA in powder form; Group 2, 2% chlorhexidine (CHX); Group 3, QMix; Group 4, 5.25% sodium hypochlorite (NaOCl) mixed with QMix; Group 5, 5.25% NaOCl mixed with CHX; Group 6, 15% EDTA mixed with CHX. The precipitates were extracted and analysed with Proton Nuclear Magnetic Resonance (1H-NMR) and Infrared (IR) Spectroscopy, using PCA as an internal standard. Results No PCA was found in any of the irrigant-mixture groups tested. Conclusions This study used the interpretation of spectral results for the amino signals of precipitate formed after mixing QMix with 5.25% NaOCl using different nondestructive analysis methods, with PCA as an internal standard (control). We conclude that mixing QMix or 2%CHX with 5.25% NaOCl does not yield free PCA.	[Irmak, Ozgur; Yaman, Batu Can] Eskisehir Osmangazi Univ, Fac Dent, Dept Restorat Dent, Eskisehir, Turkey; [Orhan, Ekim Onur] Eskisehir Osmangazi Univ, Fac Dent, Dept Endodont, Eskisehir, Turkey; [Gorgun, Kamuran] Eskisehir Osmangazi Univ, Fac Chem, Dept Sci, Eskisehir, Turkey	Eskisehir Osmangazi University; Eskisehir Osmangazi University; Eskisehir Osmangazi University	Orhan, EO (corresponding author), Eskisehir Osmangazi Univ, Fac Dent, Dept Endodont, Eskisehir, Turkey.	eonurdentus@hotmail.com	Irmak, Özgür/C-7779-2016; yaman, batu can/ABI-6253-2020; ORHAN, Ekim Onur/Q-6015-2019	Irmak, Özgür/0000-0003-3095-6815; ORHAN, Ekim Onur/0000-0002-8755-2558				Arslan H, 2015, INT ENDOD J, V48, P1199, DOI 10.1111/iej.12427; Basrani BR, 2007, J ENDODONT, V33, P966, DOI 10.1016/j.joen.2007.04.001; Basrani BR, 2010, J ENDODONT, V36, P312, DOI 10.1016/j.joen.2009.10.031; Boehncke A, 2003, CHLOROANILINE; Bui TB, 2008, J ENDODONT, V34, P181, DOI 10.1016/j.joen.2007.11.006; de Bem SHC, 2014, ACTA ODONTOL SCAND, V72, P630, DOI 10.3109/00016357.2014.880941; CHHABRA RS, 1991, FOOD CHEM TOXICOL, V29, P119, DOI 10.1016/0278-6915(91)90166-5; Darcey James, 2016, Dent Update, V43, P20; Ewing G. W., 1975, INSTRUMENTAL METHODS; Guneser MB, 2017, PHOTOMED LASER SURG, V35, P311, DOI 10.1089/pho.2016.4248; Haapasalo M, 2010, US, Patent No. [8648062 B2, 864806262]; HASSELGREN G, 1988, J ENDODONT, V14, P125, DOI 10.1016/S0099-2399(88)80212-7; Hualsmann H., 2009, ENDOD TOP, V16, P27, DOI DOI 10.1111/j.1601-1546.2009.00237.x; Karuvilla JR, 1998, J ENDODONT, V24, P472, DOI 10.1016/S0099-2399(98)80049-6; Kolosowski KP, 2014, J ENDODONT, V40, P2036, DOI 10.1016/j.joen.2014.08.017; Benavides GM, 2015, ODOVTOS INT J DENT S, V17, P53; Mortenson D, 2012, INT ENDOD J, V45, P878, DOI 10.1111/j.1365-2591.2012.02048.x; Naenni N, 2004, J ENDODONT, V30, P785, DOI 10.1097/00004770-200411000-00009; OHARA P, 1993, ENDOD DENT TRAUMATOL, V9, P95; Orhan EO, 2016, J ENDODONT, V42, P455, DOI 10.1016/j.joen.2015.12.024; Prado M, 2013, J ENDODONT, V39, P505, DOI 10.1016/j.joen.2012.11.050; SCHILDER H, 1985, ORAL SURG ORAL MED O, V59, P285, DOI 10.1016/0030-4220(85)90169-0; Thomas JE, 2010, J ENDODONT, V36, P315, DOI 10.1016/j.joen.2009.10.028; Vianna ME, 2004, ORAL SURG ORAL MED O, V97, P79, DOI 10.1016/S1079-2104(03)00360-3; Zehnder M, 2006, J ENDODONT, V32, P389, DOI 10.1016/j.joen.2005.09.014	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202081	10.1371/journal.pone.0202081	http://dx.doi.org/10.1371/journal.pone.0202081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110396	Green Submitted, Green Published, gold			2022-12-26	WOS:000441738000049
J	Ssebutinde, P; Kyamwanga, IT; Turyakira, E; Asiimwe, S; Bajunirwe, F				Ssebutinde, Peter; Kyamwanga, Imelda T.; Turyakira, Eleanor; Asiimwe, Stephen; Bajunirwe, Francis			Effect of age at initiation of antiretroviral therapy on treatment outcomes; A retrospective cohort study at a large HIV clinic in southwestern Uganda	PLOS ONE			English	Article							OLDER-ADULTS; PREVALENCE; INFECTION; AFRICA; STIGMA; EXPERIENCES; MULTICENTER; MORTALITY; HIV/AIDS; TRENDS	Background The prevalence of HIV infection among older persons is increasing yet older age at initiation of antiretroviral therapy (ART) may be associated with poorer treatment outcomes including mortality. However, majority of these studies have been done in the western world and there is limited data in resource limited settings. Our study used routinely collected health facility data to assess trends in age at initiation of ART, the effect of age at ART initiation on mortality and immunological response at a large urban hospital in south western Uganda. Methods We conducted a retrospective records review of patients attending the HIV clinic at Mbarara Regional Referral Hospital in western Uganda. We retrieved records for 8,533 patients who started ART between January 2006 and December 2012. Their data had been collected and stored as part of the larger International Epidemiological Database for the Evaluation of AIDS (IeDEA). Age was stratified into three categories namely; 18-34 (young adults), 35-49 (mid-age) and 50 years or older (older adults). Survival analysis procedures with Kaplan-Meier's plots were used to calculate the survival probability with mortality as the endpoint and Poisson regression analysis used to determine the adjusted relative risks (RR) of mortality. Results The proportion of young adults and patients at WHO stage I initiating ART increased steadily over the 7-year period. Older age at ART initiation (> = 50 years) was associated with a higher risk of mortality with adjusted relative risk (RR) at 1.63, (95% CI 1.26-2.11) compared to younger age. Male gender, WHO stages III and IV, lower CD4 count and lower body mass index were also all independently and significantly associated with higher risk for mortality. Older adults also had a poorer immunological response RR = 1.79 (95% CI 0.893.58) but was not statistically significant. Conclusions Following ART initiation, older adults compared to the young, have a higher risk of mortality. This age group should be targeted first for 'screen and treat' approach. Optimization of ART treatment regimens for this age group is also required to reduce mortality and improve immunological response.	[Ssebutinde, Peter] Mbarara Dist Directorate Hlth Serv, Mbarara, Uganda; [Ssebutinde, Peter; Kyamwanga, Imelda T.; Turyakira, Eleanor; Asiimwe, Stephen; Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Asiimwe, Stephen] Kabwohe Clin Res Ctr, Bushenyi, Uganda	Mbarara University of Science & Technology	Bajunirwe, F (corresponding author), Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda.	fbaj@yahoo.com		Bajunirwe, Francis/0000-0002-1326-5230				[Anonymous], 2018, CONSOLIDATED GUIDELI, V2nd; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Balestre E, 2012, AIDS, V26, P951, DOI 10.1097/QAD.0b013e3283528ad4; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Cornell M, 2015, LANCET HIV, V2, pE368, DOI 10.1016/S2352-3018(15)00113-7; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Eduardo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103864; ELSADR W, 1995, ARCH INTERN MED, V155, P184, DOI 10.1001/archinte.155.2.184; Emlet CA, 2007, AIDS PATIENT CARE ST, V21, P740, DOI 10.1089/apc.2007.0010; Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350; Funk A, 2012, 2 INT HIV TREATM PRE; Ghidei L, 2013, DRUG AGING, V30, P809, DOI 10.1007/s40266-013-0107-7; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greig Jane, 2012, AIDS, V26 Suppl 1, pS31; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kuteesa MO, 2014, SAHARA J-J SOC ASP H, V11, P126, DOI 10.1080/17290376.2014.938103; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Oraka E, 2018, J GERONTOL SOC WORK, V61, P460, DOI 10.1080/01634372.2018.1454565; Reniers G, 2014, AIDS, V28, pS533, DOI 10.1097/QAD.0000000000000496; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schatz E, 2019, J AGING HEALTH, V31, P709, DOI 10.1177/0898264317751945; Semeere AS, 2014, J ACQ IMMUN DEF SYND, V67, P382, DOI [10.1097/qai.0000000000000330, DOI 10.1097/44I.0000000000000330]; Skiest DJ, 1996, AM J MED, V101, P605, DOI 10.1016/S0002-9343(96)00329-4; Slaymaker E, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22789; Valcour VG, 2005, JAIDS-J ACQ IMM DEF, V38, P31, DOI 10.1097/00126334-200501010-00006; Vollmer S, 2015, LANCET HIV, V2, pE40, DOI 10.1016/S2352-3018(15)00004-1; Wallrauch C, 2010, SAMJ S AFR MED J, V100, P812, DOI 10.7196/SAMJ.4181; Wong NS, 2017, MEDICINE, V96, DOI [10.1097/md.0000000000007493, 10.1097/MD.0000000000007493]	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201898	10.1371/journal.pone.0201898	http://dx.doi.org/10.1371/journal.pone.0201898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110364	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000045
J	Watanabe, N; Kryukov, K; Nakagawa, S; Takeuchi, JS; Takeshita, M; Kirimura, Y; Mitsuhashi, S; Ishihara, T; Aoki, H; Inokuchi, S; Imanishi, T; Inoue, S				Watanabe, Nobuo; Kryukov, Kirill; Nakagawa, So; Takeuchi, Junko S.; Takeshita, Meiko; Kirimura, Yukiko; Mitsuhashi, Satomi; Ishihara, Toru; Aoki, Hiromichi; Inokuchi, Sadaki; Imanishi, Tadashi; Inoue, Shigeaki			Detection of pathogenic bacteria in the blood from sepsis patients using 16S rRNA gene amplicon sequencing analysis	PLOS ONE			English	Article							CELL-FREE DNA; GENERATION	Prompt identification of causative pathogenic bacteria is imperative for the treatment of patients suffering from infectious diseases, including sepsis and pneumonia. However, current culture-based methodologies have several drawbacks including their limitation of use to culturable bacterial species. To circumvent these problems, we attempted to detect bacterial DNA in blood using next-generation DNA sequencing (NGS) technology. We conducted metagenomic and 16S ribosomal RNA (rRNA) gene amplicon sequencing of DNA extracted from bacteria-spiked blood using an Ion Personal Genome Machine. NGS data was analyzed using our in-house pipeline Genome Search Toolkit and database GenomeSync. The metagenomic sequencing analysis successfully detected three gram-positive and three gram-negative bacteria spiked in the blood, which was associated with a significant portion of non-bacterial reads, even though human blood cells were separated by low-speed centrifugation prior to DNA extraction. Sequencing analysis of seven variable regions of the 16S rRNA gene amplicon also successfully detected all six bacteria spiked in the blood. The methodology using 16S rRNA gene amplicon analysis was verified using DNA from the blood of six patients with sepsis and four healthy volunteers with potential pathogenic bacteria in the blood being identified at the species level. These findings suggest that our system will be a potential platform for practical diagnosis in the future.	[Watanabe, Nobuo; Takeshita, Meiko; Kirimura, Yukiko; Aoki, Hiromichi; Inokuchi, Sadaki; Inoue, Shigeaki] Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa, Japan; [Kryukov, Kirill; Nakagawa, So; Takeuchi, Junko S.; Mitsuhashi, Satomi; Imanishi, Tadashi] Tokai Univ, Dept Mol Life Sci, Sch Med, Isehara, Kanagawa, Japan; [Nakagawa, So] Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan; [Ishihara, Toru] Tokai Univ, Dept Gen Med, Sch Med, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University; Tokai University	Inoue, S (corresponding author), Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa, Japan.	caf55000@gmail.com	Nakagawa, So/Q-2712-2015; Imanishi, Tadashi/R-3076-2019	Nakagawa, So/0000-0003-1760-3839; TAKEUCHI, Junko S/0000-0002-4844-9013; Imanishi, Tadashi/0000-0002-1182-9127	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of Japan Agency for Medical Research and Development (AMED) [JP17fm0108023]; Tokai University Medical School; Ministry of Education, Culture, Science, Sports, and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokai University Medical School; Ministry of Education, Culture, Science, Sports, and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities	This study is supported by a Grant (JP17fm0108023) from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of Japan Agency for Medical Research and Development (AMED) to TI, by a research grant from the Tokai University Medical School to NW, and by The Ministry of Education, Culture, Science, Sports, and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Frank MO, 2016, BIOL RES NURS, V18, P477, DOI 10.1177/1099800416642571; Gosiewski T, 2017, EUR J CLIN MICROBIOL, V36, P329, DOI 10.1007/s10096-016-2805-7; Grumaz S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0326-8; Gyarmati P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135756; Hahn A, 2016, J MICROBIOL METH, V130, P95, DOI 10.1016/j.mimet.2016.09.002; Hardwick SA, 2017, NAT REV GENET, V18, P473, DOI 10.1038/nrg.2017.44; Lita M. SC Proctor, 2013, HUMAN MICROBIOTA MIC, P1; Long Y, 2016, ARCH MED RES, V47, P365, DOI 10.1016/j.arcmed.2016.08.004; Mitsuhashi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05772-5; Tourlousse DM, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw984; Zengler K, 2013, HUMAN MICROBIOTA: HOW MICROBIAL COMMUNITIES AFFECT HEALTH AND DISEASE, P289	12	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202049	10.1371/journal.pone.0202049	http://dx.doi.org/10.1371/journal.pone.0202049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110400	Green Submitted, Green Published, gold			2022-12-26	WOS:000441738000048
J	Weissman, B; Tanner, D				Weissman, Benjamin; Tanner, Darren			A strong wink between verbal and emoji-based irony: How the brain processes ironic emojis during language comprehension	PLOS ONE			English	Article							ERP EVIDENCE; POTENTIALS; EMOTICONS; PSYCHOLINGUISTICS; INTEGRATION; COMPONENT; SARCASM; SEARCH; MUSIC; IMAGE	Emojis are ideograms that are becoming ubiquitous in digital communication. However, no research has yet investigated how humans process semantic and pragmatic content of emojis in real time. We investigated neural responses to irony-producing emojis, the question being whether emoji-generated irony is processed similarly to word-generated irony. Previous ERP studies have routinely found P600 effects to verbal irony. Our research sought to identify whether the same neural responses could also be elicited by emoji-induced irony. In three experiments, participants read sentences that ended in either a congruent, incongruent, or ironic (wink) emoji. Results across all three experiments demonstrated clear P600 effects, the amplitudes of which were correlated with participants' tendency to treat the emoji as a marker of irony, as indicated by behavioral comprehension question responses. These ironic wink emojis also elicited a strong P200 effect, also found in studies of verbal irony processing. Moreover, unexpected emojis (both mismatch and ironic emoji) also elicited late frontal positivities, which have been implicated processing unpredicted words in context. These results are the first to identify how linguistically-relevant ideograms are processed in real-time at the neural level, and specifically draw parallels between the processing of word- and emoji-induced irony.	[Weissman, Benjamin; Tanner, Darren] Univ Illinois, Dept Linguist, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Weissman, B (corresponding author), Univ Illinois, Dept Linguist, Urbana, IL 61801 USA.	bpweiss2@illinois.edu			National Science Foundation [BCS-1431324]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, grant BCS-1431324 awarded to DT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt Matt, 2015, NEW YORKER; Austin John, 1960, DO THINGS WORDS; Bennett Jessica, 2014, NY TIMES; Brothers T, 2015, COGNITION, V136, P135, DOI 10.1016/j.cognition.2014.10.017; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Bruner R, 2016, TIME; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Cochenour J., 1998, J VISUAL UTERACY, V18, P201, DOI DOI 10.1080/23796529.1998.11674539; Cohn N, 2016, COGNITION, V146, P304, DOI 10.1016/j.cognition.2015.10.007; Cohn N, 2015, NEUROPSYCHOLOGIA, V77, P267, DOI 10.1016/j.neuropsychologia.2015.08.026; Cohn N, 2015, BRAIN RES, V1601, P73, DOI 10.1016/j.brainres.2015.01.018; Cohn N, 2014, NEUROPSYCHOLOGIA, V64, P63, DOI 10.1016/j.neuropsychologia.2014.09.018; Cohn N, 2013, SEMIOTICA, V197, P35, DOI 10.1515/sem-2013-0079; Crystal David., 2001, LANGUAGE INTERNET; DeLong KA, 2014, NEUROPSYCHOLOGIA, V61, P150, DOI 10.1016/j.neuropsychologia.2014.06.016; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dresner E, 2010, COMMUN THEOR, V20, P249, DOI 10.1111/j.1468-2885.2010.01362.x; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; FILIK R, 2016, Q J EXP PSYCHOL, V69, P2130, DOI DOI 10.1080/17470218.2015.1106566; Filik R, 2014, J EXP PSYCHOL LEARN, V40, P811, DOI 10.1037/a0035658; Filik R, 2010, COGNITION, V116, P421, DOI 10.1016/j.cognition.2010.06.005; Ganis G, 1996, J COGNITIVE NEUROSCI, V8, P89, DOI 10.1162/jocn.1996.8.2.89; Gibbs RW, 2002, J PRAGMATICS, V34, P457, DOI 10.1016/S0378-2166(01)00046-7; GIBBS RW, 1986, J EXP PSYCHOL GEN, V115, P3, DOI 10.1037/0096-3445.115.1.3; GIORA R, 1995, DISCOURSE PROCESS, V19, P239, DOI 10.1080/01638539509544916; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Herring SC, 2017, PROCEEDINGS OF THE 50TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P2185; Ivanko SL, 2003, DISCOURSE PROCESS, V35, P241, DOI 10.1207/S15326950DP3503_2; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; McNeill D., 2000, LANGUAGE GESTURE; Metzner P, 2017, COGNITIVE SCI, V41, P1232, DOI 10.1111/cogs.12384; Miller H., 2016, P ICWSM 16 MAY 17 20; Miller H., 2017, P INT AAAI C WEB SOC, V11; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, MUSIC PERCEPT, V16, P27; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Riordan MA, 2017, J LANG SOC PSYCHOL, V36, P549, DOI 10.1177/0261927X17704238; Searle John, 1969, SPEECH ACTS, P33; Skovholt K, 2014, J COMPUT-MEDIAT COMM, V19, P780, DOI 10.1111/jcc4.12063; Spotorno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066839; Tanner D, 2015, PSYCHOPHYSIOLOGY, V52, P997, DOI 10.1111/psyp.12437; Thompson D, 2016, J COMPUT-MEDIAT COMM, V21, P105, DOI 10.1111/jcc4.12156; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; Tigwell GW, 2016, PROCEEDINGS OF THE 18TH INTERNATIONAL CONFERENCE ON HUMAN-COMPUTER INTERACTION WITH MOBILE DEVICES AND SERVICES (MOBILEHCI 2016), P859, DOI 10.1145/2957265.2961844; van Herten M, 2006, J COGNITIVE NEUROSCI, V18, P1181, DOI 10.1162/jocn.2006.18.7.1181	52	41	41	12	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201727	10.1371/journal.pone.0201727	http://dx.doi.org/10.1371/journal.pone.0201727			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ5PD	30110375	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000040
J	Gomez-Acebo, I; Dierssen-Sotos, T; Palazuelos, C; Fernandez-Navarro, P; Castano-Vinyals, G; Alonso-Molero, J; Urtiaga, C; Fernandez-Villa, T; Ardanaz, E; Rivas-del-Fresno, M; Molina-Barcel, A; Jimenez-Moleon, JJ; Garcia-Martinez, L; Amiano, P; Rodriguez-Cundin, P; Moreno, V; Perez-Gomez, B; Aragones, N; Kogevinas, M; Pollan, M; Llorca, J				Gomez-Acebo, Ines; Dierssen-Sotos, Trinidad; Palazuelos, Camilo; Fernandez-Navarro, Pablo; Castano-Vinyals, Gemma; Alonso-Molero, Jessica; Urtiaga, Carmen; Fernandez-Villa, Tania; Ardanaz, Eva; Rivas-del-Fresno, Manuel; Molina-Barcel, Ana; Jimenez-Moleon, Jose-Juan; Garcia-Martinez, Lidia; Amiano, Pilar; Rodriguez-Cundin, Paz; Moreno, Victor; Perez-Gomez, Beatriz; Aragones, Nuria; Kogevinas, Manolis; Pollan, Marina; Llorca, Javier			Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study	PLOS ONE			English	Article							SUN EXPOSURE; RISK-FACTORS; LIFE-STYLE; VITAMIN-D; ULTRAVIOLET-RADIATION; GENETIC EPIDEMIOLOGY; SKIN TYPE; METAANALYSIS; COHORT; DIET	Introduction Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal. Methods We examined the association between the phototype and breast and prostate cancers using a Mendelian randomization analysis. We studied 1,738 incident cases of breast cancer and another 817 cases of prostate cancer. To perform a Mendelian randomization analysis on the phototype-cancer relationship, a genetic pigmentation score was required that met the following criteria: (1) the genetic pigmentation score was associated with phototype in controls; (2) the genetic pigmentation score was not associated with confounders in the relationship between phototype and cancer, and (3) the genetic pigmentation score was associated with cancer only through its association with phototype. Once this genetic score is available, the association between genetic pigmentation score and cancer can be identified as the association between phototype and cancer. Results The association between the genetic pigmentation score and phototype in controls showed that a higher genetic pigmentation score was associated with fair skin, blond hair, blue eyes and the presence of freckles. Applying the Mendelian randomization analysis, we verified that there was no association between the genetic pigmentation score and cancers of the breast and prostate. Conclusions Phototype is not associated with breast or prostate cancer.	[Gomez-Acebo, Ines; Dierssen-Sotos, Trinidad; Fernandez-Navarro, Pablo; Castano-Vinyals, Gemma; Ardanaz, Eva; Jimenez-Moleon, Jose-Juan; Amiano, Pilar; Moreno, Victor; Perez-Gomez, Beatriz; Aragones, Nuria; Kogevinas, Manolis; Pollan, Marina; Llorca, Javier] CIBERESP, Madrid, Spain; [Gomez-Acebo, Ines; Dierssen-Sotos, Trinidad; Palazuelos, Camilo; Alonso-Molero, Jessica; Llorca, Javier] Univ Cantabria, IDIVAL, Santander, Spain; [Fernandez-Navarro, Pablo; Perez-Gomez, Beatriz; Pollan, Marina] Carlos III Inst Hlth, Natl Ctr Epidemiol, Canc & Environm Epidemiol Unit, Madrid, Spain; [Fernandez-Navarro, Pablo; Perez-Gomez, Beatriz; Pollan, Marina] IIS Puerta de Hierro IDIPHIM, Oncol & Hematol Area, Canc Epidemiol Res Grp, Madrid, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] ISGlobal Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] UPF, Barcelona, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] IMIM Hosp Del Mar Med Res Inst, Barcelona, Spain; [Urtiaga, Carmen; Amiano, Pilar] BioDonostia Res Inst, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Fernandez-Villa, Tania; Garcia-Martinez, Lidia] Univ Leon, Inst Biomed IBIOMED, Grp Invest Interacc Gen Ambiente & Salud, Leon, Spain; [Ardanaz, Eva] Navarra Publ Hlth Inst, Pamplona, Spain; [Ardanaz, Eva] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Rivas-del-Fresno, Manuel] Hosp Cabuenes, Asturias, Spain; [Molina-Barcel, Ana] Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Area Canc & Salud Publ, Valencia, Spain; [Jimenez-Moleon, Jose-Juan] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain; [Rodriguez-Cundin, Paz] Univ Hosp Marques de Valdecilla IDIVAL, Santander, Spain; [Moreno, Victor] Catalan Inst Oncol IDIBELL, Canc Prevent & Control Program, Lhospitalet De Llobregat, Spain; [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain; [Aragones, Nuria] Comunidad Madrid, Consejeria Sanidad, Direcc Gen Salud Publ, Subdirecc Gen Epidemiol, Madrid, Spain; [Kogevinas, Manolis] Sch Publ Hlth, Athens, Greece	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Cantabria; Instituto de Salud Carlos III; ISGlobal; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universidad de Leon; Public Health Institute of Navarra; Hospital de Cabuenes; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Marques de Valdecilla (HUMV); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Gomez-Acebo, I (corresponding author), CIBERESP, Madrid, Spain.	ines.gomez@unican.es	Jimenez-Moleon, Jose J/O-2519-2016; Perez-Gomez, Beatriz/C-4715-2012; Fernández-Villa, Tania/R-6534-2017; Castaño-Vinyals, Gemma/H-7021-2017; Castaño-Vinyals, Gemma/N-3885-2019; Molina-Barceló, Ana/AAH-4595-2019; Aragones, Nuria/O-5962-2015; Kogevinas, Manolis/C-3918-2017; Gomez-Acebo, Ines/C-9122-2018; Llorca, Javier/F-7371-2011; Moreno, Victor/A-1697-2010	Jimenez-Moleon, Jose J/0000-0001-7917-6145; Perez-Gomez, Beatriz/0000-0002-4299-8214; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Molina-Barceló, Ana/0000-0001-5113-6475; Aragones, Nuria/0000-0003-0983-2156; Kogevinas, Manolis/0000-0002-9605-0461; Gomez-Acebo, Ines/0000-0001-8793-8314; Llorca, Javier/0000-0001-8569-861X; Rivas Del Fresno, Manuel/0000-0002-5890-6580; Moreno, Victor/0000-0002-2818-5487; Dierssen-Sotos, Trinidad/0000-0002-6127-0077; Alonso-Molero, Jessica/0000-0002-1939-8798	Accion Transversal del Cancer; Instituto de Salud Carlos III-FEDER [PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-Leon, PI09/01903-Valencia, PI09/02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810]; Fundacion Marques de Valdecilla [API 10/09]; ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project); ICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII)); ICGC International Cancer Genome Consortium CLL (Red Tematica de Investigacion del Cancer (RTICC) del ISCIII) [RD12/0036/0036]; Junta de Castilla y Leon [LE22A10-2]; Consejeria de Salud of the Junta de Andalucia [2009-S0143]; Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; Recercaixa [2010ACUP 00310]; Regional Government of the Basque Country; Consejeria de Sanidad de la Region de Murcia; European Commission [FOOD-CT-2006-036224-HIWATE]; Spanish Association Against Cancer (AECC) Scientific Foundation; Catalan Government DURSI [2014SGR647]; Fundacion Caja de Ahorros de Asturias; University of Oviedo;  [PI11/02213];  [PI12/00488];  [PI12/00265];  [PI12/01270];  [PI12/00715];  [PI12/00150];  [PI14/01219];  [PI14/0613];  [PI15/00069];  [PI15/00914];  [PI15/01032]	Accion Transversal del Cancer(Instituto de Salud Carlos III); Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Marques de Valdecilla(Instituto de Salud Carlos III); ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project); ICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII)); ICGC International Cancer Genome Consortium CLL (Red Tematica de Investigacion del Cancer (RTICC) del ISCIII); Junta de Castilla y Leon(Junta de Castilla y Leon); Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Conselleria de Sanitat of the Generalitat Valenciana; Recercaixa(La Caixa Foundation); Regional Government of the Basque Country; Consejeria de Sanidad de la Region de Murcia; European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Association Against Cancer (AECC) Scientific Foundation; Catalan Government DURSI; Fundacion Caja de Ahorros de Asturias(Principality of Asturias); University of Oviedo; ; ; ; ; ; ; ; ; ; ; 	This work was partially funded by the "Accion Transversal del Cancer", approved by the Spanish Ministry Council on the 11th October 2007; The Instituto de Salud Carlos III-FEDER [PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-Leon, PI09/01903-Valencia, PI09/02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032]; The Fundacion Marques de Valdecilla [API 10/09]; The ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project is funded by Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII (RD12/0036/0036)); The Junta de Castilla y Leon [LE22A10-2]; The Consejeria de Salud of the Junta de Andalucia [2009-S0143]; The Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; The Recercaixa [2010ACUP 00310]; The Regional Government of the Basque Country; The Consejeria de Sanidad de la Region de Murcia; The European Commission [grants FOOD-CT-2006-036224-HIWATE]; The Spanish Association Against Cancer (AECC) Scientific Foundation; The Catalan Government DURSI [grant 2014SGR647]; The Fundacion Caja de Ahorros de Asturias; and the University of Oviedo.	Alaluf S, 2002, PIGM CELL RES, V15, P112, DOI 10.1034/j.1600-0749.2002.1o071.x; Bodiwala D, 2003, CARCINOGENESIS, V24, P711, DOI 10.1093/carcin/bgg021; Bonilla C, 2013, CANCER EPIDEM BIOMAR, V22, P597, DOI 10.1158/1055-9965.EPI-12-1248; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burks D A, 1992, Henry Ford Hosp Med J, V40, P89; Castano-Vinyals G, 2015, GAC SANIT, V29, P308, DOI 10.1016/j.gaceta.2014.12.003; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x; Dierssen-Sotos T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20832-0; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Estebanez N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27297-1; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Freedman DM, 2002, OCCUP ENVIRON MED, V59, P257, DOI 10.1136/oem.59.4.257; Gilbert R, 2009, INT J CANCER, V125, P1414, DOI 10.1002/ijc.24411; Golubnitschaja O, 2016, TUMOR BIOL, V37, P12941, DOI 10.1007/s13277-016-5168-x; Gomez-Acebo I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09386-9; Hankinson S., 2008, Textbook of cancer epidemiology, P403; Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134; Kolonel LN, 2001, EPIDEMIOL REV, V23, P72, DOI 10.1093/oxfordjournals.epirev.a000798; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kuchenbaecker KB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0492-9; Lambertini M, 2016, CANCER TREAT REV, V49, P65, DOI 10.1016/j.ctrv.2016.07.006; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; Markozannes G, 2016, EUR J CANCER, V69, P61, DOI 10.1016/j.ejca.2016.09.026; Moon SJ, 2005, MUTAT RES-FUND MOL M, V571, P207, DOI 10.1016/j.mrfmmm.2004.09.015; Murphy AB, 2017, PROSTATE CANCER P D, V20, P55, DOI 10.1038/pcan.2016.41; Natale CA, 2016, ELIFE, V5, DOI 10.7554/eLife.15104; Palmer TM, 2012, AM J EPIDEMIOL, V176, P457, DOI 10.1093/aje/kws250; PIENTA KJ, 1993, ANN INTERN MED, V118, P793, DOI 10.7326/0003-4819-118-10-199305150-00007; RAMPEN FHJ, 1988, ARCH DERMATOL, V124, P885, DOI 10.1001/archderm.124.6.885; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Walker LC, 2017, EUR J HUM GENET, V25, P432, DOI 10.1038/ejhg.2016.203; Weinstein SJ, 2013, BRIT J CANCER, V109, P747, DOI 10.1038/bjc.2013.385; Wilson KM, 2012, ASIAN J ANDROL, V14, P365, DOI 10.1038/aja.2011.142; Wolk A, 2005, ACTA ONCOL, V44, P277, DOI 10.1080/02841860510029572; World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report, 2014, DIET NUTR PHYS ACT P; Xu YH, 2014, J CANCER RES CLIN, V140, P1465, DOI 10.1007/s00432-014-1706-3; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005; Zamoiski RD, 2016, ENVIRON RES, V151, P419, DOI 10.1016/j.envres.2016.08.013	48	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201750	10.1371/journal.pone.0201750	http://dx.doi.org/10.1371/journal.pone.0201750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106959	Green Published, gold			2022-12-26	WOS:000441662800012
J	Oberbauer, AM; Daniels, R; Levy, K; Famula, TR; Mundell, P; Kelley, R				Oberbauer, A. M.; Daniels, R.; Levy, K.; Famula, T. R.; Mundell, P.; Kelley, R.			Maternal omega-3 polyunsaturated fatty acid supplementation on offspring hip joint conformation	PLOS ONE			English	Article							GROWING DOGS; OMEGA-3-FATTY-ACID SUPPLEMENTATION; ORTHOPEDIC FOUNDATION; LABRADOR RETRIEVERS; ELBOW DYSPLASIA; BONE-FORMATION; ETHYL-ESTER; FISH-OIL; ANIMALS; GROWTH	Unsaturated omega-3 fatty acids, especially docosahexaenoic acid (DHA), when fed to dogs improves cognitive and neurological development. Supplementation with omega-3 fatty acids such as DHA and eicosapentaenoic acid (EPA) has also been associated with lipid peroxidation, which in turn has been implicated in reduced body weight and altered bone formation. To assess the impact of omega-3 fatty acid supplementation on skeletal growth, diets containing three levels of DHA and EPA (0.01 and 0.01%, 0.14 and 0.12%, and 0.21 and 0.18%, respectively) were fed to bitches during gestation and lactation with puppies also supplemented through weaning. Thus, the subjects studied were the puppies supplemented with DHA and EPA through gestation and early postnatal life. The hip joint conformation of the puppies (n = 676) was recorded at adulthood using two radiographic, non-invasive evaluations. In this population, females had higher hip distraction indices (DI) than males. Males from the lower two levels of DHA and EPA supplementation had significantly smaller hip DI than all females and males from the highest DHA and EPA supplementation. In contrast, there were no diet effects on anatomical indicators of hip joint conformation and no visible arthritic changes. These data suggest that dietary supplementation of DHA and EPA during gestation and the perinatal period to weaning does not adversely influence hip joint formation of dogs.	[Oberbauer, A. M.; Famula, T. R.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Daniels, R.; Levy, K.; Mundell, P.] Canine Compan Independence, Santa Rosa, CA USA; [Kelley, R.] Iams Co, P&G Pet Care, Mason, OH USA; [Kelley, R.] PHNC, Royal Canin, Lewisburg, OH USA	University of California System; University of California Davis	Oberbauer, AM (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	amoberbauer@ucdavis.edu		Mundell, Paul/0000-0001-7569-7584	Iams Company; Canine Companions for Independence	Iams Company; Canine Companions for Independence	RK was an employee of the Iams Company at the time of the study and his salary was covered by the Iams Company, the same company that provided the diet resources for the study; RK is presently and employee of Royal Canin. KL, RD, and PM and were employees of Canine Companions for Independence at the time of the study and that entity paid their salaries. RK was not involved with the collection of the data. The funders provided support in the form of salaries for authors (KL, RD, PM, RK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Hinai M, 2018, J DEV ORIG HLTH DIS, V9, P432, DOI [10.1017/S2040174418000193, 10.1017/s2040174418000193]; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; [Anonymous], 2017, R LANG ENV STAT COMP; Bauer JE, 2016, JAVMA-J AM VET MED A, V249, P1267; Bauer JE, 2011, JAVMA-J AM VET MED A, V239, P1441, DOI 10.2460/javma.239.11.1441; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; Comblain F, 2016, J VET PHARMACOL THER, V39, P1, DOI 10.1111/jvp.12251; Cook CR, 2009, VET SURG, V38, P144, DOI 10.1111/j.1532-950X.2008.00481.x; Corley E, 1987, SEM VET MED SURG SMA; Council NR, 2006, NUTR REQ DOGS CATS; Dahms I, 2016, PROSTAG LEUKOTR ESS, V113, P1, DOI 10.1016/j.plefa.2016.08.001; Dahms I, 2016, FOOD CHEM TOXICOL, V92, P50, DOI 10.1016/j.fct.2016.03.024; DAMMRICH K, 1991, J NUTR, V121, pS114, DOI 10.1093/jn/121.suppl_11.S114; Diaz-Castro J, 2016, INFLUENCE OMEGA 3 FA, P285; DISTL O, 1991, J VET MED A, V38, P460, DOI 10.1111/j.1439-0442.1991.tb01035.x; Filburn CR, 2005, VET THER, V6, P29; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; GEUSENS P, 1994, ARTHRITIS RHEUM, V37, P824, DOI 10.1002/art.1780370608; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hall JA, 2006, J NUTR, V136, P2338, DOI 10.1093/jn/136.9.2338; Hassinger K, 1997, VCOT ARCH, V10, P15; Hedhammar A., 2007, EJCAP, V17, P141; Heinemann KM, 2006, JAVMA-J AM VET MED A, V228, P700, DOI 10.2460/javma.228.5.700; Heinemann KM, 2005, J NUTR, V135, P1960, DOI 10.1093/jn/135.8.1960; Izquierdo MS, 2013, BRIT J NUTR, V109, P1796, DOI 10.1017/S0007114512003935; Kaneene JB, 1997, J AM VET MED ASSOC, V211, P1542; KEALY RD, 1992, J AM VET MED ASSOC, V201, P857; Keller GG, 2011, VET J, V189, P197, DOI 10.1016/j.tvjl.2011.06.019; KELLER GG, 1993, CANINE PRACT, V18, P19; Kelly R., 2004, P 6 C MEX ROB TORR M; Koren N, 2014, J NUTR BIOCHEM, V25, P623, DOI 10.1016/j.jnutbio.2014.01.012; Kuratko C, 2013, WOODHEAD PUBL FOOD S, V252, P353, DOI 10.1533/9780857098863.3.353; Lenox CE, 2013, J VET INTERN MED, V27, P217, DOI 10.1111/jvim.12033; Norazlina M, 2002, ASIA PAC J CLIN NUTR, V11, P194, DOI 10.1046/j.1440-6047.2002.00290.x; Oberbauer AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172918; Ohlerth S, 1998, DEUT TIERARZTL WOCH, V105, P378; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Powers MY, 2010, JAVMA-J AM VET MED A, V237, P532, DOI 10.2460/javma.237.5.532; Prego-Dominguez J, 2016, PAIN PHYSICIAN, V19, P521; Riser WH, 1973, VET RADIOL ULTRASOUN, V14, P24, DOI DOI 10.1111/J.1740-8261.1973.TB00654.X; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roush JK, 2010, JAVMA-J AM VET MED A, V236, P67, DOI 10.2460/javma.236.1.67; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Smith GK, 2012, VET SURG, V41, P20, DOI 10.1111/j.1532-950X.2011.00935.x; SMITH GK, 1993, AM J VET RES, V54, P1021; Smith GK, 2001, J AM VET MED ASS; Smith GI, 2011, AM J CLIN NUTR, V93, P402, DOI 10.3945/ajcn.110.005611; Tryfonidou MA, 2003, DOMEST ANIM ENDOCRIN, V24, P265, DOI 10.1016/S0739-7240(03)00018-3; Tryfonidou MA, 2002, J NUTR, V132, P2644, DOI 10.1093/jn/132.9.2644; Turek JJ, 2003, J NUTR BIOCHEM, V14, P24, DOI 10.1016/S0955-2863(02)00221-8; van Hagen MAE, 2005, AM J VET RES, V66, P307, DOI 10.2460/ajvr.2005.66.307; Watkins BA, 2003, PROSTAG LEUKOTR ESS, V68, P387, DOI 10.1016/S0952-3278(03)00063-2; Weidner N, 2017, CRIT REV FOOD SCI, V57, P3850, DOI 10.1080/10408398.2016.1171202; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9; XU H, 1995, CALCIFIED TISSUE INT, V57, P293, DOI 10.1007/BF00298885; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zicker SC, 2012, JAVMA-J AM VET MED A, V241, P583, DOI 10.2460/javma.241.5.583	60	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202157	10.1371/journal.pone.0202157	http://dx.doi.org/10.1371/journal.pone.0202157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092106	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600096
J	Visser, A; Beijer, M; Oudejans, CBM; van Dijk, M				Visser, Allerdien; Beijer, Maarten; Oudejans, Cees B. M.; van Dijk, Marie			The effect of maternal NODAL on STOX1 expression in extravillous trophoblasts is mediated by IGF1	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-1; GROWTH-FACTOR-I; INSULIN; PREECLAMPSIA; INVASION; PROLIFERATION; TRIMESTER; MODELS; WOMEN; 1ST	The number of molecules identified to be involved in communication between placenta and decidua is fast expanding. Previously, we showed that NODAL expressed in maternal endometrial stromal cells is able to affect NODAL and STOX1 expression in placental extravillous trophoblasts. The effect of maternal NODAL on placental NODAL expression is achieved via Activin A, while preliminary data suggests that maternal NODAL affects STOX1 expression in trophoblasts potentially via IGF1. In the current study, T-HESC endometrial stromal cells were treated with siRNAs against NODAL after which IGF1 mRNA expression was determined by quantitative RT-PCR, while IGF1 secretion was measured by ELISA. Recombinant IGF1 and inhibitors of the MAPK and PI3K/AKT pathways were added to SGHPL-5 extravillous trophoblasts after which the effects on STOX1 mRNA and STOX1 protein expression were determined. The effect of IGF1 and the MAPK and PI3K/AKT inhibitors on the invasive capacity of SGHPL-5 cells was investigated by performing invasion assays. We found that T-HESC cells treated with NODAL siRNAs showed significant upregulation of IGF1 mRNA expression and IGF1 protein secretion. Addition of IGF1 to SGHPL5 cell media significantly upregulated STOX1 mRNA and protein expression. Using inhibitors of the PI3K/AKT and MAPK pathway showed that the effect of IGF1 on STOX1 expression is accomplished via MAPK signaling. Secondly, P13K inhibition independently leads to reduced STOX1 expression which can be rescued by adding IGF1. IGF1 was unable to influence the invasive capacity of SGHPL-5 cells, while inhibiting the PI3K/AKT pathway did reduce the invasion of these cells. To conclude, here we show that downregulated NODAL expression in endometrial stromal cells, previously associated with pre-eclampsia like symptoms in mice, increases IGF1 secretion. Increased levels of IGF1 lead to increased expression levels of STOX1 in extravillous trophoblasts via the MAPK pathway, hereby identifying a novel signaling cascade involved in maternal-fetal communication.	[Visser, Allerdien; Beijer, Maarten; Oudejans, Cees B. M.; van Dijk, Marie] Vrije Univ Amsterdam, Amsterdam UMC, Dept Clin Chem Amsterdam Reprod & Dev, Amsterdam, Netherlands; [van Dijk, Marie] Univ Amsterdam, Amsterdam UMC, Reprod Biol Lab, Amsterdam Reprod & Dev, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	van Dijk, M (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Dept Clin Chem Amsterdam Reprod & Dev, Amsterdam, Netherlands.; van Dijk, M (corresponding author), Univ Amsterdam, Amsterdam UMC, Reprod Biol Lab, Amsterdam Reprod & Dev, Amsterdam, Netherlands.	marie.vandijk@amc.uva.nl		Oudejans, Cees/0000-0003-0717-4946; van Dijk, Marie/0000-0003-1461-3441				Conti E, 2013, CYTOKINE GROWTH F R, V24, P411, DOI 10.1016/j.cytogfr.2013.05.008; Dunk C, 2003, LAB INVEST, V83, P1821, DOI 10.1097/01.LAB.0000101730.69754.5A; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Forbes K, 2008, AM J PHYSIOL-CELL PH, V294, pC1313, DOI 10.1152/ajpcell.00035.2008; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Grobman WA, 2001, OBSTET GYNECOL, V97, P521, DOI 10.1016/S0029-7844(00)01193-5; Hamilton GS, 1998, EXP CELL RES, V244, P147, DOI 10.1006/excr.1998.4195; Hills FA, 2004, J ENDOCRINOL, V183, P487, DOI 10.1677/joe.1.05867; Kee Y, 2007, GENE DEV, V21, P391, DOI 10.1101/gad.1509307; Li RH, 1997, HUM REPROD, V12, P830, DOI 10.1093/humrep/12.4.830; Mandl M, 2002, HISTOCHEM CELL BIOL, V117, P391, DOI 10.1007/s00418-002-0403-5; Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035; Park CB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098277; Sowers M, 2001, J CLIN ENDOCR METAB, V86, P5898, DOI 10.1210/jc.86.12.5898; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Thulluru HK, 2015, PLACENTA, V36, P345, DOI 10.1016/j.placenta.2015.01.010; Thulluru Hari Krishna, 2013, Frontiers in Genetics, V4, P170, DOI 10.3389/fgene.2013.00170; Tyberghein K, 2012, PLACENTA, V33, P554, DOI 10.1016/j.placenta.2012.04.002; van Abel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029769; van Dijk M, 2010, HUM MOL GENET, V19, P2658, DOI 10.1093/hmg/ddq152; Vatten LJ, 2008, EUR J ENDOCRINOL, V158, P101, DOI 10.1530/EJE-07-0386	23	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202190	10.1371/journal.pone.0202190	http://dx.doi.org/10.1371/journal.pone.0202190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092105	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600100
J	Long, MD; Singh, PK; Russell, JR; Llimos, G; Rosario, S; Rizvi, A; van den Berg, PR; Kirk, J; Sucheston-Campbell, LE; Smiraglia, DJ; Campbell, MJ				Long, Mark D.; Singh, Prashant K.; Russell, James R.; Llimos, Gerard; Rosario, Spencer; Rizvi, Abbas; van den Berg, Patrick R.; Kirk, Jason; Sucheston-Campbell, Lara E.; Smiraglia, Dominic J.; Campbell, Moray J.			The miR-96 and RAR gamma signaling axis governs androgen signaling and prostate cancer progression	ONCOGENE			English	Article							13-CIS RETINOIC ACID; TUMOR-SUPPRESSOR; RECEPTOR; EXPRESSION; IDENTIFICATION; GENES; CELLS; DIFFERENTIATION; ACTIVATION; CHROMATIN	Expression levels of retinoic acid receptor gamma (NR1B3/RARG, encodes RAR gamma) are commonly reduced in prostate cancer (PCa). Therefore, we sought to establish the cellular and gene regulatory consequences of reduced RAR gamma expression, and determine RAR gamma regulatory mechanisms. RARG shRNA approaches in non-malignant (RWPE-1 and HPr1-AR) and malignant (LNCaP) prostate models revealed that reducing RAR gamma levels, rather than adding exogenous retinoid ligand, had the greatest impact on prostate cell viability and gene expression. ChIP-Seq defined the RAR gamma cistrome, which was significantly enriched at active enhancers associated with AR binding sites. Reflecting a significant genomic role for RAR gamma to regulate androgen signaling, RAR gamma knockdown in HPr1-AR cells significantly regulated the magnitude of the AR transcriptome. RAR gamma downregulation was explained by increased miR-96 in PCa cell and mouse models, and TCGA PCa cohorts. Biochemical approaches confirmed that miR-96 directly regulated RAR gamma expression and function. Capture of the miR-96 targetome by biotin-miR-96 identified that RAR gamma and a number of RAR gamma interacting co-factors including TACC1 were all targeted by miR-96, and expression of these genes were prominently altered, positively and negatively, in the TCGA-PRAD cohort. Differential gene expression analyses between tumors in the TCGA-PRAD cohort with lower quartile expression levels of RARG and TACC1 and upper quartile miR-96, compared to the reverse, identified a gene network including several RAR gamma target genes (e.g., SOX15) that significantly associated with worse disease-free survival (hazard ratio 2.23, 95% CI 1.58 to 2.88, p = 0.015). In summary, miR-96 targets a RAR gamma network to govern AR signaling, PCa progression and disease outcome.	[Long, Mark D.; Russell, James R.; Llimos, Gerard; Rosario, Spencer; van den Berg, Patrick R.; Smiraglia, Dominic J.] RPCCC, Dept Canc Genet & Genom, Buffalo, NY 14263 USA; [Singh, Prashant K.] Roswell Pk Comprehens Canc Ctr, Ctr Personalized Med, Buffalo, NY 14263 USA; [Llimos, Gerard] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Rizvi, Abbas; Sucheston-Campbell, Lara E.] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [van den Berg, Patrick R.] Leiden Univ, Leiden Inst Phys, NL-2300 RA Leiden, Netherlands; [Kirk, Jason] Roswell Pk Comprehens Canc Ctr, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Sucheston-Campbell, Lara E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Campbell, Moray J.] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 536 Pk Hall, Columbus, OH 43210 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University System of Ohio; Ohio State University; Leiden University; Leiden University - Excl LUMC; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Campbell, MJ (corresponding author), Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 536 Pk Hall, Columbus, OH 43210 USA.	campbell.1933@osu.edu	Rosario, Spencer/AAS-5728-2021; Campbell, Moray/ABF-1264-2021; Smiraglia, Dominic/R-2069-2019	Campbell, Moray/0000-0002-3355-0928; Smiraglia, Dominic/0000-0001-8852-1510; Llimos Aubach, Gerard/0000-0003-3311-6782; Long, Mark/0000-0003-1120-8176	Roswell Park Comprehensive Cancer Center-University of Pittsburgh Cancer Institute Ovarian Cancer Specialized Program of Research Excellence National Institutes of Health [P50CA159981-01A1]; Molecular Pharmacology and Experimental Therapeutics NRSA T32 program at Roswell Park Comprehensive Cancer Center [T32CA009072]; Prostate program of the Department of Defense Congressionally Directed Medical Research Programs [W81XWH-14-1-0608, W81XWH-11-2-0033]; National Cancer Institute (NCI) [P30CA016056, P30CA016058]; European Union-United States Atlantis Program [P116J090011]; NATIONAL CANCER INSTITUTE [P50CA159981, P30CA016058, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM095459] Funding Source: NIH RePORTER	Roswell Park Comprehensive Cancer Center-University of Pittsburgh Cancer Institute Ovarian Cancer Specialized Program of Research Excellence National Institutes of Health; Molecular Pharmacology and Experimental Therapeutics NRSA T32 program at Roswell Park Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate program of the Department of Defense Congressionally Directed Medical Research Programs; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Union-United States Atlantis Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LES-C acknowledges support, in part, of Roswell Park Comprehensive Cancer Center-University of Pittsburgh Cancer Institute Ovarian Cancer Specialized Program of Research Excellence National Institutes of Health [P50CA159981-01A1]. MDL acknowledges support of Molecular Pharmacology and Experimental Therapeutics NRSA T32 program (T32CA009072) held at Roswell Park Comprehensive Cancer Center. MJC and DJS acknowledge support in part from the Prostate program of the Department of Defense Congressionally Directed Medical Research Programs (W81XWH-14-1-0608, W81XWH-11-2-0033) and the National Cancer Institute (NCI) grant P30CA016056 involving the use of Roswell Park Comprehensive Cancer Center's Genomic Shared Resource. MJC, GL, AR, and PRvdB acknowledge support from the European Union-United States Atlantis Program (P116J090011). MJC and LES-C acknowledge support from the National Cancer Institute (NCI) grant P30CA016056 involving the use of OSUCCC The James, CCSG P30CA016058.	Abe M, 2011, BJU INT, V107, P126, DOI 10.1111/j.1464-410X.2010.09344.x; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Alhasan AH, 2016, P NATL ACAD SCI USA, V113, P10655, DOI 10.1073/pnas.1611596113; Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bao YH, 2017, EUR REV MED PHARMACO, V21, P4548; Beydoun HA, 2011, CANCER CAUSE CONTROL, V22, P1483, DOI 10.1007/s10552-011-9822-8; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Campbell MJ, 1998, ENDOCRINOLOGY, V139, P1972, DOI 10.1210/en.139.4.1972; Campbell MJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/314974; Chen CF, 2004, ONCOGENE, V23, P5350, DOI 10.1038/sj.onc.1207682; Dhiman VK, 2015, ONCOTARGET, V6, P42575, DOI 10.18632/oncotarget.6471; Dingwall M, 2011, DIFFERENTIATION, V82, P57, DOI 10.1016/j.diff.2011.05.003; Dong DF, 2012, GENE EXPRESSION, V15, P153, DOI 10.3727/105221612X13372578119571; Dou MM, 2018, CELL PHYSIOL BIOCHEM, V45, P2497, DOI 10.1159/000488268; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ellis L, 2016, PROSTATE, V76, P1192, DOI 10.1002/pros.23206; Ernst J, 2017, NAT PROTOC, V12, P2478, DOI 10.1038/nprot.2017.124; Ferrari AC, 2002, J CLIN ONCOL, V20, P538, DOI 10.1200/JCO.20.2.538; Foster BA, 1997, CANCER RES, V57, P3325; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guyot R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-3; Haflidadottir BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072400; Hindley CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23208; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang H, 2014, CURR TOP MED CHEM, V14, P2175, DOI 10.2174/1568026614666141112101840; Itkonen HM, 2017, ONCOTARGET, V8, P38264, DOI 10.18632/oncotarget.16123; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Jin M, 2014, CANCER RES, V74, P4183, DOI 10.1158/0008-5472.CAN-14-0404; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kittler R, 2013, CELL REP, V3, P538, DOI 10.1016/j.celrep.2013.01.004; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Liu NH, 2016, CANCER LETT, V378, P38, DOI 10.1016/j.canlet.2016.05.010; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Long MD, 2015, NUCLEIC ACIDS RES, V43, P7330, DOI 10.1093/nar/gkv642; Long MD, 2015, NUCL RECEPT RES, V2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu XP, 1999, INT J CANCER, V80, P272, DOI 10.1002/(SICI)1097-0215(19990118)80:2<272::AID-IJC17>3.3.CO;2-O; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Luo ZJ, 2015, MOL CELL, V57, P685, DOI 10.1016/j.molcel.2015.01.007; Malinen M, 2017, NUCLEIC ACIDS RES, V45, P619, DOI 10.1093/nar/gkw855; MCBURNEY MW, 1993, CANCER INVEST, V11, P590, DOI 10.3109/07357909309011677; McCormick DL, 1999, CANCER RES, V59, P521; McDonald AC, 2018, PROSTATE, V78, P411, DOI 10.1002/pros.23485; McGrath MJ, 2013, CANCER RES, V73, P5066, DOI 10.1158/0008-5472.CAN-12-4520; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Mo WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056592; Murillo-Garzon V, 2017, NAT REV UROL, V14, P683, DOI 10.1038/nrurol.2017.144; Nash SH, 2015, CANCER EPIDEM BIOMAR, V24, P1507, DOI 10.1158/1055-9965.EPI-15-0394; Ngollo M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-994; Olokpa E, 2017, PPAR RES, V2017, DOI 10.1155/2017/9456020; Ozpolat B, 2008, APOPTOSIS, V13, P915, DOI 10.1007/s10495-008-0222-9; Pi FM, 2018, NAT NANOTECHNOL, V13, P82, DOI 10.1038/s41565-017-0012-z; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Qiu JHJ, 2010, BLOOD, V115, P643, DOI 10.1182/blood-2009-07-232652; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivera-Gonzalez GC, 2012, NUCLEIC ACIDS RES, V40, P4825, DOI 10.1093/nar/gks143; Sanda MG, 2017, JAMA ONCOL, V3, P1085, DOI 10.1001/jamaoncol.2017.0177; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Singal R, 2004, ONCOL REP, V12, P631; Singh PK, 2014, ONCOTARGET, V5, P824, DOI 10.18632/oncotarget.1776; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun JK, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-168; Tan SM, 2016, METHODS MOL BIOL, V1358, P211, DOI 10.1007/978-1-4939-3067-8_13; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thorne JL, 2011, NUCLEIC ACIDS RES, V39, P2045, DOI 10.1093/nar/gkq875; Thu KL, 2014, ONCOGENE, V33, P279, DOI 10.1038/onc.2012.595; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torrano V, 2016, NAT CELL BIOL, V18, P645, DOI 10.1038/ncb3357; Trump DL, 1997, CANCER CHEMOTH PHARM, V39, P349, DOI 10.1007/s002800050582; TRUMP DL, 1994, LEUKEMIA, V8, pS50; Tsai YC, 2017, CANCER LETT, V384, P1, DOI 10.1016/j.canlet.2016.10.014; Ulz P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12008; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Viennois E, 2012, MOL CELL ENDOCRINOL, V351, P129, DOI 10.1016/j.mce.2011.08.036; Wang BD, 2015, CLIN CANCER RES, V21, P4970, DOI 10.1158/1078-0432.CCR-14-1566; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wilde JJ, 2017, J NEUROSCI, V37, P2565, DOI 10.1523/JNEUROSCI.2121-16.2017; Zhang DX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10798; Zhang J, 2010, ONCOGENE, V29, P723, DOI 10.1038/onc.2009.373; Zhang K, 2017, GENE, V619, P10, DOI 10.1016/j.gene.2017.03.038; Zhang SS, 2012, CELL BIOCHEM FUNCT, V30, P623, DOI 10.1002/cbf.2922; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	93	25	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					421	444		10.1038/s41388-018-0450-6	http://dx.doi.org/10.1038/s41388-018-0450-6			24	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30120411	Green Published, hybrid			2022-12-26	WOS:000455851200009
J	Tang, CZ; Yang, JT; Liu, QH; Wang, YR; Wang, WS				Tang, Chao-Zhi; Yang, Jun-Tang; Liu, Qing-Hui; Wang, Ya-Ru; Wang, Wen-Sheng			Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-1 signaling pathway	FASEB JOURNAL			English	Article						synaptic transmission; hippocampal dentate gyrus; dendrite; cAMP; HPLC mass spectrometry	STRESS; METAANALYSIS; FIBULIN-2; RISK; ANTIDEPRESSANTS; PLASTICITY; BEHAVIORS; PROTECTS; DISEASE; MEMORY	Depression represents a condition characterized by cognitive deficits and neural dysfunction and has recently been correlated with microRNAs (miRs) and their respective target genes. The present study was conducted with the goal of investigating the expression of miR-192-5p and its target gene fibulin (Fbln)-2 in an attempt to evaluate their roles in the occurrence and progression of cognitive impairment and neural function in mice with chronic unpredictable mild stress (CUMS)-induced depression through regulation of the TGF-1 signal transduction pathway. Verification of the targeting relationship between miR-192-5p and Fbln2 was provided in the form of initial bioinformatics prediction, followed by a further verification in the form of a dual-luciferase reporter gene assay. Normal mice and models induced by CUMS were assigned into various groups, whereas mimics, inhibitors, and small interfering RNA were introduced to validate the regulatory mechanism by which miR-192-5p regulates Fbln2 depression. Novel object recognition, tail suspension testing, and Morris water maze were all employed 28 d after transfection. Hippocampal electrophysiological recordings, Golgi staining, HPLC mass spectrometry, and fluorescence immunohistochemistry were performed to further evaluate cognitive function and neuron regeneration. CUMS-induced depression was determined to represent a predisposing factor for cognitive impairment and damage to neural function in mice, highlighted by novel object recognition, learning and memory abilities, population spike amplitude, synaptic transmission, cAMP levels, neuronal regeneration, and increased behavioral changes that resemble depression. Furthermore, increased Fbln2 expression, an activated TGF-1 signaling pathway, and decreased expression of miR-192-5p, synaptophysin, brain-derived neurotrophic factor, N-methyl-d-aspartate receptor subunit 2B, and calmodulin-dependent protein kinase II were noted. Up-regulated miR-192-5p targeting Fbln2 acts to alleviate CUMS-induced depression by inhibiting the TGF-1 signaling pathway, resulting in the enhanced cognitive function in novel object recognition, learning and memory ability, population spike amplitude, synaptic transmission, neuron regeneration, and alleviation of behavioral symptoms. The central findings of the present study indicate that up-regulated levels of miR-192-5p expression act to suppress activation of the TGF-1 signaling pathway by means of binding to Fbln2, thereby ameliorating cognitive impairment and strengthening neural function in a mouse model of depression.Tang, C.-Z., Yang, J.-T., Liu, Q.-H., Wang, Y.-R., Wang, W.-S. Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-1 signaling pathway.	[Tang, Chao-Zhi; Yang, Jun-Tang; Liu, Qing-Hui; Wang, Ya-Ru; Wang, Wen-Sheng] Henan Normal Univ, Coll Life Sci, Lab Mol Med, 46 Jianshe East Rd, Xinxiang 453007, Henan, Peoples R China	Henan Normal University	Wang, WS (corresponding author), Henan Normal Univ, Coll Life Sci, Lab Mol Med, 46 Jianshe East Rd, Xinxiang 453007, Henan, Peoples R China.	041128@htu.cn			Key Scientific and Technological Project of Henan Province [172102310053]; Doctoral Scientific Research Start-up Foundation of Henan Normal University [QD17150]; Natural Science Foundation of Henan Province [162300410217]	Key Scientific and Technological Project of Henan Province; Doctoral Scientific Research Start-up Foundation of Henan Normal University; Natural Science Foundation of Henan Province	The authors thank the reviewers for helpful comments on the manuscript. The work was supported by Key Scientific and Technological Project of Henan Province Grant 172102310053; Doctoral Scientific Research Start-up Foundation of Henan Normal University Grant QD17150; and Natural Science Foundation of Henan Province Grant 162300410217. The authors declare no conflicts of interest.	Amin ND, 2015, SCIENCE, V350, P1525, DOI 10.1126/science.aad2509; Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Bonetti L, 2017, CLIN NEUROPHYSIOL, V128, P1923, DOI 10.1016/j.clinph.2017.07.004; Calero M Dolores, 2009, Rev Esp Geriatr Gerontol, V44, P323, DOI 10.1016/j.regg.2009.06.012; Cangemi C, 2014, ADV CLIN CHEM, V67, P245, DOI 10.1016/bs.acc.2014.09.008; Caraci F, 2012, EUR NEUROPSYCHOPHARM, V22, P281, DOI 10.1016/j.euroneuro.2011.08.006; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; COLLIN SP, 1989, VISION RES, V29, P765, DOI 10.1016/0042-6989(89)90089-8; Dai YT, 2010, J ETHNOPHARMACOL, V128, P482, DOI 10.1016/j.jep.2010.01.016; Radice PD, 2015, MOL CELL NEUROSCI, V67, P75, DOI 10.1016/j.mcn.2015.06.004; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Engel DF, 2018, NEUROCHEM RES, V43, P387, DOI 10.1007/s11064-017-2433-3; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Feinberg-Gorenshtein G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078713; Hodes GE, 2010, NEUROSCI LETT, V484, P12, DOI 10.1016/j.neulet.2010.07.084; Hong M, 2013, NEUROIMMUNOMODULAT, V20, P39, DOI 10.1159/000343100; Krattinger R, 2016, AM J PHYSIOL-GASTR L, V310, pG1044, DOI 10.1152/ajpgi.00297.2015; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Leonardi GC, 2012, INT J MOL MED, V30, P991, DOI 10.3892/ijmm.2012.1089; Li YC, 2017, APPL IMMUNOHISTO M M, V25, P251, DOI 10.1097/PAI.0000000000000296; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Moon S, 2017, ONCOTARGET, V8, P35184, DOI 10.18632/oncotarget.17059; Nguyen HT, 2017, HUM MOL GENET, V26, P3797, DOI 10.1093/hmg/ddx264; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Ossowska G, 2004, POL J PHARMACOL, V56, P305; Peng WF, 2016, EPILEPSY RES, V119, P77, DOI 10.1016/j.eplepsyres.2015.09.013; Pennisi M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8154969; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Trebaticka J, 2017, PHYSIOL RES, V66, P363, DOI 10.33549/physiolres.933430; Tsuda T, 2012, J MOL CELL CARDIOL, V52, P273, DOI 10.1016/j.yjmcc.2011.11.001; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P371, DOI 10.1007/s002130050473; Wuwongse S, 2010, PROG NEUROBIOL, V91, P362, DOI 10.1016/j.pneurobio.2010.04.005; Zhang HX, 2014, CLIN SCI, V126, P275, DOI 10.1042/CS20120636; Zhang HY, 2015, J ZHEJIANG UNIV-SC B, V16, P62, DOI 10.1631/jzus.B1400166; Zhang XC, 2018, BRAIN STRUCT FUNCT, V223, P749, DOI 10.1007/s00429-017-1521-0; Zhang YF, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21873; Zhao LX, 2013, NEURAL REGEN RES, V8, P2441, DOI 10.3969/j.issn.1673-5374.2013.26.005	50	22	28	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					606	618		10.1096/fj.201800210RR	http://dx.doi.org/10.1096/fj.201800210RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30118321				2022-12-26	WOS:000457401500047
J	Wong, LLL; Scott, DJ; Hossain, MA; Kaas, Q; Rosengren, KJ; Bathgate, RAD				Wong, Lilian L. L.; Scott, Daniel James; Hossain, Mohammed Akhter; Kaas, Quentin; Rosengren, K. Johan; Bathgate, Ross A. D.			Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						relaxin; G protein-coupled receptor (GPCR); site-directed mutagenesis; molecular modeling; molecular docking; relaxin-3; RXFP3	NUCLEUS INCERTUS; PHARMACOLOGICAL CHARACTERIZATION; MACACA-FASCICULARIS; CHIMERIC PEPTIDE; MESSENGER-RNA; FORCE-FIELD; CHAIN; GPCR142; BRAIN; LIGAND	The relaxin-3 neuropeptide activates the relaxin family peptide 3 (RXFP3) receptor to modulate stress, appetite, and cognition. RXFP3 shows promise as a target for treating neurological disorders, but realization of its clinical potential requires development of smaller RXFP3-specific drugs that can penetrate the blood-brain barrier. Designing such drugs is challenging and requires structural knowledge of agonist- and antagonist-binding modes. Here, we used structure-activity data for relaxin-3 and a peptide RXFP3 antagonist termed R3 B1-22R to guide receptor mutagenesis and develop models of their binding modes. RXFP3 residues were alanine-substituted individually and in combination and tested in cell-based binding and functional assays to refine models of agonist and antagonist binding to active- and inactive-state homology models of RXFP3, respectively. These models suggested that both agonists and antagonists interact with RXFP3 via similar residues in their B-chain central helix. The models further suggested that the B-chain Trp(27) inserts into the binding pocket of RXFP3 and interacts with Trp(138) and Lys(271), the latter through a salt bridge with the C-terminal carboxyl group of Trp(27) in relaxin-3. R3 B1-22R, which does not contain Trp(27), used a non-native Arg(23) residue to form cation-pi and salt-bridge interactions with Trp(138) and Glu(141) in RXFP3, explaining a key contribution of Arg(23) to affinity. Overall, relaxin-3 and R3 B1-22R appear to share similar binding residues but may differ in binding modes, leading to active and inactive RXFP3 conformational states, respectively. These mechanistic insights may assist structure-based drug design of smaller relaxin-3 mimetics to manage neurological disorders.	[Wong, Lilian L. L.; Scott, Daniel James; Hossain, Mohammed Akhter; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Scott, Daniel James; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Kaas, Quentin] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Rosengren, K. Johan] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Queensland; University of Queensland	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.; Rosengren, KJ (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	j.rosengren@uq.edu.au; bathgate@florey.edu.au	Bathgate, Ross/ABE-6471-2020; Rosengren, K. Johan/P-4450-2016; Kaas, Quentin/J-8727-2014; Scott, Daniel/B-9880-2017	Bathgate, Ross/0000-0001-6301-861X; Rosengren, K. Johan/0000-0002-5007-8434; Hossain, Mohammed/0000-0002-9961-0006; Wong, Lilian/0000-0001-9925-928X; Kaas, Quentin/0000-0001-9988-6152; Scott, Daniel/0000-0001-6332-2793	National Health and Medical Research Council (NHMRC) of Australia [1066369, 1065481]; Victorian Government Operational Infrastructure Support Program; Melbourne Research Scholarship (MRS); Melbourne International Fee Remission Scholarship (MIFRS); NHMRC Dementia Fellowship; Australian Research Council Future Fellowship; NHMRC Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; Melbourne Research Scholarship (MRS); Melbourne International Fee Remission Scholarship (MIFRS); NHMRC Dementia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Project Grants 1066369 and 1065481 (to R. A. D. B. and K. J. R.) and the Victorian Government Operational Infrastructure Support Program. K. J. R. and R. A. D. B. are inventors on Australian Patent 2010904046 and United States patent application 13/821726, Modified Relaxin B Chain Peptides.; Supported by the Melbourne Research Scholarship (MRS) and Melbourne International Fee Remission Scholarship (MIFRS).; Supported by an NHMRC Dementia Fellowship.; Supported by an Australian Research Council Future Fellowship.; Supported by an NHMRC Research Fellowship.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Asada H, 2018, NAT STRUCT MOL BIOL, V25, P570, DOI 10.1038/s41594-018-0079-8; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; BEDARKAR S, 1977, NATURE, V270, P449, DOI 10.1038/270449a0; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Case D. A., 2018, AMBER 2019; Chen JC, 2005, J PHARMACOL EXP THER, V312, P83, DOI 10.1124/jpet.104.073486; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Donizetti A, 2009, DEV GROWTH DIFFER, V51, P715, DOI 10.1111/j.1440-169X.2009.01131.x; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Haugaard-Kedstrom LM, 2015, AMINO ACIDS, V47, P1267, DOI 10.1007/s00726-015-1961-x; Haugaard-Kedstrom LM, 2018, J BIOL CHEM, V293, P15765, DOI 10.1074/jbc.RA118.002611; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hojo K, 2016, J MED CHEM, V59, P7445, DOI 10.1021/acs.jmedchem.6b00265; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2009, CHEM BIOL DRUG DES, V73, P46, DOI 10.1111/j.1747-0285.2008.00756.x; Hu MJ, 2016, AMINO ACIDS, V48, P2227, DOI 10.1007/s00726-016-2260-x; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Jayakody T, 2016, PEPTIDES, V84, P44, DOI 10.1016/j.peptides.2016.08.001; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Ma SR, 2009, ANN NY ACAD SCI, V1160, P256, DOI 10.1111/j.1749-6632.2009.03954.x; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Matsumoto M, 2000, GENE, V248, P183, DOI 10.1016/S0378-1119(00)00123-2; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; McGowan BMC, 2009, ANN NY ACAD SCI, V1160, P250, DOI 10.1111/j.1749-6632.2008.03796.x; Patil NA, 2017, BRIT J PHARMACOL, V174, P950, DOI 10.1111/bph.13684; Rosengren KJ, 2009, ANN NY ACAD SCI, V1160, P20, DOI 10.1111/j.1749-6632.2009.03833.x; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Ryan PJ, 2013, P NATL ACAD SCI USA, V110, P20789, DOI 10.1073/pnas.1317807110; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shabanpoor F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082567; Shabanpoor F, 2012, J MED CHEM, V55, P1671, DOI 10.1021/jm201505p; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Stoddart LA, 2014, BRIT J PHARMACOL, V171, P3827, DOI 10.1111/bph.12739; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Wang XY, 2014, FEBS J, V281, P2927, DOI 10.1111/febs.12830; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Watanabe Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00050; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011; Zhang WJ, 2014, AMINO ACIDS, V46, P1393, DOI 10.1007/s00726-014-1705-3	59	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15777	15789		10.1074/jbc.RA118.002645	http://dx.doi.org/10.1074/jbc.RA118.002645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131340	hybrid, Green Published			2022-12-26	WOS:000447256000003
J	Gainey, SJ; Horn, GP; Towers, AE; Oelschlager, ML; Tir, VL; Drnevich, J; Fent, KW; Kerber, S; Smith, DL; Freund, GG				Gainey, Stephen J.; Horn, Gavin P.; Towers, Albert E.; Oelschlager, Maci L.; Tir, Vincent L.; Drnevich, Jenny; Fent, Kenneth W.; Kerber, Stephen; Smith, Denise L.; Freund, Gregory G.			Exposure to a firefighting overhaul environment without respiratory protection increases immune dysregulation and lung disease risk	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; CANCER INCIDENCE; US FIREFIGHTERS; ANALYSIS TOOLS; MOUSE MODEL; FIRES; SUPPRESSION; MORTALITY; EMERGENCY; IMPACT	Firefighting activities appear to increase the risk of acute and chronic lung disease, including malignancy. While self-contained breathing apparatuses (SCBA) mitigate exposures to inhalable asphyxiates and carcinogens, firefighters frequently remove SCBA during overhaul when the firegrounds appear clear of visible smoke. Using a mouse model of overhaul without airway protection, the impact of fireground environment exposure on lung gene expression was assessed to identify transcripts potentially critical to firefighter-related chronic pulmonary illnesses. Lung tissue was collected 2 hrs post-overhaul and evaluated via whole genome transcriptomics by RNA-seq. Although gas metering showed that the fireground overhaul levels of carbon monoxide (CO), carbon dioxide (CO2), hydrogen cyanine (HCN), hydrogen sulfide (H2S) and oxygen (O-2) were within NIOSH ceiling recommendations, 3852 lung genes were differentially expressed when mice exposed to overhaul were compared to mice on the fireground but outside the overhaul environment. Importantly, overhaul exposure was associated with an up/down-regulation of 86 genes with a fold change of 1.5 or greater (p<0.5) including the immunomodulatory-linked genes S100a8 and Tnfsf9 (downregulation) and the cancer-linked genes, Capn11 and Rorc (upregulation). Taken together these findings indicate that, without respiratory protection, exposure to the fireground overhaul environment is associated with transcriptional changes impacting proteins potentially related to inflammation-associated lung disease and cancer.	[Gainey, Stephen J.; Freund, Gregory G.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA; [Horn, Gavin P.; Smith, Denise L.] Illinois Fire Serv Inst, Champaign, IL USA; [Towers, Albert E.; Freund, Gregory G.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Oelschlager, Maci L.; Tir, Vincent L.; Freund, Gregory G.] Univ Illinois, Coll Med, Program Integrat Immunol & Behav, Dept Pathol, Urbana, IL 61801 USA; [Drnevich, Jenny] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA; [Fent, Kenneth W.] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA; [Kerber, Stephen] UL Firefighter Safety Res Inst, Columbia, MD USA; [Smith, Denise L.] Skidmore Coll, Dept Hlth & Human Physiol Sci, Saratoga Springs, NY 12866 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Skidmore College	Freund, GG (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.; Freund, GG (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.; Freund, GG (corresponding author), Univ Illinois, Coll Med, Program Integrat Immunol & Behav, Dept Pathol, Urbana, IL 61801 USA.	freund@illinois.edu	Kerber, Stephen/ABB-4530-2020	Towers, Albert/0000-0002-7038-1481; Horn, Gavin/0000-0002-4364-9673; Kerber, Stephen/0000-0002-4951-6927	Department of Homeland Security Fire Prevention and Safety [EMW-2013-FP-00766]	Department of Homeland Security Fire Prevention and Safety	This work was supported by the Department of Homeland Security Fire Prevention and Safety Grant #EMW-2013-FP-00766 to G.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CC, 2001, AM J IND MED, V40, P683, DOI 10.1002/ajim.10023; Baxter CS, 2014, J OCCUP ENVIRON HYG, V11, pD85, DOI 10.1080/15459624.2014.890286; Benjamini Y, 1995, J ROYAL STAT SOC B, V289, P300; Bolstad-Johnson DM, 2000, AIHAJ, V61, P636, DOI 10.1202/0002-8894(2000)061<0636:COFEDF>2.0.CO;2; Boorady LM, ASHDOWN SP EXPLORA 2; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Clayton GD, 1991, PATTYS IND HYGIENE T, V3th; Daniels RD, 2014, OCCUP ENVIRON MED, V71, P388, DOI 10.1136/oemed-2013-101662; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fent KW, 2017, J OCCUP ENVIRON HYG, V14, P801, DOI 10.1080/15459624.2017.1334904; Fent Kenneth W, 2015, J Occup Environ Hyg, V12, P404, DOI 10.1080/15459624.2015.1025135; Fent KW, 2014, ANN OCCUP HYG, V58, P830, DOI 10.1093/annhyg/meu036; Fritschi L, 2014, OCCUP ENVIRON MED, V71, P525, DOI 10.1136/oemed-2014-102230; GUIDOTTI TL, 1993, AM J IND MED, V23, P921, DOI 10.1002/ajim.4700230608; Haynes H. J. G, 2017, FIRE LOSS US 2016; Huang Y, 2001, TRENDS MOL MED; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Iacovelli S, 2015, BLOOD, V125, P1578, DOI 10.1182/blood-2014-07-587790; JANKOVIC J, 1991, ANN OCCUP HYG, V35, P581, DOI 10.1093/annhyg/35.6.581; Janz S, 1995, GENOMIC INSTABILITY, P373, DOI [10.1007/978-3-642-79275-5_43, DOI 10.1007/978-3-642-79275-5_43]; Jin Lv, 2014, Genomics Proteomics & Bioinformatics, V12, P210, DOI 10.1016/j.gpb.2014.10.002; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Keir JLA, 2017, ENVIRON SCI TECHNOL, V51, P12745, DOI 10.1021/acs.est.7b02850; Laitinen J, 2010, TOXICOL LETT, V192, P61, DOI 10.1016/j.toxlet.2009.06.864; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; LeMasters GK, 2006, J OCCUP ENVIRON MED, V48, P1189, DOI 10.1097/01.jom.0000246229.68697.90; Losi CG, 2005, J CLIN IMMUNOL, V25, P496, DOI 10.1007/s10875-005-5637-2; Lyon F, 2007, IARC WORK GROUP EV C; Olfe Jakob, 2010, BMC Physiology, V10, P2, DOI 10.1186/1472-6793-10-2; PURSER DA, 1984, ARCH ENVIRON HEALTH, V39, P394, DOI 10.1080/00039896.1984.10545871; Raimundo AM, 2009, FIRE SAFETY J, V44, P514, DOI 10.1016/j.firesaf.2008.10.007; Ribeiro FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022317; Ribeiro M, 2009, AM J IND MED, V52, P261, DOI 10.1002/ajim.20669; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sage PT, 2016, NAT IMMUNOL, V17, P1436, DOI 10.1038/ni.3578; SAMA SR, 1990, AM J IND MED, V18, P47; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Scannell CH, 1995, OCCUP MED, V10, P789; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; SHEPPARD D, 1986, AM J IND MED, V9, P333, DOI 10.1002/ajim.4700090404; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soteriades ES, 2011, CARDIOL REV, V19, P202, DOI 10.1097/CRD.0b013e318215c105; Su YJ, 2010, CHINESE MED J-PEKING, V123, P2215, DOI 10.3760/cma.j.issn.0366-6999.2010.16.011; Takahara T, 2016, CANCER SCI, V107, P1572, DOI 10.1111/cas.13057; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Towers AE, 2018, METHODS MOL BIOL, V1781, P221, DOI 10.1007/978-1-4939-7828-1_13; Walters KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062412; Wingfors H, 2018, ANN WORK EXPOS HEAL, V62, P221, DOI 10.1093/annweh/wxx097	53	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0201830	10.1371/journal.pone.0201830	http://dx.doi.org/10.1371/journal.pone.0201830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130361	Green Published, Green Submitted, gold			2022-12-26	WOS:000442284500006
J	Seo, SW; Park, SK; Oh, SJ; Shin, OS				Seo, Seong-Wook; Park, Seul-Ki; Oh, Soo-Jin; Shin, Ok Sarah			TLR4-mediated activation of the ERK pathway following UVA irradiation contributes to increased cytokine and MMP expression in senescent human dermal fibroblasts	PLOS ONE			English	Article							ULTRAVIOLET; SKIN; PHOSPHORYLATION; COLLAGENASE; RESPONSES; INSIGHTS; BIOLOGY; DAMAGE; CELLS	Exposure to ultraviolet (UV) radiation is a major contributing factor to premature aging (photoaging) and skin cancer. In vitro models of cellular senescence have proven to be very useful for the study of slow and progressive accumulation of damage resulting in the growth arrest of aging skin cells. In this study, we compared UVA-induced cellular responses in non-senescent (NS) vs. senescent (S) human dermal fibroblasts (HDFs). HDFs were irradiated with a single dose of UVA (7.5 J/cm(2)) and QuantSeq 3' mRNA sequencing was performed to assess differential gene expression. Both NS and S HDFs expressed similar numbers of differentially expressed genes, although distinct sets of genes were differentially expressed between the two groups. Higher expression of matrix metalloproteinases (MMPs) and Toll-like receptor (TLR) pathway genes, such as TLR4, MyD88, and CXCL-8, was detected in S HDFs as compared with NS HDFs, and UVA exposure led to a downregulation of collagen genes, such as COL8A2 and COL5A3. Consistent with gene expression profiling, enhanced IL-6 and IL-8 secretion was observed in S HDFs compared with NS HDFs, in response to UVA. Furthermore, we show that TLR4-mediated ERK pathway is responsible for the UVA-mediated mitochondrial dysfunction as well as increased secretion of MMP-1 and IL-8 in S HDFs. Taken together, our results demonstrate the UVA-induced common and distinct molecular patterns of cellular responses between NS and S HDFs and suggest TLR4/ERK pathways as candidate targets to reduce senescent phenotypes.	[Seo, Seong-Wook; Park, Seul-Ki; Oh, Soo-Jin; Shin, Ok Sarah] Korea Univ, Coll Med, Dept Biomed Sci, Guro Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Shin, OS (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Guro Hosp, Seoul, South Korea.	oshin@korea.ac.kr		Shin, Ok Sarah/0000-0002-3977-2492	AMOREPACIFIC Basic Research Foundation; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1C1B2006493]	AMOREPACIFIC Basic Research Foundation; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the AMOREPACIFIC Basic Research Foundation and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1C1B2006493).	Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Battie C, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12388; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gilchrest Barbara A, 2013, J Invest Dermatol, V133, pE2, DOI 10.1038/skinbio.2013.176; Harberts E, 2014, INNATE IMMUN-LONDON, V20, P529, DOI 10.1177/1753425913501706; Harberts E, 2013, J INVEST DERMATOL, V133, P296, DOI 10.1038/jid.2012.288; Hari A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/437246; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161767; Kim JA, 2017, J INVEST DERMATOL, V137, P2101, DOI 10.1016/j.jid.2017.03.041; Kim JA, 2016, IMMUNE NETW, V16, P286, DOI 10.4110/in.2016.16.5.286; Kim JA, 2015, ONCOTARGET, V6, P35324, DOI 10.18632/oncotarget.6117; Krutmann J, 2000, J DERMATOL SCI, V23, pS22, DOI 10.1016/S0923-1811(99)00077-8; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Matsumura Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD765, DOI 10.2741/matsumur; Pamela Moll MA, 2014, NATURE METHODS, V12; Park SK, 2017, EXP DERMATOL, V26, P889, DOI 10.1111/exd.13323; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16512; Passos JF, 2009, AGE, V31, P353, DOI 10.1007/s11357-009-9108-1; Purcell M, 2014, CELL CYCLE, V13, P3927, DOI 10.4161/15384101.2014.973327; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; SCHARFFETTER K, 1991, ARCH DERMATOL RES, V283, P506, DOI 10.1007/BF00371923; Schieke SM, 2005, J INVEST DERMATOL, V124, P857, DOI 10.1111/j.0022-202X.2005.23671.x; Toyooka T, 2011, J INVEST DERMATOL, V131, P1313, DOI 10.1038/jid.2011.28; Trejo-de la A, 2014, GENES IMMUN, V15, P199, DOI 10.1038/gene.2014.10; Varani J, 2001, AM J PATHOL, V158, P931, DOI 10.1016/S0002-9440(10)64040-0; Wang DL, 2016, ONCOTARGET, V7, P28286, DOI 10.18632/oncotarget.8536; Watanabe H, 2004, J BIOL CHEM, V279, P1676, DOI 10.1074/jbc.M303650200; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Yanase H, 2001, PIGM CELL RES, V14, P103, DOI 10.1034/j.1600-0749.2001.140205.x; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200	38	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202323	10.1371/journal.pone.0202323	http://dx.doi.org/10.1371/journal.pone.0202323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118525	Green Submitted, gold, Green Published			2022-12-26	WOS:000442282700021
J	Burr, LD; Rogers, GB; Chen, ACH; Taylor, SL; Bowler, SD; Keating, RL; Martin, ML; Hasnain, SZ; McGuckin, MA				Burr, Lucy D.; Rogers, Geraint B.; Chen, Alice C-H; Taylor, Steven L.; Bowler, Simon D.; Keating, Rebecca L.; Martin, Megan L.; Hasnain, Sumaira Z.; McGuckin, Michael A.			PPAR gamma is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CYSTIC FIBROSIS BRONCHIECTASIS; LONG-TERM; AUTOINDUCER; EXPRESSION; MOLECULES; MORTALITY; LACTONE; TRIAL	Background Chronic airway inflammation in conditions such as cystic fibrosis (CF) and non-CF bronchiectasis is characterised by a predominant neutrophilic inflammatory response, commonly due to the presence of pathogenic bacteria such as Pseudomonas aeruginosa. We hypothesised that down-regulation of the anti-inflammatory nuclear transcription regulator peroxisome proliferator-activated receptor gamma (PPAR gamma in non-CF bronchiectasis subjects may explain why this exuberant neutrophilic inflammation is able to persist unchecked in the inflamed airway. Methods PPAR gamma gene expression was assessed in bronchoalveolar lavage fluid (BAL) of 35 macro-lide naive non-CF bronchiectasis subjects and compared with that in 20 healthy controls. Human RNA was extracted from pelleted BAL and PPAR gamma expression was determined by reverse-transcription quantitative PCR. Bacterial DNA was extracted from paired induced sputum and total bacterial load was determined by 16S rRNA qPCR. Quantification of individual bacterial species was achieved by qPCR. Results PPAR gamma expression was lower in subjects with non-CF bronchiectasis compared with healthy control subjects (control: 1.00, IQR 0.55-1.44, n = 20 vs. Bronchiectasis: 0.49, IQR 0.12-0.89; n = 35; p<0.001, Mann-Whitney U test). This lower PPAR. expression correlated negatively with Pseudomonas aeruginosa (r = -0.53, n = 31; p = 0.002). No significant association was seen between PPAR gamma and total bacterial levels or levels Haemophilus influenzae. Conclusion PPAR gamma is expressed in low levels in the airways of non-CF bronchiectasis subjects, despite an aggressive inflammatory response. This low level PPAR gamma expression is particularly associated with the presence of high levels of P. aeruginosa, and may represent an intrinsic link with this bacterial pathogen.	[Burr, Lucy D.; Chen, Alice C-H; Hasnain, Sumaira Z.; McGuckin, Michael A.] Univ Queensland, Translat Res Inst, Immun Infect & Inflammat Program, Mater Res, Woolloongabba, Qld, Australia; [Burr, Lucy D.; Bowler, Simon D.; Keating, Rebecca L.; Martin, Megan L.] Mater Misericordiae Brisbane Ltd, Dept Resp Med, South Brisbane, Qld, Australia; [Rogers, Geraint B.; Taylor, Steven L.] Flinders Univ S Australia, Sch Med, SAHMRI Infect & Immun Theme, Adelaide, SA, Australia	Mater Research; University of Queensland; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Burr, LD (corresponding author), Univ Queensland, Translat Res Inst, Immun Infect & Inflammat Program, Mater Res, Woolloongabba, Qld, Australia.; Burr, LD (corresponding author), Mater Misericordiae Brisbane Ltd, Dept Resp Med, South Brisbane, Qld, Australia.	l.burr@uq.edu.au	Bowler, Simon/AAE-1630-2019; McGuckin, Michael/G-2310-2010; Rogers, Geraint/AAD-1011-2020; Taylor, Steven/AAD-7827-2019; Burr, Lucy/F-8296-2015; Hasnain, Sumaira/N-3412-2014	McGuckin, Michael/0000-0002-8375-2675; Taylor, Steven/0000-0003-4357-8243; Burr, Lucy/0000-0003-4010-3787; Hasnain, Sumaira/0000-0001-8577-8628	Matthew Flinders Research Fellowship; Mater Respiratory Research Trust Fund; Mater Foundation Betty McGrath Clinical Research Fellowship	Matthew Flinders Research Fellowship; Mater Respiratory Research Trust Fund; Mater Foundation Betty McGrath Clinical Research Fellowship	GR is supported by a Matthew Flinders Research Fellowship, and the study was funded by Mater Respiratory Research Trust Fund, Mater Foundation Betty McGrath Clinical Research Fellowship (LDB). The authors received no specific funding for this work, however Dr Lucy Burr, Dr Simon Bowler and Rebecca Keating are employed by Mater Misericordiae Health Services Ltd. This is a not-for-profit hospital and health services company. The funder provided support in the form of salaries for the authors listed above, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bedi B, 2017, FASEB J, V31, P3608, DOI 10.1096/fj.201700075R; Bedi B, 2016, INFECT IMMUN, V84, P1975, DOI 10.1128/IAI.00164-16; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Deng QC, 2016, INFECT IMMUN, V84, P56, DOI 10.1128/IAI.00945-15; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Griffin PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042241; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Lea S, 2014, EUR RESPIR J, V43, P409, DOI 10.1183/09031936.00187812; Lee SY, 2006, AM J PHYSIOL-LUNG C, V291, pL84, DOI 10.1152/ajplung.00388.2005; Liu DS, 2009, TOXICOLOGY, V260, P112, DOI 10.1016/j.tox.2009.03.016; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Pararasa C, 2016, AGING CELL, V15, P128, DOI 10.1111/acel.12416; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Takamura T, 2001, EUR J PHARMACOL, V422, P23, DOI 10.1016/S0014-2999(01)01053-6; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202296	10.1371/journal.pone.0202296	http://dx.doi.org/10.1371/journal.pone.0202296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114278	Green Published, gold			2022-12-26	WOS:000441850400055
J	Fleps, I; Enns-Bray, WS; Guy, P; Ferguson, SJ; Cripton, PA; Helgason, B				Fleps, Ingmar; Enns-Bray, William S.; Guy, Pierre; Ferguson, Stephen J.; Cripton, Peter A.; Helgason, Benedikt			On the internal reaction forces, energy absorption, and fracture in the hip during simulated sideways fall impact	PLOS ONE			English	Article							SOFT-TISSUE THICKNESS; FINITE-ELEMENT MODELS; PROXIMAL FEMUR; FEMORAL-NECK; PREDICTION; BONE; RISK; LOAD; SUBJECT; SPINE	The majority of hip fractures have been reported to occur as a result of a fall with impact to the greater trochanter of the femur. Recently, we developed a novel cadaveric pendulum-based hip impact model and tested two cadaveric femur-pelvis constructs, embedded in a soft tissue surrogate. The outcome was a femoral neck fracture in a male specimen while a female specimen had no fracture. The aim of the present study was, first, to develop a methodology for constructing and assessing the accuracy of explicit Finite Element Models (FEMs) for simulation of sideways falls to the hip based on the experimental model. Second, to use the FEMs for quantifying the internal reaction forces and energy absorption in the hip during impact. Third, to assess the potential of the FEMs in terms of separating a femoral fracture endpoint from a non-fracture endpoint. Using a non-linear, strain rate dependent, and heterogeneous material mapping strategy for bone tissue in these models, we found the FEM-derived results to closely match the experimental test results in terms of impact forces and displacements of pelvic video markers up to the time of peak impact force with errors below 10%. We found the internal reaction forces in the femoral neck on the impact side to be approximately 35% lower than the impact force measured between soft tissue and ground for both specimens. In addition, we found the soft tissue to be the component that absorbed the largest part of the energy of the tissue types in the hip region. Finally, we found surface strain patterns derived from FEM results to match the fracture location and extent based on post testing x-rays of the specimens. This is the first study with quantitative data on the energy absorption in the pelvic region during a sideways fall.	[Fleps, Ingmar; Enns-Bray, William S.; Ferguson, Stephen J.; Helgason, Benedikt] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Guy, Pierre] Univ British Columbia, Dept Orthopaed, Div Orthopaed Trauma, Vancouver, BC, Canada; [Cripton, Peter A.] Univ British Columbia, Dept Mech Engn & Orthopaed, Orthopaed & Injury Biomech Grp, Vancouver, BC, Canada; [Cripton, Peter A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada; [Helgason, Benedikt] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of British Columbia; University of British Columbia; University of British Columbia; Reykjavik University	Fleps, I (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	Ingmar.fleps@hest.ethz.ch	Helgason, Benedikt/A-4386-2012; Ferguson, Stephen J./A-4118-2012; Fleps, Ingmar/GRK-5653-2022; Cripton, Peter Alec/AAC-8268-2020	Ferguson, Stephen J./0000-0003-0650-5889; Fleps, Ingmar/0000-0002-6254-8878; Cripton, Peter Alec/0000-0002-5067-0833; Helgason, Benedikt/0000-0001-8324-2651	ETH-Foundation [ETH1514-1]; Swiss National Science Foundation [205321-144435]; University of British Columbia	ETH-Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of British Columbia	This work was funded by the ETH-Foundation (project ETH1514-1) and Swiss National Science Foundation (project 205321-144435) and internal funds at the University of British Columbia.	Ariza O, 2015, J BIOMECH, V48, P224, DOI 10.1016/j.jbiomech.2014.11.042; Bahaloo H, 2017, ANN BIOMEDICAL ENG; Beason DP, 2003, J BIOMECH, V36, P219, DOI 10.1016/S0021-9290(02)00330-5; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Burgin LV, 2014, MED ENG PHYS, V36, P226, DOI 10.1016/j.medengphy.2013.11.002; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; Choi WJ, 2015, OSTEOPOROSIS INT, V26, P291, DOI 10.1007/s00198-014-2812-4; Comley K, 2012, INT J IMPACT ENG, V46, P1, DOI 10.1016/j.ijimpeng.2011.12.009; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Derler S, 2005, MED ENG PHYS, V27, P475, DOI 10.1016/j.medengphy.2005.02.001; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Ekstrom W, 2009, INJURY, V40, P371, DOI 10.1016/j.injury.2008.09.010; Enns-Bray WS, 2018, J MECH BEHAV BIOMED, V78, P196, DOI 10.1016/j.jmbbm.2017.10.033; Fleps I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201096; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Hammer N, 2013, SPINE J, V13, P1321, DOI 10.1016/j.spinee.2013.03.050; Hansen U, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838032; HAYES WC, 1991, RADIOL CLIN N AM, V29, P1; Helgason B, 2016, MED ENG PHYS, V38, P679, DOI 10.1016/j.medengphy.2016.03.006; Hewitt J, 2001, J ORTHOPAED RES, V19, P359, DOI 10.1016/S0736-0266(00)00035-8; Koivumaki JEM, 2012, BONE, V50, P824, DOI 10.1016/j.bone.2012.01.012; Laing AC, 2010, J BIOMECH, V43, P1898, DOI 10.1016/j.jbiomech.2010.03.025; Li Z, 2007, J BIOMECH, V40, P2758, DOI 10.1016/j.jbiomech.2007.01.023; Luo Y, 2016, OSTEOPOROSIS INT, V27, P423, DOI 10.1007/s00198-015-3316-6; Luo YH, 2014, APPL MECH MATER, V446-447, P339, DOI 10.4028/www.scientific.net/AMM.446-447.339; Majumder Santanu, 2008, International Journal of Vehicle Safety, V3, P117, DOI 10.1504/IJVS.2008.022213; Majumder S, 2008, J BIOMECH, V41, P2834, DOI 10.1016/j.jbiomech.2008.07.001; Majumder S, 2013, CLIN BIOMECH, V28, P1034, DOI 10.1016/j.clinbiomech.2013.09.008; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Nawathe S, 2014, J BONE MINER RES, V29, P507, DOI 10.1002/jbmr.2033; Osnes EK, 2004, OSTEOPOROSIS INT, V15, P567, DOI 10.1007/s00198-003-1583-0; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; REIKERAS O, 1983, ACTA ORTHOP SCAND, V54, P18, DOI 10.3109/17453678308992864; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Robinovitch SN, 1997, ANN BIOMED ENG, V25, P499, DOI 10.1007/BF02684190; Robinovitch SN, 1995, J ORTHOPAED RES, V13, P956, DOI 10.1002/jor.1100130621; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Sarvi MN, 2017, OSTEOPOROSIS INT, V28, P2759, DOI 10.1007/s00198-017-4138-5; Sarvi MN, 2015, CLIN BIOMECH, V30, P881, DOI 10.1016/j.clinbiomech.2015.05.013; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; vandenKroonenberg AJ, 1996, J BIOMECH, V29, P807, DOI 10.1016/0021-9290(95)00134-4; VANDENKROONENBERG AJ, 1995, J BIOMECH ENG-T ASME, V117, P309, DOI 10.1115/1.2794186; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4	45	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0200952	10.1371/journal.pone.0200952	http://dx.doi.org/10.1371/journal.pone.0200952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114192	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400009
J	Safarova, D; Vavrouskova, K; Candresse, T; Navratil, M				Safarova, Dana; Vavrouskova, Karolina; Candresse, Thierry; Navratil, Milan			Molecular characterization of a novel Aureusvirus infecting elderberry (Sambucus nigra L.)	PLOS ONE			English	Article							LEAF-SPOT-VIRUS; SAP-TRANSMISSIBLE VIRUSES; LINE MOSAIC-VIRUS; LATENT-VIRUS; IDENTIFICATION; GENUS; GENERATION; SEQUENCE	A novel virus infecting elderberry was identified by high-throughput Illumina sequencing of double strand RNAs isolated form elderberry leaves. The complete genome sequence obtained (4512 nucleotides in length) shows an organization typical for aureusviruses, with five open reading frames (ORFs) and the typical ORF1-RT expression by the readthrough of an amber stop codon. The analysis of the RNA-dependent RNA polymerase (RdRp) and coat protein (CP) sequences showed the highest identity (respectively 75.7% and 55%) with the corresponding amino acid sequences of Pothos latent virus. These two values, below the species demarcation criteria for the genus, indicate that the detected virus is a new member of genus Aureusvirus, family Tombusviridae, with the proposed name Elderberry aureusvirus 1 (ElAV1). A survey confirmed the wide distribution of ElAV1 in elderberry in the Czech Republic. Phylogenetic analyses of RdRp and CP sequences showed distinct micro-evolution of geographically separated isolates, with a tendency for isolates coming from close localities or from the same region to cluster together but heterogeneity of viral populations down to a local scale was also observed. The symptomatology of the new virus is not fully clear, but many infected trees were either asymptomatic or showed mild chlorotic mosaics. More severe symptoms, potentially impacting yields of flowers or berries, were observed in plants with mixed infections of ElAV1 and other elderberry viruses. Further efforts are now needed to determine ElAV1 prevalence outside the Czech Republic and to unravel its epidemiology.	[Safarova, Dana; Vavrouskova, Karolina; Navratil, Milan] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic; [Candresse, Thierry] Univ Bordeaux, INRA, UMR Biol Fruit & Pathol 1332, Bordeaux, France	Palacky University Olomouc; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Safarova, D (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic.	dana.safarova@upol.cz		Candresse, Thierry/0000-0001-9757-1835	Ministry of Education, Youth and Sport (MEYS), Czech Republic [LD15048]; European Cooperation in Science and Technology (COST) Action [FA1407]; Internal Grant Agency (IGA) of Palacky University, Olomouc [PRF-2018-005]	Ministry of Education, Youth and Sport (MEYS), Czech Republic; European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); Internal Grant Agency (IGA) of Palacky University, Olomouc	This work was funded by Ministry of Education, Youth and Sport (MEYS), Czech Republic, grant number LD15048 - Application of next generation sequencing in study of fruit tree viromes, and by European Cooperation in Science and Technology (COST) Action FA1407 - Application of next generation sequencing for the study and diagnosis of plant viral diseases in agriculture (DIVAS), Short Term Scientific Mission (STSM) Grant, both obtained by Dana Safarova. The work was also supported by the Internal Grant Agency (IGA) of Palacky University, Olomouc, grant number PRF-2018-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson MD, 2002, J ECOL, V90, P895, DOI 10.1046/j.1365-2745.2002.00698.x; Bananej K, 2014, J PHYTOPATHOL, V162, P205, DOI 10.1111/jph.12178; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bertolini E, 2003, PHYTOPATHOLOGY, V93, P286, DOI 10.1094/PHYTO.2003.93.3.286; BLATTNY C., 1950, OCHRANA ROSTLIN, V23, P9; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Breck J., 1962, PLANT VIR P 5 C CZEC, P280; CAMPBELL RN, 1991, J GEN VIROL, V72, P3115, DOI 10.1099/0022-1317-72-12-3115; Charlebois D, 2007, ISSUES NEW CROPS NEW, P284; Chen YK, 2016, J PHYTOPATHOL, V164, P650, DOI 10.1111/jph.12488; Cooper J.I., 1993, VIRUS DIS TREES SHRU; Gentit P, 2001, ARCH VIROL, V146, P1453, DOI 10.1007/s007050170071; Hejny S, 2000, KVETENA CESKE REPUBL; Ho T, 2016, VIRUS RES, V215, P72, DOI 10.1016/j.virusres.2016.01.017; ICTV, 2015, 30 ICTV MSL; ICTV, 2016, 31 ICTV MSL; IZADPANAH K, 1993, J PHYTOPATHOL, V137, P105, DOI 10.1111/j.1439-0434.1993.tb01330.x; James D, 2001, PLANT DIS, V85, P47, DOI 10.1094/PDIS.2001.85.1.47; JONES AT, 1972, ANN APPL BIOL, V70, P49, DOI 10.1111/j.1744-7348.1972.tb04687.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalinowska E, 2013, PLANT DIS, V97, P1515, DOI 10.1094/PDIS-03-13-0277-PDN; Kumar PL, 2001, PLANT DIS, V85, P208, DOI 10.1094/PDIS.2001.85.2.208; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOUIE R, 1992, PLANT DIS, V76, P1069, DOI 10.1094/PD-76-1069; LOUIE R, 1982, PLANT DIS, V66, P167, DOI 10.1094/PD-66-167; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Martelli GP, 1998, ARCH VIROL, V143, P1847, DOI 10.1007/s007050050423; Menzel W, 2014, ARCH VIROL, V159, P603, DOI 10.1007/s00705-013-1845-x; MILICIC D, 1987, Acta Botanica Croatica, V46, P1; Murant AF, 1996, PLANT VIRUSES, P139; Pantaleo V., 2001, Journal of Plant Pathology, V83, P143; POLAK Z, 1990, ARCH PHYTOPATHOL PFL, V26, P389, DOI 10.1080/03235409009438995; Polak Z, 1988, OCHR ROST, V24, P5; Rosner A, 2006, ANN APPL BIOL, V149, P313, DOI 10.1111/j.1744-7348.2006.00096.x; RUBINO L, 1995, J GEN VIROL, V76, P2835, DOI 10.1099/0022-1317-76-11-2835; SABANADZOVIC S, 1995, EUR J PLANT PATHOL, V101, P171, DOI 10.1007/BF01874763; Safarova D, 2018, ARCH VIROL, V163, P567, DOI 10.1007/s00705-017-3629-1; Sanchez-Navarro JA, 2005, EUR J PLANT PATHOL, V111, P77, DOI 10.1007/s10658-004-1422-y; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; UYEMOTO JK, 1971, PLANT DIS REP, V55, P913; VALVERDE RA, 1986, PHYTOPATHOLOGY, V76, P459, DOI 10.1094/Phyto-76-459; VANLENT JWM, 1980, NETH J PLANT PATHOL, V86, P117, DOI 10.1007/BF01974340; Villamor DEV, 2016, PLANT DIS, V100, P867, DOI 10.1094/PDIS-10-15-1197-PDN; Xu ZeYong, 2000, Acta Phytopathologica Sinica, V30, P226; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0200506	10.1371/journal.pone.0200506	http://dx.doi.org/10.1371/journal.pone.0200506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114234	Green Published, gold			2022-12-26	WOS:000441850400005
J	Knuesting, J; Brinkmann, MC; Silva, B; Schorsch, M; Bendix, J; Beck, E; Scheibe, R				Knuesting, Johannes; Brinkmann, Marie Clara; Silva, Brenner; Schorsch, Michael; Bendix, Joerg; Beck, Erwin; Scheibe, Renate			Who will win where and why? An ecophysiological dissection of the competition between a tropical pasture grass and the invasive weed Bracken over an elevation range of 1000 m in the tropical Andes	PLOS ONE			English	Article							SOUTHERN ECUADOR; UV-B; PTERIDIUM-ARACHNOIDEUM; CONDENSED TANNINS; ALTITUDINAL VARIATION; MOUNTAIN ECOSYSTEM; FUNCTIONAL ROLES; ULTRAVIOLET-B; D2 PROTEIN; FLAVONOIDS	In tropical agriculture, the vigorously growing Bracken fern causes severe problems by invading pastures and out-competing the common pasture grasses. Due to infestation by that weed, pastures are abandoned after a few years, and as a fatal consequence, the biodiversity-rich tropical forest is progressively cleared for new grazing areas. Here we present a broad physiological comparison of the two plant species that are the main competitors on the pastures in the tropical Ecuadorian Andes, the planted forage grass Setaria sphacelata and the weed Bracken (Pteridium arachnoideum). With increasing elevation, the competitive power of Bracken increases as shown by satellite data of the study region. Using data obtained from field measurements, the annual biomass production of both plant species, as a measure of their competitive strength, was modeled over an elevational gradient from 1800 to 2800 m. The model shows that with increasing elevation, biomass production of the two species shifts in favor of Bracken which, above 1800 m, is capable of outgrowing the grass. In greenhouse experiments, the effects on plant growth of the presumed key variables of the elevational gradient, temperature and UV radiation, were separately analyzed. Low temperature, as well as UV irradiation, inhibited carbon uptake of the C4-grass more than that of the C3-plant Bracken. The less temperature-sensitive photosynthesis of Bracken and its effective protection from UV radiation contribute to the success of the weed on the highland pastures. In field samples of Bracken but not of Setaria, the content of flavonoids as UV-scavengers increased with the elevation. Combining modeling with measurements in greenhouse and field allowed to explain the invasive growth of a common weed in upland pastures. The performance of Setaria decreases with elevation due to suboptimal photosynthesis at lower temperatures and the inability to adapt its cellular UV screen.	[Knuesting, Johannes; Brinkmann, Marie Clara; Schorsch, Michael; Scheibe, Renate] Osnabrueck Univ, Fac Biol & Chem, Dept Plant Physiol, Osnabruck, Germany; [Silva, Brenner; Bendix, Joerg] Philipps Univ Marburg, Fac Geog, Lab Climatol & Remote Sensing, Marburg, Germany; [Beck, Erwin] Univ Bayreuth, BAYCEER, Fac Biol Chem & Geosci, Dept Plant Physiol, Bayreuth, Germany	University Osnabruck; Philipps University Marburg; University of Bayreuth	Scheibe, R (corresponding author), Osnabrueck Univ, Fac Biol & Chem, Dept Plant Physiol, Osnabruck, Germany.	scheibe@biologie.uni-osnabrueck.de		Scheibe, Renate/0000-0002-6140-6181	German Research Foundation in the scope of the Research Unit (RU) 816 (Biodiversity and Sustainable Management of a Megadiverse Mountain Ecosystem in South Ecuador)	German Research Foundation in the scope of the Research Unit (RU) 816 (Biodiversity and Sustainable Management of a Megadiverse Mountain Ecosystem in South Ecuador)	This work was funded by the German Research Foundation in the scope of the Research Unit (RU) 816 (Biodiversity and Sustainable Management of a Megadiverse Mountain Ecosystem in South Ecuador) to JB and EB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2011, COLLOID SURFACE A, V384, P254, DOI 10.1016/j.colsurfa.2011.03.064; Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Aguilar-Dorantes K, 2014, INVAS PLANT SCI MANA, V7, P580, DOI 10.1614/IPSM-D-13-00062.1; Alonso-Amelot ME, 2004, BIOCHEM SYST ECOL, V32, P969, DOI 10.1016/j.bse.2004.03.005; Alonso-Amelot ME, 2007, BIOCHEM SYST ECOL, V35, P1, DOI 10.1016/j.bse.2006.04.013; AlonsoAmelot ME, 1996, VEGETATIO, V125, P137, DOI 10.1007/BF00044647; Bakowska A, 2003, FOOD CHEM, V81, P349, DOI 10.1016/S0308-8146(02)00429-6; Baruch Z, 2005, OECOLOGIA, V145, P522, DOI 10.1007/s00442-005-0153-x; Beck E., 2008, V198, P371; BEDDOWS A. R., 1961, New Phytologist, V60, P312, DOI 10.1111/j.1469-8137.1961.tb06258.x; Bendix J, 2006, CLIMATE RES, V30, P133, DOI 10.3354/cr030133; Bendix J, 2008, GRADIENTS TROPICAL M, P371; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; BURGE MN, 1992, CRIT REV BIOTECHNOL, V12, P299, DOI 10.3109/07388559209040626; CABRERA S, 1995, J PHOTOCH PHOTOBIO B, V28, P137, DOI 10.1016/1011-1344(94)07103-U; Cabrol NA, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00019; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519, DOI 10.1071/PP9920519; Dai Y., 2004, NCARTN461STR, V186, DOI [10.5065/D6N877R0, DOI 10.5065/D6N877R0]; Der JP, 2009, AM J BOT, V96, P1041, DOI 10.3732/ajb.0800333; Douterlungne D, 2013, J APPL ECOL, V50, P1257, DOI 10.1111/1365-2664.12077; Emck P, 2008, J APPL METEOROL CLIM, V47, P2828, DOI 10.1175/2008JAMC1861.1; Fernandez GFC, 2013, INT J REMOTE SENS, V34, P7020, DOI 10.1080/01431161.2013.813091; Fernandez GFC, 2015, REMOTE SENS-BASEL, V7, P2509, DOI 10.3390/rs70302509; Fries A, 2014, METEOROL ATMOS PHYS, V126, P13, DOI 10.1007/s00703-014-0335-3; Fries A, 2012, AGR FOREST METEOROL, V152, P17, DOI 10.1016/j.agrformet.2011.08.004; Fries A, 2009, ERDKUNDE, V63, P321, DOI 10.3112/erdkunde.2009.04.03; FRISO G, 1994, FEBS LETT, V339, P217, DOI 10.1016/0014-5793(94)80419-2; Gerhardt KE, 2008, PHOTOCHEM PHOTOBIOL, V84, P1445, DOI 10.1111/j.1751-1097.2008.00362.x; GLIESSMAN SR, 1978, J CHEM ECOL, V4, P337, DOI 10.1007/BF00989342; Gottlicher D, 2009, INT J REMOTE SENS, V30, P1867, DOI 10.1080/01431160802541531; Grabber JH, 2013, J AGR FOOD CHEM, V61, P2669, DOI 10.1021/jf304158m; Hartig Katja, 2003, Ecotropica (Bonn), V9, P3; HOFSTRA JJ, 1977, ACTA BOT NEERL, V26, P63, DOI 10.1111/j.1438-8677.1977.tb01096.x; Homeier J., 2008, V198, P87; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Jacques W. A., 1974, Proceedings of the New Zealand Grassland Association, V35, P249; Jansen MAK, 1996, PLANT J, V9, P693, DOI 10.1046/j.1365-313X.1996.9050693.x; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kishore G, 2010, FOOD SCI BIOTECHNOL, V19, P1355, DOI 10.1007/s10068-010-0193-9; Knoke T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6612; Knuesting J, 2015, TABEBUIA B, V1, P16, DOI [10.5678/lcrs/pak823-825.cit.1412, DOI 10.5678/LCRS/PAK823-825.CIT.1412]; Kreft S, 2002, J EXP BOT, V53, P1801, DOI 10.1093/jxb/erf032; Kubien DS, 2004, PLANT CELL ENVIRON, V27, P1424, DOI 10.1111/j.1365-3040.2004.01246.x; Kurepa J, 2014, PLANT J, V77, P443, DOI 10.1111/tpj.12361; Lan W, 2016, PLANT PHYSIOL, V171, P810, DOI 10.1104/pp.16.02012; Lan W, 2015, PLANT PHYSIOL, V167, P1284, DOI 10.1104/pp.114.253757; LONG SP, 1983, PLANT CELL ENVIRON, V6, P345; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Mouradov A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00620; Murai Y, 2009, BIOCHEM SYST ECOL, V37, P378, DOI 10.1016/j.bse.2009.07.005; Nikolova Milena T., 2005, Acta Biologica Szegediensis, V49, P29; Ordonez MC, 2015, EUR J SOIL BIOL, V71, P28, DOI 10.1016/j.ejsobi.2015.10.001; PAGE CN, 1976, BOT J LINN SOC, V73, P1, DOI 10.1111/j.1095-8339.1976.tb02010.x; Pang YZ, 2008, P NATL ACAD SCI USA, V105, P14210, DOI 10.1073/pnas.0805954105; Peel GJ, 2007, NAT PROD COMMUN, V2, P1009; Peters T, 2013, ECOSYSTEM SERVICES B, V221, P19, DOI [10.1007/978-3-642-38137-9_2, DOI 10.1007/978-3-642-38137-9_2]; Piazena H, 1996, SOL ENERGY, V57, P133, DOI 10.1016/S0038-092X(96)00049-7; Ramsay PM, 2001, MT RES DEV, V21, P161, DOI 10.1659/0276-4741(2001)021[0161:AAOANP]2.0.CO;2; Rieger G, 2008, J AGR FOOD CHEM, V56, P9080, DOI 10.1021/jf801104e; Rollenbeck R, 2015, ECSF CLIMATE STATION, DOI [10.5678/LCRS/PAK823-825.DAT.1415, DOI 10.5678/LCRS/PAK823-825.DAT.1415]; Rollenbeck R, 2015, TIRO CLIMATE STATION; Roos K, 2011, WEED RES, V51, P165, DOI 10.1111/j.1365-3180.2010.00833.x; Roos K., 2013, ECOSYSTEM SERVICES B, P205; Roos K, 2010, INVAS PLANT SCI MANA, V3, P402, DOI 10.1614/IPSM-D-09-00031.1; RUSSELL JS, 1976, J AUST I AGR SCI, V42, P156; Ryan KG, 2002, PHYTOCHEMISTRY, V59, P23, DOI 10.1016/S0031-9422(01)00404-6; Ryan KG, 2001, Z NATURFORSCH C, V56, P745; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Silva B, 2014, IEEE J-STARS, V7, P3038, DOI 10.1109/JSTARS.2014.2321896; Silva B, 2012, ECOL MODEL, V239, P14, DOI 10.1016/j.ecolmodel.2012.01.016; Matos DMS, 2010, BRAZ J BIOL, V70, P311, DOI 10.1590/S1519-69842010000200012; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Thies B, 2014, J LAND USE SCI, V9, P1, DOI 10.1080/1747423X.2012.718378; Thomson JA, 2002, BOT J LINN SOC, V140, P237, DOI 10.1046/j.1095-8339.2002.00089.x; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; TRYON R, 1985, P ROY SOC EDINB B, V86, P353, DOI 10.1017/S0269727000008332; Wagemann J, 2015, ERDKUNDE, V69, P3, DOI 10.3112/erdkunde.2015.01.01; Watt T. A., 1978, Herbage Abstracts, V48, P195; Wilcke W., 2008, V198, P75	81	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202255	10.1371/journal.pone.0202255	http://dx.doi.org/10.1371/journal.pone.0202255			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102718	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200040
J	Bally, M; Nadeau, L; Brophy, JM				Bally, Michele; Nadeau, Lyne; Brophy, James M.			Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarction	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POSITIVE PREDICTIVE-VALUE; HEART-FAILURE; BLOOD-PRESSURE; VALIDATED METHODS; ALL-CAUSE; ASPIRIN; EVENTS; RISK; DIAGNOSIS	Purpose There are clinical trial data on risk of acute myocardial infarction (MI) with nonsteroidal antiinflammatory drugs (NSAIDs) in patients at increased cardiovascular (CV) risk requiring chronic daily treatment. This study investigated whether risks of acute MI with real-world prescription NSAIDs, such as low-dose or intermittent use, vary according to an individual's CV profile. Methods Nested case-control analyses were carried out on an administrative health cohort from Quebec, Canada by randomly selecting 10 controls per case matched on age +/- 1 year, sex, and month and year of cohort entry. We measured the additive joint effects on acute MI of current NSAID use and presence of hypertension, coronary heart disease (CHD), history of previous MI, or concomitant use of cardioprotective aspirin. The endpoint was the relative excess risk due to interaction (RERI). To verify the robustness of interaction findings, we performed sensitivity analyses with varying specifications of NSAID exposure-related variables. Results The cohort consisted of 233 816 elderly individuals, including 21 256 acute MI cases. For hypertension, CHD, and previous MI, we identified additive interactions on MI risk with some but not all NSAIDs, which also depended on the definition of NSAID exposure. Hypertension was sub-additive with naproxen but not with the other NSAIDs. Celecoxib and CHD were sub-additive in the primary analysis only (modelling NSAID dose on index date or up to 7 days before-best-fitting base model) whereas celecoxib and rofecoxib were super-additive with a history of previous MI in the secondary analysis only (modelling NSAID use on index date). For cardioprotective aspirin we found no evidence for an additive interaction with any of the NSAIDs. Conclusions Alternative specifications of NSAID exposure concurred in finding that concomitant use of cardioprotective aspirin does not attenuate the risks of acute MI with NSAIDs. However we were unable to demonstrate consistent interactions between an individual's cardiovascular comorbidities and NSAID-associated acute MI. Our study highlights challenges of studying additive interactions in a healthcare database and underscores the need for sensitivity analyses.	[Bally, Michele] Univ Montreal Hosp, Dept Pharm, Montreal, PQ, Canada; [Bally, Michele] Univ Montreal Hosp, Res Ctr, Montreal, PQ, Canada; [Nadeau, Lyne; Brophy, James M.] McGill Univ, Hlth Ctr, Res Inst, Ctr Outcomes Res & Evaluat, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University	Bally, M (corresponding author), Univ Montreal Hosp, Dept Pharm, Montreal, PQ, Canada.; Bally, M (corresponding author), Univ Montreal Hosp, Res Ctr, Montreal, PQ, Canada.	michele.bally.chum@ssss.gouv.qc.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875; Bally, Michele/0000-0001-9587-7929; Nadeau, Lyne/0000-0003-0466-0260	Fonds de recherche du QueAbec - SanteA (FRQS)	Fonds de recherche du QueAbec - SanteA (FRQS)	JMB receives salary support from the Fonds de recherche du QueAbec - SanteA (FRQS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NS, 2006, ALIMENT PHARM THERAP, V24, P299, DOI 10.1111/j.1365-2036.2006.02985.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Health Information Management Association, 2009, COD PER VASC DIS PVD; Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Arnold JMO, 2006, CAN J CARDIOL, V22, P23, DOI 10.1016/S0828-282X(06)70237-9; Bally M, 2018, PHARMACOEPIDEM DR S, V27, P69, DOI 10.1002/pds.4358; Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Baron JA, 2008, LANCET, V372, P1756, DOI 10.1016/S0140-6736(08)61490-7; Beydoun MA, 2013, J AM GERIATR SOC, V61, P525, DOI 10.1111/jgs.12156; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brophy JM, 2007, HEART, V93, P189, DOI 10.1136/hrt.2006.089367; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Chan CC, 2009, J HYPERTENS, V27, P2332, DOI 10.1097/HJH.0b013e3283310dc9; Chang CH, 2010, STROKE, V41, P1884, DOI 10.1161/STROKEAHA.110.585828; Chu HT, 2011, EPIDEMIOLOGY, V22, P242, DOI 10.1097/EDE.0b013e318208750e; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Floyd CN, 2014, PHARMACOL THERAPEUT, V141, P69, DOI 10.1016/j.pharmthera.2013.08.005; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; GetReal, NEW METH RWE COLL SY; Gladding PA, 2008, AM J CARDIOL, V101, P1060, DOI 10.1016/j.amjcard.2007.11.054; Goltsov A, 2009, EUR J PHARM SCI, V36, P122, DOI 10.1016/j.ejps.2008.10.015; Gore M, 2011, CLIN THER, V33, P1914, DOI 10.1016/j.clinthera.2011.10.019; GREENLAND S, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431660; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S., 2008, MODERN EPIDEMIOLOGY; Greenland S, 2009, EPIDEMIOLOGY, V20, P14, DOI 10.1097/EDE.0b013e318193e7b5; Grosser T, 2017, TRENDS PHARMACOL SCI, V38, P733, DOI 10.1016/j.tips.2017.05.008; Hall AJ, 2016, EUR J PREV CARDIOL, V23, P938, DOI 10.1177/2047487315610663; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Hohlfeld T, 2015, CLIN PHARMACOL THER, V97, P131, DOI 10.1002/cpt.21; Hudson M, 2007, ARTHRIT RHEUM-ARTHR, V57, P516, DOI 10.1002/art.22614; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kohli P, 2014, AM J MED, V127, P53, DOI 10.1016/j.amjmed.2013.08.017; Kurth T, 2003, CIRCULATION, V108, P1191, DOI 10.1161/01.CIR.0000087593.07533.9B; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; Langman M, 2001, PHARMACOEPIDEM DR S, V10, P517, DOI 10.1002/pds.653; Lee DS, 2004, AM J MED, V116, P581, DOI 10.1016/j.amjmed.2003.11.025; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Li XW, 2014, P NATL ACAD SCI USA, V111, P16830, DOI 10.1073/pnas.1406997111; Liu P, 2003, CAN J CARDIOL, V19, P347; Ljungman C, 2017, BLOOD PRESSURE, V26, P220, DOI 10.1080/08037051.2017.1290503; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Meek IL, 2013, EUR J CLIN PHARMACOL, V69, P365, DOI 10.1007/s00228-012-1370-y; Meisinger C, 2006, EUR HEART J, V27, P1245, DOI 10.1093/eurheartj/ehi880; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Patrono C, 2017, CLIN PHARMACOL THER, V102, P238, DOI 10.1002/cpt.696; Pignone M, 2010, J AM COLL CARDIOL, V55, P2878, DOI 10.1016/j.jacc.2010.04.003; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; Renda G, 2006, CLIN PHARMACOL THER, V80, P264, DOI 10.1016/j.clpt.2006.05.004; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ross JS, 2009, ARCH INTERN MED, V169, P1976, DOI 10.1001/archinternmed.2009.394; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Sauer BC, 2013, PHARMACOEPIDEM DR S, V22, P1139, DOI 10.1002/pds.3506; Saxena A, 2013, EUR J PHARMACOL, V721, P215, DOI 10.1016/j.ejphar.2013.09.032; Scarpignato C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0285-8; Schmidt AF, 2014, J CLIN EPIDEMIOL, V67, P821, DOI 10.1016/j.jclinepi.2014.02.008; Schuijt MP, 2009, BRIT J PHARMACOL, V157, P931, DOI 10.1111/j.1476-5381.2009.00243.x; Schwartz S, 2006, GENES BEHAV SOCIAL E, P310; Shau WY, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-4; Solomon DH, 2008, ARTHRIT RHEUM-ARTHR, V59, P1097, DOI 10.1002/art.23911; Stepensky D, 2015, EXPERT OPIN DRUG MET, V11, P41, DOI 10.1517/17425255.2014.971010; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Tavares R, 2011, J RHEUMATOL, V38, P2342, DOI 10.3899/jrheum.110249; VanderWeele T, 2015, EXPLANATION CAUSAL I, P249; VanderWeele TJ, 2015, EXPLANATION CAUSAL I, P320; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121; VanderWeele TJ, 2012, STAT MED, V31, P2552, DOI 10.1002/sim.4354; VanderWeele TJ, 2011, AM J EPIDEMIOL, V173, P1140, DOI 10.1093/aje/kwr009; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Wilchesky M, 2004, J CLIN EPIDEMIOL, V57, P131, DOI 10.1016/S0895-4356(03)00246-4	78	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201884	10.1371/journal.pone.0201884	http://dx.doi.org/10.1371/journal.pone.0201884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096158	Green Submitted, Green Published, gold			2022-12-26	WOS:000441308500032
J	Czernekova, M; Janelt, K; Student, S; Jonsson, KI; Poprawa, I				Czernekova, Michaela; Janelt, Kamil; Student, Sebastian; Jonsson, K. Ingemar; Poprawa, Izabela			A comparative ultrastructure study of storage cells in the eutardigrade Richtersius coronifer in the hydrated state and after desiccation and heating stress	PLOS ONE			English	Article							TERM ANHYDROBIOTIC SURVIVAL; PROTEIN DENATURATION; MIDGUT EPITHELIUM; TARDIGRADES; CRYPTOBIOSIS; TEMPERATURE; CELOMOCYTES; ORGANELLES; MORPHOLOGY; NEMATODES	Tardigrades represent an invertebrate phylum with no circulatory or respiratory system. Their body cavity is filled with free storage cells of the coelomocyte-type, which are responsible for important physiological functions. We report a study comparing the ultrastructure of storage cells in anhydrobiotic and hydrated specimens of the eutardigrade Richtersius coronifer. We also analysed the effect of temperature stress on storage cell structure. Firstly, we verified two types of ultrastructurally different storage cells, which differ in cellular organelle complexity, amount and content of reserve material and connection to oogenetic stage. Type I cells were found to differ ultrastructurally depending on the oogenetic stage of the animal. The main function of these cells is energy storage. Storage cells of Type I were also observed in the single male that was found among the analysed specimens. The second cell type, Type II, found only in females, represents young undifferentiated cells, possibly stem cells. The two types of cells also differ with respect to the presence of nucleolar vacuoles, which are related to oogenetic stages and to changes in nucleolic activity during oogenesis. Secondly, this study revealed that storage cells are not ultrastructurally affected by six months of desiccation or by heating following this desiccation period. However, heating of the desiccated animals (tuns) tended to reduce animal survival, indicating that long-term desiccation makes these animals more vulnerable to heat stress. We confirmed the degradative pathways during the rehydration process after desiccation and heat stress. Our study is the first to document two ultrastructurally different types of storage cells in tardigrades and reveals new perspectives for further studies of tardigrade storage cells.	[Czernekova, Michaela; Jonsson, K. Ingemar] Kristianstad Univ, Dept Environm Sci & Biosci, Kristianstad, Sweden; [Czernekova, Michaela] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Czernekova, Michaela] Charles Univ Prague, Fac Med, Prague, Czech Republic; [Janelt, Kamil; Poprawa, Izabela] Univ Silesia Katowice, Dept Anim Histol & Embryol, Katowice, Poland; [Student, Sebastian] Silesian Tech Univ, Inst Automat Control, Gliwice, Poland	Kristianstad University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; University of Silesia in Katowice; Silesian University of Technology	Czernekova, M (corresponding author), Kristianstad Univ, Dept Environm Sci & Biosci, Kristianstad, Sweden.; Czernekova, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.; Czernekova, M (corresponding author), Charles Univ Prague, Fac Med, Prague, Czech Republic.; Poprawa, I (corresponding author), Univ Silesia Katowice, Dept Anim Histol & Embryol, Katowice, Poland.	CzernekovaM@seznam.cz; izabela.poprawa@us.edu.pl	Student, Sebastian/H-7895-2013	Student, Sebastian/0000-0003-1812-5496; Poprawa, Izabela/0000-0002-8930-1592; Janelt, Kamil/0000-0002-2193-5433; Czernekova, Michaela/0000-0001-8201-9028	Academy of Sciences of the Czech Republic [RVO: 67985823]; Mobility Fund of Charles University in Prague (Czech Republic); Kristianstad University (Sweden); Kristianstad University, Sweden;  [POIG.02.01.00-00-166/08];  [POIG.02.03.01-24-099/13]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Mobility Fund of Charles University in Prague (Czech Republic); Kristianstad University (Sweden); Kristianstad University, Sweden; ; 	This work was supported by the Academy of Sciences of the Czech Republic (RVO: 67985823) (to MC), the Mobility Fund of Charles University in Prague (Czech Republic) (to MC), and the Kristianstad University (Sweden) (to KIJ). Microscopic analysis (confocal microscopy) was performed using the infrastructure that is supported by the POIG.02.01.00-00-166/08 (to IP) and POIG.02.03.01-24-099/13 grant (to IP).r This work was supported by the Academy of Sciences of the Czech Republic (RVO: 67985823), the Mobility Fund, Charles University in Prague, and the Kristianstad University, Sweden. Microscopic analysis (confocal microscopy) was performed using the infrastructure that is supported by the POIG.02.01.00-00-166/08 and POIG.02.03.01-24-099/13 grant.	Adamowicz A, 2005, TISSUE CELL, V37, P125, DOI 10.1016/j.tice.2004.11.002; Adamowicz Anna, 2001, Zoologica Poloniae, V46, P91; Balogh G, 2013, FEBS LETT, V587, P1970, DOI 10.1016/j.febslet.2013.05.016; Boothby TC, 2017, MOL CELL, V65, P975, DOI 10.1016/j.molcel.2017.02.018; Crowe JH, 1996, BBA-BIOMEMBRANES, V1280, P187, DOI 10.1016/0005-2736(95)00287-1; Czernekova M, 2017, PROTOPLASMA, V254, P1367, DOI 10.1007/s00709-016-1027-2; Czernekova M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164062; DASTYNCH H, 1985, Acta Zoologica Cracoviensia, V28, P169; DEMEURE Y, 1979, J NEMATOL, V11, P189; Dewel NA, 1993, MICROSCOPIC ANATOMY, V12, P143; EDDS KT, 1993, J INVERTEBR PATHOL, V61, P173, DOI 10.1006/jipa.1993.1031; Guidetti R, 2002, J ZOOL, V257, P181, DOI 10.1017/S095283690200078X; Halberg KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085091; Halim AS, 2015, MED SCI, V4, P2277; Hatti SS, 2013, INDIAN J APP RES, V3, P598; Hengherr S, 2008, J ZOOL, V275, P216, DOI 10.1111/j.1469-7998.2008.00427.x; HETZEL HR, 1965, BIOL BULL, V128, P102, DOI 10.2307/1539393; Hyra M, 2016, ZOOL J LINN SOC-LOND, V178, P897, DOI 10.1111/zoj.12467; Hyra M, 2016, ZOOL J LINN SOC-LOND, V178, P878, DOI 10.1111/zoj.12463; Jennane A, 2000, PROTOPLASMA, V210, P172, DOI 10.1007/BF01276857; JOHNSON JM, 1967, AM J BOT, V54, P189, DOI 10.2307/2440797; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2002, J EXP ZOOL, V293, P578, DOI 10.1002/jez.10186; Kasschau MR, 2007, ZOOLOGY, V110, P66, DOI 10.1016/j.zool.2006.07.002; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kinchin I. M., 1993, Quekett Journal of Microscopy, V37, P52; LEPOCK JR, 1993, J CELL BIOL, V122, P1267, DOI 10.1083/jcb.122.6.1267; Lewis WH, 1943, CANCER RES, V3, P531; Li XC, 2005, J THERM BIOL, V30, P443, DOI 10.1016/j.jtherbio.2005.05.003; LITWIN JA, 1985, PROG HISTOCHEM CYTOC, V16, P1; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Nelson DR, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P347, DOI 10.1016/B978-0-12-385026-3.00017-6; Neuman Y, 2006, PROG BIOPHYS MOL BIO, V92, P258, DOI 10.1016/j.pbiomolbio.2005.11.001; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Poprawa I, 2015, PROTOPLASMA, V252, P1019, DOI 10.1007/s00709-014-0737-6; Poprawa I, 2015, PROTOPLASMA, V252, P857, DOI 10.1007/s00709-014-0725-x; Poprawa I, 2015, MICRON, V70, P26, DOI 10.1016/j.micron.2014.11.008; Poprawa Izabela, 2006, Zoologica Poloniae, V51, P13; Rahm PG, 1921, Z ALLG PHYSL, V20, P1; Ramazzotti G., 1983, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V41, P1; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; RAMLOV H, 1992, CRYOBIOLOGY, V29, P125, DOI 10.1016/0011-2240(92)90012-Q; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rebecchi L, 2006, HYDROBIOLOGIA, V558, P23, DOI 10.1007/s10750-005-1415-7; Rebecchi L, 2003, INVERTEBR BIOL, V122, P19; Rebecchi L, 2009, J EXP BIOL, V212, P4033, DOI 10.1242/jeb.033266; Rebecchi L, 2009, J LIMNOL, V68, P64, DOI 10.4081/jlimnol.2009.64; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Reuner A, 2010, CURR ZOOL, V56, P259, DOI 10.1093/czoolo/56.2.259; Rost-Roszkowska MM, 2013, J LIMNOL, V72, P54, DOI 10.4081/jlimnol.2013.s1.e7; Rost-Roszkowska MM, 2011, PROTOPLASMA, V248, P405, DOI 10.1007/s00709-010-0186-9; Stepinski D, 2014, PROTOPLASMA, V251, P1285, DOI 10.1007/s00709-014-0648-6; SZYMANSKA B, 1994, ACTA BIOL CRACOV ZOO, V36, P41; Tahseen Qudsia, 2009, International Journal of Zoology, V2009, P1, DOI 10.1155/2009/218197; Tardigrada Bertolani R., 1983, REPROD BIOL INVERTEB, VI; WALZ B, 1979, PROTOPLASMA, V99, P19, DOI 10.1007/BF01274066; Weglarska B., 1957, Part first Zool Polon, V8, P315; WEGLARSKA B, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P445; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; WOMERSLEY C, 1981, COMP BIOCHEM PHYS B, V70, P669, DOI 10.1016/0305-0491(81)90001-8; WOMERSLEY C, 1982, J NEMATOL, V14, P145; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1992, BIOL REV, V67, P1, DOI 10.1111/j.1469-185X.1992.tb01657.x	67	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201430	10.1371/journal.pone.0201430	http://dx.doi.org/10.1371/journal.pone.0201430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096140	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500017
J	Fernandez-Martinez, E; Onieva-Zafra, MD; Parra-Fernandez, ML				Fernandez-Martinez, Elia; Dolores Onieva-Zafra, Maria; Laura Parra-Fernandez, Maria			Lifestyle and prevalence of dysmenorrhea among Spanish female university students	PLOS ONE			English	Article							RISK-FACTORS; MENSTRUAL PAIN; ENDOMETRIOSIS; MANAGEMENT; IMPACT; ADOLESCENTS; KNOWLEDGE; SEVERITY; SCHOOL; WOMEN	The aim of this study was to determine the prevalence of primary dysmenorrhea in a sample of Spanish university students, and to describe their menstrual characteristics, lifestyle habits and associated risk factors. This cross-sectional study was conducted with a total of 258 young female university students recruited from the Ciudad Real Faculty of Nursing, with a mean age of 20.63 +/- 3.32 years. An anonymous self-report questionnaire was used to collect data from students. This included sociodemographic characteristics, lifestyle habits, gynecological personal history and the severity of pain using the visual analogue scale. The statistical analysis of the data included calculation of the mean, percentages, chi-square analysis of the data and logistic regression. The prevalence of dysmenorrhea was of 74.8% (n=193) with a mean pain severity of 6.88 (+/- 1.71). Our results show that 38.3% of students described their menstrual pain as severe and 58% as moderate. The bivariate analysis showed statistically significant differences between students with and without dysmenorrhea: a higher proportion of women with dysmenorrhea had a greater duration of the menstruation flow (p=.003), a longer duration of the menstrual cycle (p=.046), were not using the oral contraceptive pill (p=.026) and had a family history of dysmenorrhea (p=.001). Backward step-wise binary logistic regression analysis using all the significant bivariate variables including lifestyle variables revealed the following risk factors: drinking cola drinks, duration of the menstrual flow, eating meat and having a first-degree relative affected by dysmenorrhea.	[Fernandez-Martinez, Elia; Dolores Onieva-Zafra, Maria; Laura Parra-Fernandez, Maria] Univ Castilla La Mancha, Fac Nursing, Dept Nursing Physiotherapy & Occupat Therapy, Ciudad Real, Spain	Universidad de Castilla-La Mancha	Onieva-Zafra, MD (corresponding author), Univ Castilla La Mancha, Fac Nursing, Dept Nursing Physiotherapy & Occupat Therapy, Ciudad Real, Spain.	mariadolores.onieva@uclm.es	fernandez, Maria Laura Parra/AAB-8154-2019; Fernández-Martínez, Elia/AAA-8634-2020	fernandez, Maria Laura Parra/0000-0001-9681-1737; Fernández-Martínez, Elia/0000-0002-7700-999X; Onieva-Zafra, Maria Dolores/0000-0002-1052-2182				Abu Helwa HA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0516-1; Aparicio-Soto M, 2016, FOOD FUNCT, V7, P4492, DOI [10.1039/C6FO01094F, 10.1039/c6fo01094f]; Balbi C, 2000, EUR J OBSTET GYN R B, V91, P143, DOI 10.1016/S0301-2115(99)00277-8; Barnard ND, 2000, OBSTET GYNECOL, V95, P245, DOI 10.1016/S0029-7844(99)00525-6; Bourdel N, 2015, HUM REPROD UPDATE, V21, P136, DOI 10.1093/humupd/dmu046; Chang SF, 2012, INT J NURS PRACT, V18, P117, DOI 10.1111/j.1440-172X.2012.02007.x; Chen CZ, 2000, ENVIRON HEALTH PERSP, V108, P1019, DOI 10.2307/3434952; Chia CF, 2013, HONG KONG MED J, V19, P222, DOI 10.12809/hkmj133807; Chung FF, 2005, J OCCUP HEALTH, V47, P149, DOI 10.1539/joh.47.149; De Sanctis V, 2015, PEDIATR ENDOCR REV P, V13, P512; DESANCTIS V, 2017, ACTA BIOMED, V87, P233; Downing J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-446; Farahmand M, 2017, J OBSTET GYNAECOL RE, V43, P1726, DOI 10.1111/jog.13439; Fisher C, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1119-8; Fjerbaek A, 2007, EUR J OBSTET GYN R B, V132, P140, DOI 10.1016/j.ejogrb.2006.12.006; Gambino CM, 2018, ENDOCR METAB IMMUNE, V18, P14, DOI 10.2174/1871530317666171114113822; Gebeyehu Minaleshewa Biruk, 2017, Int J Reprod Med, V2017, P3208276, DOI 10.1155/2017/3208276; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub2; Grandi Giovanni, 2012, J Pain Res, V5, P169, DOI 10.2147/JPR.S30602; Habibi N, 2015, PAIN MANAG NURS, V16, P855, DOI 10.1016/j.pmn.2015.07.001; Hailemeskel S, 2016, INT J WOMENS HEALTH, V8, P489, DOI 10.2147/IJWH.S112768; Harel Z, 2012, EXPERT OPIN PHARMACO, V13, P2157, DOI 10.1517/14656566.2012.725045; Ju H, 2014, TOB CONTROL, DOI [10.1136/tobaccocontrol-2014-051920, DOI 10.1136/T0BACC0C0NTR0L-2014-051920]; Ju H, 2014, EPIDEMIOL REV, V36, P104, DOI 10.1093/epirev/mxt009; Kamel DM, 2017, J PAIN RES, V10, P1079, DOI 10.2147/JPR.S132544; Midilli TS, 2015, HOLIST NURS PRACT, V29, P194, DOI 10.1097/HNP.0000000000000091; Nnoaham KE, 2012, FERTIL STERIL, V98, P702, DOI 10.1016/j.fertnstert.2012.05.035; Oh Chang-Mo, 2012, J Prev Med Public Health, V45, P227, DOI 10.3961/jpmph.2012.45.4.227; Omidvar S, 2012, CURR RES MED, V3, P8; Ortiz MI, 2010, EUR J OBSTET GYN R B, V152, P73, DOI 10.1016/j.ejogrb.2010.04.015; Ozerdogan N, 2009, INT J GYNECOL OBSTET, V107, P39, DOI 10.1016/j.ijgo.2009.05.010; PARAZZINI F, 1994, EPIDEMIOLOGY, V5, P469, DOI 10.1097/00001648-199407000-00016; Parazzini F, 2004, HUM REPROD, V19, P1755, DOI 10.1093/humrep/deh395; Potur DC, 2014, PAIN MANAG NURS, V15, P768, DOI 10.1016/j.pmn.2013.07.012; Prevalence D., 2015, PAIN MANAG NURS, V16, P534, DOI [10.1016/j.pmn.2014.10, DOI 10.1016/J.PMN.2014.10]; SILBERG JL, 1987, BEHAV GENET, V17, P363, DOI 10.1007/BF01068137; Subasinghe AK, 2016, AUST FAM PHYSICIAN, V45, P829; Tavallaee M, 2011, J OBSTET GYNAECOL RE, V37, P442, DOI 10.1111/j.1447-0756.2010.01362.x; Tomas-Rodriguez MI, 2017, J PEDIATR ADOL GYNEC, V30, P199, DOI 10.1016/j.jpag.2016.09.007; Ugur HG, 2017, AGING MENT HEALTH, V21, P1280, DOI 10.1080/13607863.2016.1222348; Unsal A, 2010, UPSALA J MED SCI, V115, P138, DOI 10.3109/03009730903457218; Wong CL, 2015, J NURS SCHOLARSHIP, V47, P219, DOI 10.1111/jnu.12134; Yasir S, J AYUB MED COLL ABBO, V26, P349	43	46	47	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201894	10.1371/journal.pone.0201894	http://dx.doi.org/10.1371/journal.pone.0201894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096156	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500034
J	Prim, DA; Mohamed, MA; Lane, BA; Poblete, K; Wierzbicki, MA; Lessner, SM; Shazly, T; Eberth, JF				Prim, David A.; Mohamed, A. Mohamed; Lane, Brooks A.; Poblete, Kelley; Wierzbicki, Mark A.; Lessner, Susan M.; Shazly, Tarek; Eberth, John F.			Comparative mechanics of diverse mammalian carotid arteries	PLOS ONE			English	Article							ELASTIC PROPERTIES; STENT PLACEMENT; RAT; GRAFTS; STRESS; GROWTH; MODEL; AORTA	The prevalence of diverse animal models as surrogates for human vascular pathologies necessitate a comprehensive understanding of the differences that exist between species. Comparative passive mechanics are presented here for the common carotid arteries taken from bovine, porcine, ovine, leporine, murine-rat, and murine-mouse specimens. Data is generated using a scalable biaxial mechanical testing device following consistent circumferential (pressure-diameter) and axial (force-length) testing protocols. The structural mechanical response of carotids under equivalent loading, quantified by the deformed inner radius, deformed wall thickness, lumen area compliance and axial force, varies significantly among species but generally follows allometric scaling. Conversely, descriptors of the local mechanical response within the deformed arterial wall, including mean circumferential stress, mid-wall circumferential stretch, and mean axial stress, are relatively consistent across species. Unlike the larger animals studied, the diameter distensibility curves of murine specimens are non-monotonic and have a significantly higher value at 100 mmHg. Taken together, our results provide baseline structural and mechanical information for carotid arteries across a broad range of common animal models.	[Prim, David A.; Lane, Brooks A.; Lessner, Susan M.; Shazly, Tarek; Eberth, John F.] Univ South Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA; [Mohamed, A. Mohamed] Univ Houston, Cullen Coll Engn, Biomed Engn Dept, Houston, TX USA; [Poblete, Kelley] Texas Womens Univ, Coll Hlth Sci, Phys Therapy Program, Houston, TX USA; [Wierzbicki, Mark A.] Texas A&M Univ, Dwight Look Coll Engn, Biomed Engn Dept, College Stn, TX USA; [Lessner, Susan M.; Eberth, John F.] Univ South Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Shazly, Tarek] Univ South Carolina, Mech Engn Dept, Coll Engn & Comp, Columbia, SC USA	University of South Carolina System; University of South Carolina Columbia; University of Houston System; University of Houston; Texas Womans University; Texas A&M University System; Texas A&M University College Station; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Eberth, JF (corresponding author), Univ South Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA.; Eberth, JF (corresponding author), Univ South Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	john.eberth@uscmed.sc.edu	Prim, David A/F-8055-2015	Prim, David A/0000-0003-0018-8800; Lessner, Susan/0000-0002-8409-5216; Lane, Brooks/0000-0001-6811-4686	National Institutes of Health (NIH) [P20GM103499, R21EB022131, R01HL133662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB022131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Institutes of Health (NIH) P20GM103499 (JFE, TS); National Institutes of Health (NIH) R21EB022131 (JFE); National Institutes of Health (NIH) R01HL133662 (JFE/SML); www.nih.gov.	Benrashid E, 2016, METHODS, V99, P13, DOI 10.1016/j.ymeth.2015.07.014; Bersi MR, 2014, ANN BIOMED ENG, V42, P1207, DOI 10.1007/s10439-014-0988-6; Blondel WCPM, 2001, IEEE T BIO-MED ENG, V48, P442, DOI 10.1109/10.915710; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Cardamone L, 2009, BIOMECH MODEL MECHAN, V8, P431, DOI 10.1007/s10237-008-0146-x; CHUONG CJ, 1983, J BIOMECH ENG-T ASME, V105, P268, DOI 10.1115/1.3138417; COX RH, 1978, AM J PHYSIOL, V234, pH280, DOI 10.1152/ajpheart.1978.234.3.H280; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Daugs A, 2017, ANN BIOMED ENG, V45, P2683, DOI 10.1007/s10439-017-1892-7; Dolan EB, 2017, J MECH BEHAV BIOMED, V71, P23, DOI 10.1016/j.jmbbm.2017.02.012; Eberth JF, 2011, J BIOMECH, V44, P2532, DOI 10.1016/j.jbiomech.2011.07.018; Eberth JF, 2009, ANN BIOMED ENG, V37, P1093, DOI 10.1007/s10439-009-9686-1; Eberth JF, 2010, AM J PHYSIOL-HEART C, V299, pH1875, DOI 10.1152/ajpheart.00872.2009; Eberth JF, 2009, J HYPERTENS, V27, P2010, DOI 10.1097/HJH.0b013e32832e8dc8; Fernandez-Friera L, 2015, CIRCULATION, V131, P2104, DOI 10.1161/CIRCULATIONAHA.114.014310; Flaherty ML, 2013, NEUROEPIDEMIOLOGY, V40, P36, DOI 10.1159/000341410; Gleason RL, 2004, J BIOMECH ENG-T ASME, V126, P787, DOI 10.1115/1.1824130; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; HOLT JP, 1981, AM J PHYSIOL, V241, pR100, DOI 10.1152/ajpregu.1981.241.1.R100; Kamenskiy AV, 2015, ACTA BIOMATER, V11, P304, DOI 10.1016/j.actbio.2014.09.050; Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112; Lawson J, 2014, J VASC SURG, V59, p32S, DOI 10.1016/j.jvs.2014.03.077; Levine HJ, 1997, J AM COLL CARDIOL, V30, P1104; Masson I, 2008, J BIOMECH, V41, P2618, DOI 10.1016/j.jbiomech.2008.06.022; MATSUMOTO T, 1994, J BIOMECH ENG-T ASME, V116, P278, DOI 10.1115/1.2895731; Meschia JF, 2017, MAYO CLIN PROC, V92, P1144, DOI 10.1016/j.mayocp.2017.02.020; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Paini A, 2007, STROKE, V38, P117, DOI 10.1161/01.STR.0000251796.38954.b2; Prim DA, 2016, J MECH BEHAV BIOMED, V54, P93, DOI 10.1016/j.jmbbm.2015.09.017; Rolland PH, 2004, EUR J VASC ENDOVASC, V28, P431, DOI 10.1016/j.ejvs.2004.06.018; Rolland PH, 1999, RADIOLOGY, V213, P229, DOI 10.1148/radiology.213.1.r99oc26229; Safar ME, 2000, STROKE, V31, P782, DOI 10.1161/01.STR.31.3.782; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Sheridan WS, 2012, J MECH BEHAV BIOMED, V8, P58, DOI 10.1016/j.jmbbm.2011.12.003; Sommer G, 2012, J MECH BEHAV BIOMED, V5, P116, DOI 10.1016/j.jmbbm.2011.08.013; Takamizawa K, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028988; VONMALTZAHN WW, 1981, J BIOMECH, V14, P389, DOI 10.1016/0021-9290(81)90056-7; VONMALTZAHN WW, 1984, J BIOMECH, V17, P839, DOI 10.1016/0021-9290(84)90142-8; Weinberg PD, 2007, J BIOMECH, V40, P1594, DOI 10.1016/j.jbiomech.2006.07.020; WEIZSACKER HW, 1983, J BIOMECH, V16, P703, DOI 10.1016/0021-9290(83)90080-5; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Westerhof N, 2005, BASIC SCI CARDIOLOGI; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; Zhou B, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4037949; Zhou B, 2016, ACTA BIOMATER, V45, P286, DOI 10.1016/j.actbio.2016.09.004; Zhou B, 2014, J MECH MED BIOL, V14, DOI 10.1142/S021951941450033X	46	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202123	10.1371/journal.pone.0202123	http://dx.doi.org/10.1371/journal.pone.0202123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096185	gold, Green Published, Green Submitted			2022-12-26	WOS:000441308500051
J	Sattar, A; Zakaria, Z; Abu, J; Aziz, SA; Gabriel, RP				Sattar, Abdul; Zakaria, Zunita; Abu, Jalila; Aziz, Saleha A.; Gabriel, Rojas-Ponce			Evaluation of six decontamination procedures for isolation of Mycobacterium avium complex from avian feces	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NONTUBERCULOUS MYCOBACTERIA; SUBSP PARATUBERCULOSIS; NALC-NAOH; TUBERCULOSIS; CULTURE; BOVIS; DIAGNOSIS; DIFFERENTIATION; IDENTIFICATION	Culture is considered the gold standard for definitive diagnosis of mycobacterial infections. However, consensus about the most suitable culture procedure for isolation of nontuberculous mycobacteria is lacking. The study compared the recoveries of mycobacteria after decontamination of spiked and fresh avian feces with 4% sodium hydroxide (NaOH), 12% sulfuric acid (H2SO4), or 1 % cetylperidinium chloride (CPC), with and without mixture of three antibiotics, namely vancomycin (VAN, 100 mu g/ml), nalidixic acid (NAL, 100 mu g/ml), and amphotericin B (AMB, 100 mu g/ml). The antibiotic mixture was referred to as VNA. Decontamination procedures were evaluated using two (n = 2) avian fecal samples spiked with 10(6),10(4), and 10(2) CFU/ml of Mycobacterium avium subsp. avium (ATCC 15769) and fresh avian feces (n = 42). M. avium subsp. avium was detected on the culture media from spiked samples (10(6) and 10(4) CFU/ml) decontaminated with NaOH, NaOH-VNA, H2SO4, and H2SO4 -VNA for 2-6 weeks. These bacteria were detected in 2-4 weeks when using CPC and CPC-VNA. M. avium subsp. avium cannot be isolated on culture media from spiked samples (10(2) CFU/ml) decontaminated with any decontaminating agent. Two mycobacterial isolates, namely, Mycobacterium terrae and M. engbaekii, were isolated from field samples decontaminated with NaOH and CPC-VNA. With regard to the contamination rate, the use of CPC-VNA showed lower contamination rates (5.5% and 19.0%) from spiked and field samples than those of the other methods (NaOH: 22.2% and 59.5%, NaOH-VNA: 16.7% and 21.4%, H2SO4:11.1% and 40.5%, H2SO4-VNA: 5.5% and 21.4%, and CPC: 66.7% and 50%). In conclusion, the decontamination of fecal samples following a two-step procedure with 1 % CPC and VNA can ensure high recovery rate of many mycobacteria with the lowest contamination in cultures.	[Sattar, Abdul; Zakaria, Zunita; Aziz, Saleha A.] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang, Malaysia; [Abu, Jalila] Univ Putra Malaysia, Fac Vet Med, Dept Clin Studies, Serdang, Malaysia; [Gabriel, Rojas-Ponce] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	Universiti Putra Malaysia; Universiti Putra Malaysia; University of Alberta	Zakaria, Z (corresponding author), Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang, Malaysia.	zunita@upm.edu.my	Zakaria, Zunita/AAF-5110-2020	Sattar, Abdul/0000-0002-8153-0075; Zakaria, Zunita/0000-0001-6574-0841	Universiti Putra Malaysia [9594500]	Universiti Putra Malaysia	This research work was funded by Universiti Putra Malaysia, research grant no 9594500.	Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Ambrosio SR, 2008, BRAZ J MICROBIOL, V39, P241, DOI 10.1590/S1517-83822008000200008; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BROOKS RW, 1984, CAN J MICROBIOL, V30, P1112, DOI 10.1139/m84-174; Buijtels PCA, 2005, J MICROBIOL METH, V62, P83, DOI 10.1016/j.mimet.2005.01.010; Chatterjee M, 2013, INDIAN J MED RES, V138, P541; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; CORNER LA, 1995, NEW ZEAL VET J, V43, P129, DOI 10.1080/00480169.1995.35871; Eifert OSJD, 2018, JOORNAL FOOD SAF, P1; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Gomathi Sekar, 2013, Indian Journal of Tuberculosis, V60, P223; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; HORSBURGH CR, 1989, AM REV RESPIR DIS, V139, P4, DOI 10.1164/ajrccm/139.1.4; Hoza AS, 2016, BMC RES NOTES, V9, P1; Issa MD, 2017, BRAZ J MICROBIOL, V48, P139, DOI [10.1016/j.bjm.2016.07.026, 10.1016/j.bjm.2016.07.076]; Jeong BH, 2013, TUBERC RESPIR DIS, V74, P187, DOI 10.4046/trd.2013.74.4.187; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kantor I. N., 1998, LAB SERVICES TUBERCU, VIII; Koirala J., 2017, MEDSCAPE REF, P1; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; MARIS P, 1995, REV SCI TECH OIE, V14, P47, DOI 10.20506/rst.14.1.829; Maugein J, 2005, EUR RESPIR J, V26, P1092, DOI 10.1183/09031936.05.00148604; MENDONCA AF, 1994, APPL ENVIRON MICROB, V60, P4009, DOI 10.1128/AEM.60.11.4009-4014.1994; Moravkova M, 2011, VET MED-CZECH, V56, P333, DOI 10.17221/1588-VETMED; Patino WLC, 2018, J WILDLIFE DIS, V54, P357, DOI 10.7589/2017-05-124; Payeur J.B., 2005, P 81CP 2005, P352; Peres RL, 2009, INT J TUBERC LUNG D, V13, P1572; Radomski N, 2010, APPL ENVIRON MICROB, V76, P3514, DOI 10.1128/AEM.02659-09; Reddacliff LA, 2003, VET MICROBIOL, V95, P271, DOI 10.1016/S0378-1135(03)00181-0; Saggese MD, 2010, J AVIAN MED SURG, V24, P263, DOI 10.1647/2008-009.1; Sekar G, 2014, INT J BACTERIOL, V2014, P1; Sharma A, 2014, INT J MED DENT SCI, V3, P257; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; Shitaye JE, 2008, VET MICROBIOL, V127, P155, DOI 10.1016/j.vetmic.2007.07.026; Silva AD, 2009, CAN VET J, V50, P841; SMITHWICK RW, 1975, J CLIN MICROBIOL, V1, P411, DOI 10.1128/JCM.1.5.411-413.1975; Svastova P, 2002, VET MED-CZECH, V47, P117, DOI 10.17221/5814-VETMED; Tell LA, 2003, AVIAN DIS, V47, P444, DOI 10.1637/0005-2086(2003)047[0444:DOAMCO]2.0.CO;2; Tell LA, 2001, REV SCI TECH OIE, V20, P180, DOI 10.20506/rst.20.1.1273; Thegerstrom J, 2008, EMERG INFECT DIS, V14, P661, DOI 10.3201/eid1404.060570; Thomson R, 2008, APPL ENVIRON MICROB, V74, P3094, DOI 10.1128/AEM.02009-07; Thornton CG, 1998, J CLIN MICROBIOL, V36, P3558, DOI 10.1128/JCM.36.12.3558-3566.1998; Tu HZ, 2003, ANN CLIN LAB SCI, V33, P179; Varley CD, 2017, EMERG INFECT DIS, V23, P533, DOI 10.3201/eid2303.161708; Whittington RJ, 2009, J CLIN MICROBIOL, V47, P614, DOI 10.1128/JCM.01986-08	47	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202034	10.1371/journal.pone.0202034	http://dx.doi.org/10.1371/journal.pone.0202034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096205	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000441308500041
J	Spunda, R; Hruby, J; Mericka, P; Mlcek, M; Pecha, O; Splith, K; Schmelzle, M; Krenzien, F; Lindner, J; Matia, I; Spacek, M				Spunda, Rudolf; Hruby, Jan; Mericka, Pavel; Mlcek, Mikulas; Pecha, Ondrej; Splith, Kathrin; Schmelzle, Moritz; Krenzien, Felix; Lindner, Jaroslav; Matia, Ivan; Spacek, Miroslav			Immunosuppressive protocols with tacrolimus after cryopreserved aortal allotransplantation in rats	PLOS ONE			English	Article							TRANSPLANT ARTERIOSCLEROSIS; ALLOGRAFT REPLACEMENT; ARTERIAL ALLOGRAFTS; CHRONIC REJECTION; GRAFT INFECTION; GROWTH-FACTOR; RECONSTRUCTION; CYCLOSPORINE; FK-506; CLOPIDOGREL	Objectives and design The aim of our study was to simulate in rats all aspects and techniques used in our new clinical program of cryopreserved alloarterial transplantation and investigate the influence of two immunosuppressive protocols with tacrolimus on acute rejection of these allografts. Materials and methods Cryopreserved abdominal aortic grafts were transplanted between Brown-Norway and Lewis rats. Tacrolimus (0.2 mg/kg daily) was administered from day 1 to day 30 (TAC1) or from day 7 to day 30 (TAC7), respectively. No immunosuppressed isogeneic (ISO) and allogeneic (ALO) rats combination served as control. Aortal wall infiltration by immunocompetent cells (MHC II+ cells of recipient origin) was studied on day 30 after transplantation. Flow cytometry was used for the analysis of day 30 sera for the presence of donor specific antiMHC class I and II antibodies. Results The aortal allografts in both immunosuppressed groups showed regular morphology of aortal wall with no depositions of immunoglobulin G on day 30. The adventitial infiltration of non-immunosuppressed aortal allografts by MHC class II positive cells of recipient origin was significantly higher (ALO 20.7 +/- 6.7 cells, P<0.001) compared to both immunosuppressed groups (TAC1 5.9 +/- 5.5 cells, TAC7 6.1 +/- 5.1 cells). Day 30 sera from the allogeneic non-immunosuppressed animals decreased significantly the binding of fluorescence labelled MHC class I (46.9 +/- 19.4%) and class II (65.8 +/- 11.9%) antibody to donors spleen cells compared with day 30 sera from both immunosuppressed groups (TAC1, anti-MHC class 1102.4 +/- 4.2%, p < 0.001, anti-MHC class II 102.6 +/- 6.0%), (TAC7, anti-MHC class I 79.9 +/- 3.3%, p < 0.001, anti-MHC class II 80.9 +/- 2.7%). Conclusion Both immunosuppressed protocols with tacrolimus (administration from day 1 or from day 7 following transplantation) were able to suppress acute cell- and antibody-mediated rejection of cryopreserved abdominal aortic allografts processed in accordance with our new standardized clinical protocol.	[Spunda, Rudolf; Hruby, Jan; Lindner, Jaroslav; Spacek, Miroslav] Charles Univ Prague, Dept Surg 2, Dept Cardiovasc Surg, Fac Med 1, Prague, Czech Republic; [Spunda, Rudolf; Hruby, Jan; Lindner, Jaroslav; Spacek, Miroslav] Gen Univ Hosp, Prague, Czech Republic; [Mericka, Pavel] Charles Univ Prague, Fac Med Hradec Kralove, Tissue Bank, Fac Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Mlcek, Mikulas] Charles Univ Prague, Fac Med 1, Inst Physiol, Prague, Czech Republic; [Pecha, Ondrej] Acad Sci Czech Republ, Technol Ctr, Prague, Czech Republic; [Splith, Kathrin; Schmelzle, Moritz; Krenzien, Felix] Charite Univ Med Berlin, Dept Surg, Campus Charite Mitte, Berlin, Germany; [Splith, Kathrin; Schmelzle, Moritz; Krenzien, Felix] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany; [Matia, Ivan] Hosp Hietzing, Dept Cardiovasc Surg, Vienna, Austria; [Matia, Ivan] Karl Landsteiner Inst Cardiovasc Res, Vienna, Austria	Charles University Prague; General University Hospital Prague; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; Czech Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hietzing Hospital	Spacek, M (corresponding author), Charles Univ Prague, Dept Surg 2, Dept Cardiovasc Surg, Fac Med 1, Prague, Czech Republic.; Spacek, M (corresponding author), Gen Univ Hosp, Prague, Czech Republic.	mirekspacek@seznam.cz	Špaček, MUDr./ABA-5193-2021; Lindner, Jaroslav/I-4599-2017; Spacek, Miroslav/I-4534-2017	Splith, Katrin/0000-0002-1841-1495; Lindner, Jaroslav/0000-0001-8432-4069; Spacek, Miroslav/0000-0001-8742-8330; Krenzien, Felix/0000-0003-0593-9917	1st Medical Faculty, Charles University in Prague [2017-260 372]	1st Medical Faculty, Charles University in Prague	Funded by 1st Medical Faculty, Charles University in Prague grant 2017-260 372 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec M, 2004, TRANSPL INT, V17, P647, DOI 10.1007/s00147-004-0764-x; Azuma N, 1999, J VASC SURG, V29, P694, DOI 10.1016/S0741-5214(99)70316-2; BAHNINI A, 1991, J VASC SURG, V14, P98, DOI 10.1016/0741-5214(91)90160-V; Balaz P, 2011, ODBERY ORGANU K TRAN; DAGAMA AD, 1994, J VASC SURG, V20, P271, DOI 10.1016/0741-5214(94)90016-7; Eckl S, 2010, TRANSPL INT, V23, P959, DOI 10.1111/j.1432-2277.2010.01072.x; Fellmer P, 2011, GEFASSCHIRURGIE, V16, P403, DOI 10.1007/s00772-011-0953-8; Freguin-Bouilland C, 2011, TRANSPLANTATION, V91, P35, DOI 10.1097/TP.0b013e3181fe12d6; GOTO T, 1991, TRANSPL P, V23, P2713; GREGORY CR, 1993, TRANSPLANTATION, V55, P1409, DOI 10.1097/00007890-199306000-00037; Harlander-Locke MP, 2014, J VASC SURG, V59, P669, DOI 10.1016/j.jvs.2013.09.009; Heim C, 2015, EUR J CARDIO-THORAC, V47, P180, DOI 10.1093/ejcts/ezu098; Hullett DA, 1996, TRANSPLANTATION, V62, P1842, DOI 10.1097/00007890-199612270-00028; Khanna AK, 2002, TRANSPLANTATION, V73, P1543, DOI 10.1097/00007890-200205270-00005; Kieffer E, 2004, J VASC SURG, V39, P1009, DOI 10.1016/j.jvs.2003.12.040; Kiji T, 2003, J VASC RES, V40, P132, DOI 10.1159/000070710; Konrad H, 2017, J CLIN CELL IMMUNOL, V8, P525; Lacha J, 2000, Transpl Int, V13 Suppl 1, pS565; LEMSTROM K, 1994, TRANSPLANT P, V26, P1727; Matia I, 2008, EUR J VASC ENDOVASC, V35, P353, DOI 10.1016/j.ejvs.2007.09.022; Matia I, 2010, Rozhl Chir, V89, P45; Matia I, 2007, TRANSPL INT, V20, P371, DOI 10.1111/j.1432-2277.2006.00446.x; Matia I, 2014, ANN TRANSPL, V19, P225, DOI 10.12659/AOT.889870; MENNANDER A, 1992, TRANSPLANT P, V24, P341; Mirelli M, 1999, EUR J VASC ENDOVASC, V18, P424, DOI 10.1053/ejvs.1999.0936; MURASE N, 1987, TRANSPLANT P, V19, P71; NALESNIK MA, 1987, TRANSPLANT P, V19, P89; Nikolova Z, 2000, TRANSPLANTATION, V69, P2525, DOI 10.1097/00007890-200006270-00010; Ouyang J, 2005, TRANSPLANTATION, V79, P1386, DOI 10.1097/01.TP.0000159144.08519.E2; Pupka A, 2011, EUR J VASC ENDOVASC, V41, P61, DOI 10.1016/j.ejvs.2010.10.005; SCHMITZRIXEN T, 1988, J VASC SURG, V7, P82, DOI 10.1067/mva.1988.avs0070082; Sebesta P, 2011, Rozhl Chir, V90, P4; Sebesta P, 2010, ANN VASC SURG, V24, p[953, e7]; Spacek M, 2018, CELL TISSUE BANK, V19, P437, DOI 10.1007/s10561-018-9691-4; Splith K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091212; Spunda R, 2016, EUR SURG, V48, pS166, DOI 10.1007/s10353-016-0401-9; Takeda Y, 1999, HYPERTENSION, V33, P130, DOI 10.1161/01.HYP.33.1.130; Tepperman E, 2010, CAN J SURG, V53, P57; TODD IAIN A. D., 1966, TRANSPLANTATION, V4, P123, DOI 10.1097/00007890-196603000-00001; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; VICKERY CM, 1965, NEW ENGL J MED, V272, P325, DOI 10.1056/NEJM196502182720701; WILLIAMS GM, 1975, SURGERY, V78, P694	43	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201984	10.1371/journal.pone.0201984	http://dx.doi.org/10.1371/journal.pone.0201984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092051	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600075
J	Colecchia, D; Dapporto, F; Tronnolone, S; Salvini, L; Chiariello, M				Colecchia, David; Dapporto, Francesca; Tronnolone, Serena; Salvini, Laura; Chiariello, Mario			MAPK15 is part of the ULK complex and controls its activity to regulate early phases of the autophagic process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; vesicles; trafficking; mitogen-activated protein kinase (MAPK); cell signaling	MAMMALIAN AUTOPHAGY; CELL-PROLIFERATION; C-JUN; KINASE; PROTEIN; PHOSPHORYLATION; CANCER; IDENTIFICATION; INHIBITION; PRINCIPLES	Autophagy, a pathway for bulk protein degradation and removal of damaged organelles, represents one of the major responses of cells to stress, thereby exerting a strict control on their correct functioning. Consequently, this process has been involved in the pathogenesis and therapeutic responses of several human diseases. Mitogen-activated protein (MAP) kinase 15 (MAPK15) is an atypical member of the MAP kinase family that recently emerged as a key modulator of autophagy and, through this, of cell transformation. Still, no information is available about signaling pathways mediating the effect of MAPK15 on this process, nor is it known which phase of autophagosome biogenesis is affected by this MAP kinase. Here, we demonstrate that MAPK15 stimulated 5-AMP-activated protein kinase-dependent activity of UNC-51-like kinase 1 (ULK1), the only protein kinase among the ATG-related proteins, toward downstream substrates and signaling intermediates. Importantly, MAPK15 directly interacted with the ULK1 complex and mediated ULK1 activation induced by starvation, a classical stimulus for the autophagic process. In turn, ULK1 and its highly homologous protein ULK2 are able to transduce MAPK15 signals stimulating early phases of autophagosomal biogenesis in a multikinase cascade that offers numerous potential targets for future therapeutic intervention in cancer and other autophagy-related human diseases.	[Colecchia, David; Chiariello, Mario] CNR, IFC, I-53100 Siena, Italy; [Colecchia, David; Dapporto, Francesca; Tronnolone, Serena; Chiariello, Mario] ISPRO, CRL, Unit Signal Transduct, I-53100 Siena, Italy; [Dapporto, Francesca] Univ Siena, I-53100 Siena, Italy; [Salvini, Laura] Toscana Life Sci Fdn, I-53100 Siena, Italy; [Colecchia, David] TargImmune Therapeut, Hochbergerstr 60c, CH-4057 Basel, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Siena	Chiariello, M (corresponding author), CNR, IFC, I-53100 Siena, Italy.; Chiariello, M (corresponding author), ISPRO, CRL, Unit Signal Transduct, I-53100 Siena, Italy.	mario.chiariello@cnr.it	Colecchia, David/AAS-8110-2021; Chiariello, Mario/O-3642-2014	Chiariello, Mario/0000-0001-8434-5177; Salvini, Laura/0000-0002-2923-8157	Regione Toscana, Istituto Toscano Tumori (ITT)	Regione Toscana, Istituto Toscano Tumori (ITT)	We acknowledge the support of Regione Toscana, Istituto Toscano Tumori (ITT). We thank Laura Tinti for technical assistance and instrumental support.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Cerone MA, 2011, CANCER RES, V71, P3328, DOI 10.1158/0008-5472.CAN-10-2734; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Colecchia D, 2018, AUTOPHAGY, V14, P930, DOI 10.1080/15548627.2017.1388475; Colecchia D, 2015, AUTOPHAGY, V11, P1790, DOI 10.1080/15548627.2015.1084454; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gan WJ, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0138-8; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Jin DH, 2015, ONCOTARGET, V6, P20190, DOI 10.18632/oncotarget.4171; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2014, AUTOPHAGY, V10, P185, DOI 10.4161/auto.27367; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Puente C, 2016, J BIOL CHEM, V291, P6026, DOI 10.1074/jbc.M115.689646; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rossi M, 2016, ONCOTARGET, V7, P20981, DOI 10.18632/oncotarget.8044; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Strambi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052011; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang B, 2017, CURR OPIN CELL BIOL, V45, P47, DOI 10.1016/j.ceb.2017.02.011; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhang L, 2018, J MED CHEM, V61, P6491, DOI 10.1021/acs.jmedchem.7b01684	44	9	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15962	15976		10.1074/jbc.RA118.002527	http://dx.doi.org/10.1074/jbc.RA118.002527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131341	hybrid, Green Published			2022-12-26	WOS:000447256000018
J	Wang, C; Ke, YP; Liu, SY; Pan, SR; Liu, ZY; Zhang, H; Fan, ZC; Zhou, CY; Liu, JC; Wang, F				Wang, Cong; Ke, Yuepeng; Liu, Shaoyou; Pan, Sharon; Liu, Ziying; Zhang, Hui; Fan, Zhichao; Zhou, Changyi; Liu, Junchen; Wang, Fen			Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-kappa B signaling in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor (FGF); prostate cancer; inflammation; NF-kappa B (NF-KB); tyrosine-protein kinase (tyrosine kinase); tumor promoter; tumor cell biology; receptor tyrosine kinase; mouse genetics; ectopic FGF signaling; tumor microenvironment	ANDROGEN RECEPTOR; ACTIVATION; KINASE; PATHWAYS; TAK1; ANGIOGENESIS; RESISTANCE; EXPRESSION; INVASION; ALPHA	Initiation of expression of fibroblast growth factor receptor 1 (FGFR1) concurrent with loss of FGFR2 expression is a well-documented event in the progression of prostate cancer (PCa). Although it is known that some FGFR isoforms confer advantages in cell proliferation and survival, the mechanism by which the subversion of different FGFR isoforms contributes to PCa progression is incompletely understood. Here, we report that fibroblast growth factor (FGF) promotes NF-kappa B signaling in PCa cells and that this increase is associated with FGFR1 expression. Disruption of FGFR1 kinase activity abrogated both FGF activity and NF-kappa B signaling in PCa cells. Of note, the three common signaling pathways downstream of FGFR1 kinase, extracellular signal-regulated kinase 1/2 (ERK1/2), phosphoinositide 3-kinase (PI3K/AKT), and phosphoinositide phospholipase C gamma(PLC gamma), were not required for FGF-mediated NF-kappa B signaling. Instead, transforming growth factor beta-activating kinase 1 (TAK1), a central regulator of the NF-kappa B pathway, was required for FGFR1 to stimulate NF-kappa B signaling. Moreover, we found that FGFR1 promotes NF-kappa B signaling in PCa cells by reducing TAK1 degradation and thereby supporting sustained NF-kappa B activation. Consistently, Fgfr1 ablation in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model reduced inflammation in the tumor microenvironment. In contrast, activation of the FGFR1 kinase in the juxtaposition of chemical-induced dimerization (CID) and kinase 1 (JOCK1) mouse model increased inflammation. As inflammation plays an important role in PCa initiation and progression, these findings suggest that ectopically expressed FGFR1 promotes PCa progression, at least in part, by increasing inflammation in the tumor microenvironment.	[Wang, Cong; Liu, Ziying; Fan, Zhichao] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China; [Wang, Cong; Ke, Yuepeng; Liu, Shaoyou; Liu, Ziying; Zhang, Hui; Zhou, Changyi; Liu, Junchen; Wang, Fen] Texas A&M Univ, Coll Med, Inst Biosci & Technol, College Stn, TX 77843 USA; [Liu, Shaoyou] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou 510000, Guangdong, Peoples R China; [Pan, Sharon] Seattle Childrens Hosp, Div Gastroenterol & Hepatol, Seattle, WA 98105 USA; [Zhang, Hui] South China Univ Technol, Affiliated Hosp 2, Guangzhou 510641, Guangdong, Peoples R China; [Zhou, Changyi] Jimei Univ, Coll Food & Bioengn, Xiamen 361021, Peoples R China	Wenzhou Medical University; Texas A&M University System; Texas A&M University College Station; Guangzhou Medical University; Seattle Children's Hospital; South China University of Technology; Jimei University	Wang, C (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China.; Wang, F (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA.	cwang@wmu.edu.cn; fwang@ibt.tamhsc.edu		Liu, Shaoyou/0000-0001-5544-1661; Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [CA96824, DE023106, TAMU1400302, CPRIT 110555]; National Natural Science Foundation of China [81101712, 31371470, 81270761]; Natural Science Foundation of Zhejiang Province of China [LY16H140004]; NATIONAL CANCER INSTITUTE [R01CA096824, R56CA096824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants CA96824, DE023106, TAMU1400302, and CPRIT 110555 (to F. W.); a gift from Agilent Technologies; National Natural Science Foundation of China Grants 81101712, 31371470, and 81270761; and Natural Science Foundation of Zhejiang Province of China Grant LY16H140004 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; AVTANDILOV GG, 1989, ARK PATOL, V51, P81; Bushdid PB, 2001, DEV BIOL, V237, P107, DOI 10.1006/dbio.2001.0356; Byrd VM, 1999, J IMMUNOL, V162, P5853; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Corn PG, 2013, CLIN CANCER RES, V19, P5856, DOI 10.1158/1078-0432.CCR-13-1550; Cui J, 2014, HUM VACC IMMUNOTHER, V10, P3270, DOI 10.4161/21645515.2014.979640; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Ebelt K, 2008, PROSTATE, V68, P1, DOI 10.1002/pros.20661; Fan YH, 2012, CELL SIGNAL, V24, P1381, DOI 10.1016/j.cellsig.2012.02.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Flati V, 2006, INT J IMMUNOPATH PH, V19, P761, DOI 10.1177/039463200601900406; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Gasparian AV, 2002, J CELL SCI, V115, P141; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirata Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010205; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Huang YQ, 2015, INT J BIOL SCI, V11, P948, DOI 10.7150/ijbs.12468; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JH, 2012, CLIN EXP METASTAS, V29, P165, DOI 10.1007/s10585-011-9439-z; Jin R, 2015, ONCOGENE, V34, P3700, DOI 10.1038/onc.2014.302; Kanaya S, 2013, BONE, V56, P398, DOI 10.1016/j.bone.2013.06.031; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Liu J, 2016, ONCOGENE, V35, P1750, DOI 10.1038/onc.2015.239; Liu MH, 2015, INT J CARDIOL, V185, P320, DOI 10.1016/j.ijcard.2015.03.165; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Salazar L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086470; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Strasner A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00128; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Vandermoere F, 2005, ONCOGENE, V24, P5482, DOI 10.1038/sj.onc.1208713; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Wang F, 1999, BIOCHEMISTRY-US, V38, P160, DOI 10.1021/bi981758m; Wang F., 2013, MOL ONCOLOGY CAUSES, P186; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910	51	27	28	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14839	14849		10.1074/jbc.RA118.002907	http://dx.doi.org/10.1074/jbc.RA118.002907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093411	hybrid, Green Published			2022-12-26	WOS:000446155000020
J	Tuller, J; Marquis, RJ; Andrade, SMM; Monteiro, AB; Feria, LDB				Tuller, Juliana; Marquis, Robert J.; Andrade, Samara M. M.; Monteiro, Angelo B.; Feria, Lucas D. B.			Trade-offs between growth, reproduction and defense in response to resource availability manipulations	PLOS ONE			English	Article							STRYPHNODENDRON-ADSTRINGENS; HERBIVORY; PLANTS; PATTERNS; TANNINS; TREE; METAANALYSIS; DEFOLIATION; ALLOCATION; FERTILIZER	The Brazilian Cerrado is one of the most endangered biomes in the world. We evaluated the sustainability of leaf harvest in one of the most important Cerrado tree species, Stryphnodendron adstringens. The bark of this tree is used as a source of medicinal tannin. Harvesting bark, however, often kills the tree. In a manipulative field experiment, we tested the hypothesis that harvesting leaves, which might serve as an alternative source of tannin, would be less detrimental for tree survival, growth, reproduction, and defense than harvesting bark. In a two-way crossed experimental design, we either clipped 100% of a plant's leaves or applied NPK fertilizer to the soil. Our predictions of the experimental outcomes were based on plant resource and defense theory. Growth was determined by total leaf dry mass production, reproduction by inflorescence and fruit production traits, and defense by total phenolics, hydrolyzable tannins, and condensed tannins. Fertilization had a marginally positive effect on total leaf dry mass. Defoliation had no effect on subsequent leaf production, and most importantly, no plants died as a result of defoliation. We found high tannin amounts in leaves of S. adstringens produced both prior to and subsequent to clipping, further suggesting that leaves could serve as a sustainable alternative source of tannin. After clipping, plants invested more in tannin production and less in reproduction. Our results suggest that leaf harvest may be more sustainable than harvesting of bark in S. adstringens. We suggest the need for further investigation of the medicinal properties of leaf tannins to formulate a viable sustainable management plan for the exploitation of this plant species.	[Tuller, Juliana; Andrade, Samara M. M.; Monteiro, Angelo B.; Feria, Lucas D. B.] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Lavras, MG, Brazil; [Tuller, Juliana; Marquis, Robert J.] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Tuller, Juliana; Marquis, Robert J.] Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA	Universidade Federal de Lavras; University of Missouri System; University of Missouri Saint Louis; University of Missouri System; University of Missouri Saint Louis	Tuller, J (corresponding author), Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Lavras, MG, Brazil.; Tuller, J (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.; Tuller, J (corresponding author), Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA.	julianatullerm@gmail.com	Del Bianco Faria, Lucas/I-1832-2013	Del Bianco Faria, Lucas/0000-0002-7230-800X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02588-14]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Minas Gerais Research Foundation (FAPEMIG) [APQ-02588-14]; Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES); Brazilian National Council for Scientific and Technological Development (CNPq); FAPEMIG; CNPq	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (APQ-02588-14 to L.F. and APQ-02588-14 to J.T.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. Tuller, A. Gontijo, B. Behrmann, B. Bret, B. Pedroso, L. Coley, D. Souza, I. Boratto, J. Pinto, J. Silva, L. Cortez, L. Maia, N. de Paulo, S. Benedet, S. Pierce, and T. Morales helped us in the field and with lab work. The Federal University of Lavras, the Graduate School in Applied Ecology, and the University of Missouri-St. Louis provided logistical support. The Minas Gerais Research Foundation (FAPEMIG) provided the financial support for this study (process APQ-02588-14) and a scholarship to J.T.; the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) granted a scholarship to J.T. and A.B.M., and the Brazilian National Council for Scientific and Technological Development (CNPq) to S.M.M.A. Lastly, L.D.B.F. thanks FAPEMIG and the CNPq for their financial support.	Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; BATESMITH EC, 1977, PHYTOCHEMISTRY, V16, P1421, DOI 10.1016/S0031-9422(00)88795-6; Borges Filho Henrique Cruvinel, 2003, Rev. Árvore, V27, P735, DOI 10.1590/S0100-67622003000500016; Boudet AM, 2007, PHYTOCHEMISTRY, V68, P2722, DOI 10.1016/j.phytochem.2007.06.012; BRIGGS MA, 1990, OECOLOGIA, V83, P32, DOI 10.1007/BF00324630; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Constabel CP, 2014, REC ADV POLYPHEN RES, V4, P115; Cornelissen TG, 2001, AUSTRAL ECOL, V26, P246, DOI 10.1046/j.1442-9993.2001.01109.x; Correa VS, 2012, GENET RESOUR CROP EV, V59, P1349, DOI 10.1007/s10722-011-9761-y; Correa VSC, 2007, THESIS; Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313; Danks HV, 2002, OIKOS, V99, P10, DOI 10.1034/j.1600-0706.2002.990102.x; Dostalek T, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw026; Elfalleh W., 2012, Journal of Medicinal Plants Research, V6, P4724, DOI 10.5897/JMPR11.995; Feitosa IS, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-64; Felfili Jeanine Maria, 1999, Revista Brasileira de Botanica, V22, P83, DOI 10.1590/S0100-84041999000100011; FELFILI JM, 1993, J TROP ECOL, V9, P277, DOI 10.1017/S0266467400007306; Forkner RE, 2004, ECOL ENTOMOL, V29, P174, DOI 10.1111/j.1365-2311.2004.0590.x; Godschalx AL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0719-2; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hetherington SE, 1998, J EXP BOT, V49, P1173, DOI 10.1093/jexbot/49.324.1173; HOLM S, 1979, SCAND J STAT, V6, P65; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Hussein MS, 2006, SCI HORTIC-AMSTERDAM, V108, P322, DOI 10.1016/j.scienta.2006.01.035; Kersch-Becker MF, 2012, ECOLOGY, V93, P9, DOI 10.1890/11-0756.1; Kestring D, 2009, J PLANT BIOL, V52, P569, DOI 10.1007/s12374-009-9073-3; Kindscher K., 2014, Ethnobotany Research and Applications, V12, P175; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Lattanzio V., 2006, Phytochemistry: advances in research, P23; Lemos M.R., 2009, THESIS; Lima JCS, 1998, PHYTOTHER RES, V12, P218, DOI 10.1002/(SICI)1099-1573(199805)12:3&lt;218::AID-PTR220&gt;3.0.CO;2-4; Marquis R. J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P301; Marquis RJ, 2001, J TROP ECOL, V17, P127, DOI 10.1017/S0266467401001080; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Meloni F, 2012, ENVIRON EXP BOT, V75, P268, DOI 10.1016/j.envexpbot.2011.07.010; Miatto RC, 2016, PLANT SOIL, V404, P13, DOI 10.1007/s11104-016-2796-2; Oliveira D. G., 2007, Revista de Ciencias Farmaceuticas Basica e Aplicada, V28, P165; Ortiz PL, 2003, PLANT BIOLOGY, V5, P592, DOI 10.1055/s-2003-44720; Puiatti Mario, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P169; R Development Core Team, 2016, R LANG ENV STAT COMP; Rubert-Nason KF, 2015, J CHEM ECOL, V41, P651, DOI 10.1007/s10886-015-0600-z; Santos-Filho PR, 2011, BRAZILIAN J PHARMACO, V21, P1000; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Soldati GT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364564; Sparovek G, 2007, INT J CLIMATOL, V27, P257, DOI 10.1002/joc.1384; Sperens U, 1997, ECOGRAPHY, V20, P521, DOI 10.1111/j.1600-0587.1997.tb00421.x; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; STREETER JG, 1985, PLANT PHYSIOL, V77, P325, DOI 10.1104/pp.77.2.325; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Wang LL, 2016, S AFR J BOT, V104, P47, DOI 10.1016/j.sajb.2015.11.007; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868	57	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201873	10.1371/journal.pone.0201873	http://dx.doi.org/10.1371/journal.pone.0201873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133458	Green Published, gold			2022-12-26	WOS:000442500400043
J	Aras, O; Pearce, G; Watkins, AJ; Nurili, F; Medine, EI; Guldu, OK; Tekin, V; Wong, JL; Ma, XH; Ting, R; Unak, P; Akin, O				Aras, Omer; Pearce, Gillian; Watkins, Adam J.; Nurili, Fuad; Medine, Emin Ilker; Guldu, Ozge Kozgus; Tekin, Volkan; Wong, Julian; Ma, Xianghong; Ting, Richard; Unak, Perihan; Akin, Oguz			An in-vivo pilot study into the effects of FDG-mNP in cancer in mice	PLOS ONE			English	Article							MAGNETIC NANOPARTICLES; HYPERTHERMIA; CELLS; NEUROBLASTOMA; MECHANISMS	Purpose Previously, fluorodeoxy glucose conjugated magnetite nanoparticles (FDG-mNPs) injected into cancer cells in conjunction with the application of magnetic hyperthermia have shown promise in new FDG-mNPs applications. The aim of this study was to determine potential toxic or unwanted effects involving both tumour cells and normal tissue in other organs when FDG-mNPs are administered intravenously or intratumourally in mice. Materials and methods FDG-mNPs were synthesized. A group of six prostate-tumour bearing mice were injected with 23.42 mg/ml FDG-mNPs (intravenous injection, n = 3; intratumoural injection into the prostate tumour, n = 3). Mice were euthanized and histological sampling of tissue was conducted for the prostate tumour, as well as for lungs, lymph nodes, liver, kidneys, spleen, and brain, at 1 hour (n = 2) and 7 days (n = 4) post-injection. A second group of two normal (non-cancerous) mice received the same injection intravenously into the tail vein and were euthanised at 3 and 6 months post-injection, respectively, to investigate if FDG-mNPs remained in organs at those time points. Results In prostate-tumour bearing mice, FDG-mNPs concentrated in the prostate tumour, while relatively small amounts were found in the organs of other tissues, particularly the spleen and the liver; FDG-mNP concentrations decreased over time in all tissues. In normal mice, no detrimental effects were found in either mouse at 3 or 6 months. Conclusion Intravenous or intratumoural FDG-mNPs can be safely administered for effective cancer cell destruction. Further research on the clinical utility of FDG-mNPs will be conducted by applying hyperthermia in conjunction with FDG-mNPs in mice.	[Aras, Omer; Nurili, Fuad; Medine, Emin Ilker; Akin, Oguz] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Pearce, Gillian] Aston Univ, Sch Engn & Appl Sci, Birmingham, W Midlands, England; [Watkins, Adam J.] Aston Univ, Sch Life & Hlth Sci, Aston Res Ctr Hlth Ageing, Birmingham, W Midlands, England; [Watkins, Adam J.; Ma, Xianghong] Univ Nottingham, Queens Med Ctr, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham, England; [Medine, Emin Ilker; Guldu, Ozge Kozgus; Tekin, Volkan; Unak, Perihan] Ege Univ, Inst Nucl Sci, Dept Nucl Applicat, Izmir, Turkey; [Wong, Julian] Natl Univ Heart Ctr, Dept Cardiac Thorac & Vasc Surg, Div Vasc & Endovasc Surg, Singapore, Singapore; [Ting, Richard] Weill Cornell Med, Dept Radiol, MI3, New York, NY USA	Memorial Sloan Kettering Cancer Center; Aston University; Aston University; University of Nottingham; Ege University; National University of Singapore; Cornell University	Aras, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.	araso@mskcc.org	Medine, Emin İlker/GLS-0483-2022; Watkins, Adam J/J-4839-2013; Aras, Omer/AAV-8557-2021; KOZGUS GULDU, OZGE/GLQ-8246-2022; ÜNAK, PERIHAN/AAY-3145-2020; Watkins, Adam/AAH-9401-2021; tekin, volkan/AEE-4731-2022	Watkins, Adam J/0000-0002-0842-1251; Aras, Omer/0000-0003-1758-0542; KOZGUS GULDU, OZGE/0000-0001-7028-0720; ÜNAK, PERIHAN/0000-0002-5464-2987; Watkins, Adam/0000-0002-0842-1251; Nurili, Fuad/0000-0002-0413-9363; tekin, volkan/0000-0002-0264-3814; Ma, Xianghong/0000-0003-4957-2942; medine, emin ilker/0000-0003-0139-7110	Memorial Sloan Kettering Cancer Centre, Department of Radiology; NIH/NCI Cancer Center Support Grant [P30 CA008748]; NIH Small-Animal Imaging Research Program (SAIRP) [R24 CA83084]; NIH Prostate SPORE [P50-CA92629]; Ege University, Institute of Nuclear Sciences, Department of Nuclear Applications, Turkey; School of Engineering and Applied Science, Aston University, Birmingham, UK; Division of Vascular & Endovascular Surgery Department of Cardiac, Thoracic & Vascular Surgery National University Heart Centre, Singapore; NATIONAL CANCER INSTITUTE [P30CA008748, R24CA083084, P50CA092629] Funding Source: NIH RePORTER	Memorial Sloan Kettering Cancer Centre, Department of Radiology; NIH/NCI Cancer Center Support Grant; NIH Small-Animal Imaging Research Program (SAIRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Prostate SPORE; Ege University, Institute of Nuclear Sciences, Department of Nuclear Applications, Turkey; School of Engineering and Applied Science, Aston University, Birmingham, UK; Division of Vascular & Endovascular Surgery Department of Cardiac, Thoracic & Vascular Surgery National University Heart Centre, Singapore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by Memorial Sloan Kettering Cancer Centre, Department of Radiology, and the NIH/NCI Cancer Center Support Grant P30 CA008748, NIH Small-Animal Imaging Research Program (SAIRP), R24 CA83084; NIH Prostate SPORE, P50-CA92629; Ege University, Institute of Nuclear Sciences, Department of Nuclear Applications, 35100 Turkey; School of Engineering and Applied Science, Aston University, Birmingham, UK, B4 7E and Mr Julian Wong FRCS, Division of Vascular & Endovascular Surgery Department of Cardiac, Thoracic & Vascular Surgery National University Heart Centre, Singapore 1E Kent Ridge Road NUHS Tower Block, Level 9, Singapore 119228.; This research was funded by Memorial Sloan Kettering Cancer Centre, Department of Radiology, and the NIH/NCI Cancer Center Support Grant P30 CA008748, NIH Small-Animal Imaging Research Program (SAIRP), R24 CA83084; NIH Prostate SPORE, P50-CA92629; Ege University, Institute of Nuclear Sciences, Department of Nuclear Applications, 35100 Turkey; School of Engineering and Applied Science, Aston University, Birmingham, UK, B4 7E and Mr Julian Wong FRCS, Division of Vascular & Endovascular Surgery Department of Cardiac, Thoracic & Vascular Surgery National University Heart Centre, Singapore 1E Kent Ridge Road NUHS Tower Block, Level 9, Singapore 119228. The authors would like to thank the staff at Aston University's Biomedical research unit for animal provision and maintenance. The authors also would like to acknowledge Charlotte Bland and the Aston Research Centre for Healthy Ageing (ARCHA) imaging facility for their assistance with our tissue analysis studies.	Aminzadeh S, 2015, TRANSL PEDIATR, V4, P20, DOI 10.3978/j.issn.2224-4336.2015.01.04; Are C, 2018, EJSO-EUR J SURG ONC, V44, P43, DOI 10.1016/j.ejso.2017.07.018; ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372; BREZOVICH IA, 1984, CANCER RES, V44, P4752; Cervadoro A, 2013, DESIGN MAPS HYPERTHE, V8; Cervadoro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057332; Creixell M, 2011, ACS NANO, V5, P7124, DOI 10.1021/nn201822b; Giustini AJ, 2010, NANO LIFE, V1, P17, DOI 10.1142/S1793984410000067; Johannsen M, 2007, INT J HYPERTHER, V23, P315, DOI 10.1080/02656730601175479; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Li YF, 2011, SMALL, V7, P2965, DOI 10.1002/smll.201101059; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Ozkaya F, 2013, J RADIOANAL NUCL CH, V295, P1789, DOI 10.1007/s10967-012-2248-2; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Shan XH, 2012, EUR J RADIOL, V81, P95, DOI 10.1016/j.ejrad.2011.03.013; Subramanian M, 2015, ICON C CYRP OCT 31 N; Subramanian M, 2016, IEEE T NANOBIOSCI, V15, P517, DOI 10.1109/TNB.2016.2584543; Subramanian M, 2016, INT J HYPERTHER, V32, P112, DOI 10.3109/02656736.2015.1104732; Thiesen B, 2008, INT J HYPERTHER, V24, P467, DOI 10.1080/02656730802104757; Vallejo-Fernandez G, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/31/312001	21	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202482	10.1371/journal.pone.0202482	http://dx.doi.org/10.1371/journal.pone.0202482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125303	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000442202100030
J	Kramer, RSS; Mileva, M; Ritchie, KL				Kramer, Robin S. S.; Mileva, Mila; Ritchie, Kay L.			Inter-rater agreement in trait judgements from faces	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; COEFFICIENT-ALPHA; 1ST IMPRESSIONS; TRUSTWORTHINESS; PERSONALITY; IMAGES; RELIABILITY; PERCEPTION; INFERENCES; DOMINANCE	Researchers have long been interested in how social evaluations are made based upon first impressions of faces. It is also important to consider the level of agreement we see in such evaluations across raters and what this may tell us. Typically, high levels of inter-rater agreement for facial judgements are reported, but the measures used may be misleading. At present, studies commonly report Cronbach's a as a way to quantify agreement, although problematically, there are various issues with the use of this measure. Most importantly, because researchers treat raters as items, Cronbach's a is inflated by larger sample sizes even when agreement between raters is fixed. Here, we considered several alternative measures and investigated whether these better discriminate between traits that were predicted to show low (parental resemblance), intermediate (attractiveness, dominance, trustworthiness), and high (age, gender) levels of agreement. Importantly, the level of inter-rater agreement has not previously been studied for many of these traits. In addition, we investigated whether familiar faces resulted in differing levels of agreement in comparison with unfamiliar faces. Our results suggest that alternative measures may prove more informative than Cronbach's a when determining how well raters agree in their judgements. Further, we found no apparent influence of familiarity on levels of agreement. Finally, we show that, like attractiveness, both trustworthiness and dominance show significant levels of private taste (personal or idiosyncratic rater perceptions), although shared taste (perceptions shared with other raters) explains similar levels of variance in people's perceptions. In conclusion, we recommend that researchers investigating social judgements of faces consider alternatives to Cronbach's a but should also be prepared to examine both the potential value and origin of private taste as these might prove informative.	[Kramer, Robin S. S.; Ritchie, Kay L.] Univ Lincoln, Sch Psychol, Lincoln, England; [Mileva, Mila] Univ York, Dept Psychol, York, N Yorkshire, England	University of Lincoln; University of York - UK	Kramer, RSS (corresponding author), Univ Lincoln, Sch Psychol, Lincoln, England.	remarknibor@gmail.com	Mileva, Mila/L-3720-2018	Mileva, Mila/0000-0003-0537-9702; Ritchie, Kay/0000-0002-1348-760X; Kramer, Robin/0000-0001-8339-8832				Albright L, 1997, J PERS SOC PSYCHOL, V72, P558, DOI 10.1037/0022-3514.72.3.558; Alrajih S, 2014, BRIT J PSYCHOL, V105, P153, DOI 10.1111/bjop.12035; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Brennan R.L., 2001, GEN THEORY; Bronstad PM, 2007, PERCEPTION, V36, P1674, DOI 10.1068/p5793; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Cleeton GU, 1924, J APPL PSYCHOL, V8, P215, DOI 10.1037/h0072525; Cogsdill EJ, 2015, J EXP SOC PSYCHOL, V60, P150, DOI 10.1016/j.jesp.2015.05.007; Cogsdill EJ, 2014, PSYCHOL SCI, V25, P1132, DOI 10.1177/0956797614523297; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Ert E, 2016, TOURISM MANAGE, V55, P62, DOI 10.1016/j.tourman.2016.01.013; Feldt LS, 2006, EDUC PSYCHOL MEAS, V66, P589, DOI 10.1177/0013164405282488; Flowe HD, 2011, APPL COGNITIVE PSYCH, V25, P265, DOI 10.1002/acp.1673; Germine L, 2015, CURR BIOL, V25, P2684, DOI 10.1016/j.cub.2015.08.048; Green SB, 2009, PSYCHOMETRIKA, V74, P155, DOI 10.1007/s11336-008-9099-3; GREEN SB, 1977, EDUC PSYCHOL MEAS, V37, P827, DOI 10.1177/001316447703700403; Hehman E, 2017, J PERS SOC PSYCHOL, V113, P513, DOI 10.1037/pspa0000090; Honekopp J, 2006, J EXP PSYCHOL HUMAN, V32, P199, DOI 10.1037/0096-1523.32.2.199; Jenkins R, 2011, COGNITION, V121, P313, DOI 10.1016/j.cognition.2011.08.001; Kendall M., 1938, NATURE, V142, P402, DOI [10.2307/2280246, DOI 10.2307/2280246]; Kramer RSS, 2011, PERCEPTION, V40, P549, DOI 10.1068/p6856; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Krys K, 2014, J CROSS CULT PSYCHOL, V45, P314, DOI 10.1177/0022022113513922; LANGLOIS JH, 1994, PSYCHOL SCI, V5, P214, DOI 10.1111/j.1467-9280.1994.tb00503.x; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Leder H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00155; Little AC, 2007, BRIT J PSYCHOL, V98, P111, DOI 10.1348/000712606X109648; Mattarozzi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135529; MCARTHUR LZ, 1987, J CROSS CULT PSYCHOL, V18, P165, DOI 10.1177/0022002187018002003; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Ozono H., 2010, LETT EVOLUTIONARY BE, V1, P15, DOI DOI 10.5178/LEBS.2010.4; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Porter S, 2008, CAN J BEHAV SCI, V40, P171, DOI 10.1037/0008-400X.40.3.171; Quist MC, 2011, PERS INDIV DIFFER, V50, P1089, DOI 10.1016/j.paid.2011.01.032; Rezlescu C, 2015, J NONVERBAL BEHAV, V39, P355, DOI 10.1007/s10919-015-0214-8; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Ritchie KL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00526-9; Rosenthal R, 2018, METAANALYTIC PROCEDU; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P1, DOI 10.1037/a0017673; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Santos IM, 2011, Q J EXP PSYCHOL, V64, P751, DOI 10.1080/17470218.2010.519779; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; SIMPSON WE, 1968, PSYCHON SCI, V12, P57; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Sussman AB, 2013, J EXP SOC PSYCHOL, V49, P771, DOI 10.1016/j.jesp.2013.02.003; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Todorov A, 2014, PSYCHOL SCI, V25, P1404, DOI 10.1177/0956797614532474; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; Watkins CD, 2012, EUR J PERSONALITY, V26, P79, DOI 10.1002/per.837; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Watkins CD, 2010, BEHAV ECOL, V21, P943, DOI 10.1093/beheco/arq091; White D, 2016, BRIT J PSYCHOL, V107, P359, DOI 10.1111/bjop.12141; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wilson JP, 2015, PSYCHOL SCI, V26, P1325, DOI 10.1177/0956797615590992; ZEBROWITZ LA, 1993, J PERS SOC PSYCHOL, V65, P85, DOI 10.1037/0022-3514.65.1.85; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306; Zebrowitz LA, 2013, PSYCHOL AGING, V28, P202, DOI 10.1037/a0030927; Zebrowitz LA, 2012, J CROSS CULT PSYCHOL, V43, P119, DOI 10.1177/0022022111411386	78	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202655	10.1371/journal.pone.0202655	http://dx.doi.org/10.1371/journal.pone.0202655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR1HG	30118520	Green Accepted, gold, Green Published			2022-12-26	WOS:000442282700040
J	Lin, CY; Chung, YH; Shi, YF; Tzang, BS; Hsu, TC				Lin, Chun-Yu; Chung, Yu-Han; Shi, Ya-Fang; Tzang, Bor-Show; Hsu, Tsai-Ching			The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naive Balb/c mice	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY-TRACT INFECTION; MATRIX METALLOPROTEINASES; IL-6 PRODUCTION; ASTHMA; DISEASE; PROTEIN; BRONCHIOLITIS; INFLAMMATION; INVOLVEMENT	Both human parvovirus B19 (B19V) and human bocavirus (HBoV) are known to be important human pathogens of the Parvoviridae family. Our earlier investigation demonstrated that both B19V-VP1u and HBoV-VP1u have a significantly disruptive effect on tight junctions (TJs) in A549 cells, implying the essential role of parvovirus in airway infection and lung injury. However, no direct evidence that B19V-VP1u and HBoV-VP1u induce lung injury exists. The present study further investigates the induction of lung injury by B19V-VP1u and HBoV-VP1u in naive Balb/c mice following subcutaneous injection of PBS, recombinant B19V-VP1u or HBoV-VP1u. The experimental results reveal significantly increased activity, protein expression and ratio of matrix metalloproteinase-9 (MMP-9) to MMP-2 in Balb/c mice that received B19V-VP1u or HBoV-VP1u compared to those that received PBS. Significantly higher levels of inflammatory cytokines, including IL-6 and IL-1 beta, and greater lymphocyte infiltration in lung tissue sections were detected in mice that received B19V-VP1u or HBoV-VP1u. Additionally, significantly increased levels of phosphorylated p65 (NF-kappa B) and MAPK signaling proteins were observed in lung tissue of mice that received B19V-VP1u or HBoV-VP1u compared to those of mice that received PBS. These findings demonstrate for the first time that B19V-VP1u and HBoV-VP1u proteins induce lung inflammatory reactions through p65 (NF-kappa B) and MAPK signaling.	[Lin, Chun-Yu] Chi Mei Med Ctr, Dept Internal Med, Div Allergy Immunol Rheumatol, Tainan, Taiwan; [Lin, Chun-Yu] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Chung, Yu-Han; Shi, Ya-Fang; Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ, Immunol Res Ctr, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Tzang, BS; Hsu, TC (corresponding author), Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.; Tzang, BS (corresponding author), Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan.; Tzang, BS; Hsu, TC (corresponding author), Chung Shan Med Univ, Immunol Res Ctr, Taichung, Taiwan.	bstzang@csmu.edu.tm; htc@csmu.edu.tw		Bor-Show, Tzang/0000-0003-0140-9943	Chung Shan Medical University [CSMU-INT-102-01, CSMU-CMMC-104-02]; Chi-Mei Medical Center [CSMU-CMMC-104-02]; Ministry of Science and Technology, Taiwan [MOST-106-2314- B040-023]	Chung Shan Medical University; Chi-Mei Medical Center; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Chung Shan Medical University under Grant [CSMU-INT-102-01]; Chung Shan Medical University and Chi-Mei Medical Center cooperative project under Grant [CSMU-CMMC-104-02]; and Ministry of Science and Technology under Grant [MOST-106-2314- B040-023], Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABMAN SH, 1991, J PEDIATR-US, V119, P211, DOI 10.1016/S0022-3476(05)80729-2; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Attalah HL, 2003, EUR RESPIR J, V21, P1040, DOI 10.1183/09031936.03.00093002; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bousvaros A, 1998, PEDIATR PULM, V26, P365, DOI 10.1002/(SICI)1099-0496(199811)26:5<365::AID-PPUL11>3.3.CO;2-W; Britto CJ, 2017, CLIN CHEST MED, V38, P87, DOI 10.1016/j.ccm.2016.11.014; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Chen HL, 2009, INHAL TOXICOL, V21, P374, DOI [10.1080/08958370802449712 , 10.1080/08958370802449712]; Chiu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107970; Chuang CY, 2011, J MICROBIOL IMMUNOL, V44, P323, DOI 10.1016/j.jmii.2011.01.036; Colombo C, 2011, THORAX, V66, P260, DOI 10.1136/thx.2010.157032; Costa C, 2009, J CLIN VIROL, V46, P150, DOI 10.1016/j.jcv.2009.06.026; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Etemadi M R, 2012, Med J Malaysia, V67, P433; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Hendrix AY, 2017, PROG MOL BIOL TRANSL, V148, P1, DOI 10.1016/bs.pmbts.2017.04.004; Hsu TC, 2016, VIRULENCE, V7, P110, DOI 10.1080/21505594.2015.1122165; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kawabata K, 2010, J CARDIOVASC PHARM, V56, P369, DOI 10.1097/FJC.0b013e3181ef1aab; Kerr JR, 2016, J CLIN PATHOL, V69, P279, DOI 10.1136/jclinpath-2015-203455; Kotecha S, 1996, EUR J PEDIATR, V155, pS14, DOI 10.1007/BF01958074; Lee SH, 2010, J CELL PHYSIOL, V222, P574, DOI 10.1002/jcp.21973; Lin CY, 2018, VIRULENCE, V9, P208, DOI 10.1080/21505594.2017.1385691; Lin JT, 2014, CURR DRUG TARGETS, V15, P442, DOI 10.2174/1389450115666140211115805; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Meyer O, 2003, JOINT BONE SPINE, V70, P6, DOI 10.1016/S1297-319X(02)00004-0; Morin C, 2014, AM J PHYSIOL-HEART C, V307, pH574, DOI 10.1152/ajpheart.00814.2013; Nash EF, 2011, THORAX, V66, P259, DOI 10.1136/thx.2010.140822; Nie XJ, 2010, SCAND J INFECT DIS, V42, P121, DOI 10.3109/00365540903321580; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qu XW, 2008, BIOCHEM BIOPH RES CO, V365, P158, DOI 10.1016/j.bbrc.2007.10.164; Rahman I, 2000, FREE RADICAL BIO MED, V28, P1405, DOI 10.1016/S0891-5849(00)00215-X; Ricour C, 2008, ACTA CLIN BELG, V63, P329, DOI 10.1179/acb.2008.064; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Tan WC, 2003, AM J MED, V115, P272, DOI 10.1016/S0002-9343(03)00353-X; Triggiani M, 2000, J IMMUNOL, V164, P4908, DOI 10.4049/jimmunol.164.9.4908; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Tzang BS, 2007, CLIN CHIM ACTA, V378, P59, DOI 10.1016/j.cca.2006.10.016; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; von Linstow ML, 2008, PEDIATR INFECT DIS J, V27, P897, DOI 10.1097/INF.0b013e3181757b16; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Wiersbitzky S, 1991, Kinderarztl Prax, V59, P299; Yang Chuen-Mao, 2005, Chang Gung Med J, V28, P813; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zeng M, 2010, WORLD J PEDIATR, V6, P65, DOI 10.1007/s12519-010-0009-2; Zhang LL, 2008, CHINESE MED J-PEKING, V121, P1607, DOI 10.1097/00029330-200809010-00002	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202667	10.1371/journal.pone.0202667	http://dx.doi.org/10.1371/journal.pone.0202667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114253	gold, Green Submitted, Green Published			2022-12-26	WOS:000441850400092
J	Frye, CCJ; Rung, JM; Nall, RW; Galizio, A; Haynes, JM; Odum, AL				Frye, Charles C. J.; Rung, Jillian M.; Nall, Rusty W.; Galizio, Ann; Haynes, Jeremy M.; Odum, Amy L.			Continuous nicotine exposure does not affect resurgence of alcohol seeking in rats	PLOS ONE			English	Article							NONDRUG REINFORCEMENT; TOBACCO; SMOKING; RELAPSE; CONSUMPTION; INFUSION; COCAINE; SMOKERS; STRESS	Alcohol is the most commonly used drug in the United States and alcohol abuse can lead to alcohol use disorder. Alcohol use disorder is a persistent condition and relapse rates following successful remission are high. Many factors have been associated with relapse for alcohol use disorder, but identification of these factors has not been well translated into preventative utility. One potentially important factor, concurrent nicotine use, has not been well investigated as a causal factor in relapse for alcohol use disorder. Nicotine increases the value of other stimuli in the environment and may increase the value of alcohol. If nicotine increases the value of alcohol, then nicotine use during and after treatment may make relapse more probable. In the current study, we investigated the effect of continuous nicotine exposure (using osmotic minipumps to deliver nicotine or saline, depending on group, at a constant rate for 28 days) on resurgence of alcohol seeking in rats. Resurgence is a type of relapse preparation that consists of three phases: Baseline, Alternative Reinforcement, and Resurgence Testing. During Baseline, target responses produced a dipper of alcohol. During Alternative Reinforcement, target responses were extinguished and responses on a chain produced a chocolate pellet. During Resurgence Testing, responses on the chain were also extinguished and a return to responding on the target lever was indicative of resurgence. Multilevel modeling was used to analyze the effect of nicotine on resurgence. Both the nicotine and saline group showed resurgence of alcohol seeking, but there was no difference in the degree of resurgence across groups. Future directions could involve testing alternative drug delivery techniques.	[Frye, Charles C. J.; Rung, Jillian M.; Nall, Rusty W.; Galizio, Ann; Haynes, Jeremy M.; Odum, Amy L.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Frye, CCJ (corresponding author), Utah State Univ, Dept Psychol, Logan, UT 84322 USA.	ccjfrye@gmail.com	Haynes, Jeremy/GQY-8619-2022	Nall, Rusty/0000-0002-0646-5023	Society for the Advancement of Behavior Analysis (SABA); Innovative Student Research Grant	Society for the Advancement of Behavior Analysis (SABA); Innovative Student Research Grant	This research was partially funded by the Society for the Advancement of Behavior Analysis (SABA). The first author (CCJF) received an Innovative Student Research Grant for this work, in the sum of $2000. No members of SABA played any role in study design, data collection/analysis, the decision to publish the work, or preparation of the manuscript. http://saba.abainternational.org/	Barrett ST, 2012, BEHAV PHARMACOL, V23, P781, DOI 10.1097/FBP.0b013e32835a38d9; Barrett ST, 2011, BEHAV PHARMACOL, V22, P283, DOI 10.1097/FBP.0b013e3283473c25; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brynildsen JK, 2016, PHARMACOL BIOCHEM BE, V142, P79, DOI 10.1016/j.pbb.2015.12.010; Burns BE, 2013, ALCOHOL CLIN EXP RES, V37, pE364, DOI 10.1111/j.1530-0277.2012.01911.x; Caggiula AR, 2009, NEBR SYM MOTIV, V55, P91, DOI 10.1007/978-0-387-78748-0_6; Cassidy RN, 2014, J EXP ANAL BEHAV, V102, P353, DOI 10.1002/jeab.109; Chapman SLC, 2014, J PSYCHIATR RES, V54, P43, DOI 10.1016/j.jpsychires.2014.03.005; Chaudhri N, 2007, PSYCHOPHARMACOLOGY, V190, P353, DOI 10.1007/s00213-006-0454-8; Clark A, 2001, NEUROPHARMACOLOGY, V41, P108, DOI 10.1016/S0028-3908(01)00037-5; Cooney JL, 2003, ADDICTION, V98, P913, DOI 10.1046/j.1360-0443.2003.00337.x; Cooney NL, 2007, PSYCHOL ADDICT BEHAV, V21, P277, DOI 10.1037/0893-164X.21.3.277; Cooney NL, 2015, J CONSULT CLIN PSYCH, V83, P346, DOI 10.1037/a0038633; Cosgrove KP, 2014, P NATL ACAD SCI USA, V111, P18031, DOI 10.1073/pnas.1413947111; Dawkins L, 2007, ADDICT BEHAV, V32, P425, DOI 10.1016/j.addbeh.2006.05.010; Esser MB, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140329; FLESHLER M, 1962, J EXP ANAL BEHAV, V5, P529, DOI 10.1901/jeab.1962.5-529; Fox J, 2010, NONLINEAR REGRESSION, DOI [10.1016/j.infsof.2008.09.005, DOI 10.1016/J.INFSOF.2008.09.005]; Gilbertson R, 2011, ALCOHOL ALCOHOLISM, V46, P39, DOI 10.1093/alcalc/agq070; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Hauser SR, 2014, ADDICT BIOL, V19, P800, DOI 10.1111/adb.12048; Hitschfeld MJ, 2015, DRUG ALCOHOL DEPEN, V150, P179, DOI 10.1016/j.drugalcdep.2015.02.016; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Marchant NJ, 2013, CURR OPIN NEUROBIOL, V23, P675, DOI 10.1016/j.conb.2013.01.003; Markou A, 2008, PHILOS T R SOC B, V363, P3159, DOI 10.1098/rstb.2008.0095; MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Moretti M, 2010, MOL PHARMACOL, V78, P287, DOI 10.1124/mol.110.064071; Nall RW, 2018, BEHAV BRAIN RES, V341, P54, DOI 10.1016/j.bbr.2017.12.020; Palmatier MI, 2009, PSYCHOPHARMACOLOGY, V207, P381, DOI 10.1007/s00213-009-1666-5; Patten CA, 1996, J SUBST ABUSE TREAT, V13, P107, DOI 10.1016/0740-5472(96)00040-2; Perkins KA, 2013, PSYCHOPHARMACOLOGY, V228, P479, DOI 10.1007/s00213-013-3054-4; Podlesnik CA, 2006, BEHAV PHARMACOL, V17, P369, DOI 10.1097/01.fbp.0000224385.09486.ba; RCore Team, 2020, R LANG ENV STAT COMP; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Suess AN, 2014, J BEHAV EDUC, V23, P34, DOI 10.1007/s10864-013-9183-3; Tynan Michael A., 2012, Morbidity and Mortality Weekly Report, V61, P565; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Vinkers CH, 2009, PHARMACOL BIOCHEM BE, V93, P413, DOI 10.1016/j.pbb.2009.05.017; Winterbauer NE, 2013, LEARN MOTIV, V44, P60, DOI 10.1016/j.lmot.2012.03.003	41	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202230	10.1371/journal.pone.0202230	http://dx.doi.org/10.1371/journal.pone.0202230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110388	gold, Green Published, Green Submitted			2022-12-26	WOS:000441738000056
J	Watanabe, K; Igarashi, M; Li, X; Nakatani, A; Miyamoto, J; Inaba, Y; Sutou, A; Saito, T; Sato, T; Tachibana, N; Inoue, H; Kimura, I				Watanabe, Keita; Igarashi, Miki; Li, Xuan; Nakatani, Akiho; Miyamoto, Junki; Inaba, Yuka; Sutou, Asuka; Saito, Tsutomu; Sato, Takumi; Tachibana, Nobuhiko; Inoue, Hiroshi; Kimura, Ikuo			Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids	PLOS ONE			English	Article							BETA-CONGLYCININ; GLUCOSE-HOMEOSTASIS; BODY-FAT; BACTERIA; MICE; METABOLISM; ACTIVATION; MASS	The consumption of soybean protein has well-known favorable metabolic effects (e.g., reduced body weight, body fat, hyperglycemia, insulin resistance, hepatic steatosis, and lipogenesis). These effects of soy protein have been linked to modulation by the gut micro-biota; however, the dynamic interplay among these factors remains unclear. Accordingly, we examined the metabolic phenotype, intestinal BA pool, and the gut microbiome of male C57BL/6 mice that were randomized to receive either a regular high-fat diet (HFD) or HFD that contained soybean protein isolate (SPI) in place of dairy protein. The intake of SPI significantly reduced the HFD-induced weight gain and adipose tissue mass accumulation and attenuated hepatic steatosis. Along with an enhancement in the secretion of intestinal Glucagon-like peptide-1 (GLP-1), an enlarged cecal BA pool with an elevated secondary/primary BA ratio was observed in the mice that consumed SPI, while fecal BA excretion remained unaltered. SPI also elicited dramatic changes in the gut microbiome, characterized by an expansion of taxa that may be involved in the biotransformation of BAs. The observed effects were abolished in germ-free (GF) mice, indicating that they were dependent on the microbiota. These findings collectively indicate that the metabolic benefits of SPI under the HFD regime may arise from a microbiota-driven increase in BA transformation and increase in GLP-1 secretion.	[Watanabe, Keita; Igarashi, Miki; Li, Xuan; Nakatani, Akiho; Miyamoto, Junki; Sutou, Asuka; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Miyamoto, Junki; Kimura, Ikuo] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan; [Inaba, Yuka; Inoue, Hiroshi] Kanazawa Univ, Inst Frontier Sci Initiat, Metab & Nutr Res Unit, Takara Machi, Kanazawa, Ishikawa, Japan; [Saito, Tsutomu; Sato, Takumi; Tachibana, Nobuhiko] Fuji Oil Co Ltd, Res & Dev Div Future Creat, Hlth & Nutr Res Dept, Tsukuba, Ibaraki, Japan	Tokyo University of Agriculture & Technology; Kanazawa University; Fuji Oil Co., Ltd.	Kimura, I (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan.; Kimura, I (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan.	ikimura@cc.tuat.ac.jp	宮本, 潤基/ABG-8169-2020; Kimura, Ikuo/B-4193-2015	Inaba, Yuka/0000-0001-9757-9669; Inoue, Hiroshi/0000-0002-7724-6637	AMED [JP17gm1010007]; JST A-STEP [AS2815103U]; Fuji Oil Co., Ltd.	AMED; JST A-STEP; Fuji Oil Co., Ltd.	This work was partly supported by research grants from the AMED (JP17gm1010007) and JST A-STEP (AS2815103U) to IK. In addition, this research was supported by Fuji Oil Co., Ltd. The funder provided support in the form of salaries for T. Saito, T. Sato and NT, and supplied soybean protein, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aoyama T, 2000, NUTRITION, V16, P349, DOI 10.1016/S0899-9007(00)00230-6; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Deibert P, 2004, INT J OBESITY, V28, P1349, DOI 10.1038/sj.ijo.0802765; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Hashidume T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28183; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kisiela M, 2012, J STEROID BIOCHEM, V129, P31, DOI 10.1016/j.jsbmb.2011.08.002; Kohno M, 2006, J ATHEROSCLER THROMB, V13, P247, DOI 10.5551/jat.13.247; Kumar DP, 2016, J BIOL CHEM, V291, P6626, DOI 10.1074/jbc.M115.699504; Labbe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115175; Lin YG, 2004, J NUTR, V134, P143, DOI 10.1093/jn/134.1.143; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Miyamoto J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196579; Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002; Moriyama T, 2004, BIOSCI BIOTECH BIOCH, V68, P352, DOI 10.1271/bbb.68.352; Mouzaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151829; Murakami Y, 2016, J FOOD SCI, V81, pH216, DOI 10.1111/1750-3841.13166; Palau-Rodriguez M, 2015, FRONT MICROBIOL, V6, DOI [10.3339/fmicb.2075.07751, 10.3389/fmicb.2015.01151]; Puri P, 2018, HEPATOLOGY, V67, P534, DOI 10.1002/hep.29359; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Ridlon JM, 2015, ACTA PHARM SIN B, V5, P99, DOI 10.1016/j.apsb.2015.01.006; Ridlon JM, 2013, GUT MICROBES, V4, P382, DOI 10.4161/gmic.25723; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Vitek L, 2016, J ENDOCRINOL, V228, pR85, DOI 10.1530/JOE-15-0469; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wanezaki S, 2015, OBES RES CLIN PRACT, V9, P168, DOI 10.1016/j.orcp.2014.03.005; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; World Health Organization, 2018, OB OV; Yamazaki T, 2012, J NUTR BIOCHEM, V23, P123, DOI 10.1016/j.jnutbio.2010.11.006	36	32	34	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202083	10.1371/journal.pone.0202083	http://dx.doi.org/10.1371/journal.pone.0202083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102711	Green Published, Green Submitted			2022-12-26	WOS:000441452200031
J	Dodd, RB				Dodd, Roger B.			An exTREMe disruption in Alzheimer's cleanup	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DISEASE	Partial loss-of-function variants in the TREM2 immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of neurodegenerative disease, but the molecular bases for these connections are unknown. Three new structures of WT and R47H mutant TREM2 immunoglobulin-like (Ig-like) domain now reveal that R47 functions to correctly position elements of the ligand-binding surface. Intriguingly, the authors also demonstrate a disruption of receptor oligomerization by the R47H mutation, suggesting a role for ligand-induced clustering in receptor signaling and resultant plaque clearance.	[Dodd, Roger B.] MedImmune, Dept Antibody Discovery & Prot Engn, Sir Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England	AstraZeneca; Medimmune	Dodd, RB (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Sir Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England.	doddr@MedImmune.com		Dodd, Roger/0000-0003-4268-1863				Cheng-Hathaway PJ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0262-8; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Lee CYD, 2018, NEURON, V97, P1032, DOI 10.1016/j.neuron.2018.02.002; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Sudom A, 2018, J BIOL CHEM, V293, P12634, DOI 10.1074/jbc.RA118.002352; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12647	12648		10.1074/jbc.H118.004271	http://dx.doi.org/10.1074/jbc.H118.004271			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	30097493	hybrid, Green Published			2022-12-26	WOS:000441408500028
J	Kim, B; Moon, S; Bae, GR; Lee, H; Pai, H; Oh, SH				Kim, Bongyoung; Moon, Shinje; Bae, Geun-Ryang; Lee, Hyungmin; Pai, Hyunjoo; Oh, Sung Hee			Factors associated with severe neurologic complications in patients with either hand-foot-mouth disease or herpangina: A nationwide observational study in South Korea, 2009-2014	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; RISK-FACTORS; TAIWAN; HUMAN-ENTEROVIRUS-71; ENCEPHALOMYELITIS; OUTBREAK; MALAYSIA; CHILDREN; SARAWAK; MRI	Background In 2009, a nationwide sentinel surveillance for hand-foot-mouth disease (HFMD) and herpangina (HA) with neurologic complications was initiated in South Korea. We used this surveillance system to investigate the clinical characteristics of patients with either HFMD or HA with neurologic complications, with the aim of determining risk factors for severe neurologic complications. Methods A retrospective review of medical records was conducted on all cases of HFMD and HA with neurologic complications that were reported in the national system between April 1,2009 and December 31,2014. A severe case was defined as having HFMD or HA with encephalitis, polio-like syndrome, or cardiopulmonary failure, and less-severe cases were defined as having HFMD or HA with aseptic meningitis. Results A total of 138 cases (less-severe: 90/138, 65.2%; severe: 48/138, 24.8%) were included from 28 hospitals; 28 ineligible cases were excluded. Of 48 severe cases, 27 (56.2%) had encephalitis; 14 (29.2%) had polio-like syndrome; and seven (14.6%) had cardiopulmonary syndrome. The median patient age was 36 months (IQR: 18-60) and 63 (45.7%) patients were female. Most patients completely recovered, except for seven cases that were fatal or resulted in long-term symptoms (5.1%, 3 patients with neurologic sequelae and 4 deaths). In a multivariable logistic regression analysis, lethargy (OR = 4.67, 95% CI: 1.37-15.96, P = 0.014), female sex (OR = 3.51,95% CI: 1.17-10.50, P = 0.025), and enterovirus A71 (OR = 3.55, 95% CI: 1.09-11.57, P = 0.035) were significantly associated with severe neurologic complications in HFMD and HA patients. Conclusion In patients with HFMD and HA, lethargy, female, and enterovirus A71 may predict severe neurologic complications.	[Kim, Bongyoung; Pai, Hyunjoo] Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Bongyoung; Moon, Shinje; Bae, Geun-Ryang; Lee, Hyungmin] Korea Ctr Dis Control & Prevent, Dept Epidem Intelligence Serv, Osong, Cheongju, South Korea; [Moon, Shinje] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Bae, Geun-Ryang] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Seoul, South Korea; [Lee, Hyungmin] Korea Ctr Dis Control & Prevent, Dept Healthcare Associated Infect Control, Osong, Cheongju, South Korea; [Oh, Sung Hee] Hanyang Univ, Dept Pediat, Coll Med, Seoul, South Korea	Hanyang University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; Hallym University; Korea Institute of Radiological & Medical Sciences; Korea Centers for Disease Control & Prevention (KCDC); Hanyang University	Oh, SH (corresponding author), Hanyang Univ, Dept Pediat, Coll Med, Seoul, South Korea.	sungheeo@hanyang.ac.kr	Kim, Bongyoung/H-3409-2018	Kim, Bongyoung/0000-0002-5029-6597	Hanyang University (HY-2018)	Hanyang University (HY-2018)	This study was supported by the research fund of Hanyang University (HY-2018).	Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Choi Cheol Soon, 2011, Korean J Pediatr, V54, P11, DOI 10.3345/kjp.2011.54.1.11; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Fang YR, 2014, SCAND J INFECT DIS, V46, P515, DOI 10.3109/00365548.2014.907929; Health Insurance Review & Assessment Service, STAT KOR STAND CLASS; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Kim SJ, 2013, J KOREAN MED SCI, V28, P120, DOI 10.3346/jkms.2013.28.1.120; Li JJ, 2012, INT J NEUROSCI, V122, P338, DOI 10.3109/00207454.2012.657379; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Long L, 2016, INFECT DIS-NOR, V48, P744, DOI 10.1080/23744235.2016.1185801; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Suzuki Y, 2010, PEDIATR INT, V52, P203, DOI 10.1111/j.1442-200X.2009.02937.x; Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7; Yang Tsou-Tong, 2005, Journal of Microbiology Immunology and Infection, V38, P417; Zeng HW, 2012, NEURORADIOLOGY, V54, P623, DOI 10.1007/s00234-011-0979-3; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	21	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201726	10.1371/journal.pone.0201726	http://dx.doi.org/10.1371/journal.pone.0201726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096160	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500024
J	Mohn, J; Igland, J; Zoffmann, V; Peyrot, M; Graue, M				Mohn, Jannike; Igland, Jannicke; Zoffmann, Vibeke; Peyrot, Mark; Graue, Marit			Factors explaining variation in self-esteem among persons with type 1 diabetes and elevated HbA1c	PLOS ONE			English	Article							GLYCEMIC CONTROL; FOOT ULCERS; FOLLOW-UP; MANAGEMENT; MOTIVATION; DISTRESS; ADULTS; CARE; ADJUSTMENT; BARRIERS	Objectives To investigate associations between perceived autonomy support from health-care professionals, autonomy-driven motivation, diabetes self-perceived competence and self-esteem in adults (age 18-55 yrs) with suboptimally regulated type 1 diabetes mellitus (T1DM) with at least one HbA1 c <= 8.0% (<= 64 mmol/mol) during the past year, and whether these factors could predict decrease in self-esteem over time. Methods A cross-sectional population-based survey was performed, and 9 months follow-up data were collected. Data collection comprised clinical and socio-demographic variables, blood sampling (HbA(1c)) and self-report questionnaires; the Health Care Climate Questionnaire (HCCQ), Treatment Self-Regulation Questionnaire (TSRQ), the Perceived Competence in Diabetes Scale (PCDS), and the Rosenberg Self-esteem Scale (RSES). We fitted blockwise linear regression models to assess associations between RSES and variables of interest (HCCQ, TSRQ, PCDS, HbA(1c), clinical and socio-demographic variables) and linear regression models to assess predictors of change over time. Findings In this study sample, aged 36.7 (+/- 10.7) mean HbA(1c) 9.3% (+/- 1.1), 31.5% had long-term complications and 42.7% had experienced severe hypoglycemia within the previous 12 months. In the final regression model the association between PCDS and RSES was strongly significant (B = 1.99, p<0.001) and the associations between HCCQ, TSRQ and RSES were reduced to non-significance. All predictor variables combined explained 42% of the variability of RSES (adjusted R-2 = 0.423) with PCDS contributing 18% to explained variance (R-square change = 0.184, p<0.001). The strongest predictors of change in RSES overtime were long-term complications (B = 2.76, p<0.001), specifically foot-related problems, and being female (B = -2.16, p = 0.002). Conclusions Perceived autonomy support, autonomy-driven motivation and diabetes self-perceived competence play a significant role in explaining self-esteem among adults with suboptimally regulated T1DM. Healthcare professionals should acknowledge self-esteem as a valuable factor in understanding the multifaceted health choices people with T1DM make.	[Mohn, Jannike; Igland, Jannicke; Peyrot, Mark; Graue, Marit] Western Norway Univ Appl Sci, Ctr Evidence Based Practice, Bergen, Norway; [Mohn, Jannike; Igland, Jannicke; Graue, Marit] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Mohn, Jannike] Haukeland Hosp, Sect Endocrinol, Dept Med, Bergen, Norway; [Zoffmann, Vibeke] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark; [Peyrot, Mark] Loyola Univ Maryland, Dept Sociol, Baltimore, MD USA	Western Norway University of Applied Sciences; University of Bergen; University of Bergen; Haukeland University Hospital; Rigshospitalet; University of Copenhagen; Loyola University Maryland	Mohn, J (corresponding author), Western Norway Univ Appl Sci, Ctr Evidence Based Practice, Bergen, Norway.; Mohn, J (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.; Mohn, J (corresponding author), Haukeland Hosp, Sect Endocrinol, Dept Med, Bergen, Norway.	jmo@hvl.no	Zoffmann, Vibeke/X-7192-2019		Western Norway Regional Health Authority; Norwegian Diabetes Association; Norwegian Nurses Organisation; Western Norway University of Applied Sciences	Western Norway Regional Health Authority; Norwegian Diabetes Association; Norwegian Nurses Organisation; Western Norway University of Applied Sciences	This work was supported by the Western Norway Regional Health Authority, https://helse-vest.no/ (JM); the Norwegian Diabetes Association, https://www.diabetes.no/ (MG); the Norwegian Nurses Organisation, https://www.nsf.no/ (JM); and Western Norway University of Applied Sciences, https://www.hvl.no/ (JM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105; Barenbaum NB, 2010, HDB PERSONALITY THEO, P3; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; Cook DA, 2016, MED EDUC, V50, P997, DOI 10.1111/medu.13074; Pereira MTD, 2014, WOUNDS, V26, P172; Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0; Engel L, 2011, DIABETES RES CLIN PR, V91, P271, DOI 10.1016/j.diabres.2010.11.023; Fisher L, 2016, J DIABETES COMPLICAT, V30, P1123, DOI 10.1016/j.jdiacomp.2016.03.032; Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762; Iversen MM, 2009, DIABETES CARE, V32, P2193, DOI 10.2337/dc09-0651; Jacobson AM, 1997, DIABETES CARE, V20, P811, DOI 10.2337/diacare.20.5.811; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Jerant AF, 2005, PATIENT EDUC COUNS, V57, P300, DOI 10.1016/j.pec.2004.08.004; Khanolkar MP, 2008, QJM-INT J MED, V101, P685, DOI 10.1093/qjmed/hcn027; Klinenberg E., 2012, GOING SOLO EXTRAORDI; Lavery LA, 2007, DIABETES CARE, V30, P14, DOI 10.2337/dc06-1600; Levesque CS, 2007, HEALTH EDUC RES, V22, P691, DOI 10.1093/her/cyl148; Luyckx K, 2015, PSYCHOL HEALTH MED, V20, P77, DOI 10.1080/13548506.2014.902482; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Mohn J, 2015, DIABET MED; Mohn J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013295; Morea JM, 2008, RES NURS HEALTH, V31, P563, DOI 10.1002/nur.20294; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Peyrot M, 1996, J PEDIATR PSYCHOL, V21, P3, DOI 10.1093/jpepsy/21.1.3; Rassart J, 2014, J PSYCHOSOM RES, V76, P139, DOI 10.1016/j.jpsychores.2013.11.015; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; */* S  11, 2013, DIABETES CARE S1, V36, pS1, DOI DOI 10.2337/DC13-S011; Schmitt DP, 2016, INT J PSYCHOL; Shigaki C, 2010, CHRONIC ILLN, V6, P202, DOI 10.1177/1742395310375630; Smith-Strom H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177176; Smith-Strom H, 2016, INT J MED INFORM, V94, P59, DOI 10.1016/j.ijmedinf.2016.06.020; Spenceley SM, 2006, CAN J NURS RES, V38, P124; Sturt J, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0660-z; van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x; von Soest T., 2005, TIDSSKRIFT NORSK PSY, V42, P226; Williams GC, 1996, J PERS SOC PSYCHOL, V70, P115, DOI 10.1037/0022-3514.70.1.115; Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001; Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58; Williams GC, 2002, HEALTH PSYCHOL, V21, P40, DOI 10.1037//0278-6133.21.1.40; World Health Organization, 2016, DIAB FACT SHEET; Wylie R. C., 1979, THE SELF CONCEPT; Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017; Zoffmann V, 2012, QUAL HEALTH RES, V22, P103, DOI 10.1177/1049732311420735	48	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201006	10.1371/journal.pone.0201006	http://dx.doi.org/10.1371/journal.pone.0201006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ0KU	30096144	Green Submitted, gold, Green Published			2022-12-26	WOS:000441308500010
J	Nosheen, A; Naz, R; Tahir, AT; Yasmin, H; Keyani, R; Mitrevski, B; Bano, A; Chin, ST; Marriott, PJ; Hussain, I				Nosheen, Asia; Naz, Rabia; Tahir, Ayesha T.; Yasmin, Humaira; Keyani, Rumana; Mitrevski, Blagoj; Bano, Asghari; Chin, Sung Tong; Marriott, Philip John; Hussain, Ishtiaq			Improvement of safflower oil quality for biodiesel production by integrated application of PGPR under reduced amount of NP fertilizers	PLOS ONE			English	Article							2-DIMENSIONAL GAS-CHROMATOGRAPHY; GROWTH PROMOTING RHIZOBACTERIA; FATTY-ACID PROFILES; YIELD; NITROGEN; L.; ACCUMULATION; EXPRESSION; FUELS	Safflower is an important industrial oil seed and bioenergy crop in semi-arid subtropical regions due to its potential to grow on marginal land and having good percentage of seed oil contents which is an important parameter for biofuel production. However, it is an ignored crop in Pakistan. In order to improve the crop productivity and reduce the use of agrochemicals for sustainable biodiesel feedstock production, an experiment was conducted for two years to improve the fatty acid composition and oil quality of Carthamus tinctorius L. (safflower) by the inoculation of Azospirillum and Azotobacter alone as well as in combined application with nitrogen and phosphate (NP) fertilizers on cultivars Thori and Saif-32 under field conditions. Separation and quantification of fatty acids were done on precise comprehensive two-dimensional gas chromatography (GCxGC). The results showed that fatty acid profile specifically monounsaturated fatty acids i-e oleic acid (C18:1) was significantly improved by Azospirillum supplemented with the quarter dose of NP fertilizers (SPQ) with concomitant decrease in polyunsaturated fatty acids by the respective treatment. Oil quality attributes such as acid value, saponification number, iodine value, refractive index and free fatty acid contents were reduced by the application of Azotobacter and Azospirillum in combination with half and quarter doses of NP fertilizers treatments (BTH, SPH, BTQ and SPQ). The reduction in these variables is positively linked with improved biodiesel yield and quality. It can be concluded that application of Azospirillum and Azotobacter not only reduced the use of NP fertilizers up to 50%-75% but also improved the oil quality in order to obtain environment friendly, sustainable and green fuel.	[Nosheen, Asia; Naz, Rabia; Tahir, Ayesha T.; Yasmin, Humaira; Keyani, Rumana] COMSATS Univ, Dept Biosci, Islamabad, Pakistan; [Mitrevski, Blagoj; Chin, Sung Tong; Marriott, Philip John] Monash Univ, Sch Chem, Australian Ctr Res Separat Sci, Clayton, Vic, Australia; [Bano, Asghari] Univ Wah, Fac Basic Sci, Dept Biosci, Wah, Pakistan; [Hussain, Ishtiaq] Dept Agr, Gilgit Baltistan, Pakistan	COMSATS University Islamabad (CUI); Monash University	Nosheen, A (corresponding author), COMSATS Univ, Dept Biosci, Islamabad, Pakistan.	nosheen_asia@yahoo.com	Naz, Rabia/AAI-8801-2020; tahir, ayesha/AAS-8238-2020; Keyani, Rumana/AAN-2321-2020; Yasmin, Humaira/AAS-9944-2020; Yasmin, Humaira/AAO-6630-2020; Yasmin, Humaira/ABB-1384-2021; Marriott, Philip J/H-6426-2013	tahir, ayesha/0000-0002-3701-6052; Yasmin, Humaira/0000-0002-8738-4216; Yasmin, Humaira/0000-0002-4220-4808; Marriott, Philip J/0000-0001-5180-1041; chin, sung/0000-0002-9765-6553	Higher Education Commission of Pakistan [106-1822-Bm6-05]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Furthermore, authors are grateful to the Higher Education Commission of Pakistan for providing funding (No. 106-1822-Bm6-05) to accomplish this piece of work successfully and also extend thanks to Monash University, Australia for collaborative research.	Ahmad S, 2017, J SCI FOOD AGR, V97, P3685, DOI 10.1002/jsfa.8228; Ali S, 2008, AUST J CROP SCI, V2, P150; [Anonymous], 1980, PRINCIPLES PROCEDURE; [Anonymous], 1962, CHEM ANAL FOODS; [Anonymous], 1993, COTTON DEV; AOAC, 1984, OFFICIAL METHODS ANA; AOCS, 1993, OFFICIAL METHODS REC; AOCS, 1990, OFFICIAL METHODS REC; Atabani AE, 2012, RENEW SUST ENERG REV, V16, P2070, DOI 10.1016/j.rser.2012.01.003; Bondioli P, 2002, EUR J LIPID SCI TECH, V104, P777, DOI 10.1002/1438-9312(200212)104:12<777::AID-EJLT777>3.0.CO;2-#; Canakci M, 2001, T ASAE, V44, P1429, DOI 10.13031/2013.7010; Choudhury ATMA, 2004, BIOL FERT SOILS, V39, P219, DOI 10.1007/s00374-003-0706-2; Demirbas A, 2009, ENERG SOURCE PART A, V31, P163, DOI 10.1080/15567030701521775; DHANASEKAR R., 2012, INT J PLANT ANIM ENV, V2, P143; Di Benedetto N.A., 2016, P PLANT BIOL EUR C E, P26, DOI [10.3934/microbiol.2017.3.413, DOI 10.3934/MICROBIOL.2017.3.413]; Dodos GS, 2012, GLOBAL NEST J, V14, P175; Eid R.A., 2010, OZEAN J APPL SCI, V3, P87; El-Gawad A. M. A., 2009, Research Journal of Agriculture and Biological Sciences, V5, P82; Galavi M., 2011, Journal of Agricultural Science (Toronto), V3, P22, DOI 10.5539/jas.v3n4p22; Gopinath A, 2009, P I MECH ENG D-J AUT, V223, P565, DOI 10.1243/09544070JAUTO950; Ibeto C.N., 2012, ISRN RENEWABLE ENERG, V2012, DOI [10.5402/2012/621518, DOI 10.5402/2012/621518]; Jha JK, 2007, PLANT PHYSIOL BIOCH, V45, P490, DOI 10.1016/j.plaphy.2007.03.001; Joshi Kishore Kumar, 2006, [Korean Journal of Environmental Agriculture, 한국환경농학회지], V25, P228; Kraiser T, 2011, J EXP BOT, V62, P1455, DOI 10.1093/jxb/erq425; Lawania TK, 2011, QUALITY PARAMETERS S; Maravi DK, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0642-7; Mirshekari B, 2012, J FOOD AGRIC ENVIRON, V10, P314; Nosheen A, 2013, ENERG SOURCE PART A, V35, P1574, DOI 10.1080/15567036.2010.529561; Nosheen A., 2014, INT J AGRON AGRI RES, V4, P75; Nosheen A, 2013, J CHROMATOGR A, V1312, P118, DOI 10.1016/j.chroma.2013.08.099; Sawan Z. M., 2006, World Journal of Agricultural Sciences, V2, P56; Tikhonovich IA, 2011, ANN APPL BIOL, V159, P155, DOI 10.1111/j.1744-7348.2011.00489.x; Tranchida PQ, 2008, J SEP SCI, V31, P1797, DOI 10.1002/jssc.200800002; Treanchida PQ, 2012, COMPREHENSIVE 2 DIME; Ullah Faizan, 2011, Braz. J. Plant Physiol., V23, P27, DOI 10.1590/S1677-04202011000100005; Ye J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-91	36	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201738	10.1371/journal.pone.0201738	http://dx.doi.org/10.1371/journal.pone.0201738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096207	gold, Green Submitted, Green Published			2022-12-26	WOS:000441308500026
J	Poudel, S; Upadhaya, N; Khatri, RB; Ghimire, PR				Poudel, Samikshya; Upadhaya, Nawaraj; Khatri, Resham Bahadur; Ghimire, Pramesh Raj			Trends and factors associated with pregnancies among adolescent women in Nepal: Pooled analysis of Nepal Demographic and Health Surveys (2006, 2011 and 2016)	PLOS ONE			English	Article							COUNTRIES; MULTICOUNTRY; OUTCOMES	Introduction Adolescent pregnancy is a significant cost to mother, newborn, and their family and society. Despite the enormous health and social impact of adolescent pregnancy, there is a dearth of nationally representative studies on factors associated with adolescent pregnancies in Nepal. Therefore, this study aimed to examine trends and factors associated with adolescent pregnancies in Nepal, using pooled data of three nationally representative demographic surveys. Methods Data for this study was derived from the recent three consecutive (2006, 2011 and 2016) Nepal Demographic and Health Surveys (NDHS). A total of 7,788 adolescent women aged 15-19 years included in the analysis. Trends and multivariable logistic regression analysis was performed to examine the factors associated with adolescent pregnancy. Results Over the study period (2006-2016), the rate of adolescent pregnancy was 173 [95% Confidence Interval (CI): 159, 188] per 1000 women aged 15-19 years. Adolescent pregnancy was significantly higher among woman with middle household wealth index [adjusted Odds Ratio (aOR) 2.19, 95% confidence interval CI 1.65, 2.91] or poor household wealth index (aOR 2.37, 95% CI 1.76, 3.21). Similarly, Dalit (aOR 1.87, 95% CI 1.50, 2.34) or Madhesi (aOR 1.67, 95% CI 1.32, 2.11); and unemployed (aOR 1.28, 95% CI 1.09, 1.50) women had higher odds of adolescent pregnancies. In contrast, adolescent pregnancy was significantly lower among educated women (aOR 0.60, 95% CI 0.48, 0.74), and women with access to media exposure to public health issues (aOR 0.75, 95% CI 0.64, 0.88). Conclusions Access to the media exposure on public health issues can be the effective efforts to reduce adolescent pregnancy. Women who have low maternal education, low wealth index, unemployed, and ethnic groups such as Dalits, and Madeshi needs to be targeted while designing and implementing policies and programs.	[Poudel, Samikshya] Ujyalo Nepal, Ratnanagar Municipality, Nepal; [Upadhaya, Nawaraj] Dept Res & Dev Hlth Works, Amsterdam, Netherlands; [Khatri, Resham Bahadur] Univ Queensland, Sch Publ Hlth, Queensland, Australia; [Ghimire, Pramesh Raj] Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia	University of Queensland; Western Sydney University	Poudel, S (corresponding author), Ujyalo Nepal, Ratnanagar Municipality, Nepal.	tj_sami@hotmail.com	Khatri, Resham B/R-1532-2016	Khatri, Resham B/0000-0001-5216-606X; Poudel, Samikshya/0000-0003-0850-9728; Ghimire, Pramesh Raj/0000-0003-2816-0463; Ghimire, Pramesh/0000-0002-7902-7294				Acharya DR, 2014, HLTH SCI J, V4, P3; Adhikari RK, 2003, EARLY MARRIAGE CHILD; Aryal B, 2012, CHILD MARRIAGE NEPAL; Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; Choe MK, 2005, J BIOSOC SCI, V37, P143, DOI 10.1017/S0021932003006527; Dangal G., 2008, J NEPAL MED ASSOC, P45; Elawad T., 2020, THESIS KING COLL LON; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Ghimire PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191988; Ghimire PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181332; Imamura M, 2007, EUR J PUBLIC HEALTH, V17, P630, DOI 10.1093/eurpub/ckm014; Kirby D, 1997, CHILD YOUTH SERV REV, V19, P415, DOI 10.1016/S0190-7409(97)00025-X; Loaiza E., 2013, ADOLESCENT PREGNANCY; Ministry of Health and Population (MOHP) [Nepal] New ERA and Macro International Inc, 2007, NEW ERA MACR INC 200; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; MOHP New ERA ICF International., 2017, NEP DEM HLTH SURV 20; Nalika G., 2013, HLTH SCI J, P7; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Odimegwu C, 2016, AFR J REPROD HEALTH, V20, P94, DOI 10.29063/ajrh2016/v20i3.14; Pandey J.P., 2013, MATERNAL CHILD HLTH; Pradhan R, 2015, J EPIDEMIOL COMMUN H, V69, P918, DOI 10.1136/jech-2014-205128; Sayem AM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-16; Seamark CJ, 1998, BRIT J GEN PRACT, V48, P985; Sharma Arun K., 2002, Indian Journal of Pediatrics, V69, P19; Shrestha R., 2012, INQUIRIES J, P4; Shrestha Sarala, 2002, Int J Adolesc Med Health, V14, P101; UNFPA-Afghanistan, 2015, SOC EC SURV CHILD MO; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wang RH, 2003, PUBLIC HEALTH NURS, V20, P33, DOI 10.1046/j.1525-1446.2003.20105.x; WHO (World Health Organization), 2011, GUID PREV EARL PREGN; World Health Organization, 2014, AD PREGN; World Health Organization and Nepal Ministry of Health, 2016, AD SEX REPR HLTH PRO; World Health Organization (WHO), 2007, ADOLESCENT PREGNANCY	34	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202107	10.1371/journal.pone.0202107	http://dx.doi.org/10.1371/journal.pone.0202107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092087	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600088
J	Bonetti, P; Climent, M; Panebianco, F; Tordonato, C; Santoro, A; Marzi, MJ; Pelicci, PG; Ventura, A; Nicassio, F				Bonetti, Paola; Climent, Montserrat; Panebianco, Fabiana; Tordonato, Chiara; Santoro, Angela; Marzi, Matteo Jacopo; Pelicci, Pier Giuseppe; Ventura, Andrea; Nicassio, Francesco			Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer	ONCOGENE			English	Article							STEM-CELLS; MOLECULAR PORTRAITS; MICRORNA; METASTASIS; MIRNAS; AXIS	The role of the tumour-suppressor miR-34 family in breast physiology and in mammary stem cells (MaSCs) is largely unknown. Here, we revealed that miR-34 family, and miR-34a in particular, is implicated in mammary epithelium homoeostasis. Expression of miR-34a occurs upon luminal commitment and differentiation and serves to inhibit the expansion of the pool of MaSCs and early progenitor cells, likely in a p53-independent fashion. Mutant mice (miR34-KO) and loss-of-function approaches revealed two separate functions of miR-34a, controlling both proliferation and fate commitment in mammary progenitors by modulating several pathways involved in epithelial cell plasticity and luminal-to-basal conversion. In particular, miR-34a acts as endogenous inhibitor of the Wnt/beta-catenin signalling pathway, targeting up to nine upstream regulators at the same time, thus modulating the expansion of the MaSCs/early progenitor pool. These multiple roles of miR-34a are maintained in a model of human breast cancer, in which chronic expression of miR-34a in triple-negative mesenchymal-like cells (enriched in cancer stem cells-CSCs) could promote a luminal-like differentiation programme, restrict the CSC pool, and inhibit tumour propagation. Hence, activation of miR-34a-dependent programmes could provide a therapeutic opportunity for the subset of breast cancers, which are rich in CSCs and respond poorly to conventional therapies.	[Bonetti, Paola; Climent, Montserrat; Panebianco, Fabiana; Marzi, Matteo Jacopo; Nicassio, Francesco] ITT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Tordonato, Chiara] IFOM, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Santoro, Angela; Pelicci, Pier Giuseppe] European Inst Oncol IE0, Dept Expt Oncol, I-20100 Milan, Italy; [Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Sci Salute, I-20100 Milan, Italy; [Ventura, Andrea] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Istituto Italiano di Tecnologia - IIT; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; Memorial Sloan Kettering Cancer Center	Bonetti, P; Nicassio, F (corresponding author), ITT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy.	paola.bonetti@iit.it; francesco.nicassio@iit.it	Climent, Montserrat/K-6490-2019; Bonetti, Paola/Y-9182-2019; tordonato, chiara/AAQ-5819-2020; Pelicci, Pier Giuseppe/AAL-6572-2020; Marzi, Matteo Jacopo/AAB-9775-2019	Climent, Montserrat/0000-0002-9029-7914; Bonetti, Paola/0000-0002-8805-9837; tordonato, chiara/0000-0001-6556-1747; Marzi, Matteo Jacopo/0000-0002-5068-782X; nicassio, francesco/0000-0002-5954-5318	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG14085, IG18774]; Cariplo [2015-0590]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cariplo(Fondazione Cariplo)	We thank the Genomic Unit and Imaging Unit, Federica Pisati for IHC, Thalia Vlachou for ChIP. Veronica Raker for manuscript editing. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to FN (IG14085 and IG18774), Cariplo (2015-0590) to FN.	Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brisken C, 2000, GENE DEV, V14, P650; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jafari N, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317701652; Kang L, 2015, CANCER SCI, V106, P700, DOI 10.1111/cas.12656; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Marzi MJ, 2012, J CELL BIOL, V199, P77, DOI 10.1083/jcb.201206033; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Park EY, 2014, CANCER RES, V74, P7573, DOI 10.1158/0008-5472.CAN-14-1140; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taube JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02687; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	47	32	32	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					360	374		10.1038/s41388-018-0445-3	http://dx.doi.org/10.1038/s41388-018-0445-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30093634	Green Published, hybrid			2022-12-26	WOS:000455851200005
J	Meng, TG; Lu, XK; Guo, L; Hou, GM; Ma, XS; Li, QN; Huang, L; Fan, LH; Zhao, ZH; Ou, XH; OuYang, YC; Schatten, H; Li, L; Wang, ZB; Sun, QY				Meng, Tie-Gang; Lu, Xukun; Guo, Lei; Hou, Guan-Mei; Ma, Xue-Shan; Li, Qian-Nan; Huang, Lin; Fan, Li-Hua; Zhao, Zheng-Hui; Ou, Xiang-Hong; OuYang, Ying-Chun; Schatten, Heide; Li, Lei; Wang, Zhen-Bo; Sun, Qing-Yuan			Mettl14 is required for mouse postimplantation development by facilitating epiblast maturation	FASEB JOURNAL			English	Article						N6-methyladenosine; embryogenesis; naive state; primed state; gene expression	NUCLEAR-RNA; N6-METHYLADENOSINE; TRANSITION; METHYLATION; DEMETHYLASE; DERIVATION; COMPLEX; CULTURE; CELLS	N6-methyladenosine (m(6)A) is the most prevalent and reversible internal modification of mammalian messenger and noncoding RNAs mediated by specific m(6)A writer, reader, and eraser proteins. As an m(6)A writer, the methyltransferase-like 3-methyltransferase-like 14 (METTL14)-Wilms tumor 1-associated protein complex dynamically regulates m(6)A modification and plays important roles in diverse biologic processes. However, our knowledge about the complete functions of this RNA methyltransferase complex, the contributions of each component to the methylation, and their effects on different biologic pathways are still limited. By using both in vivo and in vitro models, we here report that METTL14 is indispensable for postimplantation embryonic development by facilitating the conversion from naive to primed state of the epiblast. Depletion of Mettl14 leads to conspicuous embryonic growth retardation from embryonic d 6.5, mainly as a result of resistance to differentiation, which further leads to embryonic lethality early in gestation. Our data highlight the critical function of METTL14 as an m(6)A modification regulator in orchestrating early mouse embryogenesis.Meng, T.-G., Lu, X., Guo, L., Hou, G.-M., Ma, X.-S., Li, Q.-N., Huang, L., Fan, L.-H., Zhao, Z.-H., Ou, X.-H., OuYang, Y.-C., Schatten, H., Li, L., Wang, Z.-B., Sun, Q.-Y. Mettl14 is required for mouse postimplantation development by facilitating epiblast maturation.	[Meng, Tie-Gang; Lu, Xukun; Guo, Lei; Hou, Guan-Mei; Ma, Xue-Shan; Li, Qian-Nan; Huang, Lin; Fan, Li-Hua; Zhao, Zheng-Hui; OuYang, Ying-Chun; Li, Lei; Wang, Zhen-Bo; Sun, Qing-Yuan] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Meng, Tie-Gang; Lu, Xukun; Fan, Li-Hua; Zhao, Zheng-Hui; Li, Lei; Wang, Zhen-Bo; Sun, Qing-Yuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guo, Lei; Ou, Xiang-Hong] Guangdong Second Prov Gen Hosp, Fertil Preservat Lab, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Wang, ZB; Sun, QY (corresponding author), Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	wangzb@ioz.ac.cn; sunqy@ioz.ac.cn	Zhao, Zhenghui/AAY-6120-2020	Sun, Qing-Yuan/0000-0002-0148-2414; Meng, Tie-Gang/0000-0001-8069-0256; Li, Lei/0000-0001-5478-5681	National Key Research and Development Program of China [2016YFA0100400, 2016YFC1000600]; National Natural Science Foundation of China [31472055, 31671559]; Youth Innovation Promotion Association [CAS 2017114]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association	This work was supported, in part, by the National Key Research and Development Program of China (2016YFA0100400, 2016YFC1000600), the National Natural Science Foundation of China (31472055, 31671559), and the Youth Innovation Promotion Association (CAS 2017114). The authors declare no conflicts of interest.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bartosovic M, 2017, NUCLEIC ACIDS RES, V45, P11356, DOI 10.1093/nar/gkx778; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Huang X, 2017, ELIFE, V6, DOI 10.7554/eLife.33333; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kalkan T, 2017, DEVELOPMENT, V144, P1221, DOI 10.1242/dev.142711; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	26	38	40	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1179	1187		10.1096/fj.201800719R	http://dx.doi.org/10.1096/fj.201800719R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30110177	Green Submitted, Bronze			2022-12-26	WOS:000457401500093
J	Alvarez-Sanchez, C; Contento, I; Jimenez-Aguilar, A; Koch, P; Gray, HL; Guerra, LA; Rivera-Dommarco, J; Uribe-Carvajal, R; Shamah-Levy, T				Alvarez-Sanchez, Cristina; Contento, Isobel; Jimenez-Aguilar, Alejandra; Koch, Pamela; Gray, Heewon Lee; Guerra, Laura A.; Rivera-Dommarco, Juan; Uribe-Carvajal, Rebeca; Shamah-Levy, Teresa			Does the Mexican sugar-sweetened beverage tax have a signaling effect? ENSANUT 2016	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; PLANNED BEHAVIOR; HEALTH-PROMOTION; NATIONAL-HEALTH; US ADULTS; CONSUMPTION; PREVALENCE; RISK; METAANALYSIS; ADOLESCENTS	Objective To evaluate the potential signaling effect of the Mexican tax on sugar-sweetened beverages (SSBs) by analyzing the association between awareness of and opinions about its effectiveness with current consumption of taxed SSBs and with a self-reported change in consumption of SSBs since the implementation of the tax. We also examined the association between psychosocial and environmental determinants of SSB consumption with current consumption of taxed SSBs and with a reported change in consumption of SSBs. Methods Cross-sectional analyses of survey and food-frequency questionnaire data from the Mexican National Health and Nutrition Survey 2016. Participants were Mexican adults (20-59 years, N = 6,650). Logistic regression was used to evaluate the probability of a person reporting a decrease in SSB consumption, given their awareness of the tax, opinion about its effectiveness, psychosocial (SSB health-related beliefs, self-efficacy, and liking of SSBs) and environmental (availability of potable water) determinants. Multiple linear regression analysis was utilized to examine the association between the aforementioned factors and current consumption of taxed SSBs. Results Compared with adults not aware, adults who were aware of the SSB tax were more likely (OR = 1.30) to report a decrease in SSB consumption (p =.012). In urban areas, adults aware of the tax drank a significantly lower amount of taxed SSBs (-15.7%; p =.023) than those not aware. Self-efficacy and liking of SSBs were significantly associated with a reported decrease in consumption and with current consumption (p <.001), while health beliefs and availability of potable water were not significantly associated with either reported change in SSB consumption or current consumption of taxed SSBs. Conclusions Implementation of an SSB tax accompanied by highly visible campaigns may further influence the impact of taxes on SSBs consumption. Future public health and nutrition education campaigns designed to increase knowledge and enhance motivation should be complemented by programs to assist individuals develop self-efficacy and self-regulation skills.	[Alvarez-Sanchez, Cristina; Contento, Isobel; Koch, Pamela; Gray, Heewon Lee; Guerra, Laura A.] Columbia Univ, Teachers Coll, Program Nutr, Dept Hlth & Behav Studies, New York, NY 10027 USA; [Jimenez-Aguilar, Alejandra; Rivera-Dommarco, Juan; Uribe-Carvajal, Rebeca; Shamah-Levy, Teresa] Mexican Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico; [Gray, Heewon Lee] Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, Tampa, FL USA	Columbia University; Columbia University Teachers College; State University System of Florida; University of South Florida	Alvarez-Sanchez, C (corresponding author), Columbia Univ, Teachers Coll, Program Nutr, Dept Hlth & Behav Studies, New York, NY 10027 USA.	cristina.alvarez@tc.columbia.edu	Gray, Heewon/AAB-2753-2021; Koch, Pamela A/AAU-8528-2020	Gray, Heewon/0000-0002-5257-5012; Alvarez Sanchez, Cristina/0000-0001-5644-6042	Bloomberg Philanthropies [CINYS/1305]; Tisch Doctoral Scholar Fund, Program in Nutrition, Teachers College, Columbia University	Bloomberg Philanthropies; Tisch Doctoral Scholar Fund, Program in Nutrition, Teachers College, Columbia University	This article was possible due to an unrestricted research grant from Bloomberg Philanthropies (project CINYS/1305) and the Tisch Doctoral Scholar Fund, Program in Nutrition, Teachers College, Columbia University. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results.	Abdukadirov S, 2016, WHO SHOULD NUDGE NUD; Alvarez-Sanchez C, 2018, THESIS; [Anonymous], 2013, LEY IMPUESTO ESPECIA; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; Bader P, 2011, INT J ENV RES PUB HE, V8, P4118, DOI 10.3390/ijerph8114118; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Baranowski T, 1999, ANNU REV NUTR, V19, P17, DOI 10.1146/annurev.nutr.19.1.17; Barigozzi F, 2006, J PUBLIC EC THEORY, V8, P611, DOI [DOI 10.1111/J.1467-9779.2006.00281.X, 10. 1111/j.1467-9779.2006.00281.x10.1111/j.1467-9779.2006.00281.x, DOI 10.1111/J.1467-9779.2006.00281.X10.1111/J.1467-9779.2006.00281.X]; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111; Barquera S, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-47; Batis C, 2016, J NUTR, V146, P1897, DOI 10.3945/jn.115.219626; Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; COLCHERO MA, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.H6704; CONAR, 2009, COD SELF REG FOOD NO; Denova-Gutierrez E, 2016, SALUD PUBLICA MEXICO, V58, P617, DOI 10.21149/spm.v58i6.7862; Donaldson E, 2015, ADVOCATING SUGAR SWE; Ellis J. A., 2007, Morbidity and Mortality Weekly Report, V56, P604; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; Field A.P., 2014, DISCOVERING STAT USI; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Gutierrez JP., 2013, SALUD PUBLICA MEX S2, V55; HABICHT JP, 1974, B OFIC SANIT PANAM, V75, P375; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Huang C, 2014, ATHEROSCLEROSIS, V234, P11, DOI 10.1016/j.atherosclerosis.2014.01.037; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; INSP, 2016, FOOD FREQ QUEST AD A; INSP, 2016, PERC OB PHYS ACT DIE; Kim S, 2017, J PUBLIC HEALTH DENT, V77, P148, DOI 10.1111/jphd.12192; Knezevic A., 2008, STATNEWS 73 OVERLAPP; Leicester A., 2012, TAX BENEFIT POLICY I; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lohman T.G., 1991, HUMAN KINETICS BOOKS; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Onufrak SJ, 2014, PUBLIC HEALTH NUTR, V17, P179, DOI 10.1017/S1368980012004600; PAHO, 2015, TAX SUG SWEET BEV PU; Park S, 2014, J ACAD NUTR DIET, V114, P1059, DOI 10.1016/j.jand.2013.11.003; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Ramirez-Silva I, 2016, SALUD PUBLICA MEXICO, V58, P629, DOI 10.21149/spm.v58i6.7974; Rodriguez-Ramirez S, 2016, J NUTR, V146, P1916, DOI 10.3945/jn.115.220145; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Romero-Mart?nez, 2017, ENCUESTA NACL SALUD; Romero-Martinez M, 2017, SALUD PUBLICA MEXICO, V59, P299, DOI 10.21149/8593; Sanchez-Pimienta TG, 2016, J NUTR, V146, P1888, DOI 10.3945/jn.115.220301; Tabachnick B. G., 2001, USING MULTIVARIATE S; University of California Los Angeles (UCLA) Institute for Digital Research and Education (IDRE), 2017, FAQ I INT REGR MOD S; Velicer WF, 1998, PSYCHOL METHODS, V3, P231, DOI 10.1037/1082-989X.3.2.231; Ventura AK, 2011, CURR OPIN CLIN NUTR, V14, P379, DOI 10.1097/MCO.0b013e328346df65; Wang M, 2015, J DIABETES INVEST, V6, P360, DOI 10.1111/jdi.12309; World Health Organization, 2016, FISC POL DIET PREV N; World Health Organization, BOD MASS IND BMI 201; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130; Zoellner J, 2012, J ACAD NUTR DIET, V112, P1774, DOI 10.1016/j.jand.2012.06.368; Zoellner J, 2012, J NUTR EDUC BEHAV, V44, P172, DOI 10.1016/j.jneb.2011.06.010	58	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0199337	10.1371/journal.pone.0199337	http://dx.doi.org/10.1371/journal.pone.0199337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR3NR	30133438	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400004
J	Weber, J; Wohland, J; Reyers, M; Moemken, J; Hoppe, C; Pinto, JG; Witthaut, D				Weber, Juliane; Wohland, Jan; Reyers, Mark; Moemken, Julia; Hoppe, Charlotte; Pinto, Joaquim G.; Witthaut, Dirk			Impact of climate change on backup energy and storage needs in wind-dominated power systems in Europe	PLOS ONE			English	Article							ELECTRICITY DEMAND; FUTURE CHANGES; POTENTIALS; CORDEX; SPEED; CMIP5	The high temporal variability of wind power generation represents a major challenge for the realization of a sustainable energy supply. Large backup and storage facilities are necessary to secure the supply in periods of low renewable generation, especially in countries with a high share of renewables. We show that strong climate change is likely to impede the system integration of intermittent wind energy. To this end, we analyze the temporal characteristics of wind power generation based on high-resolution climate projections for Europe and uncover a robust increase of backup energy and storage needs in most of Central, Northern and North-Western Europe. This effect can be traced back to an increase of the likelihood for long periods of low wind generation and an increase in the seasonal wind variability.	[Weber, Juliane; Wohland, Jan; Witthaut, Dirk] Forschungszentrum Julich, Inst Energy & Climate Res, Syst Anal & Technol Evaluat IEK STE, Julich, Germany; [Weber, Juliane; Wohland, Jan; Witthaut, Dirk] Univ Cologne, Inst Theoret Phys, Cologne, Germany; [Reyers, Mark] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany; [Moemken, Julia; Pinto, Joaquim G.] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Karlsruhe, Germany; [Hoppe, Charlotte] Forschungszentrum Julich, Inst Energy & Climate Res, Troposphere IEK 8, Julich, Germany; [Hoppe, Charlotte] Univ Cologne, Rhenish Inst Environm Res, Cologne, Germany	Helmholtz Association; Research Center Julich; University of Cologne; University of Cologne; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Research Center Julich; University of Cologne	Weber, J (corresponding author), Forschungszentrum Julich, Inst Energy & Climate Res, Syst Anal & Technol Evaluat IEK STE, Julich, Germany.; Weber, J (corresponding author), Univ Cologne, Inst Theoret Phys, Cologne, Germany.	ju.weber@fz-juelich.de	UzK, IGMK/HGU-4003-2022; Witthaut, Dirk/I-3783-2012; Witthaut, Dirk/AAA-8073-2020; Pinto, Joaquim G/A-7352-2009	Witthaut, Dirk/0000-0002-3623-5341; Witthaut, Dirk/0000-0002-3623-5341; Pinto, Joaquim G/0000-0002-8865-1769	Helmholtz Association (joint initiative "Energy System 2050 - A Contribution of the Research Field Energy") [VH-NG-1025]; Federal Ministry for Education and Research (BMBF) [03SF0472]; Helmholtz-Zentrum Geesthacht/German Climate Service Center (HZG/GERICS); AXA Research Fund; Helmholtz Association (joint initiative "Energy System 2050-A Contribution of the Research Field Energy") [VH-NG-1025]	Helmholtz Association (joint initiative "Energy System 2050 - A Contribution of the Research Field Energy"); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz-Zentrum Geesthacht/German Climate Service Center (HZG/GERICS); AXA Research Fund(AXA Research Fund); Helmholtz Association (joint initiative "Energy System 2050-A Contribution of the Research Field Energy")	This work was supported by the Helmholtz Association (via the joint initiative "Energy System 2050 - A Contribution of the Research Field Energy" and the grant no. VH-NG-1025 to D. Witthaut) and the Federal Ministry for Education and Research (BMBF grant no. 03SF0472 to D. Witthaut). For M. Reyers, J. Moemken and J. G. Pinto contributions were partially supported by the Helmholtz-Zentrum Geesthacht/German Climate Service Center (HZG/GERICS). J. G. Pinto thanks the AXA Research Fund for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the World Climate Research Programme's Working Group on Regional Climate, and the Working Group on Coupled Modelling, former coordinating body of CORDEX and responsible panel for CMIP5. We also thank the climate modelling groups (listed in Table A in S1 Appendix) for producing and making available their model output. We also acknowledge the Earth System Grid Federation infrastructure an international effort led by the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison, the European Network for Earth System Modelling and other partners in the Global Organisation for Earth System Science Portals (GO-ESSP). We thank H. Elbern, G. B. Andresen, S. Kozarcanin, T. Brown, and J. Hoersch for stimulating discussions. We gratefully acknowledge support from the Helmholtz Association (via the joint initiative "Energy System 2050-A Contribution of the Research Field Energy" and the grant no. VH-NG-1025) and the Federal Ministry for Education and Research (BMBF grant no. 03SF0472) to D. W.. For M. R., J. M. and J. G. P. contributions were partially funded by the the Helmholtz-Zentrum Geesthacht/German Climate Service Center (HZG/GERICS). J.G.P. thanks the AXA Research Fund for support.	AG Energiebilanzen e V, 2017, EN DEUTSCHL JAHR 201; Allen MR, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.103, 10.1038/nenergy.2016.103]; Andresen GB, 2015, ENERGY, V93, P1074, DOI 10.1016/j.energy.2015.09.071; [Anonymous], EUROCORDEX DAT; Auffhammer M, 2017, P NATL ACAD SCI USA, V114, P1886, DOI 10.1073/pnas.1613193114; Bakker AMR, 2012, CLIM DYNAM, V39, P767, DOI 10.1007/s00382-011-1248-1; Becker S, 2014, ENERGY, V72, P443, DOI 10.1016/j.energy.2014.05.067; Bloomfield HC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124025; Bratton D.C., 2011, ENERGY SUSTAIN, V54686, P2245; Bruckner T, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P511; Davidson MR, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.86, 10.1038/NENERGY.2016.86]; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Demuzere M, 2009, INT J CLIMATOL, V29, P1796, DOI 10.1002/joc.1821; Diaz-Gonzalez F, 2012, RENEW SUST ENERG REV, V16, P2154, DOI 10.1016/j.rser.2012.01.029; Edenhofer O., 2014, CONTRIBUTION WORKING; Egan JP, 1975, SIGNAL DETECTION THE; Elsner P, 2015, FLEXIBILITATSKONZEPT; European Network of Transmission System Operators for Electricity (ENTSO-E), HOURL LOAD VAL; Eyring V, 2016, GEOSCI MODEL DEV, V9, P1937, DOI 10.5194/gmd-9-1937-2016; Feser F, 2015, Q J ROY METEOR SOC, V141, P350, DOI 10.1002/qj.2364; Francois B, 2018, ENERGIES, V11, DOI 10.3390/en11020290; Giorgi F, 2015, ANNU REV ENV RESOUR, V40, P467, DOI 10.1146/annurev-environ-102014-021217; Grams CM, 2017, NAT CLIM CHANGE, V7, P557, DOI [10.1038/nclimate3338, 10.1038/NCLIMATE3338]; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Heide D, 2010, RENEW ENERG, V35, P2483, DOI 10.1016/j.renene.2010.03.012; Huber M, 2014, ENERGY, V69, P236, DOI 10.1016/j.energy.2014.02.109; Hueging H, 2013, J APPL METEOROL CLIM, V52, P903, DOI 10.1175/JAMC-D-12-086.1; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Jacobson MZ, 2011, ENERG POLICY, V39, P1154, DOI 10.1016/j.enpol.2010.11.040; Jensen TV, 2014, EUR PHYS J-SPEC TOP, V223, P2475, DOI 10.1140/epjst/e2014-02216-9; Jerez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10014; JONES PD, 1993, INT J CLIMATOL, V13, P655, DOI 10.1002/joc.3370130606; Kozarcanin S, 2018, ARXIV180501364; Kubik ML, 2013, RENEW ENERG, V51, P153, DOI 10.1016/j.renene.2012.08.084; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106; Manwell J.F., 2009, WIND ENERGY EXPLAINE, P83; Moemken J, 2018, J GEOPHYS RES-ATMOS, V123, P6373, DOI 10.1029/2018JD028473; Monforti F, 2016, RENEW SUST ENERG REV, V59, P1622, DOI 10.1016/j.rser.2015.12.318; Olauson J, 2016, NAT ENERGY, V1, P1, DOI [10.1038/nenergy.2016.175, 10.1038/NENERGY.2016.175]; Pinto JG, 2012, CLIM RES, V54, P1, DOI 10.3354/cr01111; Pryor SC, 2010, RENEW SUST ENERG REV, V14, P430, DOI 10.1016/j.rser.2009.07.028; Rasmussen MG, 2012, ENERG POLICY, V51, P642, DOI 10.1016/j.enpol.2012.09.009; Reyers M, 2016, INT J CLIMATOL, V36, P783, DOI 10.1002/joc.4382; Reyers M, 2015, INT J CLIMATOL, V35, P229, DOI 10.1002/joc.3975; Rodriguez RA, 2014, RENEW ENERG, V63, P467, DOI 10.1016/j.renene.2013.10.005; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x; Schlachtberger DP, 2016, ENERG CONVERS MANAGE, V125, P336, DOI 10.1016/j.enconman.2016.04.020; Schlott M, 2018, ARXIV180511673; Sims R, 2011, RENEWABLE ENERGY SOURCES AND CLIMATE CHANGE MITIGATION: SPECIAL REPORT OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P609; Stanton MCB, 2016, ENERGY, V109, P1148, DOI 10.1016/j.energy.2016.05.015; Strandberg G, 2015, CORDEX SCENARIOS EUR; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tobin I, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034013; Tobin I, 2015, CLIMATIC CHANGE, V128, P99, DOI 10.1007/s10584-014-1291-0; United Nations (UN), 2015, PAR AGR; van Vliet MTH, 2016, NAT CLIM CHANGE, V6, P375, DOI [10.1038/nclimate2903, 10.1038/NCLIMATE2903]; van Vliet MTH, 2012, NAT CLIM CHANGE, V2, P676, DOI [10.1038/nclimate1546, 10.1038/NCLIMATE1546]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, DOI 10.1007/S10584-011-0148-Z]; Weber J, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.032138; Wohland J, 2017, EARTH SYST DYNAM, V8, P1047, DOI 10.5194/esd-8-1047-2017; Woollings T, 2012, NAT GEOSCI, V5, P313, DOI [10.1038/ngeo1438, 10.1038/NGEO1438]; Zappa G, 2015, J CLIMATE, V28, P6381, DOI 10.1175/JCLI-D-14-00823.1	65	18	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201457	10.1371/journal.pone.0201457	http://dx.doi.org/10.1371/journal.pone.0201457			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133464	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400021
J	Dechbumroong, P; Aumnouypol, S; Denduangboripant, J; Sukrong, S				Dechbumroong, Piroonrat; Aumnouypol, Surattana; Denduangboripant, Jessada; Sukrong, Suchada			DNA barcoding of Aristolochia plants and development of species-specific multiplex PCR to aid HPTLC in ascertainment of Aristolochia herbal materials	PLOS ONE			English	Article							MEDICINAL MATERIALS; IDENTIFICATION; ACIDS; CYTOTOXICITY	The anecdotal evidence is outstanding on the uses of Aristolochia plants as traditional medicines and dietary supplements in many regions of the world. However, herbal materials derived from Aristolochia species have been identified as potent human carcinogens since the first case of severe renal disease after ingesting these herbal preparations. Any products containing Aristolochia species have thus been banned on many continents, including Europe, America and Asia. Therefore, the development of a method to identify these herbs is critically needed for customer safety. The present study evaluated DNA barcoding of the rbcL, matK, ITS2 and trnH-psbA regions among eleven Aristolochia species collected in Thailand. Polymorphic sites were observed in all four DNA loci. Among those eleven Aristolochia species, three species (A. pierrei, A. tagala and A. pothieri) are used as herbal materials in Thai folk medicine, namely, in Thai "Krai-Krue". "Krai-Krue" herbs are interchangeably used as an admixture in Thai traditional remedies without specific knowledge of their identities. A species-specific multiplex PCR based on nucleotide polymorphisms in the ITS2 region was developed as an identification tool to differentiate these three Aristolochia species and to supplement the HPTLC pattern in clarifying the origins of herbal materials. The combination of multiplex PCR and HPTLC profiling achieves accurate herbal identification with the goal of protecting consumers from the health risks associated with product substitution and contamination.	[Dechbumroong, Piroonrat; Aumnouypol, Surattana; Sukrong, Suchada] Chulalongkorn Univ, Drug & Hlth Prod Innovat Promot Ctr, Dept Pharmacognosy & Pharmaceut Bot, Fac Pharmaceut Sci,Res Unit DNA Barcoding Thai Me, Bangkok, Thailand; [Denduangboripant, Jessada] Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Sukrong, S (corresponding author), Chulalongkorn Univ, Drug & Hlth Prod Innovat Promot Ctr, Dept Pharmacognosy & Pharmaceut Bot, Fac Pharmaceut Sci,Res Unit DNA Barcoding Thai Me, Bangkok, Thailand.	suchada.su@chula.ac.th		Sukrong, Suchada/0000-0003-4062-2632	90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand	90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University); Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand	PD is grateful for the financial support provided by the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). This work was financially supported by Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand (SS). We thank the Research Unit of DNA Barcoding of Thai Medicinal Plants, Chulalongkorn University, Drug and Health Products Innovation Promotion Center for providing support facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, IARC MON EV CARC RIS; Athikomkulchai S, 2001, THAI J PHARM SCI, V18, P42; Bhattacharjee P, 2013, J ETHNOPHARMACOL, V145, P220, DOI 10.1016/j.jep.2012.10.056; Blatter A, 2004, JPC-J PLANAR CHROMAT, V17, P355, DOI 10.1556/JPC.17.2004.5.6; British Pharmacopoeia Commission, 2012, BRIT PHARM 2012; Bureau of Drug Control. Annoucement of Bureau of Drug Control, 2013, BUR DRUG CONTR, P50; Chan W, 2007, DRUG METAB DISPOS, V35, P866, DOI 10.1124/dmd.106.013979; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Department of Thai Traditional and Complementary Medicine, 2015, MON SEL THAI MAT MED; Gonzalez F., 1997, CALDASIA, V19, P115; Gonzalez Favio, 1999, Systematics and Geography of Plants, V68, P159, DOI 10.2307/3668598; Guo XR, 2011, BIOL PHARM BULL, V34, P1198, DOI 10.1248/bpb.34.1198; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hegde VR, 2010, BIOORG MED CHEM LETT, V20, P1344, DOI 10.1016/j.bmcl.2010.01.018; Heinrich M, 2009, J ETHNOPHARMACOL, V125, P108, DOI 10.1016/j.jep.2009.05.028; Heubl G., 2013, DNA BASED AUTHENTICA, P27; Heywood VH, 1993, FLOWERING PLANTS WOR; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Holzbach JC, 2010, MOLECULES, V15, P9462, DOI 10.3390/molecules15129462; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, REV HUMAN CARCINOGEN, V100, P1; Jain SK, 1991, MED PLANTS INDIA, V1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li M, 2014, FOOD CHEM, V147, P332, DOI 10.1016/j.foodchem.2013.09.146; Li M, 2012, FOOD CHEM, V135, P1653, DOI 10.1016/j.foodchem.2012.06.049; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Li M, 2010, J ETHNOPHARMACOL, V130, P429, DOI 10.1016/j.jep.2010.04.040; Ministry of Public Health Committee, 2013, ED KRAI KRUE CONT RE, P55; Murata Jin, 2001, Acta Phytotaxonomica et Geobotanica, V52, P75; National Toxicology Program, 2011, REP CARC, V12, P3; NEINHUIS C, 2004, PLANT SYST EVOL, V250, P7; Ohi-Toma T, 2006, SYST BOT, V31, P481, DOI 10.1600/036364406778388656; Sena PP, 2012, EUR J CANCER, V48, pS280; Phadungrakwittaya R., 2012, Journal of Traditional Thai and Alternative Medicine, V10, P93; Picheansoonthon C, 1999, EXPLANATION KING NAR; Sathornviriyapong S., 2007, Kasetsart Journal, Natural Sciences, V41, P420; Shibutani S, 2007, DRUG METAB DISPOS, V35, P1217, DOI 10.1124/dmd.107.014688; State Pharmacopoeia Committee, 2015, PHARMACOPOEIA PEOPLE; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Vuthithammavech V., 1997, ENCY HERBS; Vuthithammavech V., 2003, SUMMARY THAI PHARM U; Wattanarangsan J, 2012, SIRIRAJ MED J, V64, P110; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WHO, 2003, GUID GOOD AGR COLL P; Wu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11318; Yu JQ, 2007, ENVIRON TOXICOL PHAR, V23, P162, DOI 10.1016/j.etap.2006.08.004; Zhao ZZ, 2006, PLANTA MED, V72, P865, DOI 10.1055/s-2006-947209	48	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202625	10.1371/journal.pone.0202625	http://dx.doi.org/10.1371/journal.pone.0202625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125304	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100037
J	He, ZY; Lu, R; Zhang, T; Jiang, L; Zhou, MY; Wu, DJ; Cheng, Y				He, Zhengyi; Lu, Rui; Zhang, Ting; Jiang, Lei; Zhou, Minya; Wu, Daijin; Cheng, Yong			A novel recombinant human plasminogen activator: Efficient expression and hereditary stability in transgenic goats and in vitro thrombolytic bioactivity in the milk of transgenic goats	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; ACUTE ISCHEMIC-STROKE; PROTEINS; PURIFICATION; RETEPLASE; ANIMALS	Background Thromboses is a rapidly growing medical problem worldwide. Low-cost, high-scale production of thrombotic drugs is needed to meet the demand. The production of biomolecules in transgenic animals might help address this issue. To our knowledge, the expression of recombinant human plasminogen activator (rhPA) in goat mammary glands has never been reported before. Methods We constructed a mammary gland-specific expression vector, BLC14/rhPA, which encodes only the essential K2 fibrin-binding and P domains of wild-type tPA (deletion mutant of tPA lacking the F, E, and K1 domains), along with the goat beta-lactoglobulin gene signal peptidecoding sequence. The mammary gland-specific expression vector BLC14/rhPA was transfected into goat fetal fibroblast cells by electroporation. After selection for 3 weeks by G418, stably transfected cell colonies were obtained. PCR analysis results indicated that 24 of the resistant clones were transgenic cell lines; of these, 8 lines were selected as the donor cells. The positive cells were starved for 72 h with DMEM/F12 medium containing 0.5% FBS and were then used as do. Finally, 256 reconstructed oocytes were transferred into 26 recipients, and 7 of them became pregnant (pregnancy rate, 26.9%). Two kids were obtained (BP21 and BP22). PCR analysis confirmed that both were transgenic goats. To analyze the heredity of the rhPA expressed in BP21 F0 and F1 transgenic goats, the F0 transgenic goat BP21 was mated with a normal male goat to generate an F1 transgenic goat. Enucleated metaphase II (MII) oocytes and positive donor cells were used to reconstruct embryos, which were transplanted into the oviducts of the recipients. Results Western blot results showed a specific 39 kDa band. The rhPA expression level in transgenic goat whey was about 78.32 mu g/mL by ELISA. Results of ELISA and the in vitro thrombolysis test (FAPA) showed that specific activity of the rhPA in the milk of F0 and F1 transgenic goats was 13.3 times higher than that of the reteplase reference material. Conclusion Thus, we demonstrated that BLC14/rhPA was reasonably effective for expression in the mammary glands of transgenic goats, and was stably inherited by the offspring. This study provides the basis for the large-scale production of biological pharmaceuticals in transgenic animals. The expression of biopharmaceuticals by transgenic animals can be used for pharmacological research and bioactive analysis, and transgenic goats were demonstrated to be promising animals for the large-scale production of thrombolytic biopharmaceuticals.	[He, Zhengyi; Lu, Rui; Zhang, Ting; Jiang, Lei; Zhou, Minya; Wu, Daijin; Cheng, Yong] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Cheng, Y (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	chengyong@yzu.edu.cn		He, Zhengyi/0000-0001-5423-3983	National Key Research and Development Program of China [2016YFE0126000]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	National Key Research and Development Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	This work was supported by The National Key Research and Development Program of China (No. 2016YFE0126000), http.//wwwistcp.org.cn; A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), http://jyt.jiangsu.gov.cn. The two funders all had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The National Key Research and Development Program of China (No.2016YFE0126000) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China.	Aghaabdollahian Safieh, 2014, Adv Biomed Res, V3, P190, DOI 10.4103/2277-9175.140622; Bagis H, 2011, BIOCHEM GENET, V49, P251, DOI 10.1007/s10528-010-9403-7; Batista RITP, 2014, BIOTECHNOL LETT, V36, P2155, DOI 10.1007/s10529-014-1588-0; Bosze Z, 2008, ADV EXP MED BIOL, V606, P357; Chevreux C, 2013, GLYCOBIOLOGY, V23, P1531, DOI [10.1093/glycob/cwt085, DOI 10.1093/GLYC0B/CWT085]; Cooper CA, 2015, TRANSGENIC RES, V24, P605, DOI 10.1007/s11248-015-9885-5; Czerniawska-Piatkowska E., 2016, Folia Pomeranae Universitatis Technologiae Stetinensis, Agricultura, Alimentaria, Piscaria et Zootechnica, V330, P73; Daniel L, 2012, J APPL GENET, V53, P435, DOI [10.1007/s13353-012-0110-4, DOI 10.1007/S13353-012-0110-4]; DeMers G, 2012, J EMERG MED, V43, P1149, DOI 10.1016/j.jemermed.2012.05.005; Dyck MK, 2003, TRENDS BIOTECHNOL, V21, P394, DOI 10.1016/S0167-7799(03)00190-2; Echelard Y, 2009, TRANSGENIC RES, V18, P361, DOI 10.1007/s11248-008-9229-9; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fujiwara Y, 1997, MOL REPROD DEV, V47, P157, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;157::AID-MRD5&gt;3.0.CO;2-L; Gil GC, 2008, GLYCOBIOLOGY, V18, P526, DOI 10.1093/glycob/cwn035; Goldman IL, 2012, TRANSGENIC RES, V21, P923; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Hennighausen L., 2011, US, Patent No. [7939317 B1, 7939317]; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Khodabakhsh Fatemeh, 2013, Avicenna Journal of Medical Biotechnology, V5, P168; Khodarovich YM, 2013, APPL BIOCHEM MICRO+, V49, P711, DOI 10.1134/S0003683813090020; Kumar D, 2018, TISSUE CELL, V51, P49, DOI 10.1016/j.tice.2018.02.005; Kvell K, 2010, TRANSGENIC RES, V19, P105, DOI 10.1007/s11248-009-9288-6; Kwon JY, 2013, BIOTECHNOL BIOENG, V110, P2412, DOI 10.1002/bit.24916; Lin L, 2014, AM J CLIN EXP IMMUNO, V3, P30; Meunier JM, 2013, ACAD EMERG MED, V20, P449, DOI 10.1111/acem.12133; Moisyadi S, 2009, COMP IMMUNOL MICROB, V32, P47, DOI 10.1016/j.cimid.2008.05.003; Mukherjee A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24464; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P248, DOI 10.1097/MBC.0000000000000040; Park MH, 2004, PROTEIN EXPRES PURIF, V38, P177, DOI 10.1016/j.pep.2004.07.007; Rader R., 2008, BIOPROCESS INT, P4; Rouf SA, 1996, BIOTECHNOL ADV, V14, P239, DOI 10.1016/0734-9750(96)00019-5; Sha Hong-Ying, 2006, Journal of Experimental Animal Science, V43, P211, DOI 10.1016/j.jeas.2006.08.002; Shafiee F, 2015, JUNDISHAPUR J NAT PH, V10; SMALLING RW, 1995, CIRCULATION, V91, P2725, DOI 10.1161/01.CIR.91.11.2725; Song SZ, 2016, MOL BIOL REP, V43, P775, DOI [10.1007/s11033-016-4020-0, 10.1007/s11033-016-40]; Song SZ, 2016, TROP J PHARM RES, V15, P905, DOI 10.4314/tjpr.v15i5.2; Sunley K, 2010, BIOTECHNOL ADV, V28, P385, DOI 10.1016/j.biotechadv.2010.02.003; Wang YL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/580463; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Wei JJ, 2011, TRANSGENIC RES, V20, P321, DOI 10.1007/s11248-010-9408-3; Yu BL, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0126-9	41	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0201788	10.1371/journal.pone.0201788	http://dx.doi.org/10.1371/journal.pone.0201788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118482	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700011
J	Rosa, J; Fernandez-Gonzalez, E; Ducani, C; Hogberg, B				Rosa, Joao; Fernandez-Gonzalez, Esther; Ducani, Cosimo; Hogberg, Bjorn			BtsCI and BseGI display sequence preference in the nucleotides flanking the recognition sequence	PLOS ONE			English	Article							RESTRICTION ENDONUCLEASES; STRANDED-DNA; ENZYMES; SYSTEMS	Restriction enzymes are the bread and butter of Molecular Biology. Nonetheless, how restriction enzymes recognize and cleave their target is not always clear. When developing a method for the enzymatic production of oligonucleotides, we noticed that type II endonucleases BtsCl and BseGl, which recognize the sequence GGATGNNA, perform incomplete digestions of DNA hairpins, with the top strand nick not always occurring correctly. We tested the cutting of synthetic hairpins containing all possible combinations of dinucleotides following the recognition site and our results show that all sequences containing one adenine following GGATG were digested more efficiently. We further show that the same sequence preference is also observable in double stranded DNA at higher Mg2+ concentrations and even in optimal conditions. Kinetic results show that BtsCl has a noteworthy difference in the first-rate constants between different sequences and between the two catalytic domains. An increase in Mg 2+ resulted in a drastic decrease in the catalytic activity of the top (sense) strand that wasn't always accompanied by a nick in the bottom strand (antisense).	[Rosa, Joao; Fernandez-Gonzalez, Esther; Ducani, Cosimo; Hogberg, Bjorn] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Hogberg, B (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	bjorn.hogberg@ki.se		Ducani, Cosimo/0000-0002-5877-1049; Hogberg, Bjorn/0000-0003-2715-7887	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie [658676]; David and Astrid Hagelen Foundation; Svenka Sallskapet for Medicinsk Forskning (SSMF); Alice Wallenberg Foundation; Swedish Foundation for Strategic Research [FFL12-0219]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie; David and Astrid Hagelen Foundation; Svenka Sallskapet for Medicinsk Forskning (SSMF); Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie [grant agreement number 658676] to JR; David and Astrid Hagelen Foundation and Svenka Sallskapet for Medicinsk Forskning (SSMF) to CD; Knut and Alice Wallenberg Foundation and the Swedish Foundation for Strategic Research [grant FFL12-0219] to BH.	ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; Armalyte E, 2005, J BIOL CHEM, V280, P41584, DOI 10.1074/jbc.M506775200; Bath AJ, 2002, J BIOL CHEM, V277, P4024, DOI 10.1074/jbc.M108441200; Bernardinelli G, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx707; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ducani C, 2014, NUCLEIC ACIDS RES, V42, P10596, DOI 10.1093/nar/gku737; Ducani C, 2013, NAT METHODS, V10, P647, DOI [10.1038/NMETH.2503, 10.1038/nmeth.2503]; DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Hong SP, 2008, NAT PROTOC, V3, P1476, DOI 10.1038/nprot.2008.136; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KLEID D, 1976, P NATL ACAD SCI USA, V73, P293, DOI 10.1073/pnas.73.2.293; Koonin EV, 2017, ANNU REV MICROBIOL, V71, P233, DOI 10.1146/annurev-micro-090816-093830; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Lundin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117059; Mani M, 2005, MOL BIOL, P1, DOI [10.1038/npg.els.0003837, DOI 10.1038/NPG.ELS.0003837]; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Praetorius F, 2017, NATURE, V552, P84, DOI 10.1038/nature24650; Rao DN, 2014, NUCLEIC ACIDS RES, V42, P45, DOI 10.1093/nar/gkt616; Roberts RJ, 2005, P NATL ACAD SCI USA, V102, P5905, DOI 10.1073/pnas.0500923102; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; THOMAS M, 1975, J MOL BIOL, V91, P315, DOI 10.1016/0022-2836(75)90383-6; Too PHM, 2010, NUCLEIC ACIDS RES, V38, P1294, DOI 10.1093/nar/gkp1092; Williams RJ, 2003, MOL BIOTECHNOL, V23, P225, DOI 10.1385/MB:23:3:225	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202057	10.1371/journal.pone.0202057	http://dx.doi.org/10.1371/journal.pone.0202057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118487	gold, Green Submitted, Green Published			2022-12-26	WOS:000442282700012
J	Joseph, A; Thuy, TTT; Thanh, LT; Okada, M				Joseph, Ancy; Tran Thi Thu Thuy; Le Tat Thanh; Okada, Masayoshi			Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator	PLOS ONE			English	Article							POTASSIUM CHANNEL; K+ CHANNELS; RILUZOLE; INHIBITION; ANXIETY; REGULATIONS; BEHAVIORS; COUMARIN; STRESS; PLANTS	We screened a library of botanical compounds purified from plants of Vietnam for modulators of the activity of a two-pore domain K+ channel, TREK-1, and we identified a hydroxycoumarin-related compound, ostruthin, as an activator of this channel. Ostruthin increased whole-cell TREK-1 channel currents in 293T cells at a low concentration (EC50 = 5.3 mu M), and also activity of the TREK-2 channel (EC50 = 3.7 mM). In contrast, ostruthin inhibited other K+ channels, e.g. human ether-a-go-go-related gene (HERG1), inward-rectifier (Kir2.1), voltage-gated (Kv1.4), and two-pore domain (TASK-1) at higher concentrations, without affecting voltage-gated potassium channel (KCNQ1 and 3). We tested the effect of this compound on mouse anxiety- and depression-like behaviors and found anxiolytic activity in the open-field, elevated plus maze, and light/dark box tests. Of note, ostruthin also showed antidepressive effects in the forced swim and tail suspension tests, although previous studies reported that inhibition of TREK-1 channels resulted in an antidepressive effect. The anxiolytic and antidepressive effect was diminished by co-administration of a TREK-1 blocker, amlodipine, indicating the involvement of TREK-1 channels. Administration of ostruthin suppressed the stress-induced increase in anti-c-Fos immunoreactivity in the lateral septum, without affecting immunoreactivity in other mood disorder-related nuclei, e.g. the amygdala, paraventricular nuclei, and dorsal raphe nucleus. Ostruthin may exert its anxiolytic and antidepressive effects through a different mechanism from current drugs.	[Joseph, Ancy; Okada, Masayoshi] Kansai Med Univ, Dept Physiol, Osaka, Japan; [Tran Thi Thu Thuy; Le Tat Thanh] Vietnam Acad Sci & Technol, Inst Nat Prod Chem, Hanoi, Vietnam; [Okada, Masayoshi] Kurashiki Univ Sci & Arts, Coll Life Sci, Dept Med Life Sci, Kurashiki, Okayama, Japan; [Joseph, Ancy] Washington Univ, Sch Med, Div Mol Oncol, St Louis, MO USA	Kansai Medical University; Vietnam Academy of Science & Technology (VAST); Washington University (WUSTL)	Okada, M (corresponding author), Kansai Med Univ, Dept Physiol, Osaka, Japan.; Okada, M (corresponding author), Kurashiki Univ Sci & Arts, Coll Life Sci, Dept Med Life Sci, Kurashiki, Okayama, Japan.	mokada-tky@umin.ac.jp	Okada, Masayoshi/ABE-9020-2020; joseph, ancy/AAI-8238-2021	Okada, Masayoshi/0000-0001-8515-7143; joseph, ancy/0000-0001-7371-1696; Tran, Thuy/0000-0001-8591-9152	KAKENHI from the JSPS [25460323]; SICP from the JST; Heiwa Nakajima Foundation; Ryobi Memorial Foundation; Wesco Scientific Promotion Foundation; Fujii Memorial Foundation	KAKENHI from the JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SICP from the JST; Heiwa Nakajima Foundation; Ryobi Memorial Foundation; Wesco Scientific Promotion Foundation; Fujii Memorial Foundation	This study was supported by KAKENHI (25460323 to MO) from the JSPS, the SICP from the JST, the Heiwa Nakajima Foundation, the Ryobi Memorial Foundation, Wesco Scientific Promotion Foundation (to MO), and the Fujii Memorial Foundation (to AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andharia N, 2017, INVOLVEMENT INTRACEL; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; DADAK V, 1980, COLLECT CZECH CHEM C, V45, P653, DOI 10.1135/cccc19800653; Duprat F, 2000, MOL PHARMACOL, V57, P906; Enyeart JA, 2008, BIOCHEM BIOPH RES CO, V370, P623, DOI 10.1016/j.bbrc.2008.04.001; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Friedman AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11671; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Joa H, 2011, J NAT PROD, V74, P1513, DOI 10.1021/np200072a; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Liou YJ, 2009, PHARMACOGENET GENOM, V19, P735, DOI 10.1097/FPC.0b013e32832cbe61; Liu HY, 2007, J PHARMACOL EXP THER, V323, P39, DOI 10.1124/jpet.107.125245; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McIntyre RS, 2014, J AFFECT DISORDERS, V156, P1, DOI 10.1016/j.jad.2013.10.043; Mirkovic K, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00060; Mongeau R, 2003, J NEUROSCI, V23, P3855; Ohashi M, 2015, PSYCHOPHARMACOLOGY, V232, P391, DOI 10.1007/s00213-014-3676-1; Okada M, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0159-1; OWEN RT, 1983, DRUGS, V25, P385, DOI 10.2165/00003495-198325040-00003; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pittenger C, 2008, CNS DRUGS, V22, P761, DOI 10.2165/00023210-200822090-00004; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Punke MA, 2003, ANESTH ANALG, V96, P1665, DOI 10.1213/01.ANE.0000062524.90936.1F; Qi JH, 1999, BIOSCI BIOTECH BIOCH, V63, P1501, DOI 10.1271/bbb.63.1501; Schinkovitz A, 2003, PLANTA MED, V69, P369, DOI 10.1055/s-2003-38876; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Sugiyama A, 2012, NEUROPHARMACOLOGY, V62, P2489, DOI 10.1016/j.neuropharm.2012.02.012; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Voelker C, 2010, PLANT BIOLOGY, V12, P56, DOI 10.1111/j.1438-8677.2010.00353.x; Zaks-Makhina E, 2009, J BIOL CHEM; Zarate CA, 2004, AM J PSYCHIAT, V161, P171, DOI 10.1176/appi.ajp.161.1.171	40	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201092	10.1371/journal.pone.0201092	http://dx.doi.org/10.1371/journal.pone.0201092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110354	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000012
J	Chen, J				Chen, Jie			The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; EXTRAHEPATIC METASTASES; CLINICAL-FEATURES; ETHANOL INJECTION; BRAIN METASTASES; BLOOD-VESSELS; NODE; EPIDEMIOLOGY; SORAFENIB; THERAPY	Background The prognostic impact of different distant metastases pattern in liver cancer is unexplored still now. The aim of this study is to analyze the metastasis patterns and prognosis differences for patients with stage IV liver cancers. Methods A SEER analysis was performed. Overall survival and cancer-specific survival were calculated by the Kaplan-Meier method. Multivariable Cox regression models were used to further analyze survival outcome and other prognostic factors. Results A total of 37526 eligible cases were retrieved in the Surveillance, Epidemiology, and End Results database. Among these patients, stage of IV liver cancer accounted for 14.80% (5555/37526) at initial diagnosis. Patients who suffered bone, brain or lung metastasis occupied 55.61% (3089/5555). Comparing with other two single metastases, the patients with brain metastasis exhibited worst overall survival whose mean of survival was 4.758 months. Multivariate analysis with Cox hazard regression model showed that metastatic site was an independent prognostic factor of overall survival and cancer-specific survival in patients with single metastasis (P<0.05). The results of univariate analysis showed that metastatic pattern was significantly correlated with overall survival (P = 0.038) and cancer-specific survival (P = 0.035) of patients with two sites. Conclusions Lung was the most common site of single metastasis for liver cancers. Patients with bone metastasis had best survival outcome comparing with other two distant metastases. Patients with two metastatic sites, where one of them is the lung tends to have a slight trend to a worse outcome.	[Chen, Jie] Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Emergency, Hangzhou, Zhejiang, Peoples R China	Hangzhou Medical College; Zhejiang Provincial People's Hospital	Chen, J (corresponding author), Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Emergency, Hangzhou, Zhejiang, Peoples R China.	jsdnychm@163.com						Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Barekati Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-244; Bertuccio P, 2017, J HEPATOL, V67, P302, DOI 10.1016/j.jhep.2017.03.011; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Briganti A, 2014, EUR UROL, V65, P26, DOI 10.1016/j.eururo.2013.07.003; Brown M, 2018, SCIENCE, V359, P1408, DOI 10.1126/science.aal3662; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Del Ben M, 2003, J EXP CLIN CANC RES, V22, P641; Fukutomi M, 2001, EUR J GASTROEN HEPAT, V13, P1083, DOI 10.1097/00042737-200109000-00015; Furuya Y, 1998, UROL INT, V61, P17, DOI 10.1159/000030277; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Lee JI, 2014, CLIN EXP METASTAS, V31, P475, DOI 10.1007/s10585-014-9641-x; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mittal S, 2016, J HEPATOL, V65, P1148, DOI 10.1016/j.jhep.2016.07.025; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Parikh ND, 2017, HEPATOLOGY, V65, P122, DOI 10.1002/hep.28881; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Polesel J, 2007, EUR J CANCER, V43, P2381, DOI 10.1016/j.ejca.2007.07.012; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; SAWABE M, 1987, ACTA PATHOL JAPON, V37, P1389; Seinfeld J, 2006, J NEURO-ONCOL, V76, P93, DOI 10.1007/s11060-005-4175-3; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; SHIINA S, 1993, AM J ROENTGENOL, V160, P1023, DOI 10.2214/ajr.160.5.7682378; Shivappa N, 2016, BRIT J NUTR, V115, P324, DOI 10.1017/S0007114515004419; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Turati F, 2014, ANN ONCOL, V25, P1526, DOI 10.1093/annonc/mdu020; Turati F, 2014, J HEPATOL, V60, P606, DOI 10.1016/j.jhep.2013.10.034; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Wu WR, 2017, J CANCER, V8, P2312, DOI 10.7150/jca.19056	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0200909	10.1371/journal.pone.0200909	http://dx.doi.org/10.1371/journal.pone.0200909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102707	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200005
J	Eaton, KR; Loxterman, JL; Keeley, ER				Eaton, Kendra R.; Loxterman, Janet L.; Keeley, Ernest R.			Connections and containers: Using genetic data to understand how watershed evolution and human activities influence cutthroat trout biogeography	PLOS ONE			English	Article							BROWN TROUT; FRESH-WATER; INTRODUCED POPULATIONS; ONCORHYNCHUS-CLARKI; SALMO-TRUTTA; PHYLOGENETIC ANALYSIS; SECONDARY CONTACT; UNITED-STATES; GREAT-BASIN; DNA	Species with large geographic distributions often exhibit complex patterns of diversity that can be further complicated by human activities. Cutthroat trout (Oncorhynchus clarkii) are one of the most widely distributed freshwater fish species in western North America exhibiting substantial phenotypic and genetic variability; however, fish stocking practices have translocated populations outside of their native range and may have obscured intraspecific boundaries. This study focuses on cutthroat trout populations representing three distinct evolutionary clades that are found intermixed within a contact zone between the Bonneville and upper Snake River watersheds in the western United States. We used mitochondrial and microsatellite genetic data, as well as historical stocking records, to evaluate whether populations of cutthroat trout in the contact zone are native or are introduced. We found significant genetic differentiation and fine-scale genetic population structure that was organized primarily by watershed boundaries. While we detected increased genetic diversity in some areas in close proximity to the greatest number of stocking events, the highly organized population structure both within and between areas of the contact zone indicates that the populations are native to the watersheds. Intermixing of distinct evolutionary lineages of cutthroat trout appears to be the result of historical connections between paleodrainages. Our analyses provide a context for understanding how genetic data can be used to assess the status of populations as native or introduced.	[Eaton, Kendra R.; Loxterman, Janet L.; Keeley, Ernest R.] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA	Idaho; Idaho State University	Eaton, KR (corresponding author), Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA.	knapkend@isu.edu	Keeley, Ernest/AAD-7789-2019	Keeley, Ernest/0000-0003-2633-1361; Eaton, Kendra/0000-0001-9866-6959	Department of Biological Sciences; Molecular Research Core Facility at Idaho State University	Department of Biological Sciences; Molecular Research Core Facility at Idaho State University	Support from the Department of Biological Sciences and the Molecular Research Core Facility at Idaho State University is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank C. Feldman, T. Hallbert, H. Owens, and R. Whitworth for help in the lab or field. P. Thompson and M. McKell from the Utah Division of Wildlife Resources provided genetic samples and information about cutthroat trout in Utah. D. Megargle, and R. Hillyard from Idaho Department of Fish and Game assisted us with information about Idaho populations. Financial and technical support from the Department of Biological Sciences and the Molecular Research Core Facility at Idaho State University was greatly appreciated. Thanks are due to P. Link and two anonymous who provided helpful comments on an earlier version of the manuscript.	Abadia-Cardoso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141775; ALLENDORF FW, 1991, CAN J FISH AQUAT SCI, V48, P178, DOI 10.1139/f91-318; Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; AMEC Environment and Infrastructure Inc, 2014, F13PB00113 USFWS AME, P1; Anderson CR, 2004, J MAMMAL, V85, P1207, DOI 10.1644/BEL-111.1; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; ARTHINGTON AH, 1983, AUST J ECOL, V8, P87, DOI 10.1111/j.1442-9993.1983.tb01597.x; AUSTIN GT, 1987, GREAT BASIN NAT, V47, P186; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Beamish RJ, 2012, ENVIRON BIOL FISH, V94, P135, DOI 10.1007/s10641-011-9783-5; Behnke R.J., 1992, NATIVE TROUT W N AM; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Bingham DM, 2016, N AM J FISH MANAGE, V36, P590, DOI 10.1080/02755947.2016.1165765; Bouchard DP, 1998, PALAEOGEOGR PALAEOCL, V141, P95, DOI 10.1016/S0031-0182(98)00005-4; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Campbell MR, 2011, T AM FISH SOC, V140, P91, DOI 10.1080/00028487.2011.557001; Campbell MR, 2018, EVOLUTIONARY BIOL CU; Castley J. G., 2001, S AFR J SCI, V96, P365; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Coffin PD, 1995, LAHONTAN CUTTHROAT T, P147; Cowx I. G, 1997, STOCKING INTRO FISH; DeWalt SJ, 2011, AM J BOT, V98, P1128, DOI 10.3732/ajb.1000297; Dias MS, 2014, ECOL LETT, V17, P1130, DOI 10.1111/ele.12319; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dunham JB, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P327; Dynes C, 2001, ANN APPL BIOL, V139, P165, DOI 10.1111/j.1744-7348.2001.tb00393.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1993, PHYLOGENY INFERENCE; Frantz AC, 2017, ECOL EVOL, V7, P7650, DOI 10.1002/ece3.3282; Glotzbecker GJ, 2016, CONSERV GENET, V17, P795, DOI 10.1007/s10592-016-0822-9; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grayson DK, 2011, GREAT BASIN: A NATURAL PREHISTORY, REVISED AND EXPANDED EDITION; Gresswell R.E., 1988, American Fisheries Society Symposium, P45; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen MM, 2009, BIOL LETTERS, V5, P656, DOI 10.1098/rsbl.2009.0214; Hansen MM, 2002, MOL ECOL, V11, P1003, DOI 10.1046/j.1365-294X.2002.01495.x; Harig Amy L., 2000, North American Journal of Fisheries Management, V20, P994, DOI 10.1577/1548-8675(2000)020<0994:FISOGC>2.0.CO;2; Hershler R, 1999, MOL PHYLOGENET EVOL, V13, P377, DOI 10.1006/mpev.1999.0659; Hershler R, 1998, VELIGER, V41, P1; Hilderbrand RH, 2002, N AM J FISH MANAGE, V22, P879, DOI 10.1577/1548-8675(2002)022<0879:SSSFRA>2.0.CO;2; Hoef JMV, 2014, J STAT SOFTW, V56, P1; HUBBS CL, 1948, B U UTAH, V38, P17; Hubbs CL, 1974, HYDROGRAPHIC HIST RE; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janecke SU, 2011, GEOSPHERE, V7, P1369, DOI 10.1130/GES00587.1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson NK, 2004, EVOLUTION, V58, P1122; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Kim D, 2014, BIOL J LINN SOC, V111, P317, DOI 10.1111/bij.12209; Kohout J, 2012, FISHERIES MANAG ECOL, V19, P252, DOI 10.1111/j.1365-2400.2011.00828.x; Kolbe JJ, 2013, BIOL INVASIONS, V15, P775, DOI 10.1007/s10530-012-0325-7; Koskinen MT, 2002, ECOL LETT, V5, P193, DOI 10.1046/j.1461-0248.2002.00302.x; Kruse CG, 1997, T AM FISH SOC, V126, P418, DOI 10.1577/1548-8659(1997)126<0418:GIOTDO>2.3.CO;2; Krzeminska U, 2016, BIOL INVASIONS, V18, P1867, DOI 10.1007/s10530-016-1130-5; Kuchta SR, 2009, J BIOGEOGR, V36, P982, DOI 10.1111/j.1365-2699.2008.02052.x; Langlois DL, 1983, GREENBACK CUTTHROAT; Largiader CR, 1995, J FISH BIOL, V47, P209, DOI 10.1111/j.1095-8649.1995.tb06057.x; Latta RG, 1999, EVOLUTION, V53, P769, DOI 10.2307/2640717; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Link PK, 1999, GUIDEBOOK GEOLOGY E, P251; LOUDENSLAGER EJ, 1980, SYST ZOOL, V29, P27, DOI 10.2307/2412624; Loxterman JL, 2014, CAN J FISH AQUAT SCI, V71, P1050, DOI 10.1139/cjfas-2013-0424; Loxterman JL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-38; Matthews Kathleen R., 1999, International Journal of Wilderness, V5, P24; McPhail J.D., 1986, P615; MEFFE G K, 1988, Conservation Biology, V2, P157, DOI 10.1111/j.1523-1739.1988.tb00167.x; Merson C, 2017, J MAMMAL, V98, P365, DOI 10.1093/jmammal/gyx004; Metcalf JL, 2012, MOL ECOL, V21, P5194, DOI 10.1111/mec.12028; Metcalf JL, 2007, MOL ECOL, V16, P4445, DOI 10.1111/j.1365-294X.2007.03472.x; Mills EL, 1996, AM ZOOL, V36, P271; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Neville HM, 2006, LANDSCAPE ECOL, V21, P901, DOI 10.1007/s10980-005-5221-4; Northcote T. G., 1997, North American Journal of Fisheries Management, V17, P1029, DOI 10.1577/1548-8675(1997)017<1029:PISAMI>2.3.CO;2; Novak M. A., 2005, MOL GENETIC INVESTIG; Oberdorff T, 1997, J BIOGEOGR, V24, P461, DOI 10.1111/j.1365-2699.1997.00113.x; Olsen JB, 1998, MOL ECOL, V7, P1087; Page LM, 2017, FISHERIES, V42, P456, DOI 10.1080/03632415.2017.1356108; Palo JU, 2004, MOL ECOL, V13, P2631, DOI 10.1111/j.1365-294X.2004.02269.x; Peterson EE, 2014, J STAT SOFTW, V56, P1; Pielou EC, 1991, ICE AGE RETURN LIFE; Pinceel J, 2005, J EVOLUTION BIOL, V18, P1264, DOI 10.1111/j.1420-9101.2005.00932.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard VL, 2009, CONSERV GENET, V10, P1209, DOI 10.1007/s10592-008-9652-8; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Reheis M, 1999, QUATERNARY RES, V52, P196, DOI 10.1006/qres.1999.2064; REISENBICHLER RR, 1977, J FISH RES BOARD CAN, V34, P123, DOI 10.1139/f77-015; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; Rexroad CE, 2002, MAR BIOTECHNOL, V4, P12, DOI 10.1007/s10126-001-0058-6; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Robinson ML, 2009, MOL ECOL RESOUR, V9, P134, DOI 10.1111/j.1755-0998.2008.02367.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schenekar T, 2014, CONSERV GENET, V15, P561, DOI 10.1007/s10592-013-0561-0; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sigler W.F., 1987, FISHES GREAT BASIN N; Signorile AL, 2016, BIOL CONSERV, V195, P97, DOI 10.1016/j.biocon.2015.12.026; SMITH G R, 1978, Great Basin Naturalist Memoirs, P17; Smith GR, 2002, SMITHSON CONTRIB EAR, P175; Squirrell J, 2001, AM J BOT, V88, P1409, DOI 10.2307/3558447; Stearley RF, 2016, SALMONID FISHES MIO, P1; Stowell SML, 2015, CAN J FISH AQUAT SCI, V72, P1565, DOI 10.1139/cjfas-2015-0009; Stuber RJ, 1988, GREENBACK CUTTHROAT, P71; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor EB, 2003, MOL ECOL, V12, P2609, DOI 10.1046/j.1365-294X.2003.01937.x; Taylor EB, 2011, EVOL APPL, V4, P100, DOI 10.1111/j.1752-4571.2010.00136.x; Teske PR, 2014, ECOL EVOL, V4, P2848, DOI 10.1002/ece3.1129; Thompson P, 2002, STATUS NATIVE YELLOW; Trotter P., 2008, CUTTHROAT NATIVE TRO; U.S. Geological Survey and U.S. Department of Agriculture-Natural Resources Conservation Service, 2013, 11A3 US GEOL SURV, P63; Van Doornik DM, 2013, N AM J FISH MANAGE, V33, P693, DOI 10.1080/02755947.2013.790861; Walker D, 1998, ANNU REV ECOL SYST, V29, P23, DOI 10.1146/annurev.ecolsys.29.1.23; Waters JM, 2006, BIOL J LINN SOC, V88, P367, DOI 10.1111/j.1095-8312.2004.00622.x; Wenburg JK, 1998, MOL ECOL, V7, P733, DOI 10.1046/j.1365-294x.1998.00386.x; Wilson WD, 2009, MOL PHYLOGENET EVOL, V52, P406, DOI 10.1016/j.ympev.2009.03.018; Young MK, 2005, CAN J FISH AQUAT SCI, V62, P2399, DOI 10.1139/F05-149; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079807	127	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202043	10.1371/journal.pone.0202043	http://dx.doi.org/10.1371/journal.pone.0202043			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096159	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500043
J	Lee, DH; Yi, HC; Bae, SH; Cho, JH; Choi, SW; Kim, H				Lee, Dong-Hyun; Yi, Ho Chul; Bae, So Hyun; Cho, Joon Hee; Choi, Sang Wook; Kim, Hakyoung			Risk factors for retinal microvascular impairment in type 2 diabetic patients without diabetic retinopathy	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; FOVEAL AVASCULAR ZONE; MACULAR EDEMA; PROGRESSION; ASSOCIATION; CHOLESTEROL; EYES; DENSITY	Objectives To determine the risk factors for retinal microvascular impairment on optical coherence tomography angiography (OCT-A) in type 2 diabetic patients without clinical diabetic retinopathy (DR). Methods This retrospective and cross-sectional study enrolled 74 diabetic patients without clinically evident DR for the study group and 34 healthy subjects for the control group. OCT-A parameters were measured to determine vascular density (VD) and the foveal avascular zone (FAZ) size in the superficial and deep capillary plexuses (SCP/DCP) of the retina. Clinical data were collected on sex, age, diabetes duration, hemoglobin A1c (HbA1c), hypertension, dyslipidemia, low-density lipoprotein cholesterol (LDL-C), estimated glomerular filtration rate (eGFR) and smoking status. Multiple linear regression analyses were performed to represent the associated clinical variables with OCT-A parameters in diabetic patients. Results In comparison between the study and control groups, the VD in the SCP and DCP were significantly lower in diabetic patients compared to the controls (P = 0.022 and 0.003, respectively). The FAZ size in the SCP and DCP were significantly greater in diabetic patients compared to the controls (P = 0.035 and <0.001, respectively). In age- and sex-adjusted multiple regression analyses for the diabetic patients, dyslipidemia and hypertension were negatively associated with SCP-VD (beta = -0.357, P = 0.002; beta = -0.239, P = 0.039, respectively). Current smoking was correlated with lower DCP-VD (beta = -0.255, P= 0.043). Greater SCP-FAZ size was associated with dyslipidemia and greater LDL-C (beta = 0.254, P= 0.013; beta = 0.232, P= 0.029, respectively), and greater DCP-FAZ size, with lower eGFR and greater LDL-C (beta = -0.355, P = 0.004; beta = 0.235, P = 0.037, respectively). Conclusions Diabetic patients without clinical DR showed lower VD and greater FAZ size in the SCP and DCP compared to healthy controls. In diabetic patients without clinical DR, dyslipidemia and/or high LDL-C were important risk factors for retinal microvascular impairment. Hypertension, current smoking and lower eGFR also contributed to microvascular impairment.	[Lee, Dong-Hyun] Gyeongsang Natl Univ Hosp, Dept Lab Med, Jinju, South Korea; [Yi, Ho Chul; Bae, So Hyun; Choi, Sang Wook; Kim, Hakyoung] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea; [Cho, Joon Hee] Hyemin Eye Hosp, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Hallym University	Bae, SH (corresponding author), Hallym Univ, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea.	sohyun.bae.md@gmail.com		Cho, Joon Hee/0000-0003-4169-0645; Lee, Donghyun/0000-0001-5880-4528				American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1995, DIABETES, V44, P968; Bonnin S, 2015, RETINA-J RET VIT DIS, V35, P2347, DOI 10.1097/IAE.0000000000000839; Cao D, 2018, ACTA DIABETOL, V55, P469, DOI 10.1007/s00592-018-1115-1; Chang Yo-Chen, 2013, Rev Diabet Stud, V10, P121, DOI 10.1900/RDS.2013.10.121; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Choi SW, 2017, J KOR OPHTHALMOL SOC, V58, P811, DOI 10.3341/jkos.2017.58.7.811; Corvi F, 2018, AM J OPHTHALMOL, V186, P25, DOI 10.1016/j.ajo.2017.11.011; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; CRUICKSHANKS KJ, 1993, OPHTHALMOLOGY, V100, P862; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; De Carlo TE, 2015, RETINA-J RET VIT DIS, V35, P2364, DOI 10.1097/IAE.0000000000000882; Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7; Dimitrova G, 2017, INVEST OPHTH VIS SCI, V58, P190, DOI 10.1167/iovs.16-20531; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Goudot MM, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/8676091; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hsieh YT, 2018, JAMA OPHTHALMOL, V136, P68, DOI 10.1001/jamaophthalmol.2017.5202; Jeng CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161897; KLEIN BEK, 1991, OPHTHALMOLOGY, V98, P1261; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1993, OPHTHALMOLOGY, V100, P1140; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; KOHNER EM, 1989, BRIT MED BULL, V45, P148, DOI 10.1093/oxfordjournals.bmb.a072309; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Miljanovic B, 2004, DIABETES, V53, P2883, DOI 10.2337/diabetes.53.11.2883; Morton J, 2012, DIABETES CARE, V35, P2201, DOI 10.2337/dc12-0306; Nazaimoon EMW, 1999, DIABETES RES CLIN PR, V46, P213; Omae T, 2016, INVEST OPHTH VIS SCI, V57, P1345, DOI 10.1167/iovs.15-18813; Sas KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86976; Savastano MC, 2015, RETINA-J RET VIT DIS, V35, P2196, DOI 10.1097/IAE.0000000000000635; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shiihara H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09255-5; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Stanga PE, 2016, DEV OPHTHALMOL, V56, P13, DOI 10.1159/000442771; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Suzuma I, 2001, DIABETES, V50, P444, DOI 10.2337/diabetes.50.2.444; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Ting DSW, 2017, JAMA OPHTHALMOL, V135, P306, DOI 10.1001/jamaophthalmol.2016.5877; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEINHAUS RS, 1995, EXP EYE RES, V61, P1, DOI 10.1016/S0014-4835(95)80053-0; Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027	47	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202103	10.1371/journal.pone.0202103	http://dx.doi.org/10.1371/journal.pone.0202103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092018	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600086
J	Pan, SP; Chao, KH; Huang, CC; Wu, MY; Chen, MJ; Chang, CH; Yang, JH; Yang, YS; Chen, SU				Pan, Song-Po; Chao, Kuang-Han; Huang, Chu-Chun; Wu, Ming-Yih; Chen, Mei-Jou; Chang, Chin-Hao; Yang, Jehn-Hsiahn; Yang, Yu-Shih; Chen, Shee-Uan			Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome	PLOS ONE			English	Article							LUTEAL-PHASE SUPPORT; IN-VITRO FERTILIZATION; OVARIAN HYPERSTIMULATION SYNDROME; RANDOMIZED CONTROLLED-TRIAL; IVF; HORMONE; STIMULATION; AGONIST; RATES; GONADOTROPINS	Previous studies indicated that progesterone can be withdrawn at the time of the first positive beta-hCG test without compromising the clinical pregnancy outcome in normal ovarian responder. However, the effect of early stop of progesterone supplementation for patients with poor ovarian response (POR) has not been investigated. This study retrospectively collected data from patients with POR in 156 IVF/ICSI fresh embryo transfer (ET) cycles in single tertiary center from January 2010 to June 2016. All the patients met ESHRE consensus, the Bologna criteria, of POR and had hCG injection for luteal phase support (LPS) on day 2, 5 and 8 after ovum pick-up. The pregnant patients were divided into two groups: early stop group represented those who stopped LPS from day of positive pregnancy test; control group represented those who kept progesterone supplementation till gestational age of 9 weeks. There were no significant differences in age, BMI, parity, hormone data, number of follicles>10(mm), endometrial thickness and number of embryos transferred between the two groups. After adjustment for possible confounders with multivariate logistic regression analysis, the clinical pregnancy rates (55.0% vs. 57.1%, P = 0.35), ongoing pregnancy rates (47.0% vs. 46.4%, P = 0.66), miscarriage rates (34.0% vs. 26.7%, P = 0.66) and live-birth rates (44.0% vs. 46.4%, P = 0.41) were not statistically different between early stop group and the control group. Our study indicates that early stop of progesterone supplementation on the day of positive pregnancy test for patients of POR using hCG as LPS in fresh ET cycles does not affect pregnancy outcome.	[Pan, Song-Po; Chao, Kuang-Han; Huang, Chu-Chun; Wu, Ming-Yih; Chen, Mei-Jou; Yang, Jehn-Hsiahn; Yang, Yu-Shih; Chen, Shee-Uan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Mei-Jou] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chen, SU (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	sheeuan@ntu.edu.tw	Chen, Mei-Jou/AAS-7698-2020	YANG, JEHN-HSIAHN/0000-0001-8648-0882; CHEN, MEI-JOU/0000-0002-2305-1105; YANG, YU-SHIH/0000-0002-8633-0873; CHAO, KUANG-HAN/0000-0001-8124-1516; CHEN, SHEE-UAN/0000-0001-7592-3238				Aboulghar MA, 2008, HUM REPROD, V23, P857, DOI 10.1093/humrep/den012; Andersen AN, 2002, HUM REPROD, V17, P357, DOI 10.1093/humrep/17.2.357; Andersen CY, 2016, J ASSIST REPROD GEN, V33, P1311, DOI 10.1007/s10815-016-0764-7; Beckers NGM, 2003, J CLIN ENDOCR METAB, V88, P4186, DOI 10.1210/jc.2002-021953; BOURGAIN C, 1990, HUM REPROD, V5, P537, DOI 10.1093/oxfordjournals.humrep.a137138; Chen CD, 2012, BEST PRACT RES CL OB, V26, P817, DOI 10.1016/j.bpobgyn.2012.04.004; Chen SU, 2010, J CLIN ENDOCR METAB, V95, P3982, DOI 10.1210/jc.2009-2596; Doblinger J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151388; Fatemi HM, 2007, HUM REPROD UPDATE, V13, P581, DOI 10.1093/humupd/dmm021; Fauser BCJM, 2003, TRENDS ENDOCRIN MET, V14, P236, DOI 10.1016/S1043-2760(03)00075-4; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Griesinger G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149615; Gunnala V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176019; Haahr T, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00116; Ho CH, 2008, REPROD BIOMED ONLINE, V16, P632, DOI 10.1016/S1472-6483(10)60476-2; Hwang JL, 2018, J FORMOS MED ASSOC, V117, P535, DOI 10.1016/j.jfma.2017.05.009; Kohls G, 2012, FERTIL STERIL, V98, P858, DOI 10.1016/j.fertnstert.2012.05.046; Kolibianakis Efstratios M, 2002, Reprod Biomed Online, V5 Suppl 1, P26; Kolibianakis EM, 2003, FERTIL STERIL, V80, P464, DOI 10.1016/S0015-0282(03)00663-0; Kutlusoy F, 2014, GYNECOL ENDOCRINOL, V30, P363, DOI 10.3109/09513590.2014.887065; Kyrou D, 2011, HUM REPROD UPDATE, V17, P734, DOI 10.1093/humupd/dmr029; Lee TH, 2005, FERTIL STERIL, V83, P1700, DOI 10.1016/j.fertnstert.2004.12.037; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Papanikolaou EG, 2006, FERTIL STERIL, V85, P112, DOI 10.1016/j.fertnstert.2005.07.1292; Pritts EA, 2002, HUM REPROD, V17, P2287, DOI 10.1093/humrep/17.9.2287; Russell R, 2015, HUM FERTIL, V18, P43, DOI 10.3109/14647273.2014.921337; Segal L, 2015, REPROD BIOMED ONLINE, V31, P633, DOI 10.1016/j.rbmo.2015.07.011; Stovall DW, 1998, FERTIL STERIL, V70, P1056, DOI 10.1016/S0015-0282(98)00356-2; Tavaniotou A, 2001, ANN NY ACAD SCI, V943, P55, DOI 10.1111/j.1749-6632.2001.tb03790.x; Tay PYS, 2000, CLIN ENDOCRINOL, V53, P345; Tournaye H, 2017, HUM REPROD, V32, P1019, DOI 10.1093/humrep/dex023; Vaisbuch E, 2014, REPROD BIOMED ONLINE, V28, P330, DOI 10.1016/j.rbmo.2013.10.022; Vaisbuch E, 2012, REPROD BIOMED ONLINE, V25, P139, DOI 10.1016/j.rbmo.2012.04.005; van der Linden M, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009154.pub2, 10.1002/14651858.CD009154.pub3]; Yang PK, 2019, J FORMOS MED ASSOC, V118, P92, DOI 10.1016/j.jfma.2018.01.012	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201824	10.1371/journal.pone.0201824	http://dx.doi.org/10.1371/journal.pone.0201824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092070	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600060
J	Park, CJ; Seo, N; Hyung, WJ; Koom, WS; Kim, HS; Kim, MJ; Lim, JS				Park, Chae Jung; Seo, Nieun; Hyung, Woo Jin; Koom, Woong Sub; Kim, Hyo Song; Kim, Myeong-Jin; Lim, Joon Seok			Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy	PLOS ONE			English	Article							EXTRAMURAL VASCULAR INVASION; VENOUS INVASION; COMPUTED-TOMOGRAPHY; ADJUVANT CHEMOTHERAPY; CLINICAL-SIGNIFICANCE; RECTAL-CANCER; RISK-FACTORS; RECURRENCE; CARCINOMA; SURGERY	Background Preoperative therapy has gained wide interest in advanced gastric cancer patients due to its potential advantages of improved disease control. Selection of high risk patients based on preoperative staging is crucial to choose the candidates for neoadjuvant therapy. Methods Our institutional review board approved this retrospective study and waived the requirement for patient consent. We searched 394 advanced gastric cancer patients (pT2-4) who underwent curative resection in 2010 without neoadjuvant therapies. Two abdominal radiologists independently reviewed the preoperative CT including tumor depth on CT (CT-tumor depth), which was categorized as follows: intramural, minimal extramural (<1 mm), spiculated extramural(>1mm) and nodular extramural infiltration. The impact of clinicoradiologic factors on disease recurrence and disease free survival (DFS) was evaluated. Recursive partitioning analysis was performed to suggest prediction models for recurrence. Results Of total 394 patients, 86 patients (21.8%) experienced recurrence. Spiculated (>1mm) and nodular extramural tumor infiltration and CT size of 5-10cm were independent predictors of disease recurrence and significantly associated with worse DFS. Lymph node involvement on CT was not significantly associated with patient outcome. Among patients with same pT4a stage, the recurrence rate rises and DFS gets worse as the extramural tumor infiltration progresses (P < 0.001). The prediction model for recurrence revealed that size and CT tumor depth were the two major discriminating factors. Conclusion CT-tumor depth and size could be used as independent predictors for prognosis. Preoperative CT can be used for prognostic stratification to select high risk patients for whom neoadjuvant therapies might be considered.	[Park, Chae Jung; Seo, Nieun; Kim, Myeong-Jin; Lim, Joon Seok] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea; [Hyung, Woo Jin] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Koom, Woong Sub] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Hyo Song] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lim, JS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea.	JSLIM1@yuhs.ac	Lim, Joon Seok/R-7753-2019; Kim, Myeong-Jin/E-1623-2011	Kim, Hyo Song/0000-0002-0625-9828; Koom, Woong Sub/0000-0002-9435-7750; Park, Chae Jung/0000-0002-5567-8658; Lim, Joon seok/0000-0002-0334-5042; Kim, Myeong-Jin/0000-0001-7949-5402; Seo, Nieun/0000-0001-8745-6454; Hyung, Woo Jin/0000-0002-8593-9214				Ajani JA, 1999, J CLIN ONCOL, V17, P2403, DOI 10.1200/JCO.1999.17.8.2403; Aoyama T, 2012, ANN SURG ONCOL, V19, P1568, DOI 10.1245/s10434-011-2158-5; Bugg WG, 2014, CLIN RADIOL, V69, P619, DOI 10.1016/j.crad.2014.01.010; Cao L, 2016, J SURG ONCOL, V113, P745, DOI 10.1002/jso.24228; Castonguay MC, 2014, HISTOPATHOLOGY, V64, P693, DOI 10.1111/his.12308; Cheng J, 2016, ABDOM RADIOL, V41, P1219, DOI 10.1007/s00261-015-0627-1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; D'Ugo D, 2009, LANCET ONCOL, V10, P191, DOI 10.1016/S1470-2045(09)70021-X; Deng JY, 2014, WORLD J GASTROENTERO, V20, P3967, DOI 10.3748/wjg.v20.i14.3967; Gunderson LL, 2002, SEMIN RADIAT ONCOL, V12, P150, DOI 10.1053/srao.2002.30817; INADA K, 1990, JPN J SURG, V20, P545, DOI 10.1007/BF02471011; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; Newton AD, 2015, J GASTROINTEST ONCOL, V6, P534, DOI 10.3978/j.issn.2078-6891.2015.047; Ohashi M, 2016, WORLD J SURG, V40, P165, DOI 10.1007/s00268-015-3318-8; Papanikolaou IS, 2011, ANN GASTROENTEROL, V24, P9; Park SR, 2010, ANN SURG, V251, P428, DOI 10.1097/SLA.0b013e3181ca69a7; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Shin Hai-Rim, 2007, Cancer Res Treat, V39, P139, DOI 10.4143/crt.2007.39.4.139; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Smith NJ, 2008, BRIT J SURG, V95, P229, DOI 10.1002/bjs.5917; Sohn B, 2015, EUR RADIOL, V25, P1347, DOI 10.1007/s00330-014-3527-9; Takagane Akinori, 1999, Gastric Cancer, V2, P122, DOI 10.1007/s101200050034; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; WILKE H, 1989, J CLIN ONCOL, V7, P1318, DOI 10.1200/JCO.1989.7.9.1318	25	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202207	10.1371/journal.pone.0202207	http://dx.doi.org/10.1371/journal.pone.0202207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092078	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600101
J	Si, HW; Wang, XY; Zhang, LY; Parnell, LD; Admed, B; LeRoith, T; Ansah, TA; Zhang, LJ; Li, JW; Ordovas, JM; Si, HZ; Liu, DM; Lai, CQ				Si, Hongwei; Wang, Xiaoyong; Zhang, Longyun; Parnell, Laurence D.; Admed, Bulbul; LeRoith, Tanya; Ansah, Twum-Ampofo; Zhang, Lijuan; Li, Jianwei; Ordovas, Jose M.; Si, Hongzong; Liu, Dongmin; Lai, Chao-Qiang			Dietary epicatechin improves survival and delays skeletal muscle degeneration in aged mice	FASEB JOURNAL			English	Article						antiaging; extracellular matrix pathway; nicotinamide pathway; PPAR pathway; lifespan	LIFE-SPAN; EXTRACELLULAR-MATRIX; PPAR-GAMMA; OXIDATIVE STRESS; GENE-EXPRESSION; RESVERATROL; EXERCISE; (-)-EPICATECHIN; RESTRICTION; RESISTANCE	We recently reported that epicatechin, a bioactive compound that occurs naturally in various common foods, promoted general health and survival of obese diabetic mice. It remains to be determined whether epicatechin extends health span and delays the process of aging. In the present study, epicatechin or its analogue epigallocatechin gallate (EGCG) (0.25% w/v in drinking water) was administered to 20-mo-old male C57BL mice fed a standard chow. The goal was to determine the antiaging effect. The results showed that supplementation with epicatechin for 37 wk strikingly increased the survival rate from 39 to 69%, whereas EGCG had no significant effect. Consistently, epicatechin improved physical activity, delayed degeneration of skeletal muscle (quadriceps), and shifted the profiles of the serum metabolites and skeletal muscle general mRNA expressions in aging mice toward the profiles observed in young mice. In particular, we found that dietary epicatechin significantly reversed age-altered mRNA and protein expressions of extracellular matrix and peroxisome proliferator-activated receptor pathways in skeletal muscle, and reversed the age-induced declines of the nicotinate and nicotinamide pathway both in serum and skeletal muscle. The present study provides evidence that epicatechin supplementation can exert an antiaging effect, including an increase in survival, an attenuation of the aging-related deterioration of skeletal muscles, and a protection against the aging-related decline in nicotinate and nicotinamide metabolism.Si, H., Wang, X., Zhang, L., Parnell, L. D., Admed, B., LeRoith, T., Ansah, T.-A., Zhang, L., Li, J., Ordovas, J. M., Si, H., Liu, D., Lai, C.-Q. Dietary epicatechin improves survival and delays skeletal muscle degeneration in aged mice.	[Si, Hongwei; Wang, Xiaoyong; Zhang, Longyun; Admed, Bulbul; Zhang, Lijuan] Tennessee State Univ, Dept Human Sci, 3500 John A Merritt Blvd, Nashville, TN 37209 USA; [Li, Jianwei] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Parnell, Laurence D.; Lai, Chao-Qiang] Tufts Univ, USDA ARS, Boston, MA 02111 USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [LeRoith, Tanya] Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Ansah, Twum-Ampofo] Meharry Med Coll, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Ordovas, Jose M.] Autonomous Univ Madrid UAM, Campus Universal Excellence CEI, Res Inst Food & Hlth Sci, Madrid Inst Adv Studies IMDEA, Madrid, Spain; [Ordovas, Jose M.] Super Council Sci Invest CSIC, Madrid, Spain; [Si, Hongzong] Qingdao Univ, Inst Computat Sci & Engn, Qingdao, Peoples R China; [Liu, Dongmin] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Tennessee State University; Tennessee State University; Tufts University; United States Department of Agriculture (USDA); Tufts University; United States Department of Agriculture (USDA); Meharry Medical College; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Qingdao University; Virginia Polytechnic Institute & State University	Si, HW (corresponding author), Tennessee State Univ, Dept Human Sci, 3500 John A Merritt Blvd, Nashville, TN 37209 USA.; Liu, DM (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.; Lai, CQ (corresponding author), Tufts Univ, USDA ARS, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.	hsi@tnstate.edu; doliu@vt.edu; chaoqiang.lai@ars.usda.gov		Ahmed, Bulbul/0000-0002-9143-4538; Lai, Chao-Qiang/0000-0003-1107-8375	U.S. Department of Agriculture (USDA) Evans-Allen Program [TENX-1506-FS, TENX-1103-FS]; USDA 1890 Faculty Fellowship [58-8050-6-006]	U.S. Department of Agriculture (USDA) Evans-Allen Program; USDA 1890 Faculty Fellowship	D. L. (doliu@ vt. edu) contributed equally to this work with H.S. and C.-Q.L. and can be contacted with questions and concerns. This work was supported by grants from the U.S. Department of Agriculture (USDA) Evans-Allen Program (TENX-1506-FS and TENX-1103-FS to H.S.) and a USDA 1890 Faculty Fellowship (58-8050-6-006 to H.S. and C.-Q.L.). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the USDA. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA. The USDA is an equal opportunity provider and employer. The authors declare no conflicts of interest.	Bartel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005274; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Carrillo JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25948; Catoire M, 2015, FASEB J, V29, P1615, DOI 10.1096/fj.14-263699; Catoire M, 2014, PHYSIOL GENOMICS, V46, P256, DOI 10.1152/physiolgenomics.00174.2013; Das SK, 2017, MOL CELL ENDOCRINOL, V455, P148, DOI 10.1016/j.mce.2017.04.011; Duarte DA, 2015, J NUTR BIOCHEM, V26, P64, DOI 10.1016/j.jnutbio.2014.09.003; Ferguson MC, 2010, NEUROPHARMACOLOGY, V59, P31, DOI 10.1016/j.neuropharm.2010.03.013; Fu ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18502; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gao C, 2015, NEUROCHEM RES, V40, P818, DOI 10.1007/s11064-015-1532-2; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; Hollenberg NK, 2007, CIRCULATION, V116, P2360, DOI 10.1161/CIRCULATIONAHA.107.738070; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lai CQ, 2018, AM J CLIN NUTR, V108, P188, DOI 10.1093/ajcn/nqy081; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Martinez-Huenchullan SF, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13599; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Moreno-Ulloa A, 2015, J GERONTOL A-BIOL, V70, P1370, DOI 10.1093/gerona/glu131; Murphy Sherry L, 2017, Natl Vital Stat Rep, V66, P1; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Rinholm JE, 2007, NEUROSCIENCE, V145, P579, DOI 10.1016/j.neuroscience.2006.12.041; Rivas DA, 2012, J APPL PHYSIOL, V113, P1727, DOI 10.1152/japplphysiol.00412.2012; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sawai M, 2017, J BIOL CHEM, V292, P15538, DOI 10.1074/jbc.M117.803171; Schaffler A, 2004, BBA-GENE STRUCT EXPR, V1678, P150, DOI 10.1016/j.bbaexp.2004.02.006; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Shen LR, 2013, AGE, V35, P1133, DOI 10.1007/s11357-012-9438-2; Shen LR, 2013, BIOFACTORS, V39, P133, DOI 10.1002/biof.1086; Si HW, 2014, J NUTR BIOCHEM, V25, P581, DOI 10.1016/j.jnutbio.2014.02.001; Si HW, 2011, J NUTR, V141, P1095, DOI 10.3945/jn.110.134270; Stearns-Reider KM, 2017, AGING CELL, V16, P518, DOI 10.1111/acel.12578; Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496; Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070; Sung B, 2004, J GERONTOL A-BIOL, V59, P997; Zhang KR, 2012, HEART, V98, pE48, DOI 10.1136/heartjnl-2012-302920a.115; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhou Lan, 2014, Zhongguo Zhong Yao Za Zhi, V39, P1083	52	34	34	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					965	977		10.1096/fj.201800554RR	http://dx.doi.org/10.1096/fj.201800554RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30096038	hybrid, Green Published			2022-12-26	WOS:000457401500076
J	Mao, Y; Liu, XQ; Song, Y; Zhai, CG; Zhang, L				Mao, Yang; Liu, Xiaoqiong; Song, Yu; Zhai, Chungang; Zhang, Lei			VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-beta play important roles in promoting immature and inflammatory intraplaque angiogenesis	PLOS ONE			English	Article							VASA VASORUM; GROWTH; OVEREXPRESSION; STABILITY	Various angiogenic factors have been shown to play important roles in intraplaque angiogenesis, while little is known about the dynamic expression change and interplay between various angiogenic factors and intraplaque angiogenesis under high cholesterol conditions. New Zealand rabbits underwent balloon injury of the abdominal artery and then were assigned to a control group (n = 15, normal chow) or high cholesterol group (n = 25, 1% high cholesterol diet). At weeks 4, 6, 8, 10, and 12 after acclimation, rabbits (high cholesterol group, n = 5; control group, n = 3) were euthanized. No lesions were observed in the control group. From week 4 to week 12, the expression of vascular endothelial growth factor A (VEGF-A), VEGF receptor 2 (VEGFR-2), fibroblast growth factor 2 (FGF-2), FGF receptor 1 (FGFR-1), platelet-derived growth factor-BB (PDGF-BB), and tumor necrosis factor alpha (TNF-alpha), the vulnerability index (VI) and the microvessel density (MVD) were significantly elevated in the high cholesterol group; however, PDGF receptor beta (PDGFR-beta) expression showed little change. Analysis by double-label immunofluorescence (CD31 and Ng2) and FITC-dextran indicated that the neovessels within the plaque were leaky due to a lack of pericytes. As indicated by Pearson's correlation analysis, there was a highly positive correlation between the VI, MVD, macrophage content, and TNF-alpha level, and the levels of VEGFA/ VEGFR-2 and FGF-2/FGFR-1. However, no correlations were observed between PDGFR-beta levels and the VI or MVD. High expression of VEGF-A/VEGFR-2 and FGF-2/ FGFR-1 but not of PDGF-BB/PDGFR-beta may contribute to immature and inflammatory intraplaque angiogenesis and plaque instability in a rabbit model of atherosclerosis.	[Mao, Yang; Liu, Xiaoqiong; Zhai, Chungang; Zhang, Lei] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Mao, Yang; Liu, Xiaoqiong; Zhai, Chungang; Zhang, Lei] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan, Shandong, Peoples R China; [Liu, Xiaoqiong] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan, Shandong, Peoples R China; [Song, Yu] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai, Peoples R China	Shandong University; Shandong University; Shandong University; Fudan University	Zhang, L (corresponding author), Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China.; Zhang, L (corresponding author), Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan, Shandong, Peoples R China.	leilybao@163.com			National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [60971023, 81270351]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Basic Research Program of China (No. 2012CB518603), and grants from the National Natural Science Foundation of China (Nos. 60971023, 81270351).	Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; CHEN XHX Z., 2016, NEOPLASMA; Di Stefano R, 2009, CURR PHARM DESIGN, V15, P1095, DOI 10.2174/138161209787846892; Dong B, 2008, ARTERIOSCL THROM VAS, V28, P1270, DOI 10.1161/ATVBAHA.108.164715; Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Guo L, 2017, ARTERIOSCL THROM VAS, V37, pE33, DOI 10.1161/ATVBAHA.117.309045; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107851; Ma LY, 2015, EUR HEART J SUPPL, V17, pB5, DOI 10.1093/eurheartj/suv020; Martynova EV, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8528270; McCarty MF, 2007, J CLIN INVEST, V117, P2114, DOI 10.1172/JCI31334; Mollmark JI, 2012, ARTERIOSCL THROM VAS, V32, P2644, DOI 10.1161/ATVBAHA.112.252544; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Nakamura K, 2002, J CONTROL RELEASE, V79, P147, DOI 10.1016/S0168-3659(01)00540-5; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Taeger J, 2011, MOL CANCER THER, V10, P2157, DOI 10.1158/1535-7163.MCT-11-0312; ten Kate GL, 2010, J NUCL CARDIOL, V17, P897, DOI 10.1007/s12350-010-9263-x; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Tribolo S, 2008, ATHEROSCLEROSIS, V197, P50, DOI 10.1016/j.atherosclerosis.2007.07.040; Vindis C, 2007, REDOX REP, V12, P96, DOI 10.1179/135100007X162248; Wang YS, 2011, CLIN EXP MED, V11, P113, DOI 10.1007/s10238-010-0112-7; Woad Kathryn J, 2012, J SOC REPROD FERTILI, P1470; Zhang L, 2010, ATHEROSCLEROSIS, V211, P146, DOI 10.1016/j.atherosclerosis.2010.01.023	32	14	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201395	10.1371/journal.pone.0201395	http://dx.doi.org/10.1371/journal.pone.0201395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125282	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100009
J	Quigley-McBride, A; Franco, G; McLaren, DB; Mantonakis, A; Garry, M				Quigley-McBride, Adele; Franco, Gregory; McLaren, Daniel Bruce; Mantonakis, Antonia; Garry, Maryanne			In the real world, people prefer their last whisky when tasting options in a long sequence	PLOS ONE			English	Article							SERIAL POSITION; CHOICE; MEMORY; DANCE; ORDER; SAVE	When people in laboratory studies sample products in a sequence, they tend to prefer options presented first and last. To what extent do these primacy and recency effects carry over to real-world settings where numerous sources of information determine preferences? To investigate this question, we coded archival data from 136 actual whisky tastings each featuring seven whiskies. We analyzed people's ratings of whiskies featured at different serial positions in the tastings. We found a recency effect: people gave their highest rating to whiskies in the last position, and voted the last whisky as their favorite more frequently. This recency effect persisted when we controlled for the counter explanation that whiskies with higher alcohol content tended to occupy later serial positions. The recency effect also persisted when we controlled for the age of the whiskies. Taken together, our findings suggest that the order of presentation matters in real-world settings, closely resembling what happens in laboratory settings with longer sequences of options.	[Quigley-McBride, Adele; Franco, Gregory; Garry, Maryanne] Victoria Univ Wellington, Wellington, New Zealand; [McLaren, Daniel Bruce] Reg Wines, Wellington, New Zealand; [Mantonakis, Antonia] Brock Univ, St Catharines, ON, Canada; [Quigley-McBride, Adele] Iowa State Univ, Ames, IA USA; [Garry, Maryanne] Univ Waikato, Hamilton, New Zealand	Victoria University Wellington; Brock University; Iowa State University; University of Waikato	Garry, M (corresponding author), Victoria Univ Wellington, Wellington, New Zealand.; Garry, M (corresponding author), Univ Waikato, Hamilton, New Zealand.	maryanne.garry@waikato.ac.nz						Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; Canic E, 2014, FRONT PSYCHOL, V5, p1 , DOI [10.3389/fpsyg.2014.00001, DOI 10.3389/FPSYG.2014.00001]; Capraro V., 2018, SOCIAL SCI ELECT PUB, V13, P56, DOI [10.2139/ssrn.3186134, DOI 10.2139/SSRN.3186134]; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Carney DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035088; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Bruin WB, 2006, ACTA PSYCHOL, V123, P299, DOI 10.1016/j.actpsy.2006.01.009; de Bruin WB, 2005, ACTA PSYCHOL, V118, P245, DOI 10.1016/j.actpsy.2004.08.005; DEAN ML, 1980, J PSYCHOL, V105, P107, DOI 10.1080/00223980.1980.9915138; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; Li Y, 2009, J BEHAV DECIS MAKING, V22, P378, DOI 10.1002/bdm.638; Mantonakis A, 2009, PSYCHOL SCI, V20, P1309, DOI 10.1111/j.1467-9280.2009.02453.x; NISBETT R, 1977, PSYCHOL REV, V84, P1977, DOI DOI 10.1037/0033-295X.84.3.231; Page L, 2010, J ECON BEHAV ORGAN, V73, P186, DOI 10.1016/j.jebo.2009.08.012; Philp M, 2018, J BUSINESS RES; Pieters RGM, 1997, J CONSUM RES, V23, P362, DOI 10.1086/209489; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Sharif MA, 2016, PSYCHOL SCI, V27, P1136, DOI 10.1177/0956797616651973; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Sunstein CR, 2014, J CONSUM POLICY, V37, P583, DOI 10.1007/s10603-014-9273-1; Terry WS, 2005, J GEN PSYCHOL, V132, P151, DOI 10.3200/GENP.132.2.151-164; Thaler RichardH., 2013, BEHAV FDN PUBLIC POL, P428; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202732	10.1371/journal.pone.0202732	http://dx.doi.org/10.1371/journal.pone.0202732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR0JS	30125313	Green Published, gold			2022-12-26	WOS:000442202100045
J	Gatzke, N; Hillmeister, P; Dulsner, A; Guc, N; Dawid, R; Smith, KH; Pagonas, N; Bramlage, P; Gorath, M; Buschmann, IR				Gatzke, Nora; Hillmeister, Philipp; Duelsner, Andre; Guec, Nadija; Dawid, Rica; Smith, Katherine H.; Pagonas, Nikolaos; Bramlage, Peter; Gorath, Michaela; Buschmann, Ivo R.			Nitroglycerin application and coronary arteriogenesis	PLOS ONE			English	Article							FEMORAL-ARTERY OCCLUSION; NITRIC-OXIDE; COLLATERAL GROWTH; NITRATE TOLERANCE; VASCULAR SYSTEM; HEART-DISEASE; RAT; CLOPIDOGREL; MANAGEMENT; HINDLIMB	Background In the presence of a coronary occlusion, pre-existing small collateral vessels (arterioles) develop into much larger arteries (biological bypasses) that have the potential to allow a certain level of perfusion distal to the blockage. Termed arteriogenesis, this phenomenon proceeds via a complex combination of events, with nitric oxide (NO) playing an essential role. The aim of this study was to investigate the effects of supplemental administration of NO donors, i.e., short-acting nitroglycerin (NTG) or slow-release pelleted isosorbide dinitrate (ISDN), on collateral development in a repetitive coronary artery occlusion model in rats. Methods Coronary collateral growth was induced via a repetitive occlusion protocol (ROP) of the left anterior descending coronary artery (LAD) in rats. The primary endpoints were the histological evaluation of rat heart infarct size and ST-segment elevation (ECG-analysis) upon final permanent occlusion of the LAD (experimentally induced myocardial infarction). The effects of NTG or ISDN were also evaluated by administration during 5 days of ROP. We additionally investigated whether concomitant application of NTG can compensate for the anti-arteriogenic effect of acetylsalicylic acid (ASA). Results After 5 days of ROP, the mean infarct size and degree of ST-elevation were only slightly lower than those of the SHAM group; however, after 10 days of the protocol, the ROP group displayed significantly less severe infarct damage, indicating enhanced arteriogenesis. Intermittent NTG application greatly decreased the ST-elevation and infarct size. The ISDN also had a positive effect on arteriogenesis, but not to the same extent as the NTG. Administration of ASA increased the infarct severity; however, concomitant dosing with NTG somewhat attenuated this effect. Conclusion Intermittent treatment with the short-acting NTG decreased the size of an experimentally induced myocardial infarct by promoting coronary collateral development. These new insights are of great relevance for future clinical strategies for the treatment of occlusive vascular diseases.	[Gatzke, Nora; Hillmeister, Philipp; Dawid, Rica; Pagonas, Nikolaos; Bramlage, Peter; Buschmann, Ivo R.] Brandenburg Med Sch, Dept Angiol, Campus Brandenburg Havel, Brandenburg Havel, Germany; [Gatzke, Nora; Hillmeister, Philipp; Duelsner, Andre; Guec, Nadija; Buschmann, Ivo R.] Charite, Dept Cardiol, Campus Virchow, Berlin, Germany; [Gatzke, Nora; Hillmeister, Philipp; Duelsner, Andre; Guec, Nadija; Buschmann, Ivo R.] Charite, Ctr Cardiovasc Res, Campus Mitte, Berlin, Germany; [Smith, Katherine H.; Bramlage, Peter] Inst Pharmacol & Prevent Med, Mahlow, Germany; [Gorath, Michaela] G Pohl Boskamp GmbH & Co KG, Hohenlockstedt, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buschmann, IR (corresponding author), Brandenburg Med Sch, Dept Angiol, Campus Brandenburg Havel, Brandenburg Havel, Germany.; Buschmann, IR (corresponding author), Charite, Dept Cardiol, Campus Virchow, Berlin, Germany.; Buschmann, IR (corresponding author), Charite, Ctr Cardiovasc Res, Campus Mitte, Berlin, Germany.	i.buschmann@klinikum-brandenburg.de	Pagonas, Nikolaos/V-2241-2019		G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany	G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany	The research was funded by G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany. Michaela Gorath is the representative of the funder in the project team and was involved in the project outline and plan, the analysis of its results, a critical discussion of the research findings and in the preparation/revision of the manuscript.	Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; Carrao ACR, 2009, ARTERIOSCL THROM VAS, V29, P1817, DOI 10.1161/ATVBAHA.109.186445; Daiber A, 2015, ANTIOXID REDOX SIGN, V23, P899, DOI 10.1089/ars.2015.6376; Duelsner A, 2012, J CEREBR BLOOD F MET, V32, P105, DOI 10.1038/jcbfm.2011.113; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; FULTON W F, 1963, Scott Med J, V8, P420; Gloekler S, 2010, HEART, V96, P202, DOI 10.1136/hrt.2009.184507; HABIB GB, 1991, CIRCULATION, V83, P739, DOI 10.1161/01.CIR.83.3.739; Heil M, 2007, CURR PHARM BIOTECHNO, V8, P35, DOI 10.2174/138920107779941408; Hoefer IE, 2005, J AM COLL CARDIOL, V46, P994, DOI 10.1016/j.jacc.2005.02.094; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kleschyov AL, 2003, CIRC RES, V93, pE104, DOI 10.1161/01.RES.0000100067.62876.50; LOWN B, 1971, CIRCULATION, V44, P130, DOI 10.1161/01.CIR.44.1.130; Meier P, 2012, EUR HEART J, V33, P614, DOI 10.1093/eurheartj/ehr308; Miller MR, 2008, J VASC RES, V45, P375, DOI 10.1159/000121407; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Opelt M, 2016, J BIOL CHEM, V291, P24076, DOI 10.1074/jbc.M116.752071; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; Seiler C, 2001, CIRCULATION, V104, P2012, DOI 10.1161/hc4201.097835; THADANI U, 1994, CARDIOVASC DRUG THER, V8, P611, DOI 10.1007/BF00877415; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; Troidl K, 2010, J CARDIOVASC PHARM, V55, P153, DOI 10.1097/FJC.0b013e3181c9556f; Unthank JL, 1996, J SURG RES, V61, P463, DOI 10.1006/jsre.1996.0147; Uxa A, 2010, J CARDIOVASC PHARM, V56, P354, DOI 10.1097/FJC.0b013e3181ed2dae	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0201597	10.1371/journal.pone.0201597	http://dx.doi.org/10.1371/journal.pone.0201597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118486	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700009
J	Kinzey, D; Watters, GM; Reiss, CS				Kinzey, Douglas; Watters, George M.; Reiss, Christian S.			Parameter estimation using randomized phases in an integrated assessment model for Antarctic krill	PLOS ONE			English	Article							FISHERIES STOCK ASSESSMENT; EUPHAUSIA-SUPERBA; UNITED-STATES; DELTA METHOD; FISH STOCKS; UNCERTAINTY; CATCH; MANAGEMENT; RECRUITMENT; STRATEGIES	An integrated model assessing the status and productivity of Antarctic krill (Euphausia superba, hereafter krill) was configured to estimate different subsets of 118 potentially estimable parameters in alternative configurations. We fixed the parameters that were not estimated in any given configuration at pre-specified values. The model was fitted to over forty years of fisheries and survey data for krill in Subarea 48.1, a statistical reporting area around the Antarctic Peninsula used by the Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR). The number of estimated parameters was gradually increased across model configurations. Configurations that estimated more parameters fitted the data better, but the order in which the parameters were estimated became more important in finding the best fit. Twenty-two configurations estimating from 48 to 107 parameters were able to obtain an invertible Hessian matrix that was subsequently used to estimate parameter uncertainty. Parameter uncertainties calculated using asymptotic approximation around the maximum likelihood estimates were often larger than uncertainties based on Markov chain Monte Carlo sampling for the same parameters. Diagnostics applied to MCMC samples in the best model of each configuration that obtained an invertible Hessian indicated that the most highly parameterized configurations did not reach stationary distributions. A 96-parameter configuration was the best fitting model of those that passed the MCMC diagnostics. The Delta AIC and Delta BIC scores indicated essentially no support relative to the best model for the alternative models that also passed MCMC diagnostics. Simulated data using the configurations as operating models showed that while all configurations passed "self-tests" for spawning biomass and recruitment, there was a small negative bias due to model penalties in the fishing mortality estimates for years with the highest fishing mortalities. "Cross-tests" of configurations that estimated different parameters often differed from the operating model values.	[Kinzey, Douglas; Watters, George M.; Reiss, Christian S.] NOAA, Fisheries Antarctic Ecosyst Res Div, La Jolla, CA 92037 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Kinzey, D (corresponding author), NOAA, Fisheries Antarctic Ecosyst Res Div, La Jolla, CA 92037 USA.	doug.kinzey@noaa.gov			NOAA U. S. Antarctic Marine Living Resources (AMLR) program; Antarctic Marine Living Resources (AMLR) program	NOAA U. S. Antarctic Marine Living Resources (AMLR) program; Antarctic Marine Living Resources (AMLR) program	This project was funded by the NOAA U. S. Antarctic Marine Living Resources (AMLR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison MD, 2009, ECOL APPL, V19, P198, DOI 10.1890/07-1641.1; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2016, CCAMLR STAT B, V28; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Brooks EN, 2015, CAN J FISH AQUAT SCI, V72, P634, DOI 10.1139/cjfas-2014-0231; Bull B, 2012, CASAL C ALGORITHMIC, P135; Burnam K. P., 1998, MODEL SELECTION INFE; Conn PB, 2010, CAN J FISH AQUAT SCI, V67, P511, DOI 10.1139/F09-194; Cope JM, 2013, FISH RES, V142, P3, DOI 10.1016/j.fishres.2012.03.006; Cotter AJR, 2004, FISH FISH, V5, P235, DOI 10.1111/j.1467-2679.2004.00157.x; Deroba JJ, 2015, ICES J MAR SCI, V72, P19, DOI 10.1093/icesjms/fst237; Dichmont CM, 2016, FISH RES, V183, P447, DOI 10.1016/j.fishres.2016.07.001; FOURNIER D, 1982, CAN J FISH AQUAT SCI, V39, P1195, DOI 10.1139/f82-157; Fournier D, 2015, INTRO AD MODEL BUILD, V11; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gelman A, 2013, BRIT J MATH STAT PSY, V66, P8, DOI 10.1111/j.2044-8317.2011.02037.x; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kinzey D, 2015, FISH RES, V168, P72, DOI 10.1016/j.fishres.2015.03.023; Lee HH, 2012, FISH RES, V125, P254, DOI 10.1016/j.fishres.2012.03.001; Lee HH, 2011, FISH RES, V109, P89, DOI 10.1016/j.fishres.2011.01.021; MacCall AD, 2013, FISH RES, V142, P56, DOI 10.1016/j.fishres.2012.07.018; Magnusson A, 2013, FISH FISH, V14, P325, DOI 10.1111/j.1467-2979.2012.00473.x; Mangel M, 2013, CAN J FISH AQUAT SCI, V70, P930, DOI 10.1139/cjfas-2012-0372; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Maunder MN, 2003, CAN J FISH AQUAT SCI, V60, P1204, DOI 10.1139/F03-104; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Monk MH, 2013, FISHERY STOCK ASSESS, DOI [10.6084/m9.figshare.104717, DOI 10.6084/M9.FIGSHARE.104717]; Newman D, 2015, FISH RES, V164, P86, DOI 10.1016/j.fishres.2014.10.018; NRC, 1998, IMPR FISH STOCK ASS; Patterson K, 2001, FISH FISH, V2, P125, DOI 10.1046/j.1467-2960.2001.00042.x; Punt AE, 2008, FISH RES, V94, P251, DOI 10.1016/j.fishres.2007.12.008; Ralston S, 2011, FISH B-NOAA, V109, P217; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Reiss CS, 2017, MAR ECOL PROG SER, V568, P1, DOI 10.3354/meps12099; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Sippel T, 2017, FISH RES, V192, P135, DOI 10.1016/j.fishres.2016.12.009; Stewart IJ, 2013, FISH RES, V142, P37, DOI 10.1016/j.fishres.2012.07.003	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202545	10.1371/journal.pone.0202545	http://dx.doi.org/10.1371/journal.pone.0202545			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118523	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700033
J	Lee, CH; Jung, JH; Son, SH; Hong, CM; Jeong, JH; Jeong, SY; Lee, SW; Lee, J; Ahn, BC				Lee, Chang-Hee; Jung, Ji-Hoon; Son, Seung Hyun; Hong, Chae Moon; Jeong, Ju Hye; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol			Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer	PLOS ONE			English	Article							FOLLOW-UP; THYROGLOBULIN; CARCINOMA; SCINTIGRAPHY; RECURRENCE; IMAGES; IMPACT	Objective Post I-131 ablation single-photon emission computed tomography (SPECT)/CT can show radioactive iodine (RAI)-avid cervical metastatic lymph nodes (mLN) in differentiated thyroid cancer. This study aimed to evaluate the incidence of RAI-avid mLN on post I-131 ablation SPECT/CT and the risk factors related to metastasis among patients with papillary thyroid cancer (PTC) in the low- or intermediate-risk groups. Study design and setting Among 339 patients with PTC who underwent total thyroidectomy followed by I-131 ablation, 292 (228 women, 64 men) belonging to the low- or intermediate-risk groups before I-131 ablation, and with sufficient clinical follow-up data were enrolled. The risk groups were classified based on the American Thyroid Association 2015 guideline. Each patient was followed-up for at least 24 months after the ablation (median: 30 months). The clinical, pathologic, and biochemical factors of PTC were reviewed, and their relationships to RAI-avid mLN on SPECT/CT were analyzed. Results Of the 292 patients, 61 and 231 belonged to the low-and intermediate-risk groups, respectively. Four (6.5%) patients in the low-risk group and 31 (13.0%) patients in the intermediate-risk group had RAI-avid mLN. A high preablation TSH-stimulated serum thyroglobulin (Tg) level in the low- or intermediate-risk group predicted the presence of RAI-avid mLN (cut-off = 0.5; hazard ratio (HR): 2.96; p = 0.04). In the subgroup analysis by risk group, TSH-stimulated serum Tg only predicted RAI-avid mLN in the low-risk group (cut-off = 1.0; HR: 5.3; p = 0.03). Conclusion The incidence of RAI-avid mLN on postablation SPECT/CT was relatively high in both low-and intermediate-risk patients with PTC, and high preablation TSH-stimulated serum Tg level was a predictor of metastasis, especially in the low-risk group. A selective treatment approach should be considered in patients with high preablation TSH-stimulated serum Tg level.	[Lee, Chang-Hee; Jung, Ji-Hoon; Son, Seung Hyun; Hong, Chae Moon; Jeong, Ju Hye; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea; [Lee, Chang-Hee; Jung, Ji-Hoon; Hong, Chae Moon; Jeong, Ju Hye; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ Hosp, Dept Nucl Med, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea.; Ahn, BC (corresponding author), Kyungpook Natl Univ Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Lee, Jaetae/AAR-3317-2021; Lee, Jaetae/ABF-3980-2020	Jung, Ji-hoon/0000-0002-1173-3942; Ahn, Byeong-Cheol/0000-0001-7700-3929; Hong, Chae Moon/0000-0002-5519-6982	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2015M2A2A7A01045177]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2015M2A2A7A01045177).	Ahn BC, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1680464; Ahn BC, 2016, CLIN NUCL MED, V41, pE169, DOI 10.1097/RLU.0000000000001059; Avram AM, 2012, J NUCL MED, V53, P754, DOI 10.2967/jnumed.111.104133; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; do Rosario PWS, 2005, LARYNGOSCOPE, V115, P264, DOI 10.1097/01.mlg.0000154730.31281.0c; Giovanella L, 2005, CLIN CHEM LAB MED, V43, P843, DOI 10.1515/CCLM.2005.142; Giovanella L, 2008, CLIN ENDOCRINOL, V69, P659, DOI 10.1111/j.1365-2265.2008.03244.x; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Jeong SY, 2014, CLIN ENDOCRINOL, V81, P445, DOI 10.1111/cen.12460; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Pelttari H, 2010, EUR J ENDOCRINOL, V163, P757, DOI 10.1530/EJE-10-0553; Phan HTT, 2008, EUR J ENDOCRINOL, V158, P77, DOI 10.1530/EJE-07-0399; Polachek A, 2011, J ENDOCRINOL INVEST, V34, P855, DOI 10.3275/7768; Rosario PW, 2011, THYROID, V21, P49, DOI 10.1089/thy.2010.0145; SAMAAN NA, 1992, J CLIN ENDOCR METAB, V75, P714, DOI 10.1210/jc.75.3.714; Son SH, 2015, NUCL MED MOLEC IMAG, V49, P268, DOI 10.1007/s13139-015-0348-y; Tharp K, 2004, EUR J NUCL MED MOL I, V31, P1435, DOI 10.1007/s00259-004-1565-2; Wang H, 2009, CLIN IMAG, V33, P49, DOI 10.1016/j.clinimag.2008.06.024; Yamamoto Y, 2003, J NUCL MED, V44, P1905	19	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202644	10.1371/journal.pone.0202644	http://dx.doi.org/10.1371/journal.pone.0202644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118516	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700039
J	Moshiro, R; Perlman, JM; Kidanto, H; Kvaloy, JT; Mdoe, P; Ersdal, HL				Moshiro, Robert; Perlman, Jeffrey M.; Kidanto, Hussein; Kvaloy, Jan Terje; Mdoe, Paschal; Ersdal, Hege L.			Predictors of death including quality of positive pressure ventilation during newborn resuscitation and the relationship to outcome at seven days in a rural Tanzanian hospital	PLOS ONE			English	Article							NEONATAL RESUSCITATION; MASK VENTILATION; PRETERM INFANTS; CARDIOPULMONARY-RESUSCITATION; DELIVERY ROOM; HEART-RATE; BIRTH; VOLUME	Background Effective positive pressure ventilation (PPV) of non-breathing newborns is crucial in facilitating cardio-respiratory adaptation at birth. Identifying predictors of death in newborns receiving PPV is important in order to facilitate preventative strategies. Objective The objective of this study was to determine the perinatal predictors of death including the quality of PPV administered among admitted newborns. Methods An observational study of admitted newborns who received PPV after birth was conducted. Research assistants observed all deliveries and recorded perinatal events on data collection forms. Measured heart rate (HR) and ventilation parameters were then compared between newborns who died and survivors. Results Newborns (n = 232) were studied between October 2014 and November 2016. Newborns who died (n = 53) compared to survivors (n = 179) had more fetal heart rate (FHRT) abnormalities (12/53 vs 19/179; p = 0.03); lower initial HR (<100 beats/minute) at start of PPV (44/ 48 vs 77/139; p<0.001); and a longer time for HR to increase >100 beats/minute from birth (180 vs 149 seconds; p = 0.07). Newborns who died compared to survivors took longer time (14 vs 4 seconds; p = 0.008) and more inflations (7 vs 3; p = 0.006) to achieve an expired volume (V-t) of 6 ml/kg, respectively. Median delivered V-t during the first 60 seconds of PPV was less in newborns who died compared to survivors (5 vs 6 ml/kg; p = 0.12). Newborns who died proceeded to severe encephalopathy (15/31 vs 1/59; p<0.001) compared to survivors. Conclusion Depressed newborns who proceeded to death compared to survivors, exhibited delayed HR response to PPV which may partly reflect FHRT abnormalities related to interruption of placental blood flow, and/or a timely delay in establishing adequate V-t. Depressed newborns progressed to moderate/severe encephalopathy. Improving FHRT monitoring to identify fetuses at risk for expedited delivery, coupled with optimizing delivery room PPV might decrease mortality in this setting.	[Moshiro, Robert] Muhimbili Natl Hosp, Dept Paediat & Child Hlth, Dar Es Salaam, Tanzania; [Moshiro, Robert; Mdoe, Paschal; Ersdal, Hege L.] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Perlman, Jeffrey M.] Weill Cornell Med, Dept Pediat, New York, NY USA; [Kidanto, Hussein] Aga Khan Univ, Sch Med, Dar Es Salaam, Tanzania; [Kvaloy, Jan Terje] Univ Stavanger, Dept Math & Phys, Stavanger, Norway; [Kidanto, Hussein; Kvaloy, Jan Terje] Stavanger Univ Hosp, Res Dept, Stavanger, Norway; [Mdoe, Paschal] Haydom Lutheran Hosp, Dept Obstet & Gynecol, Manyara, Tanzania; [Ersdal, Hege L.] Stavanger Univ Hosp, Dept Anesthesiol & Intens Care, Stavanger, Norway	Universitetet i Stavanger; Cornell University; Aga Khan University; Universitetet i Stavanger; Stavanger University Hospital; Stavanger University Hospital	Moshiro, R (corresponding author), Muhimbili Natl Hosp, Dept Paediat & Child Hlth, Dar Es Salaam, Tanzania.; Moshiro, R (corresponding author), Univ Stavanger, Fac Hlth Sci, Stavanger, Norway.	moshiror@gmail.com		Moshiro, Robert/0000-0002-9036-0266	Global Health and Vaccination Research (GLOBVAC) program at the Research Council of Norway [228203]	Global Health and Vaccination Research (GLOBVAC) program at the Research Council of Norway	The study was funded by the Global Health and Vaccination Research (GLOBVAC) program at the Research Council of Norway (project number 228203). The external funding source had no role in the study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit the paper for publication.	Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Ersdal HL, 2018, INT J GYNECOL OBSTET, V141, P171, DOI 10.1002/ijgo.12430; Ersdal HL, 2012, RESUSCITATION, V83, P869, DOI 10.1016/j.resuscitation.2011.12.011; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Hooper SB, 2010, NEOREVIEWS, V11, pe474; Hooper SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070895; Kasdorf E, 2013, SEMIN FETAL NEONAT M, V18, P379, DOI 10.1016/j.siny.2013.08.004; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; Linde JE, 2017, RESUSCITATION, V117, P80, DOI 10.1016/j.resuscitation.2017.06.007; Linde JE, 2016, NEONATOLOGY, V110, P231, DOI 10.1159/000445930; Mathur NB, 2005, J TROP PEDIATRICS, V51, P341, DOI 10.1093/tropej/fmi049; Mian QN, 2014, J PEDIATR-US, V165, P702, DOI 10.1016/j.jpeds.2014.06.047; MORTOLA JP, 1982, J APPL PHYSIOL, V52, P716, DOI 10.1152/jappl.1982.52.3.716; Mullany LC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-43; O'Donnell CPF, 2005, ARCH DIS CHILD-FETAL, V90, pF392, DOI 10.1136/adc.2004.064691; PALMEKILANDER C, 1993, ARCH DIS CHILD-FETAL, V68, P11, DOI 10.1136/adc.68.1_Spec_No.11; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; PERLMAN JM, 1995, ARCH PEDIAT ADOL MED, V149, P20, DOI 10.1001/archpedi.1995.02170130022005; Schilleman K, 2013, J PEDIATR-US, V162, P457, DOI 10.1016/j.jpeds.2012.09.036; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Skare C, 2016, RESUSCITATION, V107, P25, DOI 10.1016/j.resuscitation.2016.07.231; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; Thallinger M, 2016, ARCH DIS CHILD-FETAL, V101, pF299, DOI 10.1136/archdischild-2015-308754; The American Academy of of Pediatrics, 2009, HELP BAB BREATH; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; UNICEF, 2019, LEVELS TRENDS CHILD, DOI DOI 10.1371/JOURNAL.PONE.0144443; World Health Organization, 2010, MAT NEWB CHILD AD HL; Yam CH, 2011, ARCH DIS CHILD-FETAL, V96, pF102, DOI 10.1136/adc.2009.180950	29	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202641	10.1371/journal.pone.0202641	http://dx.doi.org/10.1371/journal.pone.0202641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118519	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700038
J	Ngadze, RT; Verkerk, R; Nyanga, LK; Fogliano, V; Ferracane, R; Troise, AD; Linnemann, AR				Ngadze, Ruth T.; Verkerk, Ruud; Nyanga, Loveness K.; Fogliano, Vincenzo; Ferracane, Rosalie; Troise, Antonio D.; Linnemann, Anita R.			Effect of heat and pectinase maceration on phenolic compounds and physicochemical quality of Strychnos cocculoides juice	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; FANCYTILES APPROACH; FRUITS; ACIDS; IMPROVEMENT; PROFILE; SPP.	Strychnos cocculoides fruit is an important food source for rural populations in Zimbabwe in times of scarcity. Its thick pulp tightly adheres to its seeds, causing pulp extraction constraints and waste during processing, leading to underutilisation. Therefore, pectinase maceration combined with heat treatments was studied to improve juice yield and juice quality. Metabolite profiling according to the heat map, FancyTile chromatic scale approach and phenolic compound content were used to compare the identified compounds. Prior to treatments, 16 known phenolic compounds, predominantly belonging to the phenolic acids, flavonoids and iridoid glucoside classes, were tentatively characterized for the first time in S. cocculoides using High Resolution Mass Spectrometry and LC/MS/MS. Overall, results showed that enzymatic treatments increased pulp yield (by 26%), physicochemical quality (38% increase in juice clarity), content of phenolic compounds (predominantly kaempferol, quercetin, caffeic acid, protocatechuic acid, iridoids) and antioxidant activity.The improved extraction of S. cocculoides pulp increases juice yield as well as juice quality by supplying larger amounts of phenolic compounds that have potential health benefits and act as dietary sources of antioxidants for the prevention of diseases caused by oxidative stress.	[Ngadze, Ruth T.] Chinhoyi Univ Technol, Dept Food Sci & Technol, Chinhoyi, Zimbabwe; [Ngadze, Ruth T.; Verkerk, Ruud; Fogliano, Vincenzo; Linnemann, Anita R.] Wageningen Univ & Res, Food Qual & Design, Wageningen, Netherlands; [Nyanga, Loveness K.] Univ Zimbabwe, Inst Food Nutr & Family Sci, Harare, Zimbabwe; [Ferracane, Rosalie; Troise, Antonio D.] Univ Naples Federico II, Dept Agr Sci, Portici, NA, Italy	Wageningen University & Research; University of Zimbabwe; University of Naples Federico II	Linnemann, AR (corresponding author), Wageningen Univ & Res, Food Qual & Design, Wageningen, Netherlands.	anita.linnemann@wur.nl	Troise, Antonio Dario/O-6113-2017; fogliano, vincenzo/A-1419-2009; Fogliano, Vincenzo/M-8166-2019; fogliano, vincenzo/W-6885-2019; Linnemann, Anita/O-7509-2014	Troise, Antonio Dario/0000-0001-7635-5244; fogliano, vincenzo/0000-0001-8786-9355; fogliano, vincenzo/0000-0001-8786-9355; Ngadze, Ruth Tambudzai/0000-0002-2201-6156; Linnemann, Anita/0000-0003-3201-3343	Netherlands Fellowship Programme [CF9151/2013]	Netherlands Fellowship Programme	This study was funded by Netherlands Fellowship Programme, grant award CF9151/2013 (RTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adao RC, 2005, FOOD CHEM, V90, P705, DOI 10.1016/j.foodchem.2004.05.020; Amarteifio J., 2006, J APPL SCI ENV MANAG, V10; AOAC, 1990, OFF METH AN ASS AN C; Bello M., 2008, AFRICAN J BIOTECHNOL, V7; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T]; Deng S., 2011, ADV J FOOD SCI TECHN, V3, P155; Ferracane R, 2008, J AGR FOOD CHEM, V56, P8601, DOI 10.1021/jf800408w; Hiwilepo-van Hal P, 2013, LWT-FOOD SCI TECHNOL, V53, P70, DOI 10.1016/j.lwt.2013.02.021; Kakkar S., 2014, ISRN PHARM, V2014; Li CY, 2013, J AGR FOOD CHEM, V61, P523, DOI 10.1021/jf3046158; Lima MD, 2015, FOOD CHEM, V188, P384, DOI 10.1016/j.foodchem.2015.04.014; Mattila P, 2006, J AGR FOOD CHEM, V54, P7193, DOI 10.1021/jf0615247; Ngadze RT, 2017, FOOD SECUR, V9, P621, DOI 10.1007/s12571-017-0679-x; Ngadze RT, 2017, FOOD REV INT, V33, P123, DOI 10.1080/87559129.2016.1149862; Oliveira Lívia de Lacerda de, 2014, Rev. Ceres, V61, P764, DOI 10.1590/0034-737x201461000002; Pathare PB, 2013, FOOD BIOPROCESS TECH, V6, P36, DOI 10.1007/s11947-012-0867-9; Puri M, 2012, TRENDS BIOTECHNOL, V30, P37, DOI 10.1016/j.tibtech.2011.06.014; RANWALA AP, 1992, PLANT SCI, V84, P59, DOI 10.1016/0168-9452(92)90208-4; Ribeiro DS, 2010, INT J FOOD SCI TECH, V45, P635, DOI 10.1111/j.1365-2621.2010.02177.x; Robards K, 1999, FOOD CHEM, V66, P401, DOI 10.1016/S0308-8146(99)00093-X; Russell WR, 2009, FOOD CHEM, V115, P100, DOI 10.1016/j.foodchem.2008.11.086; Sandri IG, 2014, FOOD SCI TECH-BRAZIL, V34, P657, DOI 10.1590/1678-457X.6381; Shah NNAK, 2015, J FOOD SCI TECH MYS, V52, P5057, DOI 10.1007/s13197-014-1554-9; Sharma HP, 2014, TRENDS POSTHARVEST T, V2, P1, DOI DOI 10.1002/fsn3.74; Sharma HP, 2015, CRITICAL REV FOOD SC; Sitrit Y, 2003, J AGR FOOD CHEM, V51, P6256, DOI 10.1021/jf030289e; SREENATH HK, 1994, J FERMENT BIOENG, V78, P486, DOI 10.1016/0922-338X(94)90054-X; Sunghwa F, 2009, NAT PROD RES, V23, P1408, DOI 10.1080/14786410902750969; Troise AD, 2014, FOOD RES INT, V63, P139, DOI 10.1016/j.foodres.2014.01.001; Wang XQ, 2017, FOOD CHEM, V233, P302, DOI 10.1016/j.foodchem.2017.04.110; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; West BJ, 2016, GLYCOCONJUGATE J, V33, P671, DOI 10.1007/s10719-016-9695-x; Zhu FX, 2014, J CHROMATOGR SCI, V52, P862, DOI 10.1093/chromsci/bmt129	34	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202415	10.1371/journal.pone.0202415	http://dx.doi.org/10.1371/journal.pone.0202415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118502	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700024
J	Pal, R; Wei, N; Song, N; Wu, SY; Kim, RS; Wang, Y; Gavin, PG; Lucas, PC; Srinivasan, A; Allegra, CJ; Jacobs, SA; Paik, S; Schmitz, JC; Pogue-Geile, KL				Pal, Rekha; Wei, Ning; Song, Nan; Wu, Shaoyu; Kim, Rim S.; Wang, Ying; Gavin, Patrick G.; Lucas, Peter C.; Srinivasan, Ashok; Allegra, Carmen J.; Jacobs, Samuel A.; Paik, Soonmyung; Schmitz, John C.; Pogue-Geile, Katherine L.			Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations	PLOS ONE			English	Article							CELL LUNG-CANCER; K-RAS MUTATIONS; ACQUIRED-RESISTANCE; COLON-CANCER; MEK; INHIBITION; LANDSCAPE; GROWTH; BRAF	Molecular subtypes of colorectal tumors are associated with prognosis and prediction for treatment benefit from chemotherapy. The purpose of this study was two-fold: 1) to determine the association of colorectal (CRC) molecular subtypes with response to targeted therapies in pre-clinical models and 2) to identify treatments for CRC stem-like subtype because these tumors are associated with a very poor patient prognosis. Eleven CRC cell lines were classified into molecular subtypes and tested for their response to pan-ERBB, MEK, and ERK inhibitors as single agents and in combination. All six inflammatory or TA cell lines were exquisitely sensitive to the combination of MEK and neratinib whereas all five stemlike cell lines were resistant. Growth inhibition in sensitive cell lines was greater with the combination than with either drug alone even in cell lines with KRAS mutations. The combination inhibited pERK in inflammatory cell lines but not in four out of five stem-like cell lines. MEK162 plus neratinib were synergistic in cell culture and xenograft models in inflammatory cell lines. The ERK inhibitor, SCH772984, down-regulated pERK, decreased cell viability, and was synergistic with neratinib in both inflammatory and stem-like subtypes. These results suggest that inhibition of pERK is a critical node in decreasing cell viability of stemlike CRC tumors. Our results also suggest that CRC molecular subtypes may yield predictive information and may help to identify patients who may respond to targeted inhibitors.	[Pal, Rekha; Song, Nan; Kim, Rim S.; Wang, Ying; Gavin, Patrick G.; Lucas, Peter C.; Srinivasan, Ashok; Allegra, Carmen J.; Jacobs, Samuel A.; Paik, Soonmyung; Pogue-Geile, Katherine L.] NSABP NRG Oncol, Pittsburgh, PA 15213 USA; [Wei, Ning; Wu, Shaoyu; Schmitz, John C.] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA; [Lucas, Peter C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Allegra, Carmen J.] Univ Florida Hlth, Med Oncol, Gainesville, FL USA; [Paik, Soonmyung] Yonsei Univ, Coll Med, Seoul, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Yonsei University; Yonsei University Health System	Pogue-Geile, KL (corresponding author), NSABP NRG Oncol, Pittsburgh, PA 15213 USA.	katherine.pogue-geile@nsabp.org	WEI, NING/P-8505-2019; WEI, NING/AAF-8368-2020	WEI, NING/0000-0003-2723-4061; WEI, NING/0000-0003-2723-4061; Paik, Soonmyung/0000-0001-9688-6480; Lucas, Peter/0000-0003-4880-7172; Gavin, Patrick/0000-0003-0325-7082	Pennsylvania Department of Health; Ministry of Health and Welfare, Republic of Korea [HI13C2162]; University of Pittsburgh Cancer Institute (UPCI) CCSG [P30CA047904]	Pennsylvania Department of Health; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); University of Pittsburgh Cancer Institute (UPCI) CCSG	Supported by: Funded in part under a grant from the Pennsylvania Department of Health http://www.health.pa.gov/Pages/default.aspx#.WqFilTtOnSc (KPG). The Department specifically disclaims responsibility for any analysis, interpretations, or conclusions; The Korea Health Technology Research and Development Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number HI13C2162) http://www.khidi.or.kr/eps (SP); This project was supported by funds from the University of Pittsburgh Cancer Institute (UPCI) CCSG (P30CA047904) and used the UPCI Animal Facility (supported by funds from P30CA047904) https://upci.upmc.edu/facilities.cfm (JCS). K.L. Pogue-Geile had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Grossmann AH, 2011, ARCH PATHOL LAB MED, V135, P1278, DOI 10.5858/arpa.2011-0047-RA; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Oddo D, 2016, CANCER RES, V76, P4504, DOI 10.1158/0008-5472.CAN-16-0396; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Song N, 2016, JAMA ONCOL, V2, P1162, DOI 10.1001/jamaoncol.2016.2314; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Wong DJL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-194	20	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0200836	10.1371/journal.pone.0200836	http://dx.doi.org/10.1371/journal.pone.0200836			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118499	Green Submitted, Green Published, gold			2022-12-26	WOS:000442282700004
J	Park, YJ; Runkle, ES				Park, Yujin; Runkle, Erik S.			Spectral effects of light-emitting diodes on plant growth, visual color quality, and photosynthetic photon efficacy: White versus blue plus red radiation	PLOS ONE			English	Article							TOMATO SEEDLINGS; LETTUCE GROWTH; QUANTUM YIELD; GREEN; ACCLIMATION; PHOTORECEPTORS; CRYPTOCHROME; IMPATIENS; PETUNIA; DESIGN	Arrays of blue (B, 400-500 nm) and red (R, 600-700 nm) light-emitting diodes (LEDs) used for plant growth applications make visual assessment of plants difficult compared to a broad (white, W) spectrum. Although WLEDs are sometimes used in horticultural lighting fixtures, little research has been published using them for sole-source lighting. We grew seedlings of begonia (Begonia xsemperflorens), geranium (Pelargonium xhorturum), petunia (Petunia xhybrida), and snapdragon (Antirrhinum majus) at 20 degrees C under six sole-source LED lighting treatments with a photosynthetic photon flux density (PPFD) of 160 mu mol.m(2).s(-1) using B (peak = 447 nm), green (G, peak = 531 nm), R (peak = 660 nm), and/or mintW(MW, peak = 558 nm) LEDs that emitted 15% B, 59% G, and 26% R plus 6 mu mol.m(-2).s(-1) of far-red radiation. The lighting treatments (with percentage from each LED in subscript) were MW100, MW75R25, MW45R55, MW25R75, B15R85, and B(20)G(40)R(40). At the transplant stage, total leaf area, and fresh and dry weight were similar among treatments in all species. Surprisingly, when petunia seedlings were grown longer (beyond the transplant stage) under sole-source lighting treatments, the primary stem elongated and had flower buds earlier under MW100 and MW75R25 compared to under B15R85. The color rendering index of MW75R25 and MW45R55 were 72, and 77, respectively, which was higher than those of other treatments, which were <= 64. While photosynthetic photon efficacy of B15R85 (2.25 mu mol.J(-1)) was higher than theWlight treatments (1.51-2.13 mu mol.J(-1)), the dry weight gain per unit electric energy consumption (in g.kWh(-1)) of B15R85 was similar to those of MW25R75, MW45R55, and MW75R25 in three species. We conclude that compared to B+R radiation, Wradiation had generally similar effects on seedling growth at the same PPFD with similar electric energy consumption, and improved the visual color quality of sole-source lighting.	[Park, Yujin; Runkle, Erik S.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA	Michigan State University	Runkle, ES (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.	runkleer@msu.edu			USDA Floriculture and Nursery Research Initiative Project [0500-00059-001-00D]; Michigan State Universitys Project GREEEN; AgBioResearch; OSRAM Opto Semiconductors	USDA Floriculture and Nursery Research Initiative Project; Michigan State Universitys Project GREEEN; AgBioResearch; OSRAM Opto Semiconductors	This work was supported by the USDA Floriculture and Nursery Research Initiative Project No. 0500-00059-001-00D to E.R. (https://www.ars.usda.gov/research/project/?accnNo=402626), Michigan State Universitys Project GREEEN (http://www.canr.msu.edu/research/plant-agriculture/project_greeen) and AgBioResearch (http://www.canr.msu.edu/research/agbioresearch), and OSRAM Opto Semiconductors (https://www.osram.com/os). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J M, 1995, Photosynth Res, V46, P129, DOI 10.1007/BF00020423; [Anonymous], 2017, S640 ANSIASABE; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Both AJ, 2017, HORTTECHNOLOGY, V27, P544, DOI [10.21273/HORTTECH03648-16, 10.21273/horttech03648-16]; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; BROWN CS, 1995, J AM SOC HORTIC SCI, V120, P808, DOI 10.21273/JASHS.120.5.808; Casal J. J., 2013, ISRN Agronomy, V2013, P650439; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; Craig DS, 2016, ENVIRON EXP BOT, V121, P132, DOI 10.1016/j.envexpbot.2015.04.004; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P199, DOI 10.1562/0031-8655(2001)073&lt;0199:DITROW&gt;2.0.CO;2; Folta KM, 2004, PLANT PHYSIOL, V135, P1407, DOI 10.1104/pp.104.038893; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Hernandez R, 2016, ENVIRON EXP BOT, V121, P66, DOI 10.1016/j.envexpbot.2015.04.001; Hernandez R, 2015, HORTSCIENCE, V50, P351, DOI 10.21273/HORTSCI.50.3.351; Hogewoning SW, 2012, PLANT CELL, V24, P1921, DOI 10.1105/tpc.112.097972; Hogewoning SW, 2010, J EXP BOT, V61, P1267, DOI 10.1093/jxb/erq005; Kasajima SY, 2007, PLANT PROD SCI, V10, P286, DOI 10.1626/pps.10.286; Kim HH, 2004, HORTSCIENCE, V39, P1617, DOI 10.21273/HORTSCI.39.7.1617; Liu XY, 2011, ACTA HORTIC, V907, P325; MCCAMY CS, 1992, COLOR RES APPL, V17, P142, DOI 10.1002/col.5080170211; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; MOSS RA, 1952, PLANT PHYSIOL, V27, P370, DOI 10.1104/pp.27.2.370; Nelson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099010; Nishio JN, 2000, PLANT CELL ENVIRON, V23, P539, DOI 10.1046/j.1365-3040.2000.00563.x; Ohno Y, 2005, OPT ENG, V44, DOI 10.1117/1.2130694; Ohta N, 2005, COLORIMETRY: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1002/0470094745; Park Y, 2018, ENVIRON EXP BOT, V155, P206, DOI 10.1016/j.envexpbot.2018.06.033; Park Y, 2017, ENVIRON EXP BOT, V136, P41, DOI 10.1016/j.envexpbot.2016.12.013; Pust P, 2015, NAT MATER, V14, P454, DOI 10.1038/nmat4270; Randall WC, 2015, HORTSCIENCE, V50, P705, DOI 10.21273/HORTSCI.50.5.705; regory F.G., 1917, 3 ANN REPORT, P19; SAGER JC, 1988, T ASAE, V31, P1882; Sasabe H, 2013, J MATER CHEM C, V1, P1699, DOI 10.1039/c2tc00584k; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; Snowden MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163121; Son KH, 2013, HORTSCIENCE, V48, P988; Stutte GW, 2009, HORTSCIENCE, V44, P231, DOI 10.21273/HORTSCI.44.2.231; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Sun JD, 1998, PLANT CELL PHYSIOL, V39, P1020, DOI 10.1093/oxfordjournals.pcp.a029298; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Thejokalyani N, 2014, RENEW SUST ENERG REV, V32, P448, DOI 10.1016/j.rser.2014.01.013; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wang YH, 2015, PLANT GROWTH REGUL, V77, P147, DOI 10.1007/s10725-015-0046-x; Wollaeger HM, 2015, HORTSCIENCE, V50, P522, DOI 10.21273/HORTSCI.50.4.522; Wollaeger HM, 2014, HORTSCIENCE, V49, P734, DOI 10.21273/HORTSCI.49.6.734; Wollaeger HM, 2013, HORTSCIENCE, V48, P1478, DOI 10.21273/HORTSCI.48.12.1478; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380; Zhang TT, 2011, PLANT PHYSIOL, V157, P1528, DOI 10.1104/pp.111.180661	50	38	40	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202386	10.1371/journal.pone.0202386	http://dx.doi.org/10.1371/journal.pone.0202386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114282	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400065
J	Otsuki, N; Arakawa, R; Kaneko, K; Aoki, R; Arakawa, M; Saito, K				Otsuki, Noriko; Arakawa, Reiko; Kaneko, Kaori; Aoki, Ryoko; Arakawa, Masayuki; Saito, Kayoko			A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein	PLOS ONE			English	Article							SMN COMPLEX; SINGLE NUCLEOTIDE; GENE; DIFFERENTIATION; MONOCYTES	Spinal muscular atrophy (SMA) is a severe genetic neuromuscular disorder caused by insufficiency of functional survival motor neuron (SMN) protein. Several clinical trials have been conducted with the aim of upregulating the expression of the SMN protein in SMA patients. In order to evaluate the efficiency of these SMN-targeted approaches, it has become necessary to verify SMN protein levels in the cells of SMA patients. Accordingly, we have developed a method allowing the evaluation of the functional SMN protein with < 1.5mL of peripheral blood using imaging flow cytometry. The expression of SMN protein in CD3+, CD19+, and CD33++ cells obtained from SMA patients, was significantly reduced compared with that in cells from control subjects. In spot analysis of CD33(++) cells, the intensities of SMN spots were significantly reduced in SMA subjects, when compared with that in controls. Therefore, SMN spots implied the presence of functional SMN protein in the cell nucleus. To our knowledge, our results are the first to demonstrate the presence of functional SMN protein in freshly isolated peripheral blood cells. We anticipate that SMN spot analysis will become the primary endpoint assay for the evaluation and monitoring of therapeutic intervention, with SMN serving as a reliable biomarker of therapeutic efficacy in SMA patients.	[Otsuki, Noriko; Arakawa, Reiko; Aoki, Ryoko; Saito, Kayoko] Tokyo Womens Med Univ, Inst Med Genet, Shinjuku Ku, 10-22 Kawadacho, Tokyo 1620054, Japan; [Kaneko, Kaori; Saito, Kayoko] Tokyo Womens Med Univ, Grad Sch,Grad Course Med, Affiliated Field Med Genet,Div Biomed Engn & Sci, Shinjuku Ku, 10-22 Kawadacho, Tokyo 1620054, Japan; [Arakawa, Masayuki] Inst Microbial Chem, Lab Virol, Shinagawa Ku, 5-14-23 Kamiosaki, Tokyo 1410021, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Saito, K (corresponding author), Tokyo Womens Med Univ, Inst Med Genet, Shinjuku Ku, 10-22 Kawadacho, Tokyo 1620054, Japan.; Saito, K (corresponding author), Tokyo Womens Med Univ, Grad Sch,Grad Course Med, Affiliated Field Med Genet,Div Biomed Engn & Sci, Shinjuku Ku, 10-22 Kawadacho, Tokyo 1620054, Japan.	saito.kayoko@twmu.ac.jp	Otsuki, Noriko/K-2417-2016	Saito, Kayoko/0000-0003-2632-0873	Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development, AMED [16ek0109086h0002]; Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan [H29-nannchitou(nann)-ippann-033]; Japan Society for the Promotion of Science, JSPS [26860829, 26461555]	Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science, JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by The Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development, AMED (URL: https://www.amed.go.jp/), Grant number: 16ek0109086h0002, Principal Investigator: Dr. Kayoko Saito; The Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan (URL: http://plaza.umin.ac.jp/neuro2/), Grant number: H29-nannchitou(nann)-ippann-033, Investigator: Dr. Kayoko Saito; Japan Society for the Promotion of Science, JSPS Grants-in-Aid for Scientific Research (URL: https://www.jsps.go.jp/j-grantsinaid/), Grant number: 26860829, Principal Investigator: Dr. Reiko Arakawa; and Japan Society for the Promotion of Science, JSPS Grants-in-Aid for Scientific Research (URL: https://www.jsps.go.jp/j-grantsinaid/), Grant number: 26461555, Principal Investigator: Dr. Masayuki Arakawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2014, BIOCHEM BIOPH RES CO, V453, P368, DOI 10.1016/j.bbrc.2014.09.087; Arakawa R, 2016, PEDIATR NEUROL, V61, P70, DOI 10.1016/j.pediatrneurol.2016.05.009; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Azuma M, 2006, J PERIODONTAL RES, V41, P361, DOI 10.1111/j.1600-0765.2006.00896.x; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coady TH, 2011, WIRES RNA, V2, P546, DOI 10.1002/wrna.76; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Custer SK, 2014, MOL CELL NEUROSCI, V61, P133, DOI 10.1016/j.mcn.2014.06.006; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; Dal Mas A, 2015, AM J HUM GENET, V96, P93, DOI 10.1016/j.ajhg.2014.12.009; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Hattori H, 2012, J NEUROSCI RES, V90, P479, DOI 10.1002/jnr.22755; Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011; Hulsmans M, 2016, J MOL CELL CARDIOL, V93, P149, DOI 10.1016/j.yjmcc.2015.11.015; Kaneko K, 2017, BRAIN DEV-JPN, V39, P763, DOI 10.1016/j.braindev.2017.04.018; Kerr DA, 2000, P NATL ACAD SCI USA, V97, P13312, DOI 10.1073/pnas.230364197; Kobayashi DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024269; Kodama H, 2006, IMMUNOL CELL BIOL, V84, P209, DOI 10.1111/j.1440-1711.2006.01424.x; Kolb SJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-6; Kubo Y, 2015, J HUM GENET, V60, P233, DOI 10.1038/jhg.2015.16; Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026; Lauvau G, 2015, SEMIN IMMUNOL, V27, P397, DOI 10.1016/j.smim.2016.03.014; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Mohseni J, 2013, GENET MOL BIOL, V36, P299, DOI 10.1590/S1415-47572013000300001; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Ruhnke M, 2005, GASTROENTEROLOGY, V128, P1774, DOI 10.1053/j.gastro.2005.03.029; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Steinkellner H, 2015, ASSAY DRUG DEV TECHN, V13, P167, DOI 10.1089/adt.2015.635; Swirski FK, 2014, SEMIN IMMUNOPATHOL, V36, P137, DOI 10.1007/s00281-013-0409-1; Tapia O, 2012, HISTOCHEM CELL BIOL, V137, P657, DOI 10.1007/s00418-012-0921-8; Terheyden H, 2014, CLIN ORAL IMPLAN RES, V25, P399, DOI 10.1111/clr.12176; Tiziano FD, 2011, INT J MOL SCI, V12, P24, DOI 10.3390/ijms12010024; Ungefroren H, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7132751; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Zaworski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150640; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	58	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201764	10.1371/journal.pone.0201764	http://dx.doi.org/10.1371/journal.pone.0201764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102724	Green Published, Green Submitted			2022-12-26	WOS:000441452200017
J	Kumar, V; AlMomin, S; Al-Aqeel, H; Al-Salameen, F; Nair, S; Shajan, A				Kumar, Vinod; AlMomin, Sabah; Al-Aqeel, Hamed; Al-Salameen, Fadila; Nair, Sindhu; Shajan, Anisha			Metagenomic analysis of rhizosphere microflora of oil-contaminated soil planted with barley and alfalfa	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PHYTOREMEDIATION; DIVERSITY; DEGRADATION	The role of rhizosphere microbial communities in the degradation of hydrocarbons remains poorly understood and is a field of active study. We used high throughput sequencing to explore the rhizosphere microbial diversity in the alfalfa and barley planted oil contaminated soil samples. The analysis of 16s rRNA sequences showed Proteobacteria to be the most enriched (45.9%) followed by Bacteriodetes (21.4%) and Actinobacteria (10.4%) phyla. The results also indicated differences in the microbial diversity among the oil contaminated planted soil samples. The oil contaminated planted soil samples showed a higher richness in the microbial flora when compared to that of untreated samples, as indicated by the Chao1 indices. However, the trend was different for the diversity measure, where oil contaminated barley planted soil samples showed slightly lower diversity indices. While the clustering of soil samples grouped the oil contaminated samples within and across the plant types, the clean sandy soil samples formed a separate group. The oil contaminated rhizosphere soil showed an enrichment of known oil-degrading genera, such as Alcanivorax and Aequorivita, later being specifically enriched in the contaminated soil samples planted with barley. Overall, we found a few well known oil-degrading bacterial groups to be enriched in the oil contaminated planted soil samples compared to the untreated samples. Further, phyla such as Thermi and Gemmatimonadetes showed an enrichment in the oil contaminated soil samples, indicating their potential role in hydrocarbon degradation. The findings of the current study will be useful in understanding the rhizosphere microflora responsible for oil degradation and thus can help in designing appropriate phytoremediation strategies for oil contaminated lands.	[Kumar, Vinod; AlMomin, Sabah; Al-Aqeel, Hamed; Al-Salameen, Fadila; Nair, Sindhu; Shajan, Anisha] Kuwait Inst Sci Res, Biotechnol Program, Environm & Life Sci Res Ctr, Kuwait, Kuwait	Kuwait Institute for Scientific Research	Kumar, V (corresponding author), Kuwait Inst Sci Res, Biotechnol Program, Environm & Life Sci Res Ctr, Kuwait, Kuwait.	vinodk@kisr.edu.kw		Kumar, Vinod/0000-0003-3733-4197	Kuwait Foundation for the Advancement of Sciences [2013-4401-01]; KISR	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); KISR	This work was supported by Kuwait Foundation for the Advancement of Sciences (Grant No. 2013-4401-01) to VK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The team thanks Dr. M.T. Balba for providing oil contaminated soil for the research work. We thank Dr. Kshitish Acharya and his team from Shodhaka for their contribution in the analysis of the next generation sequencing data. We thank USDA, Agriculture Research Station, WRPIS for providing alfalfa seeds for research purpose. The support lent by the management and other departments of KISR is gratefully acknowledged.	Abed RMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114570; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; An DS, 2013, GENOME, V56, P612, DOI 10.1139/gen-2013-0083; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Bai YH, 2014, ENVIRON TECHNOL, V35, P2521, DOI 10.1080/09593330.2014.911361; Broderick NA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00072; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen ZJ, 2017, ECOTOX ENVIRON SAFE, V145, P111, DOI 10.1016/j.ecoenv.2017.07.019; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Kim J, 2006, J ENVIRON SCI HEAL A, V41, P2503, DOI 10.1080/10934520600927658; Koshlaf E, 2016, ECOTOX ENVIRON SAFE, V133, P297, DOI 10.1016/j.ecoenv.2016.07.027; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lupatini M, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02064; Ma B, 2015, J APPL MICROBIOL, V118, P890, DOI 10.1111/jam.12756; Martin R, 2014, VIRULENCE, V5, P413, DOI 10.4161/viru.27864; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Muratova A, 2003, MICROBIOL RES, V158, P151, DOI 10.1078/0944-5013-00187; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Peng M, 2015, INT J ENV RES PUB HE, V12, P12002, DOI 10.3390/ijerph121012002; RICHTER DD, 1995, BIOSCIENCE, V45, P600, DOI 10.2307/1312764; Unno Y, 2013, MICROBES ENVIRON, V28, P120, DOI 10.1264/jsme2.ME12181; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34588; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006	31	36	36	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202127	10.1371/journal.pone.0202127	http://dx.doi.org/10.1371/journal.pone.0202127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092049	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600090
J	Ureta, C; Martorell, C; Cuervo-Robayo, AP; Mandujano, MAC; Martinez-Meyer, E				Ureta, Carolina; Martorell, Carlos; Cuervo-Robayo, Angela P.; Mandujano, Maria A. C.; Martinez-Meyer, Enrique			Inferring space from time: On the relationship between demography and environmental suitability in the desert plant O. rastrera	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POPULATION-DYNAMICS; R-PACKAGE; DISTRIBUTIONS; CONSERVATION; VARIABILITY; SENSITIVITY; PREDICTION; ECOSYSTEM; HABITAT	Demographic analyses and ecological niche modeling (ENM) are two popular tools that address species persistence in relation to environmental conditions. Classic demography provides detailed information about the mechanisms that allow a population to grow or remain stable at a local scale, while ENM infers distributions from conditions suitable for species persistence at geographic scales by relating species' occurrences with environmental variables. By integrating these two tools, we may better understand population processes that determine species persistence at a geographic scale. To test this idea, we developed a model that relates climate to demography of the cactus Opuntia rastrera using 15 years of data from one locality. Using this model we determined the geographic area where populations would have positive growth rates given its climatic conditions. The climate-dependent demographic model showed poor performance as a distribution model, but it was helpful in defining some mechanisms that determine species' distributions. For instance, high rainfall had a negative impact on the population growth rate by increasing mortality. Rainy areas to the west of the distribution of O. rastrera were identified as unsuitable both by our climate dependent demographic model and by a popular ENM algorithm (MaxEnt), suggesting that distribution is constrained by excessive rains due to high mortality. Areas projected to be climatically suitable by MaxEnt were not related with higher population growth rates. Instead, we found a strong correlation between environmental distance to the niche centroid (center of the niche hypervolume, where optimal conditions may occur) and population growth rate, meaning that the niche centroid approach is helpful in finding high-fitness areas.	[Ureta, Carolina; Martorell, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City, DF, Mexico; [Cuervo-Robayo, Angela P.; Martinez-Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico; [Cuervo-Robayo, Angela P.] Comis Nacl Conocimiento & Uso Biodiversidad CONAB, Tlalpan Mexico City, Mexico; [Mandujano, Maria A. C.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico; [Ureta, Carolina] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Genet Mol Desarrollo & Evoluc Plantas, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ureta, C; Martorell, C (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City, DF, Mexico.; Ureta, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Lab Genet Mol Desarrollo & Evoluc Plantas, Mexico City, DF, Mexico.	carolina_ureta@hotmail.com; martorell@ciencias.unam.mx	Martorell, Carlos/A-2265-2008	Martorell, Carlos/0000-0002-0758-3953; Martinez-Meyer, Enrique/0000-0003-1184-9264; Ureta, Carolina/0000-0003-3010-6407; Cuervo-Robayo, Angela P./0000-0002-8490-4095; Mandujano, Maria C./0000-0001-9855-6645	DGAPA UNAM	DGAPA UNAM(Universidad Nacional Autonoma de Mexico)	The authors received no specific funding for this work. However; the first and corresponding author had a posdoctoral scholartship by DGAPA UNAM during the study period.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bosso L, 2016, HYSTRIX ITALIAN J MA, V27; Briones O, 1998, OECOLOGIA, V116, P365, DOI 10.1007/s004420050599; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evans MEK, 2016, TRENDS ECOL EVOL, V31, P860, DOI 10.1016/j.tree.2016.08.005; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gross K, 2006, POPUL ECOL, V48, P79, DOI 10.1007/s10144-005-0238-8; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Klimova A, 2017, ECOL EVOL, V7, P4919, DOI 10.1002/ece3.3036; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Mandujano MC, 2001, ECOLOGY, V82, P344, DOI 10.1890/0012-9658(2001)082[0344:IODAVI]2.0.CO;2; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Martorell C, 2012, POPUL ECOL, V54, P335, DOI 10.1007/s10144-012-0307-8; Merow C., 2014, ECOGRAPHY, V37, P1, DOI DOI 10.1111/EC0G.00845; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Nagaraju SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082066; Nenzen HK, 2012, ECOGRAPHY, V35, P577, DOI 10.1111/j.1600-0587.2012.07378.x; Nobel, 2003, ENV BIOL AGAVES CACT; Nuss ET, 2010, COMPR REV FOOD SCI F, V9, P417, DOI 10.1111/j.1541-4337.2010.00117.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pennington DD, 2007, LANDSCAPE ECOL, V22, P897, DOI 10.1007/s10980-006-9071-5; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rotella JJ, 2012, J ANIM ECOL, V81, P162, DOI 10.1111/j.1365-2656.2011.01902.x; Sandquist DR, 2014, ECOLOGY ENV; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; SMITH SD, 1984, ECOLOGY, V65, P643, DOI 10.2307/1941427; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Team RC, 2014, R LANG ENV STAT COMP; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Ureta C, 2015, J AGR SCI, P1; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Yanez-Arenas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100957; Zhang X, 2017, BIOL CONSERV, V211, P161, DOI 10.1016/j.biocon.2017.05.020	46	6	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201543	10.1371/journal.pone.0201543	http://dx.doi.org/10.1371/journal.pone.0201543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092077	gold, Green Published, Green Submitted			2022-12-26	WOS:000441232600034
J	Zhao, Q; Yang, MM; Huang, YY; Chen, WL				Zhao, Qian; Yang, Miles M.; Huang, Yu-Ying; Chen, Wenlin			How to make hand hygiene interventions more attractive to nurses: A discrete choice experiment	PLOS ONE			English	Article							HEALTH-CARE WORKERS; BEHAVIOR-CHANGE; IMPROVEMENT; GUIDELINES; PROGRAM; MODELS; IMPACT; SAFETY	Background Better understanding of the characteristics of interventions which are attractive to nurses is required in order to implement effective hand hygiene interventions. Methods The intervention characteristics were derived from diffusion of innovation theory (DIT): relative advantage, compatibility, simplicity, trialability, and observability. To identify nurses' preferences for the five characteristics, a discrete choice experiment (DCE) was conducted. Participants were nurses working at Taiwanese tertiary care hospitals selected through stratified sampling. In addition, the hand hygiene moment (before or after patient contact) was taken into consideration in the DCE to investigate whether nurses' preferences for the intervention characteristics were the same at different hand hygiene moments. Results This survey was conducted between 1 October and 31 December 2014. Among 200 nurses from three Taiwanese tertiary care hospitals, significant preferences for the five intervention characteristics were observed. That is, when an intervention makes the hand hygiene activity more convenient (p<0.001), when nurses participate in the design of the intervention (p<0.001), when an intervention is explained well to nurses before implementing it (p<0.001), when the evidence of hand hygiene is provided at a trial stage to show its effectiveness (p<0.001), and when nurses' hand hygiene performance is observable to their peers (p<0.001), nurses are more willing to wash their hands with high compliance. In addition, nurses preferred for providing evidence at a trial stage most, and well explanation about the intervention to increase simplicity was least. The rankings of the preference for the five intervention characteristics were the same at different hand hygiene moments (p = 0.453) Conclusions The findings suggest policy directions for decision makers aiming to improve overall hand hygiene compliance in healthcare facilities.	[Zhao, Qian] Chengdu Univ, Sch Informat Sci & Engn, Chengdu, Sichuan, Peoples R China; [Yang, Miles M.] Macquarie Univ, Sydney, NSW, Australia; [Huang, Yu-Ying] Commerce Dev Res Inst, Healthcare Serv Dept, Taipei, Taiwan; [Chen, Wenlin] Univ New South Wales, Business Sch, Sydney, NSW, Australia	Chengdu University; Macquarie University; University of New South Wales Sydney	Chen, WL (corresponding author), Univ New South Wales, Business Sch, Sydney, NSW, Australia.	wenlincd@126.com		Yang, Miles/0000-0002-0911-6179				Armellino D, 2012, CLIN INFECT DIS, V54, P1, DOI 10.1093/cid/cir773; Barrett R, 2008, J CLIN NURS, V17, P1851, DOI 10.1111/j.1365-2702.2007.02215.x; Boscart VM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-77; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Bryce EA, 2007, AM J INFECT CONTROL, V35, P271, DOI 10.1016/j.ajic.2006.05.293; Burgers JS, 2003, BRIT J GEN PRACT, V53, P15; Chen JK, 2016, AM J INFECT CONTROL, V44, P222, DOI 10.1016/j.ajic.2015.10.004; de Bekker-Grob EW, 2010, VALUE HEALTH, V13, P315, DOI 10.1111/j.1524-4733.2009.00670.x; Erasmus V, 2009, INFECT CONT HOSP EP, V30, P415, DOI 10.1086/596773; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Gould D., 2013, Journal of Infection Prevention, V14, P88, DOI 10.1177/1757177413482608; Gould DJ, 2008, J HOSP INFECT, V68, P193, DOI 10.1016/j.jhin.2007.11.013; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hjelmgren J, 2007, HEALTH POLICY, V83, P314, DOI 10.1016/j.healthpol.2007.02.006; Huang TT, 2008, J HOSP INFECT, V68, P164, DOI 10.1016/j.jhin.2007.11.020; Huicho L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050315; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jang JH, 2010, INFECT CONT HOSP EP, V31, P144, DOI 10.1086/649792; Kingston L, 2016, J HOSP INFECT, V92, P309, DOI 10.1016/j.jhin.2015.11.012; Lancsar E, 2007, SOC SCI MED, V64, P1738, DOI 10.1016/j.socscimed.2006.12.007; Liu WI, 2014, INT J NURS PRACT, V20, P46, DOI 10.1111/ijn.12120; McFadden D, 1973, FRONTIERS ECONOMETRI; McLaws ML, 2012, AM J INFECT CONTROL, V40, P336, DOI 10.1016/j.ajic.2011.04.004; Pan SC, 2014, AM J INFECT CONTROL, V42, P231, DOI 10.1016/j.ajic.2013.09.032; Pessoa-Silva CL, 2005, INFECT CONTROL HOSP, V26; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rogers EM, 1983, DIFFUSION INOOVATION; Rogers EM, 1962, DIFFUSION INNOVATION; Salmon S, 2015, AM J INFECT CONTROL, V43, P1086, DOI 10.1016/j.ajic.2015.05.039; Sax H, 2007, INFECT CONT HOSP EP, V28, P1267, DOI 10.1086/521663; Sharma M, 2021, THEORETICAL FDN HLTH; Smitz MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165940; Srigley JA, 2015, J HOSP INFECT, V91, P202, DOI 10.1016/j.jhin.2015.06.019; Stevens S., 2013, Healthcare Infection, V18, P86, DOI 10.1071/HI12056; TRIANDIS HC, 1976, INT J PSYCHOL, V11, P155, DOI 10.1080/00207597608247355; Vincent C, 2014, BMJ QUAL SAF, V23, P670, DOI 10.1136/bmjqs-2013-002757; Viney Rosalie, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P319, DOI 10.1586/14737167.2.4.319; Whitby M, 2007, J HOSP INFECT, V65, P1, DOI 10.1016/j.jhin.2006.09.026; Wilson S, 2011, CRIT PUBLIC HEALTH, V21, P119, DOI 10.1080/09581591003786122; Wisdom JP, 2014, ADM POLICY MENT HLTH, V41, P480, DOI 10.1007/s10488-013-0486-4	43	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202014	10.1371/journal.pone.0202014	http://dx.doi.org/10.1371/journal.pone.0202014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092024	gold, Green Submitted, Green Published			2022-12-26	WOS:000441232600077
J	Giudetti, AM; Testini, M; Vergara, D; Priore, P; Damiano, F; Gallelli, CA; Romano, A; Villani, R; Cassano, T; Siculella, L; Gnoni, GV; Moles, A; Coccurello, R; Gaetani, S				Giudetti, Anna M.; Testini, Mariangela; Vergara, Daniele; Priore, Paola; Damiano, Fabrizio; Gallelli, Cristina Anna; Romano, Adele; Villani, Rosanna; Cassano, Tommaso; Siculella, Luisa; Gnoni, Gabriele V.; Moles, Anna; Coccurello, Roberto; Gaetani, Silvana			Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet	FASEB JOURNAL			English	Article						fatty acids; liver steatosis; lipogenesis	DE-NOVO LIPOGENESIS; BODY-MASS INDEX; SOCIAL STRESS; SYMPATHETIC INNERVATION; UNCOUPLING PROTEIN-1; GENE-EXPRESSION; CITRATE CARRIER; ENERGY-BALANCE; WEIGHT; THERMOGENESIS	It is widely accepted that chronic stress may alter the homeostatic mechanisms of body weight control. In this study, we followed the metabolic changes occurring in mice when chronic stress caused by psychosocial defeat (CPD) is associated with ad libitum exposure to a palatable high-fat diet (HFD). In this model, CPD mice consumed more HFD than unstressed (Un) mice without gaining body weight. We focused on metabolic processes involved in weight control, such as de novo lipogenesis (DNL), fatty acid -oxidation (FAO), and thermogenesis. The activity and expression of DNL enzymes were reduced in the liver and white adipose tissue of mice consuming the HFD. Such effects were particularly evident in stressed mice. In both CPD and Un mice, HFD consumption increased the hepatic expression of the mitochondrial FAO enzyme carnitine palmitoyltransferase-1. In the liver of mice consuming the HFD, stress exposure prevented accumulation of triacylglycerols; however, accumulation of triacylglycerols was observed in Un mice under the same dietary regimen. In brown adipose tissue, stress increased the expression of uncoupling protein-1, which is involved in energy dissipation, both in HFD and control diet-fed mice. We consider increased FAO and energy dissipation responsible for the antiobesity effect seen in CPD/HFD mice. However, CPD associated with HFD induced hepatic oxidative stress.Giudetti, A. M., Testini, M., Vergara, D., Priore, P., Damiano, F., Gallelli, C. A., Romano, A., Villani, R., Cassano, T., Siculella, L., Gnoni, G. V., Moles, A., Coccurello, R., Gaetani, S. Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet.	[Giudetti, Anna M.; Testini, Mariangela; Vergara, Daniele; Priore, Paola; Damiano, Fabrizio; Siculella, Luisa; Gnoni, Gabriele V.] Univ Salento, Dept Biol & Environm Sci & Technol, Via Prov Lecce Monteroni, I-73100 Lecce, Italy; [Gallelli, Cristina Anna; Romano, Adele; Gaetani, Silvana] Sapienza Univ Rome, Dept Physiol & Pharmacol V Espamer, Rome, Italy; [Villani, Rosanna] Univ Foggia, Dept Med & Occupat Sci, Foggia, Italy; [Cassano, Tommaso] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Moles, Anna; Coccurello, Roberto] Natl Res Council CNR, Inst Cell Biol & Neurobiol IBCN, Rome, Italy; [Moles, Anna] Genomia Srl, Bresso, Italy; [Coccurello, Roberto] IRCCS, FSL, Rome, Italy	University of Salento; Sapienza University Rome; University of Foggia; University of Foggia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR)	Giudetti, AM (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Via Prov Lecce Monteroni, I-73100 Lecce, Italy.	anna.giudetti@unisalento.it	Damiano, Fabrizio/AAF-9594-2020; Giudetti, Anna Maria/ABF-4049-2021; villani, rosanna/K-5753-2018; Vergara, Daniele/K-3831-2014; Coccurello, Roberto/F-8460-2015	Damiano, Fabrizio/0000-0001-7828-9519; villani, rosanna/0000-0001-9875-019X; Vergara, Daniele/0000-0002-2396-7674; ROMANO, ADELE/0000-0003-3874-2627	Italian Ministry for Education, University, and Research [Project of Significant National Interest (PRIN)] [2009ESX7T3]	Italian Ministry for Education, University, and Research [Project of Significant National Interest (PRIN)](Ministry of Education, Universities and Research (MIUR))	The authors gratefully acknowledge the Consiglio Nazionale delle Ricerche/European Mouse Mutant Archive (CNR/EMMA) Animal Research Facility (Monterotondo, Rome, Italy). This research was supported by the Italian Ministry for Education, University, and Research [Project of Significant National Interest (PRIN) 2009ESX7T3]. The authors declare no conflicts of interest.	Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bartolomucci A., 2009, PLOS ONE, V4; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Coccurello R, 2018, EUR J NUTR, V57, P1485, DOI 10.1007/s00394-017-1434-y; Coccurello R, 2009, NEUROSCI BIOBEHAV R, V33, P537, DOI 10.1016/j.neubiorev.2008.05.018; Crichton PG, 2017, BIOCHIMIE, V134, P35, DOI 10.1016/j.biochi.2016.12.016; Dadomo H, 2011, PROG NEURO-PSYCHOPH, V35, P1461, DOI 10.1016/j.pnpbp.2010.11.016; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Denjean F, 1999, FEBS LETT, V444, P181, DOI 10.1016/S0014-5793(99)00056-3; Finger BC, 2012, PSYCHONEUROENDOCRINO, V37, P729, DOI 10.1016/j.psyneuen.2011.06.015; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Giudetti AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060817; Gnoni A, 2016, J PHYSIOL BIOCHEM, V72, P485, DOI 10.1007/s13105-016-0495-3; Gnoni GV, 2010, ENDOCRINOLOGY, V151, P1551, DOI 10.1210/en.2009-1352; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; Kakimoto PA, 2016, REDOX BIOL, V8, P216, DOI 10.1016/j.redox.2016.01.009; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Lee G, 2017, CELL, V171, P1545, DOI 10.1016/j.cell.2017.10.037; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004; Motoyama K, 2009, PHYSIOL GENOMICS, V37, P79, DOI 10.1152/physiolgenomics.90358.2008; Patterson ZR, 2013, ENDOCRINOLOGY, V154, P1080, DOI 10.1210/en.2012-1834; Prasad A, 1996, PHYSIOL BEHAV, V60, P1039, DOI 10.1016/0031-9384(96)00135-7; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; Rodriguez-Sureda V, 2007, ATHEROSCLEROSIS, V195, P57, DOI 10.1016/j.atherosclerosis.2006.11.038; Sanghez V, 2016, STRESS, V19, P214, DOI 10.3109/10253890.2016.1151491; Sanghez V, 2013, PSYCHONEUROENDOCRINO, V38, P2933, DOI 10.1016/j.psyneuen.2013.07.022; Sato T, 2006, TOXICOLOGY, V227, P248, DOI 10.1016/j.tox.2006.08.009; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Scott KA, 2012, CURR OBES REP, V1, DOI 10.1007/s13679-011-0006-3; Serviddio G, 2011, FREE RADICAL BIO MED, V51, P2234, DOI 10.1016/j.freeradbiomed.2011.09.004; Seydoux J, 1978, Experientia Suppl, V32, P153; Siculella L, 2006, J BIOL CHEM, V281, P19072, DOI 10.1074/jbc.M507237200; Siculella L, 2016, BBA-MOL CELL BIOL L, V1861, P471, DOI 10.1016/j.bbalip.2016.02.003; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tamashiro KLK, 2007, AM J PHYSIOL-REG I, V293, pR1864, DOI 10.1152/ajpregu.00371.2007; Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030; Yau YHC, 2013, MINERVA ENDOCRINOL, V38, P255; ZHANG D, 2016, HEPATIC NOVO LIPOGEN, P1	47	6	6	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1428	1439		10.1096/fj.201801130R	http://dx.doi.org/10.1096/fj.201801130R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133327	Bronze			2022-12-26	WOS:000457401500112
J	Tegowski, M; Fan, C; Baldwin, AS				Tegowski, Matthew; Fan, Cheng; Baldwin, Albert S.			Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G(1) arrest independent of DRD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; STAT3; interleukin 6 (IL-6); G protein-coupled receptor (GPCR); dopamine receptor; apoptosis; cell signaling; G(1) arrest; self-renewal; thioridazine; cell viability; DRD2; proliferation	DOPAMINE-RECEPTOR ANTAGONIST; TUMOR-INITIATING CELLS; ENDOGENOUS CATECHOLAMINES; ACTIVATION; GROWTH; EXPRESSION; CHEMOTHERAPY; PROLIFERATION; LYMPHOCYTES; RESISTANCE	Thioridazine is an antipsychotic that has been shown to induce cell death and inhibit self-renewal in a broad spectrum of cancer cells. The mechanisms by which these effects are mediated are currently unknown but are presumed to result from the inhibition of dopamine receptor 2 (DRD2). Here we show that the self-renewal of several, but not all, triple-negative breast cancer cell lines is inhibited by thioridazine. The inhibition of self-renewal by thioridazine in these cells is mediated by DRD2 inhibition. Further, we demonstrate that DRD2 promotes self-renewal in these cells via a STAT3- and IL-6-dependent mechanism. We also show that thioridazine induces a G(1) arrest and a loss in cell viability in all tested cell lines. However, the reduction in proliferation and cell viability is independent of DRD2 and STAT3. Our results indicate that although there are cell types in which DRD2 inhibition results in inhibition of STAT3 and self-renewal, the dramatic block in cancer cell proliferation across many cell lines caused by thioridazine treatment is independent of DRD2 inhibition.	[Tegowski, Matthew; Baldwin, Albert S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Tegowski, Matthew; Fan, Cheng; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	abaldwin@med.unc.edu			NCI, National Institutes of Health [R35CA197684]; NATIONAL CANCER INSTITUTE [R35CA197684] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant R35CA197684 (to A.S.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Basu B, 2010, J BIOL CHEM, V285, P27026, DOI 10.1074/jbc.M110.144022; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; Cheng HW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.77; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dolma S, 2016, CANCER CELL, V29, P859, DOI 10.1016/j.ccell.2016.05.002; Edwards H, 2018, CELL CYCLE, V17, P277, DOI 10.1080/15384101.2017.1421035; Greer Yoshimi Endo, 2018, Oncotarget, V9, P18454, DOI 10.18632/oncotarget.24862; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gwynne WD, 2017, ONCOTARGET, V8, P32101, DOI 10.18632/oncotarget.16646; Heo TH, 2016, ONCOTARGET, V7, P15460, DOI 10.18632/oncotarget.7102; Hsia HC, 2017, J BIOL CHEM, V292, P5405, DOI 10.1074/jbc.M116.771964; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jandaghi P, 2016, GASTROENTEROLOGY, V151, P1218, DOI 10.1053/j.gastro.2016.08.040; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; Kendellen MF, 2014, ONCOGENE, V33, P1297, DOI 10.1038/onc.2013.64; Kline CLB, 2018, NEOPLASIA, V20, P80, DOI 10.1016/j.neo.2017.10.002; Kokkinou I, 2009, J NEUROIMMUNOL, V216, P51, DOI 10.1016/j.jneuroim.2009.09.001; Konkalmatt PR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85888; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; LAJINESS ME, 1993, J PHARMACOL EXP THER, V267, P1573; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Levite M, 2016, ACTA PHYSIOL, V216, P42, DOI 10.1111/apha.12476; Li J, 2014, ONCOTARGET, V5, P882, DOI 10.18632/oncotarget.1801; Luo YQ, 1999, BRAIN RES, V850, P21, DOI 10.1016/S0006-8993(99)02021-1; Madhukar N. S., 2017, BIORXIV, DOI [10.1101/134973, DOI 10.1101/134973]; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Mei F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042746; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; Oh K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3473; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sonnenblick A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0416-2; Staniszewska AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052608; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stojanovic T, 2017, AMINO ACIDS, V49, P1101, DOI 10.1007/s00726-017-2408-3; STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yin T, 2015, MOL MED REP, V12, P4103, DOI 10.3892/mmr.2015.3967; Yoon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188078; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yue H., 2016, BIOMED RES INT, V2016, DOI [10.1155/2016/6709828, DOI 10.1155/2016/6709828]; Zahalka AH, 2017, SCIENCE, V358, P321, DOI 10.1126/science.aah5072; Zhang C, 2017, ONCOL REP, V37, P1168, DOI 10.3892/or.2016.5313; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038745	60	35	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15977	15990		10.1074/jbc.RA118.003719	http://dx.doi.org/10.1074/jbc.RA118.003719			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131338	Green Published, hybrid			2022-12-26	WOS:000447256000019
J	Swain, J; El Khoury, M; Kempf, J; Briee, F; Van Der Smissen, P; Decout, JL; Mingeot-Leclercq, MP				Swain, Jitendriya; El Khoury, Micheline; Kempf, Julie; Briee, Florian; Van Der Smissen, Patrick; Decout, Jean-Luc; Mingeot-Leclercq, Marie-Paule			Effect of cardiolipin on the antimicrobial activity of a new amphiphilic aminoglycoside derivative on Pseudomonas aeruginosa	PLOS ONE			English	Article							NEAMINE DERIVATIVES; ANIONIC PHOSPHOLIPIDS; HEXAGONAL PHASE; LIPID PHASES; MEMBRANE; ANTIBIOTICS; VESICLES; FLUORESCENCE; BACTERIA; BILAYER	Amphiphilic aminoglycoside derivatives are promising new antibacterials active against Gram- negative bacteria such as Pseudomonas aeruginosa, including colistin resistant strains. In this study, we demonstrated that addition of cardiolipin to the culture medium delayed growth of P. aeruginosa, favored asymmetrical growth and enhanced the efficiency of a new amphiphilic aminoglycoside derivative, the 3',6-dinonylneamine. By using membrane models mimicking P. aeruginosa plasma membrane composition (POPE: POPG: CL), we demonstrated the ability of 3'6-dinonylneamine to induce changes in the biophysical properties of membrane model lipid systems in a cardiolipin dependent manner. These changes include an increased membrane permeability associated with a reduced hydration and a decreased ability of membrane to mix and fuse as shown by monitoring calcein release, Generalized Polarization of Laurdan and fluorescence dequenching of octadecyl rhodamine B, respectively. Altogether, results shed light on how cardiolipin may be critical for improving antibacterial action of new amphiphilic aminoglycoside derivatives.	[Swain, Jitendriya; El Khoury, Micheline; Mingeot-Leclercq, Marie-Paule] Catholic Univ Louvain, Pharmacol Cellulaire & Mol, Louvain Drug Res Inst, Brussels, Belgium; [Kempf, Julie; Briee, Florian; Decout, Jean-Luc] Univ Grenoble Alpes, Dept Pharmacochim Mol, CNRS, Grenoble, France; [Van Der Smissen, Patrick] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Catholique Louvain	Mingeot-Leclercq, MP (corresponding author), Catholic Univ Louvain, Pharmacol Cellulaire & Mol, Louvain Drug Res Inst, Brussels, Belgium.	marie-paule.mingeot@uclouvain.be		SWAIN, JITENDRIYA/0000-0003-2921-0688; Mingeot-Leclercq, Marie-Paule/0000-0002-2569-2619	Fonds National de la Recherche Scientifique [3.4578.12, T.1003.14, J.0205.16]; Fondation pour la Recherche Medicale, SATT Linksium Grenoble Alpes and Programme Labex (ARCANE project) [DBF20161136768, ANR-11-LABX-003]	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation pour la Recherche Medicale, SATT Linksium Grenoble Alpes and Programme Labex (ARCANE project)	This work was supported by the "Fonds National de la Recherche Scientifique" (3.4578.12, T.1003.14 and J.0205.16; MEK and JS) and by Fondation pour la Recherche Medicale (DBF20161136768; JK), SATT Linksium Grenoble Alpes and Programme Labex (ARCANE project ANR-11-LABX-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 2009, J PHYS CHEM B, V113, P3437, DOI 10.1021/jp809705d; Arias-Cartin R, 2011, P NATL ACAD SCI USA, V108, P7781, DOI 10.1073/pnas.1010427108; ARNHOLD J, 1994, BBA-BIOMEMBRANES, V1191, P375, DOI 10.1016/0005-2736(94)90189-9; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Baussanne I, 2010, J MED CHEM, V53, P119, DOI 10.1021/jm900615h; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Cong X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02397-0; El Khoury M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10543-3; Epand RM, 2016, BBA-BIOMEMBRANES, V1858, P980, DOI 10.1016/j.bbamem.2015.10.018; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Garcia-Fernandez E, 2017, CELL, V171, P1354, DOI 10.1016/j.cell.2017.10.012; Ghosh C, 2015, CHEMMEDCHEM, V10, P1606, DOI 10.1002/cmdc.201500299; Green KD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00208; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hughes JS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012040; Jackowski O, 2012, TETRAHEDRON, V68, P737, DOI 10.1016/j.tet.2011.10.102; Johnston CW, 2016, NAT CHEM BIOL, V12, P233, DOI [10.1038/NCHEMBIO.2018, 10.1038/nchembio.2018]; Keller R, 2015, BIOCHEMISTRY-US, V54, P3670, DOI 10.1021/acs.biochem.5b00242; Khalifat N, 2014, BIOPHYS J, V107, P879, DOI 10.1016/j.bpj.2014.07.015; Kysela DT, 2013, ANNU REV MICROBIOL, V67, P417, DOI 10.1146/annurev-micro-092412-155622; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lin TY, 2016, APPL MICROBIOL BIOT, V100, P4255, DOI 10.1007/s00253-016-7468-x; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Lopez GA, 2016, J APPL MICROBIOL, V121, P1004, DOI 10.1111/jam.13238; Luevano-Martinez LA, 2015, ARCH BIOCHEM BIOPHYS, V585, P90, DOI 10.1016/j.abb.2015.09.015; Marrink SJ, 2004, BIOPHYS J, V87, P3894, DOI 10.1529/biophysj.104.048710; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mingeot-Leclercq MP, 2016, MEDCHEMCOMM, V7, P586, DOI 10.1039/c5md00503e; Molohon KJ, 2016, ACS INFECT DIS, V2, P207, DOI 10.1021/acsinfecdis.5b00115; Mui B, 2003, METHOD ENZYMOL, V367, P3; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Oliver PM, 2014, J BACTERIOL, V196, P3386, DOI 10.1128/JB.01877-14; Parasassi T, 1995, J Fluoresc, V5, P59, DOI 10.1007/BF00718783; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Sautrey G, 2016, J BIOL CHEM, V291, P13864, DOI 10.1074/jbc.M115.665364; Sautrey G, 2014, ANTIMICROB AGENTS CH, V58, P4420, DOI 10.1128/AAC.02536-13; SIEGEL DP, 1986, BIOPHYS J, V49, P1155, DOI 10.1016/S0006-3495(86)83744-4; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; VERKLEIJ AJ, 1980, BIOCHIM BIOPHYS ACTA, V600, P620, DOI 10.1016/0005-2736(80)90465-4; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; Zhang TH, 2014, J BIOL CHEM, V289, P11584, DOI 10.1074/jbc.M114.554444; Zimmermann L, 2016, J MED CHEM, V59, P9350, DOI 10.1021/acs.jmedchem.6b00818; Zimmermann L, 2013, J MED CHEM, V56, P7691, DOI 10.1021/jm401148j; Zweytick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090228	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201752	10.1371/journal.pone.0201752	http://dx.doi.org/10.1371/journal.pone.0201752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125281	Green Submitted, Green Published, gold			2022-12-26	WOS:000442202100011
J	Weidenauer, D; Hamp, T; Schriefl, C; Holaubek, C; Gattinger, M; Krammel, M; Winnisch, M; Weidenauer, A; Mundigler, G; Lang, I; Schreiber, W; Sterz, F; Herkner, H; Domanovits, H				Weidenauer, David; Hamp, Thomas; Schriefl, Christoph; Holaubek, Caroline; Gattinger, Markus; Krammel, Mario; Winnisch, Markus; Weidenauer, Ana; Mundigler, Gerald; Lang, Irene; Schreiber, Wolfgang; Sterz, Fritz; Herkner, Harald; Domanovits, Hans			The impact of cardiopulmonary resuscitation (CPR) manikin chest stiffness on motivation and CPR performance measures in children undergoing CPR training-A prospective, randomized, single-blind, controlled trial	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; EMERGENCY CARDIOVASCULAR CARE; ASSOCIATION GUIDELINES UPDATE; BASIC LIFE-SUPPORT; EUROPEAN RESUSCITATION; COUNCIL GUIDELINES; BYSTANDER CPR; QUALITY; SCHOOLCHILDREN; RECOMMENDATIONS	Background Cardio-pulmonary-resuscitation (CPR) training starting at the age of 12 years is recommended internationally. Training younger children is not recommended because young children lack the physical ability to perform adequate CPR and discouragement to perform CPR later is apprehended. The aim of this study was to answer the following questions: Are younger children discouraged after CPR training? Is discouragement caused by their lack in physical ability to perform adequate chest compressions on a standard manikin and would the use of manikins with a reduced resistance affect their motivation or performance? Methods We investigated the motivation and CPR performance of children aged 8-13 years after CPR training on manikins of different chest stiffness in a prospective, randomized, single-blind, controlled trial. 322 children underwent randomization and received 30 minutes CPR training in small groups at school. We used two optically identical resuscitation manikins with different compression resistances of 45kg and 30kg. Motivation was assessed with a self-administered questionnaire. Performance was measured with the Resusci (R) AnneSkillReporter (TM). Findings Motivation after the training was generally high and there was no difference between the two groups in any of the questionnaire items on motivation: Children had fun (98 vs. 99%; P = 0.32), were interested in the training (99 vs. 98%; P = 0.65), and were glad to train resuscitation again in the future (89 vs. 91%; P = 0.89). CPR performance was generally poor (median compression score (8, IQR 1-45 and 29, IQR 11-54; P<0.001) and the mean compression depth was lower in the 45kg-resistance than in the 30kg-resistance group (33 +/- 10mm vs. 41 +/- 9; P<0.001). Conclusions Compression resistances of manikins, though influencing CPR performance, did not discourage 8 to 13 year old children after CPR training. The findings refute the view that young children are discouraged when receiving CPR training even though they are physically not able to perform adequate CPR.	[Weidenauer, David; Mundigler, Gerald; Lang, Irene] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Hamp, Thomas] Med Univ Vienna, Prehosp Emergency Med Res Grp, Dept Gen Anesthesia & Intens Care, Vienna, Austria; [Schriefl, Christoph; Schreiber, Wolfgang; Sterz, Fritz; Herkner, Harald; Domanovits, Hans] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Holaubek, Caroline] Med Univ Vienna, Dept Cardiothorac & Vasc Anesthesia, Vienna, Austria; [Gattinger, Markus] Med Univ Vienna, Vienna, Austria; [Krammel, Mario] Municipal Ambulance Serv Vienna, Vienna, Austria; [Winnisch, Markus] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Weidenauer, Ana] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Hamp, T (corresponding author), Med Univ Vienna, Prehosp Emergency Med Res Grp, Dept Gen Anesthesia & Intens Care, Vienna, Austria.	thomas.hamp@meduniwien.ac.at		Hamp, Thomas/0000-0001-7294-9168; Schriefl, Christoph/0000-0003-4390-1362; Herkner, Harald/0000-0003-1329-6149; Holaubek, Caroline/0000-0002-6896-7854				Abelairas-Gomez C, 2014, RESUSCITATION; [Anonymous], 2015, RESUSCITATION, V94, pA5, DOI 10.1016/j.resuscitation.2015.07.005; Baldi E, 2017, CAN J EMERG MED, V19, P480, DOI 10.1017/cem.2016.410; Bottiger BW, 2015, LANCET, V385, P2353, DOI 10.1016/S0140-6736(15)61099-6; Bollig G, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-13; Bollig G, 2009, RESUSCITATION, V80, P689, DOI 10.1016/j.resuscitation.2009.03.012; Bottiger BW, 1999, HEART, V82, P674, DOI 10.1136/hrt.82.6.674; Brown GTL, 2015, ASSESS EDUC, V22, P444, DOI 10.1080/0969594X.2014.996523; BURGHOFER K, 2005, NOTFALL RETTUNGSMED, V8, P408; Cave DM, 2011, CIRCULATION, V123, P691, DOI 10.1161/CIR.0b013e31820b5328; Cortegiani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169591; Eisenburger P, 1999, RESUSCITATION, V41, P3, DOI 10.1016/S0300-9572(99)00034-9; Fleischhackl R, 2009, CRIT CARE, V13, DOI 10.1186/cc7984; Greif R, 2015, RESUSCITATION, V95, P288, DOI 10.1016/j.resuscitation.2015.07.032; Holmberg M, 2000, RESUSCITATION, V47, P59, DOI 10.1016/S0300-9572(00)00199-4; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jones I, 2007, BMJ-BRIT MED J, V334, P1201, DOI 10.1136/bmj.39167.459028.DE; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kronick SL, 2015, CIRCULATION, V132, pS397, DOI 10.1161/CIR.0000000000000258; Lee MJ, 2013, RESUSCITATION, V84, P889, DOI 10.1016/j.resuscitation.2013.01.009; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Nolan JP, 2015, RESUSCITATION, V95, pE1, DOI 10.1016/j.resuscitation.2015.07.039; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Plant N, 2013, RESUSCITATION, V84, P415, DOI 10.1016/j.resuscitation.2012.12.008; Sasson C, 2010, ANN INTERN MED, V153, P19, DOI 10.7326/0003-4819-153-1-201007060-00255; Stroobants J, 2014, RESUSCITATION, V85, P1769, DOI 10.1016/j.resuscitation.2014.10.013; Taniguchi D, 2012, EMERG MED CLIN N AM, V30, P1, DOI 10.1016/j.emc.2011.09.003; Uray T, 2003, RESUSCITATION, V59, P211, DOI 10.1016/S0300-9572(03)00233-8; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	30	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202430	10.1371/journal.pone.0202430	http://dx.doi.org/10.1371/journal.pone.0202430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114240	gold, Green Submitted, Green Published			2022-12-26	WOS:000441850400071
J	Johnston, CA; Rankin, EEW; Gruner, DS				Johnston, Cora A.; Rankin, Erin E. Wilson; Gruner, Daniel S.			Foraging connections: Patterns of prey use linked to invasive predator diel movement	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; ELEUTHERODACTYLUS-COQUI; FOOD-WEB; INVERTEBRATE COMMUNITIES; POPULATION-DENSITY; TROPICAL FROG; CARBON; NITROGEN; ISLAND; DISCRIMINATION	Invasive predators can profoundly impact native communities, especially in insular ecosystems where functionally equivalent predators were evolutionarily absent. Beyond direct consumption, predators can affect communities indirectly by creating or altering food web linkages among existing species. Where invasive predators consume prey from multiple distinct resource channels, novel links may couple the dynamics of disjunct modules and create indirect interactions between them. Our study focuses on invasive populations of Eleutherodactylus coqui (Anura: Leptodactylidae) on Hawaii Island. Coqui actively forage in the understory and lower canopy at night but return to the forest floor and belowground retreats by day. Recent dietary studies using gut contents and naturally occurring stable isotopes indicate higher than expected consumption of litter arthropods, which in these Hawaiian forests are primarily non-native species. We used laboratory studies to observe diurnal and nocturnal foraging behavior, and experimental field additions of C-4 vegetation as a litter tracer to distinguish epigaeic sources from food web pools in the C-3 canopy. Lab trials revealed that prey consumption during diurnal foraging was half that consumed during nocturnal foraging. Analysis of delta C-13 isotopes showed incorporation of C-4 carbon into litter arthropods within one month, and Bayesian mixing models estimated that 15-25% of the carbon in coqui tissue was derived from litter sources. These results support recent findings that E. coquiare not quiescent diurnally but instead actively forage. Such activity by a mobile invasive predator may introduce a novel linkage that integrates detrital and foliar resource pools, potentially distributing influences of invasive litter arthropods through the broader system to amplify impacts on native species.	[Johnston, Cora A.] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Rankin, Erin E. Wilson] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Johnston, Cora A.] Univ Virginia, Dept Environm Sci, Anheuser Busch Coastal Res Ctr, Oyster, VA 23310 USA	University System of Maryland; University of Maryland College Park; University of California System; University of California Riverside; University System of Maryland; University of Maryland College Park; University of Virginia	Johnston, CA (corresponding author), Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA.; Johnston, CA (corresponding author), Univ Virginia, Dept Environm Sci, Anheuser Busch Coastal Res Ctr, Oyster, VA 23310 USA.	coraj@virginia.edu	Rankin, Erin E Wilson/J-7044-2014; Gruner, Daniel Stephen/A-5166-2010; Wilson Rankin, E E/GLS-9381-2022; Rankin, Erin E. Wilson/AAX-1670-2020	Rankin, Erin E Wilson/0000-0001-7741-113X; Gruner, Daniel Stephen/0000-0002-3153-4297; Wilson Rankin, E E/0000-0001-7741-113X; Rankin, Erin E. Wilson/0000-0001-7741-113X	Research & Exploration grant from the Explorer's Club Washington Group; NSF [DEB-1020007]	Research & Exploration grant from the Explorer's Club Washington Group; NSF(National Science Foundation (NSF))	This study was funded by a Research & Exploration grant from the Explorer's Club Washington Group to CAJ; EEWR was supported by NSF DEB-1020007 awarded to DSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Banasek-Richter C, 2004, J THEOR BIOL, V226, P23, DOI 10.1016/S0022-5193(03)00305-9; Beard KH, 2008, J HERPETOL, V42, P626, DOI 10.1670/07-314R1.1; Beard KH, 2007, COPEIA, P281, DOI 10.1643/0045-8511(2007)7[281:DOTIFE]2.0.CO;2; Beard KH, 2009, PAC SCI, V63, P297, DOI 10.2984/049.063.0301; Beard KH, 2005, DIVERS DISTRIB, V11, P427, DOI 10.1111/j.1366-9516.2005.00178.x; Bishop MR, 2014, J HERPETOL, V48, P137, DOI 10.1670/12-288; Bisrat SA, 2012, DIVERS DISTRIB, V18, P648, DOI 10.1111/j.1472-4642.2011.00867.x; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Choi RT, 2012, BIOL INVASIONS, V14, P939, DOI 10.1007/s10530-011-0127-3; Cloyed CS, 2015, PHYSIOL BIOCHEM ZOOL, V88, P576, DOI 10.1086/682576; Crowder DW, 2010, BIOL INVASIONS, V12, P2857, DOI 10.1007/s10530-010-9733-8; David P, 2017, ADV ECOL RES, V56, P1, DOI 10.1016/bs.aecr.2016.10.001; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fox J., 2019, R COMPANION APPL REG, V.; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Giery ST, 2013, FUNCT ECOL, V27, P1436, DOI 10.1111/1365-2435.12139; Gruner DS, 2007, BIOL J LINN SOC, V90, P551, DOI 10.1111/j.1095-8312.2007.00748.x; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Huckembeck S, 2014, HYDROBIOLOGIA, V740, P253, DOI 10.1007/s10750-014-2022-2; Hughes RF, 2006, ECOSYSTEMS, V9, P977, DOI 10.1007/s10021-005-0083-9; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Jeschke JM, 2007, OECOLOGIA, V152, P357, DOI 10.1007/s00442-006-0654-2; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kilham SS, 2009, INT VER THEOR ANGEW, V30, P749; Krushelnycky PD, 2008, ECOL APPL, V18, P1547, DOI 10.1890/07-1293.1; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; LONG WH, 1972, ANNU REV ENTOMOL, V17, P149, DOI 10.1146/annurev.en.17.010172.001053; Martin CW, 2014, PEERJ, V2, DOI 10.7717/peerj.665; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Monterroso P, 2013, ETHOLOGY, V119, P1044, DOI 10.1111/eth.12156; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Nifong JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083953; Oelbermann K, 2008, OECOLOGIA, V155, P605, DOI 10.1007/s00442-007-0927-4; Ostrom PH, 1997, OECOLOGIA, V109, P108, DOI 10.1007/s004420050064; OVASKA K, 1992, COPEIA, P569; Patino J, 2017, J BIOGEOGR, V44, P963, DOI 10.1111/jbi.12986; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Pringle RM, 2008, ECOL LETT, V11, P1328, DOI 10.1111/j.1461-0248.2008.01252.x; R Core Team, 2017, R LANG ENV STAT COMP; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rosenblatt AE, 2013, PHYSIOL BIOCHEM ZOOL, V86, P137, DOI 10.1086/668295; Sebastian OS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130549; Shiels AB, 2014, PAC SCI, V68, P145, DOI 10.2984/68.2.1; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Smith RL, 2017, BIOL INVASIONS, V19, P1001, DOI 10.1007/s10530-016-1333-9; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Spencer J, 2017, BIOL INVASIONS, V19, P1379, DOI 10.1007/s10530-016-1352-6; STEWART MM, 1983, SCIENCE, V221, P570, DOI 10.1126/science.221.4610.570; Stewart MM, 1996, AMPHIBIANS, P273; Tuttle NC, 2009, BIOL INVASIONS, V11, P845, DOI 10.1007/s10530-008-9298-y; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wallis AC, 2016, J HERPETOL, V50, P582, DOI 10.1670/15-170; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Wilson EE, 2009, P NATL ACAD SCI USA, V106, P12809, DOI 10.1073/pnas.0902979106; WOOLBRIGHT LL, 1987, COPEIA, P69; WOOLBRIGHT LL, 1985, HERPETOLOGICA, V41, P1; ZIELINSKI WJ, 1983, J MAMMAL, V64, P387, DOI 10.2307/1380351	68	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201883	10.1371/journal.pone.0201883	http://dx.doi.org/10.1371/journal.pone.0201883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110360	Green Published, gold			2022-12-26	WOS:000441738000043
J	Steinhauer, K; Meyer, S; Pfannebecker, J; Teckemeyer, K; Ockenfeld, K; Weber, K; Becker, B				Steinhauer, Katrin; Meyer, Sonja; Pfannebecker, Jens; Teckemeyer, Karin; Ockenfeld, Klaus; Weber, Klaus; Becker, Barbara			Antimicrobial efficacy and compatibility of solid copper alloys with chemical disinfectants	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; STAINLESS-STEEL; POTENTIAL USE; SURFACES; RESISTANT; ENVIRONMENT; REDUCE; WET	Introduction Chemical disinfection is state of the art in preventing spread of infectious agents in the healthcare setting. Additionally, the antimicrobial properties of solid copper alloy surfaces against various microorganisms have recently been substantiated. Thus, antimicrobially active copper surfaces may serve as an additional barrier against distribution of pathogenic microorganisms and be combined with chemical disinfection measures in the hospital. The aim of this study was therefore to investigate on a quantitative basis whether the combination of chemical disinfectants with copper alloy surfaces results in an overall compromised, combined or even synergistic antimicrobial efficacy. Methods Experiments were carried out using the quantitative carrier test devised by the German Society for Hygiene and Microbiology (DGHM) to study antimicrobial efficacy of chemical disinfectants. Requirements for microbicidal efficacy as defined by prEN 14885 were applied. The chemical disinfectants tested in our study contained alcohols (ethanol, 1-propanol), quaternary ammonium compounds (benzalkonium chloride) and glutaraldehyde as actives. Quantitative carrier tests were carried out on different carriers (tiles, copper alloy discs, stainless steel discs) using Pseudomonas aeruginosa, Staphylococcus aureus, Kocuria rhizophila and Candida albicans as test organisms. Results For the alcohol-based disinfectant no difference in antimicrobial efficacy was observed when applied to antimicrobial active copper alloy carriers, tiles or stainless steel discs. For all test organisms microbial contamination was reduced to the detection limit of < 1 log (CFU/ml) within a contact time of 2 min indicating a >= 5 log reduction for the tested bacteria and a >= 4 log reduction for the yeast, as being requested for chemical disinfectants by prEN 14885. In order to elucidate a potential synergism the chemical disinfectant based on quaternary ammonium compounds (benzalkonium chloride) and glutaraldehyde was used at a sub-effective concentration. Hence, no complete reduction of microbial contamination was achieved on stainless steel or tile carriers for Pseudomonas aeruginosa and Candida albicans. Interestingly, when using copper alloy carriers complete reduction indicating a >= 5 log reduction for P. aeruginosa and a >= 4 log reduction for C. albicans was detected. Thus, data of this study indicates that solid copper alloy surfaces and disinfectants synergize. Conclusions According to this data, commercially available disinfectants based on alcohol, quaternary ammonium compounds and aldehyde can effectively be combined in a dual strategy with solid copper alloy surfaces to reduce microbial contamination.	[Steinhauer, Katrin; Teckemeyer, Karin; Weber, Klaus] Schulke & Mayr GmbH, Res & Regulatory Affairs, Norderstedt, Germany; [Meyer, Sonja; Pfannebecker, Jens; Becker, Barbara] Ostwestfalen Lippe Univ Appl Sci, Dept Life Sci Technol, Microbiol, Lemgo, Germany; [Ockenfeld, Klaus] Deutsch Kupferinst Berufsverband eV, Environm & Hlth, Dusseldorf, Germany		Steinhauer, K (corresponding author), Schulke & Mayr GmbH, Res & Regulatory Affairs, Norderstedt, Germany.	katrin.steinhauer@schuelke.com		Steinhauer, Katrin/0000-0002-4218-6152	Schulke Mayr GmbH; German copper society	Schulke Mayr GmbH; German copper society	This study received funding from Schulke & Mayr GmbH (www.schuelke.com) and the German copper society (www.kupferinstitut.de). KS, KT, KW and KO were involved in the conceptualization of the study as well as in data analysis and writing of the manuscript.	Airey P, 2007, J HOSP INFECT, V67, P271, DOI 10.1016/j.jhin.2007.09.002; [Anonymous], 2017, 14885 PREN EUR COMM; Ducel G, 2012, PREVENTION HOSP ACQU, V2nd; European Committee for Standardization, 2019, 123532019 PREN; Gebel J., 2001, STANDARDMETHODEN DGH; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Jean J, 2003, J FOOD PROTECT, V66, P115, DOI 10.4315/0362-028X-66.1.115; Karpanen TJ, 2012, INFECT CONT HOSP EP, V33, P3, DOI 10.1086/663644; Kawakami H, 2015, BIOCONTROL SCI, V20, P193, DOI 10.4265/bio.20.193; Kawakami H, 2014, BIOCONTROL SCI, V19, P73, DOI 10.4265/bio.19.73; Kramer A, 2008, WALLHAUSERS PAXIS ST; Molteni C, 2010, APPL ENVIRON MICROB, V76, P4099, DOI 10.1128/AEM.00424-10; Noyce JO, 2006, J HOSP INFECT, V63, P289, DOI 10.1016/j.jhin.2005.12.008; Salgado CD, 2013, INFECT CONT HOSP EP, V34, P479, DOI 10.1086/670207; Santo CE, 2011, APPL ENVIRON MICROB, V77, P794, DOI 10.1128/AEM.01599-10; Schmidt MG, 2012, J CLIN MICROBIOL, V50, P2217, DOI 10.1128/JCM.01032-12; Vincent M, 2016, INT J HYG ENVIR HEAL, V219, P585, DOI 10.1016/j.ijheh.2016.06.003; Warnes SL, 2011, APPL ENVIRON MICROB, V77, P6049, DOI 10.1128/AEM.00597-11; Warnes SL, 2016, APPL ENVIRON MICROB, V82, P2132, DOI 10.1128/AEM.03861-15; Warnes SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075017; Zhu LB, 2012, FOOD MICROBIOL, V30, P303, DOI 10.1016/j.fm.2011.12.001	21	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0200748	10.1371/journal.pone.0200748	http://dx.doi.org/10.1371/journal.pone.0200748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096209	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500006
J	Buranasin, P; Mizutani, K; Iwasaki, K; Mahasarakham, CPN; Kido, D; Takeda, K; Izumi, Y				Buranasin, Prima; Mizutani, Koji; Iwasaki, Kengo; Mahasarakham, Chantida Pawaputanon Na; Kido, Daisuke; Takeda, Kohei; Izumi, Yuichi			High glucose-induced oxidative stress impairs proliferation and migration of human gingival fibroblasts	PLOS ONE			English	Article							ACETYL-L-CYSTEINE; NONSURGICAL PERIODONTAL THERAPY; DIABETES-MELLITUS; EXPRESSION; INSIGHTS; GROWTH; CELLS; ANTIOXIDANTS; INHIBITION; ACTIVATION	Delayed gingival wound healing is widely observed in periodontal patients with diabetes. However, the molecular mechanisms of the impaired function of gingival fibroblasts in diabetes remain unclear. The purpose of this study was to investigate changes in the properties of human gingival fibroblasts (HGFs) under high-glucose conditions. Primary HGFs were isolated from healthy gingiva and cultured with 5.5, 25, 50, and 75 mM glucose for 72 h. In vitro wound healing, 5-ethynyl-2'-deoxyuridine (EdU), and water-soluble tetrazolium salt (WST-8) assays were performed to examine cell migration and proliferation. Lactase dehydrogenase (LDH) levels were measured to determine cytotoxicity. The mRNA expression levels of oxidative stress markers were quantified by real-time PCR. Intracellular reactive oxygen species (ROS) were also measured in live cells. The antioxidant N-acetyl-L-cysteine (NAC, 1 mM) was added to evaluate the involvement of ROS in the glucose effect on HGFs. As a result, the in vitro wound healing assay showed that high glucose levels significantly reduced fibroblast migration and proliferation at 6, 12, 24, 36, and 48 h. The numbers of cells positive for EdU staining were decreased, as was cell viability, at 50 and 75 mM glucose. A significant increase in LDH was proportional to the glucose concentration. The mRNA levels of heme oxygenase-1 and superoxide dismutase-1 and ROS levels were significantly increased in HGFs after 72 h of exposure to 50 mM glucose concentration. The addition of NAC diminished the inhibitory effect of high glucose in the in vitro wound healing assay. The results of the present study show that high glucose impairs the proliferation and migration of HGFs. Fibroblast dysfunction may therefore be caused by high glucose induced oxidative stress and may explain the delayed gingival wound healing in diabetic patients.	[Buranasin, Prima; Mizutani, Koji; Kido, Daisuke; Takeda, Kohei; Izumi, Yuichi] TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Iwasaki, Kengo] TMDU, Grad Sch Med & Dent Sci, Dept Nanomed, Tokyo, Japan; [Mahasarakham, Chantida Pawaputanon Na] Khon Kaen Univ, Fac Dent, Dept Restorat Dent, Khon Kaen, Thailand	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Khon Kaen University	Mizutani, K (corresponding author), TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan.	mizuperi@tmd.ac.jp	Takeda, Kohei/AAN-3401-2021; Iwasaki, Kengo/AAG-7902-2021	Takeda, Kohei/0000-0002-9063-2532; 	Japan Society for the promotion of Science [16K20666, 25862043]	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the promotion of Science, 16K20666 and 25862043 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-16K20666/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2012, MOL CELL ENDOCRINOL, V348, P155, DOI 10.1016/j.mce.2011.08.002; Al-Maskari Awatif Y, 2011, Sultan Qaboos Univ Med J, V11, P179; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Benrahmoune M, 2000, FREE RADICAL BIO MED, V29, P775, DOI 10.1016/S0891-5849(00)00380-4; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chen TC, 2011, J BIOL CHEM, V286, P25564, DOI 10.1074/jbc.M111.230540; Christgau M, 1998, J CLIN PERIODONTOL, V25, P112, DOI 10.1111/j.1600-051X.1998.tb02417.x; Clark RAF, 2008, J INVEST DERMATOL, V128, P2361, DOI 10.1038/jid.2008.257; CURCIO F, 1992, IN VITRO CELL DEV-AN, V28A, P787; Desta T, 2010, J DENT RES, V89, P609, DOI 10.1177/0022034510362960; Deveci M, 2005, BRIT J DERMATOL, V152, P217, DOI 10.1111/J.1365-2133.2004.06329.X; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Han DC, 1999, J AM SOC NEPHROL, V10, P1891; Hattori Y, 2000, CARDIOVASC RES, V46, P188, DOI 10.1016/S0008-6363(99)00425-3; Hehenberger K, 1997, CELL BIOCHEM FUNCT, V15, P197; Ji HJ, 2011, BIOMED PHARMACOTHER, V65, P369, DOI 10.1016/j.biopha.2011.04.020; Kardesler L, 2011, INFLAMM RES, V60, P143, DOI 10.1007/s00011-010-0248-7; Kashiwagi Y, 2016, ORAL DIS, V22, P578, DOI 10.1111/odi.12502; Kido D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189601; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lan CCE, 2009, BRIT J DERMATOL, V160, P1206, DOI 10.1111/j.1365-2133.2009.09089.x; LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5; Millar TM, 2007, FREE RADICAL BIO MED, V42, P1165, DOI 10.1016/j.freeradbiomed.2007.01.015; Mizutani K, 2014, J DENT RES, V93, P596, DOI 10.1177/0022034514532102; Morocutti A, 1998, J AM SOC NEPHROL, V9, P1060; Moseley R, 2004, WOUND REPAIR REGEN, V12, P419, DOI 10.1111/j.1067-1927.2004.12406.x; Navarro-Sanchez AB, 2007, J CLIN PERIODONTOL, V34, P835, DOI 10.1111/j.1600-051X.2007.01127.x; Ohgi S, 1996, J PERIODONTAL RES, V31, P579, DOI 10.1111/j.1600-0765.1996.tb00523.x; OHSHIMA M, 1995, J PERIODONTAL RES, V30, P220, DOI 10.1111/j.1600-0765.1995.tb01277.x; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Rodriguez Luis G., 2004, V294, P23; Sadowska AM, 2007, PULM PHARMACOL THER, V20, P9, DOI 10.1016/j.pupt.2005.12.007; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Shi HX, 2015, INT J BIOL SCI, V11, P845, DOI 10.7150/ijbs.11921; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Stolzing A, 2006, REJUV RES, V9, P31, DOI 10.1089/rej.2006.9.31; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; WILLERSHAUSENZONNCHEN B, 1991, J CLIN PERIODONTOL, V18, P190, DOI 10.1111/j.1600-051X.1991.tb01132.x; Xiong LY, 2012, AESTHET PLAST SURG, V36, P1260, DOI 10.1007/s00266-012-9960-8; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182	47	74	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201855	10.1371/journal.pone.0201855	http://dx.doi.org/10.1371/journal.pone.0201855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092096	gold, Green Published, Green Submitted			2022-12-26	WOS:000441232600063
J	Liu, CJ; Guo, X; Wang, KL; Sun, YK; Li, W; Liu, QC; Liu, QH				Liu, Cuiju; Guo, Xiao; Wang, Kuiling; Sun, Yingkun; Li, Wei; Liu, Qingchao; Liu, Qinghua			Nitrogen deposition does not alleviate the adverse effects of shade on Camellia japonica (Naidong) seedlings	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC CHARACTERISTICS; LIGHT-INTENSITY; GROWTH; LEAF; RESPONSES; DROUGHT; PLANTS; EVOLUTION	Camellia japonica (Naidong), a Tertiary relict species with a unique biological and cultural characteristic, is a special ecotype of C. japonica and is the northernmost distributed populations of C. japonica in the world. This study investigated the interactive responses of C. japonica (Naidong) to shade and nitrogen deposition focusing on seedling growth, leaf morphology and leaf physiology under two light regimes (15% and 65% of full sunlight to represent deep shade and slight shade respectively) and three nitrogen deposition regimes (0, 6 and 12 g N m(-2) year(-1)) in a greenhouse. After 123 d of treatment, the results showed that the deep shade reduced the growth of seedlings significantly compared to slight shade, but improved the specific leaf area, leaf water content, chlorophyll content and F-v/F-m of plants. Moderate nitrogen (6 g N m(-2) year(-1)) supply increased the crown area, specific leaf area, leaf water content, chlorophyll content and water use efficiency of seedlings. However, high nitrogen (12 g N M-2 year(-1)) supply reduced the basal diameter, crown area, specific leaf area and leaf water content. No significant interaction of shade and nitrogen deposition on C. japonica (Naidong) was found. There is a threshold of nitrogen deposition for the growth of C. japonica (Naidong). Camellia japonica (Naidong) populations should be protected by collecting of germplasm resources and carrying out the ex situ conservation.	[Liu, Cuiju; Guo, Xiao; Wang, Kuiling; Sun, Yingkun; Li, Wei; Liu, Qingchao; Liu, Qinghua] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China	Qingdao Agricultural University	Guo, X; Liu, QH (corresponding author), Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China.	xiaoguoyeah@yeah.net; lqh6205@163.com	Guo, Xiao/K-9759-2019; Guo, Xiao/B-6794-2019	Guo, Xiao/0000-0003-2268-5090; Guo, Xiao/0000-0003-2268-5090	National Natural Science Foundation of China [31500264]; Collection and conservation of characteristic and predominant, and rare and endangered forest trees germplasm resources [2016LZGC038]; National Forest Gerplasm Resources Shared Service Platform 2017	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collection and conservation of characteristic and predominant, and rare and endangered forest trees germplasm resources; National Forest Gerplasm Resources Shared Service Platform 2017	This work was supported by National Natural Science Foundation of China (No. 31500264), Collection and conservation of characteristic and predominant, and rare and endangered forest trees germplasm resources (No. 2016LZGC038) and National Forest Gerplasm Resources Shared Service Platform 2017.	Ahmed L.T., 2014, J FOR PROD IND, V3, P20; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Burns KC, 2004, DIVERS DISTRIB, V10, P105, DOI 10.1111/j.1366-9516.2004.00058.x; Craven D, 2010, ENVIRON EXP BOT, V69, P205, DOI 10.1016/j.envexpbot.2010.04.002; Dai YJ, 2009, ENVIRON EXP BOT, V65, P177, DOI 10.1016/j.envexpbot.2008.12.008; del Pino GA, 2015, PLANT ECOL, V216, P439, DOI 10.1007/s11258-015-0448-x; Deng Y., 2014, STUDY ESTIMATING ATM; Jimenez MD, 2009, FORESTRY, V82, P285, DOI 10.1093/forestry/cpp008; Du N, 2013, AGROFOREST SYST, V87, P403, DOI 10.1007/s10457-012-9562-0; Duan RY, 2015, ECOL EVOL, V5, P265, DOI 10.1002/ece3.1368; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fu YM, 2017, SCI HORTIC-AMSTERDAM, V214, P51, DOI 10.1016/j.scienta.2016.11.020; Gao JY, 2005, COLLECTION SPECIES G; Guo X, 2014, DENDROBIOLOGY, V72, P151, DOI 10.12657/denbio.072.013; Guo X, 2013, ACTA PHYSIOL PLANT, V35, P1149, DOI 10.1007/s11738-012-1154-0; Hussner A, 2010, AQUAT BOT, V93, P17, DOI 10.1016/j.aquabot.2010.02.003; Jia ZL., 2016, STUDY SPATIAL VARIAB, DOI [10.7666/d.D01036674, DOI 10.7666/D.D01036674]; Lei TT, 1996, PHYSIOL PLANTARUM, V96, P411, DOI 10.1111/j.1399-3054.1996.tb00452.x; Li MY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194261; Li MY, 2017, FLORA, V233, P171, DOI 10.1016/j.flora.2017.06.002; Lin Li, 2012, Acta Horticulturae Sinica, V39, P1531; Liu X, 2017, CURRENT POLLUTION RE, V1; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Luo YJ, 2014, PLANT SOIL, V385, P63, DOI 10.1007/s11104-014-2227-1; Ma JY, 2017, PHOTOSYNTH RES, V131, P1, DOI 10.1007/s11120-016-0281-7; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; Rodriguez-Garcia E, 2013, FOREST ECOL MANAG, V307, P196, DOI 10.1016/j.foreco.2013.06.046; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Soto DP, 2017, FOREST ECOL MANAG, V384, P303, DOI 10.1016/j.foreco.2016.11.016; Stanton KM, 2010, HORTSCIENCE, V45, P1912, DOI 10.21273/HORTSCI.45.12.1912; Strengbom J, 2004, CAN J BOT, V82, P430, DOI [10.1139/B04-017, 10.1139/b04-017]; Tobita H, 2010, TREES-STRUCT FUNCT, V24, P307, DOI 10.1007/s00468-009-0400-6; Tripathi SN, 2014, J PLANT ECOL, V7, P250, DOI 10.1093/jpe/rtt026; van der Tol C, 2009, AGR FOREST METEOROL, V149, P96, DOI 10.1016/j.agrformet.2008.07.007; Wang C, 2015, POLISH J ECOLOGY, V65, P87; Wang K.L., 2006, STUDIES GERMPLASM RE; Wang K. L, 2007, J CHINESE URBAN FORE, V5, P54; Wang Qing-wei, 2010, Yingyong Shengtai Xuebao, V21, P3255; Wang R, 1999, J AGRON CROP SCI, V34, P109; Wang R, 1998, J SHANDONG FORESTRY, P1; Wang X. B., 1992, GUIHAIA, V3, P272; Xu NN, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1853-4; Yang HL, 2017, GLOBAL CHANGE BIOL, V23, P2874, DOI 10.1111/gcb.13590; Zhang Q, 2017, FLORA, V233, P127, DOI 10.1016/j.flora.2017.05.015; Zhang R, 2013, PLANT SOIL, V370, P435, DOI 10.1007/s11104-013-1644-x; Zhang XR, 2013, J FORESTRY RES, V24, P293, DOI 10.1007/s11676-013-0352-y; Zhang Y, 2011, BIOGEOSCIENCES DISCU, V8, P1250; Zhao DQ, 2012, PLANT PHYSIOL BIOCH, V61, P187, DOI 10.1016/j.plaphy.2012.10.005; Zhu X, 2011, J CENTRAL S U FOREST, P30	55	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201896	10.1371/journal.pone.0201896	http://dx.doi.org/10.1371/journal.pone.0201896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092088	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600066
J	De Filippis, E; Li, T; Rosen, ED				De Filippis, Elena; Li, Ting; Rosen, Evan David			Exposure of adipocytes to bisphenol-A in vitro interferes with insulin action without enhancing adipogenesis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; PERINATAL EXPOSURE; METABOLIC SYNDROME; ADIPOSE-TISSUE; OBESITY; RESISTANCE; DISORDERS; CELLS	Bisphenol-A (BPA) is a lipophilic compound widely used in the manufacture of plastic items and thought to play a role in the growing obesity epidemic. Recent publications suggest that BPA may have a pro-adipogenic effect. Here we explore the effect of low, but environmentally relevant, concentrations of BPA on adipogenesis using a variety of cellular models. Mouse 3T3-L1, C3H10T1/2 and human adipose-derived stromal cells (hADSCs) were cultured with BPA concentrations ranging from 0.1nM to 100 mu M. We failed to observe positive effects on differentiation at any dose or in any model. 3T3-L1 adipocytes differentiated with high concentrations of BPA showed decreased mRNA expression of several adipocyte markers. Mature adipocytes differentiated in the presence of BPA were insulin resistant, with an approximate 25% reduction in insulin-stimulated glucose uptake. This was accompanied by a significant decrease in insulin-stimulated Akt phosphorylation, and an increase in mRNA levels of inflammatory markers (i. e. IL-6, TNFa). In conclusion, low, but environmentally relevant, doses of BPA may contribute to the development of a chronic, low-grade inflammatory state in exposed adipocytes, which in turn may affect adipose tissue insulin sensitivity, independent of adipogenesis. These studies suggest an alternative mechanism by which BPA may contribute to the development of obesity.	[De Filippis, Elena; Rosen, Evan David] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [De Filippis, Elena; Rosen, Evan David] Harvard Med Sch, Boston, MA 02115 USA; [De Filippis, Elena; Li, Ting] Mayo Clin, Hlth Program, Scottsdale, AZ 85259 USA; [De Filippis, Elena] Mayo Clin, Dept Med, Div Endocrinol, Coll Med, Scottsdale, AZ 85259 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	De Filippis, E (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.; De Filippis, E (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; De Filippis, E (corresponding author), Mayo Clin, Hlth Program, Scottsdale, AZ 85259 USA.; De Filippis, E (corresponding author), Mayo Clin, Dept Med, Div Endocrinol, Coll Med, Scottsdale, AZ 85259 USA.	defilippis.elena@mayo.edu		De Filippis, Elena/0000-0002-5622-6709	Endocrine Fellowship Foundation; Fellows Development Research Grant Program in Diabetes, Obesity and Fat Cell Biology; NIH [R01 DK102173, DK102170, DK113669, DK085171]; T32 award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113669, R01DK102173, R01DK085171, R01DK102170] Funding Source: NIH RePORTER	Endocrine Fellowship Foundation; Fellows Development Research Grant Program in Diabetes, Obesity and Fat Cell Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	EDF was supported by a grant from the Endocrine Fellowship Foundation, Fellows Development Research Grant Program in Diabetes, Obesity and Fat Cell Biology, and a T32 award. EDR is supported by NIH R01 DK102173, DK102170, DK113669, and DK085171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Zhang Xu and Su Xu for their technical assistance. We thank Sona Kang for sharing her cell culture knowledge with the authors and providing advice; Linus Tsai also provided significant intellectual support for this project. EDF was supported by a grant from the Endocrine Fellowship Foundation, Fellows Development Research Grant Program in Diabetes, Obesity and Fat Cell Biology, and a T32 award. EDR is supported by NIH R01 DK102173, DK102170, DK113669, and DK085171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Ariemma F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150762; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Batista TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033814; Boucher JG, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2013.43; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carson Rachel, 1994, SILENT SPRING; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jc.87.7.3019; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658; Kuruto-Niwa R, 2007, CHEMOSPHERE, V66, P1160, DOI 10.1016/j.chemosphere.2006.06.073; Lagarde F, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-13; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Masuno H, 2002, J LIPID RES, V43, P676; Masuno H, 2005, TOXICOL SCI, V84, P319, DOI 10.1093/toxsci/kfi088; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Valentino R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082099; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, REPROD TOXICOL, V24, P139, DOI [10.1016/j.reprotox.2007.07.010, DOI 10.1016/J.REPROTOX.2007.07.010PMID:17825522]; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045	34	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201122	10.1371/journal.pone.0201122	http://dx.doi.org/10.1371/journal.pone.0201122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133442	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400012
J	Jang, JW; Park, JH; Kim, S; Park, YH; Pyun, JM; Lim, JS; Kim, Y; Youn, YC; Kim, S				Jang, Jae-Won; Park, Jeong Hoon; Kim, Seongheon; Park, Young Ho; Pyun, Jung-Min; Lim, Jae-Sung; Kim, Youngho; Youn, Young Chul; Kim, SangYun		Alzheimers Dis Neuroimaging Initia	A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; MEDIAL TEMPORAL-LOBE; SMALL-VESSEL DISEASE; WHITE-MATTER CHANGES; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; BRAIN ATROPHY; AGING PROJECT	Background Numerous efforts have been made to identify biomarkers for predicting the progression of dementia in patients with mild cognitive impairment (MCI), and recently, a comprehensive visual rating scale (CVRS) based on magnetic resonance imaging (MRI) has been validated to assess structural changes in the brain of elderly patients. Based on this, the present study investigated the use of CVRS for predicting dementia and elucidated its association with cognitive change in patients with MCI over a three-year follow-up. Methods We included 340 patients with MCI with more than one follow-up visit. Data were obtained from the Alzheimer's disease Neuroimaging Initiative study. We assessed all the patients using CVRS and determined their progression to dementia during a follow-up period of over 3 years. The cox proportional hazards model was used to analyze hazard ratios (HRs) of CVRS for disease progression. Further, multiple cognitive measures of the patients over time were fitted using the random effect model to assess the effect of initial CVRS score on subsequent cognitive changes. Results Of 340 patients, 69 (20.2%) progressed to dementia and the median baseline score (interquartile range) of CVRS significantly differed between stable MCI and progressive MCI (9 (5 +/- 13) vs 13 (8 +/- 17), p < 0.001). The initial CVRS score was independently associated with an increased risk of progression to dementia (HR 1.123, 95% confidence interval [CI] 1.059-1.192). From 12 to 24 months, the effect of the interaction between CVRS and interval of follow-up visit on cognitive performance achieved significance (p<0.001). Conclusions Baseline CVRS predicted the progression to dementia in patients with MCI, and was independently associated with longitudinal cognitive decline.	[Jang, Jae-Won; Park, Jeong Hoon; Kim, Seongheon] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Dept Neurol, Coll Med, Chunchon, South Korea; [Park, Young Ho; Pyun, Jung-Min; Kim, SangYun] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea; [Park, Young Ho; Pyun, Jung-Min; Kim, SangYun] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Lim, Jae-Sung] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Coll Med, Anyang, South Korea; [Kim, Youngho] Seoul Natl Univ Hosp, Dept Biomed Engn, Seoul, South Korea; [Youn, Young Chul] Chung Ang Univ, Chung Ang Univ Hosp, Dept Neurol, Coll Med, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Hallym University; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital	Kim, S (corresponding author), Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea.; Kim, S (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.	neuroksy@snu.ac.kr	Lim, Jae-Sung/D-5555-2012; Youn, Young Chul/ABA-9938-2021	Lim, Jae-Sung/0000-0001-6157-2908; Jang, Jae-Won/0000-0003-3540-530X; Kim, Seongheon/0000-0002-4253-7522; Park, Jeonghoon/0000-0002-1020-116X; Youn, Young Chul/0000-0002-2742-1759	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014M3C7A1064752]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense award); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Korean government (MSIP); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. This research was also supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (No. 2014M3C7A1064752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuro-imaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Barnes J, 2013, NEUROBIOL AGING, V34, P1996, DOI 10.1016/j.neurobiolaging.2013.02.003; Bennett DA, 2013, J ALZHEIMERS DIS, V33, pS397, DOI 10.3233/JAD-2012-129007; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bresciani L, 2005, AGING CLIN EXP RES, V17, P8, DOI 10.1007/BF03337714; Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Diggle Diggle P, 2013, ANAL LONGITUDINAL DA; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; Fiford CM, 2017, HIPPOCAMPUS, V27, P249, DOI 10.1002/hipo.22690; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Frisoni GB, 2000, J NEUROL NEUROSUR PS, V69, P572, DOI 10.1136/jnnp.69.5.572; Gonzalez MM, 2016, CUREUS, V8, DOI 10.7759/cureus.544; Harper L, 2015, J NEUROL NEUROSUR PS, V86, P1225, DOI 10.1136/jnnp-2014-310090; Ikram MA, 2015, EUR J EPIDEMIOL, V30, P1299, DOI 10.1007/s10654-015-0105-7; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jang JW, 2015, J ALZHEIMERS DIS, V44, P1023, DOI 10.3233/JAD-142088; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Josephs KA, 2010, ARCH NEUROL-CHICAGO, V67, P596, DOI 10.1001/archneurol.2010.78; Kapasi A, 2017, ACTA NEUROPATHOL, V134, P171, DOI 10.1007/s00401-017-1717-7; Kipps CM, 2007, DEMENT GERIATR COGN, V23, P334, DOI 10.1159/000100973; Launer LJ, 2011, ANN NEUROL, V70, P774, DOI 10.1002/ana.22520; Mallik A, 2017, SEMIN NUCL MED, V47, P31, DOI 10.1053/j.semnuclmed.2016.09.005; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Pankratz VS, 2015, NEUROLOGY, V84, P1433, DOI 10.1212/WNL.0000000000001437; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Patel B, 2013, STROKE, V44, P356, DOI 10.1161/STROKEAHA.112.670216; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Roberts RO, 2014, NEUROLOGY, V82, P317, DOI 10.1212/WNL.0000000000000055; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Scheltens P, 1998, EUR NEUROL, V39, P80, DOI 10.1159/000007921; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Shen Qian, 2011, Alzheimers Dement, V7, pe101, DOI 10.1016/j.jalz.2010.07.002; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; van Maurik IS, 2017, JAMA NEUROL, V74, P1481, DOI 10.1001/jamaneurol.2017.2712; Wechsler D., 1987, WMS R WECHSLER MEMOR; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wirth M, 2013, JAMA NEUROL, V70, P1512, DOI 10.1001/jamaneurol.2013.4013	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201852	10.1371/journal.pone.0201852	http://dx.doi.org/10.1371/journal.pone.0201852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125290	Green Published, gold, Green Submitted			2022-12-26	WOS:000442202100013
J	Peiseler, M; Reiners, D; Pinnschmidt, HO; Sebode, M; Jung, F; Hartl, J; Zenouzi, R; Ehlken, H; Groth, S; Schachschal, G; Rosch, T; Weiler-Normann, C; Lohse, AW; Schramm, C				Peiseler, Moritz; Reiners, David; Pinnschmidt, Hans O.; Sebode, Marcial; Jung, Franziska; Hartl, Johannes; Zenouzi, Roman; Ehlken, Hanno; Groth, Stefan; Schachschal, Guido; Roesch, Thomas; Weiler-Normann, Christina; Lohse, Ansgar W.; Schramm, Christoph			Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis	PLOS ONE			English	Article							RETROGRADE CHOLANGIOPANCREATOGRAPHY; POSITION STATEMENT; LIVER-DISEASE; ERCP; COMPLICATIONS; THERAPY; CHOLANGIOGRAPHY; OUTCOMES; SURGERY	Background Endoscopic retrograde cholangiography (ERC) is a mainstay of therapy in patients with primary sclerosing cholangitis (PSC) and obstructive cholestasis. Patients with liver cirrhosis have an increased risk of surgical complications and are more susceptible to infections. Since PSC often progresses to cirrhosis, we aimed to assess whether ERC is associated with increased risk of complications in patients with PSC and cirrhosis. Methods Out of 383 patients with PSC, 208 patients received endoscopic treatment between 2009-2017. Seventy patients had cirrhosis when ERC was performed and 138 patients had no signs of cirrhosis. Overall, 663 ERC procedures were analysed, with 250 ERC in patients with cirrhosis and 413 ERC in patients without cirrhosis. Data were analysed retrospectively from a prospectively acquired database using repeated measures logistic regression. Results Overall, 40 procedure-related complications were documented in 663 ERC interventions (6%). The rate of complications was similar between patients with and without cirrhosis (4.4% vs. 7.0%). First-time ERC was associated with a higher risk of complications (17.5% vs. 4.9%). Biliary sphincterotomy, stent placement and female sex, but not presence of liver cirrhosis, were identified as risk factors for overall complications in multivariate analysis. Patients without cirrhosis showed a significant decline of ALP and bilirubin levels after the first two interventions. In contrast, in patients with cirrhosis, ALP and bilirubin levels did not significantly decline after ERC. Conclusions In patients with PSC, cirrhosis was not a risk factor for post-ERC complications. Therefore, cirrhosis should not preclude endoscopic intervention in patients with clear clinical indication.	[Peiseler, Moritz; Reiners, David; Sebode, Marcial; Jung, Franziska; Hartl, Johannes; Zenouzi, Roman; Ehlken, Hanno; Weiler-Normann, Christina; Lohse, Ansgar W.; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Pinnschmidt, Hans O.] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Ehlken, Hanno; Groth, Stefan; Schachschal, Guido; Roesch, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, Hamburg, Germany; [Weiler-Normann, Christina; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Peiseler, M; Schramm, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.; Schramm, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany.	m.peiseler@uke.de; cschramm@uke.de		Hartl, Johannes/0000-0002-4037-9938; Peiseler, Moritz/0000-0001-6195-3866	Deutsche Forschungsgemeinschaft (DFG) [SFB841, KFO306]; Helmut und Hannelore Greve Foundation; YAEL Foundation; DFG [SE 2665/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmut und Hannelore Greve Foundation; YAEL Foundation; DFG(German Research Foundation (DFG))	C.S., A.W.L. and C.W.-N. are supported by the Deutsche Forschungsgemeinschaft (DFG) (SFB841 and KFO306). C.S. is supported by the Helmut und Hannelore Greve Foundation and the YAEL Foundation. M.S. is supported by the DFG (SE 2665/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabakken L, 2017, ENDOSCOPY, V49, P588, DOI 10.1055/s-0043-107029; Adler DG, 2016, GASTROINTEST ENDOSC, V83, P353, DOI 10.1016/j.gie.2015.08.022; Ahrendt SA, 1998, ANN SURG, V227, P412, DOI 10.1097/00000658-199803000-00014; Alkhatib AA, 2011, DIGEST DIS SCI, V56, P3685, DOI 10.1007/s10620-011-1830-8; Andriulli A, 2007, AM J GASTROENTEROL, V102, P1781, DOI 10.1111/j.1572-0241.2007.01279.x; Baluyut AR, 2001, GASTROINTEST ENDOSC, V53, P308, DOI 10.1067/mge.2001.112739; Bangarulingam SY, 2009, AM J GASTROENTEROL, V104, P855, DOI 10.1038/ajg.2008.161; BEUERS U, 1992, J HEPATOL, V15, P140, DOI 10.1016/0168-8278(92)90026-L; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bjornsson E, 2004, AM J GASTROENTEROL, V99, P502, DOI 10.1111/j.1572-0241.2004.04106.x; Chandrasekhara V, 2017, GASTROINTEST ENDOSC, V85, P32, DOI 10.1016/j.gie.2016.06.051; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Corpechot C, 2014, GASTROENTEROLOGY, V146, P970, DOI 10.1053/j.gastro.2013.12.030; Dyson JK, 2018, LANCET; Enns R, 2003, CAN J GASTROENTEROL, V17, P243, DOI 10.1155/2003/475603; Etzel JP, 2008, GASTROINTEST ENDOSC, V67, P643, DOI 10.1016/j.gie.2007.07.042; Friedman LS, 1999, HEPATOLOGY, V29, P1617, DOI 10.1002/hep.510290639; Gluck M, 2008, J CLIN GASTROENTEROL, V42, P1032, DOI 10.1097/MCG.0b013e3181646713; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Ismail S, 2012, ENDOSCOPY, V44, P1133, DOI 10.1055/s-0032-1325677; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330; LEE JG, 1995, HEPATOLOGY, V21, P661, DOI 10.1002/hep.1840210310; Lindor KD, 2015, AM J GASTROENTEROL, V110, P646, DOI 10.1038/ajg.2015.112; Navaneethan U, 2015, GASTROINTEST ENDOSC, V81, P410, DOI 10.1016/j.gie.2014.06.030; Negm AA, 2010, GASTROINTEST ENDOSC, V72, P284, DOI 10.1016/j.gie.2010.02.043; Nicoll A, 2012, J GASTROEN HEPATOL, V27, P1569, DOI 10.1111/j.1440-1746.2012.07205.x; O'Leary JG, 2009, CLIN LIVER DIS, V13, P211, DOI 10.1016/j.cld.2009.02.002; Ponsioen CY, 2018, GASTROENTEROLOGY; Schramm C, 2017, HEPATOLOGY, V66, P1675, DOI 10.1002/hep.29293; Stiehl A, 2002, J HEPATOL, V36, P151, DOI 10.1016/S0168-8278(01)00251-3; van den Hazel SJ, 2000, ENDOSCOPY, V32, P779, DOI 10.1055/s-2000-7708; von Seth E, 2015, LIVER INT, V35, P254, DOI 10.1111/liv.12640	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202686	10.1371/journal.pone.0202686	http://dx.doi.org/10.1371/journal.pone.0202686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125307	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100043
J	Yu, JJ; Manus, MB; Mueller, O; Windsor, SC; Horvath, JE; Nunn, CL				Yu, James J.; Manus, Melissa B.; Mueller, Olaf; Windsor, Sarah C.; Horvath, Julie E.; Nunn, Charles L.			Antibacterial soap use impacts skin microbial communities in rural Madagascar	PLOS ONE			English	Article							TRICLOSAN; DIVERSITY; HEALTH; RESISTANCE	The skin harbors diverse communities of microorganisms, and alterations to these communities can impact the effectiveness of the skin as a barrier to infectious organisms or injury. As the global availability and adoption of antibacterial products increases, it is important to understand how these products affect skin microbial communities of people living in rural areas of developing countries, where risks of infection and injury often differ from urban populations in developed countries. We investigated the effect of antibacterial soap on skin microbial communities in a rural Malagasy population that practices subsistence agriculture in the absence of electricity and running water. We quantified the amount of soap used by each participant and obtained skin swab samples at three time points: prior to soap use, immediately after one week of soap use, and two weeks after soap use was discontinued. Soap use did not significantly impact ecological measures of diversity and richness (alpha diversity). However, the amount of soap used was a predictor of community-level change (beta diversity), with changes persisting for at least two weeks after subjects stopped using soap. Our results indicate that the overall species richness of skin microbial communities may be resistant to short-term use of antibacterial soap in settings characterized by regular contact with the natural environment, yet these communities may undergo shifts in microbial composition. Lifestyle changes associated with the use of antibacterial soap may therefore cause rapid alterations in skin microbial communities, with the potential for effects on skin health.	[Yu, James J.; Manus, Melissa B.; Horvath, Julie E.; Nunn, Charles L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Manus, Melissa B.; Nunn, Charles L.] Duke Global Hlth Inst, Durham, NC 27710 USA; [Mueller, Olaf] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Mueller, Olaf] Duke Univ, Sch Med, Ctr Genom Microbial Syst, Durham, NC USA; [Windsor, Sarah C.; Horvath, Julie E.] North Carolina Museum Nat Sci, Genom & Microbiol Res Lab, Raleigh, NC USA; [Horvath, Julie E.] North Carolina Cent Univ, Dept Biol & Biomed Sci, Durham, NC 27707 USA	Duke University; Duke University; Duke University; Duke University; University of North Carolina; North Carolina Central University	Nunn, CL (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.; Nunn, CL (corresponding author), Duke Global Hlth Inst, Durham, NC 27710 USA.	clnunn@duke.edu			Bass Connections program at Duke University	Bass Connections program at Duke University	The Bass Connections program at Duke University helped fund this work to CLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bass Connections at Duke University for funding, and the North Carolina Museum of Natural Sciences and the Duke Center for Genomic and Computational Biology for laboratory and technical support. We also thank the Duke Lemur Center SAVA Conservation staff and partners, including Desire A Razafimatratra, Lanto Andrianandrasana, Henri Lahady, Prisca Raharimalala, and Guy Irenel Raoloniaina for their professionalism and support in the field. In addition, we thank the people of Mandena for their endless hospitality. Lastly, we thank Temini Ajayi, Rachel Clark, David Samson, Ashley Sobel, Taylor Trentadue, and Anna Willoughby for their support and teamwork in the field.	Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; [Anonymous], 2015, FOLLOW YOUR GUT ENOR; Balter M, 2012, SCIENCE, V336, P1246, DOI 10.1126/science.336.6086.1246; Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Blaser MJ, 2014, MISSING MICROBES OVE; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Burton M, 2011, INT J ENV RES PUB HE, V8, P97, DOI 10.3390/ijerph8010097; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Carey DE, 2016, ENVIRON SCI TECHNOL, V50, P126, DOI 10.1021/acs.est.5b03080; Centers for Disease Control and Prevention (CDC),, 2017, ANT ANT RES; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Corp Wings, 2016, SANT MED SOAP; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Council SE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2586; FDA, 2016, FDA ISS FIN RUL SAF; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Foxman B, 2010, EPIDEMIOLOGY, V21, P757, DOI 10.1097/EDE.0b013e3181f4e1f9; Giuliano CA, 2015, PHARMACOTHERAPY, V35, P328, DOI 10.1002/phar.1553; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Johnson PI, 2016, ENVIRON INT, V92-93, P716, DOI 10.1016/j.envint.2016.03.009; Kennedy RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33430; Kennedy RCM, 2015, REPROD SCI, V22, P75, DOI 10.1177/1933719114532844; Kim SA, 2016, J HOSP INFECT, V94, P276, DOI 10.1016/j.jhin.2016.07.010; Kim SA, 2015, J ANTIMICROB CHEMOTH, V70, P3345, DOI 10.1093/jac/dkv275; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Leung MHY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11845; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Manus MB, 2017, EVOL MED PUBLIC HLTH, P144, DOI 10.1093/emph/eox013; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Parker William, 2013, Evolution Medicine and Public Health, P89, DOI 10.1093/emph/eot008; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; R Core Team, 2013, R LANG ENV STAT COMP; Rook GAW, 2005, CLIN EXP ALLERGY, V35, P841, DOI 10.1111/j.1365-2222.2005.02112.x; Rook GAW, 2005, GUT, V54, P317, DOI 10.1136/gut.2004.053785; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Syed AK, 2014, MBIO, V5, DOI 10.1128/mBio.01015-13; The Human Microbiome Project Consortium, 2012, NATURE, V486; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Urban J, 2016, PEERJ, V4, DOI 10.7717/peerj.1605; Willems A., 2014, FAMILY COMAMONADACEA, P777, DOI [DOI 10.1007/978-3-642-30197-1_238, 10.1007/978-3-642-30197-1_238]; World Health Organization, 2017, ANT RES; Yee AL, 2016, SCIENCE, V353, P348, DOI 10.1126/science.aag2698; Yueh MF, 2016, ANNU REV PHARMACOL, V56, P251, DOI 10.1146/annurev-pharmtox-010715-103417	50	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0199899	10.1371/journal.pone.0199899	http://dx.doi.org/10.1371/journal.pone.0199899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125279	Green Published, gold, Green Submitted			2022-12-26	WOS:000442202100002
J	Carvalho, PHD; Borges, ALDC; Silva, RRE; Lage, HF; Vivenza, PAD; Ruas, JRM; Facury, EJ; Palhano, RLA; Goncalves, LC; Borges, I; Saliba, EDS; Jayme, DG; de Carvalho, AU				de Araujo Carvalho, Pedro Henrique; da Costa Cruz Borges, Ana Luiza; Reis e Silva, Ricardo; Lage, Helena Ferreira; Dutra Vivenza, Paolo Antonio; Mendes Ruas, Jose Reinaldo; Facury Filho, Elias Jorge; Araujo Palhano, Rodrigo Liberio; Goncalves, Lucio Carlos; Borges, Iran; Simoes Saliba, Eloisa de Oliveira; Jayme, Diogo Gonzaga; de Carvalho, Antonio Ultimo			Energy metabolism and partition of lactating Zebu and crossbred Zebu cows in different planes of nutrition	PLOS ONE			English	Article							MILK-PRODUCTION; BEEF-CATTLE; SYSTEM; REQUIREMENTS; EFFICIENCY; HOLSTEIN; SILAGE	The aim of this study was to determine the energy metabolism and partition of lactating Gyr and F1 Holstein x Gyr (F1 HxG) cows in different planes of nutrition. Six F1 HxG and six Gyr cows with 130 days in milking (DIM) fed corn silage and concentrate were evaluated. The experiment consisted of four periods with different levels of feeding: 1st ad libitum dry matter intake (DMI) and the others with 5, 10 and 20% restricted DMI, related to the first one. An apparent digestibility assay was performed before measurements in the respiration chamber. Total feces were collected for three days. The cows were confined for 24h in the chamber in each period to determine methane and heat production (HP). F1 HxG had higher gross energy intake (GED, metabolisable energy intake (MEI) and digestible energy intake (DEI). GE lost in feces was higher in F1 HxG (23.7% GED than in Gyr (20.5%) cows. Energy lost as methane and urine was similar between the groups. The metabolisability (q) was 0.67, and the efficiency of converting ME to NE (k) was 0.56. There was no difference in the energy requirements for maintenance between breeds (426.6 MJ/kg BW0,75 average value). The energy requirements for lactation were higher in F1 HxG animals due to the higher volume of milk produced, since there was no difference in energy requirements for production of one kg of milk.	[de Araujo Carvalho, Pedro Henrique; da Costa Cruz Borges, Ana Luiza; Reis e Silva, Ricardo; Lage, Helena Ferreira; Dutra Vivenza, Paolo Antonio; Facury Filho, Elias Jorge; Araujo Palhano, Rodrigo Liberio; Goncalves, Lucio Carlos; Borges, Iran; Simoes Saliba, Eloisa de Oliveira; Jayme, Diogo Gonzaga; de Carvalho, Antonio Ultimo] Univ Fed Minas Gerais, Vet Sch, Belo Horizonte, MG, Brazil; [Mendes Ruas, Jose Reinaldo] Unimontes, Dept Anim Sci, Janauba, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros	Borges, ALDC (corresponding author), Univ Fed Minas Gerais, Vet Sch, Belo Horizonte, MG, Brazil.	analuizavetufmg@gmail.com	Borges, Ana Luiza/AAQ-8881-2020; Jayme, Diogo GONZAGA/AHB-0432-2022	Borges, Ana Luiza/0000-0002-5709-7291; Jayme, Diogo GONZAGA/0000-0003-1838-2732; Goncalves, Lucio Carlos/0000-0002-1716-4744; Saliba, Eloisa/0000-0003-4607-8404	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Universal 01/2014]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais; Fundacao de Amparo a Pesquisa [CHAMADA FAPEMIG 05/2017]; Instituto Nacional de Ciencia e Tecnologia (INCT Ciencia Animal CNPq) [16/2014]; Instituto Nacional de Pesquisa; Empresa de Pesquisa Agropecuaria do Estado de Minas Gerais (EPAMIG)- CAMPO EXPERIMENTAL DE FELIXLANDIA; Escola de Veterinaria da Universidade Federal de Minas Gerais (UFMG); BR-Nova Sistemas Nutricionais; Conselho Nacional de Desenvolvimento Cientlfico e Tecnologico (CNPq); INCT Ciencia Animal-CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais; Fundacao de Amparo a Pesquisa; Instituto Nacional de Ciencia e Tecnologia (INCT Ciencia Animal CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Pesquisa; Empresa de Pesquisa Agropecuaria do Estado de Minas Gerais (EPAMIG)- CAMPO EXPERIMENTAL DE FELIXLANDIA; Escola de Veterinaria da Universidade Federal de Minas Gerais (UFMG); BR-Nova Sistemas Nutricionais; Conselho Nacional de Desenvolvimento Cientlfico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT Ciencia Animal-CNPq	The work was supported by the following: 1- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), www.cnpq.br, edital Universal 01/2014, to RReS; 2- Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), www.fapemig.br, Programa Pesquisador Mineiro - PPM, to ALdCCB; 3- Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais, www.ufmg.br, PRPq edital para melhoria qualitativa da producao cientifica of the UFMG, to ALdCCB; 4- Fundacao de Amparo a Pesquisa, www.fapemig.br, edital CHAMADA FAPEMIG 05/2017, to ALdCCB; 5- Instituto Nacional de Ciencia e Tecnologia (INCT Ciencia Animal CNPq), www.cnpq.br, Chamada INCT-MCTI/CNPq/Capes/FAPs no 16/2014 to ALdCCB; 6- Instituto Nacional de Pesquisa, www.cnpq.br, Bolsa de Produtividade em Pesquisa, to LCG; 7- Instituto Nacional de Pesquisa, www.cnpq.br, Bolsa de Produtividade em Pesquisa, Saliba, to EdOSS; 8- Empresa de Pesquisa Agropecuaria do Estado de Minas Gerais (EPAMIG)- CAMPO EXPERIMENTAL DE FELIXLANDIA, to JRMR; 9. Escola de Veterinaria da Universidade Federal de Minas Gerais (UFMG); 10. BR-Nova Sistemas Nutricionais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge support provided by the Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientlfico e Tecnologico (CNPq), INCT Ciencia Animal-CNPq, Empresa de Pesquisa Agropecucaria do Estado de Minas Gerais (EPAMIG), Escola de Veterinaria da Universidade Federal de Minas Gerais (UFMG) and BR-Nova Sistemas Nutricionais.	AFRC, 1993, ENERGY PROTEIN REQUI; [Anonymous], 2006, USEPA GLOB ANTHR MON; Brouwer E., 1965, EAAP PUB, V11, P441, DOI DOI 10.4236/NS.2011.312129; Clark JH, 2007, J ANIM SCI, V85, P3383, DOI 10.2527/jas.2006-741; CSIRO, 1965, NUTR REQUIREMENTS DO; Ferreira A.L.N, 2014, THESIS; Ferrell CL, 2008, J ANIM SCI, V86, P2779, DOI [10.2527/jas.2008-0954, 10.2527/jas.20080954]; Flatt W., 1965, P 3 S EN MET, P111; Fox DG, 2004, ANIM FEED SCI TECH, V112, P29, DOI 10.1016/j.anifeedsci.2003.10.006; Gabel M, 2003, J DAIRY SCI, V86, P3992, DOI 10.3168/jds.S0022-0302(03)74010-7; HUNTINGTON GB, 1987, J NUTR, V117, P1167, DOI 10.1093/jn/117.6.1167; Jorge AM, 1999, REV BRAS ZOOTECN, V28, P374, DOI 10.1590/S1516-35981999000200022; Lage HF, 2011, THESIS; LOFGREEN GP, 1968, J ANIM SCI, V27, P793; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; NRBC, 2016, NUTR REQ BEEF CATTL; Rodriguez NM, 2007, ARQ BRAS MED VET ZOO, V59, P495, DOI 10.1590/S0102-09352007000200033; Santos SA, 2014, ARQ BRAS MED VET ZOO, V66, P827, DOI 10.1590/1678-41626201; TYRRELL HF, 1972, J DAIRY SCI, V55, P1106, DOI 10.3168/jds.S0022-0302(72)85632-7; Valadares RFD, 1999, J DAIRY SCI, V82, P2686, DOI 10.3168/jds.S0022-0302(99)75525-6; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Veras ASC, 2001, REV BRAS ZOOTECN, V30, P904, DOI 10.1590/S1516-35982001000300040; Xue B, 2011, J DAIRY SCI, V94, P1455, DOI 10.3168/jds.2010-3663	23	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202088	10.1371/journal.pone.0202088	http://dx.doi.org/10.1371/journal.pone.0202088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118491	Green Submitted, gold, Green Published			2022-12-26	WOS:000442282700013
J	Guo, GJ; Liu, YT; Ren, S; Kang, Y; Duscher, D; Machens, HG; Chen, ZB				Guo, Guojun; Liu, Yutian; Ren, Sen; Kang, Yu; Duscher, Dominik; Machens, Hans-Guenther; Chen, Zhenbing			Comprehensive analysis of differentially expressed microRNAs and mRNAs in dorsal root ganglia from streptozotocin-induced diabetic rats	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; GENE-EXPRESSION; PATHOGENESIS; BIOGENESIS; MECHANISMS; INHIBITOR; PATHWAY; NERVES; CELLS; PAIN	Diabetic peripheral neuropathy is a common complication associated with diabetes mellitus with a pathogenesis that is incompletely understood. By regulating RNA silencing and post-transcriptional gene expression, microRNAs participate in various biological processes and human diseases. However, the relationship between microRNAs and the progress of diabetic peripheral neuropathy still lacks a thorough exploration. Here we used microarray microRNA and mRNA expression profiling to analyze the microRNAs and mRNAs which are aberrantly expressed in dorsal root ganglia from streptozotocin-induced diabetic rats. We found that 37 microRNAs and 1357 mRNAs were differentially expressed in comparison to non-diabetic samples. Bioinformatics analysis indicated that 399 gene ontology terms and 29 Kyoto Encyclopedia of Genes and Genomes pathways were significantly enriched in diabetic rats. Additionally, a microRNA-gene network evaluation identified rno-miR-330-5p, rno-miR-17-1-3p and rno-miR-346 as important players for network regulation. Finally, quantitative real-time polymerase chain reaction analysis was used to confirm the microarray results. In conclusion, this study provides a systematic perspective of microRNA and mRNA expression in dorsal root ganglia from diabetic rats, and suggests that dysregulated microRNAs and mRNAs may be important promotors of peripheral neuropathy. Our results may be the underlying framework of future studies regarding the effect of the aberrantly expressed genes on the pathophysiology of diabetic peripheral neuropathy.	[Guo, Guojun; Liu, Yutian; Ren, Sen; Kang, Yu; Chen, Zhenbing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hand Surg, Wuhan, Hubei, Peoples R China; [Duscher, Dominik; Machens, Hans-Guenther] Tech Univ Munich, Dept Plast & Hand Surg, Munich, Germany	Huazhong University of Science & Technology; Technical University of Munich	Chen, ZB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hand Surg, Wuhan, Hubei, Peoples R China.	zhenbing_chen@163.com	Duscher, Dominik/AAH-5330-2020	Chen, Zhenbing/0000-0003-2828-866X	National Key Research and Development Program of China [2016YFC1101705]; National Natural Science Foundation of China [81772094, 81471270, 81271967, 30872627]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (ZC, 2016YFC1101705; http://www.most.gov.cn/), the National Natural Science Foundation of China (ZC, 81772094, 81471270, 81271967, 30872627; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Argyropoulos C, 2015, J CLIN MED, V4, P1498, DOI 10.3390/jcm4071498; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianchi R, 2012, J PHARMACOL EXP THER, V340, P64, DOI 10.1124/jpet.111.181529; Biessels GJ, 2014, J PERIPHER NERV SYST, V19, P77, DOI 10.1111/jns5.12072; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cai YF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00027; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Cha M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08208-2; Chavez JC, 2005, NEUROSCI LETT, V374, P179, DOI 10.1016/j.neulet.2004.10.050; Cheng C, 2015, J NEUROPATH EXP NEUR, V74, P804, DOI 10.1097/NEN.0000000000000219; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Fernyhough P, 2010, CELL CALCIUM, V47, P130, DOI 10.1016/j.ceca.2009.11.008; Gerlinger-Romero F, 2017, MOL CELL BIOCHEM, V427, P187, DOI 10.1007/s11010-016-2910-z; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Gong Q, 2015, BIOCHEM BIOPH RES CO, V456, P615, DOI 10.1016/j.bbrc.2014.12.004; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hagiwara SJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/173783; Hall KE, 2001, J NEUROPHYSIOL, V86, P760, DOI 10.1152/jn.2001.86.2.760; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Hao GM, 2017, J ETHNOPHARMACOL, V202, P162, DOI 10.1016/j.jep.2017.03.015; Islam MS, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/149452; Jazayeri L, 2008, PLAST RECONSTR SURG, V121, P1135, DOI 10.1097/01.prs.0000302499.18738.c2; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kanazawa Y, 2013, EXP NEUROL, V247, P438, DOI 10.1016/j.expneurol.2013.01.012; Kroin JS, 2010, REGION ANESTH PAIN M, V35, P343, DOI 10.1097/AAP.0b013e3181e82df0; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Li SS, 2015, AM J PHYSIOL-CELL PH, V308, pC139, DOI 10.1152/ajpcell.00311.2014; Malysz T, 2010, CLINICS, V65, P1329, DOI 10.1590/S1807-59322010001200017; McClelland AD, 2014, CLIN SCI, V126, P95, DOI 10.1042/CS20130079; Mohan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154055; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Athie MCP, 2018, LIFE SCI, V205, P54, DOI 10.1016/j.lfs.2018.05.016; Rahman MH, 2016, J BIOL CHEM, V291, P6011, DOI 10.1074/jbc.M115.699215; Ristoiu V, 2011, PAIN, V152, P936, DOI 10.1016/j.pain.2011.02.024; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Shi XH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-69; Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang L, 2014, NEUROSCIENCE, V259, P155, DOI 10.1016/j.neuroscience.2013.11.057; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yousefzadeh N, 2015, J PHYSIOL BIOCHEM, V71, P51, DOI 10.1007/s13105-014-0378-4; Zangiabadi N, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/976948; Zhang Y, 2015, EXP THER MED, V10, P106, DOI 10.3892/etm.2015.2468; Zochodne DW, 2007, DIABETES-METAB RES, V23, P490, DOI 10.1002/dmrr.716	47	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202696	10.1371/journal.pone.0202696	http://dx.doi.org/10.1371/journal.pone.0202696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118515	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700042
J	Santos, GM; Rowe, C; Hern, J; Walker, JE; Ali, A; Ornelaz, M; Prescott, M; Coffin, P; McFarland, W; Raymond, HF				Santos, Glenn-Milo; Rowe, Christopher; Hern, Jaclyn; Walker, John E.; Ali, Arsheen; Ornelaz, Marcia; Prescott, Maximo; Coffin, Phillip; McFarland, Willi; Raymond, H. Fisher			Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; RANDOMIZED CONTROLLED-TRIAL; SUBSTANCE USE; RISK BEHAVIOR; UNITED-STATES; HIV-INFECTION; DRUG-USE; GAY MEN; LEVEL ANALYSIS; USE DISORDERS	Objectives To describe heavy alcohol use patterns and correlates in a diverse sample of MSM. Methods We used respondent-driven sampling (RDS) to enroll 252 alcohol-using MSM in San Francisco from March 2015-July 2017. We examined heavy alcohol use patterns and conducted RDS-adjusted multivariable analyses to characterize correlates of hazardous alcohol consumption and binge drinking. Results RDS-adjusted prevalence of weekly and at least weekly binge drinking was 24.9% and 19.3%, respectively. Hazardous consumption was common; prevalence of mid- and highlevels of hazardous drinking was 11.4% and 29.9%, respectively. In multivariable analyses, identifying as Hispanic/Latino or mixed/other race; being moderately or extremely interested in reducing alcohol use; ever receiving alcohol treatment; using ecstasy; reporting syphilis diagnosis; and having more than 5 male partners were independently associated with hazardous alcohol consumption. Less hazardous consumption was associated with having a bachelor's degree or completing post-graduate studies; and not being in a relationship. Reporting chlamydia infection; being somewhat, moderately or extremely interested in reducing alcohol use; and having multiple male sex partners were associated with higher odds of at least weekly binge drinking. Lower odds of binge drinking were associated with completing post-graduate studies. Moreover, for the outcomes of hazardous alcohol consumption and binge-drinking, we observed significant interaction effects between race/ethnicity and interest in reducing alcohol, past receipt of alcohol treatment, use of ecstasy, syphilis diagnosis, and number of male partners. Conclusion Among alcohol-using MSM in San Francisco, heavy drinking patterns were common and independently associated with greater number of male sexual partners and sexually transmitted infections (STI). Moreover, significant racial/ethnic and socioeconomic disparities related to heavy alcohol use were observed and race/ethnicity modified the effect of the risk factors associated with these outcomes. These findings underscore the need to develop more MSM-specific interventions that jointly address heavy alcohol use and HIV/STI risk, as well as culturally-tailored and targeted strategies to alleviate health dispartities.	[Santos, Glenn-Milo; Rowe, Christopher; Walker, John E.; Ali, Arsheen; Ornelaz, Marcia; Prescott, Maximo; Coffin, Phillip; McFarland, Willi] San Francisco Dept Publ Hlth, Ctr Publ Hlth Res, San Francisco, CA 94102 USA; [Santos, Glenn-Milo] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Rowe, Christopher; Prescott, Maximo] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Hern, Jaclyn] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Coffin, Phillip] Univ Calif San Francisco, Div HIV ID & Global Med, San Francisco, CA 94143 USA; [McFarland, Willi] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Raymond, H. Fisher] Rutgers Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Santos, GM (corresponding author), San Francisco Dept Publ Hlth, Ctr Publ Hlth Res, San Francisco, CA 94102 USA.; Santos, GM (corresponding author), Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.	glenn-milo.santos@ucsf.edu		Santos, Glenn-Milo/0000-0003-1009-5317	National Institutes of Health, Office of the Director [DP50D019809]; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA028567, UG1DA015815] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019809] Funding Source: NIH RePORTER	National Institutes of Health, Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is funded by a grant from the National Institutes of Health, Office of the Director (grant # DP50D019809; url:https://projectreporter.nih.gov/project_info_description.cfm?aid=9142091&icde=35508575&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC&pball=). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by a grant from the National Institutes of Health, Office of the Director (grant # DP50D019809). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the participants of The SEEDS Study, for their time. Additionally, we thank our study staff for their efforts on this study (Jason Euren, Danielle Jennings, Mathew Sommers, Anna DeMartini, John Farley, Tim Matheson, Caitlin Turner, Todd Liou, John Rivie, Theresa Ick, Selvin Marroquin, and Julia Jung).	Australian Sports Commission, 2017, AUSPLAY SURV NAT DAT; Bauermeister JA, 2012, J STUD ALCOHOL DRUGS, V73, P834, DOI 10.15288/jsad.2012.73.834; Benotsch EG, 2007, J COMMUN HEALTH, V32, P343, DOI 10.1007/s10900-007-9054-8; Benotsch EG, 2006, AIDS PATIENT CARE ST, V20, P549, DOI 10.1089/apc.2006.20.549; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Brown RE, 2017, DRUG ALCOHOL DEPEN, V176, P176, DOI 10.1016/j.drugalcdep.2017.02.016; Bux DA, 1996, CLIN PSYCHOL REV, V16, P277, DOI 10.1016/0272-7358(96)00017-7; Coffin PO, 2014, AIDS BEHAV, V18, P1390, DOI 10.1007/s10461-014-0712-4; Colfax G, 2004, AM J EPIDEMIOL, V159, P1002, DOI 10.1093/aje/kwh135; Conner KR, 2009, J SUBST ABUSE TREAT, V37, P127, DOI 10.1016/j.jsat.2008.11.007; Folch C, 2010, EUR J PUBLIC HEALTH, V20, P139, DOI 10.1093/eurpub/ckp091; Forrest JI, 2016, J URBAN HEALTH, V93, P379, DOI 10.1007/s11524-016-0032-2; Fuqua V, 2012, AIDS BEHAV, V16, P256, DOI 10.1007/s10461-011-9918-x; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Grov C, 2014, J SEX RES, V51, P390, DOI 10.1080/00224499.2013.871626; Handcock MS, 2014, RDS ANALYST SOFTWARE; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hess KL, 2015, DRUG ALCOHOL DEPEN, V147, P46, DOI 10.1016/j.drugalcdep.2014.12.013; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hildebrand J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4762; Hughto JMW, 2017, AM J MENS HEALTH, V11, P726, DOI 10.1177/1557988316679563; Irwin TW, 2006, AIDS BEHAV, V10, P299, DOI 10.1007/s10461-005-9045-7; Irwin TW, 2005, J URBAN HEALTH, V82, pI127, DOI 10.1093/jurban/jti032; Jenkins RA, 2012, AIDS BEHAV, V16, P1411, DOI 10.1007/s10461-011-0037-5; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jones-Webb R, 2013, ADDICT BEHAV, V38, P1824, DOI 10.1016/j.addbeh.2012.11.011; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Kuhns LM, 2015, J URBAN HEALTH, V92, P151, DOI 10.1007/s11524-014-9897-0; Lambert G, 2011, AIDS BEHAV, V15, P584, DOI 10.1007/s10461-009-9605-3; Mackesy-Amiti ME, 2010, DRUG ALCOHOL DEPEN, V110, P38, DOI 10.1016/j.drugalcdep.2010.01.016; Martinez O, 2016, ADDICT RES THEORY, V24, P466, DOI 10.3109/16066359.2016.1167191; McCreesh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078402; McKnight-Eily LR, 2017, MMWR-MORBID MORTAL W, V66, P313, DOI 10.15585/mmwr.mm6612a1; Meiklejohn J, 2012, ALCOHOL ALCOHOLISM, V47, P606, DOI 10.1093/alcalc/ags042; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Mimiaga MJ, 2011, INT J STD AIDS, V22, P121, DOI 10.1258/ijsa.2009.009059; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P602, DOI 10.1007/s11524-009-9363-6; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nelson KM, 2011, ANN BEHAV MED, V42, P370, DOI 10.1007/s12160-011-9302-0; NYCDOHMH, 2008, ALC US RISK SEX NEW; Prestage G, 2009, SEX HEALTH, V6, P310, DOI 10.1071/SH09014; Rapues J, 2013, AM J PUBLIC HEALTH, V103, P1485, DOI 10.2105/AJPH.2012.301109; Read TRH, 2007, SEX HEALTH, V4, P35, DOI 10.1071/SH06043; Reisner SL, 2010, AIDS CARE, V22, P577, DOI 10.1080/09540120903311482; Reisner SL, 2009, J URBAN HEALTH, V86, P250, DOI 10.1007/s11524-008-9333-4; Rosser BRS, 2008, AIDS CARE, V20, P588, DOI 10.1080/09540120701867156; Rowe C, 2016, AIDS CARE, V28, P1566, DOI 10.1080/09540121.2016.1191616; San Francisco Department of Public Health, 2014, SAY TARG HAEV ALC US; Sander PM, 2013, AIDS, V27, P815, DOI 10.1097/QAD.0b013e32835cff4b; Santos GM, 2016, JAIDS-J ACQ IMM DEF, V72, P21, DOI 10.1097/QAI.0000000000000922; Santos GM, 2015, J URBAN HEALTH, V92, P687, DOI 10.1007/s11524-015-9958-z; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, P540, DOI 10.1097/QAI.0b013e318293f10b; Truong HHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070344; Vanable PA, 2004, HEALTH PSYCHOL, V23, P525, DOI 10.1037/0278-6133.23.5.525; Volz E, 2008, J OFF STAT, V24, P79; Vosburgh HW, 2012, AIDS BEHAV; Wang JC, 2005, DRUG ALCOHOL DEPEN, V78, P147, DOI 10.1016/j.drugalcdep.2004.10.011; Wang JC, 2007, ADDICT BEHAV, V32, P924, DOI 10.1016/j.addbeh.2006.06.031; Witbrodt J, 2014, ALCOHOL CLIN EXP RES, V38, P1662, DOI 10.1111/acer.12398; Woolf SE, 2009, AIDS BEHAV, V13, P757, DOI 10.1007/s10461-007-9354-0	64	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202170	10.1371/journal.pone.0202170	http://dx.doi.org/10.1371/journal.pone.0202170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR1HG	30118495	gold, Green Submitted, Green Published			2022-12-26	WOS:000442282700016
J	Valencia, LM; Martins, A; Ortiz, EM; Di Fiore, A				Valencia, Lina M.; Martins, Amely; Ortiz, Edgardo M.; Di Fiore, Anthony			A RAD-sequencing approach to genome-wide marker discovery, genotyping, and phylogenetic inference in a diverse radiation of primates	PLOS ONE			English	Article							INFERRING PHYLOGENY; DNA MARKERS; MONKEYS; EVOLUTIONARY; TREE; DIVERGENCE; CAPTURE; ROBUST; MODEL; LOCI	Until recently, most phylogenetic and population genetics studies of nonhuman primates have relied on mitochondrial DNA and/or a small number of nuclear DNA markers, which can limit our understanding of primate evolutionary and population history. Here, we describe a cost-effective reduced representation method (ddRAD-seq) for identifying and genotyping large numbers of SNP loci for taxa from across the New World monkeys, a diverse radiation of primates that shared a common ancestor similar to 20-26 mya. We also estimate, for the first time, the phylogenetic relationships among 15 of the 22 currently-recognized genera of New World monkeys using ddRAD-seq SNP data using both maximum likelihood and quartet-based coalescent methods. Our phylogenetic analyses robustly reconstructed three monophyletic clades corresponding to the three families of extant platyrrhines (Atelidae, Pitheciidae and Cebidae), with Pitheciidae as basal within the radiation. At the genus level, our results conformed well with previous phylogenetic studies and provide additional information relevant to the problematic position of the owl monkey (Aotus) within the family Cebidae, suggesting a need for further exploration of incomplete lineage sorting and other explanations for phylogenetic discordance, including introgression. Our study additionally provides one of the first applications of next-generation sequencing methods to the inference of phylogenetic history across an old, diverse radiation of mammals and highlights the broad promise and utility of ddRAD-seq data for molecular primatology.	[Valencia, Lina M.; Martins, Amely; Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Primate Mol Ecol & Evolut Lab, Austin, TX 78712 USA; [Martins, Amely] ICMBio MMA, Ctr Nacl Pesquisa Conservacao Primatas Brasileiro, Brasilia, DF, Brazil; [Ortiz, Edgardo M.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Valencia, LM (corresponding author), Univ Texas Austin, Dept Anthropol, Primate Mol Ecol & Evolut Lab, Austin, TX 78712 USA.	linavalencia@utexas.edu		Ortiz Valencia, Edgardo Manuel Martin/0000-0001-8052-1671	National Science Foundation [DDRI BCS 1650844, DDRI BCS 1540270]; Schlumberger Foundation's Faculty for the Future program; Primate Conservation, Inc.; Margot Marsh Biodiversity Foundation; American Society of Primatologists; Rufford Foundation; Primate Society of Great Britain; CNPq - Science Without Borders Program; University of Texas at Austin	National Science Foundation(National Science Foundation (NSF)); Schlumberger Foundation's Faculty for the Future program(Schlumberger); Primate Conservation, Inc.; Margot Marsh Biodiversity Foundation; American Society of Primatologists; Rufford Foundation; Primate Society of Great Britain; CNPq - Science Without Borders Program; University of Texas at Austin	Financial support for this study was generously provided by the National Science Foundation (DDRI BCS 1650844, DDRI BCS 1540270), the Schlumberger Foundation's Faculty for the Future program, Primate Conservation, Inc., the Margot Marsh Biodiversity Foundation, the American Society of Primatologists, the Rufford Foundation, the Primate Society of Great Britain, CNPq - Science Without Borders Program, and the University of Texas at Austin (to LMV and AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Andrews KR, 2014, MOL ECOL, V23, P1661, DOI 10.1111/mec.12686; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2014, P C 9 ANN GEN EN ENV; Avise John C., 1994, pi; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Bergey CM, 2013, INT J PRIMATOL, V34, P303, DOI 10.1007/s10764-013-9663-2; Blair C, 2015, MOL ECOL RESOUR, V15, P1079, DOI 10.1111/1755-0998.12376; Boubli JP, 2018, MOL PHYLOGENET EVOL, V120, P170, DOI 10.1016/j.ympev.2017.11.010; Bradley BJ, 2007, P ROY SOC B-BIOL SCI, V274, P2179, DOI 10.1098/rspb.2007.0407; Bradley BJ, 2011, EVOL ANTHROPOL, V20, P104, DOI 10.1002/evan.20306; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chifman J, 2015, J THEOR BIOL, V374, P35, DOI 10.1016/j.jtbi.2015.03.006; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Chiou K. L., 2015, BIORXIV, DOI [10.1101/032870, DOI 10.1101/032870]; Chou J, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S2; Clevenger J, 2015, MOL PLANT, V8, P831, DOI 10.1016/j.molp.2015.02.002; Combosch DJ, 2015, MOL PHYLOGENET EVOL, V88, P154, DOI 10.1016/j.ympev.2015.03.022; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Di Fiore A, 2003, YEARB PHYS ANTHROPOL, V46, P62, DOI 10.1002/ajpa.10382; Di Fiore A, 2015, MOL PHYLOGENET EVOL, V82, P495, DOI 10.1016/j.ympev.2014.03.028; DiFiore A, 2011, PRIMATES PERSPECTIVE, P369; Dos Reis M, 2018, SYST BIOL, V67, P594, DOI 10.1093/sysbio/syy001; Eaton D.A.R., 2016, IPYRAD INTERACTIVE A; Eaton DAR, 2017, SYST BIOL, V66, P399, DOI 10.1093/sysbio/syw092; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Franchini P, 2014, MOL ECOL, V23, P1828, DOI 10.1111/mec.12590; Fumagalli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079667; GARBER PA, 1993, AM J PRIMATOL, V29, P235, DOI 10.1002/ajp.1350290402; Garbino GST, 2018, MOL PHYLOGENET EVOL, V118, P156, DOI 10.1016/j.ympev.2017.10.002; Greminger MP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-16; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hipp AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093975; Hoban S, 2016, AM NAT, V188, P379, DOI 10.1086/688018; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Perez SI, 2012, MOL PHYLOGENET EVOL, V65, P621, DOI 10.1016/j.ympev.2012.07.014; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Karesh WB, 1998, AM J PRIMATOL, V44, P107, DOI 10.1002/(SICI)1098-2345(1998)44:2&lt;107::AID-AJP2&gt;3.0.CO;2-#; Keller I, 2013, MOL ECOL, V22, P2848, DOI 10.1111/mec.12083; Kiesling NMJ, 2015, MOL PHYLOGENET EVOL, V82, P386, DOI 10.1016/j.ympev.2014.03.027; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Kreeger T., 1999, HDB CHEM WILDLIFE IM; LAKE JA, 1987, MOL BIOL EVOL, V4, P167; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leache AD, 2015, GENOME BIOL EVOL, V7, P706, DOI 10.1093/gbe/evv026; Lepais O, 2014, MOL ECOL RESOUR, V14, P1314, DOI 10.1111/1755-0998.12273; Lerner HRL, 2010, AUK, V127, P4, DOI 10.1525/auk.2010.127.1.4; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lima MGM, 2017, J BIOGEOGR, V44, P810, DOI 10.1111/jbi.12945; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Malukiewicz J, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22587; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Martin M., 2010, EMBNET J, P5, DOI 0.14806/ej.17.1.200; McCluskey BM, 2015, MOL BIOL EVOL, V32, P635, DOI 10.1093/molbev/msu325; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Osterholz M, 2009, MOL PHYLOGENET EVOL, V50, P507, DOI 10.1016/j.ympev.2008.12.014; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Perry GH, 2014, INT J PRIMATOL, V35, P55, DOI 10.1007/s10764-013-9702-z; Perry GH, 2010, MOL ECOL, V19, P5332, DOI 10.1111/j.1365-294X.2010.04888.x; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275; Reitzel AM, 2013, MOL ECOL, V22, P2953, DOI 10.1111/mec.12228; Renaud G, 2015, BIOINFORMATICS, V31, P770, DOI 10.1093/bioinformatics/btu719; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rosenberger AL, 2013, CAM S BIO EVOL ANTHR, V65, P13; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; SAVAGE A, 1993, AM J PRIMATOL, V31, P189, DOI 10.1002/ajp.1350310304; Schneider H, 2001, CHROMOSOMA, V109, P515, DOI 10.1007/s004120000106; Schneider H, 2015, MOL PHYLOGENET EVOL, V82, P348, DOI 10.1016/j.ympev.2013.10.017; Schwartz MK, 2010, LANDSCAPE GENOMICS B; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Snyder-Mackler N, 2016, GENETICS, V203, P699, DOI 10.1534/genetics.116.187492; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Takahashi T, 2014, MOL PHYLOGENET EVOL, V80, P137, DOI 10.1016/j.ympev.2014.07.016; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Ting N, 2013, MOL PHYLOGENET EVOL, V66, P565, DOI 10.1016/j.ympev.2012.08.021; Vigilant L, 2009, PRIMATES, V50, P105, DOI 10.1007/s10329-008-0124-z; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang XQ, 2013, MOL ECOL RESOUR, V13, P938, DOI 10.1111/1755-0998.12136; Watsa Mrinalini, 2015, Neotropical Primates, V22, P59; Wessinger CA, 2016, AM J BOT, V103, P912, DOI 10.3732/ajb.1500519; Wildman DE, 2009, MOL PHYLOGENET EVOL, V53, P694, DOI 10.1016/j.ympev.2009.07.019; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yoshizawa M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0119-3	120	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0201254	10.1371/journal.pone.0201254	http://dx.doi.org/10.1371/journal.pone.0201254			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118481	Green Submitted, Green Published, gold			2022-12-26	WOS:000442282700007
J	Horokhovatskyi, Y; Dietrich, MA; Lebeda, I; Fedorov, P; Rodina, M; Dzyuba, B				Horokhovatskyi, Yevhen; Dietrich, Mariola A.; Lebeda, Ievgen; Fedorov, Pavlo; Rodina, Marek; Dzyuba, Borys			Cryopreservation effects on a viable sperm sterlet (Acipenser ruthenus) subpopulation obtained by a Percoll density gradient method	PLOS ONE			English	Article							FERTILIZING ABILITY; MOTILITY PARAMETERS; MEMBRANE INTEGRITY; LIPID-COMPOSITION; CARP SPERMATOZOA; DNA-DAMAGE; BULL SPERM; SEMEN; SEPARATION; PROTEINS	In many fish species, sperm cryopreservation has deleterious effects and leads to a significant decrease in spermatozoa viability. However, the effect of cryopreservation on sperm cells that survive this process and are still viable is not fully understood. The objective of this study was to compare the viability and proteomes of fresh and cryopreserved sterlet (Acipenser ruthenus) sperm samples before and after live-dead cell separation using Percoll density gradient centrifugation. Both fresh and cryopreserved sperm samples were divided into two groups (with or without application of Percoll separation). At each step of the experiment, sperm quality was evaluated by video microscopy combined with integrated computer-assisted sperm analysis software and flow cytometry for live-dead sperm viability analysis. Sperm motility and the percentage of live cells were reduced in the cryopreserved group compared to the fresh group from 89% to 33% for percentage of motility and from 96% to 70% for live cells. Straight line velocity and linearity of track were significantly lower in cryopreserved samples than in those separated by Percoll before and after cryopreservation. However, the percentages of motile and live spermatozoa were higher than 90% in samples subjected to Percoll separation. Proteomic analysis of spermatozoa by two-dimensional differences in-gel electrophoresis coupled with matrix-assisted laser-desorption/ionization time-of-flight/time-of-flight mass spectrometry revealed that 20 protein spot abundances underwent significant changes in cryopreserved samples compared to fresh ones. However, only one protein spot was significantly altered when samples before and after cryopreservation followed by Percoll separation were compared. Thus, the results of this study show that cryopreservation leads to minimal proteomic changes in the spermatozoa population, retaining high motility and viability parameters. The results also suggest that global differences in protein profiles between unselected fresh and cryopreserved samples are mainly due to protein loss or changes in the lethal and sublethal damaged cell subpopulations.	[Horokhovatskyi, Yevhen; Lebeda, Ievgen; Fedorov, Pavlo; Rodina, Marek; Dzyuba, Borys] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, Vodnany, Czech Republic; [Dietrich, Mariola A.] Polish Acad Sci, Inst Anim Reprod & Food Res, Dept Gametes & Embryo Biol, Olsztyn, Poland	University of South Bohemia Ceske Budejovice; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Horokhovatskyi, Y (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, Vodnany, Czech Republic.	horokhovatskyi@gmail.com	Dzyuba, Borys B/F-8997-2015; DIETRICH, Mariola A./K-1731-2013	Dzyuba, Borys B/0000-0003-2083-3010; DIETRICH, Mariola A./0000-0002-2525-0941	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/01.0024, LO1205, CZ.02.1.01./0.0/0.0/16_025/0007370]; Grant Agency of the University of South Bohemia in Ceske Budejovice [059/2016/Z]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the University of South Bohemia in Ceske Budejovice	The study was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic - projects "CENAKVA" (no. CZ.1.05/2.1.00/01.0024) and "CENAKVA II" (no. LO1205 under the NPU I program) and CZ.02.1.01./0.0/0.0/16_025/0007370 Reproductive and genetic procedures for preserving fish biodiversity and aquaculture and by the Grant Agency of the University of South Bohemia in Ceske Budejovice (no. 059/2016/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, AQUACULTURE, V211, P367, DOI [10.1016/S0044-8486(02)00003-0, DOI 10.1016/S0044-8486(02)00003-0]; [Anonymous], 2014, MED SURG MANAG MALE; [Anonymous], 2001, LIV DEAD SPERM VIAB; Ardon F, 2013, REPRODUCTION, V146, P111, DOI 10.1530/REP-12-0468; Asturiano JF, 2007, REPROD DOMEST ANIM, V42, P162, DOI 10.1111/j.1439-0531.2006.00746.x; Billard R, 2004, AQUACULTURE, V236, P1, DOI 10.1016/j.aquaculture.2003.10.029; Boryshpolets S, 2011, J APPL ICHTHYOL, V27, P1147, DOI 10.1111/j.1439-0426.2011.01866.x; Bronzi P, 2011, J APPL ICHTHYOL, V27, P169, DOI 10.1111/j.1439-0426.2011.01757.x; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Cabrita E, 2014, AQUACULTURE, V432, P389, DOI 10.1016/j.aquaculture.2014.04.034; Cabrita E, 2010, J APPL ICHTHYOL, V26, P623, DOI 10.1111/j.1439-0426.2010.01556.x; Cosson J, 2004, AQUACULT INT, V12, P69, DOI 10.1023/B:AQUI.0000017189.44263.bc; Cosson J, 2000, J FISH BIOL, V56, P1348, DOI 10.1111/j.1095-8649.2000.tb02148.x; Dietrich MA, 2017, J PROTEOMICS, V162, P52, DOI 10.1016/j.jprot.2017.04.015; Dietrich MA, 2016, J PROTEOMICS, V138, P124, DOI 10.1016/j.jprot.2016.02.029; Dietrich MA, 2014, COMP BIOCHEM PHYS D, V12, P10, DOI 10.1016/j.cbd.2014.09.003; DROBNIS EZ, 1991, J ANDROL, V12, P201; Dzyuba B, 2014, REPROD BIOL, V14, P160, DOI 10.1016/j.repbio.2014.01.003; Dzyuba B, 2012, AQUACULTURE, V356, P272, DOI 10.1016/j.aquaculture.2012.05.006; Arias ME, 2017, REPROD BIOL, V17, P126, DOI 10.1016/j.repbio.2017.03.002; Fleming S, 2012, PRACTICAL MANUAL VIT, P259; Galich, 2013, STURGEON HATCHERY MA; Gallis J.L., 1991, ACIPENSER, P143; Glogowski J, 2002, AQUACULTURE, V211, P367, DOI 10.1016/S0044-8486(02)00003-0; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4; Horokhovatskyi Y, 2016, CRYOBIOLOGY, V73, P282, DOI 10.1016/j.cryobiol.2016.08.005; Horokhovatskyi Y, 2017, THERIOGENOLOGY, V95, P89, DOI 10.1016/j.theriogenology.2017.03.007; Huang SY, 1999, THERIOGENOLOGY, V51, P1007, DOI 10.1016/S0093-691X(99)00046-1; Ilaria N., 2011, ARTIFICIAL INSEMINAT, P115; Jerrold HZ, 2014, BIOSTATISTICAL ANAL; Judycka S, 2015, CRYOBIOLOGY, V70, P184, DOI 10.1016/j.cryobiol.2015.02.005; Kopeika Eugeny, 2007, Methods Mol Biol, V368, P203; Lessard C, 2000, J ANDROL, V21, P700; Li P, 2010, THERIOGENOLOGY, V74, P413, DOI 10.1016/j.theriogenology.2010.02.024; Li P, 2010, THERIOGENOLOGY, V74, P1356, DOI 10.1016/j.theriogenology.2010.06.005; Martinez-Paramo S, 2012, ANIM REPROD SCI, V131, P211, DOI 10.1016/j.anireprosci.2012.03.008; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; MORTIMER D, 1982, J REPROD FERTIL, V64, P401; Muller K, 2008, BIOL REPROD, V78, P390, DOI 10.1095/biolreprod.107.064253; Nynca J, 2014, AQUACULTURE, V433, P62, DOI 10.1016/j.aquaculture.2014.05.037; Ollero M, 1998, THERIOGENOLOGY, V49, P547, DOI 10.1016/S0093-691X(98)00006-5; Ozkavukcu S, 2008, J ASSIST REPROD GEN, V25, P403, DOI 10.1007/s10815-008-9232-3; PoeZeigler R, 1997, J ASSIST REPROD GEN, V14, P277, DOI 10.1007/BF02765829; Seki S, 2008, CRYOBIOLOGY, V56, P171, DOI 10.1016/j.cryobiol.2008.02.001; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Valcarce DG, 2016, THERIOGENOLOGY, V86, P1195, DOI 10.1016/j.theriogenology.2016.04.010; Westfalewicz B, 2015, J ANIM SCI, V93, P5240, DOI 10.2527/jas.2015-9237; Zilli L, 2003, CRYOBIOLOGY, V47, P227, DOI 10.1016/j.cryobiol.2003.10.002	50	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202514	10.1371/journal.pone.0202514	http://dx.doi.org/10.1371/journal.pone.0202514			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114243	gold, Green Published			2022-12-26	WOS:000441850400082
J	Smits, KPJ; Sidorenkov, G; Kleefstra, N; Hendriks, SH; Bouma, M; Meulepas, M; Navis, G; Bilo, HJG; Denig, P				Smits, Kirsten P. J.; Sidorenkov, Grigory; Kleefstra, Nanne; Hendriks, Steven H.; Bouma, Margriet; Meulepas, Marianne; Navis, Gerjan; Bilo, Henk J. G.; Denig, Petra			Is guideline-adherent prescribing associated with quality of life in patients with type 2 diabetes?	PLOS ONE			English	Article							MEDICATION; SATISFACTION; COMPLEXITY; EQ-5D	Background Guideline-adherent prescribing for treatment of multiple risk factors in type 2 diabetes (T2D) patients is expected to improve clinical outcomes. However, the relationship to Health-Related Quality of Life (HRQoL) is not straightforward since guideline-adherent prescribing can increase medication burden. Objectives To test whether guideline-adherent prescribing and disease-specific medication burden are associated with HRQoL in patients with T2D. Methods Cross-sectional study including 1,044 T2D patients from the e-VitaDM/ZODIAC study in 2012 in the Netherlands. Data from the diabetes visit, such as laboratory and physical examinations and prescribed medication, and from two HRQoL questionnaires, the EuroQol 5 Dimensions 3 Levels (EQ5D-3L) and the World Health Organization Well-Being Index (WHO-5) were collected. Twenty indicators assessing prescribing of recommended glucose lowering drugs, statins, antihypertensives and renin-angiotensin-aldosterone system (RAAS)-inhibitors and potentially inappropriate drugs from a validated diabetes indicator set were included. Disease-specific medication burden was assessed using a modified version of the Medication Regimen Complexity Index (MRCI). Associations were tested with regression models, adjusting for age, gender, diabetes duration, comorbidity, body mass index and smoking. Results The mean MRCI was 7.1, the median EQ5D-3L-score was 0.86 and the mean WHO-5 score was 72. Seven indicators included too few patients and were excluded from the analysis. The remaining thirteen indicators focusing on recommended start, intensification, current and preferred use of glucose lowering drugs, statins, antihypertensives, RAAS inhibitors, and on inappropriate prescribing of glibenclamide and dual RAAS blockade were not significantly associated with HRQoL. Finally, also the MRCI was not associated with HRQoL. Conclusions We found no evidence for associations between guideline-adherent prescribing or disease-specific medication burden and HRQoL in T2D patients. This gives no rise to refrain from prescribing intensive treatment in T2D patients as recommended, but the interpretation of these results is limited by the cross-sectional study design and the selection of patients included in some indicators.	[Smits, Kirsten P. J.; Sidorenkov, Grigory; Denig, Petra] Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands; [Kleefstra, Nanne] Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Hendriks, Steven H.; Bilo, Henk J. G.] Diabet Ctr, Isala Clin, Zwolle, Netherlands; [Bouma, Margriet] Dutch Coll Gen Practitioners NHG, Utrecht, Netherlands; [Meulepas, Marianne] Dutch Inst Rat Use Med IVM, Utrecht, Netherlands; [Navis, Gerjan] Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Groningen; Langerhans Medical Research Group; University of Groningen; Isala Clinics; University of Groningen	Smits, KPJ (corresponding author), Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	kirsten.smits@radboudumc.nl	Smits, Kirsten PJ/Q-6400-2017; Denig, Petra/L-9865-2014	Smits, Kirsten PJ/0000-0003-4327-1997; Sidorenkov, Grigory/0000-0002-1926-8862; Kleefstra, Nanne/0000-0003-1473-8519; Denig, Petra/0000-0002-7929-4739	ZonMW - The Netherlands Organisation for Health Research and Development [836021007]	ZonMW - The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study was funded by ZonMW - The Netherlands Organisation for Health Research and Development with grant number 836021007 (https://www.zonmw.nl/nl/onderzoek-resultaten/geneesmiddelen/programmas/project-detail/goed-gebruik-geneesmiddelen/quality-of-prescribing-patient-specific-indicators-that-predict-better-outcomes-in-diabetes-patient/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been funded by ZonMw-The Netherlands Organisation for Health Research and Development with grant number 836021007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; Black JA, 2015, DIABETES RES CLIN PR, V109, P170, DOI 10.1016/j.diabres.2015.04.013; Chiu YW, 2009, CLIN J AM SOC NEPHRO, V4, P1089, DOI 10.2215/CJN.00290109; de Vries ST, 2014, J PSYCHOSOM RES, V76, P134, DOI 10.1016/j.jpsychores.2013.11.003; Frohlich SE, 2010, PHARM WORLD SCI, V32, P744, DOI 10.1007/s11096-010-9431-8; George J, 2004, ANN PHARMACOTHER, V38, P1369, DOI 10.1345/aph.1D479; Hendriks SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145907; Jahangiry L, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2016.35; Johnell K, 2007, DRUG SAFETY, V30, P911, DOI 10.2165/00002018-200730100-00009; Juola AL, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.12.011; Krska J, 2013, INT J CLIN PHARM-NET, V35, P1161, DOI 10.1007/s11096-013-9841-5; Kueh YC, 2017, PSYCHOL HEALTH MED, V22, P138, DOI 10.1080/13548506.2016.1147055; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Li CY, 2007, DIABETES CARE, V30, P1770, DOI 10.2337/dc06-2571; Meid AD, 2016, EUR J CLIN PHARMACOL, V72, P877, DOI 10.1007/s00228-016-2047-8; Menard J, 2007, DIABETES METAB, V33, P54, DOI 10.1016/j.diabet.2006.09.001; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Roelofsen Y, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-22; Rutten G.E.H.M., 2013, HUISARTS WETENSCHAP, V56, P512; Scheifes A, 2016, RES DEV DISABIL, V49-50, P13, DOI 10.1016/j.ridd.2015.11.017; Schunk M, 2015, J DIABETES COMPLICAT, V29, P203, DOI 10.1016/j.jdiacomp.2014.11.010; Sidorenkov G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078821; Smits KPJ, 2017, DIABETES CARE, V40, pE83, DOI 10.2337/dc17-0236; Smits KPJ, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12922; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Venskutonyte L, 2013, DIABETES VASC DIS RE, V10, P263, DOI 10.1177/1479164112463711; Wadden TA, 2014, DIABETES CARE, V37, P1544, DOI 10.2337/dc13-1928; Wasem J, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-47	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202319	10.1371/journal.pone.0202319	http://dx.doi.org/10.1371/journal.pone.0202319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114242	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400057
J	Kang, SJ; Kim, HJ; Kim, D; Ahmed, A				Kang, Seung Joo; Kim, Hwa Jung; Kim, Donghee; Ahmed, Aijaz			Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States	PLOS ONE			English	Article							EXTRAGASTRIC MANIFESTATIONS; INSULIN-RESISTANCE; TNF-ALPHA; INFECTION; SEROPREVALENCE; SEROPOSITIVITY; PATHOGENESIS; GASTRITIS; PROTEIN; RISK	We investigated the relationship of H. pylori stratified by cytotoxin-associated gene A (cagA) status with nonalcoholic fatty liver disease (NAFLD) in the general population of the United States (US). We utilized the Third National Health and Nutrition Examination Survey from 1988 to 1994 in this study. NAFLD was defined by ultrasonographic detection of hepatic steatosis in the absence of other known causes of liver diseases and significant alcohol consumption. Hepatic steatosis was assessed by parenchymal brightness, liver to kidney contrast, deep beam attenuation, bright vessel walls and gallbladder wall definition. Antibodies to H. pylori and cagA of participants were measured using H. pylori IgG and anti-cagA IgG enzyme-linked immunosorbent assays. Among 5,404 participants, the prevalence of NAFLD was higher in H. pylori positive subjects (33.5 +/- 1.8%) compared to H. pylori negative subjects (26.1 +/- 1.7%, p <0.001). In terms of cagA protein status stratification, while cagA positive H. pylori group did not demonstrate an association with NAFLD (OR: 1.05; 95% CI: 0.81-1.37), cagA negative H. pylori group was noted to have a significant association with NAFLD in a multivariable analysis (OR: 1.30; 95% CI: 1.01-1.67). In conclusion, our study demonstrated that cagA negative H. pylori infection was an independent predictor of NAFLD in the US general population.	[Kang, Seung Joo] Seoul Natl Univ, Hosp Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Dept Internal Med, Seoul, South Korea; [Kim, Hwa Jung] Univ Ulsan, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Coll Med, Seoul, South Korea; [Kim, Donghee; Ahmed, Aijaz] Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, Stanford, CA 94305 USA	Seoul National University (SNU); University of Ulsan; Asan Medical Center; Stanford University	Kim, D (corresponding author), Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, Stanford, CA 94305 USA.	messmd@chol.com	Kim, Donghee/C-4288-2013	Kim, Donghee/0000-0003-1919-6800				Ando T, 2013, HELICOBACTER, V18, P158, DOI 10.1111/hel.12028; Aydemir S, 2005, DIGEST DIS SCI, V50, P2090, DOI 10.1007/s10620-005-3012-z; Baeg MK, 2016, WORLD J GASTROENTERO, V22, P2592, DOI 10.3748/wjg.v22.i8.2592; Basso D, 2010, HELICOBACTER, V15, P14, DOI 10.1111/j.1523-5378.2010.00781.x; BLASER MJ, 1995, CANCER RES, V55, P2111; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen Y, 2013, GUT, V62, P1262, DOI 10.1136/gutjnl-2012-303018; Cho IS, 2005, AM J EPIDEMIOL, V162, P579, DOI 10.1093/aje/kwi237; Choi Su-Yeon, 2008, Korean J Hepatol, V14, P77, DOI 10.3350/kjhep.2008.14.1.77; Chung GE, 2012, J HEPATOL, V57, P150, DOI 10.1016/j.jhep.2012.02.027; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Dogan Z, 2013, EUR J GASTROEN HEPAT, V25, P107, DOI 10.1097/MEG.0b013e3283590c10; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Fan NG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00073; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Figura N, 2010, HELICOBACTER, V15, P60, DOI 10.1111/j.1523-5378.2010.00778.x; Fox JG, 2010, GUT, V59, P88, DOI 10.1136/gut.2009.183749; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Grad YH, 2012, AM J EPIDEMIOL, V175, P54, DOI 10.1093/aje/kwr288; Gunji T, 2008, AM J GASTROENTEROL, V103, P3005, DOI 10.1111/j.1572-0241.2008.02151.x; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; INGRAM DD, 1994, VITAL HLTH STAT 2, V121, P1; Jamali R, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.14679; KASL, 2013, CLIN MOL HEPATOL, V19, P325, DOI 10.3350/cmh.2013.19.4.325; Kido M, 2011, BIOCHEM BIOPH RES CO, V412, P266, DOI 10.1016/j.bbrc.2011.07.081; Kim D, 2018, LIVER INT, V38, P1839, DOI 10.1111/liv.13886; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Li M, 2013, WORLD J GASTROENTERO, V19, P7024, DOI 10.3748/wjg.v19.i41.7024; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Murphy G, 2014, HEPATOLOGY, V60, P1963, DOI 10.1002/hep.27193; NCHS, NHANES 3 HEP STEAT U; Okushin K, 2015, BMC GASTROENTEROL, P15, DOI [10.1186/s12876-015-0244-z, DOI 10.1186/S12876-015-0244-Z]; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Park HE, 2016, J CLIN ENDOCR METAB, V101, P3134, DOI 10.1210/jc.2016-1525; Park MJ, 2011, GUT LIVER, V5, P321, DOI 10.5009/gnl.2011.5.3.321; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Schottker B, 2012, ATHEROSCLEROSIS, V220, P569, DOI 10.1016/j.atherosclerosis.2011.11.029; Stein M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00328; Suzuki H, 2011, HELICOBACTER, V16, P65, DOI 10.1111/j.1523-5378.2011.00883.x; Swiderska M, 2017, CLIN EXP HEPATOL, V3, P127, DOI 10.5114/ceh.2017.68466; Wijarnpreecha K, 2018, J CLIN GASTROENTEROL, V52, P386, DOI 10.1097/MCG.0000000000000784	45	18	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202325	10.1371/journal.pone.0202325	http://dx.doi.org/10.1371/journal.pone.0202325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110395	Green Submitted, gold, Green Published			2022-12-26	WOS:000441738000063
J	Smedegaard, L; Kragholm, K; Nume, AK; Charlot, MG; Gislason, GH; Hansen, PR				Smedegaard, Laerke; Kragholm, Kristian; Nume, Anna-Karin; Charlot, Mette Gitz; Gislason, Gunnar Hilmar; Hansen, Peter Riis			Nursing home admission after myocardial infarction in the elderly: A nationwide cohort study	PLOS ONE			English	Article							OUTCOMES; DISABILITY; MORTALITY; TRENDS; RISK; HOSPITALIZATION; INDEPENDENCE; REGISTERS; DISEASE; HEALTH	Background Data on nursing home admission after myocardial infarction (MI) in the elderly are scarce. We investigated nursing home admission within 6 months and 2 years after MI including predictors for nursing home admission in a nationwide cohort of elderly patients. Methods Using Danish nationwide registries, we identified all subjects 65 years or older residing at home who were discharged following first-time MI in the period 2008-2015. We determined sex- and age-stratified incidence rates per 1000 person years (IRs) and incidence rate ratios (IRRs) of nursing home admissions using Poisson regression models compared to the Danish population 65 years or older with no prior MI. Poisson regression models were also applied to identify predictors of nursing home admission. Results The 26,539 patients who were discharged after MI had a median age of 76 (quartile 1-quartile 3: 70-83) years. The IRs of nursing home admission after MI increased with increasing age and for 80-84-year-old women IRs after 6 months and 2 years were 113.9 and 62.9, respectively, compared to 29.4 for women of the same age with no prior MI. The IRs for 8084-year-old men after MI were 56.0 and 36.2, respectively, compared to 24.3 for men of the same age with no prior MI. In adjusted analyses the 6 months and 2 years IRRs for 80-84-year-old subjects were 2.56 (95% CI 2.11-3.10) and 1.41 (95% CI 1.22-1.65) for women and 1.74 (95% CI 1.34-2.25) and 1.05 (95% CI 0.88-1.26) for men, respectively. Predictors were advanced age, dementia, home care, Parkinson's disease, cerebrovascular disease, living alone, depression, and arrhythmia. Conclusion In elderly patients discharged following first-time MI, the risk of subsequent nursing home admission within 6 months was 2-fold higher compared to an age-stratified population with no prior MI. After 2 years this risk remained higher in women.	[Smedegaard, Laerke; Nume, Anna-Karin; Charlot, Mette Gitz; Gislason, Gunnar Hilmar; Hansen, Peter Riis] Herlev & Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Kragholm, Kristian] Aalborg Univ Hosp, Dept Clin Epidemiol & Biostat, Aalborg, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Inst Publ Hlth, Copenhagen, Denmark; [Gislason, Gunnar Hilmar; Hansen, Peter Riis] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Danish Heart Fdn, Copenhagen, Denmark; [Smedegaard, Laerke] Herlev & Gentofte Univ Hosp, Dept Cardiol, Kildegaardsvej 28,Entrance 8, Hellerup, Denmark	Aalborg University; Aalborg University Hospital; University of Southern Denmark; University of Copenhagen	Smedegaard, L (corresponding author), Herlev & Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.; Smedegaard, L (corresponding author), Herlev & Gentofte Univ Hosp, Dept Cardiol, Kildegaardsvej 28,Entrance 8, Hellerup, Denmark.	LaerkeSmedegaard@gmail.com	Gislason, Gunnar/B-7561-2009; Hansen, Peter Riis/AAR-7659-2020	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X; Smedegaard, Laerke/0000-0003-0493-4671; Kragholm, Kristian/0000-0001-9629-8670	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research (EDITORS: Eastern Denmark Initiative to Improve Revascularisation Strategies) [09-066994]	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research (EDITORS: Eastern Denmark Initiative to Improve Revascularisation Strategies)	This work was supported by the Danish Agency for Science, Technology and Innovation and by the Danish Council for Strategic Research (EDITORS: Eastern Denmark Initiative to Improve Revascularisation Strategies, grant 09-066994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2007, AM J GERIATR CARDIOL, V16, P76, DOI 10.1111/j.1076-7460.2007.05519.x; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Arnold SV, 2009, J AM GERIATR SOC, V57, P209, DOI 10.1111/j.1532-5415.2008.02106.x; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Banaszak-Holl J, 2004, ALZ DIS ASSOC DIS, V18, P83, DOI 10.1097/01.wad.0000126619.80941.91; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Danmarks Statistik, AFV PLEJ FORTS; Danmarks Statistik, AELDR IMP PLEJ; Danmarks Statistik, 2012, PLEJ AELDR 2012; de Leon CFM, 2005, ARCH INTERN MED, V165, P763, DOI 10.1001/archinte.165.7.763; de Meijer CAM, 2009, MED CARE, V47, P1156, DOI 10.1097/MLR.0b013e3181b69fa8; Dodson JA, 2012, AM HEART J, V163, P790, DOI 10.1016/j.ahj.2012.02.024; Floyd KC, 2009, CIRC-CARDIOVASC QUAL, V2, P88, DOI 10.1161/CIRCOUTCOMES.108.811828; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Goodwin JE, 2011, J HYPERTENS, V29, P1347, DOI [10.1093/gerona/glr171, 10.1097/HJH.0b013e328347da54]; Guzman-Castillo M, 2017, LANCET PUBLIC HEALTH, V2, pE307, DOI 10.1016/S2468-2667(17)30091-9; Khera S, 2014, J AM MED DIR ASSOC, V15, P593, DOI 10.1016/j.jamda.2014.04.017; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kucharska-Newton A, 2017, J AM HEART ASS, V6; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301; Motivala AA, 2011, J AM COLL CARDIOL, V58, P1760, DOI 10.1016/j.jacc.2011.06.050; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Quan Hude, 2004, Home Health Care Serv Q, V23, P43, DOI 10.1300/J027v23n01_03; Quine S, 2007, HEALTH SOC CARE COMM, V15, P212, DOI 10.1111/j.1365-2524.2006.00675.x; Quinones Philip Andrew, 2014, BMC Geriatr, V14, P34, DOI 10.1186/1471-2318-14-34; Rapp K, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.05.013; Schoenenberger AW, 2016, EUR HEART J, V37, P1304, DOI 10.1093/eurheartj/ehv698; Smedegaard L, 2017, EUR HEART J CARDIOVA; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Van Rensbergen G, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-46; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202177	10.1371/journal.pone.0202177	http://dx.doi.org/10.1371/journal.pone.0202177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ5PD	30110366	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000054
J	Furuuchi, R; Shimizu, I; Yoshida, Y; Hayashi, Y; Ikegami, R; Suda, M; Katsuumi, G; Wakasugi, T; Nakao, M; Minamino, T				Furuuchi, Ryo; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Suda, Masayoshi; Katsuumi, Goro; Wakasugi, Takayuki; Nakao, Masaaki; Minamino, Tohru			Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; CELL SENESCENCE; BLOOD-PRESSURE; TNF-ALPHA; ANTHOCYANINS; CYANIDIN-3-O-GLUCOSIDE; RISK; CONSUMPTION	Endothelial cells have an important role in maintaining vascular homeostasis. Age-related disorders (including obesity, diabetes, and hypertension) or aging per se induce endothelial dysfunction that predisposes to the development of atherosclerosis. Polyphenols have been reported to suppress age-related endothelial cell disorders, but their role in vascular function is yet to be determined. We investigated the influence of boysenberry polyphenol on vascular health under metabolic stress in a murine model of dietary obesity. We found that administration of boysenberry polyphenol suppressed production of reactive oxygen species (ROS) and increased production of nitric oxide (NO) in the aorta. It has been reported that p53 induces cellular senescence and has a crucial role in age-related disorders, including heart failure and diabetes. Administration of boysenberry polyphenol significantly reduced the endothelial p53 level in the aorta and ameliorated endothelial cell dysfunction in iliac arteries under metabolic stress. Boysenberry polyphenol also reduced ROS and p53 levels in cultured human umbilical vein endothelial cells (HUVECs), while increasing NO production. Uncoupled endothelial nitric oxide synthase (eNOS monomer) is known to promote ROS production. We found that boysenberry polyphenol reduced eNOS monomer levels both in vivo and in vitro, along with an increase of eNOS dimerization. To investigate the components of boysenberry polyphenol mediating these favorable biological effects, we extracted the anthocyanin fractions. We found that anthocyanins contributed to suppression of ROS and p53, in association with increased NO production and eNOS dimerization. In an ex vivo study, anthocyanins promoted relaxation of iliac arteries from mice with dietary obesity. These findings indicate that boysenberry polyphenol and anthocyanins, a major component of this polyphenol, inhibit endothelial dysfunction and contribute to maintenance of vascular homeostasis.	[Furuuchi, Ryo; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Suda, Masayoshi; Katsuumi, Goro; Wakasugi, Takayuki; Nakao, Masaaki; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Furuuchi, Ryo] Bourbon Corp, Niigata, Japan; [Shimizu, Ippei; Yoshida, Yohko] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata, Japan	Niigata University; Niigata University	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	tminamino@med.niigata-u.ac.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Shimizu, Ippei/0000-0003-3333-8131	Bourbon; Ministry of Education, Culture, Sports, Science and Technology [17H04172, 266115008, 15K15306]	Bourbon; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from Bourbon (to R.F., I.S., Y.Y. and T.M.), grants 17H04172, 266115008, and 15K15306 from Ministry of Education, Culture, Sports, Science and Technology (to T. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt SR, 2011, EUR J PHARMACOL, V667, P258, DOI 10.1016/j.ejphar.2011.05.026; Braunlich M, 2013, NUTRIENTS, V5, P663, DOI 10.3390/nu5030663; Brodsky SV, 2004, CIRC RES, V94, P377, DOI 10.1161/01.RES.0000111802.09964.EF; Cassidy A, 2018, MOL ASPECTS MED, V61, P76, DOI 10.1016/j.mam.2017.05.002; Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408; Cheang WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10340; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Fairlie-Jones L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080908; Fratantonio D, 2015, TOXICOL LETT, V239, P152, DOI 10.1016/j.toxlet.2015.09.020; Fratantonio D, 2017, BBA-MOL CELL BIOL L, V1862, P351, DOI 10.1016/j.bbalip.2016.12.008; Furuuchi R, 2011, J AGR FOOD CHEM, V59, P3738, DOI 10.1021/jf104976n; Ghebre Yohannes T, 2016, Transl Med (Sunnyvale), V6, DOI 10.4172/2161-1025.1000183; Gogiraju R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001770; Han KH, 2006, BRIT J NUTR, V96, P1125, DOI 10.1017/BJN20061928; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23625; Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779; Kool MM, 2010, FOOD CHEM, V119, P1535, DOI 10.1016/j.foodchem.2009.09.039; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Liobikas J, 2016, PHARMACOL RES, V113, P808, DOI 10.1016/j.phrs.2016.03.036; Liu W, 2013, INT J MOL SCI, V14, P21447, DOI 10.3390/ijms141121447; Liu Y, 2014, AM J PHYSIOL-ENDOC M, V306, pE975, DOI 10.1152/ajpendo.00699.2013; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Matsushima A, 2014, J NUTR SCI VITAMINOL, V60, P43, DOI 10.3177/jnsv.60.43; Matsusima A, 2013, INT J FOOD SCI NUTR, V64, P988, DOI 10.3109/09637486.2013.812617; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Miyazaki K, 2008, J AGR FOOD CHEM, V56, P11485, DOI 10.1021/jf801876n; Molnar J, 2005, CIRC RES, V96, P1178, DOI 10.1161/01.RES.0000168634.74330.ed; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Rajapakse AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019237; Santilli F, 2015, VASC PHARMACOL, V74, P23, DOI 10.1016/j.vph.2015.09.003; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Song Y, 2016, J NEUROIMMUNOL, V301, P1, DOI 10.1016/j.jneuroim.2016.11.001; Speciale A, 2013, MOL NUTR FOOD RES, V57, P1979, DOI 10.1002/mnfr.201300102; Suganya N, 2016, BRIT J NUTR, V116, P223, DOI 10.1017/S0007114516001884; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Tresserra-Rimbau A, 2014, NUTR METAB CARDIOVAS, V24, P639, DOI 10.1016/j.numecd.2013.12.014; Tresserra-Rimbau A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-77; Tronel C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/264935; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wu XL, 2006, J AGR FOOD CHEM, V54, P4069, DOI 10.1021/jf060300l; Xia N, 2010, J PHARMACOL EXP THER, V335, P149, DOI 10.1124/jpet.110.168724; Xu JW, 2007, ATHEROSCLEROSIS, V193, P299, DOI 10.1016/j.atherosclerosis.2006.09.006; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yokoyama M, 2014, CELL REP, V7, P1691, DOI 10.1016/j.celrep.2014.04.046; Yoshida Y, 2015, J MOL CELL CARDIOL, V85, P183, DOI 10.1016/j.yjmcc.2015.06.001; Zhu YN, 2011, CLIN CHEM, V57, P1524, DOI 10.1373/clinchem.2011.167361	53	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							0202051	10.1371/journal.pone.0202051	http://dx.doi.org/10.1371/journal.pone.0202051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106986	gold, Green Submitted, Green Published			2022-12-26	WOS:000441662800026
J	de Meij, TGJ; de Groot, EFJ; Peeters, CFW; de Boer, NKH; Kneepkens, CMF; Eck, A; Benninga, MA; Savelkoul, PHM; van Bodegraven, AA; Budding, AE				de Meij, T. G. J.; de Groot, E. F. J.; Peeters, C. F. W.; de Boer, N. K. H.; Kneepkens, C. M. F.; Eck, A.; Benninga, M. A.; Savelkoul, P. H. M.; van Bodegraven, A. A.; Budding, A. E.			Variability of core microbiota in newly diagnosed treatment-naive paediatric inflammatory bowel disease patients	PLOS ONE			English	Article							CROHNS-DISEASE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; ENTERAL NUTRITION; FECAL MICROBIOTA; RISING INCIDENCE; CHILDREN; PATHOGENESIS; IMPROVEMENT; MODULATION	Background & aims Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naive) IBD, in comparison to healthy paediatric controls (HC). Methods In this prospective study, performed at two tertiary centres, faecal samples from newly diagnosed, treatment-naive paediatric IBD patients were collected prior to bowel cleansing for colonoscopy (t0) and 1, 3 and 6 weeks and 3 months after initiation of therapy. The microbial profiles of Crohn's disease (CD) and Ulcerative colitis (UC) patients were compared with HC and linked to therapeutic response. Microbiota composition was analysed by IS-pro technology. Results Microbial profiles of 104 new IBD-patients (63 CD, 41 UC, median age 14.0 years) were compared to 61 HC (median 7.8 years). IBD was mainly characterised by decreased abundance of Alistipes finegoldii and Alistipes putredinis, which characterize a healthy state microbial core. The classifier including these core species as predictors achieved an AUC of the ROC curve of .87. Core bacteria tended to regain abundance during treatment, but did not reach healthy levels. Conclusion Faecal microbiota profiles of children with de novo CD and UC can be discriminated from HC with high accuracy, mainly driven by a decreased abundance of species shaping the microbial core in the healthy state. Paediatric IBD can therefore be characterized by decreased abundance of certain bacterial species reflecting the healthy state rather than by the introduction of pathogens.	[de Meij, T. G. J.; Kneepkens, C. M. F.] Vrije Univ Amsterdam, Med Ctr, Dept Paediat Gastroenterol, Amsterdam, Netherlands; [de Groot, E. F. J.; de Boer, N. K. H.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Peeters, C. F. W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Eck, A.; Savelkoul, P. H. M.; Budding, A. E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Benninga, M. A.] Emma Childrens Hosp, Acad Med Ctr, Dept Paediat Gastroenterol, Amsterdam, Netherlands; [Savelkoul, P. H. M.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, Maastricht, Netherlands; [van Bodegraven, A. A.] Zuyderland Med Ctr, Dept Gastroenterol Geriatr Internal & Intens Care, Heerlen Sittard Geleen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	de Meij, TGJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Paediat Gastroenterol, Amsterdam, Netherlands.	t.demeij@vumc.nl	de Boer, Nanne/AAE-8731-2022; van Bodegraven, Ad/ABG-4367-2020; van Bodegraven, Ad A/L-3180-2013	Peeters, Carel/0000-0001-5766-9969; de Boer, Nanne/0000-0001-8357-9887; Budding, Andries/0000-0001-5128-5411				Ai LY, 2017, ONCOTARGET, V8, P9546, DOI 10.18632/oncotarget.14488; Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Blaser M, 2013, NAT REV MICROBIOL, V11, P213, DOI 10.1038/nrmicro2973; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Cao Y, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/872725; de Meij TGJ, 2016, FASEB J, V30, P1512, DOI 10.1096/fj.15-278622; Douglas GM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0398-3; Dunn KA, 2016, INFLAMM BOWEL DIS, V22, P2853, DOI 10.1097/MIB.0000000000000956; Dunn KA, 2016, INFLAMM BOWEL DIS, V22, P2607, DOI 10.1097/MIB.0000000000000949; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gerasimidis K, 2014, INFLAMM BOWEL DIS, V20, P861, DOI 10.1097/MIB.0000000000000023; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Henderson P, 2012, INFLAMM BOWEL DIS, V18, P999, DOI 10.1002/ibd.21797; Imhann F., 2016, GUT; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Knoll RL, 2017, AM J PHYSIOL-GASTR L, V312, pG327, DOI 10.1152/ajpgi.00293.2016; Kolho KL, 2015, AM J GASTROENTEROL, V110, P921, DOI 10.1038/ajg.2015.149; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; MacLellan A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050447; Malaty HM, 2010, J PEDIATR GASTR NUTR, V50, P27, DOI 10.1097/MPG.0b013e3181b99baa; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Qiao YQ, 2016, J DIGEST DIS, V17, P800, DOI 10.1111/1751-2980.12422; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Ruemmele FM, 2014, J CROHNS COLITIS, V8, P1179, DOI 10.1016/j.crohns.2014.04.005; Samson CM, 2012, J PEDIATR GASTR NUTR, V55, P679, DOI 10.1097/MPG.0b013e318262de16; Sartor RB, 2011, MUCOSAL IMMUNOL, V4, P127, DOI 10.1038/mi.2010.87; Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Shaw KA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0331-y; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Takahashi K, 2016, DIGESTION, V93, P59, DOI 10.1159/000441768; van de Wiel MA, 2016, STAT MED, V35, P368, DOI 10.1002/sim.6732; Wang F, 2016, CELL REP, V14, P945, DOI 10.1016/j.celrep.2015.12.088	51	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0197649	10.1371/journal.pone.0197649	http://dx.doi.org/10.1371/journal.pone.0197649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102706	Green Submitted, Green Published, gold			2022-12-26	WOS:000441452200001
J	Ng, JKC; Kwan, BCH; Chow, KM; Pang, WF; Cheng, PMS; Leung, CB; Li, PKT; Szeto, CC				Ng, Jack Kit-Chung; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Pang, Wing-Fai; Cheng, Phyllis Mei-Shan; Leung, Chi-Bon; Li, Philip Kam-To; Szeto, Cheuk-Chun			Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients	PLOS ONE			English	Article							BIOIMPEDANCE SPECTROSCOPY; BODY-COMPOSITION; HYDRATION STATUS; RISK; OVERHYDRATION; OUTCOMES	Background Fluid overload is common among asymptomatic peritoneal dialysis (PD) patients. We aim to determine the prevalence and prognostic significance of fluid overload, as measured by bioimpedance spectroscopy, in asymptomatic incident PD patients. Methods We performed a single-center study on 311 incident PD patients. Volume status was represented by the volume of overhydration (OH), OH/extracellular water (ECW) ratio, ECW/total body water (TBW) ratio, and ECW to intracellular water (ICW) ratio (E:1 ratio). Patient survival, technique survival and cardiovascular event-free survival were determined. Results The median period of follow up was 27.3 months. Fluid overload was present in 272 patients (87.5%) when defined as OH volume over 1.1L. All hydration parameters significantly correlated with Charlson Comorbidity Index, and inversely with total Kt/V and serum albumin. Multivariate cause-specific Cox analysis showed that volume status independently predicted patient survival; every 0.1 unit increase in E:1 ratio was associated with 24.5% increase in allcause mortality (adjusted cause-specific hazard ratio [ACSHR] 1.245, p = 0.002). Hydration status was also an independent predictor of cardiovascular event-free survival after excluding hospital admission for congestive heart failure; each 0.1 unit increase in E:1 ratio was associated with 18.7% decrease in cardiovascular event-free survival (ACSHR 1.187, p = 0.011). In contrast, hydration parameters were not associated with technique survival. Conclusions Fluid overload is common in asymptomatic incident PD patients and is a strong predictor of patient survival and cardiovascular event. The impact of bioimpedance spectroscopy-guided fluid management on the outcome of PD patients deserves further study.	[Ng, Jack Kit-Chung; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Pang, Wing-Fai; Cheng, Phyllis Mei-Shan; Leung, Chi-Bon; Li, Philip Kam-To; Szeto, Cheuk-Chun] Chinese Univ Hong Kong, Prince Wales Hosp, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Szeto, CC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ccszeto@cuhk.edu.hk	Ng, Jack KC/L-6473-2019; Li, Philip K. T./D-4051-2017; Szeto, Cheuk Chun/N-4954-2015; Ming, Chow Kai/Y-5568-2019; Kwan, Bonnie/N-3463-2015	Ng, Jack KC/0000-0002-9549-9611; Szeto, Cheuk Chun/0000-0002-8898-8505; Ming, Chow Kai/0000-0001-5310-5197; Kwan, Bonnie/0000-0001-6742-8480	Chinese University of Hong Kong (CUHK) [6901031, 7101215]; Baxter Healthcare	Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); Baxter Healthcare	This study was supported by the Chinese University of Hong Kong (CUHK) research accounts 6901031 and 7101215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. CC Szeto receives research grant and consultancy from Baxter Healthcare.	Beddhu S, 2002, AM J MED, V112, P696, DOI 10.1016/S0002-9343(02)01097-5; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Cooper BA, 2000, KIDNEY INT, V58, P408, DOI 10.1046/j.1523-1755.2000.00180.x; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Demirci MS, 2011, NEPHROL DIAL TRANSPL, V26, P1708, DOI 10.1093/ndt/gfq588; Guo QY, 2015, PERITON DIALYSIS INT, V35, P691, DOI 10.3747/pdi.2014.00008; Kang SWS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165638; Kim YL, 2017, SEMIN NEPHROL, V37, P43, DOI 10.1016/j.semnephrol.2016.10.006; Konings CJAM, 2003, KIDNEY INT, V63, P1556, DOI 10.1046/j.1523-1755.2003.00887.x; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Kwan BCH, 2014, PERITON DIALYSIS INT, V34, P409, DOI 10.3747/pdi.2013.00066; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Parmentier SP, 2013, INT UROL NEPHROL, V45, P229, DOI 10.1007/s11255-012-0216-y; Ronco C, 2015, NEPHROL DIAL TRANSPL, V30, P849, DOI 10.1093/ndt/gfv013; Santhakumaran T, 2016, NEPHROLOGY, V21, P404, DOI 10.1111/nep.12622; Tian N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153115; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Wong FKY, 2010, INT J NURS STUD, V47, P268, DOI 10.1016/j.ijnurstu.2009.07.001; Yoon HE, 2016, INT J MED SCI, V13, P686, DOI 10.7150/ijms.16372	22	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202203	10.1371/journal.pone.0202203	http://dx.doi.org/10.1371/journal.pone.0202203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102739	Green Submitted, gold, Green Published			2022-12-26	WOS:000441452200035
J	Tsai, CW; Chang, WS; Shen, TC; Su, CH; Wang, HC; Liu, LC; Bau, DT				Tsai, Chia-Wen; Chang, Wen-Shin; Shen, Te-Chun; Su, Chen-Hsien; Wang, Hwei-Chung; Liu, Liang-Chih; Bau, Da-Tian			Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENE XRCC3 GENOTYPES; DNA-DAMAGE RESPONSE; CARCINOMA RISK; LUNG-CANCER; ERCC1; EXPRESSION; SUSCEPTIBILITY; PATHWAYS; TARGETS	Compared with other subgroups of breast cancer, triple negative breast cancer (TNBC) is considered to be the one with the greatest invasiveness and metastatic mobility, and the highest recurrence rate. Considering the lack of predictive markers for TNBC, we aimed to examine the contribution of excision repair cross complementing-group 1 (ERCC1) genotypes to TNBC. The rs11615 and rs3212986 of ERCC1 were investigated and evaluated for their associations with susceptibility to breast cancer, especially TNBC, in Taiwan. In this study, 1,232 breast cancer patients (104 were TNBC) and 1,232 healthy controls were recruited and their genotypes at ERCC1 rs11615 and rs3212986 were revealed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis. Our results indicated that genotypes of ERCC1 rs11615 (P-trend = 2.2*10E-9), but not rs3212986 (P-trend = 0.6181), were associated with breast cancer risk. In the allelic frequency distribution analysis, breast cancer patients carried the T allele of ERCC1 rs11615 a higher rate than the control subjects, further supporting the idea that ERCC1 rs11615 TT genotype is positively associated with breast cancer susceptibility. More importantly, the frequency of the ERCC1 rs11615 TT genotype was even higher among TNBC patients than among other subtypes of breast cancer patients (P = 0.0001, odds ratio = 1.73, 95% confidence interval = 1.15-2.63). The genotypes of ERCC1 rs11615 were not associated with Ki67 status. Our findings firstly show that the T allele of ERCC1 rs 11615 can serve as a predictive biomarker for breast cancer and TNBC. We believe that ERCC1 could serve as a target for personalized treatment of breast cancer, especially for TNBC.	[Tsai, Chia-Wen; Chang, Wen-Shin; Shen, Te-Chun; Su, Chen-Hsien; Wang, Hwei-Chung; Liu, Liang-Chih; Bau, Da-Tian] China Med Univ Hosp, Translat Med Res Ctr, Terry Fox Canc Res Lab, Taichung, Taiwan; [Shen, Te-Chun; Bau, Da-Tian] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Bau, Da-Tian] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Bau, DT (corresponding author), China Med Univ Hosp, Translat Med Res Ctr, Terry Fox Canc Res Lab, Taichung, Taiwan.; Bau, DT (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Bau, DT (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	artbau2@gmail.com		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Science and Technology [MOST 106-2320-B-039-035]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW107-TDU-B-212-123004]	Taiwan Ministry of Science and Technology; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by research grants from Taiwan Ministry of Science and Technology to Dr. Bau (MOST 106-2320-B-039-035) and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW107-TDU-B-212-123004). There was no additional external funding received for this study.; The clinical team of Dr. Su, Wang and Liu in sample collection and all the participants in this study are appreciated. The consultant of statistical analysis from Cheng-Li Lin is very helpful in manuscript revision. This study was supported by research grants from Taiwan Ministry of Science and Technology to Dr. Bau (MOST 106-2320-B-039-035) and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW107-TDU-B212-123004). There was no additional external funding received for this study.	Altaha R, 2004, INT J MOL MED, V14, P959; Broustas CG, 2014, RADIAT RES, V181, P111, DOI 10.1667/RR13515.1; Chang WS, 2016, BIOMEDICINE-TAIWAN, V6, P23, DOI 10.7603/s40681-016-0004-6; Chang WS, 2015, ANTICANCER RES, V35, P4691; Chen HJ, 2015, ANTICANCER RES, V35, P3893; Chiu CF, 2008, ANTICANCER RES, V28, P267; Lima LMC, 2012, HISTOPATHOLOGY, V60, P489, DOI 10.1111/j.1365-2559.2011.04062.x; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; DABHOLKAR M, 1993, MUTAT RES, V293, P151, DOI 10.1016/0921-8777(93)90066-P; DABHOLKAR M, 1992, J NATL CANCER I, V84, P1512, DOI 10.1093/jnci/84.19.1512; Damia G, 1998, EUR J CANCER, V34, P1783, DOI 10.1016/S0959-8049(98)00190-7; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; Dumont A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1053-0; El Baiomy M, 2017, BREAST, V32, pS92, DOI 10.1016/S0960-9776(17)30295-3; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Grigoriadis A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-619; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; He BS, 2016, ONCOTARGET, V7, P84872, DOI 10.18632/oncotarget.12744; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hsieh YH, 2015, TUMOR BIOL, V36, P4101, DOI 10.1007/s13277-014-2934-5; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Kim DH, 2017, ONCOL LETT, V14, P4995, DOI 10.3892/ol.2017.6737; Koc E, 2012, MOL BIOL REP, V39, P375, DOI 10.1007/s11033-011-0748-8; Latimer JJ, 2015, PHOTOCHEM PHOTOBIOL, V91, P493, DOI 10.1111/php.12387; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Li B, 2018, BIOSCI REP; Liu JC, 2015, CHINESE J PHYSIOL, V58, P64, DOI 10.4077/CJP.2015.BAD279; Liu LC, 2014, BIOMEDICINE-TAIWAN, V4, P16, DOI 10.7603/s40681-014-0003-4; Ma HX, 2007, PHARMACOGENET GENOM, V17, P417, DOI 10.1097/01.fpc.0000239975.77088.17; Matta J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071505; Matta J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-490; Mojgan H, 2012, ARCH MED SCI, V8, P655, DOI 10.5114/aoms.2012.30289; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Ozkan C, 2012, J BUON, V17, P271; Peshkin Beth N, 2010, Breast Dis, V32, P25, DOI 10.3233/BD-2010-0306; Pongsavee Malinee, 2017, Asian Pac J Cancer Prev, V18, P2999, DOI 10.22034/APJCP.2017.18.11.2999; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Scharer Orlando D, 2013, Cold Spring Harb Perspect Biol, V5, pa012609, DOI 10.1101/cshperspect.a012609; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Su CH, 2015, CANCER GENOM PROTEOM, V12, P359; Tecza K, 2016, ONCOTARGET, V7, P66790, DOI 10.18632/oncotarget.11053; Xu ZC, 2016, GENET MOL RES, P15; Yang ZC, 2013, GENET TEST MOL BIOMA, V17, P700, DOI 10.1089/gtmb.2013.0122; Yu X, 2015, THORAC CANCER, V6, P741, DOI 10.1111/1759-7714.12251; Yueh TC, 2017, ANTICANCER RES, V37, P2307, DOI 10.21873/anticanres.11568; Zhang Y, 2009, CURR GENOMICS, V10, P250, DOI 10.2174/138920209788488544; Zhu GJ, 2015, GENET TEST MOL BIOMA, V19, P387, DOI 10.1089/gtmb.2015.0001	51	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202112	10.1371/journal.pone.0202112	http://dx.doi.org/10.1371/journal.pone.0202112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096175	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500050
J	Sbrissa, D; Semaan, L; Govindarajan, B; Li, YF; Caruthers, NJ; Stemmer, PM; Cher, ML; Sethi, S; Vaishampayan, U; Shisheva, A; Chinni, SR				Sbrissa, Diego; Semaan, Louie; Govindarajan, Barani; Li, Yanfeng; Caruthers, Nicholas J.; Stemmer, Paul M.; Cher, Michael L.; Sethi, Seema; Vaishampayan, Ulka; Shisheva, Assia; Chinni, Sreenivasa R.			A novel cross-talk between CXCR4 and PI4KIII alpha in prostate cancer cells	ONCOGENE			English	Article							CHEMOKINE RECEPTOR CXCR4; PLASMA-MEMBRANE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; SIGNALING PATHWAY; EXPRESSION; PROTEIN; MIGRATION; METASTASIS; DIMERIZATION	Chemokine signaling regulates cell migration and tumor metastasis. CXCL12, a member of the chemokine family, and its receptor, CXCR4, a G protein coupled receptor (GPCR), are key mediators of prostate-cancer (PC) bone metastasis. In PC cells androgens activate CXCR4 gene expression and receptor signaling on lipid rafts, which induces protease expression and cancer cell invasion. To identify novel lipid-raft-associated CXCR4 regulators supporting invasion/metastasis, we performed a SILAC-based quantitative proteomic analysis of lipid-rafts derived from PC3 stable cell lines with overexpression or knockdown of CXCR4. This analysis identified the evolutionarily conserved phosphatidylinositol 4-kinase III alpha (PI4KIII alpha), and SAC1 phosphatase that dephosphorylates phosphatidylinositol-4-phosphate as potential candidate CXCR4 regulators. CXCR4 interacted with PI4KIII alpha membrane targeting machinery recruiting them to the plasma membrane for PI4P production. Consistent with this interaction, PI4KIII alpha was found tightly linked to the CXCR4 induced PC cell invasion. Thus, ablation of PI4KIII alpha in CXCR4-expressing PC3 cells reduced cellular invasion in response to a variety of chemokines. Immunofluorescence microscopy in CXCR4-expressing cells revealed localized production of PI4P on the invasive projections. Human tumor studies documented increased PI4KIII alpha expression in metastatic tumors vs. the primary tumor counterparts, further supporting the PI4KIIIa role in tumor metastasis. Furthermore, we also identified an unexpected function of PI4KIII alpha in GPCR signaling where CXCR4 regulates PI4KIII alpha activity and mediate tumor metastasis. Altogether, our study identifies a novel cross-talk between PI4KIII alpha and CXCR4 in promoting tumor metastasis and suggests that PI4KIII alpha pharmacological targeting may have therapeutic benefit for advanced prostate cancer patients.	[Sbrissa, Diego; Semaan, Louie; Li, Yanfeng; Cher, Michael L.; Chinni, Sreenivasa R.] Wayne State Univ, Sch Med, Dept Urol, Detroit, MI 48201 USA; [Sbrissa, Diego; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Govindarajan, Barani; Cher, Michael L.; Sethi, Seema; Chinni, Sreenivasa R.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Caruthers, Nicholas J.; Stemmer, Paul M.] Wayne State Univ, Sch Med, Inst Environm Hlth Sci, Detroit, MI 48201 USA; [Caruthers, Nicholas J.; Stemmer, Paul M.] Wayne State Univ, Sch Med, Prote Core Facil, Detroit, MI 48201 USA; [Cher, Michael L.; Vaishampayan, Ulka; Chinni, Sreenivasa R.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Chinni, SR (corresponding author), Wayne State Univ, Sch Med, Dept Urol, Detroit, MI 48201 USA.; Chinni, SR (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.; Chinni, SR (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA.	schinni@med.wayne.edu		Stemmer, Paul/0000-0003-3315-9846; Vaishampayan, Ulka/0000-0001-5800-4571	U.S. Department of Defense [W81XWH-09-1-0250]; NIH-NCI Grant [CA151557]; Fund for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA151557] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); NIH-NCI Grant; Fund for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Special thanks to Dr. Balla for providing PI4KIII alpha and EFR3B expression constructs, Dr. DeCamilli for TTC7B construct and Dr. Mayinger for anti-Sac1 antibodies. We would like to thank Mr. Ussama A. Khan for technical assistance in preparing data. We also thank Astellas/Medivation for supporting clinical protocol for human tumor biopsy material collection. Supported by U.S. Department of Defense, W81XWH-09-1-0250, NIH-NCI Grant CA151557 and Fund for Cancer Research.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Bachelder RE, 2002, CANCER RES, V62, P7203; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Baskin JM, 2016, NAT CELL BIOL, V18, P132, DOI 10.1038/ncb3271; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bojjireddy N, 2015, J CELL SCI, V128, P118, DOI 10.1242/jcs.157495; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Burke JE, 2014, SCIENCE, V344, P1035, DOI 10.1126/science.1253397; Cai JA, 2010, TRANSL ONCOL, V3, P195, DOI 10.1593/tlo.09328; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Chu KME, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.84; Chung JY, 2015, EMBO REP, V16, P312, DOI 10.15252/embr.201439151; Coke CJ, 2016, J BIOL CHEM, V291, P9991, DOI 10.1074/jbc.M115.712661; Conley-LaComb MK, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0552-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dillenburg-Pilla P, 2015, FASEB J, V29, P1056, DOI 10.1096/fj.14-260083; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Lee BC, 2005, CANCER RES, V65, P2840, DOI 10.1158/0008-5472.CAN-04-3309; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Singareddy R, 2013, MOL CANCER RES, V11, P1349, DOI 10.1158/1541-7786.MCR-12-0705; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Wu XD, 2014, DEV CELL, V28, P19, DOI 10.1016/j.devcel.2013.11.012	43	15	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					332	344		10.1038/s41388-018-0448-0	http://dx.doi.org/10.1038/s41388-018-0448-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30111818	Green Accepted			2022-12-26	WOS:000455851200003
J	Wang, WJ; Lollis, EM; Bordeleau, F; Reinhart-King, CA				Wang, Wenjun; Lollis, Emmanuel M.; Bordeleau, Francois; Reinhart-King, Cynthia A.			Matrix stiffness regulates vascular integrity through focal adhesion kinase activity	FASEB JOURNAL			English	Article						substrate compliance; endothelial barrier function; VE-cadherin	VE-CADHERIN; TYROSINE PHOSPHORYLATION; BARRIER DISRUPTION; FAK; PERMEABILITY; METASTASIS; CANCER; EXTRAVASATION; P120-CATENIN; INHIBITION	Tumor vasculature is known to be more permeable than the vasculature found in healthy tissue, which in turn can lead to a more aggressive tumor phenotype and impair drug delivery into tumors. While the stiffening of the stroma surrounding solid tumors has been reported to increase vascular permeability, the mechanism of this process remains unclear. Here, we utilize an in vitro model of tumor stiffening, ex ovo culture, and a mouse model to investigate the molecular mechanism by which matrix stiffening alters endothelial barrier function. Our data indicate that the increased endothelial permeability caused by heightened matrix stiffness can be prevented by pharmaceutical inhibition of focal adhesion kinase (FAK) both in vitro and ex ovo. Matrix stiffness-mediated FAK activation determines Src localization to cell-cell junctions, which then induces increased vascular endothelial cadherin phosphorylation both in vitro and in vivo. Endothelial cells in stiff tumors have more activated Src and higher levels of phosphorylated vascular endothelial cadherin at adherens junctions compared to endothelial cells in more compliant tumors. Altogether, our data indicate that matrix stiffness regulates endothelial barrier integrity through FAK activity, providing one mechanism by which extracellular matrix stiffness regulates endothelial barrier function. Additionally, our work also provides further evidence that FAK is a promising potential target for cancer therapy because FAK plays a critical role in the regulation of endothelial barrier integrity.Wang, W., Lollis, E. M., Bordeleau, F., Reinhart-King, C. A. Matrix stiffness regulates vascular integrity through focal adhesion kinase activity.	[Wang, Wenjun; Bordeleau, Francois; Reinhart-King, Cynthia A.] Vanderbilt Univ, Dept Biomed Engn, PMB 351631, Nashville, TN 37235 USA; [Lollis, Emmanuel M.] Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY USA; [Reinhart-King, Cynthia A.] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA	Vanderbilt University; Cornell University; Cornell University	Reinhart-King, CA (corresponding author), Vanderbilt Univ, Dept Biomed Engn, PMB 351631, Nashville, TN 37235 USA.	cynthia.reinhart-king@vanderbilt.edu		Wang, Wenjun/0000-0003-0907-6282	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL127499]; Cancer Research Society; NIH National Cancer Institute [K99CA212270]; NATIONAL CANCER INSTITUTE [K99CA212270] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127499] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research Society; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge support from the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (R01HL127499 to C.A.R.-K.), the Scholarship for the Next Generation of Scientists from the Cancer Research Society, and the NIH National Cancer Institute (K99CA212270 to F.B.). The authors declare no conflicts of interest.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Aragon-Sanabria V, 2017, SCI REP-UK, V7, DOI 10.1038/srep45835; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Azzi S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00211; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Belvitch P, 2012, MICROVASC RES, V83, P22, DOI 10.1016/j.mvr.2011.08.012; Bordeleau F, 2017, P NATL ACAD SCI USA, V114, P492, DOI 10.1073/pnas.1613855114; Bordeleau F, 2015, P NATL ACAD SCI USA, V112, P8314, DOI 10.1073/pnas.1505421112; Bordeleau F, 2014, AM J PHYSIOL-CELL PH, V306, pC110, DOI 10.1152/ajpcell.00283.2013; Bryant PW, 2012, BIOL OPEN, V1, P723, DOI 10.1242/bio.20121008; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2013, PROG MOL BIOL TRANSL, V116, P119, DOI 10.1016/B978-0-12-394311-8.00006-6; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Lampugnani M. G., 2017, COLD SPRING HARB PER, V9, DOI 10.1101/cshperspect.a029322; Lampugnani MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029322; LaValley DJ, 2017, CONVERG SCI PHYS ONC, V3, DOI 10.1088/2057-1739/aa9263; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maskarinec G, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3378; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Urbano RL, 2017, BIOPHYS J, V113, P645, DOI 10.1016/j.bpj.2017.06.033; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Zebda N, 2012, MICROVASC RES, V83, P71, DOI 10.1016/j.mvr.2011.06.007; Zijlstra A, 2006, BLOOD, V107, P317, DOI 10.1182/blood-2005-04-1458	52	29	29	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1199	1208		10.1096/fj.201800841R	http://dx.doi.org/10.1096/fj.201800841R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30102569	Green Published			2022-12-26	WOS:000457401500095
J	Evans, IEM; Llewellyn, DJ; Matthews, FE; Woods, RT; Brayne, C; Clare, L				Evans, Isobel E. M.; Llewellyn, David J.; Matthews, Fiona E.; Woods, Robert T.; Brayne, Carol; Clare, Linda		CFAS-Wales Res Team	Social isolation, cognitive reserve, and cognition in healthy older people	PLOS ONE			English	Article							FOLLOW-UP; IMPAIRMENT; DECLINE; LONELINESS; RISK; PARTICIPATION; POPULATION; RESOURCES; MORTALITY; RESIDENTS	There is evidence to suggest that social isolation is associated with poor cognitive health, although findings are contradictory. One reason for inconsistency in reported findings may be a lack of consideration of underlying mechanisms that could influence this relationship. Cognitive reserve is a theoretical concept that may account for the role of social isolation and its association with cognitive outcomes in later life. Therefore, we aimed to examine the relationship between social isolation and cognition in later life, and to consider the role of cognitive reserve in this relationship. Baseline and two year follow-up data from the Cognitive Function and Ageing Study-Wales (CFAS-Wales) were analysed. Social isolation was assessed using the Lubben Social Network Scale-6 (LSNS-6), cognitive function was assessed using the Cambridge Cognitive Examination (CAMCOG), and cognitive reserve was assessed using a proxy measure of education, occupational complexity, and cognitive activity. Linear regression modelling was used to assess the relationship between social isolation and cognition. To assess the role of cognitive reserve in this relationship, moderation analysis was used to test for interaction effects. After controlling for age, gender, education, and physically limiting health conditions, social isolation was associated with cognitive function at baseline and two year follow-up. Cognitive reserve moderated this association longitudinally. Findings suggest that maintaining a socially active lifestyle in later life may enhance cognitive reserve and benefit cognitive function. This has important implications for interventions that may target social isolation to improve cognitive function.	[Evans, Isobel E. M.; Clare, Linda] Univ Exeter, Ctr Res Ageing & Cognit Hlth REACH, Sch Psychol, Exeter, Devon, England; [Llewellyn, David J.; Clare, Linda] Univ Exeter, Med Sch, Exeter, Devon, England; [Matthews, Fiona E.] Newcastle Univ, Fac Med, Inst Hlth & Soc, Newcastle, NSW, Australia; [Matthews, Fiona E.] Univ Cambridge, Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Woods, Robert T.] Bangor Univ, Dementia Serv Dev Ctr Wales, Sch Healthcare Sci, Bangor, Gwynedd, Wales; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Clare, Linda] Univ Exeter, Inst Hlth Res, PenCLAHRC, Med Sch, Exeter, Devon, England; [Clare, Linda] Australian Natl Univ, Ctr Res Excellence Promoting Cognit Hlth, Canberra, ACT, Australia	University of Exeter; University of Exeter; University of Newcastle; MRC Biostatistics Unit; University of Cambridge; Bangor University; University of Cambridge; University of Exeter; Australian National University	Evans, IEM (corresponding author), Univ Exeter, Ctr Res Ageing & Cognit Hlth REACH, Sch Psychol, Exeter, Devon, England.	i.evans@exeter.ac.uk	Llewellyn, David/AAZ-2859-2021; Matthews, Fiona/O-6932-2015; Brayne, Carol/AAA-4285-2020; Burholt, Vanessa/O-9960-2016	Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; Burholt, Vanessa/0000-0002-6789-127X; Llewellyn, David/0000-0002-2441-4246; Clare, Linda/0000-0003-3989-5318	ESRC [RES-060-25-0060]; HEFCW; CFAS (The Alzheimer's Society CFAS Doctoral Training Centre) [AS-DTC-2014-027]; ESRC [ES/G035954/1] Funding Source: UKRI; MRC [G0601022, G9901400] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); HEFCW; CFAS (The Alzheimer's Society CFAS Doctoral Training Centre); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the following: Brayne, C., Stephan, B., Wharton, S., Clare, L., Badger, S., Arthur, T., Bennett, K., McCracken, C., Phillips, J., & Melzer, D. Transdisciplinary training for dementia research in CFAS (The Alzheimer's Society CFAS Doctoral Training Centre). 2015 - 2018. AS-DTC-2014-027. R.T Woods, L.Clare, G.Windle, V. Burholt, J. Philips, C. Brayne, C. McCracken, K. Bennett, F. Matthews. Maintaining function and well-being in later life: a longitudinal cohort study (the CFAS Wales study). ESRC (RES-060-25-0060) and HEFCW.	Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Barnes LL, 2003, NEUROLOGY, V60, P1777, DOI 10.1212/01.WNL.0000065892.67099.2A; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bowling A., 2005, AGEING WELL QUALITY; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; Cook G, 2006, INT J OLDER PEOPLE N, V1, P216, DOI 10.1111/j.1748-3743.2006.00034.x; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; DiNapoli EA, 2014, RES AGING, V36, P161, DOI 10.1177/0164027512470704; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Gow A.J., 2007, J INDIVID DIFFER, V28, P103, DOI [10.1027/1614-0001.28.3.103, DOI 10.1027/1614-0001.28.3.103]; Hendrie Hugh C, 2006, Alzheimers Dement, V2, P12, DOI 10.1016/j.jalz.2005.11.004; Heritage Z, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-243; Holt-Lunstad J, 2012, SOC PERSONAL PSYCHOL, V6, P41, DOI 10.1111/j.1751-9004.2011.00406.x; Holwerda TJ, 2014, J NEUROL NEUROSUR PS, V85, P135, DOI 10.1136/jnnp-2012-302755; Horowitz A, 2004, TOP GERIATR REHABIL, V20, P185; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; Kuiper JS, 2016, INT J EPIDEMIOL; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Nicholson NR, 2009, J ADV NURS, V65, P1342, DOI 10.1111/j.1365-2648.2008.04959.x; Nishiguchi S, 2013, DEMENT GER COGN D EX, V3, P312, DOI 10.1159/000354962; Olesen SC, 2011, AGING MENT HEALTH, V15, P186, DOI 10.1080/13607863.2010.501053; Opdebeeck C, 2016, AGING NEUROPSYCHOL C, V23, P40, DOI 10.1080/13825585.2015.1041450; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Scharf T., 2004, GROWING OLDER QUALIT, P81; Schollgen I, 2011, HEALTH PSYCHOL, V30, P326, DOI 10.1037/a0022514; Shankar A, 2013, PSYCHOSOM MED, V75, P161, DOI 10.1097/PSY.0b013e31827f09cd; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Simning A, 2014, SOC PSYCH PSYCH EPID, V49, P477, DOI 10.1007/s00127-013-0712-0; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tervo S, 2004, DEMENT GERIATR COGN, V17, P196, DOI 10.1159/000076356; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; Tomaszewski W, 2013, J POPUL AGEING, V6, P119, DOI 10.1007/s12062-012-9077-5; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179	45	76	80	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0201008	10.1371/journal.pone.0201008	http://dx.doi.org/10.1371/journal.pone.0201008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR1HG	30118489	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700005
J	Nicoletto, BB; Sarmento, RA; Pedrollo, EF; Krolikowski, TC; Canani, LH				Nicoletto, Brune Bellincanta; Sarmento, Roberta Aguiar; Pedrollo, Elis Forcellini; Krolikowski, Thaiana Cirino; Canani, Luis Henrique			Association between progranulin serum levels and dietary intake	PLOS ONE			English	Article							GROWTH-FACTOR; ENERGY-INTAKE; FATTY-ACIDS; CARDIOVASCULAR-DISEASE; EPITHELIN PRECURSOR; WEIGHT-LOSS; INFLAMMATION; SENSITIVITY; VALIDITY; PROTEIN	Introduction Progranulin (PGRN) is secreted by adipose tissue and has been linked to obesity, insulin resistance and type 2 diabetes mellitus. There is evidence that a high fat diet increases PGRN expression in rodent adipose tissue. In humans, the relationship between diet composition and concentration of PGRN is still unknown. Objective To investigate the association between dietary intake and serum PGRN levels. Methods This is an exploratory cross-sectional study including 85 subjects. Demographic, clinical, laboratory and anthropometric data were collected. Serum PGRN was determined by enzyme-linked immunosorbent assay after overnight fasting. Dietary intake was assessed by food frequency questionnaire validated for Brazilian southern population. Focused principal component analyses (FPCA) was used to verify the association of dietary components and food groups with PGRN levels. Sensitivity analyses were performed including only subjects with reporting according to the Goldberg and Black cut-offs of energy intake-energy expenditure ratio between 0.76 and 1.24. Results The median PGRN was 51.96 (42.18 to 68.30) ng/mL. Analyzing all sample, the FPCA showed no association of serum PGRN with total energy, protein, carbohydrate, fat and its types, fiber intake and dietary glycemic index; but a significant and positive association between solid fats and PGRN levels (p<0.05). Including only subjects with reporting according cut-off of energy intake-energy expenditure ratio between 0.76 and 1.24, FCPA showed significant and positive association of serum PGRN with saturated fatty acids and solid fats intake (p<0.05). In this subgroup, PGRN correlated with saturated fatty acids (r = 0.341; p = 0.031). Solid fats intake was independently associated to serum PGRN (beta = 0.294; p = 0.004) in multivariate model. Conclusion The dietary intake of solid fats, mainly represented by saturated fatty acids, is associated to serum PGRN concentration in human subjects.	[Nicoletto, Brune Bellincanta; Sarmento, Roberta Aguiar; Pedrollo, Elis Forcellini] Univ Fed Rio Grande do Sul, Fac Med, Post Grad Med Sci Program Endocrinol, Porto Alegre, RS, Brazil; [Nicoletto, Brune Bellincanta] UCS, Area Conhecimento Ciencias Vida, Nutr Course, Caxias Do Sul, Brazil; [Krolikowski, Thaiana Cirino] Univ Fed Rio Grande do Sul, Fac Med, Nutr Course, Porto Alegre, RS, Brazil; [Canani, Luis Henrique] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul	Nicoletto, BB (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Post Grad Med Sci Program Endocrinol, Porto Alegre, RS, Brazil.; Nicoletto, BB (corresponding author), UCS, Area Conhecimento Ciencias Vida, Nutr Course, Caxias Do Sul, Brazil.	brunanicoletto@gmail.com	Canani, Luis H/G-9686-2012	Canani, Luis H/0000-0002-1813-4491; Nicoletto Gehrke, Bruna/0000-0001-9378-1130	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre [13-0332]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-www.cnpq.br) and Fundo de Incentivo a Pesquisa e Eventos (FIPE) (13-0332) at the Hospital de Clinicas de Porto Alegre (www.hcpa.edubr). BBN, TCK and LHC are recipients of scholarships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2017, DRUG DISCOV TODAY, V22, P1557, DOI 10.1016/j.drudis.2017.06.006; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Ashrafian H, 2013, METAB BRAIN DIS, V28, P341, DOI 10.1007/s11011-013-9412-4; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Avesani CM, 2005, J RENAL NUTR, V15, P159, DOI 10.1053/j.jrn.2004.09.010; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; Bluher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267; Borges Camila Aparecida, 2015, Rev. bras. epidemiol., V18, P837, DOI 10.1590/1980-5497201500040013; Canuto R, 2010, CAD SAUDE PUBLICA, V26, P2149, DOI 10.1590/S0102-311X2010001100016; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chitramuthu BP, 2017, BRAIN, V140, P3081, DOI 10.1093/brain/awx198; de Castro MBT, 2009, NUTRITION, V25, P1120, DOI 10.1016/j.nut.2009.02.006; Engin AB, 2017, ADV EXP MED BIOL, V960, P197, DOI 10.1007/978-3-319-48382-5_8; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Gomes AC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-60; Guess N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150148; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hooper L, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011737, 10.1002/14651858.CD011583.pub2]; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kim HK, 2011, ENDOCRINOLOGY, V152, P4672, DOI 10.1210/en.2011-1221; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Magni P, 2005, CLIN ENDOCRINOL, V62, P189, DOI 10.1111/j.1365-2265.2005.02195.x; Martins AM, 2015, J RENAL NUTR, V25, P321, DOI 10.1053/j.jrn.2014.10.007; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Meng X, 2013, J NUTR HEALTH AGING, V17, P112, DOI 10.1007/s12603-012-0382-8; Miraghajani M, 2017, PROBIOTICS ANTIMICRO; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicoletto BB, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0112-6; Nicoletto BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165177; Nucleo de Estudos e Pesquisas em Alimentac (NEPA), 2011, TAB BRAS COMP REV AM; Patterson E, 2014, BRIT J NUTR, V111, P1905, DOI 10.1017/S0007114514000117; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Philippi ST, 2002, TABELA COMPOSICAO AL, V2nd; Qu H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/360190; Ralston JC, 2017, ANNU REV NUTR, V37, P77, DOI 10.1146/annurev-nutr-071816-064836; Rheinheimer J, 2017, METABOLISM, V74, P1, DOI 10.1016/j.metabol.2017.06.002; Rizek RL H F, 2006, COMPOSITION FOODS AG, V8; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Sarmento RA, 2014, PUBLIC HEALTH NUTR, V17, P2237, DOI 10.1017/S1368980013002644; Sarmento RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-740; Schmid A, 2015, HORM METAB RES, V47, P571, DOI 10.1055/s-0034-1395679; Shaneshin M, 2014, J HEALTH POPUL NUTR, V32, P36; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; The Food and Agriculture Organization (FAO), 1985, REP JOINT FAO WHO UN; Wang BC, 2015, PROTEIN CELL, V6, P792, DOI 10.1007/s13238-015-0213-x; Wilczek MM, 2017, CARDIOLOGY, V138, P254, DOI 10.1159/000479956; Willet W, 1998, NUTR EPIDEMIOLOGY; Wood LG, 2018, J ALLERGY CLIN IMMUN, V6749, P30773; Yazici D, 2017, ADV EXP MED BIOL, V960, P277, DOI 10.1007/978-3-319-48382-5_12; ZHOU J, 1993, J BIOL CHEM, V268, P10863	52	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202149	10.1371/journal.pone.0202149	http://dx.doi.org/10.1371/journal.pone.0202149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118483	gold, Green Submitted, Green Published			2022-12-26	WOS:000442282700014
J	Novoa-Bravo, M; Fegraeus, KJ; Rhodin, M; Strand, E; Garcia, LF; Lindgren, G				Novoa-Bravo, Miguel; Fegraeus, Kim Jaderlcvist; Rhodin, Marie; Strand, Eric; Fernando Garcia, Luis; Lindgren, Gabriella			Selection on the Colombian paso horse's gaits has produced kinematic differences partly explained by the DMRT3 gene	PLOS ONE			English	Article							KEEPER MUTATION; QUANTIFICATION; LAMENESS; ABILITY; WINDOWS; LINUX; BREED	The Colombian paso horse, the most important horse breed in Colombia, performs specific and particular gaits (paso fino, trocha, and Colombian trot), which display different footfall patterns and stride frequencies. The breed has been selected for gait and conformation for more than 50 years and we hypothesize that this selection has led to kinematic differences of the gaits that can be explained by different genetic variants. Hence, the aims of the study were: 1. To identify if there are any differences in the kinematic and genetic variants between the Colombian paso horse's gaits. 2. To evaluate if and how much the gait differences were explained by the nonsense mutation in the DMRT3 gene and 3. To evaluate these results for selecting and controlling the horses gait performance. To test our hypotheses, kinematic data, microsatellites and DMRT3 genotypes for 187 Colombian paso horses were analyzed. The results indicated that there are significant kinematic and DMRT3 differences between the Colombian paso horse's gaits, and those parameters can be used partially to select and control the horses gait performance. However, the DMRT3 gene does not play a major role in controlling the trocha and the Colombian trot gaits. Therefore, modifying genes likely influence these gaits. This study may serve as a foundation for implementing a genetic selection program in the Colombian paso horse and future gene discovery studies for locomotion pattern in horses.	[Novoa-Bravo, Miguel] Genet Anim Colombia Ltda, Bogota, Colombia; [Novoa-Bravo, Miguel; Fegraeus, Kim Jaderlcvist; Lindgren, Gabriella] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Novoa-Bravo, Miguel; Fernando Garcia, Luis] Univ Nacl Colombia, Dept Biol, Bogota, Cundinamarca, Colombia; [Rhodin, Marie] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Strand, Eric] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Oslo, Norway	Swedish University of Agricultural Sciences; Universidad Nacional de Colombia; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences	Novoa-Bravo, M (corresponding author), Genet Anim Colombia Ltda, Bogota, Colombia.; Novoa-Bravo, M (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.; Novoa-Bravo, M (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Cundinamarca, Colombia.	miguelnovoa@geancol.com	Strand, Eric/J-4452-2019; Rhodin, Marie/AAD-7266-2020	Lindgren, Gabriella/0000-0001-6046-9669; Rhodin, Marie/0000-0003-0575-2765; NOVOA-BRAVO, MIGUEL/0000-0002-9950-2590	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Genetica Animal de Colombia Ltda.; Colfuturo-Colciencias [6172]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Genetica Animal de Colombia Ltda.; Colfuturo-Colciencias	This work was supported by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) (GL), http://www.formas.se; and Genetica Animal de Colombia Ltda., http://www.geneticaanimal.co (MNB); and Colfuturo-Colciencias, National PhD program 6172 https://www.colfuturo.org/scolciencias (MNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miguel Novoa Bravo is personal of the company Genetica Animal de Colombia Ltda. This funder provided support in the form of research materials, infrastructure, funding for research travel, and salary (after January the first 2018) for author MNB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Back W., 2013, EQUINE LOCOMOTION, V2nd; Barrey E, 2013, EQUINE LOCOMOT 2, P85; CLAYTON HM, 1995, APPL ANIM BEHAV SCI, V42, P153, DOI 10.1016/0168-1591(94)00539-Q; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fedequinas, 2006, CINCO SIGLOS HIST; Fegraeus KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177351; Fegraeus KJ, 2015, J HERED, V106, P734, DOI 10.1093/jhered/esv062; Fonseca MG, 2017, J EQUINE VET SCI, V53, P64, DOI 10.1016/j.jevs.2016.01.015; Fox J., 2014, COMPANION APPL REGRE; Friendly M, 2007, J COMPUT GRAPH STAT, V16, P421, DOI 10.1198/106186007x208407; Guisande C, 2014, RWIZARD SOFTWARE V 1; Hendricks B., 2007, INT ENCY HORSE BREED; Hinkle D.E., 2003, APPL STAT BEHAV SCI; Hobbs SJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2190; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; Ishihara A, 2009, JAVMA-J AM VET MED A, V234, P644, DOI 10.2460/javma.234.5.644; Jaderkvist K, 2014, J ANIM SCI, V92, P4279, DOI [10.2527/jas2014-7803, 10.2527/jas.2014-7803]; Keegan KG, 2007, VET CLIN N AM-EQUINE, V23, P403, DOI 10.1016/j.cveq.2007.04.008; Kramer J., 2004, Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, P231, DOI 10.1016/B978-0-7020-2671-3.50017-9; Kristjansson T, 2014, J ANIM BREED GENET, V131, P415, DOI 10.1111/jbg.12112; Nicodemus MC, 2003, APPL ANIM BEHAV SCI, V80, P133, DOI 10.1016/S0168-1591(02)00219-8; Novoa MA, 2016, J ANIM SCI, V94, P113, DOI 10.2527/jas2016.94supplement4113a; Parsons KJ, 2008, EFFECT INCLINE STRID, P935, DOI [10.1242/jeb.006650, DOI 10.1242/JEB.006650]; Patterson L, 2015, ANIM GENET, V46, P213, DOI 10.1111/age.12273; Pfau T, 2016, EQUINE VET EDUC, V28, P209, DOI 10.1111/eve.12372; Pritchard JK, 2000, GENETICS, V155, P945; Promerova M, 2014, ANIM GENET, V45, P274, DOI 10.1111/age.12120; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhodin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176253; Ricard A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0095-7; Robilliard JJ, 2007, J EXP BIOL, V210, P187, DOI 10.1242/jeb.02611; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Venables WN., 2002, MODERN APPL STAT S 4; Yamanobe A., 1992, Japanese Journal of Equine Science, V3, P143; Zips S, 2001, Equine Vet J Suppl, P109	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202584	10.1371/journal.pone.0202584	http://dx.doi.org/10.1371/journal.pone.0202584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118522	gold, Green Published, Green Submitted			2022-12-26	WOS:000442282700036
J	Gountas, I; Sypsa, V; Blach, S; Razavi, H; Hatzakis, A				Gountas, Ilias; Sypsa, Vana; Blach, Sarah; Razavi, Homie; Hatzakis, Angelos			HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ANTIVIRAL TREATMENT; PREVENTION; INFECTION; REINFECTION; IMPACT; INTERVENTIONS; EPIDEMIOLOGY; TRANSMISSION; PROJECTIONS	Background Elimination of hepatitis C virus (HCV) among people who inject drugs (PWID) is a costly investment, so strategies should not only focus on eliminating the disease, but also on preventing disease resurgence. The aims of this study are to compute the minimum necessary antiviral therapies to achieve elimination with and without the additional expansion of harm reduction (HR) programs and to examine the sustainability of HCV elimination after 2030 if treatment is discontinued. Method We considered two types of epidemic (with low (30%) and high (50%) proportion of PWID who engage in sharing equipment (sharers)) within three baseline chronic HCV (CHC) prevalence settings (30%, 45% and 60%), assuming a baseline HR coverage of 40%. We define sustainable elimination strategies, those that could maintain eliminations results for a decade (2031-2040), in the absence of additional treatment. Results The model shows that the optimum elimination strategy is dependent on risk sharing behavior of the examined population. The necessary annual treatment coverage to achieve HCV elimination under 45% baseline CHC prevalence, without the simultaneous expansion of HR programs, ranges between 4.7-5.1%. Similarly, under 60% baseline CHC prevalence the needed treatment coverage varies from 9.0-10.5%. Increasing HR coverage from 40% to 75%, reduces the required treatment coverage by 6.5-9.8% and 11.0-15.0% under 45% or 60% CHC prevalence, respectively. In settings with <= 45% baseline CHC prevalence, expanding HR to 75% could prevent the disease from rebounding after elimination, irrespective of the type of the epidemic. In high chronic HCV prevalence, counseling interventions to reduce sharing are also needed to maintain the HCV incident cases in low levels. Conclusions Harm reduction strategies have a vital role in HCV elimination strategy, as they reduce the required number of treatments to eliminate HCV and they provide sustainability after the elimination. The above underlines that HCV elimination strategies should be built upon the existing HR services, and argue for HR expansion in countries without services.	[Gountas, Ilias; Sypsa, Vana; Hatzakis, Angelos] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Gountas, Ilias; Blach, Sarah; Razavi, Homie] Ctr Dis Anal, Lafayette, CO USA	Athens Medical School; National & Kapodistrian University of Athens	Gountas, I (corresponding author), Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece.; Gountas, I (corresponding author), Ctr Dis Anal, Lafayette, CO USA.	hgkoyntas@med.uoa.gr	Gountas, Ilias/AAU-3690-2020; Blach, Sarah/J-5833-2019	Blach, Sarah/0000-0002-9252-7576; Razavi, Homie/0000-0002-2658-6930; SYPSA, VANA/0000-0002-9430-7614	Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases; Hellenic Foundation for Research and Innovation	Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases; Hellenic Foundation for Research and Innovation	The study was funded by the Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases (IG). The PhD of Ilias Gountas was funded by the Hellenic Foundation for Research and Innovation (http://www.elidek.gr/en/homepage).	Burki T, 2014, LANCET INFECT DIS, V14, P452, DOI 10.1016/S1473-3099(14)70704-2; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P603; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Cousien A, 2016, HEPATOLOGY, V63, P1090, DOI 10.1002/hep.28227; EMCDDA, 2017, STAT B 2017 HLTH SOC; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Fraser H, 2018, J HEPATOL, V68, P402, DOI 10.1016/j.jhep.2017.10.010; Fraser H, 2018, ADDICTION, V113, P173, DOI 10.1111/add.13948; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gountas I, 2017, ADDICTION, V112, P1290, DOI 10.1111/add.13764; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Heimer R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S6-S12; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Homie Razavi FC, 2015, HEPATITIS C VIRUS HC; Islam N, 2017, LANCET GASTROENTEROL, V2, P200, DOI 10.1016/S2468-1253(16)30182-0; Lima VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143836; Martin NK, 2017, J HEPATOL, V67, P5, DOI 10.1016/j.jhep.2017.03.008; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Mathei C, 2016, ACTA GASTRO-ENT BELG, V79, P227; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Philip B, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14543; Platt L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012021.pub2; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Razavi-Shearer D DO, 2016, 5 INT S HEP CAR SUBS; Rolls DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078286; Scott N, 2017, GUT, V66, P1507, DOI 10.1136/gutjnl-2016-311504; Shafran SD, 2015, CLIN INFECT DIS, V61, P1127, DOI 10.1093/cid/civ438; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Stroffolini T, 2012, J MED VIROL, V84, P1608, DOI 10.1002/jmv.23370; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P809, DOI 10.1111/j.1365-2893.2008.01041.x; Sweeting MJ, 2009, STAT METHODS MED RES, V18, P381, DOI 10.1177/0962280208094704; Sweeting MJ, 2009, AM J EPIDEMIOL, V170, P352, DOI 10.1093/aje/kwp141; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Vickerman P, 2014, ADDICTION, V109, P2060, DOI 10.1111/add.12750; Wenz B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3545-4; World Health Organization, 2015, GLOB HLTH SECT STRAT	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202109	10.1371/journal.pone.0202109	http://dx.doi.org/10.1371/journal.pone.0202109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114207	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400043
J	Sedra, L; Paluzzi, JP; Lange, AB				Sedra, Laura; Paluzzi, Jean-Paul; Lange, Angela B.			Characterization and expression of a long neuropeptide F (NPF) receptor in the Chagas disease vector Rhodnius prolixus	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DESERT LOCUST; CLONING; PHOSPHORYLATION; PREDICTION; PEPTIDES; MODEL	In this study, a long neuropeptide F receptor of the blood-feeding hemipteran, Rhodnius prolixus (RhoprNPFR) has been cloned and characterized. Approximately 70% of the RhoprNPFR deduced protein sequence is identical to that of other hemipteran NPFRs. RhoprNPFR has seven highly-conserved transmembrane domains, two cysteine residues in the 2nd and 3rd extracellular loops that likely form a disulfide bond integral for maintaining the structure of the receptor, and a conserved DRY motif after the third transmembrane domain. All of these characteristics are typical of class A rhodopsin-like GPCRs. The receptor transcript is predominantly expressed in the central nervous system (CNS) and gut of both fifth instar and adult R. prolixus. Using fluorescent in situ hybridization (FISH), we identified six bilaterally-paired large median neurosecretory cells (approximately 30 mu m in diameter) in the brain that express the RhoprNPFR mRNA transcript. We also found RhoprNPFR transcript expression in endocrine cells in the anterior midgut of fifth instars, as well as in putative pre-follicular cells present in the germarium and between developing oocytes, and in the nutritive cord. These results suggest that RhoprNPFR may play a role within the CNS, and in digestion and possibly egg production and/or egg development in R. prolixus.	[Sedra, Laura; Lange, Angela B.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Paluzzi, Jean-Paul] York Univ, Dept Biol, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; York University - Canada	Sedra, L (corresponding author), Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada.	laura.sedra@mail.utoronto.ca		Sedra, Laura/0000-0001-7157-5256	NSERC Discovery grant [RGPIN 2014-06253]; NSERC Discovery Grants	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by NSERC Discovery grant number RGPIN 2014-06253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Nikki Sarkar for maintaining the insect colony and Meet Zandawala for training in molecular biology. Research conducted in this study was funded through NSERC Discovery Grants to A.B.L. and J.P.P.	Arey BJ, 2012, GLYCOSYLATION, P273, DOI 10.5772/50262; Biasini M, 2014, NUCLEIC ACIDS RES, P42, DOI [10.1093/nar/gku340, DOI 10.1093/NAR/GKU340]; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Cerstiaens A, 1999, PEPTIDES, V20, P39, DOI 10.1016/S0196-9781(98)00152-1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Garczynski SF, 2005, PEPTIDES, V26, P99, DOI 10.1016/j.peptides.2004.07.014; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Gonzalez R, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5701; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hou L, 2017, ELIFE, V6, DOI [10.7554/eLife.22526, 10.7554/elife.22526]; IISMAA T P, 1992, Current Opinion in Cell Biology, V4, P195, DOI 10.1016/0955-0674(92)90033-9; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kim JH, 2008, ARCH PHARM RES, V31, P474, DOI 10.1007/s12272-001-1181-x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068897; Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, p1 ; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Ons S, 2016, INSECT BIOCHEM MOLEC, V69, P34, DOI 10.1016/j.ibmb.2015.05.003; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paluzzi JP, 2008, ENDOCRINOLOGY, V149, P4638, DOI 10.1210/en.2008-0353; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoofs L, 2017, ANNU REV ENTOMOL, V62, P35, DOI 10.1146/annurev-ento-031616-035500; Sedra L, 2016, PEPTIDES, V82, P1, DOI 10.1016/j.peptides.2016.05.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tensen CP, 1998, EUR J NEUROSCI, V10, P3409, DOI 10.1046/j.1460-9568.1998.00350.x; Van Wielendaele P, 2013, INSECT BIOCHEM MOLEC, V43, P252, DOI 10.1016/j.ibmb.2012.12.004; Van Wielendaele P, 2013, INSECT BIOCHEM MOLEC, V43, P102, DOI 10.1016/j.ibmb.2012.10.002	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202425	10.1371/journal.pone.0202425	http://dx.doi.org/10.1371/journal.pone.0202425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114273	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400070
J	Shi, YC; Liu, Y; Zhang, SZ; Zou, R; Tang, JM; Mu, WX; Peng, Y; Dong, SS				Shi, Yancai; Liu, Yang; Zhang, Shouzhou; Zou, Rong; Tang, Jianmin; Mu, Weixue; Peng, Yang; Dong, Shanshan			Assembly and comparative analysis of the complete mitochondrial genome sequence of Sophora japonica 'JinhuaiJ2'	PLOS ONE			English	Article							EVOLUTION; MUTATION; GENES; FLAVONOIDS; GENERATION; ANGIOSPERM; SEPARATION; DYNAMICS; ACCURATE; RUTIN	Sophora japonica L. (Faboideae, Leguminosae) is an important traditional Chinese herb with a long history of cultivation. Its flower buds and fruits contain abundant flavonoids, and therefore, the plants are cultivated for the industrial extraction of rutin. Here, we determined the complete nucleotide sequence of the mitochondrial genome of S. japonica 'JinhuaiJ2', the most widely planted variety in Guangxi region of China. The total length of the mtDNA sequence is 484,916 bp, with a GC content of 45.4%. Sophora japonica mtDNA harbors 32 known protein-coding genes, 17 tRNA genes, and three rRNA genes with 17 cis-spliced and five trans-spliced introns disrupting eight protein-coding genes. The gene coding and intron regions, and intergenic spacers account for 7.5%, 5.8% and 86.7% of the genome, respectively. The gene profile of S. japonica mitogenome differs from that of the other Faboideae species by only one or two gene gains or losses. Four of the 17 cis-spliced introns showed distinct length variations in the Faboideae, which could be attributed to the homologous recombination of the short repeats measuring a few bases located precisely at the edges of the putative deletions. This reflects the importance of small repeats in the sequence evolution in Faboideae mitogenomes. Repeated sequences of S. japonica mitogenome are mainly composed of small repeats, with only 20 medium-sized repeats, and one large repeat, adding up to 4% of its mitogenome length. Among the 25 pseudogene fragments detected in the intergenic spacer regions, the two largest ones and their corresponding functional gene copies located in two different sets of medium-sized repeats, point to their origins from homologous recombinations. As we further observed the recombined reads associated with the longest repeats of 2,160 bp with the PacBio long read data set of just 15 x in depth, repeat mediated homologous recombinations may play important role in the mitogenomic evolution of S. japonica. Our study provides insightful knowledge to the genetic background of this important herb species and the mitogenomic evolution in the Faboideae species.	[Shi, Yancai; Zou, Rong; Tang, Jianmin] Chinese Acad Sci, Guangxi Inst Bot, Guilin, Guangxi, Peoples R China; [Liu, Yang; Zhang, Shouzhou; Peng, Yang; Dong, Shanshan] Fairy Lake Bot Garden, Shenzhen, Guangdong, Peoples R China; [Liu, Yang; Zhang, Shouzhou; Peng, Yang; Dong, Shanshan] Chinese Acad Sci, Shenzhen, Guangdong, Peoples R China; [Liu, Yang; Mu, Weixue] BGI Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Beijing Genomics Institute (BGI)	Dong, SS (corresponding author), Fairy Lake Bot Garden, Shenzhen, Guangdong, Peoples R China.; Dong, SS (corresponding author), Chinese Acad Sci, Shenzhen, Guangdong, Peoples R China.	shangrilass@163.com		dong, shanshan/0000-0002-2557-3361; Mu, Weixue/0000-0002-2675-261X	National Science Foundation of China [31600171, 31470314]; Fairy Lake Science Foundation [FLSF2017-03]; Natural Science Foundation of Guangxi [2017JXNSFBA198011]; Basic Business Expenses Project of Guangxi Academy of Sciences [2017YJJ23010]; Agricultural Science and Technology Achievement Transformation Fund Project [Guikezhuan1222017-13]; BGI-Shenzhen	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fairy Lake Science Foundation; Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Basic Business Expenses Project of Guangxi Academy of Sciences; Agricultural Science and Technology Achievement Transformation Fund Project; BGI-Shenzhen	This project is funded by the National Science Foundation of China (31600171, 31470314), Fairy Lake Science Foundation (FLSF2017-03), Natural Science Foundation of Guangxi (2017JXNSFBA198011), Basic Business Expenses Project of Guangxi Academy of Sciences (2017YJJ23010), Agricultural Science and Technology Achievement Transformation Fund Project (Guikezhuan1222017-13). The funder [BGI-Shenzhen] provided support in the form of salaries for authors [Y. Liu & W. Mu], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Cheng N, 2017, NEW PHYTOL, V213, P751, DOI 10.1111/nph.14158; Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1; Davila JI, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-64; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Grewe F, 2015, INT PLANT AN GEN C 2; Gualberto JM, 2017, ANNU REV PLANT BIOL, V68, P225, DOI 10.1146/annurev-arplant-043015-112232; Gualberto JM, 2014, BIOCHIMIE, V100, P107, DOI 10.1016/j.biochi.2013.09.016; Guardia T, 2001, FARMACO, V56, P683, DOI 10.1016/S0014-827X(01)01111-9; Guo WH, 2016, MOL BIOL EVOL, V33, P1448, DOI 10.1093/molbev/msw024; Hilker R, 2012, BIOINFORMATICS, V28, P2509, DOI 10.1093/bioinformatics/bts440; ISHIDA H, 1989, CHEM PHARM BULL, V37, P1616, DOI 10.1248/cpb.37.1616; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kazakoff SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051687; Kim JM, 2008, ARCH PHARM RES, V31, P886, DOI 10.1007/s12272-001-1242-1; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lin CP, 2016, MITOCHONDRIAL DNA A, V27, P3731, DOI 10.3109/19401736.2015.1079879; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Mower JP., 2012, PLANT MITOCHONDRIAL; Naito K, 2013, BREEDING SCI, V63, P176, DOI 10.1270/jsbbs.63.176; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Salmela L, 2014, BIOINFORMATICS, V30, P3506, DOI 10.1093/bioinformatics/btu538; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Skippington E, 2015, P NATL ACAD SCI USA, V112, pE3515, DOI 10.1073/pnas.1504491112; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sun AL, 2007, J SEP SCI, V30, P1013, DOI 10.1002/jssc.200600334; Wickham H., 2015, WIRES COMP STAT, V3, P180; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; [严军 YAN Jun], 2007, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V29, P41; Yang J, 2016, PLANT BIOLOGY, V18, P527, DOI 10.1111/plb.12414; Yang JX, 2008, LWT-FOOD SCI TECHNOL, V41, P1060, DOI 10.1016/j.lwt.2007.06.010; Yang T., 2017, RES PROGR EXTRACTION, V6	46	13	14	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202485	10.1371/journal.pone.0202485	http://dx.doi.org/10.1371/journal.pone.0202485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114217	Green Submitted, gold, Green Published			2022-12-26	WOS:000441850400076
J	Fukuma, S; Kimachi, M; Omae, K; Kataoka, Y; Yamazaki, H; Muto, M; Akizawa, T; Yanagita, M; Fukuhara, S				Fukuma, Shingo; Kimachi, Miho; Omae, Kenji; Kataoka, Yuki; Yamazaki, Hajime; Muto, Manabu; Akizawa, Tadao; Yanagita, Motoko; Fukuhara, Shunichi			Dialysis physicians' referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PRACTICE PATTERNS; AMERICAN-COLLEGE; URINARY-TRACT; DIAGNOSIS; KIDNEY; POPULATION; GUIDELINES; MANAGEMENT; OUTCOMES	Background Although cancer management in dialysis patients has become a commonly encountered issue, known as "onco-nephrology", few evidence-based clinical recommendations have been proposed. Here, we examined the variation in referral behaviors adopted by dialysis physicians on encountering dialysis patients with signs/symptoms suggestive of cancer. Methods We conducted a vignette-based study in August 2015. We sent a 14-page questionnaire to 191 dialysis physicians, including the representative dialysis facilities participating in a Japanese dialysis cohort (the Japan Dialysis Outcomes and Practice Patterns Study). Using vignette scenarios for respiratory, digestive, and urological areas, we assessed the referral behaviors (expert referral or not) adopted by dialysis physicians on encountering dialysis patients with symptoms suggestive of cancer. Each scenario contained three patient functional factors: age (60 or 75 years), performance status (PS 0 or 1), and cognitive dysfunction (absence or presence). We examined the association between physician factors, patient factors, and referral behaviors. Results We obtained 94 replies (response rate: 49.2%). For the respiratory scenarios, 38.3% and 51.9% of physicians reported watchful waiting when encountering bilateral and unilateral pleural effusion, respectively. In digestive and urologic scenarios, most physicians (>85%) selected expert referral. We detected differences in referral behaviors between scenarios with different cancer biological factors. However, we found consistency in referral behaviors within the same scenario, even with different patient functional factors (intra-class correlation coefficients within each scenario all >0.7). Conclusions Physicians' referral behaviors for dialysis patients suspected of having cancer vary for different cancer biological factors (probability of having cancer). However, the referral behaviors are similar for different patient functional factors (age, PS, and cognitive dysfunction).	[Fukuma, Shingo] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Kyoto, Japan; [Kimachi, Miho; Kataoka, Yuki; Yamazaki, Hajime; Fukuhara, Shunichi] Kyoto Univ, Sch Publ Hlth, Dept Healthcare Epidemiol, Grad Sch Med, Kyoto, Kyoto, Japan; [Omae, Kenji] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Fukushima, Japan; [Kataoka, Yuki] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan; [Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto, Kyoto, Japan; [Akizawa, Tadao] Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Tokyo, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Kyoto, Japan	Kyoto University; Kyoto University; Fukushima Medical University; Kyoto University; Showa University; Kyoto University	Fukuma, S (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Kyoto, Japan.	fukuma.shingo.3m@kyoto-u.ac.jp	KATAOKA, Yuki/I-6026-2019; Fukuma, Shingo/S-6584-2019; Omae, Kenji/AAD-3200-2022; Yanagita, Motoko/AAJ-7731-2021; Omae, Kenji/H-8620-2019; KATAOKA, Yuki/GRR-4808-2022	KATAOKA, Yuki/0000-0001-7982-5213; Fukuma, Shingo/0000-0002-8379-8761; Omae, Kenji/0000-0003-0109-7425; Omae, Kenji/0000-0003-0109-7425; KATAOKA, Yuki/0000-0001-7982-5213; Yamazaki, Hajime/0000-0002-9034-4370; Yanagita, Motoko/0000-0002-0339-9008	scientific research grants from Kyowa Hakko Kirin Co. Ltd.	scientific research grants from Kyowa Hakko Kirin Co. Ltd.	This study is supported by scientific research grants from Kyowa Hakko Kirin Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakirci T, 2007, TRANSPL P, V39, P889, DOI 10.1016/j.transproceed.2007.02.020; Baldwin LM, 2012, ANN INTERN MED, V156, P182, DOI 10.7326/0003-4819-156-3-201202070-00006; Bonsib SM, 2009, CLIN J AM SOC NEPHRO, V4, P1998, DOI 10.2215/CJN.02020309; Braun V., 2022, THEMATIC ANAL PRACTI; Butler AM, 2015, AM J KIDNEY DIS, V65, P763, DOI 10.1053/j.ajkd.2014.12.013; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Chertow GM, 1996, ARCH INTERN MED, V156, P1345, DOI 10.1001/archinte.156.12.1345; Cohen EP, 2015, AM J KIDNEY DIS, V66, P869, DOI 10.1053/j.ajkd.2015.04.042; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; Davis R, 2012, J UROLOGY, V188, P2473, DOI 10.1016/j.juro.2012.09.078; Detterbeck FC, 2013, CHEST, V143, p7S, DOI 10.1378/chest.12-2377; Erickson KF, 2017, AM J KIDNEY DIS, V69, P237, DOI 10.1053/j.ajkd.2016.08.033; Holley JL, 2007, CLIN J AM SOC NEPHRO, V2, P604, DOI 10.2215/CJN.03931106; Holley JL, 2000, SEMIN DIALYSIS, V13, P369, DOI 10.1046/j.1525-139x.2000.00101.x; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Janus N, 2013, ANN ONCOL, V24, P501, DOI 10.1093/annonc/mds344; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kimachi M, 2015, NEPHRON, V131, P123, DOI 10.1159/000438870; Krause R, 2012, ANTICANCER RES, V32, P391; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lin MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122856; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Muller-Engelmann M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-260; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; Nielsen M, 2016, ANN INTERN MED, V164, P488, DOI 10.7326/M15-1496; Provenzale D, 2015, J NATL COMPR CANC NE, V13, P959, DOI 10.6004/jnccn.2015.0116; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Salahudeen AK, 2013, J AM SOC NEPHROL, V24, P26, DOI 10.1681/ASN.2012070690; Shebl FM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-65; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Taneja S, 2007, CLIN J AM SOC NEPHRO, V2, P1008, DOI 10.2215/CJN.00310107; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998; Wong G, 2009, NEPHROL DIAL TRANSPL, V24, P2136, DOI 10.1093/ndt/gfp009; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202322	10.1371/journal.pone.0202322	http://dx.doi.org/10.1371/journal.pone.0202322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110392	Green Published, Green Submitted, gold			2022-12-26	WOS:000441738000062
J	Pilipovic-Broceta, N; Vasiljevic, N; Marinkovic, J; Todorovic, N; Jankovic, J; Ostric, I; Kalimanovska-Ostric, D; Racic, M				Pilipovic-Broceta, Natasa; Vasiljevic, Nadja; Marinkovic, Jelena; Todorovic, Nevena; Jankovic, Janko; Ostric, Irena; Kalimanovska-Ostric, Dimitra; Racic, Maja			Assessment of hypertension chronic care model: Pacic application in Bosnia and Herzegovina	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; TEAM-BASED CARE; CHRONIC DISEASE; MANAGEMENT; COMMUNITY; PREVENTION; SYSTEMS; HEALTH	The objectives of this study were to evaluate patients' attitudes towards hypertension treatment according to the chronic care model and to assess the implementation of hypertension clinical guidelines in family medicine. The cross-sectional study was carried out in two randomly selected primary health care centers (Bijeljina and Prijedor), respectively in Bosnia and Herzegovina, covering the period between March and April 2016. This study sample consists of 791 respondents with hypertension purposing to measure specific actions and quality of care for hypertensive patients. The Patient Assessment of Chronic Illness Care (PACIC) was used. Treatment for the indicators of hypertension was assessed by analyzing patients' medical charts according to the recommendations of clinical guidelines. More than half of the evaluated indicators of treatment for hypertension were documented in medical charts of 84.07% patients. The average overall PACIC score was 4.18 (SD 0.59), being an average of the separate scores of 4.19 (SD 0.57) in men and 4.17 (SD 0.60) in women. Subscale means of PACIC were as follows: patient activation 4.33, delivery system design 4.36; goal setting 4.03; problem solving 4.51; follow-up and co-ordination 3.67. No statistically significant correlations in the overall score and subscale scores were found by demographic characteristics. Non-smokers had a significantly higher overall score compared to smokers (p = 0.001). As implementation of the guidelines became stronger, the reported PACIC scores rose. Continuing the education of patients in order to achieve better health care outcomes is imperative.	[Pilipovic-Broceta, Natasa; Todorovic, Nevena] Univ Banja Luka, Fac Med, Family Med Dept, Banja Luka, Bosnia & Herceg; [Pilipovic-Broceta, Natasa; Todorovic, Nevena] Primary Hlth Care Banja Luka, Family Med Teaching Ctr, Banja Luka, Bosnia & Herceg; [Vasiljevic, Nadja] Univ Belgrade, Fac Med, Inst Hyg & Med Ecol, Belgrade, Serbia; [Marinkovic, Jelena] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia; [Jankovic, Janko] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Ostric, Irena; Kalimanovska-Ostric, Dimitra] Univ Belgrade, Fac Med, Belgrade, Serbia; [Kalimanovska-Ostric, Dimitra] Clin Ctr Serbia, Inst Cardiovasc Dis, Belgrade, Serbia; [Racic, Maja] Univ East Sarajevo, Fac Med, Dept Primary Hlth Care & Publ Hlth, Foca, Bosnia & Herceg	University of Banja Luka (UNIBL); University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Pilipovic-Broceta, N (corresponding author), Univ Banja Luka, Fac Med, Family Med Dept, Banja Luka, Bosnia & Herceg.; Pilipovic-Broceta, N (corresponding author), Primary Hlth Care Banja Luka, Family Med Teaching Ctr, Banja Luka, Bosnia & Herceg.	natasa.pilipovic.broceta@gmail.com		Jankovic, Janko/0000-0002-2387-6596; Marinkovic, Jelena/0000-0001-8852-384X				AlMomen RK., 2015, IJCAR, V4, P378; Atun RA, 2007, HEALTH POLICY PLANN, V22, P28, DOI 10.1093/heapol/czl031; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Fortuna RJ, 2015, J AM SOC HYPERTENS, V9, P966, DOI 10.1016/j.jash.2015.10.004; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Horodnic AV, 2014, REV ROM BIOET, V12, P65; Houle SKD, 2014, CURR OPIN CARDIOL, V29, P344, DOI 10.1097/HCO.0000000000000071; Iglesias K, 2014, INT J QUAL HEALTH C, V26, P250, DOI 10.1093/intqhc/mzu042; Jacob V, 2015, AM J PREV MED, V49, P772, DOI 10.1016/j.amepre.2015.04.003; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Janjic B, 2009, OBOLJENJA KARDIOVASK; Koley Munmun, 2016, J Tradit Complement Med, V6, P72, DOI 10.1016/j.jtcme.2014.11.020; Krucien N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-269; Lewanczuk R, 2008, CAN J CARDIOL, V24, P483, DOI 10.1016/S0828-282X(08)70622-6; Liu CL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073010, DOI 10.1371/JOURNAL.PONE.0073010]; Low W H H, 2013, Med J Malaysia, V68, P129; Ludt S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-221; Patel P, 2016, J CLIN HYPERTENS, V18, P1284, DOI 10.1111/jch.12861; Petersen JJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-336; Pilipovic-Broceta N, 2018, EJPCH, V6, P12, DOI DOI 10.5750/EJPCH.V6I1.1368; Proia KK, 2014, AM J PREV MED, V47, P86, DOI 10.1016/j.amepre.2014.03.004; Public Health Institute of Republic of Srpska, 2014, AN POP HLTH REP SRPS; Reboussin DM, 2018, CIRCULATION, V138, pE595, DOI 10.1161/CIR.0000000000000601; Republic of Srpska Government. Ministry of Health and Social Welfare, 2004, PRIMARY HLTH CARE ST; Rick J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-293; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Zhang YT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4141-y	34	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202250	10.1371/journal.pone.0202250	http://dx.doi.org/10.1371/journal.pone.0202250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106998	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800032
J	Gottert, A; Pulerwitz, J; Siu, G; Katahoire, A; Okal, J; Ayebare, F; Jani, N; Keilig, P; Mathur, S				Gottert, Ann; Pulerwitz, Julie; Siu, Godfrey; Katahoire, Anne; Okal, Jerry; Ayebare, Florence; Jani, Nrupa; Keilig, Pamela; Mathur, Sanyukta			Male partners of young women in Uganda: Understanding their relationships and use of HIV testing	PLOS ONE			English	Article							RISK BEHAVIORS; RURAL UGANDA; MEN; PREVENTION; AFRICA; INFECTION; VIOLENCE; GENDER; SEX	Background Substantial concern exists about the high risk of sexually transmitted HIV to adolescent girls and young women (AGYW, ages 15-24) in Eastern and Southern Africa. Yet limited research has been conducted with AGYW's male sexual partners regarding their perspectives on relationships and strategies for mitigating HIV risk. We sought to fill this gap in order to inform the DREAMS Partnership and similar HIV prevention programs in Uganda. Methods We conducted 94 in-depth interviews, from April-June 2017, with male partners of AGYW in three districts: Gulu, Mukono, and Sembabule. Men were recruited at community venues identified as potential transmission areas, and via female partners enrolled in DREAMS. Analyses focused on men's current and recent partnerships and HIV service use. Results Most respondents (80%) were married and 28 years old on average. Men saw partner concurrency as pervasive, and half described their own current multiple partners. Having married in their early 20s, over time most men continued to seek out AGYW as new partners, regardless of their own age. Relationships were highly fluid, with casual short-term partnerships becoming more formalized, and more formalized partnerships characterized by periods of separation and outside partnerships. Nearly all men reported recent HIV testing and described testing at distinct relationship points (e.g., when deciding to continue a relationship/get married, or when reuniting with a partner after a separation). Testing often stemmed from distrust of partner behavior, and an HIV-negative status served to validate respondents' current relationship practices. Conclusions Across the three regions in Uganda, findings with partners of AGYW confirm earlier reports in Uganda of multiple concurrent partnerships, and demonstrate substantial HIV testing. Yet they also unearth the degree to which these partnerships are fluid (switching between casual and/or more long-term partnerships), which complicates potential HIV prevention strategies. Context-specific findings around these partnerships and risk are critical to further tailor HIV prevention programs.	[Gottert, Ann; Pulerwitz, Julie; Jani, Nrupa; Keilig, Pamela; Mathur, Sanyukta] Populat Council, HIV & AIDS Program, Washington, DC USA; [Siu, Godfrey; Katahoire, Anne; Ayebare, Florence] Makerere Univ, Child Hlth & Dev Ctr, Kampala, Uganda; [Okal, Jerry] Populat Council, HIV & AIDS Program, Nairobi, Kenya	Population Council; Makerere University	Gottert, A (corresponding author), Populat Council, HIV & AIDS Program, Washington, DC USA.	agottert@popcouncil.org		Mathur, Sanyukta/0000-0003-1645-6734; Jani, Nrupa/0000-0001-6768-9963	Bill & Melinda Gates Foundation [OPP1150068, OPP1136778]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Numbers OPP1150068 and OPP1136778, https://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Creswell J. W., 2017, QUAL INQ; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Francisco L, 2013, VIOLENCE AGAINST WOM, V19, P814, DOI 10.1177/1077801213497557; Gottert A, 2017, GENDER NORMS GENDER, P1; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Higgins JA, 2014, AM J PUBLIC HEALTH, V104, P612, DOI 10.2105/AJPH.2013.301670; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Isbell MT, 2016, LANCET HIV, V3, pE284, DOI 10.1016/S2352-3018(16)30058-3; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Mathur S, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0123-x; Mathur S, 2016, CULT HEALTH SEX, V18, P538, DOI 10.1080/13691058.2015.1091508; Matovu JKB, 2012, INT J STD AIDS, V23, P267, DOI 10.1258/ijsa.2011.011313; Mills EJ, 2009, LANCET, V374, P275, DOI 10.1016/S0140-6736(09)61348-9; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; PEPFAR, 2015, PEPFAR 2015 ANN REP; PEPFAR, 2018, WORK TOG AIDS FREE F; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P282, DOI 10.1177/003335491012500219; Ritchwood TD, 2016, JAIDS-J ACQ IMM DEF, V72, P423, DOI 10.1097/QAI.0000000000000988; Rutakumwa R, 2015, CULT HEALTH SEX, V17, P1237, DOI 10.1080/13691058.2015.1053413; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Siu GE, 2017, EUR J DEV RES, V29, P1017, DOI 10.1057/s41287-017-0103-6; Siu GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-33; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Uganda AIDS Commission, 2015, HIV AIDS UG COUNTR P; Uganda Bureau of Statistics, 2016, UG DEM HLTH SURV 201; UNAIDS, 2016, GET FAST TRACK LIFE; UNAIDS, 2014, THE GAP REP; World Health Organization, 2015, CONS STRAT INF GUID	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0200920	10.1371/journal.pone.0200920	http://dx.doi.org/10.1371/journal.pone.0200920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ0KU	30096147	gold, Green Published, Green Submitted			2022-12-26	WOS:000441308500008
J	Qiao, S; Li, XM; Zhou, YJ; Shen, ZY; Stanton, B				Qiao, Shan; Li, Xiaoming; Zhou, Yuejiao; Shen, Zhiyong; Stanton, Bonita			Attitudes toward evidence-based practices, occupational stress and work-related social support among health care providers in China: A SEM analysis	PLOS ONE			English	Article							MENTAL-HEALTH; INNOVATION IMPLEMENTATION; JOB-SATISFACTION; FAMILY CONFLICT; READINESS; ADOPTION; ORGANIZATION; PREDICTORS; ENGAGEMENT; CREATIVITY	Individuals' attitudes toward evidence-based practices (EBP) are critical in adopting, implementing and maintaining the EBP in clinical settings. Multiple empirical studies have examined how work context may shape perceptions and attitudes towards EBP. The current study aims to further explore how both work and family contexts, as assessed by three psychosocial indicators (i.e., occupational stress, work-related social support from coworkers, and work-related social support from family), may affect attitudes toward EBP among health care providers in HIV clinics in China. We analyzed cross-sectional survey data from 357 health care providers recruited from 40 HIV clinics across 16 cities/counties in Guangxi China. Structural equation model (SEM) was constructed to test the hypothesized relationships among key study variables. Occupational stress was negatively associated with workrelated social support from coworkers (beta = -.19, 95%CI = [-.31 ,-.12]), which in turn was positively associated with attitudes toward EBP (beta = .17, 95%CI = [.04, .30]). Similarly, occupational stress was negatively related to work-related social support from family (beta = -.34, 95% CI = [-.42,-.25]), which in turn was positively related to attitudes toward EBP (beta = .23, 95%CI = [.12, .35]). Occupational stress was negatively associated with attitudes toward EBP, but the magnitude of association did not reach statistical significance at alpha = .05. Work-related social support from family partially mediated the association between occupational stress and attitudes toward EBP (Sobel's z = 3.27, p < .05). Our findings suggest the importance of integrating work and family contexts, especially family support into the strategies of facilitating the adoption and implementation of EBP. The current study also underscores the needs to reduce occupational stress and enhance work-related social support among health care providers who are in frequent contact with HIV patients. In addition, lack of work-related family support may be a main barrier preventing health care providers from developing a positive attitude toward EBP. Therefore, the interventions aiming for promoting adoption and utilization of EBP need to involve specific strategies to resolve work-family conflicts and improve family members' understanding and support for health care providers in China, especially those who work in a stressful work context such as HIV care.	[Qiao, Shan; Li, Xiaoming] Univ South Carolina, Arnold Sch Publ Hlth, South Carolina SmartState Ctr Healthcare Qual CHQ, Dept Hlth Promot Educ & Behav, Columbia, SC 29201 USA; [Zhou, Yuejiao; Shen, Zhiyong] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Stanton, Bonita] Seton Hall Univ, Hackensack Meridian Sch Med, S Orange, NJ 07079 USA	University of South Carolina System; University of South Carolina Columbia; Seton Hall University	Qiao, S (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, South Carolina SmartState Ctr Healthcare Qual CHQ, Dept Hlth Promot Educ & Behav, Columbia, SC 29201 USA.	shanqiao@mailbox.sc.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Qiao, Shan/0000-0003-1834-1834	NICHD [R01HD074221]; NIAID [R21AI122919]; NIDA [P30-DA027828, IS-02-08]; Ce-PIM (Center for Prevention Implementation Methodology for Drug Abuse and Sexual Risk Behavior) training program in Northwestern University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA027828] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ce-PIM (Center for Prevention Implementation Methodology for Drug Abuse and Sexual Risk Behavior) training program in Northwestern University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The current study was sponsored by NICHD (R01HD074221) (XL), NIAID (R21AI122919) (SQ), and NIDA (P30-DA027828) (IS-02-08) (SQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the support from Ce-PIM (Center for Prevention Implementation Methodology for Drug Abuse and Sexual Risk Behavior) training program in Northwestern University School of Medicine, particularly Drs. Hendricks Brown and Gregory A. Aarons.	Aarons GA, 2005, CHILD ADOL PSYCH CL, V14, P255, DOI 10.1016/j.chc.2004.04.008; Aarons GA, 2012, IMPLEMENT SCI, V7, DOI [10.1186/1748-5908-7-32, 10.1186/1748-5908-7-56]; Ajzen I., 1991, THEORY PLANNED BEHAV; Anaya HD, 2004, AM J MED QUAL, V19, P137, DOI 10.1177/106286060401900402; [Anonymous], 2017, LOW LEVEL NATL HIV E; Boerjan M, 2010, MED EDUC, V44, P835, DOI 10.1111/j.1365-2923.2010.03724.x; Byrne Barbara M., 2013, STRUCTURAL EQUATION; Chaudoir SR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-22; Cortese CG, 2010, J NURS MANAGE, V18, P35, DOI 10.1111/j.1365-2834.2009.01064.x; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Deo S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-106; Ding YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107130; Fang XY, 2009, J PEDIATR PSYCHOL, V34, P1053, DOI 10.1093/jpepsy/jsp006; Fiabane E, 2012, MED LAV, V103, P482; Fixsen D., 2005, IMPLEMENTATION RES S; Fuller BE, 2007, J SUBST ABUSE TREAT, V33, P183, DOI 10.1016/j.jsat.2006.12.026; Gan YQ, 2015, STRESS HEALTH, V31, P336, DOI 10.1002/smi.2572; Gandi Joshua C, 2011, Ment Health Fam Med, V8, P181; Garcia-Herrero S, 2013, ACCIDENT ANAL PREV, V57, P114, DOI 10.1016/j.aap.2013.04.009; Garcia-Izquierdo M, 2012, NURS OUTLOOK, V60, P322, DOI 10.1016/j.outlook.2012.02.002; Gray-Stanley JA, 2011, RES DEV DISABIL, V32, P1065, DOI 10.1016/j.ridd.2011.01.025; Hammond MM, 2011, PSYCHOL AESTHET CREA, V5, P90, DOI 10.1037/a0018556; Hatcher L., 2005, STEP BY STEP APPROAC; Holt DT, 2010, J GEN INTERN MED, V25, P50, DOI 10.1007/s11606-009-1112-8; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobs SR, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0657-3; Jacobsen HB, 2014, AM J IND MED, V57, P940, DOI 10.1002/ajim.22340; JOHNSON JV, 1993, SCAND J WORK ENV HEA, V19, P21, DOI 10.5271/sjweh.1508; KING LA, 1995, J ORGAN BEHAV, V16, P235, DOI 10.1002/job.4030160306; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Kossek EE, 2011, PERS PSYCHOL, V64, P289, DOI 10.1111/j.1744-6570.2011.01211.x; Madsen IEH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-698; Mark G, 2012, BRIT J HEALTH PSYCH, V17, P505, DOI 10.1111/j.2044-8287.2011.02051.x; Mark G, 2012, ANXIETY STRESS COPIN, V25, P63, DOI 10.1080/10615806.2010.548088; McCrae JS, 2014, CHILD YOUTH SERV REV, V37, P28, DOI 10.1016/j.childyouth.2013.12.001; Mohammadi MM, 2018, HEALTH PROMOT PERSPE, V8, P25, DOI 10.15171/hpp.2018.03; Nakata Akinori, 2012, Methods Mol Biol, V934, P39, DOI 10.1007/978-1-62703-071-7_3; Nutley S, 2000, PUBLIC MONEY MANAGE, V20, P35, DOI 10.1111/1467-9302.00234; Othman N, 2013, J NURS MANAGE, V21, P1083, DOI 10.1111/j.1365-2834.2012.01448.x; Parmar, 2015, PRODUCTIVITY, V56, P56; Pedrazza M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01238; Ha PN, 2013, GLOB PUBLIC HEALTH, V8, pS61, DOI 10.1080/17441692.2013.799217; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Preacher K.J., 2001, CALCULATION SOBEL TE, V20, P2009; Qi XY, 2015, J THEOR SOC BEHAV, V45, P141, DOI 10.1111/jtsb.12052; Raghavan R, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-26; Rapp CA, 2010, COMMUNITY MENT HLT J, V46, P112, DOI 10.1007/s10597-009-9238-z; Ren FF, 2015, CREATIVITY RES J, V27, P16, DOI 10.1080/10400419.2015.992659; REVICKI DA, 1991, BEHAV MED, V17, P111, DOI 10.1080/08964289.1991.9937554; Rossler W, 2012, EUR ARCH PSY CLIN N, V262, pS65, DOI 10.1007/s00406-012-0353-4; Rousseau V, 2010, J SOC PSYCHOL, V150, P321, DOI 10.1080/00224540903365380; Ruotsalainen JH, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002892.pub5; Ruzek JI, 2017, ADM POLICY MENT HLTH, V44, P123, DOI 10.1007/s10488-015-0689-y; Rycroft-Malone J, 2004, J CLIN NURS, V13, P913, DOI 10.1111/j.1365-2702.2004.01007.x; Rye M, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0573-0; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Tang Z., 2017, REV 12 5 YEAR PLAN S; Thanacoody P Rani, 2009, J Health Organ Manag, V23, P53; Toyama H, 2017, JPN PSYCHOL RES, V59, P14, DOI 10.1111/jpr.12139; West MA, 2002, APPL PSYCHOL-INT REV, V51, P355, DOI 10.1111/1464-0597.00951; Williams NJ, 2017, ADM POLICY MENT HLTH, V44, P269, DOI 10.1007/s10488-016-0742-5; Wu DYH, 1985, CHINESE CULTURE MENT, P7; Wu H, 2011, RES NURS HEALTH, V34, P401, DOI 10.1002/nur.20449; Xu WX, 2012, AM J IND MED, V55, P167, DOI 10.1002/ajim.21017; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	65	10	11	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202166	10.1371/journal.pone.0202166	http://dx.doi.org/10.1371/journal.pone.0202166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ0KU	30096206	Green Submitted, Green Published, gold			2022-12-26	WOS:000441308500055
J	Nises, J; Rosander, A; Pettersson, A; Backhans, A				Nises, Janna; Rosander, Anna; Pettersson, Ann; Backhans, Annette			The occurrence of Treponema spp. in gingival plaque from dogs with varying degree of periodontal disease	PLOS ONE			English	Article							NECROTIZING ULCERATIVE GINGIVITIS; SP NOV.; SACCHAROLYTIC SPIROCHETE; CANINE PERIODONTITIS; ORAL SPIROCHETE; RED COMPLEX; LESIONS; RNA; IDENTIFICATION; DENTICOLA	Periodontal disease is common in dogs and is initiated by gingival plaque composed of several hundred bacterial species. Some of these species have specifically been pointed out as potential periodontal pathogens, such as Treponema spp. Treponema spp. are difficult to culture and therefore the majority have been detected by culture-independent methods, such as PCR (Polymerise Chain Reaction). This leaves many Treponema spp. uncharacterized and unnamed. In this study, treponemes were investigated in gingival plaque from dogs with varying degree of periodontal disease with the aim to describe their occurrence and diversity in dogs. The methods used were culture, phase-contrast microscopy, PCR targeting the 1 6SrRNA-tRNAlle intergenic spacer region (ISR2), sequencing of the ISR2 and phylogenetic analysis. Treponema spp. were detected in samples from 10 out of 11 dogs and isolates were obtained from six dogs. Both healthy and periodontitis affected dogs were Treponema positive. Phylogenetic analysis, based on ISR2 sequences, revealed a large diversity of treponemes in the study population that were found to be distributed mainly in two groups, corresponding to the human oral treponeme phylogroups II (Treponema denticola) and IV (Treponema maltophilum) genetic groups. They were generally more distantly related to other treponemes in these groups. Treponemes from dogs with periodontitis and dogs with mild gingivitis without periodontitis did not differ in any obvious way. The results indicate that several phylotypes of oral treponemes are common in dogs regardless of periodontal status.	[Nises, Janna; Pettersson, Ann; Backhans, Annette] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Rosander, Anna] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Backhans, A (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	annette.backhans@slu.se		Rosander, Anna/0000-0002-0329-3027	Svenska Djurskyddsforeningen	Svenska Djurskyddsforeningen	This project was funded by a donation from Svenska Djurskyddsforeningen (http://www.djurskydd.org) to Ann Pettersson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CHAN ECS, 1993, INT J SYST BACTERIOL, V43, P196, DOI 10.1099/00207713-43-2-196; Dahlen G, 2012, J PERIODONTAL RES, V47, P354, DOI 10.1111/j.1600-0765.2011.01440.x; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Dewhirst FE, 2000, ORAL MICROBIOL IMMUN, V15, P196, DOI 10.1034/j.1399-302x.2000.150308.x; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Di Bello A, 2014, J SMALL ANIM PRACT, V55, P160, DOI 10.1111/jsap.12179; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Elliott DR, 2005, J CLIN MICROBIOL, V43, P5470, DOI 10.1128/JCM.43.11.5470-5476.2005; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; Harvey CE, 2012, J VET DENT, V29, P222, DOI 10.1177/089875641202900402; Hennet P R, 1991, J Vet Dent, V8, P16; Hennet P R, 1991, J Vet Dent, V8, P9; Hennet P R, 1991, J Vet Dent, V8, P18; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Klein Harry S., 1946, ACTA ODONTOL SCAND, V7, P92, DOI 10.3109/00016354609040426; Moter A, 2006, J CLIN MICROBIOL, V44, P3078, DOI 10.1128/JCM.00322-06; Niemiec B., 2012, VET PERIODONTOLOGY, DOI [DOI 10.1002/9781118705018, 10.1002/9781118705018]; Nordhoff M, 2008, VET MICROBIOL, V127, P334, DOI 10.1016/j.vetmic.2007.09.011; Norris S, 2011, BERGEYS MANUAL SYSTE, P501; Perez-Chaparro PJ, 2014, J DENT RES, V93, P846, DOI 10.1177/0022034514542468; Riviere G R, 1996, J Vet Dent, V13, P135; SMIBERT RM, 1984, INT J SYST BACTERIOL, V34, P457, DOI 10.1099/00207713-34-4-457; SMIBERT RM, 1983, INT J SYST BACTERIOL, V33, P852, DOI 10.1099/00207713-33-4-852; Stamm LV, 2002, J CLIN MICROBIOL, V40, P3463, DOI 10.1128/JCM.40.9.3463-3469.2002; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Svartstrom O, 2013, VET MICROBIOL, V166, P617, DOI 10.1016/j.vetmic.2013.07.005; Umemoto T, 1997, INT J SYST BACTERIOL, V47, P67, DOI 10.1099/00207713-47-1-67; Valdez M, 2000, J VET DENT, V17, P23; Wallis C, 2015, VET MICROBIOL, V181, P271, DOI 10.1016/j.vetmic.2015.09.003; Wyss C, 2004, INT J SYST EVOL MICR, V54, P1117, DOI 10.1099/ijs.0.02806-0; Wyss C, 1996, INT J SYST BACTERIOL, V46, P745, DOI 10.1099/00207713-46-3-745; Wyss C, 1997, INT J SYST BACTERIOL, V47, P842, DOI 10.1099/00207713-47-3-842; Wyss C, 1999, INT J SYST BACTERIOL, V49, P1329, DOI 10.1099/00207713-49-4-1329; Wyss C, 2001, INT J SYST EVOL MICR, V51, P955, DOI 10.1099/00207713-51-3-955	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201888	10.1371/journal.pone.0201888	http://dx.doi.org/10.1371/journal.pone.0201888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092089	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600065
J	Pietrzak, D; Pietrzak, A; Grywalska, E; Kicinski, P; Rolinski, J; Donica, H; Franciszkiewicz-Pietrzak, K; Borzecki, A; Socha, M; Niedzialek, J; Krasowska, D				Pietrzak, Daniel; Pietrzak, Aldona; Grywalska, Ewelina; Kicinski, Pawel; Rolinski, Jacek; Donica, Helena; Franciszkiewicz-Pietrzak, Kinga; Borzecki, Andrzej; Socha, Mateusz; Niedzialek, Jaroslaw; Krasowska, Dorota			Serum concentrations of interleukin 18 and 25-hydroxyvitamin D-3 correlate with depression severity in men with psoriasis	PLOS ONE			English	Article							VITAMIN-D STATUS; QUALITY-OF-LIFE; MAJOR DEPRESSION; HPA AXIS; SKIN; INFLAMMATION; ANXIETY; STRESS; BRAIN; IL-6	Objective Psoriasis and depression may have common mechanisms, such as systemic inflammation, dysfunction of the hypothalamic-pituitary-adrenal axis, and vitamin D-3 deficiency. Among men with psoriasis, this study examined whether depression severity was associated with serum concentrations of different metabolic and inflammatory markers. Methods The study included 85 men with psoriasis (mean age standard deviation [SD], 47 14 years) and 65 men without psoriasis (mean age SD, 44 13 years). In both groups, we measured the body mass index; blood pressure; and serum concentrations of lipids, uric acid, lipase, interleukins 6 and 18, cortisol, and 25-hydroxyvitamin D-3. All participants completed the Beck Depression Inventory. Other variables analyzed included psoriasis duration, the Psoriasis Area Severity Index, and the percentage of body surface area affected by psoriatic lesions. Results Compared with controls, patients with psoriasis had significantly greater depression severity, higher body mass indices, and higher serum concentrations of total cholesterol and interleukins 6 and 18; moreover, they had significantly lower serum 25-hydroxyvitamin D concentrations. In patients with psoriasis, depression severity correlated positively with psoriasis duration, the Psoriasis Area Severity Index, the percentage of body surface area affected by psoriatic lesions, and interleukin-18 concentration. In patients with psoriasis, depression severity correlated negatively with 25-hydroxyvitamin D-3 concentration, but it did not correlate significantly with the serum concentrations of interleukin 6 and cortisol. Conclusions High concentrations of interleukin 18 and low concentrations of 25-hydroxyvitamin D-3 may be associated with depression severity in men with psoriasis. Thus, further studies should examine whether effective anti-inflammatory treatments or vitamin D-3 supplementation can improve depression outcomes in these patients.	[Pietrzak, Daniel] Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland; [Pietrzak, Aldona; Krasowska, Dorota] Med Univ Lublin, Dept Dermatol Venereol & Pediat Dermatol, Lublin, Poland; [Grywalska, Ewelina; Rolinski, Jacek] Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland; [Kicinski, Pawel] Med Univ Lublin, Dept Expt Hematooncol, Lublin, Poland; [Kicinski, Pawel] St Johns Canc Ctr, Dept Hematol, Lublin, Poland; [Donica, Helena] Med Univ Lublin, Dept Biochem Diagnost, Lublin, Poland; [Franciszkiewicz-Pietrzak, Kinga] Med Univ Lublin, Dept Surg Oncol, Lublin, Poland; [Borzecki, Andrzej] Med Univ Lublin, Dept Hyg, Lublin, Poland; [Socha, Mateusz] 1st Mil Hosp Lublin, Dept Internal Med & Cardiol, Lublin, Poland; [Niedzialek, Jaroslaw] Jaroslaw Niedzialek Individual Med Practice, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Pietrzak, A (corresponding author), Med Univ Lublin, Dept Dermatol Venereol & Pediat Dermatol, Lublin, Poland.	aldonkapietrzak@o2.pl	Franciszkiewicz-Pietrzak, Kinga/AAT-9312-2020; Krasowska, Dorota/D-2609-2019; Kiciński, Paweł/AAU-3020-2021; Kiciński, Paweł/K-3839-2019	Krasowska, Dorota/0000-0002-3176-9870; Donica, Helena/0000-0003-0677-7825; Franciszkiewicz-Pietrzak, Kinga/0000-0003-1088-0104; Borzecki, Andrzej/0000-0001-5920-2262; Grywalska, Ewelina/0000-0002-0451-4741; Kicinski, Pawel/0000-0002-0142-4812; Rolinski, Jacek/0000-0003-4841-6120; Pietrzak, Aldona/0000-0001-9494-6160; Pietrzak, Daniel/0000-0001-9814-5061	Medical University of Lublin [DS 168, DS 460/2016]; Polish National Science Center [UMO-2011/01/N/NZ6/01762]	Medical University of Lublin; Polish National Science Center	The study was supported from the Medical University of Lublin funds (grants no. DS 168 and DS 460/2016) (https://www.umlub.pl), and from the Polish National Science Center funds (grant no. UMO-2011/01/N/NZ6/01762) (https://ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay A, 2002, J EUR ACAD DERMATOL, V16, P347, DOI 10.1046/j.1468-3083.2002.00467.x; Al-Hakeim HK, 2015, J AFFECT DISORDERS, V182, P106, DOI 10.1016/j.jad.2015.04.044; Ala-Houhala MJ, 2014, ACTA DERM-VENEREOL, V94, P146, DOI 10.2340/00015555-1685; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Beurel E, 2013, BIOL PSYCHIAT, V73, P622, DOI 10.1016/j.biopsych.2012.09.021; Bohm D, 2013, J EUR ACAD DERMATOL, V27, P220, DOI 10.1111/j.1468-3083.2012.04451.x; Cohen BE, 2016, JAMA DERMATOL, V152, P73, DOI 10.1001/jamadermatol.2015.3605; Connor CJ, 2015, DERMAT RES PRACT, V2015, DOI 10.1155/2015/409637; Cowen PJ, 2010, PSYCHOL MED, V40, P1, DOI 10.1017/S0033291709005558; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Flisiak I, 2006, BIOMARKERS, V11, P194, DOI 10.1080/13547500600565735; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Golpour M, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/381905; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Granata M, 2017, PATHOBIOLOGY, V84, P71, DOI 10.1159/000447777; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Hock AD, 2014, IN VIVO, V28, P133; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jensen P, 2016, ACTA DERM-VENEREOL, V96, P39, DOI 10.2340/00015555-2183; Kang HJ, 2016, PSYCHONEUROENDOCRINO, V72, P156, DOI 10.1016/j.psyneuen.2016.07.001; Kappelmann N, 2018, MOL PSYCHIATR, V23, P335, DOI 10.1038/mp.2016.167; Kim GE, 2015, PEDIATR DERMATOL, V32, P656, DOI 10.1111/pde.12416; Koo J, 2017, J EUR ACAD DERMATOL, V31, P1999, DOI 10.1111/jdv.14460; Korman AM, 2016, EXPERT OPIN PHARMACO, V17, P147, DOI 10.1517/14656566.2016.1128894; Lakshmy S, 2015, INDIAN J PSYCHOL MED, V37, P434, DOI 10.4103/0253-7176.168587; Langub MC, 2001, NEUROSCIENCE, V104, P49, DOI 10.1016/S0306-4522(01)00049-5; Lewinson RT, 2017, J INVEST DERMATOL, V137, P828, DOI 10.1016/j.jid.2016.11.032; Liu Y, 2012, INT J RHEUM DIS, V15, P183, DOI 10.1111/j.1756-185X.2011.01673.x; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Martin-Subero M, 2016, CNS SPECTRUMS, V21, P184, DOI 10.1017/S1092852915000449; Mattozzi C, 2016, EUR REV MED PHARMACO, V20, P1675; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Okereke OI, 2016, J AFFECT DISORDERS, V198, P1, DOI 10.1016/j.jad.2016.03.022; Osmancevic A, 2010, J PHOTOCH PHOTOBIO B, V101, P117, DOI 10.1016/j.jphotobiol.2010.05.008; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Parker GB, 2017, J AFFECT DISORDERS, V208, P56, DOI 10.1016/j.jad.2016.08.082; Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342; Pietrzak AT, 2008, CLIN CHIM ACTA, V394, P7, DOI 10.1016/j.cca.2008.04.005; Pietrzak D, 2017, J AFFECT DISORDERS, V209, P229, DOI 10.1016/j.jad.2016.11.045; Prossin AR, 2011, BIOL PSYCHIAT, V69, P808, DOI 10.1016/j.biopsych.2010.10.014; Pujol RM, 2013, ACTAS DERMO-SIFILOGR, V104, P897, DOI 10.1016/j.ad.2013.04.014; Raber J, 1997, J NEUROSCI, V17, P9473; Remrod C, 2013, BRIT J DERMATOL, V169, P344, DOI 10.1111/bjd.12371; Slominski AT, 2018, ENDOCRINOLOGY, V159, P1992, DOI 10.1210/en.2017-03230; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Soleymani T, 2015, INT J DERMATOL, V54, P383, DOI 10.1111/ijd.12790; Strohal R, 2014, J EUR ACAD DERMATOL, V28, P1661, DOI 10.1111/jdv.12350; Sublette ME, 2011, BRAIN BEHAV IMMUN, V25, P1272, DOI 10.1016/j.bbi.2011.05.002; Tee SI, 2016, J EUR ACAD DERMATOL, V30, P1159, DOI 10.1111/jdv.13615; Wadhwa B, 2015, INDIAN J DERMATOL VE, V81, P344, DOI 10.4103/0378-6323.159928; Zhao CH, 2017, NEUROPSYCH DIS TREAT, V13, P91, DOI 10.2147/NDT.S124630; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	60	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201589	10.1371/journal.pone.0201589	http://dx.doi.org/10.1371/journal.pone.0201589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092066	Green Submitted, gold, Green Published			2022-12-26	WOS:000441232600038
J	Zhao, QY; He, XJ				Zhao, Qiu-Yuan; He, Xin-Jian			Exploring potential roles for the interaction of MOM1 with SUMO and the SUMO E3 ligase-like protein PIAL2 in transcriptional silencing	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; ARABIDOPSIS-THALIANA; SUMOYLATION; HETEROCHROMATIN; RESPONSES; CHROMATIN; PLANTS; MAINTENANCE; STRESS; SIZ1	The CHD3-like chromatin remodeling protein MOM1 and the PIAS-type SUMO E3 ligase-like protein PIAL2 are known to interact with each other and mediate transcriptional silencing in Arabidopsis. However, it is poorly understood whether and how the interaction is involved in transcriptional silencing. Here, we demonstrate that, while the PIAL2 interaction domain (PIAL2-IND) is required for PIAL2 dimerization, MOM-PIAL2 interaction, and transcriptional silencing, a transgene fusing the wild-type MOM1 protein with the PIAL2 protein defective in PIAL2-IND can completely restore transcriptional silencing in the mom1/pial2 double mutant, demonstrating that the artificial fusion of MOM1 and PIAL2 mimics the in vivo interaction of these two proteins so that PIAL2-IND is no longer required for transcriptional silencing in the fusion protein. Further, our yeast two-hybrid assay identifies a previously unrecognized SUMO interaction motif (SIM) in the conserved MOM1 motif CMM3 and demonstrates that the SIM is responsible for the interaction of MOM1 with SUMO. Given that eukaryotic PIAS-type SUMO E3 ligases have a conserved role in chromatin regulation, the findings reported in this study may represent a conserved chromatin regulatory mechanism in higher eukaryotes.	[Zhao, Qiu-Yuan; He, Xin-Jian] Natl Inst Biol Sci, Beijing, Peoples R China	National Institute of Biological Sciences, Beijing	He, XJ (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	hexinjian@nibs.ac.cn	He, Xin-Jian/AAV-3587-2021	He, Xin-Jian/0000-0002-2878-7461	National Key Research and Development Program of China [2016YFA0500801]; Chinese Ministry of Science and Technology [2011CB812600]	National Key Research and Development Program of China; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by the National Key Research and Development Program of China (2016YFA0500801) and the 973 Program (2011CB812600) from the Chinese Ministry of Science and Technology (to X.J.H.).	Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Budhiraja R, 2009, PLANT PHYSIOL, V149, P1529, DOI 10.1104/pp.108.135053; Caikovski M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000165; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Elrouby N, 2013, P NATL ACAD SCI USA, V110, P19956, DOI 10.1073/pnas.1319985110; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; Han YF, 2016, PLANT CELL, V28, P1215, DOI 10.1105/tpc.15.00997; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Ishida T, 2009, PLANT CELL, V21, P2284, DOI 10.1105/tpc.109.068072; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu J, 2011, CELL RES, V21, P1691, DOI 10.1038/cr.2011.173; Liu ZW, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006026; Lorkovic ZJ, 2012, CURR BIOL, V22, P933, DOI 10.1016/j.cub.2012.03.061; Luo YX, 2018, SCI CHINA LIFE SCI, V61, P235, DOI 10.1007/s11427-017-9146-2; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Miller MJ, 2013, MOL CELL PROTEOMICS, V12, P449, DOI 10.1074/mcp.M112.025056; Miller MJ, 2010, P NATL ACAD SCI USA, V107, P16512, DOI 10.1073/pnas.1004181107; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Miura K, 2010, TRENDS CELL BIOL, V20, P223, DOI 10.1016/j.tcb.2010.01.007; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Mozgova I, 2010, PLANT CELL, V22, P2768, DOI 10.1105/tpc.110.076182; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nishimura T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002484; Nukarinen E, 2017, PLANT J, V91, P505, DOI 10.1111/tpj.13575; Numa H, 2010, EMBO J, V29, P352, DOI 10.1038/emboj.2009.374; Probst AV, 2003, PLANT J, V33, P743, DOI 10.1046/j.1365-313X.2003.01667.x; Rytz TC, 2018, PLANT CELL; Sanchez DH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004806; Saracco SA, 2007, PLANT PHYSIOL, V145, P119, DOI 10.1104/pp.107.102285; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Tomanov K, 2014, PLANT CELL, V26, P4547, DOI 10.1105/tpc.114.131300; Tremblay C, 2016, BIOCHEM BIOPH RES CO, V473, P471, DOI 10.1016/j.bbrc.2016.03.034; Yokthongwattana C, 2010, EMBO J, V29, P340, DOI 10.1038/emboj.2009.328; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202137	10.1371/journal.pone.0202137	http://dx.doi.org/10.1371/journal.pone.0202137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092097	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600093
J	Lai, CY; Liu, H; Tin, KX; Huang, Y; Yeh, KH; Peng, HW; Chen, HD; He, JY; Chiang, YJ; Liu, CS; Weng, SY; Tao, MH; Yen, JJY; Yang-Yen, HF				Lai, Ching-Yu; Liu, Hsuan; Tin, Kai Xuan; Huang, Yi; Yeh, Kun-Hai; Peng, Hubert W.; Chen, Huan-Da; He, Jun-Yu; Chiang, Yun-Jung; Liu, Chun-Shan; Weng, Shih-Yen; Tao, Mi-Hua; Yen, Jeffrey Jong-Young; Yang-Yen, Hsin-Fang			Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells	ONCOGENE			English	Article							GLCNAC TRANSFERASE; C-MYC; CANCER; GLYCOSYLATION; SITE; METABOLISM; PLATFORM; GLYCANS; COMPLEX; DAMAGE	Aged hepatocyte-specific-Mcl-1 knockout (MKO-hep) mice are prone to develop liver tumors mimicking human hepatocellular carcinoma (HCC). Here we reported that a protein named UDP-N-acetylglucosamine pyrophosphorylase-1-like-1 (Uap1l1) is upregulated in the liver of young MKO-hep mice without any macroscopically detectable tumor nodules and is prominently expressed in the hepatic tumors developed in the aged MKO-hep mice. Intriguingly, human UAP1L1 is also significantly upregulated in a distinct subset of HCC tissues and patients with upregulated expression of UAP1L1 appeared to have poor prognosis. Overexpression of UAP1L1 significantly promoted, whereas UAP1L1 knockdown markedly reduced the proliferation of human hepatoma cells both in vitro and in vivo. UAP1L1 shows similar to 59% sequence identity to UDP-N-acetylglucosamine pyrophosphorylase-1 (UAP1), which is directly involved in the synthesis of the sugar donor (UDP-GlcNac) for N-acetylglucosamine modification (O-GlcNAcylation) of proteins. However, unlike UAP1, UAP1L1 harbors very limited UDP-GlcNAc synthesis activity. Moreover, although both UAP1 and UAP1L1 are required for O-GlcNAc transferase (OGT)-mediated protein O-GlcNAcylation, they appear to function distinctly from each other. UAP1L1 directly interacts with OGT, but does not seem to be an OGT substrate. In addition, UAP1L1 alone is not sufficient to activate OGT activity in vitro, suggesting that UAP1L1 may function together with other proteins to modulate OGT activity in vivo. Lastly, UAP1L1 knockdown attenuated c-MYC O-GlcNAcylation and protein stability, and overexpression of c-MYC significantly rescued the proliferation defect of UAP1L1 knockdown HepG2 cells, suggesting that c-MYC is one downstream target of UAP1L1 that contributes to UAP1L1-mediated cell proliferation, at least in HepG2 cells.	[Lai, Ching-Yu; Tin, Kai Xuan; Yeh, Kun-Hai; Peng, Hubert W.; Chen, Huan-Da; He, Jun-Yu; Weng, Shih-Yen; Yang-Yen, Hsin-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lai, Ching-Yu; Tao, Mi-Hua; Yen, Jeffrey Jong-Young; Yang-Yen, Hsin-Fang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, Hsuan; Huang, Yi] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Liu, Hsuan] Chang Gung Univ, Dept Mol & Cellular Biol, Taoyuan, Taiwan; [Huang, Yi] ACT Genom Co LTD, Taipei, Taiwan; [Chiang, Yun-Jung; Liu, Chun-Shan; Tao, Mi-Hua; Yen, Jeffrey Jong-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Weng, Shih-Yen] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Chang Gung University; Chang Gung University; Academia Sinica - Taiwan; Taipei Medical University; Taipei Municipal WanFang Hospital	Yang-Yen, HF (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.; Yang-Yen, HF (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	imbyy@gate.sinica.edu.tw	Yang-Yen, Hsin-Fang/ABA-5808-2021; Yen, Jeffrey Jong-Young/Q-5134-2018; Tao, Mi-Hua/S-7020-2018	Yang-Yen, Hsin-Fang/0000-0001-9048-4800; Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Tao, Mi-Hua/0000-0002-4307-5729; Chiang, Yun-Jung/0000-0001-5024-8977; Liu, Chun-Shan/0000-0003-0887-0484; Peng, Hubert/0000-0003-4881-1331	Academia Sinica; National Science Council of Taiwan [99-2320-B-001-009-MY3, 102-2320-B-001 -024 -MY3]; Chang Gung Memorial Hospital [CMRPG3D1512]; Ministry of Education of Taiwan [EMRPD1E1581]	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	We greatly appreciate the gift of mammalian OGT expression vectors from Dr Xiaochun Yu (Beckman Research Institute), the bacterial OGT expression vector from Dr Hsiu-Ming Shih (Academia Sinica), and various hepatoma cell lines from Dr Yuh-Shan Jou (Academia Sinica). We also thank Yi-Ning Chen at the Bioinformatics core at IMB for I-TASSER modeling and the Metabolomics Facilities of the Scientific Instrument Center at Academia Sinica for the analysis of the cellular levels of UDP-GlcNAc. This study was supported in part by an intramural fund from Academia Sinica and by grants (99-2320-B-001-009-MY3; 102-2320-B-001 -024 -MY3) from the National Science Council of Taiwan to H-FY-Y; funding to HL was provided by Chang Gung Memorial Hospital (CMRPG3D1512) and the Ministry of Education of Taiwan (EMRPD1E1581).	Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Q, 2016, NUCLEIC ACIDS RES, V44, P9266, DOI 10.1093/nar/gkw663; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Cummings RD, 2014, CHEM BIOL, V21, P1, DOI 10.1016/j.chembiol.2013.12.010; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Terasaka N, 2011, NAT STRUCT MOL BIOL, V18, P1268, DOI 10.1038/nsmb.2121; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Weng SY, 2011, J HEPATOL, V54, P685, DOI 10.1016/j.jhep.2010.07.035; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22	36	15	15	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					317	331		10.1038/s41388-018-0442-6	http://dx.doi.org/10.1038/s41388-018-0442-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30097606				2022-12-26	WOS:000455851200002
J	Lewis, WR; Bales, KL; Revell, DZ; Croyle, MJ; Engle, SE; Song, CJ; Malarkey, EB; Uytingco, CR; Shan, D; Antonellis, PJ; Nagy, TR; Kesterson, RA; Mrug, MM; Martens, JR; Berbari, NF; Gross, AK; Yoder, BK				Lewis, Wesley R.; Bales, Katie L.; Revell, Dustin Z.; Croyle, Mandy J.; Engle, Staci E.; Song, Cheng Jack; Malarkey, Erik B.; Uytingco, Cedric R.; Shan, Dan; Antonellis, Patrick J.; Nagy, Tim R.; Kesterson, Robert A.; Mrug, Michal M.; Martens, Jeffrey R.; Berbari, Nicolas F.; Gross, Alecia K.; Yoder, Bradley K.			Mks6 mutations reveal tissue- and cell type-specific roles for the cilia transition zone	FASEB JOURNAL			English	Article						ciliopathy; cystic kidney disease; retinal degeneration; obesity	CYST FORMATION; MONOCLONAL-ANTIBODIES; JOUBERT SYNDROME; PROTEINS; MEMBRANE; CC2D2A; TRANSPORT; RHODOPSIN; COMPLEX; OBESITY	The transition zone (TZ) is a domain at the base of the cilium that is involved in maintaining ciliary compartment-specific sensory and signaling activity by regulating cilia protein composition. Mutations in TZ proteins result in cilia dysfunction, often causing pleiotropic effects observed in a group of human diseases classified as ciliopathies. The purpose of this study is to describe the importance of the TZ component Meckel-Gruber syndrome 6 (Mks6) in several organ systems and tissues regarding ciliogenesis and cilia maintenance using congenital and conditional mutant mouse models. Similar to MKS, congenital loss of Mks6 is embryonic lethal, displaying cilia loss and altered cytoskeletal microtubule modifications but only in specific cell types. Conditional Mks6 mutants have a variable cystic kidney phenotype along with severe retinal degeneration with mislocalization of phototransduction cascade proteins. However, other phenotypes, such as anosmia and obesity, which are typically associated with cilia and TZ dysfunction, were not evident. These data indicate that despite Mks6 being a core TZ component, it has tissue- or cell type-specific functions important for cilia formation and cilia sensory and signaling activities. Lewis, W. R., Bales, K. L., Revell, D. Z., Croyle, M. J., Engle, S. E., Song, C. J., Malarkey, E. B., Uytingco, C. R., Shan, D., Antonellis, P. J., Nagy, T. R., Kesterson, R. A., Mrug, M. M., Martens, J. R., Berbari, N. F., Gross, A. K., Yoder, B. K. Mks6 mutations reveal tissue- and cell type-specific roles for the cilia transition zone.	[Lewis, Wesley R.; Revell, Dustin Z.; Croyle, Mandy J.; Song, Cheng Jack; Malarkey, Erik B.; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Bales, Katie L.; Gross, Alecia K.] Univ Alabama Birmingham, Dept Optometry & Vis Sci, 906 Shelby Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA; [Shan, Dan; Mrug, Michal M.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA; [Nagy, Tim R.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Engle, Staci E.; Antonellis, Patrick J.; Berbari, Nicolas F.] Indiana Univ Purdue Univ, Dept Biol, SL306,723 W Michigan St, Indianapolis, IN 46202 USA; [Uytingco, Cedric R.; Martens, Jeffrey R.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida	Gross, AK (corresponding author), Univ Alabama Birmingham, Dept Optometry & Vis Sci, 906 Shelby Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.; Berbari, NF (corresponding author), Indiana Univ Purdue Univ, Dept Biol, SL306,723 W Michigan St, Indianapolis, IN 46202 USA.	nberbari@iupui.edu; agross@uab.edu	Gross, Alecia K./AAJ-1792-2021	Gross, Alecia K./0000-0003-1857-6633; Berbari, Nicolas/0000-0003-2863-1069; Engle, Staci/0000-0002-8116-5063	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK065655, R01DK115752, R01DK114008]; NIH National Institute on Deafness and Other Communication Disorders Grant [R01DC009606]; NIH National Eye Institute (NEI) [R01EY019311]; E. Matilda Ziegler Foundation; Pilot and Feasibility Award from the Center for Diabetes and Metabolic Diseases [P30 DK097512]; NIH NIDDK [P30 DK074038, P30 DK05336, P60 DK079626, P30DK079337, P30DK079626, P30DK074038]; NIH NEI [P30EY003039]; NIH Instrumentation Grant [S10RR026887]; NIH National Cancer Institute [P30CA13148]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR048311]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089918] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, R01DK114008, P30DK074038, R01DK115752, P30DK079337, P30DK097512, R01DK065655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009606] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Deafness and Other Communication Disorders Grant; NIH National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); E. Matilda Ziegler Foundation; Pilot and Feasibility Award from the Center for Diabetes and Metabolic Diseases; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Mary Ann Accavitti-Loper (University of Alabama at Birmingham) and Logan S. Whitehouse (Indiana University Purdue University Indianapolis, Indianapolis, IN, USA) for technical assistance on the project. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants R01DK065655, R01DK115752 (to B.K.Y.), and R01DK114008 (to N.F.B.); NIH National Institute on Deafness and Other Communication Disorders Grant R01DC009606 (to J.R.M.); and NIH National Eye Institute (NEI) R01EY019311 (to A.K.G.). Additional support was from the E. Matilda Ziegler Foundation (to A.K.G.) and Pilot and Feasibility Award from the Center for Diabetes and Metabolic Diseases (P30 DK097512; to N.F.B.). Center support for the project was provided by NIH NIDDK Grants P30DK074038, P30DK079337, P30DK079626, and NIH NEI Grant P30EY003039, and the NIH Instrumentation Grant S10RR026887. Services provided in this publication through the University of Alabama at Birmingham Transgenic & Genetically Engineered Models (TGEMS) facility (R.A.K.) are supported by NIH National Cancer Institute Grant P30CA13148, NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant P30AR048311, and NIH NIDDK Grants P30 DK074038, P30 DK05336, and P60 DK079626. The authors declare no conflicts of interest.	Awata J, 2014, J CELL SCI, V127, P4714, DOI 10.1242/jcs.155275; Bachmann-Gagescu R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005575; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Barker AR, 2014, ORGANOGENESIS, V10, P96, DOI 10.4161/org.27375; Berbari NF, 2013, CYTOSKELETON, V70, P24, DOI 10.1002/cm.21088; Berbari NF, 2011, DEV BIOL, V360, P66, DOI 10.1016/j.ydbio.2011.09.001; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Guo DF, 2011, TRENDS ENDOCRIN MET, V22, P286, DOI 10.1016/j.tem.2011.02.009; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Joiner AM, 2015, J NEUROSCI, V35, P13761, DOI 10.1523/JNEUROSCI.1708-15.2015; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Klink BU, 2017, ELIFE, V6, DOI 10.7554/eLife.27434; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; McIntyre JC, 2012, NAT MED, V18, P1423, DOI 10.1038/nm.2860; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Reish NJ, 2013, INVEST OPHTH VIS SCI, V54, P6675, DOI 10.1167/iovs.13-12550; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Sharma N, 2013, J AM SOC NEPHROL, V24, P456, DOI 10.1681/ASN.2012020154; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Starremans PG, 2008, KIDNEY INT, V73, P1394, DOI 10.1038/ki.2008.111; Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Tadenev ALD, 2011, P NATL ACAD SCI USA, V108, P10320, DOI 10.1073/pnas.1016531108; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Veleri S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5207; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Williams CL, 2017, MOL THER, V25, P904, DOI 10.1016/j.ymthe.2017.02.006; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	47	12	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1440	1455		10.1096/fj.201801149R	http://dx.doi.org/10.1096/fj.201801149R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30133325	Bronze, Green Published			2022-12-26	WOS:000457401500113
J	Duggimpudi, S; Kloetgen, A; Maney, SK; Munch, PC; Hezaveh, K; Shaykhalishahi, H; Hoyer, W; McHardy, AC; Lang, PA; Borkhardt, A; Hoell, JI				Duggimpudi, Sujitha; Kloetgen, Andreas; Maney, Sathish Kumar; Munch, Philipp C.; Hezaveh, Kebria; Shaykhalishahi, Hamed; Hoyer, Wolfgang; McHardy, Alice C.; Lang, Philipp A.; Borkhardt, Arndt; Hoell, Jessica, I			Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-transcriptional regulation; RNA-binding protein; leukemia; interleukin 6 (IL-6); Janus kinase (JAK); Janus kinase (JAK); STAT signaling; mitogen-activated protein kinase (MAPK); mitogen-activated protein kinase (MAPK) signaling; phosphorylation; cancer; Musashi 2; cancer and Musashi2; PAR-CLIP	ACUTE MYELOID-LEUKEMIA; FACTOR-MEDIATED INTERACTION; HEPATOCYTE GROWTH-FACTOR; PAR-CLIP; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATED EXPRESSION; GENE-EXPRESSION; IDENTIFICATION; CANCER; HEMATOPOIESIS	The RNA-binding protein Musashi 2 (MSI2) has emerged as an important regulator in cancer initiation, progression, and drug resistance. Translocations and deregulation of the MSI2 gene are diagnostic of certain cancers, including chronic myeloid leukemia (CML) with translocation t(7;17), acute myeloid leukemia (AML) with translocation t(10;17), and some cases of B-precursor acute lymphoblastic leukemia (pB-ALL). To better understand the function of MSI2 in leukemia, the mRNA targets that are bound and regulated by MSI2 and their MSI2-binding motifs need to be identified. To this end, using photoactivatable ribonucleoside cross-linking and immunoprecipitation (PAR-CLIP) and the multiple EM for motif elicitation (MEME) analysis tool, here we identified MSI2's mRNA targets and the consensus RNA-recognition element (RRE) motif recognized by MSI2 (UUAG). Of note, MSI2 knockdown altered the expression of several genes with roles in eukaryotic initiation factor 2 (eIF2), hepatocyte growth factor (HGF), and epidermal growth factor (EGF) signaling pathways. We also show that MSI2 regulates classic interleukin-6 (IL-6) signaling by promoting the degradation of the mRNA of IL-6 signal transducer (IL6ST or GP130), which, in turn, affected the phosphorylation statuses of signal transducer and activator of transcription 3 (STAT3) and the mitogen-activated protein kinase ERK. In summary, we have identified multiple MSI2-regulated mRNAs and provided evidence that MSI2 controls IL6ST activity that control oncogenic signaling networks. Our findings may help inform strategies for unraveling the role of MSI2 in leukemia to pave the way for the development of targeted therapies.	[Duggimpudi, Sujitha; Kloetgen, Andreas; Hezaveh, Kebria; Borkhardt, Arndt; Hoell, Jessica, I] Heinrich Heine Univ, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Med Fac, Moorenstr 5, D-40225 Dusseldorf, Germany; [Maney, Sathish Kumar; Lang, Philipp A.] Heinrich Heine Univ, Dept Mol Med 2, Univ Str 1, D-40225 Dusseldorf, Germany; [Kloetgen, Andreas; Munch, Philipp C.; McHardy, Alice C.] Heinrich Heine Univ, Dept Algorithm Bioinformat, Univ Str 1, D-40225 Dusseldorf, Germany; [Kloetgen, Andreas; Munch, Philipp C.; McHardy, Alice C.] Helmholtz Ctr Infect Res, Computat Biol Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Shaykhalishahi, Hamed; Hoyer, Wolfgang] Heinrich Heine Univ, Inst Phys Biol, Univ Str 1, D-40225 Dusseldorf, Germany; [Kloetgen, Andreas] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Maney, Sathish Kumar] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Rontgenstr 20, D-48149 Munster, Germany; [Hezaveh, Kebria] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Shaykhalishahi, Hamed] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada	Helmholtz Association; Helmholtz-Center for Infection Research; Heinrich Heine University Dusseldorf; New York University; Max Planck Society; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Hoell, JI (corresponding author), Heinrich Heine Univ, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Med Fac, Moorenstr 5, D-40225 Dusseldorf, Germany.	Jessica.hoell@med.uni-duesseldorf.de	McHardy, Alice/ABF-2322-2020; Hoyer, Wolfgang/H-6193-2013	McHardy, Alice/0000-0003-2370-3430; Hoyer, Wolfgang/0000-0003-4301-5416; Kloetgen, Andreas/0000-0003-0991-4442	Heinrich-Heine University Dusseldorf Forschungskommission [17/2013]; Dusseldorf School of Oncology; Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe; Medical Faculty HHU Dusseldorf; Deutsche Forschungsgemeinschaft [HO 5456/3-1]	Heinrich-Heine University Dusseldorf Forschungskommission; Dusseldorf School of Oncology; Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe; Medical Faculty HHU Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Heinrich-Heine University Dusseldorf Forschungskommission 17/2013, the Dusseldorf School of Oncology (funded by the Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe and the Medical Faculty HHU Dusseldorf), and the Deutsche Forschungsgemeinschaft HO 5456/3-1. The authors declare that they have no conflicts of interest with the contents of this article.	Aly RM, 2015, INT J LAB HEMATOL, V37, P272, DOI 10.1111/ijlh.12284; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barbouti A, 2003, CANCER RES, V63, P1202; Bennett CG, 2016, NUCLEIC ACIDS RES, V44, P3788, DOI 10.1093/nar/gkw207; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Du YH, 2014, INT J MOL SCI, V15, P17065, DOI 10.3390/ijms150917065; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ichikawa M, 2013, INT J HEMATOL, V97, P726, DOI 10.1007/s12185-013-1347-3; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kloetgen A, 2016, PEERJ, V4, DOI 10.7717/peerj.2619; Kloetgen A, 2015, BRIEF FUNCT GENOMICS, V14, P102, DOI 10.1093/bfgp/elu020; Kudinov AE, 2016, P NATL ACAD SCI USA, V113, P6955, DOI 10.1073/pnas.1513616113; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15456; Madonna R, 2013, J CARDIOVASC MED, V14, P249, DOI 10.2459/JCM.0b013e3283542017; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Micol JB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15429; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Saleki R, 2015, LEUKEMIA LYMPHOMA, V56, P1137, DOI 10.3109/10428194.2014.947611; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Spitzer J, 2013, METHOD ENZYMOL, V529, P99, DOI 10.1016/B978-0-12-418687-3.00008-2; Sutherland JM, 2013, ADV EXP MED BIOL, V786, P233, DOI 10.1007/978-94-007-6621-1_13; Tian J, 2016, INTRACTABLE RARE DIS, V5, P76, DOI 10.5582/irdr.2015.01049; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7517; Yu CF, 2002, J BIOL CHEM, V277, P19382, DOI 10.1074/jbc.M200732200; Yu CF, 2001, J BIOL CHEM, V276, P32552, DOI 10.1074/jbc.M104493200; Zearfoss NR, 2014, J BIOL CHEM, V289, P35530, DOI 10.1074/jbc.M114.597112; Zhang HJ, 2014, EXP CELL RES, V320, P119, DOI 10.1016/j.yexcr.2013.09.009; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	48	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15359	15369		10.1074/jbc.RA118.002243	http://dx.doi.org/10.1074/jbc.RA118.002243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126842	Green Published, hybrid			2022-12-26	WOS:000446549200003
J	Robinson, AE; Lowe, JE; Koh, EI; Henderson, JP				Robinson, Anne E.; Lowe, Jessica E.; Koh, Eun-Ik; Henderson, Jeffrey P.			Uropathogenic enterobacteria use the yersiniabactin metallophore system to acquire nickel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; nickel; metal homeostasis; metalloenzyme; transport metal; metallophore; nutritional immunity; nutritional passivation; uropathogen	HIGH-PATHOGENICITY ISLAND; ESCHERICHIA-COLI; TRACT-INFECTION; SIDEROPHORE; KLEBSIELLA; BINDING; COPPER; IDENTIFICATION; TRANSPORT; PESTIS	Invasive Gram-negative bacteria often express multiple virulence-associated metal ion chelators to combat host-mediated metal deficiencies. Escherichia coli, Klebsiella, and Yersinia pestis isolates encoding the Yersinia high pathogenicity island (HPI) secrete yersiniabactin (Ybt), a metallophore originally shown to chelate iron ions during infection. However, our recent demonstration that Ybt also scavenges copper ions during infection led us to question whether it might be capable of retrieving other metals as well. Here, we find that uropathogenic E. coli also use Ybt to bind extracellular nickel ions. Using quantitative MS, we show that the canonical metal-Ybt import pathway internalizes the resulting Ni-Ybt complexes, extracts the nickel, and releases metal-free Ybt back to the extracellular space. We find that E. coli and Klebsiella direct the nickel liberated from this pathway to intracellular nickel enzymes. Thus, Ybt may provide access to nickel that is inaccessible to the conserved NikABCDE permease system. Nickel should be considered alongside iron and copper as a plausible substrate for Ybt-mediated metal import by enterobacteria during human infections.	[Robinson, Anne E.; Lowe, Jessica E.; Koh, Eun-Ik; Henderson, Jeffrey P.] Washington Univ, Ctr Womens Infect Dis Res, Dept Mol Microbiol, Div Infect Dis Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Henderson, JP (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	hendersonj@wustl.edu	Henderson, Jeffrey P/D-3337-2015	Robinson, Anne/0000-0003-1641-397X; Lowe, Jessica/0000-0002-0295-3978	NIDDK, National Institutes of Health [R01DK099534, R01DK111930]; Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111930, R01DK099534] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants R01DK099534 and R01DK111930 (to J. P. H.). The authors declare that they have no conflicts of interest with the contents of this article. The funders had no role in study design, data collection and interpretation, or in the decision to submit the work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study.	Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; BARRY AL, 1969, APPL MICROBIOL, V18, P156, DOI 10.1128/AEM.18.2.156-158.1969; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; Bleriot C, 2011, J BACTERIOL, V193, P3785, DOI 10.1128/JB.05032-11; Bobrov AG, 2017, METALLOMICS, V9, P757, DOI 10.1039/c7mt00126f; Bobrov AG, 2014, MOL MICROBIOL, V93, P759, DOI 10.1111/mmi.12693; Brumbaugh AR, 2015, INFECT IMMUN, V83, P1443, DOI 10.1128/IAI.02904-14; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Cherrier MV, 2008, BIOCHEMISTRY-US, V47, P9937, DOI 10.1021/bi801051y; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; GEST H, 1954, BACTERIOL REV, V18, P43, DOI 10.1128/MMBR.18.1.43-73.1954; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; HOPFER SM, 1989, ANN CLIN LAB SCI, V19, P161; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Koh EI, 2017, NAT CHEM BIOL, V13, P1016, DOI [10.1038/nchembio.2441, 10.1038/NCHEMBIO.2441]; Koh EI, 2016, INFECT IMMUN, V84, P1312, DOI 10.1128/IAI.01211-15; Koh EI, 2015, METALLOMICS, V7, P1011, DOI 10.1039/c4mt00341a; Lacasse MJ, 2016, BIOCHEMISTRY-US, V55, P6821, DOI 10.1021/acs.biochem.6b00706; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Lhospice S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16765-9; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Liu Q, 2007, J BACTERIOL, V189, P7593, DOI 10.1128/JB.01096-06; Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Lv HT, 2011, J PROTEOME RES, V10, P5547, DOI 10.1021/pr200756n; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; McDowall JS, 2014, P NATL ACAD SCI USA, V111, pE3948, DOI 10.1073/pnas.1407927111; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moscatello NJ, 2017, BIOTECHNOL PROGR, V33, P1548, DOI 10.1002/btpr.2542; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Nakashige TG, 2017, J AM CHEM SOC, V139, P8828, DOI 10.1021/jacs.7b01212; Ohlemacher SI, 2017, J CLIN INVEST, V127, P4018, DOI 10.1172/JCI92464; OSKARSSON A, 1979, ACTA PHARMACOL TOX, V45, P306; Pelludat C, 2003, J BACTERIOL, V185, P5648, DOI 10.1128/JB.185.18.5648-5653.2003; Perry RD, 1999, MICROBIOL-UK, V145, P1181, DOI 10.1099/13500872-145-5-1181; Robinson AE, 2018, FUTURE MICROBIOL, V13, P813, DOI 10.2217/fmb-2017-0295; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shields-Cutler RR, 2015, J BIOL CHEM, V290, P15949, DOI 10.1074/jbc.M115.645812; Sieniawska CE, 2012, ANN CLIN BIOCHEM, V49, P341, DOI 10.1258/acb.2011.011179; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; VANSOESTBERGEN M, 1972, CLIN CHEM, V18, P1478; Wang SC, 2010, BIOCHEMISTRY-US, V49, P6635, DOI 10.1021/bi100685k; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; WU LF, 1991, GENE, V107, P37; Zeer-Wanklyn CJ, 2017, CURR OPIN CHEM BIOL, V37, P80, DOI 10.1016/j.cbpa.2017.01.014	62	24	24	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14953	14961		10.1074/jbc.RA118.004483	http://dx.doi.org/10.1074/jbc.RA118.004483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30108176	Green Published, hybrid			2022-12-26	WOS:000445998400001
J	Wu, D; De Wever, V; Derua, R; Winkler, C; Beullens, M; Van Eynde, A; Bollen, M				Wu, Dan; De Wever, Veerle; Derua, Rita; Winkler, Claudia; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu			A substrate-trapping strategy for protein phosphatase PP1 holoenzymes using hypoactive subunit fusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoprotein phosphatase 1 (PP1); enzyme; substrate specificity; signal transduction; phosphatase; MYPT1; NIPP1; PNUTS; RepoMan; substrate mapping	CATALYTIC SUBUNIT; PHOSPHORYLATION SITES; REGULATORY SUBUNIT; NUCLEAR INHIBITOR; SPLICING FACTORS; REPO-MAN; NIPP1; IDENTIFICATION; KINASE; SPECIFICITY	The protein Ser/Thr phosphatase PP1 catalyzes an important fraction of protein dephosphorylation events and forms highly specific holoenzymes through an association with regulatory interactors of protein phosphatase one (RIPPOs). The functional characterization of individual PP1 holoenzymes is hampered by the lack of straightforward strategies for substrate mapping. Because efficient substrate recruitment often involves binding to both PP1 and its associated RIPPO, here we examined whether PP1-RIPPO fusions can be used to trap substrates for further analysis. Fusions of an hypoactive point mutant of PP1 and either of four tested RIPPOs accumulated in HEK293T cells with their associated substrates and were co-immunoprecipitated for subsequent identification of the substrates by immunoblotting or MS analysis. Hypoactive fusions were also used to study RIPPOs themselves as substrates for associated PP1. In contrast, substrate trapping was barely detected with active PP1-RIPPO fusions or with nonfused PP1 or RIPPO subunits. Our results suggest that hypoactive fusions of PP1 subunits represent an easy-to-use tool for substrate identification of individual holoenzymes.	[Wu, Dan; De Wever, Veerle; Winkler, Claudia; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, Leuven, Belgium; [Derua, Rita] Katholieke Univ Leuven, Dept Cellular & Mol Med, Prot Phosphorylat & Prote Lab, Leuven, Belgium; [Derua, Rita] Univ Leuven, SyBioMa, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Bollen, M (corresponding author), Katholieke Univ Leuven, Campus Gasthuisberg,Herestr 49,O&N1,PB901, B-3000 Leuven, Belgium.	Mathieu.Bollen@kuleuven.be			Fund for Scientific Research Flanders [G.078717N, G.0B9917N]; Flemish Concerted Research Action Grant [GOA 15/016]	Fund for Scientific Research Flanders(FWO); Flemish Concerted Research Action Grant	This work was supported by Fund for Scientific Research Flanders Grants G.078717N and G.0B9917N and Flemish Concerted Research Action Grant GOA 15/016. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Ciurciu A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003885; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Jagiello I, 2000, J CELL SCI, V113, P3761; Kumeta H, 2008, J BIOMOL NMR, V40, P219, DOI 10.1007/s10858-008-9222-x; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Liang FB, 2007, MOL BIOSYST, V3, P308, DOI 10.1039/b700704n; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Minnebo N, 2013, NUCLEIC ACIDS RES, V41, P842, DOI 10.1093/nar/gks1255; O'Connell N, 2012, STRUCTURE, V20, P1746, DOI 10.1016/j.str.2012.08.003; Oberoi J, 2016, P NATL ACAD SCI USA, V113, P9009, DOI 10.1073/pnas.1603059113; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Qian J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10215; Qian JB, 2013, CURR BIOL, V23, P1136, DOI 10.1016/j.cub.2013.05.017; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Ragusa MJ, 2011, FEBS LETT, V585, P36, DOI 10.1016/j.febslet.2010.11.022; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Winkler C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214932; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	35	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15152	15162		10.1074/jbc.RA118.004132	http://dx.doi.org/10.1074/jbc.RA118.004132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115685	hybrid, Green Published			2022-12-26	WOS:000445998400017
J	Yu, WT; Zhan, Y; Xue, BX; Dong, YP; Wang, YF; Jiang, P; Wang, AB; Sun, YJ; Yang, Y				Yu, Wanting; Zhan, Yang; Xue, Boxin; Dong, Yanpeng; Wang, Yanfeng; Jiang, Ping; Wang, Aibing; Sun, Yujie; Yang, Yi			Highly efficient cellular uptake of a cell-penetrating peptide (CPP) derived from the capsid protein of porcine circovirus type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-penetrating peptide (CPP); membrane; permeability; endocytosis; intracellular trafficking; cellular uptake; membrane permeability; nuclear localization signal (NLS); porcine circovirus virus (PCV); protein delivery; transport vector; capsid protein; Circoviridae	HEPARAN-SULFATE; TAT PEPTIDE; NUCLEAR-LOCALIZATION; ORF2 PROTEIN; ENDOCYTOSIS; DELIVERY; MEMBRANE; CLATHRIN; VIRUS; PORCINE-CIRCOVIRUS-2	Porcine circovirus type 2 (PCV2) is one of the smallest, nonenveloped, single-stranded DNA viruses. The PCV2 capsid protein (Cap) is the sole viral structural protein and main antigenic determinant. Previous sequence analysis has revealed that the N terminus of the PCV2 Cap contains a nuclear localization signal (NLS) enriched in positively charged residues. Here, we report that PCV2's NLS can function as a cell-penetrating peptide (CPP). We observed that this NLS can carry macromolecules, e.g. enhanced GFP (EGFP), into cells when they are fused to the NLS, indicating that it can function as a CPP, similar to the classical CPP derived from HIV type 1 transactivator of transcription protein (HIV TAT). We also found that the first 17 residues of the NLS (NLS-A) have a key role in cellular uptake. In addition to entering cells via multiple endocytic processes, NLS-A was also rapidly internalized via direct translocation enabled by increased membrane permeability and was evenly distributed throughout cells when its concentration in cell cultures was 10 m. Of note, cellular NLS-A uptake was approximate to 10 times more efficient than that of HIV TAT. We inferred that the externalized NLS of the PCV2 Cap may accumulate to a high concentration (10 m) at a local membrane area, increasing membrane permeability to facilitate viral entry into the cell to release its genome into a viral DNA reproduction center. We conclude that NLS-A has potential as a versatile vehicle for shuttling foreign molecules into cells, including pharmaceuticals for therapeutic interventions.	[Yu, Wanting; Zhan, Yang; Wang, Aibing; Yang, Yi] Hunan Agr Univ, Coll Vet Med, Key Lab Anim Vaccine & Prot Engn, Changsha 410128, Hunan, Peoples R China; [Yu, Wanting; Zhan, Yang; Wang, Aibing; Yang, Yi] Hunan Agr Univ, Coll Vet Med, LFP, Changsha 410128, Hunan, Peoples R China; [Yu, Wanting; Zhan, Yang; Wang, Aibing; Yang, Yi] Hunan Agr Univ, Coll Vet Med, RCRV, Changsha 410128, Hunan, Peoples R China; [Xue, Boxin; Sun, Yujie] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Dong, Yanpeng; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Yanfeng] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan Agricultural University; Peking University; Nanjing Agricultural University; Tsinghua University	Yang, Y (corresponding author), Hunan Agr Univ, Coll Vet Med, LFP, Changsha 410128, Hunan, Peoples R China.; Yang, Y (corresponding author), Hunan Agr Univ, Coll Vet Med, RCRV, Changsha 410128, Hunan, Peoples R China.; Sun, YJ (corresponding author), Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.	sun_yujie@pku.edu.cn; yiyang@hunau.edu.cn	Zhan, Yang/GRO-0311-2022; Yu, Wanting/ABB-9794-2021	Yang, Yi/0000-0003-2502-1011	National Nature Science Foundation of China [31270819, 31571432, 21573013]; National Key Research and Development Program of China [2017YFA0505300]; Talent Input Project of Hunan Agricultural University [540490317006]; Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines [2017TP1014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Talent Input Project of Hunan Agricultural University; Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines	This work was supported by the National Nature Science Foundation of China (Grants 31270819, 31571432, and 21573013), the National Key Research and Development Program of China (Grant 2017YFA0505300), the Talent Input Project of Hunan Agricultural University (Grant 540490317006), and the Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines (Grant 2017TP1014). The authors declare that they have no conflicts of interest with the contents of this article.	Abes R, 2007, BIOCHEM SOC T, V35, P775, DOI 10.1042/BST0350775; Beach NM, 2011, J VIROL, V85, P4591, DOI 10.1128/JVI.02294-10; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brock R, 2014, BIOCONJUGATE CHEM, V25, P863, DOI 10.1021/bc500017t; Chen B, 2008, LANGMUIR, V24, P11866, DOI 10.1021/la802048s; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Cleal K, 2013, CURR PHARM DESIGN, V19, P2878; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; DOUGLAS JL, 1994, CELL GROWTH DIFFER, V5, P475; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Kaplan IM, 2005, J CONTROL RELEASE, V107, P571, DOI 10.1016/j.jconrel.2004.10.018; Kawaguchi Y, 2016, BIOCONJUGATE CHEM, V27, P1119, DOI 10.1021/acs.bioconjchem.6b00082; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Levitan I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00065; Liu QG, 2001, VIROLOGY, V285, P91, DOI 10.1006/viro.2001.0922; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Mishra A, 2008, ANGEW CHEM INT EDIT, V47, P2986, DOI 10.1002/anie.200704444; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Misinzo G, 2009, VIRUS RES, V139, P1, DOI 10.1016/j.virusres.2008.09.005; Misinzo G, 2006, J VIROL, V80, P3487, DOI 10.1128/JVI.80.7.3487-3494.2006; Misinzo G, 2005, J GEN VIROL, V86, P2057, DOI 10.1099/vir.0.80652-0; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Najjar K, 2017, BIOCONJUGATE CHEM, V28, P2932, DOI 10.1021/acs.bioconjchem.7b00560; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; Palinski R, 2017, J VIROL, V91, DOI [10.1128/JVI.01879-16, 10.1128/jvi.01879-16]; Rapoport M, 2009, EXPERT OPIN DRUG DEL, V6, P453, DOI [10.1517/17425240902887029, 10.1517/17425240902887029 ]; Reissmann S, 2014, J PEPT SCI, V20, P760, DOI 10.1002/psc.2672; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Segales J, 2013, VET MICROBIOL, V165, P13, DOI 10.1016/j.vetmic.2012.12.033; Shuai JB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-341; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Phan TG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0642-z; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wagstaff KM, 2007, BIOCHEM J, V406, P185, DOI 10.1042/BJ20070505; Wang ND, 2016, J GEN VIROL, V97, P3331, DOI 10.1099/jgv.0.000634; Wittrup A, 2009, J BIOL CHEM, V284, P32959, DOI 10.1074/jbc.M109.036129	46	22	25	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15221	15232		10.1074/jbc.RA118.004823	http://dx.doi.org/10.1074/jbc.RA118.004823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30108178	hybrid, Green Published			2022-12-26	WOS:000445998400022
J	Chunsrivirot, S; Kanjanatanin, P; Pichyangkura, R				Chunsrivirot, Surasak; Kanjanatanin, Pongsakorn; Pichyangkura, Rath			Unraveling the structural and molecular properties of 34-residue levans with various branching degrees by replica exchange molecular dynamics simulations	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; ESCHERICHIA-COLI; OLIGOSACCHARIDES; EXPRESSION; SEQUENCE; CLONING	Levan has various potential applications in the pharmaceutical and food industries, such as cholesterol-lowering agents and prebiotics, due to its beneficial properties, which depend on its length and branching degree. A previous study also found that the branching degree of levan affected anti-tumor activities against SNU-1 and HepG2 tumor cell lines. Despite its promising potential, the properties of levans with different branching degrees are not well understood at the molecular level. In two models of the generalized Born implicit solvent (GB(HCT) and GB(OBC1)), we employed replica-exchange molecular dynamics simulations to explore conformational spaces of 34-residue levans (L-34) with branching degrees of zero (LFO34B0), one (LFO34B1), three (LFO34B3) and five (LFO34B5), as well as to elucidate their structural and molecular properties. To ensure a fair comparison of the effects of branching degree on these properties, we focused on analyzing the properties of the central 21-residue of the main chains of all systems. Our results show that all major representative conformations tend to form helix-like structures with kinks, where two-kink helix-like structures have the highest population. As branching degree increases, the population of helix-like structures with zero or one kink tends to increase slightly. As the number of kinks in the structures with the same branching degree increases, the average values of the lengths and angles among centers of masses of three consecutive turns of residue i, i+3, and i+6 tended to decrease. Due to its highest occurring frequencies, the O6 ((i))-H3O ((i+1)) hydrogen bond could be important for helix-like structure formation. Moreover, hydrogen bonds forming among the branching residue (br), branching position (bp) and other residues of L-34B1, L-34B3 and L-34B5 were identified. The O1((bp))-H3O((br)), O1((br))-H3O((br)) and O5((br))-H1O((br)) hydrogen bonds were found in the first-, second- and third-highest occurrence frequencies, respectively. Our study provides novel and important insights into conformational spaces and the structural and molecular properties of 34-residue levans with various branching degrees, which tend to form helix-like structures with kinks.	[Chunsrivirot, Surasak; Kanjanatanin, Pongsakorn; Pichyangkura, Rath] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Chunsrivirot, Surasak; Kanjanatanin, Pongsakorn] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand.	surasak.ch@chula.ac.th		Pichyangkura, Rath/0000-0003-2451-5941	Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [RGN_2558_002_01_23]; Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [07/2557]; Thailand Research Fund [TRG5880222, IRG 5780008]; 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; 90th Anniversary Chulalongkorn University (Rachadaphiseksomphot Endowment Fund); Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project"	Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University; Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement; Thailand Research Fund(Thailand Research Fund (TRF)); 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship; 90th Anniversary Chulalongkorn University (Rachadaphiseksomphot Endowment Fund); Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project"	This research is supported by the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [Grant no. RGN_2558_002_01_23], and Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University. SC was also partially supported by the Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [Grant no. 07/2557], and the Thailand Research Fund [Grant no. TRG5880222 and IRG 5780008]. PK was partially supported by the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship, and the 90th Anniversary Chulalongkorn University (Rachadaphiseksomphot Endowment Fund). RP was partially supported by Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidson SA, 2006, CARBOHYD POLYM, V65, P144, DOI 10.1016/j.carbpol.2005.12.039; Case DA, 2014, AMBER 14; Cerutti DS, 2008, J CHEM THEORY COMPUT, V4, P1669, DOI 10.1021/ct8002173; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Esawy MA, 2011, CARBOHYD POLYM, V86, P823, DOI 10.1016/j.carbpol.2011.05.035; Goldman D, 2008, J BIOL CHEM, V283, P32209, DOI 10.1074/jbc.M805985200; Han Y W, 1990, Adv Appl Microbiol, V35, P171, DOI 10.1016/S0065-2164(08)70244-2; Harteis S, 2014, INT J MOL SCI, V15, P12335, DOI 10.3390/ijms150712335; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Hettwer U, 1998, APPL ENVIRON MICROB, V64, P3180; Jo S, 2016, GLYCOBIOLOGY, V26, P19, DOI 10.1093/glycob/cwv083; Kang FK, 2005, BBA-GENE STRUCT EXPR, V1727, P5, DOI 10.1016/j.bbaexp.2004.10.012; Kanjanatanin P, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1182-7; Khuntawee W, 2016, CARBOHYD POLYM, V141, P99, DOI 10.1016/j.carbpol.2015.10.018; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Marchessault R.H., 2006, POLYSACCHARIDES DRUG; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Marx SP, 2000, FEMS MICROBIOL LETT, V182, P163, DOI 10.1016/S0378-1097(99)00584-4; Mostofian B, 2014, J PHYS CHEM B, V118, P11037, DOI 10.1021/jp502889c; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Song KB, 1998, ANN NY ACAD SCI, V864, P506, DOI 10.1111/j.1749-6632.1998.tb10369.x; STEINMETZ M, 1985, MOL GEN GENET, V200, P220, DOI 10.1007/BF00425427; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Wilman HR, 2014, PROTEINS, V82, P1960, DOI 10.1002/prot.24550; Yamaguchi T., 2014, ANGEW CHEM, V126, P11121; Yamamoto Y, 1999, J NUTR BIOCHEM, V10, P13, DOI 10.1016/S0955-2863(98)00077-1; Yang MJ, 2015, J CHEM THEORY COMPUT, V11, P2855, DOI 10.1021/acs.jctc.5b00243; Yang MJ, 2015, J CHEM THEORY COMPUT, V11, P788, DOI 10.1021/ct500993h; Yoo SH, 2004, INT J BIOL MACROMOL, V34, P37, DOI 10.1016/j.ijbiomac.2004.01.002; Yoon EJ, 2004, INT J BIOL MACROMOL, V34, P191, DOI 10.1016/j.ijbiomac.2004.04.001	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0202578	10.1371/journal.pone.0202578	http://dx.doi.org/10.1371/journal.pone.0202578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130368	Green Submitted, gold, Green Published			2022-12-26	WOS:000442284500010
J	Gregory, EF; Dao, TQ; Alexander, MA; Miller, MJ; Fletcher, JC				Gregory, Ellen F.; Dao, Thai Q.; Alexander, Martin A.; Miller, Mark J.; Fletcher, Jennifer C.			The signaling peptide-encoding genes CLE16, CLE17 and CLE27 are dispensable for Arabidopsis shoot apical meristem activity	PLOS ONE			English	Article							STEM-CELL FATE; RECEPTOR KINASE; ROOT-MERISTEM; CLAVATA3; WUSCHEL; THALIANA; DIFFERENTIATION; EXPRESSION; FAMILY; SIZE	The shoot apical meristem produces all of the leaves, stems and flowers of a flowering plant from a reservoir of stem cells at its growing tip. In Arabidopsis, the small polypeptide signaling molecule CLAVATA3 (CLV3), a member of the CLV3/EMBRYO SURROUNDING REGION-RELATED (CLE) gene family, is a key component of a negative feedback loop that maintains stem cell activity in shoot and floral meristems throughout development. Because in some plant species multiple CLE genes are involved in regulating shoot apical meristem activity, we tested the hypothesis that CLE genes other than CLV3 might function in stem cell homeostasis in Arabidopsis. We identified three Arabidopsis CLE genes expressed in the post-embryonic shoot apical meristem, generated loss-of-function alleles using genome editing, and analyzed the meristem phenotypes of the resulting mutant plants. We found that null mutations in CLE16, CLE17 or CLE27 affected neither vegetative nor reproductive shoot meristem activity under normal growth conditions, although CLE27 appears to slightly prolong vegetative growth. Our results indicate that the CLE16, CLE17 and CLE27 genes have largely redundant roles in the Arabidopsis shoot apical meristem and/or regulate meristem activity only under specific environmental conditions.	[Gregory, Ellen F.; Dao, Thai Q.; Alexander, Martin A.; Miller, Mark J.; Fletcher, Jennifer C.] USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; [Gregory, Ellen F.; Dao, Thai Q.; Alexander, Martin A.; Miller, Mark J.; Fletcher, Jennifer C.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley	Fletcher, JC (corresponding author), USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA.; Fletcher, JC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	jfletcher@berkeley.edu		Dao, Thai/0000-0002-2510-512X; Gregory, Ellen/0000-0002-2228-8258	US Department of Agriculture (CRIS grant) [2030-21000-041-00D]	US Department of Agriculture (CRIS grant)	This work was supported by the US Department of Agriculture (CRIS grant 2030-21000-041-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Araya T, 2014, P NATL ACAD SCI USA, V111, P2029, DOI 10.1073/pnas.1319953111; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Carles CC, 2004, GENETICS, V167, P1893, DOI 10.1534/genetics.104.028787; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cock JM, 2001, PLANT PHYSIOL, V126, P939, DOI 10.1104/pp.126.3.939; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Endo S, 2013, CURR BIOL, V23, P1670, DOI 10.1016/j.cub.2013.06.060; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Fiers M, 2004, GENE, V327, P37, DOI 10.1016/j.gene.2003.11.014; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Fiume E, 2010, METHODS MOL BIOL, V655, P131, DOI 10.1007/978-1-60761-765-5_9; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gaillochet C, 2015, DEVELOPMENT, V142, P2237, DOI 10.1242/dev.117614; Galli M, 2016, TRENDS GENET, V32, P372, DOI 10.1016/j.tig.2016.04.001; Gutierrez-Alanis D, 2017, DEV CELL, V41, P555, DOI 10.1016/j.devcel.2017.05.009; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Jun J, 2010, PLANT PHYSIOL, V154, P1721, DOI 10.1104/pp.110.163683; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Kondo T, 2008, BIOCHEM BIOPH RES CO, V377, P312, DOI 10.1016/j.bbrc.2008.09.139; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mantegazza O, 2014, PLANT J, V79, P861, DOI 10.1111/tpj.12585; Meng L, 2010, MOL PLANT, V3, P760, DOI 10.1093/mp/ssq021; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ni J, 2006, PLANT PHYSIOL, V140, P726, DOI 10.1104/pp.105.072678; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Somssich M, 2016, DEVELOPMENT, V143, P3238, DOI 10.1242/dev.133645; Soyars CL, 2016, CURR OPIN PLANT BIOL, V29, P163, DOI 10.1016/j.pbi.2015.12.002; Stahl Y, 2009, PLANT SIGNAL BEHAV, V4, P634, DOI 10.4161/psb.4.7.8970; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515; Suzaki T, 2006, PLANT CELL PHYSIOL, V47, P1591, DOI 10.1093/pcp/pcl025; Suzaki T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000693; Wang XH, 2005, MOL PLANT PATHOL, V6, P187, DOI [10.1111/j.1364-3703.2005.00270.x, 10.1111/J.1364-3703.2005.00270.X]; Xu C, 2015, NAT GENET, V47, P784, DOI 10.1038/ng.3309; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yaginuma H, 2011, PLANT CELL PHYSIOL, V52, P1354, DOI 10.1093/pcp/pcr081; Yamaguchi YL, 2017, PLANT CELL PHYSIOL, V58, P1848, DOI 10.1093/pcp/pcx139	49	9	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202595	10.1371/journal.pone.0202595	http://dx.doi.org/10.1371/journal.pone.0202595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114285	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400088
J	Chen, SL; Lu, XL; Bai, GY; Zhang, YQ; Li, BJ; Wang, W; Liang, L; Ma, L; Li, Y; Wang, XF; Wang, YY; Zhao, CY; Zhao, HR				Chen, Suliang; Lu, Xinli; Bai, Guangyi; Zhang, Yuqi; Li, Baojun; Wang, Wei; Liang, Liang; Ma, Lin; Li, Yan; Wang, Xiaofeng; Wang, Yingying; Zhao, Cuiying; Zhao, Hongru			Twenty-seven year surveillance of blood transfusion recipients infected with HIV-1 in Hebei Province, China	PLOS ONE			English	Article								We conducted an investigation of blood management in which blood transfusion recipients underwent molecular biological analysis, to trace the possible source of HIV infection. Epidemiological investigation was carried out among HIV-infected individuals. Blood transfusion recipients infected with HIV were tracked for the date of transfusion, reason for transfusion, hospital where transfusion was received, source of blood, components of transfusion, number of transfusions, and transfusion volume. A total of 285 blood transfusion recipients infected with HIV-1 were detected in Hebei over the study period, with 42.81% (122/285) detected through clinical diagnostic testing. These cases showed a concentrated distribution in southern Hebei, with local outbreak characteristics. A census of the population in Shahe County, which had a high concentration of cases, revealed that recipients of blood transfusions had an HIV infection rate of 15.54% (92/592). Post-transfusion infection frequently occurred among blood transfusion recipients at township medical institutions, with a peak in 1995. Owing to late detection of HIV infection among blood transfusion recipients, the rates of spousal transmission and mother-to-child transmission reached 20.87% and 28.05%, respectively. Around 1995, community medical institutions did not screen for HIV antibodies among paid blood donors, which was an important cause of the outbreak of HIV1 infection among blood transfusion recipients. Our findings indicate that cases of blood transfusion-related infection decreased rapidly with gradual improvement in the HIV screening system for blood donors that began in 1995, particularly after full implementation of HIV nucleic acid testing of volunteer blood donors was begun in 2015.	[Chen, Suliang; Lu, Xinli; Bai, Guangyi; Zhang, Yuqi; Li, Baojun; Wang, Wei; Liang, Liang; Ma, Lin; Li, Yan; Wang, Xiaofeng; Wang, Yingying; Zhao, Cuiying; Zhao, Hongru] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China		Lu, XL (corresponding author), Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China.	hebeicdc2013@sina.com	wang, yi/GVT-8516-2022; wang, yingying/GRS-3058-2022; wang, yan/GSE-6489-2022	lu, xinli/0000-0003-4613-2028	natural science fund of Hebei province [H2016303006]	natural science fund of Hebei province	This study was supported by the natural science fund of Hebei province (H2016303006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SL, 2010, CHIN J DIS CONTROL P, V14, P848; Chen Su-Liang, 1994, Zhonghua Yufang Yixue Zazhi, V28, P350; Chen SL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1073-y; Liu ShuJun, 2010, Modern Preventive Medicine, V37, P3153; Lu XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171481; Shao Y, 2008, DIAGNOSTIC CRITERIA; Shao Y, 1994, CHINESE J VIROL, V12, P291; Yan J, 2004, S CHINAJ PREV MED, V30, P1; ZHANG WH, 1990, LANCET, V335, P353, DOI 10.1016/0140-6736(90)90637-K; Zhao CY, 2010, CHIN J HLTH LAB TECH, V20, P3136; Zheng X, 2000, CHIN J EPIDEMIOL, V21, P352	11	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202265	10.1371/journal.pone.0202265	http://dx.doi.org/10.1371/journal.pone.0202265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110373	Green Published, Green Submitted, gold			2022-12-26	WOS:000441738000059
J	Hussain, MA; Katzenellenbogen, JM; Sanfilippo, FM; Murray, K; Thompson, SC				Hussain, Mohammad Akhtar; Katzenellenbogen, Judith M.; Sanfilippo, Frank M.; Murray, Kevin; Thompson, Sandra C.			Complexity in disease management: A linked data analysis of multimorbidity in Aboriginal and non-Aboriginal patients hospitalised with atherothrombotic disease in Western Australia	PLOS ONE			English	Article							HEALTH-CARE; SOCIOECONOMIC-STATUS; PREVALENCE; PATTERNS; COMORBIDITY; DISPARITIES; MORBIDITY; QUALITY; LINKAGE; STROKE	Background Hospitalisation for atherothrombotic disease (ATD) is expected to rise in coming decades. However, increasingly, associated comorbidities impose challenges in managing patients and deciding appropriate secondary prevention. We investigated the prevalence and pattern of multimorbidity (presence of two or more chronic conditions) in Aboriginal and non-Aboriginal Western Australian residents with ATDs. Methods and findings We used population-based de-identified linked administrative health data from 1 January 2000 to 30 June 2014 to identify a cohort of patients aged 25 +/- 59 years admitted to Western Australian hospitals with a discharge diagnosis of ATD. The prevalence of common chronic diseases in these patients was estimated and the patterns of comorbidities and multimorbidities empirically explored using two different approaches: identification of the most commonly occurring pairs and triplets of comorbid diseases, and through latent class analysis (LCA). Half of the cohort had multimorbidity, although this was much higher in Aboriginal people (Aboriginal: 79.2% vs. non-Aboriginal: 39.3%). Only a quarter were without any documented comorbidities. Hypertension, diabetes, alcohol abuse disorders and acid peptic diseases were the leading comorbidities in the major comorbid combinations across both Aboriginal and non-Aboriginal cohorts. The LCA identified four and six distinct clinically meaningful classes of multimorbidity for Aboriginal and non-Aboriginal patients, respectively. Out of the six groups in non-Aboriginal patients, four were similar to the groups identified in Aboriginal patients. The largest proportion of patients (33% in Aboriginal and 66% in non-Aboriginal) was assigned to the "minimally diseased" (or relatively healthy) group, with most patients having less than two conditions. Other groups showed variability in degree and pattern of multimorbidity. Conclusion Multimorbidity is common in ATD patients and the comorbidities tend to interact and cluster together. Physicians need to consider these in their clinical practice. Different treatment and secondary prevention strategies are likely to be useful for management in these cluster groups.	[Hussain, Mohammad Akhtar; Thompson, Sandra C.] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, WA, Australia; [Katzenellenbogen, Judith M.; Sanfilippo, Frank M.; Murray, Kevin] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia	University of Western Australia; University of Western Australia	Hussain, MA (corresponding author), Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, WA, Australia.	akhtar.hussain@uwa.edu.au	Hussain, Mohammad Akhtar/G-8446-2012; Thompson, Sandra/H-5955-2014; Murray, Kevin/H-5503-2014; Sanfilippo, Frank/H-9334-2013	Hussain, Mohammad Akhtar/0000-0002-6012-3702; Thompson, Sandra/0000-0003-0327-7155; Murray, Kevin/0000-0002-8856-6046; Sanfilippo, Frank/0000-0003-3639-0787; Katzenellenbogen, Judith/0000-0001-5287-5819	Australian Department of Health; National Health and Medical Research Council of Australia [1031057]; Heart Foundation of Australia Future Leader Fellowship	Australian Department of Health(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia Future Leader Fellowship	The Western Australian Centre for Rural Health receives funding from the Australian Department of Health. This work was partly supported by the National Health and Medical Research Council of Australia (Grant Number 1031057). JMK is supported by a Heart Foundation of Australia Future Leader Fellowship.	Adhikari P, 2006, SOC EC IND AR INTR U; AIHW Tong B, 2007, CARD DIS SER, V28; AIo Health, 2017, MED CARD DIS; Aspin C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-143; Atkins ER, 2013, AUST HEALTH REV, V37, P488, DOI 10.1071/AH13083; Australian Bureau of Statistics, 2016, W AUSTR 2016 CENS AL; Australian Institute of Health and Welfare, 2017, BULLETIN, V141; Australian Institute of Health and Welfare, 2016, AUSTR BURD DIS STUD, V6; Australian Institute of Health and Welfare, 2015, CARD DIAB CHRON KIDN, V5; Australian Institute of Health and Welfare, 2014, CARD DIAB CHRON KIND, V3; Australian Institute of Health and Welfare, 2016, AUSTR HLTH 2016 AUST, V15; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare. Cardiovascular Health Compendium, 2017, CARD HLTH COMP; Australian Institute of Health & Welfare, 2016, AUSTR BURD DIS STUD, V3; Azais Boris, 2016, J Comorb, V6, P1, DOI 10.15256/joc.2016.6.71; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brameld KJ, 2003, INT J EPIDEMIOL, V32, P617, DOI 10.1093/ije/dyg191; Briffa TG, 2013, INT J CARDIOL, V164, P185, DOI 10.1016/j.ijcard.2011.06.122; Briffa TG, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-111; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Byles JE, 2005, J CLIN EPIDEMIOL, V58, P997, DOI 10.1016/j.jclinepi.2005.02.025; Chandraratne NK, 2018, AUST J GEN PRACT, V47, P15, DOI 10.31128/AFP-09-17-4346; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen D, 2014, AUST J SOC ISSUES, V49, P423, DOI 10.1002/j.1839-4655.2014.tb00322.x; Crocetti E, 2013, BRIT J CANCER, V109, P219, DOI 10.1038/bjc.2013.311; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gray C., 2012, REV CARDIOVASCULAR H; Harrison C, 2016, AUST NZ J PUBL HEAL, V40, P239, DOI 10.1111/1753-6405.12509; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Health Care Homes, 2018, HDB GEN PRACT AB COM; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hussain MA, 2015, BMJ OPEN, V5; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Katzenellenbogen JM, 2015, HEART, V101, P712, DOI 10.1136/heartjnl-2014-306678; Katzenellenbogen JM, 2014, INT J STROKE, V9, P61, DOI 10.1111/ijs.12278; Katzenellenbogen JM, 2012, EUR J PREV CARDIOL, V19, P983, DOI 10.1177/1741826711417925; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Katzenellenbogen JM, 2010, HEART LUNG CIRC, V19, P717, DOI 10.1016/j.hlc.2010.08.009; Kendir C, 2017, EUR J GEN PRACT, V24, P45, DOI 10.1080/13814788.2017.1398318; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Mather T, 2014, AUST NZ J PUBL HEAL, V38, P436, DOI 10.1111/1753-6405.12239; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Millar E, 2018, J PRIM HEALTH CARE, V10, P44, DOI 10.1071/HC17074; Morgan VA, 2010, BRIT J PSYCHIAT, V197, P8, DOI 10.1192/bjp.bp.109.076588; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Palmer K, 2018, HEALTH POLICY, V122, P4, DOI 10.1016/j.healthpol.2017.09.006; Pathirana TI, 2018, AUST NZ J PUBL HEAL, V42, P186, DOI 10.1111/1753-6405.12762; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Randall DA, 2018, MED J AUSTRALIA, V209, P19, DOI 10.5694/mja17.00878; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Sarfati D, 2010, NEW ZEAL MED J, V123, P50; Sarink D, 2016, EUR J PREV CARDIOL, V23, P23, DOI 10.1177/2047487314554865; Smith SM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-6; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Teng THK, 2014, INT J CARDIOL, V173, P110, DOI 10.1016/j.ijcard.2014.02.020; Thompson SC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-133; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Wallace C, 1998, BRIT J PSYCHIAT, V172, P477, DOI 10.1192/bjp.172.6.477; Wallace E, 2015, BMJ-BRIT MED J, V350; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Whitson HE, 2016, J AM GERIATR SOC, V64, P1668, DOI 10.1111/jgs.14201; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x	68	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201496	10.1371/journal.pone.0201496	http://dx.doi.org/10.1371/journal.pone.0201496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ4SC	30106971	gold, Green Submitted, Green Published			2022-12-26	WOS:000441662800010
J	Almeida, F; Seribelli, AA; Medeiros, MIC; Rodrigues, DD; de MelloVarani, A; Luo, Y; Allard, MW; Falcao, JP				Almeida, Fernanda; Seribelli, Amanda Aparecida; Cazentini Medeiros, Marta Ines; Rodrigues, Dalia dos Prazeres; de MelloVarani, Alessandro; Luo, Yan; Allard, Marc W.; Falcao, Juliana Pfrimer			Phylogenetic and antimicrobial resistance gene analysis of Salmonella Typhimurium strains isolated in Brazil by whole genome sequencing	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; NONTYPHOIDAL SALMONELLA; MOLECULAR CHARACTERIZATION; MULTIDRUG-RESISTANT; GENOTYPIC DIVERSITY; ESCHERICHIA-COLI; RETAIL MEATS; SAO-PAULO; ENTERICA; HUMANS	Whole genome sequencing (WGS) has been used as a powerful technology for molecular epidemiology, surveillance, identification of species and serotype, identification of the sources of outbreaks, among other purposes. In Brazil, there is relatively few epidemiological data on Salmonella. In this study, 90 Salmonella Typhimurium strains had their genome sequenced to uncover the diversity of Salmonella Typhimurium isolated from humans and food, between 1983 and 2013, from different geographic regions in Brazil based on single nucleotide polymorphism (SNP) analysis. A total of 39 resistance genes were identified, such as aminoglycoside, tetracycline, sulfonamide, trimethoprim, beta-lactam, fluoroquinolone, phenicol and macrolide, as well as the occurrence of point mutations in some of the genes such as gyrA, gyrB, parC and parE. A total of 65 (72.2%) out of 90 S. Typhimurium strains studied were phenotypically resistant to sulfonamides, 44 (48.9%) strains were streptomycin resistant, 27 (30%) strains were resistant to tetracycline, 21 (23.3%) strains were gentamicin resistant, and seven (7.8%) strains were resistant to ceftriaxone. In the gyrA gene, it was observed the following amino acid substitutions: Asp(87)-> Gly, Asp(87)-> Asn, Ser(83)-> Phe, Ser(83)-> Tyr. Phylogenetic results placed the 90 S. Typhimurium strains into two major clades suggesting the existence of a prevalent subtype, likely more adapted, among strains isolated from humans, with some diversity in subtypes in foods. The variety and prevalence of resistant genes found in these Salmonella Typhimurium strains reinforces their potential hazard for humans and the risk in foods in Brazil.	[Almeida, Fernanda; Seribelli, Amanda Aparecida; Falcao, Juliana Pfrimer] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Av Cafe S-N, Ribeirao Preto, SP, Brazil; [Cazentini Medeiros, Marta Ines] Adolfo Lutz Inst, Ctr Lab Reg Ribeirao Preto, Rua Minas, Ribeirao Preto, SP, Brazil; [Rodrigues, Dalia dos Prazeres] FIOCRUZ Fundacao Inst Oswaldo Cruz, Lab Enterobacterias, Ave Brasil,Pavilhao Rocha Lima,3 Andar, Rio De Janeiro, RJ, Brazil; [de MelloVarani, Alessandro] Univ Estadual Paulista UNESP, Fac Ciencias Agr & Vet, Jaboticabal, Brazil; [Luo, Yan; Allard, Marc W.] US FDA, Div Microbiol, Off Regular Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	Universidade de Sao Paulo; Instituto Adolfo Lutz; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; US Food & Drug Administration (FDA)	Falcao, JP (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Av Cafe S-N, Ribeirao Preto, SP, Brazil.; Allard, MW (corresponding author), US FDA, Div Microbiol, Off Regular Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	marc.allard@fda.hhs.gov; jufalcao@fcfrp.usp.br	Varani, Alessandro M/F-6887-2011; Seribelli, Amanda Aparecida/O-2837-2017; Falcao, Juliana Pfrimer/E-9652-2012	Varani, Alessandro M/0000-0002-8876-3269; Falcao, Juliana Pfrimer/0000-0002-1459-9355; Seribelli, Amanda Aparecida/0000-0002-6603-9712	FDA/CFSAN; Sao Paulo Research Foundation-FAPESP [2012/19132-1, 2017/06633-6]; Coordination for the Improvement of Higher Education Personnel-CAPES [BEX 9708/14-06]	FDA/CFSAN; Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by the FDA/CFSAN research funding under Dr. Marc W. Allard supervision, by Sao Paulo Research Foundation-FAPESP (Proc. 2012/19132-1) under Dr. Juliana Pfrimer Falcao supervision and, by an international scholarship from Coordination for the Improvement of Higher Education Personnel-CAPES (Processo BEX 9708/14-06 for Fernanda Almeida). Currently, A. A. Seribelli was supported by a scholarship from Sao Paulo Research Foundation-FAPESP (Proc. 2017/06633-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABPA, 2017, ANN REPORT, P1; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Almeida F, 2016, J APPL MICROBIOL, V120, P1677, DOI 10.1111/jam.13110; Almeida F, 2017, INFECT GENET EVOL, V51, P41, DOI 10.1016/j.meegid.2017.03.009; Almeida F, 2017, J MICROBIOL METH, V133, P55, DOI 10.1016/j.mimet.2016.12.020; Almeida F, 2015, J MED MICROBIOL, V64, P1395, DOI 10.1099/jmm.0.000158; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; Campioni F, 2017, MICROB DRUG RESIST, V23, P421, DOI 10.1089/mdr.2016.0024; Campioni F, 2014, APMIS, V122, P215, DOI 10.1111/apm.12126; Cao GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055687; Choi SH, 2005, J ANTIMICROB CHEMOTH, V56, P1111, DOI 10.1093/jac/dki369; CLSI, 2015, PERF STAND ANT SUSC; Cummings KJ, 2017, ZOONOSES PUBLIC HLTH, V64, P305, DOI 10.1111/zph.12318; Davis S, 2015, PEER J COMPUTER SCI, V1, P1; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Feasey NA, 2014, EMERG INFECT DIS, V20, P1957, DOI 10.3201/eid2011.141175; Fernandes Sueli A., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P179, DOI 10.1590/S0036-46652006000400001; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hoffmann M, 2014, GENOME BIOL EVOL, V6, P1046, DOI 10.1093/gbe/evu079; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hopkins KL, 2008, EMERG INFECT DIS, V14, P340, DOI 10.3201/eid1402.070573; Jacoby GA, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.PLAS-0006-2013, 10.1128/microbiolspec.PLAS-0006.2013]; Kich JD, 2011, INT J FOOD MICROBIOL, V151, P307, DOI 10.1016/j.ijfoodmicro.2011.09.024; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Ley B, 2014, EMERG INFECT DIS, V20, P701, DOI 10.3201/eid2004.131488; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Pribul BR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00299; Saenz Y, 2003, J ANTIMICROB CHEMOTH, V51, P1001, DOI 10.1093/jac/dkg168; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Taunay A E, 1996, Rev Inst Med Trop Sao Paulo, V38, P119; Tavechio A. T., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P315, DOI 10.1590/S0036-46651996000500001; Tavechio AT, 2002, J FOOD PROTECT, V65, P1041, DOI 10.4315/0362-028X-65.6.1041; Casas MRT, 2016, DIAGN MICR INFEC DIS, V85, P85, DOI 10.1016/j.diagmicrobio.2016.01.016; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Viott AM, 2013, BRAZ J MICROBIOL, V44, P145, DOI 10.1590/S1517-83822013005000033; Wang HL, 2017, INT J MOL MED, V39, P364, DOI 10.3892/ijmm.2016.2844; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao SH, 2015, J ANTIMICROB CHEMOTH, V70, P1314, DOI 10.1093/jac/dkv001	43	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201882	10.1371/journal.pone.0201882	http://dx.doi.org/10.1371/journal.pone.0201882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102733	gold, Green Published, Green Submitted			2022-12-26	WOS:000441452200020
J	Esezobor, CI; Akintan, P; Nwaogazie, U; Akinwunmi, E; Temiye, E; Akinsulie, A; Gbadegesin, R				Esezobor, Christopher Imokhuede; Akintan, Patricia; Nwaogazie, Uche; Akinwunmi, Edna; Temiye, Edamisan; Akinsulie, Adebola; Gbadegesin, Rasheed			Enuresis in children and adolescents with sickle cell anaemia is more frequent and substantially different from the general population	PLOS ONE			English	Article							NOCTURNAL ENURESIS; CHILDHOOD ENURESIS; DISEASE; STANDARDIZATION; INCONTINENCE; PREVALENCE; ADULTS	Background No large studies have examined the prevalence of enuresis, its various forms and risk factors in children with sickle cell anaemia (SCA) in Sub-Saharan Africa using standardised definitions. We determined age and gender-specific prevalence of enuresis and compared the nature of enuresis in children with and without SCA. We also identified predictors of enuresis in children with SCA. Methods Caregivers of children with SCA attending a tertiary centre haematology clinic in Nigeria were interviewed using a questionnaire. In addition, a separate questionnaire was completed for every sibling aged 5-17 years whose haemoglobin genotype was known. Enuresis and its various forms were defined using the definitions of the International Children's Continence Society. Results The study involved 243 children with SCA and 243 controls matched for age and sex. The mean age of the study cohort was 9.9 (3.4). Females made up 45.7% of the cohorts. The prevalence of enuresis was 49.4% and 29.6% in children with and without SCA, respectively (p = 0.009). In both groups, the prevalence of enuresis declined with age but remained five times higher at 25% in children with SCA aged 14-17 years compared with controls. Also, children with SCA and enuresis were older, more likely to have non-monosymptomatic enuresis and wet at least three nights per week than controls. Independent predictors of enuresis in children with SCA were a family history of enuresis and young age. Conclusion Children with SCA had more frequent and more severe enuresis which persisted to late adolescence than age and sex-matched controls. These features indicate a subset of enuresis that is difficult to treat in the general population. Young age and enuresis in a family member define a subset of children with SCA more likely to have enuresis. Healthcare workers need to discuss enuresis with parents of children with SCA and offer referral to continence services.	[Esezobor, Christopher Imokhuede; Akintan, Patricia; Temiye, Edamisan; Akinsulie, Adebola] Univ Lagos, Fac Clin Sci, Dept Paediat, Coll Med, Lagos, Nigeria; [Esezobor, Christopher Imokhuede; Akintan, Patricia; Nwaogazie, Uche; Akinwunmi, Edna; Temiye, Edamisan; Akinsulie, Adebola] Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Gbadegesin, Rasheed] Duke Univ, Med Ctr, Dept Pediat, Div Nephrol, Durham, NC 27710 USA; [Gbadegesin, Rasheed] Duke Mol Physiol Inst, Durham, NC USA	University of Lagos; Duke University	Esezobor, CI (corresponding author), Univ Lagos, Fac Clin Sci, Dept Paediat, Coll Med, Lagos, Nigeria.; Esezobor, CI (corresponding author), Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria.	esezobor@gmail.com	Esezobor, Christopher Imokhuede/AAP-2230-2020	Esezobor, Christopher Imokhuede/0000-0003-1736-4794; Akinsulie, Adebola/0000-0003-2543-5871				AKINYANJU O, 1989, J TROP PEDIATRICS, V35, P24, DOI 10.1093/tropej/35.1.24; Aloni MN, 2012, ACTA PAEDIATR, V101, pE475, DOI 10.1111/j.1651-2227.2012.02791.x; Anele UA, 2016, NEUROUROL URODYNAM, V35, P642, DOI 10.1002/nau.22777; Austin PF, 2014, J UROLOGY, V191, P1863, DOI 10.1016/j.juro.2014.01.110; Babela JRM, 2004, ARCH PEDIATRIE, V11, P1168, DOI 10.1016/j.arcped.2004.05.017; Barakat LP, 2001, J DEV BEHAV PEDIATR, V22, P300, DOI 10.1097/00004703-200110000-00004; Bower WF, 1996, BRIT J UROL, V78, P602, DOI 10.1046/j.1464-410X.1996.13618.x; Choudhary B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155808; Ekinci O, 2013, INT J HEMATOL, V98, P430, DOI 10.1007/s12185-013-1422-9; Eneh CI, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0176-9; Esezobor CI, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2015.06.009; Esezobor CI, 2016, ACTA PAEDIATR, V105, pE379, DOI 10.1111/apa.13437; Field JJ, 2008, UROLOGY, V72, P81, DOI 10.1016/j.urology.2008.02.006; FIGUEROA TE, 1995, J UROLOGY, V153, P1987, DOI 10.1016/S0022-5347(01)67386-5; Firoozi F, 2006, J UROLOGY, V175, P1885, DOI 10.1016/S0022-5347(05)00935-3; Fockema MW, 2012, BJU INT, V110, pE1114, DOI 10.1111/j.1464-410X.2012.11416.x; Franco I, 2013, J PEDIATR UROL, V9, P234, DOI 10.1016/j.jpurol.2012.10.026; Jeyakumar A, 2012, LARYNGOSCOPE, V122, P1873, DOI 10.1002/lary.23323; Kalorin CM, 2010, J UROLOGY, V184, P2527, DOI 10.1016/j.juro.2010.08.040; Lee SD, 2000, BJU INT, V85, P869, DOI 10.1046/j.1464-410x.2000.00617.x; Lehmann GC, 2012, J UROLOGY, V188, P1572, DOI 10.1016/j.juro.2012.02.021; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Olusanya O., 1985, W AFR J MED, V4, P205; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Portocarrero ML, 2012, J UROLOGY, V187, P1037, DOI 10.1016/j.juro.2011.10.171; READETT DRJ, 1990, ARCH DIS CHILD, V65, P290, DOI 10.1136/adc.65.3.290; READETT DRJ, 1990, ARCH DIS CHILD, V65, P615, DOI 10.1136/adc.65.6.615; STOREY J, 1979, ANN TROP MED PARASIT, V73, P311, DOI 10.1080/00034983.1979.11687264; Wolf RB, 2014, EXPERT REV HEMATOL, V7, P245, DOI 10.1586/17474086.2014.892412	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201860	10.1371/journal.pone.0201860	http://dx.doi.org/10.1371/journal.pone.0201860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096167	gold, Green Published, Green Submitted			2022-12-26	WOS:000441308500031
J	Li, XT; Liu, P; Yang, PP; Fan, CZ; Sun, XM				Li, Xueting; Liu, Ping; Yang, Panpan; Fan, Chuanzhu; Sun, Xiaomei			Characterization of the glycerol-3-phosphate acyltransferase gene and its real-time expression under cold stress in Paeonia lactiflora Pall	PLOS ONE			English	Article							FATTY-ACIDS; CHILLING SENSITIVITY; CLONING; PHOTOSYNTHESIS; UNSATURATION; TOLERANCE; GROWTH; PLANTS; CDNA; L.	Elucidating the cold tolerance mechanism of Paeonia lactiflora, which is one of the most valuable ornamental and medicinal plants in Asia, fundamentally impacts its breeding and production. The glycerol-3-phosphate acyltransferase (GPAT) gene plays a pivotal role in cold resistance in a variety of plant species. Here, we cloned the P. lactiflora GPAT gene, determined its expression pattern, and tested its role in cold resistance. We obtained the full-length P. lactiflora GPAT gene using tissue-cultured seedlings and real-time polymerase chain reaction and rapid amplification of cDNA ends analyses. We named this gene PIGPAT in P. lactiflora. Phylogenetic analysis indicates that the PIGPAT gene is closely related with the GPAT genes in core eudicots. The phylogenetic tree containing 31 angiosperm species based on GPAT protein sequences is largely consistent with the known phylogeny in flowering plants. We conducted a time-course PIGPAT expression analysis and demonstrated that PIGPAT expression is correlated with low-temperature stress. Our results suggest that the PIGPAT gene plays an important role in regulating cold resistance in P. lactiflora.	[Li, Xueting; Sun, Xiaomei] Shenyang Agr Univ, Hort Coll, Shenyang, Liaoning, Peoples R China; [Liu, Ping; Yang, Panpan; Sun, Xiaomei] Shenyang Agr Univ, Forestry Coll, Shenyang, Liaoning, Peoples R China; [Fan, Chuanzhu; Sun, Xiaomei] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Shenyang Agricultural University; Shenyang Agricultural University; Wayne State University	Sun, XM (corresponding author), Shenyang Agr Univ, Hort Coll, Shenyang, Liaoning, Peoples R China.; Sun, XM (corresponding author), Shenyang Agr Univ, Forestry Coll, Shenyang, Liaoning, Peoples R China.; Fan, CZ; Sun, XM (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	cfan@wayne.edu; xiaomei7280@wayne.edu			National Natural Science Foundation of the P. R. China [31470696]; Wayne State University [176452]; China Scholarship Council (CSC) [201608210350]	National Natural Science Foundation of the P. R. China(National Natural Science Foundation of China (NSFC)); Wayne State University; China Scholarship Council (CSC)(China Scholarship Council)	This study is supported by the National Natural Science Foundation (http://www.nsfc.gov.cn/english/site_1/index.html) of the P. R. China (31470696) to X.S. C.F. is supported by start-up fund (176452) from Wayne State University (www.wayne.edu). This paper is partially supported by China Scholarship Council (CSC) (https://www.cscscholarships.net/) with the No. 201608210350 to C.F. and X.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi T, 2002, PLANT CELL PHYSIOL, V43, P751, DOI 10.1093/pcp/pcf087; Chen Li-jing, 2011, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V31, P1726; [陈丽静 Chen Lijing], 2016, [分子植物育种, Molecular Plant Breeding], V14, P2984; Chen X, 2010, NO HORTICULTURE, V10, P121; Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1; Cyril J, 2002, CROP SCI, V42, P2031, DOI 10.2135/cropsci2002.2031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Gupta SM, 2013, MOL BIOL REP, V40, P4235, DOI 10.1007/s11033-013-2505-7; Jiang W, 2014, MYCOSYSTEMA, V33; Lalitha S., 2000, BIOTECH SOFTWARE INT, V1, P270, DOI [10.1089/152791600459894, DOI 10.1089/152791600459894]; Li Mei-ru, 2000, Journal of Tropical and Subtropical Botany, V8, P70; Liu Cong, 2014, Acta Agronomica Sinica, V40, P1304; Liu J, 1998, J YUNNAN U, V20, P203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Hui, 2013, China Vegetables, P32; Manas-Fernandez A, 2010, PLANTA, V232, P987, DOI 10.1007/s00425-010-1232-8; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MURATA N, 1983, PLANT CELL PHYSIOL, V24, P81, DOI 10.1093/oxfordjournals.pcp.a076516; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; Mykytczuk NCS, 2010, ARCH MICROBIOL, V192, P1005, DOI 10.1007/s00203-010-0629-x; Nishida I, 1996, ANNU REV PLANT PHYS, V47, P541, DOI 10.1146/annurev.arplant.47.1.541; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; Paya-Milans M, 2015, PHYTOCHEMISTRY, V111, P27, DOI 10.1016/j.phytochem.2014.12.028; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ruiz-Lopez N, 2010, PLANT PHYSIOL BIOCH, V48, P73, DOI 10.1016/j.plaphy.2009.12.001; Shockey J, 2016, PLANT PHYSIOL, V170, P163, DOI 10.1104/pp.15.01563; Sui N, 2007, FUNCTIONAL ANAL CHLO; Wang Q, 2015, J ANHUI AGR, V43, P11; Wang Q, 2014, S AFR J BOT, V94, P140, DOI 10.1016/j.sajb.2014.05.012; Wang YG, 2016, CLONING EXPRESSION A; [魏琦琦 Wei Qiqi], 2016, [植物生理学报, Plant Physiology Journal], V52, P1099; Wu HongJuan, 2011, Journal of Northeast Forestry University, V39, P20; [相恒佐 Xiang Hengzuo], 2013, [分子植物育种, Molecular Plant Breeding], V11, P831; [邢蔓 Xing Man], 2016, [分子植物育种, Molecular Plant Breeding], V14, P3282; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Yokoi S, 1998, MOL BREEDING, V4, P269, DOI 10.1023/A:1009671231614; Yu X.N., 2011, J CHINESE LANDSCAPE, V27, P77; Zhang Nan, 2011, Plant Physiology Communications, V47, P181, DOI 10.1093/pcp/pcq187	40	11	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202168	10.1371/journal.pone.0202168	http://dx.doi.org/10.1371/journal.pone.0202168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096187	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500056
J	Barreau, K; Montero-Menei, C; Eyer, J				Barreau, Kristell; Montero-Menei, Claudia; Eyer, Joel			The neurofilament derived-peptide NFL-TBS.40-63 enters in-vitro in human neural stem cells and increases their differentiation	PLOS ONE			English	Article							CLATHRIN-DEPENDENT ENDOCYTOSIS; BETA-TUBULIN ISOTYPES; STEM/PROGENITOR CELLS; PENETRATING PEPTIDES; LIPID NANOCAPSULES; GLIOBLASTOMA CELLS; GLIOMA-CELLS; PROLIFERATION; EXPRESSION; TARGETS	Regenerative medicine is a promising approach to treat neurodegenerative diseases by replacing degenerating cells like neurons or oligodendrocytes. Targeting human neural stem cells directly in the brain is a big challenge in such a strategy. The neurofilament derived NFL-TBS.40-63 peptide has recently been introduced as a novel tool to target neural stem cells. Previous studies showed that this peptide can be internalized by rat neural stem cells in vitro and in vivo, which coincided with lower proliferation and self-renewal capacity and increase of differentiation. In this study, we analyzed the uptake and potential effects of the NFL-TBS.40-63 peptide on human neural stem cells isolated from human fetuses. We showed that the peptide inhibits proliferation and the ability to produce neurospheres in vitro, which is consistent with an increase in cell adhesion and differentiation. These results confirm that the peptide could be a promising molecule to target and manipulate human neural stem cells and thus could serve as a strategic tool for regenerative medicine.	[Barreau, Kristell; Eyer, Joel] Univ Angers, CNRS 6021, Lab Micro & Nanomed Translat, Inserm 1066,Inst Rech Ingn Sante,CHU, Batiment IBS, Angers, France; [Montero-Menei, Claudia] Univ Angers, Univ Nantes, INSERM, Ctr Rech Cancerol & Immunol, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers	Eyer, J (corresponding author), Univ Angers, CNRS 6021, Lab Micro & Nanomed Translat, Inserm 1066,Inst Rech Ingn Sante,CHU, Batiment IBS, Angers, France.	joel.eyer@univ-angers.fr	Eyer, Joel/K-4265-2015; Eyer, Joel/V-8679-2019	Eyer, Joel/0000-0001-6301-7465; Eyer, Joel/0000-0001-6301-7465; Montero-Menei, Claudia/0000-0002-1373-6987	AFM (Association Francaise contre les Myopathies); ARC (Association de Recherche contre le Cancer); Ligue contre le cancer 49; Ligue contre le cancer 85; LUNAM (L'universite Nantes, Angers, Le Mans); Region des Pays de la Loire; University of Angers; education, Audiovisual and Culture Executive Agency	AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); ARC (Association de Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le cancer 49; Ligue contre le cancer 85; LUNAM (L'universite Nantes, Angers, Le Mans); Region des Pays de la Loire(Region Pays de la Loire); University of Angers; education, Audiovisual and Culture Executive Agency	This work was supported by AFM (Association Francaise contre les Myopathies), ARC (Association de Recherche contre le Cancer), Ligue contre le cancer 49 and 85, LUNAM (L'universite Nantes, Angers, Le Mans) and "Region des Pays de la Loire" to EYER. J. BARREAU. K is supported by a grant from the University of Angers, in the framework of NanoFar 'European Doctorate in Nanomedicine" Erasmus Mundus Joint Doctorates program funded by the education, Audiovisual and Culture Executive Agency.	Abokrysha NKaN, 2011, STEM CELLS CLIN RES; Ajioka I, 2014, DEV GROWTH DIFFER, V56, P324, DOI 10.1111/dgd.12127; Alvarez-Palazuelos LE, 2011, CURR SIGNAL TRANSD T, V6, P320; Balzeau J, 2013, BIOMATERIALS, V34, P3381, DOI 10.1016/j.biomaterials.2013.01.068; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Berges R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049436; Berges R, 2012, MOL THER, V20, P1367, DOI 10.1038/mt.2012.45; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; Boquest AC, 1999, BIOL REPROD, V60, P1013, DOI 10.1095/biolreprod60.4.1013; Bosco DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128511; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Carradori D, 2016, J CONTROL RELEASE, V238, P253, DOI 10.1016/j.jconrel.2016.08.006; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Fressinaud C, 2015, NEUROSCIENCE, V298, P42, DOI 10.1016/j.neuroscience.2015.04.003; Fressinaud C, 2014, J NEUROSCI RES, V92, P243, DOI 10.1002/jnr.23308; Geloso MC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00085; GMC, 2000, CELL PROL DEV DIFF; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Guichet PO, 2015, STEM CELLS, V33, P21, DOI 10.1002/stem.1767; Guillaume DJ, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E21; Guizzetti M, 2011, METHODS MOL BIOL, V758, P349, DOI 10.1007/978-1-61779-170-3_24; Guo ZR, 2016, BIOMED REP, V4, P528, DOI 10.3892/br.2016.639; Hsu Yi-Chao, 2013, Biomed J, V36, P98, DOI 10.4103/2319-4170.113226; Hu YL, 2013, J BIOL CHEM, V288, P18853, DOI 10.1074/jbc.M112.443671; Itokazu Y, 2014, MOL NEUROBIOL, V50, P186, DOI 10.1007/s12035-014-8634-8; Katsetos CD, 2007, NEUROCHEM RES, V32, P1387, DOI 10.1007/s11064-007-9321-1; Laurin Y, 2017, BIOCHEMISTRY-US, V56, P1746, DOI 10.1021/acs.biochem.6b00988; Laurin Y, 2015, BIOCHEMISTRY-US, V54, P3660, DOI 10.1021/acs.biochem.5b00146; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lepinoux-Chambaud C, 2016, STEM CELL TRANSL MED, V5, P901, DOI 10.5966/sctm.2015-0221; Lepinoux-Chambaud C, 2013, INT J PHARMACEUT, V454, P738, DOI 10.1016/j.ijpharm.2013.04.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado-Soto AR, 2014, AM J PHYS MED REHAB, V93, pS132, DOI 10.1097/PHM.0000000000000111; Margolis G, 2016, CARDIOLOGY, V134, P57, DOI 10.1159/000443369; Mazzini L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0371-2; Moreno-Estelles M, 2012, STEM CELLS, V30, P2796, DOI 10.1002/stem.1243; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Nakamura Y, 2003, LAB INVEST, V83, P479, DOI 10.1097/01.LAB.0000063930.75913.B3; Narayanan G, 2016, JOVE-J VIS EXP, DOI 10.3791/54456; Oikari LE, 2016, DATA BRIEF, V7, P206, DOI 10.1016/j.dib.2016.02.030; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pino A, 2017, BIOCHEM PHARMACOL, V141, P4, DOI 10.1016/j.bcp.2017.07.003; Remaud S, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.8; Rivalin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098473; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542	49	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201578	10.1371/journal.pone.0201578	http://dx.doi.org/10.1371/journal.pone.0201578			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092042	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600037
J	Gao, Q; Wang, F; Lv, XH; Cao, H; Su, F; Zhou, JJ; Leng, PE				Gao, Qiang; Wang, Fei; Lv, Xihong; Cao, Hui; Su, Fei; Zhou, Jianjun; Leng, Peien			Aedes albopictus production in urban stormwater catch basins and manhole chambers of downtown Shanghai, China	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS DIPTERA; WEST-NILE-VIRUS; TREATMENT SYSTEMS; BACILLUS-SPHAERICUS; SOUTHERN CALIFORNIA; MOSQUITO PRODUCTION; TREATMENT DEVICES; NORTH-AMERICA; CULICIDAE; DRAINS	Background The near-surface urban drainage system in Shanghai is highly complex, with hundreds of thousands of catch basins (CBs) and manhole chambers (MCs). Comparatively little is known about the breeding of mosquitoes in this vast system, especially for the locally predominant species Aedes albopictus. A cross-sectional mosquito sampling study was conducted from late July to early August of 2017 using 539 CBs and 309 MCs located in 10 communities of downtown Shanghai. We measured the water-holding status of the drainage systems and density of mosquito larvae. Mosquito species were examined on site and in the laboratory later. Results The CBs were characterized by a lower percentage of standing water compared to MCs (47.0% vs. 79.9%, respectively; X-2 = 76.407, P<0.001), but CBs contained a higher percentage of stagnant water percent than MCs (45.2% vs. 35.3%, respectively; X-2 = 11.465, P = 0.001). There were exclusively two species of mosquito larvae found in the drainage systems, Ae. albopictus and Culex pipiens complex. Compared with MCs, the structures of CBs were more conducive to larval production and yielded more larvae-positive samples (43.4% vs 14.2%, X-2 = 53.136, P<0.001) and higher larval density (8.23 vs. 4.09 per dipper, t = 3.287, P = 0.001). Aedes albopictus was the predominant species in CBs, with a constituent ratio of 71.7%. Regarding structures with different features in different locations, CBs that had a vertical grate with an unsealed lid and MCs with plastic composite covers were the most favorable types for mosquito breeding, and residential neighborhoods yielded the highest number of Ae. albopictus. Conclusion Aedes albopictus was the predominant species in both CBs and stormwater MCs, especially in residential neighborhoods. CBs, particularly those with vertical grates, were a major source of mosquito production in downtown Shanghai. MCs featured more running water and fewer larvae by percentage, and few larvae were found in Sewage MCs. However, due to the tremendous baseline amount, MCs were still an important breeding source of mosquitoes. We suggest that Aedes control in Shanghai should focus on CBs or other potential larvae habitats in and around residential neighborhoods. The use of permeable materials and completely sealed covers should be adopted in the construction of CBs and MCs henceforth.	[Gao, Qiang; Cao, Hui; Su, Fei; Zhou, Jianjun] Shanghai Huangpu Ctr Dis Control & Prevent, Dept Vector Prevent, Shanghai, Peoples R China; [Wang, Fei] Shanghai Hongkou Ctr Dis Control & Prevent, Dept Vector Prevent, Shanghai, Peoples R China; [Lv, Xihong] Shanghai Songjiang Ctr Dis Control & Prevent, Dept Vector Prevent, Shanghai, Peoples R China; [Leng, Peien] Shanghai Municipal Ctr Dis Control & Prevent, Dept Vector Prevent, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zhou, JJ (corresponding author), Shanghai Huangpu Ctr Dis Control & Prevent, Dept Vector Prevent, Shanghai, Peoples R China.; Leng, PE (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept Vector Prevent, Shanghai, Peoples R China.	zhoujianjun271219@163.com; lengpeien1380@163.com		gao, qiang/0000-0002-3581-6662	Training Program Foundations for Excellent Youth Medical Talents of Shanghai [2017YQ071]; Major Public Health project of Huangpu District [HWZFX201805, HKW201624]	Training Program Foundations for Excellent Youth Medical Talents of Shanghai; Major Public Health project of Huangpu District	This work is funded by Training Program Foundations for Excellent Youth Medical Talents of Shanghai (2017YQ071) to QG and the Major Public Health project of Huangpu District (HWZFX201805 & HKW201624) to QG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1; [Anonymous], 2017, SHANGH REP 1 CAS LOC; Arana-Guardia R, 2014, ACTA TROP, V134, P33, DOI 10.1016/j.actatropica.2014.01.011; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Dhillon MS, 1985, ECOLOGY URBAN UNDERG; Dua V K, 2000, Southeast Asian J Trop Med Public Health, V31, P818; Gao Qiang, 2016, Zhonghua Weisheng Shachong Yaoxie, V22, P563; Gao Qiang, 2016, Zhonghua Weisheng Shachong Yaoxie, V22, P40; Giraldo-Calderon GI, 2008, BIOMEDICA, V28, P224; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Harbison JE, 2014, FORESTER DAILY NEWS; Harbison JE, 2011, J VECTOR ECOL, V36, P224, DOI 10.1111/j.1948-7134.2011.00161.x; Harbison JE, 2010, J MED ENTOMOL, V47, P67, DOI 10.1603/033.047.0109; Harbison JE, 2009, J VECTOR ECOL, V34, P182, DOI [10.1111/j.1948-7134.2009.00025.x, 10.3376/038.034.0203]; Harbison JE, 2009, J AM MOSQUITO CONTR, V25, P356, DOI 10.2987/09-5897.1; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Jackson MJ, 2013, CAN ENTOMOL, V145, P674, DOI 10.4039/tce.2013.46; Jackson MJ, 2009, WATER QUAL RES J CAN, V44, P103, DOI 10.2166/wqrj.2009.011; Kay BH, 2000, J MED ENTOMOL, V37, P846, DOI 10.1603/0022-2585-37.6.846; Kobayashi Mutsuo, 2008, Global Environmental Research, V12, P27; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491, DOI 10.1007/BF00229976; Metzger ME, 2008, J AM MOSQUITO CONTR, V24, P70, DOI 10.2987/5655.1; Metzger ME, 2012, J MED ENTOMOL, V49, P343, DOI 10.1603/ME11187; Metzger ME, 2011, J MED ENTOMOL, V48, P1136, DOI 10.1603/ME11063; METZGER ME, 2004, MANAGING MOSQUITOES; MULLIGAN FS, 1982, MOSQ NEWS, V42, P360; Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1; Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325; Rey JR, 2006, J VECTOR ECOL, V31, P334, DOI 10.3376/1081-1710(2006)31[334:FAMPFS]2.0.CO;2; Rey JR, 2004, J VECTOR ECOL, V29, P124; ROBERTSON RC, 1988, J AM MOSQUITO CONTR, V4, P179; Rydzanicz K, 2016, PARASITOL RES, V115, P1711, DOI 10.1007/s00436-016-4912-x; Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5; Su TY, 2014, J MED ENTOMOL, V51, P421, DOI 10.1603/ME13173; Su TY, 2003, J VECTOR ECOL, V28, P79; Wang XL, 1999, CHIN J VECTOR BIO CO, V10, P120	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201607	10.1371/journal.pone.0201607	http://dx.doi.org/10.1371/journal.pone.0201607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092041	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600039
J	Calderon, BM; Conn, GL				Calderon, Brenda M.; Conn, Graeme L.			A human cellular noncoding RNA activates the antiviral protein 2 '-5 '-oligoadenylate synthetase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OLIGOADENYLATE SYNTHETASE; PKR ACTIVATION; KINASE PKR; TRANSLATION; INHIBITION; REVEALS; DSRNA; ROLES; REGULATORS; INFECTION	The 2'-5'-oligoadenylate synthetase (OAS) family of enzymes sense cytosolic dsRNA, a potent signal of viral infection. In response to dsRNA binding, OAS proteins synthesize the second messenger 2'-5'-linked oligoadenylate that activates the latent ribonuclease L (RNase L). RNase L-mediated degradation of viral and cellular RNAs effectively halts viral replication and further stimulates innate immune responses by inducing type I interferon. The OAS/RNase L pathway is therefore central in innate immune recognition and promotion of antiviral host responses. However, the potential for specific RNA sequences or structures to drive OAS1 activation and the molecular mechanisms by which they act are not currently fully understood. Moreover, the cellular regulators of OAS activity are not well defined. Here, we demonstrate that the human cellular noncoding RNA 886 (nc886) activates OAS1 both in vitro and in human A549 cells. We show that a unique structure present only in one of the two structural conformers adopted by nc886 drives potent OAS1 activation. In contrast, the conformer lacking this unique structure activated OAS1 only very weakly. We also found that formation of this OAS1-activating structural motif depends on the nucleotides in the apical-most loop of nc886 and the adjacent helix. These findings identify a cellular RNA capable of activating the OAS/RNase L pathway in human cells and illustrate the importance of structural elements, and their context, in potentiating OAS1 activity.	[Calderon, Brenda M.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA; [Calderon, Brenda M.] Emory Univ, Sch Med, Grad Program Biochem Cell & Dev Biol BCDB, Atlanta, GA 30322 USA	Emory University; Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu		Calderon, Brenda/0000-0003-1130-0386; Conn, Graeme/0000-0002-2419-380X	Emory University Research Council (URC); ARCS Foundation; BCDB NIGMS Training Grant from the National Institutes of Health [T32-GM008367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	Emory University Research Council (URC); ARCS Foundation; BCDB NIGMS Training Grant from the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an award from the Emory University Research Council (URC) ( to G.L.C.), a scholarship from the ARCS Foundation (to B.M.C.), and by BCDB NIGMS Training Grant T32-GM008367 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2017, ELIFE; Banerjee S, 2015, ONCOTARGET, V6, P44360, DOI 10.18632/oncotarget.6246; Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14; Brennan-Laun SE, 2014, J INTERF CYTOK RES, V34, P275, DOI 10.1089/jir.2013.0147; Calderon BM, 2017, RNA, V23, P557, DOI 10.1261/rna.060269.116; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Dalet A, 2015, FEBS LETT, V589, P1539, DOI 10.1016/j.febslet.2015.05.006; Deo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092545; Donovan J, 2017, RNA, V23, P1660, DOI 10.1261/rna.062000.117; Donovan J, 2015, P NATL ACAD SCI USA, V112, P3949, DOI 10.1073/pnas.1419409112; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Han YC, 2012, CELL REP, V2, P902, DOI 10.1016/j.celrep.2012.09.004; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; JUSTESEN J, 1992, ANAL BIOCHEM, V207, P90, DOI 10.1016/0003-2697(92)90506-3; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; Kodym R, 2009, BIOCHEM BIOPH RES CO, V388, P317, DOI 10.1016/j.bbrc.2009.07.167; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Kunkeaw N, 2013, ONCOGENE, V32, P3722, DOI 10.1038/onc.2012.382; Kwon YC, 2013, FEBS LETT, V587, P156, DOI 10.1016/j.febslet.2012.11.010; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113; Linpinsel J. L., 2012, RECOMBINANT VITRO RN, P43; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; McKenna SA, 2007, J MOL BIOL, V372, P103, DOI 10.1016/j.jmb.2007.06.028; McKenna SA, 2006, J MOL BIOL, V358, P1270, DOI 10.1016/j.jmb.2006.03.003; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Rath S, 2015, P NATL ACAD SCI USA, V112, P15916, DOI 10.1073/pnas.1513034112; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Siddiqui MA, 2015, INT J MOL SCI, V16, P17611, DOI 10.3390/ijms160817611; Tsutsui-Takeuchi M, 2015, IMMUNOL RES, V61, P240, DOI 10.1007/s12026-014-8617-x; Vachon VK, 2016, VIRUS RES, V212, P39, DOI 10.1016/j.virusres.2015.06.018; Vachon VK, 2015, NUCLEIC ACIDS RES, V43, P544, DOI 10.1093/nar/gku1289; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson JL, 2014, J BIOL CHEM, V289, P23233, DOI 10.1074/jbc.M114.550046; Yim HCH, 2016, CELL RES, V26, P367, DOI 10.1038/cr.2016.11; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112; Zhu JZ, 2014, IMMUNITY, V40, P936, DOI 10.1016/j.immuni.2014.05.007	48	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16115	16124		10.1074/jbc.RA118.004747	http://dx.doi.org/10.1074/jbc.RA118.004747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30126839	hybrid, Green Published			2022-12-26	WOS:000447256000031
J	Bleicher, SS; Kotler, BP; Shalev, O; Dixon, A; Embar, K; Brown, JS				Bleicher, Sonny Shlomo; Kotler, Burt P.; Shalev, Omri; Dixon, Austin; Embar, Keren; Brown, Joel S.			Divergent behavior amid convergent evolution: A case of four desert rodents learning to respond to known and novel vipers	PLOS ONE			English	Article							PATCH USE; FORAGING BEHAVIOR; PREDATION RISK; COMMUNITY CONVERGENCE; KANGAROO RATS; COMPETITION; MICROHABITAT; NEGEV; FACILITATION; MORPHOLOGY	Desert communities world-wide are used as natural laboratories for the study of convergent evolution, yet inferences drawn from such studies are necessarily indirect. Here, we brought desert organisms together (rodents and vipers) from two deserts (Mojave and Negev). Both predators and prey in the Mojave have adaptations that give them competitive advantage compared to their middle-eastern counterparts. Heteromyid rodents of the Mojave, kangaroo rats and pocket mice, have fur-lined cheek pouches that allow them to carry larger loads of seeds under predation risk compared to gerbilline rodents of the Negev Deserts. Sidewinder rattlesnakes have heat-sensing pits, allowing them to hunt better on moonless nights when their Negev sidewinding counterpart, the Saharan horned vipers, are visually impaired. In behavioral-assays, we used giving-up density (GUD) to gauge how each species of rodent perceived risk posed by known and novel snakes. We repeated this for the same set of rodents at first encounter and again two months later following intensive "natural" exposure to both snake species. Pre-exposure, all rodents identified their evolutionarily familiar snake as a greater risk than the novel one. However, post-exposure all identified the heat-sensing sidewinder rattlesnake as a greater risk. The heteromyids were more likely to avoid encounters with, and discern the behavioral difference among, snakes than their gerbilline counterparts.	[Bleicher, Sonny Shlomo] Univ Arizona, Tumamoc People & Habitat, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Bleicher, Sonny Shlomo; Kotler, Burt P.; Shalev, Omri; Dixon, Austin; Embar, Keren] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Sede Boqer, Israel; [Bleicher, Sonny Shlomo; Brown, Joel S.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Brown, Joel S.] Moffitt Canc Res Ctr, Dept Integrated Math Oncol, Tampa, FL USA	University of Arizona; Ben Gurion University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; H Lee Moffitt Cancer Center & Research Institute	Bleicher, SS (corresponding author), Univ Arizona, Tumamoc People & Habitat, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.; Bleicher, SS (corresponding author), Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Sede Boqer, Israel.; Bleicher, SS (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	bleicher@email.arizona.edu	Bleicher, Sonny Shlomo/AAE-6272-2020; Kotler, Burt P/F-1381-2012	Bleicher, Sonny Shlomo/0000-0001-8727-5901; Kotler, Burt P/0000-0003-2693-8788; Dixon, Austin/0000-0003-2459-7422	US-Israel Binational Science Foundation [BSF-2008163]; US-Israel Binational Science Foundation (BSF) [BSF-2008163]; Ben Gurion University of the Negev Ethics in Animal Research Committee [IL-73-11-2009]	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Ben Gurion University of the Negev Ethics in Animal Research Committee	This work was supported by US-Israel Binational Science Foundation (BSF-2008163) to BPK and JSB.; We would like to acknowledge the US-Israel Binational Science Foundation (BSF) for funding this project (BSF-2008163). The permits for this project were obtained from Ben Gurion University of the Negev Ethics in Animal Research Committee (Permit IL-73-11-2009). The permits for animal shipping, handling and experimentation were obtained from the Israel Nature and National Parks Authority (INPA) (permits 2011/38131 and 2012/12524). We would also like to acknowledge the assistance in obtaining the research populations, field work and training of A. Bouskila, P. C. Rosen, D. Burns, J. R. St. Juliana, C. Downs, E. Kiekebusch, S. Summerfield and I. Hoffmann. We thank. C. Hammond for the illustrations. This is publication number 982 of the Mitrani Department for Desert Ecology.	Abramsky Z, 1996, OECOLOGIA, V105, P313, DOI 10.1007/BF00328733; ABRAMSKY Z, 1991, ECOLOGY, V72, P329, DOI 10.2307/1938926; Abramsky Z, 2001, J ANIM ECOL, V70, P561, DOI 10.1046/j.1365-2656.2001.00520.x; Anderson I., 2011, CERASTES CERASTES; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; BARTHOLOMEW GA, 1951, J MAMMAL, V32, P155, DOI 10.2307/1375371; Berger-Tal O, 2015, ECOLOGY, V96, P54, DOI 10.1890/14-0130.1; Bevins RA, 2002, BEHAV BRAIN RES, V129, P41, DOI 10.1016/S0166-4328(01)00326-6; Bleicher S. S., 2014, THESIS; Bleicher S.S., 2012, THESIS; Bleicher SS, 2016, ISR J ECOL EVOL, V62, P178, DOI 10.1080/15659801.2016.1176614; Bleicher SS, 2016, PEERJ, V4, DOI 10.7717/peerj.1609; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; BROWN JH, 1985, ECOLOGY, V66, P1545, DOI 10.2307/1938017; Brown JH, 2002, AM NAT, V160, P815, DOI 10.1086/343882; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BROWN JS, 1994, AUST J ZOOL, V42, P435, DOI 10.1071/ZO9940435; BROWN JS, 1994, ECOLOGY, V75, P2286, DOI 10.2307/1940884; BROWN JS, 1989, ECOL MONOGR, V59, P1, DOI 10.2307/2937289; Carthey AJR, 2014, BIOL REV, V89, P932, DOI 10.1111/brv.12087; Chebes L., 2002, CHEATODIPUS PENICILL; CHEW RM, 1970, ECOL MONOGR, V40, P1, DOI 10.2307/1942439; Clark RW, 2016, J MAMMAL, V97, P1709, DOI 10.1093/jmammal/gyw137; DAVIDSON DW, 1984, ECOLOGY, V65, P1780, DOI 10.2307/1937774; Embar K, 2018, J MAMMAL; Embar K, 2014, OECOLOGIA, V174, P1301, DOI 10.1007/s00442-013-2760-2; Embar K, 2011, OIKOS, V120, P1657, DOI 10.1111/j.1600-0706.2011.19278.x; Fowlie JA, 1965, SNAKES ARIZONA THEIR; GOODFRIEND W, 1991, J THERM BIOL, V16, P157, DOI 10.1016/0306-4565(91)90038-4; Houseman GR, 2008, ECOLOGY, V89, P2172, DOI 10.1890/07-1228.1; Joger U., 1984, VENOMOUS SNAKES NEAR; KOTLER BP, 1988, OIKOS, V53, P145, DOI 10.2307/3566056; Kotler BP, 2001, ECOLOGY, V82, P1781, DOI 10.2307/2679818; KOTLER BP, 1993, OIKOS, V67, P548, DOI 10.2307/3545367; KOTLER BP, 1993, OIKOS, V67, P309, DOI 10.2307/3545476; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KOTLER BP, 1993, J MAMMAL, V74, P614, DOI 10.2307/1382281; KOTLER BP, 1984, ECOLOGY, V65, P689, DOI 10.2307/1938041; Kotler BP, 2002, EVOL ECOL RES, V4, P495; KOTLER BP, 1993, ISRAEL J ZOOL, V39, P11; Kotler BP, 2016, ISR J ECOL EVOL, V62, P186, DOI 10.1080/15659801.2015.1125832; Lancaster E., 2000, DIPODOMYS MERRIAMI; LEMEN CA, 1978, OECOLOGIA, V33, P127, DOI 10.1007/BF00344843; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; MARES MA, 1993, BIOSCIENCE, V43, P372, DOI 10.2307/1312045; Merlin P., 2014, HETEROMYIDAE KANGARO; Meserve PL, 2011, J MAMMAL, V92, P1155, DOI 10.1644/11-MAMM-S-186.1; Ori C., 2000, CROTALUS CERASTES; Ovadia O, 2005, OECOLOGIA, V142, P480, DOI 10.1007/s00442-004-1726-9; Pappas TC, 2004, AM J PHYSIOL-CELL PH, V287, pC1219, DOI 10.1152/ajpcell.00040.2004; RANDALL JA, 1987, BEHAV ECOL SOCIOBIOL, V20, P187, DOI 10.1007/BF00299732; Randall JA, 1997, ANIM BEHAV, V54, P1167, DOI 10.1006/anbe.1997.0560; ROSENZWEIG ML, 1969, ECOLOGY, V50, P558, DOI 10.2307/1936246; ROSENZWEIG ML, 1991, PALEOBIOLOGY, V17, P202, DOI 10.1017/S0094837300010563; ROSENZWEIG ML, 1973, ECOLOGY, V54, P111, DOI 10.2307/1934379; THOMPSON SD, 1982, ECOLOGY, V63, P1303, DOI 10.2307/1938858; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Wassenaar TD, 2005, ECOLOGY, V86, P655, DOI 10.1890/03-0836; Webber MM, 2016, HERPETOLOGICA, V72, P324, DOI 10.1655/Herpetologica-D-15-00031.1; Webster D.B., 1984, CONTRIBUTIONS TO SENSORY PHYSIOLOGY, V8, P161; Weiss C, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00142; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	63	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0200672	10.1371/journal.pone.0200672	http://dx.doi.org/10.1371/journal.pone.0200672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125293	gold, Green Published, Green Submitted			2022-12-26	WOS:000442202100003
J	Cairns, R; Fischer, AW; Blanco-Munoz, P; Alvarez-Guaita, A; Meneses-Salas, E; Egert, A; Buechler, C; Hoy, AJ; Heeren, J; Enrich, C; Rentero, C; Grewal, T				Cairns, Rose; Fischer, Alexander W.; Blanco-Munoz, Patricia; Alvarez-Guaita, Anna; Meneses-Salas, Elsa; Egert, Antonia; Buechler, Christa; Hoy, Andrew J.; Heeren, Joerg; Enrich, Carlos; Rentero, Carles; Grewal, Thomas			Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ANNEXIN A6; CHOLESTEROL TRANSPORT; SIGNALING PATHWAYS; INSULIN-RESISTANCE; APO-B; LIVER; RECEPTOR; METABOLISM; GLUCONEOGENESIS	Annexin A6 (AnxA6) controls cholesterol and membrane transport in endo- and exocytosis, and modulates triglyceride accumulation and storage. In addition, AnxA6 acts as a scaffolding protein for negative regulators of growth factor receptors and their effector pathways in many different cell types. Here we investigated the role of AnxA6 in the regulation of whole body lipid metabolism and insulin-regulated glucose homeostasis. Therefore, wildtype (WT) and AnxA6-knockout (KO) mice were fed a high-fat diet (HFD) for 17 weeks. During the course of HFD feeding, AnxA6-KO mice gained less weight compared to controls, which correlated with reduced adiposity. Systemic triglyceride and cholesterol levels of HFD-fed control and AnxA6-KO mice were comparable, with slightly elevated high density lipoprotein (HDL) and reduced triglyceride-rich lipoprotein (TRL) levels in AnxA6-KO mice. AnxA6-KO mice displayed a trend towards improved insulin sensitivity in oral glucose and insulin tolerance tests (OGTT, ITT), which correlated with increased insulin-inducible phosphorylation of protein kinase B (Akt) and ribosomal protein S6 kinase (S6) in liver extracts. However, HFD-fed AnxA6-KO mice failed to downregulate hepatic gluconeogenesis, despite similar insulin levels and insulin signaling activity, as well as expression profiles of insulin-sensitive transcription factors to controls. In addition, increased glycogen storage in livers of HFD-and chow-fed AnxA6-KO animals was observed. Together with an inability to reduce glucose production upon insulin exposure in AnxA6-depleted HuH7 hepatocytes, this implicates AnxA6 contributing to the fine-tuning of hepatic glucose metabolism with potential consequences for the systemic control of glucose in health and disease.	[Cairns, Rose; Egert, Antonia; Grewal, Thomas] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia; [Fischer, Alexander W.; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany; [Blanco-Munoz, Patricia; Alvarez-Guaita, Anna; Meneses-Salas, Elsa; Enrich, Carlos; Rentero, Carles] Univ Barcelona, Fac Med & Ciencies Salut, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Biomed,Unitat Biol Cellular,Ctr Recerca Bior, Barcelona, Spain; [Buechler, Christa] Regensburg Univ Hosp, Dept Internal Med, Regensburg, Germany; [Hoy, Andrew J.] Univ Sydney, Charles Perkins Ctr, Sch Med Sci, Sydney Med Sch,Discipline Physiol, Sydney, NSW, Australia; [Cairns, Rose] Childrens Hosp Westmead, New South Wales Poisons Informat Ctr, Westmead, NSW, Australia	University of Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Regensburg; University of Sydney; University of Sydney	Grewal, T (corresponding author), Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia.; Rentero, C (corresponding author), Univ Barcelona, Fac Med & Ciencies Salut, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Biomed,Unitat Biol Cellular,Ctr Recerca Bior, Barcelona, Spain.	carles.rentero@ub.edu; thomas.grewal@sydney.edu.au	Rentero Alfonso, Carles/L-4430-2017; Buechler, Christa/AAH-3004-2020; Meneses-Salas, Elsa/AGE-7998-2022; Hoy, Andrew/J-2289-2017	Rentero Alfonso, Carles/0000-0003-4684-0278; Hoy, Andrew/0000-0003-3922-1137; Fischer, Alexander/0000-0001-6717-9090; Meneses Salas, Elsa/0000-0001-7550-253X; Enrich, Carlos/0000-0003-0382-2993; Grewal, Thomas/0000-0002-7937-8887; Alvarez-Guaita, Anna/0000-0002-9248-2275	University of Sydney, Sydney, Australia [U7007, U7042, U7113, RY253]; Ministerio de Economia y Competitividad [BFU2015-66785-P, CSD2009-00016]; Fundacio Marato TV3, Spain [PI042182]; CONSOLIDER-INGENIO (MINECO) research program [CSD2009-00016]; Helen and Robert Ellis Postdoctoral Research fellowship; Sydney Medical School Foundation, University of Sydney, Australia; German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)	University of Sydney, Sydney, Australia(University of Sydney); Ministerio de Economia y Competitividad(Spanish Government); Fundacio Marato TV3, Spain; CONSOLIDER-INGENIO (MINECO) research program; Helen and Robert Ellis Postdoctoral Research fellowship; Sydney Medical School Foundation, University of Sydney, Australia; German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)	T.G. is supported by the University of Sydney (U7007, U7042, U7113, RY253), Sydney, Australia. C.E. is supported by grants from the Ministerio de Economia y Competitividad (BFU2015-66785-P and CSD2009-00016) and Fundacio Marato TV3 (PI042182), Spain. C.R. is thankful to CONSOLIDER-INGENIO (MINECO) research program for post-doctoral fellowship [grant number CSD2009-00016] and to Fundacio Marato TV3. A.J.H. is supported by a Helen and Robert Ellis Postdoctoral Research fellowship and funding from the Sydney Medical School Foundation, University of Sydney, Australia. A.W.F and A.E. are thankful for support from the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes).	Akasheh RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082608; Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bartelt A, 2014, BONE, V62, P90, DOI 10.1016/j.bone.2014.01.001; Bartelt A, 2013, BBA-MOL CELL BIOL L, V1831, P934, DOI 10.1016/j.bbalip.2012.11.011; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; Bendayan M, 2009, J HISTOCHEM CYTOCHEM, V57, P963, DOI 10.1369/jhc.2009.954016; BRADLEY WA, 1986, J LIPID RES, V27, P40; Cairns R, 2017, EXP CELL RES, V358, P397, DOI 10.1016/j.yexcr.2017.07.015; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Caron D, 2015, FEBS LETT, V589, P985, DOI 10.1016/j.febslet.2015.03.007; Chirieac DV, 2000, AM J PHYSIOL-ENDOC M, V279, pE1003, DOI 10.1152/ajpendo.2000.279.5.E1003; Chlystun M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053774; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cornely R, 2016, IMMUNOL CELL BIOL, V94, P543, DOI 10.1038/icb.2016.15; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Drechsler M, 2015, CIRC RES, V116, P827, DOI 10.1161/CIRCRESAHA.116.305825; Engin A, 2017, ADV EXP MED BIOL, V960, P111, DOI 10.1007/978-3-319-48382-5_5; Enrich C, 2017, BBA-MOL CELL RES, V1864, P933, DOI 10.1016/j.bbamcr.2016.10.017; Enrich C, 2011, BBA-MOL CELL RES, V1813, P935, DOI 10.1016/j.bbamcr.2010.09.015; Fadini GP, 2014, ATHEROSCLEROSIS, V235, P415, DOI 10.1016/j.atherosclerosis.2014.05.942; Fairoozy RH, 2017, ATHEROSCLEROSIS, V261, P60, DOI 10.1016/j.atherosclerosis.2017.04.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; Gan L, 2015, J LIPID RES, V56, P1471, DOI 10.1194/jlr.M057679; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Haas JT, 2016, ANNU REV PHYSIOL, V78, P181, DOI 10.1146/annurev-physiol-021115-105331; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herms A, 2013, CURR BIOL, V23, P1489, DOI 10.1016/j.cub.2013.06.032; Herr Claudia, 2003, BMC Biochem, V4, P8, DOI 10.1186/1471-2091-4-8; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Hoy AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1358, DOI 10.1152/ajpendo.00133.2007; Huang J, 2004, ENDOCRINOLOGY, V145, P1579, DOI 10.1210/en.2003-1197; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kotoulas OB, 2006, PATHOL RES PRACT, V202, P631, DOI 10.1016/j.prp.2006.04.001; Krautbauer S, 2017, MOL CELL ENDOCRINOL, V439, P419, DOI 10.1016/j.mce.2016.09.033; Krautbauer S, 2016, BBA-MOL CELL BIOL L, V1861, P1767, DOI 10.1016/j.bbalip.2016.08.014; Kucejova B, 2016, CELL REP, V16, P508, DOI 10.1016/j.celrep.2016.06.006; Kusters DHM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130484; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Li AQ, 2017, CURR PHARM DESIGN, V23, P3667, DOI 10.2174/1381612823666170704124611; Lim JA, 2015, AUTOPHAGY, V11, P385, DOI 10.1080/15548627.2015.1009779; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli I, 2014, HEPATOLOGY, V60, P531, DOI 10.1002/hep.27141; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Meier EM, 2016, MOL CELL BIOCHEM, V418, P81, DOI 10.1007/s11010-016-2735-9; Minashima T, 2012, J BIOL CHEM, V287, P14803, DOI 10.1074/jbc.M111.297861; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Nielsen MF, 2000, DIABETES, V49, P2135, DOI 10.2337/diabetes.49.12.2135; Peeters A, 2010, PPAR RES, V2010, DOI 10.1155/2010/572405; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Quattrocelli M, 2017, J CLIN INVEST, V127, P2418, DOI 10.1172/JCI91445; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Scheja L, 2008, LIPIDS, V43, P1039, DOI 10.1007/s11745-008-3220-3; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Stein MP, 2003, ADV DRUG DELIVER REV, V55, P1421, DOI 10.1016/j.addr.2003.07.009; TAGOE CE, 1994, BBA-BIOMEMBRANES, V1192, P272, DOI 10.1016/0005-2736(94)90128-7; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Valanejad L, 2016, HEPATOLOGY, V63, P1424, DOI 10.1002/hep.28440; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200; Zimmers TA, 2017, AM J PHYSIOL-ENDOC M, V313, pE440, DOI 10.1152/ajpendo.00032.2017	87	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201310	10.1371/journal.pone.0201310	http://dx.doi.org/10.1371/journal.pone.0201310			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110341	Green Submitted, gold, Green Published			2022-12-26	WOS:000441738000022
J	Fernandez-Vigo, JI; Marcos, AC; Agujetas, R; Montanero, JM; Sanchez-Guillen, I; Garcia-Feijoo, J; Pandal-Blanco, A; Fernandez-Vigo, JA; Macarro-Merino, A				Ignacio Fernandez-Vigo, Jose; Marcos, Alfonso C.; Agujetas, Rafael; Maria Montanero, Jose; Sanchez-Guillen, Ines; Garcia-Feijoo, Julian; Pandal-Blanco, Adrian; Angel Fernandez-Vigo, Jose; Macarro-Merino, Ana			Computational simulation of aqueous humour dynamics in the presence of a posterior-chamber versus iris-fixed phakic intraocular lens	PLOS ONE			English	Article							CORNEAL ENDOTHELIAL-CELLS; ANTERIOR-CHAMBER; COLLAMER LENS; HIGH MYOPIA; LASER IRIDOTOMY; FOLLOW-UP; HUMAN EYE; CLINICAL-OUTCOMES; SHEAR-STRESS; CENTRAL HOLE	Purpose To compare aqueous humour (AH) dynamics in the presence of a precrystalline (Implantable Collamer Len (R); ICL) or iris-fixed (Artiflex (R)) phakic intraocular lens (PIOL). Methods By computational fluid dynamics simulation, AH flow was modelled through a peripheral iridotomy (PI) or central lens hole (both 360 mu m) in the presence of an Artiflex or ICL lens, respectively. The impacts of AH flow were then determined in terms of wall shear stress (WSS) produced on the endothelium or crystalline lens. Effects were also modelled for different scenarios of pupil diameter (PD 3.5 or 5.5 mm), ICL vault (100, 350, 800 mu m) and number of Artiflex iridotomies (1 or 2) and location (12 or 6 o'clock). Results For a PD of 3.5 mm, AH volumes flowing from the posterior to the anterior chamber were 37.6% of total flow through the lens hole (ICL) and 84.2% through PI (Artiflex). For an enlarged PD (5.5 mm), corresponding values were 10.3% and 81.9% respectively, so PI constitutes a very efficient way of evacuating AH. Central endothelial WSS in Pa was lower for the large vault ICL and the Artiflex (1(-03) and 1.1(-03) respectively) compared to the PIOL-free eye (1.6(-03)). Crystalline lens WSS was highest for the lowest vault ICL (1(-04)). Conclusions AH flow varied according to the presence of a precrystalline or iris-fixed intraocular lens. Endothelial WSS was lower for an implanted ICL with large vault and Artiflex than in the PIOL-free eye, while highest crystalline WSS was recorded for the lowest vault ICL.	[Ignacio Fernandez-Vigo, Jose; Garcia-Feijoo, Julian] Hosp Univ Clin San Carlos, Inst Invest Sanitaria San Carlos, Dept Oftalmol, Madrid, Spain; [Ignacio Fernandez-Vigo, Jose; Sanchez-Guillen, Ines; Angel Fernandez-Vigo, Jose; Macarro-Merino, Ana] Ctr Int Oftalmol Avanzada, Madrid, Spain; [Marcos, Alfonso C.] Univ Extremadura, Dept Expres Graf, Badajoz, Spain; [Agujetas, Rafael; Maria Montanero, Jose] Univ Extremadura, Dept Ingn Mecan Energet & Mat, Badajoz, Spain; [Agujetas, Rafael; Maria Montanero, Jose] Univ Extremadura, Inst Comp Cient Avanzada ICCAEx, Badajoz, Spain; [Pandal-Blanco, Adrian] Univ Oviedo, Escuela Ingn, Oviedo, Spain; [Angel Fernandez-Vigo, Jose] Univ Extremadura, Fac Med, Badajoz, Spain	Universidad de Extremadura; Universidad de Extremadura; Universidad de Extremadura; University of Oviedo; Universidad de Extremadura	Fernandez-Vigo, JI (corresponding author), Hosp Univ Clin San Carlos, Inst Invest Sanitaria San Carlos, Dept Oftalmol, Madrid, Spain.; Fernandez-Vigo, JI (corresponding author), Ctr Int Oftalmol Avanzada, Madrid, Spain.	jfvigo@hotmail.com	Romero, Alfonso C. Marcos/Q-7454-2018; Agujetas, Rafael/AAE-7971-2021; Fernández-Vigo, José Ignacio/G-9779-2017; Pandal, Adrián/G-7359-2016; Montanero, Jose Maria/Z-5522-2019	Romero, Alfonso C. Marcos/0000-0002-0882-4210; Fernández-Vigo, José Ignacio/0000-0001-8745-3464; Pandal, Adrián/0000-0001-6006-2199; Montanero, Jose Maria/0000-0002-3906-5931				Alfonso JF, 2013, J CATARACT REFR SURG, V39, P915, DOI 10.1016/j.jcrs.2013.01.036; Brandt JD, 2001, AM J OPHTHALMOL, V131, P260, DOI 10.1016/S0002-9394(00)00606-1; Bylsma SS, 2002, J CATARACT REFR SURG, V28, P2222, DOI 10.1016/S0886-3350(02)01303-2; Canning CR, 2002, IMA J MATH APPL MED, V19, P31; Doors M, 2010, INVEST OPHTH VIS SCI, V51, P811, DOI 10.1167/iovs.09-3981; Dvoriashyna M, 2018, MATH MED BIOL, V35, P447, DOI 10.1093/imammb/dqx012; Edelhauser HF, 2004, J CATARACT REFR SURG, V30, P576, DOI 10.1016/j.jcrs.2003.09.047; Fernandes P, 2011, J REFRACT SURG, V27, P765, DOI 10.3928/1081597X-20110617-01; Fitt AD, 2006, B MATH BIOL, V68, P53, DOI 10.1007/s11538-005-9015-2; Guber I, 2016, JAMA OPHTHALMOL, V134, P487, DOI 10.1001/jamaophthalmol.2016.0078; Guell JL, 2010, J CATARACT REFR SURG, V36, P1976, DOI 10.1016/j.jcrs.2010.08.014; Higueras-Esteban A, 2013, AM J OPHTHALMOL, V156, P800, DOI 10.1016/j.ajo.2013.05.018; Huseynova T, 2014, AM J OPHTHALMOL, V157, P1136, DOI 10.1016/j.ajo.2014.01.032; Igarashi A, 2014, AM J OPHTHALMOL, V157, P532, DOI 10.1016/j.ajo.2013.11.006; Fernandez-Vigo JI, 2017, AM J OPHTHALMOL, V181, P37, DOI 10.1016/j.ajo.2017.06.018; Fernandez-Vigo JI, 2016, INVEST OPHTH VIS SCI, V57, P4625, DOI 10.1167/iovs.16-19900; Jimenez-Alfaro I, 2001, OPHTHALMOLOGY, V108, P90, DOI 10.1016/S0161-6420(00)00403-6; Jonker SMR, 2018, OPHTHALMOLOGY, V125, P486, DOI 10.1016/j.ophtha.2017.08.011; Kaji Y, 2005, CORNEA, V24, pS55, DOI 10.1097/01.ico.0000178735.27674.52; Kapnisis K, 2009, J BIOMECH, V42, P2454, DOI 10.1016/j.jbiomech.2009.07.025; Kawamorita T, 2012, GRAEF ARCH CLIN EXP, V250, P935, DOI 10.1007/s00417-011-1850-2; Khongar PD, 2017, MECCANICA, V52, P577, DOI 10.1007/s11012-015-0313-y; Kohnen T, 2010, J CATARACT REFR SURG, V36, P2168, DOI 10.1016/j.jcrs.2010.10.007; Liang GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104649; Packer M, 2016, CLIN OPHTHALMOL, V10, P1059, DOI 10.2147/OPTH.S111620; Repetto R, 2015, INVEST OPHTH VIS SCI, V56, P3061, DOI 10.1167/iovs.14-16118; Sanchez-Galeana CA, 2003, OPHTHALMOLOGY, V110, P781, DOI 10.1016/S0161-6420(02)01973-5; Sanders DR, 2008, J REFRACT SURG, V24, P566, DOI 10.3928/1081597X-20080601-04; Sanders DR, 2004, OPHTHALMOLOGY, V111, P1683, DOI 10.1016/j.ophtha.2004.03.026; Shimizu K, 2012, BRIT J OPHTHALMOL, V96, P409, DOI 10.1136/bjophthalmol-2011-300148; Silver DM, 2004, J GLAUCOMA, V13, P100, DOI 10.1097/00061198-200404000-00004; Tweedy JH, 2018, MATH MED BIOL, V35, P363, DOI 10.1093/imammb/dqx007; Villamarin A, 2012, MED ENG PHYS, V34, P1462, DOI 10.1016/j.medengphy.2012.02.007; Wang WJ, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0261-3; Yamamoto Y, 2006, ARCH OPHTHALMOL-CHIC, V124, P387, DOI 10.1001/archopht.124.3.387; Yamamoto Y, 2010, INVEST OPHTH VIS SCI, V51, P1956, DOI 10.1167/iovs.09-4280	36	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202128	10.1371/journal.pone.0202128	http://dx.doi.org/10.1371/journal.pone.0202128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102728	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200032
J	Leite, CMP; Mariano, E; da Rocha, PLB				Pinto Leite, Clarissa Machado; Mariano-Neto, Eduardo; Bernardo da Rocha, Pedro Luis			Biodiversity thresholds in invertebrate communities: The responses of dung beetle subgroups to forest loss	PLOS ONE			English	Article							HABITAT FRAGMENTATION; SPECIES RICHNESS; ATLANTIC FOREST; LAND-USE; EXTINCTION; COVER; LANDSCAPES; DIVERSITY; MAMMALS; CONSERVATION	Extinction thresholds have been predicted to be critical values of habitat loss in which an abrupt reduction in populations occurs through the interaction between reduced habitat and increased isolation in the landscape. In communities, extinction thresholds are referred to as 'biodiversity thresholds'. The biodiversity threshold values documented so far occur between 30% and 50% of habitat cover in landscapes. However, the assessment of biodiversity thresholds has mainly focused on vertebrate and plant communities. Here, we evaluated the occurrence of biodiversity thresholds in dung beetle communities by sampling ten 3,600 ha Atlantic Forest landscapes with forest cover ranging from 5% to 55%. We analysed the response patterns (abundance, gamma and mean alpha diversity) of community subgroups with different levels of forest dependency (forest species, generalist species, and open-area species) using model selection, comparing null, linear, bell-shaped and logistic models. The response of the community of forest species equally fits both linear and logistic models predicting a biodiversity threshold at 25% forest cover. Generalist species showed peak abundance at 20% forest cover although this result reflects a very poor generalist assembly. Open-area specialists did not respond to the amount of forest. The two most plausible models for forest species suggest two different biodiversity management options. Since the biodiversity threshold model represents a more dramatic scenario for the loss of biodiversity in Atlantic forest landscapes, we suggest, based on precautionary principle, that our results should strength guidelines that consider minimum values of forest cover in management strategies to avoid abrupt biodiversity loss and impacts on ecosystem services.	[Pinto Leite, Clarissa Machado; Mariano-Neto, Eduardo; Bernardo da Rocha, Pedro Luis] Univ Fed Bahia, Inst Biol, Programa Posgrad Ecol & Biomonitoramento, Salvador, BA, Brazil	Universidade Federal da Bahia	Leite, CMP (corresponding author), Univ Fed Bahia, Inst Biol, Programa Posgrad Ecol & Biomonitoramento, Salvador, BA, Brazil.	clarismachado@gmail.com	Mariano-Neto, Eduardo/F-3441-2010	Mariano-Neto, Eduardo/0000-0002-4204-0882; Pinto Leite, Clarissa/0000-0001-7867-8178	Fundacao de Amparo a Pesquisa do Estado da Bahia [APP0049/2009]; Fundacao de Amparo a Pesquisa do Estado da Bahia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PNX0016/2009]; Foundation for Research Support of the State of Bahia, FAPESB [BOL1661/2011]	Fundacao de Amparo a Pesquisa do Estado da Bahia; Fundacao de Amparo a Pesquisa do Estado da Bahia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Bahia, FAPESB	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia, APP0049/2009 to PLBR; Fundacao de Amparo a Pesquisa do Estado da Bahia, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, PNX0016/2009 and the Foundation for Research Support of the State of Bahia, FAPESB, BOL1661/2011 to CMPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2009, ANN ENTOMOLOGICAL SO, DOI [10.1016/j.anbehav.2009.09.007, DOI 10.1016/J.ANBEHAV.2009.09.007]; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], PNWGTR351 USDA SERV; Bolker B., 2007, ECOLOGICAL MODELS DA; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cardoso P, 2008, ACTA OECOL, V33, P114, DOI 10.1016/j.actao.2007.10.003; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cavalcanti C., 2006, FRAGMENTOS MATA ATLA, P13; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Costa LP, 2000, BIOTROPICA, V32, P872; Crawley MJ, R BOOK; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; Davies KF, 2004, ECOLOGY, V85, P265, DOI 10.1890/03-0110; Didham RK, 1998, PHILOS T R SOC B, V353, P437, DOI 10.1098/rstb.1998.0221; Driscoll DA, 2005, CONSERV BIOL, V19, P182, DOI 10.1111/j.1523-1739.2005.00586.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Estrada A, 1998, J TROP ECOL, V14, P577, DOI 10.1017/S0266467498000418; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Ferreira PA, 2015, LANDSCAPE ECOL, V30, P2067, DOI 10.1007/s10980-015-0231-3; Filgueiras BKC, 2016, DIVERS DISTRIB, V22, P400, DOI 10.1111/ddi.12410; Filgueiras BKC, 2015, ECOL INDIC, V55, P65, DOI 10.1016/j.ecolind.2015.02.032; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Grimbacher PS, 2006, AUSTRAL ECOL, V31, P458, DOI 10.1111/j.1442-9993.2006.01606.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Halffter Gonzalo, 1991, Folia Entomologica Mexicana, V0, P195; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Lima MM, 2014, FOREST ECOL MANAG, V312, P260, DOI 10.1016/j.foreco.2013.09.003; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Moraes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139386; Muggeo V., 2014, R NEWS, V8, P20; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Ochoa-Quintero JM, 2015, CONSERV BIOL, V29, P440, DOI 10.1111/cobi.12446; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Pinheiro J, 2000, MIXED EFFECTS MODELS, DOI [10.1007/978-1-4419-0318-1, DOI 10.1007/978-1-4419-0318-1]; Prance G.T., 1982, BIOL DIVERSIFICATION, P137; Quintero I, 2005, ECOLOGY, V86, P3303, DOI 10.1890/04-1960; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rocha-Santos L, 2016, BIOL CONSERV, V196, P1, DOI 10.1016/j.biocon.2016.01.028; Saatchi S, 2001, CONSERV BIOL, V15, P867, DOI 10.1046/j.1523-1739.2001.015004867.x; Sanchez-de-Jesus HA, 2016, LANDSCAPE ECOL, V31, P843, DOI 10.1007/s10980-015-0293-2; Schmidt BC, 2006, ANN ENTOMOL SOC AM, V99, P1110, DOI 10.1603/0013-8746(2006)99[1110:MDIAFH]2.0.CO;2; Silva JMC, 2003, ATLANTIC FOREST S AM, P43; Silva RJ, 2016, DUNG BEETLE COLEOPTE, P1, DOI [10.1007/s10841-016-9885-7, DOI 10.1007/S10841-016-9885-7]; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Suarez-Rubio M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067593, 10.1371/journal.pone.0081143]; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Tyler H, 1994, SWALLOW TAIL BUTTERF; With KA, 2004, ECOL MODEL, V179, P349, DOI 10.1016/j.ecolmodel.2004.05.014; Yoshihara Y, 2015, APPL SOIL ECOL, V88, P21, DOI 10.1016/j.apsoil.2014.12.001	66	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201368	'10.1371/jou rnal. porie.0201368	http://dx.doi.org/'10.1371/jou rnal. porie.0201368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096180				2022-12-26	WOS:000441308500015
J	dos Santos, ALT; Duarte, CK; Santos, M; Zoldan, M; Almeida, JC; Gross, JL; Azevedo, MJ; Lichtenstein, AH; Zelmanovitz, T				Teixeira dos Santos, Ana Luiza; Duarte, Camila Kummel; Santos, Manoella; Zoldan, Maira; Almeida, Jussara Carnevalle; Gross, Jorge Luiz; Azevedo, Mirela Jobim; Lichtenstein, Alice Hinda; Zelmanovitz, Themis			Low linolenic and linoleic acid consumption are associated with chronic kidney disease in patients with type 2 diabetes	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; WEIGHED DIET RECORDS; CHICKEN-BASED DIET; PROTEIN-INTAKE; ALBUMINURIA; MICROALBUMINURIA; SUPPLEMENTATION; NUTRITION; PROFILE; ADULTS	Aim This cross-sectional study aimed to assess the association of the fat content in the diet with Diabetic Kidney Disease (DKD) in patients with type 2 diabetes. Methodology Patients from the Diabetes research clinic at Hospital de Clinicas de Porto Alegre (Brazil) were consecutively recruited. The inclusion criterion was the diagnosis of type 2 diabetes. The exclusion criteria were as follows: body mass index >40 kg/m(2), heart failure, gastroparesis, diabetic diarrhea, dietary counseling by a registered dietitian during the previous 12 months, and inability to perform the weighed diet records (WDR). The dietary fatty acids (saturated, monounsaturated and polyunsaturated) consumption was estimated by 3-day WDR. Compliance with the WDR technique was assessed by comparison of protein intake estimated from the 3-day WDR and from the 24-h urinary nitrogen output performed on the third day of the WDR period. The presence of DKD was defined as urinary albumin excretion (UAE) >= 30 mg /24 h or/and glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2). Urinary albumin was measured twice and eGFR was estimated by using the CKD-EPI equation. Results A total of 366 patients were evaluated; of these, 33% (n = 121) had DKD. Multivariate analysis showed that the intake of linolenic acid was negatively associated with DKD (OR = 0.57; 95% CI 0.35-0.93; P = 0.024), adjusted for gender, smoking, cardiovascular disease, ACE inhibitors and/or angiotensin receptor blocker use, systolic blood pressure, fasting plasma glucose and HDL cholesterol. In a separate model, similar results were observed for linoleic acid, adjusting to the same co-variables (OR = 0.95; 95% CI 0.91-0.99; P = 0.006). Conclusion The lower intake of polyunsaturated fatty acids, especially linolenic and linoleic acid, is associated with chronic kidney disease in patients with type 2 diabetes.	[Teixeira dos Santos, Ana Luiza; Duarte, Camila Kummel; Almeida, Jussara Carnevalle; Gross, Jorge Luiz; Azevedo, Mirela Jobim; Zelmanovitz, Themis] Univ Fed Rio Grande do Sul, Sch Med, Med Sci Postgrad Program Endocrinol, Porto Alegre, RS, Brazil; [Santos, Manoella; Zoldan, Maira; Gross, Jorge Luiz; Azevedo, Mirela Jobim; Zelmanovitz, Themis] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Endocrine Div, Porto Alegre, RS, Brazil; [Lichtenstein, Alice Hinda] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Cardiovasc Nutr Lab, Boston, MA 02111 USA	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Tufts University; United States Department of Agriculture (USDA)	Zelmanovitz, T (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Med Sci Postgrad Program Endocrinol, Porto Alegre, RS, Brazil.; Zelmanovitz, T (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Endocrine Div, Porto Alegre, RS, Brazil.	themis.voy@terra.com.br	Zelmanovitz, Themia/W-4006-2019; Duarte, Camila k/K-8686-2017; Almeida, Jussara/U-6492-2019	Duarte, Camila k/0000-0003-1930-3282; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq) [502050/2005-5]; FIPE-Hospital de Clinicas de Porto Alegre [07-612]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIPE-Hospital de Clinicas de Porto Alegre	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq # 502050/2005-5) (MJA) and FIPE-Hospital de Clinicas de Porto Alegre (07-612) (TZ).	Alberti KG, 1999, DEFINITION DIAGNOS 1; Almeida JC, 2008, J AM COLL NUTR, V27, P528, DOI 10.1080/07315724.2008.10719735; Anderson JS, 2010, AM J CLIN NUTR, V92, P1204, DOI 10.3945/ajcn.2010.29494; [Anonymous], 2015, DIABETES CARE, V38, pS58, DOI 10.2337/dc15-S012; Azadbakht L, 2003, EUR J CLIN NUTR, V57, P1292, DOI 10.1038/sj.ejcn.1601688; Baggio B, 2005, J NEPHROL, V18, P362; Brochot A, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-14; Cardenas C, 2004, Diabetes Care, V27, P1454, DOI 10.2337/diacare.27.6.1454; Chung HF, 2015, CLIN NUTR, V34, P229, DOI 10.1016/j.clnu.2014.02.009; de Mello VDF, 2008, J RENAL NUTR, V18, P440, DOI 10.1053/j.jrn.2008.04.010; de Mello VDF, 2006, AM J CLIN NUTR, V83, P1032, DOI 10.1093/ajcn/83.5.1032; DULLAART RPF, 1992, DIABETOLOGIA, V35, P165, DOI 10.1007/BF00402550; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Gopinath B, 2011, BRIT J NUTR, V105, P1361, DOI 10.1017/S0007114510005040; Gross JL, 2002, DIABETES CARE, V25, P645, DOI 10.2337/diacare.25.4.645; Lang T, 2005, PUBLIC HEALTH NUTR, V8, P730, DOI 10.1079/PHN2005772; Lee CTC, 2008, AM J KIDNEY DIS, V52, P876, DOI 10.1053/j.ajkd.2008.02.307; Lee CC, 2010, DIABETES CARE, V33, P1454, DOI 10.2337/dc09-2245; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin JL, 2010, AM J CLIN NUTR, V92, P897, DOI 10.3945/ajcn.2010.29479; Lin JL, 2010, CLIN J AM SOC NEPHRO, V5, P836, DOI 10.2215/CJN.08001109; Miller ER, 2013, DIABETES CARE, V36, P1462, DOI 10.2337/dc12-1940; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Moulin CC, 1998, AM J CLIN NUTR, V67, P853, DOI 10.1093/ajcn/67.5.853; Perassolo MS, 2008, METABOLISM, V57, P1167, DOI 10.1016/j.metabol.2008.01.006; Perassolo MS, 2003, DIABETES CARE, V26, P613, DOI 10.2337/diacare.26.3.613; Riley MD, 1998, AM J CLIN NUTR, V67, P50, DOI 10.1093/ajcn/67.1.50; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Santos ALT, 2014, ATHEROSCLEROSIS, V236, P31, DOI 10.1016/j.atherosclerosis.2014.06.014; Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.1053/j.ajkd.2014.08.001, 10.2337/dc14-1296]; Vaz JDS, 2008, J AM DIET ASSOC, V108, P867, DOI 10.1016/j.jada.2008.03.022; Xun P, 2011, J INTERN MED, V270, P175, DOI 10.1111/j.1365-2796.2010.02338.x; Yuzbashian E, 2014, J NEPHROL; Zelmanovitz T, 1995, ARQ BRAS ENDOCRINOL, V38, P207	36	22	22	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0195249	10.1371/journal.pone.0195249	http://dx.doi.org/10.1371/journal.pone.0195249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092058	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600001
J	Gimenez-Bastida, JA; Boeglin, WE; Boutaud, O; Malkowski, MG; Schneider, C				Gimenez-Bastida, Juan A.; Boeglin, William E.; Boutaud, Olivier; Malkowski, Michael G.; Schneider, Claus			Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15R-prostaglandins that inhibit platelet aggregation	FASEB JOURNAL			English	Article						arachidonic acid; stereocontrol; biosynthesis; leukocytes	LOW-DOSE ASPIRIN; ENDOPEROXIDE H SYNTHASE-1; ARACHIDONIC-ACID; PROSTAGLANDIN E-2; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SITE RESIDUES; OXYGENATION; MECHANISM; BINDING	Aspirin (acetylsalicylic acid) inhibits prostaglandin (PG) synthesis by transfer of its acetyl group to a serine residue in the cyclooxygenase (COX) active site. Acetylation of Ser530 inhibits catalysis by preventing access of arachidonic acid substrate in the COX-1 isoenzyme. Acetylated COX-2, in contrast, gains a new catalytic activity and forms 15R hydroxy-eicosatetraenoic acid (15R-HETE) as alternate product. Here we show that acetylated COX-2 also retains COX activity, forming predominantly 15R-configuration PGs (70 or 62% 15R, respectively, determined using radiolabeled substrate or LC-MS analysis). Although the K-m of arachidonic acid for acetylated COX-2 was approximate to 3-fold lower than for uninhibited COX-2, the catalytic efficiency for PG formation by the acetylated enzyme was reduced 10-fold due to a concomitant decrease in V-max. Aspirin increased 15R-PGD(2) but not 15R-PGE(2) in isolated human leukocytes activated with LPS to induce COX-2. 15R-PGD(2) inhibited human platelet aggregation induced by the thromboxane receptor agonist U46,619, and this effect was abrogated by an antagonist of the DP1 prostanoid receptor. We conclude that acetylation of Ser530 in COX-2 not only triggers formation of 15R-HETE but also allows oxygenation and cyclization of arachidonic acid to a 15R-PG endoperoxide. 15R-PGs are novel products of aspirin therapy via acetylation of COX-2 and may contribute to its antiplatelet and other pharmacologic effects.Gimenez-Bastida, J. A., Boeglin, W. E., Boutaud, O., Malkowski, M. G., Schneider, C. Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15R-prostaglandins that inhibit platelet aggregation.	[Gimenez-Bastida, Juan A.; Boeglin, William E.; Boutaud, Olivier; Schneider, Claus] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, RRB 514,23rd Ave S, Nashville, TN 37232 USA; [Gimenez-Bastida, Juan A.; Boeglin, William E.; Boutaud, Olivier; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, RRB 514,23rd Ave S, Nashville, TN 37232 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY USA	Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schneider, C (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, RRB 514,23rd Ave S, Nashville, TN 37232 USA.; Schneider, C (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, RRB 514,23rd Ave S, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Gimenez Bastida, Juan Antonio/T-2721-2017	Gimenez Bastida, Juan Antonio/0000-0002-1244-8764	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM076592, R01GM118412, R01GM115386]; American Heart Association [16POST30690001, 14GRNT20460090]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30DK058404]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118412, R01GM115386, R01GM076592] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; American Heart Association(American Heart Association); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants R01GM076592 and R01GM118412 (to C.S.) and R01GM115386 (to M.G.M.). O.B. was supported, in part, by American Heart Association Grant 14GRNT20460090. J.A.G.-B. was supported by a postdoctoral award from the American Heart Association (16POST30690001). Mass spectrometric analyses were in part performed through Vanderbilt University Medical Center's Digestive Disease Research Center, supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30DK058404 Core Scholarship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. The authors declare no conflicts of interest.	Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Boutaud O, 2016, CANCER PREV RES, V9, P855, DOI 10.1158/1940-6207.CAPR-16-0094; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Cossette C, 2007, J PHARMACOL EXP THER, V320, P173, DOI 10.1124/jpet.106.111062; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Friedman EA, 2015, THROMB RES, V136, P493, DOI 10.1016/j.thromres.2015.05.027; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3206, DOI 10.1021/bi052338h; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; GILES H, 1988, PROSTAGLANDINS, V35, P277, DOI 10.1016/0090-6980(88)90093-7; Gimenez-Bastida JA, 2017, FASEB J, V31, P1867, DOI 10.1096/fj.201601136R; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HARTER HR, 1979, NEW ENGL J MED, V301, P577, DOI 10.1056/NEJM197909133011103; HECKER M, 1987, EUR J BIOCHEM, V169, P113, DOI 10.1111/j.1432-1033.1987.tb13587.x; HIRSH PD, 1981, NEW ENGL J MED, V304, P687; HOLTZMAN MJ, 1992, J BIOL CHEM, V267, P21438; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; MAIN IHM, 1975, BRIT J PHARMACOL, V54, P309, DOI 10.1111/j.1476-5381.1975.tb07570.x; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MANCINI JA, 1994, FEBS LETT, V342, P33, DOI 10.1016/0014-5793(94)80579-2; MILLER WL, 1976, PROSTAGLANDINS, V11, P77, DOI 10.1016/0090-6980(76)90175-1; NISHIZAWA EE, 1975, PROSTAGLANDINS, V9, P109, DOI 10.1016/S0090-6980(75)80122-5; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Patrignani P, 2016, J AM COLL CARDIOL, V68, P967, DOI 10.1016/j.jacc.2016.05.083; Patrignani P, 2015, BBA-MOL CELL BIOL L, V1851, P422, DOI 10.1016/j.bbalip.2014.09.016; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Peng S, 2002, J AM CHEM SOC, V124, P10785, DOI 10.1021/ja026880u; PRESTON FE, 1981, NEW ENGL J MED, V304, P76, DOI 10.1056/NEJM198101083040203; Reina E, 2013, J PHARM PHARMACOL, V65, P1643, DOI 10.1111/jphp.12138; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schneider C, 2007, METHOD ENZYMOL, V433, P145, DOI 10.1016/S0076-6879(07)33008-5; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIO H, 1970, EXPERIENTIA, V26, P355, DOI 10.1007/BF01896883; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; Tani K, 2001, BIOORG MED CHEM LETT, V11, P2025, DOI 10.1016/S0960-894X(01)00359-6; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tosco P, 2013, J AM CHEM SOC, V135, P10404, DOI 10.1021/ja402870k; Tsai AL, 2002, J BIOL CHEM, V277, P38311, DOI 10.1074/jbc.M206961200; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; Valmsen K, 2001, P NATL ACAD SCI USA, V98, P7700, DOI 10.1073/pnas.131022398; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; WHITTLE BJR, 1978, PROSTAG OTH LIPID M, V16, P373, DOI 10.1016/0090-6980(78)90216-2; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u	54	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1033	1041		10.1096/fj.201801018R	http://dx.doi.org/10.1096/fj.201801018R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30096040	Green Published, Bronze			2022-12-26	WOS:000457401500081
J	Lieber, AD; Beier, UH; Xiao, HY; Wilkins, BJ; Jiao, J; Li, XMS; Schugar, RC; Strauch, CM; Wang, ZN; Brown, JM; Hazen, SL; Bokulich, NA; Ruggles, KV; Akimova, T; Hancock, WW; Blaser, MJ				Lieber, Arnon D.; Beier, Ulf H.; Xiao, Haiyan; Wilkins, Benjamin J.; Jiao, Jing; Li, Xinmin S.; Schugar, Rebecca C.; Strauch, Christopher M.; Wang, Zeneng; Brown, J. Mark; Hazen, Stanley L.; Bokulich, Nicholas A.; Ruggles, Kelly V.; Akimova, Tatiana; Hancock, Wayne W.; Blaser, Martin J.			Loss of HDAC6 alters gut microbiota and worsens obesity	FASEB JOURNAL			English	Article						microbiome; HDAC; T-regulatory cells; inflammation	REGULATORY T-CELLS; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GERM-FREE; FAT; INFLAMMATION; METABOLISM; GROWTH; INHIBITION; COLITIS	Alterations in gut microbiota are known to affect intestinal inflammation and obesity. Antibiotic treatment can affect weight gain by elimination of histone deacetylase (HDAC) inhibitor-producing microbes, which are anti-inflammatory by augmenting regulatory T (T-reg) cells. We asked whether mice that lack HDAC6 and have potent suppressive T-reg cells are protected from microbiota-induced accelerated weight gain. We crossed wild-type and HDAC6-deficient mice and subjected the offspring to perinatal penicillin, inducing weight gain via microbiota disturbance. We observed that male HDAC6-deficient mice were not protected and developed profoundly accelerated weight gain. The antibiotic-exposed HDAC6-deficient mice showed a mixed immune phenotype with increased CD4(+) and CD8(+) T-cell activation yet maintained the enhanced T-reg cell-suppressive function phenotype characteristic of HDAC6-deficient mice. 16S rRNA sequencing of mouse fecal samples reveals that their microbiota diverged with time, with HDAC6 deletion altering microbiome composition. On a high-fat diet, HDAC6-deficient mice were depleted in representatives of the S24-7 family and Lactobacillus but enriched with Bacteroides and Parabacteroides; these changes are associated with obesity. Our findings further our understanding of the influence of HDACs on microbiome composition and are important for the development of HDAC6 inhibitors in the treatment of human diseases.Lieber, A. D., Beier, U. H., Xiao, H., Wilkins, B. J., Jiao, J., Li, X. S., Schugar, R. C., Strauch, C. M., Wang, Z., Brown, J. M., Hazen, S. L., Bokulich, N. A., Ruggles, K. V., Akimova, T., Hancock, W. W., Blaser, M. J. Loss of HDAC6 alters gut microbiota and worsens obesity.	[Lieber, Arnon D.; Bokulich, Nicholas A.; Blaser, Martin J.] NYU, Sch Med, Dept Med, 550 First Ave,CD689, New York, NY 10016 USA; [Lieber, Arnon D.; Bokulich, Nicholas A.; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ruggles, Kelly V.] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY USA; [Ruggles, Kelly V.] NYU, Sch Med, Appl Bioinformat Labs, New York, NY USA; [Beier, Ulf H.; Xiao, Haiyan; Jiao, Jing] Univ Penn, Childrens Hosp Philadelphia, Div Nephrol, Dept Pediat, Philadelphia, PA 19104 USA; [Akimova, Tatiana; Hancock, Wayne W.] Univ Penn, Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med,Biesecker Ctr Pediat Liver, Philadelphia, PA 19104 USA; [Wilkins, Benjamin J.] Univ Penn, Childrens Hosp Philadelphia, Div Anat Pathol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Li, Xinmin S.; Schugar, Rebecca C.; Strauch, Christopher M.; Wang, Zeneng; Brown, J. Mark; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Blaser, Martin J.] New York Harbor Dept Vet Affairs Med Ctr, New York, NY USA; [Xiao, Haiyan] Ft Wayne Med Lab Corp, Ft Wayne, IN USA; [Bokulich, Nicholas A.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA	New York University; New York University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cleveland Clinic Foundation; Northern Arizona University	Blaser, MJ (corresponding author), NYU, Sch Med, Dept Med, 550 First Ave,CD689, New York, NY 10016 USA.	martin.blaser@nyumc.org	Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021	Beier, Ulf/0000-0002-3672-572X; Bokulich, Nicholas/0000-0002-1784-8935; Blaser, Martin/0000-0003-2447-2443; Ruggles, Kelly/0000-0002-0152-0863	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI095353, AI073489, AI095276]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK090989]; NIH NIAID [AI122285]; Laffey McHugh Foundation; American Society of Nephrology; C D Fund; Transatlantic Network of the Leducq Foundation; NIH National Cancer Institute [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087, P50CA150964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095353, U01AI122285] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laffey McHugh Foundation; American Society of Nephrology; C D Fund; Transatlantic Network of the Leducq Foundation; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Grants AI095353 (to U.H.B.), AI073489 and AI095276 (to W.W.H.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK090989 and NIH NIAID Grant AI122285 (to M.J.B.); by funds from the Laffey McHugh Foundation and American Society of Nephrology (to U.H.B.); and by the C & D Fund and the Transatlantic Network of the Leducq Foundation (to M.J.B. and S.L.H.). The NYU Langone Medical Center Genome Technology Center, supported by the NIH National Cancer Institute (P30CA016087), provided expert DNA sequencing. The authors declare no conflicts of interest.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Akimova T, 2014, MUCOSAL IMMUNOL, V7, P1209, DOI 10.1038/mi.2014.10; Akimova T, 2016, METHODS MOL BIOL, V1371, P43, DOI 10.1007/978-1-4939-3139-2_4; Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Berletch JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005079; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer N, 2016, P NATL ACAD SCI USA, V113, pE2993, DOI 10.1073/pnas.1605997113; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; FORBES M, 1959, J NUTR, V67, P69, DOI 10.1093/jn/67.1.69; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09211-3; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; JUKES TH, 1953, PHARMACOL REV, V5, P381; Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Levine MH, 2016, KIDNEY INT, V89, P1016, DOI 10.1016/j.kint.2015.12.051; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li XMS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99096; Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109757, 10.1371/journal.pone.0090827]; Liu YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029035; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mahana D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0297-9; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Popkin BM, 1998, NUTR REV, V56, P106; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068596; Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Ruiz VE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00531-6; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Schulfer AF, 2018, NAT MICROBIOL, V3, P234, DOI 10.1038/s41564-017-0075-5; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; TAYLOR JH, 1955, NATURE, V176, P312, DOI 10.1038/176312a0; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang LQ, 2015, J CLIN INVEST, V125, P3304, DOI 10.1172/JCI83084; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xiao HY, 2016, INT J CANCER, V138, P2477, DOI 10.1002/ijc.29979; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	76	26	28	3	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1098	1109		10.1096/fj.201701586R	http://dx.doi.org/10.1096/fj.201701586R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30102568	Green Published			2022-12-26	WOS:000457401500087
J	Nixon, BR; Sebag, SC; Glennon, MS; Hall, EJ; Kounlavong, ES; Freeman, ML; Becker, JR				Nixon, Benjamin R.; Sebag, Sara C.; Glennon, Michael S.; Hall, Eric J.; Kounlavong, Emily S.; Freeman, Michael L.; Becker, Jason R.			Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response	FASEB JOURNAL			English	Article						nuclear translocation; cancer biology; signal transduction	STRAND BREAK REPAIR; GLUCOCORTICOID-RECEPTOR; CATALYTIC SUBUNIT; STATISTICAL-MODEL; INDEPENDENT ROLE; AUTOPHOSPHORYLATION; PATHWAY; BINDING; TUMOR; CRAF	Raf1/c-Raf is a well-characterized serine/threonine-protein kinase that links Ras family members with the MAPK/ERK signaling cascade. We have identified a novel splice isoform of human Raf1 that causes protein truncation and loss of the C-terminal kinase domain (Raf1-tr). We found that Raf1-tr has increased nuclear localization compared with full-length Raf1, and this finding was secondary to reduced binding of Raf1-tr to the cytoplasmic chaperone FK506 binding protein 5. We show that Raf1-tr has increased binding to DNA-dependent protein kinase (DNA-PK), which inhibits DNA-PK function and causes amplification of irradiation- and bleomycin-induced DNA damage. We found that the human colorectal cancer cell line, HCT-116, displayed reduced expression of Raf1-tr, and reintroduction of Raf1-tr sensitized the cells to bleomycin-induced apoptosis. Furthermore, we identified differential Raf1-tr expression in breast cancer cell lines and showed that breast cancer cells with increased Raf1-tr expression become sensitized to bleomycin-induced apoptosis. Collectively, these results demonstrate a novel Raf1 isoform in humans that has a unique noncanonical role in regulating the double-stranded DNA damage response pathway through modulation of DNA-PK function.Nixon, B. R., Sebag, S. C., Glennon, M. S., Hall, E. J., Kounlavong, E. S., Freeman, M. L., Becker, J. R. Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response.	[Nixon, Benjamin R.; Sebag, Sara C.; Glennon, Michael S.; Hall, Eric J.; Kounlavong, Emily S.; Becker, Jason R.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 2220 Pierce Ave,342 Preston Res Bldg, Nashville, TN 37232 USA; [Freeman, Michael L.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Becker, Jason R.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Becker, JR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 2220 Pierce Ave,342 Preston Res Bldg, Nashville, TN 37232 USA.	jason.becker@vanderbilt.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [K08HL116803, R01HL136824, T32HL105334]; PhRMA Foundation; American Heart Association [PTF29620009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105334, R01HL136824, K08HL116803] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PhRMA Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mass spectrometry was performed in the Vanderbilt Mass Spectrometry Research Center Proteomics Core Laboratory, and the authors thank Hayes McDonald (Vanderbilt University School of Medicine) for his advice and technical support. The authors also thank David Cortez (Vanderbilt University School of Medicine) for thoughtful discussion and review of the manuscript. This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grants K08HL116803 and R01HL136824 to J.R.B., and T32HL105334 to B.R.N.); the PhRMA Foundation (Postdoctoral Fellowship to S.C.S.); and the American Heart Association (Grant PTF29620009 to B.R.N.). The authors declare no conflicts of interest.	Advani SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9154; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Eisenhardt AE, 2016, ONCOTARGET, V7, P26628, DOI 10.18632/oncotarget.8427; Geil WM, 2014, FEBS J, V281, P1170, DOI 10.1111/febs.12693; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kung JE, 2016, STRUCTURE, V24, P7, DOI 10.1016/j.str.2015.10.020; Lukic I, 2015, J MOL NEUROSCI, V55, P951, DOI 10.1007/s12031-014-0451-z; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Neal JA, 2014, MOL CELL BIOL, V34, P2162, DOI 10.1128/MCB.01554-13; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Panaccione A, 2017, ORAL ONCOL, V66, P38, DOI 10.1016/j.oraloncology.2016.12.011; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rauch J, 2011, CANCER RES, V71, P4664, DOI 10.1158/0008-5472.CAN-10-4447; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rui LX, 2016, P NATL ACAD SCI USA, V113, pE7260, DOI 10.1073/pnas.1610970113; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Thymiakou E, 2011, JOVE-J VIS EXP, DOI 10.3791/2631; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Weber CK, 2001, CANCER RES, V61, P3595; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	41	4	4	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1138	1150		10.1096/fj.201800336R	http://dx.doi.org/10.1096/fj.201800336R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30106602	Green Published, Bronze			2022-12-26	WOS:000457401500090
J	Logeman, BL; Thiele, DJ				Logeman, Brandon L.; Thiele, Dennis J.			Reconstitution of a thermophilic Cu+ importer in vitro reveals intrinsic high-affinity slow transport driving accumulation of an essential metal ion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; copper transport; metal homeostasis; liposome; thermophile; Ctr1	HUMAN COPPER TRANSPORTER; MITOCHONDRIAL METALLOCHAPERONE SCO1; ZINC TRANSPORTER; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; MEMBRANE-PROTEINS; HUMAN CTR1; YEAST; ACQUISITION	Acquisition of the trace element copper (Cu) is critical to drive essential eukaryotic processes such as oxidative phosphorylation, iron mobilization, peptide hormone biogenesis, and connective tissue maturation. The Ctr1/Ctr3 family of Cu importers, first discovered in fungi and conserved in mammals, are critical for Cu+ movement across the plasma membrane or mobilization from endosomal compartments. Whereas ablation of Ctr1 in mammals is embryonic lethal, and Ctr1 is critical for dietary Cu absorption, cardiac function, and systemic iron distribution, little is known about the intrinsic contribution of Ctr1 for Cu+ permeation through membranes or its mechanism of action. Here, we identify three members of a Cu+ importer family from the thermophilic fungus Chaetomium thermophilum: Ctr3a and Ctr3b, which function on the plasma membrane, and Ctr2, which likely functions in endosomal Cu mobilization. All three proteins drive Cu and isoelectronic silver (Ag) uptake in cells devoid of Cu+ importers. Transport activity depends on signature amino acid motifs that are conserved and essential for all Ctr1/3 transporters. Ctr3a is stable and amenable to purification and was incorporated into liposomes to reconstitute an in vitro Ag+ transport assay characterized by stopped-flow spectroscopy. Ctr3a has intrinsic high-affinity metal ion transport activity that closely reflects values determined in vivo, with slow turnover kinetics. Given structural models for mammalian Ctr1, Ctr3a likely functions as a low-efficiency Cu+ ion channel. The Ctr1/Ctr3 family may be tuned to import essential yet potentially toxic Cu+ ions at a slow rate to meet cellular needs, while minimizing labile intracellular Cu+ pools.	[Logeman, Brandon L.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Logeman, Brandon L.] Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA	Duke University; Duke University; Duke University; Harvard University	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	dennis.thiele@duke.edu		Logeman, Brandon/0000-0002-9975-3541	National Institutes of Health [R01 GM041840, DK074192]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM041840 and DK074192 (to D. J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Baker ZN, 2017, HUM MOL GENET, V26, P4617, DOI 10.1093/hmg/ddx344; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boulet A, 2018, J BIOL CHEM, V293, P1887, DOI 10.1074/jbc.RA117.000265; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Clifford RJ, 2016, J CELL SCI, V129, P1711, DOI 10.1242/jcs.173351; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrnstorfer IA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14033; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Foster AW, 2014, MOL MICROBIOL, V93, P317, DOI 10.1111/mmi.12661; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Garcia-Santamarina S, 2017, MBIO, V8, DOI [10.1128/mBio.01742-17, 10.1128/mbio.01742-17]; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hassett R, 2000, BIOCHEM J, V351, P477, DOI 10.1042/0264-6021:3510477; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Hlynialuk CJ, 2015, CELL REP, V10, P933, DOI 10.1016/j.celrep.2015.01.019; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Kahra D, 2016, BIOPHYS J, V110, P95, DOI 10.1016/j.bpj.2015.11.016; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Kim HS, 2006, ANAL CHIM ACTA, V575, P223, DOI 10.1016/j.aca.2006.05.089; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Krishnamoorthy L, 2016, NAT CHEM BIOL, V12, P586, DOI [10.1038/NCHEMBIO.2098, 10.1038/nchembio.2098]; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Levy AR, 2014, J PHYS CHEM B, V118, P5832, DOI 10.1021/jp412589b; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; LUKASEWYCZ OA, 1990, ANN NY ACAD SCI, V587, P147, DOI 10.1111/j.1749-6632.1990.tb00142.x; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Madsen E, 2007, CURR OPIN GASTROEN, V23, P187, DOI 10.1097/MOG.0b013e32801421bb; Martins V, 2012, PLANT CELL PHYSIOL, V53, P1866, DOI 10.1093/pcp/pcs125; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Ramos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149516; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Rubino JT, 2011, METALLOMICS, V3, P61, DOI 10.1039/c0mt00044b; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rubino JT, 2010, J BIOL INORG CHEM, V15, P1033, DOI 10.1007/s00775-010-0663-9; Shenberger Y, 2015, J PHYS CHEM B, V119, P4824, DOI 10.1021/acs.jpcb.5b00091; Shingles R, 2004, PLANT PHYSIOL, V135, P145, DOI 10.1104/pp.103.037895; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Smith AD, 2017, ANNU REV MICROBIOL, V71, P597, DOI 10.1146/annurev-micro-030117-020444; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; Wijekoon CJK, 2017, J AM CHEM SOC, V139, P4266, DOI 10.1021/jacs.6b12921; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	89	2	2	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15497	15512		10.1074/jbc.RA118.004802	http://dx.doi.org/10.1074/jbc.RA118.004802			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30131336	Green Published, hybrid			2022-12-26	WOS:000446549200016
J	Du, XD; Li, ME; Zhu, P; Wang, J; Hou, LS; Li, JJ; Meng, HD; Zhou, MK; Zhu, CR				Du, Xudong; Li, Mier; Zhu, Ping; Wang, Ju; Hou, Lisha; Li, Jijie; Meng, Hongdao; Zhou, Muke; Zhu, Cairong			Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data	PLOS ONE			English	Article							PROPORTIONAL-ODDS MODELS; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; COST-EFFECTIVENESS; HAZARDS; CARE	Background and objective Markov micro-simulation models are being increasingly used in health economic evaluations. An important feature of the Markov micro-simulation model is its ability to consider transition probabilities of heterogeneous subgroups with different risk profiles. A survival analysis is generally performed to accurately estimate the transition probabilities associated with the risk profiles. This study aimed to apply a flexible parametric survival model (FPSM) to estimate individual transition probabilities. Materials and methods The data were obtained from a cohort study investigating ischemic stroke outcomes in Western China. In total, 585 subjects were included in the analysis. To explore the goodness of fit of the FPSM, we compared the estimated hazard ratios and baseline cumulative hazards, both of which are necessary to the calculate individual transition probabilities, and the Markov micro-simulation models constructed using the FPSM and Cox model to determine the validity of the two Markov micro-simulation models and cost-effectiveness results. Results The flexible parametric proportional hazards model produced hazard ratio and baseline cumulative hazard estimates that were similar to those obtained using the Cox proportional hazards model. The simulated cumulative incidence of recurrent ischemic stroke and 5years cost-effectiveness of Incremental cost-effectiveness Ratios (ICERs) were also similar using the two approaches. A discrepancy in the results was evident between the 5-years cost-effectiveness and the 10-years cost-effectiveness of ICERs, which were approximately 0.9 million (China Yuan) and 0.5 million (China Yuan), respectively. Conclusions The flexible parametric survival model represents a good approach for estimating individual transition probabilities for a Markov micro-simulation model.	[Du, Xudong; Li, Mier; Zhu, Ping; Wang, Ju; Hou, Lisha; Li, Jijie; Zhu, Cairong] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Sichuan, Peoples R China; [Meng, Hongdao] Univ S Florida, Sch Aging Studies, Tampa, FL USA; [Zhou, Muke] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China	Sichuan University; State University System of Florida; University of South Florida; Sichuan University	Zhu, CR (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Sichuan, Peoples R China.	cairong.zhu@hotmail.com	Meng, Hongdao/AAF-1866-2020		National Natural Science Foundation of China [30600511, 81673273]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this study was provided entirely by a grant from National Natural Science Foundation of China (grant no. 30600511 and no. 81673273, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report.	BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Beukelman T, 2010, OSTEOPOROSIS INT, V21, P1573, DOI 10.1007/s00198-009-1114-8; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs A, 2006, DECISION MODELLING M; Briggs DA, 2004, APPL HEALTH ECON HEA, V3, P79; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Chambers MG, 2002, VALUE HEALTH, V5, P82, DOI 10.1046/j.1524-4733.2002.52011.x; Colosimo EA, 2000, BIOMETRICS, V56, P1233, DOI 10.1111/j.0006-341X.2000.01233.x; Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH D; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Du Xu-Dong, 2018, Sichuan Da Xue Xue Bao Yi Xue Ban, V49, P252; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Hinchliffe SR, 2013, STATA J, V13, P759, DOI 10.1177/1536867X1301300405; Hinchliffe SR, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-13; Kang HY, 2009, CLIN THER, V31, P2919, DOI 10.1016/j.clinthera.2009.12.013; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Liu GE, 2011, CHIN J PHARM EC, V6, P6; Ming C, 2016, ADV THER, V33, P1; National Bureau of Statistics of China, 2014, CHIN STAT YB 2017; National Development and Reform Commission, 2012, NOT NAT DEV REF COMM; National Health and Family Planning Commission of the People's Republic of China, 2015, CHIN HLTH STAT YB 20; Nau DP, 2006, PROPORTION DAYS COVE; Nijhuis RL, 2006, MED DECIS MAKING, V26, P134, DOI 10.1177/0272989X05284103; Rothlisberger JM, 2015, J COMP EFFECT RES, V4, P377, DOI [10.2217/CER.15.22, 10.2217/cer.15.22]; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2011, FLEXIBLE PARAMETRIC; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Slejko JF, 2014, VALUE HEALTH, V17, P725, DOI 10.1016/j.jval.2014.06.010; Sun X, 2008, EUR J HEALTH ECON, V9, P313, DOI 10.1007/s10198-007-0078-x; Tappenden P, 2006, EUR J CANCER, V42, P2867, DOI 10.1016/j.ejca.2006.08.010; Weinstein MC, 2006, PHARMACOECONOMICS, V24, P1043, DOI 10.2165/00019053-200624110-00002; Williams C, 2017, MED DECIS MAKING, V37, P427, DOI 10.1177/0272989X16670617	32	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0200807	10.1371/journal.pone.0200807	http://dx.doi.org/10.1371/journal.pone.0200807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133454	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400005
J	Kadowaki, MAS; Varnai, A; Jameson, JK; Leite, AET; Costa, AJ; Kumagai, PS; Prade, RA; Polikarpov, I; Eijsink, VGH				Kadowaki, Marco A. S.; Varnai, Aniko; Jameson, John-Kristian; Leite, Ana E. T.; Costa-Filho, Antonio J.; Kumagai, Patricia S.; Prade, Rolf A.; Polikarpov, Igor; Eijsink, Vincent G. H.			Functional characterization of a lytic polysaccharide monooxygenase from the thermophilic fungus Myceliophthora thermophila	PLOS ONE			English	Article							CELLOBIOSE DEHYDROGENASE; OXIDATIVE CLEAVAGE; CELLULOSE; DEGRADATION; PROTEINS; OLIGOSACCHARIDES; DETERMINANTS; DISCOVERY; PRODUCTS; FAMILY	Thermophilic fungi are a promising source of thermostable enzymes able to hydrolytically or oxidatively degrade plant cell wall components. Among these enzymes are lytic polysaccharide monooxygenases (LPMOs), enzymes capable of enhancing biomass hydrolysis through an oxidative mechanism. Myceliophthora thermophila (synonym Sporotrichum thermophile), an Ascomycete fungus, expresses and secretes over a dozen different LPMOs. In this study, we report the overexpression and biochemical study of a previously uncharacterized LPMO (MtLPMO9J) from M. thermophila M77 in Aspergillus nidulans. MtLPMO9J is a single-domain LPMO and has 63% sequence similarity with the catalytic domain of NcLPMO9C from Neurospora crassa. Biochemical characterization of MtLPMO9J revealed that it performs C4-oxidation and is active against cellulose, soluble cello-oligosaccharides and xyloglucan. Moreover, biophysical studies showed that MtLPMO9J is structurally stable at pH above 5 and at temperatures up to 50 degrees C. Importantly, LC-MS analysis of the peptides after tryptic digestion of the recombinantly produced protein revealed not only the correct processing of the signal peptide and methylation of the N-terminal histidine, but also partial autoxidation of the catalytic center. This shows that redox conditions need to be controlled, not only during LPMO reactions but also during protein production, to protect LPMOs from oxidative damage.	[Kadowaki, Marco A. S.; Leite, Ana E. T.; Kumagai, Patricia S.; Polikarpov, Igor] Univ Sao Paulo, Dept Phys & Interdisciplinary Sci, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil; [Varnai, Aniko; Jameson, John-Kristian; Eijsink, Vincent G. H.] Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, As, Norway; [Costa-Filho, Antonio J.] Univ Sao Paulo, Dept Phys, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Prade, Rolf A.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Prade, Rolf A.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	Universidade de Sao Paulo; Norwegian University of Life Sciences; Universidade de Sao Paulo; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Polikarpov, I (corresponding author), Univ Sao Paulo, Dept Phys & Interdisciplinary Sci, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil.; Eijsink, VGH (corresponding author), Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, As, Norway.	ipolikarpov@ifsc.usp.br; vincent.eijsink@nmbu.no	Kadowaki, Marco/AAA-9024-2021; Costa-Filho, Antonio José/AAZ-1808-2020; Kumagai, PS/N-3741-2019; Polikarpov, Igor/D-2575-2012; Várnai, Anikó/Z-3190-2019; Costa-Filho, Antonio J/D-3153-2012; Prade, Rolf/AAI-5104-2020	Kadowaki, Marco/0000-0003-0188-2079; Kumagai, PS/0000-0001-7546-3091; Várnai, Anikó/0000-0002-2796-514X; Costa-Filho, Antonio J/0000-0001-6730-8737; Prade, Rolf/0000-0002-8154-9286; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20505-4, 2015/13684-0]; Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq) [405191/2015-4, 440977/2016-9, 303988/2016-9, 158752/2015-5]; Research Council of Norway [243663, 262853]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Council of Norway(Research Council of Norway)	This work received support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/) grants #2011/20505-4 (MASK) and #2015/13684-0 (IP); Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq; http://cnpq.br/) grants #405191/2015-4 (IP), #440977/2016-9 (IP), #303988/2016-9 (IP) and #158752/2015-5 (IP); Research Council of Norway (https://www.forskningsradet.no) grants 243663 (VGHE) and 262853 (VGHE).r This work was partly supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants #2011/20505-4 and #2015/13684-0 and the Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq) grants #405191/2015-4, #440977/2016-9, #303988/2016-9 and #158752/2015-5. This work was also supported by the Research Council of Norway through grants 243663 and 262853. We would like to thank Dr. Livia Manzine and Dr. Maria Auxiliadora Morim Santos for technical support.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Arntzen MO, 2017, ENVIRON MICROBIOL, V19, P2701, DOI 10.1111/1462-2920.13770; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bissaro B, 2016, BIORXIV, P1, DOI [10.1101/097022, DOI 10.1101/097022]; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; dos Santos HB, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0276-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; ERIKSSON KE, 1974, FEBS LETT, V49, P282, DOI 10.1016/0014-5793(74)80531-4; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2017, CARBOHYD RES, V448, P187, DOI 10.1016/j.carres.2017.03.010; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2018, APPL MICROBIOL BIOT, V102, P1281, DOI 10.1007/s00253-017-8541-9; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hangasky JA, 2018, P NATL ACAD SCI USA, V115, P4915, DOI 10.1073/pnas.1801153115; Hangasky JA, 2018, BIOCHEMISTRY-US, V57, P3191, DOI 10.1021/acs.biochem.8b00129; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Johansen KS, 2016, BIOCHEM SOC T, V44, P143, DOI 10.1042/BST20150204; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lenfant N, 2017, CARBOHYD RES, V448, P166, DOI 10.1016/j.carres.2017.04.012; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Segato F, 2012, ENZYME MICROB TECH, V51, P100, DOI 10.1016/j.enzmictec.2012.04.008; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Span EA, 2015, CURR OPIN STRUC BIOL, V35, P93, DOI 10.1016/j.sbi.2015.10.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Villares A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40262; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2016, J CHROMATOGR A, V1445, P46, DOI 10.1016/j.chroma.2016.03.064; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	54	31	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202148	10.1371/journal.pone.0202148	http://dx.doi.org/10.1371/journal.pone.0202148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125294	Green Submitted, Green Published, gold			2022-12-26	WOS:000442202100016
J	Bharanidharan, R; Arokiyaraj, S; Kim, EB; Lee, CH; Woo, YW; Na, Y; Kim, D; Kim, KH				Bharanidharan, Rajaraman; Arokiyaraj, Selvaraj; Kim, Eun Bae; Lee, Chang Hyun; Woo, Yang Won; Na, Youngjun; Kim, Danil; Kim, Kyoung Hoon			Ruminal methane emissions, metabolic, and microbial profile of Holstein steers fed forage and concentrate, separately or as a total mixed ration	PLOS ONE			English	Article							ENTERIC METHANE; PARTICLE-SIZE; DAIRY-COWS; PROPIONATE PRODUCTION; DETERGENT FIBER; RETENTION TIME; FATTY-ACIDS; FEED-INTAKE; RUMEN; ENERGY	Few studies have examined the effects of feeding total mixed ration (TMR) versus roughage and concentrate separately (SF) on ruminant methane production. Therefore, this study compared differences in methane production, ruminal characteristics, total tract digestibility of nutrients, and rumen microbiome between the two feeding methods in Holstein steers. A total six Holstein steers of initial bodyweights 540 +/- 34 kg were divided into two groups and assigned to a same experimental diet with two different feeding systems (TMR or SF) in a crossover design with 21 d periods. The experimental diet contained 73% concentrate and 27% forage and were fed twice a day. The total tract digestibility of crude protein, neutral detergent fibre, and organic matter were not affected by the two different feeding systems. Steers fed TMR emitted more methane (138.5 vs. 118.2 L/d; P < 0.05) and lost more gross energy as methane energy (4.0 vs. 3.5% gross energy intake; P = 0.005) compared to those fed SF. Steers fed TMR had greater (P < 0.05) total volatile fatty acid (VFA), ammonia-N concentrations and propionate proportion of total VFA at 1.5 h, whereas lower after that compared to steers fed SF. The greater (P < 0.05) acetate: propionate ratio at 4.5 h for steers fed TMR reflected the shift of H-2 sink from propionate towards acetate synthesis. The lower (P < 0.05) isobutyrate and isovalerate proportions of total VFA observed in steers fed TMR implies decrease in net consumption of H-2 for microbial protein synthesis compared to SF. There were no differences in both major bacterial and archaeal diversity between TMR and SF, unlike several minor bacterial abundances. The minor groups such as Coprococcus, Succiniclasticum, Butyrivibrio, and Succinivibrio were associated with the changes in ruminal VFA profiles or methanogenesis indirectly. Overall, these results indicate that SF reduces methane emissions from ruminants and increases propionate proportion of total VFA without affecting total tract digestion compared to TMR. There were no evidences that the response differed due to different major underlying microbial population.	[Bharanidharan, Rajaraman; Kim, Kyoung Hoon] Seoul Natl Univ, Dept Int Agr Technol, Grad Sch Int Agr Technol, Pyeongchang, Gangwon, South Korea; [Arokiyaraj, Selvaraj; Woo, Yang Won; Kim, Danil; Kim, Kyoung Hoon] Seoul Natl Univ, Dept Ecofriendly Livestock Sci, Inst Green Bio Sci & Technol, Pyeongchang, Gangwon, South Korea; [Kim, Eun Bae] Kangwon Natl Univ, Dept Anim Sci, Chunchon, South Korea; [Lee, Chang Hyun; Na, Youngjun] Konkuk Univ, Dept Anim Sci & Technol, Seoul, South Korea; [Kim, Danil] Seoul Natl Univ, Coll Vet Med, Dept Farm Anim Med, Seoul, South Korea; [Arokiyaraj, Selvaraj] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Konkuk University; Seoul National University (SNU); Sejong University	Kim, KH (corresponding author), Seoul Natl Univ, Dept Int Agr Technol, Grad Sch Int Agr Technol, Pyeongchang, Gangwon, South Korea.; Kim, KH (corresponding author), Seoul Natl Univ, Dept Ecofriendly Livestock Sci, Inst Green Bio Sci & Technol, Pyeongchang, Gangwon, South Korea.	khhkim@snu.ac.kr	Na, Youngjuna/AAY-7135-2021	Na, Youngjuna/0000-0002-4643-0191; Rajaraman, Bharanidharan/0000-0003-3751-6898	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET); Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [314081-2]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET); Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This study was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET); the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (research project no. 314081-2).	ALLISON MJ, 1971, BIOCHEM J, V121, P431, DOI 10.1042/bj1210431; ALLISON MJ, 1963, ARCH BIOCHEM BIOPHYS, V101, P269, DOI 10.1016/S0003-9861(63)80012-0; ALLISON MJ, 1962, J BACTERIOL, V83, P523, DOI 10.1128/JB.83.3.523-532.1962; Aoac International, 2007, OFFICIAL METHOD ANAL, V18th; Appuhamy JADRN, 2016, GLOBAL CHANGE BIOL, V22, P3039, DOI 10.1111/gcb.13339; Beever D. E., 1993, P187; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; BLAXTER KL, 1965, BRIT J NUTR, V19, P511, DOI 10.1079/BJN19650046; Caplis J, 2005, IRISH J AGR FOOD RES, V44, P27; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chaokaur A, 2015, AGR ECOSYST ENVIRON, V199, P225, DOI 10.1016/j.agee.2014.09.014; Charmley E, 2016, ANIM PROD SCI, V56, P169, DOI 10.1071/AN15365; Cooker DWI, 2004, IRISH J AGR FOOD RES, V43, P201; DEHORITY BA, 1969, J BACTERIOL, V99, P189, DOI 10.1128/JB.99.1.189-196.1969; Dodd D, 2010, J BIOL CHEM, V285, P30261, DOI 10.1074/jbc.M110.141788; ERWIN ES, 1961, J DAIRY SCI, V44, P1768, DOI 10.3168/jds.S0022-0302(61)89956-6; FAO, 2002, STAT FOOD AGR LIV BA, P3056, DOI [10.1111/gcb.13339, DOI 10.1111/GCB.13339]; Hammer O., 2012, PALAEONTOL ELECTRON, V4, P1; Hammond KJ, 2014, ANIM FEED SCI TECH, V193, P32, DOI 10.1016/j.anifeedsci.2014.04.005; Hammond KJ, 2013, ANIM FEED SCI TECH, V179, P121, DOI 10.1016/j.anifeedsci.2012.11.004; Heinrichs AJ, 1999, J ANIM SCI, V77, P180; Hellwing ALF, 2012, J DAIRY SCI, V95, P6077, DOI 10.3168/jds.2012-5505; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; HOLTER JB, 1977, J DAIRY SCI, V60, P1288, DOI 10.3168/jds.S0022-0302(77)84024-1; HOOVER WH, 1978, J ANIM SCI, V46, P1789, DOI 10.2527/jas1978.4661789x; Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583; Hunerberg M, 2015, J ANIM SCI, V93, P1760, DOI 10.2527/jas.2014-8469; Huhtanen P, 2016, ANIM PROD SCI, V56, P501, DOI 10.1071/AN15507; HUNGATE RE, 1966, RUMEN ITS MICROBES; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jiao HR, 2014, J DAIRY SCI, V97, P7043, DOI 10.3168/jds.2014-7979; Kim KH, 2005, ASIAN AUSTRAL J ANIM, V18, P350; Kim KH, 1999, J SCI FOOD AGR, V79, P1441, DOI 10.1002/(SICI)1097-0010(199908)79:11&lt;1441::AID-JSFA385&gt;3.0.CO;2-Z; Kim M, 2014, J MICROBIOL, V52, P355, DOI 10.1007/s12275-014-3443-3; Kishimoto A, 2006, CURR MICROBIOL, V53, P173, DOI 10.1007/s00284-005-0219-3; Knapp JR, 2014, J DAIRY SCI, V97, P3231, DOI 10.3168/jds.2013-7234; Kononoff PJ, 2003, J DAIRY SCI, V86, P1445, DOI 10.3168/jds.S0022-0302(03)73728-X; Kononoff PJ, 2003, J DAIRY SCI, V86, P2438, DOI 10.3168/jds.S0022-0302(03)73838-7; Kononoff PJ, 2003, J DAIRY SCI, V86, P1858, DOI 10.3168/jds.S0022-0302(03)73773-4; Krause KM, 2002, J DAIRY SCI, V85, P1947, DOI 10.3168/jds.S0022-0302(02)74271-9; Lana RP, 1998, J ANIM SCI, V76, P2190; Lee YoonSeok, 2016, Journal of the Korean Society of Grassland and Forage Science, V36, P104; Li DY, 2003, ASIAN AUSTRAL J ANIM, V16, P1482, DOI 10.5713/ajas.2003.1482; Littell RC, 1998, J ANIM SCI, V76, P1216; Liu YF, 2016, ASIAN AUSTRAL J ANIM, V29, P659, DOI 10.5713/ajas.15.0445; Lovett D, 2003, LIVEST PROD SCI, V84, P135, DOI 10.1016/j.livprodsci.2003.09.010; Maekawa M, 2002, J DAIRY SCI, V85, P1165, DOI 10.3168/jds.S0022-0302(02)74179-9; Maulfair DD, 2011, J DAIRY SCI, V94, P3527, DOI 10.3168/jds.2010-3718; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Moate RJ, 2017, J DAIRY SCI, V100, P7139, DOI 10.3168/jds.2016-12482; MOE PW, 1979, J DAIRY SCI, V62, P1583, DOI 10.3168/jds.S0022-0302(79)83465-7; Moss AR., 2000, REPROD NUTR DEV, V40, P201; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; OKINE EK, 1989, J ANIM SCI, V67, P3388; Owens FN, 1998, J ANIM SCI, V76, P275; Paillard D, 2007, ANTON LEEUW INT J G, V91, P417, DOI 10.1007/s10482-006-9121-7; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Popova M, 2011, ANIM FEED SCI TECH, V166-67, P113, DOI 10.1016/j.anifeedsci.2011.04.060; Rajaraman B, 2017, ANIM FEED SCI TECH, V234, P72, DOI 10.1016/j.anifeedsci.2017.09.010; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Renna M, 2014, ANIM SCI J, V85, P37, DOI 10.1111/asj.12083; Revelle W., 2018, USE PSYCH PACKAGE FA; Rural Development Administration (RDA), 2012, KOR FEED STAND HANW; Shibata M, 2010, ANIM SCI J, V81, P2, DOI 10.1111/j.1740-0929.2009.00687.x; STROBEL HJ, 1992, APPL ENVIRON MICROB, V58, P2331, DOI 10.1128/AEM.58.7.2331-2333.1992; TAMMINGA S, 1979, J ANIM SCI, V49, P1615, DOI 10.2527/jas1979.4961615x; THORNTON RF, 1972, AUST J AGR RES, V23, P871, DOI 10.1071/AR9720871; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; VANSOEST PJ, 1973, J ASSOC OFF ANA CHEM, V56, P781; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang JK, 2016, APPL MICROBIOL BIOT, V100, P9757, DOI 10.1007/s00253-016-7830-z; Williams SRO, 2016, ANIM PROD SCI, V56, P304, DOI 10.1071/AN15528; Yan T, 1998, ANIM SCI, V67, P395, DOI 10.1017/S1357729800032793	75	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202446	10.1371/journal.pone.0202446	http://dx.doi.org/10.1371/journal.pone.0202446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110381	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000067
J	Sheng, ZL; Zhao, JH; Muhammad, I; Zhang, Y				Sheng, Zunlai; Zhao, Jiahong; Muhammad, Ishfaq; Zhang, Ying			Optimization of total phenolic content from Terminalia chebula Retz. fruits using response surface methodology and evaluation of their antioxidant activities	PLOS ONE			English	Article							ULTRASONIC-ASSISTED EXTRACTION; IN-VITRO; POLYPHENOLIC COMPOUNDS; OXIDATIVE STRESS; GALLIC ACID; POLYSACCHARIDES; IDENTIFICATION; GREEN; OIL; L.	Ultrasonic-assisted extraction (UAE), using aqueous ethanol as the solvent, was firstly applied to extract phenolic compounds from Terminalia chebula Retz. fruits (T. chebula fruits). In this study, ethanol concentration (%), ultrasonic intensity (W/cm(2)), particle diameter (mm), extraction temperature (degrees C), ultrasonic time (min), liquid-solid ratio (mL/g) and extraction cycle were investigated by single-factor experiment and then optimized using a Box-Behnken design. The optimized result for UAE was 68% ethanol concentration, ultrasonic intensity of 3.6 W/cm(2), solid-liquid ratio of 23 mg/mL, particle size of 0.18 mm and ultrasonic time of 20 min for 2 times at 70 degrees C. The yield of total phenolic was 448.7 +/- 2.15 mg GAE/g DW under the above optimum conditions, which agreed with the predicted value (447.8 mg GAE/g DW). Compared to conventional solvent extraction (CSE), UAE extracts showed excellent DPPH radical, DPPH, ABTS scavenging activities and reducing power in a dose-dependent manner, and better than that of CSE extracts. Additionally, the extract of the T. chebula fruits was analyzed by HPLC-ESI/MS. In summary, UAE could effectively extract phenolic compounds from T. chebula fruits. In addition, the extract could be used as a potential source of natural antioxidants.	[Sheng, Zunlai; Zhao, Jiahong; Muhammad, Ishfaq; Zhang, Ying] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Sheng, ZL (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China.	shengzunlai@neau.edu.cn	Ishfaq, Muhammad/U-9965-2019; Ishfaq, Muhammad/HGD-1422-2022	Ishfaq, Muhammad/0000-0003-1376-8986; zunlai, sheng/0000-0002-3059-022X	National Natural Science Foundation of China [31572559]; Academic Backbone Project of Northeast Agricultural University [16XG16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Backbone Project of Northeast Agricultural University	This research was supported by the National Natural Science Foundation of China (grant number 31572559); and Academic Backbone Project of Northeast Agricultural University (grant number 16XG16).	Al-Farsi MA, 2008, FOOD CHEM, V108, P977, DOI 10.1016/j.foodchem.2007.12.009; Altemimi A, 2015, MOLECULES, V20, P6611, DOI 10.3390/molecules20046611; Altemimi A, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0113-4; Altemimi A, 2015, ULTRASON SONOCHEM, V24, P247, DOI 10.1016/j.ultsonch.2014.10.023; Avula B, 2009, CHROMATOGRAPHIA, V69, P307, DOI 10.1365/s10337-008-0884-z; Avula B, 2013, PLANTA MED, V79, P181, DOI 10.1055/s-0032-1328089; Bag Anwesa, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P244, DOI 10.1016/S2221-1691(13)60059-3; Bedner M, 2011, ANAL CHEM, V83, P6169, DOI 10.1021/ac200372d; Boukroufa M, 2015, ULTRASON SONOCHEM, V24, P72, DOI 10.1016/j.ultsonch.2014.11.015; Chemat F, 2011, ULTRASON SONOCHEM, V18, P813, DOI 10.1016/j.ultsonch.2010.11.023; Entezari MH, 2004, ULTRASON SONOCHEM, V11, P379, DOI 10.1016/j.ultsonch.2003.10.005; Hassan M, 2016, INT J BIOL MACROMOL, V82, P573, DOI 10.1016/j.ijbiomac.2015.09.057; Huang B, 2011, FOOD CHEM TOXICOL, V49, P185, DOI 10.1016/j.fct.2010.10.015; Jambrak AR, 2007, CZECH J FOOD SCI, V25, P90, DOI 10.17221/757-CJFS; Konyalioglu S, 2005, PHARM BIOL, V43, P683, DOI 10.1080/13880200500383538; Lee JH, 2005, J AGR FOOD CHEM, V53, P6003, DOI 10.1021/jf050468r; Liu J, 2013, FOOD CHEM TOXICOL, V51, P310, DOI 10.1016/j.fct.2012.10.014; Lv LZ, 2015, J APPL BOT FOOD QUAL, V88, P152, DOI 10.5073/JABFQ.2015.088.022; Manna K, 2014, J ETHNOPHARMACOL, V155, P132, DOI 10.1016/j.jep.2014.04.046; Naik GH, 2002, XI BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, P551; Pawlowska AM, 2006, J AGR FOOD CHEM, V54, P10234, DOI 10.1021/jf062230o; Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018; Prado P, 2008, SCI MAR, V72, P645, DOI 10.3989/scimar.2008.72n4645; Rangsiriwong P, 2009, SEP PURIF TECHNOL, V66, P51, DOI 10.1016/j.seppur.2008.11.023; Roslan J, 2014, SAINS MALAYS, V43, P1715; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Skotti E, 2014, IND CROP PROD, V53, P46, DOI 10.1016/j.indcrop.2013.12.013; Soria AC, 2010, TRENDS FOOD SCI TECH, V21, P323, DOI 10.1016/j.tifs.2010.04.003; Sun YS, 2013, ULTRASON SONOCHEM, V20, P180, DOI 10.1016/j.ultsonch.2012.07.002; Sun YJ, 2011, ULTRASON SONOCHEM, V18, P243, DOI 10.1016/j.ultsonch.2010.05.014; Suzek H, 2016, PHARM BIOL, V54, P451, DOI 10.3109/13880209.2015.1045086; Tubtimdee C, 2011, SEP PURIF TECHNOL, V77, P339, DOI 10.1016/j.seppur.2011.01.002; Tung YT, 2009, FOOD CHEM TOXICOL, V47, P1385, DOI 10.1016/j.fct.2009.03.021; Wang BC, 2007, COLLOID SURFACE B, V57, P17, DOI 10.1016/j.colsurfb.2006.12.003; Wang CX, 2014, J KOREAN SOC APPL BI, V57, P647, DOI 10.1007/s13765-014-4058-4; Wang L, 2008, ULTRASON SONOCHEM, V15, P738, DOI 10.1016/j.ultsonch.2007.12.008; Wu MY, 2007, J AQUAT PLANT MANAGE, V45, P76; Wu T, 2013, FOOD CHEM, V138, P1333, DOI 10.1016/j.foodchem.2012.10.086; Ye CL, 2011, INT J BIOL MACROMOL, V49, P466, DOI 10.1016/j.ijbiomac.2011.05.026; Zhang GW, 2011, INNOV FOOD SCI EMERG, V12, P18, DOI 10.1016/j.ifset.2010.12.003; Zhang ZG, 2010, BIOL TRACE ELEM RES, V138, P8, DOI 10.1007/s12011-009-8606-4; Zhang ZJ, 2009, FOOD CHEM, V113, P160, DOI 10.1016/j.foodchem.2008.07.061; Zheng Y, 2014, CARBOHYD POLYM, V111, P315, DOI 10.1016/j.carbpol.2014.04.034	43	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202368	10.1371/journal.pone.0202368	http://dx.doi.org/10.1371/journal.pone.0202368			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106980	gold, Green Published, Green Submitted			2022-12-26	WOS:000441662800043
J	Calisti, L; Trabuco, MC; Boffi, A; Testi, C; Montemiglio, LC; des Georges, A; Benni, I; Ilari, A; Taciak, B; Bialasek, M; Rygiel, T; Krol, M; Baiocco, P; Bonamore, A				Calisti, Lorenzo; Trabuco, Matilde Cardoso; Boffi, Alberto; Testi, Claudia; Montemiglio, Linda Celeste; des Georges, Amedee; Benni, Irene; Ilari, Andrea; Taciak, Bartlomiej; Bialasek, Maciej; Rygiel, Tomasz; Krol, Magdalena; Baiocco, Paola; Bonamore, Alessandra			Engineered ferritin for lanthanide binding	PLOS ONE			English	Article							HIGH-AFFINITY; H-CHAIN; NANOPARTICLES; MICROSCOPY; TAGS; APOFERRITIN; DELIVERY; TERBIUM; PROBES; NMR	Ferritin H-homopolymers have been extensively used as nanocarriers for diverse applications in the targeted delivery of drugs and imaging agents, due to their unique ability to bind the transferrin receptor (CD71), highly overexpressed in most tumor cells. In order to incorporate novel fluorescence imaging properties, we have fused a lanthanide binding tag (LBT) to the C-terminal end of mouse H-chain ferritin, HFt. The HFt-LBT possesses one high affinity Terbium binding site per each of the 24 subunits provided by six coordinating aminoacid side chains and a tryptophan residue in its close proximity and is thus endowed with strong FRET sensitization properties. Accordingly, the characteristic Terbium emission band at 544 nm for the HFt-LBT Tb(III) complex was detectable upon excitation of the tag enclosed at two order of magnitude higher intensity with respect to the wtHFt protein. X-ray data at 2.9 angstrom and cryo-EM at 7 angstrom resolution demonstrated that HFt-LBT is correctly assembled as a 24-mer both in crystal and in solution. On the basis of the intrinsic Tb(III) binding properties of the wt protein, 32 additional Tb(III) binding sites, located within the natural iron binding sites of the protein, were identified besides the 24 Tb(III) ions coordinated to the LBTs. HFt-LBT Tb(III) was demonstrated to be actively uptaken by selected tumor cell lines by confocal microscopy and FACS analysis of their FITC derivatives, although direct fluorescence from Terbium emission could not be singled out with conventional, 295-375 nm, fluorescence excitation.	[Calisti, Lorenzo; Testi, Claudia; Montemiglio, Linda Celeste; Benni, Irene; Bonamore, Alessandra] Sapienza Univ Rome, Dept Biochem Sci Alessandro Rossi Fanelli, Rome, Italy; [Trabuco, Matilde Cardoso] Molirom Srl, Rome, Italy; [Boffi, Alberto; Baiocco, Paola] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Boffi, Alberto; Montemiglio, Linda Celeste; Ilari, Andrea] CNR, Inst Mol Biol & Pathol, Rome, Italy; [des Georges, Amedee] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA; [Taciak, Bartlomiej; Bialasek, Maciej; Krol, Magdalena] Warsaw Univ Life Sci, Fac Vet Med, Ul Nowoursynowska, Warsaw, Poland; [Taciak, Bartlomiej; Rygiel, Tomasz; Krol, Magdalena] Cellis Ltd, Warsaw, Poland; [Rygiel, Tomasz] Med Univ Warsaw, Ctr Biostruct Res, Dept Immunol, Warsaw, Poland	Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); City University of New York (CUNY) System; Warsaw University of Life Sciences; Medical University of Warsaw	Baiocco, P (corresponding author), Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy.	paola.baiocco@iit.it	Bonamore, Alessandra/AAB-2587-2019; Ilari, Andrea/T-5501-2017; Ilari, Andrea/AAC-7670-2022; Georges, Amédée des/C-3588-2014; Baiocco, Paola/Q-4413-2019; Krol, Magdalena/A-5554-2019	Bonamore, Alessandra/0000-0002-3940-4657; Ilari, Andrea/0000-0002-7754-399X; Ilari, Andrea/0000-0002-7754-399X; Georges, Amédée des/0000-0002-9704-3781; Baiocco, Paola/0000-0002-1084-5694; Krol, Magdalena/0000-0003-0421-5167; Testi, Claudia/0000-0003-0556-975X; Taciak, Bartlomiej/0000-0003-2623-4860; Rygiel, Tomasz/0000-0003-4746-6505	European Community [312284]; National Science Centre (NCN) in Poland [UMO-2015/18/E/NZ6/00642]; EU H2020 Project "X-Probe" [637295]; Flagship project "Nanomax" from MIUR	European Community(European Commission); National Science Centre (NCN) in Poland(National Science Centre, Poland); EU H2020 Project "X-Probe"; Flagship project "Nanomax" from MIUR	This study has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 312284. The biological part of the study was supported by the grant from National Science Centre (NCN) in Poland no. UMO-2015/18/E/NZ6/00642.EU H2020 Project "X-Probe", Grant No 637295, to A. Bonamore and M.C.T. is gratefully acknowledged. Flagship project "Nanomax" from MIUR to A. Boffi is also acknowledged. The funder provided support in the form of salaries for authors Trabuco, MC, who is employed at Molirom as a Marie Curie Fellow within the framework of the X-probe EU project, and Taciak B., Rygel T and Krol M., who are employed at Cellis within the framework of the National Science Center of Poland. The companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors are grateful to the ELETTRA XRD-1 beamline staff for their help and assistance during the data collection and fluorescence emission experiments. This study has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 312284. The biological part of the study was supported by the grant from National Science Centre (NCN) in Poland no. UMO-2015/18/E/NZ6/00642. EU H2020 Project "X-Probe", Grant No 637295, to A. Bonamore and M.C.T. is gratefully acknowledged. Flagship project "Nanomax" from MIUR to A. Boffi is also acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arosio P, 2017, IUBMB LIFE, V69, P414, DOI 10.1002/iub.1621; Bain J, 2015, PHYS CHEM CHEM PHYS, V17, P15508, DOI 10.1039/c5cp00375j; Barb AW, 2012, PROTEIN SCI, V21, P1456, DOI 10.1002/pro.2133; Barth BM, 2010, ACS NANO, V4, P1279, DOI 10.1021/nn901297q; Barthelmes D, 2015, J BIOMOL NMR, V63, P275, DOI 10.1007/s10858-015-9984-x; Bou-Abdallah F, 2003, J BIOL INORG CHEM, V8, P489, DOI 10.1007/s00775-003-0455-6; Bunzli JCG, 2006, ACCOUNTS CHEM RES, V39, P53, DOI 10.1021/ar0400894; Bunzli JCG, 2004, MET IONS BIOL SYST, V42, P39; Calisti L, 2017, BBA-GEN SUBJECTS, V1861, P450, DOI 10.1016/j.bbagen.2016.10.007; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Turris V, 2017, NANOSCALE, V9, P647, DOI 10.1039/c6nr07129e; Diaz C, 2014, ONCOGENE, V33, P758; DICKSON EFG, 1995, J PHOTOCH PHOTOBIO B, V27, P3; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falvo E, 2016, BIOMACROMOLECULES, V17, P514, DOI 10.1021/acs.biomac.5b01446; Fracasso G, 2016, J CONTROL RELEASE, V239, P10, DOI 10.1016/j.jconrel.2016.08.010; Franz KJ, 2003, CHEMBIOCHEM, V4, P265, DOI 10.1002/cbic.200390046; Goda N, 2007, BBA-MOL CELL RES, V1773, P141, DOI 10.1016/j.bbamcr.2006.11.016; Gong YM, 2013, ANTICANCER RES, V33, P123; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Handl HL, 2005, LIFE SCI, V77, P361, DOI 10.1016/j.lfs.2005.01.009; Hemmila I, 2005, J FLUORESC, V15, P529, DOI 10.1007/s10895-005-2826-6; HORROCKS WD, 1979, J AM CHEM SOC, V101, P334, DOI 10.1021/ja00496a010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Maity B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14820; Martin LJ, 2007, J AM CHEM SOC, V129, P7106, DOI 10.1021/ja070480v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitz M, 2004, ANGEW CHEM INT EDIT, V43, P3682, DOI 10.1002/anie.200460028; Nitz M, 2003, CHEMBIOCHEM, V4, P272, DOI 10.1002/cbic.200390047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajapakse HE, 2009, ANGEW CHEM INT EDIT, V48, P4990, DOI 10.1002/anie.200900858; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sculimbrene BR, 2006, J AM CHEM SOC, V128, P7346, DOI 10.1021/ja061188a; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; STEFANINI S, 1983, ARCH BIOCHEM BIOPHYS, V222, P430, DOI 10.1016/0003-9861(83)90541-6; Su XC, 2006, CHEMBIOCHEM, V7, P1599, DOI 10.1002/cbic.200600142; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang X, 2015, INT J NANOMED, V10, P227, DOI [10.2147/IJN.S88289, DOI 10.2147/IJN.S88289]; Theil EC, 2016, ACCOUNTS CHEM RES, V49, P784, DOI 10.1021/ar500469e; Tian L, 2015, ANAL CHEM, V87, P10878, DOI 10.1021/acs.analchem.5b02347; TREFFRY A, 1984, J INORG BIOCHEM, V21, P9, DOI 10.1016/0162-0134(84)85035-7; Valero E, 2014, J MED CHEM, V57, P5686, DOI 10.1021/jm5004446; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wang ZT, 2017, FRONT CHEM SCI ENG, V11, P633, DOI 10.1007/s11705-017-1620-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohnert J, 2003, J AM CHEM SOC, V125, P13338, DOI 10.1021/ja036022d; Zhen ZP, 2013, ACS NANO, V7, P4830, DOI 10.1021/nn305791q; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	60	17	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201859	10.1371/journal.pone.0201859	http://dx.doi.org/10.1371/journal.pone.0201859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102720	gold, Green Published			2022-12-26	WOS:000441452200019
J	Duquette, ML; Kim, J; Shi, LDZ; Berns, MW				Duquette, Michelle L.; Kim, Justine; Shi, Linda Z.; Berns, Michael W.			LSD1 mediated changes in the local redox environment during the DNA damage response	PLOS ONE			English	Article							HISTONE DEMETHYLASE LSD1; GENE-EXPRESSION; OXIDATIVE STRESS; SWITCHES; REPAIR; RECRUITMENT; INVOLVEMENT; MODULATION; ACTIVATION; HEALTH	The redox state of the cell can be affected by many cellular conditions. In this study we show that detectable reactive oxygen species (ROS) are also generated in response to DNA damage by the chromatin remodeling factor and monoamine oxidase LSD1/KDM1A. This raised the possibility that the localized generation of hydrogen peroxide produced by LSD1 may affect the function of proximally located DNA repair proteins. The two major pathways for repair of DNA double-strand breaks (DSBs) are homologous recombination (HR) and non-homologous end joining (NHEJ). Cells were exposed to low levels of ectopic H2O2, DNA breaks generated by laser light, and recruitment kinetics of NHEJ protein Ku80 to DNA damage sites determined. Ku80 recruitment to damage sites was significantly decreased in cells pretreated with H(2)O(2 )while HR end binding protein Nbs1 was increased. This suggests that the DNA repair pathway choice has the potential to be modulated by the local redox state. This has implications for chemotherapeutic approaches involving generating DNA damage to target actively dividing cancer cells, which may be more or less effective dependent on the redox state of the targeted cells and the predominant repair pathway required to repair the type of DNA damage generated.	[Duquette, Michelle L.; Kim, Justine; Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA; [Duquette, Michelle L.; Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine	Duquette, ML (corresponding author), Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA.; Duquette, ML (corresponding author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.	Michelledh14@gmail.com		Berns, Michael/0000-0002-9640-2885	Beckman Laser Institute Foundation; Air Force Office of Scientific Research [FA9550-17-1-0193]	Beckman Laser Institute Foundation; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by funding from the Beckman Laser Institute Foundation. This material is based upon work supported by the Air Force Office of Scientific Research under award number FA9550-17-1-0193. Any opinions, finding, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the United States Air Force.	Andrews BJ, 2006, J BIOL CHEM, V281, P13596, DOI 10.1074/jbc.M512787200; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Bennett SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-86; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Cruz GMS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv976; Duquette ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003050; Flora SJS, 2007, CELL MOL BIOL, V53, P1, DOI [10.1170/T813, 10.1170/T770]; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lee M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153199; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mimasu S, 2008, BIOCHEM BIOPH RES CO, V366, P15, DOI 10.1016/j.bbrc.2007.11.066; Mohammad HP, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1117700; Mosammaparast N, 2013, J CELL BIOL, V203, P457, DOI 10.1083/jcb.201302092; Nair VD, 2012, MOL CELL BIOL, V32, P4861, DOI 10.1128/MCB.00816-12; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Paddock MN, 2011, DNA REPAIR, V10, P338, DOI 10.1016/j.dnarep.2010.12.005; Palumaa P, 2009, ANTIOXID REDOX SIGN, V11, P981, DOI [10.1089/ars.2009.2468, 10.1089/ARS.2009.2468]; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Peng B, 2015, NUCLEIC ACIDS RES, V43, P5936, DOI 10.1093/nar/gkv528; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Xu Q, 2017, FREE RADICAL BIO MED, V109, P84, DOI 10.1016/j.freeradbiomed.2017.03.004; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	31	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201907	10.1371/journal.pone.0201907	http://dx.doi.org/10.1371/journal.pone.0201907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096172	Green Submitted, gold, Green Published			2022-12-26	WOS:000441308500036
J	Oreggia, D; Ventimiglia, E; Capogrosso, P; Boeri, L; Cazzaniga, W; Pederzoli, F; Chierigo, F; Deho, F; Montorsi, F; Salonia, A				Oreggia, Davide; Ventimiglia, Eugenio; Capogrosso, Paolo; Boeri, Luca; Cazzaniga, Walter; Pederzoli, Filippo; Chierigo, Francesco; Deho, Federico; Montorsi, Francesco; Salonia, Andrea			Multiple PDE5Is use as a marker of decreased overall men's health: A real-life study	PLOS ONE			English	Article							4TH INTERNATIONAL CONSULTATION; ERECTILE DYSFUNCTION; CONSENSUS STATEMENT; SEXUAL DYSFUNCTION; MEDICINE; DISEASE; INDEX; WOMEN	Erectile dysfunction (ED) is considered a sentinel marker for poor general men's health status. Severe ED has been associated with poor response to phosphodiesterase type 5 inhibitors (PDE5ls) therapy. We sought to assess the association of multiple PDE5ls prescription with the overall patients' health status. Socio-demographic and clinical variables from 939 consecutive white-European, heterosexual, sexually-active men seeking medical help for ED at same tertiary-referral academic outpatient clinic were analyzed. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Patients have been stratified into naive and non-naive according to their history of previous prescriptions of any PDE5I. Every patient completed the International Index of Erectile Function (IIEF) questionnaire. Logistic regression models tested the association between patients' baseline characteristics (thus including previous PDE5ls prescriptions) and the overall health status. Overall, 328 (35%) patients were non-naive for PDE5ls. Of them, 172 (52%), 99 (30%), and 57 (17%) had been prescribed with 1, 2 or 3 different PDE5ls, respectively. Naive and non-naive patients did not differ in terms of age, BMI, baseline ED severity; conversely, non-naive patients had a higher CCI score. At logistic MVA, the number of PDE5ls prescriptions emerged as an independent predictor of a higher burden of comorbidities regardless of ED severity; the higher the number of PDE5ls prescriptions, the higher the CCI score (OR 1.69, 2.49, and 2.90 for 1, 2 or 3 previous PDE5ls, respectively), after accounting for age, BMI, baseline ED severity and cigarette smoking. More than a third of patients seeking medical help for ED at a single tertiary-referral center were non-naive for PDE5ls. The increasing number of previous prescriptions of PDE5ls emerged as a worrisome marker of a poorer overall men's health status regardless of ED severity.	[Oreggia, Davide; Ventimiglia, Eugenio; Capogrosso, Paolo; Cazzaniga, Walter; Pederzoli, Filippo; Chierigo, Francesco; Montorsi, Francesco; Salonia, Andrea] Univ Vita Salute San Raffaele, Milan, Italy; [Oreggia, Davide; Ventimiglia, Eugenio; Capogrosso, Paolo; Boeri, Luca; Cazzaniga, Walter; Pederzoli, Filippo; Chierigo, Francesco; Deho, Federico; Montorsi, Francesco; Salonia, Andrea] IRCCS Osped San Raffaele, URI, Unit Urol, Div Expt Oncol, Milan, Italy; [Boeri, Luca] Univ Milan, Dept Urol, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Capogrosso, P (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Capogrosso, P (corresponding author), IRCCS Osped San Raffaele, URI, Unit Urol, Div Expt Oncol, Milan, Italy.	paolo.capogrosso@gmail.com	Deho, Federico/K-4505-2018; Salonia, Andrea/H-1025-2016; Pederzoli, Filippo/K-2383-2018; Boeri, Luca/AAC-4848-2022; Chierigo, Francesco/AFZ-9935-2022; Ventimiglia, Eugenio/ABI-2333-2020; Montorsi, Francesco/AAN-2473-2020; Cazzaniga, Walter/AFZ-0495-2022; Chierigo, Francesco/ABE-9462-2021; Chierigo, Francesco/AAG-2205-2020	Deho, Federico/0000-0002-0453-5710; Salonia, Andrea/0000-0002-0595-7165; Pederzoli, Filippo/0000-0003-3873-7465; Chierigo, Francesco/0000-0001-7357-0758; Cazzaniga, Walter/0000-0002-0372-5694; Chierigo, Francesco/0000-0001-7357-0758; Capogrosso, Paolo/0000-0003-2347-9504; Ventimiglia, Eugenio/0000-0003-3654-1629				Capogrosso P, 2017, ANDROLOGY-US, V5, P63, DOI 10.1111/andr.12299; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou KT, 2011, J SEX MED, V8, P1754, DOI 10.1111/j.1743-6109.2011.02242.x; Chung SD, 2011, J SEX MED, V8, P3316, DOI 10.1111/j.1743-6109.2011.02496.x; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Gandaglia G, 2016, EUR UROL, V70, P219, DOI 10.1016/j.eururo.2016.01.054; Gandaglia G, 2014, EUR UROL, V65, P968, DOI 10.1016/j.eururo.2013.08.023; Gandaglia G, 2013, ENDOCRINE, V43, P285, DOI 10.1007/s12020-012-9780-2; Hackett G, 2016, J SEX MED, V13, P887, DOI 10.1016/j.jsxm.2016.01.023; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hatzimouratidis K, 2016, J SEX MED, V13, P465, DOI 10.1016/j.jsxm.2016.01.016; Kupelian V, 2006, J UROLOGY, V176, P222, DOI 10.1016/S0022-5347(06)00503-9; Lahoz C, 2016, J SEX MED, V13, P63, DOI 10.1016/j.jsxm.2015.11.011; McCabe MP, 2016, J SEX MED, V13, P153, DOI 10.1016/j.jsxm.2015.12.015; McCabe MP, 2016, J SEX MED, V13, P144, DOI 10.1016/j.jsxm.2015.12.034; Mulhall JP, 2009, J UROLOGY, V181, P462, DOI 10.1016/j.juro.2008.10.047; Rastrelli G, 2016, J SEX MED, V13, P200, DOI 10.1016/j.jsxm.2015.11.014; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Salonia A, 2012, J SEX MED, V9, P2708, DOI 10.1111/j.1743-6109.2012.02869.x; Toda K, 2005, J GASTROENTEROL, V40, P894, DOI 10.1007/s00535-005-1634-8; Wespes E, 2005, EUR UROL, V48, P136, DOI 10.1016/j.eururo.2005.03.030; Yafi FA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.3	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201601	10.1371/journal.pone.0201601	http://dx.doi.org/10.1371/journal.pone.0201601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096166	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500020
J	Wong, D; Lounsbury, K; Lum, A; Song, J; Chan, S; LeBlanc, V; Chittaranjan, S; Marra, M; Yip, S				Wong, Derek; Lounsbury, Kohl; Lum, Amy; Song, Jungeun; Chan, Susanna; LeBlanc, Veronique; Chittaranjan, Suganthi; Marra, Marco; Yip, Stephen			Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer	ONCOGENE			English	Article							CELL-PROLIFERATION; DOWN-REGULATION; CAPICUA; ATAXIN-1; MUTATIONS; PROTEIN; REPRESSOR; PATHWAY; COMPLEX; TUMORS	Aberrations in Capicua (CIC) have recently been implicated as a negative prognostic factor in a multitude of cancer types through activation of the MAPK signalling cascade and derepression of oncogenic ETS transcription factors. The Ataxin-family protein ATXN1L has previously been reported to interact with CIC in developmental and disease contexts to facilitate the repression of CIC target genes. To further investigate this relationship, we performed functional in vitro studies utilizing ATX/V/L-KO and CICKO human cell lines and characterized a reciprocal functional relationship between CIC and ATXN1L. Transcriptomic interrogation of the CIC-ATXN1-ATXN1L axis in low-grade glioma, prostate adenocarcinoma and stomach adenocarcinoma TCGA cohorts revealed context-dependent convergence of gene sets and pathways related to mitotic cell cycle and division. This study highlights the CIC-ATXN1-ATXN1L axis as a more potent regulator of the cell cycle than previously appreciated.	[Wong, Derek; Yip, Stephen] Univ British Columbia, Pathol & Lab Med, Vancouver, BC, Canada; [Wong, Derek; Lum, Amy; Yip, Stephen] BC Canc, Mol Oncol, Vancouver, BC, Canada; [Lounsbury, Kohl] Univ British Columbia, Cellular & Physiol Sci, Vancouver, BC, Canada; [Song, Jungeun; Chan, Susanna; LeBlanc, Veronique; Chittaranjan, Suganthi; Marra, Marco] BC Canc, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Marra, Marco] Univ British Columbia, Med Genet, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Yip, S (corresponding author), Univ British Columbia, Pathol & Lab Med, Vancouver, BC, Canada.; Yip, S (corresponding author), BC Canc, Mol Oncol, Vancouver, BC, Canada.	Stephen.Yip@vch.ca	Wong, Derek/AAF-8587-2020; Marra, Marco A/B-5987-2008; Yip, Stephen/E-9994-2012	Wong, Derek/0000-0003-2607-5265; Marra, Marco A/0000-0001-7146-7175; Yip, Stephen/0000-0002-8514-9861	VCHRI mentored scientist award; Canada Research Chairs program; Canadian Institutes of Health Research (CIHR) [FDN-143288]	VCHRI mentored scientist award; Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank Dr Gregory Cairncross, Dr Jennifer Chan, Dr Kenneth Aldape, Dr Severa Bunda, and members of the David Huntsman and Marco Marra laboratory for helpful discussions. SY is supported by a VCHRI mentored scientist award. MM acknowledges support from the Canada Research Chairs program and the Canadian Institutes of Health Research (CIHR; FDN-143288). We would also like to acknowledge the ongoing support from BrainCare BC, the BC Cancer Foundation, BC Cancer Agency, and the University of British Columbia. The results published here are in part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov.	Alonso MM, 2008, CANCER LETT, V263, P157, DOI 10.1016/j.canlet.2008.02.001; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan AKY, 2014, MODERN PATHOL, V27, P332, DOI 10.1038/modpathol.2013.165; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chittaranjan S, 2014, ONCOTARGET, V5, P7960, DOI 10.18632/oncotarget.2401; Choi N, 2015, ONCOTARGET, V6, P23533, DOI 10.18632/oncotarget.4372; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; Eisenreich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076623; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gleize V, 2015, ANN NEUROL, V78, P355, DOI 10.1002/ana.24443; Goukassian D, 2001, BRIT J PHARMACOL, V132, P1597, DOI 10.1038/sj.bjp.0703945; Han FX, 2018, ONCOL LETT, V15, P1459, DOI 10.3892/ol.2017.7460; Huang L, 2017, BIOCHEM BIOPH RES CO, V490, P707, DOI 10.1016/j.bbrc.2017.06.105; Iglesias-Ara A, 2015, CELL DEATH DIFFER, V22, P1577, DOI 10.1038/cdd.2015.4; Jimenez G, 2000, GENE DEV, V14, P224; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; Kahle JJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003359; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kim E, 2018, HEPATOLOGY, V67, P2287, DOI 10.1002/hep.29738; Kim E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08272; Kim E, 2013, GENE DEV, V27, P590, DOI 10.1101/gad.212068.112; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; LeBlanc VG, 2017, J PATHOL, V242, P206, DOI 10.1002/path.4894; Lee CJ, 2002, MOL BRAIN RES, V106, P151, DOI 10.1016/S0169-328X(02)00439-4; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Liao SD, 2017, GENE DEV, V31, P184, DOI 10.1101/gad.291948.116; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu HC, 2017, NAT GENET, V49, P527, DOI 10.1038/ng.3808; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Muller M, 2016, STEM CELL RES, V16, P349, DOI 10.1016/j.scr.2016.02.005; Okimoto RA, 2017, NAT GENET, V49, P87, DOI 10.1038/ng.3728; Padul V, 2015, GENE CHROMOSOME CANC, V54, P725, DOI 10.1002/gcc.22283; Pasini D, 2014, CELL CYCLE, V3, P394; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Roch F, 2002, DEVELOPMENT, V129, P993; Rousseaux MWC, 2018, NEURON, V97, P1235, DOI 10.1016/j.neuron.2018.02.013; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Seim I, 2017, G3-GENES GENOM GENET, V7, P1731, DOI 10.1534/g3.117.039909; Simon-Carrasco L, 2017, GENE DEV, V31, P1456, DOI 10.1101/gad.300244.117; Sonoda Y, 2001, CANCER RES, V61, P4956; Specht K, 2014, GENE CHROMOSOME CANC, V53, P622, DOI 10.1002/gcc.22172; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tseng ASK, 2007, CURR BIOL, V17, P728, DOI 10.1016/j.cub.2007.03.023; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wang B, 2017, CELL REP, V18, P1543, DOI 10.1016/j.celrep.2017.01.031; Yang L, 2016, P NATL ACAD SCI USA, V113, P10583, DOI 10.1073/pnas.1609417113; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995	65	23	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2019	38	2					273	290		10.1038/s41388-018-0427-5	http://dx.doi.org/10.1038/s41388-018-0427-5			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HG9XX	30093628				2022-12-26	WOS:000455366700009
J	Cai, XL; Zhang, DW; Wang, J; Liu, X; Ouyang, G; Xiao, WH				Cai, Xiaolian; Zhang, Dawei; Wang, Jing; Liu, Xing; Ouyang, Gang; Xiao, Wuhan			Deletion of the fih gene encoding an inhibitor of hypoxia-inducible factors increases hypoxia tolerance in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; development; hydroxylase; zebrafish; stress tolerance; fih; hif-1a; hif-1b; hif-2a; hif-2b; factor inhibiting HIF	HIGH-ALTITUDE ADAPTATION; FACTOR 3A FOXO3A; TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAY; INDUCED AUTOPHAGY; CELL-DEATH; BECLIN 1; HYDROXYLASE; PHYSIOLOGY; FISHES	Many aerobic organisms have developed molecular mechanism to tolerate hypoxia, but the specifics of these mechanisms remain poorly understood. It is important to develop genetic methods that confer increased hypoxia tolerance to intensively farmed aquatic species, as these are maintained in environments with limited available oxygen. As an asparaginyl hydroxylase of hypoxia-inducible factors (HIFs), factor inhibiting HIF (FIH) inhibits transcriptional activation of hypoxia-inducible genes by blocking the association of HIFs with the transcriptional coactivators CREB-binding protein (CBP) and p300. Therefore, here we sought to test whether fih is involved in regulating hypoxia tolerance in the commonly used zebrafish model. Overexpressing the zebrafish fih gene in epithelioma papulosum cyprini (EPC) cells and embryos, we found that fih inhibits the transcriptional activation of zebrafish HIF- proteins. Using CRISPR/Cas9 to obtain fih-null zebrafish mutants, we noted that the fih deletion makes zebrafish more tolerant of hypoxic conditions than their WT siblings, but does not result in oxygen consumption rates that significantly differ from those of WT fish. Of note, we identified fewer apoptotic cells in adult fih-null zebrafish brains and in fih-null embryos, possibly explaining why the fih-null mutant had greater hypoxia tolerance than the WT. Moreover, the fih deletion up-regulated several hypoxia-inducible genes in fih-null zebrafish exposed to hypoxia. The findings of our study suggest that fih plays a role in hypoxia tolerance by affecting the rate of cellular apoptosis in zebrafish.	[Cai, Xiaolian; Zhang, Dawei; Wang, Jing; Liu, Xing; Ouyang, Gang; Xiao, Wuhan] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; [Xiao, Wuhan] Minist Agr, Key Lab Aquaculture Dis Control, Wuhan 430072, Hubei, Peoples R China; [Cai, Xiaolian; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022	cai, xiaolian/0000-0002-6084-1245	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08010208]; NSFC [31830101, 91631102, 31671315, 31721005]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	Supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant XDA08010208) and NSFC Grants 31830101, 91631102, 31671315, and 31721005.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bigham AW, 2016, CURR OPIN GENET DEV, V41, P8, DOI 10.1016/j.gde.2016.06.018; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Eames SC, 2010, ZEBRAFISH, V7, P205, DOI 10.1089/zeb.2009.0640; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Fernandez AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7; Foster WG, 2018, BIOL REPROD, V99, P905, DOI 10.1093/biolre/ioy137; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Hartman-Ksycinska Anna, 2016, Przegl Epidemiol, V70, P490; Hu H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006675; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jing XG, 2018, EXP CELL RES, V368, P174, DOI 10.1016/j.yexcr.2018.04.026; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lefevre S, 2014, J FISH BIOL, V84, P705, DOI 10.1111/jfb.12302; Liu X, 2016, J BIOL CHEM, V291, P25692, DOI 10.1074/jbc.M116.745471; Liu X, 2015, J BIOL CHEM, V290, P25933, DOI 10.1074/jbc.M115.663542; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Prabhakar NR, 2016, PFLUG ARCH EUR J PHY, V468, P71, DOI 10.1007/s00424-015-1719-z; Prabhakar NR, 2015, PHYSIOLOGY, V30, P340, DOI 10.1152/physiol.00022.2015; Pugh CW, 2017, EXP CELL RES, V356, P116, DOI 10.1016/j.yexcr.2017.03.008; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sowter HM, 2001, CANCER RES, V61, P6669; Tan XM, 2018, CELL TRANSPLANT, V27, P1753, DOI 10.1177/0963689718760486; Tashi T, 2017, J MOL MED, V95, P665, DOI 10.1007/s00109-017-1519-3; Wang J, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx869; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wu HW, 2015, MOL MED REP, V12, P6467, DOI 10.3892/mmr.2015.4255; Xia SX, 2015, REPROD SCI, V22, P156, DOI 10.1177/1933719114536474; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Zhang E, 2015, CELL PHYSIOL BIOCHEM, V37, P1442, DOI 10.1159/000438513; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	46	14	16	5	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15370	15380		10.1074/jbc.RA118.003004	http://dx.doi.org/10.1074/jbc.RA118.003004			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126845	hybrid, Green Published			2022-12-26	WOS:000446549200004
J	de Villar, LO; Martinez-Olmos, FJ; Junque-Jimenez, A; Amer-Cuenca, JJ; Martinez-Gramage, J; Mercer, T; Segura-Orti, E				Ortega-Perez de Villar, Lucia; Jose Martinez-Olmos, Francisco; Junque-Jimenez, Anna; Jose Amer-Cuenca, Juan; Martinez-Gramage, Javier; Mercer, Tom; Segura-Orti, Eva			Test-retest reliability and minimal detectable change scores for the short physical performance battery, one-legged standing test and timed up and go test in patients undergoing hemodialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; 6-MINUTE WALK TEST; LOWER-EXTREMITY FUNCTION; OLDER-ADULTS; EXERCISE PROGRAM; SUBSEQUENT DISABILITY; FUNCTIONAL MOBILITY; HIP-FRACTURE; BALANCE	Functional tests are commonly used for chronic kidney disease (CKD) patients undergoing hemodialysis (HD). However, the relative and absolute reliability of such physical performance-outcome assessments must first be determined in specific patient cohorts. The aims of this study were to assess the relative and the absolute reliability of the Short Physical Performance Battery (SPPB), One-Legged Stance Test (OLST), and Timed Up and Go (TUG) test, as well as the minimal detectable change (MDC) scores for these tests in CKD patients receiving HD. Seventy-one end-stage CKD patients receiving HD therapy, aged between 21 and 90 years, participated in the study. The patients completed two testing sessions one to two weeks apart and performed by the same examiner, comprising the following tests: the SPPB (n = 65), OLST (n = 62), and TUG test (n = 66). High intraclass correlation coefficients (>= 0.90) were found for all the tests, suggesting that their relative reliability is excellent. The MDC scores for the 90% confidence intervals were as follows: 1.7 points for the SPPB, 11.3 seconds for the OLST, and 2.9 seconds for the TUG test. The reliability of the SPPB, OLST, and TUG test for this sample were all considered to be acceptable. The MDC data generated by these tests can be used to monitor meaningful changes in the functional capacity of the daily living-related activity of CKD patients on HD.	[Ortega-Perez de Villar, Lucia; Jose Martinez-Olmos, Francisco; Jose Amer-Cuenca, Juan; Martinez-Gramage, Javier; Segura-Orti, Eva] Univ Cardenal Herrera CEU, CEU Univ, Dept Physiotherapy, Valencia, Spain; [Junque-Jimenez, Anna] Consorci Sanitari Terrassa, Nephrol Dept, Hosp Terrassa, Terrassa, Spain; [Mercer, Tom] Queen Margaret Univ, Ctr Hlth Act & Rehabil Res, Sch Hlth Sci, Edinburgh, Midlothian, Scotland	Universidad CEU Cardenal Herrera; Queen Margaret University	de Villar, LO (corresponding author), Univ Cardenal Herrera CEU, CEU Univ, Dept Physiotherapy, Valencia, Spain.	lucia.ortega@uchcau.es	SEGURA-ORTÍ, EVA/E-7263-2016; Gramage, Javier Martínez/M-1295-2017; Segura-Orti, Eva/AAJ-2282-2020; Martinez-Olmos, Francisco José/B-2059-2018; Amer-Cuenca, Juan J./ABD-8589-2020	SEGURA-ORTÍ, EVA/0000-0002-9172-042X; Martinez-Olmos, Francisco José/0000-0001-8308-2686; Amer-Cuenca, Juan Jose/0000-0002-3824-8664; Junque, Anna/0000-0002-2323-7604; MARTINEZ GRAMAGE, JAVIER/0000-0002-4042-3214	Ayudas para la realizacion de proyectos de Investigacioan +Docencia en la CEU-UCH 2017-2018 [IDOC17/19]	Ayudas para la realizacion de proyectos de Investigacioan +Docencia en la CEU-UCH 2017-2018	This project is supported by "Ayudas para la realizacion de proyectos de Investigacioan +Docencia en la CEU-UCH 2017-2018" code IDOC17/19 and we do not have a conflict of interest.	Anding K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008709; Beauchamp MK, 2010, ARCH PHYS MED REHAB, V91, P1460, DOI 10.1016/j.apmr.2010.06.021; Bohannon RW, 2012, GAIT POSTURE, V35, P173, DOI 10.1016/j.gaitpost.2011.07.015; Bohannon RW, 2006, TOP GERIATR REHABIL, V22, P70; BRIGGS RC, 1989, PHYS THER, V69, P748, DOI 10.1093/ptj/69.9.748; Bruck K, 2015, CLIN KIDNEY J; Chen JLT, 2010, NEPHROL DIAL TRANSPL, V25, P1936, DOI 10.1093/ndt/gfp739; Cho H, 2014, J PHYS THER SCI, V26, P1661, DOI 10.1589/jpts.26.1661; Chomiak Taylor, 2015, J Clin Med Res, V7, P182, DOI 10.14740/jocmr1878w; Cook SA, 2008, NEPHROL DIAL TRANSPL, V23, P263, DOI 10.1093/ndt/gfm511; Fix AJ., 1988, HUMAN ACTIVITY PROFI; Giorgetti M M, 1998, Physiother Res Int, V3, P274, DOI 10.1002/pri.150; Goldberg A, 2011, GAIT POSTURE, V33, P737, DOI 10.1016/j.gaitpost.2011.02.020; Gras LZ, 2015, J GERIATR PHYS THER, V38, P1, DOI 10.1519/JPT.0000000000000020; Greenwood SA, 2012, NEPHROL DIAL TRANSPL, V27, P126, DOI 10.1093/ndt/gfs272; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, AGING-CLIN EXP RES, V6, P303, DOI 10.1007/BF03324256; Huang SL, 2011, PHYS THER, V91, P114, DOI 10.2522/ptj.20090126; Hurvitz EA, 2001, ARCH PHYS MED REHAB, V82, P198, DOI 10.1053/apmr.2001.17830; Hwang R., 2015, J CARD FAIL; Johansen KL, 2001, KIDNEY INT, V59, P1121, DOI 10.1046/j.1523-1755.2001.00597.x; Kaysen GA, 2011, AM J KIDNEY DIS, V57, P101, DOI 10.1053/j.ajkd.2010.08.021; Kovacs E, 2013, EUR J PHYS REHAB MED, V49, P639; Kristensen MT, 2014, GAIT POSTURE, V39, P424, DOI 10.1016/j.gaitpost.2013.08.017; Ling KW, 2003, PERITON DIALYSIS INT, V23, pS99; Lundin H, 2014, OSTEOPOROSIS INT, V25, P1305, DOI 10.1007/s00198-013-2593-1; Maanum G, 2010, DEV MED CHILD NEUROL, V52, pE126, DOI 10.1111/j.1469-8749.2010.03614.x; Mangione KK, 2010, PHYS THER, V90, P921, DOI 10.2522/ptj.20090363; Odden MC, 2004, J AM SOC NEPHROL, V15, P2908, DOI 10.1097/01.ASN.0000143743.78092.E3; Ostir GV, 2002, J CLIN EPIDEMIOL, V55, P916, DOI 10.1016/S0895-4356(02)00436-5; Otero A, 2010, NEFROLOGIA, V30, P78, DOI 10.3265/Nefrologia.pre2009.Dic.5732; Overend T, 2010, PHYSIOTHER CAN, V62, P122, DOI 10.3138/physio.62.2.122; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portney LG, 2015, FDN CLIN RES APPL PR; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Saitoh M, 2014, CARDIORENAL MED, V4, P73, DOI 10.1159/000362252; Segura-Orti E, 2011, PHYS THER, V91, P1244, DOI 10.2522/ptj.20100141; Sherrington C, 2005, CLIN REHABIL, V19, P496, DOI 10.1191/0269215505cr833oa; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Wolinsky FD, 2005, J AGING HEALTH, V17, P111, DOI 10.1177/0898264304272784	45	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201035	10.1371/journal.pone.0201035	http://dx.doi.org/10.1371/journal.pone.0201035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR3NR	30133445	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400009
J	Navone, L; Speight, R				Navone, Laura; Speight, Robert			Understanding the dynamics of keratin weakening and hydrolysis by proteases	PLOS ONE			English	Article							STENOTROPHOMONAS-MALTOPHILIA BBE11-1; FEATHER DEGRADATION; MOLECULAR CHARACTERIZATION; EXTRACELLULAR PROTEASE; BACILLUS; HARD; DECOMPOSITION; PURIFICATION; STRAIN; WASTE	Keratin is the structural protein in hair, nails, feathers and horns. Keratin is recalcitrant, highly disulfide bonded and is generally inaccessible to common proteases. Only certain types of proteases, called keratinases, are able to cleave the peptide bonds within the keratin structure. Due to this outstanding activity, keratinases have potential application in industries such as livestock, cosmetics and pharmaceuticals. Yet, the process of enzymatic keratin degradation is poorly understood, affecting the development of industrial enzyme formulations that may require full or only partial modification or weakening. Here we investigate the dynamics of keratin weakening and hydrolysis, showing that the decrease in hair mechanical strength is associated with cuticle removal and damage to the cortex and complete breakdown is dependent on reducing agents. Proteases with keratinolytic activity were selected and applied to hair with degradation examined by mechanical, biochemical and microscopic techniques. The extent of keratin degradation was highly enhanced by the presence of reducing agents, principally sodium thioglycolate, exceeding 90% degradation within 16 h of enzymatic treatment. Application was extended to feathers showing that the findings are relevant to improving the use of keratinases in a variety of industries. Overall, the outcomes provide valuable insights into the keratin degradation process by enzymes for the optimization of cosmetic and pharmaceutical products and for livestock waste recycling among other important applications.	[Navone, Laura; Speight, Robert] Queensland Univ Technol, Sci & Engn Fac, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Navone, L (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Brisbane, Qld, Australia.	laura.navone@qut.edu.au	Speight, Robert/AAY-4466-2020	Speight, Robert/0000-0003-4161-8272	Meat and Livestock Australia [B.FLT.0228]; Science and Engineering Faculty (QUT)	Meat and Livestock Australia(Meat and Livestock Australia); Science and Engineering Faculty (QUT)	This work was funded by Meat and Livestock Australia. B.FLT.0228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Central Analytical Research Facility, operated by the Institute for Future Environments (QUT). Access to CARF is supported by funding from the Science and Engineering Faculty (QUT).	Benkiar A, 2013, INT BIODETER BIODEGR, V83, P129, DOI 10.1016/j.ibiod.2013.05.014; BOCKLE B, 1995, APPL ENVIRON MICROB, V61, P3705; Bodde SG, 2011, J MECH BEHAV BIOMED, V4, P723, DOI 10.1016/j.jmbbm.2011.01.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandelli A, 2010, APPL MICROBIOL BIOT, V85, P1735, DOI 10.1007/s00253-009-2398-5; Caldas C, 2002, APPL ENVIRON MICROB, V68, P1297, DOI 10.1128/AEM.68.3.1297-1304.2002; Cao ZJ, 2009, J IND MICROBIOL BIOT, V36, P181, DOI 10.1007/s10295-008-0469-8; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Encarna P., 2011, Patent, Patent No. [WO2011050947, 2011050947]; Evans KL, 2000, CAN J MICROBIOL, V46, P1004, DOI 10.1139/cjm-46-11-1004; Fang Z, 2016, MICROB BIOTECHNOL, V9, P35, DOI 10.1111/1751-7915.12300; Fang Z, 2014, PROCESS BIOCHEM, V49, P647, DOI 10.1016/j.procbio.2014.01.009; Fang Z, 2013, INT BIODETER BIODEGR, V82, P166, DOI 10.1016/j.ibiod.2013.03.008; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Gegeckas A, 2015, INT J BIOL MACROMOL, V75, P158, DOI 10.1016/j.ijbiomac.2015.01.031; Ghosh A, 2009, MICROBIOL-SGM, V155, P2049, DOI 10.1099/mic.0.027573-0; Gousterova A, 2005, LETT APPL MICROBIOL, V40, P335, DOI 10.1111/j.1472-765X.2005.01692.x; Grumbt M, 2013, J INVEST DERMATOL, V133, P1550, DOI 10.1038/jid.2013.41; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Gupta R, 2013, APPL MICROBIOL BIOT, V97, P9931, DOI 10.1007/s00253-013-5292-0; Harris P., 2000, Patent, Patent No. [WO 2001005266 A1, 2001005266]; Hashimoto M, 2000, J BACTERIOL, V182, P3045, DOI 10.1128/JB.182.11.3045-3054.2000; Huang Y., 2014, Denmark Patent, Patent No. [169920 A2, 169920]; Huang YH, 2015, APPL MICROBIOL BIOT, V99, P9635, DOI 10.1007/s00253-015-6805-9; Jaouadi B, 2009, BIOTECHNOL BIOPROC E, V14, P503, DOI 10.1007/s12257-008-0244-8; Jaouadi NZ, 2015, INT J BIOL MACROMOL, V79, P952, DOI 10.1016/j.ijbiomac.2015.05.038; Jaouadi NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076722; Jin HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172712; KORNILLOWICZKOWALS, 2011, WASTE MANAGE, V31, P1689, DOI DOI 10.1016/J.WASMAN.2011.03.024; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Kreplak L, 2001, BIOPOLYMERS, V58, P526, DOI 10.1002/1097-0282(20010415)58:5<526::AID-BIP1028>3.0.CO;2-L; KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649; Laba W, 2015, BRAZ J MICROBIOL, V46, P691, DOI 10.1590/S1517-838246320140098; Laba W, 2013, POL J ENVIRON STUD, V22, P1101; Lange L, 2016, APPL MICROBIOL BIOT, V100, P2083, DOI 10.1007/s00253-015-7262-1; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Makino Y, 2009, Patent, Patent No. [US 7635465 B2, 7635465]; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Mitsuiki S, 2004, ENZYME MICROB TECH, V34, P482, DOI 10.1016/j.enzmictec.2003.12.011; Nam GW, 2002, ARCH MICROBIOL, V178, P538, DOI 10.1007/s00203-002-0489-0; Persaud D, 2004, J COSMET SCI, V55, pS65; Rahayu S, 2012, BIOCATAL AGR BIOTECH, V1, P152, DOI 10.1016/j.bcab.2012.02.001; Ramnani P, 2005, CAN J MICROBIOL, V51, P191, DOI 10.1139/W04-123; Ramnani P, 2007, WORLD J MICROB BIOT, V23, P1537, DOI 10.1007/s11274-007-9398-3; Riffel A, 2007, J BIOTECHNOL, V128, P693, DOI 10.1016/j.jbiotec.2006.11.007; ROBBINS CR, 1991, J SOC COSMET CHEM, V42, P59; Saha S, 2013, J BASIC MICROB, V53, P608, DOI 10.1002/jobm.201200105; Selvam K., 2012, INT J PHARM BIOL ARC, V3; Spyros T., 2003, Patent, Patent No. [US6627192, 6627192]; Vignardet C, 2001, INT J PHARM, V224, P115, DOI 10.1016/S0378-5173(01)00749-9; Wang D, 2011, ASIAN AUSTRAL J ANIM, V24, P1718, DOI 10.5713/ajas.2011.11132; WICKETT RR, 1983, J SOC COSMET CHEM, V34, P301; Williams BW, 1989, Patent, Patent No. [US 4883657 A, 4883657]; Yamamura S, 2002, BIOCHEM BIOPH RES CO, V294, P1138, DOI 10.1016/S0006-291X(02)00580-6; Yang Y, 2012, Patent, Patent No. [CN102614104, 102614104]; Yu Y, 2017, MAT SCI ENG C-MATER, V73, P152, DOI 10.1016/j.msec.2016.12.008	56	44	46	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202608	10.1371/journal.pone.0202608	http://dx.doi.org/10.1371/journal.pone.0202608			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114294	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400090
J	Ghany, MA; Sharaf, H; Al-agamy, MH; Shibi, A; Hill-Cawthorne, GA; Hong, PY				Abd El Ghany, Moataz; Sharaf, Hazem; Al-agamy, Mohamed H.; Shibi, Atef; Hill-Cawthorne, Grant A.; Hong, Pei-Ying			Genomic characterization of NDM-1 and 5, and OXA-1 81 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; EPIDEMIOLOGY; STRAINS; YERSINIABACTIN; MECHANISMS; EMERGENCE; VIRULENCE	Urinary tract infections (UTIs) associated with Escherichia coli are a growing threat with an increase in the prevalence of multidrug resistant (MDR) strains, particularly beta-lactamase producers, occurring globally. We investigated the presence of carbapenem-resistant uropathogenic E. coli clones in community-acquired UTIs in Riyadh, Kingdom of Saudi Arabia (KSA) to identify the virulence and resistance structures of the resistant clones and relate the isolates to those circulating globally. A combination of comparative genomics and phenotypic approaches were used to characterize ten MDR-uropathogenic Escherichia coli isolates recovered from UTI patients in Riyadh between November 2014 and January 2015. We report the presence of NDM-1 and 5, and OXA-181 in carbapenem-resistant UPEC strains from Riyadh, KSA. Single nucleotide polymorphism analyses demonstrated that these ten isolates fell into four phylogenetically distinct clades within the UPEC phylogeny. Comparative genomic analyses indicate that these diverse clones could be distinguished according to their multilocus sequencing type (MLST), serology, and virulence and antimicrobial gene architectures. These clones include the b/aNDm-i carrying isolates of the globally predominant MDR ST131 and ST69 types, previously identified as one of the most common UPEC strains in KSA. This is in addition to clones of ST23Cplx (ST410) and ST448Cplx (ST448) that have likely evolved from common intestinal strains, carrying copies of beta-lactamase genes including bla(NDM-5), bla(CTX-m-15), bla(TEM-1), bla(CMY-42), bla(OXA-1) and bla(OXA-181). These data have identified an emerging public health concern and highlight the need to use comprehensive approaches to detect the structure of MDR E. coli populations associated with community-acquired UTIs in KSA.	[Abd El Ghany, Moataz] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Abd El Ghany, Moataz; Hill-Cawthorne, Grant A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Sharaf, Hazem] Virginia Polytech Inst & State Univ, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA 24061 USA; [Al-agamy, Mohamed H.] King Saud Univ, Coll Pharm, Dept Pharmaceut & Microbiol, Riyadh, Saudi Arabia; [Al-agamy, Mohamed H.] Al Azhar Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Shibi, Atef] Alfaisal Univ, Coll Med, Microbiol & Immunol Dept, Riyadh, Saudi Arabia; [Hill-Cawthorne, Grant A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Hong, Pei-Ying] KAUST, Div Biol & Environm Sci & Engn, Environm Sci & Engn, Water Desalinat & Reuse Ctr, Jeddah, Saudi Arabia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Virginia Polytechnic Institute & State University; King Saud University; Egyptian Knowledge Bank (EKB); Al Azhar University; Alfaisal University; University of Sydney; King Abdullah University of Science & Technology	Ghany, MA (corresponding author), Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia.; Ghany, MA (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Hong, PY (corresponding author), KAUST, Div Biol & Environm Sci & Engn, Environm Sci & Engn, Water Desalinat & Reuse Ctr, Jeddah, Saudi Arabia.	Moataz.mohamed@sydney.edu.au; Peiying.hong@kaust.edu.sa	Al-Agamy, Mohamed H./ABC-6861-2020; Sharaf, Hazem/ABG-5995-2021; Hill-Cawthorne, Grant/B-8039-2009; Hong, Peiying/A-4813-2009	Sharaf, Hazem/0000-0002-6728-1631; Al-Agamy, Mohamed H./0000-0001-9868-0355; Hill-Cawthorne, Grant/0000-0002-3828-5473; Abd El Ghany, Moataz/0000-0002-0020-261X; Hong, Peiying/0000-0002-4474-6600	King Saud University [RGP-038]; King Abdullah University of Science and Technology [BAS/1/1033-01-01]; Marie Bashir Institute; Sydney Medical School Foundation; Deanship of Scientific Research at King Saud University	King Saud University(King Saud University); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Marie Bashir Institute; Sydney Medical School Foundation; Deanship of Scientific Research at King Saud University(King Saud University)	This work was supported by King Saud University (research group project No RGP-038 to AS and MHA) and King Abdullah University of Science and Technology (Faculty baseline funding [BAS/1/1033-01-01] to PYH), and Marie Bashir Institute and Sydney Medical School Foundation (MA and GAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank and extend their appreciation to the Deanship of Scientific Research at King Saud University for support.	Abd El Ghany M, 2017, EMERG INFECT DIS, V23, P1640, DOI 10.3201/eid2310.161642; AbdElGhany M, 2017, TRAVEL MED INFECT DI; Al-Agamy MH, 2018, J INFECT PUBLIC HEAL, V11, P64, DOI 10.1016/j.jiph.2017.03.010; Al-Zahrani IA, 2018, SAUDI MED J, V39, P23, DOI 10.15537/smj.2018.1.21094; Alghoribi MF, 2015, J ANTIMICROB CHEMOTH, V70, P2757, DOI 10.1093/jac/dkv188; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; British Society for Antimicrobial Chemotherapy, 2015, METH ANT SUSC TEST V; Brodrick HJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0457-6; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Caza M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00080; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dortet L, 2012, CLIN MICROBIOL INFEC, V18, pE144, DOI 10.1111/j.1469-0691.2012.03796.x; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Holden NJ, 2006, MICROBIOL-SGM, V152, P1143, DOI 10.1099/mic.0.28677-0; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kallonen T, 2017, GENOME RES, DOI [10.1101/gr.16606.116, DOI 10.1101/GR.16606.116]; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Mantilla-Calderon D, 2016, ANTIMICROB AGENTS CH, V60, P5223, DOI 10.1128/AAC.00236-16; Mavroidi A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-371; Mediavilla JR, 2016, MBIO, V7, DOI 10.1128/mBio.01191-16; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Nordstrom L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00029; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Peirano G, 2014, EMERG INFECT DIS, V20, P1928, DOI 10.3201/eid2011.141388; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Porres-Osante N, 2014, J ANTIMICROB CHEMOTH, V69, P1792, DOI 10.1093/jac/dku055; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Richter SN, 2011, J CLIN MICROBIOL, V49, P2040, DOI 10.1128/JCM.00133-11; Salipante SJ, 2015, GENOME RES, V25, P119, DOI 10.1101/gr.180190.114; Sanchez GV, 2014, J ANTIMICROB CHEMOTH, V69, P3259, DOI 10.1093/jac/dku282; Sanchez GV, 2012, ANTIMICROB AGENTS CH, V56, P2181, DOI 10.1128/AAC.06060-11; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Singer RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00028; Sonnevend A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131372; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; World Health Organization, 2014, ANT RES GLOB REP SUR; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zowawi HM, 2014, ANTIMICROB AGENTS CH, V58, P3085, DOI [10.1128/AAC.02050-13, 10.1128/AAC.]	62	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201613	10.1371/journal.pone.0201613	http://dx.doi.org/10.1371/journal.pone.0201613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110357	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000037
J	Fieldhouse, JK; Toh, TH; Lima, WH; Ting, J; Ha, SJ; Hii, KC; Kong, CI; Wong, TM; Wong, SC; Warkentien, TE; Gray, GC				Fieldhouse, Jane K.; Toh, Teck-Hock; Lima, Wei-Honn; Ting, Jakie; Ha, Siaw-Jing; Hii, King-Ching; Kong, Cheng-Ing; Wong, Toh-Mee; Wong, See-Chang; Warkentien, Tyler E.; Gray, Gregory C.			Surveillance for respiratory syncytial virus and parainfluenza virus among patients hospitalized with pneumonia in Sarawak, Malaysia	PLOS ONE			English	Article							REAL-TIME PCR; REQUIRING HOSPITALIZATION; INFECTION; EPIDEMIOLOGY; CHILDREN; PATHOGENS; GAPS	Background Respiratory syncytial virus (RSV) and parainfluenza virus (PIV) are frequent causes of pneumonia and death among children at Sibu and Kapit Hospitals in Sarawak, Malaysia. Objectives To determine the prevalence and risk factors for RSV subtypes A and B and PIV types 1-4 among patients hospitalized with pneumonia. Methods In a cross-sectional, pilot study nasopharyngeal swabs were studied with real-time reverse transcription polymerase chain reaction assays. Concurrently, we helped Sibu and Kapit Hospitals adapt their first molecular diagnostics for RSV and PIV. Results Of 129 specimens collected (June to July 2017), 39 tested positive for RSV-A (30.2%), two were positive for RSV B (1.6%), one was positive for PIV-3 (0.8%) and one was positive for PIV-4 (0.8%). No samples were positive for PIV-1 or PIV-2. Of the 39 RSV-A positive specimens, 46.2% were collected from children under one year of age and only 5.1% were from patients over the age of 18. A multivariable analysis found the odds of children <1 year of age testing positive for RSV-A were 32.7 (95% CI: 3.9, 276.2) times larger than >18 years of age, and the odds of patients hospitalized at Kapit Hospital testing positive for RSV-A were 3.2 (95% CI: 1.3, 7.8) times larger than patients hospitalized at Sibu Hospital. Conclusion This study found an unusually high prevalence of RSV-A among pneumonia patients admitted to the two hospitals. Subsequently, Sibu Hospital adapted the molecular assays with the goal of providing more directed care for such pneumonia patients.	[Fieldhouse, Jane K.; Gray, Gregory C.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Fieldhouse, Jane K.; Gray, Gregory C.] Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA; [Toh, Teck-Hock; Lima, Wei-Honn; Ting, Jakie; Ha, Siaw-Jing] Sibu Hosp, Clin Res Ctr, Sibu, Sarawak, Malaysia; [Toh, Teck-Hock; Ha, Siaw-Jing; Wong, See-Chang] Sibu Hosp, Dept Paediat, Sibu, Sarawak, Malaysia; [Toh, Teck-Hock; Wong, See-Chang] SEGi Univ, Dept Paediat, Sibu Hosp, Fac Med, Sibu Clin Campus, Sibu, Sarawak, Malaysia; [Hii, King-Ching; Kong, Cheng-Ing] Kapit Hosp, Kapit, Sarawak, Malaysia; [Wong, Toh-Mee] Sibu Hosp, Dept Med, Sibu, Sarawak, Malaysia; [Warkentien, Tyler E.] United States Naval Med Res Ctr Asia, Singapore, Singapore; [Gray, Gregory C.] Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore	Duke University; Duke University; SEGi University; National University of Singapore	Fieldhouse, JK (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Fieldhouse, JK (corresponding author), Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA.	jane.fieldhouse@duke.edu	Toh, Teck-Hock/AAW-7715-2021; Gray, Gregory C./ABF-1298-2020; Lim, Wei Honn/N-4108-2017	Toh, Teck-Hock/0000-0001-5909-4855; Lim, Wei Honn/0000-0002-6408-4747; Fieldhouse, Jane/0000-0002-5450-0970	US Naval Medical Research Center-Asia; Vysnova Partners [SC-2016-SABER-003-002]; Duke Global Health Institute; Duke University's Global Health Institute; US Naval Medical Research Center, Asia via Vysnova Partners Inc.	US Naval Medical Research Center-Asia; Vysnova Partners; Duke Global Health Institute; Duke University's Global Health Institute; US Naval Medical Research Center, Asia via Vysnova Partners Inc.	This work was funded in part by the US Naval Medical Research Center-Asia (http://www.med.navy.mil/sites/nmrca/SitePages/Home.aspx) and Vysnova Partners subcontract SC-2016-SABER-003-002 (http://www.vysnova.com/), received by CGC and THT. Research conducted by JKF was supported in part by funding from the Duke Global Health Institute (https://globalhealth.duke.edu/) and by discretionary funds from Dr. Gregory Gray with Duke University's Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Director General of Health, Malaysia for his permission to publish this paper. We thank the Medical Officers of Sibu and Kapit Hospitals (namely Chuet-Zou Lau, Nga-Hung Ngu, Khai-Fatt Chao, Sing-Ling Kong, Zhen-Hao Ching, Edmund Kwang-Yuen Wong, Tiana Ti, and Hilary Hon-Yun Kueh) for enrolling patients. This work was sponsored by the US Naval Medical Research Center, Asia via Vysnova Partners Inc., and conducted in partnership with Duke University, the Duke Global Health Institute, Sibu Hospital Clinical Research Center, Kapit Hospital and SEGi University Sibu Clinical Campus.	Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Bredius RGM, 2004, PEDIAT INFECT DIS J, V23; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Department of Statistics Malaysia, 2016, POP ETHN GROUP; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jalilian FA, 2015, J BIOL REG HOMEOS AG, V29, P7; Kaplan NM, 2008, J MED VIROL, V80, P168, DOI 10.1002/jmv.21067; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kim L, 2017, CLIN INFECT DIS, V65, P1020, DOI 10.1093/cid/cix432; Langley JM, 2016, J INFECT DIS; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Obando-Pacheco P, 2018, J INFECT DIS, V217, P1356, DOI 10.1093/infdis/jiy056; Pangesti KNA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1968; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Slinger R, 2012, CLIN MICROBIOL INFEC, V18, pE286, DOI 10.1111/j.1469-0691.2012.03896.x; Tang JW, 2017, LANCET INFECT DIS, V17, pE320, DOI 10.1016/S1473-3099(17)30238-4; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; van de Pol AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wishaupt JO, 2017, J CLIN VIROL, V90, P1, DOI 10.1016/j.jcv.2017.02.010	24	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202147	10.1371/journal.pone.0202147	http://dx.doi.org/10.1371/journal.pone.0202147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110367	gold, Green Submitted, Green Published			2022-12-26	WOS:000441738000053
J	Rao, T; Pingali, P				Rao, Tanvi; Pingali, Prabhu			The role of agriculture in women's nutrition: Empirical evidence from India	PLOS ONE			English	Article							INTRAHOUSEHOLD ALLOCATION; FAMILY-MEMBERS; BIRTH-ORDER; RURAL INDIA; UNDERNUTRITION; DIVERSITY; CHILDREN; INCOME; HELP	In this paper, we establish a statistically important relationship between household agricultural income and women's BMI using a five-year panel dataset of rural households drawn from 18 villages across five Indian states. Using within household variation over time, we estimate both the extent to which short-term changes in agricultural income are associated with short-term changes in BMI, and the effect of agricultural income growth on BMI growth over a longer term. Over the longer term, and for the group of households that regularly farm, we find a 10 percentage point agricultural income growth to be associated with a 0.10 percentage point growth in BMI. Consistent with the literature, this effect is economically modest, but important considering that we do not find a corresponding effect for growth in non-agricultural income. We show that both the own-production and market purchase of food are associated with nutritional improvements. While women's BMI is associated with an increase in the consumption of own-produced cereals, the market plays an important role in facilitating access to more nutritious foods like pulses. Lastly, we also find that effects of agricultural income are driven by younger women, in the age-group 15-25 years, who face a particularly strong nutritional disadvantage in India.	[Rao, Tanvi] IMPAQ Int LLC, Washington, DC 20005 USA; [Pingali, Prabhu] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA	American Institutes for Research; Cornell University	Rao, T (corresponding author), IMPAQ Int LLC, Washington, DC 20005 USA.	tr254@cornell.edu						Ali J, 2007, LIVESTOCK RES RURAL, V19; [Anonymous], 2017, EC SURV 2017 2018; Barrett CB, 1996, J DEV ECON, V51, P193, DOI 10.1016/S0304-3878(96)00412-9; BEHRMAN JR, 1988, OXFORD ECON PAP, V40, P32, DOI 10.1093/oxfordjournals.oep.a041845; BEHRMAN JR, 1988, J DEV ECON, V28, P43, DOI 10.1016/0304-3878(88)90013-2; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bobonis GJ, 2009, J POLIT ECON, V117, P453, DOI 10.1086/600076; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Carletto G, 2015, J DEV STUD, DOI [10.1080/00220388.2015.018908, DOI 10.1080/00220388.2015.018908]; Coffey D, 2013, WOMENS STATUS CHILDR, P8540; Coffey D, 2015, P NATL ACAD SCI USA, V112, P3302, DOI 10.1073/pnas.1416964112; Dillon A, 2015, J DEV STUD, V51, P976, DOI 10.1080/00220388.2015.1018902; Fernandez M, 1997, J INTERPERS VIOLENCE, V12, P433, DOI 10.1177/088626097012003008; Gillespie S, 2012, IFPRI DISCUSS PAP; Gulati A, 2012, FOOD NUTR BULL, V33, P74, DOI 10.1177/156482651203300108; Haddad L., 1999, WOMENS STATUS LEVELS; Headey D, 2012, FOOD SECUR, V4, P87, DOI 10.1007/s12571-011-0161-0; Headey DD, 2013, WORLD DEV, V42, P76, DOI 10.1016/j.worlddev.2012.07.002; Hirvonen K, 2017, AGR ECON-BLACKWELL, V48, P469, DOI 10.1111/agec.12348; HODDINOTT J, 1995, OXFORD B ECON STAT, V57, P77, DOI 10.1111/j.1468-0084.1995.tb00028.x; Hoddinott J., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P13; Imai KS, 2014, WORLD DEV, V62, P88, DOI 10.1016/j.worlddev.2014.05.001; Jayachandran S, 2017, AM ECON REV, V107, P2600, DOI 10.1257/aer.20151282; Jones AD, 2012, SOC SCI MED, V75, P1673, DOI 10.1016/j.socscimed.2012.06.025; Kadiyala S, 2014, ANN NY ACAD SCI, V1331, P43, DOI 10.1111/nyas.12477; Kirk A, 2015, 2015 C AUG 9 14 2015; Kishtwaria J, 2007, ANTHROPOLOGIST, V9, P221, DOI [10.1080/09720073.2007.11891003, DOI 10.1080/09720073.2007.11891003]; Mishra S, 2008, INT J RURAL STUDIES, V15; Parasuraman S., 2011, Economic and Political Weekly, V46, P42; Pingali P., 2015, FIGHT HUNGER MALNUTR, P165; Pingali P, 2017, EARTHSCAN FOOD AGRIC, P292; Quisumbing A. R., 1995, Women: the key to food security.; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Singh I., 1986, Agricultural household models. Extensions, applications, and policy, P17; Slavchevska V, 2015, J DEV STUD, V51, P1016, DOI 10.1080/00220388.2015.1018906; Vulimiri R, 1996, COMMENTARY ASIAN ENI; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201115	10.1371/journal.pone.0201115	http://dx.doi.org/10.1371/journal.pone.0201115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ5PD	30110376	Green Submitted, Green Published, gold			2022-12-26	WOS:000441738000015
J	Frey, UJ; Pirscher, F				Frey, Ulrich J.; Pirscher, Frauke			Willingness to pay and moral stance: The case of farm animal welfare in Germany	PLOS ONE			English	Article							CONTINGENT VALUATION METHOD; ENVIRONMENTAL PUBLIC-GOODS; POLITICAL CONSUMERISM; CHOICE EXPERIMENTS; PROTEST RESPONSES; NONUSE VALUES; ATTITUDES; ETHICS; FOOD; CONSUMPTION	This study examines the impact of ethical attitude on the willingness to pay for farm animal welfare improvement in Germany. Little is known about the pluralism of moral attitudes that may exist behind farm animal welfare issues and its relationship to customers' willingness to pay for it. Via a large survey (n = 1334) we are able to identify different moral dimensions by employing validated scales. We find utilitarian alongside deontological attitudes as well as a mixture of both. Thus, presupposing a standard moral attitude is too simple. This has implications for decision-making on markets, since the implicit normative assumptions of a utilitarian position in economics has to be critically assessed. Furthermore, we asked for the willingness to pay for various aspects of farm animal welfare improvement. We find significant positive correlations between willingness to pay and environmental concern, altruism and less apathy. Measured in Euro, a higher environmental concern has the strongest effect on WTP for all five moral scales. Outliers with higher bids are willing to pay almost five times for any aspect of farm animal welfare than the rest of the sample. A more detailed analysis of outliers demonstrates that market-based approaches have restrictions in capturing certain moral values. Moreover, the motivations behind zero bids reveal that moral concerns outweigh indifference towards animal welfare by far. This has implications how policy can be designed to serve people's demand for higher animal welfare standards. Two other findings are of interest. First, we find a very high number of people assigning an intrinsic value to animals (90%). Second, zero bids and outlier treatment in WTP-studies deserves more careful consideration, since WTP-estimates are easily skewed by excluding these groups.	[Frey, Ulrich J.] German Aerosp Ctr, Dept Energy Syst Anal, Inst Engn Thermodynam, Stuttgart, Germany; [Pirscher, Frauke] Martin Luther Univ Halle Wittenberg, Dept Agr Environm & Food Policy, Halle, Saale, Germany	Helmholtz Association; German Aerospace Centre (DLR); Martin Luther University Halle Wittenberg	Frey, UJ (corresponding author), German Aerosp Ctr, Dept Energy Syst Anal, Inst Engn Thermodynam, Stuttgart, Germany.	ulrich.frey@dlr.de		Frey, Ulrich J./0000-0002-9803-1336				Andorfer VA, 2013, EUR SOCIOL REV, V29, P1251, DOI 10.1093/esr/jct014; [Anonymous], 2021, LANG ENV STAT COMP; Arrow K.J., 1993, REPORT NOAA PANEL CO, V58; Bateman IJ, 1997, REG STUD, V31, P571, DOI 10.1080/00343409750131703; Bateman IJ, 2002, EC VALUATION STATED, Vxx; Becker G.S., 2008, EC APPROACH HUMAN BE; Bennett R, 1996, J AGR ECON, V47, P224, DOI 10.1111/j.1477-9552.1996.tb00686.x; BENNETT R, 1995, J AGR ECON, V46, P46, DOI 10.1111/j.1477-9552.1995.tb00751.x; Bennett RM, 2002, J AGR ENVIRON ETHIC, V15, P187, DOI 10.1023/A:1015036617385; Bennett RM, 1997, FOOD POLICY, V22, P281, DOI 10.1016/S0306-9192(97)00019-5; Boogaard BK, 2011, J AGR ENVIRON ETHIC, V24, P259, DOI 10.1007/s10806-010-9256-4; Bravo CP, 2013, FOOD QUAL PREFER, V28, P60, DOI 10.1016/j.foodqual.2012.08.010; Bromley D, 2004, ENVIRON RESOUR ECON, V28, P73, DOI 10.1023/B:EARE.0000023821.33379.b7; Bromley DW, 1997, AM J AGR ECON, V79, P1383, DOI 10.2307/1244351; Carlsson F., 2007, Journal of Agricultural and Applied Economics, V39, P61; Carlsson F, 2005, ECON LETT, V89, P147, DOI 10.1016/j.econlet.2005.03.010; Carlucci A, 2009, J SENS STUD, V24, P712, DOI 10.1111/j.1745-459X.2009.00235.x; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; Cohen N, 2009, J AGR ENVIRON ETHIC, V22, P341, DOI 10.1007/s10806-009-9157-6; Conway P, 2013, J PERS SOC PSYCHOL, V104, P216, DOI 10.1037/a0031021; Cooper P, 2004, ECOL ECON, V50, P69, DOI 10.1016/j.ecolecon.2004.02.009; De Backer CJS, 2015, MEAT SCI, V99, P68, DOI 10.1016/j.meatsci.2014.08.011; Dietz T, 2016, ENVIRON BEHAV, V30, P450; Dirscherl C, 2013, BER LANDWIRTSCH, V91; Dziegielewska DA, 2007, ENVIRON RESOUR ECON, V38, P71, DOI 10.1007/s10640-006-9057-4; Eckhardt GM, 2010, J CONSUM BEHAV, V9, P426, DOI 10.1002/cb.332; EU, 2007, EUR ATT CONS WELF FA; EU, 2007, EUR ATT EU CIT AN WE; EU (European Union), 2007, TREAT LISB AM TREAT; Frey U, 2014, EXPERIMENTAL ETHICS: TOWARD AN EMPIRICAL MORAL PHILOSOPHY, P112; Garrod GD, 1997, ECOL ECON, V21, P45, DOI 10.1016/S0921-8009(96)00092-4; Grammatikopoulou I, 2013, J ENVIRON MANAGE, V130, P232, DOI 10.1016/j.jenvman.2013.08.054; Haab T. C., 2002, VALUING ENV NATURAL; Hansson H, 2015, FOOD POLICY, V50, P35, DOI 10.1016/j.foodpol.2014.10.012; Hausman J, 2012, J ECON PERSPECT, V26, P43, DOI 10.1257/jep.26.4.43; Holland A., 2002, EC ETHICS ENV POLICY, P17, DOI DOI 10.1002/9780470693674.CH2; Jacobsen E, 2007, J AGR ENVIRON ETHIC, V20, P469, DOI 10.1007/s10806-007-9043-z; Jakobsson KM, 2001, ENVIRON RESOUR ECON, V19, P211, DOI 10.1023/A:1011128620388; Johansson-Stenman O, 1998, ENVIRON RESOUR ECON, V11, P429, DOI 10.1023/A:1008239427421; Johansson-Stenman O, 2006, SHOULD ANIMAL WELFAR; Johansson-Stenman O, 2012, ECON LETT, V115, P225, DOI 10.1016/j.econlet.2011.12.050; Jorgensen BS, 2000, ECOL ECON, V33, P251, DOI 10.1016/S0921-8009(99)00145-7; Jorgensen BS, 2001, ECOL ECON, V36, P133, DOI 10.1016/S0921-8009(00)00210-X; Kant I., 1788, KRITIK PRAKTISCHEN V; Kehlbacher A, 2012, FOOD POLICY, V37, P627, DOI 10.1016/j.foodpol.2012.07.002; Kjaernes U, 2012, J AGR ENVIRON ETHIC, V25, P145, DOI 10.1007/s10806-011-9315-5; Kotchen MJ, 2000, ECOL ECON, V32, P93, DOI 10.1016/S0921-8009(99)00069-5; KRISTROM B, 1990, LAND ECON, V66, P135, DOI 10.2307/3146363; Lagerkvist C. J., 2006, AgBioForum, V9, P51; Lagerkvist CJ, 2011, EUR REV AGRIC ECON, V38, P55, DOI 10.1093/erae/jbq043; Liebe U, 2009, ENVIRON BEHAV, V43, P106; Liljenstolpe C, 2008, AGRIBUSINESS, V24, P67, DOI [10.1002/agr.20147, 10.1002/AGR.20147]; Lindeman M, 2000, APPETITE, V34, P55, DOI 10.1006/appe.1999.0293; Lusk JL, 2011, AGR HUM VALUES, V28, P561, DOI 10.1007/s10460-011-9318-x; Martinez-Alier J, 1998, ECOL ECON, V26, P277, DOI 10.1016/S0921-8009(97)00120-1; McInerney JP, 1993, ANN C AGR EC SOC; Meyerhoff J, 2006, ECOL ECON, V57, P583, DOI 10.1016/j.ecolecon.2005.04.021; Meyerhoff J, 2010, ECOL ECON, V70, P366, DOI 10.1016/j.ecolecon.2010.09.008; Miele M, 2010, ETHICS POLICY ENV, V13, P171, DOI 10.1080/13668791003778842; Morrison MD, 2000, ENVIRON RESOUR ECON, V16, P407, DOI 10.1023/A:1008368611972; Mulder M, 2017, J APPL ANIM WELF SCI, V20, P137, DOI 10.1080/10888705.2017.1281134; Neilson LA, 2010, J CONSUM BEHAV, V9, P214, DOI 10.1002/cb.313; Nickell G. S., 1998, HELPING ATTITUDE SCA; Nocella G, 2010, APPL ECON PERSPECT P, V32, P275, DOI 10.1093/aepp/ppp009; O'Neill J, 1993, ECOLOGY POLICY POLIT, VX; O'Neill J., 2013, MARKETS DELIBERATION; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; Pirscher F, 2016, J AGR ENVIRON ETHIC, V29, P67, DOI 10.1007/s10806-015-9592-5; Prischer F, 2016, J AGR ENVIRON ETHIC, V29, P67; Regan Tom, 1983, CASE ANIMAL RIGHTS; Risius A, 2017, MEAT SCI, V124, P9, DOI 10.1016/j.meatsci.2016.10.008; Robinson JS, 2012, CONSEQUENTIALIST SCA; Sagoff M, 1998, ECOL ECON, V24, P213, DOI 10.1016/S0921-8009(97)00144-4; Schroder M. J. A., 2004, INT J CONSUM STUD, V28, P168, DOI [10.1111/j.1470-6431.2003.00357.x, DOI 10.1111/J.1470-6431.2003.00357.X, 10.1111/J.1470-6431.2003.00357.X]; Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255; SEN AK, 1977, PHILOS PUBLIC AFF, V6, P317; Shaw D., 2005, ETHICAL CONSUMER; SINGER P, 1975, ANIMAL LIBERATION NE; Solgaard HS, 2011, BRIT FOOD J, V113, P997, DOI 10.1108/00070701111153751; Spash CL, 2000, ECOL ECON, V34, P195, DOI 10.1016/S0921-8009(00)00158-0; Spash CL, 1997, J ENVIRON MANAGE, V50, P403, DOI 10.1006/jema.1997.0017; Spash CL, 2006, LAND ECON, V82, P602, DOI 10.3368/le.82.4.602; Spash CL, 2009, ECOL ECON, V68, P955, DOI 10.1016/j.ecolecon.2006.09.013; Spiller A., 2008, ZUKUNFTSPERSPEKTIVEN, pV; STERN PC, 1993, ENVIRON BEHAV, V25, P322, DOI 10.1177/0013916593255002; STERN PC, 1995, ENVIRON BEHAV, V27, P723, DOI 10.1177/0013916595276001; Tarrant MA, 1997, ENVIRON BEHAV, V29, P618, DOI 10.1177/0013916597295002; Taylor P. W., 2011, RESPECT NATURE THEOR; THOMPSON SCG, 1994, J ENVIRON PSYCHOL, V14, P149; Vanhonacker F, 2014, J AGR ENVIRON ETHIC, V27, P153, DOI 10.1007/s10806-013-9479-2; Vatn A, 2005, ECOL ECON, V55, P203, DOI 10.1016/j.ecolecon.2004.12.001; Weinrich R, 2016, INT FOOD AGRIBUS MAN, V19, P1; WISSENSCHAFTLICHER BEIRAT AGRARPOLITIK BEIM BMEL, 2015, WEG GES AKZ NUTZT; Zander K, 2010, FOOD QUAL PREFER, V21, P495, DOI 10.1016/j.foodqual.2010.01.006	94	19	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202193	10.1371/journal.pone.0202193	http://dx.doi.org/10.1371/journal.pone.0202193			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ4SC	30106999	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000441662800030
J	Schlichting, N; de Jong, R; van Rijn, H				Schlichting, Nadine; de Jong, Ritske; van Rijn, Hedderik			Robustness of individual differences in temporal interference effects	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; SUBJECTIVE TIME; STROOP; MAGNITUDE; SPACE; NUMEROSITY; WORD	Magnitudes or quantities of the different dimensions that define a stimulus (e.g., space, speed or numerosity) influence the perceived duration of that stimulus, a phenomenon known as (temporal) interference effects. This complicates studying the neurobiological foundation of the perception of time, as any signatures of temporal processing are tainted by interfering dimensions. In earlier work, in which judgements on either time or numerosity were made while EEG was recorded, we used Maximum Likelihood Estimation (MLE) to estimate, for each participant separately, the influence of temporal and numerical information on making duration or numerosity judgements. We found large individual differences in the estimated magnitudes, but ML-estimates allowed us to partial out interference effects. However, for such analyses, it is essential that estimates are meaningful and stable. Therefore, in the current study, we examined the reliability of the MLE procedure by comparing the interference magnitudes estimated in two sessions, spread a week apart. In addition to the standard paradigm, we also presented task variants in which the interfering dimension was manipulated, to assess which aspects of the numerosity dimension exert the largest influence on temporal processing. The results indicate that individual interference magnitudes are stable, both between sessions and over tasks. Further, the ML-estimates of the time-numerosity judgement tasks were predictive of performance in a standard temporal judgement task. Thus, how much temporal information participants use in time estimations tasks seems to be a stable trait that can be captured with the MLE procedure. ML-estimates are, however, not predictive of performance in other interference-tasks, here operationalized by a numerical Stroop task. Taken together, the MLE procedure is a reliable tool to quantify individual differences in magnitude interference effects and can therefore reliably inform the analysis of neuroimaging data when contrasts are needed between the accumulation of a temporal and an interfering dimension.	[Schlichting, Nadine; de Jong, Ritske; van Rijn, Hedderik] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Schlichting, Nadine; de Jong, Ritske; van Rijn, Hedderik] Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen	Schlichting, N (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.; Schlichting, N (corresponding author), Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands.	n.schlichting@rug.nl	van Rijn, Hedderik/L-3685-2014	van Rijn, Hedderik/0000-0002-0461-9850; Schlichting, Nadine/0000-0001-6068-9573	EU Horizon 2020 FET Proactive grant TIMESTORM - Mind and Time: Investigation of the Temporal Traits of Human-Machine Convergence [641100]; research programme "Interval Timing in the Real World: A functional, computational and neuroscience approach" - Netherlands Organisation for Scientific Research (NWO) [453-16-005]	EU Horizon 2020 FET Proactive grant TIMESTORM - Mind and Time: Investigation of the Temporal Traits of Human-Machine Convergence; research programme "Interval Timing in the Real World: A functional, computational and neuroscience approach" - Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work has partially been supported by the EU Horizon 2020 FET Proactive grant TIMESTORM - Mind and Time: Investigation of the Temporal Traits of Human-Machine Convergence (grant no. 641100) and by the research programme "Interval Timing in the Real World: A functional, computational and neuroscience approach" with project number 453-16-005, awarded to Hedderik van Rijn, financed by the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bueti D, 2011, NEUROIMAGE, V57, P1251, DOI 10.1016/j.neuroimage.2011.05.014; Buneo CA, 2012, J NEUROPHYSIOL, V108, P187, DOI 10.1152/jn.00137.2011; Buneo CA, 2011, J NEUROSCI METH, V197, P109, DOI 10.1016/j.jneumeth.2011.02.008; Cai ZG, 2017, PREPRINT; Cai ZGG, 2016, ACTA PSYCHOL, V168, P1, DOI 10.1016/j.actpsy.2016.04.003; Cai ZGG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083159; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chang AYC, 2011, PSYCHOL SCI, V22, P1567, DOI 10.1177/0956797611418837; Charles EP, 2005, PSYCHOL METHODS, V10, P206, DOI 10.1037/1082-989X.10.2.206; Coull JT, 2015, J COGNITIVE NEUROSCI, V27, P2281, DOI 10.1162/jocn_a_00854; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Grabot L, 2017, PSYCHOL SCI, V28, P670, DOI 10.1177/0956797616689369; Green SB, 2016, PSYCHON B REV, V23, P750, DOI 10.3758/s13423-015-0968-3; HANSON B, 1992, ANN ASSOC AM GEOGR, V82, P103, DOI 10.1111/j.1467-8306.1992.tb01900.x; Hayashi MJ, 2013, NEUROSCI LETT, V543, P7, DOI 10.1016/j.neulet.2013.02.054; Hayashi MJ, 2013, J NEUROSCI, V33, P883, DOI 10.1523/JNEUROSCI.6257-11.2013; Hedge C, 2018, BEHAV RES METHODS, V50, P1166, DOI 10.3758/s13428-017-0935-1; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Jensen A.R., 1998, G FACTOR SCI MENTAL; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Lambrechts A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082122; Leibovich T, 2016, BEHAV BRAIN SCI, V8; Martin B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00680-0; Martinez-Loredo V, 2017, J ADOLESCENCE, V58, P33, DOI 10.1016/j.adolescence.2017.05.003; Matthews WJ, 2016, PSYCHOL BULL, V142, P865, DOI 10.1037/bul0000045; Miller J, 2013, PSYCHON B REV, V20, P819, DOI 10.3758/s13423-013-0404-5; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Paap KR, 2016, J NEUROSCI METH, V274, P81, DOI 10.1016/j.jneumeth.2016.10.002; Petzschner FH, 2015, TRENDS COGN SCI, V19, P285, DOI 10.1016/j.tics.2015.03.002; Schlichting N, PSYCHOL RES; Siegrist M, 1997, J PSYCHOL, V131, P299, DOI 10.1080/00223989709603516; Strauss GP, 2005, ASSESSMENT, V12, P330, DOI 10.1177/1073191105276375; van Maanen L, 2009, PSYCHON B REV, V16, P987, DOI 10.3758/PBR.16.6.987; Volet SD, 2008, Q J EXP PSYCHOL, V61, P1827, DOI 10.1080/17470210701743643; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2014, OXFORD HDB NUMERICAL, P553; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202345	10.1371/journal.pone.0202345	http://dx.doi.org/10.1371/journal.pone.0202345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ4SC	30107001	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800042
J	Hussain, M; Iqbal, MA; Till, BJ; Mehboob-ur-Rahman				Hussain, Momina; Iqbal, Muhammad Atif; Till, Bradley J.; Mehboob-ur-Rahman			Identification of induced mutations in hexaploid wheat genome using exome capture assay	PLOS ONE			English	Article							MUTANT POPULATION; POLYMORPHISM; RESISTANCE; EFFICIENCY; TOLERANCE; DISCOVERY; RESOURCE; MARKERS; STRESS; FAMILY	Wheat is a staple food crop of many countries. Improving resilience to biotic and abiotic stresses remain key breeding targets. Among these, rust diseases are the most detrimental in terms of depressing wheat production. In the present study, chemical mutagenesis was used to induce mutations in the wheat variety NN-Gandum-1. This cultivar is moderately resistant to leaf and yellow rust. The aim of mutagenesis was to improve resistance to the disease as well as to study function of genes conferring resistance to the disease. In the present investigation, a 0.8% EMS dose was found optimum for supporting 45-55% germination of NN-Gandum-1. A total of 3,634 M2 fertile plants were produced from each of the M-1 plant. Out of these, 33 (0.91%) and 20 plants (0.55%) showed absolute resistance to leaf and yellow rust, respectively. While 126 (3.46%) and 127 plants (3.49%) exhibited high susceptibility to the leaf and yellow rust, respectively. In the M-4 generation, a total of 11 M-4 lines (nine absolute resistant and two highly susceptible) and one wild type were selected for NGS-based exome capture assay. A total of 104,779 SNPs were identified that were randomly distributed throughout the wheat sub genomes (A, B and D). Induced mutations in intronic sequences predominated. The highest total number of SNPs detected in this assay were mapped to chr.2B (14,273 SNPs), which contains the highest number of targeted base pairs in the assay. The average mutation density across all regions interrogated was estimated to be one mutation per 20.91 Mb. The highest mutation frequency was found in chr.2D (1/11.7 kb) and the lowest in chr.7D (1/353.4 kb). Out of the detected mutations, 101 SNPs were filtered using analysis criteria aimed to enrich for mutations that may affect gene function. Out of these, one putative SNP detected in Lr21 were selected for further analysis. The SNP identified in chimeric allele (Lr21) of a resistant mutant (N1-252) was located in a NBS domain of chr.1BS at 3.4 Mb position. Through computational analysis, it was demonstrated that this identified SNP causes a substitution of glutamic acid with alanine, resulting in a predicted altered protein structure. This mutation, therefore, is a candidate for contributing to the resistance phenotype in the mutant line. Based on this work, we conclude that the wheat mutant resource developed is useful as a source of novel genetic variation for forward-genetic screens and also as a useful tool for gaining insights into the important biological circuits of different traits of complex genomes like wheat.	[Hussain, Momina; Iqbal, Muhammad Atif; Mehboob-ur-Rahman] NIBGE, Plant Genom & Mol Breeding Lab, Faisalabad, Pakistan; [Hussain, Momina; Iqbal, Muhammad Atif; Mehboob-ur-Rahman] Pakistan Inst Engn & Appl Sci, Dept Biotechnol, Islamabad, Pakistan; [Till, Bradley J.] Univ Vienna, Dept Chromosomenbiol, Vienna, Austria	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; University of Vienna	Mehboob-ur-Rahman (corresponding author), NIBGE, Plant Genom & Mol Breeding Lab, Faisalabad, Pakistan.; Mehboob-ur-Rahman (corresponding author), Pakistan Inst Engn & Appl Sci, Dept Biotechnol, Islamabad, Pakistan.	mehboob_phd@yahoo.com		Rahman, Mehboob-ur-/0000-0001-7237-2274; Till, Bradley/0000-0002-1300-8285	International Atomic Energy Agency; Higher Education Commission of Pakistan; International Atomic Energy Commission (IAEA), Vienna, Austria [PAK/5/047]; Higher Education Commission (HEC), Islamabad Pakistan	International Atomic Energy Agency(International Atomic Energy Agency); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); International Atomic Energy Commission (IAEA), Vienna, Austria; Higher Education Commission (HEC), Islamabad Pakistan(Higher Education Commission of Pakistan)	This work was supported by the International Atomic Energy Agency and Higher Education Commission of Pakistan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funds for the development of mutant wheat populations were provided by the International Atomic Energy Commission (IAEA), Vienna, Austria through an umbrella project entitled "Developing Germplasm through TILLING in Crop Plants Using Mutation and Genomic Approaches (PAK/5/047). We are also thankful to Dr Cristobal Uauy, Project Leader Crop Genetics, John Innes Centre, Norwich Research Park, UK for extending cooperation in providing lab facility for undertaking exome capture assay and analysis sequencing reads for the identification of SNPs. Funds for this, were provided by the Higher Education Commission (HEC), Islamabad Pakistan. This study is a part of PhD thesis research work of Ms. Momina Hussain under supervision of Dr. Mehboob-ur-Rahman, principal scientist at NIBGE Faisalabad Pakistan.	Ali Y., 2017, ADV ZOOL BOT, V5, P11, DOI [10.13189/a2b.2017.050201, DOI 10.13189/A2B.2017.050201, 10.13189/azb.2017.050201, DOI 10.13189/AZB.2017.050201]; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Arora S, 2018, BIORXIV, DOI [10.1101/248146, DOI 10.1101/248146]; Avni R, 2014, PLANTA, V239, P313, DOI 10.1007/s00425-013-1977-y; Banjare C., 2017, INDUCTION MUTATION P; Begum T, 2010, GENET MOL BIOL, V33, P761, DOI 10.1590/S1415-47572010005000090; Bolon YT, 2011, PLANT PHYSIOL, V156, P240, DOI 10.1104/pp.110.170811; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Dasgupta MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116528; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2004, GENETICS, V168, P1665, DOI 10.1534/genetics.103.024927; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Fu YB, 2010, THEOR APPL GENET, V121, P271, DOI 10.1007/s00122-010-1308-7; Genest O, 2015, J MOL BIOL, V427, P3877, DOI 10.1016/j.jmb.2015.10.010; Greene EA, 2003, GENETICS, V164, P731; Hamilton JP, 2012, PLANT J, V70, P177, DOI 10.1111/j.1365-313X.2012.04894.x; Hazard B, 2012, CROP SCI, V52, P1754, DOI 10.2135/cropsci2012.02.0126; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Huang L, 2003, GENETICS, V164, P655; Jacob P, 2017, PLANT BIOTECHNOL J, V15, P405, DOI 10.1111/pbi.12659; Jiao Y, 2016, PLANT CELL ONLINE, V2016, DOI [10.1007/978-1-4939-7315-6_5, DOI 10.1007/978-1-4939-7315-6_5]; Khan SA, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2003-8; King R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137549; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Kumar APK, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-38; Laskar R. A., 2015, Journal of Agronomy, V14, P102, DOI 10.3923/ja.2015.102.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Loegering W. Q., 1959, METHODS RECORDING CE; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Malik S, 2015, J ANIM PLANT SCI-PAK, V25, P1032; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mehboob-Ur-Rahman, 2004, PAK J BOT, V36, P595; Mishra A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0896-z; Mo YJ, 2018, MOL GENET GENOMICS, V293, P463, DOI 10.1007/s00438-017-1401-6; Mukhtar MS, 2002, EUPHYTICA, V128, P417, DOI 10.1023/A:1021261811454; Muraya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132120; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Petre B, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00005, DOI 10.3389/FPLS.2014.00005]; Rakszegi M, 2010, EUPHYTICA, V174, P409, DOI 10.1007/s10681-010-0149-4; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Rimbert H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186329; Sabetta W, 2011, PLANT METHODS, V7, P1, DOI [10.1186/1746-4811-7-1, DOI 10.1186/1746-4811-7-1]; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Sestili F, 2010, MOL BREEDING, V25, P145, DOI 10.1007/s11032-009-9314-7; Shafeeq S, 2006, PAK J BOT; Sharma M, 2014, DNA RES, V21, P267, DOI 10.1093/dnares/dst056; Shaw TM, 2008, PAK J BOT, V40, P605; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Spannagl M, 2016, NUCLEIC ACIDS RES, V44, pD1141, DOI 10.1093/nar/gkv1130; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Szurman-Zubrzycka ME, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00216; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Tsai H, 2013, PLANT PHYSIOL, V161, P1604, DOI 10.1104/pp.112.213256; Uauy C, 2017, ANNU REV GENET, DOI [10.1146/annurev-genet-120116-02453314, DOI 10.1146/ANNUREV-GENET-120116-02453314]; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weising K., 1994, DNA FINGERPRINTING P; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xia C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15407; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Yang RC, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4381-3; Zhou LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-703	73	28	29	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201918	10.1371/journal.pone.0201918	http://dx.doi.org/10.1371/journal.pone.0201918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102729	Green Submitted, Green Published			2022-12-26	WOS:000441452200021
J	Komyakova, V; Jones, GP; Monday, PL				Komyakova, Valeriya; Jones, Geoffrey P.; Monday, Philip L.			Strong effects of coral species on the diversity and structure of reef fish communities: A multi-scale analysis	PLOS ONE			English	Article							HABITAT COMPLEXITY; SPECIALIZATION; FRAGMENTATION; INVERTEBRATES; BIODIVERSITY; ASSEMBLAGES; COMPETITION; PREDATION; ABUNDANCE; SCALES	While there is increasing evidence for habitat specialization in coral reef fishes, the extent to which different corals support different fish communities is not well understood. Here we quantitatively assess the relative importance of different coral species in structuring fish communities and evaluate whether sampling scale and coral colony size affect the perceived strength of fish-habitat relationships. Fish communities present on colonies of eight coral species (Porites cylindrica, Echinopora horrida, Hydnophora rigida, Stylophora pistillata, Seriatopora hystrix, Acropora formosa, A. tenuis and A. millepora) were examined in the Lizard Island lagoon, Great Barrier Reef, Australia. Additionally, the differences in fish communities supported by three coral species (P. cylindrica, E. horrida, H. rigida) were investigated at three spatial scales of sampling (2x2 m, 1x1 m, 0.5x0.5 m). Substantial differences in fish communities were observed across the different coral species, with E. horrida and H. rigida supporting the most fish species and individuals. Coral species explained more of the variability in fish species richness (20.9-53.6%), than in fish abundance (015%). Most coral species supported distinctive fish communities, with dissimilarities ranging from 50 to 90%. For three focal coral species, a greater amount of total variation in fish species richness and fish abundance was evident at a larger scale of sampling. Together, these results indicate that the structure of reef fish communities is finely tuned to coral species. Loss of preferred coral species could have profound effects on reef fish biodiversity, potentially more so than would be predicted on the basis of declining coral cover alone.	[Komyakova, Valeriya; Jones, Geoffrey P.; Monday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Komyakova, Valeriya; Jones, Geoffrey P.; Monday, Philip L.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Komyakova, Valeriya] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Komyakova, Valeriya] Inst Marine Res, Pelag Grp, Bergen, Norway	James Cook University; James Cook University; University of Melbourne; Institute of Marine Research - Norway	Komyakova, V (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.; Komyakova, V (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Komyakova, V (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.; Komyakova, V (corresponding author), Inst Marine Res, Pelag Grp, Bergen, Norway.	Valeriya.Komyakova@gmail.com	Komyakova, Valeriya/H-4632-2013; Jones, Geoffrey P./E-9306-2010	Komyakova, Valeriya/0000-0003-3755-1546; Jones, Geoffrey P./0000-0002-6244-1245	Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561342]; ARC Centre of Excellence for Coral Reef Studies	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies (CE0561342) (www.coralcoe.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the assistance in the field provide by K. Markey, A. Downing, O. O'shea and C. Johansson. We also thank Dr. M. Sheaves for his invaluable help with statistical analysis. The manuscript was improved by comments from J. Dawson, Dr. A. Hoey, Dr. K. Dafforn, Dr. A. McKinley and Dr. J. Jaffres. Financial support was provided by the ARC Centre of Excellence for Coral Reef Studies.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrew NL, OCEANOGR MAR BIOL AN, V25, P39; Araujo APA, 2006, AUSTRAL ECOL, V31, P343, DOI 10.1111/j.1442-9993.2006.01563.x; Ault TR, 1998, OIKOS, V82, P354, DOI 10.2307/3546976; Bell SS, 1991, POPULATION BIOL SERI; Bonin MC, 2012, CORAL REEFS, V31, P287, DOI 10.1007/s00338-011-0843-2; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Clarke KR, 2006, PRIMER V 6 USER MANU; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Curtis JMR, 2005, MAR ECOL PROG SER, V291, P81, DOI 10.3354/meps291081; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P249, DOI 10.1016/0022-0981(87)90057-8; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Hewitt JE, 1998, J EXP MAR BIOL ECOL, V227, P251, DOI 10.1016/S0022-0981(97)00274-8; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P181, DOI 10.1071/MF01137; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jaxion-Harm J, 2012, J EXP MAR BIOL ECOL, V414, P19, DOI 10.1016/j.jembe.2012.01.007; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kokita T, 2001, CORAL REEFS, V20, P155, DOI 10.1007/s003380100153; Komyakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083178; KUWAMURA T, 1994, MAR ECOL PROG SER, V103, P17, DOI 10.3354/meps103017; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MacGregor-Fors I, 2008, LANDSCAPE URBAN PLAN, V84, P92, DOI 10.1016/j.landurbplan.2007.06.010; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Munday PL, 2001, OECOLOGIA, V128, P585, DOI 10.1007/s004420100690; Philpott SM, 2012, AGR ECOSYST ENVIRON, V149, P171, DOI 10.1016/j.agee.2011.02.015; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sale PF, 1998, AUST J ECOL, V23, P202, DOI 10.1111/j.1442-9993.1998.tb00721.x; SALE PF, 1984, ECOLOGY, V65, P409, DOI 10.2307/1941404; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; SYMS C, 1995, MAR ECOL PROG SER, V125, P31, DOI 10.3354/meps125031; Thompson VJ, 2007, CORAL REEFS, V26, P165, DOI 10.1007/s00338-006-0181-y; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	49	29	30	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202206	10.1371/journal.pone.0202206	http://dx.doi.org/10.1371/journal.pone.0202206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102715	gold, Green Published, Green Accepted			2022-12-26	WOS:000441452200036
J	van der Heiden, RMA; Janssen, CP; Donker, SF; Hardeman, LES; Mans, K; Kenemans, JL				van der Heiden, Remo M. A.; Janssen, Christian P.; Donker, Stella F.; Hardeman, Lotte E. S.; Mans, Keri; Kenemans, J. Leon			Susceptibility to audio signals during autonomous driving	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PERCEPTUAL LOAD; NOVELTY; PERFORMANCE; ATTENTION; P3A	We investigate how susceptible human drivers are to auditory signals in three situations: when stationary, when driving, or when being driven by an autonomous vehicle. Previous research has shown that human susceptibility is reduced when driving compared to when being stationary. However, it is not known how susceptible humans are under autonomous driving conditions. At the same time, good susceptibility is crucial under autonomous driving conditions, as such systems might use auditory signals to communicate a transition of control from the automated vehicle to the human driver. We measured susceptibility using a three-stimulus auditory oddball paradigm while participants experienced three driving conditions: stationary, autonomous, or driving. We studied susceptibility through the frontal P3 (fP3) Electroencephalography Event-Related Potential response (EEG ERP response). Results show that the fP3 component is reduced in autonomous compared to stationary conditions, but not as strongly as when participants drove themselves. In addition, the fP3 component is further reduced when the oddball task does not require a response (i.e., in a passive condition, versus active). The implication is that, even in a relatively simple autonomous driving scenario, people's susceptibility of auditory signals is not as high as would be beneficial for responding to auditory stimuli.	[Donker, Stella F.] Univ Utrecht, Expt Psychol, Utrecht, Netherlands; Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Utrecht University; Utrecht University	Donker, SF (corresponding author), Univ Utrecht, Expt Psychol, Utrecht, Netherlands.	c.p.janssen@uu.nl		Janssen, Christian/0000-0002-9849-404X; Hardeman, Lotte/0000-0001-9963-8087	Dutch Traffic Authority (Rijkswaterstaat); Marie Sklodowska-Curie fellowship of the European Commission (H2020-MSCA-IF-2015) [705010]	Dutch Traffic Authority (Rijkswaterstaat); Marie Sklodowska-Curie fellowship of the European Commission (H2020-MSCA-IF-2015)	Remo van der Heiden was supported by the Dutch Traffic Authority (Rijkswaterstaat). Christian Janssen was supported by a Marie Sklodowska-Curie fellowship of the European Commission (H2020-MSCA-IF-2015, grant agreement no. 705010, 'Detect and React'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Bliss JP, 2003, APPL ERGON, V34, P499, DOI 10.1016/j.apergo.2003.07.003; de Winter JCF, 2014, TRANSPORT RES F-TRAF, V27, P196, DOI 10.1016/j.trf.2014.06.016; DEWAARD D, 1991, ACCIDENT ANAL PREV, V23, P297, DOI 10.1016/0001-4575(91)90007-R; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; Dingus TA, 2016, P NATL ACAD SCI USA, V113, P2636, DOI 10.1073/pnas.1513271113; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; HART S G, 1988, P139; Heitland I, 2013, BEHAV BRAIN RES, V249, P55, DOI 10.1016/j.bbr.2013.04.013; Hu XS, 2017, IEEE T IND ELECTRON, V64, P8578, DOI 10.1109/TIE.2017.2703673; Janssen CP, 2015, INT J HUM-COMPUT ST, V79, P1, DOI 10.1016/j.ijhcs.2015.03.002; Janssen CP, 2018, INT J HUMAN COMPUTER; JASP Team, 2018, JASP VERS 0 8 6 COMP; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kenemans JL, 2015, NEUROSCI BIOBEHAV R, V56, P115, DOI 10.1016/j.neubiorev.2015.06.011; Khushaba RN, 2011, IEEE T BIO-MED ENG, V58, P121, DOI 10.1109/TBME.2010.2077291; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Klauer SG, 2014, NEW ENGL J MED, V370, P54, DOI 10.1056/NEJMsa1204142; Kun Andrew L., 2018, Foundations and Trends in Human-Computer Interaction, V11, P201, DOI 10.1561/1100000069; Kun AL, 2016, IEEE PERVAS COMPUT, V15, P32, DOI 10.1109/MPRV.2016.14; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lee M.D., 2013, BAYESIAN COGNITIVE M; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Massar SA, 2010, PSYCHOPHYSIOLOGY, V47, P1119, DOI 10.1111/j.1469-8986.2010.01028.x; Math R., 2012, P INT C AUTOMOTIVE U, P7; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI DOI 10.1007/978-1-4613-2173-6_19; Murphy S, 2017, HEARING RES, V352, P40, DOI 10.1016/j.heares.2017.02.005; Nees M.A., 2011, REV HUM FACTORS ERGO, V7, P58, DOI [10.1177/1557234X11410396, DOI 10.1177/1557234X11410396]; Parasuraman R, 1997, HUM FACTORS, V39, P230, DOI 10.1518/001872097778543886; Parasuraman R, 2000, IEEE T SYST MAN CY A, V30, P286, DOI 10.1109/3468.844354; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Politis I, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P4067, DOI 10.1145/2556288.2556988; SAE International, 2014, J3016 TAX DEF TERMS; Scheer M, 2016, FRONT HUM NEUROSCI, V10, P211; Schmidt EA, 2009, ACCIDENT ANAL PREV, V41, P1087, DOI 10.1016/j.aap.2009.06.007; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; SORKIN RD, 1988, HUM FACTORS, V30, P445, DOI 10.1177/001872088803000406; van der Heiden RMA, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P392, DOI 10.1145/3025453.3025507; van der Heiden Remo MA, 2018, TRANSPORT RES F-TRAF, DOI [10.1016/j.trf.2018.02.024, DOI 10.1016/J.TRF.2018.02.024]; WERTHEIM AH, 1978, ACCIDENT ANAL PREV, V10, P111, DOI 10.1016/0001-4575(78)90019-2; Wessel JR, 2017, NEURON, V93, P259, DOI 10.1016/j.neuron.2016.12.013; Wester AE, 2008, ACCIDENT ANAL PREV, V40, P1, DOI 10.1016/j.aap.2007.02.014; Wester AE, 2009, THESIS; Wester AE, 2010, J PSYCHOPHARMACOL, V24, P1333, DOI 10.1177/0269881109348168; Young MS, 2002, THEOR ISSUES ERGON S, V3, P178, DOI DOI 10.1080/14639220210123789	48	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201963	10.1371/journal.pone.0201963	http://dx.doi.org/10.1371/journal.pone.0201963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ2CL	30102723	Green Published, Green Submitted, gold			2022-12-26	WOS:000441452200024
J	Rabearisoa, N; Sabarros, PS; Romanov, EV; Lucas, V; Bach, P				Rabearisoa, Njaratiana; Sabarros, Philippe S.; Romanov, Evgeny V.; Lucas, Vincent; Bach, Pascal			Toothed whale and shark depredation indicators: A case study from the Reunion Island and Seychelles pelagic longline fisheries	PLOS ONE			English	Article							DORSAL FIN DISFIGUREMENTS; SPERM-WHALES; MITIGATION DEVICE; MARINE MAMMALS; ATLANTIC-OCEAN; KILLER WHALES; BYCATCH; CETACEANS; SOUTHERN; WATERS	Depredation in marine ecosystems is defined as the damage or removal of fish or bait from fishing gear by predators. Depredation raises concerns about the conservation of species involved, fisheries yield and profitability, and reference points based on stock assessment of depredated species. Therefore, the development of accurate indicators to assess the impact of depredation is needed. Both the Reunion Island and the Seychelles archipelago pelagic longline fisheries targeting swordfish (Xiphias gladius) and tuna (Thunnus spp.) are affected by depredation from toothed whales and pelagic sharks. In this study, we used fishery data collected between 2004 and 2015 to propose depredation indicators and to assess depredation levels in both fisheries. For both fisheries, the interaction rate (depredation occurrence) was significantly higher for shark compared to toothed whale depredation. However, when depredation occurred, toothed whale depredation impact was significantly higher than shark depredation impact, with higher depredation per unit effort (number of fish depredated per 1000 hooks) and damage rate (proportion of fish depredated per depredated set). The gross depredation rate in the Seychelles was 18.3%. A slight increase of the gross depredation rate was observed for the Reunion Island longline fleet from 2011 (4.1% in 2007-2010 and 4.4% in 2011-2015). Economic losses due to depredation were estimated by using these indicators and published official statistics. A loss of 0.09 EUR/hook due to depredation was estimated for the Reunion Island longline fleet, and 0.86 EUR/hook for the Seychelles. These results suggest a southward decreasing toothed whale and shark depredation gradient in the southwest Indian Ocean. Seychelles depredation levels are among the highest observed in the world revealing this area as a "hotspot" of interaction between pelagic longline fisheries and toothed whales. This study also highlights the need for a set of depredation indicators to allow for a global comparison of depredation rates among various fishing grounds worldwide.	[Rabearisoa, Njaratiana] Univ Montpellier, CNRS, Inst Francais Rech Exploitat Mer, Inst Rech Dev,Marine Biodivers Exploitat & Conser, St Denis, Ile De La Reuni, France; [Rabearisoa, Njaratiana; Sabarros, Philippe S.; Bach, Pascal] Univ Montpellier, CNRS, Inst Francais Rech Exploitat Mer, Inst Rech Dev,Marine Biodivers Exploitat & Conser, Sete, France; [Rabearisoa, Njaratiana; Romanov, Evgeny V.] Ctr Tech Appui Peche ReUNionnaise CAP RUN, Le Port, Ile De La Reuni, France; [Lucas, Vincent; Bach, Pascal] Seychelles Fishing Author, Victoria, Mahe, Seychelles	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Rabearisoa, N (corresponding author), Univ Montpellier, CNRS, Inst Francais Rech Exploitat Mer, Inst Rech Dev,Marine Biodivers Exploitat & Conser, St Denis, Ile De La Reuni, France.; Rabearisoa, N (corresponding author), Univ Montpellier, CNRS, Inst Francais Rech Exploitat Mer, Inst Rech Dev,Marine Biodivers Exploitat & Conser, Sete, France.; Rabearisoa, N (corresponding author), Ctr Tech Appui Peche ReUNionnaise CAP RUN, Le Port, Ile De La Reuni, France.	njaratiana.rabearisoa@ird.fr	Bach, Pascal/E-9370-2013; Sabarros, Philippe S./AAS-1921-2021; Fennell, Hannah/AAI-1408-2019	Bach, Pascal/0000-0003-0804-8466; Sabarros, Philippe S./0000-0001-6135-9015; Rabearisoa, Njaratiana/0000-0002-1149-5657	"Observatoire des Ecosystemes Pelagiques Tropicaux exploites, Ob7" of IRD (UMR MARine Biodiversity, Exploitation and Conservation, Sete); European Union Data Collection Program; Fonds Europeen pour le Developpement Economique et Regional, FEDER	"Observatoire des Ecosystemes Pelagiques Tropicaux exploites, Ob7" of IRD (UMR MARine Biodiversity, Exploitation and Conservation, Sete); European Union Data Collection Program; Fonds Europeen pour le Developpement Economique et Regional, FEDER	This study was achieved with the financial support of both the "Observatoire des Ecosystemes Pelagiques Tropicaux exploites, Ob7" of IRD (UMR MARine Biodiversity, Exploitation and Conservation, Sete) and the European Union Data Collection Program as well as a grant funded by the "Fonds Europeen pour le Developpement Economique et Regional, FEDER" allocated by Reunion Island Council (DEVIER project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, JACKKNIFE BOOTSTRAP; Ariz J, 2007, WORKSH DEPR TUN LONG; Ashford JR, 1996, MAR MAMMAL SCI, V12, P452, DOI 10.1111/j.1748-7692.1996.tb00598.x; Bach P, 2011, IOTC2011WPB09; Bach P, 2008, IOTC2008WPEBWP13; Bach P, 2013, SELF REPORTING DATA, P12; Bach P, 2013, PROTECTIVE DEVICE PR; Baird RW, 2005, PAC SCI, V59, P593, DOI 10.1353/psc.2005.0042; Bargain R-M, 2000, WPB0005; Beddington J, 2005, PHILOS T R SOC B, V360, P3, DOI 10.1098/rstb.2004.1600; Bourjea J, 2009, IOTC2009WPB07; Cauquil P, 2015, IOTC2015WPB1329; Chapman L., 2006, MARINE SPECIES IDENT, Vxi; Clapham PJ, 2003, BIOSCIENCE, V53, P210, DOI 10.1641/0006-3568(2003)053[0210:WAS]2.0.CO;2; Clark JM, 2007, WORKSH DEPR TUN LONG; Dai X-J, 2007, WORKSH DEPR TUN LONG; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; de Fries A, 2007, WORKSH DEPR TUN LONG; Donoghue M, 2002, NEW ENGLAND AQUATIC; Dorizo J, 2006, IOTC2006WPTT30; Dorizo J, 2008, IOTC2008WPB16; Etienne M-P, 2010, ARXIV10050892; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Forney KA, 2007, NMFSSWFSC412 NOAA US, P30; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Gamblin C, 2006, IOTC2006SCINF04; Garrison LP, 2007, FISH B-NOAA, V105, P408; Gilland B, 2002, FOOD POLICY, V27, P47, DOI 10.1016/S0306-9192(02)00002-7; Gilman E, 2007, SHARK DEPREDATION UN; Gilman Eric, 2006, Journal of Cetacean Research and Management, V8, P215; Goetz S, 2011, ICES J MAR SCI, V68, P228, DOI 10.1093/icesjms/fsq161; Guinet C, 2015, ICES J MAR SCI, V72, P1587, DOI 10.1093/icesjms/fsu221; Hall MA, 1996, REV FISH BIOL FISHER, V6, P319, DOI 10.1007/BF00122585; Hamer DJ, 2015, ICES J MAR SCI, V72, P1691, DOI 10.1093/icesjms/fsv013; Hernandez-Milian G, 2008, HYDROBIOLOGIA, V612, P251, DOI 10.1007/s10750-008-9501-2; Hirayama N., 1976, J TOKYO U FISH, V62, P125; Hucke-Gaete R, 2004, CCAMLR SCI, V11, P127; IOTC, 2016, IOTC2016WPB14DATA09; IOTC, 2007, WORKSH DEPR TUN LONG; Jefferson TA, 1996, OCEAN COAST MANAGE, V31, P41, DOI 10.1016/0964-5691(95)00049-6; Kiszka Jeremy, 2008, Western Indian Ocean Journal of Marine Science, V7, P185; Kock KH, 2006, POLAR BIOL, V29, P379, DOI 10.1007/s00300-005-0067-4; Kumar KVA, 2016, REV FISH SCI AQUAC, V24, P295, DOI 10.1080/23308249.2016.1162134; Lawson T., 2001, 14 M STAND COMM TUN; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lucas V, 2006, IOTC2006WPB05; MacNeil MA, 2009, ICES J MAR SCI, V66, P708, DOI 10.1093/icesjms/fsp022; Monteiro D, 2006, DEPREDACAO ORCAS LUB, P27; Munoz-Lechuga R, 2016, IOTC2016WPEB1235; Nishida T, 1954, WPTT0117, P442; Nishida T, 2000, WPTT0310, P75; Northridge S.P., 1991, UPDATED WORLD REV IN; Northridge Simon P., 1999, P99; Oleson EM, 2010, NOAATMNMFSPIFSC22 US, P140; Passadore C, 2015, ICES J MAR SCI, V72, P1637, DOI 10.1093/icesjms/fsu250; Peterson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088906; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Poisson F, 2001, ESPADON RECHERCHE EX, P231; Rabearisoa N., 2013, THESIS; Rabearisoa N, 2015, ICES J MAR SCI, V72, P1682, DOI 10.1093/icesjms/fsu252; Rabearisoa N, 2012, J EXP MAR BIOL ECOL, V432, P55, DOI 10.1016/j.jembe.2012.07.004; Ramos-Cartelle A., 2007, ICCAT COLLECT VOL SC, V62, P1721; Reeves RR, 2002, MAMMAL REV, V32, P71, DOI 10.1046/j.1365-2907.2002.00100.x; Romanov E, 2009, IOTC2009WPEBINF02; Romanov E. V., 2013, IOTC2013WPEB0947; Romanov EV, 2007, WORKSH DEPR TUN LONG; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; Silva MA, 2011, AQUAT CONSERV, V21, P17, DOI 10.1002/aqc.1158; Sivasubramaniam K., 1964, Bulletin of the Fisheries Research Station Ceylon, V17, P221; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Thode A, 2016, J ACOUST SOC AM, V140, P3941, DOI 10.1121/1.4966625; Tixier P, 2010, CCAMLR SCI, V17, P179; Tixier P, 2015, ICES J MAR SCI, V72, P1673, DOI 10.1093/icesjms/fsu166; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; Van Canneyt O, 2010, CAMPAGNE REMMOA OCEA, P74; Varghese S, 2007, WORKSH DEPR TUN LONG; Werner TB, 2015, ICES J MAR SCI, V72, P1576, DOI 10.1093/icesjms/fsv092	77	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202037	10.1371/journal.pone.0202037	http://dx.doi.org/10.1371/journal.pone.0202037			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096170	Green Published, gold			2022-12-26	WOS:000441308500042
J	Blazej, P; Wnetrzak, M; Mackiewicz, D; Mackiewicz, P				Blazej, Pawel; Wnetrzak, Malgorzata; Mackiewicz, Dorota; Mackiewicz, Pawel			Optimization of the standard genetic code according to three codon positions using an evolutionary algorithm	PLOS ONE			English	Article							ERROR MINIMIZATION; COEVOLUTION THEORY; AMINO-ACIDS; PHYSICOCHEMICAL THEORIES; FUNDAMENTAL NATURE; NEUTRAL EMERGENCE; PROTEIN-SYNTHESIS; BASE-PAIR; ORIGIN; HYPOTHESIS	Many biological systems are typically examined from the point of view of adaptation to certain conditions or requirements. One such system is the standard genetic code (SGC), which generally minimizes the cost of amino acid replacements resulting from mutations or mistranslations. However, no full consensus has been reached on the factors that caused the evolution of this feature. One of the hypotheses suggests that code optimality was directly selected as an advantage to preserve information about encoded proteins. An important feature that should be considered when studying the SGC is the different roles of the three codon positions. Therefore, we investigated the robustness of this code regarding the cost of amino acid replacements resulting from substitutions in these positions separately and the sum of these costs. We applied a modified evolutionary algorithm and included four models of the genetic code assuming various restrictions on its structure. The SGC was compared both with the codes that minimize the objective function and those that maximize it. This approach allowed us to place the SGC in the global space of possible codes, which is a more appropriate and unbiased comparison than that with randomly generated codes because they are characterized by relatively uniform amino acid assignments to codons. The SGC appeared to be well optimized at the global scale, but its individual positions were not fully optimized because there were codes that were optimized for only one codon position and simultaneously outperformed the SGC at the other positions. We also found that different code structures may lead to the same optimality and that random codes can show a tendency to minimize costs under some of the genetic code models. Our results suggest that the optimality of SGC could be a by-product of other processes.	[Blazej, Pawel; Wnetrzak, Malgorzata; Mackiewicz, Dorota; Mackiewicz, Pawel] Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland	University of Wroclaw	Mackiewicz, P (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland.	pamac@smorfland.uni.wroc.pl	Mackiewicz, Dorota/AAJ-8963-2020	Mackiewicz, Dorota/0000-0001-8922-8615; Wnetrzak, Malgorzata/0000-0003-3102-6863; Mackiewicz, Pawel/0000-0003-4855-497X; Blazej, Pawel/0000-0003-3610-2765	National Science Centre Poland (Narodowe Centrum Nauki, Polska) [2017/27/N/NZ2/00403]; Wroclaw Centre for Biotechnology programme "The Leading National Research Centre (KNOW) for years 2014-2018"	National Science Centre Poland (Narodowe Centrum Nauki, Polska); Wroclaw Centre for Biotechnology programme "The Leading National Research Centre (KNOW) for years 2014-2018"	This research was supported by the National Science Centre Poland (Narodowe Centrum Nauki, Polska) under Grant Preludium no. 2017/27/N/NZ2/00403 to M.W. and Wroclaw Centre for Biotechnology programme "The Leading National Research Centre (KNOW) for years 2014-2018" to P.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; ALFFSTEI.C, 1969, P NATL ACAD SCI USA, V64, P584, DOI 10.1073/pnas.64.2.584; Almlof M, 2007, BIOCHEMISTRY-US, V46, P200, DOI 10.1021/bi061713i; Amirnovin R, 1997, J MOL EVOL, V44, P473, DOI 10.1007/PL00006170; Andersson SGE, 1995, BIOCHEM CELL BIOL, V73, P775, DOI 10.1139/o95-086; ANDERSSON SGE, 1991, MOL BIOL EVOL, V8, P530; Ardell DH, 1998, J MOL EVOL, V47, P1, DOI 10.1007/PL00006356; Ardell DH, 2001, J MOL EVOL, V53, P269, DOI 10.1007/s002390010217; Blazej P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130411; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Davis BK, 2005, BIOESSAYS, V27, P1308, DOI 10.1002/bies.20332; de Oliveira LL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0480-9; Di Giulio M., 2004, Physics of Life Reviews, V1, P128, DOI 10.1016/j.plrev.2004.05.001; Di Giulio M, 1999, J MOL EVOL, V49, P1, DOI 10.1007/PL00006522; Di Giulio M, 1999, J MOL EVOL, V48, P253, DOI 10.1007/PL00006464; Di Giulio M, 2018, BIOSYSTEMS, V169, P1, DOI 10.1016/j.biosystems.2018.05.002; Di Giulio M, 2017, J THEOR BIOL, V414, P1, DOI 10.1016/j.jtbi.2016.11.014; Di Giulio M, 2016, J THEOR BIOL, V399, P134, DOI 10.1016/j.jtbi.2016.04.005; Di Giulio M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-37; DIGIULIO M, 1989, J MOL EVOL, V29, P288, DOI 10.1007/BF02103616; DiGiulio M, 1997, J THEOR BIOL, V187, P573, DOI 10.1006/jtbi.1996.0390; DUNNILL P, 1966, NATURE, V210, P1267, DOI 10.1038/2101267a0; EPSTEIN CJ, 1966, NATURE, V210, P25, DOI 10.1038/210025a0; Freeland SJ, 2000, MOL BIOL EVOL, V17, P511, DOI 10.1093/oxfordjournals.molbev.a026331; Freeland SJ, 2003, ORIGINS LIFE EVOL B, V33, P457, DOI 10.1023/A:1025771327614; Freeland SJ, 1998, P ROY SOC B-BIOL SCI, V265, P2111, DOI 10.1098/rspb.1998.0547; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Freeland SJ, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01531-5; FRIEDMAN SM, 1966, BIOCHIM BIOPHYS ACTA, V114, P593, DOI 10.1016/0005-2787(66)90107-9; Gilis D, 2001, GENOME BIOL, V2; GOLDBERG AL, 1966, SCIENCE, V153, P420, DOI 10.1126/science.153.3734.420; GOLDMAN N, 1993, J MOL EVOL, V37, P662; Goodarzi H, 2005, B MATH BIOL, V67, P1355, DOI 10.1016/j.bulm.2005.03.002; Grosjean Henri, 2007, Nucleic Acids Symp Ser (Oxf), P15; HAIG D, 1991, J MOL EVOL, V33, P412, DOI 10.1007/BF02103132; Higgs PG, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-16; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Judson OP, 1999, J MOL EVOL, V49, P539, DOI 10.1007/PL00006575; KHORANA HG, 1966, COLD SPRING HARB SYM, V31, P39, DOI 10.1101/SQB.1966.031.01.010; Koonin EV, 2017, ANNU REV GENET, V51, P45, DOI 10.1146/annurev-genet-120116-024713; Koonin EV, 2017, LIFE-BASEL, V7, DOI 10.3390/life7020022; Koonin EV, 2009, IUBMB LIFE, V61, P99, DOI 10.1002/iub.146; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kun A, 2018, BIOSYSTEMS, V164, P217, DOI 10.1016/j.biosystems.2017.10.006; Lehmann J, 2008, RNA, V14, P1264, DOI 10.1261/rna.1029808; Mackiewicz P, 2008, LECT NOTES COMPUT SC, V5103, P100, DOI 10.1007/978-3-540-69389-5_13; Massey SE, 2008, J MOL EVOL, V67, P510, DOI 10.1007/s00239-008-9167-4; Massey SE, 2006, J MOL EVOL, V62, P809, DOI 10.1007/s00239-005-0222-0; Massey SE, 2016, J THEOR BIOL, V408, P237, DOI 10.1016/j.jtbi.2016.08.022; Massey Steven E., 2015, Life-Basel, V5, P1301, DOI 10.3390/life5021301; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; NIRENBERG M, 1966, COLD SPRING HARB SYM, V31, P11, DOI 10.1101/SQB.1966.031.01.008; Novozhilov AS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-24; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; PELC SR, 1966, NATURE, V209, P868, DOI 10.1038/209868a0; R Core Team, 2017, R LANG ENV STAT COMP; Ronneberg TA, 2000, P NATL ACAD SCI USA, V97, P13690, DOI 10.1073/pnas.250403097; Roth A, 1998, P NATL ACAD SCI USA, V95, P6027, DOI 10.1073/pnas.95.11.6027; Santos J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1608-x; Santos J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-56; Santos J, 2010, J THEOR BIOL, V264, P854, DOI 10.1016/j.jtbi.2010.02.041; Schonauer S, 1997, COMP SCI BIOL P GERM, P65; Sella G, 2006, J MOL EVOL, V63, P297, DOI 10.1007/s00239-004-0176-7; Sivanandam S., 2008, INTRO GENETIC ALGORI, P15; SONNEBORN T. M., 1965, P377; Syswerda G., 1991, HDB GENETIC ALGORITH, P332; SZATHMARY E, 1993, P NATL ACAD SCI USA, V90, P9916, DOI 10.1073/pnas.90.21.9916; Szathmary E, 1999, TRENDS GENET, V15, P223, DOI 10.1016/S0168-9525(99)01730-8; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P1546, DOI 10.1073/pnas.54.6.1546; WOESE CR, 1968, P NATL ACAD SCI USA, V59, P110, DOI 10.1073/pnas.59.1.110; WOESE CR, 1973, NATURWISSENSCHAFTEN, V60, P447; WOESE CR, 1966, COLD SPRING HARB SYM, V31, P723, DOI 10.1101/SQB.1966.031.01.093; Wong J. Tze-Fei, 2016, Life-Basel, V6, P12, DOI 10.3390/life6010012; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Yarus M, 2005, ANNU REV BIOCHEM, V74, P179, DOI 10.1146/annurev.biochem.74.082803.133119; Yarus M, 2009, J MOL EVOL, V69, P406, DOI 10.1007/s00239-009-9270-1	77	28	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201715	10.1371/journal.pone.0201715	http://dx.doi.org/10.1371/journal.pone.0201715			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092017	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600048
J	Shimizu, K; Udagawa, D				Shimizu, Kazumi; Udagawa, Daisuke			Is human life worth peanuts? Risk attitude changes in accordance with varying stakes	PLOS ONE			English	Article							PROBABILISTIC REWARDS; GROUP-SIZE; CHOICE; REEXAMINATION; COOPERATION; PREFERENCE	Risk aversion is well-known as a general and robust characteristic of people's decision making: people are less likely to gamble when they are unsure if they will obtain the expected value of the bet made. The "peanuts effect' is, however, an exception to this general rule. The "peanuts effect," which states that people are more willing to gamble when playing for "peanuts" (a small outcome), has been stably observed in the context of a small monetary stake. We conducted two types of experiments to verify whether the peanuts effect still occurred when the type of stakes changed. We had two main findings. On the one hand, people tended to gamble more for a qualitatively smaller value when the stake was material in nature, meaning that the "peanuts effect' occurred with a qualitatively low stake. On the other hand, people were willing to take a risk for a qualitatively larger value when the stake was a human life: this is the opposite phenomenon of the "peanuts effect."	[Shimizu, Kazumi] Waseda Univ, Dept Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan; [Udagawa, Daisuke] Hannan Univ, Fac Econ, Osaka, Japan	Waseda University	Shimizu, K (corresponding author), Waseda Univ, Dept Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan.	skazumi1961@gmail.com		Shimizu, Kazumi/0000-0003-4860-7007	Global COE program of Political Economy and Institutional Construction [I-13]; Japanese Ministry of Education, Culture, Sports, Science and Technology;  [19046002];  [15K02022]	Global COE program of Political Economy and Institutional Construction; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was supported by Global COE program of Political Economy and Institutional Construction (I-13) and the Grant-in-Aid for Scientific Research on Priority Areas (19046002 and 15K02022). All support was provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology, https://www.jsps.go.jp/j-grantsinaid/.	Becher T, 1989, ACAD TRIBES TERRITOR; CAPORAEL LR, 1989, BEHAV BRAIN SCI, V12, P683, DOI 10.1017/S0140525X00025292; COSMIDES L, 1989, ETHOL SOCIOBIOL, V10, P51, DOI 10.1016/0162-3095(89)90013-7; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Dawes CT, 2012, P NATL ACAD SCI USA, V109, P6479, DOI 10.1073/pnas.1118653109; de Waal F., 1996, GOOD NATURED ORIGIN; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; DUNBAR RIM, 1995, J HUM EVOL, V28, P287, DOI 10.1006/jhev.1995.1021; Fagley NS, 1997, ORGAN BEHAV HUM DEC, V71, P355, DOI 10.1006/obhd.1997.2725; Fowler JH, 2005, NATURE, V433, DOI 10.1038/nature03256; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; HARDIN G, 1988, NEW SCI, V120, P76; Henrich J., 2005, FDN HUMAN SOCIALITY; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kuhberger A, 1999, ORGAN BEHAV HUM DEC, V78, P204, DOI 10.1006/obhd.1999.2830; Mange AP., 1980, GENETICS HUMAN ASPEC; Markowitz H, 1952, J POLIT ECON, V60, P151, DOI 10.1086/257177; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Shimizu K, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00265; Shimizu K, 2011, JUDGM DECIS MAK, V6, P156; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Tooby J., 2000, NEW COGNITIVE NEUROS, P1167; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; WANG XT, 1995, J BEHAV DECIS MAKING, V8, P279, DOI 10.1002/bdm.3960080405; Wang XT, 1996, ORGAN BEHAV HUM DEC, V68, P145, DOI 10.1006/obhd.1996.0095; Wang XT, 2001, J BEHAV DECIS MAKING, V14, P1, DOI 10.1002/1099-0771(200101)14:1<1::AID-BDM361>3.0.CO;2-N; Wang XT, 1996, ETHOL SOCIOBIOL, V17, P1, DOI 10.1016/0162-3095(95)00103-4; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V97, P31, DOI 10.1016/j.obhdp.2005.03.001	31	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201547	10.1371/journal.pone.0201547	http://dx.doi.org/10.1371/journal.pone.0201547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092062	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600035
J	Zhou, L; Middel, V; Reischl, M; Strahle, U; Nienhaus, GU				Zhou, Lu; Middel, Volker; Reischl, Markus; Straehle, Uwe; Nienhaus, G. Ulrich			Distinct amino acid motifs carrying multiple positive charges regulate membrane targeting of dysferlin and MG53	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; IN-VIVO; REPAIR; PROTEIN; CAVEOLIN-3; SARCOLEMMA; BINDING; FUSION; INJURY	Dysferlin (Dysf) and mitsugumin53 (MG53) are two key proteins involved in membrane repair of muscle cells which are efficiently recruited to the sarcolemma upon lesioning. Plasma membrane localization and recruitment of a Dysf fragment to membrane lesions in zebrafish myofibers relies on the presence of a short, polybasic amino acid motif, WRRFK. Here we show that the positive charges carried by this motif are responsible for this function. In mouse MG53, we have identified a similar motif with multiple basic residues, WKKMFR. A single amino acid replacement, K279A, leads to severe aggregation of MG53 in inclusion bodies in HeLa cells. This result is due to the loss of positive charge, as shown by studying the effects of other neutral amino acids at position 279. Consequently, our data suggest that positively charged amino acid stretches play an essential role in the localization and function of Dysf and MG53.	[Zhou, Lu; Nienhaus, G. Ulrich] KIT, Inst Appl Phys, Karlsruhe, Germany; [Zhou, Lu; Nienhaus, G. Ulrich] KIT, Inst Nanotechnol, Karlsruhe, Germany; [Middel, Volker; Straehle, Uwe; Nienhaus, G. Ulrich] KIT, Inst Toxicol & Genet, Karlsruhe, Germany; [Reischl, Markus] KIT, Inst Appl Comp Sci, Karlsruhe, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61820 USA	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Nienhaus, GU (corresponding author), KIT, Inst Appl Phys, Karlsruhe, Germany.; Nienhaus, GU (corresponding author), KIT, Inst Nanotechnol, Karlsruhe, Germany.; Nienhaus, GU (corresponding author), KIT, Inst Toxicol & Genet, Karlsruhe, Germany.; Nienhaus, GU (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61820 USA.	uli@uiuc.edu	Nienhaus, Gerd Ulrich/G-8698-2012; Straehle, Uwe/K-7054-2013; Reischl, Markus/H-6970-2013	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Reischl, Markus/0000-0002-7780-6374	Helmholtz-Gemeinschaft (HGF); Deutsche Forschungsgemeinschaft (DFG) [STR 439/8-1, Ni 291/12-1, GRK 2039]; DFG; KIT	Helmholtz-Gemeinschaft (HGF)(Helmholtz Association); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); KIT	US and GUN were funded by the Helmholtz-Gemeinschaft (HGF, grants STN and BITFTM) and Deutsche Forschungsgemeinschaft (DFG, grants STR 439/8-1, Ni 291/12-1 and GRK 2039). We also acknowledge financial support by the DFG and Open Access Publishing Fund of KIT for publication charges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36909; Bandorowicz-Pikula J, 2012, MOL MEMBR BIOL, V29, P229, DOI 10.3109/09687688.2012.693210; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Cai CX, 2015, J BIOL CHEM, V290, P13830, DOI 10.1074/jbc.M114.620690; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Griffin DA, 2016, HUM MOL GENET, V25, P1900, DOI 10.1093/hmg/ddw063; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Middel V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12875; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Yao WF, 2017, J CELL MOL MED, V21, P2503, DOI 10.1111/jcmm.13171	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202052	10.1371/journal.pone.0202052	http://dx.doi.org/10.1371/journal.pone.0202052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092031	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600084
J	Hans, F; Eckert, M; von Zweydorf, F; Gloeckner, CJ; Kahle, PJ				Hans, Friederike; Eckert, Marita; von Zweydorf, Felix; Gloeckner, Christian Johannes; Kahle, Philipp J.			Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein aggregation; protein phosphorylation; ubiquitylation (ubiquitination); mass spectrometry (MS); site-directed mutagenesis; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; frontotemporal dementia; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PHOSPHORYLATION-DEPENDENT UBIQUITINATION; NUCLEOCYTOPLASMIC TRANSPORT; TERMINAL FRAGMENTS; PROTEASOME SYSTEM; NUCLEAR IMPORT; DISEASE; ALS; DEGRADATION	TAR DNA-binding protein of 43 kDa (TDP-43) forms pathological aggregates in neurodegenerative diseases, particularly in certain forms of frontotemporal dementia and amyotrophic lateral sclerosis. Pathological modifications of TDP-43 include proteolytic fragmentation, phosphorylation, and ubiquitinylation. A pathognomonic TDP-43 C-terminal fragment (CTF) spanning amino acids 193-414 contains only four lysine residues that could be potentially ubiquitinylated. Here, serial mutagenesis of these four lysines to arginine revealed that not a single residue is responsible for the ubiquitinylation of mCherry-tagged CTF. Removal of all four lysines was necessary to suppress ubiquitinylation. Interestingly, Lys-408 substitution enhanced the pathological phosphorylation of the immediately adjacent serine residues 409/410 in the context of mCherry-CTF. Thus, Lys-408 ubiquitinylation appears to hinder Ser-409/410 phosphorylation in TDP-43 CTF. However, we did not observe the same effect for full-length TDP-43. We extended the mutagenesis study to full-length TDP-43 and performed MS. Ubiquitinylated lysine residues were identified in the nuclear localization sequence (NLS; Lys-84 and Lys-95) and RNA-binding region (mostly Lys-160, Lys-181, and Lys-263). Mutagenesis of Lys-84 confirmed its importance as the major determinant for nuclear import, whereas Lys-95 mutagenesis did not significantly affect TDP-43's nucleo-cytoplasmic distribution, solubility, aggregation, and RNA-processing activities. Nevertheless, the K95A mutant had significantly reduced Ser-409/410 phosphorylation, emphasizing the suspected interplay between TDP-43 ubiquitinylation and phosphorylation. Collectively, our analysis of TDP-43 ubiquitinylation sites indicates that the NLS residues Lys-84 and Lys-95 have more prominent roles in TDP-43 function than the more C-terminal lysines and suggests a link between specific ubiquitinylation events and pathological TDP-43 phosphorylation.	[Hans, Friederike; Eckert, Marita; von Zweydorf, Felix; Gloeckner, Christian Johannes; Kahle, Philipp J.] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Hans, Friederike; Eckert, Marita; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Gloeckner, Christian Johannes] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kahle, PJ (corresponding author), Univ Tubingen, Lab Funct Neurogenet, Dept Neurodegenerat, German Ctr Neurodegenerat Dis, Otfried Muller Str 27, D-72076 Tubingen, Germany.; Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Fac Med, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944	NOMIS Foundation; German Research Foundation (DFG) [KA1675/3-2]; German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	NOMIS Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	This work was supported by the NOMIS Foundation, German Research Foundation (DFG) Grant KA1675/3-2, the German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, and the Hertie Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Araki W, 2014, MOL NEUROBIOL, V50, P1049, DOI 10.1007/s12035-014-8644-6; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00423, 10.3339/fncel.2015.00423]; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buratti E, 2018, EXPERT OPIN THER TAR, V22, P279, DOI 10.1080/14728222.2018.1439923; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Choi JY, 2007, MOL CELL NEUROSCI, V34, P69, DOI 10.1016/j.mcn.2006.10.002; Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Davidson YS, 2011, ACTA NEUROPATHOL, V122, P703, DOI 10.1007/s00401-011-0879-y; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hebron M, 2014, J NEUROCHEM, V129, P350, DOI 10.1111/jnc.12630; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jadhav Trafina, 2009, J Proteomics Bioinform, V2, P316; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kai M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115111; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Kapeli K, 2017, HUM GENET, V136, P1193, DOI 10.1007/s00439-017-1830-7; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee S, 2015, FEBS LETT, V589, P1825, DOI 10.1016/j.febslet.2015.05.040; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Pentecost M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004739; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Ruegsegger C, 2016, BRAIN RES, V1648, P571, DOI 10.1016/j.brainres.2016.03.032; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walker AK, 2015, HUM MOL GENET, V24, P7241, DOI 10.1093/hmg/ddv424; Wang P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00088-4; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	67	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16083	16099		10.1074/jbc.RA118.003440	http://dx.doi.org/10.1074/jbc.RA118.003440			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30120199	hybrid, Green Published			2022-12-26	WOS:000447256000027
J	Schrader, CU; Heinz, A; Majovsky, P; Mayack, BK; Brinckmann, J; Sippl, W; Schmelzer, CEH				Schraeder, Christoph U.; Heinz, Andrea; Majovsky, Petra; Mayack, Berin Karaman; Brinckmann, Juergen; Sippl, Wolfgang; Schmelzer, Christian E. H.			Elastin is heterogeneously cross-linked	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix protein; elastin; lysyl oxidase; mass spectrometry (MS); protein cross-linking; protein structure; allysine aldol; desmosine; elastin; elastic fibers; lysinonorleucine	LINKING AMINO-ACID; HUMAN SKIN ELASTIN; BOVINE ELASTIN; IN-VITRO; HUMAN TROPOELASTIN; PORCINE AORTA; LYSYL OXIDASE; PROTEIN; PEPTIDES; DOMAIN	Elastin is an essential vertebrate protein responsible for the elasticity of force-bearing tissues such as those of the lungs, blood vessels, and skin. One of the key features required for the exceptional properties of this durable biopolymer is the extensive covalent cross-linking between domains of its monomer molecule tropoelastin. To date, elastin's exact molecular assembly and mechanical properties are poorly understood. Here, using bovine elastin, we investigated the different types of cross-links in mature elastin to gain insight into its structure. We purified and proteolytically cleaved elastin from a single tissue sample into soluble cross-linked and noncross-linked peptides that we studied by high-resolution MS. This analysis enabled the elucidation of cross-links and other elastin modifications. We found that the lysine residues within the tropoelastin sequence were simultaneously unmodified and involved in various types of cross-links with different other domains. The Lys-Pro domains were almost exclusively linked via lysinonorleucine, whereas Lys-Ala domains were found to be cross-linked via lysinonorleucine, allysine aldol, and desmosine. Unexpectedly, we identified a high number of intramolecular cross-links between lysine residues in close proximity. In summary, we show on the molecular level that elastin formation involves random cross-linking of tropoelastin monomers resulting in an unordered network, an unexpected finding compared with previous assumptions of an overall beaded structure.	[Sippl, Wolfgang; Schmelzer, Christian E. H.] Martin Luther Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Saale, Germany; [Heinz, Andrea] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark; [Majovsky, Petra] Leibniz Inst Plant Biochem, Proteome Analyt Res Grp, D-06120 Halle, Saale, Germany; [Brinckmann, Juergen] Univ Lubeck, Dept Dermatol, Inst Virol & Cell Biol, D-23538 Lubeck, Germany; [Schmelzer, Christian E. H.] Fraunhofer Inst Microstruct Mat & Syst IMWS, Walter Hulse Str 1, D-06120 Halle, Saale, Germany; [Schraeder, Christoph U.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4Z6, Canada; [Mayack, Berin Karaman] Biruni Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34010 Istanbul, Turkey	Martin Luther University Halle Wittenberg; University of Copenhagen; Leibniz Institut fur Pflanzenbiochemie; University of Lubeck; Fraunhofer Gesellschaft; University of Calgary; Biruni University	Schmelzer, CEH (corresponding author), Fraunhofer Inst Microstruct Mat & Syst IMWS, Walter Hulse Str 1, D-06120 Halle, Saale, Germany.	schmelzer@pharmazie.uni-halle.de	Heinz, Andreas/ABB-7736-2020; Schmelzer, Christian/AAG-1246-2019; Sippl, Wolfgang/P-5944-2014; Heinz, Andrea/ABL-8318-2022	Heinz, Andreas/0000-0001-5405-9065; Schmelzer, Christian/0000-0002-1180-0201; Sippl, Wolfgang/0000-0002-5985-9261; Heinz, Andrea/0000-0002-8609-4460	German Research Foundation (DFG) [HE 6190/1-2]; LEO Foundation Center for Cutaneous Drug Delivery Grant [2016-11-01]; European Regional Development Fund of the European Commission; Fraunhofer Internal Programs [Attract 069-608203]	German Research Foundation (DFG)(German Research Foundation (DFG)); LEO Foundation Center for Cutaneous Drug Delivery Grant; European Regional Development Fund of the European Commission; Fraunhofer Internal Programs	This work was supported by the German Research Foundation (DFG) Grant HE 6190/1-2 (to A. H.), LEO Foundation Center for Cutaneous Drug Delivery Grant 2016-11-01 (to A. H.), the European Regional Development Fund of the European Commission (to C. U. S.), and the Fraunhofer Internal Programs under Grant Attract 069-608203 (to C. E. H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akagawa M, 1999, ARCH BIOCHEM BIOPHYS, V372, P112, DOI 10.1006/abbi.1999.1462; Akagawa M, 2000, CONNECT TISSUE RES, V41, P131, DOI 10.3109/03008200009067665; Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088; BAIG KM, 1980, BIOCHEM J, V185, P611, DOI 10.1042/bj1850611; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Bochicchio B, 2013, BIOMACROMOLECULES, V14, P4278, DOI 10.1021/bm4011529; Broekelmann TJ, 2008, MATRIX BIOL, V27, P631, DOI 10.1016/j.matbio.2008.06.001; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Chung MIS, 2006, MATRIX BIOL, V25, P492, DOI 10.1016/j.matbio.2006.08.258; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; DAVRIL M, 1976, INT J PEPT PROT RES, V8, P177; DAVRIL M, 1974, FEBS LETT, V43, P331, DOI 10.1016/0014-5793(74)80673-3; Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; FRANCIS G, 1973, BIOCHEM J, V136, P45, DOI 10.1042/bj1360045; FRANZBLA.C, 1969, BIOCHEMISTRY-US, V8, P2833, DOI 10.1021/bi00835a021; GERBER GE, 1975, BIOCHEM J, V149, P685, DOI 10.1042/bj1490685; GERBER GE, 1974, J BIOL CHEM, V249, P5200; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; Heinz A, 2014, MATRIX BIOL, V38, P12, DOI 10.1016/j.matbio.2014.07.006; Heinz A, 2013, BBA-GEN SUBJECTS, V1830, P2994, DOI 10.1016/j.bbagen.2013.01.014; Heinz A, 2012, BIOCHIMIE, V94, P192, DOI 10.1016/j.biochi.2011.10.006; Heinz A, 2011, BIOCHIMIE, V93, P187, DOI 10.1016/j.biochi.2010.09.011; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kim J, 2017, J BIOMECH, V61, P199, DOI 10.1016/j.jbiomech.2017.07.011; Kim WM, 2000, MOL CELLS, V10, P498, DOI 10.1007/s10059-000-0498-2; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; LENT RW, 1969, BIOCHEMISTRY-US, V8, P2837, DOI 10.1021/bi00835a022; Li B, 2001, J AM CHEM SOC, V123, P11991, DOI 10.1021/ja010363e; Miao M, 2009, MATRIX BIOL, V28, P432, DOI 10.1016/j.matbio.2009.07.003; Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; NAKAMURA F, 1992, BIOCHEM BIOPH RES CO, V186, P1533, DOI 10.1016/S0006-291X(05)81581-5; Ongay S, 2013, J AM SOC MASS SPECTR, V24, P83, DOI 10.1007/s13361-012-0504-x; PARTRIDGE SM, 1963, NATURE, V197, P1297, DOI 10.1038/1971297a0; RAJU K, 1987, J BIOL CHEM, V262, P5755; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rauscher S, 2017, ELIFE, V6, DOI 10.7554/eLife.26526; Rietschel B, 2009, MOL CELL PROTEOMICS, V8, P1029, DOI 10.1074/mcp.M800223-MCP200; RUCKER RB, 1978, AM J CLIN NUTR, V31, P1221, DOI 10.1093/ajcn/31.7.1221; SAGE H, 1979, COMP BIOCHEM PHYS B, V64, P313, DOI 10.1016/0305-0491(79)90277-3; SAGE H, 1982, J INVEST DERMATOL, V79, pS146, DOI 10.1111/1523-1747.ep12546048; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Schmelzer CEH, 2005, J CHROMATOGR A, V1083, P120, DOI 10.1016/j.chroma.2005.06.034; Schmelzer CEH, 2016, BBA-GEN SUBJECTS, V1860, P2169, DOI 10.1016/j.bbagen.2016.05.013; Schmelzer CEH, 2012, FEBS J, V279, P4191, DOI 10.1111/febs.12012; Schmutz C, 2016, EPIDEMIOL INFECT, P1; Schrader CU, 2015, J AM SOC MASS SPECTR, V26, P762, DOI 10.1007/s13361-014-1075-9; Taddese S, 2008, MATRIX BIOL, V27, P420, DOI 10.1016/j.matbio.2008.02.001; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Umeda H, 2011, BIOCHEM BIOPH RES CO, V411, P281, DOI 10.1016/j.bbrc.2011.06.124; Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003; YEH H, 1987, COLLAGEN REL RES, V7, P235	64	29	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15107	15119		10.1074/jbc.RA118.004322	http://dx.doi.org/10.1074/jbc.RA118.004322			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30108173	Green Published, hybrid			2022-12-26	WOS:000445998400014
J	Lin, LL; Liang, LN; Yang, X; Sun, H; Li, Y; Pei, DQ; Zheng, H				Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui			The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reprogramming; bone morphogenetic protein (BMP); cadherin-1 (CDH1); epithelial cadherin (E-cadherin); GATA transcription factor; Kruppel-like factor 4 (KLF4); homeobox transcription factor; MET; Msx2; Sall4; stem cell	PLURIPOTENT STEM-CELLS; MESENCHYMAL TRANSITION; HUMAN FIBROBLASTS; INDUCTION; EXPRESSION; EVOLUTION; GROWTH; HOX-8; GENE; EMT	Bone morphogenetic proteins (BMPs) induce mesenchymal-epithelial transition (MET) and enhance the generation of induced pluripotent stem cells (iPSCs). However, BMPs are also signaling molecules critical for arresting reprogramming in the pre-iPSC state. In this study, using mouse embryonic fibroblasts, we found that the time- and concentration-dependent effects of BMPs on reprogramming are mediated by Msh homeobox 2 (MSX2), a homeobox-containing transcription factor. BMPs up-regulated Msx2 by activating SMAD1/5, and MSX2 then directly bound to the promoters and up-regulated the expression of the cadherin 1 (Cdh1, also known as E-cadherin), GATA-binding protein 3 (Gata3), and Nanog genes. Cdh1 contributed to BMP4- and MSX2-induced MET and subsequently promoted reprogramming. On the other hand, GATA3 promoted reprogramming, possibly by up-regulating Spalt-like transcription factor 4 (SALL4) expression. As key transcriptional factors in maintaining pluripotency, up-regulation of SALL4 and NANOG enhanced reprogramming. Moreover, the ability of MSX2 to up-regulate Cdh1, Gata3, Nanog, and Sall4 was further potentiated in the presence of Kruppel-like factor 4 (KLF4). However, MSX2 did not mediate the effects of BMP4 signaling on activation of the microRNAs miR-205 and miR-200 or the inhibitory effects that arrested reprogramming in the pre-iPSC state. In conclusion, MSX2 partially mediates the effects of BMP4 signaling during reprogramming, improving our understanding of the role of BMP signaling in MET and of the connection between cell lineage specifiers such as MSX2 and GATA3 and pluripotency.	[Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Zheng, Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences	Zheng, H (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.	zheng_hui@gibh.ac.cn		Zheng, Hui/0000-0001-6801-0529	National Natural Science Foundation of China [U1601228, 31671475, 31422032, 31421004]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16000000]; Key Research Program of Frontier Sciences, Chinese Academy of Sciences [QYZDB-SSW-SMC031]; Guangdong Natural Science Foundation [2014A030308002]; Science and Technology Planning Project of Guangdong Province [2017B030314056]; Guangzhou branch of the Supercomputing Center of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research Program of Frontier Sciences, Chinese Academy of Sciences; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Guangzhou branch of the Supercomputing Center of the Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (U1601228, 31671475, 31422032, and 31421004); the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16000000); the Key Research Program of Frontier Sciences, Chinese Academy of Sciences (QYZDB-SSW-SMC031); the Guangdong Natural Science Foundation (2014A030308002); and the Science and Technology Planning Project of Guangdong Province (2017B030314056). This work was also supported by the Guangzhou branch of the Supercomputing Center of the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BELL JR, 1993, GENOMICS, V16, P123, DOI 10.1006/geno.1993.1149; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Cheng SL, 2013, ARTERIOSCL THROM VAS, V33, P1679, DOI 10.1161/ATVBAHA.113.300647; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Di Bari MG, 2009, J CELL PHYSIOL, V219, P659, DOI 10.1002/jcp.21712; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Y, 2010, J CELL BIOCHEM, V111, P1346, DOI 10.1002/jcb.22861; Liang LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156839; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Richter A, 2014, STEM CELLS, V32, P636, DOI 10.1002/stem.1592; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shu J, 2015, CELL RES, V25, P169, DOI 10.1038/cr.2015.6; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wu QQ, 2015, CELL RES, V25, P1314, DOI 10.1038/cr.2015.118; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	33	3	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14905	14915		10.1074/jbc.RA118.003913	http://dx.doi.org/10.1074/jbc.RA118.003913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30097516	hybrid, Green Published			2022-12-26	WOS:000446155000025
J	Park, BY; Misra, DP; Moye, J; Miller, RK; Croen, L; Fallin, MD; Walker, C; Newschaffer, CJ; Salafia, CM				Park, Bo Y.; Misra, Dawn P.; Moye, John; Miller, Richard K.; Croen, Lisa; Fallin, M. Dani; Walker, Cheryl; Newschaffer, Craig J.; Salafia, Caroline M.		Natl Childrens Study Consortium	Placental gross shape differences in a high autism risk cohort and the general population	PLOS ONE			English	Article							SPECTRUM DISORDERS; FETAL; PREECLAMPSIA; CHILDREN; GROWTH	A growing body of evidence suggests that prenatal environment is important in Autism Spectrum Disorder (ASD) etiology. In this study, we compare placental shape features in younger siblings of children with ASD, who themselves are at high ASD risk, to a sample of low risk peers. Digital photographs of the fetal placenta surface and of the sliced placental disk from 129 high ASD risk newborns and from 267 newborns in the National Children's Study Vanguard pilot were analysed to extract comparable measures of placental chorionic surface shape, umbilical cord displacement and disk thickness. Placental thickness measures were moderately higher in siblings of ASD cases. The placentas of ASD-case siblings were also rounder and more regular in perimeter than general population placentas. After stratification by sex, these across-group differences persisted for both sexes but were more pronounced in females. No significant differences were observed in cord insertion measures. Variations in placental shape features are generally considered to reflect flexibility in placental growth in response to changes in intrauterine environment as the placenta establishes and matures. Reduced placental shape variability observed in high ASD risk siblings compared to low-risk controls may indicate restricted ability to compensate for intrauterine changes.	[Park, Bo Y.; Fallin, M. Dani] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Park, Bo Y.; Fallin, M. Dani] Johns Hopkins Bloomberg Sch Publ Hlth, Wendy Klag Ctr Autism & Dev Disabil, Dept Mental Hlth, Baltimore, MD 21205 USA; [Misra, Dawn P.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Moye, John] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Miller, Richard K.] Univ Rochester, Sch Med & Dent, Dept Obstet Gynecol Pathol & Clin Lab Med, Rochester, NY USA; [Croen, Lisa] Kaiser Permanente Div Res, Oakland, CA USA; [Walker, Cheryl] Univ Calif Davis, MIND Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA; [Newschaffer, Craig J.] AJ Drexel Autism Inst, Philadelphia, PA USA; [Salafia, Caroline M.] Inst Basic Res Dev Disabil, Placental Modulat Lab, Staten Isl, NY USA; [Salafia, Caroline M.] Placental Analyt LLC, Larchmont, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Rochester; Kaiser Permanente; University of California System; University of California Davis; Drexel University	Park, BY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA.; Park, BY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Wendy Klag Ctr Autism & Dev Disabil, Dept Mental Hlth, Baltimore, MD 21205 USA.	bpark25@jhu.edu		Park, Bo/0000-0002-3748-8041	NICHD [HHSN275200503414C, HHSN275200503411C, HHSN275200603416C, HHSN275200503415C, HHSN275200503413C, HHSN275200503410C, HHSN275200503396C NIH- NCS LOI 2-BIO-18]	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by NICHD Contracts HHSN275200503414C, HHSN275200503411C, HHSN275200603416C, HHSN275200503415C, HHSN275200503413C, HHSN275200503410C, and HHSN275200503396C NIH- NCS LOI 2-BIO-18. The funder provided support in obtaining placental morphology measures but did not have any additional role in the study design, data collection and analysis decision to publish or preparation of the manuscript. Dr. Carolyn Salafia was employed by Placental Analytics, LLC. The funder provided support in the form of salaries to Dr. Carolyn Salafia, but did not have any additional role in the study design, data collection and analysis decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baergen RN BK, 2012, MACROSCOPIC FEATURES; Baker D, 2014, AM J EPIDEMIOL, V179, P1366, DOI 10.1093/aje/kwu062; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Galinsky R, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/412831; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Longtine MS, 2011, SEMIN REPROD MED, V29, P187, DOI 10.1055/s-0031-1275515; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; Newschaffer CJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-7; Norwitz ER, 2006, REPROD BIOMED ONLINE, V13, P591, DOI 10.1016/S1472-6483(10)60649-9; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Pereira RD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814543; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Roescher AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089419; Salafia C, 2014, CHARACTERIZATION PLA; Salafia CM, 2012, PLACENTA, V33, P164, DOI 10.1016/j.placenta.2011.12.002; Salafia CM, 2010, PLACENTA, V31, P958, DOI 10.1016/j.placenta.2010.09.005; Salafia CM, 2009, PLACENTA, V30, P355, DOI 10.1016/j.placenta.2009.01.006; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; Salafia CM, 2005, AM J EPIDEMIOL, V162, P991, DOI 10.1093/aje/kwi305; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Sankar KD, 2013, ANAT CELL BIOL, V46, P285, DOI 10.5115/acb.2013.46.4.285; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walker CK, 2015, JAMA PEDIATR, V169, P154, DOI 10.1001/jamapediatrics.2014.2645; Walker CK, 2013, BIOL PSYCHIAT, V74, P204, DOI 10.1016/j.biopsych.2013.03.006; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu GF, 2014, J AUTISM DEV DISORD, V44, P766, DOI 10.1007/s10803-013-1928-2; Yampolsky M, 2009, PLACENTA, V30, P1058, DOI 10.1016/j.placenta.2009.10.001	39	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0191276	10.1371/journal.pone.0191276	http://dx.doi.org/10.1371/journal.pone.0191276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR3NR	30133439	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400001
J	Yamamori, L; Kato, M				Yamamori, Luna; Kato, Makoto			Morphological and ecological adaptation of limpet-shaped top shells (Gastropoda: Trochidae: Fossarininae) to wave-swept rock reef habitats	PLOS ONE			English	Article							EVOLUTION; PREDATION; PATTERNS	Flattening of coiled shells has occurred in several gastropod lineages, while the evolutionary process of shell flattening is little known. The subfamily Fossarininae of the top shell family ( Trochidae) is unique, because it includes four genera at various stages of shell flattening. Broderipia and Roya, have zygomorphic shells that has lost coiling, while the sister genera, Fossarina and Synaptocochlea, have respectively turbiniform and auriform shells. Therefore, comparisons of biology, habitats and detailed morphology among these four genera may help us to detect selection pressure driving shell flattening and loss of coiling. Although Broderipia has recently been identified as living symbiotically in the pits of sea urchins, the habitats and biology of the other three Fossarininae species, especially Roya are poorly known. After an extensive search on rocky shores of the Japanese Archipelago, we found live Roya eximia snails on intertidal/ subtidal rock surfaces exposed to strong waves. Roya snails crept on the bare rock surface to graze periphyton at low tide, and fled into vacant barnacle shells at high tide. Comparison of the morphology of soft bodies in Fossarininae revealed that the columellar muscle of flattened species has been drastically elongated and arranged in posterior semi- outer edge of the flattened shell as observed in true limpets. The flattering and loss of coiling of the shell in Roya caused acquisition of a zygomorphic flat body, retraction of coiled visceral mass, and expansion of the foot sole. All of these changes improved tolerance against strong waves and the ability to cling to rock surfaces, and thus enabled a lifestyle utilizing both wave- swept rock surfaces and the inside of vacant barnacle shells.	[Yamamori, Luna; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan	Kyoto University	Yamamori, L (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan.	strobilation980@gmail.com			Japan Ministry of Education, Culture, Science, Sports, and Technology [15H02420]; Sasakawa Scientific Research Grant [29-537]	Japan Ministry of Education, Culture, Science, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Scientific Research Grant	This study was supported by a Japan Ministry of Education, Culture, Science, Sports, and Technology Grant-in-Aid for Scientific Research (15H02420; https://www.jsps.go.jp/english/index.html) and The Sasakawa Scientific Research Grant (29-537; http://www.jss.or.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Akester RJ, 2000, CAN J ZOOL, V78, P240, DOI 10.1139/cjz-78-2-240; Alexander RR, 2003, T GEOBIOL, V20, P141; Branch G.M., 1985, P187; Branch G.M., 1981, BIOL LIMPETS PHYS FA; Checa AG, 1998, PALEOBIOLOGY, V24, P109, DOI 10.1017/S0094837300020005; Collin R, 2003, BIOL J LINN SOC, V78, P541, DOI 10.1046/j.0024-4066.2002.00166.x; Davies MS, 2006, MAR BIOL, V149, P775, DOI 10.1007/s00227-006-0258-8; Denny M., 2014, BIOL MECH WAVE SWEPT; EAGAR RMC, 1978, BIOL REV, V53, P169, DOI 10.1111/j.1469-185X.1978.tb01436.x; IWASAKI K, 1992, ECOL RES, V7, P305, DOI 10.1007/BF02347099; PALMER AR, 1979, EVOLUTION, V33, P697, DOI 10.1111/j.1558-5646.1979.tb04722.x; Uribe JE, 2017, MOL PHYLOGENET EVOL, V107, P64, DOI 10.1016/j.ympev.2016.10.009; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vermeij G.J., 1995, NATURAL HIST SHELLS, VVolume 15; Vermeij GJ, 2017, BIOL J LINN SOC, V120, P22; VERMEIJ GJ, 1973, MAR BIOL, V20, P319, DOI 10.1007/BF00354275; Williams ST, 2010, MOL PHYLOGENET EVOL, V54, P783, DOI 10.1016/j.ympev.2009.11.008; Yamamori L, 2017, MAR BIOL, V164, DOI [10.1007/s00227-017-3081-5, DOI 10.1007/S00227-017-3081-5]	20	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0197719	10.1371/journal.pone.0197719	http://dx.doi.org/10.1371/journal.pone.0197719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133456	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400002
J	Cheng, RR; Haglund, E; Tiee, NS; Morcos, F; Levine, H; Adams, JA; Jennings, PA; Onuchic, JN				Cheng, Ryan R.; Haglund, Ellinor; Tiee, Nicholas S.; Morcos, Faruck; Levine, Herbert; Adams, Joseph A.; Jennings, Patricia A.; Onuchic, Jose N.			Designing bacterial signaling interactions with coevolutionary landscapes	PLOS ONE			English	Article							2-COMPONENT; SPECIFICITY; CONTACTS; IDENTIFICATION; PHOSPHORELAY; SPORULATION; EPISTASIS; SYSTEMS	Selecting amino acids to design novel protein-protein interactions that facilitate catalysis is a daunting challenge. We propose that a computational coevolutionary landscape based on sequence analysis alone offers a major advantage over expensive, time-consuming bruteforce approaches currently employed. Our coevolutionary landscape allows prediction of single amino acid substitutions that produce functional interactions between non-cognate, interspecies signaling partners. In addition, it can also predict mutations that maintain segregation of signaling pathways across species. Specifically, predictions of phosphotransfer activity between the Escherichia coli histidine kinase EnvZ to the non-cognate receiver Spo0F from Bacillus subtilis were compiled. Twelve mutations designed to enhance, suppress, or have a neutral effect on kinase phosphotransfer activity to a non-cognate partner were selected. We experimentally tested the ability of the kinase to relay phosphate to the respective designed Spo0F receiver proteins against the theoretical predictions. Our key finding is that the coevolutionary landscape theory, with limited structural data, can significantly reduce the search-space for successful prediction of single amino acid substitutions that modulate phosphotransfer between the two-component His-Asp relay partners in a predicted fashion. This combined approach offers significant improvements over large-scale mutations studies currently used for protein engineering and design.	[Cheng, Ryan R.; Haglund, Ellinor; Levine, Herbert; Onuchic, Jose N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Tiee, Nicholas S.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Morcos, Faruck] Univ Texas Dallas, Dept Biol Sci, Dallas, TX USA; [Morcos, Faruck] Univ Texas Dallas, Dept Bioengn, Dallas, TX USA; [Levine, Herbert] Rice Univ, Dept Bioengn, Houston, TX USA; [Levine, Herbert; Onuchic, Jose N.] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Levine, Herbert; Onuchic, Jose N.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Onuchic, Jose N.] Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University; University of California System; University of California San Diego; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; Rice University; Rice University; Rice University; University of California System; University of California San Diego; Rice University	Cheng, RR; Onuchic, JN (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Chem, Houston, TX 77005 USA.	ryan.cheng@rice.edu; jonuchic@rice.edu	Levine, Herbert/C-1704-2008	Levine, Herbert/0000-0002-8819-9055	National Science Foundation [PHY-1427654, MCB-1212312]; Welch Foundation [C-1792]; NSF INSPIRE award [MCB-1241332]; Direct For Biological Sciences [1241332] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NSF INSPIRE award(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work at the Center for Theoretical Biological Physics was sponsored by the National Science Foundation (Grants PHY-1427654), the Welch Foundation (Grant C-1792), and the NSF INSPIRE award (MCB-1241332). Research performed at the University of California was sponsored by the National Science Foundation (Grants MCB-1212312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bitbol AF, 2016, P NATL ACAD SCI USA, V113, P12180, DOI 10.1073/pnas.1606762113; Boyd JS, 2016, J BACTERIOL, V198, P2439, DOI 10.1128/JB.00235-16; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cheng RR, 2016, MOL BIOL EVOL, V33, P3054, DOI 10.1093/molbev/msw188; Cheng RR, 2014, P NATL ACAD SCI USA, V111, pE563, DOI 10.1073/pnas.1323734111; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; dos Santos RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13652; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Figliuzzi M, 2016, MOL BIOL EVOL, V33, P268, DOI 10.1093/molbev/msv211; Ganesh I, 2013, J BIOTECHNOL, V168, P560, DOI 10.1016/j.jbiotec.2013.09.003; Gueudre T, 2016, P NATL ACAD SCI USA, V113, P12186, DOI 10.1073/pnas.1607570113; Hansen J, 2016, NAT COMPUT, V15, P5, DOI 10.1007/s11047-015-9526-1; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hopf TA, 2017, NAT BIOTECHNOL, V35, P128, DOI 10.1038/nbt.3769; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Laub MT, 2007, METHOD ENZYMOL, V423, P531, DOI 10.1016/S0076-6879(07)23026-5; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Mukhopadhyay D, 2004, ACTA CRYSTALLOGR D, V60, P638, DOI 10.1107/S0907444904002148; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Podgornaia AI, 2015, SCIENCE, V347, P673, DOI 10.1126/science.1257360; Podgornaia AI, 2013, CURR OPIN MICROBIOL, V16, P156, DOI 10.1016/j.mib.2013.01.004; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Schmid SR, 2014, ACS SYNTH BIOL, V3, P820, DOI 10.1021/sb500273n; Schrodinger L.L.C., 2015, PYMOL MOL GRAPH SYST; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Starr TN, 2016, PROTEIN SCI, V25, P1204, DOI 10.1002/pro.2897; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Whitaker WR, 2012, P NATL ACAD SCI USA, V109, P18090, DOI 10.1073/pnas.1209230109; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201734	10.1371/journal.pone.0201734	http://dx.doi.org/10.1371/journal.pone.0201734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125296	gold, Green Published, Green Submitted			2022-12-26	WOS:000442202100010
J	Renz, N; Mudrovcic, S; Perka, C; Trampuz, A				Renz, Nora; Mudrovcic, Stasa; Perka, Carsten; Trampuz, Andrej			Orthopedic implant-associated infections caused by Cutibacterium spp. -A remaining diagnostic challenge	PLOS ONE			English	Article							PERIPROSTHETIC JOINT INFECTION; PROPIONIBACTERIUM-ACNES INFECTION; SONICATION FLUID; IN-VITRO; BIOFILM; RESISTANCE; MUTATIONS; ABSCESS; AVIDUM; HIP	Background The definition criteria and clinical characteristics of implant-associated infection (IAI) caused by Cutibacterium (formerly Propionibacterium) spp. are poorly known. We analyzed microbiologically proven Cutibacterium orthopedic IAI in a prospective cohort. Methods Patients with periprosthetic joint infections (PJI) and fixation device-associated infections (FDAI) caused by Cutibacterium spp. were prospectively included. IAI was defined by significant growth of Cutibacterium spp. and presence of at least one non-microbiological criterion for infection. The McNemar's chi-squared or binomial test was used to compare the performance of diagnostic tests. Results Of 121 patients with Cutibacterium IAI, 62 patients (51%) had PJI and 59 (49%) had FDAI. 109 infections (90%) were caused by C. acnes and 12 (10%) by C. avidum. The median time from implantation until diagnosis of infection was 15.7 months (interquartile range, 5-46.5 months). Clinical local signs were present in 30 patients (28%) and radiological implant loosening in 64 patients (63%). Culture sensitivity of sonication fluid was 84%, of peri-implant tissue 84% and of synovial or peri-implant fluid 56% after 14 days of incubation. Conclusion Cutibacterium IAI was diagnosed late in the disease course and presented with subtle signs. Prolonged culture incubation and implant sonication improved the poor performance of conventional microbiological tests. Due to lack of reliable diagnostic tests, Cutibacterium remains difficult to detect making the diagnosis challenging.	[Renz, Nora; Mudrovcic, Stasa; Perka, Carsten; Trampuz, Andrej] Humboldt Univ, Charite Univ Med Berlin, Freie Univ Berlin, Berlin, Germany; [Renz, Nora; Mudrovcic, Stasa; Perka, Carsten; Trampuz, Andrej] Berlin Inst Hlth, Ctr Musculoskeletal Surg CMSC, Berlin, Germany; [Perka, Carsten; Trampuz, Andrej] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Renz, N (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Freie Univ Berlin, Berlin, Germany.; Renz, N (corresponding author), Berlin Inst Hlth, Ctr Musculoskeletal Surg CMSC, Berlin, Germany.	nora.renz@charite.de	Perka, Carsten/ABG-6505-2021	Perka, Carsten/0000-0002-0993-581X	PROIMPLANT Foundation	PROIMPLANT Foundation	This work was supported by the PROIMPLANT Foundation (https://www.pro-implant-foundation.org) providing an educational grant to NR.	Achermann Y, 2018, CLIN INFECT DIS, V66, P54, DOI 10.1093/cid/cix665; Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Achermann Y, 2010, J CLIN MICROBIOL, V48, P1208, DOI 10.1128/JCM.00006-10; Bayston R, 2007, J ANTIMICROB CHEMOTH, V60, P1298, DOI 10.1093/jac/dkm408; Bernard A, 2015, J INFECTION, V71, P200, DOI 10.1016/j.jinf.2015.03.013; Butler-Wu SM, 2011, J CLIN MICROBIOL, V49, P2490, DOI 10.1128/JCM.00450-11; Chiang HY, 2014, J NEUROSURG, V120, P509, DOI 10.3171/2013.9.JNS13843; Chuang MJ, 2015, ARTHROSCOPY, V31, P1702, DOI 10.1016/j.arthro.2015.01.029; Corvec S, 2012, INT J ARTIF ORGANS, V35, P923, DOI 10.5301/ijao.5000168; Dababneh AS, 2011, CLEV CLIN J MED, V78, P529, DOI 10.3949/ccjm.78a.10169; Deramo VA, 2001, CURR OPIN OPHTHALMOL, V12, P225, DOI 10.1097/00055735-200106000-00015; Dessinioti C, 2017, CLIN DERMATOL, V35, P163, DOI 10.1016/j.clindermatol.2016.10.008; di Summa PG, 2015, J SURG CASE REP, DOI 10.1093/jscr/rjv002; Dodson CC, 2010, J SHOULDER ELB SURG, V19, P303, DOI 10.1016/j.jse.2009.07.065; Portillo ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804391; Figa R, 2017, ANAEROBE, V44, P143, DOI 10.1016/j.anaerobe.2017.03.008; Hahn F, 2005, EUR SPINE J, V14, P783, DOI 10.1007/s00586-004-0854-6; Heckmann N, 2018, ARTHROSCOPY, V34, P1786, DOI 10.1016/j.arthro.2018.01.019; Hsu JE, 2016, J BONE JOINT SURG AM, V98, P2047, DOI 10.2106/JBJS.16.00149; Kadler BK, 2015, INT J SHOULDER SURG, V9, P139, DOI 10.4103/0973-6042.167957; Kanafani ZA, 2009, CLIN INFECT DIS, V49, P1083, DOI 10.1086/605577; Kranick SM, 2009, ARCH NEUROL-CHICAGO, V66, P793, DOI 10.1001/archneurol.2009.75; Krenn V, 2014, PATHOL RES PRACT, V210, P779, DOI 10.1016/j.prp.2014.09.017; Kritikos A., 2015, New Microbes and New Infections, V4, P9, DOI 10.1016/j.nmni.2014.12.001; Lutz MF, 2005, EUR J CLIN MICROBIOL, V24, P739, DOI 10.1007/s10096-005-0040-8; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; Moroder P, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.16.00838; Nodzo SR, 2016, J ARTHROPLASTY, V31, P1986, DOI 10.1016/j.arth.2016.02.025; Ochsner PE, 2016, INFECT MUSCULOSKELET; Ochsner PE, 2006, INJURY, V37, P49, DOI 10.1016/j.injury.2006.04.009; Panagea Stavroula, 2005, J Infect, V51, pe253, DOI 10.1016/j.jinf.2005.04.005; Renz N, 2018, J BONE JOINT SURG AM, V100, P742, DOI 10.2106/JBJS.17.01005; Renz N, 2017, INFECTION, V45, P877, DOI 10.1007/s15010-017-1073-5; Rieger UM, 2013, BRIT J SURG, V100, P768, DOI 10.1002/bjs.9084; Rienmuller Anna, 2016, Eur J Orthop Surg Traumatol, V26, P429, DOI 10.1007/s00590-016-1766-y; Sampedro MF, 2010, SPINE, V35, P1218, DOI 10.1097/BRS.0b013e3181c3b2f3; Scholz CFP, 2016, INT J SYST EVOL MICR, V66, P4422, DOI 10.1099/ijsem.0.001367; Street TL, 2017, J CLIN MICROBIOL, V55, P2334, DOI 10.1128/JCM.00462-17; Tafin UF, 2015, ANAEROBE, V34, P116, DOI 10.1016/j.anaerobe.2015.05.003; Tafin UF, 2012, ANTIMICROB AGENTS CH, V56, P1885, DOI 10.1128/AAC.05552-11; Takoudju EM, 2017, ANAEROBE, V47, P194, DOI 10.1016/j.anaerobe.2017.06.005; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; Tunney MM, 1999, METHOD ENZYMOL, V310, P566; Wang TKF, 2002, MICROBIOLOGICA, V25, P239; Wildeman P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158164; Zappe B, 2008, ARCH ORTHOP TRAUM SU, V128, P1039, DOI 10.1007/s00402-007-0454-0; Zeller V, 2007, J INFECTION, V55, P119, DOI 10.1016/j.jinf.2007.02.006; Zeller VA, 2018, J ARTHROPLASTY, V33, P2246, DOI 10.1016/j.arth.2018.02.008; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	50	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202639	10.1371/journal.pone.0202639	http://dx.doi.org/10.1371/journal.pone.0202639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125299	gold, Green Published, Green Submitted			2022-12-26	WOS:000442202100040
J	Saintome, C; Delagoutte, E				Saintome, Carole; Delagoutte, Emmanuelle			Probing hyper-negatively supercoiled mini-circles with nucleases and DNA binding proteins	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA-DNA; SUPERHELICAL DNA; REPLICATIVE-FORM; STRANDED-DNA; INTEGRATIVE RECOMBINATION; NUCLEOSOME DYNAMICS; SECONDARY STRUCTURE; MOLECULAR-DYNAMICS; HELICASE ACTIVITY; ETHIDIUM-BROMIDE	It is well accepted that the introduction of negative supercoils locally unwinds the DNA double helix, influencing thus the activity of proteins. Despite the use of recent methods of molecular dynamics simulations to model the DNA supercoiling-induced DNA deformation, the precise extent and location of unpaired bases induced by the negative supercoiling have never been investigated at the nucleotide level. Our goals in this study were to use radiolabeled double-stranded DNA mini-circles (dsMCs) to locate the unpaired bases on dsMCs whose topology ranged from relaxed to hyper-negatively supercoiled states, and to characterize the binding of proteins involved in the DNA metabolism. Our results show that the Nuclease SI is nearly ten times more active on hyper-negatively supercoiled than relaxed DNA. The structural changes responsible for this stimulation of activity were mapped for the first time with a base pair resolution and shown to be subtle and distributed along the entire sequence. As divalent cations modify the DNA topology, our binding studies were conducted with or without magnesium. Without magnesium, the dsMCs topoisomers mostly differ by their twist. Under these conditions, the Escherichia coli topoisomerase I weakly binds relaxed dsMCs and exhibits a stronger binding on negatively and hyper-negatively supercoiled dsMCs than relaxed dsMCs, with no significant difference in the binding activity among the supercoiled topoisomers. For the human replication protein A (hRPA), the more negatively supercoiled is the DNA, the better the binding, illustrating the twist-dependent binding activity for this protein. The presence of magnesium permits the dsMCs to writhe upon introduction of negative supercoiling and greatly modifies the binding properties of the hRPA and Escherichia coli SSB on dsMCs, indicating a magnesium-dependent DNA binding behavior. Finally, our experiments that probe the topology of the DNA in the hRPA-dsMC complexes show that naked and hRPA-bound dsMCs have the same topology.	[Saintome, Carole] CNRS, INSERM, Struct Acides Nucle Telomeres & Evolut Museum Nat, Paris, France; [Saintome, Carole] France Sorbonne Univ, UFR 927, Paris, France; [Delagoutte, Emmanuelle] CNRS, INSERM, Museum Natl Hist Nat, Physiol & Genom Adaptat, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN)	Delagoutte, E (corresponding author), CNRS, INSERM, Museum Natl Hist Nat, Physiol & Genom Adaptat, Paris, France.	emmanuelle.delagoutte@mnhn.fr	saintome, carole/A-3703-2015	saintome, carole/0000-0002-7609-6913	Institut National de la Sante Et de la Recherche Medicale, Centre National de Recherche Scientifque, Museum national d'Histoire naturelle; Ligue Nationale Contre le Cancer	Institut National de la Sante Et de la Recherche Medicale, Centre National de Recherche Scientifque, Museum national d'Histoire naturelle; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by Institut National de la Sante Et de la Recherche Medicale, Centre National de Recherche Scientifque, Museum national d'Histoire naturelle and Ligue Nationale Contre le Cancer.	ADRIAN M, 1990, EMBO J, V9, P4551, DOI 10.1002/j.1460-2075.1990.tb07907.x; Amzallag A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl675; Anderson BG, 2014, BIOCHEMISTRY-US, V53, P4302, DOI 10.1021/bi500571q; Audry J, 2015, EMBO J, V34, P1942, DOI 10.15252/embj.201490773; Bates AD, 2013, BIOCHEM SOC T, V41, P565, DOI 10.1042/BST20120320; BEARD P, 1973, J VIROL, V12, P1303, DOI 10.1128/JVI.12.6.1303-1313.1973; BEDNAR J, 1994, J MOL BIOL, V235, P825, DOI 10.1006/jmbi.1994.1042; BEERMAN TA, 1973, J MOL BIOL, V79, P451, DOI 10.1016/0022-2836(73)90398-7; Benedetti F, 2015, NUCLEIC ACIDS RES, V43, P2390, DOI 10.1093/nar/gkv055; BOTCHAN P, 1973, P NATL ACAD SCI USA, V70, P3077, DOI 10.1073/pnas.70.11.3077; BRACK C, 1975, J MOL BIOL, V96, P693, DOI 10.1016/0022-2836(75)90146-1; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Davenport EP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159242; DEAN WW, 1971, NATURE-NEW BIOL, V231, P5; DELIUS H, 1972, J MOL BIOL, V67, P341, DOI 10.1016/0022-2836(72)90454-8; Demurtas D, 2009, NUCLEIC ACIDS RES, V37, P2882, DOI 10.1093/nar/gkp137; DOUCRASY S, 1989, NUCLEIC ACIDS RES, V17, P5173, DOI 10.1093/nar/17.13.5173; DOUCRASY S, 1986, P NATL ACAD SCI USA, V83, P7152, DOI 10.1073/pnas.83.19.7152; Du Q, 2008, NUCLEIC ACIDS RES, V36, P1120, DOI 10.1093/nar/gkm1125; EISENBERG S, 1976, P NATL ACAD SCI USA, V73, P1594, DOI 10.1073/pnas.73.5.1594; Esteban JA, 1996, NUCLEIC ACIDS RES, V20, P4932; FALCO SC, 1978, P NATL ACAD SCI USA, V75, P3220, DOI 10.1073/pnas.75.7.3220; Fogg JM, 2006, J PHYS-CONDENS MAT, V18, pS145, DOI 10.1088/0953-8984/18/14/S01; Green M, 2014, BIOSENS BIOELECTRON, V61, P579, DOI 10.1016/j.bios.2014.06.011; HAMICHE A, 1992, J MOL BIOL, V228, P327, DOI 10.1016/0022-2836(92)90821-Z; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Harris SA, 2008, NUCLEIC ACIDS RES, V36, P21, DOI 10.1093/nar/gkm891; HAYS JB, 1978, P NATL ACAD SCI USA, V75, P4125, DOI 10.1073/pnas.75.9.4125; HOLLOMAN WK, 1975, P NATL ACAD SCI USA, V72, P2394, DOI 10.1073/pnas.72.6.2394; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; Irobalieva RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9440; Jeon JH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.208101; LANDY A, 1977, SCIENCE, V197, P1147, DOI 10.1126/science.331474; LILLEY DMJ, 1981, NATURE, V292, P380, DOI 10.1038/292380a0; LILLEY DMJ, 1983, NUCLEIC ACIDS RES, V11, P3097, DOI 10.1093/nar/11.10.3097; Lim HM, 2003, BIOCHEMISTRY-US, V42, P10718, DOI 10.1021/bi030110t; MARIANS KJ, 1977, P NATL ACAD SCI USA, V74, P1965, DOI 10.1073/pnas.74.5.1965; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Millet A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13154; MIZUUCHI K, 1978, J MOL BIOL, V121, P375, DOI 10.1016/0022-2836(78)90370-4; MIZUUCHI K, 1976, P NATL ACAD SCI USA, V73, P3524, DOI 10.1073/pnas.73.10.3524; Nakamura Y, 2002, J BIOCHEM, V131, P153, DOI 10.1093/oxfordjournals.jbchem.a003070; PANAYOTATOS N, 1981, NATURE, V289, P466, DOI 10.1038/289466a0; Pasi M, 2016, NUCLEIC ACIDS RES, V44, P7830, DOI 10.1093/nar/gkw651; Pasi M, 2016, NUCLEIC ACIDS RES, V44, P5450, DOI 10.1093/nar/gkw293; Randall GL, 2009, NUCLEIC ACIDS RES, V37, P5568, DOI 10.1093/nar/gkp556; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; Safa L, 2016, J BIOL CHEM, V291, P21246, DOI 10.1074/jbc.M115.709667; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; SHURE M, 1976, CELL, V8, P215, DOI 10.1016/0092-8674(76)90005-2; Sivolob A, 1999, J MOL BIOL, V285, P1081, DOI 10.1006/jmbi.1998.2380; Sivolob A, 2000, J MOL BIOL, V295, P41, DOI 10.1006/jmbi.1999.3301; SUMIDAYASUMOTO C, 1977, P NATL ACAD SCI USA, V74, P4195, DOI 10.1073/pnas.74.10.4195; Sutton DH, 1997, BIOCHEM J, V321, P481, DOI 10.1042/bj3210481; Takahashi S, 2015, ANAL CHEM, V87, P3490, DOI 10.1021/acs.analchem.5b00044; Tan KM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1073; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; VEAUTE X, 1991, NUCLEIC ACIDS RES, V19, P5603, DOI 10.1093/nar/19.20.5603; VOGEL T, 1976, J BIOL CHEM, V251, P2334; VOGEL T, 1975, P NATL ACAD SCI USA, V72, P2597, DOI 10.1073/pnas.72.7.2597; WANG JC, 1974, J MOL BIOL, V87, P797, DOI 10.1016/0022-2836(74)90085-0	62	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202138	10.1371/journal.pone.0202138	http://dx.doi.org/10.1371/journal.pone.0202138			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114256	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400047
J	Kreuger, AL; Middelburg, RA; Beckers, EAM; de Vooght, KMK; Zwaginga, JJ; Kerkhoffs, JLH; van der Bom, JG				Kreuger, Aukje L.; Middelburg, Rutger A.; Beckers, Erik A. M.; de Vooght, Karen M. K.; Zwaginga, Jaap Jan; Kerkhoffs, Jean-Louis H.; van der Bom, Johanna G.			The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data	PLOS ONE			English	Article							PROPHYLACTIC PLATELET TRANSFUSIONS; BIG DATA; PREVENTION; RISK	Introduction Electronic health care data offers the opportunity to study rare events, although detecting these events in large datasets remains difficult. We aimed to develop a model to identify leukemia patients with major hemorrhages within routinely recorded health records. Methods The model was developed using routinely recorded health records of a cohort of leukemia patients admitted to an academic hospital in the Netherlands between June 2011 and December 2015. Major hemorrhage was assessed by chart review. The model comprised CT-brain, hemoglobin drop, and transfusion need within 24 hours for which the best discriminating cut off values were taken. External validation was performed within a cohort of two other academic hospitals. Results The derivation cohort consisted of 255 patients, 10,638 hospitalization days, of which chart review was performed for 353 days. The incidence of major hemorrhage was 0.22 per 100 days in hospital. The model consisted of CT-brain (yes/no), hemoglobin drop of >= 0.8 g/dl and transfusion of >= 6 units. The C-statistic was 0.988 (CI 0.981-0.995). In the external validation cohort of 436 patients (19,188 days), the incidence of major hemorrhage was 0.46 per 100 hospitalization days and the C-statistic was 0.975 (CI 0.970-0.980). Presence of at least one indicator had a sensitivity of 100% (CI 95.8-100) and a specificity of 90.7% (CI 90.2-91.1). The number of days to screen to find one case decreased from 217.4 to 23.6. Interpretation A model based on information on CT-brain, hemoglobin drop and need of transfusions can accurately identify cases of major hemorrhage within routinely recorded health records.	[Kreuger, Aukje L.; Middelburg, Rutger A.; Zwaginga, Jaap Jan; Kerkhoffs, Jean-Louis H.; van der Bom, Johanna G.] Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands; [Kreuger, Aukje L.; Middelburg, Rutger A.; van der Bom, Johanna G.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Beckers, Erik A. M.] Maastricht Univ, Med Ctr, Dept Hematol, Maastricht, Netherlands; [de Vooght, Karen M. K.] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Zwaginga, Jaap Jan] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Kerkhoffs, Jean-Louis H.] Haga Hosp, Dept Hematol, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital	van der Bom, JG (corresponding author), Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands.; van der Bom, JG (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	j.g.vanderbom@lumc.nl	Middelburg, Rutger/N-9134-2017	Middelburg, Rutger/0000-0002-6545-7277; Kreuger, Aukje/0000-0002-1658-9257				Barry SJE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075379; Diez ID, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0565-7; Ehrenstein V, 2017, CLIN EPIDEMIOL, V9, P245, DOI 10.2147/CLEP.S129779; Ehrenstein V, 2016, CLIN EPIDEMIOL, V8, P49, DOI 10.2147/CLEP.S104448; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heddle NM, 2011, TRANSFUSION, V51, P430, DOI 10.1111/j.1537-2995.2010.02982.x; Heddle NM, 2009, BLOOD, V113, P1564, DOI 10.1182/blood-2008-09-178236; Hemkens Lars G, 2016, CMAJ Open, V4, pE132, DOI 10.9778/cmajo.20150036; Hemkens LG, 2016, CAN MED ASSOC J, V188, pE158, DOI 10.1503/cmaj.150653; Krabbe-Alkemade YJFM, 2017, EUR J HEALTH ECON, V18, P139, DOI 10.1007/s10198-016-0762-9; Langner I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-193; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moriarty JP, 2017, AM J MED QUAL, V32, P391, DOI 10.1177/1062860616660757; Murthy SC, 2016, J THORAC CARDIOV SUR, V151, P629, DOI 10.1016/j.jtcvs.2015.11.016; Nicholls SG, 2016, CLIN EPIDEMIOL, V8, P389, DOI 10.2147/CLEP.S110528; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Stanworth SJ, 2015, HAEMATOLOGICA, V100, P740, DOI 10.3324/haematol.2014.118075; Stanworth SJ, 2013, NEW ENGL J MED, V368, P1771, DOI 10.1056/NEJMoa1212772; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Webert KE, 2006, HAEMATOLOGICA, V91, P1530; Ypma PF, 2012, TRANSFUSION MED, V22, P426, DOI 10.1111/j.1365-3148.2012.01193.x	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0200655	10.1371/journal.pone.0200655	http://dx.doi.org/10.1371/journal.pone.0200655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110326	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000004
J	Spada, FP; da Silva, PPM; Mandro, GF; Margiotta, GB; Spoto, MHF; Canniatti-Brazaca, SG				Spada, Fernanda Papa; Moreira da Silva, Paula Porrelli; Mandro, Gabriela Fernanda; Margiotta, Gregorio Borghese; Fillet Spoto, Marta Helena; Canniatti-Brazaca, Solange Guidolin			Physicochemical characteristics and high sensory acceptability in cappuccinos made with jackfruit seeds replacing cocoa powder	PLOS ONE			English	Article							FOOD POWDERS; REHYDRATION; VARIETIES; STARCH	Jackfruit seeds are an under-utilized waste product in many tropical countries. In this work, we demonstrate the potential of roasted jackfruit seeds to substitute for cocoa powder in cappuccino formulations. Two different flours were produced from a hard variety jackfruit by drying or fermenting the seeds prior to roasting. Next, formulations were prepared with 50%, 75%, and 100% substitution of cocoa powder with jackfruit seed flours, totalizing seven with control formulation. The acceptance of cappuccinos by consumers (n = 126) and quantitative descriptive analysis (QDA (R)) were used to describe the preparations. Physicochemical properties were also evaluated. When 50% and 75% cocoa powder was replaced with dry jackfruit seed flour, there was no change in sensory acceptability or technological properties; however, it is possible to identify advantages tousing dry jackfruit seed flour, including moisture reduction and high wettability, solubility and sensory acceptation of the chocolate aroma. The principal component analysis of QDA explained90% variances; cluster analysis enabled the definition of four groups for six cappuccino preparations. In fact, dry jackfruit seed flour is an innovative cocoa powder substitute; it could be used in food preparations, consequently utilizing this tropical fruit waste by incorporating it as an ingredient in a common product of the human diet.	[Spada, Fernanda Papa; Moreira da Silva, Paula Porrelli; Mandro, Gabriela Fernanda; Margiotta, Gregorio Borghese; Fillet Spoto, Marta Helena; Canniatti-Brazaca, Solange Guidolin] Univ Sao Paulo, ESALQ, Dept Agrifood Ind Food & Nutr, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Spada, FP (corresponding author), Univ Sao Paulo, ESALQ, Dept Agrifood Ind Food & Nutr, Piracicaba, SP, Brazil.	fpspada@hotmail.com	Papa Spada, Fernanda/V-7354-2017	Papa Spada, Fernanda/0000-0002-9679-8066	Sao Paulo Research Foundation (FAPESP) [2013/20323-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP) [Project number 2013/20323-9].	Afoakwa E. O, 2010, CHOCOLATE SCI TECHNO, P12; Ayala-Zavala JF, 2011, FOOD RES INT, V44, P1866, DOI 10.1016/j.foodres.2011.02.021; Barua AG, 2004, INT J FOOD SCI NUTR, V55, P479, DOI 10.1080/09637480400015810; Beckett ST., 1999, IND CHOCOLATE MANUFA; Cochran W, 1950, EXPT DESIGNS; Dogan M, 2016, EUR FOOD RES TECHNOL, V242, P953, DOI 10.1007/s00217-015-2602-z; Fadel HHM, 2006, EUR FOOD RES TECHNOL, V223, P125, DOI 10.1007/s00217-005-0162-3; FAO-Food and Agriculture, PROYECC AN 2010 DOC; Fitzpatrick JJ, 2016, POWDER TECHNOL, V297, P340, DOI 10.1016/j.powtec.2016.04.036; Gu FL, 2013, FOODS, V2, P183, DOI 10.3390/foods2020183; Hogekamp S, 2003, FOOD SCI TECHNOL INT, V9, P223, DOI 10.1177/1082013203034938; Kongor JE, 2016, FOOD RES INT, V82, P44, DOI 10.1016/j.foodres.2016.01.012; Madrigal-Aldana DL, 2011, STARCH-STARKE, V63, P364, DOI 10.1002/star.201100008; Madruga MS, 2014, FOOD CHEM, V143, P440, DOI 10.1016/j.foodchem.2013.08.003; Medeiros ML, 2009, CIENCIA TECNOL ALIME, V29, P247, DOI 10.1590/S0101-20612009000200002; Meilgaard M. C., 2007, SENSORY EVAL TECHN, V4th; MEYER LH, 1960, FOOD CHEM; Micha, 1983, FOOD ENG, P293; Moskowitz H., 1983, FOOD NUTR; Ohanningsmeier J, 2005, J FOOD SCI, V70, P44; Ostrowska-Ligeza E, 2015, LWT-FOOD SCI TECHNOL, V60, P1054, DOI 10.1016/j.lwt.2014.10.040; Prescott J., 2015, FLAVOUR DEV ANAL PER, P369, DOI 10.1016/B978-1-78242-103-0.00017-5; Saxena A, 2011, WOODHEAD PUBL FOOD S, P275; Sokal R.R., 1980, BIOMETRY; Spada FP, 2017, J AGR FOOD CHEM; Srour N, 2016, J SCI FOOD AGR, V96, P3047, DOI 10.1002/jsfa.7476; Stone H, 1998, FOOD TECHNOL-CHICAGO, V52, P48; Menezes AGT, 2016, FOOD RES INT, V81, P83, DOI 10.1016/j.foodres.2015.12.036; Yousif AK, 2000, FOOD CHEM, V69, P283, DOI 10.1016/S0308-8146(99)00265-4; Zeller B. L., 1998, US Patent, Patent No. [US 5721003, 5721003, 5,721,003]	30	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0197654	10.1371/journal.pone.0197654	http://dx.doi.org/10.1371/journal.pone.0197654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110324	Green Published, Green Submitted, gold			2022-12-26	WOS:000441738000001
J	Kim, J; Kwak, HR; Kim, M; Seo, JK; Yang, JW; Chung, MN; Kil, EJ; Choi, HS; Lee, S				Kim, Jaedeok; Kwak, Hae-Ryun; Kim, Mikyeong; Seo, Jang-Kyun; Yang, Jung Wook; Chung, Mi-Nam; Kil, Eui-Joon; Choi, Hong-Soo; Lee, Sukchan			Phylogeographic analysis of the full genome of Sweepovirus to trace virus dispersal and introduction to Korea	PLOS ONE			English	Article							LEAF-CURL-VIRUS; INFECTING SWEET-POTATO; FEATHERY-MOTTLE-VIRUS; TURNIP-MOSAIC-VIRUS; MOLECULAR CHARACTERIZATION; RECOMBINATION; EVOLUTION; CLASSIFICATION; BEGOMOVIRUSES; NOMENCLATURE	Sweet potato is a vegetatively propagated crop that is produced for both growth in Korean fields and for export out of the country. The viruses that are present in introduced sweet potatoes can spread both domestically and to foreign countries. Determining the time and path of virus movement could help curtail its spread and prevent future dispersal of related viruses. Determining the consequences of past virus and sweet potato dispersal could provide insight into the ecological and economic risks associated with other sweet potato-infecting viral invasions. We therefore applied Bayesian phylogeographic inferences and recombination analyses of the available Sweepovirus sequences (including 25 Korean Sweepovirus genomes) and reconstructed a plausible history of Sweepovirus diversification and movement across the globe. The Mediterranean basin and Central America were found to be the launchpad of global Sweepovirus dispersal. Currently, China and Brazil are acting as convergence regions for Sweepoviruses. Recently reported Korean Sweepovirus isolates were introduced from China in a recent phase and the regions around China and Brazil continue to act as centers of Sweepovirus diversity and sites of ongoing Sweepovirus evolution. The evidence indicates that the region is an epidemiological hotspot, which suggests that novel Sweepovirus variants might be found. Sweet potato is a vegetatively propagated crop that is produced for both growth in Korean fields and for export out of the country. The viruses that are present in introduced sweet potatoes can spread both domestically and to foreign countries. Determining the time and path of virus movement could help curtail its spread and prevent future dispersal of related viruses. Determining the consequences of past virus and sweet potato dispersal could provide insight into the ecological and economic risks associated with other sweet potato-infecting viral invasions. We therefore applied Bayesian phylogeographic inferences and recombination analyses of the available Sweepovirus sequences (including 25 Korean Sweepovirus genomes) and reconstructed a plausible history of Sweepovirus diversification and movement across the globe. The Mediterranean basin and Central America were found to be the launchpad of global Sweepovirus dispersal. Currently, China and Brazil are acting as convergence regions for Sweepoviruses. Recently reported Korean Sweepovirus isolates were introduced from China in a recent phase and the regions around China and Brazil continue to act as centers of Sweepovirus diversity and sites of ongoing Sweepovirus evolution. The evidence indicates that the region is an epidemiological hotspot, which suggests that novel Sweepovirus variants might be found.	[Kim, Jaedeok; Kwak, Hae-Ryun; Kim, Mikyeong; Choi, Hong-Soo] Natl Inst Agr Sci, Crop Protect Div, Wonju, South Korea; [Kim, Jaedeok; Kil, Eui-Joon; Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Seo, Jang-Kyun] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang, South Korea; [Yang, Jung Wook] Natl Inst Crop Sci, Bioenergy Crop Res Inst, Muan, South Korea; [Chung, Mi-Nam] Rural Dev Adm, Res Policy Bur, Jeonju, South Korea	National Institute of Agricultural Sciences; Sungkyunkwan University (SKKU); Seoul National University (SNU); Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Rural Development Administration (RDA), Republic of Korea	Choi, HS (corresponding author), Natl Inst Agr Sci, Crop Protect Div, Wonju, South Korea.; Lee, S (corresponding author), Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea.	hschoi@korea.kr; cell4u@skku.edu	Kil, Eui-Joon/AAZ-9823-2020	Kil, Eui-Joon/0000-0002-7256-3879	Rural Development Administration [PJ0101132017]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by: Grant Number: PJ0101132017, Funding institution: Rural Development Administration, URL for Fund information: http://atis.rda.go.kr, Fund received by M. Kim.	Abubakar Z, 2003, J GEN VIROL, V84, P733, DOI 10.1099/vir.0.18759-0; Albuquerque LC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-241; Albuquerque LC, 2011, ARCH VIROL, V156, P1291, DOI 10.1007/s00705-011-1016-x; Alkhamis MA, 2015, VIRUSES-BASEL, V7, P3310, DOI 10.3390/v7062773; Arenal FG, VARIABILITY GENETIC; Banks G K, 1999, Plant Dis, V83, P486, DOI 10.1094/PDIS.1999.83.5.486B; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Briddon RW, 2008, ARCH VIROL, V153, P763, DOI 10.1007/s00705-007-0013-6; Briddon RW, 2006, PLANT PATHOL, V55, P286, DOI 10.1111/j.1365-3059.2005.01273.x; Briddon RW, 2003, MOL PLANT PATHOLOGY; Carnieli P, 2011, ARCH VIROL, V156, P1007, DOI 10.1007/s00705-011-0942-y; Choi E, 2012, ACTA VIROL, V56, P187, DOI 10.4149/av_2012_03_187; Cohen J, 1991, PLANT DIS; Cuevas JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037853; Fauquet CM, 2003, ANN APPL BIOL, V142, P165, DOI 10.1111/j.1744-7348.2003.tb00241.x; Garcia-Andres S, 2007, VIROLOGY, V359, P302, DOI 10.1016/j.virol.2006.09.030; Gutierrez DL, 2003, PLANT DIS, V87, P297, DOI [10.1094/PDIS.2003.87.3.297, 10.1094/PDIS.2003.87.1.98C]; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; Kwak Hae-ryun, 2006, The Plant Pathology Journal, V22, P239; Kwak HR, 2007, PLANT PATHOLOGY J, V23, P13, DOI 10.5423/PPJ.2007.23.1.013; Kwak HR, 2015, PLANT PATHOLOGY J, V31, P388, DOI 10.5423/PPJ.OA.04.2015.0072; Kwak HR, 2014, PLANT PATHOLOGY J, V30, P416, DOI 10.5423/PPJ.OA.04.2014.0029; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Loebenstein G, 2009, SWEETPOTATO, DOI [10.1007/978-1-4020-9475-0, DOI 10.1007/978-1-4020-9475-0]; Lotrakul P, 1998, PLANT DIS, V82, P1253, DOI 10.1094/PDIS.1998.82.11.1253; Lotrakul P, 1999, MOLECULAR PLANT PATH; Lozano G, 2009, J GEN VIROL, V90, P2550, DOI 10.1099/vir.0.012542-0; Luan YS, 2006, PLANT DIS, V90, P1111, DOI 10.1094/PD-90-1111C; Mello FCA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-236; Miano DW, 2006, PLANT DIS, V90, P832, DOI 10.1094/PD-90-0832B; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Paprotka T, 2010, VIRUS RES, V149, P224, DOI 10.1016/j.virusres.2010.02.003; Park J, 2011, ACTA VIROL, V55, P327, DOI 10.4149/av_2011_04_327; Prasanth G, 2008, PLANT DIS, V92, P311, DOI 10.1094/PDIS-92-2-0311B; Roossinck MJ, 2003, CURR OPIN MICROBIOL, V6, P406, DOI 10.1016/S1369-5274(03)00087-0; Roossinck MJ, 1999, J VIROL, V73, P6752, DOI 10.1128/JVI.73.8.6752-6758.1999; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Rubio L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00151; Schuh AJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002411; Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Wasswa P, 2011, PLANT PATHOL, V60, P1030, DOI 10.1111/j.1365-3059.2011.02464.x	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202174	10.1371/journal.pone.0202174	http://dx.doi.org/10.1371/journal.pone.0202174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102735	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200034
J	Wong, LSC; Lynch, TP; Barrett, NS; Wright, JT; Green, MA; Flynn, DJH				Wong, Lincoln S. C.; Lynch, Tim P.; Barrett, Neville S.; Wright, Jeffrey T.; Green, Mark A.; Flynn, David J. H.			Local densities and habitat preference of the critically endangered spotted handfish (Brachionichthys hirsutus): Large scale field trial of GPS parameterised underwater visual census and diver attached camera	PLOS ONE			English	Article							ASTERIAS-AMURENSIS; MARINE POPULATIONS; REEF FISHES; ABUNDANCE; CONSERVATION; EXTINCTION; EVOLUTION; SELECTION; TASMANIA; SEA	The critically endangered spotted handfish (Brachionichthys hirsutus) is restricted to a limited number of locations in south-eastern Tasmania, Australia. As is often the case for rare species, conducting statistically adequate surveys for B. hirsutus can be costly and time consuming due to the low probability of encountering individuals. For the first time we used a highly efficient and rigorous Global Positioning System (GPS) parameterised underwater visual census (GUVC) to survey B. hirsutus abundance within all nine known local populations in the Derwent Estuary within one season. In addition, a benthic microhabitat assessment was conducted simultaneously using a GoPro (R) camera attached to diver to determine B. hirsutus microhabitat preferences. B. hirsutus local populations varied between sites, with densities ranging from 1.58 to 43.0 fishes per hectare. B. hirsutus demonstrates a strong preference for complex microhabitat features, such as depressions and ripple formations filled with biogenic substrates (e.g. shells) but avoids simple, low relief microhabitats (e.g. sand flats) and areas dominated by ephemeral, filamentous algae. Complex microhabitats may enable B. hirsutus to avoid predators, increase forage opportunities or provide higher quality spawning sites. This first wide-scale application of GUVC for B. hirsutus allowed us to survey a larger number of sites than previously possible to provide a robust reference point for future long-term monitoring.	[Wong, Lincoln S. C.; Barrett, Neville S.; Wright, Jeffrey T.; Flynn, David J. H.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Wong, Lincoln S. C.; Lynch, Tim P.; Green, Mark A.; Flynn, David J. H.] CSIRO Ocean & Atmosphere, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wong, LSC (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.; Wong, LSC (corresponding author), CSIRO Ocean & Atmosphere, Hobart, Tas, Australia.	lscwong@utas.edu.au	Barrett, Neville S/J-7593-2014; Wright, Jeffrey/J-7536-2014	Barrett, Neville S/0000-0002-6167-1356; Wright, Jeffrey/0000-0002-1085-4582	Office of the Threatened Species Commissioner Landcare project of the Federal Department of the Environment [TSCDG-06]	Office of the Threatened Species Commissioner Landcare project of the Federal Department of the Environment	This work was funded by the Office of the Threatened Species Commissioner Landcare project of the Federal Department of the Environment (Grant number: TSCDG-06) to one author (TPL). The funding body was not involved in the process of study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TJ, 2009, MAR ECOL PROG SER, V389, P31, DOI 10.3354/meps08210; Anderson TJ, 2008, MAPPING SEAFLOOR HAB, V47, P71; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; AUSTER PJ, 1995, MAR ECOL PROG SER, V127, P77, DOI 10.3354/meps127077; Auster PJ, 2003, ENVIRON BIOL FISH, V68, P381, DOI 10.1023/B:EBFI.0000005751.30906.d5; Baguette M, 2003, J APPL ECOL, V40, P404, DOI 10.1046/j.1365-2664.2003.00791.x; Barrett N. S., 1996, SPOTTED HANDFISH SUR; Beck HJ, 2014, B MAR SCI, V90, P705, DOI 10.5343/bms.2013.1055; Bruce B.D., 1997, DEV HUSBANDRY TECHNI; Bruce B.D., 1998, SPOTTED HANDFISH REC; Byrne M, 1997, MAR BIOL, V127, P673, DOI 10.1007/s002270050058; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Colin P. L., 2005, 7 IND PAC FISH C TAI; Commonwealth of Australia, 2015, REC PLAN 3 HANDF SPE; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; DoE, 2015, REC PLAN 3 HANDF SPE; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Edgar GJ, 2005, CONSERV BIOL, V19, P1294, DOI 10.1111/j.1523-1739.2005.00159.x; Edgar GJ, 2004, CONSERV BIOL, V18, P1579, DOI 10.1111/j.1523-1739.2004.00191.x; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2000, BIOL CONSERV, V92, P383, DOI 10.1016/S0006-3207(99)00111-1; Edgar GJ, 2017, BIOL CONSERV, V208, P174, DOI 10.1016/j.biocon.2016.07.028; Gascoigne J, 2004, MAR ECOL PROG SER, V269, P49, DOI 10.3354/meps269049; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; Gintert B, 2012, P 12 INT COR REEF MA, P9; Grant E. M., 1978, SPOTTED HANDFISH MON; Gray J. E., 1854, SPOTTED HANDFISH REC; Green, 2005, MARINE HABITAT REHAB; Green M.A., 1998, SPOTTED HANDFISH DIS; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jordan F, 1997, J EXP MAR BIOL ECOL, V208, P45, DOI 10.1016/S0022-0981(96)02656-1; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kutti T, 2015, MAR ECOL PROG SER, V520, P175, DOI 10.3354/meps11047; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Arroyo NL, 2012, J EXP MAR BIOL ECOL, V420, P77, DOI 10.1016/j.jembe.2012.03.020; Last PR, 2007, ZOOTAXA, P53; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Last PR, 2009, ZOOTAXA, P1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lucieer V. L., 2007, ESTUARINE HABITAT MA; Lutken C. F., 1863, DIRECT CONSERVATION, V2, P292; Lynch T, 2015, BIOL CONSERV, V191, P700, DOI 10.1016/j.biocon.2015.08.009; Mapstone B. D., 1998, INVESTIGATION OPTIMU; MAST, 2016, MAST MOOR REV 2016; MCCORMICK MI, 1987, MAR BIOL, V96, P469, DOI 10.1007/BF00397964; Moriarty T., 2012, THESIS; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Niedzwiedz G, 2013, GLOBAL POSITIONING S, p155 ; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; SAUCIER MH, 1993, ENVIRON BIOL FISH, V36, P257, DOI 10.1007/BF00001722; Scharf FS, 2006, J EXP MAR BIOL ECOL, V335, P167, DOI 10.1016/j.jembe.2006.03.018; Schmidt VE, 2012, 2012 OCEANS, V2012; Schories D, 2012, ENVIRON MONIT ASSESS, V184, P2359, DOI 10.1007/s10661-011-2122-7; Seiler J, 2012, FISH RES, V129, P64, DOI 10.1016/j.fishres.2012.06.011; Stoner AW, 2007, J SEA RES, V57, P137, DOI 10.1016/j.seares.2006.08.005; Strathmann RR, 2002, B MAR SCI, V70, P377; Struthers DP, 2015, FISHERIES, V40, P502, DOI 10.1080/03632415.2015.1082472; Swearer SE, 2002, B MAR SCI, V70, P251; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; White JW, 2010, ECOLOGY, V91, P1949, DOI 10.1890/09-0298.1; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	65	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201518	10.1371/journal.pone.0201518	http://dx.doi.org/10.1371/journal.pone.0201518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102710	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000441452200013
J	Aarts, SABM; Reiche, ME; den Toom, M; Beckers, L; Gijbels, MJJ; Gerdes, N; de Winther, MPJ; Lutgens, E				Aarts, Suzanne A. B. M.; Reiche, Myrthe E.; den Toom, Myrthe; Beckers, Linda; Gijbels, Marion J. J.; Gerdes, Norbert; de Winther, Menno P. J.; Lutgens, Esther			Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION	Obesity is a low-grade inflammatory disease that increases the risk for metabolic disorders. CD40-CD40L signaling plays a central role in obesity-induced inflammation. Genetic deficiency of CD40L in diet-induced obesity (DIO) ameliorates adipose tissue inflammation, hepatic steatosis and increases insulin sensitivity. Unexpectedly, absence of CD40 worsened insulin resistance and caused excessive adipose tissue inflammation and hepatosteatosis. To investigate whether deficiency of macrophage CD40 is responsible for the phenotype observed in the CD40(-/-) mice, we generated CD40(flfl)LysM(cre) and fed them a standard (SFD) and 54% high fat obesogenic diet (HFD) for 13 weeks. No differences in body weight, adipose tissue weight, adipocyte size, plasma cholesterol or triglyceride levels could be observed between CD40(flfl)LysM(cre) and wild type (WT) mice. CD40(flfl)LysM(cre) displayed no changes in glucose tolerance or insulin resistance, but had higher plasma adiponectin levels when fed a SFD. Liver weights, liver cholesterol and triglyceride levels, as well as the degree of hepatosteatosis were not affected by absence of macrophage CD40. CD40(flfl)LysM(cre) mice displayed a minor increase in adipose tissue leukocyte infiltration on SFD and HFD, which did not result in differences in adipose tissue cytokine levels. We here show that loss of macrophage CD40 signaling does not affect obesity induced metabolic dysregulation and indicates that CD40-deficiency on other cell-types than the macrophage is responsible for the metabolic dysregulation, adipose tissue inflammation and hepatosteatosis that are observed in CD40(-/-) mice.	[Aarts, Suzanne A. B. M.; Reiche, Myrthe E.; den Toom, Myrthe; Beckers, Linda; Gijbels, Marion J. J.; de Winther, Menno P. J.; Lutgens, Esther] Univ Amsterdam, Amsterdam UMC, Amsterdam Cardiovasc Sci, Dept Med Biochem, Amsterdam, Netherlands; [Gijbels, Marion J. J.] Univ Maastricht, Dept Biochem, Maastricht, Netherlands; [Gerdes, Norbert; de Winther, Menno P. J.; Lutgens, Esther] LMU, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Gerdes, Norbert] Univ Hosp Dusseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany	University of Amsterdam; Maastricht University; University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Lutgens, E (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Cardiovasc Sci, Dept Med Biochem, Amsterdam, Netherlands.; Lutgens, E (corresponding author), LMU, Inst Cardiovasc Prevent IPEK, Munich, Germany.	e.lutgens@amc.uva.nl	; Gerdes, Norbert/E-2787-2010	Reiche, Myrthe/0000-0002-9295-6418; Gerdes, Norbert/0000-0002-4546-7208	Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation"; Netherlands CardioVascular Research Initiative": Dutch Federation of University Medical Centres"; Netherlands CardioVascular Research Initiative": Netherlands Organisation for Health Research and Development"; Netherlands CardioVascular Research Initiative": Royal Netherlands Academy of Sciences" [CVON2011-19]; European Research Council [ERC]	Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation"; Netherlands CardioVascular Research Initiative": Dutch Federation of University Medical Centres"; Netherlands CardioVascular Research Initiative": Netherlands Organisation for Health Research and Development"; Netherlands CardioVascular Research Initiative": Royal Netherlands Academy of Sciences"; European Research Council [ERC](European Research Council (ERC))	We acknowledge the support from the Netherlands CardioVascular Research Initiative": the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences" for the GENIUS project "Generating the best evidence-based pharmaceutical targets for atherosclerosis" (CVON2011-19); This work was supported by The European Research Council [ERC Consolidator grant to E.L.].	Chatzigeorgioua A, 2014, P NATL ACAD SCI USA, V111, P2686, DOI 10.1073/pnas.1400419111; Chen Z, 2012, DIABETES, V61, P566, DOI 10.2337/db11-0474; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Guo CA, 2013, AM J PHYSIOL-ENDOC M, V304, pE951, DOI 10.1152/ajpendo.00514.2012; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Michel NA, 2018, CIRC RES, V122, P693, DOI [10.1161/CIRCRESAHA.117.312055, 10.1161/circresaha.117.312055]; Morris DL, 2016, J LEUKOCYTE BIOL, V99, P1107, DOI 10.1189/jlb.3A0115-009R; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Poggi M, 2011, ARTERIOSCL THROM VAS, V31, P2251, DOI 10.1161/ATVBAHA.111.231357; Public health agency of Sweden, 2018, OV OB; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Seijkens TTP, 2018, J AM COLL CARDIOL, V71, P527, DOI 10.1016/j.jacc.2017.11.055; Steven S, 2018, CARDIOVASC RES, V114, P312, DOI 10.1093/cvr/cvx197; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; van den Berg SM, 2015, INT J OBESITY, V39, P782, DOI 10.1038/ijo.2014.198; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf D, 2014, CIRCULATION, V129, P2414, DOI 10.1161/CIRCULATIONAHA.113.008055; Yi ZA, 2014, DIABETES, V63, P2751, DOI 10.2337/db13-1657	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202150	10.1371/journal.pone.0202150	http://dx.doi.org/10.1371/journal.pone.0202150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096208	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500054
J	Larson, BA; Bii, M; Halim, N; Rohr, JK; Sugut, W; Sawe, F				Larson, Bruce A.; Bii, Margaret; Halim, Nafisa; Rohr, Julia K.; Sugut, William; Sawe, Fredrick			Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; OPTION B PLUS; CARE; TRANSMISSION; PREVENTION; PROGRAMS; DELIVERY; OUTCOMES; ACCESS; PMTCT	Background To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiated on ART during pregnancy over the first one and two years on treatment. The study site was the District Hospital in Kericho, Kenya. Methods A micro-costing approach from the provider's perspective, based on a retrospective review of patient medical records, was used to evaluate incremental costs of care (2012 USD). Cost per patient in two cohorts were evaluated: the MCH clinic group comprised of adult women who initiated ART at the site's MCH clinic during pregnancy between 2008-2011; and for comparison, the ART clinic group comprised of adult, non-pregnant women who initiated ART at the site's ART clinic during 2008-2011. The two groups were matched on age and baseline CD4 count at initiation. Retention at year one/two on ART was defined as having completed a clinic visit at 365/730 days on ART +/- 90 days. Results For patients defined as retained in care at year one, average incremental costs per patient were $234 for the MCH clinic group (median: 215; IQR: 186, 282) and $292 in the ART clinic group (median: 227; IQR: 178, 357). ARV and laboratory costs were less on average for the MCH clinic group compared to the ART clinic group (due to lower cost regimens and fewer tests), while personnel costs were higher for the MCH clinic group. Conclusions The annual incremental cost per patient of providing ART were similar in the two clinic settings in 2012. With shifts in recommended ARV regimens and lab monitoring overtime, annual costs of care (using 2016 USD unit costs) have remained relatively constant in nominal terms for the MCH clinic group but have fallen substantially for the ART clinic group (from nominal $292 in 2012 to nominal $227 in 2016).	[Larson, Bruce A.; Halim, Nafisa] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Bii, Margaret; Sugut, William; Sawe, Fredrick] Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya; [Bii, Margaret; Sugut, William; Sawe, Fredrick] HJF Med Res Int Inc, Nairobi, Kenya; [Rohr, Julia K.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA	Boston University; Kenya Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Larson, BA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.	blarson@bu.edu		Larson, Bruce/0000-0002-9322-2387	President's Emergency Plan for AIDS Relief (PEPFAR) [W81XWH-11-2-0174]; U.S. Military HIV Research Program; United States Army Military Research Directorate, Kenya; U.S. Government through PEPFAR	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Military HIV Research Program; United States Army Military Research Directorate, Kenya; U.S. Government through PEPFAR	The President's Emergency Plan for AIDS Relief (PEPFAR) funded this study through a cooperative agreement (W81XWH-11-2-0174) between the U.S. Department of Defense and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The funder, the U.S. Government through PEPFAR, did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the U.S. Military HIV Research Program and the United States Army Military Research Directorate, Kenya throughout this study as well as the many individuals who contributed to the completion of this study, including the participating clinic staff. In addition, the authors thank Dr. Peter Rockers for his assistance with coding a pill-count STATA do file.	Achieng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032727; Bii M, 2016, 21 INT AIDS C AIDS 2; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Clinton Health Access Initiative, 2016, 2016 ANT ARV CHAI RE; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Herlihy JM, 2015, JAIDS-J ACQ IMM DEF, V70, pE123, DOI 10.1097/QAI.0000000000000760; Iyer HS, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/235483; Kenya National AIDS and STI Control Programme (NASCOP), 2009, GUID PREV MOTH CHILD; Larson BA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18026; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Ministry of Health, 2016, GUIDELINES USE ANTIR; Ministry of Health Government of Kenya, 2012, GUIDELINES PREVENTIO, V4th ed; NACC, 2016, PROGR RESP; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; National AIDS and STI Control Programme (NASCOP), 2011, GUID ANT THER ART KE; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rollins NC, 2014, JAIDS-J ACQ IMM DEF, V67, pS150, DOI 10.1097/QAI.0000000000000355; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Scott CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-296; Scott CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072444; Scott CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067910; Suthar AB, 2013, B WORLD HEALTH ORGAN, V91, P46, DOI 10.2471/BLT.12.107003; The World Bank, DAT IND; Zolfo M, 2010, JAIDS-J ACQ IMM DEF, V55, P287, DOI 10.1097/QAI.0b013e3181eef3da	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0200199	10.1371/journal.pone.0200199	http://dx.doi.org/10.1371/journal.pone.0200199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096177	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500003
J	Di Pietro, N; Potenza, MA; Di Silvestre, S; Addabbo, F; Di Pietrantonio, N; Di Tomo, P; Pipino, C; Mandatori, D; Palmerini, C; Failli, P; Bonomini, M; Montagnani, M; Pandolfi, A				Di Pietro, Natalia; Potenza, Maria Assunta; Di Silvestre, Sara; Addabbo, Francesco; Di Pietrantonio, Nadia; Di Tomo, Pamela; Pipino, Caterina; Mandatori, Domitilla; Palmerini, Carola; Failli, Paola; Bonomini, Mario; Montagnani, Monica; Pandolfi, Assunta			Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs)	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; NITRIC-OXIDE SYNTHASE; BLOOD-PRESSURE MODULATION; EXTRACELLULAR CALCIUM; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; PROTEIN-KINASE; INSULIN-RESISTANCE; DIABETIC-RATS; CA2+ CHANNELS	The potential role of calcimimetics as vasculotropic agents has been suggested since the discovery that calcium sensing receptors (CaSRs) are expressed in cardiovascular tissues. However, whether this effect is CaSR-dependent or-independent is still unclear. In the present study the vascular activity of calcimimetic R-568 was investigated in mesenteric vascular beds (MVBs) isolated from Spontaneously Hypertensive rats (SHR) and the relative age matched Wistar-Kyoto (WKY) control rats. Pre-constricted MBVs were perfused with increasing concentrations of R-568 (10 nM- 30 mu M) resulting in a rapid dose-dependent vasodilatation. However, in MVBs from SHR this was preceded by a small but significant vasoconstriction at lowest nanomolar concentrations used (10-300 nM). Pre-treatment with pharmacological inhibitors of nitric oxide (NO) synthase (NOS, L-NAME), K-Ca channels (CTX), cyclo-oxygenase (INDO) and CaSR (Calhex) or the endothelium removal suggest that NO, CaSR and the endothelium itself contribute to the R-568 vasodilatory/vasoconstrictor effects observed respectively in WKY/SHR MVBs. Conversely, the vasodilatory effects resulted by highest R-568 concentration were independent of these factors. Then, the ability of lower R-568 doses (0.1-1 mu M) to activate endothelial-NOS (eNOS) pathway in MVBs homogenates was evaluated. The Akt and eNOS phosphorylation levels resulted increased in WKY homogenates and Calhex significantly blocked this effect. Notably, this did not occur in the SHR. Similarly, vascular smooth muscle cells (vSMCs) stimulation with lower R-568 doses resulted in Akt activation and increased NO production in WKY but not in SHR cells. Interestingly, in these cells this was associated with the absence of the biologically active dimeric form of the CaSR thus potentially contributing to explain the impaired vasorelaxant effect observed in response to R-568 in MVB from SHR compared to WKY. Overall, these findings provide new insight on the mechanisms of action of the calcimimetic R-568 in modulating vascular tone both in physiological and pathological conditions such as hypertension.	[Di Pietro, Natalia; Di Tomo, Pamela; Mandatori, Domitilla; Bonomini, Mario] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Di Pietro, Natalia; Di Silvestre, Sara; Di Pietrantonio, Nadia; Di Tomo, Pamela; Pipino, Caterina; Mandatori, Domitilla; Palmerini, Carola; Bonomini, Mario; Pandolfi, Assunta] Univ G dAnnunzio, Aging & Translat Med Res Ctr CeSI MeT, Chieti, Italy; [Di Pietro, Natalia; Di Silvestre, Sara; Di Pietrantonio, Nadia; Di Tomo, Pamela; Pipino, Caterina; Mandatori, Domitilla; Palmerini, Carola; Pandolfi, Assunta] Univ G dAnnunzio, Chieti, Italy; [Potenza, Maria Assunta; Addabbo, Francesco; Montagnani, Monica] Univ Bari, Dept Pharmacol & Human Physiol, Bari, Italy; [Di Silvestre, Sara; Di Pietrantonio, Nadia; Pipino, Caterina; Palmerini, Carola; Pandolfi, Assunta] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Failli, Paola] Univ Florence, Dept Neurofarba, Pharmacol & Toxicol Unit, Florence, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universita degli Studi di Bari Aldo Moro; G d'Annunzio University of Chieti-Pescara; University of Florence	Pandolfi, A (corresponding author), Univ G dAnnunzio, Aging & Translat Med Res Ctr CeSI MeT, Chieti, Italy.; Pandolfi, A (corresponding author), Univ G dAnnunzio, Chieti, Italy.; Pandolfi, A (corresponding author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.	assunta.pandolfi@unich.it	Pipino, Caterina/N-2078-2019; Di Pietro, Natalia/K-1604-2016; Montagnani, Monica/AAV-2057-2020; PANDOLFI, Assunta/K-4595-2016	Pipino, Caterina/0000-0002-4350-8686; Di Pietro, Natalia/0000-0001-9720-2116; Montagnani, Monica/0000-0002-5697-8185; PANDOLFI, Assunta/0000-0003-4135-7631				Al-Aly Z, 2009, KIDNEY INT, V75, P9, DOI 10.1038/ki.2008.563; Awumey EM, 2013, J PHARMACOL EXP THER, V346, P38, DOI 10.1124/jpet.113.205534; Bai M, 1999, P NATL ACAD SCI USA, V96, P2834, DOI 10.1073/pnas.96.6.2834; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bernatova I, 2009, J HYPERTENS, V27, pS27, DOI 10.1097/01.hjh.0000358834.18311.fc; Bonomini M, 2005, KIDNEY INT, V67, P1899, DOI 10.1111/j.1523-1755.2005.00288.x; Bonomini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030682; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; Cavanaugh A, 2010, J BIOL CHEM, V285, P19854, DOI 10.1074/jbc.M110.124792; Di Pietro N, 2013, ATHEROSCLEROSIS, V226, P88, DOI 10.1016/j.atherosclerosis.2012.10.062; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Failli P, 2005, ANN NY ACAD SCI, V1041, P311, DOI 10.1196/annals.1282.048; Farzaneh-Far A, 2000, BIOCHEM BIOPH RES CO, V277, P736, DOI 10.1006/bbrc.2000.3747; FIELD FP, 1985, HYPERTENSION, V7, P228, DOI 10.1161/01.HYP.7.2.228; Filopanti M, 2013, CLIN CASES MINER BON, V10, P162, DOI 10.11138/ccmbm/2013.10.3.162; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; Gonzalez J, 2014, WORLD J CARDIOL, V6, P353, DOI 10.4330/wjc.v6.i6.353; Greenberg HZE, 2017, VASC PHARMACOL, V96-98, P53, DOI 10.1016/j.vph.2017.08.005; Greenberg HZE, 2016, EUR J PHARMACOL, V791, P659, DOI 10.1016/j.ejphar.2016.10.008; Harno E, 2008, CELL CALCIUM, V44, P210, DOI 10.1016/j.ceca.2007.11.011; Hayashi K, 2009, J MECH BEHAV BIOMED, V2, P3, DOI 10.1016/j.jmbbm.2008.05.002; Henaut L, 2014, CARDIOVASC RES, V101, P256, DOI 10.1093/cvr/cvt249; Hilgers RHP, 2006, AM J PHYSIOL-HEART C, V291, pH216, DOI 10.1152/ajpheart.01383.2005; Koleganova N, 2009, KIDNEY INT, V75, P60, DOI 10.1038/ki.2008.490; Liang Y, 2006, INT J NEUROSCI, V116, P1403, DOI 10.1080/00207450500514375; Loot AE, 2013, J CARDIOVASC PHARM, V61, P528, DOI 10.1097/FJC.0b013e31828d0fa3; Lopez-Fernandez I, 2015, EXP PHYSIOL, V100, P1392, DOI 10.1113/EP085137; Mannelli LD, 2009, J HYPERTENS, V27, P1258, DOI 10.1097/HJH.0b013e328329d18c; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Montagnani M, 1999, J HYPERTENS, V17, P45, DOI 10.1097/00004872-199917010-00008; Nabha L, 2005, CLIN EXP HYPERTENS, V27, P71, DOI 10.1081/CEH-200044267; Nacci C, 2009, ENDOCRINOLOGY, V150, P849, DOI 10.1210/en.2008-1069; Nakagawa K, 2009, PEDIATR NEPHROL, V24, P1385, DOI 10.1007/s00467-009-1153-6; Ogata H, 2003, J AM SOC NEPHROL, V14, P959, DOI 10.1097/01.ASN.0000056188.23717.E5; Ohanian J, 2005, AM J PHYSIOL-HEART C, V288, pH1756, DOI 10.1152/ajpheart.00739.2004; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; Pandolfi A, 2003, J CELL PHYSIOL, V196, P378, DOI 10.1002/jcp.10325; PARSONS SJW, 1994, BRIT J PHARMACOL, V113, P1275, DOI 10.1111/j.1476-5381.1994.tb17136.x; Pechanova O, 2006, CLIN SCI, V110, P235, DOI 10.1042/CS20050227; Pi M, 2004, J BONE MINER RES, V19, P862, DOI 10.1359/JBMR.040114; Pimentel AML, 2007, VASC PHARMACOL, V46, P353, DOI 10.1016/j.vph.2006.12.003; Pinterova M, 2011, PHYSIOL RES, V60, P381, DOI 10.33549/physiolres.932189; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Potenza MA, 2002, AM J PHYSIOL-GASTR L, V283, pG587, DOI 10.1152/ajpgi.00391.2001; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE685, DOI 10.1152/ajpendo.00291.2009; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Rybczynska A, 2005, AM J HYPERTENS, V18, P364, DOI 10.1016/j.amjhyper.2004.10.019; Rybczynska A, 2006, PHARMACOL REP, V58, P533; Schepelmann M, 2016, AM J PHYSIOL-CELL PH, V310, pC193, DOI 10.1152/ajpcell.00248.2015; Smajilovic S, 2008, HYPERTENSION, V52, P994, DOI 10.1161/HYPERTENSIONAHA.108.117689; Smajilovic S, 2007, VASC PHARMACOL, V47, P222, DOI 10.1016/j.vph.2007.06.010; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Smajilovic S, 2011, BRIT J PHARMACOL, V164, P884, DOI 10.1111/j.1476-5381.2011.01317.x; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Thakore P, 2011, BRIT J PHARMACOL, V162, P749, DOI 10.1111/j.1476-5381.2010.01079.x; Trovati M, 1999, DIABETOLOGIA, V42, P831, DOI 10.1007/s001250051234; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Wonneberger K, 2000, J MEMBRANE BIOL, V175, P203, DOI 10.1007/s002320001068; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	64	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202354	10.1371/journal.pone.0202354	http://dx.doi.org/10.1371/journal.pone.0202354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092054	gold, Green Published, Green Submitted			2022-12-26	WOS:000441232600113
J	Vieira, A; Vergoni, B; Courtney, M; Druelle, N; Gjernes, E; Hadzic, B; Avolio, F; Napolitano, T; Sanz, SN; Mansouri, A; Collombat, P				Vieira, Andhira; Vergoni, Bastien; Courtney, Monica; Druelle, Noemie; Gjernes, Elisabet; Hadzic, Biljana; Avolio, Fabio; Napolitano, Tiziana; Sanz, Sergi Navarro; Mansouri, Ahmed; Collombat, Patrick			Neurog3 misexpression unravels mouse pancreatic ductal cell plasticity	PLOS ONE			English	Article							BETA-CELLS; ADULT PANCREAS; ENDOCRINE; DIFFERENTIATION; REGENERATION; PROGENITORS; EXPRESSION; LINEAGES; MICE; ACTIVATION	In the context of type 1 diabetes research and the development of insulin-producing beta-cell replacement strategies, whether pancreatic ductal cells retain their developmental capability to adopt an endocrine cell identity remains debated, most likely due to the diversity of models employed to induce pancreatic regeneration. In this work, rather than injuring the pancreas, we developed a mouse model allowing the inducible misexpression of the proendocrine gene Neurog3 in ductal cells in vivo. These animals developed a progressive islet hypertrophy attributed to a proportional increase in all endocrine cell populations. Lineage tracing experiments indicated a continuous neo-generation of endocrine cells exhibiting a ductal ontogeny. Interestingly, the resulting supplementary beta-like cells were found to be functional. Based on these findings, we suggest that ductal cells could represent a renewable source of new beta-like cells and that strategies aiming at controlling the expression of Neurog3, or of its molecular targets/co-factors, may pave new avenues for the improved treatments of diabetes.	[Vieira, Andhira; Vergoni, Bastien; Courtney, Monica; Druelle, Noemie; Gjernes, Elisabet; Hadzic, Biljana; Avolio, Fabio; Napolitano, Tiziana; Sanz, Sergi Navarro; Collombat, Patrick] Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, Nice, France; [Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Gottingen, Germany; [Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Vergoni, Bastien] INSERM, U1065, C3M, Team Mol & Cellular Physiopathol Obes & Diabet 7, Nice, France; [Courtney, Monica] EVOTEC Int, Gottingen, Germany; [Druelle, Noemie] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA; [Druelle, Noemie] Columbia Univ, Dept Med, New York, NY USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Max Planck Society; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Evotec; Columbia University; Columbia University	Collombat, P (corresponding author), Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, Nice, France.	collombat@unice.fr	Druelle, Noémie/T-6899-2019; collombat, patrick/F-4495-2015; collombat, patrick/P-3741-2019	collombat, patrick/0000-0001-8232-1438; collombat, patrick/0000-0001-8232-1438; Avolio, Fabio/0000-0003-2067-5315; Gjernes, Elisabet/0000-0001-9477-5904	Juvenile Diabetes Research Foundation [C1-1-SRA-2018-536-M-R, 3-SRA-2014-282-Q-R, 3-SRA-2017-415-S-B, 2-SRA-2017-416-S-B, 17-2013-426]; Institut National de la Sante et de la Recherche Medicale AVE NIR program; Institut National de la Sante et de la Recherche Medicale; European Research Council [StG-2011-281265]; Fondation pour la Recherche Medicale [DRC20091217179]; Agence Nationale de la Recherche [2009 GENO 105 01/01KU0906, ANR-17-ERC2-0004-01, ANR-16-CE18-0005-02]; "Investments for the Future" LAB EX SIG NAL IFE [ANR-11-LABX-0028-01]; Dujean family; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Institut National de la Sante et de la Recherche Medicale AVE NIR program; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); "Investments for the Future" LAB EX SIG NAL IFE; Dujean family; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche(Schlumberger)	Patrick COLLOMBAT received the grants funding this work from Juvenile Diabetes Research Foundation (C1-1-SRA-2018-536-M-R, 3-SRA-2014-282-Q-R, 3-SRA-2017-415-S-B, 2-SRA-2017-416-S-B, and 17-2013-426), the Institut National de la Sante et de la Recherche Medicale AVE NIR program, the Institut National de la Sante et de la Recherche Medicale, the European Research Council (StG-2011-281265), the Fondation pour la Recherche Medicale (DRC20091217179), the Agence Nationale de la Recherche (2009 GENO 105 01/01KU0906, ANR-17-ERC2-0004-01, ANR-16-CE18-0005-02, and Betaplasticity), the "Investments for the Future" LAB EX SIG NAL IFE (ANR-11-LABX-0028-01), Mr. and Mrs. Dorato, Mr. and Mrs. Peter de Marffy-Mantuano, the Dujean family, the Fondation Generale de Sante, and the Foundation Schlumberger pour l'Education et la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Alwan A., 2010, WORLD HLTH, P176; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2016, ENDOCRINOLOGY, V157, P166, DOI 10.1210/en.2015-1175; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Herrera PL, 2002, INT J DEV BIOL, V46, P97; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopinke D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-38; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Miyashita K, 2014, BIOCHEM BIOPH RES CO, V444, P514, DOI 10.1016/j.bbrc.2014.01.083; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Roark R, 2012, BIOL OPEN, V1, P1264, DOI 10.1242/bio.20121750; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Soyer J, 2010, DEVELOPMENT, V137, P203, DOI 10.1242/dev.041673; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Tellez N, 2011, ENDOCRINOLOGY, V152, P2580, DOI 10.1210/en.2011-0066; Villasenor A, 2008, DEV DYNAM, V237, P3270, DOI 10.1002/dvdy.21740; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang MF, 2016, P NATL ACAD SCI USA, V113, P650, DOI 10.1073/pnas.1524200113; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201536	10.1371/journal.pone.0201536	http://dx.doi.org/10.1371/journal.pone.0201536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092080	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600033
J	Zhang, J; Huang, JQ; Qi, TY; Huang, YZ; Lu, YT; Zhan, TW; Gong, H; Zhu, ZY; Shi, YL; Zhou, JH; Yu, LY; Zhang, X; Cheng, HQ; Ke, YH				Zhang, Jie; Huang, Jiaqi; Qi, Tongyun; Huang, Yizhou; Lu, Yuting; Zhan, Tianwei; Gong, Hui; Zhu, Zhengyi; Shi, Yueli; Zhou, Jianhong; Yu, Luyang; Zhang, Xue; Cheng, Hongqiang; Ke, Yuehai			SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1	FASEB JOURNAL			English	Article						adherens junctions; permeability; vascular development; protein tyrosine phosphatase; vascular leakage	TYROSINE-PHOSPHATASE SHP2; LEUKOCYTE EXTRAVASATION; VASCULAR-PERMEABILITY; ACTIVATION; MECHANISMS; JUNCTIONS; INHIBITION; DISRUPTION; PROTEINS; KINASE	Vascular endothelial (VE)-cadherin junctional localization is known to play a central role in vascular development, endothelial barrier integrity, and homeostasis. The sarcoma homology domain containing protein tyrosine phosphatase (SHP)2 has been shown to be involved in regulating endothelial barrier function; however, the mechanisms remain largely unknown. In this work SHP2 knockdown in an HUVEC monolayer increased VE-cadherin internalization and endothelial barrier permeability. Loss of SHP2 specifically augmented the GTPase activity of ADP-ribosylation factor (ARF)-1. ARF1 knockdown or inhibition of its guanine nucleotide exchange factors (GEFs) markedly attenuated VE-cadherin internalization and barrier hyperpermeability induced by SHP2 deficiency. SHP2 knockdown increased the total and phosphorylated levels of MET, whose activity was necessary for ARF1 activation and VE-cadherin internalization. Furthermore, constitutive endothelium-specific deletion of Shp2 in mice led to disrupted endothelial cell junctions, massive hemorrhage, and lethality in embryos. Induced and endothelium-specific deletion of Shp2 in adult mice resulted in lung hyperpermeability. Inhibitors for ARF1-GEF or MET used in pregnant mice prevented the vascular leakage in endothelial Shp2-deleted embryos. Together, our findings define a novel role of SHP2 in stabilizing junctional VE-cadherin in the resting endothelial barrier through suppressing MET and ARF1 activation.Zhang, J., Huang, J., Qi, T., Huang, Y., Lu, Y., Zhan, T., Gong, H., Zhu, Z., Shi, Y., Zhou, J., Yu, L., Zhang, X., Cheng, H., Ke, Y. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.	[Zhang, Jie; Huang, Jiaqi; Lu, Yuting; Zhan, Tianwei; Gong, Hui; Zhu, Zhengyi; Shi, Yueli; Zhang, Xue; Cheng, Hongqiang; Ke, Yuehai] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, POB 59,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Qi, Tongyun; Huang, Yizhou; Zhou, Jianhong] Zhejiang Univ, Dept Gynecol, Hangzhou, Zhejiang, Peoples R China; [Yu, Luyang] Zhejiang Univ, Inst Genet, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Ke, Yuehai] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Cheng, HQ; Ke, YH (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, POB 59,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	hqcheng11@zju.edu.cn; yke@zju.edu.cn		Yu, Luyang/0000-0002-1301-6285	National Natural Science Foundation of China [31471258, 81530001, 81170117]; Zhejiang Provincial Natural Science Foundation of China [LZ18H020001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors thank Dr. Gen-sheng Feng (University of California San Diego, La Jolla, CA, USA) for providing the Shp2<SUP>f/f</SUP> mice. This work was supported by National Natural Science Foundation of China Grants 31471258 (to H.C.), 81530001 (to Y.K.), and 81170117 (to H.C.), and Zhejiang Provincial Natural Science Foundation of China Grant LZ18H020001 (to H.C.). The authors declare no conflicts of interest.	Barabutis N, 2016, AM J PHYSIOL-LUNG C, V311, pL832, DOI 10.1152/ajplung.00233.2016; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chichger H, 2015, AM J RESP CELL MOL, V52, P695, DOI 10.1165/rcmb.2013-0489OC; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daher Z, 2010, J BIOL CHEM, V285, P24591, DOI 10.1074/jbc.M110.115311; Daneshjou N, 2015, J CELL BIOL, V209, P181, DOI 10.1083/jcb.20140910803202015c; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Duan HF, 2006, CELL SIGNAL, V18, P2049, DOI 10.1016/j.cellsig.2006.04.002; Fraccaroli A, 2015, CIRC RES, V117, P29, DOI 10.1161/CIRCRESAHA.117.305818; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hongu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8925; Huang MG, 2016, J CLIN INVEST, V126, P1801, DOI 10.1172/JCI84876; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kuppers V, 2014, CELL TISSUE RES, V355, P577, DOI 10.1007/s00441-014-1812-1; Mannell H, 2014, MINI-REV MED CHEM, V14, P471, DOI 10.2174/1389557514999140506094738; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitola S, 2006, CIRC RES, V98, P45, DOI 10.1161/01.RES.0000199355.32422.7b; MITRA P, 1991, BIOTECHNIQUES, V11, P504; Muharram G, 2014, DEV CELL, V29, P421, DOI 10.1016/j.devcel.2014.03.024; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Sun MJ, 2012, ANAL BIOCHEM, V425, P96, DOI 10.1016/j.ab.2012.03.010; Tajan M, 2015, EUR J MED GENET, V58, P509, DOI 10.1016/j.ejmg.2015.08.005; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Tien SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10420; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7; Wall N., 2008, CSH PROTOC, V2008; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; YU G, 2016, AM J RESP CRIT CARE, V193; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	48	12	12	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1124	1137		10.1096/fj.201800284R	http://dx.doi.org/10.1096/fj.201800284R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30102570	Bronze			2022-12-26	WOS:000457401500089
J	Balchak, DM; Thompson, RN; Kashlan, OB				Balchak, Deidra M.; Thompson, Rebecca N.; Kashlan, Ossama B.			The epithelial Na+ channel subunit autoinhibitory tract suppresses channel activity by binding the gamma subunit's finger-thumb domain interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteolysis; allosteric regulation; cysteine-mediated cross-linking; protein conformation; epithelial sodium channel (ENaC); autoinhibition; cation channel; finger-thumb domain	SODIUM-CHANNEL; EXTRACELLULAR DOMAIN; HISTIDINE-RESIDUES; SELF-INHIBITION; ALPHA-SUBUNIT; ACTIVATION; ENAC; FURIN; PEPTIDE; SELECTIVITY	Epithelial Na+ channel (ENaC) maturation and activation require proteolysis of both the and subunits. Cleavage at multiple sites in the finger domain of each subunit liberates their autoinhibitory tracts. Synthetic peptides derived from the proteolytically released fragments inhibit the channel, likely by reconstituting key interactions removed by the proteolysis. We previously showed that a peptide derived from the subunit's autoinhibitory sequence (-8) binds at the subunit's finger-thumb domain interface. Despite low sequence similarity between the and subunit finger domains, we hypothesized that a peptide derived from the subunit's autoinhibitory sequence (-11) inhibits the channel through an analogous mechanism. Using Xenopus oocytes, we found here that channels lacking a subunit thumb domain were no longer sensitive to -11, but remained sensitive to -8. We identified finger domain sites in the subunit that dramatically reduced -11 inhibition. Using cysteines and sulfhydryl reactive cross-linkers introduced into both the peptide and the subunit, we also could cross-link -11 to both the finger domain and the thumb domain of the subunit. Our results suggest that -8 and -11 occupy similar binding pockets within their respective subunits, and that proteolysis of the and subunits activate the channel through analogous mechanisms.	[Balchak, Deidra M.; Thompson, Rebecca N.; Kashlan, Ossama B.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Dept Med, S828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu			NIDDK, National Institutes of Health [R01 DK098204, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098204, P30DK079307] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grant R01 DK098204 (to O. B. K.) and the Pittsburgh Center for Kidney Research was supported by NIDDK Grant P30 DK079307, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Blobner BM, 2018, J BIOL CHEM, V293, P4928, DOI 10.1074/jbc.M117.819367; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Frindt G, 2016, J GEN PHYSIOL, V147, P217, DOI 10.1085/jgp.201511533; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2018, J BIOL CHEM, V293, P17582, DOI 10.1074/jbc.RA118.003618; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	45	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16217	16225		10.1074/jbc.RA118.004362	http://dx.doi.org/10.1074/jbc.RA118.004362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30131333	Green Published, hybrid			2022-12-26	WOS:000447833600010
J	Hoff, S; Epting, D; Falk, N; Schroda, S; Braun, DA; Halbritter, J; Hildebrandt, F; Kramer-Zucker, A; Bergmann, C; Walz, G; Lienkamp, SS				Hoff, Sylvia; Epting, Daniel; Falk, Nathalie; Schroda, Sophie; Braun, Daniela A.; Halbritter, Jan; Hildebrandt, Friedhelm; Kramer-Zucker, Albrecht; Bergmann, Carsten; Walz, Gerd; Lienkamp, Soeren S.			The nucleoside-diphosphate kinase NME3 associates with nephronophthisis proteins and is required for ciliary function during renal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						primary cilium; kidney; DNA damage response; nucleoside; nucleotide metabolism; Xenopus; zebrafish; ciliopathies; nephronophthisis	LEFT-RIGHT ASYMMETRY; SITUS-INVERSUS; BASAL BODY; ZEBRAFISH PRONEPHROS; MULTICILIATED CELLS; JOUBERT-SYNDROME; NEK-FAMILY; MUTATIONS; CILIOPATHIES; DISEASE	Nephronophthisis (NPH) is an autosomal recessive renal disease leading to kidney failure in children and young adults. The protein products of the corresponding genes (NPHPs) are localized in primary cilia or their appendages. Only about 70% of affected individuals have a mutation in one of 100 renal ciliopathy genes, and no unifying pathogenic mechanism has been identified. Recently, some NPHPs, including NIMA-related kinase 8 (NEK8) and centrosomal protein 164 (CEP164), have been found to act in the DNA-damage response pathway and to contribute to genome stability. Here, we show that NME/NM23 nucleoside-diphosphate kinase 3 (NME3) that has recently been found to facilitate DNA-repair mechanisms binds to several NPHPs, including NEK8, CEP164, and ankyrin repeat and sterile motif domain-containing 6 (ANKS6). Depletion of nme3 in zebrafish and Xenopus resulted in typical ciliopathy-associated phenotypes, such as renal malformations and left-right asymmetry defects. We further found that endogenous NME3 localizes to the basal body and that it associates also with centrosomal proteins, such as NEK6, which regulates cell cycle arrest after DNA damage. The ciliopathy-typical manifestations of NME3 depletion in two vertebrate in vivo models, the biochemical association of NME3 with validated NPHPs, and its localization to the basal body reveal a role for NME3 in ciliary function. We conclude that mutations in the NME3 gene may aggravate the ciliopathy phenotypes observed in humans.	[Hoff, Sylvia; Epting, Daniel; Falk, Nathalie; Schroda, Sophie; Kramer-Zucker, Albrecht; Bergmann, Carsten; Walz, Gerd; Lienkamp, Soeren S.] Univ Freiburg, Fac Med, Med Ctr, Dept Med,Renal Div, D-79106 Freiburg, Germany; [Braun, Daniela A.; Halbritter, Jan; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, D-55218 Ingelheim, Germany; [Walz, Gerd; Lienkamp, Soeren S.] Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; Harvard University; Boston Children's Hospital; Harvard Medical School	Lienkamp, SS (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Med,Renal Div, D-79106 Freiburg, Germany.; Lienkamp, SS (corresponding author), Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany.	soeren.lienkamp@uniklinik-freiburg.de	Lienkamp, Soeren/AAH-6296-2020	Lienkamp, Soeren/0000-0003-2963-6865; Halbritter, Jan/0000-0002-1377-9880	National Institutes of Health [DK1068306]; Deutsche Forschungsgemeinschaft (DFG) [KFO 201]; DFG [SFB1140]; Emmy Noether Program of the DFG [LI 1817/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Emmy Noether Program of the DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK1068306 (to F. H.), Deutsche Forschungsgemeinschaft (DFG) Grant KFO 201 (to A. K. Z., G. W., and S. S. L.), DFG-funded Grant SFB1140 (Kidney Disease-from Genes to Mechanisms (KIDGEM)) (to S. S. L., C. B., and G. W.), and Emmy Noether Program LI 1817/2-1 of the DFG (to S. S. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeyta A, 2017, CELL CYCLE, V16, P335, DOI 10.1080/15384101.2016.1259038; Bauer H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002567; Betleja E, 2010, CURR BIOL, V20, pR928, DOI 10.1016/j.cub.2010.09.058; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Burckle C, 2011, HUM MOL GENET, V20, P2611, DOI 10.1093/hmg/ddr164; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Epting D, 2015, DEVELOPMENT, V142, P1553, DOI 10.1242/dev.124214; Epting D, 2015, DEVELOPMENT, V142, P174, DOI 10.1242/dev.112250; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Failler M, 2014, AM J HUM GENET, V94, P905, DOI 10.1016/j.ajhg.2014.05.002; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hsiau T, 2018, BIORXIV, DOI [10.1101/251082, DOI 10.1101/251082]; Huet D, 2014, ELIFE, V3, DOI 10.7554/eLife.02419; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Macia MS, 2017, AM J HUM GENET, V100, P323, DOI 10.1016/j.ajhg.2016.12.011; Manning DK, 2013, J AM SOC NEPHROL, V24, P100, DOI 10.1681/ASN.2012050490; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Meirelles GV, 2010, J PROTEOME RES, V9, P6298, DOI 10.1021/pr100562w; Nakata K, 2012, CYTOSKELETON, V69, P221, DOI 10.1002/cm.21014; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Reish O, 2016, HUM MUTAT, V37, P727, DOI 10.1002/humu.22998; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Suizu F, 2016, EMBO J, V35, P1346, DOI 10.15252/embj.201593003; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Tsao N, 2016, BIOCHEM J, V473, P1237, DOI 10.1042/BCJ20160122; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Wolf MTF, 2015, CURR OPIN PEDIATR, V27, P201, DOI 10.1097/MOP.0000000000000194; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Zhang BY, 2017, J BIOL CHEM, V292, P1351, DOI 10.1074/jbc.M116.765438; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	60	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15243	15255		10.1074/jbc.RA117.000847	http://dx.doi.org/10.1074/jbc.RA117.000847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30111592	Green Published, hybrid			2022-12-26	WOS:000445998400024
J	Kurup, JT; Kidder, BL				Kurup, Jiji T.; Kidder, Benjamin L.			Identification of H4K20me3-and H3K4me3-associated RNAs using CARIP-Seq expands the transcriptional and epigenetic networks of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; chromatin; RNA; epigenetics; histone modification; CARIP-Seq; H3K4me3; H4K20me3	LONG NONCODING RNAS; HISTONE LYSINE METHYLATION; BINDING PROTEINS; GENE-EXPRESSION; GENOME INTEGRITY; MESSENGER-RNAS; ACTIVE GENES; CHROMATIN; MOUSE; CHIP	RNA has been shown to interact with various proteins to regulate chromatin dynamics and gene expression. However, it is unknown whether RNAs associate with epigenetic marks such as post-translational modifications of histones, including histone 4 lysine 20 trimethylation (H4K20me3) or trimethylated histone 3 lysine 4 (H3K4me3), to regulate chromatin and gene expression. Here, we used chromatin-associated RNA immunoprecipitation (CARIP) followed by next-generation sequencing (CARIP-Seq) to survey RNAs associated with H4K20me3- and H3K4me3-marked chromatin on a global scale in embryonic stem (ES) cells. We identified thousands of mRNAs and noncoding RNAs that associate with H4K20me3- and H3K4me3-marked chromatin. H4K20me3- and H3K4me3-interacting RNAs are involved in chromatin organization and modification and RNA processing, whereas H4K20me3-only RNAs are involved in cell motility and differentiation, and H3K4me3-only RNAs are involved in metabolic processes and RNA processing. Expression of H3K4me3-associated RNAs is enriched in ES cells, whereas expression of H4K20me3-associated RNAs is enriched in ES cells and differentiated cells. H4K20me3- and H3K4me3-interacting RNAs originate from genes that co-localize with features of active chromatin, including transcriptional machinery and active promoter regions, and the histone modification H3K36me3 in gene body regions. We also found that H4K20me3 and H3K4me3 are associated with distinct gene features including transcripts of greater length and exon number relative to unoccupied transcripts. H4K20me3- and H3K4me3-marked chromatin is also associated with processed RNAs (exon transcripts) relative to unspliced pre-mRNA and ncRNA transcripts. In summary, our results provide evidence that H4K20me3- and H3K4me3-associated RNAs represent a distinct subnetwork of the ES cell transcriptional repertoire.	[Kurup, Jiji T.; Kidder, Benjamin L.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Kurup, Jiji T.; Kidder, Benjamin L.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Kidder, BL (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA.	benjamin.kidder@wayne.edu		Thulaseedhara Kurup, Jiji/0000-0001-6291-3911	NHLBI, National Institutes of Health [1K22HL126842-01A1]; Wayne State University; Karmanos Cancer Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL126842] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wayne State University; Karmanos Cancer Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grant 1K22HL126842-01A1 and by funds from the Wayne State University and Karmanos Cancer Institute (to B.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; He RS, 2017, NUCLEIC ACIDS RES, V45, P6427, DOI 10.1093/nar/gkx251; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendrickson DG, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0878-3; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson WL, 2017, CURR OPIN CELL BIOL, V46, P102, DOI 10.1016/j.ceb.2017.05.004; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Kidder B.L., 2018, J VIS EXP, V135, pe57481, DOI [10.3791/57481, DOI 10.3791/57481]; Kidder BL, 2017, CANCER RES, V77, P6729, DOI 10.1158/0008-5472.CAN-17-0828; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; Kidder BL, 2014, METHODS MOL BIOL, V1150, P227, DOI 10.1007/978-1-4939-0512-6_15; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Kidder BL, 2013, MOL CELL BIOL, V33, P4793, DOI 10.1128/MCB.00692-13; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kornblihtt AR, 2009, NAT STRUCT MOL BIOL, V16, P902, DOI 10.1038/nsmb0909-902; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao J, 2014, METHODS MOL BIOL, V1150, P215, DOI 10.1007/978-1-4939-0512-6_14; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xu J., 2018, BIOL OPEN, P7; Xu J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4886-4; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875	73	5	6	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15120	15135		10.1074/jbc.RA118.004974	http://dx.doi.org/10.1074/jbc.RA118.004974			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115682	hybrid, Green Published			2022-12-26	WOS:000445998400015
J	Clasen, L; Eickholt, C; Angendohr, S; Jungen, C; Shin, DI; Donner, B; Fuernkranz, A; Kelm, M; Kloecker, N; Meyer, C; Makimoto, H				Clasen, Lukas; Eickholt, Christian; Angendohr, Stephan; Jungen, Christiane; Shin, Dong-In; Donner, Birgit; Fuernkranz, Alexander; Kelm, Malte; Kloecker, Nikolaj; Meyer, Christian; Makimoto, Hisaki			A modified approach for programmed electrical stimulation in mice: Inducibility of ventricular arrhythmias	PLOS ONE			English	Article							PREMATURE COMPLEXES; CARDIAC-ARRHYTHMIA; MOUSE; TACHYCARDIA; MORTALITY; HEART; ELECTROPHYSIOLOGY; FIBRILLATION; MYOCARDIUM; FLECAINIDE	Background Electrophysiological studies in mice, the prevailing model organism in the field of basic cardiovascular research, are impeded by the low yield of programmed electrical stimulation (PES). Objective To investigate a modified approach for ventricular arrhythmia (VA) induction and a novel scoring system in mice. Method A systematic review of literature on current methods for PES in mice searching the PubMed database revealed that VA inducibility was low and ranged widely (4.6 +/- 10.7%). Based on this literature review, a modified PES protocol with 3 to 10 extrastimuli was developed and tested in comparison to the conventional PES protocol using up to 3 extrastimuli in anesthetized wildtype mice (C57BL/6J, n = 12). Induced VA, classified according to the Lambeth Convention, were assessed by established arrhythmia scores as well as a novel arrhythmia score based on VA duration. Results PES with the modified approach raised both the occurrence and the duration of VA compared to conventional PES (0% vs 50%; novel VA score p = 0.0002). Particularly, coupling of >6 extrastimuli raised the induction of VA. Predominantly, premature ventricular complexes (n = 6) and ventricular tachycardia <1s (n = 4) were observed. Repeated PES after adrenergic stimulation using isoprenaline resulted in enhanced induction of ventricular tachycardia <1s in both protocols. Conclusion Our findings suggest that the presented approach of modified PES enables effective induction and quantification of VA in wildtype mice and may well be suited to document and evaluate detailed VA characteristics in mice.	[Clasen, Lukas; Eickholt, Christian; Angendohr, Stephan; Jungen, Christiane; Shin, Dong-In; Fuernkranz, Alexander; Kelm, Malte; Meyer, Christian; Makimoto, Hisaki] Univ Duesseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Clasen, Lukas; Angendohr, Stephan; Shin, Dong-In; Fuernkranz, Alexander; Kelm, Malte; Makimoto, Hisaki] Univ Duesseldorf, Med Fac, Cardiovasc Res Inst Duesseldorf CARID, Dusseldorf, Germany; [Donner, Birgit] Univ Childrens Hosp, Dept Pediat Cardiol & Pneumol, Dusseldorf, Germany; [Kloecker, Nikolaj] Heinrich Heine Univ, Med Fac, Inst Neuro & Sensory Physiol, Dusseldorf, Germany; [Eickholt, Christian; Jungen, Christiane; Meyer, Christian] Univ Hosp, Univ Heart Ctr, Dept Electrophysiol, Eppendorf, Germany; [Donner, Birgit] Univ Childrens Hosp, Dept Paediat Cardiol, Basel, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Meyer, C; Makimoto, H (corresponding author), Univ Duesseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.; Makimoto, H (corresponding author), Univ Duesseldorf, Med Fac, Cardiovasc Res Inst Duesseldorf CARID, Dusseldorf, Germany.; Meyer, C (corresponding author), Univ Hosp, Univ Heart Ctr, Dept Electrophysiol, Eppendorf, Germany.	chr.meyer@uke.de; hisaki.makimoto@med.uni-duesseldorf.de	Eickholt, Christian/G-1466-2013; Makimoto, Hisaki/ABH-9630-2020	Eickholt, Christian/0000-0002-5458-9688; Meyer, Christian/0000-0003-0217-3960; Jungen, Christiane/0000-0003-4062-3299; Kelm, Malte/0000-0003-0060-1052	Deutsche Forschungsgemeinschaft [SFB1116, TPA01]; Research Committee of the Medical Faculty of the Heinrich Heine University [43/2013]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Committee of the Medical Faculty of the Heinrich Heine University	This study was supported by the Deutsche Forschungsgemeinschaft SFB1116, TPA01 to N.K. and by the Research Committee of the Medical Faculty of the Heinrich Heine University (43/2013).	Aistrup GL, 2006, CIRC RES, V99, pE65, DOI 10.1161/01.RES.0000244087.36230.bf; Antoons G, 2002, J PHYSIOL-LONDON, V543, P889, DOI 10.1113/jphysiol.2002.025619; Ataklte F, 2013, AM J CARDIOL, V112, P1263, DOI 10.1016/j.amjcard.2013.05.065; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Cabrera-Fuentes HA, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0586-x; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Faggioni M, 2013, CIRC RES, V112, P689, DOI 10.1161/CIRCRESAHA.111.300076; Garrey WE, 1914, ANN NONINVAS ELECTRO, V3, P163, DOI [10.1111/j.1542-474X.1998.tb00416.x12, DOI 10.1111/J.1542-474X.1998.TB00416.X12]; GILMOUR RF, 1983, AM J CARDIOL, V51, P137, DOI 10.1016/S0002-9149(83)80024-1; Gorressen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120961; Hearse DJ, 2000, PHARMACOL RES, V41, P597, DOI 10.1006/phrs.1999.0651; JOSEPHSON ME, 1978, CIRCULATION, V57, P659, DOI 10.1161/01.CIR.57.4.659; Jungen C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14155; Kodirov SA, 2004, AM J PHYSIOL-HEART C, V286, pH368, DOI 10.1152/ajpheart.00303.2003; KOLLER BS, 1995, CIRCULATION, V91, P2378, DOI 10.1161/01.CIR.91.9.2378; Leroy J, 2011, J CLIN INVEST, V121, P2651, DOI 10.1172/JCI44747; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Louch WE, 2012, PHYSIOLOGY, V27, P308, DOI 10.1152/physiol.00021.2012; Maguire CT, 2003, PHYSIOL GENOMICS, V15, P84, DOI 10.1152/physiolgenomics.00034.2003; MASON JW, 1989, CIRCULATION, V79, P1354; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; MUGELLI A, 1986, J MOL CELL CARDIOL, V18, P1313, DOI 10.1016/S0022-2828(86)80434-5; Nabben M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0447-4; National Research Council, 2011, GUIDE CARE USE LAB A; Ng Fu Siong, 2016, JACC Clin Electrophysiol, V2, P574, DOI 10.1016/j.jacep.2016.03.007; Petric S, 2012, CELL PHYSIOL BIOCHEM, V30, P523, DOI 10.1159/000341435; Prestia KA, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00001; Qureshi W, 2014, AM J CARDIOL, V114, P59, DOI 10.1016/j.amjcard.2014.04.005; Shusterman V, 2010, AM J PHYSIOL-HEART C, V298, pH440, DOI 10.1152/ajpheart.01024.2008; Vaidya D, 1999, CIRC RES, V85, P174, DOI 10.1161/01.RES.85.2.174; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Yamada T, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004959; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zuberi Z, 2010, CIRC-ARRHYTHMIA ELEC, V3, P391, DOI 10.1161/CIRCEP.109.894329	36	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201910	10.1371/journal.pone.0201910	http://dx.doi.org/10.1371/journal.pone.0201910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133474	gold, Green Published, Green Submitted			2022-12-26	WOS:000442500400047
J	Modrzynska, J; Berthing, T; Ravn-Haren, G; Kling, K; Mortensen, A; Rasmussen, RR; Larsen, EH; Saber, AT; Vogel, U; Loeschner, K				Modrzynska, Justyna; Berthing, Trine; Ravn-Haren, Gitte; Kling, Kirsten; Mortensen, Alicja; Rasmussen, Rie R.; Larsen, Erik H.; Saber, Anne T.; Vogel, Ulla; Loeschner, Katrin			In vivo-induced size transformation of cerium oxide nanoparticles in both lung and liver does not affect long-term hepatic accumulation following pulmonary exposure	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; INSOLUBLE IRIDIUM PARTICLES; SPRAGUE-DAWLEY RATS; INTRATRACHEAL INSTILLATION; GOLD NANOPARTICLES; PHYSICOCHEMICAL PROPERTIES; SILVER NANOPARTICLES; ULTRAFINE PARTICLES; INHALATION EXPOSURE; TISSUE DISTRIBUTION	Recent findings show that cerium oxide (CeO2) nanoparticles may undergo in vivo-induced size transformation with the formation of smaller particles that could result in a higher translocation following pulmonary exposure compared to virtually insoluble particles, like titanium dioxide (TiO2). Therefore, we compared liver deposition of CeO2 and TiO2 nanoparticles of similar primary sizes 1, 28 or 180 days after intratracheal instillation of 162 mu g of NPs in female C57BL/6 mice. Mice exposed to 162 mu g CeO2 or TiO2 nanoparticles by intravenous injection or oral gavage were included as reference groups to assess the amount of NPs that reach the liver bypassing the lungs and the translocation of NPs from the gastrointestinal tract to the liver, respectively. Pulmonary deposited CeO2 nanoparticles were detected in the liver 28 and 180 days post-exposure and TiO2 nanoparticles 180 days post-exposure as determined by darkfield imaging and by the quantification of Ce and Ti mass concentration by inductively coupled plasma-mass spectrometry (ICP-MS). Ce and Ti concentrations increased over time and 180 days post-exposure the translocation to the liver was 2.87 +/- 3.37% and 1.24 +/- 1.98% of the initial pulmonary dose, respectively. Single particle ICP-MS showed that the size of CeO2 nanoparticles in both lung and liver tissue decreased over time. No nanoparticles were detected in the liver following oral gavage. Our results suggest that pulmonary deposited CeO2 and TiO2 nanoparticles translocate to the liver with similar calculated translocation rates despite their different chemical composition and shape. The observed particle size distributions of CeO2 nanoparticles indicate in vivo processing over time both in lung and liver. The fact that no particles were detected in the liver following oral exposure showed that direct translocation of nanoparticles from lung to the systemic circulation was the most important route of translocation for pulmonary deposited particles.	[Modrzynska, Justyna; Ravn-Haren, Gitte; Rasmussen, Rie R.; Larsen, Erik H.; Loeschner, Katrin] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Modrzynska, Justyna; Berthing, Trine; Kling, Kirsten; Mortensen, Alicja; Saber, Anne T.; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	Technical University of Denmark; National Research Centre for the Working Environment; Technical University of Denmark	Loeschner, K (corresponding author), Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark.	kals@food.dtu.dk	Vogel, Ulla B/I-5048-2012; Löschner, Katrin/AAA-1569-2020; Ravn-Haren, Gitte/I-8551-2018; Vogel, Ulla/ABC-2212-2020	Vogel, Ulla B/0000-0001-6807-1524; Löschner, Katrin/0000-0003-1741-8406; Ravn-Haren, Gitte/0000-0002-4587-089X; Vogel, Ulla/0000-0001-6807-1524; Kling, Kirsten Inga/0000-0003-2765-4007; Berthing, Trine/0000-0003-0723-9869	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation [20110092173-3]	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation	The project was supported by the Danish Centre for Nanosafety (grant no. 20110092173-3) from the Danish Working Environment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; EFSA, 2004, EFSA J, V415, P1; Feng XD, 2006, SCIENCE, V312, P1504, DOI 10.1126/science.1125767; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Geraets L, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-30; Graham UM, 2014, CHEMPLUSCHEM, V79, P1083, DOI 10.1002/cplu.201402080; Hadrup N, 2017, MUTAGENESIS, V32, P581, DOI 10.1093/mutage/gex042; Halappanavar S, 2018, WIRES NANOMED NANOBI, V10, DOI 10.1002/wnan.1465; Halappanavar S, 2015, ENVIRON MOL MUTAGEN, V56, P245, DOI 10.1002/em.21936; Han SG, 2015, ARCH TOXICOL, V89, P1083, DOI 10.1007/s00204-014-1292-9; Hoet Peter Hm, 2004, J Nanobiotechnology, V2, P12, DOI 10.1186/1477-3155-2-12; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; Husain M, 2015, NANOTOXICOLOGY, V9, P1013, DOI 10.3109/17435390.2014.996192; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Jasinski P, 2003, SENSOR ACTUAT B-CHEM, V95, P73, DOI 10.1016/S0925-4005(03)00407-6; Kermanizadeh A, 2015, CRIT REV TOXICOL, V45, P837, DOI 10.3109/10408444.2015.1058747; Kermanizadeh A, 2014, NANOTOXICOLOGY, V8, P149, DOI 10.3109/17435390.2013.866284; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Kreyling WG, 2017, NANOTOXICOLOGY, V11, P454, DOI 10.1080/17435390.2017.1306894; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Kyjovska ZO, 2015, ENVIRON MOL MUTAGEN, V56, P41, DOI 10.1002/em.21888; Lee WW, 2015, J ANAL ATOM SPECTROM, V30, P1245, DOI 10.1039/c4ja00408f; LEHNERT BE, 1992, ENVIRON HEALTH PERSP, V97, P17, DOI 10.2307/3431327; Levin M, 2015, J NANOPART RES, V17, P1, DOI 10.1007/s11051-015-3139-6; Lide D. R., 2003, CRC HDB CHEM PHYS CD; Lipka J, 2010, BIOMATERIALS, V31, P6574, DOI 10.1016/j.biomaterials.2010.05.009; Loeschner K, 2013, ANAL BIOANAL CHEM, V405, P8185, DOI 10.1007/s00216-013-7228-z; Madl AK, 2009, CRIT REV TOXICOL, V39, P629, DOI 10.1080/10408440903133788; Modrzynska J, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-017-0238-9; Nalabotu SK, 2011, INT J NANOMED, V6, P2327, DOI 10.2147/IJN.S25119; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; OBERDORSTER G, 1992, ENVIRON HEALTH PERSP, V97, P193, DOI 10.2307/3431353; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pace HE, 2011, ANAL CHEM, V83, P9361, DOI 10.1021/ac201952t; Park EJ, 2009, TOX RESEARCH, V25, P79, DOI 10.5487/TR.2009.25.2.079; Park EJ, 2009, TOXICOLOGY, V260, P37, DOI 10.1016/j.tox.2009.03.005; Park JK, 2016, NANOMED-NANOTECHNOL, V12, P1365, DOI 10.1016/j.nano.2016.01.013; Poulsen SS, 2016, NANOTOXICOLOGY, V10, P1263, DOI 10.1080/17435390.2016.1202351; Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011; Sadauskas E, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-16; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Sadauskas E, 2009, NANOMED-NANOTECHNOL, V5, P162, DOI 10.1016/j.nano.2008.11.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semmler M, 2004, INHAL TOXICOL, V16, P453, DOI 10.1080/08958370490439650; Semmler-Behnke M, 2007, ENVIRON HEALTH PERSP, V115, P728, DOI 10.1289/ehp.9685; Semmler-Behnke M, 2008, SMALL, V4, P2108, DOI 10.1002/smll.200800922; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Takenaka S, 2006, INHAL TOXICOL, V18, P733, DOI 10.1080/08958370600748281; Tuoriniemi J, 2012, ANAL CHEM, V84, P3965, DOI 10.1021/ac203005r; Wallin H, 2017, MUTAGENESIS, V32, P47, DOI 10.1093/mutage/gew046; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang Y, 2013, SMALL, V9, P1742, DOI 10.1002/smll.201201185; Wiebert P, 2006, EUR RESPIR J, V28, P286, DOI 10.1183/09031936.06.00103805; Xie GP, 2011, TOXICOL LETT, V205, P55, DOI 10.1016/j.toxlet.2011.04.034; Yu LE, 2007, NANOTOXICOLOGY, V1, P235, DOI 10.1080/17435390701763108; Zhu WZ, 2003, MAT SCI ENG A-STRUCT, V362, P228, DOI 10.1016/S0921-5093(03)00620-8	59	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202477	10.1371/journal.pone.0202477	http://dx.doi.org/10.1371/journal.pone.0202477			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125308	gold, Green Published, Green Submitted			2022-12-26	WOS:000442202100029
J	Soto, D; De Palmas, S; Ho, MJ; Denis, V; Chen, CA				Soto, Derek; De Palmas, Stephane; Ho, Ming Jay; Denis, Vianney; Chen, Chaolun Allen			Spatial variation in the morphological traits of Pocillopora verrucosa along a depth gradient in Taiwan	PLOS ONE			English	Article							CORAL STYLOPHORA-PISTILLATA; REEF-BUILDING CORAL; PHENOTYPIC PLASTICITY; PHYSIOLOGICAL PLASTICITY; LIGHT MICROENVIRONMENT; MONTASTREA-CAVERNOSA; GREEN ISLAND; GROWTH; ACCLIMATIZATION; PACIFIC	Pocillopora verrucosa is a widely distributed depth-generalist coral that presents plasticity in its skeletal macro- and microstructure in response to environmental gradients. Light and water movement, which covary with depth, are the main environmental drivers of morphological plasticity in this genus; however, assessing environmentally-induced plasticity may be confounded by the extent of interspecific variation in Pocillopora. We examine the morphology of 8 typed P. verrucosa specimens collected along a depth gradient ranging from 7 to 45 meters and comprising 3 sites throughout Ludao, Taiwan. We measured 36 morphological characters, 14 which are novel, in 3 regions on the corallum-the apex, branch and base-in order to quantify their relationship to site and depth. We found significant correlation between depth and 19 morphological characters, notably branch verruca area, branch verruca height, base verruca spacing, base spinule length, and branch corallite area. 60% of microstructural characters and 25% of macrostructural characters showed a correlative relation to depth, suggesting that depth acclimatization is manifested primarily at the microstructural level. Canonical discriminant analysis of all morphometric characters by depth supports clustering into 3 groups: an overlapping 7m and 15m group, a 23-30m group, and a 38-45m group. Canonical discriminant analysis by site supports clustering into low- and high-current sites, differentiated primarily by branch septa width, base septa width, pre-terminal branch width, terminal branch maximum length, and terminal branch minimum length. We conclude that distinctive patterns of morphological variation in mesophotic specimens of P. verrucosa could reflect the effects of abiotic parameters such as light and water flow. Elucidating the mechanisms behind the morphological changes that occur in response to environmental gradients can help clarify the role that physiological plasticity plays in the acclimatization of corals to the unique environmental settings of mesophotic coral ecosystems.	[Soto, Derek; De Palmas, Stephane; Ho, Ming Jay; Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan; [Soto, Derek; De Palmas, Stephane; Ho, Ming Jay; Chen, Chaolun Allen] Natl Taiwan Normal Univ, Taipei, Taiwan; [Soto, Derek; De Palmas, Stephane; Chen, Chaolun Allen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Soto, Derek; De Palmas, Stephane; Ho, Ming Jay; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Ho, Ming Jay] Acad Sinica, Green Isl Marine Res Stn, Ludao, Taiwan; [Denis, Vianney; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan Normal University; National Taiwan Normal University; Academia Sinica - Taiwan; National Taiwan University	Chen, CA (corresponding author), Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan.; Chen, CA (corresponding author), Natl Taiwan Normal Univ, Taipei, Taiwan.; Chen, CA (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.; Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.; Denis, V; Chen, CA (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	vianneydenis@ntu.edu.tw; cac@gate.sinica.edu.tw	Denis, Vianney/E-6868-2013; , de PALMAS Stéphane/AAS-8982-2021	Denis, Vianney/0000-0002-0914-5586; , de PALMAS Stéphane/0000-0002-2567-1789; Soto, Derek/0000-0002-5956-6223	Taiwan International Graduate Program Fellowship; Taiwan Ministry of Science and Technology [103-2621-B-001-004-MY3, 106-2611-M-002-008]	Taiwan International Graduate Program Fellowship; Taiwan Ministry of Science and Technology	DS and SDP are recipients of the Taiwan International Graduate Program Fellowship. This research was funded by a Taiwan Ministry of Science and Technology Grant number 103-2621-B-001-004-MY3 to CAC (https://www.most.gov.tw/?l=en) and Taiwan Ministry of Science and Technology Grant number 106-2611-M-002-008 to VD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMS Coral Fact Sheets [internet], 2018, AIMS COR FACT SHEETS; AMARAL FD, 1994, CORAL REEFS, V13, P113, DOI 10.1007/BF00300771; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anthony KRN, 2005, FUNCT ECOL, V19, P17, DOI 10.1111/j.0269-8463.2005.00925.x; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; BAKER PA, 1975, PHYS EARTH PLANET IN, V10, P135, DOI 10.1016/0031-9201(75)90031-X; Baums Iliana B., 2014, Frontiers in Marine Science, V1, P00059; Bay RA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701413; BELTRANTORRES AU, 1993, REV BIOL TROP, V41, P559; Bergman Johanna, 2017, THESIS; Bessell-Browne P, 2017, MAR POLLUT BULL, V117, P161, DOI 10.1016/j.marpolbul.2017.01.050; Bhagooli R., 2012, UOM RES J, V18, P145; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brown B.E., 1983, Coral Reefs, V2, P81, DOI 10.1007/BF02395278; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; BUDD AF, 1990, SYST BOT, V15, P150, DOI 10.2307/2419024; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Calixto-Botia I, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0900-8; Chang MH, 2013, J GEOPHYS RES-OCEANS, V118, P1508, DOI 10.1002/jgrc.20151; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Crabbe MJC, 2006, COMPUT BIOL CHEM, V30, P155, DOI 10.1016/j.compbiolchem.2005.11.004; CUFFEY R J, 1990, Palaios, V5, P580, DOI 10.2307/3514863; Dai C-F, 2009, SCLERACTINIA FAUNA T, VII; Denis V, 2018, MESOPHOTIC CORAL ECO; DUSTAN P, 1975, MAR BIOL, V33, P101, DOI 10.1007/BF00390714; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; Eyal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128697; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Filatov MV, 2010, P ROY SOC B-BIOL SCI, V277, P3555, DOI 10.1098/rspb.2010.0957; Forsman Z, 2015, PEERJ, V3, DOI 10.7717/peerj.751; FOSTER AB, 1979, J EXP MAR BIOL ECOL, V39, P25, DOI 10.1016/0022-0981(79)90003-0; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; Friendly M, 2012, PACKAGE CANDISC R VI; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Gattuso JP, 1999, AM ZOOL, V39, P160; Gelin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169692; Glasl B, 2017, CORAL REEFS, V36, P447, DOI 10.1007/s00338-016-1517-x; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Gonzalez-Zapata FL, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00029; Goodbody-Gringley G, 2018, ECOLOGY; GRAUS R R, 1982, Smithsonian Contributions to the Marine Sciences, P441; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Hoogenboom MO, 2008, ECOLOGY, V89, P1144, DOI 10.1890/07-1272.1; Hsu TW, 2015, RENEW ENERG, V81, P853, DOI 10.1016/j.renene.2015.03.089; IRYU Y, 1995, SEDIMENT GEOL, V99, P243, DOI 10.1016/0037-0738(95)00047-C; Jaubert J., 1977, P 3 INT COR REEF S, P483; Johnston EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06085-3; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kaandorp JA, 1996, PHYS REV LETT, V77, P2328, DOI 10.1103/PhysRevLett.77.2328; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; Kaniewska P, 2011, J PHYCOL, V47, P846, DOI 10.1111/j.1529-8817.2011.01021.x; Kaniewska P, 2009, J EXP BIOL, V212, P662, DOI 10.1242/jeb.022624; Kenkel CD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0014; Klaus JS, 2007, B MAR SCI, V80, P233; Kleypas JA, 1999, AM ZOOL, V39, P146; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Loya Y, 2016, CORAL REEFS, V35, P1, DOI 10.1007/s00338-016-1410-7; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Maritorena S, 2002, OCEANOL ACTA, V25, P125, DOI 10.1016/S0399-1784(02)01189-1; Marti-Puig P, 2014, B MAR SCI, V90, P211, DOI 10.5343/bms.2012.1080; Mass T, 2008, MAR ECOL PROG SER, V369, P131, DOI 10.3354/meps07578; Mass T, 2011, LIMNOL OCEANOGR, V56, P2176, DOI 10.4319/lo.2011.56.6.2176; Masse Lola M., 2012, Western Indian Ocean Journal of Marine Science, V11, P55; Muir P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117933; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; OBIS, 2022, OC BIOG INF SYST; Ow YX, 2010, CORAL REEFS, V29, P797, DOI 10.1007/s00338-010-0631-4; Padilla-Gamino JL, 2012, J EXP MAR BIOL ECOL, V434, P71, DOI 10.1016/j.jembe.2012.08.006; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Paz-Garcia DA, 2015, AM NAT, V186, P434, DOI 10.1086/682363; Paz-Garcia DA, 2015, OECOLOGIA, V178, P207, DOI 10.1007/s00442-014-3199-9; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Poli D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171456; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Pyle RL, 2016, PEERJ, V4, DOI 10.7717/peerj.2475; Raymundo LJ, 2001, CORAL REEFS, V20, P263, DOI 10.1007/s003380100170; RCore Team, 2020, R LANG ENV STAT COMP; Richier S, 2008, J EXP MAR BIOL ECOL, V357, P48, DOI 10.1016/j.jembe.2007.12.026; Rocha RJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105863; ROSS MA, 1984, PSZNI MAR ECOL, V5, P75; Sawall Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08940; SCHLICHTER D, 1985, MAR BIOL, V89, P143, DOI 10.1007/BF00392885; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Shaish L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000644; Smith EG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0320; Smith H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10560-2; Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4; Stefani F, 2011, CORAL REEFS, V30, P1033, DOI 10.1007/s00338-011-0797-4; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V263, P211, DOI 10.1016/S0022-0981(01)00309-4; Todd PA, 2001, HYDROBIOLOGIA, V444, P227, DOI 10.1023/A:1017570100029; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Torda G, 2017, NAT CLIM CHANGE, V7, P627, DOI 10.1038/NCLIMATE3374; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; Veron J. E., 2000, CORALS WORLD, V1; Veron J. E. N., 1976, SCLERACTINIA E AUSTR; VERON JEN, 1995, CORALS SPACE TIME BI; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Wangpraseurt D, 2016, ISME J, V10, P788, DOI 10.1038/ismej.2015.133; Wangpraseurt D, 2014, LIMNOL OCEANOGR, V59, P917, DOI 10.4319/lo.2014.59.3.0917; WEBER JN, 1976, GEOCHIM COSMOCHIM AC, V40, P31, DOI 10.1016/0016-7037(76)90191-5; WEST JM, 1993, MAR ECOL PROG SER, V94, P61, DOI 10.3354/meps094061; Wijsman-Best M., 1974, Proceedings int Coral Reef Symp, V2, P217; Willis BL, 1985, P 5 INT COR REEF S, V4; Ziegler M, 2015, MAR ECOL PROG SER, V533, P149, DOI 10.3354/meps11365; Ziegler M, 2014, CORAL REEFS, V33, P1115, DOI 10.1007/s00338-014-1192-8	114	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202586	10.1371/journal.pone.0202586	http://dx.doi.org/10.1371/journal.pone.0202586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118513	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700037
J	Abreu, LRA; Ribeiro, VMP; Gouveia, GC; Cardoso, EP; Toral, FLB				Alves Abreu, Luiza Rodrigues; Pereira Ribeiro, Virginia Mara; Gouveia, Gabriela Canabrava; Cardoso, Eduardo Penteado; Buranelo Toral, Fabio Luiz			Genetic trends and trade-offs between growth and reproductive traits in a Nellore herd	PLOS ONE			English	Article							WEANING WEIGHT; MILK-YIELD; PERFORMANCE; PARAMETERS; COMPONENTS; SELECTION; IMPACT	The knowledge of genetic trends and trade-offs between growth and reproductive traits might be useful to understand the evolution of these traits in livestock and natural populations of animals. We estimated the genetic trends and trade-offs between pre-weaning growth and calving intervals of Nellore animals from a commercial farm. Two-trait animal models were used to estimate covariance components and breeding values (EBV) for direct and maternal genetic effects of pre-weaning growth and direct genetic effects of calving intervals. Regression analyses were performed to examine the relationship between direct and maternal EBV of pre-weaning growth and direct EBV of calving intervals (dependent variables) and the coefficient of generation of each animal (independent variable). We also performed regression analyses to examine the relationship between direct EBV of calving intervals (dependent variables) and direct and maternal EBV of pre-weaning growth (independent variables). The genetic trends for direct and maternal genetic effect for pre-weaning growth were significant and presented genetic evolution in the studied Nellore herd. The genetic trends for the reproductive traits were also significant but indicated genetic changes in an unfavorable way. The genetic correlations between direct effects of pre-weaning growth and calving intervals traits and the genetic correlations between maternal effects of pre-weaning growth traits and direct effects of calving interval traits were not different from zero. The presence of trade-offs between the direct effects of growth and reproductive traits were confirmed through regression from direct EBV of calving intervals over EBV of pre-weaning growth traits. In addition, regression analyses showed that selection to increase pre-weaning growth also increased calving intervals. Our results showed that pre-weaning growth and calving intervals are increasing over generations and that trade-offs occurred between those traits in the studied Nellore herd.	[Alves Abreu, Luiza Rodrigues; Pereira Ribeiro, Virginia Mara; Gouveia, Gabriela Canabrava; Buranelo Toral, Fabio Luiz] Univ Fed Minas Gerais, Dept Zootecnia, Escola Vet, Belo Horizonte, MG, Brazil; [Cardoso, Eduardo Penteado] Fazenda Mundo Novo, Uberaba, MG, Brazil	Universidade Federal de Minas Gerais	Toral, FLB (corresponding author), Univ Fed Minas Gerais, Dept Zootecnia, Escola Vet, Belo Horizonte, MG, Brazil.	flbtoral@ufmg.br	Toral, Fabio/W-3158-2019; Toral, Fabio LB/G-1961-2015	Toral, Fabio/0000-0002-6798-0758; Toral, Fabio LB/0000-0002-6798-0758; Gouveia, Gabriela/0000-0002-8164-3221	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-01609-16]; Pro-Reitoria de Pesquisa da UFMG (Belo Horizonte, MG, Brazil)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da UFMG (Belo Horizonte, MG, Brazil)	The authors thank the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (APQ-01609-16) and the Pro-Reitoria de Pesquisa da UFMG (Belo Horizonte, MG, Brazil) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardes PA, 2015, J ANIM SCI, V93, P5175, DOI 10.2527/jas.2015-9212; Bertazzo RP, 2004, REV BRAS ZOOTECN, V33, P1118, DOI 10.1590/S1516-35982004000500003; Boligon AA, 2010, J ANIM SCI, V88, P849, DOI 10.2527/jas.2008-1511; Cortes-Lacruz X, 2017, LIVEST SCI, V202, P143, DOI 10.1016/j.livsci.2017.05.025; Cruz A, 2016, ANIMAL, V10, P1, DOI [10.1017/S1751731115001810, DOI 10.1017/S1751731115001810]; David I, 2015, J ANIM SCI, V93, P5639, DOI 10.2527/jas.2015-9548; Falconer DS, 1996, TRENDS GENET; Garland T, 2014, CURR BIOL, V24, pR60, DOI 10.1016/j.cub.2013.11.036; Head ML, 2012, EVOLUTION, V66, P3570, DOI 10.1111/j.1558-5646.2012.01699.x; Henderson C.R., 1973, J ANIM SCI, V1973, P10, DOI DOI 10.1093/ANSCI/1973.SYMPOSIUM.10; Hoffmann AA, 2016, EVOLUTION, V70, DOI 10.1111/evo.12992; Jorge J, 2007, REV BRAS ZOOTECN, V36, P1549, DOI 10.1590/S1516-35982007000700013; KOCH RM, 1972, J ANIM SCI, V35, P1316; Kolliker M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7850; Lim JN, 2014, EVOLUTION, V68, P2306, DOI 10.1111/evo.12446; Ljungstrom G, 2016, J EVOLUTION BIOL, V29, P979, DOI 10.1111/jeb.12838; Lopes FB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147180; Lopes FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075423; Maniatis N, 2003, J ANIM SCI, V81, P101; Martinez RA, 2016, J ANIM SCI, V94, P2761, DOI 10.2527/jas.2016-0453; Mercadante MEZ, 2003, J ANIM SCI, V81, P376; Mercadante MEZ, 2000, REV BRAS ZOOTECN, V29, P997, DOI 10.1590/S1516-35982000000400008; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Mrode R.A, 2014, LINEAR MODELS PREDIC; NASEM, 2016, NUTR REQ BEEF CATTL, V8; NEBEL RL, 1993, J DAIRY SCI, V76, P3257, DOI 10.3168/jds.S0022-0302(93)77662-6; Roff Derek, 2002, pi; Sartori Roberto, 2010, R. Bras. Zootec., V39, P422; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; WILLHAM RL, 1972, J ANIM SCI, V35, P1288; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wolf JB, 2016, EVOLUTION, V70, P827, DOI 10.1111/evo.12905; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Yin T, 2018, J DAIRY SCI, V101, P2158, DOI 10.3168/jds.2017-13835; Zuin RG, 2012, MEAT SCI, V91, P352, DOI 10.1016/j.meatsci.2012.02.018	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201392	10.1371/journal.pone.0201392	http://dx.doi.org/10.1371/journal.pone.0201392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114191	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400014
J	Kim, SH; Jun, JH; Oh, JE; Shin, EJ; Oh, YJ; Choi, YS				Kim, Seung Hyun; Jun, Ji Hae; Oh, Ju Eun; Shin, Eun-Jung; Oh, Young Jun; Choi, Yong Seon			Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; ISCHEMIA/REPERFUSION INJURY; SIGNALING PATHWAY; RENAL INJURY; ACTIVATION; PROTECTS	Background Diabetic patients are susceptible to renal ischemia-reperfusion injury, which leads to perioperative complications. Activation of NOD-like receptor protein 3 (NLRP3) inflammasome participates in the development of diabetes, and contributes to renal ischemia-reperfusion injury. Dexmedetomidine (DEX), a highly selective alpha 2-adrenoreceptor agonist, shows renoprotective effects against ischemia-reperfusion injury. We aimed to elucidate the effects, underlying mechanisms, and optimal timing of DEX treatment in diabetic rats. Methods Male Sprague-Dawley rats (n = 12 per group) were randomly divided into normal-sham, diabetes- sham, diabetes-ischemia-reperfusion-control, diabetes-ischemia-reperfusion-DEX-pre-treatment, and diabetes-ischemia-reperfusion-DEX-post-treatment groups. Renal ischemia-reperfusion injury was induced in diabetic rats by occlusion of both renal arteries for 45 min, followed by reperfusion for 24 h. DEX (10 mu g/kg) was administered intraperitoneally 1 h before ischemia (pre-treatment) or upon reperfusion (post-treatment). After reperfusion, renal tissue was biochemically and histopathologically evaluated. Results DEX treatment attenuated ischemia reperfusion-induced increase in NLRP3, caspase-1, IL-1 beta, phospho-AKT, and phospho-ERK signaling. Moreover, oxidative stress injury, inflammatory reactions, apoptosis, and renal tubular damage were favorably modulated by DEX treatment. Furthermore, post-reperfusion treatment with DEX was significantly more effective than pre-treatment in modulating NLRP3 inflammasome, AKT and ERK signaling, and oxidative stress. Conclusions This study shows that the protective effects of DEX in renal ischemia-reperfusion injury are preserved in diabetic conditions and may potentially provide a basis for the use of DEX in clinical treatment of renal ischemia-reperfusion injury.	[Kim, Seung Hyun; Oh, Young Jun; Choi, Yong Seon] Yonsei Univ, Coll Med, Severance Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Jun, Ji Hae; Oh, Ju Eun; Shin, Eun-Jung; Oh, Young Jun; Choi, Yong Seon] Yonsei Univ, Coll Med, Severance Hosp, Anesthesia & Pain Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, YS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.; Choi, YS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Anesthesia & Pain Res Inst, Seoul, South Korea.	yschoi@yuhs.ac		Kim, Seung Hyun/0000-0003-2127-6324; CHOI, YONG SEON/0000-0002-5348-864X; Oh, Young Jun/0000-0002-6258-5695; Jun, Ji Hae/0000-0002-8080-0715	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF2014R1A1A3053428]; Korean Society for Transplantation	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korean Society for Transplantation	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF2014R1A1A3053428) and by funding for Young Investigator research (2017), Korean Society for Transplantation.	Bol CJJG, 1997, J PHARMACOL EXP THER, V283, P1051; Cai Y, 2014, MOL MED REP, V9, P1542, DOI 10.3892/mmr.2014.2034; Cakir M, 2015, RENAL FAILURE, V37, P704, DOI 10.3109/0886022X.2015.1011550; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Cheng XY, 2016, MOL MED REP, V14, P797, DOI 10.3892/mmr.2016.5345; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; Erbatur ME, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1270021; Gonullu E, 2014, REV BRAS ANESTESIOL, V64, P152, DOI 10.1016/j.bjane.2013.06.002; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; Hirose R, 2008, ANESTHESIOLOGY, V108, P402, DOI 10.1097/ALN.0b013e318164cff8; Hobson C, 2015, ANN SURG, V261, P1207, DOI 10.1097/SLA.0000000000000732; Hu CY, 2015, P NATL ACAD SCI USA, V112, P11318, DOI 10.1073/pnas.1513509112; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Kip G, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.27828; Lejay A, 2016, J MOL CELL CARDIOL, V91, P11, DOI 10.1016/j.yjmcc.2015.12.020; Minutoli Letteria, 2016, Oxid Med Cell Longev, V2016, P2183026, DOI 10.1155/2016/2183026; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Ozaki K, 2016, AM J PHYSIOL-ENDOC M, V310, pE643, DOI 10.1152/ajpendo.00445.2015; Qiu YY, 2016, PHARMACOL RES, V114, P251, DOI 10.1016/j.phrs.2016.11.004; Si YN, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-141; Sun YJ, 2017, CLIN EXP PHARMACOL P, V44, P946, DOI 10.1111/1440-1681.12791; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Wang SF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.292; Wang Y, 2013, BRAZ J MED BIOL RES, V46, P861, DOI 10.1590/1414-431X20133036; WYBENGA DR, 1971, CLIN CHEM, V17, P891; Xiao YD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2386068; Xiao YD, 2017, ACTA CIR BRAS, V32, P429, DOI 10.1590/s0102-865020170060000003; Yoo YC, 2013, J SURG RES, V183, P783, DOI 10.1016/j.jss.2013.02.017; Zeng XZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151620; Zhang QY, 2017, CELL PHYSIOL BIOCHEM, V42, P1907, DOI 10.1159/000479609; Zhang XY, 2012, ANESTHESIOLOGY, V116, P1035, DOI 10.1097/ALN.0b013e3182503964; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	34	15	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0198307	10.1371/journal.pone.0198307	http://dx.doi.org/10.1371/journal.pone.0198307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114208	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400002
J	Mirzaali, MJ; Libonati, F; Ferrario, D; Rinaudo, L; Messina, C; Ulivieri, FM; Cesana, BM; Strano, M; Vergani, L				Mirzaali, Mohammad J.; Libonati, Flavia; Ferrario, Davide; Rinaudo, Luca; Messina, Carmelo; Ulivieri, Fabio M.; Cesana, Bruno M.; Strano, Matteo; Vergani, Laura			Determinants of bone damage: An ex-vivo study on porcine vertebrae	PLOS ONE			English	Article							HUMAN TRABECULAR BONE; QUANTITATIVE COMPUTED-TOMOGRAPHY; PREDICTS OSTEOPOROTIC FRACTURES; HUMAN CANCELLOUS BONE; SCORE TBS; MINERAL DENSITY; IN-VIVO; MICRODAMAGE ACCUMULATION; MECHANICAL-PROPERTIES; VOLUME FRACTION	Bone's resistance to fracture depends on several factors, such as bone mass, microarchitecture, and tissue material properties. The clinical assessment of bone strength is generally performed by Dual-X Ray Photon Absorptiometry (DXA), measuring bone mineral density (BMD) and trabecular bone score (TBS). Although it is considered the major predictor of bone strength, BMD only accounts for about 70% of fragility fractures, while the remaining 30% could be described by bone "quality" impairment parameters, mainly related to tissue microarchitecture. The assessment of bone microarchitecture generally requires more invasive techniques, which are not applicable in routine clinical practice, or X-Ray based imaging techniques, requiring a longer post-processing. Another important aspect is the presence of local damage in the bony tissue that may also affect the prediction of bone strength and fracture risk. To provide a more comprehensive analysis of bone quality and quantity, and to assess the effect of damage, here we adopt a framework that includes clinical, morphological, and mechanical analyses, carried out by means of DXA, mu CT and mechanical compressive testing, respectively. This study has been carried out on trabecular bones, taken from porcine trabecular vertebrae, for the similarity with human lumbar spine. This study confirms that no single method can provide a complete characterization of bone tissue, and the combination of complementary characterization techniques is required for an accurate and exhaustive description of bone status. BMD and TBS have shown to be complementary parameters to assess bone strength, the former assessing the bone quantity and resistance to damage, and the latter the bone quality and the presence of damage accumulation without being able to predict the risk of fracture.	[Mirzaali, Mohammad J.; Libonati, Flavia; Ferrario, Davide; Strano, Matteo; Vergani, Laura] Politecn Milan, Dept Mech Engn, Milan, Italy; [Rinaudo, Luca] TECHNOL Srl Hol Italia, Turin, Italy; [Messina, Carmelo] Ist Ortoped Galeazzi IRCCS, Radiodiagnost Unit, Milan, Italy; [Ulivieri, Fabio M.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nucl Med Bone Metab Unit, Milan, Italy; [Cesana, Bruno M.] Univ Milan, Fac Med & Surg, Unit Med Stat Biometry & Bioinformat Giulio A Mac, Dept Clin Sci & Community Hlth, Milan, Italy; [Mirzaali, Mohammad J.] Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, Dept Biomech Engn, Delft, Netherlands	Polytechnic University of Milan; IRCCS Istituto Ortopedico Galeazzi; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Ulivieri, FM (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nucl Med Bone Metab Unit, Milan, Italy.	ulivieri@gmail.com	Libonati, Flavia/ABD-5143-2021; Mirzaali, Mohammad J./P-4427-2017; strano, matteo/A-8345-2012; Messina, Carmelo/B-5604-2018; Ulivieri, Fabio Massimo/M-2923-2015	Mirzaali, Mohammad J./0000-0002-5349-6922; strano, matteo/0000-0003-3652-9320; Messina, Carmelo/0000-0001-7518-5773; Ulivieri, Fabio Massimo/0000-0003-1357-3425	TECHNOLOGIC S.r.l.	TECHNOLOGIC S.r.l.	The authors received no specific funding for this work. TECHNOLOGIC S.r.l. provided support in the form of salary for author LR, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of the author are articulated in the author contribution section.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; [Anonymous], 1994, WHO STUD GROUP M HEL; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Badilatti SD, 2016, J BIOMECH, V49, P3770, DOI 10.1016/j.jbiomech.2016.10.002; Binkley N, 2016, CLIN REV BONE MINER, V14, P14, DOI 10.1007/s12018-016-9203-7; Bolotin HH, 2007, BONE, V41, P138, DOI 10.1016/j.bone.2007.02.022; Bousson V, 2012, OSTEOPOROSIS INT, V23, P1489, DOI 10.1007/s00198-011-1824-6; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1990, CLIN ORTHOP RELAT R, P305, DOI 10.1097/00003086-199011000-00047; Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9; CAMERONJR, 1963, SCIENCE, V142, P230, DOI 10.1126/science.142.3589.230; Cohen A, 2010, OSTEOPOROSIS INT, V21, P263, DOI 10.1007/s00198-009-0945-7; Consensus N., 2001, JAMA-J AM MED ASSOC, P285; COWIN SC, 1985, MECH MATER, V4, P137, DOI 10.1016/0167-6636(85)90012-2; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Drews S, 2008, SURG RADIOL ANAT, V30, P209, DOI 10.1007/s00276-008-0317-6; Fang GH, 2010, COMPUT METHOD BIOMEC, V13, P605, DOI 10.1080/10255840903405660; Fields AJ, 2009, J BONE MINER RES, V24, P1523, DOI [10.1359/jbmr.090317, 10.1359/JBMR.090317]; Frost H M, 1998, J Orthop Sci, V3, P272, DOI 10.1007/s007760050053; FYHRIE DP, 1994, BONE, V15, P105, DOI 10.1016/8756-3282(94)90900-8; FYHRIE DP, 1993, J BIOMECH, V26, P955, DOI 10.1016/0021-9290(93)90057-L; Garrison JG, 2011, J BIOMECH, V44, P2747, DOI 10.1016/j.jbiomech.2011.09.002; Gdyczynski CM, 2014, PHYSIOL MEAS, V35, P2415, DOI 10.1088/0967-3334/35/12/2415; Goff MG, 2015, J BIOMECH, V48, P4142, DOI 10.1016/j.jbiomech.2015.10.023; Graeff C, 2013, BONE, V52, P568, DOI 10.1016/j.bone.2012.10.036; Hambli R, 2013, BONE, V56, P363, DOI 10.1016/j.bone.2013.06.028; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Hans D, 2011, J CLIN DENSITOM, V14, P302, DOI 10.1016/j.jocd.2011.05.005; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; Harvey NC, 2015, BONE, V78, P216, DOI 10.1016/j.bone.2015.05.016; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hosseini HS, 2017, BONE, V97, P114, DOI 10.1016/j.bone.2017.01.016; Hunt HB, 2016, CLIN REV BONE MINER, V14, P133, DOI 10.1007/s12018-016-9222-4; Karim L, 2011, J ORTHOP RES, V29, P1739, DOI 10.1002/jor.21448; Keaveny TM, 1999, J ORTHOPAED RES, V17, P346, DOI 10.1002/jor.1100170308; Keaveny TM, 1999, J BIOMECH ENG-T ASME, V121, P99, DOI 10.1115/1.2798051; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; KEAVENY TM, 1994, J BIOMECH, V27, P1309, DOI 10.1016/0021-9290(94)90040-X; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Kinney JH, 2000, J BONE MINER RES, V15, P1981, DOI 10.1359/jbmr.2000.15.10.1981; Kopperdahl DL, 2000, J ORTHOPAED RES, V18, P685, DOI 10.1002/jor.1100180502; Krueger D, 2014, J CLIN DENSITOM, V17, P60, DOI 10.1016/j.jocd.2013.05.001; Larrue A, 2007, P ANN INT IEEE EMBS, P3918, DOI 10.1109/IEMBS.2007.4353190; Lee T C, 2006, Technol Health Care, V14, P359; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Leslie WD, 2014, BONE, V67, P10, DOI 10.1016/j.bone.2014.06.034; Looker Anne C, 2013, Vital Health Stat 11, P1; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Majumdar S, 1997, J BONE MINER RES, V12, P111, DOI 10.1359/jbmr.1997.12.1.111; Maquer G, 2015, J BONE MINER RES, V30, P1000, DOI 10.1002/jbmr.2437; Mirzaali MJ, 2017, MATER DESIGN, V126, P207, DOI 10.1016/j.matdes.2017.04.039; Mirzaali MJ, 2015, J MECH BEHAV BIOMED, V49, P355, DOI 10.1016/j.jmbbm.2015.05.007; Moore TLA, 2001, J BIOMECH ENG-T ASME, V123, P613, DOI 10.1115/1.1407828; Morgan Elise F., 2005, European Journal of Morphology, V42, P13, DOI 10.1080/09243860500095273; MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009; Muschitz C, 2015, BONE, V79, P259, DOI 10.1016/j.bone.2015.06.007; Nagaraja S, 2005, J BIOMECH, V38, P707, DOI 10.1016/j.jbiomech.2004.05.013; Nazarian A, 2006, BONE, V39, P1196, DOI 10.1016/j.bone.2006.06.013; Nishiyama KK, 2013, CURR OSTEOPOROS REP, V11, P147, DOI 10.1007/s11914-013-0142-7; O'Brien FJ, 2005, J ORTHOP RES, V23, P475, DOI 10.1016/j.orthres.2004.08.005; Oftadeh R, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029176; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perilli E, 2008, J BIOMECH, V41, P438, DOI 10.1016/j.jbiomech.2007.08.003; Piodi LP, 2014, WORLD J GASTROENTERO, V20, P14087, DOI 10.3748/wjg.v20.i39.14087; Pothuaud L, 2009, J CLIN DENSITOM, V12, P170, DOI 10.1016/j.jocd.2008.11.006; Roux JP, 2013, OSTEOPOROSIS INT, V24, P2455, DOI 10.1007/s00198-013-2316-7; Ryan G, 2008, CLIN BIOMECH, V23, P859, DOI 10.1016/j.clinbiomech.2008.03.066; Shepherd JA, 2015, J CLIN DENSITOM, V18, P274, DOI 10.1016/j.jocd.2015.06.013; Silva BC, 2015, J CLIN DENSITOM, V18, P309, DOI 10.1016/j.jocd.2015.06.008; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Souzanchi MF, 2012, J BONE MINER RES, V27, P2562, DOI 10.1002/jbmr.1710; Teo JCM, 2006, CLIN BIOMECH, V21, P235, DOI 10.1016/j.clinbiomech.2005.11.001; Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Ulivieri FM, 2014, ENDOCRINE, V47, P435, DOI 10.1007/s12020-014-0280-4; Wachter NJ, 2001, BONE, V28, P133, DOI 10.1016/S8756-3282(00)00455-5; Wang XA, 2006, J BIOMECH, V39, P781, DOI 10.1016/j.jbiomech.2005.02.007; Wang X, 2007, J BIOMECH, V40, P3397, DOI 10.1016/j.jbiomech.2007.05.009; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Winzenrieth R, 2013, J CLIN DENSITOM, V16, P287, DOI 10.1016/j.jocd.2012.05.001; Wolfram U, 2016, J MICROSC-OXFORD, V264, P268, DOI 10.1111/jmi.12440; Wolfram U, 2011, J BIOMECH, V44, P1164, DOI 10.1016/j.jbiomech.2011.01.018; ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420; Zysset P., 1994, CONSTITUTIVE LAW TRA; Zysset PK, 1996, J BIOMECH, V29, P1549, DOI 10.1016/S0021-9290(96)80006-6	86	19	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202210	10.1371/journal.pone.0202210	http://dx.doi.org/10.1371/journal.pone.0202210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114229	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400050
J	Brust, ACB; Desojo, JB; Schultz, CL; Paes-Neto, VD; Da-Rosa, AAS				Biacchi Brust, Ana Carolina; Brenda Desojo, Julia; Schultz, Cesar Leandro; Paes-Neto, Voltaire Dutra; Stock Da-Rosa, Atila Augusto			Osteology of the first skull of Aetosauroides scagliai Casamiquela 1960 (Archosauria: Aetosauria) from the Upper Triassic of southern Brazil (Hyperodapedon Assemblage Zone) and its phylogenetic importance	PLOS ONE			English	Article							TAXONOMIC STATUS; CRANIAL ANATOMY; PSEUDOSUCHIA; BASIN; EVOLUTION; REPTILIA; ONTOGENY; SUTURES; ORIGIN; TEXAS	Aetosauria, which includes 30 species, is a diverse group of armored pseudosuchian archosaurs restricted to Upper Triassic beds. Three species occur in Brazil, and one of these, Aetosauroides scagliai Casamiquela, 1960, also occurs in Argentina. The specimen UFSM 11505, found at Faixa Nova-Cerrito I Outcrop, Santa Maria Formation (Hyperodapedon Assemblage Zone), Santa Maria, Rio Grande do Sul State, Brazil, is here referred to as Aetosauroides scagliai. This specimen preserves most of the skull with both hemimandibles in association with most of the postcranium, thus representing one of the most complete aetosaur skeletons found in Brazil. The premaxilla, one of the key elements of the cranial morphology of aetosaurs, along with the posterior portion of the mandible, was not described until now for A. scagliai. In contrast to the typothoracinae aetosaurs, the premaxilla of UFSM 11505 presents a shovel-shaped tip, but it is not as prominent as the lateral expansion of desmatosuchian aetosaurs, including both species of Stagonolepis, S. robertsoni Agassiz, 1844 and S. olenkae Sulej, 2010. The retroarticular process of the mandible is elongate and not tall, as in Stenomity huangae Small & Martz, 2013 and other typothoracinae aetosaurs. Unlike previous descriptions of A. scagliai, the maxillary teeth are recurved ziphodont-like with serrations on the entire length of both margins. Premaxillary teeth are also present, being less recurved than the maxillary teeth and cylindrical. We recovered Aetosauroides scagliai as the most basal taxon within Aetosauria, like previous phylogenetic analyses. Furthermore, our analyses reinforce that recurved and unconstricted maxillary teeth, the shovel-shaped premaxilla and the presence of a tuber on the surangular are plesiomorphic features of Aetosauria.	[Biacchi Brust, Ana Carolina; Paes-Neto, Voltaire Dutra] Univ Fed Rio Grande do Sul, Programa Posgrad Geociencias, Inst Geociencias, Porto Alegre, RS, Brazil; [Brenda Desojo, Julia] Fac Ciencias Nat & Museo, Div Paleontol Vertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina; [Schultz, Cesar Leandro] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Inst Geociencias, Porto Alegre, RS, Brazil; [Stock Da-Rosa, Atila Augusto] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Geociencias, Santa Maria, RS, Brazil	Universidade Federal do Rio Grande do Sul; National University of La Plata; Museo La Plata; Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Maria (UFSM)	Brust, ACB (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Geociencias, Inst Geociencias, Porto Alegre, RS, Brazil.	anacarolinabrust@gmail.com	DaRosa, Atila/Q-6884-2019; DaRosa, Atila A. S./E-1926-2013	DaRosa, Atila A. S./0000-0003-4074-0794; Desojo, Julia Brenda/0000-0002-2739-3276; Biacchi Brust, Ana Carolina/0000-0001-7762-1284	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1487364 (PROEX - 0487)]; project PICT of Argentina [2014-609]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); project PICT of Argentina	This work was supported by Process Number 1487364 (PROEX - 0487) of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior to ACBB (URL: http://www.capes.gov.br/). We also thank project PICT 2014-609 of Argentina (to J. B. Desojo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassiz L, 1844, MONOGRAPHIE POISSONS, DOI [10.5962/bhl.title.5752French, DOI 10.5962/BHL.TITLE.5752FRENCH]; Bailleul AM, 2016, J ANAT, V229, P252, DOI 10.1111/joa.12471; BARBERENA MC, 1985, NATL GEOGR RES, V1, P5; Bonaparte J.F., 1969, GONDWANA STRATIGRAPH, V2, P283; Desojo JB, 2007, PALAEONTOLOGY, V50, P266; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; CASAMIQUELA R M, 1967, Revista del Museo de La Plata Seccion Paleontologia, V5, P173; Casamiquela R.M., 1980, ACTAS 2 CONGRESO ARG, VI, P135; Casamiquela R. M., 1961, REV ASOC GEOL ARGENT, V16, P143; Casamiquela RM, 1960, AMEGHINIANA, V2, P3; Cerda IA, 2011, LETHAIA, V44, P417, DOI 10.1111/j.1502-3931.2010.00252.x; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; CODDINGTON J, 1994, CLADISTICS, V10, P415; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cope E.D., 1875, ANN REPORT GEOGRAPHI, P981; Da Rosa Atila Augusto Stock, 2002, Arquivos do Museu Nacional Rio de Janeiro, V60, P149; Da-Rosa AAS, 2009, B RESUMOS REUNIAO AN; Da-Rosa AAS, 2014, THESIS; Da-Rosa AAS, 2015, J S AM EARTH SCI, V61, P108, DOI 10.1016/j.jsames.2014.10.008; Da-Rosa Atila Augusto Stock, 2004, Ciencia e Natura, V26, P75; Desojo JB, 2002, J VERTEBR PALEONTOL, V22; Desojo JB, 2005, AMEGHINIANA, V42, P24; Desojo JB, 2005, THESIS; Desojo JB, 2012, ZOOTAXA, P1; Desojo JB, 2013, GEOL SOC SPEC PUBL, V379, P203, DOI 10.1144/SP379.17; Desojo JB, 2011, J VERTEBR PALEONTOL, V31, P596, DOI 10.1080/02724634.2011.572936; Horn BLD, 2015, REV BRAS PALEONTOLOG, V18, P91, DOI 10.4072/rbp.2015.1.06; Ezcurra MD, 2016, PEERJ, V4, DOI 10.7717/peerj.1778; Fraas O, 1877, WURTTEMBERGISCHE NAT, V33, P1; Gauthier J., 1985, P185; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Heckert A.B., 2000, ZENTRALBLATT GEOLO 1, V1998, P1539; Heckert AB, 1999, J VERTEBR PALEONTOL, V19, P50, DOI 10.1080/02724634.1999.10011122; Heckert Andrew B., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V10, P604; Heckert AB, 2017, J PALEONTOL, V91, P162, DOI 10.1017/jpa.2016.130; Heckert AB, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.881831; Hendrickx C, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.982797; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Hunt A.P., 1989, P355; Huxley T. H., 1859, P GEOLOGICAL SOC, V15, P440, DOI DOI 10.1144/GSL.JGS.1859.015.01-02.54; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Long RA, 1985, MUS N ARIZ B; Lucas SG, 1998, PALAEONTOLOGY, V41, P1215; Lucas Spencer G., 1993, New Mexico Geological Society Field Conference Guidebook, V44, P237; Marsh O. C., 1884, NATURE, V31, P68, DOI DOI 10.1038/031068A0; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nicholson H.A., 1889, MANUAL PALAEONTOLOGY; Parker WG, 2005, CR PALEVOL, V4, P327, DOI 10.1016/j.crpv.2005.03.002; Parker WG, 2007, J SYST PALAEONTOL, V5, P41, DOI 10.1017/S1477201906001994; Parker WG, 2016, PEERJ, V4, DOI 10.7717/peerj.1583; Parker WG, 2010, EARTH ENV SCI T R SO, V101, P231, DOI 10.1017/S1755691011020020; Parker WG, 2010, J VERTEBR PALEONTOL, V30, P1100, DOI 10.1080/02724634.2010.483536; PARRISH JM, 1994, J VERTEBR PALEONTOL, V14, P196, DOI 10.1080/02724634.1994.10011552; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Roberto-Da-Silva L, 2014, ZOOTAXA, V 3764, P240, DOI 10.11646/zootaxa.3764.3.1; Romer A, 1956, OSTEOLOGY REPTILES; Schoch RR, 2007, NEUES JAHRB GEOL P-A, V246, P1, DOI 10.1127/0077-7749/2007/0246-0001; Schoch RR, 2016, NEUES JAHRB GEOL P-A, V279, P73, DOI 10.1127/njgpa/2016/0542; Small BJ, 2002, ZOOL J LINN SOC-LOND, V136, P97, DOI 10.1046/j.1096-3642.2002.00028.x; Small BJ, 1998, NEUES JB FURGEOLOGIE, P285; Small BJ, 2013, GEOL SOC SPEC PUBL, V379, P393, DOI 10.1144/SP379.18; Sulej T, 2010, ZOOL J LINN SOC-LOND, V158, P860, DOI 10.1111/j.1096-3642.2009.00566.x; Taborda JRA, 2015, AMEGHINIANA, V52, P173, DOI 10.5710/AMGH.05.01.2015.2824; Taborda JRA, 2013, GEOL SOC SPEC PUBL, V379, P413, DOI 10.1144/SP379.19; WALKER AD, 1961, PHILOS T R SOC B, V244, P103, DOI 10.1098/rstb.1961.0007; Zacarias JD, 1982, THESIS; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4; Zittel KA, 1887, HDB PALAONTOLOGIE, VIII	71	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201450	10.1371/journal.pone.0201450	http://dx.doi.org/10.1371/journal.pone.0201450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110362	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000030
J	Matz, M; Heinrich, F; Lorkowski, C; Wu, KY; Klotsche, J; Zhang, Q; Lachmann, N; Durek, P; Budde, K; Mashreghi, MF				Matz, Mareen; Heinrich, Frederik; Lorkowski, Christine; Wu, Kaiyin; Klotsche, Jens; Zhang, Qiang; Lachmann, Nils; Durek, Pawel; Budde, Klemens; Mashreghi, Mir-Farzin			MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection	PLOS ONE			English	Article							CHRONIC ALLOGRAFT DYSFUNCTION; IDENTIFICATION; MIR-143/145; EXPRESSION; SERUM; PROFILES; INVASION; INJURY	Interstitial fibrosis/tubular atrophy (IFTA) is associated with reduced allograft survival, whereas antibody-mediated rejection (ABMR) is the major cause for renal allograft failure. To identify specific microRNAs and their regulation involved in these processes, total RNA from blood cells of 16 kidney transplanted (KTx) patients with ABMR, stable graft function (SGF) and with T-cell mediated rejection (TCMR) was isolated. MicroRNA expression was determined by high-throughput sequencing. Differentially expressed candidate microRNAs were analyzed with RT-PCR in patients with SGF (n = 53), urinary tract infection (UTI) (n = 17), borderline rejection (BL) (n = 19), TCMR (n = 40), ABMR (n = 22) and IFTA (n = 30). From the 301 detected microRNAs, 64 were significantly regulated between the three cohorts. Selected candidate microRNAs miR-223-3p, miR-424-3p and miR-145-5p distin-guished TCMR and ABMR from SGF, but not from other pathologies. Most importantly, miR-145-5p expression in IFTA patients was significantly downregulated and displayed a high diagnostic accuracy compared to SGF alone (AUC = 0.891) and compared to SGF, UTI, BL, TCMR and ABMR patients combined (AUC = 0.835), which was verified by cross-validation. The identification of miR-145-5p as IFTA specific marker in blood constitutes the basis for evaluating this potentially diagnostic microRNA as biomarker in studies including high numbers of patients and different pathologies and also the further analysis of fibrosis causing etiologies after kidney transplantation.	[Matz, Mareen; Lorkowski, Christine; Zhang, Qiang; Budde, Klemens] Charite Univ Med Berlin, Dept Nephrol, Berlin, Germany; [Heinrich, Frederik; Klotsche, Jens; Durek, Pawel; Mashreghi, Mir-Farzin] Deutsch Rheuma Forschungszentrum Berlin, Berlin, Germany; [Wu, Kaiyin] Charite Univ Med Berlin, Dept Pathol, Berlin, Germany; [Lachmann, Nils] Charite Univ Med Berlin, Ctr Tumor Med, HLA Lab, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Matz, M (corresponding author), Charite Univ Med Berlin, Dept Nephrol, Berlin, Germany.	mareen.matz@charite.de	Budde, Klemens/AAD-2170-2020; Mashreghi, Mir-Farzin/S-2911-2019	Budde, Klemens/0000-0002-7929-5942; Mashreghi, Mir-Farzin/0000-0002-8015-6907; Matz, Mareen/0000-0003-1874-6284	Rahel-Hirsch scholarship (Kommission fur wissenschaftliche Nachwuchsforderung, Charite Berlin, Germany); Sonnenfeld-Stiftung, (Berlin, Germany); state of Berlin; European Regional Development Fund [EFRE 1.8/11]	Rahel-Hirsch scholarship (Kommission fur wissenschaftliche Nachwuchsforderung, Charite Berlin, Germany); Sonnenfeld-Stiftung, (Berlin, Germany); state of Berlin; European Regional Development Fund(European Commission)	M.M. was supported by a Rahel-Hirsch scholarship (Kommission fur wissenschaftliche Nachwuchsforderung, Charite Berlin, Germany) and by the Sonnenfeld-Stiftung, (Berlin, Germany). This work was supported by the state of Berlin and the "European Regional Development Fund" to F.H. and M.F.M (ERDF 2014-2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 2001, ANN STAT; Benjamini YaH Y, 1995, J ROYAL STAT SOC B, V57; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Betts G, 2014, TRANSPLANTATION, V97, pE28, DOI 10.1097/01.TP.0000441098.68212.de; Boor P, 2015, AM J TRANSPLANT, V15, P863, DOI 10.1111/ajt.13180; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Danger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060702; Das AV, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0247-4; Dimitrova N, 2016, CANCER DISCOV, V6, P188, DOI 10.1158/2159-8290.CD-15-0854; Fricke A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0424-z; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Gomez IG, 2016, AM J PHYSIOL-RENAL, V310, pP931, DOI 10.1152/ajprenal.00523.2015; Gosset C, 2014, CURR OPIN NEPHROL HY, V23, P597, DOI 10.1097/MNH.0000000000000069; Iwasaki K, 2017, BIOMARKERS, V22, P45, DOI 10.1080/1354750X.2016.1204000; Juzenas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132327; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Liep J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157801; Loboda A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8319283; Lopez-Raton M, 2014, J STAT SOFTWARE, V61; Lorenzen JM, 2011, AM J TRANSPLANT, V11, P2221, DOI 10.1111/j.1600-6143.2011.03679.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma ZH, 2016, IUBMB LIFE, V68, P394, DOI 10.1002/iub.1494; Matz M, 2016, TRANSPLANTATION, V100, P898, DOI 10.1097/TP.0000000000000873; Medrano S, 2014, AM J PATHOL, V184, P3226, DOI 10.1016/j.ajpath.2014.08.012; Morais M, 2017, BBA-GEN SUBJECTS, V1861, P2175, DOI 10.1016/j.bbagen.2017.05.028; Moriya N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169702; Morris MR, 2017, NAT REV NEPHROL, V13, P47, DOI 10.1038/nrneph.2016.168; Peck BCE, 2015, INFLAMM BOWEL DIS, V21, P2178, DOI 10.1097/MIB.0000000000000478; Rapa I, 2015, NEUROENDOCRINOLOGY, V101, P246, DOI 10.1159/000381454; Scian MJ, 2011, AM J TRANSPLANT, V11, P2110, DOI 10.1111/j.1600-6143.2011.03666.x; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Soltaninejad E, 2015, IRAN J ALLERGY ASTHM, V14, P615; Soltaninejad E, 2015, TRANSPL IMMUNOL, V33, P1, DOI 10.1016/j.trim.2015.05.002; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Tao J, 2015, TRANSPL P, V47, P1683, DOI 10.1016/j.transproceed.2015.04.094; Torres S, 2017, J PATHOL, V242, P39, DOI 10.1002/path.4874; Wang GD, 2017, MOL MED REP, V15, P75, DOI 10.3892/mmr.2016.5981; Warnecke-Eberz U, 2015, TUMOR BIOL, V36, P4643, DOI 10.1007/s13277-015-3112-0; Wu SF, 2016, GENE, V584, P83, DOI 10.1016/j.gene.2016.03.021; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493; Yiu WH, 2014, KIDNEY INT SUPPL, V4, P20, DOI 10.1038/kisup.2014.5	44	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201925	10.1371/journal.pone.0201925	http://dx.doi.org/10.1371/journal.pone.0201925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102719	Green Published, Green Submitted, gold			2022-12-26	WOS:000441452200022
J	Lovero, D; Giordano, L; Marsano, RM; Sanchez-Martinez, A; Boukhatmi, H; Drechsler, M; Oliva, M; Whitworth, AJ; Porcelli, D; Caggese, C				Lovero, Domenica; Giordano, Luca; Marsano, Rene Massimiliano; Sanchez-Martinez, Alvaro; Boukhatmi, Hadi; Drechsler, Maik; Oliva, Marta; Whitworth, Alexander J.; Porcelli, Damiano; Caggese, Corrado			Characterization of Drosophila ATPsynC mutants as a new model of mitochondrial ATP synthase disorders	PLOS ONE			English	Article							MITOCHONDRIAL ATP SYNTHASE; NUCLEAR GENETIC-DEFECTS; DROSOPHILA-MELANOGASTER; OXIDATIVE-PHOSPHORYLATION; EPSILON-SUBUNIT; DEFICIENCY; MUTANTS; GENERATION; MUTATIONS; EVOLUTION	Mitochondrial disorders associated with genetic defects of the ATP synthase are among the most deleterious diseases of the neuromuscular system that primarily manifest in newborns. Nevertheless, the number of established animal models for the elucidation of the molecular mechanisms behind such pathologies is limited. In this paper, we target the Drosophila melanogaster gene encoding for the ATP synthase subunit c, ATPsynC, in order to create a fruit fly model for investigating defects in mitochondrial bioenergetics and to better understand the comprehensive pathological spectrum associated with mitochondrial ATP synthase dysfunctions. Using P-element and EMS mutagenesis, we isolated a set of mutations showing a wide range of effects, from larval lethality to complex pleiotropic phenotypes encompassing developmental delay, early adult lethality, hypoactivity, sterility, hypofertility, aberrant male courtship behavior, locomotor defects and aberrant gonadogenesis. ATPsynC mutations impair ATP synthesis and mitochondrial morphology, and represent a powerful toolkit for the screening of genetic modifiers that can lead to potential therapeutic solutions. Furthermore, the molecular characterization of ATPsynC mutations allowed us to better understand the genetics of the ATPsynC locus and to define three broad pathological consequences of mutations affecting the mitochondrial ATP synthase functionality in Drosophila: i) pre-adult lethality; ii) multi-trait pathology accompanied by early adult lethality; iii) multi-trait adult pathology. We finally predict plausible parallelisms with genetic defects of mitochondrial ATP synthase in humans.	[Lovero, Domenica; Giordano, Luca; Marsano, Rene Massimiliano; Oliva, Marta; Porcelli, Damiano; Caggese, Corrado] Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy; [Sanchez-Martinez, Alvaro; Whitworth, Alexander J.] Cambridge Biomed Campus, MRC, Mitochondrial Biol Unit, Cambridge, England; [Boukhatmi, Hadi; Porcelli, Damiano] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Drechsler, Maik] Univ Cambridge, Dept Zool, Cambridge, England; [Lovero, Domenica] Univ Bari, Sect Internal Med & Oncol, Dept Biomed Sci & Human Oncol, Bari, Italy; [Giordano, Luca] Univ Tampere, Inst Biomed Technol, Tampere, Finland; [Giordano, Luca] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	Universita degli Studi di Bari Aldo Moro; University of Cambridge; University of Cambridge; Universita degli Studi di Bari Aldo Moro; Tampere University; University of Helsinki	Porcelli, D (corresponding author), Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy.; Porcelli, D (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dp519@cam.ac.uk	Boukhatmi, Hadi/AAM-7041-2021; Marsano, René Massimiliano/B-9640-2012; Lovero, Domenica/I-7849-2018; Sanchez-Martinez, Alvaro/L-3851-2019	Marsano, René Massimiliano/0000-0001-8450-1010; Lovero, Domenica/0000-0002-7883-8896; Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Whitworth, Alexander/0000-0002-1154-6629; Giordano, Luca/0000-0001-6315-7361	Ministero dell'Istruzione, dell'Universit a e della Ricerca (MIUR); University of Bari [12939]; MRC [MC_UU_00015/6] Funding Source: UKRI	Ministero dell'Istruzione, dell'Universit a e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Bari; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Ministero dell'Istruzione, dell'Universit a e della Ricerca (MIUR) to C.C. and University of Bari D.R. n. 12939 to D.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Cagin U, 2015, P NATL ACAD SCI USA, V112, pE6000, DOI 10.1073/pnas.1505036112; CASTRILLON DH, 1993, GENETICS, V135, P489; Catteruccia M, 2014, MOL GENET METAB, V111, P353, DOI 10.1016/j.ymgme.2014.01.001; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Chen YN, 2015, ARCH INSECT BIOCHEM, V88, P144, DOI 10.1002/arch.21209; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; De Grassi A, 2006, GENE, V371, P224, DOI 10.1016/j.gene.2005.11.022; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; DiMauro S, 2009, ADV EXP MED BIOL, V652, P139, DOI 10.1007/978-90-481-2813-6_10; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; GRIGLIATTI TA, 1998, DROSOPHILA PRACTICAL, P55; Hejzlarova K, 2014, PHYSIOL RES, V63, pS57, DOI 10.33549/physiolres.932643; Hunt LC, 2013, NAT PROTOC, V8, P2496, DOI 10.1038/nprot.2013.156; Jacobs H, 1998, MOL GEN GENET, V259, P383, DOI 10.1007/s004380050826; Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kidd T, 2005, GENETICS, V170, P697, DOI 10.1534/genetics.104.037648; Kramarova TV, 2008, FASEB J, V22, P55, DOI 10.1096/fj.07-8581com; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Oberfeld B, 2006, BIOCHEMISTRY-US, V45, P1841, DOI 10.1021/bi052304+; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Palladino MJ, 2002, GENETICS, V161, P1197; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Porcelli D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-215; ROBERTSON HM, 1988, GENETICS, V118, P461; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santacatterina F, 2016, ONCOTARGET, V7, P490, DOI 10.18632/oncotarget.6357; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Torraco A, 2012, NEUROGENETICS, V13, P375, DOI 10.1007/s10048-012-0343-8; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201811	10.1371/journal.pone.0201811	http://dx.doi.org/10.1371/journal.pone.0201811			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096161	Green Published, gold			2022-12-26	WOS:000441308500028
J	He, B; Su, TJ; Wu, YP; Xu, JS; Huang, DY				He, Bo; Su, Tianjuan; Wu, Yupeng; Xu, Jinshan; Huang, Dunyuan			Phylogenetic analysis of the mitochondrial genomes in bees (Hymenoptera: Apoidea: Anthophila)	PLOS ONE			English	Article							GENE REARRANGEMENTS; MOLECULAR PHYLOGENY; EVOLUTION; NUCLEAR; UTILITY; COMPILATION; HISTORY; BLOCKS	In this study, the first complete mitogenome of Andrenidae, namely Andrena camellia, is newly sequenced. It includes 13 protein-coding (PCG) genes, 22 transfer RNA (rRNA) genes, two ribosomal RNA (tRNA) genes, and a control region. Among PCGs, high conservation is observed in cytochrome oxidase genes with cox/ exhibits the highest conservation. Conversely, NADH dehydrogenase and ATPase subunit genes are more variable with atp8 presents the maximal variation. Comparison of the gene order indicates complex rearrangement in bees. Most of the rearranged events are located in the tRNA clusters of trnl-trnQ-trnM, trnW-trnC-trnY, and trnA-trnR-trnN-trnS1-trnE-trnF. Furthermore, we present the most comprehensive mitochondrial phylogeny of bee families. The monophyly of each family and the long-tongued bees is highly supported. However, short-tongued bees are inferred as paraphyletic relative to the sister relationship between Melittidae and other bee families. Furthermore, to improve the resolution of phylogeny, various datasets and analytical approaches are performed. It is indicated that datasets including third codons of PCGs facilitate to produce identical topology and higher nodal support. The tRNA genes that have typical cloverleaf secondary structures also exhibit similar positive effects. However, rRNAs present poor sequence alignment and distinct substitution saturation, which result in negative effects on both tree topology and nodal support. In addition, Gblocks treatment can increase the congruence of topologies, but has opposite effects on nodal support between the two inference methods of maximum likelihood and Bayesian inference.	[He, Bo; Xu, Jinshan; Huang, Dunyuan] Chongqing Normal Univ, Chongqing Key Lab Vector Insects, Chongqing Key Lab Anim Biol, Chongqing, Peoples R China; [He, Bo] Cent South Univ Forestry & Technol, Minist Educ, Key Lab Cultivat & Protect Nonwood Forest Trees, Changsha, Hunan, Peoples R China; [Su, Tianjuan] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wu, Yupeng] Taiyuan Univ Sci & Technol, Coll Environm & Safety, Taiyuan, Shanxi, Peoples R China	Chongqing Normal University; Central South University of Forestry & Technology; Chinese Academy of Sciences; Institute of Zoology, CAS; Taiyuan University of Science & Technology	Huang, DY (corresponding author), Chongqing Normal Univ, Chongqing Key Lab Vector Insects, Chongqing Key Lab Anim Biol, Chongqing, Peoples R China.	huangdunyuan@126.com	Su, Tianjuan/AAJ-6290-2021; HE, BO/GQR-0492-2022	He, Bo/0000-0002-4560-9747	China Postdoctoral Science Foundation [2015M571120]; earmarked fund for China Agriculture Research System [CARS-44-KXJ21]; Natural Science Foundation of Shanxi Province in China [2015011077]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); earmarked fund for China Agriculture Research System; Natural Science Foundation of Shanxi Province in China(Natural Science Foundation of Shanxi Province)	This work was supported by China Postdoctoral Science Foundation (No. 2015M571120, to D. H.; http://jj.chinapostdoctor.org.cn/), the earmarked fund for China Agriculture Research System (No.CARS-44-KXJ21, to J.X.; http://www.moa.gov.cn/), and the Natural Science Foundation of Shanxi Province in China (No. 2015011077, to Y. W.; http://www.sxinfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Byron A., 1995, University of Kansas Science Bulletin, V55, P377; Almeida EAB, 2009, MOL PHYLOGENET EVOL, V50, P290, DOI 10.1016/j.ympev.2008.09.028; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Brady SG, 2011, MOL PHYLOGENET EVOL, V60, P295, DOI 10.1016/j.ympev.2011.05.002; Branstetter MG, 2017, CURR BIOL, V27, P1019, DOI 10.1016/j.cub.2017.03.027; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25338-3; Crampton-Platt A, 2015, MOL BIOL EVOL, V32, P2302, DOI 10.1093/molbev/msv111; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Danforth BN, 2006, MOL PHYLOGENET EVOL, V39, P358, DOI 10.1016/j.ympev.2005.09.022; Danforth BN, 2006, P NATL ACAD SCI USA, V103, P15118, DOI 10.1073/pnas.0604033103; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; Debevec AH, 2012, ZOOL SCR, V41, P527, DOI 10.1111/j.1463-6409.2012.00549.x; Dellicour S, 2014, MOL PHYLOGENET EVOL, V70, P412, DOI 10.1016/j.ympev.2013.08.013; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedtke SM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-138; Kahnt B, 2015, BIOL J LINN SOC, V116, P940, DOI 10.1111/bij.12627; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Mao M, 2015, MOL PHYLOGENET EVOL, V84, P34, DOI 10.1016/j.ympev.2014.12.009; Mao M, 2014, MOL BIOL REP, V41, P6419, DOI 10.1007/s11033-014-3522-x; Michener C.D., 2007, BEES WORLD, Vsecond; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Miller M.A., 2010, P GAT COMP ENV WORKS; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Peters RS, 2017, CURR BIOL, V27, P1013, DOI 10.1016/j.cub.2017.01.027; Pratlong M, 2017, ZOOL SCR, V46, P363, DOI 10.1111/zsc.12208; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song F, 2016, GENOME BIOL EVOL, V8, P1411, DOI 10.1093/gbe/evw086; Song SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep20972; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timmermans MJTN, 2016, GENOME BIOL EVOL, V8, P161, DOI 10.1093/gbe/evv241; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yang XS, 2015, MOL PHYLOGENET EVOL, V85, P230, DOI 10.1016/j.ympev.2015.02.005; Yang XS, 2013, GENE, V515, P349, DOI 10.1016/j.gene.2012.11.031	53	10	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202187	10.1371/journal.pone.0202187	http://dx.doi.org/10.1371/journal.pone.0202187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092091	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600099
J	Bao, YH; Guo, YC; Yang, YQ; Wei, XN; Zhang, SS; Zhang, YM; Li, K; Yuan, M; Guo, DL; Macias, V; Zhu, XD; Zhang, W; Yang, WC				Bao, Yonghua; Guo, Yongchen; Yang, Yiqiong; Wei, Xiaonan; Zhang, Shanshan; Zhang, Yongmeng; Li, Kai; Yuan, Ming; Guo, Dongli; Macias, Virgilia; Zhu, Xiangdong; Zhang, Wei; Yang, Wancai			PRSS8 suppresses colorectal carcinogenesis and metastasis	ONCOGENE			English	Article							E-CADHERIN EXPRESSION; BETA-CATENIN; IN-VITRO; CANCER; PROSTASIN; INVASIVENESS; LOCALIZATION; INFLAMMATION; WNT; APC	The serine protease PRSS8 has shown important physiological and pathological functions, but its roles in cancer initiation and progression are unclear. We developed and dynamically characterized a conditional knockout Prss8(fl/fl), p-Villin-Cre(+) mouse model. We found that genetic deficiency of the Prss8 gene caused spontaneous colitis and an inflamed rectum at an early age and caused intestinal tumors at a late age, which were linked to increased intestinal cell proliferation and migration but decreased cell differentiation. Increased PRSS8 expression inhibited cancer cell growth and metastasis in nude mice and inhibited cancer cell migration, invasion, colony formation and tumor sphere formation in vitro, but decreased PRSS8 expression facilitated malignancies in vivo and in vitro. Gene profiling on manipulated cancer cells and intestinal epithelial cells of Prss8 mouse models, gene set enrichment analysis and mechanistic studies revealed that PRSS8 targeted the Wnt/beta-catenin, epithelial-mesenchymal transition, and stem cell signaling pathways, which were further supported by the results from the TCGA data mining and validated by immunohistochemical staining on colorectal cancer tissue microarrays. In conclusion, PRSS8 is a novel tumor suppressor that plays critical roles in the suppression of colorectal carcinogenesis and metastasis.	[Bao, Yonghua; Guo, Yongchen; Yang, Yiqiong; Wei, Xiaonan; Zhu, Xiangdong; Zhang, Wei; Yang, Wancai] Jining Med Univ, Dept Pathol, Jining 272067, Peoples R China; [Bao, Yonghua; Guo, Yongchen; Yang, Yiqiong; Wei, Xiaonan; Zhu, Xiangdong; Zhang, Wei; Yang, Wancai] Jining Med Univ, Inst Precis Med, Jining 272067, Peoples R China; [Zhang, Shanshan; Zhang, Yongmeng; Li, Kai; Yuan, Ming] Xinxiang Med Univ, Dept Pathol, Xinxiang 453003, Peoples R China; [Guo, Dongli] Jining Med Univ, Affiliated Hosp, Dept Gastrointestinal Surg, Jining 272067, Peoples R China; [Macias, Virgilia; Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Zhu, Xiangdong] Univ Illinois, Dept Emergency Med, Chicago, IL 60612 USA; [Zhang, Wei] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	Jining Medical University; Jining Medical University; Xinxiang Medical University; Jining Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Yang, WC (corresponding author), Jining Med Univ, Dept Pathol, Jining 272067, Peoples R China.; Yang, WC (corresponding author), Jining Med Univ, Inst Precis Med, Jining 272067, Peoples R China.; Yang, WC (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60612 USA.	wyang06@uic.edu	Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197; Zhang, Wei/0000-0003-0875-263X	National Nature Science Foundation of China [81672750, 91229115, 81502105]; Key Laboratory of Higher Education Institutes of Shandong Province; Nature Science Foundation of Shandong Province [2016ZRB14436]; Taishan Scholar Program of Shandong Province, China; Innovation Team of Science and Technology, Henan Province, China; Startup Fund from Jining Medical University; Fostering fund from Jining Medical University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Higher Education Institutes of Shandong Province; Nature Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Taishan Scholar Program of Shandong Province, China; Innovation Team of Science and Technology, Henan Province, China; Startup Fund from Jining Medical University; Fostering fund from Jining Medical University	This work was supported in part by grants from the National Nature Science Foundation of China (grants 81672750 and 91229115 to WY, grant 81502105 to YB), a grant from the Key Laboratory of Higher Education Institutes of Shandong Province, the Nature Science Foundation of Shandong Province (grant 2016ZRB14436 to YG) and Taishan Scholar Program of Shandong Province, China, a grant from the Innovation Team of Science and Technology, Henan Province, China, the Startup Fund from Jining Medical University (to YB and YG) and Fostering fund from Jining Medical University (to YG). We would like to thank Prof. Weixing Zhao (Xinxiang Medical University, Xinxiang, China), Prof. Renya Zhang (Jining Medical University, Jining, China) and Prof. Anjia Han (Sun Yat-sen University, Guangzhou, China) for assistance with the histopathology analysis of the mouse models, Prof. Alan Diamond (University of Illinois at Chicago, Chicago, USA) for critical discussion, and Springer Nature Author Services for editing this manuscript. We would also like to thank the Research Histology and Tissue Imaging Core (RHTIC) facility at the University of Illinois at Chicago (Chicago, IL) for their technical assistance.	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao YH, 2016, ONCOTARGET, V7, P28540, DOI 10.18632/oncotarget.8677; Bao YH, 2016, ONCOTARGET, V7, P26780, DOI 10.18632/oncotarget.8511; Bao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099132; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Chen LM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-377; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen LM, 2002, INT J CANCER, V97, P323, DOI 10.1002/ijc.1601; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; DOKI Y, 1993, CANCER RES, V53, P3421; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keppner A, 2016, INFLAMM BOWEL DIS, V22, P2824, DOI 10.1097/MIB.0000000000000940; Lee SY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0577-4; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Mok SC, 2001, J NATL CANCER I, V93, P1458, DOI 10.1093/jnci/93.19.1458; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; OKA H, 1993, CANCER RES, V53, P1696; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ordonez-Moran P, 2015, CANCER CELL, V28, P815, DOI 10.1016/j.ccell.2015.11.001; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Rodriguez-Salas N, 2017, CRIT REV ONCOL HEMAT, V109, P9, DOI 10.1016/j.critrevonc.2016.11.007; Sakashita K, 2008, J SURG ONCOL, V98, P559, DOI 10.1002/jso.21158; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sarojini S, 2012, J ONCOL, V2012, DOI 10.1155/2012/709049; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi S, 2003, PROSTATE, V54, P187, DOI 10.1002/pros.10178; Uchimura K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4428; UMBAS R, 1994, CANCER RES, V54, P3929; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yu JX, 1996, GENOMICS, V32, P334, DOI 10.1006/geno.1996.0127; YU JX, 1994, J BIOL CHEM, V269, P18843	50	15	15	2	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					497	517		10.1038/s41388-018-0453-3	http://dx.doi.org/10.1038/s41388-018-0453-3			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30115975				2022-12-26	WOS:000456589800004
J	Sarwar, M; Khaja, ASS; Aleskandarany, M; Karlsson, R; Althobiti, M; Odum, N; Mongan, NP; Dizeyi, N; Johnson, H; Green, AR; Ellis, IO; Rakha, EA; Persson, JL				Sarwar, Martuza; Khaja, Azharuddin Sajid Syed; Aleskandarany, Mohammed; Karlsson, Richard; Althobiti, Maryam; Odum, Niels; Mongan, Nigel P.; Dizeyi, Nisthman; Johnson, Heather; Green, Andrew R.; Ellis, Ian O.; Rakha, Emad A.; Persson, Jenny L.			The role of PIP5K1 alpha/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1 alpha inhibitor	ONCOGENE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; ESTROGEN-RECEPTOR; METASTASIS; EXPRESSION; PREVENTION; RESISTANCE; PATHWAY; PROTEIN; ALPHA; BONE	Despite recent improvement in adjuvant therapies, triple-negative, and ER+ subtypes of breast cancer (BC) with metastatic potentials remain the leading cause of BC-related deaths. We investigated the role of phosphatidylinositol-4-phosphate 5-kinase alpha (PIP5K alpha), a key upstream factor of PI3K/AKT, and the therapeutic effect of PIP5K alpha inhibitor on subtypes of BC. The clinical importance of PIP5K1 alpha and its association with survivals were analyzed using three BC cohorts from Nottingham (n = 913), KM plotter (n = 112) and TCGA (n = 817). Targeted overexpression or knockdown of PIP5K1 alpha were introduced into BC cell lines. The effects of PIP5K1 alpha and its inhibitor on growth and invasion of BC were confirmed by using in vitro assays including proliferation, migration, apoptosis and luciferase reporter assays and in vivo xenograft mouse models. All statistical tests were two-sided. PIP5K1 alpha was associated with poor patient outcome in triple-negative BC (for PIP5K1 alpha protein, p = 0.011 and for mRNA expression, p = 0.028, log-rank test). 29% of triple-negative BC had PIP5K1A gene amplification. Elevated level of PIP5K1 alpha increased expression of pSer-473 AKT (p < 0.001) and invasiveness of triple-negative MDA-MB-231 cells (p < 0.001). Conversely, inhibition of PIP5K1 alpha using its inhibitor ISA-2011B, or via knockdown suppressed growth and invasiveness of MDA-MB-231 xenografts (mean vehicle-treated controls = 2160 mm(3), and mean ISA-2011B-treated = 600 mm(3), p < 0.001). ISA-2011B-treatment reduced expression of pSer-473 AKT (p < 0.001) and its downstream effectors including cyclin D1, VEGF and its receptors, VEGFR1 and VEGFR2 (p < 0.001) in xenograft tumors. In ER+ cancer cells, PIP5K1 alpha acted on pSer-473 AKT, and was in complexes with VEGFR2, serving as co-factor of ER-alpha to regulate activities of target genes including cyclin D1 and CDK1. Our study suggests that our developed PIP5K1 alpha inhibitor has a great potential on refining targeted therapeutics for treatment of triple-negative and ER+ BC with abnormal PI3K/AKT pathways.	[Sarwar, Martuza; Persson, Jenny L.] Lund Univ, Clin Res Ctr, Dept Translat Med, Div Expt Canc Res, Malmo, Sweden; [Khaja, Azharuddin Sajid Syed; Karlsson, Richard; Persson, Jenny L.] Umea Univ, Dept Mol Biol, Div Basal Tumor Biol, Umea, Sweden; [Aleskandarany, Mohammed; Althobiti, Maryam; Green, Andrew R.; Ellis, Ian O.; Rakha, Emad A.] Univ Nottingham, Acad Pathol, Sch Med, Div Canc & Stem Cells, Nottingham, England; [Odum, Niels] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Mongan, Nigel P.] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Nottingham, England; [Mongan, Nigel P.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Dizeyi, Nisthman] Lund Univ, Clin Res Ctr, Dept Translat Med, Div Reprod Res, Malmo, Sweden; [Johnson, Heather] Beijing Inst Basic Med Sci, Dept Biodiag, Beijing, Peoples R China	Lund University; Umea University; University of Nottingham; University of Copenhagen; University of Nottingham; Cornell University; Lund University; Academy of Military Medical Sciences - China	Persson, JL (corresponding author), Lund Univ, Clin Res Ctr, Dept Translat Med, Div Expt Canc Res, Malmo, Sweden.; Persson, JL (corresponding author), Umea Univ, Dept Mol Biol, Div Basal Tumor Biol, Umea, Sweden.	jenny_l.persson@med.lu.se	Syed Khaja, Azharuddin Sajid/AAF-2693-2021; Rakha, Emad/Q-5554-2019; Aleskandarany, Mohammed/X-8585-2019; Green, Andrew/AAF-1991-2020; Aleskandarany, Mohammed/D-9162-2018	Syed Khaja, Azharuddin Sajid/0000-0003-1594-1826; Persson, Jenny/0000-0001-7682-7678; Rakha, Emad/0000-0002-5009-5525; Aleskandarany, Mohammed/0000-0001-5538-5946; Mongan, Nigel/0000-0001-5438-1126; Ellis, Ian/0000-0001-5292-8474; Green, Andrew/0000-0002-0488-5913; Karlsson, Richard Torbjorn Gustav/0000-0003-0448-6135; JOHNSON, HEATHER/0000-0001-7468-0705	Swedish Cancer Society; Swedish National Research Council; Swedish Children Foundation; Malmo Cancer Foundation; Government Health Innovation Grant; Kempe STF; Umea University; Medical Faculty Grants; Royal Physiographical Foundation; University of Nottingham; Weill Cornell Medicine	Swedish Cancer Society(Swedish Cancer Society); Swedish National Research Council; Swedish Children Foundation; Malmo Cancer Foundation; Government Health Innovation Grant; Kempe STF; Umea University; Medical Faculty Grants; Royal Physiographical Foundation; University of Nottingham; Weill Cornell Medicine	This work was supported by grants from the Swedish Cancer Society, The Swedish National Research Council, The Swedish Children Foundation, Malmo Cancer Foundation, Malmo Cancer Foundation, the Government Health Innovation Grant, Kempe STF, Umea University, Medical Faculty Grants to JLP. The Royal Physiographical Foundation to MS. We acknowledge the support of the University of Nottingham and Weill Cornell Medicine (NPM). The authors sincerely thank Teresa Frisan (Umea University, Umea and Karolinska Institute, Stockholm), Pirkko Harkonen (University of Turku, Turku), Yafang Mei (Umea University, Umea) and Yvonne Lundberg Giwercman (Lund University, Lund) for providing reagents for this study. We also thank Per-Anders Bertilsson, Kristina Ekstrom-Holka and Elise Nilsson for technical help, and the Nottingham Health Science Biobank and Breast Cancer Now Tissue Bank for the provision of tissue samples.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Aesoy R, 2008, MOL CANCER RES, V6, P1630, DOI 10.1158/1541-7786.MCR-07-2172; Aleskandarany MA, 2016, BREAST CANCER RES TR, V156, P9, DOI 10.1007/s10549-016-3709-z; Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P407, DOI 10.1007/s10549-010-1012-y; Andruska N, 2012, J BIOMOL SCREEN, V17, P921, DOI 10.1177/1087057112442960; Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Coleman RE, 2002, AM J CLIN ONCOL-CANC, V25, pS32, DOI 10.1097/00000421-200212001-00006; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Khaja ASS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072210; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lim E, 2012, ONCOLOGY-NY, V26, P688; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Marino N, 2013, AM J PATHOL, V183, P1084, DOI 10.1016/j.ajpath.2013.06.012; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sarwar M, 2016, ONCOTARGET, V7, P63065, DOI 10.18632/oncotarget.11757; Semenas J, 2014, P NATL ACAD SCI USA, V111, pE3689, DOI 10.1073/pnas.1405801111; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Solzak JP, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0016-8; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07758; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838	36	18	18	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					375	389		10.1038/s41388-018-0438-2	http://dx.doi.org/10.1038/s41388-018-0438-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30104711	Green Published, hybrid			2022-12-26	WOS:000455851200006
J	Zhou, J; Zhu, CY; Luo, HW; Shen, L; Gong, J; Wu, YM; Magdalou, J; Chen, LB; Guo, Y; Wang, H				Zhou, Jin; Zhu, Chunyan; Luo, Hanwen; Shen, Lang; Gong, Jun; Wu, Yimeng; Magdalou, Jacques; Chen, Liaobin; Guo, Yu; Wang, Hui			Two intrauterine programming mechanisms of adult hypercholesterolemia induced by prenatal nicotine exposure in male offspring rats	FASEB JOURNAL			English	Article						glucocorticoid; hepatic cholesterol metabolism; IGF1; epigenetics	PITUITARY-ADRENAL AXIS; FATTY LIVER-DISEASE; GROWTH-RETARDATION; INCREASED SUSCEPTIBILITY; CARDIOVASCULAR-DISEASE; CHOLESTEROL TRANSPORT; HISTONE DEACETYLASE; INDUCED INHIBITION; MATERNAL SMOKING; OVER-EXPOSURE	Epidemiologic studies showed that low birth weight is associated with high cholesterol and an increased risk of cardiovascular diseases in adulthood. This study aimed to elucidate the intrauterine programming mechanisms of adult hypercholesterolemia. The results showed that prenatal nicotine exposure (PNE) caused intrauterine growth retardation and hypercholesterolemia in male adult offspring rats. Hepatic cholesterol synthesis and output were deceased in utero but increased in adults; hepatic reverse cholesterol transport (RCT) persistently deceased before and after birth. Meanwhile, PNE elevated serum corticosterone level and decreased hepatic IGF1 pathway activity in male fetuses, whereas converse changes were observed in male adults. The chronic stress model and cortisol-treated HepG2 cells verified that excessive glucocorticoid (GC)-induced GC-IGF1 axis programming enhanced hepatic cholesterol synthesis and output. In addition, PNE decreased the expression of specific protein 1 and P300 enrichment and H3K27 acetylation at the promoter region of genes responsible for RCT both in fetal and adult, male livers and reduced expression of those genes, similar alterations were also confirmed in cortisol-treated HepG2 cells, suggesting that excessive GC-related programming induced continuous RCT reduction by epigenetic modification. Taken together, the 2-programming approach discussed above may ultimately contribute to the development of hypercholesterolemia in male adult offspring.Zhou, J., Zhu, C., Luo, H., Shen, L., Gong, J., Wu, Y., Magdalou, J., Chen, L., Guo, Y., Wang, H. Two intrauterine programming mechanisms of adult hypercholesterolemia induced by prenatal nicotine exposure in male offspring rats.	[Zhou, Jin; Zhu, Chunyan; Shen, Lang; Gong, Jun; Wu, Yimeng; Guo, Yu; Wang, Hui] Wuhan Univ, Dept Pharmacol, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Luo, Hanwen; Chen, Liaobin] Wuhan Univ, Dept Orthoped Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Magdalou, Jacques] Nancy Univ, CNRS, UMR 7561, Vandoeuvre Les Nancy, France; [Chen, Liaobin; Guo, Yu; Wang, Hui] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Guo, Y; Wang, H (corresponding author), Wuhan Univ, Dept Pharmacol, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	guoy@whu.edu.cn; wanghui19@whu.edu.cn			National Natural Science Foundation of China [81673524, 81220108026, 81430089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the help provided by G. H. Zhang (Zhongnan Hospital, Wuhan University) and L. T. Yu (Basic Medical School, Wuhan University) during the revision process. The authors are grateful to staff of the Center for Animal Experiment of Wuhan University. This work was supported by the National Natural Science Foundation of China (Grants 81673524, 81220108026, and 81430089). The authors declare no conflicts of interest.	Akhtar S, 2015, PAK J PHARM SCI, V28, P2273; Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Amigo H, 2010, J EPIDEMIOL COMMUN H, V64, P855, DOI 10.1136/jech.2008.078345; Baardman ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.003; Bao W, 2016, INT J EPIDEMIOL, V45, P160, DOI 10.1093/ije/dyv334; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Barouki R, 2018, ENVIRON INT, V114, P77, DOI 10.1016/j.envint.2018.02.014; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Baumann M, 2013, PLACENTA, V34, P1079, DOI 10.1016/j.placenta.2013.06.309; Busada JT, 2017, CURR TOP DEV BIOL, V125, P147, DOI 10.1016/bs.ctdb.2016.12.004; Chen CJ, 2008, EUR J PHARMACOL, V591, P36, DOI 10.1016/j.ejphar.2008.06.041; Chen LH, 2017, J CHIN MED ASSOC, V80, P44, DOI 10.1016/j.jcma.2016.08.001; Chen M, 2007, EXP TOXICOL PATHOL, V59, P245, DOI 10.1016/j.etp.2007.05.007; Cong RH, 2012, J NUTR BIOCHEM, V23, P1647, DOI 10.1016/j.jnutbio.2011.11.007; Pereira PPD, 2017, NICOTINE TOB RES, V19, P497, DOI 10.1093/ntr/ntw228; Delpisheh A, 2006, WOMENS HEALTH, V2, P389, DOI 10.2217/17455057.2.3.389; Driver PM, 2001, MOL HUM REPROD, V7, P357, DOI 10.1093/molehr/7.4.357; Engelbregt MJT, 2001, PEDIATR RES, V50, P474, DOI 10.1203/00006450-200110000-00009; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Feng JH, 2014, MOL CELL ENDOCRINOL, V394, P59, DOI 10.1016/j.mce.2014.06.016; Formisano L, 2015, J NEUROSCI, V35, P7332, DOI 10.1523/JNEUROSCI.2174-14.2015; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Grefhorst A, 2012, ATHEROSCLEROSIS, V222, P382, DOI 10.1016/j.atherosclerosis.2012.02.014; Hadidi KA, 2004, SAUDI MED J, V25, P912; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; He X, 2017, ARCH TOXICOL, V91, P3927, DOI 10.1007/s00204-017-1996-8; He Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14881-0; Hochberg Z, 2002, HORM RES, V58, P33, DOI 10.1159/000064764; Hong LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20503; Huang HG, 2015, TOXICOL APPL PHARM, V288, P84, DOI 10.1016/j.taap.2015.07.005; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jaddoe VWV, 2008, ATHEROSCLEROSIS, V196, P42, DOI 10.1016/j.atherosclerosis.2007.01.032; Knopik VS, 2016, BEHAV GENET, V46, P353, DOI 10.1007/s10519-015-9750-6; Koch S, 2012, Z GEBURTSH NEONATOL, V216, P77, DOI [10.1055/s-0032-1308958, 10.1055/s-0032-1309153]; Kuchmin A N, 2010, Voen Med Zh, V331, P25; Kumar P, 2014, J BIOL CHEM, V289, P6991, DOI 10.1074/jbc.M113.511444; Li JN, 2013, J CLIN ENDOCR METAB, V98, pE1189, DOI 10.1210/jc.2012-4291; Liang G, 2011, EXP TOXICOL PATHOL, V63, P607, DOI 10.1016/j.etp.2010.04.015; Liu L, 2012, TOXICOL LETT, V214, P307, DOI 10.1016/j.toxlet.2012.09.001; Liu MX, 2017, ACTA PHARMACOL SIN, V38, P660, DOI 10.1038/aps.2016.158; Liu XM, 2014, J CLIN BIOCHEM NUTR, V55, P40, DOI 10.3164/jcbn.13-100; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Martino F, 2016, J CARDIOVASC MED, V17, P539, DOI 10.2459/JCM.0000000000000334; Mauvais-Jarvis F, 2017, CELL METAB, V25, P1216, DOI 10.1016/j.cmet.2017.04.033; Nikkila K, 2014, AM J TRANSPLANT, V14, P2898, DOI 10.1111/ajt.12961; Ono K, 2012, J CARDIOL, V60, P339, DOI 10.1016/j.jjcc.2012.07.014; Ozkan H, 1999, BIOL NEONATE, V76, P274, DOI 10.1159/000014169; Pecks Ulrich, 2013, Pregnancy Hypertens, V3, P78, DOI 10.1016/j.preghy.2013.04.059; Pecks U, 2012, J PERINAT MED, V40, P287, DOI [10.1515/jpm.2011.135, 10.1515/JPM.2011.135]; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Restrepo MC, 2009, CAD SAUDE PUBLICA, V25, P2345, DOI 10.1590/S0102-311X2009001100005; Rosengren L, 2005, J BIOMOL SCREEN, V10, P260, DOI 10.1177/1087057104273802; Shen L, 2014, TOXICOL APPL PHARM, V274, P263, DOI 10.1016/j.taap.2013.11.009; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Succurro E, 2010, EUR J ENDOCRINOL, V163, P75, DOI 10.1530/EJE-10-0113; Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007; Tie K, 2016, REPROD TOXICOL, V60, P11, DOI 10.1016/j.reprotox.2015.12.010; Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184; Venkatesan N, 2003, EUR J NUTR, V42, P262, DOI 10.1007/s00394-003-0420-8; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006; Wang T, 2009, ENVIRON TOXICOL, V24, P33, DOI 10.1002/tox.20391; Wen YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107024; Wu JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE1087, DOI 10.1152/ajpendo.1999.277.6.E1087; Xu D, 2012, TOXICOL LETT, V209, P282, DOI 10.1016/j.toxlet.2012.01.006; Xu D, 2015, TOXICOL RES-UK, V4, P112, DOI 10.1039/c4tx00092g; Xu D, 2013, ACTA PHARMACOL SIN, V34, P1526, DOI 10.1038/aps.2013.171; Yang F, 2016, BBA-MOL CELL BIOL L, V1861, P1066, DOI 10.1016/j.bbalip.2016.06.001; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017; Zhang YL, 2018, DESTECH TRANS SOC, P60; Zhao Q, 2004, J BIOL CHEM, V279, P41477, DOI 10.1074/jbc.M405129200; Zwier MV, 2017, ACTA PHYSIOL, V220, P471, DOI 10.1111/apha.12845	76	14	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1110	1123		10.1096/fj.201800172R	http://dx.doi.org/10.1096/fj.201800172R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113880	Bronze			2022-12-26	WOS:000457401500088
J	Avanzino, BC; Jue, H; Miller, CM; Cheung, E; Fuchs, G; Fraser, CS				Avanzino, Brian C.; Jue, Helen; Miller, Clare M.; Cheung, Emily; Fuchs, Gabriele; Fraser, Christopher S.			Molecular mechanism of poliovirus Sabin vaccine strain attenuation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						poliovirus; eukaryotic translation initiation factor 4G (eIF4G); eukaryotic initiation factor 4A (eIF4A); RNA-binding protein; eukaryotic translation initiation; plus-stranded RNA virus; internal ribosome entry site (IRES); vaccine; virulence	TRACT-BINDING-PROTEIN; INTERNAL RIBOSOME ENTRY; HUMAN NEUROBLASTOMA; ATPASE ACTIVITIES; NONCODING REGION; HELICASE EIF4A; TRANSLATION; INITIATION; RNA; TYPE-3	Recruitment of poliovirus (PV) RNA to the human ribosome requires the coordinated interaction of the viral internal ribosome entry site (IRES) and several host cellular initiation factors and IRES trans-acting factors (ITAFs). Attenuated PV Sabin strains contain point mutations in the PV IRES domain V (dV) that inhibit viral translation. Remarkably, attenuation is most apparent in cells of the central nervous system, but the molecular basis to explain this is poorly understood. The dV contains binding sites for eukaryotic initiation factor 4G (eIF4G) and polypyrimidine tract-binding protein (PTB). Impaired binding of these proteins to the mutant IRESs has been observed, but these effects have not been quantitated. We used a fluorescence anisotropy assay to reveal that the Sabin mutants reduce the equilibrium dissociation constants of eIF4G and PTB to the PV IRES by up to 6-fold. Using the most inhibitory Sabin 3 mutant, we used a real-time fluorescence helicase assay to show that the apparent affinity of an active eIF4G/4A/4B helicase complex for the IRES is reduced by 2.5-fold. The Sabin 3 mutant did not alter the maximum rate of eIF4A-dependent helicase activity, suggesting that this mutant primarily reduces the affinity, rather than activity, of the unwinding complex. To confirm this affinity model of attenuation, we show that eIF4G overexpression in HeLa cells overcomes the attenuation of a Sabin 3 mutant PV-luciferase replicon. Our study provides a quantitative framework for understanding the mechanism of PV Sabin attenuation and provides an explanation for the previously observed cell type-specific translational attenuation.	[Avanzino, Brian C.; Jue, Helen; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Miller, Clare M.; Cheung, Emily; Fuchs, Gabriele] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Fraser, CS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA.; Fuchs, G (corresponding author), SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA.	gfuchs@albany.edu; csfraser@ucdavis.edu		Miller, Clare M/0000-0001-8266-6479; Fuchs, Gabriele/0000-0002-6838-2100	NIGMS; National Institutes of Health [R01GM092927]; American Heart Association; Myocarditis Foundation; University at Albany; State University of New York; University at Albany Faculty Research Awards Program (FRAP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092927] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Myocarditis Foundation; University at Albany; State University of New York; University at Albany Faculty Research Awards Program (FRAP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM092927 (to C. S. F.), an American Heart Association and Myocarditis Foundation predoctoral fellowship (to B. C. A.), and by startup funds from the University at Albany, State University of New York, and the University at Albany Faculty Research Awards Program (FRAP) (to G. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGOL VI, 1989, J VIROL, V63, P4034, DOI 10.1128/JVI.63.9.4034-4038.1989; ALMOND JW, 1987, ANNU REV MICROBIOL, V41, P153; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Goetz C, 2011, FUTURE VIROL, V6, P1045, DOI 10.2217/FVL.11.76; Guest S, 2004, J VIROL, V78, P11097, DOI 10.1128/JVI.78.20.11097-11107.2004; Gutierrez AL, 1997, J VIROL, V71, P3826; Haller AA, 1996, J VIROL, V70, P1467, DOI 10.1128/JVI.70.3.1467-1474.1996; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hunt SL, 1999, RNA, V5, P344, DOI 10.1017/S1355838299981414; Kafasla P, 2010, EMBO J, V29, P3710, DOI 10.1038/emboj.2010.231; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kauder SE, 2004, J CLIN INVEST, V113, P1743, DOI 10.1172/JCI200421323; KAWAMURA N, 1989, J VIROL, V63, P1302, DOI 10.1128/JVI.63.3.1302-1309.1989; LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989; Lillevali K, 2001, MECH DEVELOP, V101, P217, DOI 10.1016/S0925-4773(00)00566-9; Malnou CE, 2004, J BIOL CHEM, V279, P10261, DOI 10.1074/jbc.M307806200; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; MOSS EG, 1989, J VIROL, V63, P1884, DOI 10.1128/JVI.63.5.1884-1890.1989; Ochs K, 2003, J VIROL, V77, P115, DOI 10.1128/JVI.77.1.115-122.2003; Ochs K, 2002, J VIROL, V76, P2113, DOI 10.1128/JVI.76.5.2113-2122.2002; Ozes A, 2014, NAT PROTOC, V9, P1645, DOI 10.1038/nprot.2014.112; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Ohka S, 2001, Dev Biol (Basel), V105, P51; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Racaniello V R, 1988, Adv Virus Res, V34, P217, DOI 10.1016/S0065-3527(08)60519-9; SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420; Sokabe M, 2017, P NATL ACAD SCI USA, V114, P6304, DOI 10.1073/pnas.1620426114; Sokabe M, 2014, J BIOL CHEM, V289, P31827, DOI 10.1074/jbc.M114.602870; SVITKIN YV, 1985, VIROLOGY, V147, P243, DOI 10.1016/0042-6822(85)90127-8; SVITKIN YV, 1990, VIROLOGY, V175, P103, DOI 10.1016/0042-6822(90)90190-3; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Vogt DA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000936; WESTROP GD, 1989, J VIROL, V63, P1338, DOI 10.1128/JVI.63.3.1338-1344.1989	40	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15471	15482		10.1074/jbc.RA118.004913	http://dx.doi.org/10.1074/jbc.RA118.004913			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126841	hybrid, Green Published			2022-12-26	WOS:000446549200014
J	Wang, T; Reingruber, J; Woodruff, ML; Majumderil, A; Camarena, A; Artemyev, NO; Fain, GL; Chen, J				Wang, Tian; Reingruber, Juergen; Woodruff, Michael L.; Majumderil, Anurima; Camarena, Andres; Artemyev, Nikolai O.; Fain, Gordon L.; Chen, Jeannie			The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; phosphodiesterases; cyclic GMP (cGMP); retinal degeneration; phototransduction; cell death; protein translocation; protein stability; cGMP-gated channels; missense mutation; PDE6; protein transport; protein mislocalization	ROD CGMP-PHOSPHODIESTERASE; RECESSIVE RETINITIS-PIGMENTOSA; NUCLEOTIDE-GATED CHANNEL; BETA-SUBUNIT; OUTER SEGMENTS; SENSITIVE CONDUCTANCE; PHOTORECEPTOR CELLS; RHODOPSIN KINASE; LIGHT ADAPTATION; RESTORES VISION	The retinal degeneration model rd10 contains a missense mutation of the catalytic PDE6 subunit, which hydrolyzes cGMP in response to light. This model produces cell death more slowly than others caused by PDE6 loss of function, making it of particular interest for studying potential therapeutics. We used morphology, biochemistry, and single-cell physiology to examine the mechanism of rd10 degeneration. Our results show that the mutation produces no alteration of Pde6b RNA but does dramatically decrease maximal and basal PDE6 activity, apparently caused by a decrease in protein stability and transport. The enzymatic properties of the remaining mutant PDE6 appear to be nearly normal. We demonstrate that an increase in free cGMP, which would result from decreased PDE6 activity and serve to increase opening of the cGMP-gated channels and calcium influx, is an underlying cause of cell death: degeneration of rd10/Cngb1(-/-) double mutants is slower than the parent rd10 line. Paradoxically, degeneration in rd10/Cngb1(-/-) is also slower than in Cngb1(-/-). This rescue is correlated with a lowering of cGMP content in Cngb1(-/-) retinas and suggests that it may be caused by mislocalization of active PDE6. Single-cell recordings from rd10 rods show that the rates of rise and decay of the response are significantly slower; simulations indicate that these changes are primarily the result of the decrease in PDE6 concentration and rod collecting area. Together, these results provide insights into the complex mechanisms that underlie rd10-mediated retinal degeneration and a cautionary note for analysis of therapeutic interventions.	[Wang, Tian; Camarena, Andres; Chen, Jeannie] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Tian; Camarena, Andres; Chen, Jeannie] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90089 USA; [Reingruber, Juergen] Ecole Normale Super, Inst Biol, Grp Computat Biol & Appl Math, F-75005 Paris, France; [Woodruff, Michael L.; Fain, Gordon L.] UCLA, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Majumderil, Anurima; Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Fain, Gordon L.] UCLA, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of California System; University of California Los Angeles; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, J (corresponding author), 1501 San Pablo St,ZNI Rm 227, Los Angeles, CA 90089 USA.	jeannie@usc.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Fain, Gordon/0000-0002-9813-0342; Chen, Jeannie/0000-0002-7904-9629; Artemyev, Nikolai/0000-0002-5266-6854; Reingruber, Juergen/0000-0002-7167-8092	National Institutes of Health [EY01844, EY10843, EY027193, EY027387, EY12155]; NATIONAL EYE INSTITUTE [R01EY027387, R01EY027193, R01EY012155, R01EY001844, R37EY001844, R01EY010843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY01844 (to G.L.F.), EY10843 (to N.O.A.), and EY027193, EY027387, and EY12155 (to J.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANANT JS, 1992, J BIOL CHEM, V267, P687; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boye SL, 2015, HUM GENE THER, V26, P575, DOI 10.1089/hum.2015.053; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cheguru P, 2014, J NEUROCHEM, V129, P256, DOI 10.1111/jnc.12501; Chen CK, 2015, J GEN PHYSIOL, V145, P213, DOI 10.1085/jgp.201411273; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen J, 2010, J NEUROSCI, V30, P16232, DOI 10.1523/JNEUROSCI.2868-10.2010; COTE RH, 1993, J BIOL CHEM, V268, P17190; Cronin T, 2012, ADV EXP MED BIOL, V723, P129, DOI 10.1007/978-1-4614-0631-0_18; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Deng WT, 2013, J NEUROSCI, V33, P11745, DOI 10.1523/JNEUROSCI.1536-13.2013; Dong EH, 2017, MOL VIS, V23, P90; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; HAHN LB, 1994, INVEST OPHTH VIS SCI, V35, P1077; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Hasegawa T, 2016, JPN J OPHTHALMOL, V60, P111, DOI 10.1007/s10384-015-0422-0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; HURLEY JB, 1981, BIOCHIM BIOPHYS ACTA, V675, P359, DOI 10.1016/0304-4165(81)90026-X; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; Muradov H, 2012, VISION RES, V57, P1, DOI 10.1016/j.visres.2012.01.017; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2012, J PHYSIOL-LONDON, V590, P2353, DOI 10.1113/jphysiol.2012.228627; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reingruber J, 2013, P NATL ACAD SCI USA, V110, P19378, DOI 10.1073/pnas.1314030110; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Schnetkamp PPM, 2014, CURR TOP MEMBR, V73, P263, DOI 10.1016/B978-0-12-800223-0.00007-4; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Vinberg F, 2017, ELIFE, V6, DOI 10.7554/eLife.24550; Wang T, 2017, HUM MOL GENET, V26, P2299, DOI 10.1093/hmg/ddx121; Wang T, 2014, J BIOL CHEM, V289, P29310, DOI 10.1074/jbc.M114.595207; Warren R, 2002, ADV EXP MED BIOL, V514, P205; Wert KJ, 2014, DEV OPHTHALMOL, V53, P33, DOI 10.1159/000357294; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	62	26	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15332	15346		10.1074/jbc.RA118.004459	http://dx.doi.org/10.1074/jbc.RA118.004459			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126843	hybrid, Green Published			2022-12-26	WOS:000446549200001
J	Sun, LN; Ishihara, M; Middleton, DR; Tiemeyer, M; Avci, FY				Sun, Lina; Ishihara, Mayumi; Middleton, Dustin R.; Tiemeyer, Michael; Avci, Fikri Y.			Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; antigen; N-linked glycosylation; click chemistry; metabolic engineering	HUMAN-IMMUNODEFICIENCY-VIRUS; O-LINKED GLYCOSYLATION; MANNOSE-BINDING LECTIN; FREE CLICK CHEMISTRY; MASS-SPECTROMETRY; DC-SIGN; COPPER-FREE; NEUTRALIZING ANTIBODIES; MODIFIED PROTEINS; LIVING ANIMALS	The glycan shield on the envelope glycoprotein gp120 of HIV-1 has drawn immense attention as a vulnerable site for broadly neutralizing antibodies and for its significant impact on host adaptive immune response to HIV-1. Glycosylation sites and glycan composition/structure at each site on gp120 along with the interactions of gp120 glycan shield with broadly neutralizing antibodies have been extensively studied. However, a method for directly and selectively tracking gp120 glycans has been lacking. Here, we integrate metabolic labeling and click chemistry technology with recombinant gp120 expression to demonstrate that gp120 glycans could be specifically labeled and directly detected. Selective labeling of gp120 by N-azidoacetylmannosamine (ManNAz) and N-azidoacetylgalactosamine (GalNAz) incorporation into the gp120 glycan shield was characterized by MS of tryptic glycopeptides. By using metabolically labeled gp120, we investigated the impact of gp120 glycosylation on its interaction with host cells and demonstrated that oligomannose enrichment and sialic acid deficiency drastically enhanced gp120 uptake by bone marrow-derived dendritic cells. Collectively, our data reveal an effective labeling and detection method for gp120, serving as a tool for functional characterization of the gp120 glycans and potentially other glycosylated proteins.	[Sun, Lina; Middleton, Dustin R.; Avci, Fikri Y.] Univ Georgia, Dept Biochem & Mol Biol, Ctr Mol Med, Athens, GA 30602 USA; [Ishihara, Mayumi; Tiemeyer, Michael; Avci, Fikri Y.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Avci, FY (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Ctr Mol Med, 315 Riverbend Rd, Athens, GA 30602 USA.	avci@uga.edu		Avci, Fikri/0000-0002-1902-7532; Aoki, Mayumi/0000-0002-8368-8546	National Institutes of Health [R01AI123383, P41GM103490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01AI123383 and P41GM103490. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andre S, 1998, J VIROL, V72, P1497; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; BARIN F, 1985, SCIENCE, V228, P1094, DOI 10.1126/science.2986291; Behrens AJ, 2017, J VIROL, V91, DOI 10.1128/JVI.01894-16; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burnham-Marusich AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049020; Caminschi I, 2006, INT IMMUNOL, V18, P741, DOI 10.1093/intimm/dxl011; Canis K, 2018, J THROMB HAEMOST, V16, P1592, DOI 10.1111/jth.14204; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Guttman M, 2015, ELECTROPHORESIS, V36, P1305, DOI 10.1002/elps.201500054; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hart C, 2011, METHODS MOL BIOL, V698, P459, DOI 10.1007/978-1-60761-999-4_33; Hart ML, 2003, J GEN VIROL, V84, P353, DOI 10.1099/vir.0.18734-0; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lai J, 2009, J BIOL CHEM, V284, P11027, DOI 10.1074/jbc.M809698200; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li HL, 2008, J IMMUNOL, V180, P4011, DOI 10.4049/jimmunol.180.6.4011; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Lim JM, 2009, J PROTEOME RES, V8, P673, DOI 10.1021/pr800855f; Luchansky SJ, 2004, BIOCHEMISTRY-US, V43, P12358, DOI 10.1021/bi049274f; Luchansky SJ, 2003, METHOD ENZYMOL, V362, P249; MANCA F, 1992, J IMMUNOL, V148, P2278; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mbua NE, 2013, ANGEW CHEM INT EDIT, V52, P13012, DOI 10.1002/anie.201307095; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MOORE JP, 1993, J VIROL, V67, P4785, DOI 10.1128/JVI.67.8.4785-4796.1993; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Morales JF, 2014, J BIOL CHEM, V289, P20526, DOI 10.1074/jbc.M114.554089; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Porterfield M, 2014, J PROTEOME RES, V13, P395, DOI 10.1021/pr400422g; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Pritchard LK, 2015, J VIROL, V89, P8932, DOI 10.1128/JVI.01190-15; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Raska M, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-23; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Roper SM, 2013, PROTEOM CLIN APPL, V7, P367, DOI 10.1002/prca.201300006; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Struwe WB, 2017, ACS CHEM BIOL, V12, P357, DOI 10.1021/acschembio.6b00854; Sun LN, 2016, GLYCOBIOLOGY, V26, P1029, DOI 10.1093/glycob/cww062; Teo CF, 2014, ANAL BIOCHEM, V464, P70, DOI 10.1016/j.ab.2014.06.010; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vainauskas S, 2012, CARBOHYD RES, V362, P62, DOI 10.1016/j.carres.2012.09.012; van Montfort T, 2011, J IMMUNOL, V187, P4676, DOI 10.4049/jimmunol.1101876; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; Woo CM, 2017, J PROTEOME RES, V16, P1706, DOI 10.1021/acs.jproteome.6b01053; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiang Y, 2016, P NATL ACAD SCI USA, V113, pE7890, DOI 10.1073/pnas.1611213113; Zhang X, 2013, MOLECULES, V18, P7145, DOI 10.3390/molecules18067145; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	81	7	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15178	15194		10.1074/jbc.RA118.004798	http://dx.doi.org/10.1074/jbc.RA118.004798			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115684	Green Published, hybrid			2022-12-26	WOS:000445998400019
J	Clark, KL; Branch, LC; Farrington, J				Clark, Kenneth L.; Branch, Lyn C.; Farrington, Jennifer			Bioturbation by mammals and fire interact to alter ecosystem-level nutrient dynamics in longleaf pine forests	PLOS ONE			English	Article							GOPHER THOMOMYS-TALPOIDES; FINE-SCALE VARIATION; NITROGEN DYNAMICS; PALUSTRIS SANDHILL; WIREGRASS SAVANNAS; FUEL CONSUMPTION; SOIL DISTURBANCE; POCKET GOPHERS; PATTERNS; LITTER	Activities of ecosystem engineers can interact with other disturbances to modulate rates of key processes such as productivity and nutrient cycling. Bioturbation, movement of soil by organisms, is a widespread form of ecosystem engineering in terrestrial ecosystems. We propose that bioturbation by southeastern pocket gophers (Geomys pinetis), an abundant but declining ecosystem engineer in longleaf pine (Pinus palustris Mill.) forests, accelerates nutrient dynamics of the forest floor by burying litter and then reduces litter consumption and nitrogen (N) volatilization losses in the presence of fire. We evaluated our hypothesis by measuring how litter burial alters decomposition and N and phosphorus (P) turnover of longleaf pine and turkey oak (Quercus laevis Walt.) litter over four years, and then simulated interactive ecosystem-level effects of litter burial and low-intensity fires on N and P dynamics of the litter layer. In the field, mass loss was over two times greater and N and P were released much more rapidly from litter buried beneath mounds than on the surface of the forest floor. At a measured rate of mound formation covering 2.3 +/- 0.6% of the forest floor per year, litter mass and N and P content of the forest floor simulated over an eight-year period were approximately 11% less than amounts in areas without pocket gopher mounds. In contrast to unburied litter, litter beneath mounds is protected from consumption during fires, and as fire interval increased, consumption rates decreased because mounds cover more years of accumulated litter. Our research indicates that bioturbation and burial of litter by pocket gophers accelerates turnover of N and P on the forest floor, and in the presence of fire, conserves N in this ecosystem where productivity is known to be nutrient limited.	[Clark, Kenneth L.] US Forest Serv, USDA, Northern Res Stn, New Lisbon, NJ 08064 USA; [Branch, Lyn C.; Farrington, Jennifer] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	United States Department of Agriculture (USDA); United States Forest Service; State University System of Florida; University of Florida	Clark, KL (corresponding author), US Forest Serv, USDA, Northern Res Stn, New Lisbon, NJ 08064 USA.	kennethclark@fs.fed.us						ABER JD, 1990, CAN J BOT, V68, P2201, DOI 10.1139/b90-287; Alabama Department of Conservation and Natural Resources, 2005, AL COMPR WILDL CONS, P295; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berg B., 2014, ISRN FOR, V2014, P838169, DOI [10.1155/2014/838169, DOI 10.1155/2014/838169]; Boring LR, 2004, INT J WILDLAND FIRE, V13, P443, DOI 10.1071/WF03060; Branch LC, 1996, OECOLOGIA, V106, P389, DOI 10.1007/BF00334567; Brockway D.G., 2005, SRS83 USDA FOR SERV, P1; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Canals RM, 2003, ECOLOGY, V84, P875, DOI 10.1890/0012-9658(2003)084[0875:HDBFMA]2.0.CO;2; Carter MC, 2004, FOREST ECOL MANAG, V191, P93, DOI 10.1016/j.foreco.2003.11.006; Carvalho Karine S., 2011, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/780713; Clark KL, 2016, SOIL BIOL BIOCHEM, V103, P253, DOI 10.1016/j.soilbio.2016.08.027; Clark KL, 2015, J SUSTAIN FOREST, V34, P125, DOI 10.1080/10549811.2014.973607; Cortinas MR, 1996, PEDOBIOLOGIA, V40, P162; Cronan JB, 2015, FOREST ECOL MANAG, V354, P318, DOI 10.1016/j.foreco.2015.05.018; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Dell JE, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1964; Eldridge David J., 2009, Ecological Management & Restoration, V10, pS27, DOI 10.1111/j.1442-8903.2009.00452.x; Fleming PA, 2014, MAMMAL REV, V44, P94, DOI 10.1111/mam.12014; Florida Fish and Wildlife Conservation Commission, 2012, FLOR WILDL LEG IN FL; Gagnon PR, 2015, J ECOL, V103, P1009, DOI 10.1111/1365-2745.12421; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; GHOLZ HL, 1985, FOREST SCI, V31, P463; Hayward MW, 2016, ANIM CONSERV, V19, P490, DOI 10.1111/acv.12269; Hector A., 2015, NEW STAT R; Hendricks JJ, 2002, CAN J FOREST RES, V32, P928, DOI [10.1139/x02-020, 10.1139/X02-020]; Hierro Jose L, 2011, Oecologia, V166, P1121, DOI 10.1007/s00442-011-1954-8; Hiers JK, 2007, ECOL APPL, V17, P806, DOI 10.1890/06-1015; Hiers JK, 2014, J WILDLIFE MANAGE, V78, P383, DOI 10.1002/jwmg.676; Hiers JK, 2009, INT J WILDLAND FIRE, V18, P315, DOI 10.1071/WF08084; HOBBS RJ, 1991, ECOLOGY, V72, P59, DOI 10.2307/1938902; Hood GA, 2008, BIOL CONSERV, V141, P556, DOI 10.1016/j.biocon.2007.12.003; James AI, 2007, BIOL CONSERV, V138, P351, DOI 10.1016/j.biocon.2007.04.029; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KACZOR SA, 1990, AM MIDL NAT, V123, P100, DOI 10.2307/2425763; KALISZ PJ, 1984, SOIL SCI SOC AM J, V48, P169, DOI 10.2136/sssaj1984.03615995004800010031x; Kirkman LK, 2016, ECOLOGY, V97, P2259, DOI 10.1002/ecy.1456; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; LANDERS JL, 1995, J FOREST, V93, P39; Lavoie M, 2014, FORESTS, V5, P498, DOI 10.3390/f5030498; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Loudermilk EL, 2011, ECOL MODEL, V222, P2733, DOI 10.1016/j.ecolmodel.2011.05.004; Loudermilk EL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1361; Machicote M, 2004, OIKOS, V106, P527, DOI 10.1111/j.0030-1299.2004.13139.x; Meyers R, 1990, ECOSYSTEMS FLORIDA; Mitchell RJ, 2006, CAN J FOREST RES, V36, P2724, DOI 10.1139/X06-100; Mitchell RJ, 2014, FOREST ECOL MANAG, V327, P316, DOI 10.1016/j.foreco.2013.12.003; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; Nugent DT, 2014, WILDLIFE RES, V41, P203, DOI 10.1071/WR14052; O'Brien JJ, 2016, CAN J REMOTE SENS, V42, P489, DOI 10.1080/07038992.2016.1199271; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Ottmar RD, 2016, INT J WILDLAND FIRE, V25, P10, DOI 10.1071/WF15092; Ozier J, 2016, GEORGIAS STATE WILDL; Palmquist KA, 2015, J ECOL, V103, P998, DOI 10.1111/1365-2745.12412; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Platt BF, 2016, SOIL SCI, V181, P175, DOI 10.1097/SS.0000000000000150; Prichard SJ, 2017, FOREST ECOL MANAG, V405, P328, DOI 10.1016/j.foreco.2017.09.025; Readle EL, 1990, SOIL SURV PUTN COUNT; Reichman OJ, 2002, TRENDS ECOL EVOL, V17, P44, DOI 10.1016/S0169-5347(01)02329-1; Reid AM, 2012, CAN J FOREST RES, V42, P1611, DOI [10.1139/X2012-096, 10.1139/x2012-096]; Sherrod SK, 2005, ARCT ANTARCT ALP RES, V37, P585, DOI 10.1657/1523-0430(2005)037[0585:NPGTTC]2.0.CO;2; Sherrod SK, 2001, BIOGEOCHEMISTRY, V55, P195, DOI 10.1023/A:1010621102330; Simkin SM, 2005, SOUTHEAST NAT, V4, P133, DOI 10.1656/1528-7092(2005)004[0133:FSDROA]2.0.CO;2; Simkin SM, 2004, AM MIDL NAT, V152, P12, DOI 10.1674/0003-0031(2004)152[0012:MMNASS]2.0.CO;2; Simkin SM, 2001, J TORREY BOT SOC, V128, P208, DOI 10.2307/3088712; U.S. Fish and Wildlife Service, GOPH TORT GOPH POL, DOI [10.2193/2006-337, DOI 10.2193/2006-337]; Villarreal D, 2008, J MAMMAL, V89, P700, DOI 10.1644/07-MAMM-A-025R1.1; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; Walker JL, 2006, SPRINGER SER ENV MAN, P297; Warren AE, 2017, J FISH WILDL MANAG, V8, P544, DOI 10.3996/032017-JFWM-023; Whitford WG, 1999, J ARID ENVIRON, V41, P203, DOI 10.1006/jare.1998.0482; Wiggers MS, 2013, FOREST ECOL MANAG, V310, P54, DOI 10.1016/j.foreco.2013.07.030; Wilson CA, 1999, CAN J FOREST RES, V29, P752, DOI 10.1139/cjfr-29-6-752; Yurkewycz RP, 2014, OECOLOGIA, V176, P1135, DOI 10.1007/s00442-014-3075-7	75	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201137	10.1371/journal.pone.0201137	http://dx.doi.org/10.1371/journal.pone.0201137			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133444	Green Submitted, gold, Green Published			2022-12-26	WOS:000442500400014
J	Persson, J; Stenfors, C				Persson, Jonas; Stenfors, Cecilia			Superior cognitive goal maintenance in carriers of genetic markers linked to reduced striatal D2 receptor density (C957T and DRD2/ANKK1-TaqIA)	PLOS ONE			English	Article							SELECTION WORKING-MEMORY; PREFRONTAL CORTEX; IN-VIVO; SCHIZOPHRENIC DEFICITS; HEALTHY-VOLUNTEERS; INHIBITORY CONTROL; ATTENTIONAL BLINK; DRD2 POLYMORPHISM; DOPAMINE FUNCTION; NETWORK MODEL	Maintaining goal representations is a critical component of cognitive control and is required for successful performance in many daily activities. This is particularly important when goal-relevant information needs to be maintained in working memory (WM), updated in response to changing task demands or internal goal states, and protected from interference by inhibiting counter-goal behaviors. Modulation of fronto-striatal dopamine is critical for updating and maintaining goals and representations. Here we test the hypothesis that a genetic predisposition (C957T T+ and DRD2/ANKK1-TaqIA A+) for reduced striatal D2 receptor availability would facilitate goal maintenance using the AX-continuous performance task (AXCPT), on a sample of 196 adults (25 +/- 67 y). We demonstrate that carriers of two polymorphisms that have been linked to reduced striatal D2 receptor density show increased performance on context-dependent (BX) trials, and that the effect of these polymorphisms was only significant for long ISI trials where the demand for goal maintenance is high. The current results add further knowledge to the role of D2 receptor functioning in cognitive stability and flexibility, and could have implications for understanding cognitive deficits in patients characterized by altered dopamine functioning.	[Persson, Jonas; Stenfors, Cecilia] Karolinska Inst, Aging Res Ctr, Solna, Sweden; [Persson, Jonas; Stenfors, Cecilia] Stockholm Univ, Solna, Sweden; [Stenfors, Cecilia] Stockholm Univ, Stress Res Inst, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Stockholm University	Persson, J (corresponding author), Karolinska Inst, Aging Res Ctr, Solna, Sweden.; Persson, J (corresponding author), Stockholm Univ, Solna, Sweden.	jonas.persson.1@ki.se		Stenfors, Cecilia/0000-0002-8411-0666; Persson, Jonas/0000-0001-9143-3730	Swedish Research Council [Dnr 421-2013-1409]; Swedish Research Council for Health, Working Life and Welfare [Dnr 2009-0764]; Afa insurance [Dnr 090283]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Afa insurance	This study was funded by The Swedish Research Council (Dnr 421-2013-1409), The Swedish Research Council for Health, Working Life and Welfare (Dnr 2009-0764), and Afa insurance (Dnr 090283).	Barch DM, 2008, BIOL PSYCHIAT, V64, P11, DOI 10.1016/j.biopsych.2008.03.003; Barch DM, 2012, SCHIZOPHRENIA BULL, V38, P43, DOI 10.1093/schbul/sbr160; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P136, DOI 10.1093/schbul/sbn153; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Berryhill ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055862; Braver T S, 1999, Prog Brain Res, V121, P327; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Colzato LS, 2016, CORTEX, V82, P217, DOI 10.1016/j.cortex.2016.06.010; Colzato LS, 2013, NEUROPSYCHOLOGIA, V51, P1377, DOI 10.1016/j.neuropsychologia.2013.01.014; Colzato LS, 2011, J COGNITIVE NEUROSCI, V23, P3576, DOI 10.1162/jocn_a_00049; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2009, DOPAMINE HDB, P249; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Eisenstein SA, 2016, SYNAPSE, V70, P418, DOI 10.1002/syn.21916; Frank MJ, 2009, NEUROSCIENCE, V164, P131, DOI 10.1016/j.neuroscience.2009.04.048; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Garcia-Garcia M, 2011, NEUROIMAGE, V56, P1641, DOI 10.1016/j.neuroimage.2011.02.053; Garcia-Garcia M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172362; Gibbs SEB, 2006, NEUROSCIENCE, V139, P359, DOI 10.1016/j.neuroscience.2005.11.055; Gibbs SEB, 2005, COGN AFFECT BEHAV NE, V5, P212, DOI 10.3758/CABN.5.2.212; Gluskin BS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.22; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Lee J, 2006, SCHIZOPHR RES, V81, P191, DOI 10.1016/j.schres.2005.08.015; Leineweber C, 2013, EUR J PUBLIC HEALTH, V23, P710, DOI 10.1093/eurpub/cks064; Lyon GJ, 2011, SCHIZOPHRENIA BULL, V37, P108, DOI 10.1093/schbul/sbp010; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; Mattay VS, 1996, J NEUROSCI, V16, P4816; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Nyberg L, 2014, J COGNITIVE NEUROSCI, V26, P746, DOI 10.1162/jocn_a_00521; Persson J, 2015, HUM BRAIN MAPP, V36, P1325, DOI 10.1002/hbm.22704; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; ServanSchreiber D, 1996, ARCH GEN PSYCHIAT, V53, P1105; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Smith CT, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.45; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Stenfors CUD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060637; Stratta P, 1998, ARCH GEN PSYCHIAT, V55, P186, DOI 10.1001/archpsyc.55.2.186; Tian T, 2013, J NEUROSCI, V33, P17519, DOI 10.1523/JNEUROSCI.2163-13.2013; Unsworth N, 2012, Q J EXP PSYCHOL, V65, P326, DOI 10.1080/17470218.2011.597865; Westbrook A, 2016, NEURON, V89, P695, DOI [10.1016/j.neuron.2015.12.029, 10.1016/j.neuron.2016.07.020]; Willson MC, 2004, BIOL PSYCHIAT, V56, P284, DOI 10.1016/j.biopsych.2004.06.008; Yu Y, 2013, J NEUROSCI, V33, P14040, DOI 10.1523/JNEUROSCI.1176-13.2013	58	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201837	10.1371/journal.pone.0201837	http://dx.doi.org/10.1371/journal.pone.0201837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR0JS	30125286	Green Submitted, gold, Green Published			2022-12-26	WOS:000442202100012
J	Mela, AP; Momany, M				Mela, Alexander P.; Momany, Michelle			Internuclear diffusion of histone H1 within cellular compartments of Aspergillus nidulans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MITOSIS; SEPTATION; FUNGI	Histone H1 is an evolutionarily conserved linker histone protein that functions in arranging and stabilizing chromatin structure and is frequently fused to a fluorescent protein to track nuclei in live cells. In time-lapse analyses, we observed stochastic exchange of photoactivated Dendra2-histone H1 protein between nuclei within the same cellular compartment. We also observed exchange of histones between genetically distinct nuclei in a heterokaryon derived from fusion of strains carrying histone H1-RFP or H1-GFP. Subsequent analysis of the resulting uninucleate conidia containing both RFP-and GFP-labeled histone H1 proteins showed only parental genotypes, ruling out genetic recombination and diploidization. These data together suggest that the linker histone H1 protein can diffuse between non-daughter nuclei in the filamentous fungus Aspergillus nidulans.	[Momany, Michelle] Univ Georgia, Fungal Biol Grp, Athens, GA 30602 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Momany, M (corresponding author), Univ Georgia, Fungal Biol Grp, Athens, GA 30602 USA.	mmomany@uga.edu						APPELS R, 1974, J MOL BIOL, V87, P339, DOI 10.1016/0022-2836(74)90154-5; COLE GT, 1986, MICROBIOL REV, V50, P95, DOI 10.1128/MMBR.50.2.95-132.1986; De Souza CP, 2009, TRENDS GENET, V25, P545, DOI 10.1016/j.tig.2009.10.005; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; Delgado-Ramos L, 2014, G3-GENES GENOM GENET, V4, P2271, DOI 10.1534/g3.114.014357; Fernandez-Abalos JM, 1998, MOL MICROBIOL, V27, P121, DOI 10.1046/j.1365-2958.1998.00664.x; FIDDY C, 1976, J GEN MICROBIOL, V97, P169, DOI 10.1099/00221287-97-2-169; Gladfelter AS, 2006, CURR OPIN MICROBIOL, V9, P547, DOI 10.1016/j.mib.2006.09.002; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kaminskyj SGW, 1998, GENETICS, V148, P669; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kurian SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195634; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Richards RC, 2001, BIOCHEM BIOPH RES CO, V284, P549, DOI 10.1006/bbrc.2001.5020; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roper M, 2013, P NATL ACAD SCI USA, V110, P12875, DOI 10.1073/pnas.1220842110; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201828	10.1371/journal.pone.0201828	http://dx.doi.org/10.1371/journal.pone.0201828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114268	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400029
J	Duarte, JP; Valente-dos-Santos, J; Coelho-e-Silva, MJ; Couto, P; Costa, D; Martinho, D; Seabra, A; Cyrino, ES; Conde, J; Rosado, J; Goncalves, RS				Duarte, Joao P.; Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.; Couto, Pedro; Costa, Daniela; Martinho, Diogo; Seabra, Andre; Cyrino, Edilson S.; Conde, Jorge; Rosado, Joana; Goncalves, Rui S.			Reproducibility of isokinetic strength assessment of knee muscle actions in adult athletes: Torques and antagonist-agonist ratios derived at the same angle position	PLOS ONE			English	Article							STATISTICAL-METHODS; RELIABILITY; EXTENSION; DYNAMOMETRY; COACTIVATION; QUADRICEPS; HAMSTRINGS; VALIDITY; FLEXION; BIODEX	The current study aimed to examine the reliability of the conventional and functional ratios derived from peak torques (PTs) and those obtained from the combination of knee flexors torque at the angle of knee extensors PT. Twenty-six male athletes (mean of 24.0 +/- 0.7 years) from different sports completed a test-to-test variation in isokinetic strength (Biodex, System 3) within a period of one week. Anthropometry and body composition assessed by Dual Energy X-ray Absorptiometry were also measured. The proposed isokinetic strength ratio measurements appeared to be highly reliable: conventional ratio at PT angle (intraclass correlation, ICC = 0.98; 95% confidence interval; 95%CI: 0.95 to 0.99); functional extension ratio at PT angle (ICC = 0.98; 95%CI: 0.96 to 0.99); and, functional flexion ratio at PT angle (ICC = 0.95; 95%CI: 0.89 to 0.98). Technical error of measurement (TEM) and associated percentage of the coefficient of variation (%CV) were as follows: conventional ratio at PT angle (TEM = 0.02; %CV = 4.1); functional extension ratio at PT angle (TEM = 0.02; %CV = 3.8); and, functional flexion ratio at PT angle (TEM = 0.03; %CV = 3.6). The current study demonstrated that the traditional and new obtained simple and combined isokinetic indicators seem highly reliable to assess muscle strength and function in adult male athletes. A single testing session seems to be sufficiently to obtain these isokinetic strength indicators.	[Duarte, Joao P.; Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.; Couto, Pedro; Costa, Daniela; Martinho, Diogo] Univ Coimbra, Res Unity Sport & Phys Act CIDAF, UID DTP 04213 2016, Coimbra, Portugal; [Duarte, Joao P.; Coelho-e-Silva, Manuel J.; Couto, Pedro; Costa, Daniela; Martinho, Diogo; Rosado, Joana] Univ Coimbra, Fac Sport Sci & Phys Educ, Coimbra, Portugal; [Duarte, Joao P.] Portuguese Fdn Sci & Technol SFRH BD 101083 2014, Lisbon, Portugal; [Valente-dos-Santos, Joao] Portuguese Fdn Sci & Technol SFRH BPD 100470 2014, Lisbon, Portugal; [Valente-dos-Santos, Joao] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Coimbra, Portugal; [Valente-dos-Santos, Joao] Lusofona Univ Humanities & Technol, Fac Phys Educ & Sport, Lisbon, Portugal; [Martinho, Diogo] Portuguese Fdn Sci & Technol SFRH BD 121441 2016, Lisbon, Portugal; [Seabra, Andre] Univ Porto, Fac Sport, Res Ctr Phys Act Hlth & Leisure CIAFEL, Porto, Portugal; [Seabra, Andre] Portuguese Football Federat, Portugal Football Sch, Lisbon, Portugal; [Cyrino, Edilson S.] State Univ Londrina UEL, Metab Nutr & Exercise Lab GEPEMENE, Londrina, Brazil; [Conde, Jorge; Rosado, Joana; Goncalves, Rui S.] Polytech Inst Coimbra, Sch Hlth & Technol, Coimbra, Portugal; [Goncalves, Rui S.] Univ Coimbra, Ctr Hlth Studies & Res, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Lusofona University; Universidade do Porto; Universidade Estadual de Londrina; Universidade de Coimbra	Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, Res Unity Sport & Phys Act CIDAF, UID DTP 04213 2016, Coimbra, Portugal.; Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, Fac Sport Sci & Phys Educ, Coimbra, Portugal.	mjcesilva@hotmail.com	CYRINO, EDILSON S/GQB-5068-2022; Valente-dos-Santos, Joao/ABE-3220-2020; Martinho, Diogo V./ABB-7438-2020; Silva, Manuel Coelho E/O-2604-2019; Gonçalves, Rui/B-8049-2010; CYRINO, EDILSON S/F-7196-2012; Rosado, Joana Cristina Oliveira/E-5738-2015	CYRINO, EDILSON S/0000-0001-9016-8779; Valente-dos-Santos, Joao/0000-0003-0980-0269; Martinho, Diogo V./0000-0003-0825-4032; Silva, Manuel Coelho E/0000-0003-4512-7331; Gonçalves, Rui/0000-0002-6118-0338; CYRINO, EDILSON S/0000-0001-9016-8779; Rosado, Joana Cristina Oliveira/0000-0002-8671-3962; Conde, Jorge/0000-0002-2225-8569; Marques Duarte, Joao Pedro/0000-0002-7536-9780	Portuguese Foundation for Science and Technology [SFRH/BD/101083/2014, SFRH/BPD/100470/2014, SFRH/BD/121441/2016]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	Joao P. Duarte (SFRH/BD/101083/2014), Joao Valente-dos-Santos (SFRH/BPD/100470/2014) and Diogo Martinho (SFRH/BD/121441/2016) were partially supported by the Portuguese Foundation for Science and Technology. CIDAF is registered in the Portuguese Foundation for Science and Technology: uid/dtp/04213/2016. There are no other current funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD P, 1994, EUR J APPL PHYSIOL O, V69, P376, DOI 10.1007/BF00865398; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Arnold Brent L., 1993, Journal of Athletic Training, V28, P227; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Ayala F, 2013, CLIN PHYSIOL FUNCT I, V33, P45, DOI 10.1111/j.1475-097X.2012.01162.x; BALTZOPOULOS V, 1989, SPORTS MED, V8, P101, DOI 10.2165/00007256-198908020-00003; BALTZOPOULOS V, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P138; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; Birmingham TB, 1998, PERCEPT MOTOR SKILL, V87, P1183, DOI 10.2466/pms.1998.87.3f.1183; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown LE, 2000, ISOKINETICS IN HUMAN PERFORMANCE, P97; Carvalho HM, 2011, MED LITH, V47, P446, DOI 10.3390/medicina47080063; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Andrade ACPDF, 2013, J HUM KINET, V37, P47, DOI 10.2478/hukin-2013-0024; De Ste Croix M, 2017, KNEE, V24, P745, DOI 10.1016/j.knee.2017.03.012; De Ste Croix MBA, 2009, APPL PHYSIOL NUTR ME, V34, P725, DOI 10.1139/H09-064; DRAGANICH LF, 1989, J BONE JOINT SURG AM, V71A, P1075, DOI 10.2106/00004623-198971070-00015; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; FEIRING D C, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P298; Gleeson NP, 1996, SPORTS MED, V21, P18, DOI 10.2165/00007256-199621010-00003; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; KANNUS P, 1992, MED SCI SPORT EXER, V24, P292; KNAPIK JJ, 1980, ARCH PHYS MED REHAB, V61, P64; Lohmann TG, 1988, ANTHROPOMETRIC STAND; Lund H, 2005, CLIN PHYSIOL FUNCT I, V25, P75, DOI 10.1111/j.1475-097X.2004.00593.x; MORE RC, 1993, AM J SPORT MED, V21, P231, DOI 10.1177/036354659302100212; OSTERNIG LR, 1986, EXERCISE SPORT SCI R, V14, P45; Perrin D., 1993, ISOKINETIC EXERCISE; THISTLE HOWARD G., 1967, ARCH PHYS MED REHABIL, V48, P279; Thorstensson, 1976, Acta Physiol Scand Suppl, V443, P1	30	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202261	10.1371/journal.pone.0202261	http://dx.doi.org/10.1371/journal.pone.0202261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110385	Green Submitted, gold, Green Published			2022-12-26	WOS:000441738000058
J	Hasegawa, Y; Hiraoka, T; Nakano, S; Okamoto, F; Oshika, T				Hasegawa, Yumi; Hiraoka, Takahiro; Nakano, Shinichiro; Okamoto, Fumiki; Oshika, Tetsuro			Effects of astigmatic defocus on binocular contrast sensitivity	PLOS ONE			English	Article							UNCORRECTED VISUAL-ACUITY; OCULAR DOMINANCE; PUPIL SIZE; ANISOMETROPIA; PERFORMANCE; EYES; ASSOCIATION; ORIENTATION; PREVALENCE; CHILDREN	Purpose To determine the effects of astigmatism on contrast sensitivity (CS). Methods Eighteen normal volunteers (30.5 +/- 6.0 [mean +/- SD] years) were recruited. After correcting each refractive error by spectacles, against-the-rule (ATR) or with-the-rule (WTR) astigmatism of +1.00, +2.00 and +3.00 D was intentionally produced in both eyes, and then binocular CS was measured. The cylindrical addition of different powers (+1.00 -+3.00 D) was compensated with spherical lenses so that the spherical equivalent refraction became zero in each eye. Subsequently, the above cylindrical addition was monocularly induced, and binocular CS was measured again. The relation between CS and astigmatic power, axis, and monocular or binocular astigmatism was investigated. Results With binocular ATR and WTR astigmatism, increases in astigmatic power significantly correlated with decreases in the area under the log contrast sensitivity function (AULCSF). With monocular astigmatic defocus, astigmatic power addition did not affect AULCSF. With binocular astigmatic defocus of high-power (+2.00 and +3.00 D), ATR astigmatism deteriorated AULCSF more than WTR astigmatism. In a comparison between binocular and monocular astigmatic defocus, CS was significantly worse with binocular astigmatic defocus than with monocular astigmatic defocus at higher spatial frequencies regardless of astigmatic power. Conclusions Binocular astigmatic defocus deteriorates CS depending on the amount of astigmatic power. ATR astigmatism reduces CS more than WTR astigmatism dose. In addition, binocular astigmatic defocus affects CS more severely than monocular astigmatic defocus especially at high spatial frequencies.	[Hasegawa, Yumi; Hiraoka, Takahiro; Okamoto, Fumiki; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan; [Nakano, Shinichiro] Ryugasaki Saiseikai Hosp, Dept Ophthalmol, Ibaraki, Japan	University of Tsukuba	Hasegawa, Y (corresponding author), Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan.	tam_y110@yahoo.co.jp		Hasegawa, Yumi/0000-0001-6005-9811				Applegate RA, 1998, J REFRACT SURG, V14, P397, DOI 10.3928/1081-597X-19980701-05; BRADLEY A, 1991, OPTOMETRY VISION SCI, V68, P418, DOI 10.1097/00006324-199106000-00003; Brooks SE, 1996, OPHTHALMOLOGY, V103, P1139, DOI 10.1016/S0161-6420(96)30555-1; Chen SI, 2005, OPTOMETRY VISION SCI, V82, P101, DOI 10.1097/01.OPX.0000153251.39450.B4; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; Kamiya K, 2012, BRIT J OPHTHALMOL, V96, P267, DOI 10.1136/bjo.2011.202481; Kobashi H, 2012, J CATARACT REFR SURG, V38, P1352, DOI 10.1016/j.jcrs.2012.03.032; Linke SJ, 2011, INVEST OPHTH VIS SCI, V52, P9166, DOI 10.1167/iovs.11-8131; Nanavaty MA, 2006, J CATARACT REFR SURG, V32, P1091, DOI 10.1016/j.jcrs.2006.03.021; O'Donoghue L, 2013, INVEST OPHTH VIS SCI, V54, P602, DOI 10.1167/iovs.12-11066; Oguz H, 2000, J PEDIAT OPHTH STRAB, V37, P214; Ohlendorf A, 2011, VISION RES, V51, P529, DOI 10.1016/j.visres.2011.01.010; Remon L, 2006, OPTOMETRY VISION SCI, V83, P311, DOI 10.1097/01.opx.0000216099.29968.36; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; SCHOR C, 1987, AM J OPTOM PHYS OPT, V64, P723; Trindade F, 1997, J CATARACT REFR SURG, V23, P82, DOI 10.1016/S0886-3350(97)80155-1; Watanabe K, 2013, J REFRACT SURG, V29, P25, DOI 10.3928/1081597X-20121106-03; Watanabe K, 2013, J REFRACT SURG, V29, P19, DOI 10.3928/1081597X-20121211-01; Wills J, 2012, OPTOMETRY VISION SCI, V89, P271, DOI 10.1097/OPX.0b013e3182429c6b; Wolffsohn JS, 2011, J CATARACT REFR SURG, V37, P454, DOI 10.1016/j.jcrs.2010.09.022; Woods RL, 2000, OPHTHAL PHYSL OPT, V20, P442, DOI 10.1111/j.1475-1313.2000.tb01122.x	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202340	10.1371/journal.pone.0202340	http://dx.doi.org/10.1371/journal.pone.0202340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106991	gold, Green Submitted, Green Published			2022-12-26	WOS:000441662800041
J	Knauer, J; El-Madany, TS; Zaehle, S; Migliavacca, M				Knauer, Juergen; El-Madany, Tarek S.; Zaehle, Soenke; Migliavacca, Mirco			Bigleaf-An R package for the calculation of physical and physiological ecosystem properties from eddy covariance data	PLOS ONE			English	Article							WATER-VAPOR EXCHANGE; TEMPERATURE RESPONSE FUNCTIONS; CARBON-DIOXIDE; CANOPY CONDUCTANCE; USE EFFICIENCY; MESOPHYLL CONDUCTANCE; BIOCHEMICAL-MODEL; FLUX MEASUREMENTS; STOMATAL CONTROL; ENERGY-EXCHANGE	We present the R package bigleaf (version 0.6.5), an open source toolset for the derivation of meteorological, aerodynamic, and physiological ecosystem properties from eddy covariance (EC) flux observations and concurrent meteorological measurements. A 'big-leaf' framework, in which vegetation is represented as a single, uniform layer, is employed to infer bulk ecosystem characteristics top-down from the measured fluxes. Central to the package is the calculation of a bulk surface/canopy conductance (G(s)/G(c)) and a bulk aerodynamic conductance (G(a)), with the latter including formulations for the turbulent and canopy boundary layer components. The derivation of physical land surface characteristics such as surface roughness parameters, wind profile, aerodynamic and radiometric surface temperature, surface vapor pressure deficit (VPD), potential evapotranspiration (ET), imposed and equilibrium ET, as well as vegetation-atmosphere decoupling coefficients, is described. The package further provides calculation routines for physiological ecosytem properties (stomatal slope parameters, stomatal sensitivity to VPD, bulk intercellular CO2 concentration, canopy photosynthetic capacity), energy balance characteristics (closure, biochemical energy), ancillary meteorological variables (psychrometric constant, saturation vapor pressure, air density, etc.), customary unit interconversions and data filtering. The target variables can be calculated with a different degree of complexity, depending on the amount of available site-specific information. The utilities of the package are demonstrated for three single-level (above-canopy) eddy covariance sites representing a temperate grassland, a temperate needle-leaf forest, and a Mediterranean evergreen broadleaf forest. The routines are further tested for a two-level EC site (tree and grass layer) located in a Mediterranean oak savanna. The limitations and the ecophysiological interpretation of the derived ecosystem properties are discussed and practical guidelines are given. The package provides the basis for a consistent, physically sound, and reproducible characterization of biometeorological conditions and ecosystem physiology, and is applicable to EC sites across vegetation types and climatic conditions with minimal ancillary data requirements.	[Knauer, Juergen; El-Madany, Tarek S.; Zaehle, Soenke; Migliavacca, Mirco] Max Planck Inst Biogeochem, Dept Biogeochem Integrat, Jena, Germany; [Zaehle, Soenke] Michael Stifel Ctr Jena Data Driven & Simulat Sci, Jena, Germany	Max Planck Society	Knauer, J (corresponding author), Max Planck Inst Biogeochem, Dept Biogeochem Integrat, Jena, Germany.	jknauer@bgc-jena.mpg.de	El-Madany, Tarek S./AAO-6528-2020; Migliavacca, Mirco/J-9986-2019; Zaehle, Sönke/C-9528-2017	El-Madany, Tarek S./0000-0002-0726-7141; Migliavacca, Mirco/0000-0003-3546-8407; Zaehle, Sönke/0000-0001-5602-7956; Knauer, Jurgen/0000-0002-4947-7067	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (QUINCY) [647204]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [721995]; Alexander von Humboldt foundation; CDIAC; ICOS Ecosystem Thematic Center; OzFlux office; ChinaFlux office; AsiaFlux office	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (QUINCY); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); CDIAC; ICOS Ecosystem Thematic Center; OzFlux office; ChinaFlux office; AsiaFlux office	SZ was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (QUINCY; grant no. 647204). MM received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 721995 (TRuStEE). MM and TSEM thank the Alexander von Humboldt foundation for supporting the research activity in Majadas de Tietar through the Max Planck Research Prize to Markus Reichstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work used eddy covariance data acquired and shared by the FLUXNET community, including these networks: AmeriFlux, AfriFlux, AsiaFlux, CarboAfrica, CarboEuropeIP, CarboItaly, CarboMont, ChinaFlux, Fluxnet-Canada, GreenGrass, ICOS, KoFlux, LBA, NECC, OzFlux-TERN, TCOS-Siberia, and USCCC. The ERA-Interim reanalysis data are provided by ECMWF and processed by LSCE. The FLUXNET eddy covariance data processing and harmonization was carried out by the European Fluxes Database Cluster, AmeriFlux Management Project, and Fluxdata project of FLUXNET, with the support of CDIAC and ICOS Ecosystem Thematic Center, and the OzFlux, ChinaFlux and AsiaFlux offices. We thank Clemens G. Klein for technical support with Fig 1. We additionally thank Arnaud Carrara for providing flux and ancillary data for the site ES-LMa. SZ was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (QUINCY; grant no. 647204). MM received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 721995 (TRuStEE). MM and TSEM thank the Alexander von Humboldt foundation for supporting the research activity in Majadas de Tietar through the Max Planck Research Prize to Markus Reichstein.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1987, PROGR PHOTOSYNTHESIS, DOI [DOI 10.1007/978-94-017-0519-6_48, 10.1007/978-94-017-0519-6_48]; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 1997, J GEOPHYS RES-ATMOS, V102, P28939, DOI 10.1029/96JD03325; BALDOCCHI DD, 1995, PLANT CELL ENVIRON, V18, P1157, DOI 10.1111/j.1365-3040.1995.tb00626.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baldocchi D, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.19994; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Beringer J, 2017, BIOGEOSCIENCES, V14, P1457, DOI 10.5194/bg-14-1457-2017; Bernacchi CJ, 2003, PLANT CELL ENVIRON, V26, P1419, DOI 10.1046/j.0016-8025.2003.01050.x; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1111/j.1365-3040.2001.00668.x; Blanken PD, 2004, HYDROL PROCESS, V18, P1561, DOI 10.1002/hyp.1406; BUSINGER JA, 1971, J ATMOS SCI, V28, P181, DOI 10.1175/1520-0469(1971)028<0181:FPRITA>2.0.CO;2; Casals P, 2009, SOIL BIOL BIOCHEM, V41, P1915, DOI 10.1016/j.soilbio.2009.06.015; CHOUDHURY BJ, 1988, Q J ROY METEOR SOC, V114, P373, DOI 10.1002/qj.49711448006; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; De Kauwe MG, 2017, BIOGEOSCIENCES, V14, P4435, DOI 10.5194/bg-14-4435-2017; DEBRUIN HAR, 1983, J CLIM APPL METEOROL, V22, P572, DOI 10.1175/1520-0450(1983)022<0572:AMFTPT>2.0.CO;2; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; DYER AJ, 1970, Q J ROY METEOR SOC, V96, P715, DOI 10.1002/qj.49709641012; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Finnigan J, 2008, ECOL APPL, V18, P1340, DOI 10.1890/07-2105.1; GARRATT JR, 1973, Q J ROY METEOR SOC, V99, P680, DOI 10.1002/qj.49709942209; Goldberg V, 2008, ANN GEOPHYS-GERMANY, V26, P1977, DOI 10.5194/angeo-26-1977-2008; GRANTZ DA, 1990, PLANT CELL ENVIRON, V13, P27, DOI 10.1111/j.1365-3040.1990.tb01296.x; Grunwald T, 2007, TELLUS B, V59, P387, DOI 10.1111/j.1600-0889.2007.00259.x; HICKS BB, 1987, WATER AIR SOIL POLL, V36, P311, DOI 10.1007/BF00229675; Hollinger DY, 2005, TREE PHYSIOL, V25, P873, DOI 10.1093/treephys/25.7.873; Hong J, 2012, Q J ROY METEOR SOC, V138, P699, DOI 10.1002/qj.944; Jarvis PG, 1986, TREE PHYSIOL, V2, P347, DOI 10.1093/treephys/2.1-2-3.347; JARVIS PG, 1986, ADV ECOL RES, V15, P1, DOI 10.1016/S0065-2504(08)60119-1; Keenan T, 2010, AGR FOREST METEOROL, V150, P443, DOI 10.1016/j.agrformet.2010.01.008; Keenan T, 2010, GLOBAL CHANGE BIOL, V16, P1019, DOI 10.1111/j.1365-2486.2009.02017.x; KELLIHER FM, 1995, AGR FOREST METEOROL, V73, P1, DOI 10.1016/0168-1923(94)02178-M; Khatun R, 2011, HYDROL RES LETT, V5, P83, DOI 10.3178/HRL.5.83; Kljun N, 2015, GEOSCI MODEL DEV, V8, P3695, DOI 10.5194/gmd-8-3695-2015; Knauer J, 2018, GLOBAL CHANGE BIOL, V24, P694, DOI 10.1111/gcb.13893; Knohl A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000663; Kosugi Y, 2013, ECOL RES, V28, P373, DOI 10.1007/s11284-012-1019-4; Kumagai T, 2004, J HYDROL, V287, P237, DOI 10.1016/j.jhydrol.2003.10.002; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Launiainen S, 2010, BIOGEOSCIENCES, V7, P3921, DOI 10.5194/bg-7-3921-2010; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Leuning R, 2012, AGR FOREST METEOROL, V156, P65, DOI 10.1016/j.agrformet.2011.12.002; Luo XZ, 2018, J GEOPHYS RES-BIOGEO, V123, P207, DOI 10.1002/2017JG003978; MARTIN P, 1989, AGR FOREST METEOROL, V49, P45, DOI 10.1016/0168-1923(89)90061-0; Martin TA, 2001, FOREST ECOL MANAG, V152, P211, DOI 10.1016/S0378-1127(00)00604-6; Massman WJ, 1999, J HYDROL, V223, P27, DOI 10.1016/S0022-1694(99)00104-3; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; MCNAUGHTON KG, 1995, BOUND-LAY METEOROL, V74, P261, DOI 10.1007/BF00712121; MCNAUGHTON KG, 1973, WATER RESOUR RES, V9, P1579, DOI 10.1029/WR009i006p01579; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Medlyn BE, 2017, NEW PHYTOL, V216, P758, DOI 10.1111/nph.14626; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Metzger S, 2017, GEOSCI MODEL DEV, V10, P3189, DOI 10.5194/gmd-10-3189-2017; Meyers TP, 2004, AGR FOREST METEOROL, V125, P105, DOI 10.1016/j.agrformet.2004.03.001; Migliavacca M, 2009, AGR FOREST METEOROL, V149, P1460, DOI 10.1016/j.agrformet.2009.04.003; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Monteith JL., 2008, PRINCIPLES ENV PHYS, V3, P229; Novick KA, 2016, NAT CLIM CHANGE, V6, P1023, DOI [10.1038/nclimate3114, 10.1038/NCLIMATE3114]; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Pastorello G, 2017, T AM GEOPHYS UNION, V98; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rambal S, 2003, GLOBAL CHANGE BIOL, V9, P1813, DOI 10.1111/j.1365-2486.2003.00687.x; RAUPACH MR, 1988, AUST J PLANT PHYSIOL, V15, P705, DOI 10.1071/PP9880705; Rayment MB, 2002, TREE PHYSIOL, V22, P219, DOI 10.1093/treephys/22.4.219; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003430; Reichstein M, 2014, P NATL ACAD SCI USA, V111, P13697, DOI 10.1073/pnas.1216065111; Richardson A.D., 2012, EDDY COVARIANCE, P173; SHAW RH, 1982, AGR METEOROL, V26, P51, DOI 10.1016/0002-1571(82)90057-7; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; Su Z, 2001, J APPL METEOROL, V40, P1933, DOI 10.1175/1520-0450(2001)040<1933:AEOTMF>2.0.CO;2; Teuling AJ, 2010, NAT GEOSCI, V3, P722, DOI 10.1038/NGEO950; THOM AS, 1972, Q J ROY METEOR SOC, V98, P124, DOI 10.1002/qj.49709841510; Ueyama M, 2016, AGR FOREST METEOROL, V222, P98, DOI 10.1016/j.agrformet.2016.03.007; Verhoef A, 1997, J APPL METEOROL, V36, P560, DOI 10.1175/1520-0450(1997)036<0560:SPNOTP>2.0.CO;2; Verma S. B., 1989, IAHS Publication, P13; Wang W, 2008, REMOTE SENS ENVIRON, V112, P623, DOI 10.1016/j.rse.2007.05.024; Wang YP, 1998, AGR FOREST METEOROL, V91, P89, DOI 10.1016/S0168-1923(98)00061-6; Williams CA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011586; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wilson KB, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000989; Wohlfahrt G, 2015, PLANT CELL ENVIRON, V38, P2500, DOI 10.1111/pce.12569; Wohlfahrt G, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009286; Wohlfahrt G, 2009, AGR FOREST METEOROL, V149, P1556, DOI 10.1016/j.agrformet.2009.03.015; Wolf A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005927; Wutzler T, 2018, BIOGEOSCIENCES DISCU, V15, P1, DOI [10.5194/bg-2018-56, DOI 10.5194/BG-2018-56, 10.5194/bg-2018-56.]; Xu K, 2018, AGR FOREST METEOROL, V255, P81, DOI 10.1016/j.agrformet.2017.10.011; Zhou S, 2014, GEOPHYS RES LETT, V41, P5005, DOI 10.1002/2014GL060741	95	42	42	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201114	10.1371/journal.pone.0201114	http://dx.doi.org/10.1371/journal.pone.0201114			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106974	Green Submitted, Green Published, gold			2022-12-26	WOS:000441662800004
J	Fervers, P; Fervers, F; Makalowski, W; Jakalski, M				Fervers, Philipp; Fervers, Florian; Makalowski, Wojciech; Jakalski, Marcin			Life cycle adapted upstream open reading frames (uORFs) in Trypanosoma congolense: A post-transcriptional approach to accurate gene regulation	PLOS ONE			English	Article							CODON ADAPTATION INDEX; MESSENGER-RNA; TRANSCRIPTIONAL CONTROL; USAGE BIAS; EXPRESSION; BRUCEI; LEISHMANIA; EFFICIENCY; INITIATION; MECHANISM	The presented work explores the regulatory influence of upstream open reading frames (uORFs) on gene expression in Trypanosoma congolense. More than 31,000 uORFs in total were identified and characterized here. We found evidence for the uORFs' appearance in the transcriptome to be correlated with proteomic expression data, clearly indicating their repressive potential in T. congolense, which has to rely on post-transcriptional gene expression regulation due to its unique genomic organization. Our data show that uORF's translation repressive potential does not only correlate with elemental sequence features such as length, position and quantity, but involves more subtle components, in particular the codon and amino acid profiles. This corresponds with the popular mechanistic model of a ribosome shedding initiation factors during the translation of a uORF, which can prevent reinitiation at the downstream start codon of the actual protein-coding sequence, due to the former extensive consumption of crucial translation components. We suggest that uORFs with uncommon codon and amino acid usage can slow down the translation elongation process in T. congolense, systematically deplete the limited factors, and restrict downstream reinitiation, setting up a bottleneck for subsequent translation of the protein-coding sequence. Additionally we conclude that uORFs dynamically influence the T. congolense life cycle. We found evidence that transition to epimastigote form could be supported by gain of uORFs due to alternative trans-splicing, which down-regulate housekeeping genes' expression and render the trypanosome in a metabolically reduced state of endurance.	[Fervers, Philipp; Makalowski, Wojciech; Jakalski, Marcin] Univ Munster, Inst Bioinformat, Fac Med, Munster, Germany; [Fervers, Florian] Karlsruhe Inst Technol, Dept Informat, Karlsruhe, Germany; [Jakalski, Marcin] Univ Gdansk, Dept Plant Taxon & Nat Conservat, Gdansk, Poland	University of Munster; Helmholtz Association; Karlsruhe Institute of Technology; Fahrenheit Universities; University of Gdansk	Makalowski, W; Jakalski, M (corresponding author), Univ Munster, Inst Bioinformat, Fac Med, Munster, Germany.; Jakalski, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, Gdansk, Poland.	wojmak@uni-muenster.de; marcin.jakalski@biol.ug.edu.pl	Jąkalski, Marcin/AAG-4767-2019	Jąkalski, Marcin/0000-0002-5481-9148; Fervers, Philipp/0000-0003-3663-3486	University of Muenster	University of Muenster	We acknowledge the Open Access Publishing Fund of University of Muenster. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Avila CCDC, 2016, MOL BIOCHEM PARASIT, V205, P16, DOI 10.1016/j.molbiopara.2016.03.004; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Cevallos AM, 2005, FEMS MICROBIOL LETT, V246, P259, DOI 10.1016/j.femsle.2005.04.017; Chew GL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11663; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Despons L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-56; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Eyford BA, 2011, MOL BIOCHEM PARASIT, V177, P116, DOI 10.1016/j.molbiopara.2011.02.009; Fuller HR, 2012, QUANTITATIVE PROTEOM, DOI [10.5772/31469, DOI 10.5772/31469]; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HIRUMI H, 1991, PARASITOLOGY, V102, P225, DOI 10.1017/S0031182000062533; HORN D, 2008, BIOMED CENTRAL, V9, DOI DOI 10.1186/1471-2164-9-2; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jackson AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-432; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Jones DC, 2012, MOL MICROBIOL, V86, P51, DOI 10.1111/j.1365-2958.2012.08189.x; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Maree JP, 2014, BBA-GENE REGUL MECH, V1839, P743, DOI 10.1016/j.bbagrm.2014.05.028; Meleppattu S, 2015, NUCLEIC ACIDS RES, V43, P6222, DOI 10.1093/nar/gkv564; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Neafsey DE, 2007, MOL BIOL EVOL, V24, P1744, DOI 10.1093/molbev/msm093; Chau NVV, 2016, CLIN INFECT DIS, V62, P1002, DOI 10.1093/cid/ciw052; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Peacock L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-109; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Rao SJ, 2017, J BIOSCIENCES, V42, P189, DOI 10.1007/s12038-016-9660-7; RICHMOND RC, 1970, NATURE, V225, P1025, DOI 10.1038/2251025a0; Rotureau B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00053; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHPAER E G, 1989, Protein Sequences and Data Analysis, V2, P107; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Subramanian A, 2015, GENOMICS, V106, P232, DOI 10.1016/j.ygeno.2015.05.009; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; Wethmar K, 2014, NUCLEIC ACIDS RES, V42, pD60, DOI 10.1093/nar/gkt952; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201461	10.1371/journal.pone.0201461	http://dx.doi.org/10.1371/journal.pone.0201461			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092050	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600030
J	Nakamura, M; Yasukawa, Y; Furusawa, A; Fuchiwaki, T; Honda, T; Okamura, Y; Fujita, K; Iwai, H				Nakamura, Masayuki; Yasukawa, Yuino; Furusawa, Akira; Fuchiwaki, Tamao; Honda, Takashi; Okamura, Yuta; Fujita, Kiyotaka; Iwai, Hisashi			Functional characterization of unique enzymes in Xanthomonas euvesicatoria related to degradation of arabinofurano-oligosaccharides on hydroxyproline-rich glycoproteins	PLOS ONE			English	Article							CAMPESTRIS PV VESICATORIA; EFFICIENT PRODUCTION; ANTIBODY FRAGMENTS; EXPRESSION SYSTEM; HRP GENES; CELL-WALL; PATHOGENICITY; DEFENSE; PROTEINS; PEPPER	In this study, we clarified the functions of three uncharacterized enzymes, XCV2724, XCV2728, and XCV2729, in Xanthomonas euvesicatoria, the causal agent of bacterial spot of tomato and pepper. The genes corresponding to the three enzymes are homologs of hypBA1, hypBA2, and hypAA from Bifidobacterium longum and are unique to Xanthomonas spp. among plant pathogenic bacteria. Functional characterization of the recombinant enzymes expressed using microbial systems revealed that they degrade the arabinofurano-oligosaccharides present on hydroxyproline (Hyp)-rich glycoproteins (HRGPs) such as extensin and solanaceous lectins in plant cell walls. These enzymes work coordinately to degrade the oligosaccharides. First, XeHypAA (XCV2728), belonging to the glycoside hydrolase (GH) 43 family, releases L-arabinose from L-arabinofuranose (Araf)-alpha 1,3-Araf-beta 1,2-Araf-beta 1,2-Araf-beta-Hyp (Ara(4)-Hyp), cleaving its alpha 1,3 bond; second, XeHypBA2 (XCV2729), belonging to the GH121 family, releases the disaccharide Araf-beta 1,2-Araf from Araf-beta 1,2-Araf-beta 1,2-Araf-beta-Hyp (Ara(3)-Hyp); finally, XeHypBA1 (XCV2724), belonging to GH family 127, releases L-arabinose from Araf-beta-Hyp (Ara-Hyp). In summary, the main oligosaccharide structure of Ara(4)-Hyp on the HRGPs is degraded to Ara(3)-Hyp, then to Ara-Hyp, and finally to Ara monosaccharides by the action of these three enzymes. HRGPs containing oligosaccharide substrates have been reported to contribute to plant defense, and interestingly, the promoter region of the operon (xehypBA2 and xehypAA) contains the plant-inducible promoter box for binding the regulator protein HrpX involved in pathogenicity. We then analyzed the expression level of the operon gene in hrp-inducing medium and in plants and constructed gene-deletion mutants. However, although the operon was evidently upregulated by HrpX, three single-gene deletion mutants (Delta xehypBA1, Delta xehypBA2, Delta xehypAA) and even a triple-gene deletion mutant (Delta xehypBA1-BA2-AA) remained pathogenic, and had no effect on nonhost resistance, either, indicating that these three enzymes are not involved in either pathogenicity or nonhost resistance reactions. This is the first report of enzymes in plant pathogenic bacteria that catalyze the degradation of Hyp-linked-L-arabinofuranosides in plant cell walls.	[Nakamura, Masayuki; Yasukawa, Yuino; Furusawa, Akira; Fuchiwaki, Tamao; Honda, Takashi; Okamura, Yuta; Fujita, Kiyotaka; Iwai, Hisashi] Kagoshima Univ, Fac Agr, Kagoshima, Japan	Kagoshima University	Nakamura, M (corresponding author), Kagoshima Univ, Fac Agr, Kagoshima, Japan.	masa@agri.kagoshima-u.ac.jp		Iwai, Hisashi/0000-0003-0243-7911; Fujita, Kiyotaka/0000-0002-3780-3750	Japan Society for the Promotion of Science [23780042, 25450061]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aids for Scientific Research (No. 23780042 and 25450061) from Japan Society for the Promotion of Science, on data collection and analysis.	Adlung N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01796; AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; Coelho LCBB, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/1594074; Brown I, 1995, MOL PLANT MICROBE IN, V8, P825, DOI 10.1094/MPMI-8-0825; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; Deepak S, 2007, PHYTOCHEMISTRY, V68, P298, DOI 10.1016/j.phytochem.2006.10.024; ESQUERRETUGAYE MT, 1979, PLANT PHYSIOL, V64, P320, DOI 10.1104/pp.64.2.320; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; Fujita K, 2014, J BIOL CHEM, V289, P5240, DOI 10.1074/jbc.M113.528711; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; HOLMES EW, 1979, ANAL BIOCHEM, V93, P167, DOI 10.1016/S0003-2697(79)80060-3; Hwang IS, 2011, PLANT PHYSIOL, V155, P447, DOI 10.1104/pp.110.164848; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizukami M, 2015, PROTEIN EXPRES PURIF, V105, P23, DOI 10.1016/j.pep.2014.09.017; Moretti C, 2009, LETT APPL MICROBIOL, V49, P466, DOI 10.1111/j.1472-765X.2009.02690.x; Nejat N, 2012, INT J MOL SCI, V13, P2301, DOI 10.3390/ijms13022301; Onishi H, 2013, PROTEIN EXPRES PURIF, V91, P184, DOI 10.1016/j.pep.2013.08.005; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Ruh M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4087-6; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Scott JW, 1989, MICROTOM MINIATURE S, VS-370, P1; SHOWALTER AM, 1985, P NATL ACAD SCI USA, V82, P6551, DOI 10.1073/pnas.82.19.6551; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Stoyanova M, 2014, INT J MICROBIOL, DOI [10.1155/2014/495476, DOI 10.1155/2014/495476]; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Tokunaga M, 2013, APPL MICROBIOL BIOT, V97, P8569, DOI 10.1007/s00253-013-4695-2; Tsuchiya Kenichi, 2003, Journal of General Plant Pathology, V69, P310, DOI 10.1007/s10327-003-0058-7; Van Damme EJM, 2004, PLANT J, V37, P34, DOI 10.1046/j.1365-313X.2003.01929.x; Wei G, 2006, MOL PLANT PATHOL, V7, P579, DOI [10.1111/j.1364-3703.2006.00363.x, 10.1111/j.1364-3703.2006.00363.X]; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201982	10.1371/journal.pone.0201982	http://dx.doi.org/10.1371/journal.pone.0201982			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092047	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600074
J	Romsang, A; Duang-nkern, J; Saninjuk, K; Vattanaviboon, P; Mongkolsuk, S				Romsang, Adisak; Duang-nkern, Jintana; Saninjuk, Kritsakorn; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			Pseudomonas aeruginosa nfuA: Gene regulation and its physiological roles in sustaining growth under stress and anaerobic conditions and maintaining bacterial virulence	PLOS ONE			English	Article							IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; SUF OPERON; CAENORHABDITIS-ELEGANS; AZOTOBACTER-VINELANDII; ASSEMBLY PROTEINS; EXPRESSION; ISCR	The role of the nfuA gene encoding an iron-sulfur ([Fe-S]) cluster-delivery protein in the pathogenic bacterium Pseudomonas aeruginosa was investigated. The analysis of nfuA expression under various stress conditions showed that superoxide generators, a thiol-depleting agent and CuCl2 highly induced nfuA expression. The expression of nfuA was regulated by a global [2Fe-2S] cluster containing the transcription regulator IscR. Increased expression of nfuA in the AiscR mutant under uninduced conditions suggests that IscR acts as a transcriptional repressor. In vitro experiments revealed that IscR directly bound to a sequence homologous to the Escherichia co/iType-I IscR-binding motifs on a putative nfuA promoter that overlapped the-35 element. Binding of IscR prevented RNA polymerase from binding to the nfuA promoter, leading to repression of the nfuA transcription. Physiologically, deletion of nfuA reduced the bacterial ability to cope with oxidative stress, iron deprivation conditions and attenuated virulence in the Caenorhabditis elegans infection model. Site directed mutagenesis analysis revealed that the conserved CXXC motif of the Nfu-type scaffold protein domain at the N-terminus was required for the NfuA functions in conferring the stress resistance phenotype. Furthermore, anaerobic growth of the AnfuA mutant in the presence of nitrate was drastically retarded. This phenotype was associated with a reduction in the [Fe-S] cluster containing nitrate reductase enzyme activity. However, NfuA was not required for the maturation of [Fe-S]-containing proteins such as aconitase, succinate dehydrogenase, SoxR and IscR. Taken together, our results indicate that NfuA functions in [Fe-S] cluster delivery to selected target proteins that link to many physiological processes such as anaerobic growth, bacterial virulence and stress responses in P. aeruginosa.	[Romsang, Adisak; Saninjuk, Kritsakorn; Mongkolsuk, Skorn] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand; [Duang-nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Lab Biotechnol, Bangkok, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Royal Acad, Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand	Mahidol University; Mahidol University; Chulabhorn Research Institute; Chulabhorn Graduate Institute; Chulabhorn Royal Academy	Mongkolsuk, S (corresponding author), Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Chulabhorn Res Inst, Lab Biotechnol, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand.	skorn@cri.or.th	Saninjuk, Kritsakorn/V-1916-2019; Romsang, Adisak/H-7142-2014; Vattanaviboon, Paiboon/V-1380-2019; Romsang, Adisak/K-2630-2019	Saninjuk, Kritsakorn/0000-0002-7511-2985; Romsang, Adisak/0000-0002-5339-5443; Romsang, Adisak/0000-0002-5339-5443	Chulabhorn Research Institute, Mahidol University; Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Center for Emerging Bacterial Infections (EBI) of Faculty of Science, the Mahidol University; Central Instrument Facility (CIF grant) of Faculty of Science, the Mahidol University; Office of the Higher Education Commission [MRG5980047]; Thailand Research Fund, Thailand [MRG5980047]; Royal Golden Jubilee Ph.D. Scholarship from Thailand Research Fund [PHD/0047/2557]; Chulabhorn Graduate Institute	Chulabhorn Research Institute, Mahidol University; Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Center for Emerging Bacterial Infections (EBI) of Faculty of Science, the Mahidol University; Central Instrument Facility (CIF grant) of Faculty of Science, the Mahidol University; Office of the Higher Education Commission; Thailand Research Fund, Thailand(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Scholarship from Thailand Research Fund; Chulabhorn Graduate Institute	This work was supported by grants from the Chulabhorn Research Institute (http://www.cri.or.th/en/index.php), Mahidol University (https://www.mahidol.ac.th) and Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand (http://www.eht.sc.mahidol.ac.th). A.R. was supported by the grants from the Center for Emerging Bacterial Infections (EBI) and the Central Instrument Facility (CIF grant) of Faculty of Science, the Mahidol University (http://science.mahidol.ac.th) and the joint funding of the Office of the Higher Education Commission and the Thailand Research Fund (MRG5980047), Thailand (https://www.trf.or.th). K.S. was supported by the Royal Golden Jubilee Ph.D. Scholarship (PHD/0047/2557) from Thailand Research Fund (http://rgj.trf.or.th/eng/rgje11.asp). P.V. was supported by the grant from Chulabhorn Graduate Institute (https://www.cgi.ac.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Atichartpongkul S, 2010, J BACTERIOL, V192, P2093, DOI 10.1128/JB.01510-09; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Boonma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172071; Cassier-Chauvat C, 2015, INT J MOL SCI, V16, P871, DOI 10.3390/ijms16010871; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Daung-nkern J, 2010, J ANTIMICROB CHEMOTH, V65, P1831, DOI 10.1093/jac/dkq194; de Bruijn F. J, 2016, STRESS ENV REGULATIO, P1090; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; EnosBerlage JL, 1997, J BACTERIOL, V179, P3989, DOI 10.1128/jb.179.12.3989-3996.1997; Fuangthong M, 2015, MICROBIOL RES, V170, P139, DOI 10.1016/j.micres.2014.08.004; Gaudu P, 1997, J BIOL CHEM, V272, P5082, DOI 10.1074/jbc.272.8.5082; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Green J, 2014, VIRULENCE, V5, P794, DOI 10.4161/viru.27794; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; JOERGER RD, 1989, J BACTERIOL, V171, P1075, DOI 10.1128/jb.171.2.1075-1086.1989; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Lin TH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01984; Liu HL, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00070; MACGREGOR CH, 1974, J BIOL CHEM, V249, P5321; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Py B, 2018, J BIOL CHEM, V293, P7689, DOI 10.1074/jbc.RA118.002160; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romsang A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134374; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Sambrook J., 2001, MOL CLONING LAB MANU; Sander K, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0394-9; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Utari PD, 2013, TRENDS MICROBIOL, V21, P315, DOI 10.1016/j.tim.2013.04.006; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vergnes A, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12680; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; ZENNARO E, 1993, FEMS MICROBIOL LETT, V109, P243, DOI 10.1016/0378-1097(93)90027-Y	49	8	8	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202151	10.1371/journal.pone.0202151	http://dx.doi.org/10.1371/journal.pone.0202151			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092083	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600094
J	Zhang, J; Chen, XS; Huang, SW; Wang, Y; Lin, W; Zhou, R; Zou, H				Zhang, Jia; Chen, Xiaoshu; Huang, Shiwei; Wang, Yi; Lin, Wei; Zhou, Rui; Zou, He			Two-minute walk test: Reference equations for healthy adults in China	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TEST-PERFORMANCE; COPD PATIENTS; OLDER-ADULTS; 6-MINUTE; RELIABILITY; DISTANCE; RESPONSIVENESS; EXERCISE; CAPACITY	Background and objective Although the six-minute walk test (6MWT) is widely used as a measure of exercise capacity, it may not be applicable in some settings and populations. This issue has led to increased use of the two-minute walk test (2MWT) to assess exercise capacity. The main objective of this study is to establish reference equations for the two-minute walk distance (2MWD) in healthy Chinese adults aged 18-85 years. Methods A total of 973 volunteers took part in the study. We obtained verbal consent from all participants before the test, and the study design was approved by the ethics committees of Wenzhou People's Hospital. The participants performed two 2MWTs using a standardized protocol, and the longer distance was used for further analysis. Stepwise multiple regression analysis was performed using age, height and weight as independent variables and was used to establish the reference equations for the 2MWD in the male and female groups. Results The mean walking distance for all participants was 199.1 +/- 25.81 m. Age and height were identified as independent factors that influenced the 2MWD, and they explained 35% and 34% of the variance in distance for the male and female groups, respectively. Conclusion This study resulted in determination of reference equations for predicting the 2MWD in healthy Chinese adults. These 2MWD standards will provide useful references for medical care in some settings and populations.	[Zhang, Jia] Wenzhou Med Univ, Dept Inspect Med, Wenzhou Peoples Hosp, Wenzhou Clin Inst 3, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiaoshu; Huang, Shiwei; Wang, Yi; Lin, Wei; Zhou, Rui; Zou, He] Wenzhou Med Univ, Dept Cardiovasc Med, Wenzhou Peoples Hosp, Wenzhou Clin Inst 3, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zou, H (corresponding author), Wenzhou Med Univ, Dept Cardiovasc Med, Wenzhou Peoples Hosp, Wenzhou Clin Inst 3, Wenzhou, Zhejiang, Peoples R China.	476159415@163.com	Zou, He/GXH-0280-2022					[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1990, MED SCI SPORT EXER, V22, P265; Bansal V, 2008, CHEST, V133, P1155, DOI 10.1378/chest.07-2823; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bohannon RW, 2015, ARCH PHYS MED REHAB, V96, P472, DOI 10.1016/j.apmr.2014.10.006; Brooks D, 2004, ARCH PHYS MED REHAB, V85, P1525, DOI 10.1016/j.apmr.2004.01.023; Brooks D, 2002, ARCH PHYS MED REHAB, V83, P1562, DOI 10.1053/apmr.2002.34600; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; COGGAN AR, 1993, J APPL PHYSIOL, V75, P2125, DOI 10.1152/jappl.1993.75.5.2125; Connelly DM, 2009, PHYSIOTH CAN, V61, P78, DOI 10.3138/physio.61.2.78; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Eiser N, 2003, RESP MED, V97, P407, DOI 10.1053/rmed.2002.1462; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; Harth L, 2009, CAN RESPIR J, V16, P86, DOI 10.1155/2009/393941; Kosak M, 2005, J REHABIL RES DEV, V42, P103, DOI 10.1682/JRRD.2003.11.0171; Langeskov-Christensen D, 2017, J NEUROL SCI, V382, P131, DOI 10.1016/j.jns.2017.09.049; Leung ASY, 2006, CHEST, V130, P119, DOI 10.1378/chest.130.1.119; Liu WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162444; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; Mirza FT, 2018, RESPIROLOGY, V23, P674, DOI 10.1111/resp.13262; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Reid L, 2015, J REHABIL MED, V47, P256, DOI 10.2340/16501977-1916; Sciurba F, 2003, AM J RESP CRIT CARE, V167, P1522, DOI 10.1164/rccm.200203-166OC; Selman JPR, 2014, RESP CARE, V59, P525, DOI 10.4187/respcare.02649; Unnanuntana A, 2012, J ARTHROPLASTY, V27, P770, DOI 10.1016/j.arth.2011.08.005; Vivas LLY, 2017, DISABIL REHABIL, V39, P36, DOI 10.3109/09638288.2016.1140831; White DK, 2014, PHYS THER, V94, P1285, DOI 10.2522/ptj.20130628; Zou H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184669; Zugck C, 2000, EUR HEART J, V21, P540, DOI 10.1053/euhj.1999.1861	30	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201988	10.1371/journal.pone.0201988	http://dx.doi.org/10.1371/journal.pone.0201988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092036	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600076
J	Shao, YW; Wood, GA; Lu, JC; Tang, QL; Liu, J; Molyneux, S; Chen, Y; Fang, H; Adissu, H; McKee, T; Waterhouse, P; Khokha, R				Shao, Yang W.; Wood, Geoffrey A.; Lu, Jinchang; Tang, Qing-Lian; Liu, Jonathan; Molyneux, Sam; Chen, Yan; Fang, Hui; Adissu, Hibret; McKee, Trevor; Waterhouse, Paul; Khokha, Rama			Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma	ONCOGENE			English	Article							GENE-EXPRESSION; COPY NUMBER; G-PROTEINS; HYBRIDIZATION; REARRANGEMENT; POLARITY; GTPASES; CANCER; CANINE; EVENT	Leveraging the conserved cancer genomes across mammals has the potential to transform driver gene discovery in orphan cancers. Here, we combine cross-species genomics with validation across human-dog-mouse systems to uncover a new bone tumor suppressor gene. Comparative genomics of spontaneous human and dog osteosarcomas (OS) expose Disks Large Homolog 2 (DLG2) as a tumor suppressor candidate. DLG2 copy number loss occurs in 42% of human and 56% of canine OS. Functional validation through pertinent human and canine OS DLG2-deficient cell lines identifies a regulatory role of DLG2 in cell division, migration and tumorigenesis. Moreover, osteoblast-specific deletion of Dlg2 in a clinically relevant genetically engineered mouse model leads to acceleration of OS development, establishing DLG2 as a critical determinant of OS. This widely applicable cross-species approach serves as a platform to expedite the search of cancer drivers in rare human malignancies, offering new targets for cancer therapy.	[Shao, Yang W.; Lu, Jinchang; Tang, Qing-Lian; Molyneux, Sam; Chen, Yan; Fang, Hui; McKee, Trevor; Waterhouse, Paul; Khokha, Rama] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Wood, Geoffrey A.; Liu, Jonathan; Adissu, Hibret] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Lu, Jinchang; Tang, Qing-Lian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped Oncol, Guangzhou 510080, Guangdong, Peoples R China	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Guelph; Sun Yat Sen University	Khokha, R (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.	rama.khokha@utoronto.ca	adissu, hibret a/R-3282-2018; Wood, Geoffrey/ABB-2052-2021	adissu, hibret a/0000-0003-3365-7466; Wood, Geoffrey/0000-0003-1756-8607; Waterhouse, Paul/0000-0001-8745-5224	Canadian Institutes of Health Research (CIHR); Ontario Institute for Cancer Research (OICR); Global Leadership Round in Genomics and Life Sciences (GL2); OVC Pet Trust; National Natural Science Foundation of China [81702665]; National Postdoctoral Program for Innovative Talents [BX201600196]; China Postdoctoral Science Foundation [2017M610571]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research (OICR); Global Leadership Round in Genomics and Life Sciences (GL2); OVC Pet Trust; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Program for Innovative Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study is supported by funding from the Canadian Institutes of Health Research (CIHR), Ontario Institute for Cancer Research (OICR), and Global Leadership Round in Genomics and Life Sciences (GL2) to RK and the OVC Pet Trust to GW. J. Lu is also supported by National Natural Science Foundation of China (81702665), National Postdoctoral Program for Innovative Talents (BX201600196) and China Postdoctoral Science Foundation (2017M610571).	Aguiar SD, 2007, CANCER GENET CYTOGEN, V175, P35, DOI 10.1016/j.cancergencyto.2007.01.007; Aljubran AH, 2009, ANN ONCOL, V20, P1136, DOI 10.1093/annonc/mdn731; Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Angstadt AY, 2011, GENE CHROMOSOME CANC, V50, P859, DOI 10.1002/gcc.20908; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chen X, 2014, CELL, V158, P1187, DOI 10.1016/j.cell.2014.07.034; Chen Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0295; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Mohseny AB, 2010, GENE CHROMOSOME CANC, V49, P1095, DOI 10.1002/gcc.20817; Nathrath MH, 2002, ONCOGENE, V21, P5975, DOI 10.1038/sj.onc.1205764; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Roberts S, 2012, FEBS J, V279, P3549, DOI 10.1111/j.1742-4658.2012.08729.x; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; Tsai PC, 2012, AM J VET RES, V73, P1335, DOI 10.2460/ajvr.73.9.1335; van Dam Teunis J P, 2011, Small GTPases, V2, P4; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469	31	41	42	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2019	38	2					291	298		10.1038/s41388-018-0444-4	http://dx.doi.org/10.1038/s41388-018-0444-4			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HG9XX	30093633	Green Published, hybrid			2022-12-26	WOS:000455366700010
J	Correa, R; Arenas, J; Montoya, G; Hoz, L; Lopez, S; Salgado, F; Arroyo, R; Salmeron, N; Romo, E; Zeichner-David, M; Arzate, H				Correa, Rodrigo; Arenas, Jesus; Montoya, Gonzalo; Hoz, Lia; Lopez, Sonia; Salgado, Fabiola; Arroyo, Rita; Salmeron, Nahum; Romo, Enrique; Zeichner-David, Margarita; Arzate, Higinio			Synthetic cementum protein 1-derived peptide regulates mineralization in vitro and promotes bone regeneration in vivo	FASEB JOURNAL			English	Article						hydroxyapatite; mineralization; osteogenesis	PERIODONTAL-LIGAMENT CELLS; OSTEOBLAST DIFFERENTIATION; CRYSTAL-FORMATION; CRITICAL-SIZE; EXPRESSION; BIOMINERALIZATION; HYDROXYAPATITE; OSTERIX; GROWTH; CEMP1	The use of recombinant proteins has revolutionized the development of biologic pharmaceuticals; however, they are not free of complications. Some have very high molecular weight, some demonstrate in vivo instability, and the high cost of producing them remains a major problem. On the other hand, it has been shown that peptides derived from active domains keep their biologic activity and can trigger events, such as osteogenesis and bone regeneration. Small peptides are advantageous because of their ease of synthesis and handling and their low immunogenic activity. The purpose of this study was to investigate the functions of a synthetic peptide, cementum protein 1-peptide1 (CEMP-1-p1), both in vitro and in vivo. Our results show that CEMP-1-p1 significantly enhanced the proliferation and differentiation of human periodontal ligament cells toward a mineralizing-like phenotype, as evidenced by increasing alkaline phosphatase (ALP)-specific activity and osterix, runt-related transcription factor (RUNX)-2, integrin binding sialoprotein, bone morphogenetic protein-2, osteocalcin, and cementum protein (CEMP)-1 expression at mRNA and protein levels. In vivo assays performed through standardized critical-size calvarial defects in rats treated with CEMP-1-p1 resulted in newly formed bone after 30 and 60 d. These data demonstrate that CEMP-1-p1 is an effective bioactive peptide for bone tissue regeneration. The application of this bioactive peptide may lead to implementing new strategies for the regeneration of bone and other mineralized tissues.Correa, R., Arenas, J., Montoya, G., Hoz, L., Lopez, S., Salgado, F., Arroyo, R., Salmeron, N., Romo, E., Zeichner-David, M., Arzate, H. Synthetic cementum protein 1-derived peptide regulates mineralization in vitro and promotes bone regeneration in vivo.	[Correa, Rodrigo; Montoya, Gonzalo; Hoz, Lia; Lopez, Sonia; Salgado, Fabiola; Arroyo, Rita; Salmeron, Nahum; Romo, Enrique; Arzate, Higinio] Univ Nacl Autonoma Mexico, Lab Biol Periodontal, Fac Odontol, Ave Univ 3000, Mexico City 04510, DF, Mexico; [Arenas, Jesus] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City, DF, Mexico; [Zeichner-David, Margarita] Univ Southern Calif, Ostrow Sch Dent, Los Angeles, CA USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Southern California	Arzate, H (corresponding author), Univ Nacl Autonoma Mexico, Lab Biol Periodontal, Fac Odontol, Ave Univ 3000, Mexico City 04510, DF, Mexico.	harzate@unam.mx	AYALA, GONZALO MONTOYA/AAT-3910-2021; Salmerón-Valdés, Elias Nahum/GQP-2349-2022; Salmerón-Valdés, Elias Nahum/AAE-9679-2020	AYALA, GONZALO MONTOYA/0000-0001-9376-7347; Salmerón-Valdés, Elias Nahum/0000-0001-6732-6388; Salmerón-Valdés, Elias Nahum/0000-0001-6732-6388	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM [IT200717, IA200917, IA203518, IA202618]	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM(Universidad Nacional Autonoma de Mexico)	The authors thank M. Aguilar, S. Tehuacanero, R. Hernandez, and J. Canetas [all from Instituto de FIsica, Universidad Nacional Autonoma de Mexico (UNAM)] for technical assistance. This work is part of the U.S. Patent Application No. US 2017/0088584 A1. This work was partially supported by Grants IT200717, IA200917, IA203518, IA202618, and postdoctoral scholarship to N.S. from Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM. The authors declare no conflicts of interest.	Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Amos FF, 2009, BIOMACROMOLECULES, V10, P3298, DOI 10.1021/bm900893f; Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793; Arzate H, 2002, J DENT RES, V81, P541, DOI 10.1177/154405910208100808; Arzate H, 2015, PERIODONTOL 2000, V67, P211, DOI 10.1111/prd.12062; Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmona-Rodriguez B, 2007, BIOCHEM BIOPH RES CO, V358, P763, DOI 10.1016/j.bbrc.2007.04.204; Chen XF, 2016, INT J NANOMED, V11, P3145, DOI 10.2147/IJN.S104324; Chen XF, 2016, MAT SCI ENG C-MATER, V59, P384, DOI 10.1016/j.msec.2015.10.029; Choi JW, 2016, PLAST RECONSTR SURG, V138, p64E, DOI 10.1097/PRS.0000000000002290; Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; Paula-Silva FWG, 2010, CALCIFIED TISSUE INT, V87, P144, DOI 10.1007/s00223-010-9368-x; Goncalves PF, 2008, J PERIODONTOL, V79, P323, DOI 10.1902/jop.2008.070327 ; Han PP, 2015, J BONE MINER RES, V30, P1160, DOI 10.1002/jbmr.2445; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hough TA, 2007, J BONE MINER RES, V22, P1397, DOI 10.1359/jbmr.070515; Hoz L, 2012, CELL BIOL INT, V36, P129, DOI 10.1042/CBI20110168; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Inubushi T, 2008, J PERIODONTOL, V79, P1984, DOI [10.1902/jop.2008.080081, 10.1902/jop.2008.080081 ]; Jakob F, 2013, MATURITAS, V75, P118, DOI 10.1016/j.maturitas.2013.03.004; Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3; Komaki M, 2012, J CELL PHYSIOL, V227, P649, DOI 10.1002/jcp.22770; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lowery JW, 2011, CRIT REV EUKAR GENE, V21, P177, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.60; LOWRY OH, 1954, J BIOL CHEM, V207, P19; Maria CG, 2013, INJURY, V44, P1871, DOI 10.1016/j.injury.2013.08.012; Mercado AE, 2014, J TISSUE ENG REGEN M, V8, P15, DOI 10.1002/term.1487; Montoya G, 2014, BONE, V69, P154, DOI 10.1016/j.bone.2014.09.014; Nudelman F, 2007, FARADAY DISCUSS, V136, P9, DOI 10.1039/b704418f; Nunez J, 2012, J PERIODONTAL RES, V47, P33, DOI 10.1111/j.1600-0765.2011.01402.x; Pountos I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0646-y; Pountos I, 2013, ACTA ORTHOP, V84, P65, DOI 10.3109/17453674.2013.765624; Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romo-Arevalo E, 2016, FEBS LETT, V590, P129, DOI 10.1002/1873-3468.12032; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Serrano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078807; Sugamori Y, 2016, BIOESSAYS, V38, P717, DOI 10.1002/bies.201600104; Sun S, 2008, INT J ORAL MAX SURG, V37, P350, DOI 10.1016/j.ijom.2007.11.024; Tavafoghi M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0462; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Villarreal-Ramirez E, 2009, BIOCHEM BIOPH RES CO, V384, P49, DOI 10.1016/j.bbrc.2009.04.072; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	54	11	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1167	1178		10.1096/fj.201800434RR	http://dx.doi.org/10.1096/fj.201800434RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113883	Bronze			2022-12-26	WOS:000457401500092
J	Sonigo, C; Beau, I; Grynberg, M; Binart, N				Sonigo, Charlotte; Beau, Isabelle; Grynberg, Michael; Binart, Nadine			AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice	FASEB JOURNAL			English	Article						anti-Mullerian hormone; alkylating agents; burnout effect; oncofertility; autophagy	ANTI-MULLERIAN HORMONE; INHIBITS INITIATION; ACTIVATION; AUTOPHAGY; RESERVE; SUPPRESSION; PATHWAY; GROWTH; DAMAGE; PRESERVATION	The follicular ovarian reserve, constituted by primordial follicles (PMFs), is established early in life, then keeps declining regularly along reproductive life. The maintenance of a normal female reproductive function implies the presence of a vast amount of dormant PMFs. This process involves a continuous repression of PMF activation into early growing follicle through the balance between factors activating the initiation of follicular growth, mainly actors of the PI3K signaling pathway, and inhibiting factors such as anti-Mullerian hormone (AMH). Any disruption of this balance may induce follicle depletion and subsequent infertility. It has been recently proposed that cyclophosphamide (Cy), an alkylating agent commonly used for treating breast cancer, triggers PMF activation, further leading to premature ovarian insufficiency. Preventing chemotherapy-induced ovarian dysfunction might represent an interesting option for preserving optimal chances of natural or medically assisted conceptions after healing. The aim of the present study was to evaluate, in a model of Cy-treated pubertal mice, whether AMH administration might restrain PMF depletion. The counting of the total PMF number within mouse ovaries showed that recombinant AMH prevented Cy-induced PMF loss. Western blot analysis revealed activation of PI3K signaling pathway after Cy administration. After AMH injection, FOXO3A phosphorylation, a main actor of PMF activation, was significantly decreased. Taken together, these results support a protective role of AMH against Cy-induced follicular loss. We also provide evidence for a possible role of autophagy in the preservation of follicular pool reserve. Therefore, concomitant recombinant AMH administration during chemotherapy might offer a new option for preserving young patients' fertility.Sonigo, C., Beau, I., Grynberg, M., Binart, N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.	[Sonigo, Charlotte; Beau, Isabelle; Binart, Nadine] Univ Paris Saclay, Fac Med Paris Sud, INSERM, Unite 1185, Le Kremlin Bicetre, France; [Grynberg, Michael] Hop Antoine Beclere, Dept Reprod Med & Fertil Preservat, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Binart, N (corresponding author), Univ Paris Sud, INSERM, Unite 1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Beau, Isabelle/M-4423-2017; Sonigo, Charlotte/S-6438-2018; Binart, Nadine/F-2949-2013	Beau, Isabelle/0000-0002-3352-6813; Sonigo, Charlotte/0000-0002-0875-1592; Binart, Nadine/0000-0002-5606-3866	Plan Cancer 2014-2019; Canceropole Ile de France/Institut National du Cancer (INCA); Convention de Recherche [2015-1-EMERG-02-INSERM11-1]	Plan Cancer 2014-2019; Canceropole Ile de France/Institut National du Cancer (INCA); Convention de Recherche	The authors thank N. Ba and O. Trassard (Institut Biomedical de Recherche Unite Mixte de Service (UMS) 32, Plateau d'Imagerie, Histologie de Recherche, le Kremlin-Bicetre, France) for assistance in pathologic proceedings and slide scanning. Funding was received from Plan Cancer 2014-2019. This work was supported by the Canceropole Ile de France/Institut National du Cancer (INCA) and Convention de Recherche (Grant 2015-1-EMERG-02-INSERM11-1). The authors declare no conflicts of interest.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Assi J, 2018, J ASSIST REPROD GEN, V35, P601, DOI 10.1007/s10815-018-1131-7; Bedoschi G, 2016, FUTURE ONCOL, V12, P2333, DOI 10.2217/fon-2016-0176; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chang EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144245; Chen XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060836; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Donnez J, 2017, NEW ENGL J MED, V377, P1657, DOI 10.1056/NEJMra1614676; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Fisch B, 2018, REPRODUCTION, V156, pF11, DOI 10.1530/REP-17-0483; Gannon AM, 2012, TOXICOL SCI, V125, P274, DOI 10.1093/toxsci/kfr279; Gawriluk TR, 2011, REPRODUCTION, V141, P759, DOI 10.1530/REP-10-0489; Gigli I, 2005, MOL REPROD DEV, V71, P480, DOI 10.1002/mrd.20338; Goldman KN, 2017, P NATL ACAD SCI USA, V114, P3186, DOI 10.1073/pnas.1617233114; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hayes E, 2016, MOL CELL ENDOCRINOL, V433, P56, DOI 10.1016/j.mce.2016.05.019; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Jang H, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12432; Jang H, 2016, J PINEAL RES, V60, P336, DOI 10.1111/jpi.12316; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kano M, 2017, P NATL ACAD SCI USA, V114, pE1688, DOI 10.1073/pnas.1620729114; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Meirow D, 1999, HUM REPROD, V14, P1903, DOI 10.1093/humrep/14.7.1903; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pfeifer S, 2013, FERTIL STERIL, V100, P1214, DOI 10.1016/j.fertnstert.2013.08.012; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Roness H, 2014, HUM REPROD UPDATE, V20, P759, DOI 10.1093/humupd/dmu019; Song ZH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.559; Sonigo C, 2012, J CLIN INVEST, V122, P3791, DOI 10.1172/JCI63937; Steiner AZ, 2017, JAMA-J AM MED ASSOC, V318, P1367, DOI 10.1001/jama.2017.14588; Sun YC, 2018, AGING-US, V10, P197, DOI 10.18632/aging.101376; Sun YC, 2017, INT J BIOL SCI, V13, P449, DOI 10.7150/ijbs.18836; Visser JA, 2014, MOL CELL ENDOCRINOL, V382, P460, DOI 10.1016/j.mce.2013.08.012; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Woodruff TK, 2009, NAT MED, V15, P1124, DOI 10.1038/nm1009-1124; Yang MY, 2017, MOL HUM REPROD, V23, P282, DOI 10.1093/molehr/gax010; Zhang XM, 2013, GENE, V523, P82, DOI 10.1016/j.gene.2013.03.039; Zhou LY, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0350-3	45	54	59	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1278	1287		10.1096/fj.201801089R	http://dx.doi.org/10.1096/fj.201801089R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113879				2022-12-26	WOS:000457401500101
J	De, S; Karim, F; Kiessu, E; Cushing, L; Lin, LL; Ghandil, P; Hoarau, C; Casanova, JL; Puel, A; Rao, VR				De, Saurav; Karim, Fawziya; Kiessu, Ezechielle; Cushing, Leah; Lin, Lih-Ling; Ghandil, Pegah; Hoarau, Cyrille; Casanova, Jean-Laurent; Puel, Anne; Rao, Vikram R.			Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin 1 (IL-1); myeloid differentiation primary response gene 88 (MyD88); Toll; interleukin-1 receptor (TIR); protein kinase; inflammation; cytokine; cell signaling; innate immunity; interleukin-1 receptor-associated kinase 4 (IRAK4)	BACTERIAL-INFECTIONS; MYD88; ACTIVATION; REDUNDANT; AUTOPHOSPHORYLATION; PHOSPHORYLATION; INFLAMMATION	Interleukin-1 receptor (IL1R)-associated kinase 4 (IRAK4) is a central regulator of innate immune signaling, controlling IL1R and Toll-like receptor (TLR)-mediated responses and containing both scaffolding and kinase activities. Humans deficient in IRAK4 activity have autosomal recessive primary immune deficiency (PID). Here, we characterized the molecular mechanism of dysfunction of two IRAK4 PID variants, G298D and the compound variant R12C (R12C/R391H/T458I). Using these variants and the kinase-inactive D329A variant to delineate the contributions of IRAK4's scaffolding and kinase activities to IL1R signaling, we found that the G298D variant is kinase-inactive and expressed at extremely low levels, acting functionally as a null mutation. The R12C compound variant possessed WT kinase activity, but could not interact with myeloid differentiation primary response 88 (MyD88) and IRAK1, causing impairment of IL-1-induced signaling and cytokine production. Quantitation of IL-1 signaling in IRAK4-deficient cells complemented with either WT or the R12C or D329A variant indicated that the loss of MyD88 interaction had a greater impact on IL-1-induced signaling and cytokine expression than the loss of IRAK4 kinase activity. Importantly, kinase-inactive IRAK4 exhibited a greater association with MyD88 and a weaker association with IRAK1 in IRAK4-deficient cells expressing kinase-inactive IRAK4 and in primary cells treated with a selective IRAK4 inhibitor. Loss of IRAK4 kinase activity only partially inhibited IL-1-induced cytokine and NF-B signaling. Therefore, the IRAK4-MyD88 scaffolding function is essential for IL-1 signaling, but IRAK4 kinase activity can control IL-1 signal strength by modulating the association of IRAK4, MyD88, and IRAK1.	[De, Saurav; Karim, Fawziya; Kiessu, Ezechielle; Cushing, Leah; Lin, Lih-Ling; Rao, Vikram R.] Pfizer Inc, Inflammat & Immunol Res Unit, Cambridge, MA 02139 USA; [Casanova, Jean-Laurent; Puel, Anne] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Casanova, Jean-Laurent; Puel, Anne] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Casanova, Jean-Laurent; Puel, Anne] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Hoarau, Cyrille] Reg Univ Hosp Ctr Tours, Transversal Unit Allergol & Clin Immunol, F-37044 Tours 9, France; [Ghandil, Pegah] Ahvaz Jundishapur Univ Med Sci, Diabet Res Ctr, Ahvaz 6135715794, Iran; [Ghandil, Pegah] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Med Genet, Ahvaz 6135715794, Iran; [Karim, Fawziya] Pfizer Biotherapeut Pharmaceut Res & Dev, Formulat & Proc Dev, Andover, MA 01810 USA; [Kiessu, Ezechielle] Shenandoah Univ, Sch Pharm, Winchester, VA 22601 USA; [Cushing, Leah] EMD Serono Inc, 45 Middlesex Turnpike, Billerica, MA 01821 USA; [Lin, Lih-Ling] Sanofi Immunol & Inflammat, 270 Albany St, Cambridge, MA 02139 USA	Pfizer; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Pfizer; Merck KGaA; EMD Serono Inc.	Rao, VR (corresponding author), Inflammat & Immunol Res Unit, 1 Portland St, Cambridge, MA 02139 USA.	vikram.rao@pfizer.com	Puel, Anne/H-7305-2017	Puel, Anne/0000-0003-2603-0323	Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was supported by Pfizer Inc. S. D., F. K,. and V. R. R. are paid employees of Pfizer Inc. E. K., L. C., and L.- L. L. were paid employees of Pfizer Inc. at the time of this work.	Alsina L, 2014, NAT IMMUNOL, V15, P1134, DOI 10.1038/ni.3028; Chaudhary D, 2015, J MED CHEM, V58, P96, DOI 10.1021/jm5016044; Cushing L, 2017, J BIOL CHEM, V292, P18689, DOI 10.1074/jbc.M117.796912; Cushing L, 2014, J BIOL CHEM, V289, P10865, DOI 10.1074/jbc.M113.544809; Dossang ACG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37267; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Israel L, 2017, CELL, V168, P789, DOI 10.1016/j.cell.2017.01.039; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Yamamoto T, 2014, MOL IMMUNOL, V58, P66, DOI 10.1016/j.molimm.2013.11.008	20	11	12	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15208	15220		10.1074/jbc.RA118.003831	http://dx.doi.org/10.1074/jbc.RA118.003831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115681	Green Published, hybrid			2022-12-26	WOS:000445998400021
J	Li, SH; Sato, K; Gordon, WC; Sendtner, M; Bazan, NG; Jin, MH				Li, Songhua; Sato, Kota; Gordon, William C.; Sendtner, Michael; Bazan, Nicolas G.; Jin, Minghao			Ciliary neurotrophic factor (CNTF) protects retinal cone and rod photoreceptors by suppressing excessive formation of the visual pigments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phototransduction; retinal degeneration; retinoid; photoreceptor; vision; CNTF; electroretinography; opsin; RPE65; visual cycle	LEUKEMIA INHIBITORY FACTOR; CELL INTRAOCULAR IMPLANTS; LIGHT-INDUCED DEGENERATION; RETINITIS-PIGMENTOSA; MOUSE RETINA; IN-VIVO; BINDING PROTEIN; RAT RETINA; MEDIATED DIFFERENTIATION; MACULAR DEGENERATION	The retinal pigment epithelium (RPE)-dependent visual cycle provides 11-cis-retinal to opsins in the photoreceptor outer segments to generate functional visual pigments that initiate phototransduction in response to light stimuli. Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration. These findings suggest that the expression and function of RPE65 and rhodopsin need to be coordinately controlled to sustain normal vision and to protect the retina from photodamage. However, the mechanism controlling the development of the retinal visual system remains poorly understood. Here, we show that deficiency in ciliary neurotrophic factor (CNTF) up-regulates the levels of rod and cone opsins accompanied by an increase in the thickness of the outer nuclear layers and the lengths of cone and rod outer segments in the mouse retina. Moreover, retinoid isomerase activity, expression levels of RPE65 and lecithin:retinol acyltransferase (LRAT), which synthesizes the RPE65 substrate, were also significantly increased in the Cntf(-/-) RPE. Rod a-wave and cone b-wave amplitudes of electroretinograms were increased in Cntf(-/-) mice, but rod b-wave amplitudes were unchanged compared with those in WT mice. Up-regulated RPE65 and LRAT levels accelerated both the visual cycle rate and recovery rate of rod light sensitivity in Cntf(-/-) mice. Of note, rods and cones in Cntf(-/-) mice exhibited hypersusceptibility to light-induced degeneration. These results indicate that CNTF is a common extracellular factor that prevents excessive production of opsins, the photoreceptor outer segments, and 11-cis-retinal to protect rods and cones from photodamage.	[Li, Songhua; Sato, Kota; Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Sch Med, Dept Ophthalmol, New Orleans, LA 70112 USA; [Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany	Louisiana State University System; Louisiana State University System; University of Wurzburg	Jin, MH (corresponding author), LSU Sch Med, Neurosci Ctr, 2020 Gravier St, New Orleans, LA 70112 USA.	mjin@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020; Sendtner, Michael/M-8137-2014	Bazan, Nicolas/0000-0002-9243-5444; Sendtner, Michael/0000-0002-4737-2974	National Institutes of Health [EY021208, GM103340, EY005121]; Louisiana State University School of Medicine Research Enhancement Fund; Interdisziplinares Zentrum fur Klinische Forschung Grant [N-304]; NATIONAL EYE INSTITUTE [R01EY028572, R01EY021208, R01EY005121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University School of Medicine Research Enhancement Fund; Interdisziplinares Zentrum fur Klinische Forschung Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants EY021208 (to M. J.), GM103340 (to N. G. B.), and EY005121 (to N. G. B), Louisiana State University School of Medicine Research Enhancement Fund (to M. J.), and Interdisziplinares Zentrum fur Klinische Forschung Grant N-304 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BATTELLE BA, 1978, EXP EYE RES, V26, P487, DOI 10.1016/0014-4835(78)90134-3; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Beltran WA, 2005, MOL VIS, V11, P232; Beltran WA, 2003, INVEST OPHTH VIS SCI, V44, P3642, DOI 10.1167/iovs.02-0763; Beltran WA, 2007, EXP EYE RES, V84, P753, DOI 10.1016/j.exer.2006.12.019; Bhattacharya S, 2004, MOL CELL NEUROSCI, V27, P32, DOI 10.1016/j.mcn.2004.05.004; Birch DG, 2016, AM J OPHTHALMOL, V170, P10, DOI 10.1016/j.ajo.2016.07.013; Birch DG, 2013, AM J OPHTHALMOL, V156, P283, DOI 10.1016/j.ajo.2013.03.021; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Bush RA, 2004, INVEST OPHTH VIS SCI, V45, P2420, DOI 10.1167/iovs.03-1342; Campochiaro PA, 2018, PROG RETIN EYE RES, V62, P24, DOI 10.1016/j.preteyeres.2017.08.004; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Elliott J, 2006, DEV BIOL, V300, P583, DOI 10.1016/j.ydbio.2006.09.002; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Fischer D, 2017, EYE, V31, P173, DOI 10.1038/eye.2016.234; FUHRMANN S, 1995, DEVELOPMENT, V121, P2695; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Graham DR, 2005, INVEST OPHTH VIS SCI, V46, P2601, DOI 10.1167/iovs.05-0129; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Gupta SK, 1997, BIOCHEM CELL BIOL, V75, P119, DOI 10.1139/bcb-75-2-119; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Ju WK, 1999, NEUROREPORT, V10, P419, DOI 10.1097/00001756-199902050-00038; Kaschula CH, 2006, EXP EYE RES, V82, P111, DOI 10.1016/j.exer.2005.05.010; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; Kaylor JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125921; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Komeima K, 2008, FREE RADICAL BIO MED, V45, P905, DOI 10.1016/j.freeradbiomed.2008.06.020; Kondo M, 2001, INVEST OPHTH VIS SCI, V42, P305; Kunchithapautham K, 2011, INVEST OPHTH VIS SCI, V52, P2967, DOI 10.1167/iovs.10-6278; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lee M, 2016, INVEST OPHTH VIS SCI, V57, P1553, DOI 10.1167/iovs.15-18551; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Li SH, 2016, J NEUROSCI, V36, P5808, DOI 10.1523/JNEUROSCI.3857-15.2016; Li SH, 2014, J BIOL CHEM, V289, P18943, DOI 10.1074/jbc.M114.552117; Li SH, 2013, J BIOL CHEM, V288, P11395, DOI 10.1074/jbc.M112.418251; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Okano K, 2012, J NEUROCHEM, V121, P146, DOI 10.1111/j.1471-4159.2012.07647.x; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Rhee KD, 2003, MOL VIS, V9, P715; Rhee KD, 2013, P NATL ACAD SCI USA, V110, pE4520, DOI 10.1073/pnas.1303604110; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Sherry DM, 2005, J NEUROSCI RES, V82, P316, DOI 10.1002/jnr.20619; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Walsh N, 2001, EXP EYE RES, V72, P495, DOI 10.1006/exer.2000.0984; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Xie HQ, 2000, INVEST OPHTH VIS SCI, V41, P4317; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Xue W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020326; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	84	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15256	15268		10.1074/jbc.RA118.004008	http://dx.doi.org/10.1074/jbc.RA118.004008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115683	Green Published, hybrid			2022-12-26	WOS:000445998400025
J	Archambault, AS; Turcotte, C; Martin, C; Provost, V; Larose, MC; Laprise, C; Chakir, J; Bissonnette, E; Laviolette, M; Bosse, Y; Flamand, N				Archambault, Anne-Sophie; Turcotte, Caroline; Martin, Cyril; Provost, Veronique; Larose, Marie-Chantal; Laprise, Catherine; Chakir, Jamila; Bissonnette, Elyse; Laviolette, Michel; Bosse, Ynuk; Flamand, Nicolas			Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLISM; 15-HYDROXY-EICOSATETRAENOIC ACID; 5-LIPOXYGENASE INHIBITORS; LEUKOTRIENE-B4 FORMATION; INFLAMMATION; RECEPTORS; INVITRO; POTENT; 2-ARACHIDONOYL-GLYCEROL; PHOSPHORYLATION	Neutrophils and eosinophils are important sources of bioactive lipids from the 5- and the 15-lipoxygenase (LO) pathways. Herein, we compared the effectiveness of humans eosinophils and eosinophil-depleted neutrophils to synthesize 15-LO metabolites using a cocktail of different 15-LO substrates as well as their sensitivities to eight documented 15-lipoxygenase inhibitors. The treatment of neutrophils and eosinophils with linoleic acid, dihomo-y-linolenic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid and arachidonylethanolamide, led to the synthesis of 13-HODE, 15-HETrE, 15-HETE, 15-HEPE, 14-HDHA/ 17-HDHA, and 15-hydroxy-AEA. Neutrophils and eosinophils also metabolized the endocannabinoid 2-arachidonoyl-glycerol into 15-HETE-glycerol, although this required 2-arachidonoyl-glycerol hydrolysis inhibition. Neutrophils and eosinophils differed in regard to dihomo-ylinolenic acid and linoleic acid utilization with 15-HETrE/13-HODE ratios of 0.014 +/- 0.0008 and 0.474 +/- 0.114 for neutrophils and eosinophils respectively. 15-LO metabolite synthesis by neutrophils and eosinophils also differed in regard to their relative production of 17-HDHA and 14-HDHA.The synthesis of 15-LO metabolites by neutrophils was concentration-dependent and rapid, reaching a plateau after one minute. While investigating the biosynthetic routes involved, we found that eosinophil-depleted neutrophils express the 15-lipoxygenase- 2 but not the 15-LO-1, in contrast to eosinophils which express the 15-LO-1 but not the 15LO-2. Moreover, 15-LO metabolite synthesis by neutrophils was not inhibited by the 15-LO-1 inhibitors BLX769, BLX3887, and ML351. However, 15-LO product synthesis was partially inhibited by 100 pM NDGA. Altogether, our data indicate that the best 15-LO-1 inhibitors in eosinophils are BLX3887, BLX769, NDGA and ML351 and that the synthesis of 15-LO metabolites by neutrophils does not involve the 15-LO-1 nor the phosphorylation of 5-LO on Ser-663 but is rather the consequence of 15-L0-2 or another unidentified 15-LO.	[Archambault, Anne-Sophie; Turcotte, Caroline; Martin, Cyril; Provost, Veronique; Larose, Marie-Chantal; Chakir, Jamila; Bissonnette, Elyse; Laviolette, Michel; Bosse, Ynuk; Flamand, Nicolas] Univ Laval, Fac Med, Dept Med, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Ctr Integre Univ Sante & Serv Sociaux Saguenay La, Saguenay, PQ, Canada	Laval University; University of Quebec; University of Quebec Chicoutimi	Flamand, N (corresponding author), Univ Laval, Fac Med, Dept Med, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Nicolas.Flamand@criucpq.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200; Laprise, Catherine/0000-0001-5526-9945; Archambault, Anne-Sophie/0000-0001-7243-7445	Natural Sciences and Engineering Research Council of Canada; Respiratory Health Network of the Fonds de recherche du Quebec-Sante; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Respiratory Health Network of the Fonds de recherche du Quebec-Sante; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants to NF from the Natural Sciences and Engineering Research Council of Canada, and the Respiratory Health Network of the Fonds de recherche du Quebec-Sante. CL, JC, EB, ML, YB and NF are members of the inflammation group of the Respiratory Health Network of the Fonds de recherche du Quebec-Sante. CT and MCL are the recipients of a doctoral award from the Canadian Institutes of Health Research. ASA is the recipient of a doctoral award from the Fonds de Recherche du Quebec-Sante. CL is chair holder of the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADDING P, 1995, AM J RESP CRIT CARE, V151, P1201; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; CHANG J, 1984, INFLAMMATION, V8, P143, DOI 10.1007/BF00916090; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; ChiltonLopez T, 1996, J IMMUNOL, V156, P2941; Chouinard F, 2013, J LEUKOCYTE BIOL, V93, P267, DOI 10.1189/jlb.0412200; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; Edgemond WS, 1998, MOL PHARMACOL, V54, P180, DOI 10.1124/mol.54.1.180; Eleftheriadis N, 2015, J MED CHEM, V58, P7850, DOI 10.1021/acs.jmedchem.5b01121; Engels F, 1996, PROSTAGLANDINS, V52, P117, DOI 10.1016/0090-6980(96)00057-3; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Flamand N, 2000, AM J RESP CRIT CARE, V161, pS88, DOI 10.1164/ajrccm.161.supplement_1.ltta-18; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; Flamand N, 2006, J LEUKOCYTE BIOL, V79, P1043, DOI 10.1189/jlb.1005614; FOGH K, 1988, ARCH DERMATOL RES, V280, P430, DOI 10.1007/BF00429983; FOGH K, 1992, AGENTS ACTIONS, V35, P227, DOI 10.1007/BF01997504; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hamel P, 1997, J MED CHEM, V40, P2866, DOI 10.1021/jm970046b; Han HY, 2017, FASEB J, V31, P491, DOI 10.1096/fj.201600679RR; HENDERSON WR, 1984, IMMUNOLOGY, V51, P679; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; IVERSEN L, 1991, AGENTS ACTIONS, V33, P286, DOI 10.1007/BF01986575; James A, 2013, INT ARCH ALLERGY IMM, V162, P37, DOI 10.1159/000351422; Jameson JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104094; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; MORITA E, 1990, SCAND J IMMUNOL, V32, P497, DOI 10.1111/j.1365-3083.1990.tb03190.x; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; Pelcman B, 2015, BIOORG MED CHEM LETT, V25, P3024, DOI 10.1016/j.bmcl.2015.05.004; Rai G, 2010, PROBE REPORTS NIH MO; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Tan CM, 2011, BIOORGAN MED CHEM, V19, P6316, DOI 10.1016/j.bmc.2011.09.003; Turcotte C, 2017, J IMMUNOL, V198, P3255, DOI 10.4049/jimmunol.1601767; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Whitman S, 2002, J MED CHEM, V45, P2659, DOI 10.1021/jm0201262	38	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202424	10.1371/journal.pone.0202424	http://dx.doi.org/10.1371/journal.pone.0202424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118527	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700027
J	Tuskan, GA; Mewalal, R; Gunter, LE; Palla, KJ; Carter, K; Jacobson, DA; Jones, PC; Garcia, BJ; Weighill, DA; Hyatt, PD; Yang, Y; Zhang, J; Reis, N; Chen, JG; Muchero, W				Tuskan, Gerald A.; Mewalal, Ritesh; Gunter, Lee E.; Palla, Kaitlin J.; Carter, Kelsey; Jacobson, Daniel A.; Jones, Piet C.; Garcia, Benjamin J.; Weighill, Deborah A.; Hyatt, Philip D.; Yang, Yongil; Zhang, Jin; Reis, Nicholas; Chen, Jin-Gui; Muchero, Wellington			Defining the genetic components of callus formation: A GWAS approach	PLOS ONE			English	Article							TRANSCRIPTIONAL ADAPTER PROTEIN; GENOME; REGENERATION; PROPORZ1; ARRAY; SPP.	A characteristic feature of plant cells is the ability to form callus from parenchyma cells in response to biotic and abiotic stimuli. Tissue culture propagation of recalcitrant plant species and genetic engineering for desired phenotypes typically depends on efficient in vitro callus generation. Callus formation is under genetic regulation, and consequently, a molecular understanding of this process underlies successful generation for propagation materials and/or introduction of genetic elements in experimental or industrial applications. Herein, we identified 11 genetic loci significantly associated with callus formation in Populus trichocarpa using a genome-wide association study (GWAS) approach. Eight of the 11 significant gene associations were consistent across biological replications, exceeding a chromosomewide-log10 (p) = 4.46 [p = 3.47E-05] Bonferroni-adjusted significance threshold. These eight genes were used as hub genes in a high-resolution co-expression network analysis to gain insight into the genome-wide basis of callus formation. A network of positively and negatively co-expressed genes, including several transcription factors, was identified. As proof-of-principle, a transient protoplast assay confirmed the negative regulation of a Chloroplast Nucleoid DNA-binding-related gene (Potri.018G014800) by the LEC2 transcription factor. Many of the candidate genes and co-expressed genes were 1) linked to cell division and cell cycling in plants and 2) showed homology to tumor and cancer-related genes in humans. The GWAS approach based on a high-resolution marker set, and the ability to manipulate targets genes in vitro, provided a catalog of high-confidence genes linked to callus formation that can serve as an important resource for successful manipulation of model and nonmodel plant species, and likewise, suggests a robust method of discovering common homologous functions across organisms.	[Tuskan, Gerald A.; Gunter, Lee E.; Yang, Yongil; Zhang, Jin; Chen, Jin-Gui; Muchero, Wellington] Oak Ridge Natl Lab, Biosci Div, Plant Syst Biol Grp, Oak Ridge, TN 37830 USA; [Mewalal, Ritesh] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Palla, Kaitlin J.; Jones, Piet C.; Weighill, Deborah A.] Univ Tennessee, Bredesen Ctr Interdisciplinary Res & Grad Educ, Knoxville, TN USA; [Carter, Kelsey] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Jacobson, Daniel A.; Jones, Piet C.; Garcia, Benjamin J.; Weighill, Deborah A.; Hyatt, Philip D.] Oak Ridge Natl Lab, Biosci Div, Computat Biol Grp, Oak Ridge, TN USA; [Reis, Nicholas] Oak Ridge Associated Univ, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Oregon State University; University of Tennessee System; University of Tennessee Knoxville; Michigan Technological University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Tuskan, GA (corresponding author), Oak Ridge Natl Lab, Biosci Div, Plant Syst Biol Grp, Oak Ridge, TN 37830 USA.	tuskanga@ornl.gov	Chen, Jin-Gui/A-4773-2011; Gunter, Lee E/L-3480-2016; Zhang, Jin/J-9618-2019	Chen, Jin-Gui/0000-0002-1752-4201; Gunter, Lee E/0000-0003-1211-7532; Zhang, Jin/0000-0002-8397-5078; Jacobson, Daniel/0000-0002-9822-8251; Garcia, Benjamin/0000-0001-5524-6946; Carter, Kelsey/0000-0001-8327-6413; Jones, Piet/0000-0003-3645-7021	Oak Ridge National Laboratory (ORNL) Laboratory Directed Research and Development funding [8042]; Center for Bioenergy Innovation (CBI), a U.S. Department of Energy (DOE) Bioenergy Research Center; Biological and Environmental Research in the DOE Office of Science; U.S. Dept. of Energy [DE-AC05-00OR22725]; Oak Ridge Associated Universities' HERE program for high school research experience; U.S. Department of Energy [DE-AC05-00OR22725]; United States Government	Oak Ridge National Laboratory (ORNL) Laboratory Directed Research and Development funding; Center for Bioenergy Innovation (CBI), a U.S. Department of Energy (DOE) Bioenergy Research Center(United States Department of Energy (DOE)); Biological and Environmental Research in the DOE Office of Science; U.S. Dept. of Energy(United States Department of Energy (DOE)); Oak Ridge Associated Universities' HERE program for high school research experience; U.S. Department of Energy(United States Department of Energy (DOE)); United States Government	This research was supported, in part, by funding from the Oak Ridge National Laboratory (ORNL) Laboratory Directed Research and Development funding (Seed Project 8042) and by funds from the Center for Bioenergy Innovation (CBI), a U.S. Department of Energy (DOE) Bioenergy Research Center supported by the Biological and Environmental Research in the DOE Office of Science. This research used resources of the Oak Ridge Leadership Computing Facility and the Compute and Data Environment for Science (CADES) at ORNL. ORNL is managed by UT-Battelle, LLC, for the U.S. Dept. of Energy under contract DE-AC05-00OR22725. Nicholas Reis was funded by the Oak Ridge Associated Universities' HERE program for high school research experience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported, in part, by funding from the Oak Ridge National Laboratory (ORNL) Laboratory Directed Research and Development funding (Seed Project 8042) and by funds from the Center for Bioenergy Innovation (CBI), a U.S. Department of Energy (DOE) Bioenergy Research Center supported by the Biological and Environmental Research in the DOE Office of Science. This research used resources of the Oak Ridge Leadership Computing Facility and the Compute and Data Environment for Science (CADES) at ORNL. ORNL is managed by UT-Battelle, LLC, for the U.S. Dept. of Energy under contract DE-AC05-00OR22725. Nicholas Reis was funded by the Oak Ridge Associated Universities' HERE program for high school research experience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also wish to thank Dr. Dan Close, Melissa Cregger and Jennifer Giltnane for their input during the final editing. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan [http://energy.gov/downloads/doe-public-access-plan].	Anzola JM, 2010, P NATL ACAD SCI USA, V107, P10308, DOI 10.1073/pnas.0913918107; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; BRAUN AC, 1954, ANNU REV PLANT PHYS, V5, P133, DOI 10.1146/annurev.pp.05.060154.001025; Bryan AC, 2018, G3-GENES GENOM GENET; Butt SJ, 2015, ADV LIFE SCI-PAK, V2, P48; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Cohen Idan, 2011, Genes Cancer, V2, P631, DOI 10.1177/1947601911417176; Diaz-Mendoza M, 2016, GENET MOL BIOL, V39, P329, DOI 10.1590/1678-4685-GMB-2016-0015; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Fan MZ, 2012, CELL RES, V22, P1169, DOI 10.1038/cr.2012.63; Frank M, 2002, PLANT J, V29, P73, DOI 10.1046/j.1365-313x.2002.01197.x; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gaur A, 2016, ISR J PLANT SCI, V63, P77, DOI 10.1080/07929978.2015.1076982; Geraldes A, 2013, MOL ECOL RESOUR, V13, P306, DOI 10.1111/1755-0998.12056; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guo JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044908; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Ikeda M, 2014, FRONT PLANT SCI, V5; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Iwase A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.27432; Kang BG, 2009, PLANT CELL TISS ORG, V99, P251, DOI 10.1007/s11240-009-9596-9; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kato Y, 2005, PLANTA, V222, P643, DOI 10.1007/s00425-005-0011-4; Liu DG, 2016, CURR OPIN PLANT BIOL, V30, P70, DOI 10.1016/j.pbi.2016.01.007; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Ma YX, 2002, MOL HUM REPROD, V8, P24, DOI 10.1093/molehr/8.1.24; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; McDonald ER, 2001, ANN MED, V33, P113, DOI 10.3109/07853890109002066; Meilan R., 2007, AGROBACTERIUM PROTOC, V2, P143; Mingossi FB, 2010, PLANT MOL BIOL, V73, P271, DOI 10.1007/s11103-010-9613-8; Muchero W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1215-z; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nicole MC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-223; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Ramirez-Parra E, 2017, NEW PHYTOL, V213, P1787, DOI 10.1111/nph.14315; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; SIMON S, 1908, JB WISS BOT, V45, P351; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Skoog F, 1944, AM J BOT, V31, P19, DOI 10.2307/2437663; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; THORPE TA, 2000, KOREAN J PLANT TISS, V27, P245; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Warnes G.R., 2009, R PACKAGE VERSION, V2, P1; Zhang J, 2018, NEW PHYTOL, V220, P502, DOI 10.1111/nph.15297; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	57	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202519	10.1371/journal.pone.0202519	http://dx.doi.org/10.1371/journal.pone.0202519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118526	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700031
J	Zhang, HY; Zhao, ZX; Xu, J; Xu, P; Bai, QL; Yang, SY; Jiang, LK; Chen, BH				Zhang, Han-Yuan; Zhao, Zi-Xia; Xu, Jian; Xu, Peng; Bai, Qing-Li; Yang, Shi-Yong; Jiang, Li-Kun; Chen, Bao-Hua			Population genetic analysis of aquaculture salmonid populations in China using a 57K rainbow trout SNP array	PLOS ONE			English	Article							GENOME DUPLICATION; DOUBLED HAPLOIDS; LINKAGE MAP; TRUTTA; MANAGEMENT; PACKAGE; MODEL; PLINK; FISH	Various salmonid species are cultivated in cold water aquaculture. However, due to limited genomic data resources, specific high-throughput genotyping tools are not available to many of the salmonid species. In this study, a 57K single nucleotide polymorphism (SNP) array for rainbow trout (Oncorhynchus mykiss) was utilized to detect polymorphisms in seven salmonid species, including Hucho taimen, Oncorhynchus masou, Salvelinus fontinalis, Brachymystax lenok, Salvelinus leucomaenis, O. kisutch, and O. mykiss. The number of polymorphic markers per population ranged from 3,844 (O. kisutch) to 53,734 (O. mykiss), indicating that the rainbow trout SNP array was applicable as a universal genotyping tool for other salmonid species. Among the six other salmonid populations from four genera, 28,882 SNPs were shared, whereas 525 SNPs were polymorphic in all four genera. The genetic diversity and population relationships of the seven salmonid species were studied by principal component analysis (PCA). The phylogenetic relationships among populations were analyzed using the maximum likelihood method, which indicated that the shared SNP markers provide reliable genomic information for population genetic analyses in common aquaculture salmonid fishes. Furthermore, this obtained genomic information may be applicable for population genetic evaluation, marker-assisted breeding, and propagative parent selection in fry production.	[Zhang, Han-Yuan; Zhao, Zi-Xia; Xu, Jian; Xu, Peng; Jiang, Li-Kun; Chen, Bao-Hua] Chinese Acad Fishery Sci, Key Lab Aquat Genom, Beijing Key Lab Fishery Biotechnol, Minist Agr, Beijing, Peoples R China; [Xu, Peng; Chen, Bao-Hua] Xiamen Univ, Coll Ocean & Earth Sci, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China; [Bai, Qing-Li] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Heilongjiang, Peoples R China; [Yang, Shi-Yong] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China	Chinese Academy of Fishery Sciences; Ministry of Agriculture & Rural Affairs; Xiamen University; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Sichuan Agricultural University	Zhao, ZX; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Aquat Genom, Beijing Key Lab Fishery Biotechnol, Minist Agr, Beijing, Peoples R China.; Xu, P (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China.	zhaozx@cafs.ac.cn; xupeng77@xmu.edu.cn	Yang, Shiyong/AAL-9273-2020; Chen, Baohua/AAG-5930-2021; Xu, Peng/J-4018-2012; Zhao, Zi-Xia/AAM-8065-2021; Chen, Baohua/HHR-8952-2022; Xu, Jian/H-5349-2019	Chen, Baohua/0000-0002-3065-0739; Xu, Peng/0000-0002-1531-5078; Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268	Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences [2015C007, 2016HY-ZD0302, 2016GH02]; National Science and Technology Pillar Program [2015BAD25B01]; Central Public-interest Scientific Institution Basal Research Fund, CAFS [2015C007, 2016HY-ZD0302, 2016GH02]	Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences; National Science and Technology Pillar Program; Central Public-interest Scientific Institution Basal Research Fund, CAFS	This work was supported by Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences (2015C007 to ZZ, 2016HY-ZD0302 to JX, 2016GH02 to JX), and National Science and Technology Pillar Program (2015BAD25B01) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Yniv Palti for the authorization and kind help in use of the rainbow trout 57K SNP array. The Central Public-interest Scientific Institution Basal Research Fund, CAFS (2015C007, 2016HY-ZD0302, 2016GH02), and the National Science and Technology Pillar Program (2015BAD25B01) supported this study.	Alexandrou MA, 2013, MOL PHYLOGENET EVOL, V69, P514, DOI 10.1016/j.ympev.2013.07.026; Allendorf F.W., 1984, P1; Allendorf Fred W., 1996, P238; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Boussaha M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-238; CAMPTON DE, 1995, AM FISH S S, V15, P337; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Genet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-314; Gharbi K, 2006, GENETICS, V172, P2405, DOI 10.1534/genetics.105.048330; Gonzalez-Pena D, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00203; Hansen MM, 2005, CONSERV GENET, V6, P297, DOI 10.1007/s10592-004-7827-5; Hansen MM, 2000, CAN J FISH AQUAT SCI, V57, P2130, DOI 10.1139/cjfas-57-10-2130; Hard JJ, 2000, J FISH BIOL, V56, P1387, DOI 10.1111/j.1095-8649.2000.tb02151.x; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Kodama M, 2014, G3-GENES GENOM GENET, V4, P1717; Kodama M, 2014, G3-GENES GENOM GENET, V4, P1717, DOI 10.1534/g3.114.012294; Macqueen DJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3862-8; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Naish KA, 2013, G3-GENES GENOM GENET, V3, P2281, DOI 10.1534/g3.113.008003; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Palti Y, 2014, MOL ECOL RESOUR, V14, P588, DOI 10.1111/1755-0998.12204; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; RYMAN N, 1991, J FISH BIOL, V39, P211, DOI 10.1111/j.1095-8649.1991.tb05085.x; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Small MP, 2010, MOL ECOL, V7, P141; Vallejo RL, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0293-6; VERSPOOR E, 1988, CAN J FISH AQUAT SCI, V45, P1686, DOI 10.1139/f88-199; Weeks JP, 2010, J STAT SOFTW, V35, P1; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Young WP, 1998, GENETICS, V148, P839; Yu JN, 2010, ZOOL SCI, V27, P375, DOI 10.2108/zsj.27.375; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhao Z, 2018, J FISHERY SCI CHINA, DOI [10.3724/SP.J.1118.2018.17340, DOI 10.3724/SP.J.1118.2018.17340]	39	4	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202582	10.1371/journal.pone.0202582	http://dx.doi.org/10.1371/journal.pone.0202582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118517	gold, Green Published, Green Submitted			2022-12-26	WOS:000442282700034
J	Berkovic, B; Coelho, N; Gouveia, L; Serrao, EA; Alberto, F				Berkovic, Buga; Coelho, Nelson; Gouveia, Licinia; Serrao, Ester A.; Alberto, Filipe			Individual-based genetic analyses support asexual hydrochory dispersal in Zostera noltei	PLOS ONE			English	Article							SEAGRASS CYMODOCEA-NODOSA; VEGETATIVE FRAGMENTS; RIA-FORMOSA; HALOPHILA-JOHNSONII; PLANT DISPERSAL; SEED DISPERSAL; LIFE-HISTORY; REPRODUCTION; POPULATION; EELGRASS	Dispersal beyond the local patch in clonal plants was typically thought to result from sexual reproduction via seed dispersal. However, evidence for the separation, transport by water, and re-establishment of asexual propagules (asexual hydrochory) is mounting suggesting other important means of dispersal in aquatic plants. Using an unprecedented sampling size and microsatellite genetic identification, we describe the distribution of seagrass clones along tens of km within a coastal lagoon in Southern Portugal. Our spatially explicit individual-based sampling design covered 84 km(2) and collected 3 185 Zostera noltei ramets from 803 sites. We estimated clone age, assuming rhizome elongation as the only mechanism of clone spread, and contrasted it with paleo-oceanographic sea level change. We also studied the association between a source of disturbance and the location of large clones. A total of 16 clones were sampled more than 10 times and the most abundant one was sampled 59 times. The largest distance between two samples from the same clone was 26.4 km and a total of 58 and 10 clones were sampled across more than 2 and 10 km, respectively. The number of extremely large clone sizes, and their old ages when assuming the rhizome elongation as the single causal mechanism, suggests other processes are behind the span of these clones. We discuss how the dispersal of vegetative fragments in a stepping-stone manner might have produced this pattern. We found higher probabilities to sample large clones away from the lagoon inlet, considered a source of disturbance. This study corroborates previous experiments on the success of transport and re-establishment of asexual fragments and supports the hypothesis that asexual hydrochory is responsible for the extent of these clones.	[Berkovic, Buga; Coelho, Nelson; Gouveia, Licinia; Serrao, Ester A.] Univ Algarve, Ctr Ciencias Mar, Faro, Portugal; [Alberto, Filipe] Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA; [Coelho, Nelson] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Universidade do Algarve; University of Wisconsin System; University of Wisconsin Milwaukee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alberto, F (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	albertof@uwm.edu	Gouveia, Licínia/M-7650-2013; Serrao, Ester A/C-6686-2012	Gouveia, Licínia/0000-0002-5531-8476; Serrao, Ester A/0000-0003-1316-658X; Alberto, Filipe/0000-0003-0593-3240	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/MAR/099887/2008]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/68570/2010]; Fundação para a Ciência e a Tecnologia [PTDC/MAR/099887/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was funded by project (PTDC/MAR/099887/2008) financed by Fundacao para a Ciencia e a Tecnologia, Portugal (www.fct.pt) awarded to FA. B.B. was supported by a doctoral grant (SFRH/BD/68570/2010) from Fundacao para a Ciencia e Tecnologia (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2001, MAR ECOL PROG SER, V221, P299, DOI 10.3354/meps221299; Alberto F, 2008, J BIOGEOGR, V35, P1279, DOI 10.1111/j.1365-2699.2007.01876.x; Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; Alexandre A, 2006, AQUAT BOT, V85, P219, DOI 10.1016/j.aquabot.2006.05.002; Andrade C, 2004, MAR GEOL, V210, P339, DOI 10.1016/j.margeo.2004.05.016; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; AYRE DJ, 1984, OECOLOGIA, V62, P222, DOI 10.1007/BF00379017; Balestri E, 2011, BIOL CONSERV, V144, P1644, DOI 10.1016/j.biocon.2011.02.020; Barton NH, 2002, THEOR POPUL BIOL, V61, P31, DOI 10.1006/tpbi.2001.1557; Bergstrom L, 2005, J PHYCOL, V41, P1025, DOI 10.1111/j.1529-8817.2005.00125.x; Berkovic B, 2014, AQUAT BOT, V113, P123, DOI 10.1016/j.aquabot.2013.10.007; Berkovie B., 2015, LANDSCAPE GENETICS S; Billingham MR, 2003, MAR ECOL PROG SER, V265, P77, DOI 10.3354/meps265077; Boedeltje G, 2003, J ECOL, V91, P855, DOI 10.1046/j.1365-2745.2003.00820.x; Bricker E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00435; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Cabaco S, 2005, MAR ECOL PROG SER, V298, P123, DOI 10.3354/meps298123; Cabaco S, 2012, ECOL INDIC, V23, P116, DOI 10.1016/j.ecolind.2012.03.022; Campbell ML, 2003, AQUAT BOT, V76, P175, DOI 10.1016/S0304-3770(03)00016-0; Ceccherelli G, 2001, BOT MAR, V44, P209, DOI 10.1515/BOT.2001.027; Cleavitt NL, 2002, J ECOL, V90, P785, DOI 10.1046/j.1365-2745.2002.00713.x; Coyer JA, 2004, MOL ECOL NOTES, V4, P497, DOI 10.1111/j.1471-8286.2004.00725.x; CRUMP RG, 1985, J EXP MAR BIOL ECOL, V88, P109, DOI 10.1016/0022-0981(85)90032-2; Cunha AH, 2005, ESTUAR COAST SHELF S, V64, P636, DOI 10.1016/j.ecss.2005.03.018; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Dias JMA, 2000, MAR GEOL, V170, P177, DOI 10.1016/S0025-3227(00)00073-6; Almela ED, 2008, AQUAT BOT, V89, P397, DOI 10.1016/j.aquabot.2008.04.012; DISRAELI DJ, 1984, J ECOL, V72, P145, DOI 10.2307/2260010; Doyle JJ, 1987, JSTOR, P715; Eckert CG, 2016, AQUAT BOT, V135, P46, DOI 10.1016/j.aquabot.2016.03.006; Erftemeijer PLA, 2008, MAR ECOL PROG SER, V358, P115, DOI 10.3354/meps07304; Fabbri F, 2015, SCI MAR, V79, P7, DOI 10.3989/scimar.04165.19B; Freeland JR, 2000, J EVOLUTION BIOL, V13, P383; GALLEGOS ME, 1992, AQUAT BOT, V43, P249, DOI 10.1016/0304-3770(92)90070-Y; GLIDDON C, 1987, HEREDITY, V59, P29, DOI 10.1038/hdy.1987.93; Green E.P., 2003, WORLD ATLAS SEAGRASS; Guimaraes MHME, 2012, J NAT CONSERV, V20, P30, DOI 10.1016/j.jnc.2011.07.005; Hall LM, 2006, MAR ECOL PROG SER, V310, P109, DOI 10.3354/meps310109; HARRISON PG, 1993, AQUAT BOT, V45, P63, DOI 10.1016/0304-3770(93)90053-Y; Harwell MC, 2002, ECOLOGY, V83, P3319, DOI 10.2307/3072082; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hughes RN, 1989, FUNCTIONAL BIOL CLON; JACKSON JBC, 1986, B MAR SCI, V39, P588; Jahnke M, 2016, MAR ENVIRON RES, V117, P54, DOI 10.1016/j.marenvres.2016.04.004; JOHANSSON ME, 1993, J ECOL, V81, P81, DOI 10.2307/2261226; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Karako S, 2002, MAR ECOL PROG SER, V234, P139, DOI 10.3354/meps234139; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; van Dijk JK, 2010, AQUAT BOT, V92, P63, DOI 10.1016/j.aquabot.2009.10.005; Kuo J, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P31, DOI 10.1016/B978-044450891-1/50003-7; Lacap CDA, 2002, MAR ECOL PROG SER, V235, P75, DOI 10.3354/meps235075; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marba N, 1996, MAR ECOL PROG SER, V133, P203, DOI 10.3354/meps133203; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; McKenzie PF, 2008, J PHYCOL, V44, P1108, DOI 10.1111/j.1529-8817.2008.00563.x; McMahon K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0878; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; MSHIGENI KE, 1978, BOT MAR, V21, P49, DOI 10.1515/botm.1978.21.1.49; Orth RJ, 2000, MAR ECOL PROG SER, V200, P277, DOI 10.3354/meps200277; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Procaccini G, 2001, RESTOR ECOL, V9, P332, DOI 10.1046/j.1526-100x.2001.009003332.x; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Reusch TBH, 1999, MAR BIOL, V133, P519, DOI 10.1007/s002270050492; Riis T, 2006, FRESHWATER BIOL, V51, P274, DOI 10.1111/j.1365-2427.2005.01496.x; Sand-Jensen K, 1999, INT REV HYDROBIOL, V84, P497; Short FT, 2006, MAR ECOL-EVOL PERSP, V27, P277, DOI 10.1111/j.1439-0485.2006.00095.x; Short FT, 2014, MAR POLLUT BULL, V83, P408, DOI 10.1016/j.marpolbul.2014.03.036; SILBERHORN GM, 1983, AQUAT BOT, V15, P133, DOI 10.1016/0304-3770(83)90024-4; Silvertown J, 2008, INT J PLANT SCI, V169, P157, DOI 10.1086/523357; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Stafford-Bell RE, 2015, J EXP MAR BIOL ECOL, V464, P52, DOI 10.1016/j.jembe.2014.12.014; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Thomson ACG, 2015, ESTUAR COAST, V38, P927, DOI 10.1007/s12237-014-9850-1; Tiffney BH, 1985, CLONAL GROWTH LAND P; Triest L, 2014, HYDROBIOLOGIA, V737, P145, DOI 10.1007/s10750-013-1583-9; Tuya F, 2013, AQUAT BOT, V105, P1, DOI 10.1016/j.aquabot.2012.10.006; Umetsu CA, 2012, AQUAT ECOL, V46, P443, DOI 10.1007/s10452-012-9413-0; Vigouroux Y, 1998, MOL BIOL, P1251; Virnstein RW, 2009, AQUAT BOT, V90, P89, DOI 10.1016/j.aquabot.2008.05.007; Weatherall EJ, 2016, ESTUAR COAST SHELF S, V169, P207, DOI 10.1016/j.ecss.2015.11.026; Wu KY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156585; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Zhang XW, 2011, LIMNOL OCEANOGR, V56, P233, DOI 10.4319/lo.2011.56.1.0233; Zhou ZH, 2003, MOL ECOL, V12, P1361, DOI 10.1046/j.1365-294X.2003.01816.x	88	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0199275	10.1371/journal.pone.0199275	http://dx.doi.org/10.1371/journal.pone.0199275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114218	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400003
J	Kalozoumi, G; Kel-Margoulis, O; Vafiadaki, E; Greenberg, D; Bernard, H; Soreq, H; Depaulis, A; Sanoudou, D				Kalozoumi, Georgia; Kel-Margoulis, Olga; Vafiadaki, Elizabeth; Greenberg, David; Bernard, Helene; Soreq, Hermona; Depaulis, Antoine; Sanoudou, Despina			Glial responses during epileptogenesis in Mus musculus point to potential therapeutic targets	PLOS ONE			English	Article							GRANULE CELL DISPERSION; TEMPORAL-LOBE EPILEPSY; MOUSE MODEL; NADPH OXIDASE; MICROGLIAL ACTIVATION; KAINIC ACID; HIPPOCAMPAL SCLEROSIS; SUPEROXIDE-PRODUCTION; SPONTANEOUS SEIZURES; RECURRENT SEIZURES	The Mesio-Temporal Lobe Epilepsy syndrome is the most common form of intractable epilepsy. It is characterized by recurrence of focal seizures and is often associated with hippocampal sclerosis and drug resistance. We aimed to characterize the molecular changes occurring during the initial stages of epileptogenesis in search of new therapeutic targets for Mesio-Temporal Lobe Epilepsy. We used a mouse model obtained by intra-hippocampal microinjection of kainate and performed hippocampal whole genome expression analysis at 6h, 12h and 24h post-injection, followed by multilevel bioinformatics analysis. We report significant changes in immune and inflammatory responses, neuronal network reorganization processes and glial functions, predominantly initiated during status epilepticus at 12h and persistent after the end of status epilepticus at 24h post-kainate. Upstream regulator analysis highlighted Cyba, Cybb and Vim as central regulators of multiple overexpressed genes implicated in glial responses at 24h. In silico microRNA analysis indicated that miR-9, miR19b, miR-129, and miR-223 may regulate the expression of glial-associated genes at 24h. Our data support the hypothesis that glial-mediated inflammatory response holds a key role during epileptogenesis, and that microglial cells may participate in the initial process of epileptogenesis through increased ROS production via the NOX complex.	[Kalozoumi, Georgia; Sanoudou, Despina] Univ Athens, Attikon Hosp, Clin Genom & Pharmacogen Unit, Med Sch,Dept Internal Med 4, Athens, Greece; [Kel-Margoulis, Olga] geneXplain GmbH, Wolfenbuttel, Germany; [Vafiadaki, Elizabeth; Sanoudou, Despina] Acad Athens, Biomed Res Fdn, Mol Biol Div, Athens, Greece; [Greenberg, David; Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Bernard, Helene; Depaulis, Antoine] INSERM, Grenoble, France; [Depaulis, Antoine] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Depaulis, Antoine] CHU Grenoble, Hop Michallon, Grenoble, France	National & Kapodistrian University of Athens; University Hospital Attikon; Academy of Athens; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Sanoudou, D (corresponding author), Univ Athens, Attikon Hosp, Clin Genom & Pharmacogen Unit, Med Sch,Dept Internal Med 4, Athens, Greece.; Sanoudou, D (corresponding author), Acad Athens, Biomed Res Fdn, Mol Biol Div, Athens, Greece.	dsanoudou@med.uoa.gr	Vafiadaki, Elizabeth/K-1171-2019; Sanoudou, Despina/AAD-8139-2019; Depaulis, Antoine/B-6098-2012	Sanoudou, Despina/0000-0003-3704-1941; Depaulis, Antoine/0000-0001-6543-6700; Greenberg, David/0000-0001-8959-8640; Soreq, Hermona/0000-0002-0955-526X	INSERM; European Union 6th Framework Program for Research and Technological Development, "Life sciences, genomics and biotechnology for health", VALAPODYN [LSHG-CT-2006-037277]; geneXplain GmbH	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Union 6th Framework Program for Research and Technological Development, "Life sciences, genomics and biotechnology for health", VALAPODYN; geneXplain GmbH	Research funding was provided by INSERM and from the European Union 6th Framework Program for Research and Technological Development, "Life sciences, genomics and biotechnology for health", VALAPODYN, contract #LSHG-CT-2006-037277. This work was also supported by geneXplain GmbH (http://genexplain.com/). The funder provided support in the form of salaries for author OK-M, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham J, 2012, NEUROBIOL DIS, V46, P425, DOI 10.1016/j.nbd.2012.02.006; Akiyama K, 2008, BRAIN RES, V1189, P236, DOI 10.1016/j.brainres.2007.10.102; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Aronica E, 2000, EUR J NEUROSCI, V12, P2333, DOI 10.1046/j.1460-9568.2000.00131.x; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Bar-Klein G, 2016, ANN NEUROL, V80, P896, DOI 10.1002/ana.24804; BENARI Y, 1980, NEUROSCIENCE, V5, P515, DOI 10.1016/0306-4522(80)90049-4; Bitsika V, 2016, J PROTEOME RES, V15, P1546, DOI 10.1021/acs.jproteome.6b00003; Borges K, 2003, NEURONAL GLIAL PATHO, DOI [10.1016/S0014-4886(03)000864, DOI 10.1016/S0014-4886(03)000864]; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Brennan GP, 2018, NEUROSCI LETT, V667, P47, DOI 10.1016/j.neulet.2017.01.017; Caberoy NB, 2012, J NEUROIMMUNOL, V252, P40, DOI 10.1016/j.jneuroim.2012.07.009; Cendes F, 2011, NEUROLOGY, V77, P518, DOI 10.1212/WNL.0b013e318228c16f; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Christensen KV, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-9; Clark PJ, 2011, NEUROSCIENCE, V184, P16, DOI 10.1016/j.neuroscience.2011.03.072; Crespel A, 2002, NEUROSCI LETT, V330, P114, DOI 10.1016/S0304-3940(02)00718-8; de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; Depaulis A, 2015, REV NEUROL-FRANCE, V171, P217, DOI 10.1016/j.neurol.2015.01.558; Di Maio R, 2013, NEUROBIOL DIS, V49, P87, DOI 10.1016/j.nbd.2012.07.013; Di Maio R, 2011, NEUROBIOL DIS, V42, P482, DOI 10.1016/j.nbd.2011.02.012; Dubois B, 2014, ADV RES DIAGNOSTIC C, DOI [10.1016/S1474-4422(14)70090-0, DOI 10.1016/S1474-4422(14)70090-0]; Dugladze T, 2007, P NATL ACAD SCI USA, V104, P17530, DOI 10.1073/pnas.0708301104; Duveau V, 2016, CNS NEUROSCI THER, V22, P497, DOI 10.1111/cns.12523; Eacker SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025068; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Farooqui Akhlaq A, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P85, DOI 10.2174/1568006043481239; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Foresti ML, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-40; Gerstein H, 2012, NEUROBIOL LEARN MEM, V97, P17, DOI 10.1016/j.nlm.2011.08.009; Gnatek Y, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00066; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Guemez-Gamboa A, 2011, J NEUROPATH EXP NEUR, V70, P1020, DOI 10.1097/NEN.0b013e3182358e4e; Guillemain I, 2012, EPILEPTIC DISORD, V14, P217, DOI 10.1684/epd.2012.0528; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha JS, 2010, BRAIN RES, V1359, P291, DOI 10.1016/j.brainres.2010.08.086; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Hernandez-Enriquez B, 2011, J NEUROCHEM, V117, P654, DOI 10.1111/j.1471-4159.2011.07231.x; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jiang SX, 2012, J NEUROCHEM, V122, P764, DOI 10.1111/j.1471-4159.2012.07823.x; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kaushik DK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-57; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kim J., 2013, P 2013 RES ADAPTIVE, P1, DOI [10.1016/j.brainres.2013.01, DOI 10.1016/J.BRAINRES.2013.01]; Koschmann Jeannette, 2015, Microarrays (Basel), V4, P270, DOI 10.3390/microarrays4020270; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Li Q, 2011, J BIOL CHEM, V286, P40151, DOI 10.1074/jbc.M111.279711; Loscher W, 2015, EPILEPSY BEHAV, V52, P78, DOI 10.1016/j.yebeh.2015.08.037; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; MATHERN GW, 1995, J NEUROSURG, V82, P220, DOI 10.3171/jns.1995.82.2.0220; Mathern GW, 1997, MOL CHEM NEUROPATHOL, V30, P53, DOI 10.1007/BF02815150; Mead EL, 2012, J NEUROCHEM, V121, P287, DOI 10.1111/j.1471-4159.2012.07659.x; Meier R, 2007, NEUROIMAGE, V38, P138, DOI 10.1016/j.neuroimage.2007.07.016; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mitchell HM, 2011, COLD PRECONDITIONING, DOI [10.1111/j.1471-4159, DOI 10.1111/J.1471-4159]; Motti D, 2010, EUR J NEUROSCI, V32, P1364, DOI 10.1111/j.1460-9568.2010.07403.x; Nahm WK, 1998, J NEUROSCI, V18, P9245; Nitta N, 2008, EPILEPSIA, V49, P1711, DOI 10.1111/j.1528-1167.2008.01595.x; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Patel M, 2005, J NEUROCHEM, V92, P123, DOI 10.1111/j.1471-4159.2004.02838.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pecorelli A, 2015, BBA-MOL BASIS DIS, V1852, P507, DOI 10.1016/j.bbadis.2014.11.016; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Ramiro-Cortes Y, 2011, INT J BIOCHEM CELL B, V43, P1373, DOI 10.1016/j.biocel.2011.06.001; Raoof R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02969-6; Ravizza T, 2006, NEUROSCIENCE, V137, P301, DOI 10.1016/j.neuroscience.2005.07.063; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Sandhya TL, 1998, BRAIN RES, V788, P223, DOI 10.1016/S0006-8993(97)01552-7; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Sanoudou D, 2010, PHARMACOGENOMICS J, V10, P165, DOI 10.1038/tpj.2009.51; Sanoudou D, 2006, HUM MOL GENET, V15, P2603, DOI 10.1093/hmg/ddl186; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Sharma AK, 2009, TOXICOL PATHOL, V37, P776, DOI 10.1177/0192623309344202; Shinohara Y, 2011, BIOCHEM BIOPH RES CO, V409, P293, DOI 10.1016/j.bbrc.2011.05.004; Sosanya NM, 2015, NEUROBIOL DIS, V73, P96, DOI 10.1016/j.nbd.2014.09.011; Sundaram JR, 2012, J NEUROSCI, V32, P1020, DOI 10.1523/JNEUROSCI.5177-11.2012; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Tsompanidis A, 2016, METABOLISM, V65, P915, DOI 10.1016/j.metabol.2016.03.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulmann L, 2013, GLIA, V61, P1306, DOI 10.1002/glia.22516; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vieira Agdylannah Felix, 2016, RNA SEQUENCING REVEA, P1, DOI [10.1038/srep2241616, 10.1111/j.1750-3639.2008.00254.x, DOI 10.1038/SREP2241616]; Wang N, 2015, NEUROSCIENCE, V287, P144, DOI 10.1016/j.neuroscience.2014.12.021; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; Williams S, 2015, NEUROSCIENCE, V303, P160, DOI 10.1016/j.neuroscience.2015.07.005; Wyatt SK, 2017, EXP NEUROL, V295, P184, DOI 10.1016/j.expneurol.2017.06.009; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1; Zhang YT, 2006, J NEUROSCI, V26, P12174, DOI 10.1523/JNEUROSCI.2289-06.2006	110	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201742	10.1371/journal.pone.0201742	http://dx.doi.org/10.1371/journal.pone.0201742			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114263	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400023
J	Talagrand-Reboul, E; Latif-Eugenin, F; Beaz-Hidalgo, R; Colston, S; Figueras, MJ; Graf, J; Jumas-Bilak, E; Lamy, B				Talagrand-Reboul, Emilie; Latif-Eugenin, Fadua; Beaz-Hidalgo, Roxana; Colston, Sophie; Figueras, Maria-Jose; Graf, Joerg; Jumas-Bilak, Estelle; Lamy, Brigitte			Genome-driven evaluation and redesign of PCR tools for improving the detection of virulence-associated genes in aeromonads	PLOS ONE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI; CYTOTOXIC ENTEROTOXIN; GENUS AEROMONAS; HYDROPHILA; TOXIN; AEROLYSIN; SALMONICIDA; STRAINS; AEXT	Many virulence factors have been described for opportunistic pathogens within the genus Aeromonas. Polymerase Chain Reactions (PCRs) are commonly used in population studies of aeromonads to detect virulence-associated genes in order to better understand the epidemiology and emergence of Aeromonas from the environment to host, but their performances have never been thoroughly evaluated. We aimed to determine diagnostic sensitivity and specificity of PCR assays for the detection of virulence-associated genes in a collection of Aeromonas isolates representative for the genetic diversity in the genus. Thirty-nine Aeromonas strains belonging to 27 recognized species were screened by published PCR assays for virulence-associated genes (act, aerA, aexT, alt, ascFG, ascV, ast, lafA, lip, ser, stx1, stx2A). In parallel, homologues of the 12 putative virulence genes were searched from the genomes of the 39 strains. Of the 12 published PCR assays for virulence factors, the comparison of PCR results and genome analysis estimated diagnostic sensitivities ranging from 34% to 100% and diagnostic specificities ranged from 71% to 100% depending upon the gene. To improve the detection of virulence-associated genes in aeromonads, we have designed new primer pairs for aerA/act, ser, lafA, ascFG and ascV, which showed excellent diagnostic sensitivity and specificity. Altogether, the analysis of high quality genomic data, which are more and more easy to obtain, provides significant improvements in the genetic detection of virulence factors in bacterial strains.	[Talagrand-Reboul, Emilie; Jumas-Bilak, Estelle; Lamy, Brigitte] Univ Montpellier, Equipe Pathogenes Hydr Sante Environm, UMR HSM 5569, Montpellier, France; [Talagrand-Reboul, Emilie] Hop Univ Strasbourg, Lab Bacteriol, Strasbourg, France; [Latif-Eugenin, Fadua; Beaz-Hidalgo, Roxana; Figueras, Maria-Jose] Univ Rovira & Virgili, Fac Med & Ciencias Salud, Dept Ciencias Med Basicas, IISPV,Unidad Microbiol, Reus, Spain; [Colston, Sophie; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Jumas-Bilak, Estelle] CHRU Montpellier, Dept Hyg Hosp, Montpellier, France; [Lamy, Brigitte] CHU Nice, Dept Bacteriol, Nice, France	Universite de Montpellier; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Connecticut; Universite de Montpellier; CHU de Montpellier; CHU Nice	Talagrand-Reboul, E; Lamy, B (corresponding author), Univ Montpellier, Equipe Pathogenes Hydr Sante Environm, UMR HSM 5569, Montpellier, France.; Talagrand-Reboul, E (corresponding author), Hop Univ Strasbourg, Lab Bacteriol, Strasbourg, France.; Lamy, B (corresponding author), CHU Nice, Dept Bacteriol, Nice, France.	emilie.talagrand@wanadoo.fr; brigitte_lamy@yahoo.fr	Graf, Joerg/ABI-2447-2020; Lamy, Brigitte/A-8401-2015; Talagrand-Reboul, Emilie/B-6352-2019	Graf, Joerg/0000-0001-5320-2712; Lamy, Brigitte/0000-0003-2370-8186; Talagrand-Reboul, Emilie/0000-0001-9767-0753	Association des Biologistes de l'Ouest (ABO); Association pour la recherche et le developpement en microbiologie et pharmacie (ADEREMPHA); USDA [58-1930-4-002]; ARS [58-1930-4-002]	Association des Biologistes de l'Ouest (ABO); Association pour la recherche et le developpement en microbiologie et pharmacie (ADEREMPHA); USDA(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Association des Biologistes de l'Ouest (ABO) and the Association pour la recherche et le developpement en microbiologie et pharmacie (ADEREMPHA) to ETR. Part of this research was supported by USDA and ARS agreement 58-1930-4-002 to JG.	Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Aguilera-Arreola MG, 2005, FEMS MICROBIOL LETT, V242, P231, DOI 10.1016/j.femsle.2004.11.011; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; Alperi A, 2010, CLIN MICROBIOL INFEC, V16, P1563, DOI 10.1111/j.1469-0691.2010.03203.x; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Balsalobre LC, 2009, J WATER HEALTH, V7, P685, DOI 10.2166/wh.2009.082; BERNHEIMER AW, 1974, INFECT IMMUN, V9, P1016, DOI 10.1128/IAI.9.6.1016-1021.1974; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Braun M, 2002, J BACTERIOL, V184, P1851, DOI 10.1128/JB.184.7.1851-1858.2002; Buckley JT, 1999, INFECT IMMUN, V67, P466; Bucker R, 2011, J INFECT DIS, V204, P1283, DOI 10.1093/infdis/jir504; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Chacon MR, 2004, J CLIN MICROBIOL, V42, P1285, DOI 10.1128/JCM.42.3.1285-1287.2004; Chacon MR, 2003, ANTON LEEUW INT J G, V84, P269, DOI 10.1023/A:1026042125243; CHAKRABORTY T, 1986, J BACTERIOL, V167, P368, DOI 10.1128/jb.167.1.368-374.1986; Chen PL, 2014, CLIN MICROBIOL INFEC, V20, pO428, DOI 10.1111/1469-0691.12456; Chen PL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00793; Chopra AK, 1996, MICROB PATHOGENESIS, V21, P357, DOI 10.1006/mpat.1996.0068; Colston SM, 2014, MBIO, V5, DOI 10.1128/mBio.02136-14; Ferguson MR, 1997, INFECT IMMUN, V65, P4299, DOI 10.1128/IAI.65.10.4299-4308.1997; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hossain MJ, 2014, MBIO, V5, DOI 10.1128/mBio.00848-14; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; Figueras MJ, 2015, AEROMONAS, P65; Joseph SW, 2000, ASM NEWS, V66, P218; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Kilcullen K, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2076.00069, 10.3389/fmicb.2016.00069]; Lamy B, 2004, J MICROBIOL METH, V56, P137, DOI 10.1016/j.mimet.2003.10.001; Li FJ, 2015, J INFECTION, V70, P600, DOI 10.1016/j.jinf.2014.11.004; Lund V, 2004, DIS AQUAT ORGAN, V61, P257, DOI 10.3354/dao061257; Martins LM, 2002, FEMS IMMUNOL MED MIC, V32, P237, DOI 10.1111/j.1574-695X.2002.tb00559.x; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; Merino S, 2003, APPL ENVIRON MICROB, V69, P663, DOI 10.1128/AEM.69.1.663-667.2003; Mosser T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01218; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Nawaz M, 2010, FOOD MICROBIOL, V27, P327, DOI 10.1016/j.fm.2009.11.007; Nyenje ME, 2012, INT J ENV RES PUB HE, V9, P2608, DOI 10.3390/ijerph9082608; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Roger F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-62; Roger F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046268; ROSE JM, 1989, INFECT IMMUN, V57, P1165, DOI 10.1128/IAI.57.4.1165-1169.1989; Senderovich Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030070; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; Soler L, 2002, FEMS IMMUNOL MED MIC, V32, P243, DOI 10.1016/S0928-8244(01)00303-0; Spataro N, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00382-13; Talagrand-Reboul E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00621; Tomas J M, 2012, ISRN Microbiol, V2012, P256261, DOI 10.5402/2012/256261; Wang G, 1996, J CLIN MICROBIOL, V34, P3203, DOI 10.1128/JCM.34.12.3203-3205.1996; Wang GH, 2002, J CLIN MICROBIOL, V40, P3613, DOI 10.1128/JCM.40.10.3613-3619.2002; WILMSEN HU, 1990, J MEMBRANE BIOL, V115, P71, DOI 10.1007/BF01869107	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201428	10.1371/journal.pone.0201428	http://dx.doi.org/10.1371/journal.pone.0201428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110345	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000027
J	Won, HJ; Ji, HJ; Song, JK; Kim, YD; Won, HS				Won, Hyung-Jin; Ji, Hyun-Ju; Song, Jae Kyeong; Kim, Yeon-Dong; Won, Hyung-Sun			Topographical study of the trapezius muscle, greater occipital nerve, and occipital artery for facilitating blockade of the greater occipital nerve	PLOS ONE			English	Article							LANDMARKS; IDENTIFICATION; HEADACHE	The aim of this study was to clarify the topographical relationships between the greater occipital nerve and the trapezius muscle and between the greater occipital nerve and the occipital artery in the occiput in order to increase the success rate of greater occipital nerve blockade. Fifty-six halved heads of 28 cadavers were used in this study. The piercing points and the courses of the greater occipital nerve and occipital artery were analyzed by dividing a line connecting between the external occipital protuberance and mastoid process into three equal parts. A circle with a radius of 2 cm drawn at the medial trisection point of this line was divided into four equal sectors. The greater occipital nerve simply passed the lateral border of the trapezius muscle and then pierced the fascia connecting the cranial attachment of the trapezius muscle with the sternocleidomastoid muscle in 62.5% of the specimens, whereas it pierced the muscle itself in the other 37.5%. The greater occipital nerve and occipital artery pierced the fascia within the 2-cm-radius circle in 85.7% and 98.2% of the specimens, respectively. The piercing points of the greater occipital nerve and occipital artery were observed most frequently in the inferomedial (42.9%) and inferolateral (37.5%) sectors of the circle, respectively. The greater occipital nerve and occipital artery pierced the same sector of the circle and accompanied each other in 51.8% of the specimens. These results are expected to improve the understanding of the topographical relationships between the greater occipital nerve and trapezius muscle and between the greater occipital nerve and occipital artery in the occiput, and thus provide helpful information for the management of occipital neuralgia.	[Won, Hyung-Jin] Kangwon Natl Univ, Sch Med, Dept Anat, Chunchon, South Korea; [Won, Hyung-Jin] Eulji Univ, Dept Mortuary Sci, Seongnam, South Korea; [Ji, Hyun-Ju] Yonsei Univ, Coll Med, Surg Anat Educ Ctr, Seoul, South Korea; [Song, Jae Kyeong; Kim, Yeon-Dong] Wonkwang Univ, Coll Med, Wonkwang Inst Sci, Dept Anesthesiol & Pain Med, Iksan, South Korea; [Won, Hyung-Sun] Wonkwang Univ, Coll Med, Dept Anat, Iksan, South Korea	Kangwon National University; Eulji University; Yonsei University; Yonsei University Health System; Wonkwang University; Wonkwang University	Kim, YD (corresponding author), Wonkwang Univ, Coll Med, Wonkwang Inst Sci, Dept Anesthesiol & Pain Med, Iksan, South Korea.; Won, HS (corresponding author), Wonkwang Univ, Coll Med, Dept Anat, Iksan, South Korea.	kydpain@hanmail.net; hswon01@wku.ac.kr	Won, Hyung-Sun/AAE-8397-2020; 김, 연동/HII-9114-2022	김, 연동/0000-0003-0404-2657; Won, Hyung-Sun/0000-0001-6084-6698	Wonkwang University	Wonkwang University	This work was supported by Wonkwang University in 2017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix NE, 1999, J MANIP PHYSIOL THER, V22, P534, DOI [10.1016/S0161-4754(99)70006-0, DOI 10.1016/S0161-4754(99)70006-0]; ANTHONY M, 1992, CLIN NEUROL NEUROSUR, V94, P297, DOI 10.1016/0303-8467(92)90177-5; Arai T, 2013, J ANESTH, V27, P801, DOI 10.1007/s00540-013-1587-7; Ashkenazi A, 2004, POSTGRAD MED, V116, P16, DOI 10.3810/pgm.2004.09.1579; Benzon H, 2018, ESSENTIALS PAIN MED, P769; Berry MM, 1995, GRAYS ANATOMY, V38th, P1322; Biondi D M, 2001, Curr Pain Headache Rep, V5, P361, DOI 10.1007/s11916-001-0026-x; Bogduk N, 1981, Clin Exp Neurol, V17, P167; BOVIM G, 1991, SPINE, V16, P475, DOI 10.1097/00007632-199104000-00017; BOVIM G, 1992, HEADACHE, V32, P175, DOI 10.1111/j.1526-4610.1992.hed3204175.x; Buckley P, 2000, MANAGEMENT PAIN, P1893; Fernandez-De-Las-Penas C, 2006, HEADACHE, V46, P1264, DOI 10.1111/j.1526-4610.2006.00440.x; HUNTER CR, 1949, AM J SURG, V78, P743, DOI 10.1016/0002-9610(49)90316-5; Kim ED, 2013, KOREAN J PAIN, V26, P186, DOI 10.3344/kjp.2013.26.2.186; Kuhn Walter F., 1997, Journal of Orofacial Pain, V11, P158; Loukas M., 2006, Folia Morphologica, V65, P337; Murphy TM, 1998, NEURAL BLOCKADE CLIN, P489; Naja Zoher M, 2006, Pain Pract, V6, P89; Natsis K, 2006, CLIN ANAT, V19, P332, DOI 10.1002/ca.20190; STECHISON MT, 1994, ACTA NEUROCHIR, V131, P236, DOI 10.1007/BF01808620; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Trescot AM, 2016, PERIPHERAL NERVE ENT; Tubbs RS, 2007, CLIN ANAT, V20, P235, DOI 10.1002/ca.20297; Tubbs R Shane, 2014, Surg Neurol Int, V5, P155, DOI 10.4103/2152-7806.143743; VITAL JM, 1989, SURG RADIOL ANAT, V11, P205, DOI 10.1007/BF02337823; Weiner RL, 1999, NEUROMODULATION, V2, P217, DOI 10.1046/j.1525-1403.1999.00217.x; Zipfel J, 2016, PAIN PHYSICIAN, V19, pE1027	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202448	10.1371/journal.pone.0202448	http://dx.doi.org/10.1371/journal.pone.0202448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110386	gold, Green Published, Green Submitted			2022-12-26	WOS:000441738000068
J	Kawasaki, T; Mikami, K; Kamo, T; Aoki, R; Ishiguro, R; Nakamura, H; Tozawa, R; Asada, N; Hiiragi, Y; Yamada, Y; Hirano, M; Katsuki, K				Kawasaki, Tsubasa; Mikami, Kyohei; Kamo, Tsutomu; Aoki, Ryoma; Ishiguro, Rumiko; Nakamura, Hiroshi; Tozawa, Ryosuke; Asada, Nao; Hiiragi, Yukinobu; Yamada, Yoichi; Hirano, Masahiro; Katsuki, Kazuko			Motor planning error in Parkinson's disease and its clinical correlates	PLOS ONE			English	Article							EXECUTIVE DYSFUNCTION; NEURAL CIRCUITRY; IMPAIRMENT; SCALE	This study aimed to investigate (a) motor planning difficulty by using a two-step test in Parkinson's disease (PD) compared with age-matched healthy subjects and (b) the relationship between motor planning difficulty and clinical factors. The two-step test was performed by 58 patients with PD with Hoehn & Yahr (H&Y) stage I-IV and 110 age-matched healthy older adult controls. In the two-step test, the participants estimated the two-step distance with maximum effort. Subsequently, they performed the actual two-step trial to measure the actual maximum distance. We calculated the accuracy of the estimation (estimated distance minus actual distance). In both groups, subjects who estimated >5 cm were defined as the overestimation group, and those who estimated <5 cm over- and underestimation were defined as the non-overestimation group. The overestimation group consisted of 17 healthy older adults (15.5%) and 23 patients with PD (39.7%). The number of patients with PD with overestimation was significantly more than that of healthy controls by Chi-squared test. H&Y stage and the Unified Parkinson's Disease Rating Scale (UPDRS) part II and III scores in overestimation group in PD patients were significantly higher than those in overestimation group in PD patients. Moreover, multiple regression using H&Y stage and UPDRS parts II and III as independent variables showed that the UPDRS part II score was the only related factor for the estimation error distance. Estimation error distance was significant correlated with UPDRS parts II and III. Patients with PD easily have higher rates of motor-related overestimation than age-matched healthy controls. In addition, UPDRS parts II and III expressed ability of activities of daily living and motor function as influences on motor-related overestimation. Particularly, multiple regression indicated that UPDRS part II directly showed the ability of daily living as an essential factor for overestimation.	[Kawasaki, Tsubasa; Mikami, Kyohei; Kamo, Tsutomu; Aoki, Ryoma; Ishiguro, Rumiko; Nakamura, Hiroshi; Tozawa, Ryosuke; Asada, Nao; Hiiragi, Yukinobu; Yamada, Yoichi; Hirano, Masahiro; Katsuki, Kazuko] Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan; [Mikami, Kyohei; Kamo, Tsutomu; Aoki, Ryoma; Ishiguro, Rumiko] Noborito Neurol Clin, Tama Ku, 434 Nobotitoshinmachi, Kawasaki, Kanagawa, Japan; [Nakamura, Hiroshi; Tozawa, Ryosuke; Asada, Nao; Hiiragi, Yukinobu; Yamada, Yoichi; Hirano, Masahiro; Katsuki, Kazuko] Ryotokuji Univ, Fac Hlth Sci, Dept Phys Therapy, 5-8-1 Akemi, Urayasu, Chiba, Japan		Kawasaki, T (corresponding author), Tokyo Int Univ, Inst Sports Med & Sci, Kawagoe, Saitama, Japan.	kawasaki.283@gmail.com	Tazawa, Ryosuke/HHD-3002-2022	Tazawa, Ryosuke/0000-0002-5791-3367; Kawasaki, Tsubasa/0000-0002-0832-0290				Bartels AL, 2009, CORTEX, V45, P915, DOI 10.1016/j.cortex.2008.11.010; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Cohen RG, 2011, NEUROPSYCHOLOGIA, V49, P3981, DOI 10.1016/j.neuropsychologia.2011.10.014; Dancey CP, 2011, CORRELATIONAL ANAL P; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; GOLDENBERG G, 1986, J NEUROL NEUROSUR PS, V49, P1266, DOI 10.1136/jnnp.49.11.1266; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kamata N, 2007, CLIN REHABIL, V21, P357, DOI 10.1177/0269215507073346; Kamei S, 2008, MOVEMENT DISORD, V23, P566, DOI 10.1002/mds.21890; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Ogata T, 2015, J ORTHOP SCI, V20, P888, DOI 10.1007/s00776-015-0737-1; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Ray NJ, 2012, MOVEMENT DISORD, V27, P1484, DOI 10.1002/mds.25173; Robinovitch SN, 1999, J GERONTOL A-BIOL, V54, pB124, DOI 10.1093/gerona/54.3.B124; Sakurai R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-44	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202228	10.1371/journal.pone.0202228	http://dx.doi.org/10.1371/journal.pone.0202228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ2CL	30102731	gold, Green Published, Green Submitted			2022-12-26	WOS:000441452200039
J	Hudak, J; Rosenbaum, D; Barth, B; Fallgatter, AJ; Ehlis, AC				Hudak, Justin; Rosenbaum, David; Barth, Beatrix; Fallgatter, Andreas J.; Ehlis, Ann-Christine			Functionally disconnected: A look at how study design influences neurofeedback data and mechanisms in attention-deficit/hyperactivity disorder	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; DEFAULT-MODE; COGNITIVE CONTROL; CONNECTIVITY MRI; ADHD; NETWORKS; METHYLPHENIDATE; HYPERACTIVITY; METAANALYSIS; PREVALENCE	Neurofeedback (NF) is a form of behavioral therapy used to treat e.g. attention-deficit/hyperactivity disorder (ADHD). Briefly, subjects are fed-back a putatively dysfunctional parameter of their brain activity in real time and must learn to control it in a suggested direction. NF protocols for ADHD have been used in practice for decades, though no clear standards on NF design have been implemented. Furthermore, studies often present only data from the general outcome of the NF treatment and do not look at how exactly the NF paradigm affects brain functionality, or what exactly the NF is training. The current study is two-fold: firstly, we look at how the functional connectivity (FC) patterns within key networks associated with ADHD differ between rests, feedback trials, success and failure in a complete functional near-infrared spectroscopy-based NF experiment on adults with ADHD. Secondly, due to methodological concerns discovered during the analysis of our data, we address important considerations in the design of NF that are often ignored in protocols being used widely in therapy and research today. In particular, we examine the common average reference and its impact on network activity as well as the importance of balancing the randomization in a design. Finally, we discuss how these methodological considerations may have influenced our FC results.	[Hudak, Justin; Fallgatter, Andreas J.; Ehlis, Ann-Christine] Univ Tubingen, LEAD Grad Sch & Res Network, Tubingen, Germany; [Hudak, Justin; Rosenbaum, David; Barth, Beatrix; Fallgatter, Andreas J.; Ehlis, Ann-Christine] Univ Hosp Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Barth, Beatrix] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Fallgatter, Andreas J.] Univ Tubingen, Grad Sch Neural & Behav Sci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hudak, J (corresponding author), Univ Tubingen, LEAD Grad Sch & Res Network, Tubingen, Germany.; Hudak, J (corresponding author), Univ Hosp Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	justin.hudak@med.uni-tuebingen.de	Barth, Beatrix/AAE-8088-2020	Barth, Beatrix/0000-0002-3792-3357; Ehlis, Ann-Christine/0000-0002-8142-9743	German Research Foundation (Deutsche Forschungsgemeinschaft [DFG]) [FA 361/21-1, STR 597/7-1]; IZKF Tubingen [2115-0-0]; LEAD Graduate School & Research Network, a project of the Excellence Initiative of the German federal and state governments [GSC1028]; Open Access Publishing Fund of the University of Tubingen; STORZ MEDICAL AG	German Research Foundation (Deutsche Forschungsgemeinschaft [DFG])(German Research Foundation (DFG)); IZKF Tubingen; LEAD Graduate School & Research Network, a project of the Excellence Initiative of the German federal and state governments; Open Access Publishing Fund of the University of Tubingen; STORZ MEDICAL AG	The multicenter study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG] project numbers FA 361/21-1 and STR 597/7-1). Ann-Christine Ehlis was partly supported by IZKF Tubingen (Junior Research Group, grant 2115-0-0). Justin Hudak was funded by the LEAD Graduate School & Research Network (GSC1028), a project of the Excellence Initiative of the German federal and state governments. We acknowledge the support of the Open Access Publishing Fund of the University of Tubingen.; We would like to thank all participants for their patience in taking part in such an extensive study. Additionally, we extend our gratitude to Ramona Taglich, Betti Schopp, Nina Gehrer, Lisa K. Schreiber, Stefanie Kettner and Sophie Grumbach for their help and invaluable contribution with the measurements. This research was funded by the LEAD Graduate School & Research Network [GSC1028], a project of the Excellence Initiative of the German federal and state governments. Justin Hudak is a doctoral candidate at the LEAD Graduate School & Research Network. The multicenter study, which provided the data of the NIRS feedback group, was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG] project numbers FA361/21-1 and STR 597/7-1). David Rosenbaum was partly supported by STORZ MEDICAL AG. Ann-Christine Ehlis was partly supported by IZKF Tubingen (Junior Research Group, grant 2115-0-0).	Abarbanel A., 1995, J NEUROTHERAPY, V1, P15, DOI DOI 10.1300/J184V01N02_02; Alegria AA, 2017, HUM BRAIN MAPP, V38, P3190, DOI 10.1002/hbm.23584; Aranyi Gabor, 2015, Symbiotic Interaction. 4th International Workshop, Symbiotic 2015. Proceedings: LNCS 9359, P7, DOI 10.1007/978-3-319-24917-9_2; Arns M, 2014, BIOL PSYCHOL, V95, P108, DOI 10.1016/j.biopsycho.2013.11.013; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Barth B, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00633; Blume F, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1769-3; Bluschke A, 2016, PSYCHOL MED, V46, P1277, DOI 10.1017/S0033291715002822; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Cortese S, 2016, J AM ACAD CHILD PSY, V55, P444, DOI 10.1016/j.jaac.2016.03.007; Dodds CM, 2008, J NEUROSCI, V28, P5976, DOI 10.1523/JNEUROSCI.1153-08.2008; Egner T, 2004, J NEUROTHER, V8, P37, DOI [10.1300/J184v08n01, DOI 10.1300/J184V08N01]; Ehlis AC, 2014, NEUROIMAGE, V85, P478, DOI 10.1016/j.neuroimage.2013.03.067; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Godwin CA, 2017, NEUROPSYCHOLOGIA, V103, P140, DOI 10.1016/j.neuropsychologia.2017.07.006; Grady CL, 2017, MULTIVARIATE ANAL AG, DOI [10.1093/cercor/bhp207, DOI 10.1093/CERCOR/BHP207]; Gruzelier JH, 2014, NEUROSCI BIOBEHAV R, V44, P124, DOI 10.1016/j.neubiorev.2013.09.015; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Heinzel S, 2013, NEUROBIOL AGING, V34, P439, DOI 10.1016/j.neurobiolaging.2012.05.021; Hernandez LD, 2018, NEUROSCIENCE, V378, P146, DOI 10.1016/j.neuroscience.2016.12.005; Holtmann M, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-202; Hudak J, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00425; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Jausovec N, 2010, NEUROPSYCHOLOGIA, V48, P3918, DOI 10.1016/j.neuropsychologia.2010.09.020; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Lofthouse N, 2012, J ATTEN DISORD, V16, P351, DOI 10.1177/1087054711427530; Marx AM, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01038; Mayer K, 2016, PSYCHIAT ANN, V46, P594, DOI 10.3928/00485713-20160906-01; Mayer K, 2016, CLIN NEUROPHYSIOL, V127, P1374, DOI 10.1016/j.clinph.2015.11.013; Mayer K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0683-4; Mehta RK, 2013, NEUROERGONOMICS REV, V7, P1, DOI [10.3389/fnhum.2013.00889, DOI 10.3389/FNHUM.2013.00889]; Nunez P. L., 2006, ELECT FIELDS BRAIN N, DOI DOI 10.1093/ACPROF:OSO/9780195050387.001.0001; Plichta MM, 2007, NEUROIMAGE, V35, P625, DOI 10.1016/j.neuroimage.2006.11.028; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Posner J, 2014, NEUROPSYCHOL REV, V24, P3, DOI 10.1007/s11065-014-9251-z; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Radua J, 2018, NEUROSCIENCE, V378, P11, DOI 10.1016/j.neuroscience.2016.04.003; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao SM, 2000, AM J PSYCHIAT, V157, P1697, DOI 10.1176/appi.ajp.157.10.1697; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rosler M., 2008, HOMBURGER ADHS SKALE; Schonenberg M, 2017, LANCET PSYCHIAT, V4, P673, DOI 10.1016/S2215-0366(17)30291-2; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Soekadar S, 2011, ERD BASED ONLINE BRA; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strehl U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00894; Thibault RT, 2017, BRAIN, V140, P862, DOI 10.1093/brain/awx033; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	56	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0200931	10.1371/journal.pone.0200931	http://dx.doi.org/10.1371/journal.pone.0200931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ0KU	30096196	Green Submitted, gold, Green Published			2022-12-26	WOS:000441308500009
J	Joshi, B; Lestari, T; Graham, SM; Baral, SC; Verma, SC; Ghimire, G; Bhatta, B; Dumre, SP; Utarini, A				Joshi, Basant; Lestari, Trisasi; Graham, Stephen Michael; Baral, Sushil Chandra; Verma, Sharat Chandra; Ghimire, Gokarna; Bhatta, Bandana; Dumre, Shyam Prakash; Utarini, Adi			The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis	PLOS ONE			English	Article							CHALLENGES; PROGRAMS; IMPACT	Background Tuberculosis (TB) is a major public health problem in low and middle-income countries. Early detection and enrolment of TB cases is a challenge for National TB Programs. Objective To understand the performance and feasibility for scale-up of Xpert MTB/RIF assay for the TB diagnosis in Nepal. Design Implementation research employed mixed-method sequential explanatory design. The results of Xpert MTB/RIF assay were analysed in 26 TB diagnostic centres where Xpert machines had been installed before 2015. In-depth interviews and focus group discussions were conducted with stakeholders, purposively selected to represent experiences in centres that were functioning well, poorly or not functioning. Results During a one-year period in 2015/16, 23,075 Xpert MTB/RIF assays were performed in 21 diagnostic centres with 22,288 people also tested by sputum microscopy. Among these, 77% had concordant (positive or negative) results, demonstrating fair agreement (Kappa score, 0.3) between test results. Test failure and positivity rates in diagnostic centres ranged from 2.6% to 13.4% and 6.5% to 49%, respectively. The number of cartridges per positive result varied from 2.3 to 10.2. Xpert assay was positive in 3314 (15% of all cases) sputum smear microscopy negative cases. Of 4280 bacteriologicaliy confirmed cases by Xpert assay, 355 (8%) were rifampicin resistant. Xpert machines were no longer functioning regularly throughout the year in 5 diagnostic centres. The main barriers for effective implementation of Xpert in Nepal were the lack of: timely supply of cartridges; replacement of damaged modules; maintenance of Xpert machines; and stock verification for timely procurement of cartridges. Inadequate laboratory infrastructure for maintaining functional Xpert equipment further challenges implementation and scale-up. Conclusion The implementation of Xpert MTB/RIF assay has increased case-finding of TB and MDR-TB in Nepal. However, there is a need to improve laboratory performance and strengthen laboratory infrastructure for optimal utilisation and scale-up of Xpert.	[Joshi, Basant] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Grad Program Implementat Res, Publ Hlth, Yogyakarta, Indonesia; [Lestari, Trisasi; Utarini, Adi] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Hlth Policy & Management, Yogyakarta, Indonesia; [Graham, Stephen Michael] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Graham, Stephen Michael] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Graham, Stephen Michael] Int Union TB & Lung Dis, Paris, France; [Baral, Sushil Chandra] Hlth Res & Social Dev Forum HERD, Kathmandu, Nepal; [Verma, Sharat Chandra; Ghimire, Gokarna] Minist Hlth, Natl TB Ctr, Bhaktapur, Nepal; [Bhatta, Bandana] Save Children Int, Dhangadhi, Nepal; [Dumre, Shyam Prakash] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan	Gadjah Mada University; Gadjah Mada University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Save the Children; Nagasaki University	Joshi, B (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Grad Program Implementat Res, Publ Hlth, Yogyakarta, Indonesia.; Utarini, A (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Hlth Policy & Management, Yogyakarta, Indonesia.	basantjoshi26@gmail.com; adiutarini@gmail.com	Utarini, Adi/GQI-1980-2022; Dumre, Shyam Prakash/AAG-7863-2019; Joshi, Basant/AAO-2687-2020	Graham, Stephen/0000-0003-3525-2294; Lestari, Trisasi/0000-0002-4799-5338; Dumre, Shyam Prakash/0000-0002-4072-0745	Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR); Universitas Gadjah Mada, Indonesia; WHO/TDR, Universitas Gadjah Mada, Indonesia; Nepal NTP, District Health/Public Health Office	Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR); Universitas Gadjah Mada, Indonesia; WHO/TDR, Universitas Gadjah Mada, Indonesia; Nepal NTP, District Health/Public Health Office	This research was a part of postgraduate thesis. The scholarship for this degree was funded by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR) and Universitas Gadjah Mada, Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to WHO/TDR, Universitas Gadjah Mada, Indonesia for providing scholarship for Postgraduate study in implementation research on tropical diseases. We would also like to thank Nepal NTP, District Health/Public Health Office for providing support during the research. We are also thankful to all the participants for their active participation in this research.	Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; [Anonymous], 2016, ANN REP; Ardizzoni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144656; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Central Bureau of Statistics, 2014, POPULATION MONOGRAPH; Clouse K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171384; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Gagnon RJ., 2015, FACTORS IMPACTING PR; Hales S, 2016, B WORLD HEALTH ORGAN, V94, P58, DOI 10.2471/BLT.15.167585; Ho J, 2016, INT J MYCOBACT, V5, P374, DOI 10.1016/j.ijmyco.2016.09.023; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Joshi B, 2015, PUBLIC HEALTH ACTION, V5, P93, DOI 10.5588/pha.15.0004; Khanal S, 2016, PUBLIC HLTH ACTION, V6; Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Pinnock H, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013318; Praveen JV, 2014, J EVOL MED DENT SCI-, V3, P8756, DOI 10.14260/jemds/2014/3118; Raizada N., 2014, PLOS ONE, V9; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Rendell NL, 2017, PEERJ, V5, DOI 10.7717/peerj.3567; Sandhu GK, 2011, J GLOB INFECT DIS, V3, P143, DOI 10.4103/0974-777X.81691; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; WHO, 2017, GLOB TUB REP 2017; World Health Organization. Regional Office for South-East Asia, 2016, TUBERCULOSIS CONTROL; Wynne A., 2014, INT J AFRICA NURS SC, V1, P6, DOI [10.1016/j.ijans.2014.05.001, DOI 10.1016/J.IJANS.2014.05.001]; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	28	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201731	10.1371/journal.pone.0201731	http://dx.doi.org/10.1371/journal.pone.0201731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096174	Green Published, gold			2022-12-26	WOS:000441308500025
J	Takamura, Y; Aoki, W; Satomura, A; Shibasaki, S; Ueda, M				Takamura, Yosuke; Aoki, Wataru; Satomura, Atsushi; Shibasaki, Seiji; Ueda, Mitsuyoshi			Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-alpha stimulation	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; EXTRACELLULAR VESICLES; OSTEOCLAST DIFFERENTIATION; ALTERED EXPRESSION; KAPPA-B; MICRORNAS; ARTHRITIS; BIOLOGY; INFLAMMATION; GENERATION	Rheumatoid arthritis (RA) is an autoimmune disease that causes the chronic inflammation of the joints. Intercellular communication containing synovial fibroblasts seems to play a major role in RA pathogenesis. In this study, to better understand intercellular communication related to RA pathogenesis, we identified exosomal microRNAs (miRNAs) derived from synovial fibroblasts. Exosomes were collected from an RA synovial fibroblast (RASF) cell line, namely, MH7A, with or without stimulation by tumor necrosis factor alpha (TNF-alpha). We used small RNA sequencing to analyze the profile of small RNAs, including miRNAs, in MH7A exosomes and cells. By using differential expression analysis, we identified four miRNAs (miR-155-5p, miR-146a-5p, miR-323a-5p, and miR-1307-3p) that are upregulated in exosomes with TNF-alpha stimulation. The identification of miR-155-5p and miR-146a-5p which have been reported in RA patients demonstrated the validity of our experimental model. Other two miRNAs were newly identified. miR-323a-5p was predicted to target the protein encoding gene CD6, which attenuates T-cell activation signals, and miR-1307-3p was predicted to target the protein encoding gene N-myc downstream-regulated gene 2 (NDRG2), which inhibits osteoclast-related gene expression. The results suggested that these miRNAs might be involved in RA pathogenesis. We hope our results will help us understand the role of RASF exosomes in RA pathogenesis.	[Takamura, Yosuke; Aoki, Wataru; Satomura, Atsushi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Japan; [Shibasaki, Seiji] Hyogo Univ Hlth Sci, Gen Educ Ctr, Kobe, Hyogo, Japan	Kyoto University	Ueda, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp		Aoki, Wataru/0000-0002-3118-9390	JST CREST [JPMJCR16G2]	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by JST CREST (Grant No. JPMJCR16G2, http://www.jst.go.jp/kisoken/crest/en/index.html) (MU). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baglio SR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0116-z; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cambier L, 2017, EMBO MOL MED, V9, P337, DOI 10.15252/emmm.201606924; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Davis JM, 2012, MAYO CLIN PROC, V87, P659, DOI 10.1016/j.mayocp.2012.03.011; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; GANGEMI RMR, 1989, J IMMUNOL, V143, P2439; Goldie BJ, 2014, NUCLEIC ACIDS RES, V42, P9195, DOI 10.1093/nar/gku594; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Haderk F, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5509; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; Hill AF, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22859; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kang K, 2015, BIOCHEM BIOPH RES CO, V468, P611, DOI 10.1016/j.bbrc.2015.10.167; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JC, 2014, DRUG DES DEV THER, V8, P315, DOI 10.2147/DDDT.S52354; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Long L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/296139; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Makarova JA, 2016, PROG HISTOCHEM CYTO, V51, P33, DOI 10.1016/j.proghi.2016.06.001; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Miyazawa K, 1998, J BIOCHEM-TOKYO, V124, P1153, DOI 10.1093/oxfordjournals.jbchem.a022233; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; OSORIO LM, 1994, CELL IMMUNOL, V154, P123, DOI 10.1006/cimm.1994.1062; PAN BT, 1984, J BIOL CHEM, V259, P9776; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Patil VS, 2014, CRIT REV BIOCHEM MOL, V49, P16, DOI 10.3109/10409238.2013.844092; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Pinto M, 2013, BIODRUGS, V27, P191, DOI 10.1007/s40259-013-0027-4; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salehi E, 2015, CLIN RHEUMATOL, V34, P615, DOI 10.1007/s10067-015-2898-x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shibasaki S, 2016, FEBS OPEN BIO, V6, P418, DOI 10.1002/2211-5463.12049; Shigeyama Y, 2000, ARTHRITIS RHEUM, V43, P2523, DOI 10.1002/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tavasolian F, 2018, J CELL BIOCHEM, V119, P478, DOI 10.1002/jcb.26205; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Turner JD, 2015, CURR OPIN RHEUMATOL, V27, P175, DOI 10.1097/BOR.0000000000000148; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Withrow J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1178-8; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20424; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang HG, 2006, J IMMUNOL, V176, P7385, DOI 10.4049/jimmunol.176.12.7385; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	78	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201851	10.1371/journal.pone.0201851	http://dx.doi.org/10.1371/journal.pone.0201851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096164	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500030
J	Chen, Q; Sun, YM; Sun, WD; Hao, MQ; Li, GY; Su, XL; Xin, RL; Lu, HY				Chen, Qiang; Sun, Yanming; Sun, Weidong; Hao, Mingqiang; Li, Guiying; Su, Xueli; Xin, Ruolei; Lu, Hongyan			Trends of HIV incidence and prevalence among men who have sex with men in Beijing, China: Nine consecutive cross-sectional surveys, 2008-2016	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; SURVEILLANCE; INFECTIONS; TRANSMISSION; MIGRATION; EPIDEMIC; MOBILITY; CITIES	Background Sexual transmission of HIV among men who have sex with men (MSM) increased markedly in China during the past decade. HIV incidence is a critical indicator in HIV surveillance and we use a HIV-1 BED-capture-enzyme immunoassay (BED-CEIA) to examine the incidence among MSM in Beijing from 2008 to 2016. Risk factors related to recent HIV infection were also assessed. Methods Consecutive cross-sectional surveys on MSM were conducted yearly from 2008 through 2016. Demographic and behaviors data were collected. HIV status was determined and HIV positive specimens were tested for recent infection using BED-CEIA. Specimens with ODn values <= 0.8 were considered recently infected, HIV incidence rates and prevalence were then calculated. Risk factors associated with recent HIV infection were assessed by univariate and multivariable logistic regression. Results From 2008 to 2016, the numbers of eligible participants in the nine consecutive years ranged from 472 to 616. All the 261 eligible HIV-positive specimens were subjected to recent HIV infection testing. HIV prevalence ranged from 5.0% (3.3%-6.8%) to 10.2% (7.8%-12.7%), and incidence ranged from 1.57% (0.19%-2.95%) to 6.63% (3.65%-9.61%). MSM who never or sometimes used condoms during anal sex with men in the past 6 months (aOR = 1.515, 95%Cl: 1.016-2.257, p = 0.041), or having syphilis infection (aOR = 1.561, 95%Cl: 0.946-2.575, p = 0.081) were more likely to be recently infected with HIV. Being a Beijing resident (aOR = 0.409, 95%CI: 0.212-0.790, p = 0.008), or having only one male anal sex partner in the past 6 months (aOR = 0.467, 95%CI: 0.220-0.994, p = 0.048) were associated with a lower risk for recent HIV infection. Conclusions The HIV incidence fluctuated among MSM in Beijing. Unprotected anal sex, having multiple sex partners, being a non-registered Beijing resident and having a syphilis infection play important roles in the recent HIV infection. Effective intervention measures for HIV and syphilis control and prevention should be continuously strengthened.	[Chen, Qiang; Sun, Yanming; Sun, Weidong; Hao, Mingqiang; Li, Guiying; Su, Xueli; Xin, Ruolei; Lu, Hongyan] Beijing Ctr Prevent Med Res, Beijing Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Beijing, Peoples R China		Lu, HY (corresponding author), Beijing Ctr Prevent Med Res, Beijing Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Beijing, Peoples R China.	luhy@bjcdc.org			Beijing Municipal Science & Technology Commission [D161100000416002]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was supported by Beijing Municipal Science & Technology Commission, Grant No.D161100000416002 (http://www.bjkw.gov.cn/) to HL. The funder had no role in study design, data collection and analysis, but had a role in decision to publish and preparation of the manuscript.	Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Beijing health and Family Planning Commission, REP HIV AIDS EP 2016; BROOKMEYER R, 1995, AM J EPIDEMIOL, V142, P709, DOI 10.1093/oxfordjournals.aje.a117700; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Celik DG, 2012, TRANSFUS APHER SCI, V47, P3, DOI 10.1016/j.transci.2012.03.003; Centers for Disease Control and Prevention, 2006, INT REC US BED CAPT; China Ministry of Health Joint United Nations Programme on HIV/ AIDS World Health Organization, 2011, NAT REP HIV AIDS EST; Chinese Center for Disease Control and Prevention, 2013, OP MAN REC HIV INF S; Chun Helen M, 2013, J Sex Transm Dis, V2013, P176459, DOI 10.1155/2013/176459; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Hargrove JW, 2017, AIDS RES HUM RETROV, V33, P902, DOI [10.1089/aid.2016.0319, 10.1089/AID.2016.0319]; Hofmann A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2585-4; Hu HY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080795; Jiang Y, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000304696.62508.8a; Lu F, 2006, SEX TRANSM INFECT, V82, pIII87, DOI 10.1136/sti.2006.020404; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; Palk L, 2015, JAIDS-J ACQ IMM DEF, V68, P604, DOI 10.1097/QAI.0000000000000526; Qin QQ, 2017, CLIN INFECT DIS, V64, P956, DOI 10.1093/cid/cix031; UNAIDS/ WHO Working Group on Global HIV/ AIDS and STI Surveillance, 2011, US ASS REC INF EST H; Wang XF, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-367; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xiao Y, 2007, CLIN VACCINE IMMUNOL, V14, P1384, DOI 10.1128/CVI.00356-06; Xu JJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0178-x; Xu JJ, 2010, INT J INFECT DIS, V14, pE608, DOI 10.1016/j.ijid.2009.09.004; Yang L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1722-5; Zhang J, 2017, HIV INCIDENCE CARE L, DOI [10.1007/s10461-017-1840-4, DOI 10.1007/S10461-017-1840-4]; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]; Zhang YQ, 2012, SEX TRANSM INFECT, V88, P444, DOI 10.1136/sextrans-2011-050295; Zhong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103136	30	23	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201953	10.1371/journal.pone.0201953	http://dx.doi.org/10.1371/journal.pone.0201953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092072	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600070
J	Cheong, AT; Khoo, EM; Liew, SM; Chinna, K				Cheong, Ai Theng; Khoo, Ee Ming; Liew, Su May; Chinna, Karuthan			What are the determinants for individuals to undergo cardiovascular disease health checks? A cross sectional survey	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; OLDER-PEOPLE; BELIEFS	Background There is a need to improve public's participation in health checks for early identification of individuals at high risk of CVD for prevention. The objective of this study is to identify significant determinants associated with individuals' intention to undergo CVD health checks. These determinants could be used to develop effective strategies to improve CVD health check participation. Methods This was a cross sectional survey using mall intercept interviews. It was carried out in a hypermarket surrounded by housing estates with a population of varying socioeconomic backgrounds. Inclusion criteria were Malaysian nationality and age 30 years and older. The validated CVD health check questionnaire was used to assess participants' intention and the determinants that influenced their intention to undergo CVD health checks. Results A total of 413 participants were recruited. The median age of the participants was 45 years (IQR 17 years) and 60% of them were female. Participants indicated they were likely (45.0%) or very likely (38.7%) to undergo CVD health checks while 16.2% were not sure, unlikely or very unlikely to undergo health checks. Using ordinal regression analysis, perception of benefits, drawbacks of CVD health checks, perception of external barriers and readiness to handle outcomes following CVD health checks were the significant determinants of individuals' intention to undergo CVD health checks. Conclusions To improve individuals' participation in CVD health checks, we need to develop strategies to address their perception of benefits and drawbacks of CVD health checks, the perceived external barriers and their readiness to handle outcomes following CVD health checks.	[Cheong, Ai Theng] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia; [Khoo, Ee Ming; Liew, Su May] Univ Malaya, UMPCRG, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia; [Chinna, Karuthan] Taylors Univ Malaysia, Sch Med, Fac Hlth & Med Sci, Subang Jaya, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Malaya	Cheong, AT (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia.	cheaitheng@upm.edu.my	KHOO, EE MING/B-8785-2010; LIEW, Su May/B-8852-2010; Cheong, Ai Theng/H-9884-2014	KHOO, EE MING/0000-0003-3191-1264; LIEW, Su May/0000-0003-2865-7955; Cheong, Ai Theng/0000-0002-3895-530X	University of Malaya via EMK [PG049-2014A]	University of Malaya via EMK	Financial support for this study was provided by University of Malaya Postgraduate Research Fund (PG049-2014A) via EMK. The funder had no role in study design, analysis and interpretation of this study. (URL of funder website: https://www.um.edu.my/research-and-community.)	[Anonymous], 2013, THE STAR ONLINE; Ashida S, 2010, AM J PREV MED, V38, P396, DOI 10.1016/j.amepre.2009.12.028; Chan Y. H., 2005, SMJ Singapore Medical Journal, V46, P259; Cheong AT, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-016-0579-8; Cheong AT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188259; Cheong AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159438; Cohen J., 2003, APPL MULTIPLE REGRES; Community Development Department (KEMAS), 2015, KOSPEN B; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Edwards AGK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub3; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Forster AS, 2016, J PUBLIC HEALTH-UK, V38, P552, DOI 10.1093/pubmed/fdv119; Hair J., 2010, MULTIVARIATE DATA AN, V7; Harari D, 2008, AGE AGEING, V37, P565, DOI 10.1093/ageing/afn150; Hsu HY, 2001, J ADV NURS, V35, P864, DOI 10.1046/j.1365-2648.2001.01924.x; Hutchison B, 1998, BMJ-BRIT MED J, V316, P1208, DOI 10.1136/bmj.316.7139.1208; Institute for Public Health (IPH), 2011, HEALTHC DEM OUT OF P, VIII; Institute for Public Health (IPH), 2015, NONC DIS RISK FACT O, VII; Institute for Public Health (IPH), 2015, HEALTHC DEM, VIII; Institute for Public Health (IPH), 2011, NONC DIS, VII; Keith T.Z, 2006, MULTIPLE REGRESSION, V3rd; Khoo K L, 1991, Med J Malaysia, V46, P7; Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ministry of Health Malaysia, 2017, PLANN DIV; NORMAN P, 1995, BRIT J CLIN PSYCHOL, V34, P461, DOI 10.1111/j.2044-8260.1995.tb01480.x; NORMAN P, 1993, SOC SCI MED, V37, P53, DOI 10.1016/0277-9536(93)90317-W; Norman P., 1991, COUNS PSYCHOL, V4, P143; Petter J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1379-0; Shiloh S, 1997, PSYCHOL HEALTH, V12, P301, DOI 10.1080/08870449708406709; Simpson WM, 1997, SCOT MED J, V42, P178, DOI 10.1177/003693309704200606; SOCSO, 2016, SOCSO HLTH SCREEN PR; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Tong SF, 2015, MALAYISAN J QUALITAT, VII, P18; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wilson S, 1997, AAOHN J, V45, P254; World Health Organization, 2016, PROJ MORT CAUS DEATH; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zikmund W.G., 2010, BUSINESS RES METHODS	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201931	10.1371/journal.pone.0201931	http://dx.doi.org/10.1371/journal.pone.0201931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092064	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600069
J	Ranchod, H; Ndlandla, F; Lemmer, Y; Beukes, M; Niebuhr, J; Al-Dulayymi, J; Wemmer, S; Fehrsen, J; Baird, M; Verschoor, J				Ranchod, Heena; Ndlandla, Fortunate; Lemmer, Yolandy; Beukes, Mervyn; Niebuhr, Johann; Al-Dulayymi, Juma; Wemmer, Susan; Fehrsen, Jeanni; Baird, Mark; Verschoor, Jan			The antigenicity and cholesteroid nature of mycolic acids determined by recombinant chicken antibodies	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SINGLE ENANTIOMERS; PHAGE-DISPLAY; KETOMYCOLIC ACIDS; RECOGNITION; FRAGMENTS; STABILITY; EPICHOLESTEROL; TECHNOLOGY; GENERATION	Mycolic acids (MA) are major, species-specific lipid components of Mycobacteria and related genera. In Mycobacterium tuberculosis, it is made up of alpha-, methoxy- and ketoMA, each with specific biological functions and conformational characteristics. Antibodies in tuberculosis (TB) patient sera respond differently towards the three MA classes and were reported to cross-react with cholesterol. To understand the antigenicity and cholesterol cross-reactivity of MA, we generated three different chicken-derived phage-displayed single-chain variable fragments (scFv) that reacted similarly towards the natural mixture of MA, but the first recognized all three classes of chemically synthetic MAs, the second only the two oxygenated types of MAs and the third only methoxy MA. The cholesterol cross-reactivity was investigated after grafting each of the three scFv types onto two configurations of constant chain domains CH1-4 and CH2-4. Weak but significant cross-reactivity with cholesterol was found only with CH2-4 versions, notably those two that were also able to recognize the trans-keto MA. The cholesteroid nature of mycobacterial mycolic acids therefore seems to be determined by the trans-keto MA subclass. The significantly weaker binding to cholesterol in comparison to MA confirms the potential TB diagnostic application of these antibodies.	[Ranchod, Heena; Ndlandla, Fortunate; Lemmer, Yolandy] CSIR, Polymers & Composites, Pretoria, South Africa; [Ranchod, Heena; Ndlandla, Fortunate; Beukes, Mervyn; Niebuhr, Johann; Verschoor, Jan] Univ Pretoria, Dept Biochem, Pretoria, South Africa; [Al-Dulayymi, Juma; Baird, Mark] Bangor Univ, Sch Chem, Bangor, Gwynedd, Wales; [Wemmer, Susan; Fehrsen, Jeanni] Agr Res Council, Onderstepoort Vet Inst, Serol & Immunochem, Vaccines & Diagnost Dev Programme, Pretoria, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; University of Pretoria; Bangor University; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council	Ranchod, H (corresponding author), CSIR, Polymers & Composites, Pretoria, South Africa.; Ranchod, H (corresponding author), Univ Pretoria, Dept Biochem, Pretoria, South Africa.	hranchod@csir.co.za	Baird, Mark/A-2470-2009; Beukes, Mervyn/E-8977-2011	Baird, Mark/0000-0001-5340-8745; Beukes, Mervyn/0000-0003-1319-613X; Ranchod, Heena/0000-0001-6889-8126	Council for Scientific and Industrial Research (CSIR); National Research Foundation of South Africa [99386, 88622, 80577, TTK1206281756]	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); National Research Foundation of South Africa(National Research Foundation - South Africa)	This study was partly funded by the Council for Scientific and Industrial Research (CSIR) parliamentary grants (YL) and the National Research Foundation of South Africa for the grants, unique grant numbers: 99386 (HR), 88622, 80577 (YL) and TTK1206281756 (LN). Any opinion, finding and conclusion or recommendation expressed in this material is that of the authors and the NRF does not accept any liability in this regard; https://www.csir.co.za/; http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Al Dulayymi JR, 2005, TETRAHEDRON, V61, P11939, DOI 10.1016/j.tet.2005.09.056; Al Dulayymi JR, 2003, CHEM COMMUN, P228, DOI 10.1039/b209876h; Al Dulayymi JR, 2000, TETRAHEDRON LETT, V41, P7107, DOI 10.1016/S0040-4039(00)01147-3; Al Dulayymi JR, 2007, TETRAHEDRON, V63, P2571, DOI 10.1016/j.tet.2007.01.007; Al Dulayymi JR, 2006, TETRAHEDRON, V62, P11867, DOI 10.1016/j.tet.2006.09.019; Al-Dulayymi JR, 2006, TETRAHEDRON, V62, P4851, DOI 10.1016/j.tet.2006.03.007; Barrios Y, 2004, J MOL RECOGNIT, V17, P332, DOI 10.1002/jmr.679; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Benadie Y, 2008, CHEM PHYS LIPIDS, V152, P95, DOI 10.1016/j.chemphyslip.2008.01.004; Beukes M, 2010, CHEM PHYS LIPIDS, V163, P800, DOI 10.1016/j.chemphyslip.2010.09.006; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brockmann Eeva-Christine, 2012, Methods Mol Biol, V907, P123, DOI 10.1007/978-1-61779-974-7_7; Carmen Sara, 2002, Briefings in Functional Genomics & Proteomics, V1, P189, DOI 10.1093/bfgp/1.2.189; Chan CE, 2013, J LIPID RES, V54, P2924, DOI 10.1194/jlr.D036137; COLLET TA, 1992, P NATL ACAD SCI USA, V89, P10026, DOI 10.1073/pnas.89.21.10026; Dvir H, 2010, J IMMUNOL, V184, P2504, DOI 10.4049/jimmunol.0903509; Geva M, 2001, CHEMBIOCHEM, V2, P265, DOI 10.1002/1439-7633(20010401)2:4<265::AID-CBIC265>3.3.CO;2-M; Greunke K, 2006, J BIOTECHNOL, V124, P446, DOI 10.1016/j.jbiotec.2005.12.032; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Helmerhorst EJ, 1998, INFECT IMMUN, V66, P870, DOI 10.1128/IAI.66.2.870-873.1998; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Islam MO, 2012, INT J MOL SCI, V13, P4937, DOI 10.3390/ijms13044937; Izhaky D, 2000, CHEM-EUR J, V6, P869; Izhaky D, 1998, ADV MATER, V10, P1009, DOI 10.1002/(SICI)1521-4095(199809)10:13<1009::AID-ADMA1009>3.0.CO;2-N; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; KOCH R, 1982, REV INFECT DIS, V4, P1270; Koza G, 2007, TETRAHEDRON LETT, V48, P2165, DOI 10.1016/j.tetlet.2007.01.100; Koza G, 2009, TETRAHEDRON, V65, P10214, DOI 10.1016/j.tet.2009.09.099; Mathebula NS, 2009, CHEM COMMUN, P3345, DOI 10.1039/b905192a; Minnikin D., 1982, BIOL MYCOBACTERIA; MINNIKIN DE, 1982, BIOCHIM BIOPHYS ACTA, V712, P616, DOI 10.1016/0005-2760(82)90290-9; Monnier PP, 2013, ANTIBODIES, V2, P193, DOI 10.3390/antib2020193; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; PARVARI R, 1988, EMBO J, V7, P739, DOI 10.1002/j.1460-2075.1988.tb02870.x; PerlTreves D, 1996, CHEM BIOL, V3, P567, DOI 10.1016/S1074-5521(96)90148-9; Pretorius A., 1999, THESIS; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schleicher GK, 2002, CLIN CHEM LAB MED, V40, P882, DOI 10.1515/CCLM.2002.156; SHIMIZU M, 1992, BIOSCI BIOTECH BIOCH, V56, P270, DOI 10.1271/bbb.56.270; SWARTZ GM, 1988, P NATL ACAD SCI USA, V85, P1902, DOI 10.1073/pnas.85.6.1902; Thanyani ST, 2008, J IMMUNOL METHODS, V332, P61, DOI 10.1016/j.jim.2007.12.009; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; van Wyngaardt W, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-6; Vermeulen I, 2017, J LIPID RES, V58, P709, DOI 10.1194/jlr.M073171; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003; Villeneuve M, 2013, MICROBIOL-SGM, V159, P2405, DOI 10.1099/mic.0.068866-0; Villeneuve M, 2010, CHEM PHYS LIPIDS, V163, P569, DOI 10.1016/j.chemphyslip.2010.04.010; Watanabe M, 2002, MICROBIOL-SGM, V148, P1881, DOI 10.1099/00221287-148-6-1881; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; Wemmer S, 2010, BIOLOGICALS, V38, P407, DOI 10.1016/j.biologicals.2010.02.002; WHO, 2017, GLOB TUB REP 2017, V30, P596; Willuda J, 1999, CANCER RES, V59, P5758	55	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0200298	10.1371/journal.pone.0200298	http://dx.doi.org/10.1371/journal.pone.0200298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092023	Green Published, gold			2022-12-26	WOS:000441232600007
J	Deng, JC; Chen, M; Liu, ZQ; Song, YN; Sui, TT; Lai, LX; Li, ZJ				Deng, Jichao; Chen, Mao; Liu, Zhiquan; Song, Yuning; Sui, Tingting; Lai, Liangxue; Li, Zhanjun			The disrupted balance between hair follicles and sebaceous glands in Hoxc13-ablated rabbits	FASEB JOURNAL			English	Article						ECTD-9; hypotrichosis; HFs; SGs	NAIL ECTODERMAL DYSPLASIA; UNDERLIES PURE HAIR; HOXC13; GENE; MUTATION; HYPOTRICHOSIS; KERATINS	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans. Unlike patients with ECTD-9, Hoxc13-mutated mice and pigs do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically. Here, the homozygous Hoxc13(-/-) rabbits showed complete loss of hair on the head and dorsum, whereas hypotrichosis in the limbs and tail were determined in the Hoxc13(-/-) rabbits. In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (SGs) were also found in the Hoxc13(-/-) rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically. Therefore, our findings demonstrate that Hoxc13(-/-) rabbits can be used as a model for human ECTD-9, especially to understand the pathologic mechanism of hypotrichosis. Moreover, the disrupted balance between HFs and SGs, especially in the Hoxc13(-/-) rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z. The disrupted balance between hair follicles and sebaceous glands in Hoxc13-ablated rabbits.	[Deng, Jichao; Chen, Mao; Liu, Zhiquan; Song, Yuning; Sui, Tingting; Lai, Liangxue; Li, Zhanjun] Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Inst Zoonosis, Changchun, Jilin, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Lai, LX; Li, ZJ (corresponding author), Jilin Univ, Dept Biotechnol, Room 409,5333 Xian Rd, Changchun 130062, Jilin, Peoples R China.	lai_liangxue@gibh.ac.cn; lizj_1998@jlu.edu.cn		li, zhanjun/0000-0001-6914-8589	National Key Research and Development Program of China Stem Cell and Translational Research [2017YFA0105101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_16R32]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030501, XDA16030503]; GuangDong Province Science and Technology Plan Project [2014B020225003]	National Key Research and Development Program of China Stem Cell and Translational Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); GuangDong Province Science and Technology Plan Project	The authors thank Peiran Hu (Embryo Engineering Center for Technical Assistance, Chuangchun, China). This study was supported by National Key Research and Development Program of China Stem Cell and Translational Research (Grant 2017YFA0105101), The Program for Changjiang Scholars and Innovative Research Team in University (Grant IRT_16R32), The Strategic Priority Research Program of the Chinese Academy of Sciences (Grants XDA16030501 and XDA16030503), and GuangDong Province Science and Technology Plan Project (Grant 2014B020225003). The authors declare no conflicts of interest.	Ali RH, 2013, BRIT J DERMATOL, V169, P478, DOI 10.1111/bjd.12302; [Anonymous], 1942, Ann Surg, V115, P465; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Combalia Andrea, 2017, Int J Trichology, V9, P54, DOI 10.4103/ijt.ijt_100_16; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P25211, DOI 10.1074/jbc.M114.572511; de Berker D, 1999, INT J DERMATOL, V38, P25, DOI 10.1046/j.1365-4362.1999.00005.x; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Farooq M, 2013, HUM MUTAT, V34, P578, DOI 10.1002/humu.22271; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Hall BK, 2000, METH MOL B, V135, P127; Han K, 2017, HUM MOL GENET, V26, P184, DOI 10.1093/hmg/ddw378; He YY, 2015, ANAT REC, V298, P1796, DOI 10.1002/ar.23185; Karsenty G, 1998, DEV GENET, V22, P301, DOI 10.1002/(SICI)1520-6408(1998)22:4&lt;301::AID-DVG1&gt;3.0.CO;2-A; Khan AK, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0402-y; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Mascaro JM, 2000, J DERMATOL TREAT, V11, pS1; Mehmood S, 2017, CLIN EXP DERMATOL, V42, P585, DOI 10.1111/ced.13115; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Neri I, 2016, J DERMATOL SCI, V81, P63, DOI 10.1016/j.jdermsci.2015.10.012; Oros J, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1545-6; Peterson RL, 2005, J INVEST DERM SYMP P, V10, P238, DOI 10.1111/j.1087-0024.2005.10114.x; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Qiu WM, 2016, CELL TISSUE RES, V364, P149, DOI 10.1007/s00441-015-2312-7; Rocha MA, 2018, ARCH DERMATOL RES, V310, P181, DOI 10.1007/s00403-017-1795-3; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Sui TT, 2016, HUM MOL GENET, V25, P2661, DOI 10.1093/hmg/ddw125; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Wang JM, 2015, INT J DERMATOL, V54, P1163, DOI 10.1111/ijd.12889; Wang Yu, 2014, Cell Regen, V3, P3, DOI 10.1186/2045-9769-3-3; Wei JCJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15830-7; Zhang J, 2015, GENE, V566, P84, DOI 10.1016/j.gene.2015.04.039	37	12	13	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1226	1234		10.1096/fj.201800928RR	http://dx.doi.org/10.1096/fj.201800928RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30125135	Bronze			2022-12-26	WOS:000457401500097
J	Keul, P; Polzin, A; Kaiser, K; Graler, M; Dannenberg, L; Daum, G; Heusch, G; Levkau, B				Keul, Petra; Polzin, Amin; Kaiser, Klaus; Graeler, Markus; Dannenberg, Lisa; Daum, Guenter; Heusch, Gerd; Levkau, Bodo			Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy	FASEB JOURNAL			English	Article						inflammation; CAD; TNF-; S1P; VSMC	HIGH-DENSITY-LIPOPROTEIN; NF-KAPPA-B; SPHINGOSINE 1-PHOSPHATE RECEPTORS; APOLIPOPROTEIN-M; BETA-RECEPTOR; P65 SUBUNIT; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; EXPRESSION; PTEN	Dysfunctional HDL is associated with coronary artery disease (CAD), but its effect on inflammation in vascular smooth muscle cells (VSMCs) in atherosclerosis is unknown. We investigated the effect of healthy human HDL and CAD-HDL on TNF--driven inflammation in VSMCs and examined whether HDL-associated sphingosine-1-phosphate (HDL-S1P) could modulate inflammation with the aim of designing novel HDL-based anti-inflammatory strategies. Healthy human HDL, human CAD-HDL, and mouse HDL were isolated by ultracentrifugation, S1P was measured by liquid chromatography-tandem mass spectrometry, and TNF--induced inflammation was characterized by gene expression and analysis of NF-B-dependent signaling. Mechanisms of S1P interference with TNF- were assessed by S1P receptor antagonists, mouse knockouts, and short interfering RNA. We observed that healthy HDL potently inhibited the induction of TNF--stimulated inflammatory genes, such as iNOS (inducible NO synthase) and MMP9 (matrix metalloproteinase 9), a process that was entirely dependent on HDL-S1P, as evidenced by loss-of-function using S1P-less HDL and mimicked by genuine S1P. Inhibition was based on suppression of TNF--activated Akt signaling resulting in reduced IkBSer32 and p65Ser534 NF-B phosphorylation based on a persistent phosphatase and tensin homolog activation by S1P through the S1P receptor 2. Intriguingly, S1P suppressed inflammation even hours after initial TNF- stimulation. The anti-inflammatory effect of healthy HDL correlated with HDL-S1P content and was superior to that of CAD-HDL featuring lower HDL-S1P. Nevertheless, therapeutic loading of HDL with S1P completely restored the anti-inflammatory capacity of CAD-HDL and greatly boosted that of both healthy and CAD-HDL. Suppression of inflammation by HDL-S1P defines a novel pathophysiologic characteristic that distinguishes functional from dysfunctional HDL. The anti-inflammatory HDL function can be boosted by S1P-loading and exploited by S1P receptor-targeting to prevent and even turn off ongoing inflammation.Keul, P., Polzin, A., Kaiser, K., Graler, M., Dannenberg, L., Daum, G., Heusch, G., Levkau, B. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.	[Keul, Petra; Kaiser, Klaus; Heusch, Gerd; Levkau, Bodo] Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany; [Polzin, Amin; Dannenberg, Lisa] Heinrich Heine Univ, Med Ctr Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Graeler, Markus] Univ Hosp Jena, Dept Anesthesiol & Intens Care Med, Ctr Sepsis Control & Care, Jena, Germany; [Graeler, Markus] Univ Hosp Jena, Ctr Mol Biomed, Jena, Germany; [Daum, Guenter] Univ Med Ctr Hamburg Eppendorf, Clin & Polyclin Vasc Med, Univ Heart Ctr, Hamburg, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Hamburg; University Medical Center Hamburg-Eppendorf	Levkau, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany.	bodo.levkau@uni-due.de	Heusch, Gerd/ABE-6675-2020; Gräler, Markus/ABH-1905-2021	Gräler, Markus/0000-0001-6650-7849	Deutsche Herzstiftung [F/26/17]; Deutsche Forschungsgemeinschaft [GRK 2098]	Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by Deutsche Herzstiftung to P.K. (Grant F/26/17) and by Deutsche Forschungsgemeinschaft (Grant GRK 2098, Projects 9, 10, and 11, to B.L. and P.K.). The authors declare no conflicts of interest.	Abbey-Hosch SE, 2004, HYPERTENSION, V43, P1103, DOI 10.1161/01.HYP.0000124668.80811.d3; Ahnstrom J, 2008, J LIPID RES, V49, P1912, DOI 10.1194/jlr.M700471-JLR200; Annema W, 2016, J CLIN LIPIDOL, V10, P1318, DOI 10.1016/j.jacl.2016.08.003; Ansell BJ, 2007, AM J CARDIOL, V100, p3N, DOI 10.1016/j.amjcard.2007.08.006; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Arkensteijn BWC, 2013, INT J MOL SCI, V14, P4419, DOI 10.3390/ijms14034419; Badimon JJ, 2015, J AM COLL CARDIOL, V66, P1486, DOI 10.1016/j.jacc.2015.08.008; Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P976, DOI 10.1161/01.ATV.0000162171.30089.f6; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chrisman Ted D, 2003, Cell Commun Signal, V1, P4, DOI 10.1186/1478-811X-1-4; Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Christoffersen C, 2010, CIRC RES, V106, P1624, DOI 10.1161/CIRCRESAHA.109.211086; Fragoso R, 2015, METHODS, V77-78, P75, DOI 10.1016/j.ymeth.2014.10.015; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gomaraschi M, 2013, CARDIOVASC RES, V100, P36, DOI 10.1093/cvr/cvt169; Gonzalez-Diez M, 2008, THROMB HAEMOSTASIS, V100, P119, DOI 10.1160/TH07-11-0675; Gordts SC, 2014, CURR MOL MED, V14, P481, DOI 10.2174/1566524013666131118113927; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; Kimura T, 2006, CELL SIGNAL, V18, P841, DOI 10.1016/j.cellsig.2005.07.011; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Levkau B, 2002, CELL DEATH DIFFER, V9, P1360, DOI 10.1038/sj.cdd.4401106; Levkau B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00243; Moon SK, 2004, ARCH BIOCHEM BIOPHYS, V421, P267, DOI 10.1016/j.abb.2003.11.007; Muthuramu I, 2017, EXPERT OPIN BIOL TH, V17, P793, DOI 10.1080/14712598.2017.1333597; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Nussbaum C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7416; Poti F, 2014, CARDIOVASC RES, V103, P395, DOI 10.1093/cvr/cvu136; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Ruiz M, 2017, ARTERIOSCL THROM VAS, V37, P118, DOI 10.1161/ATVBAHA.116.308435; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sattler K, 2015, J AM COLL CARDIOL, V66, P1470, DOI 10.1016/j.jacc.2015.07.057; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Swendeman SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2722; Tamama K, 2005, ATHEROSCLEROSIS, V178, P19, DOI 10.1016/j.atherosclerosis.2004.07.032; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Tong XL, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-82; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Vorst EPC, 2013, FASEB J, V27, P1413, DOI 10.1096/fj.12-212753; Whetzel AM, 2006, CIRC RES, V99, P731, DOI 10.1161/01.RES.0000244088.33375.52; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zhang GQ, 2013, BLOOD, V122, P443, DOI 10.1182/blood-2012-11-467191; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	59	30	33	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1482	1495		10.1096/fj.201801245R	http://dx.doi.org/10.1096/fj.201801245R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130432				2022-12-26	WOS:000457401500116
J	Wang, Y; Wehling-Henricks, M; Welc, SS; Fisher, AL; Zuo, Q; Tidball, JG				Wang, Ying; Wehling-Henricks, Michelle; Welc, Steven S.; Fisher, Allison L.; Zuo, Qun; Tidball, James G.			Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia	FASEB JOURNAL			English	Article						skeletal muscle; macrophage; satellite cell; bone marrow transplantation; muscle fibrosis	SATELLITE CELLS; CHRONIC INFLAMMATION; SKELETAL-MUSCLES; AGE; REGENERATION; MACROPHAGES; MECHANISMS; INCREASES; MICE; REJUVENATION	Aging is associated with diminished muscle mass, reductions in muscle stem cell functions, and increased muscle fibrosis. The immune system, especially macrophages, can have important roles in modulating muscle growth and regeneration, suggesting that the immune system may also have significant influences on muscle aging. Moreover, the immune system experiences changes in function during senescence, suggesting that regulatory interaction between muscle cells and the immune system may also change during aging. In this study, we performed bone marrow transplantations between age-mismatched donor and recipient mice to test the influence of the age of the immune system on muscle aging. Transplantation of young bone marrow cells into old recipients prevented sarcopenia and prevented age-related change in muscle fiber phenotype. Transplantation of old bone marrow cells into young animals reduced satellite cell numbers and promoted satellite cells to switch toward a fibrogenic phenotype. We also demonstrated that conditioned media from young, but not old, bone marrow cells promoted myoblast proliferation in vitro, and we found that factors released by young bone marrow cells were more supportive of myotube differentiation in vitro. Together, our results demonstrate that aging of bone marrow cells promotes the age-related reduction of satellite cell number and function and contributes to sarcopenia.Wang, Y., Wehling-Henricks, M., Welc, S. S., Fisher, A. L., Zuo, Q., Tidball, J. G. Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia.	[Wang, Ying; Fisher, Allison L.; Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA; [Wehling-Henricks, Michelle; Welc, Steven S.; Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Zuo, Qun] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai University of Sport	Tidball, JG (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 1135 Terasaki Bldg, Los Angeles, CA 90095 USA.	jtidball@physci.ucla.edu		Tidball, James/0000-0003-1202-8038; Fisher, Allison/0000-0002-9393-2442; Welc, Steven/0000-0002-2353-0325	U.S. National Institutes of Health, National Institute on Aging; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR054451, RO1AG041147]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041147] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Mr. David Rangel and Ms. Katherine Wen for their expert technical assistance, and Ms. Christine Phan and Mr. Edward Garcia (all from University of California, Los Angeles) for performing fiber counts. Research reported in this publication was supported by the U.S. National Institutes of Health, National Institute on Aging and National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants R01AR054451 and RO1AG041147 to J.G.T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. National Institutes of Health. The authors declare no conflicts of interest.	Akahori H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8792; ALNAQEEB MA, 1984, J ANAT, V139, P677; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Du HQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00522-7; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fulop T, 2016, REV INVEST CLIN, V68, P84; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Haynes L, 2012, SEMIN IMMUNOL, V24, P350, DOI 10.1016/j.smim.2012.04.001; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Jo E, 2012, AGING CLIN EXP RES, V24, P412, DOI 10.3275/8464; Kung TA, 2014, J GERONTOL A-BIOL, V69, P657, DOI 10.1093/gerona/glt135; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Marty E, 2017, BONE, V105, P276, DOI 10.1016/j.bone.2017.09.008; Merly F, 1999, MUSCLE NERVE, V22, P724, DOI 10.1002/(SICI)1097-4598(199906)22:6<724::AID-MUS9>3.0.CO;2-O; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Roberts P, 1997, J ANAT, V191, P585, DOI 10.1046/j.1469-7580.1997.19140585.x; Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001; Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350; Wehling-Henricks M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010763; Wilson D, 2017, AGEING RES REV, V36, P1, DOI 10.1016/j.arr.2017.01.006; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014; Zamir O, 1992, Mediators Inflamm, V1, P247, DOI 10.1155/S0962935192000371	49	35	35	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1415	1427		10.1096/fj.201800973R	http://dx.doi.org/10.1096/fj.201800973R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130434	Green Published, Bronze			2022-12-26	WOS:000457401500111
J	Li, WJ; Xiong, XH; Abdalla, A; Alejo, S; Zhu, LY; Lu, F; Sun, H				Li, Wenjing; Xiong, Xiahui; Abdalla, Amro; Alejo, Salvador; Zhu, Linyu; Lu, Fei; Sun, Hong			HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; receptor tyrosine kinase; Ras-related C3 botulinum toxin substrate 1 (Rac1); guanine nucleotide exchange factor (GEF); cell migration; cell invasion; glioblastoma; cancer	SMALL-MOLECULE INHIBITOR; TYROSINE KINASE; PROLONGS SURVIVAL; BREAST-CANCER; HUMAN GLIOMAS; AXL KINASE; MET; RESISTANCE; GROWTH; PATHWAY	The MET proto-oncogene-encoded receptor tyrosine kinase (MET) and AXL receptor tyrosine kinase (AXL) are independently operating receptor tyrosine kinases (RTKs) that are functionally associated with aggressive and invasive cancer cell growth. However, how MET and AXL regulate the migratory properties of cancer cells remains largely unclear. We report here that the addition of hepatocyte growth factor (HGF), the natural ligand of MET, to serum-starved human glioblastoma cells induces the rapid activation of both MET and AXL and formation of highly polarized MET-AXL clusters on the plasma membrane. HGF also promoted the formation of the MET and AXL protein complexes and phosphorylation of AXL, independent of AXL's ligand, growth arrest-specific 6 (GAS6). The HGF-induced MET-AXL complex stimulated rapid and dynamic cytoskeleton reorganization by activating the small GTPase RAC1, a process requiring both MET and AXL kinase activities. We further found that HGF also promotes the recruitment of ELMO2 and DOCK180, a bipartite guanine nucleotide exchange factor for RAC1, to the MET-AXL complex and thereby stimulates the RAC1-dependent cytoskeleton reorganization. We also demonstrated that the MET-AXL-ELMO2-DOCK180 complex is critical for HGF-induced cell migration and invasion in glioblastoma or other cancer cells. Our findings uncover a critical HGF-dependent signaling pathway that involves the assembly of a large protein complex consisting of MET, AXL, ELMO2, and DOCK180 on the plasma membrane, leading to RAC1-dependent cell migration and invasion in various cancer cells.	[Li, Wenjing; Xiong, Xiahui; Abdalla, Amro; Alejo, Salvador; Zhu, Linyu; Sun, Hong] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA; [Li, Wenjing; Lu, Fei] Peking Univ, Sch Chem Biol & Biotechnol, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Peking University; University Town of Shenzhen	Sun, H (corresponding author), Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA.	hong.sun@unlv.edu		Alejo, Salvador/0000-0002-1390-9892; Sun, Hong/0000-0003-2100-1451; Li, Wenjing/0000-0001-9151-9219	National Institutes of Health [R15NS096694]; Cancer Research Gift Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS096694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Gift Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R15NS096694 and a grant from the Cancer Research Gift Fund to the College of Sciences at University of Nevada, Las Vegas (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14; Baumann C, 2017, MOL ONCOL, V11, P1430, DOI 10.1002/1878-0261.12109; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cao HH, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0367-4; Cavet ME, 2008, ARTERIOSCL THROM VAS, V28, P886, DOI 10.1161/ATVBAHA.108.162693; Cheng P, 2015, STEM CELL REP, V4, P899, DOI 10.1016/j.stemcr.2015.03.005; Clague MJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002422; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fay David S, 2013, WormBook, P1, DOI 10.1895/wormbook.1.159.1; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gajiwala KS, 2017, J BIOL CHEM, V292, P15705, DOI 10.1074/jbc.M116.771485; Harder T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00050; Heideman MR, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3564; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Koochekpour S, 1997, CANCER RES, V57, P5391; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin L., 2012, CHEMOTHER RES PRACT, V2012, DOI DOI 10.1155/2012/817297; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Menard L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4907; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Onken J, 2017, ONCOTARGET, V8, P50403, DOI 10.18632/oncotarget.18468; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Postel-Vinay S, 2012, NAT GENET, V44, P835, DOI 10.1038/ng.2362; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Salian-Mehta S, 2013, MOL CELL ENDOCRINOL, V374, P92, DOI 10.1016/j.mce.2013.04.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhu LY, 2016, J CELL SCI, V129, P4238, DOI 10.1242/jcs.191684	45	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15397	15418		10.1074/jbc.RA118.003063	http://dx.doi.org/10.1074/jbc.RA118.003063			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30108175	hybrid, Green Published			2022-12-26	WOS:000446549200006
J	Schwerter, D; Grimm, I; Girzalsky, W; Erdmann, R				Schwerter, Daniel; Grimm, Immanuel; Girzalsky, Wolfgang; Erdmann, Ralf			Receptor recognition by the peroxisomal AAA complex depends on the presence of the ubiquitin moiety and is mediated by Pex1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxisome; protein targeting; protein translocation; protein sorting; ATPases associated with diverse cellular activities (AAA); ubiquitin	MATRIX PROTEIN IMPORT; SIGNAL TYPE-1 RECEPTOR; N-TERMINAL HALF; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; CONSERVED CYSTEINE; MEMBRANE-RECEPTOR; ESCHERICHIA-COLI; PEROXINS PEX1P; GENETIC-CODE	The receptor cycle of type I peroxisomal matrix protein import is completed by ubiquitination of the membrane-bound peroxisome biogenesis factor 5 (Pex5p) and its subsequent export back to the cytosol. The receptor export is the only ATP-dependent step of the whole process and is facilitated by two members of the AAA family of proteins (ATPases associated with various cellular activities), namely Pex1p and Pex6p. To gain further insight into substrate recognition by the AAA complex, we generated an N-terminally linked ubiquitin-Pex5p fusion protein. This fusion protein displayed biological activity because it is able to functionally complement a PEX5-deletion in Saccharomyces cerevisiae. In vitro assays revealed its interaction at WT level with the native cargo protein Pcs60p and Pex14p, a constituent of the receptor docking complex. We also demonstrate in vitro deubiquitination by the deubiquitinating enzyme Ubp15p. In vitro pulldown assays and cross-linking studies demonstrate that Pex5p recognition by the AAA complex depends on the presence of the ubiquitin moiety and is mediated by Pex1p.	[Schwerter, Daniel; Grimm, Immanuel; Girzalsky, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Fac Med, Inst Biochem & Pathobiochem, Syst Biochem, D-44780 Bochum, Germany	Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Univ Str 150, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de			Deutsche Forschungsgemeinschaft [FOR1905]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1905 (to R. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Beyer A, 1997, PROTEIN SCI, V6, P2043; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; Blok NB, 2015, P NATL ACAD SCI USA, V112, pE4017, DOI 10.1073/pnas.1500257112; Braverman NE, 2016, MOL GENET METAB, V117, P313, DOI 10.1016/j.ymgme.2015.12.009; Brown LA, 2003, J CELL MOL MED, V7, P388, DOI 10.1111/j.1582-4934.2003.tb00241.x; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Francisco T, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700047; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; Gardner BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02474-4; Gardner BM, 2015, J MOL BIOL, V427, P1375, DOI 10.1016/j.jmb.2015.01.019; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Gouveia AM, 2003, ADV EXP MED BIOL, V544, P219; Grimm I, 2016, BBA-MOL CELL RES, V1863, P828, DOI 10.1016/j.bbamcr.2015.10.001; Grimm I, 2016, SCI REP-UK, V6, DOI 10.1038/srep19838; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Hagen S, 2015, J BIOL CHEM, V290, P26610, DOI 10.1074/jbc.M115.657973; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harlow E., 1988, ANTIBODIES LAB MANUA; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Huseinovic A, 2018, TOXICOL IN VITRO, V47, P259, DOI 10.1016/j.tiv.2017.12.007; JAMES GL, 1994, J BIOL CHEM, V269, P14182; James P, 1996, GENETICS, V144, P1425; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Montilla-Martinez M, 2015, CELL REP, V13, P2126, DOI 10.1016/j.celrep.2015.11.016; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta H. W., 2014, MOL MACHINES INVOLVE, P347; Platta HW, 2008, BIOCHEM SOC T, V36, P99, DOI 10.1042/BST0360099; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2016, BBA-MOL CELL RES, V1863, P838, DOI 10.1016/j.bbamcr.2015.09.010; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Rodrigues TA, 2014, MOL CELL BIOL, V34, P2917, DOI 10.1128/MCB.01727-13; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; Saffian D, 2012, J STRUCT BIOL, V179, P126, DOI 10.1016/j.jsb.2012.06.002; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schwartzkopff B, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150103; Schwerter DP, 2017, BIOL CHEM, V398, P607, DOI 10.1515/hsz-2016-0293; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Tamura S, 2014, J BIOL CHEM, V289, P24336, DOI 10.1074/jbc.M114.588038; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Varland S, 2015, PROTEOMICS, V15, P2385, DOI 10.1002/pmic.201400619; VOORNBROUWER T, 1993, BIOCHIM BIOPHYS ACTA, V1216, P325, DOI 10.1016/0167-4781(93)90166-B; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	84	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15458	15470		10.1074/jbc.RA118.003936	http://dx.doi.org/10.1074/jbc.RA118.003936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30097517	Green Published, hybrid			2022-12-26	WOS:000446549200013
J	Ceckova, M; Reznicek, J; Deutsch, B; Fromm, MF; Staud, F				Ceckova, Martina; Reznicek, Josef; Deutsch, Birgit; Fromm, Martin F.; Staud, Frantisek			Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate)	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; DRUG-INTERACTIONS; P-GLYCOPROTEIN; PHARMACOKINETICS; NUCLEOSIDE; CONSORTIUM; CIMETIDINE; TRIMETHOPRIM	Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor used in first-line combination antiretroviral therapy (cART). It is usually administered with nucleoside reverse transcriptase inhibitors (NRTI), many of which are substrates of OCT uptake solute carriers (SLC22A) and MATE (SLC47A), P-gp (MDR1, ABCB1), BCRP (ABCG2), or MRP2 (ABCC2) efflux transporters. The aim of this study was to evaluate the inhibitory potential of efavirenz towards these transporters and investigate its effects on the pharmacokinetics and tissue distribution of a known Oct/Mate substrate, lamivudine, in rats. Accumulation and transport assays showed that efavirenz inhibits the uptake of metformin by OCT1-, OCT2 and MATE1-expressing MDCK cells and reduces transcellular transport of lamivudine across OCT1/OCT2-and MATE1-expressing MDCK monolayers. Only negligible inhibition of MATE2-K was observed in HEK-MATE2-K cells. Efavirenz also reduced the efflux of calcein from MDCK-MRP2 cells, but had a rather weak inhibitory effect on Hoechst 33342 accumulation in MDCK-MDR1 and MDCK-BCRP cells. An in vivo pharmacokinetic interaction study in male Wistar rats revealed that intravenous injection of efavirenz or the control Oct/Mate inhibitor cimetidine significantly reduced the recovery of lamivudine in urine and greatly increased lamivudine retention in the renal tissue. Co-administration with efavirenz or cimetidine also increased the AUC(0-infinity) value and reduced total body clearance of lamivudine. These data suggest that efavirenz is a potent inhibitor of OCT/Oct and MATE/Mate transporters. Consequently, it can engage in drug-drug interactions that reduce renal excretion of co-administered substrates and enhance their retention in the kidneys, potentially compromising therapeutic safety.	[Ceckova, Martina; Reznicek, Josef; Staud, Frantisek] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic; [Deutsch, Birgit; Fromm, Martin F.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany	Charles University Prague; University of Erlangen Nuremberg	Staud, F (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic.	frantisek.staud@faf.cuni.cz		Leggas, Markos/0000-0003-4314-4533	Grant Agency of the Charles University in Prague [SVV/2017/260 414]; Czech Science Foundation [GACR 17-16169S]	Grant Agency of the Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Grant Agency of the Charles University in Prague [SVV/2017/260 414] and the Czech Science Foundation [GACR 17-16169S]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEDOYIN A, 1987, XENOBIOTICA, V17, P595, DOI 10.3109/00498258709043966; AIDSinfo, 2017, GUID US ANT RETR AG; Almond LM, 2005, J ANTIMICROB CHEMOTH, V56, P738, DOI 10.1093/jac/dki308; Baynes HW, 2017, HIV AIDS-RES PALLIAT, V9, P1, DOI 10.2147/HIV.S120979; Bednasz CJ, 2017, CLIN PHARM DRUG DEV, V6, P135, DOI 10.1002/cpdd.313; Ceckova M, 2016, ANTIMICROB AGENTS CH, V60, P5563, DOI 10.1128/AAC.00648-16; Council of Europe, 1986, EXPL REP EUR CONV PR; De Souza J, 2009, J PHARM SCI-US, V98, P4413, DOI 10.1002/jps.21744; DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529; Dirson G, 2006, PHARM RES, V23, P1525, DOI 10.1007/s11095-006-0279-5; EMA, 2017, COMM HUM MED PROD CO; FDA, 2012, CLIN PHARM; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Ito S, 2012, J PHARMACOL EXP THER, V340, P393, DOI 10.1124/jpet.111.184986; Johnson MA, 1999, CLIN PHARMACOKINET, V36, P41, DOI 10.2165/00003088-199936010-00004; Jung N, 2008, DRUG METAB DISPOS, V36, P1616, DOI 10.1124/dmd.108.020826; Kido Y, 2011, J MED CHEM, V54, P4548, DOI 10.1021/jm2001629; Kim HS, 2007, BRIT J CLIN PHARMACO, V64, P645, DOI 10.1111/j.1365-2125.2007.02944.x; Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001; Konig J, 2011, BRIT J PHARMACOL, V163, P546, DOI 10.1111/j.1476-5381.2010.01052.x; Maggi P, 2012, AIDS PATIENT CARE ST, V26, P5, DOI 10.1089/apc.2011.0185; Marzolini C, 2001, AIDS, V15, P1193, DOI 10.1097/00002030-200106150-00023; Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225; Moore KHP, 1996, CLIN PHARMACOL THER, V59, P550, DOI 10.1016/S0009-9236(96)90183-6; Morris AAM, 2001, AIDS, V15, P140, DOI 10.1097/00002030-200101050-00027; Moss DM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00078; Mouton JP, 2016, EXPERT REV CLIN PHAR, V9, P1493, DOI 10.1080/17512433.2016.1221760; Muller F, 2015, EUR J CLIN PHARMACOL, V71, P85, DOI 10.1007/s00228-014-1770-2; Muller F, 2013, BIOCHEM PHARMACOL, V86, P808, DOI 10.1016/j.bcp.2013.07.008; National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (U.S.) National Academies Press (U.S.), 2011, GUIDE CARE USE LAB A; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Reznicek J, 2017, XENOBIOTICA, V47, P77, DOI 10.3109/00498254.2016.1158886; Said SM, 2007, KIDNEY INT, V71, P1071, DOI 10.1038/sj.ki.5002134; Stahle L, 2004, THER DRUG MONIT, V26, P267, DOI 10.1097/00007691-200406000-00008; Storch CH, 2007, BIOCHEM PHARMACOL, V73, P1573, DOI 10.1016/j.bcp.2007.01.027; Stormer E, 2002, PHARMACEUT RES, V19, P1038, DOI 10.1023/A:1016430825740; Takubo T, 2000, J PHARM PHARMACOL, V52, P315, DOI 10.1211/0022357001774011; Takubo T, 2002, J PHARM PHARMACOL, V54, P111, DOI 10.1211/0022357021771814; Tsuda M, 2009, J PHARMACOL EXP THER, V329, P185, DOI 10.1124/jpet.108.147918; Tweedie D, 2013, CLIN PHARMACOL THER, V94, P113, DOI 10.1038/clpt.2013.77; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474; Weiss J, 2007, DRUG METAB DISPOS, V35, P340, DOI 10.1124/dmd.106.012765; World Health Organization, 2016, CONS GUID US ANT DRU; Zamek-Gliszczynski MJ, 2012, CLIN PHARMACOL THER, V92, P553, DOI 10.1038/clpt.2012.126; Zelena L, 2017, J PHARMACEUT BIOMED, V137, P70, DOI 10.1016/j.jpba.2017.01.012; Zolk O, 2011, CLIN PHARMACOL THER, V89, P798, DOI 10.1038/clpt.2010.354	47	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202706	10.1371/journal.pone.0202706	http://dx.doi.org/10.1371/journal.pone.0202706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114293	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400093
J	De Giorgio, A; Sellami, M; Kuvacic, G; Lawrence, G; Padulo, J; Mingardi, M; Mainolfi, L				De Giorgio, Andrea; Sellami, Maha; Kuvacic, Goran; Lawrence, Gavin; Padulo, Johnny; Mingardi, Marco; Mainolfi, Luigi			Enhancing motor learning of young soccer players through preventing an internal focus of attention: The effect of shoes colour	PLOS ONE			English	Article							EXTERNAL-FOCUS; RECOGNITION MEMORY; PERFORMANCE; INSTRUCTIONS; SKILL; GOLF; AFFORDANCES; PERCEPTION; ADVANTAGES; ACCURACY	The purpose of this research was to assess how the motor learning skills in 7-years old soccer players can be improved by preventing an internal focus of attention via the use coloured shoes. We painted the classic black soccer shoes in six areas corresponding to six regions of the foot with which it is possible to interact with the ball. Thirty-four 7-years-old soccer players were randomized to two groups (Coloured n = 17 and Black, n = 17) to perform four basic football manoeuvres/tasks: reception (RECP), passing (PASS), ball management (MAGT), and shooting (SHOT). We found highly significant differences (P<0.001) in all four performance tests: mean(sd) RECP: 0.82(0.07) vs. 0.45(0.12); PASS: 0.85(0.07) vs. 0.47 (0.09); MAGI: 0.91(0.09); SHOT: 1.00(1.00) vs. 0.44(0.16). Colored shoes appear to draw children's attention away from body centered cues without explicit verbal communications. We propose that this cognitive adaptation enhanced the technical gesture by preventing the negative processes associated with action constraining when adopting an internal focus attention (perhaps by allowing the foot to adapt to surfaces and movements more naturally than conditions that promote a focus on the body movement). Consequently, this type of coloured footwear could be used during childhood to allow children to enhance the performance of basic football exercises through preventing action constraining and promoting intuitive (non-body centered) action knowledge.	[De Giorgio, Andrea; Padulo, Johnny; Mingardi, Marco; Mainolfi, Luigi] eCampus Univ, Fac Psychol, Novedrate, Italy; [De Giorgio, Andrea; Sellami, Maha; Kuvacic, Goran; Padulo, Johnny] Univ Split, Fac Kinesiol, Split, Croatia; [Lawrence, Gavin] Bangor Univ, Inst Psychol Elite Performance, Sch Sport Hlth & Exercise Sci, Bangor, Gwynedd, Wales; [Padulo, Johnny] Natl Ctr Med & Sci Sport, Tunisian Res Lab Sports Performance Optimizat, Tunis, Tunisia	Universita Ecampus; University of Split; Bangor University; Centre National de la Medecine Sciences des Sports	Padulo, J (corresponding author), eCampus Univ, Fac Psychol, Novedrate, Italy.; Padulo, J (corresponding author), Univ Split, Fac Kinesiol, Split, Croatia.; Padulo, J (corresponding author), Natl Ctr Med & Sci Sport, Tunisian Res Lab Sports Performance Optimizat, Tunis, Tunisia.	sportcinetic@gmail.com	Padulo, Johnny/AAK-2207-2020; Kuvačić, Goran/D-4903-2017	Padulo, Johnny/0000-0002-4254-3105; Kuvačić, Goran/0000-0001-5302-7192				Abdollahipour R, 2016, RES Q EXERCISE SPORT, V87, P408, DOI 10.1080/02701367.2016.1224295; Al-Abood SA, 2002, J SPORT SCI, V20, P271, DOI 10.1080/026404102317284817; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bell JJ, 2009, J APPL SPORT PSYCHOL, V21, P163, DOI 10.1080/10413200902795323; BELLIZZI JA, 1983, J RETAILING, V59, P21; Castaneda B, 2007, J SPORT EXERCISE PSY, V29, P60, DOI 10.1123/jsep.29.1.60; Chaouachi A, 2012, J STRENGTH COND RES, V26, P2667, DOI 10.1519/JSC.0b013e318242f97a; Chiviacowsky S, 2013, J INTELL DISABIL RES, V57, P627, DOI 10.1111/j.1365-2788.2012.01569.x; Coe R, EFF SIZ CALC; Cohen MA, 2009, P NATL ACAD SCI USA, V106, P6008, DOI 10.1073/pnas.0811884106; Dzulkifli MA, 2013, MALAYS J MED SCI, V20, P3; Fajen BR, 2007, ECOL PSYCHOL, V19, P383, DOI 10.1080/10407410701557877; Fajen BR, 2011, J EXP PSYCHOL HUMAN, V37, P1442, DOI 10.1037/a0023510; Fitts PM., 1967, HUM PERFORM; Garganta J., 2009, REV PORTUGUESA CIENC, V9, P115, DOI [DOI 10.5628/RPCD.09.01.115, 10.5628/rpcd.09.01.115]; Gentile A.M., 2000, SKILL ACQUISITION AC; Gibson J.J., 1979, ECOLOGICAL APPROACH; Gottlieb J, 2012, NEURON, V76, P281, DOI 10.1016/j.neuron.2012.09.034; Greenlees Iain A, 2013, Percept Mot Skills, V117, P1043; GREHAIGNE JF, 1995, QUEST, V47, P490, DOI 10.1080/00336297.1995.10484171; Hennig EM, 2010, FOOTWEAR SCI, V2, P3, DOI 10.1080/19424281003691999; Hopkins WG, SPREADSHEET COMP MEA; Hopkins WG., SCALE MAGNITUDES EFF; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hunchendorf L., 2007, UW L J UNDERGRADUATE, VX, P1; Kurt S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014525423; Lawrence GP, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00468; Lawrence GP, 2011, RES Q EXERCISE SPORT, V82, P431, DOI 10.1080/02701367.2011.10599775; Luyat M, 2009, ANN PSYCHOL, V109, P297; McNevin NH, 2003, PSYCHOL RES-PSYCH FO, V67, P22, DOI 10.1007/s00426-002-0093-6; Olafsdottir IM, 2016, COGN RES, V1, DOI 10.1186/s41235-016-0016-5; Pourazar M, 2017, WORLD ACAD SCI ENG T, V11, P307; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Querfurth S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00633; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Shea CH, 1999, HUM MOVEMENT SCI, V18, P553, DOI 10.1016/S0167-9457(99)00031-7; Shitova N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161052; Sterzing T, 2009, FOOTWEAR SCI, V1, P5, DOI 10.1080/19424280902915350; Stratton G., 2004, YOUTH SOCCER SCI PER; Tsetseli M, 2016, ACTA GYMNICA, V46, P162, DOI 10.5507/ag.2016.021; Vando Stefano, 2014, Muscles Ligaments Tendons J, V4, P137; Vrbik I, 2017, PEDIATR EXERC SCI, V29, P278, DOI 10.1123/pes.2016-0091; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; Willats J., 2006, MAKING SENSE CHILDRE; Williams AM, 2000, J SPORT SCI, V18, P737, DOI 10.1080/02640410050120113; Wing-Kai Lam, 2017, Footwear Science, V9, pS3, DOI 10.1080/19424280.2017.1313889; Wright A, 2008, IT WORKS; Wulf G, 1999, RES Q EXERCISE SPORT, V70, P120, DOI 10.1080/02701367.1999.10608029; Wulf G, 1998, J MOTOR BEHAV, V30, P169, DOI 10.1080/00222899809601334; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2007, E J BEWEGUNG TRAIN, P1; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035	55	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0200689	10.1371/journal.pone.0200689	http://dx.doi.org/10.1371/journal.pone.0200689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ5PD	30110332	Green Submitted, Green Published, gold			2022-12-26	WOS:000441738000005
J	Kumar, V; Tiwari, M; Rengarajan, R				Kumar, Vikash; Tiwari, Manish; Rengarajan, R.			Warming in the Arctic Captured by productivity variability at an Arctic Fjord over the past two centuries	PLOS ONE			English	Article							PHYTOPLANKTON BIOMASS; BENTHIC FORAMINIFERA; ATLANTIC OSCILLATION; SEDIMENT CORE; MASS-BALANCE; SVALBARD; KONGSFJORDEN; GLACIERS; PB-210; SHELF	Arctic fjords feature among some of the most climate-sensitive regions on the planet. The site of this study-Kongsfjorden-is one such fjord in which sedimentation and sediment geochemistry reflect climate-mediated changes in glacial melt and marine primary productivity. Here, we have shown that the fjord is particularly sensitive to the changing melt dynamics of the surrounding glaciers which are a direct consequence of warming/cooling in the region and is reflected in the productivity at the fjord. Warming increases meltwater influx into the fjord leading to enhanced turbidity which results in lower productivity. A multi-proxy study (sedimentary organic matter content, carbon and nitrogen isotope ratios, and microfossil abundance) using a 21 cm long sediment core from the Kongsfjorden helped us reconstruct warming driven melt-dynamics history for the past two centuries. Proxy data show a general decreasing trend in productivity along with a few excursions over the last two centuries. Warming driven glacial-melt dynamics appears to be the dominant control on productivity throughout the span of the core.	[Kumar, Vikash; Tiwari, Manish] Natl Ctr Antarctic & Ocean Res, Vasco Da Gama, Goa, India; [Rengarajan, R.] Phys Res Lab, Ahmadabad, Gujarat, India	Ministry of Earth Sciences (MoES) - India; National Centre for Polar and Ocean Research (NCPOR); Department of Space (DoS), Government of India; Physical Research Laboratory - India	Tiwari, M (corresponding author), Natl Ctr Antarctic & Ocean Res, Vasco Da Gama, Goa, India.	manish@ncaor.gov.in	Kumar, Vikash/GSN-3140-2022; Rengarajan, Ramabadran/L-4055-2019	Kumar, Vikash/0000-0002-6180-2192; Tiwari, Manish/0000-0003-3143-1658	NCAOR under the Ministry of the Earth Sciences; Ministry of Earth Sciences; National Centre for Antarctic & Ocean Research (NCAOR) [28/2018]	NCAOR under the Ministry of the Earth Sciences; Ministry of Earth Sciences; National Centre for Antarctic & Ocean Research (NCAOR)	The funding is through the parent institute (NCAOR under the Ministry of the Earth Sciences). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ministry of Earth Sciences and National Centre for Antarctic & Ocean Research for support (NCAOR Contribution no. 28/2018). We also thank the colleagues for their help during sample collection at Kongsfjorden onboard the boat R/V Tiesten.	Aracena C, 2011, CONT SHELF RES, V31, P340, DOI 10.1016/j.csr.2010.08.008; Baskaran M, 2014, J ENVIRON RADIOACTIV, V138, P355, DOI 10.1016/j.jenvrad.2014.07.006; Bischof K, 1998, POLAR BIOL, V20, P388, DOI 10.1007/s003000050319; BRENNER M, 1994, LIMNOL OCEANOGR, V39, P1222, DOI 10.4319/lo.1994.39.5.1222; Brodie CR, 2011, QUATERNARY SCI REV, V30, P3076, DOI 10.1016/j.quascirev.2011.07.003; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; CORLISS BH, 1991, MAR MICROPALEONTOL, V17, P195, DOI 10.1016/0377-8398(91)90014-W; Cottier F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002757; Cottier FR, 2010, GEOL SOC SPEC PUBL, V344, P35, DOI 10.1144/SP344.4; CRUSIUS J, 1995, J PALEOLIMNOL, V13, P119, DOI 10.1007/BF00678102; Delworth TL, 2000, J CLIMATE, V13, P3721, DOI 10.1175/1520-0442(2000)013<3721:IOTRTI>2.0.CO;2; Elverhoi A., 1980, NOR POLARINST SKR, V172, P33; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Hagen JO, 2003, ARCT ANTARCT ALP RES, V35, P264, DOI 10.1657/1523-0430(2003)035[0264:OTNMBO]2.0.CO;2; Hald M, 1987, PALEOCEANOGRAPHY, V2, P583, DOI 10.1029/PA002i006p00583; Hald Morten, 1994, Cushman Foundation for Foraminiferal Research Special Publication, V32, P141; HALLDAL P, 1973, Norwegian Journal of Botany, V20, P99; Hegseth EN, 2013, J MARINE SYST, V113, P94, DOI 10.1016/j.jmarsys.2013.01.003; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Isaksson E, 2005, HOLOCENE, V15, P501, DOI 10.1191/0959683605hl820rp; JENNINGS AE, 1994, J FORAMIN RES, V24, P123, DOI 10.2113/gsjfr.24.2.123; Juul-Pedersen T, 2015, MAR ECOL PROG SER, V524, P27, DOI 10.3354/meps11174; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Keck A, 1999, ICES J MAR SCI, V56, P203, DOI 10.1006/jmsc.1999.0631; Korsun S, 2000, J FORAMIN RES, V30, P251, DOI 10.2113/0300251; KORSUN SA, 1995, POLAR RES, V14, P15, DOI 10.1111/j.1751-8369.1995.tb00707.x; KORSUN SA, 1989, OKEANOLOGIYA+, V29, P838; Kumar V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36192; MacLachlan SE, 2007, POLAR RES, V26, P160, DOI 10.1111/j.1751-8369.2007.00016.x; Martin-Espanol A, 2015, J GLACIOL, V61, P29, DOI 10.3189/2015JoG14J159; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; Nordli O., 2010, B GEOGR PHYS GEOGR S, V3, P5, DOI DOI 10.2478/2326; Nordli O, 2014, POLAR RES, V33, DOI 10.3402/polar.v33.21349; Nuth C, 2013, CRYOSPHERE, V7, P1603, DOI 10.5194/tc-7-1603-2013; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Piwosz K, 2009, POLAR BIOL, V32, P549, DOI 10.1007/s00300-008-0549-2; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; Schubert CJ, 2001, DEEP-SEA RES PT I, V48, P789, DOI 10.1016/S0967-0637(00)00069-8; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Silva N., 2008, PROGR OCEANOGRAPHIC, P69; Stein R., 2004, ORGANIC CARBON CYCLE, P24, DOI DOI 10.1007/978-3-642-18912-8_7; Steinsund P.I., 1994, THESIS; Svendsen H, 2002, POLAR RES, V21, P133, DOI 10.1111/j.1751-8369.2002.tb00072.x; Swann AL, 2010, P NATL ACAD SCI USA, V107, P1295, DOI 10.1073/pnas.0913846107; Syvitski J.P.M., 1995, DEV SEDIMENTOL, V53, P113, DOI DOI 10.1016/S0070-4571(05)80025-1; Van Pelt W, 2015, J GLACIOL, V61, P731, DOI 10.3189/2015JoG14J223; WOFSY SC, 1983, LIMNOL OCEANOGR, V28, P1144, DOI 10.4319/lo.1983.28.6.1144; Zhang XD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035607	51	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201456	10.1371/journal.pone.0201456	http://dx.doi.org/10.1371/journal.pone.0201456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110352	Green Published, Green Submitted, gold			2022-12-26	WOS:000441738000032
J	Fujita, K; Kunito, T; Matsushita, J; Nakamura, K; Moro, H; Yoshida, S; Toda, H; Otsuka, S; Nagaoka, K				Fujita, Kazuki; Kunito, Takashi; Matsushita, Junko; Nakamura, Kaori; Moro, Hitoshi; Yoshida, Seishi; Toda, Hideshige; Otsuka, Shigeto; Nagaoka, Kazunari			Nitrogen supply rate regulates microbial resource allocation for synthesis of nitrogen-acquiring enzymes	PLOS ONE			English	Article							L-ASPARAGINASE; SACCHAROMYCES-CEREVISIAE; CATABOLITE REPRESSION; NUTRIENT LIMITATION; SOIL; PHOSPHORUS; INDEXES; MICROORGANISMS; FERTILIZATION; AVAILABILITY	Although microorganisms will preferentially allocate resources to synthesis of nitrogen (N)-acquiring enzymes when soil N availability is low according to the resource allocation model for extracellular enzyme synthesis, a robust link between microbial N-acquiring enzyme activity and soil N concentration has not been reported. To verify this link, we measured several indices of soil N availability and enzyme activity of four N-acquiring enzymes [N-acetyl-beta-glucosaminidase (NAG), protease (PR), urease (UR), and L-asparaginase (LA)] and a carbon (C)-acquiring enzyme [beta-D-glucosidase (BG)] in arable and forest soils. Although the ratios of NAG/BG and PR/BG were not significantly related with indices of soil N availability, ratios of LA/BG and UR/BG were strongly and negatively related with potentially mineralizable N estimated by aerobic incubation but not with pools of labile inorganic N and organic N. These results suggest that microorganisms might allocate their resources to LA and UR synthesis in response to N supply rate rather than the size of the easily available N pools. It was also suggested that the underlying mechanism for synthesis was different between these N-acquiring enzymes in soil microorganisms: microbial LA and UR were primarily synthesized to acquire N, whereas NAG and PR syntheses were regulated not only by N availability but also by other factors.	[Fujita, Kazuki; Kunito, Takashi; Matsushita, Junko; Nakamura, Kaori; Moro, Hitoshi; Toda, Hideshige] Shinshu Univ, Fac Sci, Dept Environm Sci, Matsumoto, Nagano, Japan; [Yoshida, Seishi] Nagano Prefecture Vegetable & Ornamental Crops Ex, Shiojiri, Japan; [Otsuka, Shigeto] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Nagaoka, Kazunari] NARO, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan; [Nagaoka, Kazunari] NARO, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan	Shinshu University; University of Tokyo; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Kunito, T (corresponding author), Shinshu Univ, Fac Sci, Dept Environm Sci, Matsumoto, Nagano, Japan.	kunito@shinshu-u.ac.jp	Kunito, Takashi/D-8449-2012	Kunito, Takashi/0000-0002-3028-736X; Fujita, Kazuki/0000-0002-9739-2447	JSPS KAKENHI [JP24510012, JP26292035]; Management Expenses Grant from Shinshu University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Management Expenses Grant from Shinshu University	This study was supported by JSPS (https://www.jsps.go.jp/english/index.html) KAKENHI Grant Number JP24510012 (to TK) and JP26292035 (to SO) and by a Management Expenses Grant from Shinshu University (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe K, 2001, METHODS SOIL WATER P, P188; ALLISON C, 1990, APPL ENVIRON MICROB, V56, P3485, DOI 10.1128/AEM.56.11.3485-3490.1990; [Anonymous], 2008, NITROGEN AGR SYSTEMS; ARIMA K, 1972, AGR BIOL CHEM TOKYO, V36, P356, DOI 10.1080/00021369.1972.10860270; ATKINSON MR, 1991, J BACTERIOL, V173, P23, DOI 10.1128/jb.173.1.23-27.1991; Averill C, 2014, ECOL LETT, V17, P1202, DOI 10.1111/ele.12324; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Binkley D., 1989, Advances in Soil Science, V10, P57; Binkley D., 1989, Plant physiological ecology: field methods and instrumentation., P75; Bundy LG., 1994, METHODS SOIL ANAL PA, P951; Dong NM, 2011, ENVIRON SCI TECHNOL, V45, P1048, DOI 10.1021/es1030036; DUNLOP PC, 1980, J BIOL CHEM, V255, P1542; DUNLOP PC, 1975, J BACTERIOL, V122, P1017, DOI 10.1128/JB.122.3.1017-1024.1975; Fisher SH, 2002, J BACTERIOL, V184, P2148, DOI 10.1128/JB.184.8.2148-2154.2002; Fujita K, 2017, BIOGEOCHEMISTRY, V136, P325, DOI 10.1007/s10533-017-0398-6; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; GOLDEN KJ, 1985, J BACTERIOL, V164, P938, DOI 10.1128/JB.164.2.938-940.1985; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1016/S0168-6445(99)00022-4; Higuchi M., 1982, JPN J SOIL SCI PLANT, V53, P1; Hill BH, 2006, FRESHWATER BIOL, V51, P1670, DOI 10.1111/j.1365-2427.2006.01606.x; HONG SD, 1990, PLANT SOIL, V123, P83, DOI 10.1007/BF00009929; HOWARD JB, 1972, J BIOL CHEM, V247, P1020; Jian SY, 2016, SOIL BIOL BIOCHEM, V101, P32, DOI 10.1016/j.soilbio.2016.07.003; KANAZAWA S, 1995, SOIL SCI PLANT NUTR, V41, P305, DOI 10.1080/00380768.1995.10419587; Kandeler E., 1996, METHODS SOIL BIOL, P406; Kandeler E., 1996, METHODS SOIL BIOL, P141; KANDELER E, 1996, METHODS SOIL BIOL, P165; KEENEY DR, 1980, FOREST SCI, V26, P159; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Klose S, 1999, SOIL BIOL BIOCHEM, V31, P205, DOI 10.1016/S0038-0717(98)00090-X; Kunito T, 2012, PEDOBIOLOGIA, V55, P263, DOI 10.1016/j.pedobi.2012.05.002; Liao XL, 2014, ECOL INDIC, V46, P358, DOI 10.1016/j.ecolind.2014.07.001; Margesin R, 1996, METHODS SOIL BIOL, P171; Matsumoto S, 2004, SOIL SCI PLANT NUTR, V50, P1, DOI 10.1080/00380768.2004.10408446; Matsumoto S, 2000, SOIL SCI PLANT NUTR, V46, P139, DOI 10.1080/00380768.2000.10408770; MCCARTY GW, 1992, BIOL FERT SOILS, V12, P261, DOI 10.1007/BF00336041; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Miah MY, 2000, SOIL SCI PLANT NUTR, V46, P787, DOI 10.1080/00380768.2000.10409144; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Moro H, 2015, ARCH AGRON SOIL SCI, V61, P1107, DOI 10.1080/03650340.2014.984697; Mulvaney R. L., 1996, Methods of soil analysis. Part 3 - chemical methods., P1123; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Nielsen TH, 1998, FEMS MICROBIOL ECOL, V25, P147, DOI 10.1016/S0168-6496(97)00091-3; NORTH MJ, 1982, MICROBIOL REV, V46, P308, DOI 10.1128/MMBR.46.3.308-340.1982; Ogawa Y., 1997, DOJO KANKYO BUNSEKIH, P255; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; POCSI I, 1993, J BASIC MICROB, V33, P259, DOI 10.1002/jobm.3620330409; Qin SP, 2010, SOIL SCI, V175, P568, DOI 10.1097/SS.0b013e3181fa2810; RCore Team, 2020, R LANG ENV STAT COMP; Saito M., 1990, JPN J SOIL SCI PLANT, V61, P265; SAITO M, 1988, JPN J SOIL SCI PLANT, V59, P493; Sharifi M, 2007, SOIL SCI SOC AM J, V71, P1233, DOI 10.2136/sssaj2006.0265; SINSABAUGH RL, 1994, SOIL BIOL BIOCHEM, V26, P1305, DOI 10.1016/0038-0717(94)90211-9; SINSABAUGH RL, 1993, ECOLOGY, V74, P1586, DOI 10.2307/1940086; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2012, BIOGEOCHEMISTRY, V111, P455, DOI 10.1007/s10533-011-9676-x; St Luce M, 2011, ADV AGRON, V112, P55, DOI 10.1016/B978-0-12-385538-1.00002-0; Sullivan BW, 2014, ECOLOGY, V95, P668, DOI 10.1890/13-0825.1; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Tate RL, 2002, BOOK SOIL P, P227; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Weintraub SR, 2013, BIOGEOCHEMISTRY, V114, P313, DOI 10.1007/s10533-012-9812-2; WHOOLEY MA, 1983, J GEN MICROBIOL, V129, P981; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X	66	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202086	10.1371/journal.pone.0202086	http://dx.doi.org/10.1371/journal.pone.0202086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106996	gold, Green Published, Green Submitted			2022-12-26	WOS:000441662800027
J	Singh, D; Singh, CK; Singh, YP; Singh, V; Singh, R; Tomar, RSS; Sanwal, SK; Karwa, S; Mishra, VK; Sarkar, SK; Pal, M; Kumar, A; Yadav, RK; Sharma, PC				Singh, Dharmendra; Singh, Chandan Kumar; Singh, Yash Pal; Singh, Vijayata; Singh, Rajendra; Tomar, Ram Sewak Singh; Sanwal, Satish Kumar; Karwa, Sourabh; Mishra, Vinay Kumar; Sarkar, Susheel Kumar; Pal, Madan; Kumar, Arun; Yadav, Rajendra Kumar; Sharma, Parbodh Chander			Evaluation of cultivated and wild genotypes of Lens species under alkalinity stress and their molecular collocation using microsatellite markers	PLOS ONE			English	Article							LINKAGE MAP; ACCUMULATION; SALINITY; GROWTH; LENTIL; BICARBONATE; TOLERANCE; RESPONSES; SORGHUM; L.	In this study, 285 lentil genotypes were phenotyped under hydroponic and alkaline field conditions. Significant genotypic variation for alkalinity stress was observed among the six Lens species screened hydroponically and in the field having pH up to 9.1. The crucial parameters, like whole Na+ and K+ contents and the Na+/K+ ratio at 40 mM NaHCO3 were found significantly correlated with seedling survivability under hydroponics (r = -0.95, r = 0.93 and -0.97). Genotypes, ranked on the bases of seed yield, restricted uptake of Na+ with thick pith area, increased vascular bundles, less H2O2 production and low Na+/K+ ratio, were found important physio-anatomical traits for alkalinity stress tolerance. The proper regulation of Na+ uptake was found for maintaining higher K+. This relationship is probably the main factor responsible for a better mechanism for tolerance to high pH up to 9.1 in tolerant breeding lines PDL-1 and PSL-9 (cultivars) and ILWL-15, ILWL-192 and ILWL-20 (wild accessions). Based on UPGMA dendrogram, all the genotypes were clustered into four diverse groups. DMRT was implied within the group to differentiate genotypes based on phenotypic response under alkalinity stress. These results can be utilized for selecting diverse parents for developing alkalinity tolerant genotypes.	[Singh, Dharmendra; Singh, Chandan Kumar] Indian Agr Res Inst, ICAR, Div Genet, New Delhi, India; [Singh, Yash Pal; Mishra, Vinay Kumar] Cent Soil Salin Res Inst, ICAR, Reg Stn, Lucknow, Uttar Pradesh, India; [Singh, Vijayata; Sanwal, Satish Kumar; Sharma, Parbodh Chander] Cent Soil Salin Res Inst, ICAR, Karnal, India; [Singh, Rajendra] Indian Agr Res Inst, ICAR, Div Soil Sci, New Delhi, India; [Singh, Rajendra] Indian Agr Res Inst, ICAR, Div Agr Chem, New Delhi, India; [Tomar, Ram Sewak Singh] Natl Res Ctr Plant Biotechnol, ICAR, Pusa Campus, New Delhi, India; [Karwa, Sourabh; Pal, Madan] Indian Agr Res Inst, ICAR, Div Plant Physiol, New Delhi, India; [Sarkar, Susheel Kumar] Indian Agr Res Inst, ICAR, New Delhi, India; [Kumar, Arun] Indian Agr Res Inst, ICAR, Natl Phytotron Facil, New Delhi, India; [Yadav, Rajendra Kumar] Chandra Shekhar Azad Univ Agr & Technol, Dept Genet & Plant Breeding, Kanpur, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Soil Salinity Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Soil Salinity Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, D (corresponding author), Indian Agr Res Inst, ICAR, Div Genet, New Delhi, India.; Singh, R (corresponding author), Indian Agr Res Inst, ICAR, Div Soil Sci, New Delhi, India.; Singh, R (corresponding author), Indian Agr Res Inst, ICAR, Div Agr Chem, New Delhi, India.; Pal, M (corresponding author), Indian Agr Res Inst, ICAR, Div Plant Physiol, New Delhi, India.	dharmendrapbg@rediffmail.com; rajendra.singh_phyto@yahoo.com; madanpal@yahoo.com	PAL, MRINAL/ABG-9676-2020; TOMAR, RAM SEWAK SINGH/AAF-5619-2021; karwa, sourabh D/O-5266-2018; Tomar, Dr. Rukam Singh/I-3474-2013	PAL, MRINAL/0000-0002-1032-272X; TOMAR, RAM SEWAK SINGH/0000-0001-9959-4395; karwa, sourabh D/0000-0002-6232-6765; Tomar, Dr. Rukam Singh/0000-0001-9156-5311	Indian Agricultural Research Institute, New Delhi [JAN 09 / 16]; ICAR-Indian Agricultural Research Institute (IARI), New Delhi	Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); ICAR-Indian Agricultural Research Institute (IARI), New Delhi	Funded by Indian Agricultural Research Institute, New Delhi, and Project no-JAN 09 / 16, (DS), http://www.iari.res.in/.; We are grateful to the Director, Joint Director (Res), ICAR-Indian Agricultural Research Institute (IARI), New Delhi, Head, Division of Genetics and Incharge, National Phytotron Facility, IARI, New Delhi, for providing support to carry out all research activities. Supply of lentil seeds from International Center for Agricultural Research in the Dry Areas (ICARDA), Aleppo, Syria and National Bureau of Plant Genetic Resources (NBPGR), New Delhi, India is duly acknowledged. We sincerely thank Dr. Shiv Kumar Agarwal for providing information on the origin of wild accessions.	Alhendawi RA, 1997, J PLANT NUTR, V20, P1731, DOI 10.1080/01904169709365371; [Anonymous], 2011, GLOBAL REGIONAL TREN, P23; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; BIALCZYK J, 1994, J PLANT NUTR, V17, P801, DOI 10.1080/01904169409364768; Ceccoli G, 2011, BIOCELL, V35, P9; Paz RC, 2012, J PLANT GROWTH REGUL, V31, P448, DOI 10.1007/s00344-011-9254-4; de Lacerda CF, 2003, ENVIRON EXP BOT, V49, P107, DOI 10.1016/S0098-8472(02)00064-3; Dikshit HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138101; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Gharsalli M., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P606; Gupta D, 2012, MOL BREEDING, V30, P429, DOI 10.1007/s11032-011-9634-2; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Idrissi O, 2015, PLANT BREEDING, V134, P322, DOI 10.1111/pbr.12261; Jackson M. L., 1958, Soil Chemical Analysis.; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; Javid M, 2012, FUNCT PLANT BIOL, V39, P699, DOI 10.1071/FP12109; Jin L, 2008, ACTA AGRONO SIN, V34, P1901, DOI DOI 10.1016/S1875-2780(09)60015-8; Kahraman A, 2004, CROP SCI, V44, P13, DOI 10.2135/cropsci2004.0013; Kaur S, 2014, THEOR APPL GENET, V127, P703, DOI 10.1007/s00122-013-2252-0; Krishnamurthy L, 2014, PLANT SCI, V227, P51, DOI 10.1016/j.plantsci.2014.07.001; Kushwaha UKS, 2013, INT J APPL SCI BIOTE, V1, P132, DOI DOI 10.3126/ijasbt.v1i3.8608; Li R, 2010, S AFR J BOT, V76, P380, DOI 10.1016/j.sajb.2010.01.004; Lin JiXiang, 2012, African Journal of Agricultural Research, V7, P467; Liu K, 2015, POWER MARKER NEW GEN; Maas EV, 1981, CAL PLANT SOIL C NEW, P10; Millar AL, 2007, DEV PLANT BREED, V12, P395; Murillo-Amador B., 2006, GROWTH SCI HORTIC, V108, P432; Murillo-Amador E, 2001, PRODUCT SCI, V41, P81; Pritchard JK, 2000, GENETICS, V155, P945; Radi A. A., 2012, Journal of Biology and Earth Sciences, V2, pB18; Sharma S. K., 2001, Indian Journal of Plant Physiology, V6, P275; Singh D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147213; Singh D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177465; Singh YP., 2013, J SOIL SALIN WATER Q, V5, P40; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanyolac B, 2010, J AGR BIOTECH SUSTAI, V2; Tavakkoli E, 2012, FIELD CROP RES, V127, P99, DOI 10.1016/j.fcr.2011.10.016; Valdez-Aguilar LA, 2008, J PLANT NUTR, V31, P867, DOI 10.1080/01904160802043213; Wang YC, 2008, PLANT PHYSIOL BIOCH, V46, P977, DOI 10.1016/j.plaphy.2008.06.001; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; YANG X, 1994, PLANT SOIL, V164, P1, DOI 10.1007/BF00010104; Zhang PP, 2012, ECOTOXICOLOGY, V21, P1911, DOI 10.1007/s10646-012-0924-1	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0199933	10.1371/journal.pone.0199933	http://dx.doi.org/10.1371/journal.pone.0199933			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102704	Green Published, Green Submitted			2022-12-26	WOS:000441452200002
J	Pinheiro, DH; Velez, AM; Fishilevich, E; Wang, HC; Carneiro, NP; Valencia-Jimenez, A; Valicente, FH; Narva, KE; Siegfried, BD				Pinheiro, Daniele H.; Velez, Ana M.; Fishilevich, Elane; Wang, Haichuan; Carneiro, Newton P.; Valencia-Jimenez, Arnubio; Valicente, Fernando H.; Narva, Kenneth E.; Siegfried, Blair D.			Clathrin-dependent endocytosis is associated with RNAi response in the western corn rootworm, Diabrotica virgifera virgifera LeConte	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; RECEPTOR-MEDIATED ENDOCYTOSIS; SYSTEMIC RNAI; INSECT PEST; INTERFERENCE; DSRNA; GENE; COLEOPTERA; SIRNA; SUSCEPTIBILITY	The cellular uptake of dsRNA after dietary exposure is critical for RNAi efficiency; however, the mechanism of its uptake in many insects remains to be understood. In this study, we evaluated the roles of the endocytic pathway genes Clathrin heavy chain (Chc), Clathrin adaptor protein AP50, ADP ribosylation factor-like 1 (Arf72A), Vacuolar H+ ATPase 16 kDa subunit (Vhal6), and small GTPase Rab7 and putative sic-1-like genes (silA and silC) in RNAi response in western corn rootworm (WCR) using a two-stage dsRNA exposure bioassay. Silencing of Chc, Vha16, and AP50 led to a significant decrease in the effects of laccase2dsRNA reporter, indicating that these genes are involved in RNAi response. However, the knockdown of either Arf72A or Rab7 did not suppress the response to laccase2 dsRNA. The silencing of the silC gene did not lead to a significant reduction in mortality or increase in the expression of V-ATPase A reporter. While the silencing of the silA gene significantly decreased insect mortality, significant changes in V-ATPase A expression were not detected. These results suggest that clathrin-dependent endocytosis is a biological mechanism that plays an important role during RNAi response in WCR adults. The fact that no definitive support for the roles of silA or silC in RNAi response was obtained support the idea that RNAi response varies greatly in different insect species, demanding additional studies focused on elucidating their involvement in this mechanism.	[Pinheiro, Daniele H.; Siegfried, Blair D.] Univ Florida, Entomol & Nematol Dept, Charles Steinmetz Hall, Gainesville, FL 32611 USA; [Pinheiro, Daniele H.] Univ Fed Lavras, Dept Chem, Lavras, MG, Brazil; [Velez, Ana M.; Fishilevich, Elane; Wang, Haichuan; Carneiro, Newton P.] Univ Lincoln, Dept Entomol, Entomol Hall, Lincoln, NE USA; [Fishilevich, Elane; Narva, Kenneth E.] Corteva Agrisci, Agr Div DowDuPont, Indianapolis, IN USA; [Carneiro, Newton P.; Valicente, Fernando H.] Embrapa Maize & Sorghum, Nucleus Appl Biol, Sete Lagoas, MG, Brazil; [Valencia-Jimenez, Arnubio] Univ Caldas, Dept Prod Agr, Manizales, Caldas, Colombia	State University System of Florida; University of Florida; Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidad de Caldas	Velez, AM (corresponding author), Univ Lincoln, Dept Entomol, Entomol Hall, Lincoln, NE USA.	avelezarango2@unl.edu		Velez, Ana Maria/0000-0002-8329-6243; Valencia-Jimenez, Arnubio/0000-0003-3328-2932; Narva, Kenneth/0000-0001-8094-6418	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; University of Nebraska-Lincoln; Corteva Agriscience(TM), Agriculture Division of DowDuPont(TM)	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Nebraska-Lincoln; Corteva Agriscience(TM), Agriculture Division of DowDuPont(TM)	This work was partially supported by CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for DHP's scholarship (DHP). AMV, HW, AVJ and BDS were funded by the University of Nebraska-Lincoln. Corteva Agriscience (TM), Agriculture Division of DowDuPont (TM) provided support in the form of salaries for authors KEN and EF but did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Bally J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01453; Bansal R, 2013, INT J MOL SCI, V14, P3786, DOI 10.3390/ijms14023786; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; BRANSON TF, 1988, J KANSAS ENTOMOL SOC, V61, P353; Cappelle K, 2016, INSECT MOL BIOL, V25, P315, DOI 10.1111/imb.12222; Devos Y, 2013, TRANSGENIC RES, V22, P269, DOI 10.1007/s11248-012-9657-4; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, DOI 10.1038/nrm3159; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Ghosh S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-775; Gong L, 2015, INT J AGRIC BIOL, V17, P937, DOI 10.17957/IJAB/15.0005; Hinas A, 2012, CURR BIOL, V22, P1938, DOI 10.1016/j.cub.2012.08.020; Hu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep30542; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jin SX, 2015, PLANT BIOTECHNOL J, V13, P435, DOI 10.1111/pbi.12355; Joga MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00553; Jose AM, 2012, P NATL ACAD SCI USA, V109, P14520, DOI 10.1073/pnas.1201153109; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lee J, 2011, INT J BIOCHEM CELL B, V43, P1392, DOI 10.1016/j.biocel.2011.06.004; Levine Eli, 2002, American Entomologist, V48, P94; Li H, 2015, J APPL ENTOMOL, V139, P432, DOI 10.1111/jen.12224; Li XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep08700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu L, 2001, J CELL SCI, V114, P4543; Luo Y, 2012, RNA BIOL, V9, P663, DOI 10.4161/rna.19986; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; McEwan DL, 2012, MOL CELL, V47, P746, DOI 10.1016/j.molcel.2012.07.014; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Metcalf R. L., 1983, Pest resistance to pesticides, P703; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101661; Ni M, 2017, PLANT BIOTECHNOL J, V15, P1204, DOI 10.1111/pbi.12709; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Ren D, 2014, INSECT MOL BIOL, V23, P175, DOI 10.1111/imb.12074; Rocheleau CE, 2012, CURR BIOL, V22, pR873, DOI 10.1016/j.cub.2012.08.039; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Rosenwald AG, 2002, YEAST, V19, P1039, DOI 10.1002/yea.897; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Sappington TW, 2006, COORDINATED DIABROTI, P90; SAS-Institute, 2011, SAS US MAN; Shukla JN, 2016, RNA BIOL, V13, P656, DOI 10.1080/15476286.2016.1191728; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Torres IL, 2014, J CELL SCI, V127, P2151, DOI 10.1242/jcs.122028; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valdes VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033962; van Rozen K, 2010, J APPL ENTOMOL, V134, P376, DOI 10.1111/j.1439-0418.2009.01504.x; Velez AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157520; Wang HD, 2014, ARCH INSECT BIOCHEM, V87, P164, DOI 10.1002/arch.21189; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Whangbo JS, 2017, G3-GENES GENOM GENET, V7, P3887, DOI 10.1534/g3.117.300308; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wynant N, 2014, INSECT MOL BIOL, V23, P320, DOI 10.1111/imb.12083; Xiao D, 2015, INSECT BIOCHEM MOLEC, V60, P68, DOI 10.1016/j.ibmb.2015.03.009; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Yoon JS, 2017, INSECT BIOCHEM MOLEC, V90, P53, DOI 10.1016/j.ibmb.2017.09.011; Yoon JS, 2016, INSECT BIOCHEM MOLEC, V78, P78, DOI 10.1016/j.ibmb.2016.09.002; Zhang J, 2015, SCIENCE, V347, P991, DOI 10.1126/science.1261680	72	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201849	10.1371/journal.pone.0201849	http://dx.doi.org/10.1371/journal.pone.0201849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092086	Green Published, gold			2022-12-26	WOS:000441232600061
J	Chambers, DM; Moretti, L; Zhang, JJ; Cooper, SW; Chambers, DM; Santangelo, PJ; Barker, TH				Chambers, Dwight M.; Moretti, Leandro; Zhang, Jennifer J.; Cooper, Spencer W.; Chambers, Davis M.; Santangelo, Philip J.; Barker, Thomas H.			LEM domain-containing protein 3 antagonizes TGF beta-SMAD2/3 signaling in a stiffness-dependent manner in both the nucleus and cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SMAD transcription factor; transforming growth factor (TGF-); mechanotransduction; pulmonary fibrosis; nuclear membrane; actin; Buschke-Ollendorff syndrome; LEM; LEMD3; MAN1; nuclear lamina	BUSCHKE-OLLENDORFF-SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; MEMBRANE PROTEIN; IN-VITRO; EXTRACELLULAR-MATRIX; NONSENSE MUTATION; LATENT TGF-BETA-1; INTEGRAL PROTEIN; SMAD PROTEINS	Transforming growth factor-beta (TGF beta) signaling through SMAD2/3 is an important driver of pathological fibrosis in multiple organ systems. TGF signaling and extracellular matrix (ECM) stiffness form an unvirtuous pathological circuit in which matrix stiffness drives activation of latent TGF beta, and TGF beta signaling then drives cellular stress and ECM synthesis. Moreover, ECM stiffness also appears to sensitize cells to exogenously activated TGF beta through unknown mechanisms. Here, using human fibroblasts, we explored the effect of ECM stiffness on a putative inner nuclear membrane protein, LEM domain-containing protein 3 (LEMD3), which is physically connected to the cell's actin cytoskeleton and inhibits TGF beta signaling. We showed that LEMD3-SMAD2/3 interactions are inversely correlated with ECM stiffness and TGF beta-driven luciferase activity and that LEMD3 expression is correlated with the mechanical response of the TGF beta-driven luciferase reporter. We found that actin polymerization but not cellular stress or LEMD3-nuclear-cytoplasmic couplings were necessary for LEMD3-SMAD2/3 interactions. Intriguingly, LEMD3 and SMAD2/3 frequently interacted in the cytosol, and we discovered LEMD3 was proteolytically cleaved into protein fragments. We confirmed that a consensus C-terminal LEMD3 fragment binds SMAD2/3 in a stiffness-dependent manner throughout the cell and is sufficient for antagonizing SMAD2/3 signaling. Using human lung biopsies, we observed that these nuclear and cytosolic interactions are also present in tissue and found that fibrotic tissues exhibit locally diminished and cytoplasmically shifted LEMD3-SMAD2/3 interactions, as noted in vitro. Our work reveals novel LEMD3 biology and stiffness-dependent regulation of TGF beta by LEMD3, providing a novel target to antagonize pathological TGF beta signaling.	[Chambers, Dwight M.; Zhang, Jennifer J.; Cooper, Spencer W.; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chambers, Dwight M.; Zhang, Jennifer J.; Cooper, Spencer W.; Santangelo, Philip J.] Emory Univ, Sch Med, Atlanta, GA 30332 USA; [Moretti, Leandro; Barker, Thomas H.] Univ Virginia, Biomed Engn, Charlottesville, VA 22908 USA; [Chambers, Davis M.] Georgia State Univ, Coll Arts & Sci, Atlanta, GA 30303 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University of Virginia; University System of Georgia; Georgia State University	Barker, TH (corresponding author), Univ Virginia, Biomed Engn, Charlottesville, VA 22908 USA.	thomas.barker@virginia.edu	Barker, Thomas/I-1608-2016	Barker, Thomas/0000-0002-3218-8111; Chambers, Dwight/0000-0003-0814-9136; Cooper, Spencer/0000-0002-8466-9531	National Institutes of Health [R01 HL127283, R01 HL132585, F30 HL122065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL122065, R01HL132585, R01HL127283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL127283 and R01 HL132585 (to T. H. B.) and F30 HL122065 (to Dwight M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abascal F, 2015, BIOINFORMATICS, V31, P2257, DOI 10.1093/bioinformatics/btv132; Bermeo S, 2017, J CELL BIOCHEM, V118, P4425, DOI 10.1002/jcb.26096; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Burger B, 2010, EUR J DERMATOL, V20, P693, DOI 10.1684/ejd.2010.1051; Caputo S, 2006, J BIOL CHEM, V281, P18208, DOI 10.1074/jbc.M601980200; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Condorelli A, 2017, PEDIATR DERMATOL, V34, pE345, DOI 10.1111/pde.13287; Couto AR, 2007, CALCIFIED TISSUE INT, V81, P81, DOI 10.1007/s00223-007-9043-z; DePianto DJ, 2015, THORAX, V70, P48, DOI 10.1136/thoraxjnl-2013-204596; Du J, 2017, BLOOD, V129, P2570, DOI 10.1182/blood-2017-01-758854; Fukuda Y, 1998, LAB INVEST, V78, P687; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gardinassi LG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005123; Gass JK, 2008, J AM ACAD DERMATOL, V58, pS103, DOI 10.1016/j.jaad.2007.03.031; Grannas K, 2015, J MOL BIOL, V427, P3407, DOI 10.1016/j.jmb.2015.04.015; Gutierrez D, 2015, PEDIATR DERMATOL, V32, pE219, DOI 10.1111/pde.12634; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Holt I, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0105-9; Jones MG, 2013, RESPIRATION, V86, P353, DOI 10.1159/000356958; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Klingberg F, 2014, J CELL BIOL, V207, P283, DOI 10.1083/jcb.201402006; Kobayashi Y, 2006, EXP CELL RES, V312, P3152, DOI 10.1016/j.yexcr.2006.06.026; Konde E, 2010, BIOCHEMISTRY-US, V49, P8020, DOI 10.1021/bi101153w; Korekawa A, 2012, BRIT J DERMATOL, V166, P900, DOI 10.1111/j.1365-2133.2011.10691.x; Kratzsch J, 2016, JAMA DERMATOL, V152, P844, DOI 10.1001/jamadermatol.2016.0350; Kristensen JH, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0048-5; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Nance T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092111; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Pope V, 2016, BRIT J DERMATOL, V174, P723, DOI 10.1111/bjd.14366; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rajgor D, 2016, MOL BIOL CELL, V27, P3894, DOI 10.1091/mbc.E16-06-0346; Rajgor D, 2014, J CELL BIOL, V205, P457, DOI 10.1083/jcb.201306076; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rinker TE, 2018, ACTA BIOMATER, V68, P125, DOI 10.1016/j.actbio.2017.12.038; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Santos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113732; Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Srivastava M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-54; Stahnke T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172592; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Vancheri C, 2018, AM J RESP CRIT CARE, V197, P356, DOI 10.1164/rccm.201706-1301OC; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wagner N, 2006, EUR J CELL BIOL, V85, P91, DOI 10.1016/j.ejcb.2005.10.002; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wang YG, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0472-9; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu W, 2002, J CELL SCI, V115, P1361; Yadegari M, 2010, ARCH DERMATOL, V146, P63, DOI 10.1001/archdermatol.2009.320; Yamashita CM, 2011, AM J PATHOL, V179, P1733, DOI 10.1016/j.ajpath.2011.06.041; Yuste-Chaves M, 2011, PEDIATR DERMATOL, V28, P447, DOI 10.1111/j.1525-1470.2010.01206.x; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang W, 2017, GENE, V627, P123, DOI 10.1016/j.gene.2017.06.009; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099; Zurla C, 2017, METHODS MOL BIOL, V1468, P155, DOI 10.1007/978-1-4939-4035-6_12	84	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15867	15886		10.1074/jbc.RA118.003658	http://dx.doi.org/10.1074/jbc.RA118.003658			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30108174	Green Published, hybrid			2022-12-26	WOS:000447256000010
J	Abeywardana, T; Oh, M; Jiang, L; Yang, Y; Kong, M; Song, JK; Yang, YZ				Abeywardana, Tharindumala; Oh, Myungeun; Jiang, Lei; Yang, Ying; Kong, Mei; Song, Jikui; Yang, Yanzhong			CARM1 suppresses de novo serine synthesis by promoting PKM2 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; pyruvate kinase; serine; metabolic regulation; proliferation; CARM1	PYRUVATE-KINASE M2; METHYLTRANSFERASE 1 CARM1; ONE-CARBON METABOLISM; CELL-PROLIFERATION; ARGININE METHYLATION; CANCER-CELLS; LACTATE METABOLISM; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; TUMOR PROGRESSION	Glucose is a critical nutrient for cell proliferation. However, the molecular pathways that regulate glucose metabolism are still elusive. We discovered that co-activator-associated arginine methyltransferase 1 (CARM1) suppresses glucose metabolism toward serine biosynthesis. By tracing the C-13-labeled glucose, we found that Carm1 knockout mouse embryonic fibroblasts exhibit significantly increased de novo serine synthesis than WT cells. This is caused, at least in part, by the reduced pyruvate kinase (PK) activity in these cells. The M2 isoform of PK (PKM2) is arginine-methylated by CARM1, and methylation enhances its activity. Mechanistically, CARM1 methylates PKM2 at arginines 445 and 447, which enhances PKM2 tetramer formation. Consequently, Carm1 knockout cells exhibit significant survival advantages over WT cells when extracellular serine is limited, likely due to their enhanced de novo serine synthesis capacity. Altogether, we identified CARM1 as an important regulator of glucose metabolism and serine synthesis.	[Abeywardana, Tharindumala; Yang, Yanzhong] City Hope Canc Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA; [Oh, Myungeun; Jiang, Lei] City Hope Canc Ctr, Beckman Res Inst, Dept Mol & Cellular Endocrinol, Duarte, CA 91010 USA; [Yang, Ying; Kong, Mei] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Song, Jikui] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; University of California System; University of California Riverside	Yang, YZ (corresponding author), City Hope Canc Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.	yyang@coh.org	yang, yanzhong/AAH-6132-2019; Yang, Ying/I-8380-2019	Abeywardana, Tharindumala/0000-0002-1743-0491	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [R01CA183989, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119721] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lei Zhang and Yunan Miao from TBDC for their assistance with LC-MS/MS. We thank Kerin Higa for providing helpful comments on scientific writing. Research reported in this publication includes work performed in the Translational Biomarker Discovery Core supported by NCI, National Institutes of Health, under Award P30CA33572.	Al-Dhaheri M, 2011, CANCER RES, V71, P2118, DOI 10.1158/0008-5472.CAN-10-2426; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheng HX, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-129; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; de Freitas RF, 2016, J MED CHEM, V59, P6838, DOI 10.1021/acs.jmedchem.6b00668; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Drew AE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18446-z; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Gao X, 2016, CELL METAB, V24, P777, DOI 10.1016/j.cmet.2016.11.012; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GOSALVEZ M, 1974, EUR J BIOCHEM, V46, P133, DOI 10.1111/j.1432-1033.1974.tb03605.x; GOSALVEZ M, 1975, EUR J BIOCHEM, V55, P315, DOI 10.1111/j.1432-1033.1975.tb02165.x; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang LF, 2018, NUCLEIC ACIDS RES, V46, P3061, DOI 10.1093/nar/gky103; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jiang L, 2017, METAB ENG, V43, P198, DOI 10.1016/j.ymben.2016.11.004; Kaniskan HUU, 2016, MEDCHEMCOMM, V7, P1793, DOI [10.1039/c6md00342g, 10.1039/C6MD00342G]; Kim YR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-197; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Li SH, 2018, CELL REP, V23, P389, DOI 10.1016/j.celrep.2018.03.051; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu FB, 2017, NAT CELL BIOL, V19, P1358, DOI 10.1038/ncb3630; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Morita M, 2018, CANCER CELL, V33, P355, DOI 10.1016/j.ccell.2018.02.004; Mulukutla BC, 2016, TRENDS BIOTECHNOL, V34, P638, DOI 10.1016/j.tibtech.2016.04.012; Narayanan N, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.48; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Parnell KM, 2013, MOL CANCER THER, V12, P1453, DOI 10.1158/1535-7163.MCT-13-0026; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Sanchez G, 2016, NUCLEIC ACIDS RES, V44, P2661, DOI 10.1093/nar/gkv1334; Shen YD, 2016, J MED CHEM, V59, P9124, DOI 10.1021/acs.jmedchem.6b01033; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Walsh M. J., 2010, PROBE REPORTS NIH MO; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wang YP, 2016, MOL CELL, V64, P673, DOI 10.1016/j.molcel.2016.09.028; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	68	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15290	15303		10.1074/jbc.RA118.004512	http://dx.doi.org/10.1074/jbc.RA118.004512			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30131339	Green Published, hybrid			2022-12-26	WOS:000445998400028
J	Dempsey, A; Keating, SE; Carty, M; Bowie, AG				Dempsey, Alan; Keating, Sinead E.; Carty, Michael; Bowie, Andrew G.			Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toll-like receptor (TLR); signal transduction; pattern recognition receptor (PRR); poxvirus; NF-B (NF-KB); interleukin 6 (IL-6); innate immunity; host-pathogen interaction; DExD; H-box helicase (DHX9); Immune evasion	DOUBLE-STRANDED-RNA; VIRUS E3 PROTEIN; NF-KAPPA-B; DENDRITIC CELLS; INNATE IMMUNITY; MESSENGER-RNAS; A INTERACTS; HELA-CELLS; GENE; DNA	Host pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) detect viruses and other pathogens, inducing production of cytokines that cause inflammation and mobilize cells to control infection. Vaccinia virus (VACV) encodes proteins that antagonize these host innate immune responses, and elucidating the mechanisms of action of these viral proteins helped shed light on PRR signaling mechanisms. The VACV virulence factor E3 is one of the most intensely studied VACV proteins and has multiple effects on host cells, many of which cannot be explained by the currently known cellular targets of E3. Here, we report that E3 expression in human monocytes alters TLR2- and TLR8-dependent cytokine induction, and particularly inhibits interleukin (IL)-6. Using MS, we identified DExD/H-box helicase 9 (DHX9) as an E3 target. Although DHX9 has previously been implicated as a PRR for sensing nucleic acid in dendritic cells, we found no role for DHX9 as a nucleic acid-sensing PRR in monocytes. Rather, DHX9 suppression in these cells phenocopied the effects of E3 expression on TLR2- and TLR8-dependent cytokine induction, in that DHX9 was required for all TLR8-dependent cytokines measured, and for TLR2-dependent IL-6. Furthermore, DHX9 also had a cell- and stimulus-independent role in IL-6 promoter induction. DHX9 enhanced NF-B-dependent IL-6 promoter activation, which was directly antagonized by E3. These results indicate new roles for DHX9 in regulating cytokines in innate immunity and reveal that VACV E3 disrupts innate immune responses by targeting of DHX9.	[Dempsey, Alan; Keating, Sinead E.; Carty, Michael; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Keating, Sinead E.] Pfizer Biotherapeut R&D, BioMed Design, Grange Castle Business Pk, Dublin 22, Ireland	Trinity College Dublin; Pfizer	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Carty, Michael/AAG-1249-2022; Carty, Michael/AFK-2889-2022	Bowie, Andrew/0000-0001-5316-4373; Carty, Michael/0000-0003-1588-7479	Irish Health Research Board [PHD/2007/09]; Science Foundation Ireland [11/PI/1056, 16/IA/4376]	Irish Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Irish Health Research Board Grant PHD/2007/09 and Science Foundation Ireland Grants 11/PI/1056 and 16/IA/4376. The authors declare that they have no conflicts of interest with the contents of this article.	Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brady G, 2017, J VIROL, V91, DOI 10.1128/JVI.00545-17; Brady G, 2014, CYTOKINE GROWTH F R, V25, P611, DOI 10.1016/j.cytogfr.2014.07.004; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Dueck KJ, 2015, J VIROL, V89, P5382, DOI 10.1128/JVI.03288-14; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Gurtler C, 2014, J IMMUNOL, V192, P4821, DOI 10.4049/jimmunol.1302980; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Huang M, 2008, NUCLEOS NUCLEOT NUCL, V27, P704, DOI 10.1080/15257770802145132; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jimenez-Dalmaroni MJ, 2016, AUTOIMMUN REV, V15, P1, DOI 10.1016/j.autrev.2015.08.009; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kwon JA, 2005, P NATL ACAD SCI USA, V102, P12759, DOI 10.1073/pnas.0506011102; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Lawrence P, 2009, J VIROL, V83, P11356, DOI 10.1128/JVI.02677-08; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11; Myskiw C, 2011, J VIROL, V85, P12280, DOI 10.1128/JVI.05505-11; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Tettweiler G, 2006, TRENDS BIOCHEM SCI, V31, P607, DOI 10.1016/j.tibs.2006.09.008; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Valentine R, 2010, J GEN VIROL, V91, P2221, DOI 10.1099/vir.0.021998-0; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307	46	14	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14989	15001		10.1074/jbc.RA118.005089	http://dx.doi.org/10.1074/jbc.RA118.005089			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30111593	hybrid, Green Published			2022-12-26	WOS:000445998400005
J	Rathore, U; Purwar, M; Vignesh, VS; Das, R; Kumar, AA; Bhattacharyya, S; Arendt, H; DeStefano, J; Wilson, A; Parks, C; La Branche, CC; Montefiori, DC; Varadarajan, R				Rathore, Ujjwal; Purwar, Mansi; Vignesh, Venkada Subramanian; Das, Raksha; Kumar, Aditya Arun; Bhattacharyya, Sanchari; Arendt, Heather; DeStefano, Joanne; Wilson, Aaron; Parks, Christopher; La Branche, Celia C.; Montefiori, David C.; Varadarajan, Raghavan			Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein design; mutagenesis; glycosylation; hydrogen-deuterium exchange; vaccine development; protein refolding; yeast surface display	IMMUNODEFICIENCY-VIRUS TYPE-1; YEAST SURFACE DISPLAY; RECOMBINANT GLYCOPROTEIN-120 VACCINE; CROSS-STRAND DISULFIDES; ENVELOPE GLYCOPROTEIN; PROTEIN STABILITY; STRUCTURAL BASIS; CD4-INDUCED ACTIVATION; SEQUENCE STATISTICS; VIRAL INFECTIVITY	Protein minimization is an attractive approach for designing vaccines against rapidly evolving pathogens such as human immunodeficiency virus, type 1 (HIV-1), because it can help in focusing the immune response toward conserved conformational epitopes present on complex targets. The outer domain (OD) of HIV-1 gp120 contains epitopes for a large number of neutralizing antibodies and therefore is a primary target for structure-based vaccine design. We have previously designed a bacterially expressed outer-domain immunogen (ODEC) that bound CD4-binding site (CD4bs) ligands with 3-12 m affinity and elicited a modest neutralizing antibody response in rabbits. In this study, we have optimized ODEC using consensus sequence design, cyclic permutation, and structure-guided mutations to generate a number of variants with improved yields, biophysical properties, stabilities, and affinities (K-D of 10-50 nm) for various CD4bs targeting broadly neutralizing antibodies, including the germline-reverted version of the broadly neutralizing antibody VRC01. In contrast to ODEC, the optimized immunogens elicited high anti-gp120 titers in rabbits as early as 6 weeks post-immunization, before any gp120 boost was given. Following two gp120 boosts, sera collected at week 22 showed cross-clade neutralization of tier 1 HIV-1 viruses. Using a number of different prime/boost combinations, we have identified a cyclically permuted OD fragment as the best priming immunogen, and a trimeric, cyclically permuted gp120 as the most suitable boosting molecule among the tested immunogens. This study also provides insights into some of the biophysical correlates of improved immunogenicity.	[Rathore, Ujjwal; Purwar, Mansi; Vignesh, Venkada Subramanian; Das, Raksha; Kumar, Aditya Arun; Bhattacharyya, Sanchari; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Arendt, Heather; DeStefano, Joanne; Wilson, Aaron; Parks, Christopher] Int AIDS Vaccine Initiat, Brooklyn, NY 11226 USA; [La Branche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27707 USA; [Varadarajan, Raghavan] Dept Sci & Technol, Durham, NC USA	Indian Institute of Science (IISC) - Bangalore; International AIDS Vaccine Initiative; Duke University	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Bhattacharyya, Sanchari/L-4344-2019; Rathore, Ujjwal/AAD-9974-2021	Bhattacharyya, Sanchari/0000-0003-3421-4755; Rathore, Ujjwal/0000-0002-0329-7431; Venkadasubramanian, Vignesh/0000-0003-1700-7439	Bill and Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); Government of India: Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure; University Grants Commission Center for Advanced Study; Department of Biotechnology-IISc Partnership Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118366] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of India: Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure; University Grants Commission Center for Advanced Study; Department of Biotechnology-IISc Partnership Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Monoclonal antibodies b12, VRC01, and sCD4 protein were obtained from the Neutralizing Antibody Consortium of International AIDS Vaccine Initiative. GL-VRC01 was kindly provided by Dr. John R. Mascola. The yeast display vector pPNLS was kindly provided by Dr. Dennis Burton. We thank the Proteomics Facility at the Molecular Biophysics Unit, Indian Institute of Science, especially Sunita Prakash and Raghu Tadala, for assistance with mass spectrometric data generation. The assistance of N. S. Srilatha is duly acknowledged for the SPR experiments. We thank Prof. Jayant Udgaonkar, Pooja Malhotra, Joginder Singh, and Prashant Jethva for help with the use of MS machine for carrying out HDX-MS experiments. We also acknowledge Wayne Koff, Rick King, and Michael Caulfield from International AIDS Vaccine Initiative for their help with the iVSV work. The work of the International AIDS Vaccine Initiative is made possible by the generous support from many donors, including the following: Bill and Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of International AIDS Vaccine Initiative AIDS Vaccine Initiative donors is available at www.iavi.org. We also acknowledge funding for infrastructural support from the following programs of the Government of India: Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure, University Grants Commission Center for Advanced Study, and the Department of Biotechnology-IISc Partnership Program.	Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; BRINKMANN U, 1992, P NATL ACAD SCI USA, V89, P3075, DOI 10.1073/pnas.89.7.3075; Chakraborty K, 2005, BIOCHEMISTRY-US, V44, P14638, DOI 10.1021/bi050921s; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Guttman M, 2012, J VIROL, V86, P8750, DOI 10.1128/JVI.07224-11; Hu DY, 2017, VACCINE, V35, P3067, DOI 10.1016/j.vaccine.2017.04.054; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Indu S, 2010, PROTEINS, V78, P1228, DOI 10.1002/prot.22641; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jones AT, 2018, J VIROL, V92, DOI 10.1128/JVI.01796-17; KELLEY RF, 1987, BIOCHEMISTRY-US, V26, P1406, DOI 10.1021/bi00379a029; Kesavardhana S, 2017, J BIOL CHEM, V292, P278, DOI 10.1074/jbc.M116.725614; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Magliery TJ, 2015, CURR OPIN STRUC BIOL, V33, P161, DOI 10.1016/j.sbi.2015.09.002; MATTHEW JB, 1986, METHOD ENZYMOL, V130, P413; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Najar TA, 2017, STRUCTURE, V25, P395, DOI 10.1016/j.str.2016.12.016; Nakane S, 2015, J BIOL CHEM, V290, P15279, DOI 10.1074/jbc.M114.628610; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Qin YL, 2014, VIROLOGY, V462, P363, DOI 10.1016/j.virol.2014.06.006; Rabinovich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106597; Rathore U, 2017, J BIOL CHEM, V292, P10197, DOI 10.1074/jbc.M117.788919; Rathore U, 2014, BBA-PROTEINS PROTEOM, V1844, P1891, DOI 10.1016/j.bbapap.2014.05.010; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Sahoo A, 2015, ELIFE, V4, DOI 10.7554/eLife.09532; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; Sheshadri S, 1999, PROTEIN SCI, V8, P1689, DOI 10.1110/ps.8.8.1689; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Street TO, 2006, P NATL ACAD SCI USA, V103, P17064, DOI 10.1073/pnas.0606236103; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Whitehead TA, 2009, PROTEIN ENG DES SEL, V22, P607, DOI 10.1093/protein/gzp034; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	71	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15002	15020		10.1074/jbc.RA118.005006	http://dx.doi.org/10.1074/jbc.RA118.005006			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30093409	Green Published, hybrid			2022-12-26	WOS:000445998400006
J	Yogavel, M; Nettleship, JE; Sharma, A; Harlos, K; Jamwal, A; Chaturvedi, R; Sharma, M; Jain, V; Chhibber-Goel, J; Sharma, A				Yogavel, Manickam; Nettleship, Joanne E.; Sharma, Akansha; Harlos, Karl; Jamwal, Abhishek; Chaturvedi, Rini; Sharma, Manmohan; Jain, Vitul; Chhibber-Goel, Jyoti; Sharma, Amit			Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; malaria; plasmodium; crystal structure; infectious disease; dihydropteroate synthase; HPPK-DHPS; p-aminobenzoic acid; Plasmodium vivax; sulfadoxine	HIV-1 PROTEASE INHIBITORS; AMINO-ACID MUTATIONS; CRYSTAL-STRUCTURE; FOLATE METABOLISM; MALARIA; PYRIMETHAMINE; FALCIPARUM; SUBSTRATE; DHPS; REFINEMENT	The genomes of the malaria-causing Plasmodium parasites encode a protein fused of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS) domains that catalyze sequential reactions in the folate biosynthetic pathway. Whereas higher organisms derive folate from their diet and lack the enzymes for its synthesis, most eubacteria and a number of lower eukaryotes including malaria parasites synthesize tetrahydrofolate via DHPS. Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) HPPK-DHPSs are currently targets of drugs like sulfadoxine (SDX). The SDX effectiveness as an antimalarial drug is increasingly diminished by the rise and spread of drug-resistant mutations. Here, we present the crystal structure of PvHPPK-DHPS in complex with four substrates/analogs, revealing the bifunctional PvHPPK-DHPS architecture in an unprecedented state of enzymatic activation. SDX's effect on HPPK-DHPS is due to 4-amino benzoic acid (pABA) mimicry, and the PvHPPK-DHPS structure sheds light on the SDX-binding cavity, as well as on mutations that effect SDX potency. We mapped five dominant drug resistance mutations in PvHPPK-DHPS: S382A, A383G, K512E/D, A553G, and V585A, most of which occur individually or in clusters proximal to the pABA-binding site. We found that these resistance mutations subtly alter the intricate enzyme/pABA/SDX interactions such that DHPS affinity for pABA is diminished only moderately, but its affinity for SDX is changed substantially. In conclusion, the PvHPPK-DHPS structure rationalizes and unravels the structural bases for SDX resistance mutations and highlights architectural features in HPPK-DHPSs from malaria parasites that can form the basis for developing next-generation anti-folate agents to combat malaria parasites.	[Yogavel, Manickam; Sharma, Akansha; Jamwal, Abhishek; Chaturvedi, Rini; Sharma, Manmohan; Chhibber-Goel, Jyoti; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Mol Med Struct Parasitol Grp, New Delhi 110067, India; [Nettleship, Joanne E.; Harlos, Karl; Jain, Vitul] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Nettleship, Joanne E.] Rutherford Appleton Lab, Oxford Prot Prod Facil, United Kingdom Res Complex Harwell, Oxford OX11 0FA, England	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Oxford; Wellcome Centre for Human Genetics; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford	Yogavel, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct Parasitol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	myogavel@gmail.com	Chaturvedi, Rini/GLU-2991-2022; Chhibber-Goel, Jyoti/AAC-5735-2020; Jain, Vitul/AAP-9467-2020; Sharma, Akansha/HGA-9893-2022; Goel, Jyoti/L-4510-2019; Manickam, Yogavel/O-4570-2015	Chhibber-Goel, Jyoti/0000-0003-4654-5463; Jain, Vitul/0000-0002-8396-8329; Chaturvedi, Rini/0000-0003-1437-5121; Manickam, Yogavel/0000-0002-2119-062X; sharma, Manmohan/0000-0002-0215-6223	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India [EMR/2016/004898]; Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA); Wellcome Centre for Human Genetics [090532/Z/09/Z]; DST, Ministry of Science and Technology, Government of India; MRC [MR/K018779/1] Funding Source: UKRI	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India; Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); Wellcome Centre for Human Genetics; DST, Ministry of Science and Technology, Government of India; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grant (EMR/2016/004898) from Department of Science and Technology (DST), Ministry of Science and Technology, Government of India. This work was also supported in part by a travel grant from the Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) (to M. Y. and M. S.), Core Grant Award 090532/Z/09/Z from the Wellcome Centre for Human Genetics (to K. H.), and a J.C. Bose fellowship from DST, Ministry of Science and Technology, Government of India (to Am. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman MD, 2008, J AM CHEM SOC, V130, P6099, DOI 10.1021/ja076558p; Auliff A, 2006, AM J TROP MED HYG, V75, P617, DOI 10.4269/ajtmh.2006.75.617; Baca AM, 2000, J MOL BIOL, V302, P1193, DOI 10.1006/jmbi.2000.4094; Dias MVB, 2018, FUTURE MED CHEM, V10, P935, DOI 10.4155/fmc-2017-0168; Blaszczyk J, 2004, STRUCTURE, V12, P467, DOI 10.1016/j.str.2004.02.003; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; Chhabra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029444; Chotpatiwetchkul W, 2017, ORG BIOMOL CHEM, V15, P5593, DOI 10.1039/c7ob01272a; CHULAY JD, 1984, AM J TROP MED HYG, V33, P325, DOI 10.4269/ajtmh.1984.33.325; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERONE R, 1970, J BIOL CHEM, V245, P850; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Garcon A, 2006, J MOL BIOL, V360, P644, DOI 10.1016/j.jmb.2006.05.038; Gaudilliere JP, 2009, B HIST MED, V83, P218; Hammoudeh DI, 2013, FUTURE MED CHEM, V5, P1331, DOI 10.4155/fmc.13.97; Hawkins VN, 2009, AM J TROP MED HYG, V81, P348, DOI 10.4269/ajtmh.2009.81.348; HURLEY M. G. D., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P412, DOI 10.1016/0035-9203(59)90044-6; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller IB, 2013, MOL BIOCHEM PARASIT, V188, P63, DOI 10.1016/j.molbiopara.2013.02.008; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nalam MNL, 2010, J VIROL, V84, P5368, DOI 10.1128/JVI.02531-09; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINICHPONGSE S, 1982, B WORLD HEALTH ORGAN, V60, P907; Pornthanakasem W, 2016, ANTIMICROB AGENTS CH, V60, P4453, DOI 10.1128/AAC.01835-15; Ragsdale SW, 2008, VITAM HORM, V79, P293, DOI 10.1016/S0083-6729(08)00410-X; ROLAND S, 1979, J BIOL CHEM, V254, P337; Rungsihirunrat K, 2008, AM J TROP MED HYG, V78, P462, DOI 10.4269/ajtmh.2008.78.462; SHIOTA T, 1984, CHEM BIOCH FOLATES, P121; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; THAITHONG S, 1992, MOL BIOCHEM PARASIT, V52, P149, DOI 10.1016/0166-6851(92)90047-N; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504; World Health Organization (WHO), 2010, WHO MOD LIST ESS MED, P4; Wright DL, 2011, EXPERT OPIN THER PAT, V21, P1293, DOI 10.1517/13543776.2011.587804; Yun MK, 2014, BIOORGAN MED CHEM, V22, P2157, DOI 10.1016/j.bmc.2014.02.022; Yun MK, 2012, SCIENCE, V335, P1110, DOI 10.1126/science.1214641	47	9	9	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14962	14972		10.1074/jbc.RA118.004558	http://dx.doi.org/10.1074/jbc.RA118.004558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30104413	Green Published, hybrid			2022-12-26	WOS:000445998400002
J	Choi, S; Park, M; Kim, J; Park, W; Kim, S; Lee, DK; Hwang, JY; Choe, J; Won, MH; Ryoo, S; Ha, KS; Kwon, YG; Kim, YM				Choi, Seunghwan; Park, Minsik; Kim, Joohwan; Park, Wonjin; Kim, Suji; Lee, Dong-Keon; Hwang, Jong Yun; Choe, Jongseon; Won, Moo-Ho; Ryoo, Sungwoo; Ha, Kwon-Soo; Kwon, Young-Guen; Kim, Young-Myeong			TNF-alpha elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p-dependent down-regulation of cGMP-dependent kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); protein kinase G (PKG); microRNA (miRNA); NF-kappa B (NF-B); vascular smooth muscle cells; cGMP-dependent protein kinase 1	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NEOINTIMAL LESION FORMATION; NITRIC-OXIDE; INFLAMMATORY CYTOKINES; IN-VIVO; EXPRESSION; ATHEROSCLEROSIS; PROLIFERATION; HYPERTENSION	cGMP-dependent protein kinase 1 (PKG1) plays an important role in nitric oxide (NO)/cGMP-mediated maintenance of vascular smooth muscle cell (VSMC) phenotype and vasorelaxation. Inflammatory cytokines, including tumor necrosis factor-alpha(TNF alpha), have long been understood to mediate several inflammatory vascular diseases. However, the underlying mechanism of TNF alpha-dependent inflammatory vascular disease is unclear. Here, we found that TNF alpha treatment decreased PKG1 expression in cultured VSMCs, which correlated with NF-kappa B-dependent biogenesis of miR-155-5p that targeted the 3'-UTR of PKG1 mRNA. TNF alpha induced VSMC phenotypic switching from a contractile to a synthetic state through the down-regulation of VSMC marker genes, suppression of actin polymerization, alteration of cell morphology, and elevation of cell proliferation and migration. All of these events were blocked by treatment with an inhibitor of miR-155-5p or PKG1, whereas transfection with miR-155-5p mimic or PKG1 siRNA promoted phenotypic modulation, similar to the response to TNF alpha. In addition, TNF alpha-induced miR-155-5p inhibited the vasorelaxant response of de-endothelialized mouse aortic vessels to 8-Br-cGMP by suppressing phosphorylation of myosin phosphatase and myosin light chain, both of which are downstream signal modulators of PKG1. Moreover, TNF alpha-induced VSMC phenotypic alteration and vasodilatory dysfunction were blocked by NF-kappa B inhibition. These results suggest that TNF alpha impairs NO/cGMP-mediated maintenance of the VSMC contractile phenotype and vascular relaxation by down-regulating PKG1 through NF-kappa B-dependent biogenesis of miR-155-5p. Thus, the NF-kappa B/miR-155-5p/PKG1 axis may be crucial in the pathogenesis of inflammatory vascular diseases, such as atherosclerotic intimal hyperplasia and preeclamptic hypertension.	[Choi, Seunghwan; Park, Minsik; Kim, Joohwan; Park, Wonjin; Kim, Suji; Lee, Dong-Keon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea; [Hwang, Jong Yun] Kangwon Natl Univ, Sch Med, Dept Obstet & Gynecol, Chunchon 24341, Gangwon Do, South Korea; [Choe, Jongseon] Kangwon Natl Univ, Sch Med, Dept Immunol, Chunchon 24341, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 24341, Gangwon Do, South Korea; [Ryoo, Sungwoo] Kangwon Natl Univ, Dept Biol, Coll Nat Sci, Chunchon 24341, Gangwon Do, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University	Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea.	ymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016M3A9B6903103]; Kangwon National University [520170431]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Kangwon National University	This work was supported by the National Research Foundation of Korea (NRF) Grant 2016M3A9B6903103 funded by the Korea government (MSIP) and also a 2017 Research Grant from Kangwon National University (Grant 520170431). The authors declare that they have no conflicts of interest with the contents of this article.	Afzal TA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004629; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Anderson PG, 2000, ARTERIOSCL THROM VAS, V20, P2192, DOI 10.1161/01.ATV.20.10.2192; Baek YY, 2012, EUR J PHARMACOL, V674, P188, DOI 10.1016/j.ejphar.2011.11.022; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Browner NC, 2004, AM J PHYSIOL-CELL PH, V287, pC88, DOI 10.1152/ajpcell.00039.2004; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen LH, 2004, ARTERIOSCL THROM VAS, V24, P1403, DOI 10.1161/01.ATV.0000134705.39654.53; Chen QS, 2015, J MOL CELL CARDIOL, V89, P75, DOI 10.1016/j.yjmcc.2015.10.017; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cherepanova OA, 2016, NAT MED, V22, P657, DOI 10.1038/nm.4109; Choi S, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.193; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Gao YS, 2008, AM J PHYSIOL-LUNG C, V295, pL889, DOI 10.1152/ajplung.00463.2007; Ishida A, 1999, MOL PHARMACOL, V56, P938, DOI 10.1124/mol.56.5.938; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kim J, 2017, FREE RADICAL BIO MED, V104, P185, DOI 10.1016/j.freeradbiomed.2017.01.010; Kim JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36979; Kitazawa T, 2009, J PHYSIOL-LONDON, V587, P3587, DOI 10.1113/jphysiol.2009.172189; Lee KS, 2014, BIOCHEM BIOPH RES CO, V448, P101, DOI 10.1016/j.bbrc.2014.04.079; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Ma XC, 2013, HEART LUNG CIRC, V22, P811, DOI 10.1016/j.hlc.2013.05.651; Martin-Sanchez P, 2018, FASEB J, V32, P920, DOI 10.1096/fj.201700134RRRR; MORISAKI N, 1993, SCAND J CLIN LAB INV, V53, P347, DOI 10.3109/00365519309086626; Naya M, 2007, HYPERTENS RES, V30, P541, DOI 10.1291/hypres.30.541; Nguyen T, 2015, MOL CELL BIOCHEM, V405, P81, DOI 10.1007/s11010-015-2398-y; Peeters ACTM, 2001, EUR J CLIN INVEST, V31, P31, DOI 10.1046/j.1365-2362.2001.00743.x; Peppel K, 2005, CARDIOVASC RES, V65, P674, DOI 10.1016/j.cardiores.2004.10.031; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Ren J, 2016, J PHARMACOL EXP THER, V356, P137, DOI 10.1124/jpet.115.227934; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Shaw J, 2016, PLACENTA, V43, P1, DOI 10.1016/j.placenta.2016.04.015; Sinnaeve P, 2002, CIRCULATION, V105, P2911, DOI 10.1161/01.CIR.0000018169.59205.CA; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Sun Y, 2016, ARTERIOSCL THROM VAS, V36, P1230, DOI 10.1161/ATVBAHA.115.306691; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Virtue A, 2017, J BIOL CHEM, V292, P1267, DOI 10.1074/jbc.M116.739839; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Wang SX, 2009, AM J PHYSIOL-HEART C, V297, pH2075, DOI 10.1152/ajpheart.00521.2009; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Yang F, 2018, CIRCULATION, V137, P1824, DOI 10.1161/CIRCULATIONAHA.117.027799; Yang LB, 2017, CIRC RES, V121, P1251, DOI 10.1161/CIRCRESAHA.117.311819; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230	50	21	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14812	14822		10.1074/jbc.RA118.004220	http://dx.doi.org/10.1074/jbc.RA118.004220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30104414	Green Published, hybrid			2022-12-26	WOS:000446155000018
J	Linan, A; Lawrenz, B; El Khatib, I; Bayram, A; Arnan, A; Rubio, C; Chopra, R; Fatemi, HM				Linan, Alberto; Lawrenz, Barbara; El Khatib, Ibrahim; Bayram, Asina; Arnan, Ana; Rubio, Carmen; Chopra, Rupali; Fatemi, Human M.			Clinical reassessment of human embryo ploidy status between cleavage and blastocyst stage by Next Generation Sequencing	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PREIMPLANTATION GENETIC DIAGNOSIS; INNER CELL MASS; CHROMOSOMAL-ABNORMALITIES; SELF-CORRECTION; SEGMENTAL ANEUPLOIDIES; ARRAY-CGH; MOSAICISM; BIOPSY; ORIGIN	One of the most important limitations of genetic testing in preimplantation embryos is embryonic mosaicism, especially when performed on D3 with only a single blastomere evaluated. Previous publications, using Array-Comparative Genomic Hybridization (a-CGH) to compare day 3 (D3) biopsies versus trophectoderm biopsies for the analysis of aneuploid embryos, showed similar high concordance rates per embryo diagnosis for D3 biopsies and trophectoderm biopsies. Next generation sequencing (NGS) was introduced lately as a new technique for preimplantation genetic testing for aneuploidies (PGT-A). Using this technique, this retrospective descriptive study evaluated the degree of the concordance of the diagnosis between preimplantation human cleavage stage (D3) and blastocyst stage (D5) embryos. Double biopsies on D3 and D5 were performed on 118 embryos, reaching blastocyst stage on D5 and had not been selected for transfer. As the fertilization law of the United Arab Emirates does not allow embryo freezing, also surplus euploid embryos after D 3 biopsy were included. Analysis of the NGS results from D3 and D5 embryo biopsies showed a total concordance rate per embryo diagnosis of 85.6% for euploid and aneuploid embryos. The concordance rates per embryo chromosomal pattern for embryo diagnosed as aneuploid at both biopsy stages was 82.2%. However, the status regarding the affected chromosomes was not identical on D3 and D5. Hence, the total concordance rate between D3 biopsy and D5 biopsy was limited to 67.8%. This current study clearly demonstrated that the concordance rates between D3 and D5 biopsies in aneuploid and euploid embryos are lower than previously reported.	[Linan, Alberto; El Khatib, Ibrahim; Bayram, Asina; Arnan, Ana] IVIRMA Middle East Fertil Clin, IVF Lab, Abu Dhabi, U Arab Emirates; [Lawrenz, Barbara] IVIRMA Middle East Fertil Clin, IVF Dept, Abu Dhabi, U Arab Emirates; [Lawrenz, Barbara; Fatemi, Human M.] Womens Univ Hosp Tuebingen, Obstet Dept, Tubingen, Germany; [Rubio, Carmen] Igenomix, Valencia, Spain; [Chopra, Rupali] Igenomix, Dubai, U Arab Emirates	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lawrenz, B (corresponding author), IVIRMA Middle East Fertil Clin, IVF Dept, Abu Dhabi, U Arab Emirates.; Lawrenz, B (corresponding author), Womens Univ Hosp Tuebingen, Obstet Dept, Tubingen, Germany.	barbara.lawrenz@ivirma.com	Rubio, Carmen/D-7753-2018; fatemi, human/AAH-3250-2020; Lawrenz, Barbara/AAH-3399-2020	Linan Tegedor, Alberto/0000-0003-4487-5215; Lawrenz, Barbara/0000-0001-6209-4223	Igenomix	Igenomix	This study was supported by Igenomix who provided support in the form of salaries for authors [C.R. and R.C.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation of C.R. and R.C. did not play any role in the study. The specific roles of these authors are articulated in the 'author contributions' section.	Barbash-Hazan S, 2009, FERTIL STERIL, V92, P890, DOI 10.1016/j.fertnstert.2008.07.1761; Bazrgar M, 2013, STEM CELLS DEV, V22, P2449, DOI 10.1089/scd.2013.0053; Calhaz-Jorge C, 2016, HUM REPROD, V31, P1638, DOI 10.1093/humrep/dew151; Capalbo A, 2017, HUM REPROD, V32, P492, DOI 10.1093/humrep/dew250; Capalbo A, 2015, EUR J HUM GENET, V23, P901, DOI 10.1038/ejhg.2014.222; Capalbo A, 2013, HUM REPROD, V28, P2298, DOI 10.1093/humrep/det245; Capalbo A, 2013, HUM REPROD, V28, P509, DOI 10.1093/humrep/des394; Chambers GM, 2016, HUM REPROD, V31, P2632, DOI 10.1093/humrep/dew232; Cimadomo D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7193075; Farfalli VI, 2007, GYNECOL OBSTET INVES, V64, P161, DOI 10.1159/000101741; Fesahat F, 2017, INT J REPROD BIOMED, V15, P297; Fiorentino F, 2011, HUM REPROD, V26, P1925, DOI 10.1093/humrep/der082; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Fragouli E, 2011, HUM REPROD, V26, P480, DOI 10.1093/humrep/deq344; HARPER JC, 1995, PRENATAL DIAG, V15, P41, DOI 10.1002/pd.1970150109; Johnson DS, 2010, MOL HUM REPROD, V16, P944, DOI 10.1093/molehr/gaq062; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; Kokkali G, 2007, HUM REPROD, V22, P1443, DOI 10.1093/humrep/del506; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kung A, 2015, REPROD BIOMED ONLINE, V31, P760, DOI 10.1016/j.rbmo.2015.09.002; La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037; Lai HH, 2017, MOL CYTOGENET, V10, DOI 10.1186/s13039-017-0315-7; Li M, 2005, FERTIL STERIL, V84, P1395, DOI 10.1016/j.fertnstert.2005.04.068; Mantikou E, 2012, BBA-MOL BASIS DIS, V1822, P1921, DOI 10.1016/j.bbadis.2012.06.013; Mascarenhas MN, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-17; McCoy RC, 2017, TRENDS GENET, V33, P448, DOI 10.1016/j.tig.2017.04.001; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; MCLERNON DJ, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I5735; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Mir P, 2016, J ASSIST REPROD GEN, V33, P59, DOI 10.1007/s10815-015-0605-0; Munne S, 2003, PLACENTA, V24, pS70, DOI 10.1016/S0143-4004(03)00177-2; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; Munne S, 2010, REPROD BIOMED ONLINE, V20, P92, DOI 10.1016/j.rbmo.2009.10.015; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Prezina P, 2011, NATURE PRECEDINGS; Rubio C, 2007, PRENATAL DIAG, V27, P748, DOI 10.1002/pd.1773; Sandalinas M, 2001, HUM REPROD, V16, P1954, DOI 10.1093/humrep/16.9.1954; Santos MA, 2010, HUM REPROD, V25, P1916, DOI 10.1093/humrep/deq139; Schmid TE, 2007, HUM REPROD, V22, P180, DOI 10.1093/humrep/del338; Schoolcraft WB, 2011, FERTIL STERIL, V96, P638, DOI 10.1016/j.fertnstert.2011.06.049; Scott KL, 2013, FERTIL STERIL, V100, P608, DOI 10.1016/j.fertnstert.2013.07.004; Sher G, 2009, FERTIL STERIL, V92, P1886, DOI 10.1016/j.fertnstert.2008.11.029; Swain JE, 2016, FERTIL STERIL, V105, P571, DOI 10.1016/j.fertnstert.2016.01.035; Swain JE, 2013, J ASSIST REPROD GEN, V30, P1081, DOI 10.1007/s10815-013-0048-4; Tao X, 2011, FERTIL STERIL, V96, pS21, DOI 10.1016/j.fertnstert.2011.07.090; Taylor TH, 2014, HUM REPROD UPDATE, V20, P571, DOI 10.1093/humupd/dmu016; Templado C, 2013, MOL HUM REPROD, V19, P634, DOI 10.1093/molehr/gat039; Treff NR, 2013, FERTIL STERIL, V99, P1049, DOI 10.1016/j.fertnstert.2012.11.007; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vera-Rodriguez M, 2017, FERTIL STERIL, V107, P1107, DOI 10.1016/j.fertnstert.2017.03.019; Vera-Rodriguez M, 2016, FERTIL STERIL, V105, P1047, DOI 10.1016/j.fertnstert.2015.12.022; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; Wells D, 2014, FERTIL STERIL, V101, P1250, DOI 10.1016/j.fertnstert.2014.03.006	55	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201652	10.1371/journal.pone.0201652	http://dx.doi.org/10.1371/journal.pone.0201652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133476	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400028
J	Wong, SK; Ijichi, M; Kaneko, R; Kogure, K; Hamasaki, K				Wong, Shu-Kuan; Ijichi, Minoru; Kaneko, Ryo; Kogure, Kazuhiro; Hamasaki, Koji			Ammonia oxidizers in the sea-surface microlayer of a coastal marine inlet	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PLANKTONIC ARCHAEA; PHYLOGENETIC CHARACTERIZATION; VERTICAL-DISTRIBUTION; BACTERIAL; NITRIFICATION; DIVERSITY; ATLANTIC; OCEAN; CRENARCHAEOTA	Planktonic archaea are thought to play an important role in ammonia oxidation in marine environments. Data on the distribution, abundance, and diversity of ammonia oxidizers in the coastal sea-surface microlayer (SML) are lacking, despite previous reports of high abundance of Thaumarchaeota in the SML of estuaries and freshwater lakes. Here, we failed to detect the presence of ammonia-oxidizing bacteria in any of our samples taken from a semienclosed marine inlet in Japan. Therefore, we shifted our focus to examine the archaeal community composition as well as the Thaumarchaeota marine group I (MG-I) and ammonia monooxygenase subunit A (amoA) gene copy numbers and composition in the SML and corresponding underlying water (UW, 20 cm). amoA gene copy numbers obtained by quantitative PCR were consistent with the typical values observed in the surface waters of oceanic and coastal environments where nitrification activity has been detected, but the copy numbers were two-to three-fold less than those reported from the surface layers and UW of high mountain lakes. Both amoA and MG-I 16S rRNA gene copy numbers were significantly negatively correlated with chlorophyll-a and transparent exopolymer particle concentrations in the SML. Communities of archaea and ammonia-oxidizing archaea in SML samples collected during low wind conditions (<= 5 m s(-1)) differed the most from those in UW samples, whereas the communities in SML samples collected during high wind conditions were similar to the UW communities. In the SML, low ratios of amoA to MG-I 16S rRNA genes were observed, implying that most of the SML Thaumarchaeota lacked amoA. To our knowledge, our results provide the first comparison of ammonia-oxidizing communities in the coastal SML with those in the UW.	[Wong, Shu-Kuan; Ijichi, Minoru; Kogure, Kazuhiro; Hamasaki, Koji] Univ Tokyo, Atmosphere & Ocean Res Inst, Dept Marine Ecosyst Dynam, Lab Marine Microbiol, Kashiwa, Chiba, Japan; [Kaneko, Ryo] Natl Inst Polar Res, Tachikawa, Tokyo, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Wong, SK (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Dept Marine Ecosyst Dynam, Lab Marine Microbiol, Kashiwa, Chiba, Japan.	skwong@aori.u-tokyo.ac.jp		Wong, Shu-Kuan/0000-0003-3565-3805; Hamasaki, Koji/0000-0002-8514-506X	Japan Society for the Promotion of Science (KAKENHI) [24121004, 24241002, 18K14787]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (KAKENHI Grant Numbers 24121004, 24241002 and 18K14787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Auguet JC, 2008, ENVIRON MICROBIOL, V10, P1080, DOI 10.1111/j.1462-2920.2007.01498.x; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; BAIER RE, 1975, ADV CHEM SER, P1; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Bureekul S, 2014, GEOCHEM J, V48, pE1, DOI 10.2343/geochemj.2.0315; Christman GD, 2011, APPL ENVIRON MICROB, V77, P2016; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Cunliffe M, 2008, ISME J, V2, P776, DOI 10.1038/ismej.2008.28; Cunliffe M, 2013, PROG OCEANOGR, V109, P104, DOI 10.1016/j.pocean.2012.08.004; Cunliffe M, 2009, AQUAT MICROB ECOL, V57, P69, DOI 10.3354/ame01330; De Corte D, 2009, ISME J, V3, P147, DOI 10.1038/ismej.2008.94; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Harvey GW, 1966, LIMNOL OCEANOGR, V10, P602; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hornek R, 2006, J MICROBIOL METH, V66, P147, DOI 10.1016/j.mimet.2005.11.001; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hugoni M, 2013, P NATL ACAD SCI USA, V110, P6004, DOI 10.1073/pnas.1216863110; Ijichi M, 2011, J OCEANOGR, V68, P369; Jung M-Y, 2014, APPL ENVIRON MICROB, V80, P3465; Kalanetra KM, 2009, ENVIRON MICROBIOL, V11, P2434, DOI 10.1111/j.1462-2920.2009.01974.x; Kjelleberg S., 1985, BACTERIAL ADHESION M, P163; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kuznetsova M, 2004, LIMNOL OCEANOGR, V49, P1605, DOI 10.4319/lo.2004.49.5.1605; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Luo HW, 2014, ISME J, V8, P732, DOI 10.1038/ismej.2013.202; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Massana R, 1998, LIMNOL OCEANOGR, V43, P607, DOI 10.4319/lo.1998.43.4.0607; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Murray AE, 1999, AQUAT MICROB ECOL, V20, P129, DOI 10.3354/ame020129; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Pedneault E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04661; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; R Core Development Team, 2015, R LANG ENV STAT COMP; Reinthaler T, 2008, LIMNOL OCEANOGR, V53, P122, DOI 10.4319/lo.2008.53.1.0122; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sintes E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00077; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Smith JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108173; Smith JM, 2014, ISME J, V8, P1704, DOI 10.1038/ismej.2014.11; Stolle C, 2011, APPL ENVIRON MICROB, V77, P3726, DOI 10.1128/AEM.00042-11; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Takayanagi K, 1999, J OCEANOGR, P463; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; TESKE A, 1994, J BACTERIOL, V176, P6623, DOI 10.1128/JB.176.21.6623-6630.1994; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Urakawa H, 2014, LIMNOL OCEANOGR, V59, P1321, DOI 10.4319/lo.2014.59.4.1321; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vila-Costa M, 2013, FEMS MICROBIOL ECOL, V84, P387, DOI 10.1111/1574-6941.12068; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Ward BB, 2007, OCEANOGRAPHY, V20, P101, DOI 10.5670/oceanog.2007.53; Wietz M, 2010, AQUAT MICROB ECOL, V61, P179, DOI 10.3354/ame01443; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Wurl O, 2008, MAR CHEM, V110, P89, DOI 10.1016/j.marchem.2008.02.009; Wurl O, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007342; YAMAGUCHI M, 1975, MAR BIOL, V29, P253, DOI 10.1007/BF00391851; Zhang QF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01180	72	2	2	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202636	10.1371/journal.pone.0202636	http://dx.doi.org/10.1371/journal.pone.0202636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125317	Green Published, gold			2022-12-26	WOS:000442202100038
J	Zhao, B; Zhao, WQ; Wang, YQ; Zhao, Z; Zhao, CF; Wang, S; Gao, CZ				Zhao, Bin; Zhao, Wenqian; Wang, Yiqiang; Zhao, Zhao; Zhao, Changfeng; Wang, Shue; Gao, Chunzheng			Prior administration of vitamin K-2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization	PLOS ONE			English	Article							BONE METABOLISM; IN-VITRO; CELLS; OSTEOPOROSIS; SOST; DIFFERENTIATION; SCLEROSTEOSIS; CBFA1/RUNX2; EXPRESSION; APOPTOSIS	Zoledronic acid (ZA) exerts complex influence on bone by suppressing bone resorption, mostly due to the direct osteoclasts inhibition and uncertain influence on osteoblasts. Vitamin K-2 (VK2, Menaquinone-4) as an anabolic agent stimulates bone formation via anti-apoptosis in osteoblasts and mild osteoclasts inhibition. Based on these knowledge, the therapeutic effect of the combined or sequential therapy of VK2 and ZA depends on the influence on the osteoblasts, since both cases exert similar inhibitory effect on osteoclasts. In a series of in vitro studies, we confirmed the protective effect of VK2 in osteoblasts culture, especially when followed by exposure to ZA, and the proliferation and mineralization inhibition induced by ZA towards osteoblasts. For mechanism study, expression of bcl-2/bax, Runx2 and Sost in cells were examined. For in vivo studies, an osteoporosis animal model was established in rats via ovariectomy (OVX) and subjected to sequential treatment, namely VK2 followed by ZA. Bone mineral density (BMD) was measured by Dual energy X-ray absorptionmetry (DEXA), morphology and mechanical parameters by micro-computed tomography (micro-CT), mechanical strength by an electro-hydraulic fatigue-testing machine. The bone calcium, hydroxyproline content, blood lipids were evaluated using microplate technique, and the bone surface turnover was evaluated using the fluorescence in corporation method. It was found that VK2 pretreatment partially prevented the inhibition of bone formation caused by ZA, which was reflected by indices like BMD, bone calcium content and bone strength. The underling mechanisms for protection of VK2 pretreatment, mainly demonstrated via in vitro studies, included inhibiting apoptosis and depressing Sost expression in osteoblasts, which in turn improved the osteoporosis therapeutic effects of ZA. These findings suggested that pretreatment with VK2 before ZA therapy might serve a new long-term therapy protocol for osteoporosis.	[Zhao, Bin; Gao, Chunzheng] Shandong Univ, Hosp 2, Dept Orthoped, Jinan, Shandong, Peoples R China; [Zhao, Bin] Shouguang Hosp Tradit Chinese Med, Dept Orthoped, Shouguang, Shandong, Peoples R China; [Zhao, Wenqian] Peoples Hosp Shouguang, Dept Tradit Chinese Med & Dermatol, Shouguang, Shandong, Peoples R China; [Wang, Yiqiang] Soochow Univ, Jiangsu Inst Hematol, MOH Key Lab Thrombosis & Hemostasis, Affiliated Hosp 1, Suzhou, Peoples R China; [Zhao, Zhao] Shandong Univ, Qilu Hosp, Dept Cytol, Jinan, Shandong, Peoples R China; [Zhao, Changfeng; Wang, Shue] Shandong Univ, Sch Publ Hlth, Dept Nutr, Jinan, Shandong, Peoples R China	Shandong University; Soochow University - China; Shandong University; Shandong University	Gao, CZ (corresponding author), Shandong Univ, Hosp 2, Dept Orthoped, Jinan, Shandong, Peoples R China.	gaochunzheng2016@163.com	zhao, bin/GWC-4839-2022	gao, chunzheng/0000-0002-2375-7626				Ataoglu B, 2016, EKLEM HAST CERRAHISI, V27, P54, DOI 10.5606/ehc.2016.11; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Basso FG, 2013, GERONTOLOGY, V59, P534, DOI 10.1159/000351194; Belfrage O, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-240; Borba VZC, 2007, INT J CLIN PRACT, V61, P1058, DOI 10.1111/j.1742-1241.2007.01392.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001; FROST HM, 1991, BONE, V12, P429, DOI 10.1016/8756-3282(91)90032-E; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Hao Y, 2015, BONE, V81, P702, DOI 10.1016/j.bone.2015.09.018; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048; Iwamoto J, 2014, NUTRIENTS, V6, P1971, DOI 10.3390/nu6051971; Iwamoto J, 2011, BONE, V48, P1015, DOI 10.1016/j.bone.2011.02.015; Katsuyama H, 2015, EXP THER MED, V10, P843, DOI 10.3892/etm.2015.2621; Kishimoto Hideaki, 2009, Nihon Rinsho, V67, P975; Knapen MHJ, 2007, OSTEOPOROSIS INT, V18, P963, DOI 10.1007/s00198-007-0337-9; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kopecka J, 2015, ONCOTARGET, V6, P31461, DOI 10.18632/oncotarget.5058; Mattinzoli D, 2014, JOVE-J VIS EXP, DOI 10.3791/51465; Myneni V, 2017, ORAL DIS, V23, P1021, DOI 10.1111/odi.12624; Olejnik C, 2016, BONE, V89, P32, DOI 10.1016/j.bone.2016.05.002; Patntirapong S, 2012, J ORAL PATHOL MED, V41, P713, DOI 10.1111/j.1600-0714.2012.01154.x; Rubin MR, 2003, ENDOCRIN METAB CLIN, V32, P285, DOI 10.1016/S0889-8529(02)00056-7; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; Schwalfenberg GK, 2017, J NUTR METAB, V2017, DOI 10.1155/2017/6254836; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; Shiraki M, 2017, J BONE MINER METAB, V35, P675, DOI 10.1007/s00774-016-0806-3; Talukdar Y, 2014, BIOMATERIALS, V35, P4863, DOI 10.1016/j.biomaterials.2014.02.054; Urayama S, 2000, J LAB CLIN MED, V136, P181, DOI 10.1067/mlc.2000.108754; VERMEER C, 1995, ANNU REV NUTR, V15, P1, DOI 10.1146/annurev.nutr.15.1.1; Yamaguchi M, 2011, INT J MOL MED, V27, P3, DOI 10.3892/ijmm.2010.562; Yang XM, 2013, INTRACTABLE RARE DIS, V2, P18, DOI 10.5582/irdr.2013.v2.1.18	35	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202269	10.1371/journal.pone.0202269	http://dx.doi.org/10.1371/journal.pone.0202269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125322	Green Submitted, Green Published, gold			2022-12-26	WOS:000442202100023
J	Kim, DS; Kim, DW; Heo, YJ; Baek, JW; Lee, YJ; Choo, HJ; Park, YM; Park, HK; Ha, TK; Kim, DH; Jung, SJ; Park, JS; Ahn, KJ; Baek, HJ; Kang, T				Kim, Da Som; Kim, Dong Wook; Heo, Young Jin; Baek, Jin Wook; Lee, Yoo Jin; Choo, Hye Jung; Park, Young Mi; Park, Ha Kyoung; Ha, Tae Kwun; Kim, Do Hun; Jung, Soo Jin; Park, Ji Sun; Ahn, Ki Jung; Baek, Hye Jin; Kang, Taewoo			Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules	PLOS ONE			English	Article							BRAF(V600E) MUTATION; UNDETERMINED SIGNIFICANCE; BETHESDA SYSTEM; V600E MUTATION; ULTRASOUND; CARCINOMA; FEATURES; ATYPIA; CLASSIFICATION; CYTOPATHOLOGY	This study investigated the role of BRAF mutation analysis in thyroid fine-needle aspiration (FNA) samples compared to ultrasonographic and cytological diagnoses. A total 316 patients underwent ultrasonography (US)-guided FNA with BRAF(V)(600E) mutation analysis to diagnose thyroid nodules. One hundred sixteen patients with insufficient US images (n = 6), follow-up loss (n = 43), or unknown final diagnosis (n = 67) were excluded from the study. Comparisons between US diagnoses, cytological diagnoses, and BRAF mutation analysis were performed. Of 200 thyroid nodules, there was US diagnosis with 1 false negative and 11 false positive cases, cytological diagnosis with 10 false negative and 2 false positive cases, and BRAF(V600E) mutation analysis with 19 false negative and 2 false positive cases. The sensitivity, specificity, positive and negative predictive values, and accuracy of BRAF(V600E) mutation analysis were 83.2%, 98.1%, 97.5%, 86.6%, and 91%, respectively. Of the 18 nodules with Bethesda category III, 9 were true positive, 6 were true negative, 3 was a false negative, and none were false positive on BRAF mutation analysis. In conclusion, we recommend that BRAF(V600E) mutation analysis only be performed for evaluating thyroid nodules with Bethesda category III, regardless of US diagnosis.	[Kim, Da Som; Kim, Dong Wook; Heo, Young Jin; Baek, Jin Wook; Lee, Yoo Jin; Choo, Hye Jung; Park, Young Mi] Inje Univ, Busan Paik Hosp, Dept Radiol, Coll Med, Busan, South Korea; [Park, Ha Kyoung; Ha, Tae Kwun] Inje Univ, Busan Paik Hosp, Dept Gen Surg, Coll Med, Busan, South Korea; [Kim, Do Hun] Inje Univ, Busan Paik Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Busan, South Korea; [Jung, Soo Jin] Inje Univ, Busan Paik Hosp, Dept Pathol, Coll Med, Busan, South Korea; [Park, Ji Sun] Inje Univ, Busan Paik Hosp, Dept Nucl Med, Coll Med, Busan, South Korea; [Ahn, Ki Jung] Inje Univ, Busan Paik Hosp, Dept Radiat Oncol, Coll Med, Busan, South Korea; [Baek, Hye Jin] Gyeongsang Natl Univ, Changwon Hosp, Sch Med, Dept Radiol, Chang Won, South Korea; [Kang, Taewoo] Pusan Natl Univ, Pusan Natl Univ Hosp, Busan Canc Ctr, Dept Surg,Coll Med, Busan, South Korea	Inje University; Inje University; Inje University; Inje University; Inje University; Inje University; Gyeongsang National University; Pusan National University; Pusan National University Hospital	Kim, DW (corresponding author), Inje Univ, Busan Paik Hosp, Dept Radiol, Coll Med, Busan, South Korea.	dwultra@nate.com	Baek, Hye Jin/AAC-7595-2020; Baek, Hye Jin/T-2076-2019; Kim, Dong Wook/I-7600-2015	Baek, Hye Jin/0000-0001-7349-2841; TAEKWUN, HA/0000-0001-7980-3700; Jung, Soo Jin/0000-0002-9139-701X; BAEK, JINWOOK/0000-0003-4632-4951; Kim, Dong Wook/0000-0002-9826-1326				Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Di Benedetto G, 2014, ENDOCRINE, V47, P351, DOI 10.1007/s12020-014-0222-1; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hyeon J, 2014, CANCER CYTOPATHOL, V122, P368, DOI 10.1002/cncy.21396; Jeong SH, 2013, AM J ROENTGENOL, V201, pW854, DOI 10.2214/AJR.12.9901; Kim DW, 2012, AM J NEURORADIOL, V33, P1144, DOI 10.3174/ajnr.A2923; Kim DW, 2015, CAN ASSOC RADIOL J, V66, P79, DOI 10.1016/j.carj.2014.01.004; Kim DW, 2012, DIAGN CYTOPATHOL, V40, pE48, DOI 10.1002/dc.21669; Kim SY, 2015, SURGERY, V157, P354, DOI 10.1016/j.surg.2014.09.003; Kim SW, 2010, J CLIN ENDOCR METAB, V95, P3693, DOI 10.1210/jc.2009-2795; Koh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064505; Lee JH, 2007, CANCER-AM CANCER SOC, V110, P38, DOI 10.1002/cncr.22754; Lee YJ, 2015, DIAGN CYTOPATHOL, V43, P953, DOI 10.1002/dc.23363; Moon HJ, 2011, ANN SURG ONCOL, V18, P792, DOI 10.1245/s10434-010-1354-z; Moon WJ, 2012, AM J ROENTGENOL, V198, P668, DOI 10.2214/AJR.11.7185; Nam SY, 2010, THYROID, V20, P273, DOI 10.1089/thy.2009.0226; Ohori NP, 2013, CANCER CYTOPATHOL, V121, P197, DOI 10.1002/cncy.21229; Park HJ, 2014, CANCER CYTOPATHOL, V122, P512, DOI 10.1002/cncy.21411; Puxeddu E, 2014, ENDOCRINE, V45, P341, DOI 10.1007/s12020-013-0139-0; Su XY, 2016, ONCOTARGETS THER, V9, P2495, DOI 10.2147/OTT.S101800; Zatelli MC, 2009, EUR J ENDOCRINOL, V161, P467, DOI 10.1530/EJE-09-0353	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202687	10.1371/journal.pone.0202687	http://dx.doi.org/10.1371/journal.pone.0202687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118506	Green Published, gold, Green Submitted			2022-12-26	WOS:000442282700041
J	Alba-Alejandre, I; Hunter, WB; Alba-Tercedor, J				Alba-Alejandre, Ignacio; Hunter, Wayne B.; Alba-Tercedor, Javier			Micro-CT study of male genitalia and reproductive system of the Asian citrus psyllid, Diaphorina citri Kuwayama, 1908 (Insecta: Hemiptera, Liviidae)	PLOS ONE			English	Article							HOMOPTERA; PSYLLOIDEA; STERNORRHYNCHA; BIOLOGY	The Asian citrus psyllid (ACP), Diaphorina citri, is a major vector of the bacteria Candidatus Liberibacter asiaticus and C.L.americanus, which cause Huanglongbing disease (HLB) (aka Citrus greening disease), considered the most serious bacterial disease of citrus trees. As part of a multidisciplinary project on psyllid biology (www.citrusgreening.org), the results presented here concern a detailed anatomical study of the male reproductive system (testes, seminal vesicles, accessory glands, sperm pump, connecting ducts, and aedeagus) using micro-computed tomography (micro-CT). The study summarizes current knowledge on psyllids male reproductive system and represents significant advances in the knowledge of ACP anatomy.	[Alba-Alejandre, Ignacio; Alba-Tercedor, Javier] Univ Granada, Fac Sci, Dept Zool, Campus Fuentenueva, Granada, Spain; [Hunter, Wayne B.] ARS, USDA, Ft Pierce, FL USA	University of Granada; United States Department of Agriculture (USDA)	Alba-Tercedor, J (corresponding author), Univ Granada, Fac Sci, Dept Zool, Campus Fuentenueva, Granada, Spain.	jalba@ugr.es	Alba-Tercedor, Javier/C-3679-2015; hunter, wayne/AAB-9096-2020	hunter, wayne/0000-0001-8603-3337; Alba-Tercedor, Javier/0000-0002-3461-5340; Alba-Alejandre, Ignacio/0000-0002-3917-6949	USDA-NIFA [2014-70016-23028]; Kansas State University (KSU) [S15192.01]; University of Granada [S15192.01]	USDA-NIFA(United States Department of Agriculture (USDA)); Kansas State University (KSU); University of Granada	This work was supported by USDA-NIFA Award 2014-70016-23028 "Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease", 2015-2020; https://portal.nifa.usda.gov/web/crisprojectpages/1005600-developing-an-infrastructure-and-product-test-pipeline-to-deliver-novel-therapies-for-citrus-greening-disease.html; led by Susan J. Brown (Kansas State University); Subaward agreement S15192.01 between the Kansas State University (KSU) and the University of Granada, as a part of the USDA-NIFA Award 2014-70016-23028, led by J. Alba-Tercedor (University of Granada).; This work benefitted from the sub-award agreement S15192.01 between the Kansas State University (KSU) and the University of Granada, as a part of the USDA-NIFA Award 2014-70016-23028 to Dr. Susan J. Brown (KSU), "Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease" (2015-2020).	Alba-Tercedor J., 2017, BRUK MICR CT US M 20, P270; Alba-Tercedor J, 2017, J CITRUS PATHOL, V4, P1; Alba-Tercedor J, 2014, BRUKER MICROCT USERS, P260; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064938; Barcellos MS, 2017, MICRON, V99, P49, DOI 10.1016/j.micron.2017.03.017; Bitsch J., 1979, RAITE ZOOLOGIE ANATO, P420; Brittain WH., 1922, P ACAD ENTOMOL SOC, V8, P23; Brown R.G., 1988, ENTOMON, V9, P1; Burckhard Daniel, 1994, Revista Chilena de Entomologia, V21, P57; BURCKHARDT D, 1987, ZOOL J LINN SOC-LOND, V90, P145, DOI 10.1111/j.1096-3642.1987.tb01353.x; CONCI C., 1988, ANN MUSEI CIVICI ROV, V4, P307; FEI, 2017, AM 3D VIS AN SOFTW; GLOWACKA E, 1993, FOLIA BIOL-KRAKOW, V41, P55; Glowacka E, 1995, FOLIA BIOL-KRAKOW, V43, P115; Glowacka E, 1998, FOLIA BIOL-KRAKOW, V46, P17; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hodkinson ID., 1979, HOMOPTERA PSYLLOIDEA; Ibanez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111745; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Kuwayama S., 1907, T SAPPORO NAT HIST S, V2, P149; Kuznetsova VG, 2012, ZOOTAXA, P55; Kuznetsova VG, 1997, FOLIA BIOL-KRAKOW, V45, P143; Kuznetsova VG, 1997, ENTOMOL REV, V1, P21; Labina ES, 2014, FOLIA BIOL-KRAKOW, V62, P321, DOI 10.3409/fb62_4.321; Liu YH, 2000, ANN APPL BIOL, V137, P201, DOI 10.1111/j.1744-7348.2000.tb00060.x; Macharashvili ID., 1997, ENTOMOL, V77, P12; Maryanska-Nadachowska A, 2005, FOLIA BIOL-KRAKOW, V53, P143, DOI 10.3409/173491605775142710; Maryanska-Nadachowska A, 1997, FOLIA BIOL-KRAKOW, V45, P125; Maryanska-Nadachowska A, 2001, AUST J ENTOMOL, V40, P357, DOI 10.1046/j.1440-6055.2001.00231.x; Maryanska-Nadachowska A, 2001, AUST J ENTOMOL, V40, P349, DOI 10.1046/j.1440-6055.2001.00230.x; MaryanskaNadachowska A, 1996, CARYOLOGIA, V49, P279, DOI 10.1080/00087114.1996.10797372; Mathur R. N., 1975, PSYLLIDAE INDIAN SUB; Matsuda R., 1976, MORPHOLOGY EVOLUTION, P280, DOI [10.1016/B978-0-08-018753-2.50040-X, DOI 10.1016/B978-0-08-018753-2.50040-X]; Muir FL, 1930, ANN MAG NAT HIST, V10, P545, DOI [10.1080/00222933008673163, DOI 10.1080/00222933008673163]; Nava DE, 2007, J APPL ENTOMOL, V131, P709, DOI 10.1111/j.1439-0418.2007.01230.x; Park Hee Cheon, 2003, Korean Journal of Systematic Zoology, V19, P139; Pelz-Stelinski KS, 2016, ANN ENTOMOL SOC AM, V109, P371, DOI 10.1093/aesa/saw007; Prophetou-Athanasiadou DA, 2016, ENTOMOL HELL, V12, P37; QADRI M. A. H., 1949, JOUR ZOOL SOC INDIA, V1, P129; Saunders L. G., 1921, THESIS; SCHLEE D, 1969, Z MORPHOL TIERE, V64, P95, DOI 10.1007/BF00391783; Shen W, 2013, J PLANT PATHOL, V95, P361; Stockton DG, 2017, ENTOMOL EXP APPL, V164, P16, DOI 10.1111/eea.12590; Sukthankar P, 2014, BBA-BIOMEMBRANES, V1838, P2296, DOI 10.1016/j.bbamem.2014.02.005; Wang YJ, 2017, PEST MANAG SCI, V73, P2090, DOI 10.1002/ps.4582; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Wenninger EJ, 2009, ANN ENTOMOL SOC AM, V102, P547, DOI 10.1603/008.102.0327; Wenninger EJ, 2009, ANN ENTOMOL SOC AM, V102, P476, DOI 10.1603/008.102.0318; Witlaczil E., 1885, Z WISSENSCHAFTLICHE, V42, P569; Wu FN, 2016, MITOCHONDRIAL DNA B, V1, P239, DOI 10.1080/23802359.2016.1156491; Zucht B., 1972, ZOOL JB ANAT, V231, P167	51	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202234	10.1371/journal.pone.0202234	http://dx.doi.org/10.1371/journal.pone.0202234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114289	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400053
J	Nayak, VKR; Nayak, KR; Vidyasagar, S; Kamath, A				Nayak, Vineetha K. Ramdas; Nayak, Kirtana Raghurama; Vidyasagar, Sudha; Kamath, Asha			Body composition analysis, anthropometric indices and lipid profile markers as predictors for prediabetes	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; WAIST CIRCUMFERENCE; OBESITY INDICATORS; HIGH PREVALENCE; MASS INDEX; RISK; ASSOCIATIONS; POPULATION; TOLERANCE; HISTORY	Objectives To compare different anthropometric indices, Body composition analysis and lipid profile markers in terms of their ability to predict prediabetes (PD). Methods We enrolled 83 subjects with PD and 84 normoglycemic subjects who were matched for age and gender. The diagnosis of prediabetes was done according to the American Diabetes Association (ADA) criteria. All subjects were aged between 30-55 years of age and visited the outpatient department of tertiary care hospital. Anthropometric and lipid profile measurements were obtained. Analysis of body composition was done using Bodystat 1500MDD Instrument. Backward logistic regression was performed for detecting the predictors of PD. A receiver operator characteristic curve (ROC) with area under curve (AUC) was utilized for the accuracy of the predictors of PD. Results Comparison of anthropometric measurement and body composition analysis parameters between the two groups showed that Waist circumference (WC), Body mass index, Body Fat% were significantly higher whereas Extracellular water and Dry lean weight in percentage (ECW% and DLW%) were found to be lower in PD (p<0.05). Higher triglyceride (TG) levels and lower high-density cholesterol (HDL-C) with high TG/HDL-C were seen in subjects with PD. Backward logistic regression analysis found the combination of Body Fat% with WC, TG, ECW% and DLW% as strong predictors of PD. In ROC analysis, ECW% (AUC = 0.703) was the most predictive measure, followed by WC (AUC = 0.702). Conclusion This study demonstrated that estimation of Body Fat % combined with waist circumference, Extracellular water and Dry lean weight in percentage are valuable in screening and diagnosis of prediabetes. Plasma levels of TG in lipid profile measurements can also serve as an additional marker for prediction of prediabetes.	[Nayak, Vineetha K. Ramdas; Nayak, Kirtana Raghurama] Manipal Acad Higher Educ, KMC Manipal, Dept Physiol, Manipal, Karnataka, India; [Vidyasagar, Sudha] Manipal Acad Higher Educ, KMC Manipal, Dept Med, Manipal, Karnataka, India; [Kamath, Asha] Manipal Acad Higher Educ, PSPH, Dept Stat, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE)	Nayak, KR (corresponding author), Manipal Acad Higher Educ, KMC Manipal, Dept Physiol, Manipal, Karnataka, India.	kirtana.pai@manipal.edu	Nayak, Krishnananda/AAD-9907-2020; Nayak, Vineetha K Ramdas/W-4182-2019; pai, kirtana/D-7951-2017	Nayak, Vineetha K Ramdas/0000-0001-6201-2558; pai, kirtana/0000-0001-6124-2239				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Anjana RM, 2017, LANCET DIABETES ENDO, V5, P585, DOI 10.1016/S2213-8587(17)30174-2; Arner P., 2002, DIABETES-METAB RES, V18, pE40; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Benjamin SM, 2003, DIABETES CARE, V26, P645, DOI 10.2337/diacare.26.3.645; Bosy-Westphal A, 2013, EUR J CLIN NUTR, V67, pS14, DOI 10.1038/ejcn.2012.160; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Buchholz AC, 2003, ARCH PHYS MED REHAB, V84, P854, DOI 10.1016/S0003-9993(02)04950-X; Cameron AJ, 2013, OBES REV, V14, P86, DOI 10.1111/j.1467-789X.2012.01051.x; Chamukuttan S, 2016, DIABETES-METAB RES, V32, P762, DOI 10.1002/dmrr.2799; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Gholi Z, 2016, J RES MED SCI, V21, P120, DOI 10.4103/1735-1995.179888; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heymsfield SB, 1996, AM J CLIN NUTR, V64, P478, DOI 10.1093/ajcn/64.3.478S; HOSMER DW, 2000, WILEY PS TX, P1; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang LH, 2012, OBES RES CLIN PRACT, V6, pE314, DOI 10.1016/j.orcp.2011.11.003; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Kansal Subodh, 2016, J Assoc Physicians India, V64, P18; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Misra A, 2014, DIABETIC MED, V31, P1153, DOI 10.1111/dme.12540; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Miyazaki Y, 2012, J DIABETES MELLITUS, V2, P272; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Overweight and Obesity in Adults, 2000, NIH PUBL; PACE N, 1945, J BIOL CHEM, V158, P685; Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353; Paul Uttam Kumar, 2012, J Indian Med Assoc, V110, P616; Pratyush Daliparthy Devi, 2012, Indian J Endocrinol Metab, V16, P112, DOI 10.4103/2230-8210.91205; Rajpathak SN, 2011, J IMMIGR MINOR HEALT, V13, P181, DOI 10.1007/s10903-010-9356-2; Ramachandran A, 2004, DIABETES RES CLIN PR, V65, P189, DOI 10.1016/j.diabres.2004.03.012; RAMACHANDRAN A, 1988, BRIT MED J, V297, P587, DOI 10.1136/bmj.297.6648.587; Ren XX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154345; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tillin T, 2012, DIABETES CARE, V7; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Zhang L, 2008, DIABETES RES CLIN PR, V82, P364, DOI 10.1016/j.diabres.2008.08.022; Zheng S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1020-8	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0200775	10.1371/journal.pone.0200775	http://dx.doi.org/10.1371/journal.pone.0200775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114196	Green Submitted, gold, Green Published			2022-12-26	WOS:000441850400007
J	Pereda, E; Garcia-Torres, M; Melian-Batista, B; Manas, S; Mendez, L; Gonzalez, JJ				Pereda, Ernesto; Garcia-Torres, Miguel; Melian-Batista, Belen; Manas, Soledad; Mendez, Leopoldo; Gonzalez, Julian J.			The blessing of Dimensionality: Feature Selection outperforms functional connectivity-based feature transformation to classify ADHD subjects from EEG patterns of phase synchronisation	PLOS ONE			English	Article							BAYESIAN BELIEF NETWORKS; PROBABILISTIC INFERENCE; BRAIN NETWORKS; STATES; MEG; INTERDEPENDENCIES; SURROGATES; RELEVANCE; SIGNALS; GRAPHS	Functional connectivity (FC) characterizes brain activity from a multivariate set of N brain signals by means of an NxN matrix A, whose elements estimate the dependence within each possible pair of signals. Such matrix can be used as a feature vector for (un) supervised subject classification. Yet if N is large, A is highly dimensional. Little is known on the effect that different strategies to reduce its dimensionality may have on its classification ability. Here, we apply different machine learning algorithms to classify 33 children (age [6-14 years]) into two groups (healthy controls and Attention Deficit Hyperactivity Disorder patients) using EEG FC patterns obtained from two phase synchronisation indices. We found that the classification is highly successful (around 95%) if the whole matrix A is taken into account, and the relevant features are selected using machine learning methods. However, if FC algorithms are applied instead to transform A into a lower dimensionality matrix, the classification rate drops to less than 80%. We conclude that, for the purpose of pattern classification, the relevant features should be selected among the elements of A by using appropriate machine learning algorithms.	[Pereda, Ernesto] Univ La Laguna, Elect Engn & Bioengn Grp, Dept Ind Engn, Santa Cruz De Tenerife, Spain; [Pereda, Ernesto] Univ La Laguna, Inst Univ Neurociencia IUNE, Santa Cruz De Tenerife, Spain; [Pereda, Ernesto] UPM, CTB, Lab Cognit & Computat Neurosci, Madrid, Spain; [Pereda, Ernesto] Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium; [Garcia-Torres, Miguel] Univ Pablo de Olavide, Div Comp Sci, ES-41013 Seville, Spain; [Melian-Batista, Belen] Univ La Laguna, Dept Informat & Syst Engn, Santa Cruz De Tenerife, Spain; [Manas, Soledad; Mendez, Leopoldo] Teaching Hosp Ntra Sra Candelaria, Unit Clin Neurophysiol, Santa Cruz De Tenerife, Spain; [Gonzalez, Julian J.] Univ La Laguna, Dept Basic Med Sci, Santa Cruz De Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Ghent University; Universidad Pablo de Olavide; Universidad de la Laguna; Universidad de la Laguna	Pereda, E (corresponding author), Univ La Laguna, Elect Engn & Bioengn Grp, Dept Ind Engn, Santa Cruz De Tenerife, Spain.; Pereda, E (corresponding author), Univ La Laguna, Inst Univ Neurociencia IUNE, Santa Cruz De Tenerife, Spain.	eperdepa@ull.edu.es	GARCIA TORRES, MIGUEL/K-5782-2014; Pereda, Ernesto/K-5185-2014; De Pablo, Ernesto Pereda/AAB-7440-2021; Melian-Batista, Belen/M-1240-2014	GARCIA TORRES, MIGUEL/0000-0002-6867-7080; Pereda, Ernesto/0000-0001-5965-164X; De Pablo, Ernesto Pereda/0000-0001-5965-164X; Melian-Batista, Belen/0000-0001-9577-6247	Spanish MINECO [TEC2012-38453-C04-03, TEC2016-80063-C3-2-R]	Spanish MINECO(Spanish Government)	E. Pereda and J.J. Gonzalez acknowledge the financial support of the Spanish MINECO through the grant TEC2012-38453-C04-03. E. Pereda acknowledges the financial support of the Spanish MINECO through the grant TEC2016-80063-C3-2-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Juan Garcia Prieto and Prof. Pedro Larranaga for fruitful discussions on the application of machine learning to patterns of functional brain connectivity. E. Pereda and J.J. Gonzalez acknowledge the financial support of the Spanish MINECO through the grant TEC2012-38453-C04-03. E. Pereda acknowledges the financial support of the Spanish MINECO through the grant TEC2016-80063-C3-2-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of the computer time was provided by the Centro Informatico Cientifico de Andaluca (CIC).	Al-Khassaweneh M, 2016, IEEE T SIGNAL PROCES, V64, P2774, DOI 10.1109/TSP.2016.2529586; Alba G, 2015, NEUROPSYCH DIS TREAT, V11, P2755, DOI 10.2147/NDT.S51783; Allefeld C, 2004, INT J BIFURCAT CHAOS, V14, P417, DOI 10.1142/S0218127404009521; Allefeld C, 2007, INT J BIFURCAT CHAOS, V17, P3493, DOI 10.1142/S0218127407019251; Andrzejak RG, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066202; Atluri G, 2013, NEUROIMAGE-CLIN, V3, P123, DOI 10.1016/j.nicl.2013.07.004; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Bjornsdotter Malin, 2010, Application of Machine Learning, P147; Bruna R, 2017, PHASE LOCKING VALUE; Bruns A, 2004, J NEUROSCI METH, V137, P321, DOI 10.1016/j.jneumeth.2004.03.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Cabral J, 2014, NEUROIMAGE, V90, P423, DOI 10.1016/j.neuroimage.2013.11.047; Caspers S, 2013, NEUROIMAGE, V80, P18, DOI 10.1016/j.neuroimage.2013.04.003; Chella F, 2014, NEUROIMAGE, V91, P146, DOI 10.1016/j.neuroimage.2013.12.064; Chella F, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.052420; Christodoulakis M, 2014, NEUROMETHODS, P103; COOPER GF, 1990, ARTIF INTELL, V42, P393, DOI 10.1016/0004-3702(90)90060-D; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; DAGUM P, 1993, ARTIF INTELL, V60, P141, DOI 10.1016/0004-3702(93)90036-B; de la Cruz DM, 2007, CEREB CORTEX, V17, P583, DOI 10.1093/cercor/bhk002; Dimitriadis SI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00306; Finger H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005025; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Garcia-Prieto J, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00008; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; Gonzalez JJ, 2013, CLIN NEUROPHYSIOL, V124, P1139, DOI 10.1016/j.clinph.2012.12.006; Gorgolewski KJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002506; Guzman Alba E, 2016, CLIN NEUROPHYSIOL, V127, P1321, DOI [10.1016/j.clinph.2015.09.134, DOI 10.1016/J.CLINPH.2015.09.134]; Hall M. A., 1998, CORRELATION BASED FE; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hegger R, 1999, PHYS REV E, V60, P4970, DOI 10.1103/PhysRevE.60.4970; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Kipinski L, 2011, BIOL CYBERN, V105, P183, DOI 10.1007/s00422-011-0456-4; La Rocca D, 2014, HUMAN BRAIN DISTINCT; Langs G, 2012, MACHINE LEARNING INT; Lopez FG, 2006, EUR J OPER RES, V169, P477, DOI 10.1016/j.ejor.2004.08.010; Lopez-Ibor JJ, 2002, DSM 4 TR MANUAL DIAG; Maximo JO, 2014, NEUROPSYCHOL REV, V24, P16, DOI 10.1007/s11065-014-9250-0; Mwangi B, 2013, NEUROINFORMATICS; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niso G, 2013, NEUROINFORMATICS, V11, P405, DOI 10.1007/s12021-013-9186-1; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pereda E, 2001, PHYSICA D, V148, P147, DOI 10.1016/S0167-2789(00)00190-1; Porz S, 2014, CHAOS, V24, DOI 10.1063/1.4890568; Pulini A, 2018, BIOL PSYCHIAT COGNIT; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Richiardi J, 2013, IEEE SIGNAL PROC MAG, V30, P58, DOI 10.1109/MSP.2012.2233865; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Romano MC, 2009, CHAOS, V19, DOI 10.1063/1.3072784; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Schelter B, 2007, PHYS LETT A, V366, P382, DOI 10.1016/j.physleta.2007.01.085; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Soriano MC, 2017, FRONT NEUROINFORM, V11, P1, DOI 10.3389/fninf.2017.00043; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Terrien J, 2013, MED ENG PHYS, V35, P1188, DOI 10.1016/j.medengphy.2012.12.010; Thiel M, 2008, PHILOS T R SOC A, V366, P545, DOI 10.1098/rsta.2007.2109; Thiel M, 2006, EUROPHYS LETT, V75, P535, DOI 10.1209/epl/i2006-10147-0; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; Van Diessen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059764; World Health Organization, 2002, WHO ICD 10 CLASS MEN; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zanin M, 2016, PHYS REP, V635, P1, DOI 10.1016/j.physrep.2016.04.005; Zanin M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00630; Zhou J, 2014, BIOL PSYCHIAT, V75, P565, DOI 10.1016/j.biopsych.2014.01.020	70	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201660	10.1371/journal.pone.0201660	http://dx.doi.org/10.1371/journal.pone.0201660			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114248	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400022
J	Rebollo-Neira, L				Rebollo-Neira, Laura			A competitive scheme for storing sparse representation of X-Ray medical images	PLOS ONE			English	Article							BREAST-CANCER; DICTIONARIES; APPROXIMATION; PURSUIT	A competitive scheme for economic storage of the informational content of an X-Ray image, as it can be used for further processing, is presented. It is demonstrated that sparse representation of that type of data can be encapsulated in a small file without affecting the quality of the recovered image. The proposed representation, which is inscribed within the context of data reduction, provides a format for saving the image information in a way that could assist methodologies for analysis and classification. The competitiveness of the resulting file is compared against the compression standards JPEG and JPEG2000.	[Rebollo-Neira, Laura] Aston Univ, Math Dept, Birmingham B4 7ET, W Midlands, England	Aston University	Rebollo-Neira, L (corresponding author), Aston Univ, Math Dept, Birmingham B4 7ET, W Midlands, England.	l.rebollo-neira@aston.ac.uk		Rebollo-Neira, Laura/0000-0002-7420-8977				Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Bar Y, 2015, IEEE 12 INT S BIOM I; Bowley J., 2011, IEEE SIGNAL PROC LET, V18, P189, DOI [10.1109/LSP.2011.2106496, DOI 10.1109/LSP.2011.2106496]; Carneiro G, 2017, ADV COMPUT VIS PATT, P11, DOI 10.1007/978-3-319-42999-1_2; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Dheeba J, 2014, J BIOMED INFORM, V49, P45, DOI 10.1016/j.jbi.2014.01.010; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Kowalik-Urbaniak I. A., 2014, MED IMAGING IMAGE PE; Kreutz-Delgado K, 2003, NEURAL COMPUT, V15, P349, DOI 10.1162/089976603762552951; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu B., 2015, IEEE C COMP VIS PATT, P248, DOI [10.1109/CVPR.2015.7298681, DOI 10.1109/CVPR.2015.7298681]; Liu XM, 2015, NEUROCOMPUTING, V152, P388, DOI 10.1016/j.neucom.2014.10.040; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Nithila EE, 2017, ENG SCI TECHNOL, V20, P1192, DOI 10.1016/j.jestch.2016.12.006; PATI YC, 1993, CONFERENCE RECORD OF THE TWENTY-SEVENTH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS & COMPUTERS, VOLS 1 AND 2, P40, DOI 10.1109/ACSSC.1993.342465; Pereira DC, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.014; Qayyum A, 2017, NEUROCOMPUTING, V266, P8, DOI 10.1016/j.neucom.2017.05.025; Rebollo-Neira L, 2012, PHYSICA A, V391, P5858, DOI 10.1016/j.physa.2012.06.042; Rebollo-Neira L, 2002, IEEE SIGNAL PROC LET, V9, P137, DOI 10.1109/LSP.2002.1001652; Rebollo-Neira L, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2886; Rebollo-Neira L, 2013, IEEE SIGNAL PROC LET, V20, P1175, DOI 10.1109/LSP.2013.2283510; Rebollo-Neira L, 2013, J OPT SOC AM A, V30, P758, DOI 10.1364/JOSAA.30.000758; Rubinstein R, 2010, IEEE T SIGNAL PROCES, V58, P1553, DOI 10.1109/TSP.2009.2036477; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Srinivas M, 2015, NEUROCOMPUTING, V168, P880, DOI 10.1016/j.neucom.2015.05.036; Summers RM, 2017, ADV COMPUT VIS PATT, P3, DOI 10.1007/978-3-319-42999-1_1; Tosic I, 2011, IEEE SIGNAL PROC MAG, V28, P27, DOI 10.1109/MSP.2010.939537; Wang X., IEEE CVPR; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang ZQ, 2014, NEUROCOMPUTING, V128, P175, DOI 10.1016/j.neucom.2013.05.053; Wasser L. A., 2015, HIERARCHICAL DATA FO; Yoon J, 2017, IEEE J BIOMED HEALTH, V21, P1133, DOI 10.1109/JBHI.2016.2574857; Zepeda J, 2011, IEEE J-STSP, V5, P1061, DOI 10.1109/JSTSP.2011.2135332; Zhang XF, 2016, IEEE J BIOMED HEALTH, V20, DOI 10.1109/JBHI.2015.2461671; Zhu PF, 2018, PATTERN RECOGN, V74, P488, DOI 10.1016/j.patcog.2017.09.036; Zhu PF, 2017, IMAGE VISION COMPUT, V60, P22, DOI 10.1016/j.imavis.2016.11.014; Zhu PF, 2017, PATTERN RECOGN, V66, P364, DOI 10.1016/j.patcog.2017.01.016; Zhu PF, 2016, INFORM SCIENCES, V370, P270, DOI 10.1016/j.ins.2016.08.004; Zhu PF, 2015, PATTERN RECOGN, V48, P438, DOI 10.1016/j.patcog.2014.08.006; Zou QG, 2016, ANAL BIOCHEM, V494, P4, DOI 10.1016/j.ab.2015.10.009	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201455	10.1371/journal.pone.0201455	http://dx.doi.org/10.1371/journal.pone.0201455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114219	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000441850400015
J	Won, JS; Nam, H; Lee, HW; Hwang, JY; Noh, YJ; Nam, DH; Lee, SH; Joo, KM				Won, Jeong-Seob; Nam, Hyun; Lee, Hye Won; Hwang, Ji-Yoon; Noh, Yu-Jeong; Nam, Do-Hyun; Lee, Sun-Ho; Joo, Kyeung Min			In vivo distribution of U87MG cells injected into the lateral ventricle of rats with spinal cord injury	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CEREBROSPINAL-FLUID; CSF FLOW; TRANSPLANTATION; DELIVERY; THERAPY; REGENERATION; CIRCULATION; MIGRATION; BRAIN	Stem cells could be the next generation therapeutic option for neurodegenerative diseases including spinal cord injury (SCI). However, several critical factors such as delivery method should be determined before their clinical applications. Previously, we have demonstrated that lateral ventricle (LV) injection as preclinical simulation could be used for intrathecal administration in clinical trials using rodent animal models. In this study, we further analyzed in vivo distribution of cells that were injected into LVs of rats with SCI at thoracic level using in vivo imaging techniques. When 5 x 10(6) U87MG cells labelled with fluorescent magnetic nanoparticle (FMNP-labelled U87MG) were administrated into LVs at 7 days after SCI, FMNP-labelled U87MG cells were observed in all regions of the spinal cord at 24 hours after the injection. Compared to water-soluble Cy5.5 fluorescent dye or rats without SCI, in vivo distribution pattern of FMNP-labelled U87MG cells was not different, although migration to the spinal cord was significantly reduced in both Cy5.5 fluorescent dye and FMNP-labelled U87MG cells caused by the injury. The presence of FMNP-labelled U87MG cells in the spinal cord was confirmed by quantitative PCR for human specific sequence and immunohistochemistry staining using antibody against human specific antigen. These data indicate that LV injection could recapitulate intrathecal administration of stem cells for SCI patients. Results of this study might be applied further to the planning of optimal preclinical and clinical trials of stem cell therapeutics for SCI.	[Won, Jeong-Seob; Nam, Do-Hyun; Lee, Sun-Ho; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Won, Jeong-Seob; Nam, Hyun; Lee, Hye Won; Hwang, Ji-Yoon; Noh, Yu-Jeong; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Single Cell Network Res Ctr, Suwon, South Korea; [Won, Jeong-Seob; Nam, Hyun; Hwang, Ji-Yoon; Noh, Yu-Jeong; Nam, Do-Hyun; Lee, Sun-Ho; Joo, Kyeung Min] Samsung Med Ctr, Res Inst Future Med, Stem Cell & Regenerat Med Ctr, Seoul, South Korea; [Nam, Hyun; Nam, Do-Hyun; Lee, Sun-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Lee, Hye Won; Hwang, Ji-Yoon; Noh, Yu-Jeong; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Lee, SH; Joo, KM (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Joo, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Single Cell Network Res Ctr, Suwon, South Korea.; Lee, SH; Joo, KM (corresponding author), Samsung Med Ctr, Res Inst Future Med, Stem Cell & Regenerat Med Ctr, Seoul, South Korea.; Lee, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea.; Joo, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea.	sobotta72@gmail.com; kmjoo@skku.edu	Lee, Sun-ho/AAD-6712-2022; joo, kyeung min/A-1270-2018	joo, kyeung min/0000-0003-2750-405X; Lee, Hye Won/0000-0002-0303-4658	Ministry of Food and Drug Safety [18172MFDS182]; National Research Foundation [NRF-2016R1A5A2945889, NRF-2016R1D1A1B03933833, NRF-2016R1A6A3A11930396]; National Research Foundation (Ministry of Food and Drug Safety)	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation; National Research Foundation (Ministry of Food and Drug Safety)	This research was supported by grants from Ministry of Food and Drug Safety in 2018 (18172MFDS182) to KMJ and National Research Foundation (NRF-2016R1A5A2945889 to KMJ, NRF-2016R1D1A1B03933833 to S-HL, and NRF-2016R1A6A3A11930396 to HN) (Ministry of Food and Drug Safety: http://www.mfds.go.kr/index.do; National Research Foundation: http://www.nrf.re.kr/index).; This research was supported by grants from Ministry of Food and Drug Safety in 2018 (18172MFDS182) and National Research Foundation (NRF-2016R1A5A2945889, NRF-2016R1D1A1B03933833, and NRF-2016R1A6A3A11930396).	Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P330, DOI 10.3171/spi.2004.1.3.0330; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BERING EA, 1962, J NEUROSURG, V19, P405, DOI 10.3171/jns.1962.19.5.0405; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao GH, 2012, BIOMATERIALS, V33, P9157, DOI 10.1016/j.biomaterials.2012.09.016; GRUNDY HF, 1962, J PHYSIOL-LONDON, V163, P457, DOI 10.1113/jphysiol.1962.sp006989; Han SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-145; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hastings CL, 2015, ADV DRUG DELIVER REV, V84, P85, DOI 10.1016/j.addr.2014.08.006; Holmes D, 2017, NATURE, V552, pS49, DOI 10.1038/d41586-017-07550-9; Kim HS, 2017, BIOCHEM BIOPH RES CO, V493, P751, DOI 10.1016/j.bbrc.2017.08.115; Kwon YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085736; Lee KH, 2018, J KOREAN NEUROSURG S, V61, P434, DOI 10.3340/jkns.2017.0252; Lee NK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155912; MILHORAT TH, 1971, SCIENCE, V173, P330, DOI 10.1126/science.173.3994.330; Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124; Oraee-Yazdani S, 2016, SPINAL CORD, V54, P102, DOI 10.1038/sc.2015.142; Park SE, 2016, NEUROBIOL AGING, V47, P192, DOI 10.1016/j.neurobiolaging.2016.08.002; Patki G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117498; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Piltti KM, 2017, STEM CELL REP, V8, P1534, DOI 10.1016/j.stemcr.2017.04.009; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502; Saito F, 2008, J TRAUMA, V64, P53, DOI 10.1097/TA.0b013e31815b847d; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; SHERMAN JL, 1986, AM J NEURORADIOL, V7, P3; Simon MJ, 2016, BBA-MOL BASIS DIS, V1862, P442, DOI 10.1016/j.bbadis.2015.10.014; Szabo S, 2012, INT J LEGAL MED, V126, P63, DOI 10.1007/s00414-011-0566-5; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Visted T, 2003, FRONT BIOSCI-LANDMRK, V8, pE289, DOI 10.2741/1026; Yang HY, 2017, ACS APPL MATER INTER, V9, P19184, DOI 10.1021/acsami.7b03747; Zhao H, 2016, MOL NEUROBIOL, V53, P187, DOI 10.1007/s12035-014-9000-6	37	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202307	10.1371/journal.pone.0202307	http://dx.doi.org/10.1371/journal.pone.0202307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114270	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400056
J	Bhadra, S; Pothukuchy, A; Shroff, R; Cole, AW; Byrom, M; Ellefson, JW; Gollihar, JD; Ellington, AD				Bhadra, Sanchita; Pothukuchy, Arti; Shroff, Raghav; Cole, Austin W.; Byrom, Michelle; Ellefson, Jared W.; Gollihar, Jimmy D.; Ellington, Andrew D.			Cellular reagents for diagnostics and synthetic biology	PLOS ONE			English	Article							DNA-POLYMERASE GENE; MOLECULAR-BIOLOGY; ESCHERICHIA-COLI; ISOTHERMAL AMPLIFICATION; AFFINITY TAGS; PROTEIN; PURIFICATION; SEQUENCE; ROBUST; CELLS	We have found that the overproduction of enzymes in bacteria followed by their lyophilization leads to 'cellular reagents' that can be directly used to carry out numerous molecular biology reactions. We demonstrate the use of cellular reagents in a variety of molecular diagnostics, such as TaqMan qPCR with no diminution in sensitivity, and in synthetic biology cornerstones such as the Gibson assembly of DNA fragments, where new plasmids can be constructed solely based on adding cellular reagents. Cellular reagents have significantly reduced complexity and cost of production, storage and implementation, features that should facilitate accessibility and use in resource-poor conditions.	[Bhadra, Sanchita; Pothukuchy, Arti; Shroff, Raghav; Cole, Austin W.; Byrom, Michelle; Ellefson, Jared W.; Gollihar, Jimmy D.; Ellington, Andrew D.] Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ellington, AD (corresponding author), Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Cole, Austin/0000-0002-2828-811X; Bhadra, Sanchita/0000-0002-4956-2405; Gollihar, Jimmy/0000-0003-3957-2092	Welch Foundation [F-1654]; Bill and Melinda Gates Foundation [OPP1182120]	Welch Foundation(The Welch Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the Welch Foundation (F-1654) and by the Bill and Melinda Gates Foundation (OPP1182120).	Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Buchan BW, 2014, CLIN MICROBIOL REV, V27, P783, DOI 10.1128/CMR.00003-14; Burden DW, 1995, BIOTECHNOLOGY PROTEI, P93; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; Chong S, 2014, CURRENT PROTOCOLS MO, V108, P16; Ellefson JW, 2016, SCIENCE, V352, P1590, DOI 10.1126/science.aaf5409; Ersson B., 2011, PROTEIN PURIFICATION, V3rd; Gan R, 2014, BIOTECHNOL J, V9, P641, DOI 10.1002/biot.201300545; Garibyan L, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2013.1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goh HC, 2017, PROTEIN EXPRES PURIF, V129, P18, DOI 10.1016/j.pep.2016.09.001; Green R, 2013, METHOD ENZYMOL, V529, P329, DOI 10.1016/B978-0-12-418687-3.00028-8; Guan DL, 2014, BIOTECHNOL LETT, V36, P1391, DOI 10.1007/s10529-014-1509-2; Harve KS, 2010, NUCLEIC ACIDS RES, V38, P172, DOI 10.1093/nar/gkp884; Hodgman CE, 2012, METAB ENG, V14, P261, DOI 10.1016/j.ymben.2011.09.002; Hunt JP, 2017, BIOENGINEERED, V8, P325, DOI 10.1080/21655979.2016.1241925; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Jiang YS, 2015, ANAL CHEM, V87, P3314, DOI 10.1021/ac504387c; Kelwick R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv129; Kwon YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08663; LAWYER FC, 1989, J BIOL CHEM, V264, P6427; Lianidou E, 2014, CLIN CHIM ACTA, V436, P5, DOI 10.1016/j.cca.2014.04.031; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; MACKEY BM, 1991, J GEN MICROBIOL, V137, P2361, DOI 10.1099/00221287-137-10-2361; Markarian MZ, 2010, J PHYS CHEM B, V114, P10620, DOI 10.1021/jp103213w; Mattanovich D, 2012, METHODS MOL BIOL, V824, P329, DOI 10.1007/978-1-61779-433-9_17; Milligan JN, 2018, BIOCHEMISTRY; Ogonah OW, 2017, CURR OPIN CHEM ENG, V18, P77, DOI 10.1016/j.coche.2017.10.003; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Parra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183480; PATCHETT ML, 1989, ENZYME MICROB TECH, V11, P113, DOI 10.1016/0141-0229(89)90069-0; PHANG SM, 1995, GENE, V163, P65, DOI 10.1016/0378-1119(95)00387-L; Rittie L, 2008, J CELL COMMUN SIGNAL, V2, P25, DOI 10.1007/s12079-008-0026-2; Schofield David A, 2012, Bacteriophage, V2, P105; Scopes R. K, 1994, PROTEIN PURIFICATION, V3rd, DOI 10.1007/978-1-4757-2333-5; Seetharam C, 2009, PROCESS BIOCHEM, V44, P246, DOI 10.1016/j.procbio.2008.10.015; Si T, 2016, SYN SYST BIOTECHNO, V1, P258, DOI 10.1016/j.synbio.2016.08.003; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24; Smith MT, 2014, BIOTECHNIQUES, V56, P186, DOI 10.2144/000114158; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Treacy DJ, 2011, CBE-LIFE SCI EDUC, V10, P18, DOI 10.1187/cbe.10-07-0085; UEMORI T, 1993, NUCLEIC ACIDS RES, V21, P259, DOI 10.1093/nar/21.2.259; Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Ward W, 2012, ART PROTEIN PURIFICA; Wessman P, 2013, JOVE-J VIS EXP, DOI 10.3791/4058; Zhang HL, 2016, AM J CLIN PATHOL, V146, P199, DOI [10.1093/AJCP/AQW083, 10.1093/ajcp/aqw083]; Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201681	10.1371/journal.pone.0201681	http://dx.doi.org/10.1371/journal.pone.0201681			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110361	Green Submitted, Green Published, gold			2022-12-26	WOS:000441738000038
J	Sorokina, AM; Saul, M; Goncalves, TM; Gogola, JV; Majdak, P; Rodriguez-Zas, SL; Rhodes, JS				Sorokina, Anastasia M.; Saul, Michael; Goncalves, Tassia M.; Gogola, Joseph, V; Majdak, Petra; Rodriguez-Zas, Sandra L.; Rhodes, Justin S.			Striatal transcriptome of a mouse model of ADHD reveals a pattern of synaptic remodeling	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MEDIAL PREFRONTAL CORTEX; STIMULANT MEDICATION; FEMALE RATS; GENE; WNT; ASSOCIATION; CHILDREN; NUMBER	Despite the prevalence and high heritability of Attention-Deficit/Hyperactivity Disorder (ADHD), genetic etiology remains elusive. Clinical evidence points in part to reduced function of the striatum, but which specific genes are differentially expressed and how they sculpt striatal physiology to predispose ADHD are not well understood. As an exploratory tool, a polygenic mouse model of ADHD was recently developed through selective breeding for high home cage activity. Relative to the Control line, the High-Active line displays hyperactivity and motor impulsivity which are ameliorated with amphetamine. This study compared gene expression in the striatum between Control and High-Active mice to develop a coherent hypothesis for how genes might affect striatal physiology and predispose ADHD-like symptoms. To this end, striatal transcriptomes of High-Active and Control mice were analyzed after mice were treated with saline or amphetamines. The pseudogene Gm6180 for n-cofilin (Cfl1) displayed 20-fold higher expression in High-Active mice corresponding with reduced Cfl1 expression suggesting synaptic actin dysregulation. Latrophilin 3 (Lphn3), which is associated with ADHD in human populations and is involved in synapse structure, and its ligand fibronectin leucine rich transmembrane protein 3 (Flrt3), were downregulated in High-Active mice. Multiple genes were altered in High-Active mice in a manner predicted to downregulate the canonical Wnt pathway. A smaller and different set of genes including glyoxalase (Glo1) were differentially regulated in High-Active as compared to Control in response to amphetamine. Together, results suggest genes involved in excitatory synapse regulation and maintenance are downregulated in ADHD-like mice. Consistent with the molecular prediction, stereological analysis of the striatum from a separate set of mice processed for imunohistochemical detection of synaptophysin revealed approximately a 46% reduction in synaptophysin immunoreactivity in High-Active relative to Control. Results provide a new set of molecular targets related to synapse maintenance for the next generation of ADHD medicines.	[Sorokina, Anastasia M.; Gogola, Joseph, V; Rhodes, Justin S.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Psychol, Urbana, IL 61801 USA; [Saul, Michael; Rhodes, Justin S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Goncalves, Tassia M.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA; [Gogola, Joseph, V] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Majdak, Petra; Rhodes, Justin S.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign	Rhodes, JS (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Psychol, Urbana, IL 61801 USA.; Rhodes, JS (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Rhodes, JS (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.	jrhodes@illinois.edu	Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Mangetti Goncalves, Tassia/0000-0003-2929-9686	NIH [RO1 MH083807, DA027487, P30 DA018310]; USDA [NIFAILLU-538-909]; Haferkamp family; school of Molecular and Cellular Biology at the University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, R01DA027487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Haferkamp family; school of Molecular and Cellular Biology at the University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in total, by NIH (https://www.nih.gov/) RO1 MH083807 and DA027487 to J.S.R., and NIH (https://www.usda.gov/) P30 DA018310 and USDA NIFAILLU-538-909 to SR-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in total by NIH RO1 MH083807 and DA027487 to J.S.R., and NIH P30 DA018310 and USDA NIFAILLU-538-909 to S.R-Z. There was no additional external funding received for this study. We also wish to thank Dr. Laura Bolton, Dr. Russell Bolton, the Haferkamp family, and the school of Molecular and Cellular Biology at the University of Illinois at Urbana-Champaign for funding for A.S. We wish to thank Alvaro Hernandez at the Roy J. Carver Biotechnology Center for performing the deep sequencing, and the Beckman Institute animal care staff. The authors report no conflicts of interest.	Aleksic B, 2010, SCHIZOPHR RES, V118, P113, DOI 10.1016/j.schres.2010.01.014; Alimohamad H, 2005, J NEUROCHEM, V95, P513, DOI 10.1111/j.1471-4159.2005.03388.x; Arcos-Burgos M, 2010, MOL PSYCHIATR, V15, P1053, DOI 10.1038/mp.2010.6; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Belanger M, 2011, J NEUROSCI, V31, P18338, DOI 10.1523/JNEUROSCI.1249-11.2011; Benjamini Y, 1995, J ROYAL STAT SOC B, V289, P300; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; Brookes KJ, 2005, AM J MED GENET B, V139B, P33, DOI 10.1002/ajmg.b.30216; Brot S, 2014, EUR J NEUROSCI, V40, P3010, DOI 10.1111/ejn.12674; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Chen JR, 2004, J NUTR BIOCHEM, V15, P467, DOI 10.1016/j.jnutbio.2004.01.008; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Chisholm NC, 2012, MENOPAUSE, V19, P804, DOI 10.1097/gme.0b013e31824d1fc4; Colter AL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-8; COOK EH, 1995, AM J HUM GENET, V56, P993; Dark C, 2018, ROLE ADHD ASS GENES; Distler Margaret G., 2012, Frontiers in Genetics, V3, P250, DOI 10.3389/fgene.2012.00250; Drzewiecki CM, 2016, SYNAPSE, V70, P361, DOI 10.1002/syn.21909; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Kozlovsky N, 2006, INT J NEUROPSYCHOPH, V9, P337, DOI 10.1017/S1461145705006097; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li Z, 2014, PSYCHIAT RES, V219, P10, DOI 10.1016/j.psychres.2014.05.005; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Majdak P, 2016, SCI REP-UK, V6, DOI 10.1038/srep39472; Majdak P, 2016, BEHAV BRAIN RES, V313, P282, DOI 10.1016/j.bbr.2016.07.033; MITCHELL EA, 1987, CLIN PEDIATR, V26, P406, DOI 10.1177/000992288702600805; Moline S, 2001, PSYCHOL SCHOOLS, V38, P569, DOI 10.1002/pits.1044; O'Sullivan ML, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-7; Okerlund ND, 2011, J NEURODEV DISORD, V3, P162, DOI 10.1007/s11689-011-9083-6; Paxinos G, 2013, PAXINOS FRANKLINS MO; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Saul MC, 2017, GENES BRAIN BEHAV, V16, P328, DOI 10.1111/gbb.12347; Scassellati C, 2004, NEUROPSYCHOBIOLOGY, V50, P16, DOI 10.1159/000077936; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Varga MD, 2012, J EVID-INFORM SOC WO, V9, P293, DOI 10.1080/15433714.2010.525402; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Vitiello B, 2001, J CHILD ADOL PSYCHOP, V11, P25, DOI 10.1089/104454601750143384; Wallis D, 2012, BRAIN RES, V1463, P85, DOI 10.1016/j.brainres.2012.04.053; White BP, 2006, J AM COLL HEALTH, V54, P261, DOI 10.3200/JACH.54.5.261-268; Willson TM, 1997, CURR OPIN CHEM BIOL, V1, P235, DOI 10.1016/S1367-5931(97)80015-4; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zimmermann AM, 2015, BIOL PSYCHIAT, V78, P95, DOI 10.1016/j.biopsych.2014.03.011	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201553	10.1371/journal.pone.0201553	http://dx.doi.org/10.1371/journal.pone.0201553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ5PD	30110355	Green Submitted, gold, Green Published			2022-12-26	WOS:000441738000034
J	Sun, SM; Hanzawa, F; Umeki, M; Ikeda, S; Mochizuki, S; Oda, H				Sun, Shumin; Hanzawa, Fumiaki; Umeki, Miki; Ikeda, Saiko; Mochizuki, Satoshi; Oda, Hiroaki			Time-restricted feeding suppresses excess sucrose-induced plasma and liver lipid accumulation in rats	PLOS ONE			English	Article							HIGH-FAT DIET; METABOLIC SYNDROME; CIRCADIAN-RHYTHMS; INSULIN-RESISTANCE; FRUCTOSE; CLOCK; MICE; CORTICOSTERONE; OBESITY; SUGAR	The etiology of metabolic syndrome involves several complicated factors. One of the main factors contributing to metabolic syndrome has been proposed to be excessive intake of sucrose, which disturbs hepatic lipid metabolism, resulting in fatty liver. However, the mechanism by which sucrose induces fatty liver remains to be elucidated. Considering feeding behavior important for metabolism, we investigated whether time-restricted feeding of high sucrose diet (HSD), only in the active phase (the dark phase of the daily light/dark cycle), would ameliorate adverse effects of sucrose on lipid homeostasis in rats. Male Wistar rats, fed either an ad libitum (ad lib.) or time-restricted control starch diet (CD) or HSD were investigated. Rats fed ad lib. (CD and HSD) completed approximately 20% of food intake in the daytime. Time-restricted feeding did not significantly suppress total food intake of rats. However, time-restricted feeding of HSD significantly suppressed the increased plasma triglyceride levels. Moreover, time-restricted feeding also ameliorated HSD-induced liver lipid accumulation, whereas circadian oscillations of liver clock gene or transcriptional factor gene expression for lipid metabolism were not altered significantly. These results demonstrated that restricting sucrose intake only during the active phase in rats ameliorates the abnormal lipid metabolism caused by excess sucrose intake.	[Sun, Shumin; Oda, Hiroaki] Nagoya Univ, Lab Nutr Biochem, Nagoya, Aichi, Japan; [Hanzawa, Fumiaki; Ikeda, Saiko] Nagoya Univ Arts & Sci, Dept Nutr Sci, Nisshin, Japan; [Umeki, Miki; Mochizuki, Satoshi] Oita Univ, Fac Educ & Welf Sci, Oita, Japan; [Umeki, Miki] Beppu Univ, Fac Food Sci & Nutr, Beppu, Oita, Japan	Nagoya University; Oita University	Oda, H (corresponding author), Nagoya Univ, Lab Nutr Biochem, Nagoya, Aichi, Japan.	hirooda@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science [21658052, 25292069, 16H04922]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/) (Recipient: HO; No.21658052; No.25292069; No.16H04922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN RC, 1967, J BIOL CHEM, V242, P3360; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; BARON H, 1968, J NUTR, V94, P95, DOI 10.1093/jn/94.1.95; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bizeau ME, 2005, METABOLISM, V54, P1189, DOI 10.1016/j.metabol.2005.04.004; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARK DG, 1974, J BIOL CHEM, V249, P2028; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duncan MJ, 2016, PHYSIOL BEHAV, V167, P1, DOI 10.1016/j.physbeh.2016.08.027; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUKAGAWA K, 1994, AM J PHYSIOL-REG I, V267, pR1385, DOI 10.1152/ajpregu.1994.267.5.R1385; Gill S, 2015, CELL METAB, V22, P789, DOI 10.1016/j.cmet.2015.09.005; Gnocchi Davide, 2015, Biology-Basel, V4, P104, DOI 10.3390/biology4010104; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Jackson SE, 2017, OBESITY, V25, P539, DOI 10.1002/oby.21733; Karagianni P, 2015, BBA-MOL CELL BIOL L, V1851, P2, DOI 10.1016/j.bbalip.2014.05.001; Kinlein SA, 2017, ENDOCRINOLOGY, V158, P2239, DOI 10.1210/en.2017-00208; Kunes J, 2015, PHYSIOL RES, V64, P611, DOI 10.33549/physiolres.933174; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Llansola M, 2013, ARCH BIOCHEM BIOPHYS, V536, P164, DOI 10.1016/j.abb.2013.01.009; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Pagliassotti MJ, 1996, AM J PHYSIOL-REG I, V271, pR1319, DOI 10.1152/ajpregu.1996.271.5.R1319; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; ROMON M, 1993, AM J CLIN NUTR, V57, P476, DOI 10.1093/ajcn/57.4.476; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sancar G, 2014, CELL MOL LIFE SCI, V71, P2667, DOI 10.1007/s00018-014-1574-7; SCHLIERF G, 1973, J CLIN INVEST, V52, P732, DOI 10.1172/JCI107235; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Yamada K, 2003, J BIOL CHEM, V278, P30719, DOI 10.1074/jbc.M301597200; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yamajuku D, 2009, CIRC RES, V105, P545, DOI 10.1161/CIRCRESAHA.109.199034	49	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201261	10.1371/journal.pone.0201261	http://dx.doi.org/10.1371/journal.pone.0201261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110343	gold, Green Published, Green Submitted			2022-12-26	WOS:000441738000019
J	Brazill-Boast, J; Williams, M; Rickwood, B; Partridge, T; Bywater, G; Cumbo, B; Shannon, I; Probert, WJM; Ravallion, J; Possingham, H; Maloney, RF				Brazill-Boast, James; Williams, Moira; Rickwood, Beth; Partridge, Thalie; Bywater, Grant; Cumbo, Bronwyn; Shannon, Ian; Probert, William J. M.; Ravallion, Julie; Possingham, Hugh; Maloney, Richard F.			A large-scale application of project prioritization to threatened species investment by a government agency	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; MAXIMIZING RETURN; MANAGEMENT; QUANTIFICATION; RESOURCES; COSTS	In a global environment of increasing species extinctions and decreasing availability of funds with which to combat the causes of biodiversity loss, maximising the efficiency of conservation efforts is crucial. The only way to ensure maximum return on conservation investment is to incorporate the cost, benefit and likelihood of success of conservation actions into decision-making in a systematic and objective way. Here we report on the application of a Project Prioritization Protocol (PPP), first implemented by the New Zealand Government, to target and prioritize investment in threatened species in New South Wales, Australia, under the state's new Saving our Species program. Detailed management prescriptions for 368 threatened species were developed via an expert elicitation process, and were then prioritized using quantitative data on benefit, likelihood of success and implementation cost, and a simple cost-efficiency equation. We discuss the outcomes that have been realized even in the early stages of the program; including the efficient development of planning resources made available to all potential threatened species investors and the demonstration of a transparent and objective approach to threatened species management that will significantly increase the probability of meeting an objective to secure the greatest number of threatened species from extinction.	[Brazill-Boast, James; Williams, Moira; Rickwood, Beth; Partridge, Thalie; Bywater, Grant; Cumbo, Bronwyn; Shannon, Ian; Ravallion, Julie] New South Wales Govt, Off Environm & Heritage, Sydney, NSW, Australia; [Probert, William J. M.; Possingham, Hugh] Univ Queensland, Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Maloney, Richard F.] Dept Conservat, Christchurch, New Zealand; [Williams, Moira] 350 Org, Brisbane, Qld, Australia; [Partridge, Thalie] Cent Land Council, Alice Springs, NT, Australia; [Cumbo, Bronwyn] Univ Technol, Inst Sustainable Futures, Sydney, NSW, Australia; [Probert, William J. M.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Nuffield Dept Med, Oxford, England; [Ravallion, Julie] New South Wales Rd & Maritime Serv, Sydney, NSW, Australia; [Possingham, Hugh] Nature Conservancy, Washington, DC USA	Office of Environment & Heritage - New South Wales; University of Queensland; University of Technology Sydney; University of Oxford; Nature Conservancy	Brazill-Boast, J (corresponding author), New South Wales Govt, Off Environm & Heritage, Sydney, NSW, Australia.	james.brazillboast@environment.nsw.gov.au	Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Brazill-Boast, James/R-6195-2019	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Partridge, Thalie/0000-0002-5551-2869; Brazill-Boast, James/0000-0002-3816-9755	NSW Government (Australia) as part of the Saving our Species program; New Zealand Department of Conservation	NSW Government (Australia) as part of the Saving our Species program; New Zealand Department of Conservation	The project was funded by the NSW Government (Australia) as part of the Saving our Species program.; We thank P. Adam, T. Auld, M. Burgman, M. Fleming, R. Spindler and C. Yates for insightful comments on earlier versions of the report that formed the basis of this manuscript. We are grateful to L. Bell, S. Briggs, T. Grosskopf and members of the Saving our Species internal working group for helpful discussions. We also thank the New Zealand Department of Conservation for advice and support in developing the Saving our Species program.	[Anonymous], 2010, R LANG ENV STAT COMP; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Bascompte J, 2002, AM NAT, V159, P128, DOI 10.1086/324793; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Brook BW, 2011, TRENDS ECOL EVOL, V26, P619, DOI 10.1016/j.tree.2011.09.006; Burgman M., 2005, RISKS DECISIONS CONS; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Di Fonzo M. M. I, 2015, CONSERV LETT, V9, P51, DOI [10.1086/324793, DOI 10.1086/324793]; Doak DF, 2005, ECOLOGY, V86, P1154, DOI 10.1890/04-0611; ESRI, 2009, ARCMAP 9 3 ARCGIS 9; Fieberg J, 2001, ECOL LETT, V4, P244, DOI 10.1046/j.1461-0248.2001.00202.x; Firn J, 2015, J APPL ECOL, V52, P1135, DOI 10.1111/1365-2664.12500; Freudenberger L, 2013, BIODIVERS CONSERV, V22, P1255, DOI 10.1007/s10531-012-0428-6; Gilroy JJ, 2012, CONSERV LETT, V5, P313, DOI 10.1111/j.1755-263X.2012.00245.x; International Union for Conservation of Nature (IUCN), 2010, GUID US IUCN RED LIS; Joint Nature Conservation Committee (JNCC), 2008, UK BIOD ACT PLAN HIG; Joseph Liana N., 2009, Ecological Management & Restoration, V10, pS143, DOI 10.1111/j.1442-8903.2009.00466.x; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Joseph Liana N., 2008, Pacific Conservation Biology, V14, P154; Jsoftware, 2006, J HIGH PERF DEV PLAT; Kindvall O, 2003, CONSERV BIOL, V17, P316, DOI 10.1046/j.1523-1739.2003.01316.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Metrick A, 1998, J ECON PERSPECT, V12, P21, DOI 10.1257/jep.12.3.21; Miller JK, 2002, BIOSCIENCE, V52, P163, DOI 10.1641/0006-3568(2002)052[0163:TESADA]2.0.CO;2; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Ng CF, 2014, CONSERV BIOL, V28, P1617, DOI 10.1111/cobi.12382; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; O'Connor S., 2009, SPECIES MANAGEMENT C, P21; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; OEH, 2013, SAV OUR SPEC TECHN R; OEH (New South Wales Office of Environment and Heritage), 2016, MOR PLANTS AN BE SAV; OEH (New South Wales Office of Environment and Heritage), 2013, REV NSW THREAT SPEC; OEH (New South Wales Office of Environment and Heritage), 2010, REV THREAT SPEC REC; Pimm SL, 2000, SCIENCE, V289, P2289, DOI 10.1126/science.289.5488.2289; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Soderquist Todd, 2011, Australian Mammalogy, V33, P202, DOI 10.1071/AM10053; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Truong PN, 2013, GEODERMA, V202, P142, DOI 10.1016/j.geoderma.2013.03.016; Walsh JC, 2013, ORYX, V47, P134, DOI 10.1017/S003060531100161X; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wintle BA, 2011, NAT CLIM CHANGE, V1, P355, DOI 10.1038/NCLIMATE1227	46	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201413	10.1371/journal.pone.0201413	http://dx.doi.org/10.1371/journal.pone.0201413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106972	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800008
J	Liu, F; Wang, Z; Zhou, XG; Liu, Q; Chen, G; Xiao, HL; Yin, WH; Nakamura, S; Rao, H				Liu, Fang; Wang, Zhe; Zhou, Xiaoge; Liu, Qing; Chen, Gang; Xiao, Hualiang; Yin, Weihua; Nakamura, Shigeo; Rao, Huilan			Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma	PLOS ONE			English	Article							LYMPHOPROLIFERATIVE DISORDERS; EXPRESSION; EVOLUTION; CARCINOMA; EFFUSION; CANCER	Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (EBV+ DLBCL) is typically an aggressive tumor in elderly patients. However, in a subset of young patients, EBV+ DLBCL follows a relatively indolent clinical course and exhibits a good response to chemotherapy. This lymphoma comprises polymorphous lymphoma and large cell lymphomas subtypes, with the latter subtype showing a significantly poorer prognosis. It is unknown whether the genetic background differs between age groups and histopathological subtypes. To investigate the genetic basis, heterogeneity, and recurrently mutated genes in EBV+ DLBCL, we performed whole-exome sequencing of DNA from 11 tissue samples of this lymphoma. Sequencing revealed that the most common substitution was the transition C>T/G>A. Genetic features-including the numbers of mutated genes in exonic region, single-nucleotide variants (SNV), and indels-did not significantly differ between age groups or histological subtypes. Matching with the COSMIC database revealed that the main mutational signature was signature 3, which is associated with failure of DNA double-strand break-repair by homologous recombination. Mutant-Allele Tumor Heterogeneity (MATH) scores showed that EBV+ DLBCL exhibited broad intratumor heterogeneity, and were positively correlated with Ann Arbor Stage and >= 2 extranodal lesion sites. We identified 57 selected recurrently mutated genes. The most commonly mutated five genes-LNP1 (11/11), PRSS3 (10/11), MUC3A (9/11), FADS6 (9/11), and TRAK1 (8/11)-were validated by Sanger sequencing. These mutated genes have not previously been identified. Overall, our present results demonstrate the tremendous genetic heterogeneity underlying EBV+ DLBCLs, and highlight the need for personalized therapeutic approaches to treating these patients.	[Liu, Fang; Liu, Qing] Sun Yat Sen Univ, Foshan Hosp, Dept Pathol, Foshan, Guangdong, Peoples R China; [Wang, Zhe] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Zhou, Xiaoge] Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China; [Chen, Gang] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Xiao, Hualiang] Army Med Univ, Daping Hosp, Chongqing, Peoples R China; [Yin, Weihua] Peking Univ, Shenzhen Hosp, Dept Pathol, Shenzhen, Guangdong, Peoples R China; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Clin Labs, Nagoya, Aichi, Japan; [Rao, Huilan] Sun Yat Sen Univ, Canc Ctr, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Rao, Huilan] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Rao, Huilan] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Air Force Military Medical University; Capital Medical University; Army Medical University; Peking University; Nagoya University; Sun Yat Sen University; State Key Lab Oncology South China	Rao, H (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Pathol, Guangzhou, Guangdong, Peoples R China.; Rao, H (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Rao, H (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	huilanrao@hotmail.com	Nakamura, Shigeo/I-1571-2012	Liu, Fang/0000-0001-9385-0896	Chinese National Nature Science Fund [81302035]; Foshan Science technology and Medical foundation [2016AB001661]	Chinese National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Foshan Science technology and Medical foundation	This study was Supported in part by grants 81302035 from Chinese National Nature Science Fund and 2016AB001661 from the Foshan Science technology and Medical foundation.	Abd El Gawad Iman A, 2009, J Egypt Natl Canc Inst, V21, P209; Al-Humood S, 2014, ACTA HAEMATOL-BASEL, V131, P1, DOI 10.1159/000350493; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Casey AK, 2015, MOL BIOL CELL, V26, P2833, DOI 10.1091/mbc.E15-01-0053; Crescenzi B, 2015, LEUKEMIA RES, V39, P769, DOI 10.1016/j.leukres.2015.04.014; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Fadlelmola FM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-2; Gebauer N, 2015, LEUKEMIA LYMPHOMA, V56, P1100, DOI 10.3109/10428194.2014.944522; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hong JY, 2015, ANN ONCOL, V26, P548, DOI 10.1093/annonc/mdu556; Kato H, 2014, CANCER SCI, V105, P537, DOI 10.1111/cas.12389; Kitamoto S, 2010, BIOCHEM BIOPH RES CO, V397, P333, DOI 10.1016/j.bbrc.2010.05.124; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Mroz EA, 2013, ORAL ONCOL, V49, P211, DOI 10.1016/j.oraloncology.2012.09.007; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; Nicolae A, 2015, BLOOD, V126, P863, DOI 10.1182/blood-2015-02-630632; Niu T, 2016, ONCOTARGET, V7, P50017, DOI 10.18632/oncotarget.10312; Oyama T, 2003, AM J SURG PATHOL, V27, P16, DOI 10.1097/00000478-200301000-00003; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Pettersen HS, 2015, DNA REPAIR, V25, P60, DOI 10.1016/j.dnarep.2014.11.006; Prochazka V, 2012, INT J HEMATOL, V96, P58, DOI 10.1007/s12185-012-1102-1; Qian L, 2017, ONCOTARGET, V8, P21444, DOI 10.18632/oncotarget.15590; Rajput A, 2017, CLIN COLORECTAL CANC, V16, pE165, DOI 10.1016/j.clcc.2016.11.004; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Rossi D, 2011, BLOOD, V117, P2405, DOI 10.1182/blood-2010-07-296244; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Swerdlow SH, 2016, WHO CLASSIFICATION T; Takegawa S, 2008, CANCER SCI, V99, P296, DOI 10.1111/j.1349-7006.2007.00687.x; Wagener R, 2015, LEUKEMIA, V29, P1612, DOI 10.1038/leu.2015.22; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu JZ, 2016, CANCER BIOMARK, V17, P205, DOI 10.3233/CBM-160632; Yamada Atsuko, 2013, Rinsho Ketsueki, V54, P463; Yoon H, 2015, GENE CHROMOSOME CANC, V54, P383, DOI 10.1002/gcc.22249; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	37	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201546	10.1371/journal.pone.0201546	http://dx.doi.org/10.1371/journal.pone.0201546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106962	gold, Green Published, Green Submitted			2022-12-26	WOS:000441662800011
J	Camoni, L; Barbero, F; Aducci, P; Maffei, ME				Camoni, Lorenzo; Barbero, Francesca; Aducci, Patrizia; Maffei, Massimo E.			Spodoptera littoralis oral secretions inhibit the activity of Phaseolus lunatus plasma membrane H+-ATPase	PLOS ONE			English	Article							LIMA-BEAN LEAVES; 14-3-3 PROTEINS; PLANT PHYSIOLOGY; RESPONSES; BINDING; PHOSPHORYLATION; ARABIDOPSIS; HERBIVORY; TOXIN; ASSOCIATION	Biotic stresses induced by herbivores result in diverse physiological changes in plants. In the interaction between the Lima bean (Phaseolus lunatus) and the herbivore Spodoptera littoralis, the earliest event induced by feeding on leaves is the depolarization of the plasma membrane potential (Vm), which is the results of both mechanical damage and insect oral secretions (OS). Although this herbivore-induced Vm depolarization depends on a calcium-dependent opening of potassium channels, the attacked leaf remains depolarized for an extended period, which cannot be explained by the sole action of potassium channels. Here we show that the plasma membrane H+-ATPase of P. lunatus leaves is strongly inhibited by S. littoralis OS. Inhibition of the H+-ATPase was also found in plasma membranes purified from leaf sections located distally from the application zone of OS, thus suggesting a long-distance transport of a signaling molecule(s). S. littoralis'OS did not influence the amount of the plasma membrane H+-ATPase, whereas the levels of membrane-bound 14-3-3 proteins were significantly decreased in membranes purified from treated leaves. Furthermore, OS strongly reduced the in vitro interaction between P. lunatus H+-ATPase and 14-3-3 proteins. The results of this work demonstrate that inhibition of the plasma membrane H+-ATPase is a key component of the S. littoralis OS mechanism leading to an enduring Vm depolarization in P. lunatus wounded leaves.	[Camoni, Lorenzo; Aducci, Patrizia] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, Rome, Italy; [Barbero, Francesca; Maffei, Massimo E.] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Rome Tor Vergata; University of Turin	Maffei, ME (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	massimo.maffei@unito.it	Maffei, Massimo E/K-9593-2015; Barbero, Francesca/J-3555-2016	Maffei, Massimo E/0000-0001-6814-2353; Barbero, Francesca/0000-0003-2667-0435; CAMONI, LORENZO/0000-0001-9020-0812	University of Rome Tor Vergata; University of Turin	University of Rome Tor Vergata; University of Turin	This research was sponsored by the University of Rome Tor Vergata and the University of Turin research funds.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aducci P, 2002, IUBMB LIFE, V53, P49, DOI 10.1080/15216540210813; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Arimura G, 2010, BIOCHEM BIOPH RES CO, V400, P455, DOI 10.1016/j.bbrc.2010.08.134; BALLIO A, 1964, NATURE, V203, P297, DOI 10.1038/203297a0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricchi I, 2013, PLANT J, V73, P14, DOI 10.1111/j.1365-313X.2012.05103.x; Bricchi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046673; Camoni L, 2000, J BIOL CHEM, V275, P9919, DOI 10.1074/jbc.275.14.9919; Camoni L, 2001, J BIOL CHEM, V276, P31709, DOI 10.1074/jbc.M104194200; Camoni L, 2013, IUBMB LIFE, V65, P513, DOI 10.1002/iub.1167; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Falhof J, 2016, MOL PLANT, V9, P323, DOI 10.1016/j.molp.2015.11.002; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; HEDRICH R, 1989, ANNU REV PLANT PHYS, V40, P539, DOI 10.1146/annurev.pp.40.060189.002543; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Maffei ME, 2007, PHYTOCHEMISTRY, V68, P2946, DOI 10.1016/j.phytochem.2007.07.016; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Maffei ME, 2012, NAT PROD REP, V29, P1288, DOI 10.1039/c2np20053h; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Maffei S. A. Zebelo. M. E., 2012, PLANT ELECTROPHYSIOL, P1; Muzi C, 2016, PLANT PHYSIOL BIOCH, V108, P328, DOI 10.1016/j.plaphy.2016.07.027; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Olivari C, 1998, PLANT PHYSIOL, V116, P529, DOI 10.1104/pp.116.2.529; Pallucca R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090764; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Visconti S, 2003, J BIOL CHEM, V278, P8172, DOI 10.1074/jbc.M211039200; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zebelo SA, 2015, J EXP BOT, V66, P435, DOI 10.1093/jxb/eru480; Zebelo SA, 2012, ARTHROPOD-PLANT INTE, V6, P543, DOI 10.1007/s11829-012-9200-9	36	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202142	10.1371/journal.pone.0202142	http://dx.doi.org/10.1371/journal.pone.0202142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096181	gold, Green Published, Green Submitted			2022-12-26	WOS:000441308500053
J	Kamuf, J; Garcia-Bardon, A; Ziebart, A; Thomas, R; Folkert, K; Frauenknecht, K; Thal, SC; Hartmann, EK				Kamuf, Jens; Garcia-Bardon, Andreas; Ziebart, Alexander; Thomas, Rainer; Folkert, Konstantin; Frauenknecht, Katrin; Thal, Serge C.; Hartmann, Erik K.			Lung injury does not aggravate mechanical ventilation-induced early cerebral inflammation or apoptosis in an animal model	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SYSTEMIC INFLAMMATION; COGNITIVE IMPAIRMENT; PORCINE MODELS; BRAIN-INJURY; OLEIC-ACID; OUTCOMES; SEPSIS; LIFE	Introduction The acute respiratory distress syndrome is not only associated with a high mortality, but also goes along with cognitive impairment in survivors. The cause for this cognitive impairment is still not clear. One possible mechanism could be cerebral inflammation as result of a "lung-brain-crosstalk". Even mechanical ventilation itself can induce cerebral inflammation. We hypothesized, that an acute lung injury aggravates the cerebral inflammation induced by mechanical ventilation itself and leads to neuronal damage. Methods After approval of the institutional and state animal care committee 20 pigs were randomized to one of three groups: lung injury by central venous injection of oleic acid (n = 8), lung injury by bronchoalveolar lavage in combination with one hour of injurious ventilation (n = 8) or control (n = 6). Brain tissue of four native animals from a different study served as native group. For six hours all animals were ventilated with a tidal volume of 7 ml kg-land a scheme for positive end-expiratory pressure and inspired oxygen fraction, which was adapted from the ARDS network tables. Afterwards the animals were killed and the brains were harvested for histological (number of neurons and microglia) and molecular biologic (TNFalpha, IL-1beta, and IL-6) examinations. Results There was no difference in the number of neurons or microglia cells between the groups. TNFalpha was significantly higher in all groups compared to native (p < 0.05), IL-6 was only increased in the lavage group compared to native (p < 0.05), IL-1beta showed no difference between the groups. Discussion With our data we can confirm earlier results, that mechanical ventilation itself seems to trigger cerebral inflammation. This is not aggravated by acute lung injury, at least not within the first 6 hours after onset. Nevertheless, it seems too early to dismiss the idea of lung-injury induced cerebral inflammation, as 6 hours might be just not enough time to see any profound effect.	[Kamuf, Jens; Garcia-Bardon, Andreas; Ziebart, Alexander; Thomas, Rainer; Folkert, Konstantin; Thal, Serge C.; Hartmann, Erik K.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Frauenknecht, Katrin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neuropathol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Kamuf, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany.	kamuf@uni-mainz.de	Thal, Serge/D-6593-2011; Frauenknecht, Katrin/AAF-1638-2020	Thal, Serge/0000-0002-1222-8729; Frauenknecht, Katrin/0000-0002-1372-3297				Ballard-Croft C, 2012, ANN THORAC SURG, V93, P1331, DOI 10.1016/j.athoracsur.2011.06.107; BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Bickenbach J, 2011, RESP PHYSIOL NEUROBI, V179, P174, DOI 10.1016/j.resp.2011.08.003; Chen T, 2016, BRAIN BEHAV IMMUN, V56, P42, DOI 10.1016/j.bbi.2016.04.004; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Goncalves-de-Albuquerque CF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/260465; Goncalves-de-Albuquerque CF, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/956509; Gonzalez-Lopez A, 2013, AM J RESP CRIT CARE, V188, P693, DOI 10.1164/rccm.201304-0691OC; Grotjohan HP, 1996, INTENS CARE MED, V22, P336, DOI 10.1007/BF01700456; Hartmann EK, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0002-6; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Heuer JF, 2012, CRIT CARE, V16, DOI 10.1186/cc11214; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Kamuf J, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0585-y; Kandikattu HK, 2017, PHYSIOL BEHAV, V175, P56, DOI 10.1016/j.physbeh.2017.03.035; Karmrodt J, 2006, BRIT J ANAESTH, V97, P883, DOI 10.1093/bja/ael275; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Klein KU, 2016, CRIT CARE MED, V44, pE253, DOI 10.1097/CCM.0000000000001399; Laffey JG, 2017, AM J RESP CRIT CARE, V196, P18, DOI 10.1164/rccm.201612-2415CI; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Meier T, 2008, ANESTH ANALG, V107, P1265, DOI 10.1213/ane.0b013e3181806212; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; Sensen B, 2017, MED KLIN-INTENSIVMED, V112, P605, DOI 10.1007/s00063-017-0350-5; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Songarj P, 2015, NEUROSCI LETT, V584, P253, DOI 10.1016/j.neulet.2014.10.037; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Wang HM, 2010, EUR SURG RES, V45, P121, DOI 10.1159/000318599; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Ziebart A, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0101-6	34	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202131	10.1371/journal.pone.0202131	http://dx.doi.org/10.1371/journal.pone.0202131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092082	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600092
J	Long, TM; Rath, SR; Wallman, KE; Howie, EK; Straker, LM; Bullock, A; Walwyn, TS; Gottardo, NG; Cole, CH; Choong, CS; Naylor, LH				Long, Treya M.; Rath, Shoshana R.; Wallman, Karen E.; Howie, Erin K.; Straker, Leon M.; Bullock, Andrew; Walwyn, Thomas S.; Gottardo, Nicholas G.; Cole, Catherine H.; Choong, Catherine S.; Naylor, Louise H.			Exercise training improves vascular function and secondary health measures in survivors of pediatric oncology related cerebral insult	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; ADULT SURVIVORS; PHYSICAL-ACTIVITY; GROWTH-HORMONE; ENDOTHELIAL FUNCTION; 5-YEAR SURVIVORS; LATE MORTALITY; FINAL HEIGHT; BRAIN-TUMOR	Adolescent and young adult (AYA) survivors of pediatric oncology related cerebral insult are vulnerable to numerous treatment-induced deficits that significantly enhance cardiovascular disease risk. Regular exercise improves endothelial function, fitness, body composition and musculoskeletal function which may reduce predisposition for cardiovascular disease. Here we assessed the feasibility and effectiveness of a 24-week exercise intervention on cardiovascular, physical and metabolic outcomes in this population. Thirteen survivors (6 male, 7 female; median age 19 y (range 16-23 y) were recruited to participate in a 48-week study consisting of a 24-week control period (regular care) followed by a 24-week exercise intervention. Outcome measures were collected at entry (week 0) and following regular care (24 week) and exercise (48-week). Assessed variables included endothelial function (flow mediated dilation, FMD), blood pressure, heart rate (HR), aerobic capacity, anthropometry, body composition, muscular strength (3 repetition maximum testing), muscular endurance (repetitions/min) and physical activity levels (accelerometry). Compared to baseline, delta diameter (p = 0.008) and FMD (p = 0.029) of the brachial artery increased following exercise. Bicep-curl strength also increased following exercise compared to baseline (p = 0.019), while submaximal (6 min mark) measures of ventilation (p = 0.012), rating of perceived exertion (p = 0.012), HR (p = 0.001), absolute (p = 0.000) and relative (p = 0.000) aerobic capacity decreased. Breaks in sedentary time increased (p = 0.043) following exercise compared to regular care. Although the sample was small and heterogeneous, this study demonstrates that exercise is achievable and has positive effects on vascular function, submaximal fitness, local strength and physical activity in a population of AYA survivors of pediatric oncology related cerebral insult.	[Long, Treya M.; Wallman, Karen E.; Naylor, Louise H.] Univ Western Australia, Sch Human Sci Exercise & Sport Sci, Perth, WA, Australia; [Rath, Shoshana R.; Choong, Catherine S.] Perth Childrens Hosp, Dept Endocrinol, Perth, WA, Australia; [Rath, Shoshana R.; Walwyn, Thomas S.; Gottardo, Nicholas G.; Cole, Catherine H.; Choong, Catherine S.] Univ Western Australia, Sch Med, Pediat, Perth, WA, Australia; [Howie, Erin K.; Straker, Leon M.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia; [Bullock, Andrew] Perth Childrens Hosp, Dept Cardiol, Perth, WA, Australia; [Walwyn, Thomas S.; Gottardo, Nicholas G.; Cole, Catherine H.] Perth Childrens Hosp, Dept Hematol & Oncol, Perth, WA, Australia; [Gottardo, Nicholas G.; Cole, Catherine H.] Telethon Kids Inst, Perth, WA, Australia; [Cole, Catherine H.] PathWest Lab Serv, Hematol, Perth, WA, Australia	University of Western Australia; University of Western Australia; Curtin University; Telethon Kids Institute	Naylor, LH (corresponding author), Univ Western Australia, Sch Human Sci Exercise & Sport Sci, Perth, WA, Australia.	louise.naylor@uwa.edu.au	choong, catherine S/D-4051-2012; Straker, Leon M/B-2407-2013; Naylor, Louise H/B-8186-2013; Choong, Catherine/J-4646-2014	choong, catherine S/0000-0002-3982-271X; Straker, Leon M/0000-0002-7786-4128; Naylor, Louise H/0000-0002-6210-912X; Choong, Catherine/0000-0002-3982-271X; Gottardo, Nicholas/0000-0002-1082-6776	Princess Margaret Hospital Foundation "Early Career Investigator Grant" [9324]; Telethon New Children's Hospital Research Fund [4749600]; Perron Family Foundation; NHMRC Early Career Fellowship [1072593]; Cancer Council of Western Australia Research Fellowship	Princess Margaret Hospital Foundation "Early Career Investigator Grant"; Telethon New Children's Hospital Research Fund; Perron Family Foundation; NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia Research Fellowship(Cancer Council Western Australia)	This work was supported by a Princess Margaret Hospital Foundation "Early Career Investigator Grant" No. 9324 awarded to SRR, the Telethon New Children's Hospital Research Fund (No. 4749600, to CSC, CHC & NGG) and the Perron Family Foundation which supports the Chair of Pediatric Hematology/Oncology (CHC). AB is supported by an NHMRC Early Career Fellowship (No. 1072593). NGG is supported by a Cancer Council of Western Australia Research Fellowship. None of these funding sources contributed to or influenced the design of the study, collection, analysis or interpretation of data, writing of the paper, decision to publish or preparation of the manuscript.	American College of Sports M, 2014, ACSMS GUIDELINES EXE; [Anonymous], 2017, GLOB DAT BOD MASS IN; Armstrong GT, 2014, J CLIN ONCOL, V32, P1218, DOI 10.1200/JCO.2013.51.1055; Australian Government, 2014, AUSTR PHYS ACT SED B; Australian Institute of Health and Welfare, 2014, CANC AUSTR OV 2014; Baechle TR, 2008, ESSENTIALS STRENGTH, P395; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brownstein CM, 2004, J CLIN ENDOCR METAB, V89, P4422, DOI 10.1210/jc.2004-0160; Cameron AC, 2016, CAN J CARDIOL, V32, P852, DOI 10.1016/j.cjca.2015.12.023; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colley Rachel C, 2011, Health Rep, V22, P15; Colley Rachel C, 2011, Health Rep, V22, P7; Fiuza-Luces C, 2017, MED SCI SPORT EXER, V49, P223, DOI 10.1249/MSS.0000000000001094; Florin TA, 2007, CANCER EPIDEM BIOMAR, V16, P1356, DOI 10.1158/1055-9965.EPI-07-0048; Freedson P.S., 1997, MED SCI SPORT EXER S, V29, P45, DOI DOI 10.1097/00005768-199705001-00256; Galvao DA, 2005, J CLIN ONCOL, V23, P899, DOI 10.1200/JCO.2005.06.085; Gleeson H, 2007, CLIN ENDOCRINOL, V66, P466, DOI 10.1111/j.1365-2265.2007.02753.x; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Greving Dawn M, 2005, J Pediatr Oncol Nurs, V22, P38, DOI 10.1177/1043454204272531; Gurney JG, 2003, J CLIN ENDOCR METAB, V88, P4731, DOI 10.1210/jc.2003-030784; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Hojan K, 2014, REP PRACT ONCOL RADI, V19, P1, DOI 10.1016/j.rpor.2013.07.007; Hsu HY, 1998, RADIAT RES, V149, P482, DOI 10.2307/3579788; Huang TT, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/461512; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Jarvela LS, 2013, PEDIATR BLOOD CANCER, V60, P1546, DOI 10.1002/pbc.24565; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Keats MR, 2008, J PEDIAT HEMATOL ONC, V30, P272, DOI 10.1097/MPH.0b013e318162c476; Liesse K, 2018, J PEDIAT HEMATOL ONC; Long TM, 2017, INT J ADOLESC MED HL; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mueller S, 2013, INT J RADIAT ONCOL, V86, P649, DOI 10.1016/j.ijrobp.2013.03.034; National Cancer Intelligence Network, 2012, NAT REG CHILDH TUM; Naylor LH, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12713; Ness KK, 2007, PEDIATR BLOOD CANCER, V49, P975, DOI 10.1002/pbc.21091; Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; Noorda EM, 2001, EUR J CANCER, V37, P605, DOI 10.1016/S0959-8049(00)00438-X; Norton K, 2010, J SCI MED SPORT, V13, P496, DOI 10.1016/j.jsams.2009.09.008; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Packer RJ, 2003, J CLIN ONCOL, V21, P3255, DOI 10.1200/JCO.2003.01.202; Pereira AM, 2005, CLIN ENDOCRINOL, V62, P197, DOI 10.1111/j.1365-2265.2004.02196.x; Piscione PJ, 2017, EUR J CANCER, V80, P63, DOI 10.1016/j.ejca.2017.04.020; Poreba M, 2016, CARDIOVASC TOXICOL, V16, P156, DOI 10.1007/s12012-015-9324-0; San Juan AF, 2008, INT J SPORTS MED, V29, P439, DOI 10.1055/s-2007-965571; San Juan AF, 2007, MED SCI SPORT EXER, V39, P13, DOI 10.1249/01.mss.0000240326.54147.fc; Sklar C, 2011, J CLIN ONCOL, V29, P4743, DOI 10.1200/JCO.2011.38.9833; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Straker LM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-54; Takase B, 1998, AM J CARDIOL, V82, P1535, DOI 10.1016/S0002-9149(98)00702-4; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Wolin KY, 2010, LEUKEMIA, V24, P1113, DOI 10.1038/leu.2010.54	55	17	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201449	10.1371/journal.pone.0201449	http://dx.doi.org/10.1371/journal.pone.0201449			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092052	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600028
J	Okamura, T; Shimmei, M; Takase, A; Toishiba, S; Hayashida, K; Yumiyama, T; Ogawa, Y				Okamura, Tsuyoshi; Shimmei, Masaya; Takase, Akinori; Toishiba, Shiho; Hayashida, Kojun; Yumiyama, Tatsuya; Ogawa, Yukan			A positive attitude towards provision of end of-life care may protect against burnout: Burnout and religion in a super-aging society	PLOS ONE			English	Article								Aim The aim of our study was to investigate factors associated with burnout of nurses and care workers in nursing homes and geriatric hospitals in Japan. The use of Buddhist priests, the major religion in Japan, was also explored. Methods Questionnaires for nurses and care workers were sent to 10 care facilities. The survey questions included basic demographic information, the Japanese Burnout Index and the Japanese version of the Frommelt Attitude Toward Care Of Dying Scale Form B. They also asked questions about use of Buddhist priests for tasks such as helping to manage the anxiety or distress of patients, families, and staff, or providing sutra chanting. Results In total, 323 questionnaires were returned, of which 260 were used for analysis. Only 18 (6.9%) answered that they had any religious beliefs, which was relatively low compared to 27% from governmental survey data. In total, however, 71% expressed a need for Buddhist priests to help with anxiety or distress among patients. A positive attitude towards providing end-of-life care was a protective factor against depersonalization. It was, however, also related to lower feelings of personal accomplishment. Conclusion Care homes and geriatric hospitals may want to consider calling more on religious resources as a support for staff and patients.	[Okamura, Tsuyoshi] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Shimmei, Masaya] Inst Future Engn, Tokyo, Japan; [Takase, Akinori; Ogawa, Yukan] Taisho Univ, Inst Reg Dev, Tokyo, Japan; [Toishiba, Shiho] Univ Tsukuba, Grad Sch Humanities & Social Sci, Tsukuba, Ibaraki, Japan; [Hayashida, Kojun] Taisho Univ, Dept Buddhist Studies, Tokyo, Japan; [Yumiyama, Tatsuya] Tokyo Inst Technol, Dept Social & Human Sci, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; University of Tsukuba; Tokyo Institute of Technology	Okamura, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan.	t.okamura.jp@gmail.com			JSPS KAKENHI [JP15K12814]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K12814. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, JAPAN TIMES; Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Cooper SL., 2016, BURNOUT RES, V3, P76, DOI [10.1016/j.burn.2016.06.003., DOI 10.1016/J.BURN.2016.06.003, 10.1016/j.burn.2016.06.003]; Frommelt K H, 1991, Am J Hosp Palliat Care, V8, P37, DOI 10.1177/104990919100800509; Ghaligi S., 2006, INDIAN J TRADIT KNOW, V5, P177; Hayashi F., 2010, P I STAT MATH, V58, P39; Kubo M., 1994, JAPANESE J EXPT SOCI, V34, P33, DOI [DOI 10.2130/JJESP.34.33, 10.2130/jjesp.34.33]; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; Ministry of Education Culture Sports Science and Technology, REL YB 2016; Murphy PE, 2000, J CONSULT CLIN PSYCH, V68, P1102, DOI 10.1037/0022-006X.68.6.1102; Nakai Y., 2006, JAPANESE J CANC NURS, V11, P723, DOI DOI 10.15106/J03022.2007018347; Odbehr L, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-12; OECD, 2014, INT MIGR OUTL 2014, DOI [10.1787/migr_outlook-2014-en, DOI 10.1787/MIGR_OUTLOOK-2014-EN]; Pargament KI, 2004, J HEALTH PSYCHOL, V9, P713, DOI 10.1177/1359105304045366; Takeda, 2006, KAWASAKI MED WELFARE, V16, P53; Tanaka K, 2015, INT J GERONTOL, V9, P161, DOI 10.1016/j.ijge.2015.04.001; The Cabinet Office, AG SOC CURR SIT IMPL; The Cabinet Office, ANN REP AG SOC 2013; The Ministry of Health Labor and Welfare, DOC C 29 MARCH 2017; The Ministry of Internal Affairs and Communications Statistics Bureau Japan, MONTHL REP	21	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202277	10.1371/journal.pone.0202277	http://dx.doi.org/10.1371/journal.pone.0202277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092065	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600106
J	van der Merwe, I; Lukats, A; Blahova, V; Oosthuizen, MK; Bennett, NC; Nemec, P				van der Merwe, Ingrid; Lukats, Akos; Blahova, Veronika; Oosthuizen, Maria K.; Bennett, Nigel C.; Nemec, Pavel			The topography of rods, cones and intrinsically photosensitive retinal ganglion cells in the retinas of a nocturnal (Micaelamys namaquensis) and a diurnal (Rhabdomys pumilio) rodent	PLOS ONE			English	Article							PHOTORECEPTOR TYPES; LOCOMOTOR-ACTIVITY; MOUSE; LIGHT; VISION; EYE; PHOTOENTRAINMENT; ARCHITECTURE; POPULATIONS; SENSITIVITY	We used immunocytochemistry to determine the presence and topographical density distributions of rods, cones, and intrinsically photosensitive retinal ganglion cells (ipRGCs) in the four-striped field mouse (Rhabdomys pumilio) and the Namaqua rock mouse (Micaelamys namaquensis). Both species possessed duplex retinas that were rod dominated. In R. pumilio, the density of both cones and rods were high (cone to rod ratio: 1:1.23) and reflected the species' fundamentally diurnal, but largely crepuscular lifestyle. Similarly, the ratio of cones to rods in M. namaquensis (1:12.4) reflected its nocturnal lifestyle. Similar rod density peaks were observed (R. pumilio: similar to 84467/mm(2); M. namaquensis: similar to 81088/mm(2)), but a density gradient yielded higher values in the central (similar to 56618/mm(2)) rather than in the peripheral retinal region (similar to 32689/mm(2)) in R. pumilio. Two separate cone types (S-cones and M/L-cones) were identified implying dichromatic color vision in the study species. In M. namaquensis, both cone populations showed a centro-peripheral density gradient and a consistent S- to M/L-cone ratio (similar to 1:7.8). In R. pumilio, S cones showed a centro-peripheral gradient (S- to M/L-cone ratio; central: 1:7.8; peripheral: 1:6.8) which appeared to form a visual streak, and a specialized area of M/L-cones (S- to M/L-cone ratio: 1:15) was observed inferior to the optic nerve. The number of photoreceptors per linear degree of visual angle, estimated from peak photoreceptor densities and eye size, were four cones and 15 rods per degree in M. namaquensis and 11 cones and 12 rods per degree in R. pumilio. Thus, in nocturnal M. namaquensis rods provide much finer image sampling than cones, whereas in diurnal/crepuscular R. pumilio both photoreceptor types provide fine image sampling. IpRGCs were comparably sparse in R. pumilio (total = 1012) and M. namaquensis (total = 862), but were homogeneously distributed in M. namaquensis and densest in the dorso-nasal quadrant in R. pumilio. The adaptive significance of the latter needs further investigation.	[van der Merwe, Ingrid; Oosthuizen, Maria K.; Bennett, Nigel C.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa; [Lukats, Akos] Semmelweis Univ, Dept Anat Histol & Embryol, Budapest, Hungary; [Blahova, Veronika; Nemec, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic	University of Pretoria; Semmelweis University; Charles University Prague	van der Merwe, I (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa.; Nemec, P (corresponding author), Charles Univ Prague, Dept Zool, Prague, Czech Republic.	ivdmerwe@zoology.up.ac.za; pgnemec@natur.cuni.cz	Oosthuizen, Maria Kathleen/K-7923-2012; Nemec, Pavel/K-1163-2012	Oosthuizen, Maria Kathleen/0000-0001-6305-8283; Nemec, Pavel/0000-0003-0277-0239; Lukats, Akos/0000-0003-3468-2866	Grant Agency of Charles University [325515]; DST-NRF SARChI chair of Mammal Behavioural Ecology and Physiology [64756]; European Regional Development Fund; state budget of the Czech Republic [CZ.1.05/4.1.00/16.0347, CZ.2.16/3.1.00/21515]	Grant Agency of Charles University; DST-NRF SARChI chair of Mammal Behavioural Ecology and Physiology; European Regional Development Fund(European Commission); state budget of the Czech Republic	The study was supported by the Grant Agency of Charles University (325515, to VB) and the DST-NRF SARChI chair of Mammal Behavioural Ecology and Physiology (64756, to NCB). Microscopy was performed in the Laboratory of Confocal and Fluorescence Microscopy co-financed by the European Regional Development Fund and the state budget of the Czech Republic (CZ.1.05/4.1.00/16.0347 and CZ.2.16/3.1.00/21515).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Bobu C, 2008, VISION RES, V48, P424, DOI 10.1016/j.visres.2007.08.011; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; CALDERONE JB, 1995, VISUAL NEUROSCI, V12, P463, DOI 10.1017/S0952523800008361; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Collin SP, 2008, CLIN EXP OPTOM, V91, P85, DOI 10.1111/j.1444-0938.2007.00228.x; D'Angelo GJ, 2008, CAN J ZOOL, V86, P735, DOI 10.1139/Z08-050; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; FELDMAN JL, 1984, J MAMMAL, V65, P231, DOI 10.2307/1381162; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gaillard F, 2008, J COMP NEUROL, V510, P525, DOI 10.1002/cne.21798; GOVARDOVSKII VI, 1992, VISION RES, V32, P19, DOI 10.1016/0042-6989(92)90108-U; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Henning Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22705-y; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Jacobs GH, 2003, J COMP PHYSIOL A, V189, P347, DOI 10.1007/s00359-003-0408-0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karnas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073343; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; Kott O, 2014, J ZOOL, V294, P67, DOI 10.1111/jzo.12152; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Land M.F., 2012, ANIMAL EYES, P1; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lukats A, 2002, INVEST OPHTH VIS SCI, V43, P2468; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Peichl L, 2000, VISUAL NEUROSCI, V17, P937, DOI 10.1017/S0952523800176138; Peichl L, 1998, EUR J NEUROSCI, V10, P2586, DOI 10.1046/j.1460-9568.1998.t01-1-00265.x; PETRY HM, 1993, BRAIN RES, V616, P344, DOI 10.1016/0006-8993(93)90230-K; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; Reifler AN, 2015, EXP EYE RES, V130, P17, DOI 10.1016/j.exer.2014.11.010; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; Saidi T, 2007, GRAEFES ARCH CLIN EX, V249, P1029; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Schumann DM, 2005, PHYSIOL BEHAV, V85, P231, DOI 10.1016/j.physbeh.2005.03.024; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SZEL A, 1994, CELL TISSUE RES, V276, P143, DOI 10.1007/BF00354793; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445; van der Merwe I, 2014, CAN J ZOOL, V92, P1083, DOI 10.1139/cjz-2014-0161; vonSchantz M, 1997, BRAIN RES, V770, P131, DOI 10.1016/S0006-8993(97)00791-9; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weng S, 2013, PLOS ONE, V8	55	13	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202106	10.1371/journal.pone.0202106	http://dx.doi.org/10.1371/journal.pone.0202106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092025	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600087
J	Weng, CH; Chen, LY; Lin, YC; Shih, JY; Lin, YC; Tseng, RY; Chiu, AC; Yeh, YH; Liu, C; Lin, YT; Fang, JM; Chen, CC				Weng, Chien-Hui; Chen, Li-Yu; Lin, Yu-Chin; Shih, Jin-Yuan; Lin, Yun-Chieh; Tseng, Ruo-Yu; Chiu, An-Chieh; Yeh, Yu-Hsuan; Liu, Chi; Lin, Yi-Ting; Fang, Jim-Min; Chen, Ching-Chow			Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI	ONCOGENE			English	Article							COENZYME-A REDUCTASE; STEM-CELLS; HISTONE DEACETYLASE; VIMENTIN EXPRESSION; DRUG-RESISTANCE; TYROSINE KINASE; CANCER; INHIBITORS; THERAPY; ROLES	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is a major advance in treating NSCLC with EGFR-activating mutations. However, acquired resistance, due partially to secondary mutations limits their use. Here we report that NSCLC cells with acquired resistance to gefitinib or osimertinib (AZD9291) exhibit EMT features, with a decrease in E-cadherin, and increases in vimentin and stemness, without possessing any EGFR secondary mutations. Knockdown of E-cadherin in parental cells increased gefitinib resistance and stemness, while knockdown of vimentin in resistant cells resulted in opposite effects. Src activation and Hakai upregulation were found in gefitinib-resistant cells. Knockdown of Hakai elevated E-cadherin expression, attenuated stemness, and resensitized the cells to gefitinib. Clinical cancer specimens with acquired gefitinib resistance also showed a decrease in E-cadherin and an increase in Hakai expression. The dual HDAC and HMGR inhibitor JMF3086 inhibited the Src/Hakai and Hakai/E-cadherin interaction to reverse E-cadherin expression, and attenuated vimentin and stemness to restore gefitinib sensitivity. The EMT features of AZD9291-resistant H1975 cells were related to the upregulation of Zeb1. Both gefitinib and AZD9291 sensitivity was restored by JMF3086 through reversing EMT. Our study not only revealed a common mechanism of EMT in both gefitinib and AZD9291 resistance beyond EGFR mutations per se, but also provides a new strategy to overcome it.	[Weng, Chien-Hui; Chen, Li-Yu; Lin, Yu-Chin; Lin, Yun-Chieh; Tseng, Ruo-Yu; Chiu, An-Chieh; Yeh, Yu-Hsuan; Liu, Chi; Lin, Yi-Ting; Chen, Ching-Chow] Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei, Taiwan; [Lin, Yu-Chin] Mennonite Christian Hosp, Dept Internal Med, Hualien, Taiwan; [Shih, Jin-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Fang, Jim-Min] Natl Taiwan Univ, Dept Chem, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei, Taiwan.	chingchowchen@ntu.edu.tw	LIN, YU-CHIN/T-9092-2019	SHIH, JIN-YUAN/0000-0002-2854-5067	Ministry of Science and Technology [MOST-106-2320-B002-003]; Excellent Translational Medicine Research Projects of National Taiwan University, College of Medicine; National Taiwan University Hospital [106R39012]; National Health Research Institute of Taiwan [NHRI-EX107-10707BI]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Excellent Translational Medicine Research Projects of National Taiwan University, College of Medicine; National Taiwan University Hospital(National Taiwan University); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the Ministry of Science and Technology (MOST-106-2320-B002-003), Excellent Translational Medicine Research Projects of National Taiwan University, College of Medicine and National Taiwan University Hospital (106R39012), and the National Health Research Institute of Taiwan (NHRI-EX107-10707BI). We thank the technical assistance of the First Core Labs in the National Taiwan University College of Medicine.	Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Chen JB, 2013, J MED CHEM, V56, P3645, DOI 10.1021/jm400179b; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dou J, 2014, CELL BIOL INT, V38, P452, DOI 10.1002/cbin.10223; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Honke K, 1997, JPN J CANCER RES, V88, P484, DOI 10.1111/j.1349-7006.1997.tb00407.x; Ishiguro T, 2017, CANCER SCI, V108, P283, DOI 10.1111/cas.13155; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.10.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Katz MS, 2005, NAT CLIN PRACT ONCOL, V2, P82, DOI 10.1038/ncponc0097; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Lin YC, 2015, CLIN CANCER RES, V21, P428, DOI 10.1158/1078-0432.CCR-14-1150; Liu YN, 2015, ONCOTARGET, V6, P10415, DOI 10.18632/oncotarget.3389; Locke I, 2002, NEW ENGL J MED, V346, P1498; Meidhof S, 2015, EMBO MOL MED, V7, P831, DOI 10.15252/emmm.201404396; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Wei TT, 2016, EBIOMEDICINE, V10, P124, DOI 10.1016/j.ebiom.2016.07.019; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang PM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03219; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	48	112	119	1	40	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2019	38	4					455	468		10.1038/s41388-018-0454-2	http://dx.doi.org/10.1038/s41388-018-0454-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HI6UB	30111817				2022-12-26	WOS:000456589800001
J	Chen-Wichmann, L; Shvartsman, M; Preiss, C; Hockings, C; Windisch, R; Monte, ER; Leubolt, G; Spiekermann, K; Lausen, J; Brendel, C; Grez, M; Greif, PA; Wichmann, C				Chen-Wichmann, Linping; Shvartsman, Marina; Preiss, Caro; Hockings, Colin; Windisch, Roland; Monte, Enric Redondo; Leubolt, Georg; Spiekermann, Karsten; Lausen, Jorn; Brendel, Christian; Grez, Manuel; Greif, Philipp A.; Wichmann, Christian			Compatibility of RUNX1/ETO fusion protein modules driving CD34+human progenitor cell expansion	ONCOGENE			English	Article							ETO HOMOLOGS; AML1-ETO; DOMAIN; LEUKEMIA; PROMOTES; COMPLEX; GENE; TRANSCRIPTION; REPRESSION; PARTNER	Chromosomal translocations represent frequent events in leukemia. In t(8;21)+ acute myeloid leukemia, RUNX1 is fused to nearly the entire ETO protein, which contains four conserved nervy homology regions, NHR1-4. Furthermore RUNX1/ETO interacts with ETO-homologous proteins via NHR2, thereby multiplying NHR domain contacts. As shown recently, RUNX1/ETO retains oncogenic activity upon either deletion of the NHR3 + 4 N-CoR/SMRT interaction domain or substitution of the NHR2 tetramer domain. Thus, we aimed to clarify the specificities of the NHR domains. A C-terminally NHR3 + 4 truncated RUNX1/ETO containing a heterologous, structurally highly related non-NHR2 tetramer interface translocated into the nucleus and bound to RUNX1 consensus motifs. However, it failed to interact with ETO-homologues, repress RUNX1 targets, and transform progenitors. Surprisingly, transforming capacity was fully restored by C-terminal fusion with ETO's NHR4 zinc-finger or the repressor domain 3 of N-CoR, while other repression domains failed. With an inducible protein assembly system, we further demonstrated that NHR4 domain activity is critically required early in the establishment of progenitor cultures expressing the NHR2 exchanged truncated RUNX1/ETO. Together, we can show that NHR2 and NHR4 domains can be replaced by heterologous protein domains conferring tetramerization and repressor functions, thus showing that the NHR2 and NHR4 domain structures do not have irreplaceable functions concerning RUNX1/ETO activity for the establishment of human CD34+ cell expansion. We could resemble the function of RUNX1/ETO through modular recomposition with protein domains from RUNX1, ETO, BCR and N-CoR without any NHR2 and NHR4 sequences. As most transcriptional repressor proteins do not comprise tetramerization domains, our results provide a possible explanation as to the reason that RUNX1 is recurrently found translocated to ETO family members, which all contain tetramer together with transcriptional repressor moieties.	[Chen-Wichmann, Linping; Shvartsman, Marina; Preiss, Caro; Windisch, Roland; Wichmann, Christian] Ludwig Maximilians Univ Munchen, Hosp Munich, Dept Transfus Med Cell Therapeut & Hemostaseol, Munich, Germany; [Hockings, Colin] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Monte, Enric Redondo; Leubolt, Georg; Spiekermann, Karsten; Greif, Philipp A.] Ludwig Maximilians Univ Hosp Munich, Dept Internal Med 3, Munich, Germany; [Spiekermann, Karsten; Greif, Philipp A.] German Canc Consortium DKTK, Heidelberg, Germany; [Spiekermann, Karsten; Greif, Philipp A.] German Canc Res Ctr, Heidelberg, Germany; [Lausen, Jorn] Goethe Univ Frankfurt, Inst Transfus Med & Immunohematol, Frankfurt, Germany; [Lausen, Jorn] German Red Cross Blood Serv, Frankfurt, Germany; [Brendel, Christian] Harvard Med Sch, Dana Farber Canc Inst, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Grez, Manuel] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany	University of Munich; University of Cambridge; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Wichmann, C (corresponding author), Ludwig Maximilians Univ Munchen, Hosp Munich, Dept Transfus Med Cell Therapeut & Hemostaseol, Munich, Germany.	christian.wichmann@med.uni-muenchen.de	Wichmann, Christian/H-2491-2017; Brendel, Christian/HDN-6077-2022	Greif, Philipp/0000-0002-3744-7936; Redondo Monte, Enric/0000-0002-3588-223X; Brendel, Christian/0000-0003-4081-4351; Hockings, Colin/0000-0002-0248-0517	Jose Carreras Leukemia Foundation [DJCLS R 12/28]; Wilhelm Sander-Foundation [2014.162.2]; Friedrich-Baur Foundation; Deutsche Forschungsgemeinschaft [DFG LA 1389/6-1]	Jose Carreras Leukemia Foundation; Wilhelm Sander-Foundation; Friedrich-Baur Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Simone Schwarz for expert technical assistance and Sandra Moore for critical comments on the manuscript. We are supported by research grants from the Jose Carreras Leukemia Foundation (DJCLS R 12/28, CW), the Wilhelm Sander-Foundation (2014.162.2, PG & CW) the Friedrich-Baur Foundation (CW) and the Deutsche Forschungsgemeinschaft (DFG LA 1389/6-1, JL).	Ahn EY, 2008, P NATL ACAD SCI USA, V105, P17103, DOI 10.1073/pnas.0802696105; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; DeKelver RC, 2013, BLOOD, V121, P3714, DOI 10.1182/blood-2012-11-465641; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Guastadisegni MC, 2010, LEUKEMIA, V24, P1516, DOI 10.1038/leu.2010.106; Huang EY, 2000, GENE DEV, V14, P45; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; Kohrs N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005946; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Lausen J, 2004, J BIOL CHEM, V279, P49281, DOI 10.1074/jbc.M407239200; Lindberg SR, 2003, EUR J HAEMATOL, V71, P439, DOI 10.1046/j.0902-4441.2003.00166.x; Lindberg SR, 2005, EXP HEMATOL, V33, P189, DOI 10.1016/j.exphem.2004.10.011; Link KA, 2016, P NATL ACAD SCI USA, V113, P9075, DOI 10.1073/pnas.1524225113; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Okumura AJ, 2008, BLOOD, V112, P1392, DOI 10.1182/blood-2007-11-124735; Okumura AJ, 2007, EXP HEMATOL, V35, P978, DOI 10.1016/j.exphem.2007.03.002; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Ponnusamy K, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.6; Pownall ME, 2003, DEV BIOL, V256, P89, DOI 10.1016/S0012-1606(02)00120-3; Salomon-Nguyen F, 2000, LEUKEMIA, V14, P1704, DOI 10.1038/sj.leu.2401885; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Wichmann C, 2015, LEUKEMIA, V29, P279, DOI 10.1038/leu.2014.179; Wichmann C, 2010, BLOOD, V116, P603, DOI 10.1182/blood-2009-10-248047; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Zhao X, 2002, NAT STRUCT BIOL, V9, P117	31	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2019	38	2					261	272		10.1038/s41388-018-0441-7	http://dx.doi.org/10.1038/s41388-018-0441-7			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HG9XX	30093631				2022-12-26	WOS:000455366700008
J	Yang, C; Ma, X; Guan, G; Liu, H; Yang, YL; Niu, QH; Wu, ZH; Jiang, YP; Bian, C; Zang, YJ; Zhuang, LK				Yang, Chao; Ma, Xiang; Guan, Ge; Liu, Huan; Yang, Yuling; Niu, Qinghui; Wu, Zehua; Jiang, Yueping; Bian, Cheng; Zang, Yunjin; Zhuang, Likun			MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma	FASEB JOURNAL			English	Article						miR-766; HCC; -catenin; proliferation; metastasis	METASTASIS; BIOMARKER; GROWTH; CELLS; ACTS	MicroRNAs (miRNAs) have been reported to play important roles in tumor progression of various cancers. However, the clinical significance and biologic function of miR-766 in hepatocellular carcinoma (HCC) remain unknown. In this study, we investigated the roles of miR-766 in HCC progression using HCC cell lines and a xenograft mouse model. miR-766 expression in tumor tissues and adjacent nontumorous liver tissues of patients with HCC was evaluated by quantitative RT-PCR. Our results showed that miR-766 promoted proliferation and metastasis of HCC cells in vitro and in vivo and that NR3C2 was a direct target of miR-766 and involved in miR-766-mediated proliferation and metastasis of HCC cells. We also found that miR-766 affected the -catenin signaling pathway by targeting NR3C2. Furthermore, miR-766 was significantly up-regulated in HCC tissues and was correlated with the prognosis of patients with liver cancer. Taken together, our results show that miR-766 affects HCC progression by modulating NR3C2 expression and is a possible new therapeutic target for patients with HCC.Yang, C., Ma, X., Guan, G., Liu, H., Yang, Y., Niu, Q., Wu, Z., Jiang, Y., Bian, C., Zang, Y., Zhuang, L. MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.	[Yang, Chao; Yang, Yuling; Niu, Qinghui; Jiang, Yueping; Bian, Cheng] Qingdao Univ, Affiliated Hosp, Dept Infect Dis, Qingdao, Peoples R China; [Ma, Xiang; Wu, Zehua] Qingdao Univ, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Qingdao, Peoples R China; [Guan, Ge; Zang, Yunjin] Qingdao Univ, Affiliated Hosp, Organ Transplantat Ctr, Qingdao, Peoples R China; [Liu, Huan; Zang, Yunjin; Zhuang, Likun] Qingdao Univ, Affiliated Hosp, Inst Transplantat Sci, 16 Jiangsu Rd, Qingdao 266003, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University	Zhuang, LK (corresponding author), Qingdao Univ, Affiliated Hosp, Inst Transplantat Sci, 16 Jiangsu Rd, Qingdao 266003, Peoples R China.	zlk0823@163.com		Zhuang, Likun/0000-0003-3002-2406	National Natural Science Foundation of China [81501812]; Natural Science Foundation of Shandong Province [BS2015SW013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China Grant 81501812 (to L.Z.), and Natural Science Foundation of Shandong Province Grant BS2015SW013 (to L.Z.).	Afgar A, 2016, CANCER BIOL THER, V17, P1126, DOI 10.1080/15384047.2016.1235657; Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bao X, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.31; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Chen C, 2017, INT J CANCER, V141, P1867, DOI 10.1002/ijc.30853; Das R, 2017, CANCER RES, V77, P1021, DOI 10.1158/0008-5472.CAN-16-2529; HORISBERGER JD, 1992, HYPERTENSION, V19, P221, DOI 10.1161/01.HYP.19.3.221; Jin XC, 2017, CLIN CANCER RES, V23, P5311, DOI 10.1158/1078-0432.CCR-17-0577; Lee HA, 2013, CIRC RES, V112, P1004, DOI 10.1161/CIRCRESAHA.113.301071; Li C, 2018, INT J ONCOL, V52, P536, DOI 10.3892/ijo.2017.4224; Li YC, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S89459; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Ma X, 2017, THER ADV MED ONCOL, V9, P665, DOI 10.1177/1758834017731052; Ma X, 2016, ANTICANCER RES, V36, P6389, DOI 10.21873/anticanres.11236; Mathiyalagan P, 2017, METHODS MOL BIOL, V1521, P139, DOI 10.1007/978-1-4939-6588-5_9; Morise Z, 2014, FRONT SURG, V1, DOI 10.3389/fsurg.2014.00021; Sethi S, 2018, CLIN LAB MED, V38, P237, DOI 10.1016/j.cll.2018.02.003; Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841; Zhan MN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.440; Zhao ZJ, 2018, J CELL PHYSIOL, V233, P6825, DOI 10.1002/jcp.26550; Zhuang LK, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.100; Zhuang LK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.216; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	25	35	35	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1456	1467		10.1096/fj.201801151R	http://dx.doi.org/10.1096/fj.201801151R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30130435				2022-12-26	WOS:000457401500114
J	Haugaard-Kedstrom, LM; Lee, HS; Jones, MV; Song, A; Rathod, V; Hossain, MA; Bathgate, RAD; Rosengren, KJ				Haugaard-Kedstrom, Linda M.; Lee, Han Siean; Jones, Maryon V.; Song, Angela; Rathod, Vishaal; Hossain, Mohammed Akhter; Bathgate, Ross A. D.; Rosengren, K. Johan			Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						relaxin-3; G protein-coupled receptor (GPCR); neuropeptide; peptide conformation; peptide interaction; antagonist; R3 B1-22R; RXFP3; alanine scan; peptide stapling	B-CHAIN; BIOLOGICAL-ACTIVITY; NUCLEUS INCERTUS; CHIMERIC PEPTIDE; FAMILY PEPTIDES; AMINO-ACIDS; H3 RELAXIN; GPCR142; AGONIST; LIGAND	The neuropeptide relaxin-3 and its receptor relaxin family peptide receptor-3 (RXFP3) play key roles in modulating behavior such as memory and learning, food intake, and reward seeking. A linear relaxin-3 antagonist (R3 B1-22R) based on a modified and truncated relaxin-3 B-chain was recently developed. R3 B1-22R is unstructured in solution; thus, the binding conformation and determinants of receptor binding are unclear. Here, we have designed, chemically synthesized, and pharmacologically characterized more than 60 analogues of R3 B1-22R to develop an extensive understanding of its structure-activity relationships. We show that the key driver for affinity is the nonnative C-terminal Arg(23). Additional contributors to binding include amino acid residues that are important also for relaxin-3 binding, including Arg(12), Ile(15), and Ile(19). Intriguingly, amino acid residues that are not exposed in native relaxin-3, including Phe(14) and Ala(17), also interact with RXFP3. We show that R3 B1-22R has a propensity to form a helical structure, and modifications that support a helical conformation are functionally well-tolerated, whereas helix breakers such as proline residues disrupt binding. These data suggest that the peptide adopts a helical conformation, like relaxin-3, upon binding to RXFP3, but that its smaller size allows it to penetrate deeper into the orthosteric binding site, creating more extensive contacts with the receptor.	[Haugaard-Kedstrom, Linda M.; Lee, Han Siean; Jones, Maryon V.; Song, Angela; Rathod, Vishaal; Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Fac Med, Brisbane, Qld 4072, Australia; [Haugaard-Kedstrom, Linda M.] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Hossain, Mohammed Akhter; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	University of Queensland; University of Copenhagen; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.; Rosengren, KJ (corresponding author), Univ Queensland, Sch Biomed Sci, Fac Med, St Lucia, Qld 4072, Australia.	bathgate@florey.edu.au; j.rosengren@uq.edu.au	Rosengren, K. Johan/P-4450-2016; Bathgate, Ross/ABE-6471-2020; Song, Angela/AAE-3472-2021; Haugaard-Kedstrom, Linda/F-3705-2011	Rosengren, K. Johan/0000-0002-5007-8434; Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Haugaard-Kedstrom, Linda/0000-0003-0113-6535	National Health and Medical Research Council (NHMRC), Australia [1063425, 1066369]; Victorian Government Operational Infrastructure Support Program; Australian Research Council Future Fellowship	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by the National Health and Medical Research Council (NHMRC), Australia, through Project Grants 1063425 and 1066369 (to R. A. D. B. and K. J. R.). Research at the Florey was supported by the Victorian Government Operational Infrastructure Support Program. L. M. H. K., K. J. R., and R. A. D. B. are inventors on Australian Patent 2010904046 and United States patent application 13/821726, Modified Relaxin B Chain Peptides.; Supported by an Australian Research Council Future Fellowship.	Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Calvez J, 2016, NEUROPHARMACOLOGY, V102, P207, DOI 10.1016/j.neuropharm.2015.11.014; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; de Araujo AD, 2014, ANGEW CHEM INT EDIT, V53, P6965, DOI 10.1002/anie.201310245; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Haugaard-Kedstrom LM, 2015, AMINO ACIDS, V47, P1267, DOI 10.1007/s00726-015-1961-x; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hojo K, 2016, J MED CHEM, V59, P7445, DOI 10.1021/acs.jmedchem.6b00265; Hossain MA, 2016, J PEPT SCI, V22, pS126, DOI 10.1039/C5SC04754D; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2009, CHEM BIOL DRUG DES, V73, P46, DOI 10.1111/j.1747-0285.2008.00756.x; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hu MJ, 2016, AMINO ACIDS, V48, P2227, DOI 10.1007/s00726-016-2260-x; Jayakody T, 2016, PEPTIDES, V84, P44, DOI 10.1016/j.peptides.2016.08.001; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Mahalakshmi Radhakrishnan, 2006, V340, P71; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; Patil NA, 2017, BRIT J PHARMACOL, V174, P950, DOI 10.1111/bph.13684; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Ryan PJ, 2013, P NATL ACAD SCI USA, V110, P20789, DOI 10.1073/pnas.1317807110; Shabanpoor F, 2012, J MED CHEM, V55, P1671, DOI 10.1021/jm201505p; Shabanpoor F, 2010, AMINO ACIDS, V38, P121, DOI 10.1007/s00726-008-0219-2; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Smith CM, 2014, BEHAV BRAIN RES, V268, P117, DOI 10.1016/j.bbr.2014.03.037; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; Van Der Westhuizen ET, 2005, ANN NY ACAD SCI, V1041, P332, DOI 10.1196/annals.1282.053; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong LLL, 2018, J BIOL CHEM, V293, P15777, DOI 10.1074/jbc.RA118.002645; Zhang WJ, 2014, AMINO ACIDS, V46, P1393, DOI 10.1007/s00726-014-1705-3	41	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15765	15776		10.1074/jbc.RA118.002611	http://dx.doi.org/10.1074/jbc.RA118.002611			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131342	Green Published, hybrid			2022-12-26	WOS:000447256000002
J	Rosener, NS; Gremer, L; Reinartz, E; Konig, A; Brener, O; Heise, H; Hoyer, W; Neudecker, P; Willbold, D				Roesener, Nadine S.; Gremer, Lothar; Reinartz, Elke; Koenig, Anna; Brener, Oleksandr; Heise, Henrike; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter			A D-enantiomeric peptide interferes with heteroassociation of amyloid-beta oligomers and prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid- (A); atomic force microscopy (AFM); oligomerization; protein aggregation; protein-protein interaction; nuclear magnetic resonance (NMR); D-enantiomeric peptides; density gradient ultracentrifugation (DGC); prion protein	N-TERMINAL FRAGMENT; IMAGE PHAGE DISPLAY; ALZHEIMERS A-BETA; TRANSGENIC MICE; PHARMACOKINETIC PROPERTIES; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; IN-VIVO; DISEASE; RECEPTOR	Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. One AD hallmark is the aggregation of beta-amyloid (A beta) into soluble oligomers and insoluble fibrils. Several studies have reported that oligomers rather than fibrils are the most toxic species in AD progression. A beta oligomers bind with high affinity to membrane-associated prion protein (PrP), leading to toxic signaling across the cell membrane, which makes the A beta-PrP interaction an attractive therapeutic target. Here, probing this interaction in more detail, we found that both full-length, soluble human (hu) PrP(23-230) and huPrP(23-144), lacking the globular C-terminal domain, bind to A beta oligomers to form large complexes above the megadalton size range. Following purification by sucrose density-gradient ultracentrifugation, the A beta and huPrP contents in these heteroassemblies were quantified by reversed-phase HPLC. The A beta:PrP molar ratio in these assemblies exhibited some limited variation depending on the molar ratio of the initial mixture. Specifically, a molar ratio of about four A beta to one huPrP in the presence of an excess of huPrP(23-230) or huPrP(23-144) suggested that four A beta units are required to form one huPrP-binding site. Of note, an A beta-binding all-D-enantiomeric peptide, RD2D3, competed with huPrP for A beta oligomers and interfered with A beta-PrP heteroassembly in a concentration-dependent manner. Our results highlight the importance of multivalent epitopes on A beta oligomers for A beta-PrP interactions and have yielded an all-D-peptide-based, therapeutically promising agent that competes with PrP for these interactions.	[Roesener, Nadine S.; Gremer, Lothar; Reinartz, Elke; Koenig, Anna; Brener, Oleksandr; Heise, Henrike; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Roesener, Nadine S.; Gremer, Lothar; Koenig, Anna; Brener, Oleksandr; Heise, Henrike; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Willbold, D (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Neudecker, Philipp/AAP-9005-2020; Neudecker, Philipp/G-5265-2013; Hoyer, Wolfgang/H-6193-2013; Heise, Henrike/A-7703-2010; Gremer, Lothar/H-9128-2013; Willbold, Dieter/A-6280-2013	Neudecker, Philipp/0000-0002-0557-966X; Neudecker, Philipp/0000-0002-0557-966X; Hoyer, Wolfgang/0000-0003-4301-5416; Heise, Henrike/0000-0002-9081-3894; Gremer, Lothar/0000-0001-7065-5027; Rosener, Nadine/0000-0002-9481-6347; Willbold, Dieter/0000-0002-0065-7366; Brener, Oleksandr/0000-0001-9771-7515	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Research" of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; Deutsche Forschungsgemeinschaft [SFB 1208]; European Research Council Consolidator Grant [726368]	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Research" of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Consolidator Grant(European Research Council (ERC))	This work was supported by "Portfolio Technology and Medicine," the Helmholtz-Validierungsfonds of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft (to N. S. R. and D. W.), "Portfolio Drug Research" of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft (to D. W.), Deutsche Forschungsgemeinschaft Grant SFB 1208 (to P. N. and D. W.), and European Research Council Consolidator Grant 726368 (to W. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aimi T, 2015, J NEUROCHEM, V134, P611, DOI 10.1111/jnc.13166; Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Beland M, 2014, NEUROBIOL AGING, V35, P1537, DOI 10.1016/j.neurobiolaging.2014.02.001; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Canet-Ferrer J, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/39/395703; Cavini IA, 2018, CHEM COMMUN, V54, P3294, DOI 10.1039/c8cc01458b; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Choi JK, 2016, P NATL ACAD SCI USA, V113, P13851, DOI 10.1073/pnas.1610716113; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Dawson R. M. C., 1986, DATA BIOCH RES, P545; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DINTZIS HM, 1993, PROTEINS, V16, P306, DOI 10.1002/prot.340160309; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Elezgarai SR, 2016, BIOL CHEM, V397, P1115, DOI 10.1515/hsz-2016-0190; Elfgen A, 2017, EUR J PHARM SCI, V107, P203, DOI 10.1016/j.ejps.2017.07.015; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jiang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128553; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.63; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kutzsche J, 2017, MOLECULES, V22, DOI 10.3390/molecules22101693; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leithold LHE, 2016, EUR J PHARM SCI, V89, P31, DOI 10.1016/j.ejps.2016.04.016; Leithold LHE, 2016, PHARM RES-DORDR, V33, P328, DOI 10.1007/s11095-015-1791-2; Luers L, 2010, REJUV RES, V13, P214, DOI 10.1089/rej.2009.0932; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Olubiyi OO, 2014, CURR MED CHEM, V21, P1448, DOI 10.2174/0929867321666131129122247; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Peixoto PDS, 2016, LANGMUIR, V32, P7821, DOI 10.1021/acs.langmuir.6b01015; Peters C, 2015, NEUROBIOL AGING, V36, P1369, DOI 10.1016/j.neurobiolaging.2014.11.019; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Risse E, 2015, J BIOL CHEM, V290, P17020, DOI 10.1074/jbc.M115.637124; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Scott-McKean JJ, 2016, NEUROBIOL DIS, V91, P124, DOI 10.1016/j.nbd.2016.03.001; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Tavares GM, 2015, FOOD HYDROCOLLOID, V48, P238, DOI 10.1016/j.foodhyd.2015.02.027; Theint T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00794-z; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; van Groen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16565-1; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Wahlberg E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06377-8; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	80	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15748	15764		10.1074/jbc.RA118.003116	http://dx.doi.org/10.1074/jbc.RA118.003116			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131337	hybrid, Green Published			2022-12-26	WOS:000447256000001
J	Gannoun-Zaki, L; Patzold, L; Huc-Brandt, S; Baronian, G; Elhawy, MI; Gaupp, R; Martin, M; Blanc-Potard, AB; Letourneur, F; Bischoff, M; Molle, V				Gannoun-Zaki, Laila; Paetzold, Linda; Huc-Brandt, Sylvaine; Baronian, Gregory; Elhawy, Mohamed Ibrahem; Gaupp, Rosmarie; Martin, Marianne; Blanc-Potard, Anne-Beatrice; Letourneur, Francois; Bischoff, Markus; Molle, Virginie			PtpA, a secreted tyrosine phosphatase from Staphylococcus aureus, contributes to virulence and interacts with coronin-1A during infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); bacterial protein phosphatase; host-pathogen interaction; bacterial pathogenesis; protein phosphorylation; coronin	PROTEIN-KINASE; PATHOGENIC MYCOBACTERIA; PHOSPHORYLATION; SURVIVAL; YERSINIA; MACROPHAGES; IDENTIFICATION; RECOGNITION; DETERMINANT; ACTIVATION	Secretion of bacterial signaling proteins and adaptation to the host, especially during infection, are processes that are often linked in pathogenic bacteria. The human pathogen Staphylococcus aureus is equipped with a large arsenal of immune-modulating factors, allowing it to either subvert the host immune response or to create permissive niches for its survival. Recently, we showed that one of the low-molecular-weight protein tyrosine phosphatases produced by S. aureus, PtpA, is secreted during growth. Here, we report that deletion of ptpA in S. aureus affects intramacrophage survival and infectivity. We also observed that PtpA is secreted during macrophage infection. Immunoprecipitation assays identified several host proteins as putative intracellular binding partners for PtpA, including coronin-1A, a cytoskeleton-associated protein that is implicated in a variety of cellular processes. Of note, we demonstrated that coronin-1A is phosphorylated on tyrosine residues upon S. aureus infection and that its phosphorylation profile is linked to PtpA expression. Our results confirm that PtpA has a critical role during infection as a bacterial effector protein that counteracts host defenses.	[Gannoun-Zaki, Laila; Huc-Brandt, Sylvaine; Baronian, Gregory; Martin, Marianne; Blanc-Potard, Anne-Beatrice; Letourneur, Francois; Molle, Virginie] Univ Montpellier, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34000 Montpellier, France; [Paetzold, Linda; Elhawy, Mohamed Ibrahem; Gaupp, Rosmarie; Bischoff, Markus] Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Saarland University	Gannoun-Zaki, L (corresponding author), Univ Montpellier, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34000 Montpellier, France.	laila.gannoun@umontpellier.fr; virginie.molle@univ-montp2.fr	Elhawy, Mohamed Ibrahem/AAQ-9990-2021; Brandt, Sylvaine/AAJ-1277-2021; Blanc-Potard, Anne/AAI-9542-2021; Bischoff, Markus/D-2130-2014; MOLLE, Virginie/D-4050-2019	Elhawy, Mohamed Ibrahem/0000-0002-8252-1832; Brandt, Sylvaine/0000-0002-5582-4643; Bischoff, Markus/0000-0001-6734-2732; MOLLE, Virginie/0000-0002-6573-3411; Gannoun, Laila/0000-0002-9644-1083; Letourneur, Francois/0000-0003-2232-6127; MARTIN, Marianne/0000-0001-8932-3129; Blanc-Potard, Anne/0000-0001-9963-6786	ATIP/AVENIR Program; German Egyptian Research Long-term Scholarship (GERLS) program	ATIP/AVENIR Program; German Egyptian Research Long-term Scholarship (GERLS) program	This work was supported by grants from the ATIP/AVENIR Program (to V. M. and L. G.-Z.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the German Egyptian Research Long-term Scholarship (GERLS) program.	Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bischoff M, 2016, STAPHYLOCOCCUS: GENETICS AND PHYSIOLOGY, P301; Black DS, 1998, MOL MICROBIOL, V29, P1263, DOI 10.1046/j.1365-2958.1998.01014.x; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Bliska JB, 2000, TRENDS MICROBIOL, V8, P205, DOI 10.1016/S0966-842X(00)01738-8; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; BoseDasgupta S, 2014, FEBS LETT, V588, P3898, DOI 10.1016/j.febslet.2014.08.036; BoseDasgupta S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003879; Brelle S, 2016, BIOCHEM BIOPH RES CO, V469, P619, DOI 10.1016/j.bbrc.2015.11.123; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Cornejo E, 2017, J CELL BIOL, V216, P3931, DOI 10.1083/jcb.201701095; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; DIMENT S, 1989, J BIOL CHEM, V264, P13403; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Flannagan RS, 2015, PATHOGENS, V4, P826, DOI 10.3390/pathogens4040826; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Gaupp R, 2016, INFECT IMMUN, V84, P2031, DOI 10.1128/IAI.00285-16; Gemayel R, 2007, FEBS J, V274, P4360, DOI 10.1111/j.1742-4658.2007.05948.x; Hamza T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0207-5; Heneberg P, 2012, CURR MED CHEM, V19, P1530, DOI 10.2174/092986712799828274; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Horn J, 2018, INT J MED MICROBIOL, V308, P607, DOI 10.1016/j.ijmm.2017.11.009; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jubrail J, 2016, CELL MICROBIOL, V18, P80, DOI 10.1111/cmi.12485; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Koziel J, 2015, J INNATE IMMUN, V7, P187, DOI 10.1159/000368048; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee YG, 2009, INT J BIOCHEM CELL B, V41, P811, DOI 10.1016/j.biocel.2008.08.011; Lin SL, 2003, CELL MICROBIOL, V5, P267, DOI 10.1046/j.1462-5822.2003.t01-1-00274.x; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Oku T, 2012, J BIOL CHEM, V287, P42910, DOI 10.1074/jbc.M112.349829; Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Schlievert PM, 2016, STAPHYLOCOCCUS: GENETICS AND PHYSIOLOGY, P81; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Singh B, 2003, CLIN EXP IMMUNOL, V134, P70, DOI 10.1046/j.1365-2249.2003.02258.x; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Soulat D, 2002, J BACTERIOL, V184, P5194, DOI 10.1128/JB.184.18.5194-5199.2002; Surewaard BGJ, 2016, J EXP MED, V213, P1141, DOI 10.1084/jem.20160334; Tranchemontagne ZR, 2016, INFECT IMMUN, V84, P241, DOI 10.1128/IAI.00704-15; Vega C, 2011, J MOL BIOL, V413, P24, DOI 10.1016/j.jmb.2011.08.015; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00279-z; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30018; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Wienke D, 2006, EUR J CELL BIOL, V85, P991, DOI 10.1016/j.ejcb.2006.04.010; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Yi YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/270302	65	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15569	15580		10.1074/jbc.RA118.003555	http://dx.doi.org/10.1074/jbc.RA118.003555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30131335	Green Published, hybrid			2022-12-26	WOS:000446549200021
J	Masiira, B; Makumbi, I; Matovu, JKB; Ario, AR; Nabukenya, I; Kihembo, C; Kaharuza, F; Musenero, M; Mbonye, A				Masiira, Ben; Makumbi, Issa; Matovu, Joseph K. B.; Ario, Alex Riolexus; Nabukenya, Immaculate; Kihembo, Christine; Kaharuza, Frank; Musenero, Monica; Mbonye, Anthony			Long term trends and spatial distribution of animal bite injuries and deaths due to human rabies infection in Uganda, 2001-2015	PLOS ONE			English	Article							DOG BITES; EPIDEMIOLOGY; BURDEN; ELIMINATION; DISEASE	Background In the absence of accurate data on trends and the burden of human rabies infection in developing countries, animal bite injuries provide useful information to bridge that gap. Rabies is one of the most deadly infectious diseases, with a case fatality rate approaching 100%. Despite availability of effective prevention and control strategies, rabies still kills 50,000 to 60,000 people worldwide annually, the majority of whom are in the developing world. We describe trends and geographical distribution of animal bite injuries (a proxy of potential exposure to rabies) and deaths due to suspected human rabies in Uganda from 2001 to 2015. Methods We used 2001-2015 surveillance data on suspected animal bite injuries, collected from health facilities in Uganda. To describe annual trends, line graphs were used and linear regression tested significance of observed trends at P<0.05. We used maps to describe geographical distribution of animal bites by district. Results A total of 208,720 cases of animal bite injuries were reported. Of these, 27% were in Central, 22% in Eastern, 27% in Northern and 23% in Western regions. Out of 48,720 animal bites between 2013 and 2015, 59% were suffered by males and 81% were persons aged above 5 years. Between 2001 and 2015, the overall incidence (per 100,000 population) of animal bites was 58 in Uganda, 76 in Northern, 58 in Central, 53 in Western and 50 in Eastern region. From 2001 to 2015, the annual incidence (per 100,000 population) increased from 21 to 47 (P = 0.02) in Central, 27 to 34 (P = 0.04) in Eastern, 23 to 70 (P = 0.01) in Northern and 16 to 46 (P = 0.001) in Western region. A total of 486 suspected human rabies deaths were reported, of which 29% were reported from Eastern, 28% from Central, 27% from Northern and 17% from Western region. Conclusion Animal bite injuries, a potential exposure to rabies infection, and mortality attributed to rabies infection are public health challenges affecting all regions of Uganda. Eliminating rabies requires strengthening of rabies prevention and control strategies at all levels of the health sector. These strategies should utilize the "One Health" approach with strategic focus on strengthening rabies surveillance, controlling rabies in dogs and ensuring availability of post exposure prophylaxis at lower health facilities.	[Masiira, Ben; Ario, Alex Riolexus; Kihembo, Christine] Minist Hlth, Dept Natl Dis Control, Uganda Publ Hlth Fellowship Program, Kampala, Uganda; [Makumbi, Issa; Nabukenya, Immaculate; Musenero, Monica] Minist Hlth, Dept Natl Dis Control, Kampala, Uganda; [Matovu, Joseph K. B.] Makerere Univ, Coll Hlth Sci, Makerere Sch Publ Hlth, Dept Dis Control & Environm, Kampala, Uganda; [Nabukenya, Immaculate] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Kaharuza, Frank] African Field Epidemiol Network, Programs Dept, Kampala, Uganda; [Mbonye, Anthony] Minist Hlth, Dept Community Hlth, Kampala, Uganda	Makerere University; Makerere University	Masiira, B (corresponding author), Minist Hlth, Dept Natl Dis Control, Uganda Publ Hlth Fellowship Program, Kampala, Uganda.	ben.masiira@musph.ac.ug	Ario, Alex Riolexus/AAE-9387-2019; Kihembo, Christine/ABA-2095-2020; Matovu, Joseph/AAO-5790-2020					Agarwal N, 2004, TROP DOCT, V34, P76, DOI 10.1177/004947550403400205; BROOKS R, 1990, VET REC, V127, P592; Byrnes H, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00028; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Cleaveland S, 1998, T ROY SOC TROP MED H, V92, P131, DOI 10.1016/S0035-9203(98)90718-0; Cleaveland S., 1996, EPIDEMIOLOGY RABIES; Debasis Das DAKM, 2015, IOSR J DENT MED SCI, V14, P55; Dodet B, 2010, Bull Soc Pathol Exot, V103, P51, DOI 10.1007/s13149-009-0034-3; EZEOKOLI CD, 1987, T ROY SOC TROP MED H, V81, P268, DOI 10.1016/0035-9203(87)90237-9; Fevre EM, 2005, TROP MED INT HEALTH, V10, P790, DOI 10.1111/j.1365-3156.2005.01447.x; Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Frey J, 2013, TROP MED INT HEALTH, V18, P1555, DOI 10.1111/tmi.12202; Gilchrist J, 2008, INJURY PREV, V14, P296, DOI 10.1136/ip.2007.016220; Godlonton J, 2001, P 6 INT S SO E AFR R, P196; Hasler B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003270; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3; Kiberu VM, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-40; Kitala PM, 1995, 3 INT C SO E AFR RAB; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lal P., 2005, Health and Population - Perspectives and Issues, V28, P50; Mallewa M, 2007, EMERG INFECT DIS, V13, P136, DOI 10.3201/eid1301.060810; Meslin F, 1996, OVERVIEW LAB TECHNIQ, P9; Ministry of Health Division of Health Information, 2016, UG HLTH FAC MAST LIS; Mpolya EA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00021; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nel LH, 2013, EMERG INFECT DIS, V19, P529, DOI 10.3201/eid1904.120185; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; Taghvaii M. R. E., 2013, Biomedical & Pharmacology Journal, V6, P301, DOI 10.13005/bpj/418; Tenzin, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001391; Townsend SE, 2013, COMP IMMUNOL MICROB, V36, P249, DOI 10.1016/j.cimid.2012.10.008; Uganda Bureau of statistics, 2016, NAT POP HOUS CENS 20; Uganda Bureau of Statistics, NAT LIV CENS REP 200; Uganda Bureau of Statistics, 2002 UG POP HOUS CEN; Uganda Ministry of Health, 2011, REP MTRACK NAT LAUCH; Ugolini G, 2011, ADV VIRUS RES, V79, P165, DOI 10.1016/B978-0-12-387040-7.00010-X; WHO, 2013, WHO TECH REP SER, V982, P1; *WHO, 1997, WHO REC RAB POST EXP; *WHO, 1999, WHOCDSCSRAPH996; WHO, GLOB EL DOG MED HUM; World Health Organization, 1996, 29 WHO WORLD SURV; World Health Organization, 1999, 34 WHO WORLD SURV; World Health Organization, 1999, 33 WHO WORLD SURV; World Health Organization, 1997, 31 WHO WORLD SURV; World Health Organization, 1998, 32 WHO WORLD SURV; World Health Organization, 2005, WHO EXP CONS RAB 1 R	46	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0198568	10.1371/journal.pone.0198568	http://dx.doi.org/10.1371/journal.pone.0198568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130364	Green Published, gold			2022-12-26	WOS:000442284500001
J	Middaugh, CR; Magoulick, DD				Middaugh, Christopher R.; Magoulick, Daniel D.			Forecasting effects of angler harvest and climate change on smallmouth bass abundance at the southern edge of their range	PLOS ONE			English	Article							HEAVY PRECIPITATION; THERMAL HABITAT; LARGEMOUTH BASS; CLASS STRENGTH; UNITED-STATES; STREAM-FLOW; LAND-USE; TEMPERATURE; FISH; RIVERS	Climate change will affect stream systems in numerous ways over the coming century. Globally, streams are expected to experience changes in temperature and flow regime. Previous work has indicated that these changes will likely affect fish distributions, but little work has been conducted examining population level effects of climate change on warmwater fish at the warmest portion of their range. We model several potential climate change-related stressors and the resulting effects on smallmouth bass Micropterus dolomieu populations in the Buffalo National River, Arkansas, USA, located near the southern extent of smallmouth bass range. Smallmouth bass are a popular recreational fish in the region and angler harvest likely contributes substantially to annual mortality. We created a simulation model parameterized with data collected from the Buffalo National River to evaluate the relative importance of climate stressors and angler harvest on smallmouth bass populations. Our simulations suggest that increases in springtime temperature and reductions in river discharge during the spawning period could increase recruitment, resulting in increases in adult abundance (8% higher). However, when increased flooding and drought probabilities are considered, our model indicates the Buffalo National River could experience large reductions in adult smallmouth bass abundance (>= 50% decline) and increased probability of extinction compared to present levels. Simulations showed that harvest reduction could be a viable strategy to reduce the negative effects of climate change, but that even with complete closure of harvest, smallmouth bass population levels would still be well below present abundance (46% lower than present). Efforts to reduce flooding and drought effects related to climate change in the Buffalo National River could help offset the predicted reduction in the smallmouth bass population.	[Middaugh, Christopher R.] Univ Arkansas, Dept Biol Sci, Arkansas Cooperat Fish & Wildlife Res Unit, Fayetteville, AR 72701 USA; [Magoulick, Daniel D.] Univ Arkansas, US Geol Survey, Arkansas Cooperat Fish & Wildlife Res Unit, Dept Biol Sci, Fayetteville, AR 72701 USA; [Middaugh, Christopher R.] Arkansas Game & Fish Commiss, Res Evaluat & Compliance Div, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of the Interior; United States Geological Survey; University of Arkansas System; University of Arkansas Fayetteville	Middaugh, CR (corresponding author), Univ Arkansas, Dept Biol Sci, Arkansas Cooperat Fish & Wildlife Res Unit, Fayetteville, AR 72701 USA.; Middaugh, CR (corresponding author), Arkansas Game & Fish Commiss, Res Evaluat & Compliance Div, Little Rock, AR 72205 USA.	christopher.middaugh@agfc.ar.gov	Magoulick, Daniel/AAG-1556-2020	Magoulick, Daniel/0000-0001-9665-5957	Arkansas Game and Fish Commission	Arkansas Game and Fish Commission	Funding for this work was provided by the Arkansas Game and Fish Commission. The funders also provided data for this project.	[Anonymous], HARVEST EVALUATION S; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Armour C.L., 1993, RESOURCE PUBLICATION, V191; Bartholomew A, 2005, REV FISH BIOL FISHER, V15, P129, DOI 10.1007/s11160-005-2175-1; Bonvechio TF, 2005, HYDROBIOLOGIA, V532, P193, DOI 10.1007/s10750-004-1388-y; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Buynak GL, 2002, N AM J FISH MANAGE, V22, P500, DOI 10.1577/1548-8675(2002)022<0500:ROSBTR>2.0.CO;2; CHRISTIE GC, 1988, CAN J FISH AQUAT SCI, V45, P301, DOI 10.1139/f88-036; Cooke SJ, 2002, AM FISH S S, V31, P489; Dixon P.M., 2001, DESIGN ANAL ECOLOGIC, P267; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Groisman PY, 2001, B AM METEOROL SOC, V82, P219, DOI 10.1175/1520-0477(2001)082&lt;0219:HPAHSI&gt;2.3.CO;2; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Hafs AW, 2010, N AM J FISH MANAGE, V30, P604, DOI 10.1577/M08-183.1; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; HARVEY BC, 1987, T AM FISH SOC, V116, P851, DOI 10.1577/1548-8659(1987)116<851:SOYFTD>2.0.CO;2; HARVEY BC, 1991, OECOLOGIA, V87, P336, DOI 10.1007/BF00634588; Hines HS, 1975, 12 USGS WAT RES ARK; Kanno Y, 2010, FISHERIES MANAG ECOL, V17, P272, DOI 10.1111/j.1365-2400.2009.00724.x; Kilambi R. V, 1977, Proceedings of the Arkansas Academy of Science, V31, P62; Kolander Todd D., 1993, North American Journal of Fisheries Management, V13, P398, DOI 10.1577/1548-8675(1993)013<0398:PROTSW>2.3.CO;2; Kundzewicz ZW, 2014, HYDROLOG SCI J, V59, P1, DOI 10.1080/02626667.2013.857411; Larimore RW, 2002, AM FISH S S, V31, P115; Leasure DR, 2016, RIVER RES APPL, V32, P18, DOI 10.1002/rra.2838; LUKAS JA, 1995, T AM FISH SOC, V124, P726, DOI 10.1577/1548-8659(1995)124<0726:FANSOS>2.3.CO;2; Maceina Michael J., 2007, P121; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; Middaugh CR, 2018, ECOL FRESHW FISH, V27, P19, DOI 10.1111/eff.12320; Middaugh CR, 2016, N AM J FISH MANAGE, V36, P958, DOI 10.1080/02755947.2016.1176970; Middaugh CR, 2018, MANAGING CENTRARCHID; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; National Park Service, 2016, VIS US STAT; Novotny EV, 2007, J HYDROL, V334, P319, DOI 10.1016/j.jhydrol.2006.10.011; Orth DJ, 2002, AM FISH S S, V31, P251; Peterson JT, 1999, ECOL APPL, V9, P1391, DOI 10.2307/2641404; Poff NL, 2002, TECHNICAL REPORT; Punt AE, 2014, ICES J MAR SCI, V71, P2208, DOI 10.1093/icesjms/fst057; Reed M.S., 1989, North American Journal of Fisheries Management, V9, P420, DOI 10.1577/1548-8675(1989)009<0420:COAUSB>2.3.CO;2; SHUTER BJ, 1980, T AM FISH SOC, V109, P1, DOI 10.1577/1548-8659(1980)109&lt;1:SSOTEO&gt;2.0.CO;2; SIMONSON TD, 1990, T AM FISH SOC, V119, P902, DOI 10.1577/1548-8659(1990)119<0902:CSVFYS>2.3.CO;2; Smith SM, 2005, N AM J FISH MANAGE, V25, P1112, DOI 10.1577/M04-047.1; Strzepek K, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044012; Swenson WA, 2002, AM FISH S S, V31, P101; Thodsen H, 2007, J HYDROL, V333, P226, DOI 10.1016/j.jhydrol.2006.08.012; Todd S., 2018, BUFFALO RIVER FLOATI; Walters C, 1996, CAN J FISH AQUAT SCI, V53, P148, DOI 10.1139/f95-151; Warren DR, 2009, T AM FISH SOC, V138, P200, DOI 10.1577/T08-046.1; Whisenant KA, 1989, 28 COOP NAT PARK RES; Whitledge GW, 2006, ECOL APPL, V16, P1461, DOI 10.1890/1051-0761(2006)016[1461:RSAGEG]2.0.CO;2; WINEMILLER KO, 1982, OHIO J SCI, V82, P266; Woodside KL, 2015, AM FISH S S, V82, P139; WRENN WB, 1984, T AM FISH SOC, V113, P295, DOI 10.1577/1548-8659(1984)113<295:SBRIET>2.0.CO;2; ZARET TM, 1971, ECOLOGY, V52, P336, DOI 10.2307/1934593; Zweifel Richard D., 1999, North American Journal of Fisheries Management, V19, P192, DOI 10.1577/1548-8675(1999)019<0192:BIIBBD>2.0.CO;2	58	0	0	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202737	10.1371/journal.pone.0202737	http://dx.doi.org/10.1371/journal.pone.0202737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125314	Green Published, gold, Green Submitted			2022-12-26	WOS:000442202100046
J	Quadri, SS; Culver, S; Ramkumar, N; Kohan, DE; Siragy, HM				Quadri, Syed S.; Culver, Silas; Ramkumar, Nrupama; Kohan, Donald E.; Siragy, Helmy M.			(Pro)Renin receptor mediates obesity-induced antinatriuresis and elevated blood pressure via upregulation of the renal epithelial sodium channel	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; PRORENIN RECEPTOR; NA+ CHANNEL; COLLECTING DUCT; HYPERTENSION; EXPRESSION; INFLAMMATION; RENIN; ALDOSTERONE; CONTRIBUTES	Recent studies have demonstrated that the renal (pro)renin receptor (PRR) regulates expression of the alpha subunit of the epithelial sodium channel (alpha-ENaC). In this study we hypothesized that the renal PRR mediates high fat diet (HFD)-induced sodium retention and elevated systolic blood pressure (SBP) by enhancing expression of the epithelial sodium channel (alpha-ENaC). In our study we used a recently developed inducible nephron specific PRR knockout mouse. Mice (n = 6 each group) were allocated to receive regular diet (RD, 12 kcal% fat) or a high-fat diet (HFD, 45 kcal% fat) for 10 weeks. Body weight (BW), SBP, urine volume (UV) and urine sodium (UNaV), as well as renal interstitial Angiotensin II (Ang II), and renal medullary expression of PRR, p-SGK-1, alpha-ENaC were monitored in RD and HFD mice with or without PRR knockout. At baseline, there were no significant differences in BW, BP, UV or UNaV between different animal groups. At the end of the study, HFD mice had significant increases in SBP, BW, and significant reductions in UV and UNaV. Compared to RD, HFD significantly increased mRNA and protein expression of PRR, alpha-ENaC, p-SGK-1, and Ang II. Compared to HFD alone, PRR knockout mice on HFD had reduced mRNA and protein expression of PRR, p-SGK-1, and alpha-ENaC, as well as increased UV, UNaV and significantly reduced SBP. RIF Ang II was significantly increased by HFD and did not change in response to PRR knockout. We conclude that obesity induced sodium retention and elevated SBP are mediated by the PRR-SGK-1- alpha-ENaC pathway independent of Ang II.	[Quadri, Syed S.] Lincoln Mem Univ, DeBusk Coll Osteopath Med, Harrogate, TN USA; [Culver, Silas; Siragy, Helmy M.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22903 USA; [Ramkumar, Nrupama; Kohan, Donald E.] Univ Utah, Hlth Sci Ctr, Div Nephrol & Hypertens, Salt Lake City, UT USA	University of Virginia; Utah System of Higher Education; University of Utah	Siragy, HM (corresponding author), Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22903 USA.	hms7a@virginia.edu	SIRAGY, HELMY/AAP-2651-2021	Siragy, Helmy/0000-0001-8121-9052	National Institutes of Health [DK114875, DK078757, HL091535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK113698, R01DK114875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK114875, DK078757 and HL091535 to HMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; da Silva AA, 2009, CURR HYPERTENS REP, V11, P206, DOI 10.1007/s11906-009-0036-3; Davies M, 2014, AM J PHYSIOL-RENAL, V307, pF96, DOI 10.1152/ajprenal.00524.2013; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Hamada K, 2013, CLIN EXP NEPHROL, V17, P848, DOI 10.1007/s10157-013-0803-y; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JQ, 2010, ENDOCRINOLOGY, V151, P3317, DOI 10.1210/en.2009-1368; Jones DW, 1996, AM J HYPERTENS, V9, pS50, DOI 10.1016/0895-7061(96)00183-5; JONES DW, 1994, J HYPERTENS, V12, P1433, DOI 10.1097/00004872-199412000-00018; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Li CX, 2015, AM J PHYSIOL-ENDOC M, V309, pE302, DOI 10.1152/ajpendo.00603.2014; Li CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089233; Li WC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/290635; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Matavelli LC, 2012, AM J PHYSIOL-RENAL, V303, pF1652, DOI 10.1152/ajprenal.00204.2012; Matavelli LC, 2010, CLIN EXP PHARMACOL P, V37, P277, DOI 10.1111/j.1440-1681.2009.05292.x; Muller DN, 2012, ANN MED, V44, pS43, DOI 10.3109/07853890.2012.660496; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pao AC, 2012, CURR OPIN NEPHROL HY, V21, P534, DOI 10.1097/MNH.0b013e32835571be; Persu A, 1998, HYPERTENSION, V32, P129, DOI 10.1161/01.HYP.32.1.129; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Prieto MC, 2017, AM J PHYSIOL-RENAL, V313, pF1243, DOI 10.1152/ajprenal.00152.2017; Prieto MC, 2013, OCHSNER J, V13, P26; Quadri S, 2016, J HYPERTENS, V34, P486, DOI 10.1097/HJH.0000000000000825; Quadri S, 2014, AM J PHYSIOL-RENAL, V307, pF593, DOI 10.1152/ajprenal.00245.2014; Ramkumar N, 2016, AM J PHYSIOL-RENAL, V311, pF186, DOI 10.1152/ajprenal.00088.2016; Ramkumar N, 2015, AM J PHYSIOL-RENAL, V309, pF48, DOI 10.1152/ajprenal.00126.2015; Saha C, 2005, HYPERTENSION, V46, P481, DOI 10.1161/01.HYP.0000179582.42830.1d; Satoh N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/971697; Shehata Marlene F, 2010, Int Arch Med, V3, P14, DOI 10.1186/1755-7682-3-14; Shehata Marlene F, 2009, Int Arch Med, V2, P28, DOI 10.1186/1755-7682-2-28; Song RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063835; SU HY, 1995, AM J HYPERTENS, V8, P1067, DOI 10.1016/0895-7061(95)00330-R; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA	40	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202419	10.1371/journal.pone.0202419	http://dx.doi.org/10.1371/journal.pone.0202419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118514	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700026
J	Minion, JT; Butcher, F; Timpson, N; Murtagh, MJ				Minion, Joel T.; Butcher, Frances; Timpson, Nicholas; Murtagh, Madeleine J.			The ethics conundrum in Recall by Genotype (RbG) research: Perspectives from birth cohort participants	PLOS ONE			English	Article							GENETIC RESEARCH	Purpose Recall by genotype (RbG) research recruits on the basis of genetic variation. Increased use of this approach presents an ethical conundrum for cohort studies/biobanks: whether to inform individuals of their genetic information and deviate from standard practice of non-disclosure of results, or mask this information at the level of the individual participant. This paper examines the perspectives of research study participants on RbG research. Methods Fifty-three semi-structured interviews were conducted with young adult participants of the Avon Longitudinal Study of Parents and Children (ALSPAC). Topics included understandings of RbG research, expectations around recruitment and communication of research findings. Results Participants uniformly expressed a deep trust and faith in ALSPAC and considered themselves part of the ALSPAC team. Such perspectives, alongside a limited knowledge of genetics and modest interest in reported research outcomes, meant few participants reported immediate concerns about being recruited by genotype. Conclusion Our findings highlight the responsibility and duty of care on RbG researchers, and longitudinal studies more generally, and the importance of solidarity, reciprocity and co-production in study-participant relations. As such, we consider existing recommendations for conducting RbG research in longitudinal studies in light of our results and speak to recent changes in the approach used by ALSPAC.	[Minion, Joel T.; Murtagh, Madeleine J.] Newcastle Univ, Policy Eth & Life Sci PEALS Res Ctr, Sch Geog Polit & Sociol, Newcastle Upon Tyne, Tyne & Wear, England; [Butcher, Frances] Oxford Sch Publ Hlth, Oxford, England; [Timpson, Nicholas] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England	Newcastle University - UK; University of Bristol	Murtagh, MJ (corresponding author), Newcastle Univ, Policy Eth & Life Sci PEALS Res Ctr, Sch Geog Polit & Sociol, Newcastle Upon Tyne, Tyne & Wear, England.	madeleine.murtagh@newcastle.ac.uk	Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015	Timpson, Nicholas John/0000-0002-7141-9189; Murtagh, Madeleine/0000-0003-1073-6161; Butcher, Frances/0000-0003-0348-3434; Minion, Joel/0000-0002-2105-3211	UK Medical Research Council [102215/2/13/2]; Wellcome Trust [102215/2/13/2]; UK Medical Research Council, MRC Integrative Epidemiology Unit at the University of Bristol [MC_UU_12013/3]; UK Medical Research Council; MRC [MC_UU_12013/3, MR/N01104X/2] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council, MRC Integrative Epidemiology Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (Grant ref: 102215/2/13/2) and Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This research was specifically supported by the UK Medical Research Council, MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_12013/3).; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The authors also acknowledge the valuable contributions made by Dr Sylvia Camporesi of King's College London in her role as supervisor of FB's Master's research based on 20 of the interviews conducted. The UK Medical Research Council and Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and MJM will serve as guarantor for the contents of this paper. This research was specifically supported by the UK Medical Research Council, MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_12013/3).	ALSPAC) ALSoPaC, 2018, REC GEN WHATS IT ALL; (ALSPAC) ALSoPaC, 2018, AV LONG STUD PAR CHI; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Beskow LM, 2012, HUM GENET, V131, P1423, DOI 10.1007/s00439-012-1177-z; Beskow LM, 2010, GENOME RES, V20, P705, DOI 10.1101/gr.104455.109; Bethea J, 2015, BMC PUBLIC HEALTH, V15, P9, DOI [10.1186/s12889-014-1338-1, DOI 10.1186/S12889-014-1338-1]; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Budin-Ljosne I, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-19; Cadigan RJ, 2011, J EMPIR RES HUM RES, V6, P30, DOI 10.1525/jer.2011.6.4.30; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Committee AEL, 2018, POL REG DISCL BIOM I; Corbin LJ, 2017, BIORXIV124586; Denzin N., 1994, HDB QUALITATIVE RES; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Geertz Clifford, 1973, THICK DESCRIPTION IN, P3; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Grant RW, 2011, CLIN TRIALS, V8, P609, DOI 10.1177/1740774511414159; Green J, 2013, QUALITATIVE METHODS; Jacob K, 2013, OPTIONS STRENGTHENIN; Jasanoff S., 2006, STATES KNOWLEDGE COP, DOI 10.4324/9780203413845; Kaye J, 2014, EUR J HUM GENET, V22, P1100, DOI 10.1038/ejhg.2013.290; Knoppers BM, 2014, HUM GENET, V133, P895, DOI 10.1007/s00439-014-1432-6; Marteau TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035249; McGuire AL, 2010, TRENDS GENET, V26, P199, DOI 10.1016/j.tig.2009.12.007; McGuire SE, 2008, GENOME RES, V18, P1683, DOI 10.1101/gr.083584.108; Michie M, 2012, GENET MED, V14, P983, DOI 10.1038/gim.2012.88; Mol A, 1999, ACTOR NETWORK THEORY AND AFTER, P74, DOI 10.1111/j.1467-954X.1999.tb03483.x; Mol Annemarie, 2002, BODY MULTIPLE ONTOLO, DOI DOI 10.1215/9780822384151; Morse JM, 1999, QUAL HEALTH RES, V9, P5, DOI 10.1177/104973299129121622; Olson JE, 2014, CLIN GENET, V86, P50, DOI 10.1111/cge.12370; Owen R, 2012, SCI PUBL POLICY, V39, P751, DOI 10.1093/scipol/scs093; Patton M. Q., 1990, QUALITATIVE EVALUATI; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Potter J., 1996, REPRESENTING REALITY; Prainsack B., 2016, SOLIDARITY BIOMEDICI; Ravitsky V, 2006, AM J BIOETHICS, V6, P8, DOI 10.1080/15265160600934772; Robinson JO, 2013, J EMPIR RES HUM RES, V8, P42, DOI 10.1525/jer.2013.8.4.42; Schwandt TA, 1994, PRODUCTION REALITY E, P40; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Tabor HK, 2011, J EMPIR RES HUM RES, V6, P41, DOI 10.1525/jer.2011.6.4.41; Wade KH, 2017, BIORXIV112912	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202502	10.1371/journal.pone.0202502	http://dx.doi.org/10.1371/journal.pone.0202502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114272	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000441850400079
J	Soji, K; Doi, S; Nakashima, A; Sasaki, K; Doi, T; Masaki, T				Soji, Kotaro; Doi, Shigehiro; Nakashima, Ayumu; Sasaki, Kensuke; Doi, Toshiki; Masaki, Takao			Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction	PLOS ONE			English	Article							TGF-BETA; MOLECULAR-MECHANISMS; UBIQUITIN; KIDNEY; PHOSPHORYLATION; INFLAMMATION; PROGRESSION; PREVALENCE; STABILIZES; APOPTOSIS	Deubiquitinating enzymes (DUBs) remove ubiquitin from their substrates and, together with ubiquitin ligases, play an important role in the regulation of protein expression. Although transforming growth factor (TGF)-beta 1-Smad signaling is a central pathway of renal fibrosis, the role of DUBs in the expression of TGF-beta receptors and Smads during the development of renal fibrosis remains unknown. In this study, we investigated whether PR-619, a pan-DUB inhibitor, suppresses fibrosis in mice with unilateral ureteral obstruction (UUO) and TGF-beta 1-stimulated normal rat kidney (NRK)-49F cells, a rat renal fibroblast cell line. Either the vehicle (dimethyl sulfoxide) or PR-619 (100 mu g) was intraperitoneally administered to mice after UUO induction once a day for 7 days. Administration of PR-619 attenuated renal fibrosis with downregulation of mesenchymal markers, extracellular matrix proteins, matrix metalloproteinases, apoptosis, macrophage infiltration, and the TGF-beta 1 mRNA level in UUO mice. Although type I TGF-beta receptor (TGF-beta RI), Smad2, Smad3, and Smad4 protein expression levels were markedly increased in mice with UUO, administration of PR-619 suppressed only Smad4 expression but not TGF-beta RI, Smad2, or Smad3 expression. PR-619 also had an inhibitory effect on TGF-beta 1-induced alpha-smooth muscle actin expression and reduced Smad4 levels in NRK-49F cells. Our results indicate that PR-619 ameliorates renal fibrosis, which is accompanied by the reduction of Smad4 expression.	[Soji, Kotaro; Doi, Shigehiro; Nakashima, Ayumu; Sasaki, Kensuke; Doi, Toshiki; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan	Hiroshima University	Doi, S (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	sdoi@hiroshima-u.ac.jp	Doi, Shigehiro/AAQ-2655-2020; Nakashima, Ayumu/N-9158-2017; Nakashima, Ayumu/CAF-0274-2022	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; Doi, Shigehiro/0000-0001-9420-4124; SASAKI, KENSUKE/0000-0001-5899-0885; DOI, TOSHIKI/0000-0001-8870-5790	JSPS KAKENHI [JP16K09618]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP16K09618 (https://www.jsps.go.jp/j-grantsinaid/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cho HS, 2017, SCI REP-UK, V7, DOI 10.1038/srep46065; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Doi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093513; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Han KJ, 2012, J BIOL CHEM, V287, P43741, DOI 10.1074/jbc.M112.372318; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kawaoka K, 2017, CLIN EXP NEPHROL, V21, P771, DOI 10.1007/s10157-016-1365-6; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; McDonell LM, 2013, NAT GENET, V45, P556, DOI 10.1038/ng.2602; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Pani A, 2014, J AM SOC NEPHROL, V25, P1533, DOI 10.1681/ASN.2013060591; Sasaki K, 2016, J AM SOC NEPHROL, V27, P203, DOI 10.1681/ASN.2014090850; Schinner E, 2017, FEBS OPEN BIO, V7, P550, DOI 10.1002/2211-5463.12202; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; Shen G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-393; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Tveitaras MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143390; Wang S, 2016, ONCOTARGET, V7, P8809, DOI 10.18632/oncotarget.6604; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522	46	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202409	10.1371/journal.pone.0202409	http://dx.doi.org/10.1371/journal.pone.0202409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114247	Green Submitted, gold, Green Published			2022-12-26	WOS:000441850400068
J	Tomitaka, S; Kawasaki, Y; Ide, K; Akutagawa, M; Ono, Y; Furukawa, TA				Tomitaka, Shinichiro; Kawasaki, Yohei; Ide, Kazuki; Akutagawa, Maiko; Ono, Yutaka; Furukawa, Toshiaki A.			Distribution of item responses and total item scores for the Center for Epidemiologic Studies Depression Scale (CES-D): Data from the Irish Longitudinal Study on Ageing (TILDA)	PLOS ONE			English	Article							PREVALENCE; HEALTH; SAMPLE	Background Previous studies have shown that item responses and total scores on depression screening scales follow characteristic distribution patterns in the United States and Japanese general populations. However, the degree to which these findings, especially in terms of item responses, can be generalized to a European population is unknown. Thus, we analyzed the item responses and total score distribution for the Center for Epidemiologic Studies Depression Scale (CES-D) in a representative Irish cohort from a large, recent study-the Irish Longitudinal Study on Ageing (TILDA). Methods We used CES-D data from the 2009 +/- 2011 TILDA (8504 individuals). Responses for the 16 depressive symptoms included "rarely," "some of the time," "occasionally," and "all of the time." Item response patterns and total score distribution across these 16 depressive symptom items were examined using graphical analyses and exponential regression modeling. Results Lines for item responses followed the same pattern across the 16 items. These lines were characterized by intersections in the vicinity of a single point between "rarely" and "some of the time" and parallel patterns from "some of the time" to "all of the time" on a log-normal scale. Total scores for the 16 items exhibited an exponential pattern, except for at the lower end of the distribution. Conclusions The present findings suggest that item responses and total scores on depression screening scales among the general population follow the same characteristic patterns across populations from multiple nations.	[Tomitaka, Shinichiro] Panasonic Hlth Ctr, Dept Mental Hlth, Tokyo, Japan; [Tomitaka, Shinichiro; Furukawa, Toshiaki A.] Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth, Kyoto, Japan; [Kawasaki, Yohei] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Ide, Kazuki] Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto, Japan; [Ide, Kazuki] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan; [Ide, Kazuki; Akutagawa, Maiko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan; [Ono, Yutaka] Ctr Dev Cognit Behav Therapy Training, Tokyo, Japan	Panasonic; Kyoto University; Chiba University; Kyoto University; Kyoto University; University of Shizuoka	Tomitaka, S (corresponding author), Panasonic Hlth Ctr, Dept Mental Hlth, Tokyo, Japan.; Tomitaka, S (corresponding author), Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth, Kyoto, Japan.	tomitaka.shinichiro@jp.panasonic.com	Ide, Kazuki/H-3154-2018; Furukawa, Toshi A./B-9259-2011	Ide, Kazuki/0000-0001-6377-1361; Furukawa, Toshi A./0000-0003-2159-3776; Kawasaki, Yohei/0000-0002-7474-7647; Tomitaka, Shinichiro/0000-0002-7161-6967	Japan Society for the Promotion of Science (JSPS) KAKENHI [18K03145]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research grant from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 18K03145; ST received the research grant; https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Brugha T, 2009, ADULT PSYCHIAT MORBI; Cho MJ, 1998, PSYCHIAT RES, V81, P341, DOI 10.1016/S0165-1781(98)00122-X; Dhingra SS, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-11; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; Gelman A, 2004, J COMPUT GRAPH STAT, V13, P755, DOI 10.1198/106186004X11435; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; Irwin RJ, 2017, NZ EC PAP, V51, P49, DOI [10.1080/00779954.2015.1130739, DOI 10.1080/00779954.2015.1130739]; Jebb AT, 2017, HUM RESOUR MANAGE R, V27, P265, DOI 10.1016/j.hrmr.2016.08.003; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Kenny R. A, 2014, IRISH LONGITUDINAL S, DOI [10.3886/ICPSR34315.v1, DOI 10.3886/ICPSR34315.V1]; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Melzer D, 2002, PSYCHOL MED, V32, P1195, DOI 10.1017/S0033291702006049; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Munro B. H., 2005, STAT METHODS HLTH CA, DOI DOI 10.1093/annonc/mdx645; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Tomitaka S, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1696-9; Tomitaka Shinichiro, 2017, BMC Res Notes, V10, P614, DOI 10.1186/s13104-017-2937-6; Tomitaka S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00251; Tomitaka S, 2017, PEERJ, V5, DOI 10.7717/peerj.2987; Tomitaka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165928; Tomitaka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147577; Tomitaka S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008599; Tomitaka S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114624; vander Vaart AW, 1996, WEAK CONVERGENCE EMP, P16, DOI DOI 10.1007/978-1-4757-2545-2_3	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202607	10.1371/journal.pone.0202607	http://dx.doi.org/10.1371/journal.pone.0202607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114259	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400089
J	Yildirim, Y; Anderson, MJ; Hansson, B; Patel, S; Millar, CD; Rainey, PB				Yildirim, Yeserin; Anderson, Marti J.; Hansson, Bengt; Patel, Selina; Millar, Craig D.; Rainey, Paul B.			Genetic structure of the grey side-gilled sea slug (Pleurobranchaea maculata) in coastal waters of New Zealand	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; DEMOGRAPHIC HISTORY; STYLOCHOPLANA SP.; SOFTWARE PACKAGE; COMPUTER-PROGRAM; F-STATISTICS; TETRODOTOXIN; PHYLOGEOGRAPHY; DIVERSITY	Pleurobranchaea maculata is a rarely studied species of the Heterobranchia found throughout the south and western Pacific-and recently recorded in Argentina-whose population genetic structure is unknown. Interest in the species was sparked in New Zealand following a series of dog deaths caused by ingestions of slugs containing high levels of the neurotoxin tetrodotoxin. Here we describe the genetic structure and demographic history of P. maculata populations from five principle locations in New Zealand based on extensive analyses of 12 microsatellite loci and the COI and CytB regions of mitochondrial DNA (mtDNA). Microsatellite data showed significant differentiation between northern and southern populations with population structure being associated with previously described regional variations in tetrodotoxin concentrations. However, mtDNA sequence data did not support such structure, revealing a star-shaped haplotype network with estimates of expansion time suggesting a population expansion in the Pleistocene era. Inclusion of publicly available mtDNA sequence sea slugs from Argentina did not alter the star-shaped network. We interpret our data as indicative of a single founding population that fragmented following geographical changes that brought about the present day north-south divide in New Zealand waters. Lack of evidence of cryptic species supports data indicating that differences in toxicity of individuals among regions are a consequence of differences in diet.	[Yildirim, Yeserin; Anderson, Marti J.; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Anderson, Marti J.] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Hansson, Bengt] Lund Univ, Dept Biol, Lund, Sweden; [Patel, Selina; Millar, Craig D.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Dept Microbial Populat Biol, Plon, Germany; [Rainey, Paul B.] PSL Res Univ, Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, CNRS UMR 8231, Paris, France; [Yildirim, Yeserin] Linnaeus Univ, Ctr Ecol & Evolut Microbial Syst EEMiS, Dept Biol & Environm Sci, Kalmar, Sweden	Massey University; Massey University; Lund University; University of Auckland; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Linnaeus University	Yildirim, Y (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.; Yildirim, Y (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Syst EEMiS, Dept Biol & Environm Sci, Kalmar, Sweden.	yeserin.yildirim@lnu.se	Anderson, Marti J./AAQ-9038-2021; Hansson, Bengt/L-8874-2013	Anderson, Marti J./0000-0002-4018-4049; Hansson, Bengt/0000-0001-6694-8169; Yildirim, Yeserin/0000-0002-0431-8417	Auckland Regional Council; Allan Wilson Centre; Massey University	Auckland Regional Council; Allan Wilson Centre; Massey University	The project was funded by Auckland Regional Council, Allan Wilson Centre and Massey University. YY's PhD scholarship was funded by Allan Wilson Centre.	Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bokenhans V, 2018, NZ J ZOOL, P1; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chau R, 2013, MAR DRUGS, V11, P2695, DOI 10.3390/md11082695; Clarke K.R., 2006, PRIMER V6 USER MANUA; Crandall ED, 2012, MOL BIOL EVOL, V29, P707, DOI 10.1093/molbev/msr227; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Donald KM, 2005, EVOLUTION, V59, P1701, DOI 10.1554/04-553.1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farias NE, 2016, NEW ZEAL J ZOOL, V43, P292, DOI 10.1080/03014223.2016.1159582; Farias NE, 2015, NEW ZEAL J ZOOL, V42, P51, DOI 10.1080/03014223.2014.990045; Fleming AM, 2018, NEW ZEAL J MAR FRESH, V52, P100, DOI 10.1080/00288330.2017.1340899; Fu YX, 1997, GENETICS, V147, P915; Gardner JPA., 2010, NZ AQUAT ENV BIODIVE, P1; Gibson GD, 2003, BIOL BULL-US, V205, P121, DOI 10.2307/1543233; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; HARPENDING HC, 1994, HUM BIOL, V66, P591; HEATH RA, 1982, NEW ZEAL J MAR FRESH, V16, P215, DOI 10.1080/00288330.1982.9515964; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hickey AJR, 2009, MOL ECOL, V18, P680, DOI 10.1111/j.1365-294X.2008.04052.x; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keeney DB, 2013, MAR BIOL, V160, P1477, DOI 10.1007/s00227-013-2201-0; Khor S, 2014, MAR DRUGS, V12, P1, DOI 10.3390/md12010001; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEWIS KB, 1994, MAR GEOL, V116, P293, DOI 10.1016/0025-3227(94)90047-7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Magarlamov TY, 2017, TOXINS, V9, DOI 10.3390/toxins9050166; Marx A, 2016, GENOM PROTEOM BIOINF, V14, P55, DOI 10.1016/j.gpb.2015.11.004; MATSUMURA K, 1995, APPL ENVIRON MICROB, V61, P3468, DOI 10.1128/AEM.61.9.3468-3470.1995; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McNabb P, 2010, TOXICON, V56, P466, DOI 10.1016/j.toxicon.2010.04.017; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Muangmai N, 2015, J PHYCOL, V51, P574, DOI 10.1111/jpy.12305; Munoz MM, 2013, MOL ECOL, V22, P2668, DOI 10.1111/mec.12295; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Noguchi T, 2008, MAR DRUGS, V6, P220, DOI 10.3390/md20080011; Norris RD, 2012, EVOL ECOL, V26, P393, DOI 10.1007/s10682-011-9488-4; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2018, SYST BIOL, V10; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ridenhour BJ, 2007, J BIOGEOGR, V34, P724, DOI 10.1111/j.1365-2699.2006.01642.x; Riginos C, 2014, AM NAT, V184, P52, DOI 10.1086/676505; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross PM, 2009, NEW ZEAL J MAR FRESH, V43, P1009, DOI 10.1080/00288330.2009.9626525; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Salvitti L, 2017, AQUAT SCI, V79, P335, DOI 10.1007/s00027-016-0500-5; Salvitti L, 2015, TOXICON, V95, P23, DOI 10.1016/j.toxicon.2014.12.006; Salvitti LR, 2015, TOXINS, V7, P255, DOI 10.3390/toxins7020255; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider S, 1999, GENETICS, V152, P1079; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; SLATKIN M, 1991, GENETICS, V129, P555; Stevens MI, 2004, BIOL J LINN SOC, V81, P119, DOI 10.1111/j.1095-8312.2004.00270.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Taylor DI, 2015, MAR ECOL PROG SER, V537, P39, DOI 10.3354/meps11466; Trewick SA, 2012, J ROY SOC NEW ZEAL, V42, P153, DOI 10.1080/03036758.2010.549493; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waters JM, 2005, MOL ECOL, V14, P2789, DOI 10.1111/j.1365-294X.2005.02635.x; Weaver PPE, 1998, PALEOCEANOGRAPHY, V13, P70, DOI 10.1029/97PA02982; Wei KJ, 2013, MAR BIOL, V160, P931, DOI 10.1007/s00227-012-2145-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILLAN RC, 1983, MALACOLOGIA, V23, P221; Wood SA, 2012, J CHEM ECOL, V38, P1342, DOI 10.1007/s10886-012-0212-9; Wood SA, 2012, MAR DRUGS, V10, P163, DOI 10.3390/md10010163; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1946, GENETICS, V31, P39; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yildirim Y, 2014, BIOCHEM SYST ECOL, V55, P342, DOI 10.1016/j.bse.2014.04.001; Yotsu-Yamashita M, 2012, TOXICON, V59, P257, DOI 10.1016/j.toxicon.2011.12.004; Zink RM, 2013, AUK, V130, P449, DOI 10.1525/auk.2013.12241	106	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202197	10.1371/journal.pone.0202197	http://dx.doi.org/10.1371/journal.pone.0202197			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114275	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400049
J	Hinman, A; Holst, CR; Latham, JC; Bruegger, JJ; Ulas, G; McCusker, KP; Amagata, A; Davis, D; Hoff, KG; Kahn-Kirby, AH; Kim, V; Kosaka, Y; Lee, E; Malone, SA; Mei, JJ; Richards, SJ; Rivera, V; Miller, G; Trimmer, JK; Shrader, WD				Hinman, Andrew; Holst, Charles R.; Latham, Joey C.; Bruegger, Joel J.; Ulas, Gozde; McCusker, Kevin P.; Amagata, Akiko; Davis, Dana; Hoff, Kevin G.; Kahn-Kirby, Amanda H.; Kim, Virna; Kosaka, Yuko; Lee, Edgar; Malone, Stephanie A.; Mei, Janet J.; Richards, Steve James; Rivera, Veronica; Miller, Guy; Trimmer, Jeffrey K.; Shrader, William D.			Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GLUTATHIONE-PEROXIDASE 4; CELL-DEATH; ALPHA-TOCOPHEROL; LIPID-PEROXIDATION; MITOCHONDRIAL DISEASE; LIQUID-CHROMATOGRAPHY; REDUCTION; QUINONE; LIPOXYGENASES	Ferroptosis is a form of programmed cell death associated with inflammation, neurodegeneration, and ischemia. Vitamin E (alpha-tocopherol) has been reported to prevent ferroptosis, but the mechanism by which this occurs is controversial. To elucidate the biochemical mechanism of vitamin E activity, we systematically investigated the effects of its major vitamers and metabolites on lipid oxidation and ferroptosis in a striatal cell model. We found that a specific endogenous metabolite of vitamin E, alpha-tocopherol hydroquinone, was a dramatically more potent inhibitor of ferroptosis than its parent compound, and inhibits 15-lipoxygenase via reduction of the enzyme's non-heme iron from its active Fe3+ state to an inactive Fe2+ state. Furthermore, a non-metabolizable isosteric analog of vitamin E which retains antioxidant activity neither inhibited 15-lipoxygenase nor prevented ferroptosis. These results call into question the prevailing model that vitamin E acts predominantly as a non-specific lipophilic antioxidant. We propose that, similar to the other lipophilic vitamins A, D and K, vitamin E is instead a pro-vitamin, with its quinone/hydroquinone metabolites responsible for its anti-ferroptotic cytoprotective activity.	[Hinman, Andrew; Holst, Charles R.; Latham, Joey C.; Bruegger, Joel J.; Ulas, Gozde; McCusker, Kevin P.; Amagata, Akiko; Davis, Dana; Hoff, Kevin G.; Kahn-Kirby, Amanda H.; Kim, Virna; Kosaka, Yuko; Lee, Edgar; Malone, Stephanie A.; Mei, Janet J.; Richards, Steve James; Rivera, Veronica; Miller, Guy; Trimmer, Jeffrey K.; Shrader, William D.] BioElectron Technol Corp Inc, Mountain View, CA 94043 USA		Shrader, WD (corresponding author), BioElectron Technol Corp Inc, Mountain View, CA 94043 USA.	bshrader@bioelectron.com		Holst, Charles/0000-0001-8010-1677	BioElectron Technology Corporation, Inc.	BioElectron Technology Corporation, Inc.	This work was funded by BioElectron Technology Corporation, Inc. The funding entities had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005; Angeli JPF, 2014, FREE RADICAL BIO MED, V76, pS77, DOI 10.1016/j.freeradbiomed.2014.10.276; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Carlson BA, 2016, REDOX BIOL, V9, P22, DOI 10.1016/j.redox.2016.05.003; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; CSALLANY AS, 1962, ARCH BIOCHEM BIOPHYS, V98, P142, DOI 10.1016/0003-9861(62)90159-5; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Drefs M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8325754; Emmerson OH, 1939, J BIOL CHEM, V131, P409; Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009; Evans HM, 1939, J ORG CHEM, V4, P376, DOI 10.1021/jo01216a003; Galli F, 2007, VITAM HORM, V76, P263, DOI 10.1016/S0083-6729(07)76009-0; HAYASHI T, 1992, BIOCHEM PHARMACOL, V44, P489; Hinman AW, 2018, WIPO-World Intellectual Property Organization, Patent No. [WO 2018/081644 Al, 2018081644]; HUGHES PE, 1980, J BIOL CHEM, V255, P7095; JAIN SK, 1995, FREE RADICAL BIO MED, V18, P337, DOI 10.1016/0891-5849(94)00114-Y; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/nchembio.2238, 10.1038/NCHEMBIO.2238]; Kaneko K, 2000, J LIPID RES, V41, P357; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Kiyose C, 1999, LIPIDS, V34, P415, DOI 10.1007/s11745-999-0380-x; Lebold KM, 2014, FREE RADICAL BIO MED, V66, P13, DOI 10.1016/j.freeradbiomed.2013.07.039; Lynch DR, 2012, MOVEMENT DISORD, V27, P1026, DOI 10.1002/mds.25058; Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Mottier P, 2002, ANAL BIOCHEM, V301, P128, DOI 10.1006/abio.2001.5486; NELSON MJ, 1991, J BIOL CHEM, V266, P8225; PLACK PA, 1964, BIOCHIM BIOPHYS ACTA, V84, P729, DOI 10.1016/0926-6542(64)90031-9; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Schmolz Lisa, 2016, World J Biol Chem, V7, P14, DOI 10.4331/wjbc.v7.i1.14; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shah R, 2018, ACS CENTRAL SCI, V4, P387, DOI 10.1021/acscentsci.7b00589; Shah R, 2017, ACS CHEM BIOL, V12, P2538, DOI 10.1021/acschembio.7b00730; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Shrader WD, 2012, BIOORG MED CHEM LETT, V22, P391, DOI 10.1016/j.bmcl.2011.10.117; Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Terentis AC, 2002, CIRC RES, V90, P333, DOI 10.1161/hh0302.104454; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Upston JM, 2001, FREE RADICAL BIO MED, V31, P1245, DOI 10.1016/S0891-5849(01)00721-3; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wu JH, 2007, MOL ASPECTS MED, V28, P437, DOI 10.1016/j.mam.2006.12.007; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	48	77	84	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201369	10.1371/journal.pone.0201369	http://dx.doi.org/10.1371/journal.pone.0201369			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110365	Green Published, Green Submitted, gold			2022-12-26	WOS:000441738000025
J	Maksimov, V; Oya, E; Tanaka, M; Kawaguchi, T; Hachisuka, A; Ekwall, K; Bjerling, P; Nakayama, J				Maksimov, Vladimir; Oya, Eriko; Tanaka, Mayo; Kawaguchi, Takayuki; Hachisuka, Aki; Ekwall, Karl; Bjerling, Pernilla; Nakayama, Jun-ichi			The binding of Chp2's chromodomain to methylated H3K9 is essential for Chp2's role in heterochromatin assembly in fission yeast	PLOS ONE			English	Article							HISTONE DEACETYLASE; HP1; MAINTENANCE; NUCLEATION; GENE; RNAI; ACETYLATION; SPECIFICITY; INHERITANCE; COMPLEX	The binding of heterochromatin protein 1 (HP1) to lysine 9-methylated histone H3 (H3K9me) is an essential step in heterochromatin assembly. Chp2, an HP1-family protein in the fission yeast Schizosaccharomyces pombe, is required for heterochromatic silencing. Chp2 recruits SHREC, a multifunctional protein complex containing the nucleosome remodeler Mit1 and the histone deacetylase Clr3. Although the targeting of SHREC to chromatin is thought to occur via two distinct modules regulated by the SHREC components Chp2 and Clr2, it is not clear how Chp2's chromatin binding regulates SHREC function. Here, we show that H3K9me binding by Chp2's chromodomain (CD) is essential for Chp2's silencing function and for SHREC's targeting to chromatin. Cells expressing a Chp2 mutant with defective H3K9me binding (Chp2-W199A) have a silencing defect, with a phenotype similar to that of chp2-null cells. Genetic analysis using a synthetic silencing system revealed that a Chp2 mutant and SHREC-component mutants had similar phenotypes, suggesting that Chp2's function also affects SHREC's chromatin binding. Size-exclusion chromatography of native protein complexes showed that Chp2-CD's binding of H3K9me3 ensures Clr3's chromatin binding, and suggested that SHREC's chromatin binding is mediated by separable functional modules. Interestingly, we found that the stability of the Chp2 protein depended on the Clr3 protein's histone deacetylase activity. Our findings demonstrate that Chp2's H3K9me binding is critical for SHREC function and that the two modules within the SHREC complex are interdependent.	[Maksimov, Vladimir; Bjerling, Pernilla] Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, Sci Life Lab, Uppsala, Sweden; [Maksimov, Vladimir; Oya, Eriko; Ekwall, Karl] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Tanaka, Mayo; Kawaguchi, Takayuki; Hachisuka, Aki; Nakayama, Jun-ichi] Natl Inst Basic Biol, Div Chromatin Regulat, Okazaki, Aichi, Japan; [Hachisuka, Aki] Univ Fukui, Dept Mat Sci & Biotechnol, Fukui, Japan; [Kawaguchi, Takayuki] Inst Jacques Monod, Epigenet Regulat Genome Org, Paris, France	Uppsala University; Karolinska Institutet; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Fukui; UDICE-French Research Universities; Universite Paris Cite	Bjerling, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, Sci Life Lab, Uppsala, Sweden.; Nakayama, J (corresponding author), Natl Inst Basic Biol, Div Chromatin Regulat, Okazaki, Aichi, Japan.	Pernilla.Bjerling@imbim.uu.se; jnakayama@nibb.ac.jp	Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239; Kawaguchi, Takayuki/0000-0001-6688-3879; Ekwall, Karl/0000-0002-3029-4041	Swedish Cancer Society [2008/939]; Swedish Research Council [521-2011-2437]; Ministry of Education, Culture, Sports, Science and Technology Japan [JP16H01315, JP17H03713]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Swedish Cancer Society (grant number 2008/939), the Swedish Research Council (grant number 521-2011-2437), and Ministry of Education, Culture, Sports, Science and Technology Japan (grant number JP16H01315 and JP17H03713).	Al-Sady B, 2013, MOL CELL, V51, P80, DOI 10.1016/j.molcel.2013.06.013; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barres R, 2016, NAT REV ENDOCRINOL, V12, P441, DOI 10.1038/nrendo.2016.87; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Buscaino A, 2013, EMBO J, V32, P1250, DOI 10.1038/emboj.2013.72; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Job G, 2016, MOL CELL, V62, P207, DOI 10.1016/j.molcel.2016.03.016; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Nishibuchi G, 2014, NUCLEIC ACIDS RES, V42, P12498, DOI 10.1093/nar/gku995; Nishibuchi G, 2014, J BIOCHEM, V156, P11, DOI 10.1093/jb/mvu032; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Robyr D, 2003, METHODS, V31, P83, DOI 10.1016/S1046-2023(03)00091-4; Rodriguez A, 2013, BIOCHEM SOC T, V41, P1634, DOI 10.1042/BST20130213; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; SMIRNOV MN, 1967, BIOCHEM BIOPH RES CO, V27, P299, DOI 10.1016/S0006-291X(67)80096-2; Soshnev AA, 2016, MOL CELL, V62, P681, DOI 10.1016/j.molcel.2016.05.004; Steinhauf D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086948; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Thon G, 1997, GENETICS, V145, P685; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201101	10.1371/journal.pone.0201101	http://dx.doi.org/10.1371/journal.pone.0201101			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110338	Green Published, Green Submitted, gold			2022-12-26	WOS:000441738000013
J	Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Tomatis, S; Scorsetti, M				Cozzi, Luca; Comito, Tiziana; Fogliata, Antonella; Franzese, Ciro; Tomatis, Stefano; Scorsetti, Marta			Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma	PLOS ONE			English	Article							BEAM THERAPY; ARC THERAPY; RADIOTHERAPY; OPTIMIZATION; MITIGATION; SYSTEM; CANCER; MODEL	Purpose To investigate the role of intensity modulated proton therapy (IMPT) for advanced hepatocellular carcinoma in comparison with volumetric modulated arc therapy (VMAT). Methods An in-silico planning study was performed on 20 patients. The prescription dose was 60Gy in 6 fractions. Patients were planned with abdominal compression. IMPT plans were optimized with or without the inclusion of CT calibration (3%) and isocenter positioning (2,4,6mm) uncertainties. Plan robustness was appraised comparing rubust optimized plans vs standard plans and also in terms of the worst-case scenario. VMAT plans were optimized for 10FFF photon beams using 2 partial arcs. Results Target coverage was fully achieved by both VMAT and IMPT plans with a significant improvement in homogeneity (similar to 25%) with IMPT. Integral dose was reduced of similar to 60% with IMPT while the conformality of the dose distributions was similar among techniques. The sparing of the organs at risk was strongly improved with IMPT although all clinical objectives were met for both techniques. The inclusion of the uncertainties in the optimization lead to some deterioration in the target dose homogeneity (from 40 to 80% worse with 4 or 6mm position uncertainty) while none of the coverage parameters or OAR objective was violated. The worst-case scenario analysis demonstrated the risk of a major target underdosage only in the case of the most extreme errors (6mm) with D(98% )in average similar to 12% lower than the threshold. Conclusion IMPT with the support of abdominal compression, can be considered a viable solution also for advanced hepatocellular carcinoma patients. Great care shall be put in the minimization of the residual respiration and positioning uncertainties but the dosimetric advantage for organs at risk and the relative robustness on target coverage are promising factors.	[Cozzi, Luca; Comito, Tiziana; Fogliata, Antonella; Franzese, Ciro; Tomatis, Stefano; Scorsetti, Marta] Humanitas Res Hosp & Canc Ctr, Radiotherapy & Radiosurg, Milan, Italy; [Cozzi, Luca; Scorsetti, Marta] Humanitas Univ, Dept Biomed Sci, Milan, Italy	Humanitas University	Cozzi, L (corresponding author), Humanitas Res Hosp & Canc Ctr, Radiotherapy & Radiosurg, Milan, Italy.; Cozzi, L (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.	luca.cozzi@humanitas.it	cozzi, luca/GZL-4895-2022; Tomatis, Stefano/AAA-6002-2021; Franzese, Ciro/AAJ-7311-2020; franzese, ciro/P-5195-2019	cozzi, luca/0000-0001-7862-898X; Franzese, Ciro/0000-0001-6893-6284; comito, tiziana/0000-0002-5667-0535; Fogliata, Antonella/0000-0002-2282-9894; Scorsetti, Marta/0000-0003-0320-559X; Tomatis, Stefano/0000-0002-4791-0373				Arjomandy B, 2010, MED PHYS, V37, P5831, DOI 10.1118/1.3505011; Bernatowicz K, 2013, PHYS MED BIOL, V58, P7905, DOI 10.1088/0031-9155/58/22/7905; Bernatowicz K, 2017, PHYS MED BIOL, V62, P6595, DOI 10.1088/1361-6560/aa7ab8; Choi BO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-351; Culleton S, 2014, RADIOTHER ONCOL, V111, P412, DOI 10.1016/j.radonc.2014.05.002; Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fogliata A, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0236-0; Gillin MT, 2010, MED PHYS, V37, P154, DOI 10.1118/1.3259742; Granovetter M, 2016, LANCET ONCOL, V17, pE49, DOI 10.1016/S1470-2045(15)00616-6; Hong TS, 2016, J CLIN ONCOL, V34, P460, DOI 10.1200/JCO.2015.64.2710; Igaki H, 2017, INT J CLIN ONCOL, DOI [10.1007/s10147-017-1190-2cancer, DOI 10.1007/S10147-017-1190-2CANCER]; Jacob R, 2014, ADJUVANT STEREOTACTI; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lin LY, 2017, MED PHYS, V44, P703, DOI 10.1002/mp.12040; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Poulsen PR, 2018, INT J RADIAT ONCOL, V100, P226, DOI 10.1016/j.ijrobp.2017.09.043; Rah JE, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0717-4; Scorsetti M, 2015, J CANCER RES CLIN, V141, P1301, DOI 10.1007/s00432-015-1929-y; Vassiliev ON, 2010, PHYS MED BIOL, V55, P581, DOI 10.1088/0031-9155/55/3/002; Wang PM, 2013, STRAHLENTHER ONKOL, V189, P301, DOI 10.1007/s00066-012-0298-6; Wang PM, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-18; Wang PM, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-207; Yeung RH, 2017, EXPERT REV ANTICANC, V17, P911, DOI 10.1080/14737140.2017.1368392; Zhang Y, 2018, RADIOTHER ONCOL; Zhang Y, 2016, RADIOTHER ONCOL, V121, P281, DOI 10.1016/j.radonc.2016.09.011; Zhang Y, 2015, PHYS MED BIOL, V60, P8141, DOI 10.1088/0031-9155/60/20/8141; Zhang Y, 2012, PHYS MED BIOL, V57, P1779, DOI 10.1088/0031-9155/57/7/1779; Zhong NB, 2014, MOL CLIN ONCOL, V2, P839, DOI 10.3892/mco.2014.304	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201992	10.1371/journal.pone.0201992	http://dx.doi.org/10.1371/journal.pone.0201992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102749	Green Published, Green Submitted			2022-12-26	WOS:000441452200026
J	Silva, GA; Santos, IB; Campos, SO; Galdino, TVS; Morais, EGF; Martins, JC; Ferreira, LR; Guedes, RNC; Picanco, MC				Silva, Gerson Adriano; Santos, Izailda Barbosa; Campos, Silverio Oliveira; Silva Galdino, Tarcisio Visintin; Fidelis Morais, Elisangela Gomes; Martins, Julio Claudio; Ferreira, Lino Roberto; Carvalho Guedes, Raul Narciso; Picanco, Marcelo Coutinho			Spatial distribution and losses by grain destroying insects in transgenic corn expressing the toxin Cry1 Ab	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; BORER COLEOPTERA-CURCULIONIDAE; BACILLUS-THURINGIENSIS TOXIN; HELICOVERPA-ZEA LEPIDOPTERA; SWEET CORN; AGGREGATION PHEROMONE; SITOPHILUS-ORYZAE; FALL ARMYWORM; HOST-PLANT; MAIZE	Insect pests are one of the factors that most impact plant yield. The magnitude of the losses and the spatiotemporal pest distribution in crops is a result of their interactions with the environment. Therefore, the understanding of the causes of production losses and the pest spatial patterns is important for the development of suitable sampling plans and pest management programs. Thus, this study aimed to quantify grain losses caused by insects and to determine the spatial distribution pattern of arthropod pest species in Bt and non-Bt corn. The prevailing insect pests in the corn ears were the earworm and fall armyworm caterpillars (Helicoverpa spp. and Spodoptera frugiperda), the cornsilk fly (Euxesta spp.), the maize weevil (Sitophilus zeamais), and the square-necked grain beetle (Cathartus quadricollis). The non-Bt corn was more attacked by the caterpillars and the weevil, while Bt corn was more affected by the cornsilk fly Euxesta spp. Spatial dependence was significant for the damage caused by the caterpillars, the grain beetle and the maize weevil in both the Bt and non-Bt corn genotypes. The range of the damage caused by the insects was between 9.0-9.7 m for the caterpillars, 6.9-12.20 m for the cornsilk fly, 10.7-80.4 m for the square-necked grain beetle, and 51.9-170.7 m for the maize weevil. The pattern of the spatial distribution of pest damage in both corn genotypes (i.e., Bt and non-Bt corn) was similar with a prevalence of moderate to strong spatial dependence and aggregate damage distribution. The plants near to the sampling points exhibited injury and infestation levels similar to those of the sampled plants.	[Silva, Gerson Adriano; Silva Galdino, Tarcisio Visintin; Ferreira, Lino Roberto; Picanco, Marcelo Coutinho] Univ Fed Vicosa, Dept Fitotecnia, Vicosa, MG, Brazil; [Santos, Izailda Barbosa; Campos, Silverio Oliveira; Fidelis Morais, Elisangela Gomes; Martins, Julio Claudio; Carvalho Guedes, Raul Narciso] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Silva, Gerson Adriano] Univ Estadual Norte Fluminense, Lab Entomol & Fitopatol, Campos Goytacazes, Rio De Janeiro, Brazil; [Fidelis Morais, Elisangela Gomes] Empresa Brasileira Pesquisa Agr, Boa Vista, Roraima, Brazil; [Martins, Julio Claudio] Inst Fed Educ Ciencia & Tecnol Baiano, Campus Teixeira Freitas, Teixeira De Freitas, BA, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Estadual do Norte Fluminense; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Instituto Federal Baiano (IFBAIANO)	Silva, GA (corresponding author), Univ Fed Vicosa, Dept Fitotecnia, Vicosa, MG, Brazil.; Silva, GA (corresponding author), Univ Estadual Norte Fluminense, Lab Entomol & Fitopatol, Campos Goytacazes, Rio De Janeiro, Brazil.	silva.gersonadriano@gmail.com	Guedes, Raul Narciso Carvalho/L-3924-2013; Picanço, Marcelo Coutinho/P-6172-2019; Rocha, Pedro Luís B./A-3325-2008; Silva, Gerson Adriano/AAK-4887-2020; Picanço, Marcelo/AAQ-2477-2020; Martins, Julio C./M-2873-2013	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Rocha, Pedro Luís B./0000-0002-8330-483X; Silva, Gerson Adriano/0000-0002-1445-9758; Picanço, Marcelo/0000-0002-1294-6210; Martins, Julio C./0000-0002-0048-707X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico who provided resources and the Post-Graduate Program in Entomology and Plant Science at the Federal University of Vicosa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriotti JLS, 2005, FUNDAMENTOS ESTATIST; ARMSTRONG CL, 1995, CROP SCI, V35, P550, DOI 10.2135/cropsci1995.0011183X003500020045x; Ayala OR, 2013, REV FAC CIENC AGRAR, V45, P1; Bacca T, 2008, J APPL ENTOMOL, V132, P430, DOI 10.1111/j.1439-0418.2007.01264.x; Bacca T, 2006, ENTOMOL EXP APPL, V119, P39, DOI 10.1111/j.1570-7458.2006.00389.x; Barrigossi JAF, 2001, ENVIRON ENTOMOL, V30, P244, DOI 10.1603/0046-225X-30.2.244; Bernardi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140130; Binns M.R., 2000, SAMPLING MONITORING; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Buntin GD, 2008, FLA ENTOMOL, V91, P523; Burkness EC, 2002, CROP PROT, V21, P157, DOI 10.1016/S0261-2194(01)00080-1; Burkness EC, 2001, J ECON ENTOMOL, V94, P197, DOI 10.1603/0022-0493-94.1.197; Carvalho RPL, 1980, MELHORAMENTO PRODUCA, P505; Chilcutt CF, 2006, J ECON ENTOMOL, V99, P728, DOI 10.1603/0022-0493-99.3.728; Correa AS, 2013, INSECT SCI, V20, P763, DOI 10.1111/j.1744-7917.2012.01559.x; Coster-Longman C, 2002, J INSECT BEHAV, V15, P331, DOI 10.1023/A:1016213125161; Galdino TVD, 2017, J ECON ENTOMOL, V110, P865, DOI 10.1093/jee/tox063; Daly T, 2005, ENVIRON ENTOMOL, V34, P1292, DOI 10.1603/0046-225X(2005)034[1292:EOBTTC]2.0.CO;2; Darvas Bela, 2011, Insects, V2, P1, DOI 10.3390/insects2010001; Faleiro FG, 1995, REV CIENC PRAT, V19, P272; Farias Paulo Roberto Silva, 2003, Rev. Bras. Frutic., V25, P235, DOI 10.1590/S0100-29452003000200013; Fernandes FL, 2011, J ECON ENTOMOL, V104, P1909, DOI 10.1603/EC11032; Follett PA, 2016, BIOL CONTROL, V101, P152, DOI 10.1016/j.biocontrol.2016.07.002; Frizzas MR, 2014, CIENC RURAL, V44, P203, DOI 10.1590/S0103-84782014000200002; Galvao JCC, 2004, TECNOLOGIA PRODUCAO; Giolo, 2006, REV BRASILEIRA AGROC, V12, P167, DOI DOI 10.18539/CAST.V12I2.4519; Goyal G, 2012, ENTOMOL EXP APPL, V143, P177, DOI 10.1111/j.1570-7458.2012.01245.x; Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x; Gumprecht D, 2009, GEOGR ANAL, V41, P127, DOI 10.1111/j.1538-4632.2009.00736.x; Hunter AF, 2000, OIKOS, V91, P213, DOI 10.1034/j.1600-0706.2000.910202.x; Isaaks EH, 1989, APPL GEOSTATISTICS; Johnson SJ, 1986, THEORY TACTICS HELIO; Kalsi M, 2014, FLA ENTOMOL, V97, P911, DOI 10.1653/024.097.0349; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Likhayo PW, 2000, J STORED PROD RES, V36, P341, DOI 10.1016/S0022-474X(99)00052-1; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Michelotto M.D., 2011, Arq. Inst. Biol., V78, P71, DOI 10.1590/1808-1657v78p0712011; Miguens Flavio Costa, 2011, EntomoBrasilis, V4, P49; Muzemu S., 2013, International Journal of Plant Research, V3, P17; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Nuessly GS, 2007, J ECON ENTOMOL, V100, P1887, DOI 10.1603/0022-0493(2007)100[1887:RTSFLN]2.0.CO;2; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Pereira E. J. G., 2000, Acta Scientiarum, V22, P931; PHILLIPS JK, 1985, J CHEM ECOL, V11, P1263, DOI 10.1007/BF01024114; Picanco M. C., 2004, Acta Scientiarum - Agronomy, V26, P161; Picanco MC, 2003, CIENC AGROTEC, V27, P339, DOI 10.1590/S1413-70542003000200013; PIERCE HD, 1988, J CHEM ECOL, V14, P2169, DOI 10.1007/BF01014023; RAINA AK, 1992, SCIENCE, V255, P592, DOI 10.1126/science.255.5044.592; Ray AM, 2009, J CHEM ECOL, V35, P96, DOI 10.1007/s10886-008-9576-2; RINKLEFF JH, 1995, J ECON ENTOMOL, V88, P246, DOI 10.1093/jee/88.2.246; ROSS SE, 1990, J ECON ENTOMOL, V83, P831, DOI 10.1093/jee/83.3.831; Santos-Amaya OF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18243; Seal DR, 1996, FLA ENTOMOL, V79, P413, DOI 10.2307/3495591; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Siegfried Blair D, 2012, GM Crops Food, V3, P184, DOI 10.4161/gmcr.20715; Sterling WL, 1979, EC THRESHOLD SAMPLIN; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabile R. A., 2008, SCI AGRARIA, V9, P505, DOI [10.5380/rsa.v9i4.11709, DOI 10.5380/RSA.V9I4.11709]; Thiery D, 1995, J CHEM ECOL, V21, P2015, DOI 10.1007/BF02033859; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Velasco P, 2002, CROP SCI, V42, P724, DOI 10.2135/cropsci2002.0724; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Wright RJ, 2002, ENVIRON ENTOMOL, V31, P160, DOI 10.1603/0046-225X-31.1.160; Young L.J., 1998, STAT ECOLOGY POPULAT	66	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201201	10.1371/journal.pone.0201201	http://dx.doi.org/10.1371/journal.pone.0201201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096146	gold, Green Submitted, Green Published			2022-12-26	WOS:000441308500013
J	Steiner, N; Muller, U; Hajek, R; Sevcikova, S; Borjan, B; Johrer, K; Gobel, G; Pircher, A; Gunsilius, E				Steiner, Normann; Mueller, Udo; Hajek, Roman; Sevcikova, Sabina; Borjan, Bojana; Joehrer, Karin; Goebel, Georg; Pircher, Andreas; Gunsilius, Eberhard			The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets	PLOS ONE			English	Article							PROMOTES CELL-PROLIFERATION; INDOLEAMINE 2,3-DIOXYGENASE; MULTIPLE-MYELOMA; ASYMMETRIC DIMETHYLARGININE; CANCER PROGRESSION; BCAT1 PROMOTES; DISEASE; RESISTANCE; LETHALITY; PATHWAY	Introduction Multiple myeloma (MM), a malignant plasma cell disorder, is still an incurable disease. Thus, the identification of novel therapeutic targets is of utmost importance. Here, we evaluated the peripheral blood-based metabolic profile of patients with MM. Material & methods Peripheral blood plasma levels of 188 endogenous metabolites, including amino acids, biogenic amines, acylcarnitines, glycerophospholipids, sphingomyelins, and hexoses were determined in patients with plasma cell dyscrasias: monoclonal gammopathy of undetermined significance, a precursor stage of MM (MGUS, n = 15), newly diagnosed MM, (NDMM, n = 32), relapsed/refractory MM (RRMM, n = 19) and in 25 healthy controls by mass spectrometry. Results Patients with NDMM, RRMM and MGUS have a substantially different metabolomic profile than healthy controls. The amount of eight plasma metabolites significantly differs between the NDMM and MGUS group: free carnitine, acetylcarnitine, glutamate, asymmetric dimethylarginine (ADMA) and four phosphatidylcholine (PC) species. In addition, the levels of octadecanoylcarnitine, ADMA and six PCs were significantly different between RRMM and MGUS patients. 13 different concentrations of metabolites were found between RRMM and NDMM patients (free carnitine, acetyicarnitine, creatinine, five LysoPCs and PCs). Pathway analyses revealed a distinct metabolic profile with significant alterations in amino acid, lipid, and energy metabolism in healthy volunteers compared to MGUS/MM patients. Conclusion We identified different metabolic profiles in MGUS und MM patients in comparison to healthy controls. Thus, different metabolic processes, potentially the immunoregulation by indoleamine 2,3 dioxygenase-1 (IDO), which is involved in cancer development and progression supporting inflammatory processes in the tumor microenvironment and glutaminolysis, can serve as novel promising therapeutic targets in MM.	[Steiner, Normann; Borjan, Bojana; Pircher, Andreas; Gunsilius, Eberhard] Med Univ Innsbruck, Lab Tumor Biol & Angiogenesis, Dept Internal Med Hematol & Med Oncol 5, Innsbruck, Austria; [Mueller, Udo] Biocrates Life Sci AG, Innsbruck, Austria; [Hajek, Roman] Univ Ostrava, Fac Med, Ostrava, Czech Republic; [Hajek, Roman] Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic; [Sevcikova, Sabina] Masaryk Univ, Dept Pathol Physiol, Babak Myeloma Grp, Fac Med, Brno, Czech Republic; [Sevcikova, Sabina] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic; [Joehrer, Karin] Tyrolean Canc Res Inst, Innsbruck, Austria; [Joehrer, Karin] Salzburg Canc Res Inst, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Goebel, Georg] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria	Medical University of Innsbruck; University of Ostrava; University Hospital Ostrava; Masaryk University Brno; University Hospital Brno; Medical University of Innsbruck	Steiner, N (corresponding author), Med Univ Innsbruck, Lab Tumor Biol & Angiogenesis, Dept Internal Med Hematol & Med Oncol 5, Innsbruck, Austria.	normann.steiner@i-med.ac.at	Gunsilius, Eberhard/AAI-9333-2021; Hajek, Roman/I-6639-2017; Jöhrer, Karin/H-9143-2019; Sevcikova, Sabina/AAB-4267-2021; Pircher, Andreas/L-2150-2019	Gunsilius, Eberhard/0000-0003-1327-2921; Hajek, Roman/0000-0001-6955-6267; Jöhrer, Karin/0000-0002-6400-6175; Pircher, Andreas/0000-0002-7747-3012	Biocrates Life Sciences AG	Biocrates Life Sciences AG	The authors received no specific funding for this work. Biocrates Life Sciences AG provided support in the form of salaries for author Muller Udo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bajpai R, 2016, ONCOGENE, V35, P3955, DOI 10.1038/onc.2015.464; Beger RD, 2013, METABOLITES, V3, P552, DOI 10.3390/metabo3030552; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; El Arfani C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041200; Glavey SV, 2017, LEUKEMIA, V31, P2426, DOI 10.1038/leu.2017.102; Goveia J, 2016, EMBO MOL MED, V8, P1134, DOI 10.15252/emmm.201606798; Armitage EG, 2015, ELECTROPHORESIS, V36, P3050, DOI 10.1002/elps.201500352; Hattori A, 2017, NATURE, V545, P500, DOI 10.1038/nature22314; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heng B, 2016, ONCOTARGET, V7, P6506, DOI 10.18632/oncotarget.6467; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Johnson TS, 2012, IMMUNOL INVEST, V41, P765, DOI 10.3109/08820139.2012.689405; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Ludwig C, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.85; Maiso P, 2015, CANCER RES, V75, P2071, DOI 10.1158/0008-5472.CAN-14-3400; Mayers JR, 2017, CANCER RES, V77, P3131, DOI 10.1158/0008-5472.CAN-17-0165; Moon YW, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0094-9; Nooka AK, 2015, BLOOD, V125, P3085, DOI 10.1182/blood-2014-11-568923; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Prendergast GC, 2014, CANCER IMMUNOL IMMUN, V63, P721, DOI 10.1007/s00262-014-1549-4; Puchades-Carrasco L, 2013, CLIN CANCER RES, V19, P4770, DOI 10.1158/1078-0432.CCR-12-2917; Rajkumar SV, 2015, BLOOD, V125, P3069, DOI 10.1182/blood-2014-09-568899; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Raynor A, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0070-x; Rollig C, 2015, LANCET, V385, P2197, DOI 10.1016/S0140-6736(14)60493-1; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang ZQ, 2015, ONCOTARGET, V6, P31522, DOI 10.18632/oncotarget.5159; Wilcken DEL, 2007, MOL GENET METAB, V91, P309, DOI 10.1016/j.ymgme.2007.04.017; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546; Zaal EA, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0169-9; Zairis MN, 2012, HEART, V98, P860, DOI 10.1136/heartjnl-2011-301372; Zhang L, 2017, BIOCHEM BIOPH RES CO, V486, P224, DOI 10.1016/j.bbrc.2017.02.101; Zheng YH, 2016, LIVER INT, V36, P1836, DOI 10.1111/liv.13178	38	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202045	10.1371/journal.pone.0202045	http://dx.doi.org/10.1371/journal.pone.0202045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096165	gold, Green Published, Green Submitted			2022-12-26	WOS:000441308500045
J	Lamothe, SM; Hogan-Cann, AE; Li, WT; Guo, J; Yang, TH; Tschirhart, JN; Zhang, ST				Lamothe, Shawn M.; Hogan-Cann, Aja E.; Li, Wentao; Guo, Jun; Yang, Tonghua; Tschirhart, Jared N.; Zhang, Shetuan			The N terminus and transmembrane segment S1 of Kv1.5 can coassemble with the rest of the channel independently of the S1-S2 linkage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; structure-function relationships; voltage-gated potassium channel; molecular biology; patch clamp; trafficking; channel assembly; ion channel; Kv1; 5; transmembrane domain; Shaker superfamily	GATED K+ CHANNELS; POTASSIUM CHANNEL; T1 DOMAIN; COMPLEMENTARY FRAGMENTS; CHLORIDE CHANNELS; MOLECULAR-BASIS; I-KR; SUBUNIT; INACTIVATION; EXPRESSION	The voltage-gated potassium channel Kv1.5 belongs to the Shaker superfamily. Kv1.5 is composed of four subunits, each comprising 613 amino acids, which make up the N terminus, six transmembrane segments (S1-S6), and the C terminus. We recently demonstrated that, in HEK cells, extracellularly applied proteinase K (PK) cleaves Kv1.5 channels at a single site in the S1-S2 linker. This cleavage separates Kv1.5 into an N-fragment (N terminus to S1) and a C-fragment (S2 to C terminus). Interestingly, the cleavage does not impair channel function. Here, we investigated the role of the N terminus and S1 in Kv1.5 expression and function by creating plasmids encoding various fragments, including those that mimic PK-cleaved products. Our results disclosed that although expression of the pore-containing fragment (Frag(304-613)) alone could not produce current, coexpression with Frag(1-303) generated a functional channel. Immunofluorescence and biotinylation analyses uncovered that Frag(1-303) was required for Frag(304-613) to traffic to the plasma membrane. Biochemical analysis revealed that the two fragments interacted throughout channel trafficking and maturation. In Frag(1-303)+(304-613)-coassembled channels, which lack a covalent linkage between S1 and S2, amino acid residues 1-209 were important for association with Frag(304-613), and residues 210-303 were necessary for mediating trafficking of coassembled channels to the plasma membrane. We conclude that the N terminus and S1 of Kv1.5 can attract and coassemble with the rest of the channel (i.e. Frag(304-613)) to form a functional channel independently of the S1-S2 linkage.	[Lamothe, Shawn M.; Hogan-Cann, Aja E.; Li, Wentao; Guo, Jun; Yang, Tonghua; Tschirhart, Jared N.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Tschirhart, Jared/0000-0003-1313-350X; Hogan-Cann, Aja/0000-0003-2272-1776; Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Natural Sciences and Engineering Research Council of Canada [RGPIN-2018-05037]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2018-05037 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eldstrom J, 2003, FEBS LETT, V547, P205, DOI 10.1016/S0014-5793(03)00668-9; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Kurata HT, 2001, J GEN PHYSIOL, V118, P315, DOI 10.1085/jgp.118.3.315; Lamothe SM, 2016, J BIOL CHEM, V291, P20387, DOI 10.1074/jbc.M116.743138; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mo L, 2004, AM J PHYSIOL-CELL PH, V286, pC79, DOI 10.1152/ajpcell.00009.2003; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005	41	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15347	15358		10.1074/jbc.RA118.004065	http://dx.doi.org/10.1074/jbc.RA118.004065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30121572	Green Published, hybrid			2022-12-26	WOS:000446549200002
J	Fedders, R; Muenzner, M; Weber, P; Sommerfeld, M; Knauer, M; Kedziora, S; Kast, N; Heidenreich, S; Raila, J; Weger, S; Henze, A; Schupp, M				Fedders, Ronja; Muenzner, Matthias; Weber, Pamela; Sommerfeld, Manuela; Knauer, Miriam; Kedziora, Sarah; Kast, Naomi; Heidenreich, Steffi; Raila, Jens; Weger, Stefan; Henze, Andrea; Schupp, Michael			Liver-secreted RBP4 does not impair glucose homeostasis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; retinoid-binding protein; glucose metabolism; insulin resistance; mouse; TTR	RETINOL-BINDING-PROTEIN; TRANSTHYRETIN-DEFICIENT MICE; VITAMIN-A-DEFICIENCY; INSULIN-RESISTANCE; INDEPENDENT MECHANISM; MEMBRANE-RECEPTOR; ADIPOSE-TISSUE; RETINOL-BINDING-PROTEIN-4; GENE; EXPRESSION	Retinol-binding protein 4 (RBP4) is the major transport protein for retinol in blood. Recent evidence from genetic mouse models shows that circulating RBP4 derives exclusively from hepatocytes. Because RBP4 is elevated in obesity and associates with the development of glucose intolerance and insulin resistance, we tested whether a liver-specific overexpression of RBP4 in mice impairs glucose homeostasis. We used adeno-associated viruses (AAV) that contain a highly liver-specific promoter to drive expression of murine RBP4 in livers of adult mice. The resulting increase in serum RBP4 levels in these mice was comparable with elevated levels that were reported in obesity. Surprisingly, we found that increasing circulating RBP4 had no effect on glucose homeostasis. Also during a high-fat diet challenge, elevated levels of RBP4 in the circulation failed to aggravate the worsening of systemic parameters of glucose and energy homeostasis. These findings show that liver-secreted RBP4 does not impair glucose homeostasis. We conclude that a modest increase of its circulating levels in mice, as observed in the obese, insulin-resistant state, is unlikely to be a causative factor for impaired glucose homeostasis.	[Fedders, Ronja; Muenzner, Matthias; Weber, Pamela; Sommerfeld, Manuela; Knauer, Miriam; Kedziora, Sarah; Kast, Naomi; Heidenreich, Steffi; Schupp, Michael] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, D-10115 Berlin, Germany; [Fedders, Ronja; Muenzner, Matthias; Weber, Pamela; Sommerfeld, Manuela; Knauer, Miriam; Kedziora, Sarah; Kast, Naomi; Heidenreich, Steffi; Schupp, Michael] Berlin Inst Hlth, Inst Pharmacol, D-10115 Berlin, Germany; [Raila, Jens; Henze, Andrea] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol, D-14558 Nuthetal, Germany; [Weger, Stefan] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Weger, Stefan] Berlin Inst Hlth, Inst Virol, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Henze, Andrea] Univ Potsdam, Inst Nutr Sci, Jr Res Grp ProAID, D-14558 Nuthetal, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam	Schupp, M (corresponding author), Charite Univ Med Berlin, Inst Pharmacol, D-10115 Berlin, Germany.	michael.schupp@charite.de	Henze, Andrea/A-9176-2019	Henze, Andrea/0000-0002-5708-2989; Schupp, Michael/0000-0003-3720-1052; Weger, Stefan/0000-0002-0906-5252	German Research Foundation (Deutsche Forschungsgemeinschaft) [SCHU 2546/1-1, SCHU 2546/5-1]; European Union [CIG 291867]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant SCHU 2546/1-1 Emmy Noether and SCHU 2546/5-1 and a Career Integration Grant CIG 291867 from the European Union (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Buxbaum JN, 2014, NEUROSCIENCE, V275, P352, DOI 10.1016/j.neuroscience.2014.06.019; Du M, 2015, MOL CELL BIOL, V35, P2771, DOI 10.1128/MCB.00181-15; Fedders R, 2015, HORM MOL BIOL CLIN I, V22, P27, DOI 10.1515/hmbci-2015-0013; Gaetani S, 2002, CLIN CHEM LAB MED, V40, P1211, DOI 10.1515/CCLM.2002.211; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Heidenreich S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00430-w; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lee SA, 2016, HEPATOLOGY, V64, P1534, DOI 10.1002/hep.28659; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mody N, 2008, AM J PHYSIOL-ENDOC M, V294, pE785, DOI 10.1152/ajpendo.00521.2007; Monk JA, 2013, AM J PHYSIOL-ENDOC M, V304, pE23, DOI 10.1152/ajpendo.00216.2012; Moraes-Vieira PM, 2016, DIABETES, V65, P1317, DOI 10.2337/db15-1696; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Perduca M, 2018, BBA-MOL CELL BIOL L, V1863, P458, DOI 10.1016/j.bbalip.2018.01.010; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Raila J, 2007, KIDNEY INT, V72, P505, DOI 10.1038/sj.ki.5002372; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thompson SJ, 2017, DIABETES, V66, P58, DOI 10.2337/db16-0286; Trasino SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15893; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	33	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15269	15276		10.1074/jbc.RA118.004294	http://dx.doi.org/10.1074/jbc.RA118.004294			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30126844	hybrid, Green Published			2022-12-26	WOS:000445998400026
J	Heinitz, S; Kivel, N; Schumann, D; Koster, U; Balata, M; Biasotti, M; Ceriale, V; De Gerone, M; Faverzani, M; Ferri, E; Gallucci, G; Gatti, F; Giachero, A; Nisi, S; Nucciotti, A; Orlando, A; Pessina, G; Puiu, A; Ragazzi, S				Heinitz, S.; Kivel, N.; Schumann, D.; Koster, U.; Balata, M.; Biasotti, M.; Ceriale, V; De Gerone, M.; Faverzani, M.; Ferri, E.; Gallucci, G.; Gatti, F.; Giachero, A.; Nisi, S.; Nucciotti, A.; Orlando, A.; Pessina, G.; Puiu, A.; Ragazzi, S.			Production and separation of Ho-163 for nuclear physics experiments	PLOS ONE			English	Article							HALF-LIFE; ELECTRON-CAPTURE; CROSS-SECTION; MASS	This paper describes the production and chemical separation of the Ho-163 isotope that will be used in several nuclear physics experiments aiming at measuring the neutrino mass as well as the neutron cross section of the Ho-163 isotope. For this purpose, several batches of enriched Er-162 have been irradiated at the Institut Laue-Langevin high flux reactor to finally produce 6 mg or 100 MBq of the desired Ho-163 isotope. A portion of the Er/Ho mixture is then subjected to a sophisticated chemical separation involving ion exchange chromatography to isolate the Ho product from the Er target material. Before irradiation, a thorough analysis of the impurity content was performed and its implication on the produced nuclide inventory will be discussed.	[Heinitz, S.; Kivel, N.; Schumann, D.] Paul Scherrer Inst, Nucl Energy & Safety Dept, Villigen, Switzerland; [Koster, U.] Inst Laue Langevin, Grenoble, France; [Balata, M.; Nisi, S.] Lab Nazl Gran Sasso, Assergi, Italy; [Biasotti, M.] Univ Genoa, Dipartimento Fis, Genoa, Italy; [Biasotti, M.; Ceriale, V; De Gerone, M.; Gallucci, G.] Ist Nazl Fis Nucl Genova, Genoa, Italy; [Faverzani, M.; Ferri, E.; Gatti, F.; Giachero, A.; Nucciotti, A.; Orlando, A.; Puiu, A.; Ragazzi, S.] Univ Milano Bicocca, Dipartimento Fis, Milan, Italy; [Faverzani, M.; Ferri, E.; Gatti, F.; Giachero, A.; Nucciotti, A.; Pessina, G.; Puiu, A.; Ragazzi, S.] Ist Nazl Fis Nucl, Milan, Italy; [Kivel, N.] Paul Scherrer Inst, Large Res Facil Dept, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Institut Laue-Langevin (ILL); Gran Sasso Science Institute (GSSI); University of Genoa; Istituto Nazionale di Fisica Nucleare (INFN); University of Milano-Bicocca; Istituto Nazionale di Fisica Nucleare (INFN); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Heinitz, S (corresponding author), Paul Scherrer Inst, Nucl Energy & Safety Dept, Villigen, Switzerland.	stephan.heinitz@psi.ch	Faverzani, Marco/K-3865-2016; Nucciotti, Angelo/I-8888-2012; Gatti, Flavio/A-4430-2015; Köster, Ulli/N-3016-2017; Orlando, Angiola/AAI-3379-2021; Orlando, Angiola/AAH-6918-2020; Ferri, Elena/L-8531-2014; Biasotti, Michele/C-7890-2017; Puiu, Andrei/AAF-6469-2020; Giachero, Andrea/I-1081-2013; De Gerone, Matteo/AAA-1683-2020	Faverzani, Marco/0000-0001-8119-2953; Nucciotti, Angelo/0000-0002-8458-1556; Gatti, Flavio/0000-0001-8991-0382; Orlando, Angiola/0000-0001-9464-3100; Ferri, Elena/0000-0003-1425-3669; Biasotti, Michele/0000-0002-7241-8479; Giachero, Andrea/0000-0003-0493-695X; De Gerone, Matteo/0000-0002-5489-6581; andrei, puiu/0000-0003-1143-224X; , Marco/0000-0001-6745-6983	ERC: European Research Council [340321]; EC FP7: European Commission, 7th Framework Programme [605203]; EC FP7 Programme under the CHANDA project [605203]; European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC [340321]	ERC: European Research Council(European Research Council (ERC)); EC FP7: European Commission, 7th Framework Programme; EC FP7 Programme under the CHANDA project; European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC	This work was supported by ERC: European Research Council, https://erc.europa.eu/, grant number 340321, S. Ragazzi; and EC FP7: European Commission, 7th Framework Programme, https://ec.europa.eu/research/fp7, grant number 605203, D. Schumann.; Many thanks to S. Tietze and K. Domnanich for the support during ICP-OES measurements. A. Vogele is acknowledged for his help during neutron activation. This work has received funding from the EC FP7 Programme under the CHANDA project (Grant no. 605203). The HOLMES experiment is funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement no. 340321.	Alpert B, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3329-5; BAISDEN PA, 1983, PHYS REV C, V28, P337, DOI 10.1103/PhysRevC.28.337; Croce MP, 2016, J LOW TEMP PHYS, V184, P958, DOI 10.1007/s10909-015-1451-2; DANILENKO VN, 1989, APPL RADIAT ISOTOPES, V40, P789, DOI 10.1016/0883-2889(89)90098-1; Dorrer H, 2018, RADIOCHIM ACTA, V106, P535, DOI 10.1515/ract-2017-2877; Dzysiuk N, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.034609; Eliseev S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.062501; Engle JW, 2013, NUCL INSTRUM METH B, V311, P131, DOI 10.1016/j.nimb.2013.06.017; Gastaldo L, 2017, EUR PHYS J-SPEC TOP, V226, P1623, DOI 10.1140/epjst/e2017-70071-y; Guerrero C, 2017, EUR PHYS J A, V53, DOI 10.1140/epja/i2017-12261-2; Heinitz S, 2017, RADIOCHIM ACTA, V105, P801, DOI 10.1515/ract-2016-2728; Jaag S, 1996, ASTROPHYS J, V464, P874, DOI 10.1086/177375; JUNG M, 1992, PHYS REV LETT, V69, P2164, DOI 10.1103/PhysRevLett.69.2164; Katoh T, 2002, J NUCL SCI TECHNOL, V39, P705, DOI 10.3327/jnst.39.705; KAWAKAMI O, 1988, PHYS REV C, V38, P1857, DOI 10.1103/PhysRevC.38.1857; Mocko V, 2015, RADIOCHIM ACTA, V103, P577, DOI 10.1515/ract-2014-2362; Nakamura S, 2014, J NUCL SCI TECHNOL, V39, P258; Nedjadi Y, 2012, APPL RADIAT ISOTOPES, V70, P1990, DOI 10.1016/j.apradiso.2012.02.063; Nucciotti A, 2016, ADV HIGH ENERGY PHYS, V2016, DOI 10.1155/2016/9153024; QAIM SM, 1984, RADIOCHIM ACTA, V35, P5; QAIM SM, 1979, RADIOCHIM ACTA, V26, P59; Ranitzsch PCO, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.122501; Romanov EG, 2005, ORIP 21 COMPUTER PRO	23	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0200910	10.1371/journal.pone.0200910	http://dx.doi.org/10.1371/journal.pone.0200910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133443	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400007
J	Abdala-Roberts, L; Galman, A; Petry, WK; Covelo, F; de la Fuente, M; Glauser, G; Moreira, X				Abdala-Roberts, Luis; Galman, Andrea; Petry, William K.; Covelo, Felisa; de la Fuente, Maria; Glauser, Gaetan; Moreira, Xoaquin			Interspecific variation in leaf functional and defensive traits in oak species and its underlying climatic drivers	PLOS ONE			English	Article							ANTI-HERBIVORE DEFENSE; PLANT DEFENSE; RESOURCE AVAILABILITY; LATITUDINAL VARIATION; CHEMICAL DEFENSES; GLOBAL PATTERNS; TANNINS; ECOLOGY; GROWTH; DIMENSIONS	Plants exhibit a diverse set of functional traits and ecological strategies which reflect an adaptation process to the biotic and abiotic components of the environment. The Plant Economic Spectrum organizes these traits along a continuum from conservative to acquisitive resource use strategies and shows how the abiotic environment governs a species' position along the continuum. However, this framework does not typically account for leaf traits associated with herbivore resistance, despite fundamental metabolic links (and therefore co-variance) between resource use traits and defensive traits. Here we analyzed a suite of leaf traits associated with either resource use (specific leaf area [SLA], nutrients and water content) or defenses (phenolic compounds) for saplings of 11 species of oaks (Quercus spp.), and further investigated whether climatic variables underlie patterns of trait interspecific variation. An ordination of leaf traits revealed the primary axis of trait variation to be leaf economic spectrum traits associated with resource use (SLA, nitrogen, water content) in conjunction with a defensive trait (condensed tannins). Secondary and tertiary axes of trait variation were mainly associated with other defensive traits (lignins, flavonoids, and hydrolysable tannins). Within the primary axis we found a trade-off between resource use traits and both water content and condensed tannins; species with high SLA and leaf N values invested less in condensed tannins and viceversa. Moreover, temperature and precipitation mediated the trait space occupied by species, such that species distributed in warmer and drier climates had less leaf N, lower SLA, and more defenses (condensed tannins, lignins and flavonoids), whereas opposite values were observed for species distributed in colder and wetter climates. These results emphasize the role of abiotic controls over all-inclusive axes of trait variation and contribute to a more complete understanding of interspecific variation in plant functional strategies.	[Abdala-Roberts, Luis] Univ Autonoma Yucatan, Dept Ecol Trop, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico; [Galman, Andrea; de la Fuente, Maria; Moreira, Xoaquin] CSIC, MBG, Pontevedra, Galicia, Spain; [Petry, William K.] Eidgenoss Tech Hsch ETH Zurich, Inst Integrat Biol, Univ Str 16, Zurich, Switzerland; [Covelo, Felisa] Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain; [Glauser, Gaetan] Univ Neuchatel, Neuchatel Platform Analyt Chem, Neuchatel, Switzerland	Universidad Autonoma de Yucatan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG); Universidad Pablo de Olavide; University of Neuchatel	Moreira, X (corresponding author), CSIC, MBG, Pontevedra, Galicia, Spain.	xmoreira1@gmail.com	DE LA FUENTE, MARIA/R-9993-2018; Covelo, Felisa/R-9941-2018; Glauser, Gaetan/K-7574-2017; Moreira, Xoaquin/J-9427-2018	DE LA FUENTE, MARIA/0000-0002-3688-3808; Glauser, Gaetan/0000-0002-0983-8614; Petry, William/0000-0002-5230-5987; Covelo Nunez, Maria Felisa/0000-0001-8273-9340; Moreira, Xoaquin/0000-0003-0166-838X	Spanish National Research Grant [AGL2015-70748-R]	Spanish National Research Grant(Spanish Government)	This research was financially supported by a Spanish National Research Grant (AGL2015-70748-R) to XM.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Anstett DN, 2016, TRENDS ECOL EVOL, V31, P789, DOI 10.1016/j.tree.2016.07.011; Anstett DN, 2015, ECOL LETT, V18, P1376, DOI 10.1111/ele.12532; Caudullo G, 2017, DATA BRIEF, V12, P662, DOI 10.1016/j.dib.2017.05.007; Chamberlain S., 2016, SCRUBR CLEAN BIOL OC; Chauvin KM, 2018, OECOLOGIA, V186, P765, DOI 10.1007/s00442-017-4043-9; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Defossez E, 2018, ECOL LETT, V21, P609, DOI 10.1111/ele.12926; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Forkner RE, 2004, ECOL ENTOMOL, V29, P174, DOI 10.1111/j.1365-2311.2004.0590.x; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Karinho-Betancourt E, 2015, NEW PHYTOL, V206, P796, DOI 10.1111/nph.13300; Kitajima K., 2008, TROPICAL FOREST COMM, P160; Little EL, 1971, USDA MISCELLANEOUS P, V1; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Moreira X, 2018, ECOGRAPHY, DOI [10.1111/ecog.02845, DOI 10.1111/ECOG.02845]; Moreira X, 2018, ECOGRAPHY, V41, P1124, DOI 10.1111/ecog.03326; Moreira X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04314-3; Moreira X, 2014, ECOL LETT, V17, P537, DOI 10.1111/ele.12253; Moreira X, 2012, J ECOL, V100, P810, DOI 10.1111/j.1365-2745.2011.01938.x; Moreira X, 2015, AM J BOT, V102, P1300, DOI 10.3732/ajb.1500255; Orme D., 2013, R PACKAGE VERSION, V5, P1; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Perez-Ramos IM, 2015, J ECOL, V103, P691, DOI 10.1111/1365-2745.12400; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poorter H., 2007, FUNCTIONAL PLANT ECO, P67, DOI DOI 10.1201/9781420007626; R Core Team, 2018, R LANG ENV STAT COMP; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Roslin T, 2008, OIKOS, V117, P1560, DOI 10.1111/j.0030-1299.2008.16725.x; Salgado CS, 2005, ECOLOGY, V86, P1571, DOI 10.1890/04-1257; Salminen JP, 2011, FUNCT ECOL, V25, P325, DOI 10.1111/j.1365-2435.2010.01826.x; Sawada Y, 2012, PHYTOCHEMISTRY, V82, P38, DOI 10.1016/j.phytochem.2012.07.007; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Tikkanen OP, 2003, OECOLOGIA, V136, P244, DOI 10.1007/s00442-003-1267-7; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Walinga I., 1995, PLANT ANAL MANUAL; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	46	21	22	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202548	10.1371/journal.pone.0202548	http://dx.doi.org/10.1371/journal.pone.0202548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125315	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100034
J	Vega, EC; Jerez-Mayorga, D; Payer, RM; Jara, CC; Guzman-Guzman, I; Ponce, AR; Chirosa, LJ				Cerda Vega, Enrique; Jerez-Mayorga, Daniel; Machado Payer, Ramon; Campos Jara, Christian; Guzman-Guzman, Iris; Reyes Ponce, Alvaro; Javier Chirosa, Luis			Validity and reliability of evaluating hip abductor strength using different normalization methods in a functional electromechanical device	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; PATELLOFEMORAL PAIN SYNDROME; MUSCLE-ACTIVITY; BODY-SIZE; CORRELATION-COEFFICIENT; INTRARATER RELIABILITY; SOCCER PLAYERS; OSTEOARTHRITIS; TORQUE; JOINT	The hip abductor muscles are vitally important for pelvis stability, and common strength deficits can negatively affect functionality. The muscle strength can be measured using different dynamometers and be evaluated in three positions (side-lying, standing, and supine). Obtained strength data can be expressed in different ways, with data normalization providing more objective and comparable results. The aim of this study was to establish the validity and reliability of three protocols in evaluating the isometric strength of the hip abductor muscles. A new functional electromechanical dynamometer assessed strength in three positions, with findings subjected to three data normalization methods. In two identical sessions, the hip abductor strengths of 29 subjects were recorded in the side-lying, standing, and supine positions. Peak force was recorded in absolute terms and normalized against body mass, fat- free mass, and an allometric technique. The peak force recorded in the side-lying position was 30% and 27% higher than in the standing and supine positions, respectively, independent of data normalization methodology. High inter-protocol correlations were found (r: 0.72 to 0.98, p <= 0.001). The supine position with allometric data normalization had the highest test-retest reliability (0.94 intraclass correlation coefficient and 5.64% coefficient of variation). In contrast, the side-lying position with body mass data normalization had a 0.66 intraclass correlation coefficient and 9.8% coefficient of variation. In conclusion, the functional electromechanical dynamometer is a valid device for measuring isometric strength in the hip abductor muscles. The three assessed positions are reliable, although the supine position with allometric data normalization provided the best results.	[Cerda Vega, Enrique] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Kinesiol, Santiago, Chile; [Jerez-Mayorga, Daniel; Campos Jara, Christian; Reyes Ponce, Alvaro] Univ Andres Bello, Fac Ciencias Rehabil, Santiago, Chile; [Machado Payer, Ramon; Javier Chirosa, Luis] Univ Granada, Fac Sci Phys Act & Sport, Granada, Spain; [Guzman-Guzman, Iris] Univ Autonoma Guerrero, Unidad Acad Ciencias Quim Biol, Chilpancingo, Mexico	Pontificia Universidad Catolica de Chile; Universidad Andres Bello; University of Granada	Vega, EC (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Kinesiol, Santiago, Chile.	ecerdav@uc.cl	Ríos, Luis Javier Chirosa/AAX-2127-2020; Cerda, Enrique/GWN-0106-2022; Campos-Jara, Christian/AGJ-4657-2022; Jerez-Mayorga, Daniel/AAO-3045-2020; Jerez-Mayorga, Daniel/GQP-1860-2022; Campos, Christian Campos-Jara/H-9347-2016	Ríos, Luis Javier Chirosa/0000-0002-1008-176X; Jerez-Mayorga, Daniel/0000-0002-6878-8004; Jerez-Mayorga, Daniel/0000-0002-6878-8004; Campos, Christian Campos-Jara/0000-0002-0298-837X; Reyes, Alvaro/0000-0001-7703-2893; Cerda Vega, Enrique/0000-0003-0813-3695				Amorim AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177575; [Anonymous], 2014, DANIELS WORTHINGHAMS; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Barton CJ, 2013, BRIT J SPORT MED, V47, P207, DOI 10.1136/bjsports-2012-090953; Bazett-Jones DM, 2011, ARCH PHYS MED REHAB, V92, P76, DOI 10.1016/j.apmr.2010.08.020; BEMBEN MG, 1990, RES Q EXERCISE SPORT, V61, P96, DOI 10.1080/02701367.1990.10607484; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Boling MC, 2009, J ATHL TRAINING, V44, P7, DOI 10.4085/1062-6050-44.1.7; CAHALAN TD, 1989, CLIN ORTHOP RELAT R, P136; Campos Jara Christian Alex, 2014, CPD, V14, P91; Canadian Society for Exercise Physiology (CSEP), 2002, PHYS ACT READ QUEST; Chen T, 2017, ARCH PHYS MED REHAB, V98, P2471, DOI 10.1016/j.apmr.2017.04.003; Cuthbert Scott C, 2007, Chiropr Osteopat, V15, P4, DOI 10.1186/1746-1340-15-4; Davies MJ, 1997, MED SCI SPORT EXER, V29, P713, DOI 10.1097/00005768-199705000-00020; De Marche Baldon R, 2009, J ATHL TRAINING, V44, P490, DOI [10.4085/1062-6050-44.5.490PMC2742458, DOI 10.4085/1062-6050-44.5.490PMC2742458]; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Dwyer MK, 2013, CLIN BIOMECH, V28, P757, DOI 10.1016/j.clinbiomech.2013.07.007; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; FARRELL M, 1986, MED SCI SPORT EXER, V18, P44; Fenter PC, 2003, BRIT J SPORT MED, V37, P331, DOI 10.1136/bjsm.37.4.331; Finnoff JT, 2011, PM&R, V3, P792, DOI 10.1016/j.pmrj.2011.04.007; FRESE E, 1987, PHYS THER, V67, P1072, DOI 10.1093/ptj/67.7.1072; Gafner S, 2017, EUR REV AGING PHYS A, V14, DOI 10.1186/s11556-017-0174-6; Hansen EM, 2015, INT J SPORTS PHYS TH, V10, P62; HARDCASTLE P, 1985, J BONE JOINT SURG BR, V67, P741, DOI 10.1302/0301-620X.67B5.4055873; HAYES KW, 1992, J ORTHOP SPORT PHYS, V16, P145, DOI 10.2519/jospt.1992.16.3.145; Horstmann T, 2013, CLIN BIOMECH, V28, P762, DOI 10.1016/j.clinbiomech.2013.07.001; Jackson SM, 2017, MUSCULOSKEL SCI PRAC, V27, P137, DOI 10.1016/j.math.2016.07.010; Jara Christian Campos, 2017, Fisioter. mov., V30, P133, DOI 10.1590/1980-5918.030.001.ao14; JARAMILLO J, 1994, J ORTHOP SPORT PHYS, V20, P160, DOI 10.2519/jospt.1994.20.3.160; Jaric S, 2002, EUR J APPL PHYSIOL, V87, P304, DOI 10.1007/s00421-002-0638-9; Johnson ME, 2004, ARCH PHYS MED REHAB, V85, P593, DOI 10.1016/j.apmr.2003.07.022; Kindel C, 2017, PHYSIOTHER THEOR PR, V33, P568, DOI 10.1080/09593985.2017.1323357; Klemetti R, 2014, J BIOMECH, V47, P2263, DOI 10.1016/j.jbiomech.2014.04.052; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lawson A, 1997, PERCEPT MOTOR SKILL, V84, P539, DOI 10.2466/pms.1997.84.2.539; Lazennec Jean-Yves, 2011, Eur Spine J, V20 Suppl 5, P686, DOI 10.1007/s00586-011-1937-9; Lee SP, 2012, GAIT POSTURE, V36, P425, DOI 10.1016/j.gaitpost.2012.03.024; Lenhart R, 2014, J ORTHOP SPORT PHYS, V44, P766, DOI 10.2519/jospt.2014.5575; Loureiro A, 2013, ARTHRIT CARE RES, V65, P340, DOI 10.1002/acr.21806; Lourencin FTC, 2012, ACTA FISIATR, V19, P16, DOI DOI 10.5935/0104-7795.20120004; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Meyer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081149; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nadler SF, 2000, ARCH PHYS MED REHAB, V81, P1072, DOI 10.1053/apmr.2000.7165; Paul DJ, 2015, J STRENGTH COND RES, V29, P1748, DOI 10.1519/JSC.0000000000000807; SALE DG, 1988, MED SCI SPORT EXER, V20, pS135, DOI 10.1249/00005768-198810001-00009; Schmitt Walter H Jr, 2008, Chiropr Osteopat, V16, P16, DOI 10.1186/1746-1340-16-16; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith JA, 2014, J ORTHOP SPORT PHYS, V44, P525, DOI 10.2519/jospt.2014.5028; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; STOKES M, 1985, Physiotherapy Practice, V1, P71; Thorborg K, 2013, SCAND J MED SCI SPOR, V23, P487, DOI 10.1111/j.1600-0838.2011.01405.x; Thorborg K, 2011, AM J SPORT MED, V39, P121, DOI 10.1177/0363546510378081; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Widler KS, 2009, J BONE JOINT SURG AM, V91A, P2666, DOI 10.2106/JBJS.H.01119; Willson JD, 2011, CLIN BIOMECH, V26, P735, DOI 10.1016/j.clinbiomech.2011.02.012	57	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202248	10.1371/journal.pone.0202248	http://dx.doi.org/10.1371/journal.pone.0202248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125320	Green Submitted, Green Published, gold			2022-12-26	WOS:000442202100021
J	Kyogoku, H; Wakayama, T; Kitajima, TS; Miyano, T				Kyogoku, Hirohisa; Wakayama, Teruhiko; Kitajima, Tomoya S.; Miyano, Takashi			Single nucleolus precursor body formation in the pronucleus of mouse zygotes and SCNT embryos	PLOS ONE			English	Article							FULL-TERM DEVELOPMENT; PHASE-TRANSITIONS; PREIMPLANTATION EMBRYOS; MATERNAL NUCLEOLUS; GROWN OOCYTES; PROTEIN; MICE; ORGANIZATION; DETERMINES; ORGANELLES	Mammalian oocytes and zygotes have nucleoli that are transcriptionally inactive and structurally distinct from nucleoli in somatic cells. These nucleoli have been termed nucleolus precursor bodies (NPBs). Recent research has shown that NPBs are important for embryonic development, but they are only required during pronuclear formation. After fertilization, multiple small NPBs are transiently formed in male and female pronuclei and then fuse into a single large NPB in zygotes. In cloned embryos produced by somatic cell nuclear transfer (SCNT), multiple NPBs are formed and maintained in the pseudo-pronucleus, and this is considered an abnormality of the cloned embryos. Despite this difference between SCNT and normal embryos, it is unclear how the size and number of NPBs in pronuclei is determined. Here, we show that in mouse embryos, the volume of NPB materials plays a major role in the NPB scaling through a limiting component mechanism and determines whether a single or multiple NPBs will form in the pronucleus. Extra NPB-and extra MII spindle-injection experiments demonstrated that the total volume of NPBs was maintained regardless of the pronucleus number and the ratio of pronucleus/ NPB is important for fusion into a single NPB. Based on these results, we examined whether extra-NPB injection rescued multiple NPB maintenance in SCNT embryos. When extra-NPBs were injected into enucleated-MII oocytes before SCNT, the number of NPBs in pseudo-pronuclei of SCNT embryos was reduced. These results indicate that multiple NPB maintenance in SCNT embryos is caused by insufficient volume of NPB.	[Kyogoku, Hirohisa; Miyano, Takashi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Kyogoku, Hirohisa; Kitajima, Tomoya S.] RIKEN, Lab Chromosome Segregat, Ctr Dev Biol, Kobe, Hyogo, Japan; [Kyogoku, Hirohisa; Kitajima, Tomoya S.] RIKEN, Ctr Biosyst Dynam Res, Lab Chromosome Segregat, Kobe, Hyogo, Japan; [Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan	Kobe University; RIKEN; RIKEN; University of Yamanashi	Kyogoku, H (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan.; Kyogoku, H (corresponding author), RIKEN, Lab Chromosome Segregat, Ctr Dev Biol, Kobe, Hyogo, Japan.; Kyogoku, H (corresponding author), RIKEN, Ctr Biosyst Dynam Res, Lab Chromosome Segregat, Kobe, Hyogo, Japan.	kyogoku@cdb.riken.jp	Kyogoku, Hirohisa/ABF-4724-2020; Kitajima, Tomoya/A-7049-2016; Kyogoku, Hirohisa/C-9779-2017	Kitajima, Tomoya/0000-0002-6486-7143; Kyogoku, Hirohisa/0000-0002-0364-3971	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science to H.K. and Grants-in-Aid to T.M. from the Japan Society for the Promotion of Science.	Aguilera-Gomez A, 2017, DEV BIOL, V428, P310, DOI 10.1016/j.ydbio.2017.03.029; Aguirre-Lavin T, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-30; [Anonymous], 2011, BIOL REPROD, V85, P70, DOI 10.1095/biolreprod.110.089342; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; CHOUINARD LA, 1975, J CELL SCI, V17, P589; Flechon JE, 1998, ZYGOTE, V6, P183, DOI 10.1017/S0967199498000112; Fulka H, 2015, TRENDS MOL MED, V21, P663, DOI 10.1016/j.molmed.2015.09.005; Fulka H, 2014, DEVELOPMENT, V141, P1694, DOI 10.1242/dev.105940; Fulka H, 2012, J REPROD DEVELOP, V58, P371, DOI 10.1262/jrd.2011-004; Fulka J, 2004, NAT BIOTECHNOL, V22, P25, DOI 10.1038/nbt0104-25; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Inoue A, 2010, FASEB J, V24, P485, DOI 10.1096/fj.09-143370; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kyogoku H, 2017, DEV CELL, V41, P287, DOI 10.1016/j.devcel.2017.04.009; Kyogoku H, 2014, DEVELOPMENT, V141, P2255, DOI 10.1242/dev.106948; Kyogoku H, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103119; Kyogoku H, 2011, MOL REPROD DEV, V78, P426, DOI 10.1002/mrd.21320; Kyogoku H, 2010, MOL REPROD DEV, V77, P167, DOI 10.1002/mrd.21126; Li JJ, 2012, ZYGOTE, V20, P291, DOI 10.1017/S0967199411000219; Lian HY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120188; Mitrea DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03255-3; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Ogushi S, 2017, J CELL SCI, V130, P2416, DOI 10.1242/jcs.195875; Ogushi S, 2010, J REPROD DEVELOP, V56, P495, DOI 10.1262/jrd.09-184H; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Tesarik J, 1999, HUM REPROD, V14, P1318, DOI 10.1093/humrep/14.5.1318; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yamagata K, 2010, METHODS, V52, P259, DOI 10.1016/j.ymeth.2010.04.008; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhou LQ, 2015, TRENDS CELL BIOL, V25, P82, DOI 10.1016/j.tcb.2014.09.006	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202663	10.1371/journal.pone.0202663	http://dx.doi.org/10.1371/journal.pone.0202663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125305	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100041
J	Petean, FD; de Carvalho, MR				Petean, Flavia de Figueiredo; de Carvalho, Marcelo R.			Comparative morphology and systematics of the cookiecutter sharks, genus Isistius Gill (1864) (Chondrichthyes: Squaliformes: Dalatiidae)	PLOS ONE			English	Article							CHIMERAS CHONDRICHTHYES; CARTILAGINOUS FISHES; ANNOTATED CHECKLIST; BEAKED-WHALE; EUPROTOMICROIDES-ZANTEDESCHIA; PHYLOGENETIC-RELATIONSHIPS; SUPERORDER SQUALOMORPHI; ELASMOBRANCH PHYLOGENY; MEGAPTERA-NOVAEANGLIAE; PEPONOCEPHALA-ELECTRA	The dalatiid genus Isistius Gill (1864) has three valid species currently recognized in the literature: Isistius brasiliensis Quoy & Gaimard (1824), I. plutodus Garrick & Springer (1964), and I. labialis Meng, Zhu & Li (1985). The most common species, I. brasiliensis, has a wide geographic distribution and is found in subtemperate and tropical seas circumglobally. A comparative analysis of specimens from different localities throughout its range, however, had never been undertaken. In the present paper, the morphological variation of this species along its entire distribution has been thoroughly analyzed, corroborating that it represents a single widespread species and that I. labialis is its junior synonym. The other congeneric species, I. plutodus, is known from only a few specimens and is also distributed worldwide. A detailed comparative analysis of available material of I. plutodus was conducted verifying its validity as a single widespread species. The present study analyzed in detail the external morphology (coloration, dentition, dermal denticles), internal morphology (skeleton, musculature), lateral- line canals, and morphometric and meristic characters of species of Isistius in order to better define the genus and its included valid species.	[Petean, Flavia de Figueiredo] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bot & Zool, Natal, RN, Brazil; [Petean, Flavia de Figueiredo] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil; [de Carvalho, Marcelo R.] Amer Museum Nat Hist, New York, NY 10024 USA	Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo; American Museum of Natural History (AMNH)	Petean, FD (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bot & Zool, Natal, RN, Brazil.; Petean, FD (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil.	ffpetean@gmail.com	Petean, Flavia/AAU-4041-2020	Petean, Flavia/0000-0002-9949-5116	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/07668-4, 2013/09270-0, 2012/05391-5, 2012/09877-0, 2012/02349-8]; Conselho Nacional de Desenvolvimento Cietifico e Tecnologico [133880/2012-5, 305271/2015-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cietifico e Tecnologico	The work was supported by the following: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2012/07668-4, 2013/09270-0), FFP, http://www.fapesp.br/en/; Conselho Nacional de Desenvolvimento Cietifico e Tecnologico (133880/2012-5), FFP, http://cnpq.br/; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2012/05391-5, 2012/09877-0, 2012/02349-8), MRC, http://www.fapesp.br/en/; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (305271/2015-6), MRC, http://cnpq.br/. All funders had important roles in the study design, data collection and analysis, and decision to publish.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Addink M.J., 2001, Zoologische Verhandelingen (Leiden), V334, P37; Adnet S, 2001, LETHAIA, V34, P234; Aguiar Aline Augusto, 2010, Oecologia Australis, V14, P464; Alardo Souto Luciano Raimundo, 2009, Marine Biodiversity Records, V2, pe123, DOI 10.1017/S1755267209000992; Alcorn D, 1993, HAWAIIAN MONK SEAL L; Amorim AF, 1998, MAR FRESHWATER RES, V49, P621, DOI 10.1071/MF97111; Anderson PSL, 2008, J EXP BIOL, V211, P3619, DOI 10.1242/jeb.020586; Anderson R.C., 1993, SHARK FISHERIES MALD; [Anonymous], 2005, OCEANA; [Anonymous], 1876, ARCH MUSEE TEYLER; Araujo M.E., 2010, MARINE BIODIVERSITY, V3, P1, DOI DOI 10.1017/S1755267210000588; Azevedo Alexandre F., 2003, Aquatic Mammals, V29, P411, DOI 10.1578/01675420360736613; Babcock E, 2008, SHARKS OPEN OCEAN BI, P427; Bacilieri S., 2005, REVISAO TAXONOMICA G; Backus R. H., 1960, No 2 Copeia, V1960, P243; Baird R, 2008, DIEL VARIATION BEAKE; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Balfour F. M., 1881, Proceedings of the Zoological Society, P656; Bass A, 1976, SHARKS E COAST SO AF, DOI [10.1590/S1516-18462008000300012, DOI 10.1590/S1516-18462008000300012]; Bass A.J., 1978, P545; Beardsley Jr G, 1972, P INT BILLF S KAIL K, P9; BEEBE WILLIAM, 1941, ZOOLOGICA [NEW YORK], V26, P245; Belcher Rebecca L., 2002, Mammalian Species, V700, P1, DOI 10.1644/1545-1410(2002)700<0001:AT>2.0.CO;2; Bennett F. D., 1840, NARRATIVE WHALING VO; Bennett G, 1860, GATHERINGS NATURALIS; Benz G, 2004, ELASMOBRANCH HUSBAND; Benzer Paul, 1944, COPEIA, V1944, P179, DOI 10.2307/1437813; Bermudez-Villapol L.A., 2008, REV CIENTIFICA UDO A, V8, P154; Bertilsson-Friedman P, 2006, J ZOOL, V268, P361, DOI 10.1111/j.1469-7998.2006.00066.x; Best PB, 2001, MAR ECOL PROG SER, V220, P277, DOI 10.3354/meps220277; Bigelow H, 1945, APPENDIX A B GUIDE C; Bigelow HB, 1948, FISHES W N ATLANTI 1, P59; Bigelow HB, 1957, B MUSEUM COMP ZOOL, V117, P617; Bleeker P., 1874, RECHERCHES FAUNE MAD, P89; BONDE RK, 1989, J MAMMAL, V70, P447, DOI 10.2307/1381540; Bonnaterre L., 1788, TABLEAU ENCY METHODI; Bornatowski Hugo, 2009, Marine Biodiversity Records, V2, pe158, DOI 10.1017/S1755267209990868; Borsa Philippe, 2005, Pacific Science, V59, P467, DOI 10.1353/psc.2005.0033; Bossart Gregory D., 2007, Aquatic Mammals, V33, P235, DOI 10.1578/AM.33.2.2007.235; Bozzano A, 2000, BRAIN BEHAV EVOLUT, V55, P191, DOI 10.1159/000006652; Brauer A., 1908, TIEFSEE FISCHE LIEF, p[1, 1]; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; Broussonet P.M.A., 1780, HIST ACAD ROYALE SCI, V1780, P641; Brownell RL, 2007, PLANT CELL MONOGRAPH, P1; Bunkley-Williams L, 2008, COMP PARASITOL, V75, P263, DOI 10.1654/4252.1; Burckchardt Rud., 1907, Nova Acta Leopoldina, V73; Burckhardt R., 1900, ANAT ANZEIGER, V18, P488; Burckhardt R., 1900, ANN MAG NAT HIST   7, V6, P558; BURDIN A. M., 2007, SC59SM4 IWC; Bustamante C, 2014, J FISH BIOL, V85, P1617, DOI 10.1111/jfb.12517; Cadenat J, 1981, REQUIENS MEDITERRANE; Camhi MD, 2009, CONSERVATION STATUS; Carrillo-Briceno JD, 2015, J S AM EARTH SCI, V60, P56, DOI 10.1016/j.jsames.2015.02.001; Carrillo-Briceno JD, 2014, J S AM EARTH SCI, V51, P76, DOI 10.1016/j.jsames.2014.01.001; Castro J. I, 2011, SHARKS N AM; CAVANAGH RD, 2003, CONSERVATION STATUS, P170; Choy B, 1992, HAWAIIAN MONK SEAL G; Chu YT., 1979, STUDY LATERAL LINE C; Claes JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04328; Claes JM, 2012, J EXP BIOL, V215, P1691, DOI 10.1242/jeb.066704; Claes JM, 2011, J EXP MAR BIOL ECOL, V406, P1, DOI 10.1016/j.jembe.2011.05.033; Claes JM, 2010, J EXP MAR BIOL ECOL, V388, P28, DOI 10.1016/j.jembe.2010.03.009; Claes JM, 2009, J EXP BIOL, V212, P3684, DOI 10.1242/jeb.034363; Clark E., 1990, ELASMOBRANCHS LIVING, P269; Cocke J., 2002, FOSSIL SHARK TEETH W; Coello S., 2005, ADM CHONDRICHTHYES E; Compagno L., 1979, CARCHARHINOID SHARKS, VI; Compagno L., 1979, CARCHARHINOID SHARKS, VII; Compagno L, 2005, P IN SO QUEENSL EL R, P23; Compagno L.J.V., 1973, Zoological J Linn Soc, V53, P15; COMPAGNO L J V, 1970, Proceedings of the California Academy of Sciences, V38, P63; Compagno L.J.V., 2005, 243 CSIRO MAR LAB, P1; Compagno L.J.V., 1986, FAO SPECIES CAT FISH, P278, DOI [10.1016/j.neuropharm.2006.07.020, DOI 10.1016/J.NEUROPHARM.2006.07.020]; Compagno L.J.V., 1988, SHARKS ORDER CARCHAR; Compagno L.J.V., 2005, SHARKS WORLD; Compagno Leonard J.V., 2005, P503; Compagno Leonard J.V., 2008, Fish and Aquatic Resources Series, V13, P14; Compagno LJ V., 1984, FAO FISHERIES SYNOPS, V4, DOI [10.1071/MF9920109, DOI 10.1071/MF9920109]; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Compagno LJV, 1999, SHARKS, SKATES, AND RAYS, P69; COMPAGNO LJV, 1981, OCEANUS, V24, P5; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; COMPAGNO LJV, 1990, ELASMOBRANCHS LIVING, P357; Crow G.L., 2004, ELASMOBRANCH HUSBAND, V1st ed., P467; Cunha CM, 2006, ENVIRON BIOL FISH, V75, P465, DOI 10.1007/s10641-006-0034-0; Cuvier G, 1817, REGNE ANIMAL DISTRIB, VIV; Da Silva JPCB, 2018, ZOOL J LINN SOC-LOND, V182, P614, DOI 10.1093/zoolinnean/zlx051; da Silva JPCB, 2015, COPEIA, V103, P874, DOI 10.1643/CI-14-138; da Silva JPCB, 2015, ZOOL J LINN SOC-LOND, V175, P525, DOI 10.1111/zoj.12287; Dalebout ML, 2004, J ROY SOC NEW ZEAL, V34, P347, DOI 10.1080/03014223.2004.9517771; Dalebout ML, 2002, MAR MAMMAL SCI, V18, P577, DOI 10.1111/j.1748-7692.2002.tb01061.x; Daniel J. F., 1934, ELASMOBRANCH FISHES; de Carvalho Marcelo R., 1996, P35, DOI 10.1016/B978-012670950-6/50004-7; de Carvalho MR, 2004, B AM MUS NAT HIST, V284, P136; Deakos MH, 2010, AQUAT MAMM, V36, P121, DOI 10.1578/AM.36.2.2010.121; Dean B., 1891, BIBLIO FISHES, VII; Dean MN, 2005, BIOL LETTERS, V1, P357, DOI 10.1098/rsbl.2005.0319; Delgado-Estrella A, 1998, ANALES I BIOL U NACL, P129; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Dolce Jocelyne L., 2013, Bulletin of the Museum of Comparative Zoology, V161, P79, DOI 10.3099/MCZ2.1; DOLGANOV VN, 1984, ZOOL ZH, V63, P1589; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dumeril AHA, 1861, ARCH MUSEUM HIST NAT, V10, P241; Dumeril AHA, 1865, HIST NATURELLE POISS, VPremier; Duncker G., 1929, Mitteilungen aus dem Zoologischen Museum in Hamburg, V44, P57; Dwyer SL, 2011, AQUAT MAMM, V37, P111, DOI 10.1578/AM.37.2.2011.111; Dyldin Yury V., 2015, Publications of the Seto Marine Biological Laboratory, V43, P40; Ebert D.A., 2013, FAO SPECIES CAT FISH, V7, P1; Ebert D.A., 2015, POCKET GUIDE SHARKS; Ebert DA., 2013, SHARKS WORLD; Ebert David A., 2015, Marine Biodiversity Records, V8, pe118, DOI 10.1017/S1755267215000962; Ebert DA, 2013, ZOOTAXA, V 3752, P279, DOI 10.11646/zootaxa.3752.1.17; Ebert DA, 2013, ZOOTAXA, V 3752, P5, DOI 10.11646/zootaxa.3752.1.3; ELLIS JR, 1995, J FISH BIOL, V47, P155, DOI 10.1111/j.1095-8649.1995.tb01881.x; Falcon-Matos Limarie, 2003, Mastozoologia Neotropical, V10, P161; Fatio V, 1902, EXTR ARCH SCI PHYS N, V107, P524; Fergusson IK, 2008, ENVIRON BIOL FISH, V81, P207, DOI 10.1007/s10641-007-9193-x; Figueiredo JL, 1977, MANUAL PEIXES MARINH, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Fish FE, 2000, J FISH BIOL, V56, P1062, DOI 10.1111/j.1095-8649.2000.tb02123.x; Fitzpatrick B, 2006, B MAR SCI, V78, P397; FLMNH, 2018, INT SHARK ATT FIL; Foster N.R., 1990, Northwestern Naturalist, V71, P49, DOI 10.2307/3536590; Fowler H., 1928, MEM BERNICE PAUAHI B, V10, P539; Fowler H., 1941, CONTRIBUTIONS BIOL P; FOWLER HENRY W., 1934, PROC ACAD NAT SCI PHILADELPHIA, V85, P233; FOWLER HENRY W., 1926, ANN NATAL MUS, V5, P399; Fowler HW, 1930, SYNOPSIS FISHES CH 1, P24; FULTON W N, 1990, Victorian Naturalist (Blackburn), V107, P124; Furbringer M., 1903, GEGENBAURS MORPHOL J, V31, P123; Gadig O., 1994, FAUNA TUBAROES COSTA; Gadig O.B.F., 1998, CECILIANA, V8, P41; Gadig OBF, 2002, J FISH BIOL, V60, P1322, DOI 10.1006/jfbi.2002.1904; GADIG Otto Bismarck Fazzano, 2001, TUBAROES COSTA BRASI; Gardiner JM, 2012, CRC MAR BIOL SER, P349; Garman S, 1899, REPORTS EXPLORATION, VXXVI; Garman S., 1913, MEMOIRS MUSEUM COMP, VXXXVI, DOI [10.1038/188022b0, DOI 10.1038/188022B0]; Garrick J. A. F., 1964, Copeia, V1964, P678, DOI 10.2307/1441443; Gasparini JL, 1996, MAR MAMMAL SCI, V12, P308, DOI 10.1111/j.1748-7692.1996.tb00582.x; George Michael R., 2006, Zeitschrift fuer Fischkunde, V8, P71; Giglioli EH, 1912, ANN AGRICOLTURA STUD; GILBERT PW, 1972, COMP BIOCHEM PHYSIOL, V42, P97, DOI 10.1016/0300-9629(72)90371-4; Gill T., 1896, P US NATL MUS, V18, P191; Gill Th., 1864, Proceedings of the Academy of Natural Sciences of Philadelphia, P258; GILL TN, 1893, MEMOIRS NATL ACAD SC, V6, P127, DOI DOI 10.5962/BHL.PART.6303; Gmelin J.F., 1788, SYSTEMA NATURAE REGN, VI; GOLOVAN GA, 1986, J ICHTHYOL+, V26, P117; Gomes U.L., 2010, GUIA IDENTIFICACAO T, V1st ed.; Gonzalez M., 2005, TUBAROES RAIAS PREHI; Gonzalez Matheus M.B., 2000, Publicacoes Avulsas do Instituto Pau Brasil de Historia Natural, V03, P31; Goto M, 2009, SCJ09JR28, P1; Gray JE, 1851, LIST SPECIMENS FISH; Greenberg R., 2008, BEAUTY BEAST PRESENT; Grey M, 1956, FIELDIANA ZOLLOGY, V36, P77, DOI [10.5962/bhl.title.2788, DOI 10.5962/BHL.TITLE.2788]; Gunther A., 1870, BRIT MUSEUM, V8; Gunther A., 1909, J MUSEUM GODEFFROY, VIII; Haney TA, 2004, B MAR SCI, V75, P409; HAZIN FHV, 2008, SHARKS OPEN OCEAN BI, P213; Hebb R., 1903, J ROYAL MICROSCOPICA; Heithaus MR, 2012, CRC MAR BIOL SER, P505; Heithaus MR, 2001, J ZOOL, V253, P53, DOI 10.1017/S0952836901000061; Helfman G., 2014, SHARKS ANIMAL ANSWER; HERMAN J, 1989, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V59, P101; HIRUKI LM, 1993, CAN J ZOOL, V71, P469, DOI 10.1139/z93-067; HIRUKI LM, 1993, CAN J ZOOL, V71, P458, DOI 10.1139/z93-066; Hodgson ES, 1978, SENSORY BIOL SHARKS; Holmgren N., 1941, ACTA ZOOLOGICA, VXXII; Honebrink R, 2011, PAC SCI, V65, P365, DOI 10.2984/65.3.365; Howe JC, 1993, CATALOG TYPE SPECIME; Hubbs CL, 1967, B SCRIPPS I OCEANOGR, V78, DOI [10.1126/science.84.2169.83, DOI 10.1126/SCIENCE.84.2169.83]; Huber J., 2000, HAPLOCHYLUS LACAZEI; HULLEY PA, 1966, B MAR SCI, V16, P222; Hutchins M, 2003, GRZIMEKS ANIMAL LIFE, V4- 5; Iglesias S.P., 2013, CHONDRICHTHYANS CYCL; Iserbyt A, 2012, GEOL BELG, V15, P147; ISOUCHI T, 1970, Japanese Journal of Ichthyology, V17, P124; ITO RY, 1994, JPN J ICHTHYOL, V40, P482; JAHN AE, 1988, BIOL OCEANOGR, V5, P297, DOI DOI 10.1080/01965581.1987.10749519; Jefferson Thomas A., 1997, Mammalian Species, V553, P1; Jefferson Thomas A., 2003, Mammalian Species, V726, P1, DOI 10.1644/726; Jefferson Thomas A., 1994, Mammalian Species, V470, P1; Johann L., 1899, Z WISS ZOOL, V66, P136; Johnsen S, 2004, BIOL BULL-US, V207, P1, DOI 10.2307/1543624; JOHNSON JH, 1984, MAR FISH REV, V46, P30; JONES EC, 1971, FISH BULL NATL OC AT, V69, P791; Jordan D, 1913, J COLL SCI, VXXXIII, P497; JUCA-QUEIROZ B., 2008, ARQ CIENC MAR, V41, P73; Jungersen H., 1899, APPENDICES GENITALES; Kemp N., 1999, SHARKS SKATES RAYS B, P521; KING JOSEPH E., 1956, PACIFIC SCI, V10, P17; Kiraly SJ, 2000, DEEPWATER OTHER SHAR, V65, P1; Klug S, 2010, ZOOL SCR, V39, P331, DOI 10.1111/j.1463-6409.2010.00427.x; Kner R., 1864, ANZEIGER AKAD WISSEN, V1, P185; Kocsis L, 2007, GEOL CARPATH, V58, P27; Kriwet J, 2004, PALAEOGEOGR PALAEOCL, V214, P181, DOI 10.1016/j.palaeo.2004.02.049; Kriwet J, 2003, ACTA PALAEONTOL POL, V48, P583; Kriwet J, 2009, BIOLOGY AND MANAGEMENT OF DOGFISH SHARKS, P19; KYNE P, 2006, IUCN SHARK SPECIALIS; Kyne P. M., 2005, Memoirs of the Queensland Museum, V50, P321; Kyne PM, 2007, COLLATION SUMMARIZAT; Kyne PM., 2012, CONSERVATION STATUS, DOI [10.13140/2.1.4172.6403, DOI 10.13140/2.1.4172.6403]; Kyushin K., 1982, DTSCH SUDPOLAR EXPED; Lane J., 2010, AM MUS NOVIT, V3681, P70; Largacha A, 2010, 13 S BIOL MAR SANT S, V111, P4; Last PR, 2007, 014 CSIRO; Laurito C.A.M., 1996, REV GEOL AM CENT, V19, P87, DOI [10.15517/rgac.v0i19-20.8628, DOI 10.15517/RGAC.V0I19-20.8628]; LEBOEUF BJ, 1987, FISH B-NOAA, V85, P387; Leriche M., 1905, MEMOIRES MUSEE ROYAL, VIII; Lessa R, 1999, BIODIVERSIDADE ELASM, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; LEWIS RW, 1969, COMP BIOCHEM PHYSIOL, V31, P715, DOI 10.1016/0010-406X(69)92071-4; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Lisney TJ, 2007, BRAIN BEHAV EVOLUT, V69, P266, DOI 10.1159/000100036; Lowry D, 2009, MAR BIOL, V156, P2483, DOI 10.1007/s00227-009-1273-3; Lucas ZN, 2000, CAN FIELD NAT, V114, P45; Lydekker R, 1912, REPTILES AMPHIBIA FI, P405; Macleay W., 1881, P LINN SOC NEW S W 4, V1, P202; MacLeod CD, 1998, J ZOOL, V244, P71, DOI 10.1017/S0952836998001083; Madagascar Frontier, 2005, 19 FRONT MAD ENV; MAISEY J G, 1983, American Museum Novitates, P1; Maisey JG, 2013, COPEIA, P378, DOI 10.1643/CG-12-130; Maisey JG, 2014, J MORPHOL, V275, P586, DOI 10.1002/jmor.20242; Makino Y, 2004, AM J FOREN MED PATH, V25, P169, DOI 10.1097/01.paf.0000127390.07879.62; Mandelman JW, 2008, REV FISH BIOL FISHER, V18, P427, DOI 10.1007/s11160-008-9084-z; Mangold Ernst, 1907, Archiv fuer die Gesamte Physiologie Bonn, V119; Mannering AA, 2008, PALAEONTOLOGY, V51, P1341, DOI 10.1111/j.1475-4983.2008.00812.x; Martinez-Perez C, 2018, HIST BIOL, V30, P422, DOI 10.1080/08912963.2017.1326111; Matott M., 2003, EXAMINATION MODULATI; Mauricio Hoyos-Padilla E., 2012, Aqua, V18, P15; Mazzoleni R.C., 1999, NOTAS TEC FACIMAR, V3, P111; MCCORMICK HW, 1963, SHADOWS SEA SHARKS S; McKinnell S, 1998, FISH RES, V39, P127, DOI 10.1016/S0165-7836(98)00179-9; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Mejía Falla Paola A., 2007, Bol. Invest. Mar. Cost., V36, P111; Mendonca FF, 2010, CONSERV GENET RESOUR, V2, P31, DOI 10.1007/s12686-009-9131-7; Meneses T., 2008, FAUNA PESCA CONTAMIN; Meneses T.S., 2005, ARQ CIENC MAR, V38, P79, DOI [10.32360/acmar.v38i1-2.6396, DOI 10.32360/ACMAR.V38I1-2.6396]; Menezes N., 2010, BIOTA NEOTROP, V11, P33; Meng Q.-w., 1985, Acta Zootaxonomica Sinica, V10, P442; Metzelaar J., 1919, J BOEKE DUTCH W INDI; Mikhalev YA, 1997, MAR ECOL PROG SER, V149, P13, DOI 10.3354/meps149013; Mincarone Michael M., 2001, Mare Magnum, V1, P121; Miranda Ribeiro A de, 1907, ARCH MUS NAC, V14, P137; Miranda Ribeiro A de, 1923, FAUNA BRAZILIENSE PE, VII, P1; MIYAKE T, 1992, BIOL J LINN SOC, V46, P259, DOI 10.1111/j.1095-8312.1992.tb00864.x; Moore Michael, 2003, Aquatic Mammals, V29, P383, DOI 10.1578/01675420360736569; MORRIS RJ, 1983, J MAR BIOL ASSOC UK, V63, P295, DOI 10.1017/S0025315400070685; MOSS SA, 1977, AM ZOOL, V17, P355; MOSS SA, 1981, OCEANUS, V24, P23; Motta PJ, 2012, CRC MAR BIOL SER, P153; Motta PJ, 2002, COPEIA, P24, DOI 10.1643/0045-8511(2002)002[0024:KAOSFI]2.0.CO;2; Motta PJ, 2001, ENVIRON BIOL FISH, V60, P131, DOI 10.1023/A:1007649900712; Moyer JK, 2016, COPEIA, V104, P529, DOI 10.1643/CI-15-288; Muller J., 1839, SYSTEMATISCHE BESCHR; MULLIN KD, 1994, MAR MAMMAL SCI, V10, P464, DOI 10.1111/j.1748-7692.1994.tb00502.x; Munroe SEM, 2014, REV FISH BIOL FISHER, V24, P317, DOI 10.1007/s11160-013-9333-7; Musick John A., 2005, P45; NAKANO H, 1990, JPN J ICHTHYOL, V37, P60; Nakaya K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27786; Naylor GJP, 2012, CRC MAR BIOL SER, P31; NAYLOR GJP, 2012, B AM MUS NAT HIST, V367, P262; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nelson JS, 2016, FISHES WORLD, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Neto E. S., 2007, MARINE BIODIVERSITY, DOI DOI 10.1017/S1755267207009840; NORRIS KS, 1980, FISH B-NOAA, V77, P821; Nunan GW, 2007, SER LIVROS MUS NAC, V24, P163; Ohishi K, 2007, VET REC, V160, P628, DOI 10.1136/vr.160.18.628; Papastamatiou YP, 2010, ENVIRON BIOL FISH, V88, P361, DOI 10.1007/s10641-010-9649-2; Parin N., 1966, T I OKEANOL, V73, P173; Parin N., 1975, JAPANESE SOC ICHTHYO, V25, P1; Parr A.E., 1937, B BINGHAM OCEANOGR C, V3, P1; Peach MB, 2004, ACTA ZOOL-STOCKHOLM, V85, P233, DOI 10.1111/j.0001-7272.2004.00176.x; Peach MB, 2000, PHILOS T ROY SOC B, V355, P1131, DOI 10.1098/rstb.2000.0653; Perez Victor J., 2017, Bulletin of the Florida Museum of Natural History, V55, P139; Perez-Zayas Jose J., 2002, Aquatic Mammals, V28, P308; PERRIN WF, 1981, J MAMMAL, V62, P583, DOI 10.2307/1380405; Peters W., 1876, MONATSBER AKAD WISSE, P435; Petersen S., 2008, WWF S AFRICA REPORT; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Priede IG, 2006, P ROY SOC B-BIOL SCI, V273, P1435, DOI 10.1098/rspb.2005.3461; Probst J., 1879, BEITRAGE KENNTNISS F; PROEST J., 1879, JAHRESHEFTE VEREINS, V35, P127; Quoy J.R.C., 1824, VOYAGE AUTOUR MONDEE, P192, DOI 10.5962/bhl.title.152367; Rafinesque C.S., 1810, CARATTERI ALCUNI NUO; Ramsay JB, 2007, J MORPHOL, V268, P664, DOI 10.1002/jmor.10530; RASCHI W, 1992, AUST J MAR FRESH RES, V43, P123, DOI 10.1071/MF9920123; Reddy M, 1988, HAWAIIAN MONK SEAL P; Regan C. T., 1908, Annals & Magazine of Natural History, V2; REIF WE, 1985, ACTA ZOOL-STOCKHOLM, V66, P111, DOI 10.1111/j.1463-6395.1985.tb00829.x; Renner M, 2008, ARCTIC, V61, P102; Rochebrune A., 1883, ACTES SOC LINNEENNE, V36, P188; Rochebrune A. T. De., 1885, Bulletin de la Societe Philomathique, V(7), P86; Romero P., 2002, FISHBASE; Rosa Ricardo S., 2014, Arquivos de Zoologia (Sao Paulo), V45, P89; SADOWSKY V., 1988, CIENC CULT CIENTIS S, V40, P919; Sadowsky V, 1987, CIENC CULT S, V3, P660; Saez S, 2010, LAT AM J AQUAT RES, V38, P474, DOI 10.3856/vol38-issue3-fulltext-11; Saez S, 2010, REV BIOL MAR OCEANOG, V45, P619, DOI 10.4067/S0718-19572010000400008; Santos M.C.O., 2009, ARQUIVOS CIENCIAS MA, V43, P1, DOI [10.32360/acmar.v42i2.6032, DOI 10.32360/ACMAR.V42I2.6032]; Sauvage M., 1891, HIST PHYS NATURELLE, P543; Schmeltz J.D.E., 1866, CATALOG 3 ZUM VERKAU; SEIGEL JA, 1978, COPEIA, P602; Shimada K, 2002, J MORPHOL, V251, P38, DOI 10.1002/jmor.1073; SHIRAI S, 1992, ZOOL SCI, V9, P811; SHIRAI S, 1992, JPN J ICHTHYOL, V39, P139, DOI 10.1007/BF02905997; SHIRAI S, 1992, COPEIA, P505; Shirai S, 1990, NAT OCEANIC ATMOSPHE, V90, P347; Shirai S., 1992, SQUALEAN PHYLOGENY N; Shirai Shigeru, 1996, P9, DOI 10.1016/B978-012670950-6/50003-5; Sielfeld Walter, 2004, Ciencia y Tecnologia del Mar, V27, P77; Sigler MF, 2006, J FISH BIOL, V69, P392, DOI 10.1111/j.1095-8649.2006.01096.x; Silva JM, 2007, SCI MAR, V71, P505; Silva-Jr José Martins, 2003, Biota Neotrop., V3, P1, DOI 10.1590/S1676-06032003000200012; SMITH HM, 1912, P US NATL MUS, V41, P677, DOI DOI 10.5479/SI.00963801.41-1877.677; Soto Jules M. R., 2001, Mare Magnum, V1, P27; Soto Jules M. R., 2001, Mare Magnum, V1, P51; Soto Jules M. R., 2004, Mare Magnum, V2, P1; Soto Jules M. R., 2001, Mare Magnum, V1, P23; Souto Luciano Raimundo Alardo, 2007, Biotemas, V20, P19; Souza SP., 2005, LAT AM J AQUAT RES, V4, P129, DOI [10.5597/lajam00077, DOI 10.5597/LAJAM00077]; Stacey Pam J., 1994, Mammalian Species, V456, P1; STEHMANN M, 1988, ARCH FISCHEREIWISS, V39, P1; Stehmann M., 1999, J ICHTHYOL, V39, P606; Stehmann MFW, 2015, CYBIUM, V39, P73; Steiner L., 2008, MAR BIODIVERS REC, V1, pArticl, DOI [10.1017/S1755267207007282, DOI 10.1017/S1755267207007282]; Strasburg D.W., 1963, COPEIA, V1, P33, DOI [10.2307/1441272, DOI 10.2307/1441272]; Straube N, 2010, MOL PHYLOGENET EVOL, V56, P905, DOI 10.1016/j.ympev.2010.04.042; Taylor L. R., 1983, P CALIFORNIA ACAD SC, V43, P87, DOI DOI 10.1017/CBO9781107415324.004; THOMSON KS, 1977, AM ZOOL, V17, P343; Tinker S.W., 1944, HAWAIIAN FISHES HDB; Van den Hoff J, 2005, J WILDLIFE MANAGE, V69, P1015, DOI 10.2193/0022-541X(2005)069[1015:EBMACO]2.0.CO;2; Van Waerebeek K, 2008, FDN INT BANC ARG, DOI [10.13140/RG.2.1.2596.9763, DOI 10.13140/RG.2.1.2596.9763]; Velozo Raquel Sa, 2009, Marine Biodiversity Records, V2, pe117, DOI 10.1017/S1755267209000980; Vialle Nicolas, 2011, Swiss Journal of Palaeontology, V130, P241, DOI 10.1007/s13358-011-0025-4; Visser IN, 1999, NEW ZEAL J MAR FRESH, V33, P515, DOI 10.1080/00288330.1999.9516896; Waite E., 1897, REC AUST MUS, VIII, P233; Waite E. R., 1904, Records of the Australian Museum, Vv, P187; Waite E. R., 1900, Records of the Australian Museum, Viii, P193; Walker WA, 1999, MAR MAMMAL SCI, V15, P1314, DOI 10.1111/j.1748-7692.1999.tb00893.x; Wardle WJ, 2000, CRUSTACEANA, V73, P639, DOI 10.1163/156854000504615; Weigmann S, 2016, J FISH BIOL, V88, P837, DOI 10.1111/jfb.12874; Weir JS, 2008, CAN J ZOOL, V86, P1225, DOI 10.1139/Z08-101; Wenzel Frederick W., 2012, Zoologia Caboverdiana, V3, P57; Wetherbee BM, 1990, ELASMOBRANCHS LIVING, V90, P29; Wetherbee BM, 2012, CRC MAR BIOL SER, P239; White EG, 1938, B AM MUS NAT HIST, V74, P25; White WT, 2010, J FISH BIOL, V76, P1362, DOI 10.1111/j.1095-8649.2010.02560.x; White W.T., 2006, EC IMPORTANT SHARKS; White WT, 2013, ZOOTAXA, V 3752, P228, DOI 10.11646/zootaxa.3752.1.14; Whitley G. P., 1927, Records of the Australian Museum, V15, P289; Whitley G. P., 1940, FISHES AUSTR 1; Widder EA, 1998, ENVIRON BIOL FISH, V53, P267, DOI 10.1023/A:1007498915860; Wilga CAD, 2004, CRC MAR BIOL SER, P139; Williams ME, 2001, J VERTEBR PALEONTOL, V21, P214, DOI 10.1671/0272-4634(2001)021[0214:TRICSW]2.0.CO;2; Wullimann MF., 1987, P 5 C EUR ICHTH P 5 C EUR ICHTH, P65; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yearsley G, 2006, STANDARD NAMES AUSTR; Zanelatto Regina Celia, 1995, Iheringia Serie Zoologia, V79, P141; Zerbini Alexandre N., 1997, Aquatic Mammals, V23, P105; Zidowitz H, 2004, J FISH BIOL, V64, P1430, DOI 10.1111/j.0022-1112.2004.00382.x; Zidowitz H., 2003, BIOL GATTUNG ZIGARRE, P1; [No title captured]	361	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201913	10.1371/journal.pone.0201913	http://dx.doi.org/10.1371/journal.pone.0201913			98	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125292	gold, Green Published			2022-12-26	WOS:000442202100014
J	Goodliffe, JW; Song, HB; Rubakovic, A; Chang, WY; Medalla, M; Weaver, CM; Luebke, JI				Goodliffe, Joseph W.; Song, Hanbing; Rubakovic, Anastasia; Chang, Wayne; Medalla, Maria; Weaver, Christina M.; Luebke, Jennifer, I			Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175(+/-) mouse model of Huntington's Disease	PLOS ONE			English	Article							PYRAMIDAL NEURONS; RHESUS-MONKEY; PREFRONTAL CORTEX; TRANSGENIC MICE; IN-VIVO; DOPAMINE; PATHWAY; PET; DYSFUNCTION; PREPROENKEPHALIN	Huntington's Disease (HD) is an autosomal dominant, progressive neurodegenerative disorder caused by deleterious expansion of CAG repeats in the Huntingtin gene and production of neurotoxic mutant Huntingtin protein (mHTT). The key pathological feature of HD is a profound degeneration of the striatum and a loss of cortical volume. The initial loss of indirect pathway (D2) medium spiny neuron (MSN) projections in early stages of HD, followed by a loss of direct pathway (D1) projections in advanced stages has important implications for the trajectory of motor and cognitive dysfunction in HD, but is not yet understood. Mouse models of HD have yielded important information on the effects and mechanisms of mHTT toxicity; however, whether these models recapitulate differential vulnerability of D1 vs. D2 MSNs is unknown. Here, we employed 12-month-old Q175(+/-) x D2-eGFP mice to examine the detailed structural and functional properties of D1 vs. D2 MSNs. While both D1 and D2 MSNs exhibited increased input resistance, depolarized resting membrane potentials and action potential threshold, only D1 MSNs showed reduced rheobase, action potential amplitude and frequency of spontaneous excitatory postsynaptic currents. Furthermore, D1 but not D2 MSNs showed marked proliferative changes to their dendritic arbors and reductions in spine density. Immunohistochemical assessment showed no loss of glutamatergic afferent inputs from cortical and subcortical sources onto identified D1 and D2 MSNs. Computational models constrained by empirical data predict that the increased dendritic complexity in Q175(+/-) D1 MSNs likely leads to greater dendritic filtering and attenuation of signals propagating to the soma from the dendrites. Together these findings reveal that, by twelve months, D1 and D2 MSNs exhibit distinctive responses to the presence of mHTT in this important mouse model of HD. This further highlights the need to incorporate findings from D1 and D2 MSNs independently in the context of HD models.	[Goodliffe, Joseph W.; Rubakovic, Anastasia; Chang, Wayne; Medalla, Maria; Luebke, Jennifer, I] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Song, Hanbing; Weaver, Christina M.] Franklin & Marshall Coll, Dept Math & Comp Sci, Lancaster, PA 17604 USA	Boston University; Franklin & Marshall College	Luebke, JI (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	jluebke@bu.edu	Song, Hanbing/HHN-1741-2022; Song, Hanbing/HII-7745-2022	Medalla, Maria/0000-0003-4890-2532; Luebke, Jennifer/0000-0003-1399-6073	CHDI Foundation; National Science Foundation [ACI-1548562]	CHDI Foundation; National Science Foundation(National Science Foundation (NSF))	CHDI Foundation funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported generously by CHDI Foundation. Simulations used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1548562.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Akbergenova Y, 2017, J NEUROSCI, V37, P3425, DOI 10.1523/JNEUROSCI.2752-16.2017; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Amatrudo JM, 2012, J NEUROSCI, V32, P13644, DOI 10.1523/JNEUROSCI.2581-12.2012; Andre VM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00046; Ansari AM, 2016, STEM CELL REV REP, V12, P553, DOI 10.1007/s12015-016-9670-8; Ariano MA, 2005, J NEUROSCI RES, V80, P634, DOI 10.1002/jnr.20492; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Barry J, 2018, J NEUROSCI, V38, P4678, DOI 10.1523/JNEUROSCI.0434-18.2018; BROWN TH, 1992, SINGLE NEURON COMPUT, P81; Carnevale NT, 1997, J NEUROPHYSIOL, V78, P703, DOI 10.1152/jn.1997.78.2.703; Carnevale NT, 2006, NEURON BOOK; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2008, EUR J NEUROSCI, V27, P671, DOI 10.1111/j.1460-9568.2008.06038.x; Cepeda C, 2013, J NEUROSCI, V33, P7393, DOI 10.1523/JNEUROSCI.2137-12.2013; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Coskren PJ, 2015, J COMPUT NEUROSCI, V38, P263, DOI 10.1007/s10827-014-0541-5; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; Deng YP, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00198; Dickey AS, 2017, AM J MED GENET A; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; Evans RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002493; Ganini D, 2017, REDOX BIOL, V12, P462, DOI 10.1016/j.redox.2017.03.002; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Ginovart N, 1997, BRAIN, V120, P503, DOI 10.1093/brain/120.3.503; Glass M, 2000, NEUROSCIENCE, V97, P505, DOI 10.1016/S0306-4522(00)00008-7; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Haddad MS, 1997, PSYCHIAT CLIN N AM, V20, P791, DOI 10.1016/S0193-953X(05)70345-2; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Huerta-Ocampo I, 2014, BRAIN STRUCT FUNCT, V219, P1787, DOI 10.1007/s00429-013-0601-z; Indersmitten T, 2015, J NEUROPHYSIOL, V113, P2953, DOI 10.1152/jn.01056.2014; Ionis Pharmaceuticals, 2018, IONIS PHARM SAFETY T; Jensen EC, 2012, ANAT REC, V295, P2031, DOI 10.1002/ar.22602; JOYCE JN, 1988, SYNAPSE, V2, P546, DOI 10.1002/syn.890020511; Kabaso D, 2009, CEREB CORTEX, V19, P2248, DOI 10.1093/cercor/bhn242; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kay C, 2014, CLIN GENET, V86, P29, DOI 10.1111/cge.12385; KEMP JM, 1971, PHILOS T R SOC B, V262, P429, DOI 10.1098/rstb.1971.0105; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Medalla M, 2017, J NEUROSCI, V37, P4717, DOI 10.1523/JNEUROSCI.3757-16.2017; Medalla M, 2015, J NEUROSCI, V35, P112, DOI 10.1523/JNEUROSCI.3426-14.2015; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Nakamura T, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00056; Niccolini F, 2018, J NEUROL NEUROSUR PS, V89, P185, DOI 10.1136/jnnp-2017-316633; Plotkin JL, 2014, NEURON, V83, P178, DOI 10.1016/j.neuron.2014.05.032; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Raymond LA, 2017, BIOCHEM BIOPH RES CO, V483, P1051, DOI 10.1016/j.bbrc.2016.07.058; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rocher AB, 2016, NEUROBIOL DIS, V86, P131, DOI 10.1016/j.nbd.2015.10.016; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rumbell TH, 2016, J COMPUT NEUROSCI, V41, P65, DOI 10.1007/s10827-016-0605-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastianutto I, 2017, NEUROBIOL DIS, V105, P117, DOI 10.1016/j.nbd.2017.05.011; Smith GS, 1998, NEUROPSYCHOPHARMACOL, V18, P18; Southwell AL, 2016, HUM MOL GENET, V25, P3654, DOI 10.1093/hmg/ddw212; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tabrizi, 2017, EUR J NEUROL; Tomkins A, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00192; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; TSAI KY, 1994, NETWORK-COMP NEURAL, V5, P21, DOI 10.1088/0954-898X/5/1/002; TURJANSKI N, 1995, BRAIN, V118, P689, DOI 10.1093/brain/118.3.689; Tyler WA, 2015, J NEUROSCI, V35, P6142, DOI 10.1523/JNEUROSCI.0335-15.2015; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wilson H, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00011; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Wyant KJ, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0739-9; Zheng PS, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00070	76	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0200626	10.1371/journal.pone.0200626	http://dx.doi.org/10.1371/journal.pone.0200626			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118496	gold, Green Submitted, Green Published			2022-12-26	WOS:000442282700003
J	Hao, J; Godley, A; Shoemake, JD; Han, ZY; Magnelli, A; Yu, JS				Hao, Jing; Godley, Andrew; Shoemake, Jocelyn D.; Han, Zheyi; Magnelli, Anthony; Yu, Jennifer S.			The effects of extra high dose rate irradiation on glioma stem-like cells	PLOS ONE			English	Article							BRAIN-TUMORS; ADJUVANT TEMOZOLOMIDE; RADIATION-RESISTANCE; GLIOBLASTOMA; SURVIVAL; IDENTIFICATION; RADIOTHERAPY; CONCOMITANT; GROWTH; BEAMS	Radiation therapy is an integral part of treatment for patients with glioblastoma. New technological advances in linear accelerators have made extra-high dose rate irradiation possible. This shortens patient treatment time significantly compared to standard dose rate irradiation, but the biologic effects of extra high dose rate irradiation are poorly understood. Glioma stem-like cells (GSCs) are resistant to standard radiation and contribute to tumor progression. Here, we assess the therapeutic effect of extra high dose rate vs. standard dose rate irradiation on GSCs. GSCs were exposed to 2, 4 and 6 Gy X-irradiation at dose rates of 4.2 Gy/min or 21.2 Gy/min (400 monitoring units (MU)/min or 2100 MU/min). We analyzed cell survival with cell growth assays, tumorsphere formation assays and colony formation assays. Cell kill and self-renewal were dependent on the total dose of radiation delivered. However, there was no difference in survival of GSCs or DNA damage repair in GSCs irradiated at different dose rates. GSCs exhibited significant G1 and G2/M phase arrest and increased apoptosis with higher doses of radiation but there was no difference between the two dose rates at each given dose. In a GSC-derived preclinical model of glioblastoma, radiation extended animal survival, but there was no difference in survival in mice receiving different dose rates of radiation. We conclude that GSCs respond to larger fractions of radiation, but extra high dose rate irradiation has no significant biologic advantage in comparison with standard dose rate irradiation.	[Hao, Jing; Shoemake, Jocelyn D.; Yu, Jennifer S.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Godley, Andrew; Magnelli, Anthony; Yu, Jennifer S.] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Han, Zheyi; Yu, Jennifer S.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Yu, Jennifer S.] Cleveland Clin, Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Yu, JS (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.; Yu, JS (corresponding author), Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44106 USA.; Yu, JS (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.; Yu, JS (corresponding author), Cleveland Clin, Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA.	yuj2@ccf.org		Godley, Andrew/0000-0002-8896-5231; , Jennifer/0000-0002-0244-4014	Cleveland Clinic; National Institutes of Health, National Institute of Neurologic Disorders and Stroke [R01NS094199, R01NS092641]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092641, R01NS094199] Funding Source: NIH RePORTER	Cleveland Clinic; National Institutes of Health, National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Cleveland Clinic, by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke, R01NS094199 and R01NS092641 (JSY). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Adeberg S, 2017, RADIOL ONCOL, V51, P431, DOI 10.1515/raon-2017-0042; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hambardzumyan D, 2006, CANCER CELL, V10, P454, DOI 10.1016/j.ccr.2006.11.008; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Karan T, 2013, PHYS MED BIOL, V58, P1075, DOI 10.1088/0031-9155/58/4/1075; Lasio G, 2014, RADIAT ENVIRON BIOPH, V53, P671, DOI 10.1007/s00411-014-0565-2; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu JF, 2018, INT J RADIAT BIOL, V94, P394, DOI 10.1080/09553002.2018.1440094; Lohse I, 2011, RADIOTHER ONCOL, V101, P226, DOI 10.1016/j.radonc.2011.05.072; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Man JH, 2018, CELL STEM CELL, V22, P104, DOI 10.1016/j.stem.2017.10.005; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Sarojini S, 2015, MELANOMA RES, V25, P376, DOI 10.1097/CMR.0000000000000174; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Verbakel WFAR, 2013, ACTA ONCOL, V52, P652, DOI 10.3109/0284186X.2012.737021; Wang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133728	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202533	10.1371/journal.pone.0202533	http://dx.doi.org/10.1371/journal.pone.0202533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118510	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700032
J	Seyedsadjadi, N; Berg, J; Bilgin, AA; Braidy, N; Salonikas, C; Grant, R				Seyedsadjadi, Neda; Berg, Jade; Bilgin, Ayse A.; Braidy, Nady; Salonikas, Chris; Grant, Ross			High protein intake is associated with low plasma NAD(+) levels in a healthy human cohort	PLOS ONE			English	Article							OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CALORIC RESTRICTION; KYNURENINE PATHWAY; LIFE-SPAN; METABOLISM; CELLS; CD38; INFLAMMATION; PERFORMANCE	High protein intake and reduced levels of the essential pyridine nucleotide nicotinamide adenine dinucleotide (NAD(+)) have both been independently associated with promotion of the ageing phenotype. However, it has not yet been shown whether these two independent observations are biochemically linked. To investigate this possibility, we used a cross-sectional study design of 100 apparently healthy middle-aged males (n = 48) and females, in which we assessed average dietary intakes of multiple components using a validated questionnaire. We also analysed fasting blood levels of urea, NAD(+) and its metabolites, and inflammation-linked biomarkers, including interleukin-6 (IL-6), Kynurenine (Kyn), and Tryptophan (Trp). One-way ANOVA and ANCOVA were then performed for statistical analysis. Our results have shown for the first time that plasma levels of NAD(+) and Total NAD(H) were lower with increasing protein intake (F (2, 92) = 4.61, P = 0.012; F (2, 92) = 4.55, P = 0.013, respectively). The associated decrease in NAD(+) and NAD(H) levels was even stronger with increasing plasma levels of the protein breakdown product urea (F (2, 93) = 25.11, P <= 0.001; F (2, 93) = 21.10, P <= 0.001). These associations were all independent of age, gender and energy intake. However, no significant association was observed between protein intake or plasma urea, and plasma levels of NAD(+) metabolites. We also observed that plasma levels of the inflammatory cytokine IL-6, and both Kyn, and Trp, but not the Kyn/Trp ratio were higher with increasing plasma urea levels (F (2, 94) = 3.30, P = 0.041; F (2, 95) = 7.41, P <= 0.001; F (2, 96) = 4.23, P = 0.017, respectively). These associations were dependent on eGFR and energy intake, except for the urea and Trp association that was independent of all. In conclusion, we report for the first time, a novel association between protein intake, its metabolism, and plasma NAD(+) levels with a possible link to inflammation. These findings provide further insight into how protein restriction may contribute to the anti-ageing process observed in several studies.	[Seyedsadjadi, Neda; Grant, Ross] Univ New South Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Seyedsadjadi, Neda; Berg, Jade; Salonikas, Chris; Grant, Ross] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia; [Bilgin, Ayse A.] Macquarie Univ, Dept Stat, Sydney, NSW, Australia; [Braidy, Nady] Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia; [Grant, Ross] Univ Sydney, Sydney Adventist Hosp Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; Sydney Adventist Hospital; Macquarie University; University of New South Wales Sydney; University of Sydney	Grant, R (corresponding author), Univ New South Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia.; Grant, R (corresponding author), Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia.; Grant, R (corresponding author), Univ Sydney, Sydney Adventist Hosp Clin Sch, Sydney, NSW, Australia.	r.grant@unsw.edu.au		Bilgin, Ayse/0000-0001-8760-5763; Braidy, Nady/0000-0002-0497-5572	Australasian Research Institute; University of New South Wales	Australasian Research Institute; University of New South Wales	This study was funded by internal funding from the Australasian Research Institute (received by RG) and student allocated funding from the University of New South Wales (received by NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Braidy N, 2017, NEURAL REGEN RES, V12, P39, DOI 10.4103/1673-5374.198971; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Bustamante S, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-017-1310-z; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; CLARK JB, 1966, NATURE, V210, P631, DOI 10.1038/210631b0; D'Apolito M, 2015, ATHEROSCLEROSIS, V239, P393, DOI 10.1016/j.atherosclerosis.2015.01.034; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Eskelinen MH, 2011, DEMENT GER COGN D EX, V1, P103, DOI 10.1159/000327518; Fanson BG, 2009, AGING CELL, V8, P514, DOI 10.1111/j.1474-9726.2009.00497.x; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Gambini J, 2011, ARCH BIOCHEM BIOPHYS, V512, P24, DOI 10.1016/j.abb.2011.04.020; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; IBM Corp. Released, 2015, IBM SPSS STAT WINDOW; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; KUBOTA H, 1982, J NUTR SCI VITAMINOL, V28, P57, DOI 10.3177/jnsv.28.57; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; MacKay D, 2012, NUTR REV, V70, P357, DOI 10.1111/j.1753-4887.2012.00479.x; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Massudi H, 2012, REDOX REP, V17, P28, DOI 10.1179/1351000212Y.0000000001; Menon RM, 2007, INT J CLIN PHARM TH, V45, P448; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009; Parrella E, 2013, AGING CELL, V12, P257, DOI 10.1111/acel.12049; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Pawlak D., 2001, International Urology and Nephrology, V33, P399, DOI 10.1023/A:1015238418500; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Schweitzer K, 2001, ANAL BIOCHEM, V299, P218, DOI 10.1006/abio.2001.5419; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Song H, 2011, INT IMMUNOPHARMACOL, V11, P932, DOI 10.1016/j.intimp.2011.02.005; Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011; Nguyen-Pham TN, 2011, CELL MOL IMMUNOL, V8, P341, DOI 10.1038/cmi.2011.7; Thorpe JM, 1999, J NUTR, V129, P343, DOI 10.1093/jn/129.2.343; Wang QX, 2015, FRONT BIOSCI-LANDMRK, V20, P1116, DOI 10.2741/4363; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zhen QN, 2011, CLIN BIOCHEM, V44, P226, DOI 10.1016/j.clinbiochem.2010.10.011; Zhu XH, 2015, P NATL ACAD SCI USA, V112, P2876, DOI 10.1073/pnas.1417921112	48	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201968	10.1371/journal.pone.0201968	http://dx.doi.org/10.1371/journal.pone.0201968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114226	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400035
J	Rearick, DC; Telgmann, L; Hintelmann, H; Frost, PC; Xenopoulos, MA				Rearick, Daniel C.; Telgmann, Lena; Hintelmann, Holger; Frost, Paul C.; Xenopoulos, Marguerite A.			Spatial and temporal trends in the fate of silver nanoparticles in a whole-lake addition study	PLOS ONE			English	Article							MICROCOSMS DETERMINE FATE; ENVIRONMENTAL FATE; ORGANIC-CARBON; BOREAL LAKE; ENGINEERED NANOMATERIALS; AGGREGATION KINETICS; ABIOTIC INTERACTIONS; CONSUMER PRODUCTS; TOXICITY; IMPACT	Studies of the fate and toxicity of nanoparticles, including nanosilver (AgNPs), have been primarily conducted using bench scale studies over relatively short periods of time. To better understand the fate of AgNPs in natural aquatic ecosystems over longer time scales and ecological settings, we released suspensions of AgNPs (30-50 nm, capped with polyvinylpyrrolidone) into a boreal lake at the Experimental Lakes Area in Canada. Approximately 9 kg of silver was added from a shoreline point source from June to October 2014, which resulted in total Ag (TAg) concentrations of about 10 mu g L-1 or less. In addition, dissolved Ag concentrations (DAg) were typically very low. Using single particle inductively coupled plasma mass spectrometry (sp-ICP-MS) analysis of grab samples, we found that the nanoparticles typically ranged in the 40-60 nm size class and were widely distributed throughout the lake, while larger aggregates (i.e. >100 nm) were infrequently detected. The highest occurrence of aggregates was found near the addition site; however, size distributions did not vary significantly among spatial locations or time suggesting rapid dispersal upon entry into the lake. Lake stratification at the thermocline was not a barrier to mobility of the AgNPs, as the particles were also detected in the hypolimnion. Environmental factors influenced Ag size distributions over sampling locations and time. Total dissolved phosphorus, bacterio-plankton chlorophyll-a, and sampling time strongly correlated with aggregation and dissolution dynamics. AgNPs thus appear to be relatively mobile and persistent over the growing season in lake ecosystems.	[Rearick, Daniel C.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada; [Telgmann, Lena; Hintelmann, Holger] Trent Univ, Water Qual Ctr, Dept Chem, Peterborough, ON, Canada; [Frost, Paul C.; Xenopoulos, Marguerite A.] Trent Univ, Dept Biol, Peterborough, ON, Canada	Trent University; Trent University; Trent University	Rearick, DC (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada.	danielrearick@trentu.ca	Hintelmann, Holger/AEV-0466-2022; Frost, Paul/AAT-6633-2021	Hintelmann, Holger/0000-0002-5287-483X; 	Natural Sciences and Engineering Research Council (NSERC) of Canada [413230-2011]; Environment and Climate Change Canada; Ontario Trillium Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment and Climate Change Canada; Ontario Trillium Scholarship	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada through the Strategic Grants Program (Project 413230-2011), http://www.nserc-crsng.gc.ca/index_eng.asp, HH, PCF, MAX. Matching grants from Environment and Climate Change Canada also funded the project, https://www.ec.gc.ca/?lang=en, HH, PCF, MAX. Support from an Ontario Trillium Scholarship was awarded to DCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken GR, 2011, ENVIRON SCI TECHNOL, V45, P3196, DOI 10.1021/es103992s; Arar E.J., 1997, 4460 US EPA, P1; Baalousha M, 2013, SCI TOTAL ENVIRON, V454, P119, DOI 10.1016/j.scitotenv.2013.02.093; Blakelock GC, 2016, FRESHWATER BIOL, V61, P2211, DOI 10.1111/fwb.12788; Boehrer B, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000210; Bone AJ, 2012, ENVIRON SCI TECHNOL, V46, P6925, DOI 10.1021/es204683m; Brauer A, 2004, CLIMATE HIST TIMES S; Cleveland D, 2012, SCI TOTAL ENVIRON, V421, P267, DOI 10.1016/j.scitotenv.2012.01.025; Colman BP, 2014, ENVIRON SCI TECHNOL, V48, P5229, DOI 10.1021/es405454v; CRUMPTON WG, 1992, LIMNOL OCEANOGR, V37, P907, DOI 10.4319/lo.1992.37.4.0907; Das P, 2014, ENVIRON SCI TECHNOL, V48, P4573, DOI 10.1021/es405039w; El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Furtado LM, 2015, ENVIRON SCI TECHNOL, V49, P8441, DOI 10.1021/acs.est.5b01116; Furtado LM, 2014, ENVIRON CHEM, V11, P419, DOI 10.1071/EN14064; Gao J, 2009, ENVIRON SCI TECHNOL, V43, P3322, DOI 10.1021/es803315v; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Greensberg A. E., 1992, WATER WORK, V18, P108; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Hotter DA, 2014, ENVIRON TOXICOL CHEM, V33, p[Are nanosized or dissolved metals more toxic in the environment? A meta, 2733], DOI [10.1002latc.2732, DOI 10.1002LATC.2732]; Howard AG, 2010, J ENVIRON MONITOR, V12, P135, DOI [10.1039/013681a, 10.1039/b913681a, 10.1039/B913681A]; Hudson JJ, 2000, NATURE, V406, P54, DOI 10.1038/35017531; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Levard C, 2013, ENVIRON SCI TECHNOL, V47, P5738, DOI 10.1021/es400396f; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Li X, 2012, ENVIRON SCI TECHNOL, V46, P5378, DOI 10.1021/es204531y; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Martin JD, 2017, B ENVIRON CONTAM TOX, V98, P589, DOI 10.1007/s00128-017-2067-9; McTeer J, 2014, NANOTOXICOLOGY, V8, P305, DOI 10.3109/17435390.2013.778346; Metz KM, 2009, ENVIRON SCI TECHNOL, V43, P1598, DOI 10.1021/es802217y; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Mitrano DM, 2012, J ANAL ATOM SPECTROM, V27, P1131, DOI 10.1039/c2ja30021d; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Pace HE, 2011, ANAL CHEM, V83, P9361, DOI 10.1021/ac201952t; Poda AR, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1673-7; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Rusak JA, 1999, AM NAT, V153, P46, DOI 10.1086/303147; Sun TY, 2014, ENVIRON POLLUT, V185, P69, DOI 10.1016/j.envpol.2013.10.004; Telgmann L, 2014, J ANAL ATOM SPECTROM, V29, P1265, DOI 10.1039/c4ja00115j; Tuoriniemi J, 2012, ANAL CHEM, V84, P3965, DOI 10.1021/ac203005r; Unrine JM, 2012, ENVIRON SCI TECHNOL, V46, P6915, DOI 10.1021/es204682q; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Vincent JL, 2017, ECOTOXICOLOGY, V26, P502, DOI 10.1007/s10646-017-1781-8; Wilson HF, 2008, ECOSYSTEMS, V11, P555, DOI 10.1007/s10021-008-9142-3; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wolfaardt G, 1999, MICROBIAL EXTRACELLU, P118; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Zhang CQ, 2016, WATER RES, V88, P403, DOI 10.1016/j.watres.2015.10.025; Zhang HY, 2012, WATER RES, V46, P691, DOI 10.1016/j.watres.2011.11.037; Zhang W, 2011, ENVIRON POLLUT, V159, P3757, DOI 10.1016/j.envpol.2011.07.013	53	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201412	10.1371/journal.pone.0201412	http://dx.doi.org/10.1371/journal.pone.0201412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110351	Green Submitted, gold, Green Published			2022-12-26	WOS:000441738000026
J	Nojima, S; Classen, A; Groot, AT; Schal, C				Nojima, Satoshi; Classen, Alice; Groot, Astrid T.; Schal, Coby			Qualitative and quantitative analysis of chemicals emitted from the pheromone gland of individual Heliothis subflexa females	PLOS ONE			English	Article							SEX-PHEROMONE; LEPIDOPTERA; RELEASE; NOCTUIDAE; VIRESCENS; BLENDS; RATIO; MOTHS	The chemicals emitted from the sex pheromone gland of individual Heliothis subflexa females were sampled using a short section of thick-film megabore fused silica capillary column, and the pheromone glands of the same females were extracted after the effluvia collection. Both samples were treated with a silylation reagent, and then subjected to gas chromatography-chemical ionization-mass spectrometry for quantitative and qualitative analysis of all components. The total amount of all 11 components emitted from the glands of calling females was 153 ng/female/hr, which was substantially higher than previously reported. The ratios of the pheromone components in the volatile emissions and pheromone gland extracts were generally similar to previous studies, but with notable differences. The collections of volatiles and gland extractions contained, respectively: Z9-14: Ald (1.57%, 1.35%), 14: Ald (3.78%, 1.51%), Z7 + Z9-16: Ald (9.60%, 3.59%), Z11-16: Ald (76.14%, 18.94%), 16: Ald (2.95%, 2.17%), Z9-16: OH (0.07%, 7.21%), Z11-16: OH (1.11%, 49.04%), Z7-16: OAc (0.48%, 1.73%), Z9-16: OAc (1.32%, 4.02%), and Z11-16: OAc (2.98%, 10.43%). The thick-film megabore column is an efficient approach for sampling the head-space for semiochemicals.	[Nojima, Satoshi; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant pathol, Raleigh, NC 27695 USA; [Classen, Alice; Groot, Astrid T.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Schal, Coby] North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Nojima, Satoshi] Shin Etsu Chem Co Ltd, Tokyo, Japan	University of North Carolina; North Carolina State University; University of Amsterdam; University of North Carolina; North Carolina State University; Shin-Etsu Chemical Company	Schal, C (corresponding author), North Carolina State Univ, Dept Entomol & Plant pathol, Raleigh, NC 27695 USA.; Schal, C (corresponding author), North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010; Classen, Alice/H-7655-2013; Groot, Astrid T/A-8954-2013	Schal, Coby/0000-0001-7195-6358; Classen, Alice/0000-0002-7813-8806; Groot, Astrid T/0000-0001-9595-0161	National Science Foundation [IOS-1456973]; Blanton J. Whitmire Endowment at North Carolina State University	National Science Foundation(National Science Foundation (NSF)); Blanton J. Whitmire Endowment at North Carolina State University	This research was supported by the National Science Foundation (award IOS-1456973) and the Blanton J. Whitmire Endowment at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P1; Allison JD, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P11; [Anonymous], 2014, PHEROMONES ANIMAL BE; [Anonymous], 2018, PHEROBASE DATABASE I; ATTYGALLE AB, 1986, ANAL CHEM, V58, P3054, DOI 10.1021/ac00127a034; Choi MY, 2005, ARCH INSECT BIOCHEM, V59, P53, DOI 10.1002/arch.20051; GROB K, 1976, J CHROMATOGR, V117, P285, DOI 10.1016/0021-9673(76)80005-2; Groot AT, 2007, J CHEM ECOL, V33, P353, DOI 10.1007/s10886-006-9233-6; Groot Astrid T, 2018, J Chem Ecol, V44, P621, DOI 10.1007/s10886-018-0995-4; HEATH RR, 1992, J CHEM ECOL, V18, P1209, DOI 10.1007/BF00980075; HEATH RR, 1990, J CHEM ECOL, V16, P1259, DOI 10.1007/BF01021024; HEATH RR, 1991, ANN ENTOMOL SOC AM, V84, P182, DOI 10.1093/aesa/84.2.182; KLUN JA, 1982, ENVIRON ENTOMOL, V11, P1084, DOI 10.1093/ee/11.5.1084; Kuenen LPS, 2015, J CHEM ECOL, V41, P303, DOI 10.1007/s10886-015-0557-y; Kuenen LPS, 2015, ENTOMOL EXP APPL, V154, P35, DOI 10.1111/eea.12253; Lievers R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161138; McELVARE R. R., 1941, BULL BROOKLYN ENT SOC, V36, P29; Morse D., 1987, P121; Nojima S, 2008, J CHEM ECOL, V34, P418, DOI 10.1007/s10886-008-9437-z; Nojima S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018178; Nongonierma A, 2006, FOOD REV INT, V22, P51, DOI 10.1080/87559120500379951; Percy-Cunningham J.E., 1987, P27; Qualley AV, 2009, METHODS MOL BIOL, V553, P329, DOI 10.1007/978-1-60327-563-7_17; Roelofs WL, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P3; SOWER LL, 1971, ANN ENTOMOL SOC AM, V64, P488, DOI 10.1093/aesa/64.2.488; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; TEAL PEA, 1986, J CHEM ECOL, V12, P353, DOI 10.1007/BF01020561; Vickers NJ, 2002, J CHEM ECOL, V28, P1255, DOI 10.1023/A:1016242019571	28	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202035	10.1371/journal.pone.0202035	http://dx.doi.org/10.1371/journal.pone.0202035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106983	Green Published, gold, Green Submitted			2022-12-26	WOS:000441662800024
J	Turner, T; Chen, X; Zahner, M; Opsahi, A; DeMarco, G; Boucher, M; Goodwin, B; Perreault, M				Turner, Tod; Chen, Xian; Zahner, Matthew; Opsahi, Alan; DeMarco, George; Boucher, Magalie; Goodwin, Bryan; Perreault, Mylene			FGF21 increases water intake, urine output and blood pressure in rats	PLOS ONE			English	Article							GROWTH-FACTOR 21; IMPROVES INSULIN SENSITIVITY; ENERGY-EXPENDITURE; MALE-MICE; NONHUMAN-PRIMATES; NEWBORN RATS; BODY-WEIGHT; GUANETHIDINE; HYPERTENSION; PF-05231023	Fibroblast growth factor 21 (FGF21) is a hormone secreted by the liver in response to metabolic stress. In addition to its well-characterized effects on energy homeostasis, FGF21 has been shown to increase water intake in animals. In this study, we sought to further explore the effects of FGF21 on fluid homeostasis in rats. A single dose of a long-acting FGF21 analog, PF-05231023, significantly increased water consumption, which was accompanied by an elevation in urine output that appeared prior to a significant change in water intake. We observed that FGF21 rapidly and significantly increased heart rate and blood pressure in telemeter-implanted rats, before changes in urine output and water intake were observed. Our data suggest that sympathetic activation may contribute to the pathogenesis by which FGF21 increases blood pressure as the baroreceptor unloading induced reflex tachycardia was significantly elevated in FGF21-treated animals. However, FGF21 was still capable of causing hypertension in animals in which approximately 40% of the sympathetic post-ganglionic neurons were ablated. Our data suggest that FGF21-induced water intake is in fact secondary to diuresis, which we propose to be a compensatory mechanism engaged to alleviate the acute hypertension caused by FGF21.	[Turner, Tod; Goodwin, Bryan; Perreault, Mylene] Pfizer Inc, Internal Med Res Unit, Cambridge, MA 02139 USA; [Chen, Xian; DeMarco, George] Pfizer Inc, Comparat Med, Cambridge, MA USA; [Zahner, Matthew; Opsahi, Alan] Pfizer Inc, DSRD, Groton, CT 06340 USA; [Boucher, Magalie] Pfizer Inc, DSRD, Cambridge, MA USA; [Turner, Tod] Abbvie, Cambridge, MA USA; [Zahner, Matthew] East Tennessee State Univ, Johnson City, TN USA; [DeMarco, George] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA; [Goodwin, Bryan] Enanta, Watertown, MA USA; [Perreault, Mylene] Synlogic, Cambridge, MA 02142 USA	Pfizer; Pfizer; Pfizer; Pfizer; AbbVie; East Tennessee State University; University of Massachusetts System; University of Massachusetts Worcester	Perreault, M (corresponding author), Pfizer Inc, Internal Med Res Unit, Cambridge, MA 02139 USA.; Perreault, M (corresponding author), Synlogic, Cambridge, MA 02142 USA.	mylene@synlogictx.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was sponsored by Pfizer Inc. The funder provided support in the form of salaries for authors TT, XC, MZ, AO, GD, MB, BG, MP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Bernardo B, 2015, SCI REP-UK, V5, DOI 10.1038/srep11382; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; BURNSTOCK G, 1971, BRIT J PHARMACOL, V43, P295; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294; Cheung BMY, 2008, AM J HYPERTENS, V21, P17, DOI 10.1038/ajh.2007.19; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Eto K, 2010, DIABETES RES CLIN PR, V89, P52, DOI 10.1016/j.diabres.2010.03.019; Ferrara LA, 2002, J HUM HYPERTENS, V16, P337, DOI 10.1038/sj.jhh.1001388; FULLER LM, 1988, AM J PHYSIOL, V255, pR217, DOI 10.1152/ajpregu.1988.255.2.R217; Giragossian C, 2015, DRUG METAB DISPOS, V43, P803, DOI 10.1124/dmd.114.061713; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; He JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29582; HEAD GA, 1987, J AUTONOM NERV SYST, V21, P203, DOI 10.1016/0165-1838(87)90023-3; HEATH JW, 1977, J NEUROCYTOL, V6, P397, DOI 10.1007/BF01178225; Jin QR, 2014, J MED INVESTIG, V61, P28, DOI 10.2152/jmi.61.28; JOHNSON EM, 1976, EUR J PHARMACOL, V37, P45, DOI 10.1016/0014-2999(76)90006-6; JOHNSON EM, 1975, J PHARMACOL EXP THER, V193, P503; JUUL P, 1973, ACTA PHARMACOL TOX, V32, P487; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kim AM, 2017, DIABETES OBES METAB, V19, P1762, DOI 10.1111/dom.13023; MANNING PT, 1983, J NEUROSCI, V3, P714; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; Patel R, 2015, MOL ENDOCRINOL, V29, P213, DOI 10.1210/me.2014-1259; Perreault M, 2016, DIABETES, V65, pA275; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Riebl SK, 2013, ACSMS HEALTH FIT J, V17, P21, DOI 10.1249/FIT.0b013e3182a9570f; Samms RJ, 2016, ENDOCRINOLOGY, V157, P1467, DOI 10.1210/en.2015-1722; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Semba RD, 2013, J HUM HYPERTENS, V27, P397, DOI 10.1038/jhh.2012.52; Soberg S, 2017, CELL METAB, V25, P1045, DOI 10.1016/j.cmet.2017.04.009; Talukdar S, 2016, CELL METAB, V23, P427, DOI 10.1016/j.cmet.2016.02.001; Talukdar S, 2016, CELL METAB, V23, P344, DOI 10.1016/j.cmet.2015.12.008; von Holstein-Rathlou S, 2016, CELL METAB, V23, P335, DOI 10.1016/j.cmet.2015.12.003; Weng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119104; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zahner MR, 2016, J PHARMACOL TOX MET, V80, P59, DOI 10.1016/j.vascn.2016.04.010; Zahner MR, 2017, J PHARM TOXICOLOGY M; Zhang XY, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0190-7	45	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202182	10.1371/journal.pone.0202182	http://dx.doi.org/10.1371/journal.pone.0202182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106981	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800029
J	Ghei, D; Sane, R				Ghei, Dhananjay; Sane, Renuka			Estimates of air pollution in Delhi from the burning of firecrackers during the festival of Diwali	PLOS ONE			English	Article							INDIA; QUALITY	Delhi has had the distinction of being one of the most polluted cities in the world, especially in the winter months from October-January. These months coincide with the religious festival of Diwali. It is argued that air quality gets worse in the aftermath of Diwali on account of firecrackers that get burned during the festival. We use hourly data on PM 2.5 particulate concentration from 2013 to 2017 to estimate the Diwali effect on air quality in Delhi. We improve on existing work by using the event study technique as well as a difference-in-difference regression framework to estimate the Diwali effect on air quality. The results suggest that Diwali leads to a small, but statistically significant increase in air pollution. The effect is different across locations within Delhi. To our knowledge, this is the first causal estimate of the contribution of Diwali firecracker burning to air pollution.	[Ghei, Dhananjay] Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA; [Sane, Renuka] Natl Inst Publ Finance & Policy, Delhi, India	University of Minnesota System; University of Minnesota Twin Cities; National Institute of Public Finance & Policy (NIPFP)	Sane, R (corresponding author), Natl Inst Publ Finance & Policy, Delhi, India.	renuka@saner.org.in						[Anonymous], 2014, TIMES INDIA; Arora A, 2018, CURR WORLD ENVIRON, V13, DOI [10.12944/CWE.13.1.02, DOI 10.12944/CWE.13.1.02]; Barman SC, 2008, ENVIRON MONIT ASSESS, V137, P495, DOI 10.1007/s10661-007-9784-1; Chatterjee A, 2013, AEROSOL AIR QUAL RES, V13, P1133, DOI 10.4209/aaqr.2012.03.0062; Chauhan C., 2014, HINDUSTAN TIMES; Devara PCS, 2018, WATER SCI TECHNOL LI, V77, P293, DOI 10.1007/978-981-10-5792-2_24; Jain N, 2014, AEROSOL AIR QUAL RES, V14, P422, DOI 10.4209/aaqr.2013.01.0031; Kulshrestha UC, 2004, ATMOS ENVIRON, V38, P4421, DOI 10.1016/j.atmosenv.2004.05.044; MacKinlay AC, 1997, J ECON LIT, V35, P13; Mandal P, 2012, ENVIRON MONIT ASSESS, V184, P209, DOI 10.1007/s10661-011-1960-7; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Mohan D, 2017, TRANSPORT RES REC, P9, DOI 10.3141/2627-02; NUMBEO, 2018, POLL IND 2018; Ravindra K, 2003, J ENVIRON MONITOR, V5, P260, DOI 10.1039/b211943a; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Singh DP, 2010, ENVIRON MONIT ASSESS, V169, P1, DOI 10.1007/s10661-009-1145-9; Song Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168297; Swamy YV, 2013, ENV MONITORING ASSES, V185; Thakur B, 2010, ATMOSFERA, V23, P347	19	28	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0200371	10.1371/journal.pone.0200371	http://dx.doi.org/10.1371/journal.pone.0200371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102708	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200003
J	Xiang, AH; Black, MH; Shu, YH; Wu, J; MacKay, A; Koebnick, C; Watanabe, RM; Buchanan, TA				Xiang, Anny H.; Black, Mary Helen; Shu, Yu-Hsiang; Wu, Jun; MacKay, Adrienne; Koebnick, Corinna; Watanabe, Richard M.; Buchanan, Thomas A.			Association of weight gain and fifteen adipokines with declining beta-cell function in Mexican Americans	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; INSULIN SENSITIVITY; HISPANIC WOMEN; ADIPOSE-TISSUE; ADIPONECTIN; RESISTANCE; PREVENTION; ACTIVATION; INCREASES; GLYCEMIA	Obesity and adipokines are associated with development of type 2 diabetes. However, limited longitudinal studies have examined their roles on declining beta-cell function over time. This report assessed three adiposity measures (BMI, percent body fat, trunk fat), insulin resistance, and fifteen adipokines in relationship to longitudinal change in beta-cell function measured by disposition index (DI) from frequently-sampled-intravenous-glucose-tolerance testing. The results showed that three factors were significantly and independently associated with rate of change in DI over time: rate of change in BMI (negative), rate of change in IL-6 (negative), and baseline adiponectin (positive). The association was the strongest for changing BMI and was largely explained by changing insulin resistance; the association with changing IL-6 was also largely explained by changing insulin resistance. Baseline adiponectin remained positively associated after adjustment for changing insulin resistance, suggesting an independent effect of adiponectin to preserve or improve beta-cell function. These findings provide evidence and potential mechanisms for the role of obesity in promoting beta-cell dysfunction, highlighting the potential importance of mitigating obesity and its metabolic effects in preventing and treating type 2 diabetes.	[Xiang, Anny H.; Black, Mary Helen; Shu, Yu-Hsiang; Wu, Jun; Koebnick, Corinna] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [MacKay, Adrienne; Watanabe, Richard M.] USC, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [MacKay, Adrienne; Watanabe, Richard M.; Buchanan, Thomas A.] Univ Southern Calif, Diabet & Obes Res Inst, Los Angeles, CA USA; [Buchanan, Thomas A.] USC, Keck Sch Med, Dept Med, Los Angeles, CA USA	Kaiser Permanente; University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California; University of Southern California Keck Hospital	Xiang, AH (corresponding author), Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.	Anny.H.Xiang@kp.org		Xiang, Anny/0000-0003-2786-1268	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) [R01DK61628, R01DK10032]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100302] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01DK61628 (TAB) and R01DK10032 (AHX) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; Black MH, 2018, OBESITY, V26, P703, DOI 10.1002/oby.22128; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Carstensen-Kirberg M, 2016, EUR J CLIN INVEST, V46, P535, DOI 10.1111/eci.12629; Chetboun M, 2012, J CELL BIOCHEM, V113, P1966, DOI 10.1002/jcb.24065; Corlateanu Alexandru, 2017, COPD RES PRACTICE, V3, DOI [DOI 10.1186/S12933-017-0591-X, 10.1186/s40749-017-0025-x, DOI 10.1186/S40749-017-0025-X]; Hanley AJG, 2007, J CLIN ENDOCR METAB, V92, P2665, DOI 10.1210/jc.2006-2614; Herder C, 2016, EUR J ENDOCRINOL, V175, P367, DOI 10.1530/EJE-16-0528; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; R Development Core Team, 2016, R LANG ENV STAT COMP; Retnakaran R, 2017, DIABETES CARE, V40, pE101, DOI 10.2337/dc17-0781; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Xiang AH, 2013, DIABETOLOGIA, V56, P2753, DOI 10.1007/s00125-013-3048-0; Xiang AH, 2010, DIABETES, V59, P2625, DOI 10.2337/db10-0521; Xiang AH, 2010, DIABETES CARE, V33, P396, DOI 10.2337/dc09-1493	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201568	10.1371/journal.pone.0201568	http://dx.doi.org/10.1371/journal.pone.0201568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102726	Green Published, Green Submitted			2022-12-26	WOS:000441452200014
J	Samaras, A; Pavlidis, M				Samaras, Athanasios; Pavlidis, Michail			Regulation of divergent Cortisol responsiveness in European sea bass, Dicentrarchus labrax L.	PLOS ONE			English	Article							STRESS-RESPONSE; RAINBOW-TROUT; AXIS; EXPRESSION; RECEPTOR; ACTH; MELANOCORTIN-2; INDIVIDUALS; INDICATORS; SECRETION	Mechanisms regulating differences in Cortisol responsiveness between low (LR) and high response (HR) individuals have been poorly studied. In this context, we aimed to study key regulatory processes in Cortisol dynamics at the head kidneys of LR and HR European sea bass. To do so, resting plasma Cortisol and ACTH concentrations were quantified in these fish. Additionally, the head kidneys of these individuals were superfused through an in vitro superfusion system and stimulated with the same amount of ACTH to assess their Cortisol biosynthetic capacity. Moreover, the expression of important genes in Cortisol regulation was assessed. Results showed that LR fish had lower resting Cortisol concentrations than HR, although no differences existed in the circulating levels of ACTH. Additionally, the biosynthetic capacity of HR was higher than that of LR fish when in vitro stimulated with ACTH. At the molecular level, a statistically significant 3.4-fold higher expression of the ACTH receptor, mc2r, and a 2.3-fold, though not significant, higher expression of 11 <^>-hydroxylase (cyp11b1), an enzyme involved in Cortisol biosynthesis, was observed in the HR fish. Finally, a statistically significant 1.3-fold lower expression of 11f3-hydroxysteroid dehydrogenase 2 (hsdl 1b2), an enzyme involved in Cortisol inactivation, was observed in HR when compared to LR fish. Therefore, it was for the first time indicated that Cortisol dynamics can also be regulated at the post-production level in the head kidney. Collectively, our results highlight the crucial role of the interrenal tissue in the regulation of differences in Cortisol response between LR and HR sea bass individuals.	[Samaras, Athanasios; Pavlidis, Michail] Univ Crete, Dept Biol, Iraklion, Crete, Greece	University of Crete	Samaras, A (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	a.samaras@uoc.gr	Pavlidis, Michail/CAA-2503-2022	Pavlidis, Michail/0000-0003-1937-5032; Samaras, Athanasios/0000-0003-3616-7032	Greek Ministry of Rural Development and Food, Operational Programme "EPAL" [185359]; Onassis Foundation, Greece; University of Crete	Greek Ministry of Rural Development and Food, Operational Programme "EPAL"; Onassis Foundation, Greece; University of Crete	This study has been partially funded by the Greek Ministry of Rural Development and Food, Operational Programme "EPAL 2007-2013" under grant agreement no 185359. A. Samaras was supported by a postgraduate scholarship of the Onassis Foundation, Greece. The authors would also like to thank the Special Account for Research Funds of University of Crete for the financial support to cover the publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman SL, 2012, J ENDOCRINOL, V215, P393, DOI 10.1530/JOE-12-0379; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Backstrom T, 2011, HORM BEHAV, V59, P180, DOI 10.1016/j.yhbeh.2010.11.008; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; CARSIA RV, 1986, P SOC EXP BIOL MED, V183, P99; CARSIA RV, 1988, DOMEST ANIM ENDOCRIN, V5, P231, DOI 10.1016/0739-7240(88)90034-3; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Dores RM, 2016, J MOL ENDOCRINOL, V56, pT119, DOI 10.1530/JME-15-0292; Dores RM, 2014, J MOL ENDOCRINOL, V52, pT29, DOI 10.1530/JME-14-0050; FAO, 2020, CULT AQ SPEC INF PRO; Faught E, 2016, FISH PHYSIOL, V35, P113, DOI 10.1016/B978-0-12-802728-8.00004-7; Fekedulegn DB, 2007, PSYCHOSOM MED, V69, P651, DOI 10.1097/PSY.0b013e31814c405c; Flik G, 2006, GEN COMP ENDOCR, V146, P36, DOI 10.1016/j.ygcen.2005.11.005; Gomez F, 1996, NEUROENDOCRINOLOGY, V63, P327, DOI 10.1159/000126973; Gorissen M, 2016, FISH PHYSIOL, V35, P75, DOI 10.1016/B978-0-12-802728-8.00003-5; Hori TS, 2012, GEN COMP ENDOCR, V175, P311, DOI 10.1016/j.ygcen.2011.11.031; Agulleiro MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065450; Kanitz E, 1999, ANIM SCI, V68, P519, DOI 10.1017/S1357729800050542; Khan UW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28969; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Liang L, 2013, GEN COMP ENDOCR, V181, P203, DOI 10.1016/j.ygcen.2012.11.011; Liu XH, 2016, COMP BIOCHEM PHYS C, V185, P112, DOI 10.1016/j.cbpc.2016.03.009; Metz JR, 2005, AM J PHYSIOL-REG I, V289, pR814, DOI 10.1152/ajpregu.00826.2004; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Musajo F, 1996, LIFE SCI, V59, P1401, DOI 10.1016/0024-3205(96)00467-5; Navarro S, 2016, J MOL ENDOCRINOL, V56, pT113, DOI 10.1530/JME-15-0288; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Pemmasani JK, 2011, COMP BIOCHEM PHYS D, V6, P406, DOI 10.1016/j.cbd.2011.09.001; POTTINGER TG, 1992, AQUACULTURE, V103, P275, DOI 10.1016/0044-8486(92)90172-H; Pottinger TG, 2001, COMP BIOCHEM PHYS A, V129, P399, DOI 10.1016/S1095-6433(00)00357-3; Pottinger TG, 2006, AQUACULTURE, V256, P140, DOI 10.1016/j.aquaculture.2006.01.023; Prunet P, 2006, GEN COMP ENDOCR, V147, P17, DOI 10.1016/j.ygcen.2006.01.015; Rotllant J, 2003, COMP BIOCHEM PHYS A, V136, P613, DOI 10.1016/S1095-6433(03)00211-3; Samaras A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34858; Samaras A, 2017, AQUAC RES, V48, P990, DOI 10.1111/are.12942; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1403, DOI 10.1016/S0031-9384(96)00229-6; Takei Y, FISH PHYSL, V35; Tsalafouta A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05525; Uchoa ET, 2014, J NEUROENDOCRINOL, V26, P557, DOI 10.1111/jne.12157; Vandeputte M, 2016, AQUACULTURE, V455, P1, DOI 10.1016/j.aquaculture.2016.01.003; Wang CM, 2004, AQUACULTURE, V232, P665, DOI 10.1016/j.aquaculture.2003.08.008; Weber GM, 2007, N AM J AQUACULT, V69, P69, DOI 10.1577/A05-103.1	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202195	10.1371/journal.pone.0202195	http://dx.doi.org/10.1371/journal.pone.0202195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096195	Green Submitted, gold, Green Published			2022-12-26	WOS:000441308500057
J	Rood, JAJ; Lissenberg-Witte, BI; Eeltink, C; Stam, F; van Zuuren, FJ; Zweegman, S; Verdonck-de Leeuw, IM				Rood, Janneke A. J.; Lissenberg-Witte, Birgit I.; Eeltink, Corien; Stam, Frank; van Zuuren, Florence J.; Zweegman, Sonja; Verdonck-de Leeuw, Irma M.			The need for information among patients with hematological malignancies: Psychometric analyses of the 62-item Hematology Information Needs Questionnaire (HINQ-62)	PLOS ONE			English	Article							QUALITY-OF-LIFE; SHARED DECISION-MAKING; CANCER-PATIENTS; LYMPHOMA SURVIVORS; MYELOID-LEUKEMIA; PERCEIVED NEED; ADULT PATIENTS; BREAST-CANCER; SATISFACTION; PROVISION	The purpose of this study was to investigate the psychometric characteristics (content validity, internal consistency, and subscale structure) of the Hematology Information Needs Questionnaire-62 (HIND-62), a patient reported outcome measure (PROM) for assessing the need for information among patients with hematological malignancies (HM-patients). Baseline data were used from a prospective study on the need for information which 336 newly diagnosed HM-patients had completed. In phase 1 (design phase), data from the first 135 patients were used and in phase 2 (validation phase), data from the remaining 201 HM patients were used. Content validity was analyzed by examining irrelevance of items. Items were considered irrelevant if more than 10% of the patients scored totally disagree on that item. The subscale structure of the HIND-62 was investigated with Factor analysis (FA) (exploratory FA in phase 1 and confirmatory FA in phase 2). Cronbach's a was computed for the different subscales and >.70 was considered as good internal consistency. None of the 62 HIND-items were irrelevant. Exploratory FA identified five subscales: "Disease, symptoms, treatment and side-effects", "Etiology, sleep and physical changes", "Self-care", "Medical tests and prognosis", and "Psychosocial". Root Mean Square Error of Approximation (RMSEA) among patients was 0.037 in phase 1 and 0.045 in phase 2. The comparative fit index (CFO/Tucker-Lewis index-non-normed fit index among patients was 0.984/0.983 and 0.948/0.946, in phase 1 and 2 respectively. The internal consistency of the subscales was good, with Cronbach's a 0.82-0.99. The HIND is a valid PROM for assessing the need for information among Dutch HM-patients at diagnosis.	[Rood, Janneke A. J.; Eeltink, Corien; Zweegman, Sonja] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Rood, Janneke A. J.; Stam, Frank] Northwest Clin, Dept Internal Med, Alkmaar, Netherlands; [Lissenberg-Witte, Birgit I.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Zuuren, Florence J.] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Verdonck-de Leeuw, Irma M.] Vrije Univ Amsterdam Med Ctr, Dept Clin Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Rood, JAJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands.; Rood, JAJ (corresponding author), Northwest Clin, Dept Internal Med, Alkmaar, Netherlands.	J.Rood@vumc.nl		Zweegman, Sonja/0000-0002-5011-1820; Verdonck-de Leeuw, Irma/0000-0002-4507-4607	Northwest Academy	Northwest Academy	This work was supported by a grant of the Northwest Academy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata MA, 1998, TUMORI J, V84, P619, DOI 10.1177/030089169808400601; BUBELA N, 1990, PATIENT EDUC COUNS, V16, P21, DOI 10.1016/0738-3991(90)90041-I; Cavusoglu H, 2000, Issues Compr Pediatr Nurs, V23, P15, DOI 10.1080/014608600265183; Dy SM, 2012, SOC SCI MED, V74, P582, DOI 10.1016/j.socscimed.2011.11.015; Efficace F, 2012, BRIT J CANCER, V107, P904, DOI 10.1038/bjc.2012.348; Ernst J, 2011, EUR J CANCER CARE, V20, P534, DOI 10.1111/j.1365-2354.2010.01219.x; Ferlay J, GLOBOCAN 2012 V1 0 C; Friedman DR, 2010, AM J HEMATOL, V85, P528, DOI 10.1002/ajh.21725; Friis LS, 2003, SUPPORT CARE CANCER, V11, P162, DOI 10.1007/s00520-002-0424-6; Galloway S, 1997, J ADV NURS, V25, P1175, DOI 10.1046/j.1365-2648.1997.19970251175.x; Gansler T, 2010, J CANCER EDUC, V25, P302, DOI 10.1007/s13187-009-0034-9; Gee PM, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4067; Gupta D, 2007, J PAIN SYMPTOM MANAG, V34, P40, DOI 10.1016/j.jpainsymman.2006.10.012; Hammond CTC, 2008, FERTIL STERIL, V90, P1256, DOI 10.1016/j.fertnstert.2007.08.081; Husson O, 2014, ACTA ONCOL, V53, P917, DOI 10.3109/0284186X.2013.879201; Husson O, 2011, ANN ONCOL, V22, P761, DOI 10.1093/annonc/mdq413; Kashaf MS, 2015, MED DECIS MAKING, V35, P1037, DOI 10.1177/0272989X15598529; Keating NL, 2002, J CLIN ONCOL, V20, P1473, DOI 10.1200/JCO.20.6.1473; Koehler M, 2009, CRIT REV ONCOL HEMAT, V69, P237, DOI 10.1016/j.critrevonc.2008.09.014; Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409; Lobb EA, 2009, PATIENT EDUC COUNS, V77, P103, DOI 10.1016/j.pec.2009.02.005; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; McCorkle R, 2011, CA-CANCER J CLIN, V61, P50, DOI 10.3322/caac.20093; Mesters N, 2001, PATIENT EDUC COUNS, V43, P253; Mistry A, 2010, JRSM Short Rep, V1, P30, DOI 10.1258/shorts.2010.010032; Molisani A, 2014, J CANCER EDUC, V29, P158, DOI 10.1007/s13187-013-0564-z; Montgomery C, 2002, PSYCHO-ONCOLOGY, V11, P239, DOI 10.1002/pon.557; Oerlemans S, 2014, EUR J HAEMATOL, V93, P229, DOI 10.1111/ejh.12335; Oerlemans S, 2013, HAEMATOLOGICA, V98, P479, DOI 10.3324/haematol.2012.064907; Oerlemans S, 2012, ANN HEMATOL, V91, P1587, DOI 10.1007/s00277-012-1495-1; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Parry C, 2011, J PSYCHOSOC ONCOL, V29, P175, DOI 10.1080/07347332.2010.548444; Rood JAJ, 2015, HEMATOL ONCOL, V33, P85, DOI 10.1002/hon.2138; Rood JAJ, 2015, PSYCHO-ONCOLOGY, V24, P564, DOI 10.1002/pon.3699; Rood JAJ, 2015, J CLIN NURS, V24, P353, DOI 10.1111/jocn.12630; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Sant M, 2014, LANCET ONCOL, V15, P931, DOI 10.1016/S1470-2045(14)70282-7; Squiers L, 2005, J HEALTH COMMUN, V10, P15, DOI 10.1080/10810730500263620; Stacey D, 2014, COCHRANE DATABASE SY; Stiggelbout AM, 2015, PATIENT EDUC COUNS, V98, P1172, DOI 10.1016/j.pec.2015.06.022; Tariman Joseph D, 2015, J Adv Pract Oncol, V6, P14; Turner S, 1996, BRIT J CANCER, V73, P222, DOI 10.1038/bjc.1996.39; Yogaparan T, 2009, LEUKEMIA RES, V33, P1288, DOI 10.1016/j.leukres.2008.12.008	43	0	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201699	10.1371/journal.pone.0201699	http://dx.doi.org/10.1371/journal.pone.0201699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092035	gold, Green Published, Green Submitted			2022-12-26	WOS:000441232600047
J	Walentynowicz, M; Schneider, S; Stone, AA				Walentynowicz, Marta; Schneider, Stefan; Stone, Arthur A.			The effects of time frames on self-report	PLOS ONE			English	Article							MECHANICAL TURK; RECALL; SYMPTOMS; PERIODS; BELIEF; PAIN	Background The degree to which episodic and semantic memory processes contribute to retrospective self-reports have been shown to depend on the length of reporting period. Robinson and Clore (2002) argued that when the amount of accessible detail decreases due to longer reporting periods, an episodic retrieval strategy is abandoned in favor of a semantic retrieval strategy. The current study further examines this shift between retrieval strategies by conceptually replicating the model of Robinson and Clore (2002) for both emotions and symptoms and by attempting to estimate the exact moment of the theorized shift. Method A sample of 469 adults reported the extent to which they experienced 8 states (excited, happy, calm, sad, anxious, angry, pain, stress) over 12 time frames (right now to in general). A series of curvilinear and piecewise linear multilevel growth models were used to examine the pattern of response times and response levels (i.e., rated intensity on a 1-5 scale) across the different time frames. Results Replicating previous results, both response times and response levels increased with longer time frames. In contrast to prior work, no consistent evidence was found for a change in response patterns that would suggest a shift in retrieval strategies (i.e., a flattening or decrease of the slope for longer time frames). The relationship between the time frames and response times/levels was similar for emotions and symptoms. Conclusions Although the current study showed a pronounced effect of time frame on response times and response levels, it did not replicate prior work that suggested a shift from episodic to semantic memory as time frame duration increased. This indicates that even for longer time frames individuals might attempt to retrieve episodic information to provide a response. We suggest that studies relying on self-report should use the same well-defined time frames across all self-reported measures.	[Walentynowicz, Marta; Schneider, Stefan; Stone, Arthur A.] Univ Southern Calif, Dornsife Ctr Self Report Sci, Los Angeles, CA 90007 USA; [Stone, Arthur A.] Univ Southern Calif, Dept Psychol, Los Angeles, CA USA	University of Southern California; University of Southern California	Walentynowicz, M (corresponding author), Univ Southern Calif, Dornsife Ctr Self Report Sci, Los Angeles, CA 90007 USA.	marta.walentynowicz@gmail.com	Walentynowicz, Marta/M-9889-2018; Schneider, Stefan/K-2815-2012; Stone, Arthur A./AAC-3610-2019	Walentynowicz, Marta/0000-0002-7049-7943; 	National Institute on Aging [R01AG042407]; Center for Self-Report Science, University of Southern California; NATIONAL INSTITUTE ON AGING [R01AG042407] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Self-Report Science, University of Southern California; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute on Aging, R01AG042407 (AAS) and by the Center for Self-Report Science, University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alicke MD, 2009, EUR REV SOC PSYCHOL, V20, P1, DOI 10.1080/10463280802613866; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Batterham PJ, 2019, ASSESSMENT, V26, P249, DOI 10.1177/1073191116685809; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Broderick JE, 2008, PAIN, V139, P146, DOI 10.1016/j.pain.2008.03.024; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Conner TS, 2012, PSYCHOSOM MED, V74, P327, DOI 10.1097/PSY.0b013e3182546f18; Feitosa J, 2015, PERS INDIV DIFFER, V75, P47, DOI 10.1016/j.paid.2014.11.017; Geng XW, 2013, J BEHAV DECIS MAKING, V26, P225, DOI 10.1002/bdm.1755; Gerlitz Y., 2005, DIW RES NOTES, V4; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Houtveen JH, 2007, J PSYCHOSOM RES, V62, P277, DOI 10.1016/j.jpsychores.2006.11.006; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Laferton JAC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00233; Luhmann M, 2012, J RES PERS, V46, P431, DOI 10.1016/j.jrp.2012.04.004; Maniaci MR, 2014, J RES PERS, V48, P61, DOI 10.1016/j.jrp.2013.09.008; MCFARLAND C, 1989, J PERS SOC PSYCHOL, V57, P522, DOI 10.1037/0022-3514.57.3.522; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; Norquist JM, 2012, QUAL LIFE RES, V21, P1013, DOI 10.1007/s11136-011-0003-8; Osborne JW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00220; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; Ramsey SR, 2016, COMPUT HUM BEHAV, V58, P354, DOI 10.1016/j.chb.2015.12.049; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Robinson MD, 2002, J PERS SOC PSYCHOL, V83, P198, DOI 10.1037//0022-3514.83.1.198; Robinson MD, 2010, SELF IDENTITY, V9, P87, DOI 10.1080/15298860902728274; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Stone AA, 2008, MED CARE, V46, P662, DOI 10.1097/MLR.0b013e3181789387; Stull DE, 2009, CURR MED RES OPIN, V25, P929, DOI [10.1185/03007990902774765, 10.1185/03007990902774765 ]; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT, DOI [DOI 10.17077/48VTM4T2, 10.17077/48vt-m4t2]; Winkielman P, 1998, J PERS SOC PSYCHOL, V75, P719, DOI 10.1037/0022-3514.75.3.719; Zijlema WL, 2013, J PSYCHOSOM RES, V74, P459, DOI 10.1016/j.jpsychores.2013.03.093	39	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201655	10.1371/journal.pone.0201655	http://dx.doi.org/10.1371/journal.pone.0201655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092034	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600042
J	Han, JH; Wang, FY; Lan, YL; Wang, JB; Nie, CL; Liang, YJ; Song, RP; Zheng, TS; Pan, SH; Pei, TM; Xie, CM; Yang, GC; Liu, XR; Zhu, MX; Wang, Y; Liu, Y; Meng, FZ; Cui, YF; Zhang, B; Liu, YF; Meng, XZ; Zhang, JW; Liu, LX				Han, Jihua; Wang, Fengyue; Lan, Yaliang; Wang, Jiabei; Nie, Chunlei; Liang, Yingjian; Song, Ruipeng; Zheng, Tongsen; Pan, Shangha; Pei, Tiemin; Xie, Changming; Yang, Guangchao; Liu, Xirui; Zhu, Mingxi; Wang, Yan; Liu, Yao; Meng, Fanzheng; Cui, Yifeng; Zhang, Bo; Liu, Yufeng; Meng, Xianzhi; Zhang, Jiewu; Liu, Lianxin			KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling	ONCOGENE			English	Article							CANCER; PROLIFERATION; PROGRESSION; EXPRESSION; IL-6/STAT3; MICRORNA; MIRNA; TWIST	Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide. The poor survival may be due to a high proportions of tumor recurrence and metastasis. Kinesin family member C1 (KIFC1) is highly expressed in a variety of neoplasms and is a potential marker for non-small cell lung cancer or ovarian adenocarcinoma metastasis. Nevertheless, the role of KIFC1 in HCC metastasis remains obscure. We investigated this in the present study using HCC cell lines and clinical specimens. Our results indicated that increased levels of KIFC1 were associated with poor prognosis and metastasis in HCC. In addition, KIFC1 induced epithelial-to-mesenchymal transition (EMT) and HCC metastasis both in vitro and in vivo. This tumorigenic effect depended on gankyrin; inhibiting gankyrin activity reversed EMT via activation of protein kinase B (AKT)/Twist family BHLH transcription factor 1 (AKT/TWIST1). We also found that KIFC1 was directly regulated by the microRNA miR-532-3p, whose downregulation was associated with metastatic progression in HCC. These results denote that a decrease in miR-532-3p levels results in increased KIFC1 expression in HCC, leading to metastasis via activation of the gankyrin/AKT/TWIST1 signaling pathway.	[Han, Jihua; Wang, Fengyue; Lan, Yaliang; Wang, Jiabei; Liang, Yingjian; Song, Ruipeng; Pan, Shangha; Pei, Tiemin; Xie, Changming; Yang, Guangchao; Liu, Xirui; Zhu, Mingxi; Wang, Yan; Liu, Yao; Meng, Fanzheng; Cui, Yifeng; Zhang, Bo; Liu, Yufeng; Meng, Xianzhi; Liu, Lianxin] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Key Lab Hepatosplen Surg,Minist Educ, Harbin, Heilongjiang, Peoples R China; [Han, Jihua; Nie, Chunlei; Zhang, Jiewu] Harbin Med Univ, Affiliated Hosp 3, Dept Head & Neck Surg, Harbin, Heilongjiang, Peoples R China; [Zheng, Tongsen] Harbin Med Univ, Affiliated Hosp 3, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Meng, XZ; Liu, LX (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Key Lab Hepatosplen Surg,Minist Educ, Harbin, Heilongjiang, Peoples R China.; Zhang, JW (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Head & Neck Surg, Harbin, Heilongjiang, Peoples R China.	mengxianzhi@sina.com; drzhangjiewu@sohu.com; liulx@ems.hrbmu.edu.cn	zheng, tongsen/ABB-9572-2021	zheng, tongsen/0000-0002-7539-3924	National Key Program for Science and Technology Research and Development [2016YFC0106503, 2016YFC0106500, 2016YFC0905902]; Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province [2009td06]; Changjiang Scholars and Innovative Research Team in University [IRT1122]; National Natural Scientific Foundation of China [81602058, 81772588, 81773194]; Hei Longjiang Postdoctoral Foundation; China Postdoctoral Science Foundation [2018M630368]; Science and Technology Research Projects of Hei Longjiang Province [GC12C304-5]; Haiyan Research Fund of the Third Affiliated Hospital of Harbin Medical University [JJZD2017-03, JJQN2018-14]; Fundamental Research Funds for the Provincial Universities [2017LCZX24]; Foundation of the First Affiliated Hospital of Harbin Medical University [2018B017]; Innovative Research Program for Graduate of Harbin Medical University [YJSCX2015-17HYD]	National Key Program for Science and Technology Research and Development; Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hei Longjiang Postdoctoral Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Research Projects of Hei Longjiang Province; Haiyan Research Fund of the Third Affiliated Hospital of Harbin Medical University; Fundamental Research Funds for the Provincial Universities; Foundation of the First Affiliated Hospital of Harbin Medical University; Innovative Research Program for Graduate of Harbin Medical University	This study was supported by National Key Program for Science and Technology Research and Development (grant no. 2016YFC0106503, no. 2016YFC0106500 and no. 2016YFC0905902), Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province (grant no. 2009td06), Changjiang Scholars and Innovative Research Team in University (grant no. IRT1122), the National Natural Scientific Foundation of China (grant no. 81602058, no. 81772588, no. 81773194), Hei Longjiang Postdoctoral Foundation, China Postdoctoral Science Foundation Grant (grant no. 2018M630368), the Science and Technology Research Projects of Hei Longjiang Province (grant no. GC12C304-5), Haiyan Research Fund of the Third Affiliated Hospital of Harbin Medical University (grant no. JJZD2017-03, no. JJQN2018-14), the Fundamental Research Funds for the Provincial Universities (grant no. 2017LCZX24), the Foundation of the First Affiliated Hospital of Harbin Medical University (grant no. 2018B017), Innovative Research Program for Graduate of Harbin Medical University (grant no. YJSCX2015-17HYD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bai ZF, 2013, CANCER RES, V73, P4548, DOI 10.1158/0008-5472.CAN-12-4586; Benson EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141279; Chang RM, 2017, CLIN CANCER RES, V23, P2593, DOI 10.1158/1078-0432.CCR-16-0851; Chen J, 2016, ONCOGENE, V35, P2506, DOI 10.1038/onc.2015.316; Fu J, 2011, HEPATOLOGY, V53, P181, DOI 10.1002/hep.24015; Goh GBB, 2015, BEST PRACT RES CL GA, V29, P919, DOI 10.1016/j.bpg.2015.09.007; Grinberg-Rashi H, 2009, CLIN CANCER RES, V15, P1755, DOI 10.1158/1078-0432.CCR-08-2124; Han J., 2017, IEEE J SOLID-ST CIRC, V1, P1; Hu J, 2016, CANCER CELL, V29, P49, DOI 10.1016/j.ccell.2015.12.005; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Li YH, 2015, CANCER BIOL THER, V16, P1316, DOI 10.1080/15384047.2015.1070980; Liu YF, 2016, J THORAC DIS, V8, P2911, DOI 10.21037/jtd.2016.10.67; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095043, 10.1371/journal.pone.0086026]; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Nath S, 2007, MOL BIOL CELL, V18, P1839, DOI 10.1091/mbc.E06-06-0524; Oue N, 2016, ONCOL REP, V36, P349, DOI 10.3892/or.2016.4781; Pawar S, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-53; Pei TM, 2015, ONCOTARGET, V6, P17206, DOI 10.18632/oncotarget.4043; Pospisilova S, 2016, NEOPLASMA, V63, P799, DOI 10.4149/neo_2016_518; Riahi MM, 2017, NEOPLASMA, V63, P1560; Rokavec M, 2017, CANCER RES, V77, P1854, DOI 10.1158/0008-5472.CAN-16-3236; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Serper M, 2017, GASTROENTEROLOGY, V152, P1954, DOI 10.1053/j.gastro.2017.02.040; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang JB, 2016, HEPATOLOGY, V64, P1606, DOI 10.1002/hep.28781; Wang WP, 2017, ONCOTARGET, V8, P5909, DOI 10.18632/oncotarget.13947; Wang WP, 2015, PATHOL RES PRACT, V211, P939, DOI 10.1016/j.prp.2015.09.010; Xiao YX, 2016, ONCOTARGET, V7, P48656, DOI 10.18632/oncotarget.8799; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhao BS, 2013, ASIAN PAC J CANCER P, V14, P139, DOI 10.7314/APJCP.2013.14.1.139; Zheng TS, 2014, HEPATOLOGY, V59, P935, DOI 10.1002/hep.26705; Zhou SL, 2016, HEPATOLOGY, V63, P1560, DOI 10.1002/hep.28445; Zou H, 2015, HEPATOL INT, V9, P399, DOI 10.1007/s12072-015-9634-0	35	49	54	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					406	420		10.1038/s41388-018-0440-8	http://dx.doi.org/10.1038/s41388-018-0440-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30115976	Green Published, hybrid			2022-12-26	WOS:000455851200008
J	Jiang, MZ; Xu, B; Li, XW; Shang, YL; Chu, Y; Wang, WJ; Chen, D; Wu, N; Hu, SJ; Zhang, S; Li, MB; Wu, KC; Yang, XY; Liang, J; Nie, YZ; Fan, DM				Jiang, Mingzuo; Xu, Bing; Li, Xiaowei; Shang, Yulong; Chu, Yi; Wang, Weijie; Chen, Di; Wu, Nan; Hu, Sijun; Zhang, Song; Li, Mengbin; Wu, Kaichun; Yang, Xiaoyong; Liang, Jie; Nie, Yongzhan; Fan, Daiming			O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; E-CADHERIN; C-MYC; EZH2; COLON; PROTEIN; EXPRESSION; MIGRATION	Advanced colorectal cancer (CRC) is one of the deadliest cancers, and the 5-year survival rate of patients with metastasis is extremely low. The epithelial-mesenchymal transition (EMT) is considered essential for metastatic CRC, but the fundamental molecular basis underlying this effect remains unknown. Here, we identified that O-GlcNAcylation, a unique posttranslational modification (PTM) involved in cancer metabolic reprogramming, increased the metastatic capability of CRC. The levels of O-GlcNAcylation were increased in the metastatic CRC tissues and cell lines, which likely promoted the EMT by enhancing EZH2 protein stability and function. The CRC patients with higher levels of O-GlcNAcylation exhibited greater lymph node metastasis potential and lower overall survival. Bioinformatic analysis and luciferase reporter assays revealed that both O-GlcNAcylation transferase (OGT) and EZH2 are posttranscriptionally inhibited by microRNA-101. In addition, O-GlcNAcylation and H3K27me3 modification in the miR-101 promoter region further inhibited the transcription of miR-101, resulting in the upregulation of OGT and EZH2 in metastatic CRC, thus forming a vicious cycle. In this study, we demonstrated that O-GlcNAcylation, which is negatively regulated by microRNA-101, likely promotes CRC metastasis by enhancing EZH2 protein stability and function. Reducing O-GlcNAcylation may be a potential therapeutic strategy for metastatic CRC.	[Jiang, Mingzuo; Xu, Bing; Li, Xiaowei; Shang, Yulong; Chu, Yi; Wang, Weijie; Chen, Di; Wu, Nan; Hu, Sijun; Zhang, Song; Li, Mengbin; Wu, Kaichun; Liang, Jie; Nie, Yongzhan; Fan, Daiming] Fourth Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Jiang, Mingzuo; Xu, Bing; Li, Xiaowei; Shang, Yulong; Chu, Yi; Wang, Weijie; Chen, Di; Wu, Nan; Hu, Sijun; Zhang, Song; Li, Mengbin; Wu, Kaichun; Liang, Jie; Nie, Yongzhan; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China; [Xu, Bing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gastroenterol, Xian 710004, Shaanxi, Peoples R China; [Wu, Nan] Northwest Univ, Fac Life Sci, Lab Tissue Engn, Xian, Shaanxi, Peoples R China; [Yang, Xiaoyong] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Northwest University Xi'an; Yale University	Nie, YZ; Fan, DM (corresponding author), Fourth Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.; Nie, YZ; Fan, DM (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China.	yongznie@fmmu.edu.cn; daimingfan@fmmu.edu.cn		nan, wu/0000-0002-9939-9810	National Natural Science Foundation of China [81430072, 81730016, 81421003, 81572302, 81772650, 2015BAI13B07, CBSKL2015Z12]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Natural Science Foundation of China (Nos. 81430072, 81730016, 81421003, 81572302, 81772650, 2015BAI13B07, and CBSKL2015Z12). We acknowledge Xiang-Yuan Zhang, Miao-Miao Tian, Zu-Hong Tian, Ying Zhang, and Hai-Bin Ruan for their technical assistance.	Babae N, 2014, ONCOTARGET, V5, P6687, DOI 10.18632/oncotarget.2235; Ben Harosh-Davidovich S, 2018, EXP CELL RES, V364, P42, DOI 10.1016/j.yexcr.2018.01.024; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Buren S, 2016, CANCER CELL, V30, P290, DOI 10.1016/j.ccell.2016.06.023; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chaiyawat P, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00193; Cheng SM, 2016, BIOCHEM BIOPH RES CO, V478, P1497, DOI 10.1016/j.bbrc.2016.08.074; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Duranton B, 2003, AMINO ACIDS, V24, P63, DOI 10.1007/s00726-002-0333-5; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Ferrer CM, 2017, ONCOGENE, V36, P559, DOI 10.1038/onc.2016.228; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Geng F, 2012, J CELL SCI, V125, P2615, DOI 10.1242/jcs.096735; Gollner S, 2017, NAT MED, V23, P69, DOI 10.1038/nm.4247; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Guo HB, 2017, J BIOL CHEM, V292, P4123, DOI 10.1074/jbc.M116.763201; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Jiang MZ, 2016, ONCOTARGET, V7, P61390, DOI 10.18632/oncotarget.11359; Jin FZ, 2013, EXP CELL RES, V319, P1482, DOI 10.1016/j.yexcr.2013.03.013; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kim Sang Wook, 2017, Korean J Gastroenterol, V69, P206, DOI 10.4166/kjg.2017.69.4.206; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luo P, 2015, MOL MED REP, V12, P1163, DOI 10.3892/mmr.2015.3491; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Mangalhara KC, 2017, CANCER LETT, V391, P59, DOI 10.1016/j.canlet.2017.01.016; Meyerhardt Jeffrey A, 2013, Clin Adv Hematol Oncol, V11, P93; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mohammadi A, 2016, BIOMED PHARMACOTHER, V84, P705, DOI 10.1016/j.biopha.2016.09.099; O'Dwyer PJ, 2007, J CLIN ONCOL, V25, P2313, DOI 10.1200/JCO.2006.08.6900; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Shimomoto T, 2012, CLIN EXP METASTAS, V29, P915, DOI 10.1007/s10585-012-9480-6; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sodi VL, 2015, MOL CANCER RES, V13, P923, DOI 10.1158/1541-7786.MCR-14-0536; Soumyanarayanan U, 2016, FUTURE MED CHEM, V8, P1635, DOI 10.4155/fmc-2016-0096; Steenackers A, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00046; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Vaiana CA, 2016, J BIOL CHEM, V291, P1529, DOI 10.1074/jbc.M115.672220; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Very N, 2018, J BIOENERG BIOMEMBR, V50, P213, DOI 10.1007/s10863-018-9747-y; Wang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/823620; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang YR, 2015, ONCOTARGET, V6, P12529, DOI 10.18632/oncotarget.3725; Zhang Z, 2015, ONCOGENE, V34, P4808, DOI 10.1038/onc.2014.404; Zheng F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004873; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	60	68	73	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					301	316		10.1038/s41388-018-0435-5	http://dx.doi.org/10.1038/s41388-018-0435-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30093632	hybrid, Green Published			2022-12-26	WOS:000455851200001
J	Tetley, GJN; Szeto, A; Fountain, AJ; Mott, HR; Owen, D				Tetley, George J. N.; Szeto, Aydan; Fountain, Adam J.; Mott, Helen R.; Owen, Darerca			Bond swapping from a charge cloud allows flexible coordination of upstream signals through WASP: Multiple regulatory roles for the WASP basic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDC42; cell signaling; cytoskeleton; intrinsically disordered protein; protein conformation; protein motif; protein-protein interaction; small GTPase; structure-function; thermodynamics	ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING DOMAIN; CDC42 EFFECTOR PROTEINS; N-WASP; ARP2/3 COMPLEX; ACTIN POLYMERIZATION; COALESCE MECHANISM; ACTIVATION; RHO; MOTIF	Wiskott-Aldrich syndrome protein (WASP) activates the actin-related protein 2/3 homolog (Arp2/3) complex and regulates actin polymerization in a physiological setting. Cell division cycle 42 (Cdc42) is a key activator of WASP, which binds Cdc42 through a Cdc42/Rac-interactive binding (CRIB)-containing region that defines a subset of Cdc42 effectors. Here, using site-directed mutagenesis and binding affinity determination and kinetic assays, we report the results of an investigation into the energetic contributions of individual WASP residues to both the Cdc42-WASP binding interface and the kinetics of complex formation. Our results support the previously proposed dock-and-coalesce binding mechanism, initiated by electrostatic steering driven by WASP's basic region and followed by a coalescence phase likely driven by the conserved CRIB motif. The WASP basic region, however, appears also to play a role in the final complex, as its mutation affected both on- and off-rates, suggesting a more comprehensive physiological role for this region centered on the C-terminal triad of positive residues. These results highlight the expanding roles of the basic region in WASP and other CRIB-containing effector proteins in regulating complex cellular processes and coordinating multiple input signals. The data presented improve our understanding of the Cdc42-WASP interface and also add to the body of information available for Cdc42-effector complex formation, therapeutic targeting of which has promise for Ras-driven cancers. Our findings suggest that combining high-affinity peptide-binding sequences with short electrostatic steering sequences could increase the efficacy of peptidomimetic candidates designed to interfere with Cdc42 signaling in cancer.	[Tetley, George J. N.; Szeto, Aydan; Fountain, Adam J.; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Szeto, Aydan] MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk		Tetley, George/0000-0002-7134-7066	Medical Research Council CASE Studentship [MR/K017101/1]; Wellcome Trust Biomedical Vacation Scholarship [2202640/Z/16/Z]; short-term Glover Research Fund Fellowship	Medical Research Council CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Biomedical Vacation Scholarship(Wellcome Trust); short-term Glover Research Fund Fellowship	This work was supported by Medical Research Council CASE Studentship MR/K017101/1 (to D. O. and H. R. M.), a Wellcome Trust Biomedical Vacation Scholarship 2202640/Z/16/Z (to A. J. F.), and a short-term Glover Research Fund Fellowship (to G. J. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2013, EXPERT OPIN THER TAR, V17, P1263, DOI 10.1517/14728222.2013.828037; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Ha BH, 2018, P NATL ACAD SCI USA, V115, P531, DOI 10.1073/pnas.1717437115; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Jain N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15031; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lin Q, 2012, BIOCHEM J, V445, P255, DOI 10.1042/BJ20111575; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott H. R., 2018, SEMIN CANCER BIOL, V2018, DOI [10.1016/S1044-579X(17)30243-2, DOI 10.1016/S1044-579X(17)30243-2]; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Ou L, 2017, FEBS J, V284, P3381, DOI 10.1111/febs.14197; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pang XD, 2016, PROTEINS, V84, P674, DOI 10.1002/prot.25018; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Suetsugu S, 2001, J BIOL CHEM, V276, P33175, DOI 10.1074/jbc.M102866200; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Tetley GJN, 2017, J BIOL CHEM, V292, P11361, DOI 10.1074/jbc.M117.789883; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Watson JR, 2016, J BIOL CHEM, V291, P13875, DOI 10.1074/jbc.M116.724294	48	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15136	15151		10.1074/jbc.RA118.003290	http://dx.doi.org/10.1074/jbc.RA118.003290			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30104412	hybrid, Green Published			2022-12-26	WOS:000445998400016
J	Zhao, Z; Yang, G; Lin, YS; Pang, HB; Wang, MY				Zhao, Zhe; Yang, Guan; Lin, Yusong; Pang, Haibo; Wang, Meiyun			Automated glioma detection and segmentation using graphical models	PLOS ONE			English	Article							BRAIN-TUMOR; CLASSIFICATION; IMAGES	Glioma detection and segmentation is a challenging task for radiologists and clinicians. The research reported in this paper seeks to develop a better clinical decision support algorithm for clinicians diagnosis. This paper presents a probabilistic method for detection and segmentation between abnormal tissue regions and brain tumour (tumour core and edema) portions from Magnetic Resonance Imaging (MRI). A framework is constructed to learn structure of undirected graphical models that can represent the spatial relationships among variables and apply it to glioma segmentation. Compared with the pixel of image, the super-pixel is more consistent with human visual cognition and contains less redundancy, thus, the superpixels are considered as the basic unit of structure learning and glioma segmentation scheme. l(1)-regularization techniques are applied to learn the appropriate structure for modeling graphical models. Conditional Random Fields (CRF) are used to model the spatial interactions among image superpixel regions and their measurements. A number of features including statistics features, the combined features from the local binary pattern as well as gray level run length, curve features, and fractal features were extracted from each superpixel. The features are then passed by l(1)-regularization to ensure a robust classification. The proposed method is compared with support vector machine and Fuzzy c-means to classify each superpixel into normal and abnormal tissue. The proposed system is tested for the presence of low grade as well as high grade glioma tumors on images collected from BRATS2013, BRATS2015 data set and Henan Provincial People's Hospital (HNPPH) data set. The experiments performed provides similarity between segmented and truth image up to 91.5% by correlation method.	[Zhao, Zhe; Lin, Yusong; Pang, Haibo] Zhengzhou Univ, Collaborat Innovat Ctr Internet Healthcare, Software & Appl Sci & Technol Inst, Zhengzhou 450002, Henan, Peoples R China; [Yang, Guan] Zhongyuan Univ Technol, Sch Comp Sci, Zhengzhou 450007, Henan, Peoples R China; [Wang, Meiyun] Henan Prov Peoples Hosp, Dept Radiol, Zhengzhou 450001, Henan, Peoples R China	Zhengzhou University; Zhongyuan University of Technology; Zhengzhou University	Yang, G (corresponding author), Zhongyuan Univ Technol, Sch Comp Sci, Zhengzhou 450007, Henan, Peoples R China.	g.yang@zut.edu.cn			National Natural Science Foundation of China [U1404606, 61772576, 81772009, 81720108021]; Science & Technology Development Project of Henan Province in China [172102210587]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Development Project of Henan Province in China	This research has been funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under the grant number U1404606, 61772576, 81772009, and 81720108021, the Science & Technology Development Project of Henan Province in China (http://www.hnkjt.gov.cn/) under the grant number 172102210587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Arridge SR, NOTE IMAGE CURVATURE; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; CHEN CC, 1989, IEEE T MED IMAGING, V8, P133, DOI 10.1109/42.24861; Crum WR, 2006, IEEE T MED IMAGING, V25, P1451, DOI 10.1109/TMI.2006.880587; Friedman J., 2010, TECHNICAL REPORT; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Ganzetti M, 2015, NEURORADIOLOGY, V57, P917, DOI 10.1007/s00234-015-1550-4; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Gupta N, 2017, J COMPUTATIONAL SCI; Hamamci A, 2010, LECT NOTES COMPUT SC, V6363, P137; Hamilton SR, 2000, WHO CLASSIFICATION T; Jain A., 1989, FUNDAMENTALS DIGITAL, P484; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kumar S, 2006, INT J COMPUT VISION, V68, P179, DOI 10.1007/s11263-006-7007-9; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lee CH, 2008, LECT NOTES COMPUT SC, V5241, P359; Li CM, 2014, MAGN RESON IMAGING, V32, P913, DOI 10.1016/j.mri.2014.03.010; Li S. Z., 2009, MARKOV RANDOM FIELD; Liu H, 2017, ELECTRON J STAT, V11, P241, DOI 10.1214/16-EJS1195; Liu H, 2009, J MACH LEARN RES, V10, P2295; Liu J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P547; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Nambura A, 2017, APPL SOFT COMPUT, V54, P456, DOI 10.1016/j.asoc.2016.08.020; [南柄飞 Nan Bingfei], 2014, [仪器仪表学报, Chinese Journal of Scientific Instrument], V35, P527; Nesterov Y, 2004, INTRO LECT CONVEX OP; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Sachdeva J, 2016, APPL SOFT COMPUT, V47, P151, DOI 10.1016/j.asoc.2016.05.020; SARKAR N, 1994, IEEE T SYST MAN CYB, V24, P115, DOI 10.1109/21.259692; Subbanna N, 2014, PROC CVPR IEEE, P400, DOI 10.1109/CVPR.2014.58; Sutton M. A., 2008, DIGITAL IMAGE CORREL; Thiruvenkadam K, 2016, INT J IMAG SYST TECH, V26, P305, DOI 10.1002/ima.22202; Wainwright MJ, 2008, FOUND TRENDS MACH LE, V1, P1, DOI 10.1561/2200000001; Xu XP, 2017, INT J COMPUT ASS RAD, V12, P645, DOI 10.1007/s11548-017-1522-8; Zhang L, 2010, IEEE T PATTERN ANAL, V32, P1406, DOI 10.1109/TPAMI.2009.145; Zhao P., 2017, COMPUTER ENG APPL, V3; Zhu Y, 2012, ACAD RADIOL, V19, P977, DOI 10.1016/j.acra.2012.03.026	44	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0200745	10.1371/journal.pone.0200745	http://dx.doi.org/10.1371/journal.pone.0200745			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130371	gold, Green Submitted, Green Published			2022-12-26	WOS:000442284500003
J	Mahjabin, T; Garcia, S; Grady, C; Mejia, A				Mahjabin, Tasnuva; Garcia, Susana; Grady, Caitlin; Mejia, Alfonso			Large cities get more for less: Water footprint efficiency across the US	PLOS ONE			English	Article							URBAN; METABOLISM; FOOD	Many urban indicators and functional citywide properties have been shown to scale with population due to agglomeration effects. We hypothesize that scaling relations may also exist for water-related urban indicators such as the water footprint. The water footprint is an indicator of water use that measures humans' appropriation of freshwater resources. We analyze the scaling of the water footprint for 65 mid- to large-sized US cities using both empirical estimates and a social interaction network model of city functioning. The network model is used to explain the presence of any scaling exponent in the empirical estimates of the urban water footprint by linking to previous theories of urban scaling. We find that the urban water footprint tends to approximately show sublinear scaling behavior with both population and gross domestic product. Thus, large cities tend to be more water footprint efficient and productive than mid-sized cities, where efficiency and productivity are quantified, in a broad sense, as deviations from a linear scaling exponent. We find the sublinear scaling may be linked to changes in urban economic structure with city size, which lead to large cities shifting water intensive economic activities to less populated regions. In addition, we find that green water contributes to the scaling both positively by transferring the dependence of food consumption on population into the water footprint and negatively by increasing heterogeneity. Overall, the proposed scaling relations allow for the comparison of water footprint efficiency and productivity of cities. Comparing these properties and identifying deviations from the expected behavior has implications for water resources and urban sustainability.	[Mahjabin, Tasnuva; Garcia, Susana; Grady, Caitlin; Mejia, Alfonso] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Grady, Caitlin] Penn State Univ, Rock Eth Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Grady, C (corresponding author), Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA.; Grady, C (corresponding author), Penn State Univ, Rock Eth Inst, University Pk, PA 16802 USA.	cgrady@psu.edu	Garcia, Susana/J-9757-2019	Garcia, Susana/0000-0001-7210-2717; Mahjabin, Tasnuva/0000-0001-5183-0061; Grady, Caitlin/0000-0002-9151-6664; Mejia, Alfonso/0000-0003-3891-1822	Department of Civil and Environmental Engineering at the Pennsylvania State University; National Science Foundation (NSF) [ACI-1639529]	Department of Civil and Environmental Engineering at the Pennsylvania State University; National Science Foundation (NSF)(National Science Foundation (NSF))	The authors gratefully acknowledge the funding support provided by the Department of Civil and Environmental Engineering at the Pennsylvania State University. In addition, this material is partially based upon work supported by the National Science Foundation (NSF) under Grant No. ACI-1639529. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the anonymous reviewer for the feedback and suggestions that helped improve the overall quality of the original manuscript. We thank Dr. Benjamin Ruddell from Northern Arizona University for helpful discussions. This material is partially based upon work supported by the National Science Foundation (NSF) under grant No. ACI-1639529. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the view of the NSF.	Ahams IC, 2017, J AM WATER RESOUR AS, V53, P1147, DOI 10.1111/1752-1688.12563; Alonso W., 1964, LOCATION LAND USE; Angel S., 2005, DYNAMICS GLOBAL URBA; [Anonymous], 2009, ESTIMATED USE WATER; Bai XM, 2016, CURR OPIN ENV SUST, V23, P69, DOI 10.1016/j.cosust.2016.11.010; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0022; Bettencourt L., 2013, ARXIV13015919; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0005; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; CDM-Smith, 1996, IWR MAIN WAT US COEF; Chini CM, 2017, WATER RESOUR RES, V53, P316, DOI 10.1002/2016WR019473; Crane P, 2005, SCIENCE, V308, P1225, DOI 10.1126/science.1114165; Creutzig F, 2015, P NATL ACAD SCI USA, V112, P6283, DOI 10.1073/pnas.1315545112; Dang Q, 2015, WATER RESOUR RES, V51, P973, DOI 10.1002/2014WR015919; Decker E. H, 2000, ANNU REV ENERG ENV, V25; Dermody BJ, 2018, EARTH SYST DYNAM, V9, P103, DOI 10.5194/esd-9-103-2018; Facchini A, 2017, APPL ENERG, V186, P86, DOI 10.1016/j.apenergy.2016.09.025; Fragkias M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064727; Fujita, 1989, URBAN EC THEORY LAND; Fujita M., 1999, SPATIAL EC CITIES RE; Gomez-Lievano A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0012; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Hoekstra AY, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010020; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Kennedy CA, 2015, P NATL ACAD SCI USA; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Konar M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010307; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Louf R, 2014, ENVIRON PLANN B, V41, P767, DOI 10.1068/b4105c; Louf R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102007; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Milan BF, 2017, SUST WAT RESOUR MAN, V3, P479, DOI 10.1007/s40899-017-0117-4; Mubako S., 2011, FRAMEWORKS ESTIMATIN; Mubako S, 2013, ECOL ECON, V93, P230, DOI 10.1016/j.ecolecon.2013.06.005; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; Paterson W, 2015, SUSTAINABILITY-BASEL, V7, P8461, DOI 10.3390/su7078461; Ramaswami A, 2016, SCIENCE, V352, P940, DOI 10.1126/science.aaf7160; Rushforth RR, 2016, WATER RESOUR RES, V52, P2698, DOI 10.1002/2015WR018006; Rushforth RR, 2015, SUSTAINABILITY-BASEL, V7, P8522, DOI 10.3390/su7078522; Scanlon BR, 2017, WATER RESOUR RES, V53, P3550, DOI 10.1002/2017WR020889; Solley W. B., 1998, ESTIMATED USE WATER; Southworth F., 2011, FREIGHT ANAL FRAMEWO; U.S. Census Bureau, 2007, COUNT CIT DAT BOOK; United Nations, 2015, WORLD URB PROSP 2014; Vanham D, 2019, J HYDROL, V573, P1075, DOI 10.1016/j.jhydrol.2017.12.004; Vanham D, 2016, SCI TOTAL ENVIRON, V573, P96, DOI 10.1016/j.scitotenv.2016.08.111; Vanham D, 2014, WATER SCI TECHNOL, V69, P789, DOI 10.2166/wst.2013.759; Youn H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0937	53	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202301	10.1371/journal.pone.0202301	http://dx.doi.org/10.1371/journal.pone.0202301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125324	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100024
J	Cui, WP; Mehta, P				Cui, Wenping; Mehta, Pankaj			Identifying feasible operating regimes for early T-cell recognition: The speed, energy, accuracy trade-off in kinetic proofreading and adaptive sorting	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; LIGAND DISCRIMINATION; BIOCHEMICAL NETWORKS; INFORMATION; DISSIPATION; ERROR; AMPLIFICATION; SPECIFICITY; SENSITIVITY; ADAPTATION	In the immune system, T cells can quickly discriminate between foreign and self ligands with high accuracy. There is evidence that T-cells achieve this remarkable performance utilizing a network architecture based on a generalization of kinetic proofreading (KPR). KPR-based mechanisms actively consume energy to increase the specificity beyond what is possible in equilibrium. An important theoretical question that arises is to understand the trade-offs and fundamental limits on accuracy, speed, and dissipation (energy consumption) in KPR and its generalization. Here, we revisit this question through numerical simulations where we simultaneously measure the speed, accuracy, and energy consumption of the KPR and adaptive sorting networks for different parameter choices. Our simulations highlight the existence of a "feasible operating regime" in the speed-energy-accuracy plane where T-cells can quickly differentiate between foreign and self ligands at reasonable energy expenditure. We give general arguments for why we expect this feasible operating regime to be a generic property of all KPR-based biochemical networks and discuss implications for our understanding of the T cell receptor circuit.	[Cui, Wenping; Mehta, Pankaj] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Cui, Wenping] Boston Coll, Dept Phys, Chestnut Hill, MA 02167 USA	Boston University; Boston College	Mehta, P (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	pankajm@bu.edu		Cui, Wenping/0000-0002-9900-5092	NIH NIGMS MIRA [R35GM119461]; Simons grant in the Mathematical Modeling of Living Systems; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119461] Funding Source: NIH RePORTER	NIH NIGMS MIRA; Simons grant in the Mathematical Modeling of Living Systems; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NIGMS MIRA (https://www.nigms.nih.gov/Research/mechanisms/MIRA/Pages/default.aspx) grant number R35GM119461 to WC and Simons grant (https://www.simonsfoundation.org/mathematical-modeling-living-systems/) in the Mathematical Modeling of Living Systems to PM.; This work was supported by NIH NIGMS MIRA grant number R35GM119461 and Simons grant in the Mathematical Modeling of Living Systems to PM.	Alon U., 2006, INTRO SYSTEMS BIOL D; Andrieux D, 2008, P NATL ACAD SCI USA, V105, P9516, DOI 10.1073/pnas.0802049105; Banerjee K, 2017, P NATL ACAD SCI USA, V114, P5183, DOI 10.1073/pnas.1614838114; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bel G, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016003; BENNETT CH, 1979, BIOSYSTEMS, V11, P85, DOI 10.1016/0303-2647(79)90003-0; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Das J, 2016, BIOPHYS J, V110, P1180, DOI 10.1016/j.bpj.2016.01.022; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dushek O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000578; EHRENBERG M, 1980, BIOPHYS J, V31, P333, DOI 10.1016/S0006-3495(80)85063-6; Feinerman O, 2008, MOL IMMUNOL, V45, P619, DOI 10.1016/j.molimm.2007.03.028; Francois P, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/6/066011; Francois P, 2016, J STAT PHYS, V162, P1130, DOI 10.1007/s10955-015-1444-1; Francois P, 2013, P NATL ACAD SCI USA, V110, pE888, DOI 10.1073/pnas.1300752110; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; FRETER RR, 1980, J THEOR BIOL, V85, P99, DOI 10.1016/0022-5193(80)90284-2; Gascoigne N R, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002502; Hartich D, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/055026; Hill T., 2012, FREE ENERGY TRANSDUC; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kajita MK, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012405; KIM SK, 1958, J CHEM PHYS, V28, P1057, DOI 10.1063/1.1744343; Lahiri S., 2016, ARXIV160307758; Lalanne JB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.218102; Lan G, 2012, NAT PHYS, V8, P422, DOI 10.1038/NPHYS2276; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Lang AH, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.148103; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Lever M, 2014, NAT REV IMMUNOL, V14, P619, DOI 10.1038/nri3728; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mehta P, 2016, J STAT PHYS, V162, P1153, DOI 10.1007/s10955-015-1431-6; Mehta P, 2012, P NATL ACAD SCI USA, V109, P17978, DOI 10.1073/pnas.1207814109; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Mora T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.038102; Murugan A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021016; Murugan A, 2012, P NATL ACAD SCI USA, V109, P12034, DOI 10.1073/pnas.1119911109; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ohzeki M, 2015, J PHYS CONF SER, V638, DOI 10.1088/1742-6596/638/1/012003; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Qian H, 2006, J MOL BIOL, V362, P387, DOI 10.1016/j.jmb.2006.07.068; Rao R, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/06/P06001; ROSING J, 1972, BIOCHIM BIOPHYS ACTA, V267, P275, DOI 10.1016/0005-2728(72)90116-8; Sartori P, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041039; Sartori P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.188101; SAVAGEAU MA, 1979, BIOCHEMISTRY-US, V18, P3486, DOI 10.1021/bi00583a008; Sharma AK, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026005; Srivastava V, 2015, P AMER CONTR CONF, P2113, DOI 10.1109/ACC.2015.7171045; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1	55	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202331	10.1371/journal.pone.0202331	http://dx.doi.org/10.1371/journal.pone.0202331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114236	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400060
J	McKelvey, KJ; Milner, MJ; Doyle, TC; Stamp, LK; Highton, J; Hessian, PA				McKelvey, Kelly J.; Milner, Melanie J.; Doyle, Terence C.; Stamp, Lisa K.; Highton, John; Hessian, Paul A.			Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation	PLOS ONE			English	Article							JOINT DAMAGE; ARTHRITIS; CELLS; INTERLEUKIN-17; EXPRESSION; NEOGENESIS; CXCL13; TISSUE; TRANSCRIPTION; AUTOIMMUNITY	Objective To determine whether the expression of IL17A and CD21L genes in inflamed rheumatoid synovia is associated with the neogenesis of ectopic lymphoid follicle-like structures (ELS), and if this aids the stratification of rheumatoid inflammation and thereby distinguishes patients with rheumatoid arthritis that might be responsive to specific targeted biologic therapies. Methods Expression of IL17A and CD21L genes was assessed by RT-PCR, qRT-PCR and dPCR in synovia from 54 patients with rheumatoid arthritis. A subset of synovia (n = 30) was assessed by immunohistology for the presence of CD20(+) B-lymphocytes and size of CD20+ B-lymphocyte aggregates as indicated by maximum radial cell count. The molecular profiles of six IL17A(+)/CD21L(+) and six IL17A(-)/CD21L(-) synovia were determined by complementary DNA microarray analysis. Results By RT-PCR, 26% of synovia expressed IL17A and 52% expressed CD21L. This provided the basis for distinguishing four subgroups of rheumatoid synovia: IL17A(+)/CD21L(+) (18.5% of synovia), IL17A(+)/CD21L(-) (7.5%), IL17A(-)/CD21L(+) (33.3%) and IL17A(-)/CD21L(-) (40.7%). While the subgroups did not predict clinical outcome measures, comparisons between the synovial subgroups revealed the IL17A(+)/CD21L(+) subgroup had significantly larger CD20(+) B-lymphocyte aggregates (P = 0.007) and a gene expression profile skewed toward B-cell-and antibody-mediated immunity. In contrast, genes associated with bone and cartilage remodelling were prominent in IL17A(-)/CD21L(-) synovia. Conclusions Rheumatoid synovia can be subdivided on the basis of IL17A and CD21L gene expression. Ensuing molecular subgroups do not predict clinical outcome for patients but highlight high inflammation and the predominance of B-lymphocyte mediated mechanisms operating in IL17A(+)/CD21L(+) synovia. This may provide a rationale for more refined therapeutic selection due to the distinct molecular profiles associated with IL17A(+)/CD21L(+) and IL17A(-)/CD21L(-) rheumatoid synovia.	[McKelvey, Kelly J.; Milner, Melanie J.; Doyle, Terence C.; Highton, John; Hessian, Paul A.] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [Stamp, Lisa K.] Univ Otago, Dept Med, Christchurch, New Zealand; [McKelvey, Kelly J.] Univ Sydney, Northern Sydney Local Hlth Dist Res Kolling Inst, Bill Walsh Translat Canc Res, Sydney, NSW, Australia; [McKelvey, Kelly J.] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia	University of Otago; University of Otago; University of Sydney; University of Sydney	Hessian, PA (corresponding author), Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand.	paul.hessian@otago.ac.nz		Millier, Melanie/0000-0002-4702-6078; McKelvey, Kelly/0000-0002-4923-791X; Hessian, Paul/0000-0001-6972-1242	Health Research Council of New Zealand [13/065]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded by the Health Research Council of New Zealand, www.hrc.govt.nz, grant No 13/065 to LKS, PAH, and JH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armas-Gonzalez E, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1611-2; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bombardieri M, 2017, NAT REV RHEUMATOL, V13, P141, DOI 10.1038/nrrheum.2016.217; Canete JD, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0688-0; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; de Sande MGHV, 2011, ANN RHEUM DIS, V70, P700, DOI 10.1136/ard.2010.139287; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finch DK, 2013, EUR J CLIN INVEST, V43, P501, DOI 10.1111/eci.12063; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones GW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00401; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Kishi Y, 2016, J EXP MED, V213, P2489, DOI 10.1084/jem.20151118; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Manzo A, 2010, IMMUNOL REV, V233, P267, DOI 10.1111/j.0105-2896.2009.00861.x; Millier MJ, 2017, SCI REP, V7, P943; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; Noort AR, 2015, AM J PATHOL, V185, P1935, DOI 10.1016/j.ajpath.2015.03.012; Nylander AN, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92321; Orr C, 2017, ARTHRITIS RHEUMATOL, V69, P2114, DOI 10.1002/art.40218; Pitzalis C, 2013, CURR OPIN RHEUMATOL, V25, P334, DOI 10.1097/BOR.0b013e32835fd8eb; RANDEN I, 1995, SCAND J IMMUNOL, V41, P481, DOI 10.1111/j.1365-3083.1995.tb03596.x; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Scheel T, 2011, ARTHRITIS RHEUM-US, V63, P63, DOI 10.1002/art.27767; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P1602, DOI 10.1002/art.27415; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wei M, 2016, DRUG DES DEV THER, V10, P2771, DOI 10.2147/DDDT.S91374; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297; YANNI G, 1992, SEMIN ARTHRITIS RHEU, V21, P393, DOI 10.1016/0049-0172(92)90040-K; Zhang X, 2008, J IMMUNOL, V180, P6988, DOI 10.4049/jimmunol.180.10.6988	46	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202135	10.1371/journal.pone.0202135	http://dx.doi.org/10.1371/journal.pone.0202135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114200	Green Submitted, gold, Green Published			2022-12-26	WOS:000441850400046
J	Naji, A; Houston, J; Rog, CS; Al Hatem, A; Rizvi, S; van der Hoeven, R				Naji, Ali; Houston, John; Rog, Caroline Skalley; Al Hatem, Ali; Rizvi, Saba; van der Hoeven, Ransome			The activation of the oxidative stress response transcription factor SKN-1 in Caenorhabditis elegans by mitis group streptococci	PLOS ONE			English	Article							VIRIDANS GROUP STREPTOCOCCI; HYDROGEN-PEROXIDE; MOLECULAR-BASIS; HOST; ENDOCARDITIS	The mitis group, a member of the genetically diverse viridans group streptococci, predominately colonizes the human oropharynx. This group has been shown to cause a wide range of infectious complications in humans, including bacteremia in patients with neutropenia, orbital cellulitis and infective endocarditis. Hydrogen peroxide (H2O2) has been identified as a virulence factor produced by this group of streptococci. More importantly, it has been shown that Streptococcus oralis and S. mitis induce epithelial cell and macrophage death via the production of H2O2. Previously, H2O2 mediated killing was observed in the nematode Caenorhabditis elegans in response to S. oralis and S. mitis. The genetically tractable model organism C. elegans is an excellent system to study mechanisms of pathogenicity and stress responses. Using this model, we observed rapid H2O2 mediated killing of the worms by S. gordonii in addition to S. mitis and S. oralis. Furthermore, we observed colonization of the intestine of the worms when exposed to S. gordonii suggesting the involvement of an infection-like process. In response to the H2O2 produced by the mitis group, we demonstrate the oxidative stress response is activated in the worms. The oxidative stress response transcription factor SKN-1 is required for the survival of the worms and provides protection against H2O2 produced by S. gordonii. We show during infection, H2O2 is required for the activation of SKN-1 and is mediated via the p38-MAPK pathway. The activation of the p38 signaling pathway in the presence of S. gordonii is not mediated by the endoplasmic reticulum (ER) transmembrane protein kinase IRE-1. However, IRE-1 is required for the survival of worms in response to S. gordonii. These finding suggests a parallel pathway senses H2O2 produced by the mitis group and activates the phosphorylation of p38. Additionally, the unfolded protein response plays an important role during infection.	[Naji, Ali; Houston, John; Rog, Caroline Skalley; Al Hatem, Ali; Rizvi, Saba; van der Hoeven, Ransome] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	van der Hoeven, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA.	ransome.vanderhoeven@uth.tmc.edu		van der Hoeven, Ransome/0000-0001-9686-832X	University of Texas Health Science Center at Houston, School of Dentistry startup funds; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	University of Texas Health Science Center at Houston, School of Dentistry startup funds; NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by University of Texas Health Science Center at Houston, School of Dentistry startup funds awarded to R. van der Hoeven (PI). Some worm strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Bing-Yan Wang and Dr. Gena Tribble (The University of Texas, School of Dentistry) for providing the streptococcal strains. We also thank Dr. Richard Lamont (University of Louisville, School of Dentistry) for providing the Delta spxB mutant and the Delta spxB;spxB<SUP>+</SUP> complement strains of S. gordonii. We are grateful to Dr. Samuel Shelburne (MD Anderson Cancer Center) for providing clinical strains of S. oralis and S. mitis and Dr. Keith Blackwell for the C. elegans strains. Final we thank Dr. Danielle Garsin and her lab (The University of Texas, McGovern Medical School) for providing reagents and worm strains to conduct the study. Some worm strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; Bolm M, 2004, INFECT IMMUN, V72, P1192, DOI 10.1128/IAI.72.2.1192-1194.2004; Cheng XQ, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01697-17; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Glover-Cutter KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003701; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Hope IA., 1999, C ELEGANS PRACTICAL; Hourihan JM, 2016, MOL CELL, V63, P553, DOI 10.1016/j.molcel.2016.07.019; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Jeong DE, 2017, EMBO J, V36, P1046, DOI 10.15252/embj.201694781; Kell A, 2007, FREE RADICAL BIO MED, V43, P1560, DOI 10.1016/j.freeradbiomed.2007.08.025; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Zhu L, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/473932; Loose M, 2015, J INFECT DIS, V211, P306, DOI 10.1093/infdis/jiu428; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Okahashi N, 2016, INFECT IMMUN, V84, P2042, DOI 10.1128/IAI.00134-16; Okahashi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088136; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Pallepati P, 2011, BBA-MOL CELL RES, V1813, P1987, DOI 10.1016/j.bbamcr.2011.07.021; Papp D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002673; Sahasrabhojane P, 2014, INT J ANTIMICROB AG, V43, P558, DOI 10.1016/j.ijantimicag.2014.01.031; Shelburne SA, 2014, EMERG INFECT DIS, V20, P762, DOI 10.3201/eid2005.130953; Shelburne SA, 2014, AM J INFECT CONTROL, V42, P1127, DOI 10.1016/j.ajic.2014.06.012; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Wang JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001048; Xu YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086685, 10.1371/journal.pone.0087863]; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yuen GJ, 2014, J MICROBIOL, V52, P200, DOI 10.1007/s12275-014-4011-6	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202233	10.1371/journal.pone.0202233	http://dx.doi.org/10.1371/journal.pone.0202233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114261	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400052
J	Shah, AC; Ma, K; Faraoni, D; Oh, DCS; Rooke, GA; Van Norman, GA				Shah, Aalap C.; Ma, Kevin; Faraoni, David; Oh, Daniel C. S.; Rooke, G. Alec; Van Norman, Gail A.			Self-reported functional status predicts post-operative outcomes in non-cardiac surgery patients with pulmonary hypertension	PLOS ONE			English	Article							6-MINUTE WALK TEST; NONOBSTETRIC SURGERY; HEART-FAILURE; RISK; MANAGEMENT; INSUFFICIENCY; SURVIVAL; DISEASE; STRAIN; IMPACT	Background Pulmonary hypertension (PHTN) is associated with increased post-procedure morbidity and mortality. Pre-procedure echocardiography (ECHO) is a widely used tool for evaluation of these patients, but its accuracy in predicting post-procedure outcomes is unproven. Selfreported exercise tolerance has not been evaluated for operative risk stratification of PHTN patients. Objective We analyzed whether self-reported exercise tolerance predicts outcomes (hospital length-of-stay [LOS], mortality and morbidity) in PHTN patients (WHO Class I +/- V) undergoing anesthesia and surgery. Methods and findings We reviewed 550 non-cardiac, non-obstetric procedures performed on 370 PHTN patients at a single institution between 2007 and 2013. All patients had cardiac ECHO documented within 1 year prior to the procedure. Pre-procedure comorbidities and ECHO data were collected. Functional status (< or >= 4 metabolic equivalents of task [METs]) was assigned based on responses to standard patient interview questions during the pre-anesthesia clinic visit. Multiple logistic regression was used to develop a risk score model (Pulmonary Hypertension Outcome Risk Score; PHORS) and determine its value in predicting post-procedure outcomes. In an adjusted model, functional status < 4 METs was independently associated with a LOS > 7 days (p <.003), as were higher ASA class (p <.002), open surgical approach (p <.002), procedure duration > 2 hours (p <.001), and the absence of systemic hypertension (p =.012). PHORS Score >= 2 was associated with an increased 30-day major complication rate (28.7% vs. 19.2%; p < 0.001) and ICU admission rate (8.6% s 2.8%; p =.007), but no statistical difference in hospital readmissions rate (17.6% vs. 14.0%; p =.29), or mortality (3.5% vs. 1.4%; p =.75). Similar ECHO findings did not further improve outcome prediction. Conclusions Poor functional status is associated with severe PHTN and predicts increased LOS and post-procedure complications in patients with moderate to severe pulmonary hypertension with different etiologies. A risk assessment model predicts increased LOS with fair accuracy. A thorough evaluation of underlying etiologies of PHTN should be undertaken in every patient.	[Shah, Aalap C.; Ma, Kevin; Rooke, G. Alec; Van Norman, Gail A.] Univ Washington, Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Faraoni, David] Univ Toronto, Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON, Canada; [Oh, Daniel C. S.] Univ Washington, Sch Med, Seattle, WA USA; [Shah, Aalap C.] Aalap C Shah MD Inc, West Hollywood, CA USA	University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Washington; University of Washington Seattle	Shah, AC (corresponding author), Univ Washington, Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.; Shah, AC (corresponding author), Aalap C Shah MD Inc, West Hollywood, CA USA.	aalap.c.shah@gmail.com	Faraoni, David/L-6617-2018; Shah, Aalap/ABC-7932-2020; Rooke, Alec/F-8909-2013	Faraoni, David/0000-0002-1093-4523; Shah, Aalap/0000-0001-8761-0458; 				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Blumberg FC, 2013, EUR J HEART FAIL, V15, P771, DOI 10.1093/eurjhf/hft044; Boult M, 2015, J VASC SURG, V62, P299, DOI 10.1016/j.jvs.2015.03.022; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Chen Y, 2015, BIOSTATISTICS, V16, P727, DOI 10.1093/biostatistics/kxv008; Cioffi G, 2007, EUR J ECHOCARDIOGR, V8, P322, DOI 10.1016/j.euje.2006.06.006; Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2; De Meester P, 2012, J HEART VALVE DIS, V21, P743; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Ghio S, 2010, INT J CARDIOL, V140, P272, DOI 10.1016/j.ijcard.2008.11.051; Girish M, 2001, CHEST, V120, P1147, DOI 10.1378/chest.120.4.1147; Guazzi M, 2014, CIRC-HEART FAIL, V7, P367, DOI 10.1161/CIRCHEARTFAILURE.113.000823; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; Hoeper MM, 2011, AM J RESP CRIT CARE, V184, P1114, DOI 10.1164/rccm.201104-0662CI; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kaw R, 2011, RESP MED, V105, P619, DOI 10.1016/j.rmed.2010.12.006; Kehmeier ES, 2016, INT J CARDIOL, V203, P90, DOI 10.1016/j.ijcard.2015.10.074; Kim David, 2014, HSS J, V10, P131, DOI 10.1007/s11420-014-9391-y; Lai HC, 2007, BRIT J ANAESTH, V99, P184, DOI 10.1093/bja/aem126; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540; McLaughlin VV, 2004, CURR PROB CARDIOLOGY, V29, P575, DOI 10.1016/j.cpcardiol.2004.04.001; Memtsoudis SG, 2010, ANESTH ANALG, V111, P1110, DOI 10.1213/ANE.0b013e3181f43149; Meyer S, 2013, EUR RESPIR J, V41, P1302, DOI 10.1183/09031936.00089212; Min JK, 2017, CLIN IMAG, V43, P97, DOI 10.1016/j.clinimag.2017.01.015; Minai Omar A, 2006, Conn Med, V70, P239; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Opitz CF, 2016, J AM COLL CARDIOL, V68, P368, DOI 10.1016/j.jacc.2016.05.047; Parikh KS, 2015, AM HEART J, V170, P419, DOI 10.1016/j.ahj.2015.06.010; Pilkington SA, 2015, ANAESTHESIA, V70, P56, DOI 10.1111/anae.12831; Price LC, 2010, EUR RESPIR J, V35, P1294, DOI 10.1183/09031936.00113009; Ramakrishna G, 2005, J AM COLL CARDIOL, V45, P1691, DOI 10.1016/j.jacc.2005.02.055; Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8; Reilly DF, 1999, ARCH INTERN MED, V159, P2185, DOI 10.1001/archinte.159.18.2185; Rodriguez RM, 1998, ANESTH ANALG, V87, P812, DOI 10.1097/00000539-199810000-00013; Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015; Selimovic N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002108; Shah SJ, 2009, CIRC-HEART FAIL, V2, P278, DOI 10.1161/CIRCHEARTFAILURE.108.807826; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Squires MH, 2014, J AM COLL SURGEONS, V219, P914, DOI 10.1016/j.jamcollsurg.2014.05.015; Taichman DB, 2009, MAYO CLIN PROC, V84, P586, DOI 10.1016/S0025-6196(11)60747-7; Tempe DK, 2009, J CARDIOTHOR VASC AN, V23, P298, DOI 10.1053/j.jvca.2009.01.011; Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801; Yang EI, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-014-0490-z	47	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201914	10.1371/journal.pone.0201914	http://dx.doi.org/10.1371/journal.pone.0201914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114222	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400032
J	Santos, FM; de Macedo, GC; Barreto, WTG; Oliveira-Santos, LGR; Garcia, CM; Mourao, GD; Porfirio, GED; Marino, ED; Andre, MR; Perles, L; de Oliveira, CE; de Andrade, GB; Jansen, AM; Herrera, HM				Santos, Filipe Martins; de Macedo, Gabriel Carvalho; Gomes Barreto, Wanessa Teixeira; Rodrigues Oliveira-Santos, Luiz Gustavo; Garcia, Carolina Martins; Mourao, Guilherme de Miranda; de Oliveira Porfirio, Grasiela Edith; Marino, Elizangela Domenis; Andre, Marcos Rogerio; Perles, Livia; de Oliveira, Carina Elisei; de Andrade, Gisela Braziliano; Jansen, Ana Maria; Herrera, Heitor Miraglia			Outcomes of Trypanosoma cruzi and Trypanosoma evansi infections on health of Southern coati (Nasua nasua), crab-eating fox (Cerdocyon thous), and ocelot (Leopardus pardalis) in the Brazilian Pantanal	PLOS ONE			English	Article							SENSITIVE DETECTION; CHAGAS-DISEASE; IRON; WILDLIFE; MAMMALS; ANEMIA; DOGS; DIAGNOSIS	The occurrence of Trypanosoma spp. in wild carnivore populations has been intensively investigated during the last decades. However, the impact of these parasites on the health of free-living infected animals has been largely neglected. The Pantanal biome is the world's largest seasonal wetland, harboring a great diversity of species and habitats. This includes 174 species of mammals, of which 20 belong to the order Carnivora. The present study aimed to investigate the effect of Trypanosoma evansi and Trypanosoma cruzi infections and coinfections on the health of the most abundant carnivores in the Pantanal: coati (Nasua nasua), crab-eating fox (Cerdocyon thous), and ocelot (Leopardus pardalis). We captured 39 coatis, 48 crab-eating foxes, and 19 ocelots. Diagnostic tests showed T. cruzi infection in 7 crab-eating foxes and 5 coatis. Additionally, 7 crab-eating foxes, 10 coatis, and 12 ocelots were positive for T. evansi. We observed coinfections in 9 crab-eating foxes, 8 coatis, and 2 ocelots. This is the first report of T. evansi and T. cruzi infection on the health of free-living ocelots and crab-eating foxes. We showed that single T. evansi or T. cruzi infection, as well as coinfection, caused some degree of anemia in all animals, as well as an indirect negative effect on body condition in coatis and crab-eating foxes via anemia indicators and immune investment, respectively. Furthermore, the vigorous immune investment observed in sampled coatis, crab-eating foxes and ocelots infected by T. evansi, T. cruzi and coinfected can be highly harmful to their health. Overall, our results indicate that single and combined infection with T. evansi and T. cruzi represent a severe risk to the health of wild carnivores in the Pantanal region.	[Santos, Filipe Martins; de Macedo, Gabriel Carvalho; de Oliveira Porfirio, Grasiela Edith; Marino, Elizangela Domenis; de Oliveira, Carina Elisei; de Andrade, Gisela Braziliano; Jansen, Ana Maria; Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Programa Posgrad Ciencias Ambientais & Sustentabi, Campo Grande, MS, Brazil; [Gomes Barreto, Wanessa Teixeira; Rodrigues Oliveira-Santos, Luiz Gustavo; Garcia, Carolina Martins; Mourao, Guilherme de Miranda; Herrera, Heitor Miraglia] Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Mourao, Guilherme de Miranda] Empresa Brasileira Pesquisa Agr, Ctr Pesquisa Agr Pantanal, Lab Vida Selvagem, Corumba, MS, Brazil; [Andre, Marcos Rogerio; Perles, Livia] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Jansen, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, RJ, Brazil	Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Mato Grosso do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Fundacao Oswaldo Cruz	Santos, FM (corresponding author), Univ Catolica Dom Bosco, Programa Posgrad Ciencias Ambientais & Sustentabi, Campo Grande, MS, Brazil.	filipemsantos@outlook.com	Oliveira, Carina/AAV-9574-2021; Herrera, Heitor Miraglia/K-3759-2012; de Oliveira, Carina Elisei/I-5653-2017; Oliveira, Carina Elisei/F-3677-2019; Porfirio, Grasiela/F-3353-2019; Mourão, Guilherme M/C-3319-2013; Santos, Filipe Martins/GYJ-8093-2022; Oliveira-Santos, Luiz Gustavo Rodrigues/F-9562-2012; Barreto, Wanessa/A-4937-2016; André, Marcos Rogério/C-4395-2012; Santos, Filipe Martins/M-1061-2019	Oliveira, Carina/0000-0001-9240-4376; Herrera, Heitor Miraglia/0000-0003-2404-8765; Oliveira, Carina Elisei/0000-0001-9240-4376; Porfirio, Grasiela/0000-0003-0837-7489; Mourão, Guilherme M/0000-0002-8300-4191; Santos, Filipe Martins/0000-0003-2032-8129; Oliveira-Santos, Luiz Gustavo Rodrigues/0000-0001-9632-5173; Barreto, Wanessa/0000-0003-2970-1321; André, Marcos Rogério/0000-0002-1713-5222; Santos, Filipe Martins/0000-0003-2032-8129; Jansen, Ana Maria/0000-0001-5804-6210; Macedo, Gabriel/0000-0002-4596-5733; Perles, Livia/0000-0002-0287-5252	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [PRONEX 006/2015]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was funded by Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT; grant PRONEX 006/2015) to GMM and FMS, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to the first author, FMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho CJR, 2011, BRAZ J BIOL, V71, P297, DOI 10.1590/S1519-69842011000200009; Alves FM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1649-4; Alves FM, 2011, VECTOR-BORNE ZOONOT, V11, P835, DOI 10.1089/vbz.2010.0096; Aquino LPCT, 2002, ARQ BRAS MED VET ZOO, V54, P8, DOI 10.1590/S0102-09352002000100002; Arias JF, 1997, J WILDLIFE DIS, V33, P359, DOI 10.7589/0090-3558-33.2.359; BARR SC, 1991, AM J VET RES, V52, P954; BARRETTCONNOR E, 1973, ARCH INTERN MED, V131, P574, DOI 10.1001/archinte.131.4.574; Bianchi RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162893; Bottari NB, 2014, EXP PARASITOL, V147, P1, DOI 10.1016/j.exppara.2014.09.002; Cordeiro FD, 2001, CLIN DIAGN LAB IMMUN, V8, P112, DOI 10.1128/CDLI.8.1.112-118.2001; Curtis-Robles R, 2016, INT J PARASITOL-PAR, V5, P117, DOI 10.1016/j.ijppaw.2016.04.001; Aquino LPCT, 2010, REV BRAS PARASITOL V, V19, P112, DOI 10.1590/S1984-29612010000200009; Da Silva AS, 2010, RES VET SCI, V88, P281, DOI 10.1016/j.rvsc.2009.08.011; Da Silva AS, 2011, EXP PARASITOL, V127, P475, DOI 10.1016/j.exppara.2010.10.017; Da Silva AS, 2009, EXP PARASITOL, V123, P31, DOI 10.1016/j.exppara.2009.05.008; da Silva CB, 2013, EXP PARASITOL, V133, P357, DOI 10.1016/j.exppara.2012.12.010; De Sousa KCM, 2017, EPIDEMIOL INFECT, V145, P3424, DOI 10.1017/S095026881700245X; De Sousa KCM, 2017, TICKS TICK-BORNE DIS, V17, P30162; Duz ALC, 2014, MEM I OSWALDO CRUZ, V109, P1005, DOI 10.1590/0074-02760140208; Girones N, 2003, TRENDS PARASITOL, V19, P19, DOI 10.1016/S1471-4922(02)00006-5; Goto H, 2009, REV I MED TROP, V51, P241, DOI 10.1590/S0036-46652009000500002; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Haag J, 1998, MOL BIOCHEM PARASIT, V91, P37, DOI 10.1016/S0166-6851(97)00185-0; Herrera HM, 2008, PARASITOL RES, V103, P619, DOI 10.1007/s00436-008-1021-5; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Herrera HM, 2004, VET PARASITOL, V125, P263, DOI 10.1016/j.vetpar.2004.07.013; Herrera HM, 2002, ACTA TROP, V81, P203, DOI 10.1016/S0001-706X(01)00204-2; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Jansen AM, 2015, ACTA TROP, V151, P1, DOI 10.1016/j.actatropica.2015.07.018; Jirku M, 2015, INT J PARASITOL-PAR, V4, P277, DOI 10.1016/j.ijppaw.2015.05.001; Kipper M, 2011, RES VET SCI, V91, P240, DOI 10.1016/j.rvsc.2010.11.018; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; LALONDE RG, 1984, J CLIN INVEST, V73, P470, DOI 10.1172/JCI111233; LOO VG, 1984, INFECT IMMUN, V45, P726, DOI 10.1128/IAI.45.3.726-730.1984; Luna-Gomes T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090582; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; de Sousa KCM, 2017, ACTA TROP, V171, P172, DOI 10.1016/j.actatropica.2017.03.030; Martinez-Hernandez F, 2016, VECTOR-BORNE ZOONOT, V16, P709, DOI 10.1089/vbz.2016.1986; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; MASSEY AC, 1992, MED CLIN N AM, V76, P549, DOI 10.1016/S0025-7125(16)30339-X; Guedes PMM, 2012, REV BRAS PARASITOL V, V21, P151, DOI 10.1590/S1984-29612012000200015; Melo RCN, 2001, EXP PARASITOL, V97, P15, DOI 10.1006/expr.2000.4576; Misra K.K., 2016, Journal of Parasitic Diseases, V40, P1047, DOI 10.1007/s12639-014-0633-1; Monteiro RV, 2007, PARASITOL RES, V101, P1689, DOI 10.1007/s00436-007-0652-2; Monteiro RV, 2006, J MED PRIMATOL, V35, P48, DOI 10.1111/j.1600-0684.2005.00139.x; Oates PS, 2007, HISTOL HISTOPATHOL, V22, P791, DOI 10.14670/HH-22.791; Olifiers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143997; Pandey V, 2015, VET PARASITOL, V212, P118, DOI 10.1016/j.vetpar.2015.07.025; Parreira DR, 2016, ACTA TROP, V163, P98, DOI 10.1016/j.actatropica.2016.08.005; PATTISON JR, 1985, PARASITE IMMUNOL, V7, P81, DOI 10.1111/j.1365-3024.1985.tb00480.x; Pinazo MJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001965; R Core Team, 2016, R FDN STAT COMP; Reddy B Sudhakara, 2016, J Parasit Dis, V40, P491, DOI 10.1007/s12639-014-0531-6; Robar N, 2010, OIKOS, V119, P1273, DOI 10.1111/j.1600-0706.2009.18292.x; Rocha FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067463; Roque ALR, 2005, EXP PARASITOL, V111, P37, DOI 10.1016/j.exppara.2005.05.003; Roque FO, 2016, CONSERV BIOL, V30, P1131, DOI 10.1111/cobi.12713; Schwanz LE, 2008, BEHAV ECOL SOCIOBIOL, V62, P1351, DOI 10.1007/s00265-008-0563-y; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; Silva R.A.M.S., 1999, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V52, P119; Smith A, 2008, PARASITOLOGY, V135, P1329, DOI 10.1017/S0031182008004824; Soares MBP, 2001, AN ACAD BRAS CIENC, V73, P547, DOI 10.1590/S0001-37652001000400008; SOUTO RP, 1993, MOL BIOCHEM PARASIT, V62, P45, DOI 10.1016/0166-6851(93)90176-X; Stevens J, 1999, MEM I OSWALDO CRUZ, V94, P225, DOI 10.1590/S0074-02761999000200019; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Thomas F., 2009, ECOLOGY EVOLUTION PA; Thompson Craig K., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P57, DOI 10.1016/j.ijppaw.2014.02.002; Thompson RCA, 2015, INT J PARASITOL-PAR, V4, P197, DOI 10.1016/j.ijppaw.2015.03.001; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Voigt GL, 2000, AMES PROFESSIONAL B; Wolkmer P, 2009, VET PARASITOL, V165, P41, DOI 10.1016/j.vetpar.2009.06.032; Woo P. T. K., 1970, Acta trop., V27, P384	72	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201357	10.1371/journal.pone.0201357	http://dx.doi.org/10.1371/journal.pone.0201357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110344	Green Published, gold			2022-12-26	WOS:000441738000023
J	Jaber, H; Lohman, E; Daher, N; Bains, G; Nagaraj, A; Mayekar, P; Shanbhag, M; Alameri, M				Jaber, Hatem; Lohman, Everett; Daher, Noha; Bains, Gurinder; Nagaraj, Abhay; Mayekar, Prajakta; Shanbhag, Manali; Alameri, Mansoor			Neuromuscular control of ankle and hip during performance of the star excursion balance test in subjects with and without chronic ankle instability	PLOS ONE			English	Article							LOWER-EXTREMITY; MUSCLE ACTIVATION; FUNCTIONAL INSTABILITY; POSTURAL-CONTROL; INDIVIDUALS; DEFICITS; INJURY; KINEMATICS; FATIGUE; JOINT	Background/Purpose Ankle sprains are common and potentially disabling musculoskeletal injuries that often lead to chronic ankle instability (CAI). CAI has been linked to impairments in postural and neuromuscular control; however, inconsistent findings have been reported. Individuals who experience a lateral ankle sprain, but do not develop instability, termed copers, may adapt different neuromuscular control strategies after injury. This study aimed to compare postural control and electromyographic (EMG) activity of hip and ankle muscles during the performance of the Star Excursion Balance Test (SEBT) in subjects with and without CAI. Method 48 participants were classified into three groups (16 control, 16 copers, 16 CAI) based on ankle sprain history and Cumberland Ankle Instability Tool score. Outcome measures included normalized reach distance, center of pressure (COP), and integrated EMG activation of gluteus medius (Gmed), gluteus maximus (Gmax), tibialis anterior (TA), and peroneus longus (PL) during each reach direction of SEBT. Results Compared to copers and controls, CAI group demonstrated significantly diminished postural control (reach distance and COP measures, p < 0.05) and less EMG activity of TA during the anterior direction (CAI: 33.1% +/- 10.1% versus copers: 44.8% +/- 12.7% versus controls: 51.7% +/- 8.4%, p < 0.01) and Gmax in the posterolateral direction (CAI: 25.6% +/- 9.4% versus copers: 37.5% +/- 13.8% versus controls: 40.2% +/- 17.2%, p = 0.011). Conclusion Alteration in proximal and distal muscle activity appears to negatively affect postural control and quality of movement, which may lead to prolonged functional impairments. Hence, implementing hip and ankle muscle exercises in the rehabilitation of ankle instability might benefit these patients.	[Jaber, Hatem; Lohman, Everett; Nagaraj, Abhay; Mayekar, Prajakta; Shanbhag, Manali; Alameri, Mansoor] Loma Linda Univ, Sch Allied Hlth Profess, Dept Phys Therapy, Loma Linda, CA 92350 USA; [Daher, Noha; Bains, Gurinder] Loma Linda Univ, Sch Allied Hlth Profess, Dept Allied Hlth Studies, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University	Jaber, H (corresponding author), Loma Linda Univ, Sch Allied Hlth Profess, Dept Phys Therapy, Loma Linda, CA 92350 USA.	hjaber@llu.ed		Jaber, Hatem/0000-0002-2080-4538				Ayotte NW, 2007, J ORTHOP SPORT PHYS, V37, P48, DOI 10.2519/jospt.2007.2354; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; BULLOCKSAXTON JE, 1994, INT J SPORTS MED, V15, P330, DOI 10.1055/s-2007-1021069; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Delahunt E, 2006, J ORTHOP RES, V24, P1991, DOI 10.1002/jor.20235; Delahunt E, 2006, AM J SPORT MED, V34, P1970, DOI 10.1177/0363546506290989; Donahue M, 2011, FOOT ANKLE INT, V32, P1140, DOI 10.3113/FAI.2011.1140; Drewes LK, 2009, J SCI MED SPORT, V12, P685, DOI 10.1016/j.jsams.2008.07.003; Dundas MA, 2014, J SPORT SCI, V32, P926, DOI 10.1080/02640414.2013.868917; Evans T, 2004, FOOT ANKLE INT, V25, P833, DOI 10.1177/107110070402501114; Farrokhi S, 2008, J ORTHOP SPORT PHYS, V38, P403, DOI 10.2519/jospt.2008.2634; Feger Mark A, 2014, PM R, V6, P602, DOI 10.1016/j.pmrj.2013.12.013; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Gerber JP, 1998, FOOT ANKLE INT, V19, P653, DOI 10.1177/107110079801901002; Gribble, 2003, MEAS PHYS ED EXERC S, V7, P89, DOI [10.1207/S15327841MPEE0702_3, DOI 10.1207/S15327841MPEE0702_3]; Gribble PA, 2007, INT J SPORTS MED, V28, P236, DOI 10.1055/s-2006-924289; Gribble PA, 2004, J ATHL TRAINING, V39, P321; Gribble PA, 2013, J ORTHOP SPORT PHYS, V43, P585, DOI 10.2519/jospt.2013.0303; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Gutierrez GM, 2012, AM J SPORT MED, V40, P193, DOI 10.1177/0363546511422323; Hale SA, 2014, J ATHL TRAINING, V49, P181, DOI 10.4085/1062-6050-49.2.06; Hass CJ, 2010, AM J SPORT MED, V38, P829, DOI 10.1177/0363546509351562; Hermans H., 1999, SENIAM EUROPEAN RECO, P15; Hertel J, 2006, J ORTHOP SPORT PHYS, V36, P131, DOI 10.2519/jospt.2006.36.3.131; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hertel J, 2000, SPORTS MED, V29, P361, DOI 10.2165/00007256-200029050-00005; Hiller CE, 2006, ARCH PHYS MED REHAB, V87, P1235, DOI 10.1016/j.apmr.2006.05.022; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Jacobs R, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P300; Lemay JF, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-8; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; Neumann DA, 2010, J ORTHOP SPORT PHYS, V40, P82, DOI 10.2519/jospt.2010.3025; Olmsted LC, 2002, J ATHL TRAINING, V37, P501; Pietrosimone BG, 2012, J ATHL TRAINING, V47, P621, DOI 10.4085/1062-6050-47.6.11; Pozzi F, 2015, INT J SPORTS PHYS TH, V10, P520; Riemann BL, 2003, ARCH PHYS MED REHAB, V84, P90, DOI 10.1053/apmr.2003.50004; Van Deun S, 2007, AM J SPORT MED, V35, P274, DOI 10.1177/0363546506294470; Waterman BR, 2010, AM J SPORT MED, V38, P979, DOI 10.1177/0363546509350757; Webster KA, 2016, J ATHL TRAINING, V51, P629, DOI 10.4085/1062-6050-51.10.01; Webster KA, 2013, PHYS THER SPORT, V14, P17, DOI 10.1016/j.ptsp.2012.02.002; WINTER DA, 1990, MED PROG TECHNOL, V16, P31	42	28	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201479	10.1371/journal.pone.0201479	http://dx.doi.org/10.1371/journal.pone.0201479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102713	Green Published, Green Submitted			2022-12-26	WOS:000441452200011
J	Burford, BP; Lee, G; Friedman, DA; Brachmann, E; Khan, R; MacArthur-Waltz, DJ; McCarty, AD; Gordon, DM				Burford, Benjamin P.; Lee, Gail; Friedman, Daniel A.; Brachmann, Esme; Khan, Rebia; MacArthur-Waltz, Dylan J.; McCarty, Aidan D.; Gordon, Deborah M.			Foraging behavior and locomotion of the invasive Argentine ant from winter aggregations	PLOS ONE			English	Article							LINEPITHEMA-HUMILE HYMENOPTERA; LIFE-HISTORY; NATIVE ANTS; TEMPERATURE; FORMICIDAE; CALIFORNIA; THERMOKINETICS; EXPLOITATION; IRIDOMYRMEX; DISTURBANCE	The collective behavior of ant colonies, and locomotion of individuals within a colony, both respond to changing conditions. The invasive Argentine ant (Linepithema humile) thrives in Mediterranean climates with hot, dry summers and colder, wet winters. However, its foraging behavior and locomotion has rarely been studied in the winter. We examined how the foraging behavior of three distinct L. humile colonies was related to environmental conditions and the locomotion of workers during winter in northern California. We found that colonies foraged most between 10 and 15 degrees C, regardless of the maximum daily temperature. Worker walking speed was positively associated with temperature (range 6-24 degrees C) and negatively associated with humidity (range 25-93%RH). All colonies foraged during all day and night hours in a predictable daily cycle, with a correlation between the rate of incoming and outgoing foragers. Foraging activity was unrelated to the activity of a competing native ant species, Prenolepis imparis, which was present in low abundance, and ceased only during heavy rain when ants left foraging trails and aggregated in small sheltered areas on trees.	[Burford, Benjamin P.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Lee, Gail; Friedman, Daniel A.; Khan, Rebia; MacArthur-Waltz, Dylan J.; McCarty, Aidan D.; Gordon, Deborah M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Brachmann, Esme] Univ Calif Berkeley, Coll Letters & Sci, Berkeley, CA 94720 USA	Stanford University; Stanford University; University of California System; University of California Berkeley	Burford, BP (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	bburford@stanford.edu		Burford, Benjamin/0000-0002-2120-3769				ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Abril S, 2008, SOCIOBIOLOGY, V51, P645; [Anonymous], 2010, ANT ENCOUNTERS INTER; BARTLETT B. R., 1961, ANN ENT SOC AMER, V54, P543, DOI 10.1093/aesa/54.4.543; Brightwell RJ, 2011, ENVIRON ENTOMOL, V40, P1019, DOI 10.1603/EN11038; Carpintero S, 2007, ENVIRON ENTOMOL, V36, P1100, DOI 10.1603/0046-225X(2007)36[1100:ESOTIA]2.0.CO;2; Cerda X, 1998, FUNCT ECOL, V12, P45, DOI 10.1046/j.1365-2435.1998.00160.x; CRIST TO, 1991, ENVIRON ENTOMOL, V20, P265, DOI 10.1093/ee/20.1.265; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Ellis S, 2017, INSECT SOC, V64, P19, DOI 10.1007/s00040-016-0534-7; Farji-Brener AG, 2018, INSECTES SOC, V1-7; Fitzgerald K, 2012, CONSERV BIOL, V26, P525, DOI 10.1111/j.1523-1739.2012.01836.x; Flanagan TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070888; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2014, MYRMECOL NEWS, V19, P103; Grover CD, 2008, ECOL ENTOMOL, V33, P101, DOI 10.1111/j.1365-2311.2007.00942.x; Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x; Heller NE, 2008, INSECT SOC, V55, P397, DOI 10.1007/s00040-008-1019-0; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; HODGSON ES, 1955, ECOLOGY, V36, P293, DOI 10.2307/1933235; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Human KG, 1998, ENVIRON ENTOMOL, V27, P822, DOI 10.1093/ee/27.4.822; Hurlbert AH, 2008, ECOL ENTOMOL, V33, P144, DOI 10.1111/j.1365-2311.2007.00962.x; Jayatilaka P, 2011, J EXP BIOL, V214, P2730, DOI 10.1242/jeb.053710; Jumbam KR, 2008, J INSECT PHYSIOL, V54, P1008, DOI 10.1016/j.jinsphys.2008.03.011; Latty T, 2017, J EXP BIOL, V220, P686, DOI 10.1242/jeb.144238; Lopez F, 1992, ECOSYSTEMS FUNCTION, P119; MARKIN GP, 1970, J ECON ENTOMOL, V63, P740, DOI 10.1093/jee/63.3.740; MARKIN GP, 1970, ANN ENTOMOL SOC AM, V63, P1238, DOI 10.1093/aesa/63.5.1238; Mathworks, 2012, MATLAB STAT TOOLB RE; McGrannachan CM, 2013, J APPL ENTOMOL, V137, P550, DOI 10.1111/jen.12032; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Mooney HA., 1983, CARBON GAINING CAPIC, P103; NONACS P, 1990, ECOLOGY, V71, P1886, DOI 10.2307/1937596; R_Core_Team, 2015, R LANG ENV STAT COMP; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Reuter M, 2001, J EVOLUTION BIOL, V14, P954, DOI 10.1046/j.1420-9101.2001.00345.x; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; Ruano F, 2000, BEHAV ECOL, V11, P396, DOI 10.1093/beheco/11.4.396; Shapley H, 1924, P NATL ACAD SCI USA, V10, P436, DOI 10.1073/pnas.10.10.436; Shapley H, 1920, P NATL ACAD SCI USA, V6, P204, DOI 10.1073/pnas.6.4.204; Sorrells TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018717; Suckling DM, 2010, J CHEM ECOL, V36, P122, DOI 10.1007/s10886-009-9734-1; Thomas ML, 2005, J ANIM ECOL, V74, P532, DOI 10.1111/j.1365-2656.2005.00952.x; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; TRANIELLO JFA, 1984, BEHAV ECOL SOCIOBIOL, V15, P65, DOI 10.1007/BF00310217; TSCHINKEL WR, 1987, INSECT SOC, V34, P143, DOI 10.1007/BF02224081; Vonshak M, 2015, BIOL CONSERV, V186, P359, DOI 10.1016/j.biocon.2015.03.024	52	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202117	10.1371/journal.pone.0202117	http://dx.doi.org/10.1371/journal.pone.0202117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092038	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600089
J	Chang, TZ; Deng, L; Wang, BZ; Champion, JA				Chang, Timothy Z.; Deng, Lei; Wang, Bao-Zhong; Champion, Julie A.			H7 Hemagglutinin nanoparticles retain immunogenicity after > 3 months of 25 degrees C storage	PLOS ONE			English	Article							INFLUENZA; VACCINES	Vaccine distribution infrastructure remains inadequate in many parts of the world, and it is estimated that up to 40-50% of all vaccine doses are wasted in certain countries. Vaccines that can maintain viability outside of the cold chain would decrease vaccine wastage and increase immunization rates in regions of the world with underdeveloped vaccine distribution infrastructure. We examined the potential of crosslinked protein nanoparticles, made from trimerized influenza hemagglutinin (3HA), to maintain immunogenicity after cold-chain independent storage. We found that the nanoparticles could be stored for 112 days at room temperature without any loss in hemagglutinating activity or immunogenicity, and that nano particles could be stored at 37 degrees C for 2 weeks without any loss in hemagglutinating activity. As vaccine development moves towards the use of recombinant subunit antigens, our results demonstrate the potential of crosslinked antigen nanoparticles as an immunogenic vehicle for bringing effective vaccines to underdeveloped regions outside of the cold chain.	[Chang, Timothy Z.; Champion, Julie A.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Deng, Lei; Wang, Bao-Zhong] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia State University	Champion, JA (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	julie.champion@chbe.gatech.edu		Wang, Bao-Zhong/0000-0002-1561-4318; Chang, Timothy/0000-0002-5620-6062	National Institutes of Health [1R01AI101047-01]; National Science Foundation [DGE-1650044]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (Grant # 1R01AI101047-01) and by the National Science Foundation's Graduate Research Fellowship Program (Grant # DGE-1650044 for T.Z.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2004, VACCINES HANDLED CAR; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Brydak LB, 2000, DRUGS, V60, P35, DOI 10.2165/00003495-200060010-00004; Chang TZ, 2017, BIOMATER SCI-UK, V5, P223, DOI 10.1039/c6bm00500d; Choi HJ, 2015, PLOS ONE, V10; Flood A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164692; Health UDo Services H, 2007, HLTH UDO SERVICES H; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kumru OS, 2014, BIOLOGICALS, V42, P237, DOI 10.1016/j.biologicals.2014.05.007; Pelliccia M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13520; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Wang L., 2016, NANOMEDICINE, V13, P253, DOI DOI 10.1016/J.NAN0.2016.09.001; Wang L, 2014, NANOMED-NANOTECHNOL, V10, P473, DOI 10.1016/j.nano.2013.08.005; Zaffran M, 2013, VACCINE, V31, pB73, DOI 10.1016/j.vaccine.2012.11.036	15	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202300	10.1371/journal.pone.0202300	http://dx.doi.org/10.1371/journal.pone.0202300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092060	gold, Green Published, Green Submitted			2022-12-26	WOS:000441232600108
J	Chen, C; Xu, XL; Yan, Y				Chen, Cheng; Xu, Xianglong; Yan, Yan			Estimated global overweight and obesity burden in pregnant women based on panel data model	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; RISK-FACTORS; PREPREGNANCY OBESITY; FOOD ENVIRONMENT; WEIGHT-GAIN; URBANIZATION; ENERGY; PREVALENCE; NUTRITION	Objective To estimate the global and country-level burden of overweight and obesity among pregnant women from 2005 to 2014. Methods Publicly accessible country-level data were collected from the World Health Organization, the World Bank and the Food and Agricultural Organization. We estimated the number of overweight and obese pregnant women among 184 countries and determined the time related trend from 2005 to 2014. Based on panel data model, we determined the effects of food energy supply, urbanization, gross national income and female employment on the number of overweight and obese pregnant women. Results We estimated that 38.9 million overweight and obese pregnant women and 14.6 million obese pregnant women existed globally in 2014. In upper middle income countries and lower middle income countries, there were sharp increases in the number of overweight and obese pregnant women. In 2014, the percentage of female with overweight and obesity in India was 21.7%, and India had the largest number of overweight and obese pregnant women (4.3 million), which accounted for 11.1% in the world. In the United States of America, a third of women were obese, and the number of obese pregnant women was 1.1 million. In high income countries, caloric supply and urbanization were positively associated with the number of overweight and obese pregnant women. The percentage of employment in agriculture was inversely associated with the number of overweight and obese pregnant women, but only in upper middle income countries and lower middle income countries. Conclusion The number of overweight and obese pregnant women has increased in high income and middle income countries. Environmental changes could lead to increased caloric supply and decreased energy expenditure among women. National and local governments should work together to create a healthy food environment.	[Chen, Cheng; Yan, Yan] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Xu, Xianglong] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Xu, Xianglong] Chongqing Med Univ, Res Ctr Med & Social Dev, Chongqing, Peoples R China; [Xu, Xianglong] Chongqing Med Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Chongqing, Peoples R China	Central South University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yan, Y (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	849352541@qq.com		Yan, Yan/0000-0001-9790-7685; Yan, Yan/0000-0001-7479-637X	National Natural Science Foundation of China [81373101, 81673276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was supported by the National Natural Science Foundation of China (81373101, 81673276).	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Aitsi-Selmi A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-769; Angkurawaranon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113547; [Anonymous], 2000, WHO TECH REP SER, P894; Bjermo H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1624-6; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Chang MW, 2016, MATERN CHILD HLTH J, V20, P1506, DOI 10.1007/s10995-016-1949-5; Chu AHY, 2013, PREV MED, V57, pS14, DOI 10.1016/j.ypmed.2012.12.011; DEATON A, 1985, J ECONOMETRICS, V30, P109, DOI 10.1016/0304-4076(85)90134-4; Eiriksdottir VH, 2015, EUR J PUBLIC HEALTH, V25, P638, DOI 10.1093/eurpub/ckv047; Ewing R, 2014, HEALTH PLACE, V26, P118, DOI 10.1016/j.healthplace.2013.12.008; Food and Agriculture Organization of the United Nations, FOOD BALANCE SHEETS; Forsyth S, 2016, ANN NUTR METAB, V68, P258, DOI 10.1159/000446855; Fowles ER, 2011, WESTERN J NURS RES, V33, P630, DOI 10.1177/0193945910389083; Gonzalez-Gross M, 2013, NUTR HOSP, V28, P89, DOI 10.3305/nh.2013.28.sup5.6923; Goryakin Y, 2017, ECON HUM BIOL, V26, P151, DOI 10.1016/j.ehb.2017.03.004; Hosler AS, 2016, J NUTR EDUC BEHAV, V48, P361, DOI 10.1016/j.jneb.2016.03.003; Ijas H, 2013, EUR J ENDOCRINOL, V169, P605, DOI 10.1530/EJE-13-0412; International Weight Management in Pregnancy (i-WIP) Collaborative Group, 2017, BMJ, V358, pj3119, DOI 10.1136/bmj.j3119; Kazemian E, 2014, J HEALTH POPUL NUTR, V32, P486; Kim J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080898; Lamminpaa R, 2018, EUR J NUTR, V57, P1721, DOI 10.1007/s00394-017-1567-z; Lisonkova S, 2017, JAMA-J AM MED ASSOC, V318, P1777, DOI 10.1001/jama.2017.16191; MacInnis N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22895; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Mi YJ, 2015, AM J PREV MED, V49, P661, DOI 10.1016/j.amepre.2015.05.005; Michimi A, 2015, GEOSPATIAL HEALTH, V10, P223, DOI 10.4081/gh.2015.368; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Onubi OJ, 2016, J PUBLIC HEALTH-UK, V38, pE218, DOI 10.1093/pubmed/fdv138; Opie RS, 2016, AUST NZ J OBSTET GYN, V56, P364, DOI 10.1111/ajo.12474; Parnell AS, 2017, MATERN CHILD HLTH J, V21, P1105, DOI 10.1007/s10995-016-2209-4; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Pradeepa R, 2015, INDIAN J MED RES, V142, P139, DOI 10.4103/0971-5916.164234; Rasmussen KM, 2009, WEIGHT GAIN PREGNANC; Seidell JC, 2015, ANN NUTR METAB, V66, P7, DOI 10.1159/000375143; Sha TT, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050458; Sheehy T, 2013, PUBLIC HEALTH NUTR, V16, P1693, DOI 10.1017/S136898001200537X; Sheehy T, 2011, BRIT J NUTR, V106, P1078, DOI 10.1017/S0007114511001395; Sugarman J, 2014, LANCET GLOB HEALTH, V2, pE710, DOI 10.1016/S2214-109X(14)70330-4; Taheri M, 2015, IRAN J MED LIFE, V8, P212; Talebian A, 2015, IRAN J CHILD NEUROL, V9, P50; Tian XY, 2014, J RURAL HEALTH, V30, P101, DOI 10.1111/jrh.12041; Trivedi T, 2015, RURAL REMOTE HEALTH, V15; Usta A, 2017, PAN AFR MED J, V27, DOI [10.11604/pamj.2017.26.62.11440, 10.11604/pamj.2017.27.198.12295]; Van Hook J, 2013, PUBLIC HEALTH NUTR, V16, P573, DOI 10.1017/S1368980012001164; Vandevijvere S, 2015, B WORLD HEALTH ORGAN, V93, P446, DOI 10.2471/BLT.14.150565; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Wang LF, 2015, J PERINATOL, V35, P985, DOI 10.1038/jp.2015.119; World Bank, WORLD DEV IND; Wu Y, 2017, ASIA PAC J CLIN NUTR, V26, P504, DOI 10.6133/apjcn.032016.09; Xu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114707; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yeo S, 2017, OBES REV, V18, P385, DOI 10.1111/obr.12511	53	147	151	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202183	10.1371/journal.pone.0202183	http://dx.doi.org/10.1371/journal.pone.0202183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GP9JF	30092099	Green Submitted, gold, Green Published			2022-12-26	WOS:000441232600098
J	Guo, XT; Zhang, MM; Cao, MH; Zhang, W; Kang, ZQ; Xu, P; Ma, CQ; Gao, C				Guo, Xiaoting; Zhang, Manman; Cao, Menghao; Zhang, Wen; Kang, Zhaoqi; Xu, Ping; Ma, Cuiqing; Gao, Chao			d-2-Hydroxyglutarate dehydrogenase plays a dual role in l-serine biosynthesis and d-malate utilization in the bacterium Pseudomonas stutzeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; serine; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); enzyme kinetics; Pseudomonas; D-2-hydroxyglutarate; D-2-hydroxyglutarate dehydrogenase; D-malate; oxaloacetate; phosphoglycerate dehydrogenase	ESCHERICHIA-COLI; TARTRATE DEHYDROGENASE; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; OXIDATIVE DECARBOXYLATION; MICROBIAL-PRODUCTION; MUTATIONS; METABOLISM; MECHANISM; LACTATE; BINDING	Pseudomonas is a very large bacterial genus in which several species can use d-malate for growth. However, the enzymes that can metabolize d-malate, such as d-malate dehydrogenase, appear to be absent in most Pseudomonas species. d-3-Phosphoglycerate dehydrogenase (SerA) can catalyze the production of d-2-hydroxyglutarate (d-2-HG) from 2-ketoglutarate to support d-3-phosphoglycerate dehydrogenation, which is the initial reaction in bacterial l-serine biosynthesis. In this study, we show that SerA of the Pseudomonas stutzeri strain A1501 reduces oxaloacetate to d-malate and that d-2-HG dehydrogenase (D2HGDH) from P. stutzeri displays d-malate-oxidizing activity. Of note, D2HGDH participates in converting a trace amount of d-malate to oxaloacetate during bacterial l-serine biosynthesis. Moreover, D2HGDH is crucial for the utilization of d-malate as the sole carbon source for growth of P. stutzeri A1501. We also found that the D2HGDH expression is induced by the exogenously added d-2-HG or d-malate and that a flavoprotein functions as a soluble electron carrier between D2HGDH and electron transport chains to support d-malate utilization by P. stutzeri. These results support the idea that D2HGDH evolves as an enzyme for both d-malate and d-2-HG dehydrogenation in P. stutzeri. In summary, D2HGDH from P. stutzeri A1501 participates in both a core metabolic pathway for l-serine biosynthesis and utilization of extracellular d-malate.	[Guo, Xiaoting; Zhang, Manman; Cao, Menghao; Kang, Zhaoqi; Ma, Cuiqing; Gao, Chao] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Zhang, Wen] Shandong Univ, Inst Med Sci, Hosp 2, Jinan 250033, Shandong, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Joint Int Res Lab Metab & Dev Sci, Shanghai 200240, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Shandong University; Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	jieerbu@sdu.edu.cn		Zhang, Wen/0000-0003-0821-7143; Gao, Chao/0000-0002-5205-0670; Xu, Ping/0000-0002-4418-9680	National Natural Science Foundation of China [31470164, 31670041]; Shandong Provincial Funds for Distinguished Young Scientists [JQ 201806]; Shandong University [2015WLJH25]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Funds for Distinguished Young Scientists; Shandong University	This work was supported by National Natural Science Foundation of China Grants 31470164 and 31670041, Shandong Provincial Funds for Distinguished Young Scientists Grant JQ 201806, and Young Scholars Program of Shandong University Grant 2015WLJH25 (to C. G.). The authors declare that they have no conflicts of interest with the contents of this article.	AlRabiee R, 1996, J BIOL CHEM, V271, P23235, DOI 10.1074/jbc.271.38.23235; ASANO Y, 1993, APPL ENVIRON MICROB, V59, P1110, DOI 10.1128/AEM.59.4.1110-1113.1993; Becker-Kettern J, 2016, J BIOL CHEM, V291, P6036, DOI 10.1074/jbc.M115.704494; Burton RL, 2007, J BIOL CHEM, V282, P31517, DOI 10.1074/jbc.M704032200; Dang L, 2017, ANNU REV BIOCHEM, V86, P305, DOI 10.1146/annurev-biochem-061516-044732; Engqvist M, 2009, J BIOL CHEM, V284, P25026, DOI 10.1074/jbc.M109.021253; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Grant GA, 2018, BIOCHEMISTRY-US, V57, P1798, DOI 10.1021/acs.biochem.8b00074; Gu PF, 2014, J IND MICROBIOL BIOT, V41, P1443, DOI 10.1007/s10295-014-1476-6; Gusyatiner M.M., 2015, REF J CHEM, V5, P21, DOI [10.1134/S2079978015010021, DOI 10.1134/S2079978015010021]; HOPPER DJ, 1970, J BACTERIOL, V104, P1197, DOI 10.1128/JB.104.3.1197-1202.1970; Karlstaedt A, 2016, P NATL ACAD SCI USA, V113, P10436, DOI 10.1073/pnas.1601650113; Karsten WE, 2002, BIOCHEMISTRY-US, V41, P12193, DOI 10.1021/bi026278g; Karsten WE, 2006, BIOCHEMISTRY-US, V45, P9000, DOI 10.1021/bi0607251; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Kranendijk M, 2010, HUM MUTAT, V31, P279, DOI 10.1002/humu.21186; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liu K, 2015, APPL ENVIRON MICROB, V81, P5753, DOI 10.1128/AEM.00975-15; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lukas H, 2010, J BACTERIOL, V192, P2503, DOI 10.1128/JB.01665-09; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Martinez-Luque M, 2001, CURR MICROBIOL, V43, P154, DOI 10.1007/s002840010279; Mundhada H, 2016, BIOTECHNOL BIOENG, V113, P807, DOI 10.1002/bit.25844; RABIN R, 1965, SCIENCE, V150, P1548, DOI 10.1126/science.150.3703.1548; REEVES HC, 1963, BIOCHEM BIOPH RES CO, V12, P132, DOI 10.1016/0006-291X(63)90248-1; Rudolph J, 2010, BIOCHEMISTRY-US, V49, P9249, DOI 10.1021/bi101291d; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Tazoe M, 2006, J BACTERIOL, V188, P4635, DOI 10.1128/JB.01999-05; TIPTON PA, 1993, BIOCHEMISTRY-US, V32, P2822, DOI 10.1021/bi00062a013; Unden Gottfried, 2016, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0021-2015; Vorobieva AA, 2014, J BIOL CHEM, V289, P29086, DOI 10.1074/jbc.M114.595363; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124925; Zhang W, 2017, P NATL ACAD SCI USA, V114, pE7574, DOI 10.1073/pnas.1619034114; Zhang XM, 2018, TRENDS BIOTECHNOL, V36, P700, DOI 10.1016/j.tibtech.2018.02.001; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	39	7	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15513	15523		10.1074/jbc.RA118.003897	http://dx.doi.org/10.1074/jbc.RA118.003897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30131334	Green Published, hybrid			2022-12-26	WOS:000446549200017
J	Gerber, KJ; Squires, KE; Hepler, JR				Gerber, Kyle J.; Squires, Katherine E.; Hepler, John R.			14-3-3 gamma binds regulator of G protein signaling 14 (RGS14) at distinct sites to inhibit the RGS14:G alpha(i)-AIF(4)(-) signaling complex and RGS14 nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						regulator of G protein signaling (RGS); 14-3-3 protein; protein-protein interaction; Ras protein; G protein; heterotrimeric G protein; nucleus; Gi; G protein regulatory (GPR) motif; GoLoco motif; H-Ras; RGS14	LONG-TERM POTENTIATION; EXOENZYME-S; PSEUDOMONAS-AERUGINOSA; COUPLED RECEPTORS; STRUCTURAL BASIS; KINASE-ACTIVITY; RAF-1 KINASE; LIVE CELLS; PHOSPHORYLATION; ACTIVATION	Regulator of G protein signaling 14 (RGS14) is a multifunctional brain scaffolding protein that integrates G protein and Ras/ERK signaling pathways. It is also a nucleocytoplasmic shuttling protein. RGS14 binds active G alpha(i/o) via its RGS domain, Raf and active H-Ras-GTP via its R1 Ras-binding domain (RBD), and inactive G alpha(i1/3) via its G protein regulatory (GPR) domain. RGS14 suppresses long-term potentiation (LTP) in the CA2 region of the hippocampus, thereby regulating hippocampally based learning and memory. The 14-3-3 family of proteins is necessary for hippocampal LTP and associative learning and memory. Here, we show direct interaction between RGS14 and 14-3-3 gamma at two distinct sties, one phosphorylation-independent and the other phosphorylation-dependent at Ser-218 that is markedly potentiated by signaling downstream of active H-Ras. Using bioluminescence resonance energy transfer (BRET), we show that the pSer-218-dependent RGS14/14-3-3 gamma interaction inhibits active G alpha(i1)-AlF4- binding to the RGS domain of RGS14 but has no effect on active H-Ras and inactive G alpha(i1)-GDP binding to RGS14. By contrast, the phosphorylation-independent binding of 14-3-3 has no effect on RGS14/G alpha(i) interactions but, instead, inhibits (directly or indirectly) RGS14 nuclear import and nucleocytoplasmic shuttling. Together, our findings describe a novel mechanism of negative regulation of RGS14 functions, specifically interactions with active G alpha(i) and nuclear import, while leaving the function of other RGS14 domains intact. Ongoing studies will further elucidate the physiological function of this interaction between RGS14 and 14-3-3 gamma, providing insight into the functions of both RGS14 and 14-3-3 in their roles in modulating synaptic plasticity in the hippocampus.	[Gerber, Kyle J.; Squires, Katherine E.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr, 1510 Clifton Rd,Suite G205, Atlanta, GA 30322 USA.	jhepler@emory.edu			NINDS, National Institutes of Health Core Facilities Grant [5P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS037112, F31NS098648, R21NS087488] Funding Source: NIH RePORTER	NINDS, National Institutes of Health Core Facilities Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Haian Fu (Emory University, Atlanta, GA) for the very generous contribution of the 14-3-3 plasmids used for this study. We also thank Suneela Ramineni for outstanding technical assistance. The Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience was supported by NINDS, National Institutes of Health Core Facilities Grant 5P30NS055077.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P2209, DOI 10.1016/j.cellsig.2006.05.011; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; ALAM R, 1994, J BIOCHEM-TOKYO, V116, P416, DOI 10.1093/oxfordjournals.jbchem.a124541; Astuti P, 2011, CELL CYCLE, V10, P1960, DOI 10.4161/cc.10.12.15819; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Branch MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184497; Brown NE, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.249; Brown NE, 2015, J BIOL CHEM, V290, P9037, DOI 10.1074/jbc.M114.634329; Burchett SA, 2003, J NEUROCHEM, V87, P551, DOI 10.1046/j.1471-4159.2003.02047.x; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Campbell JK, 1997, BIOCHEMISTRY-US, V36, P15363, DOI 10.1021/bi9708085; Chatterjee TK, 2000, J BIOL CHEM, V275, P29660, DOI 10.1074/jbc.M000330200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; Chen J, 2007, J NEUROSCI RES, V85, P1724, DOI 10.1002/jnr.21304; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Lee JK, 2015, PROG MOL BIOL TRANSL, V133, P153, DOI 10.1016/bs.pmbts.2015.01.005; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pinto SM, 2015, PROTEOMICS, V15, P532, DOI 10.1002/pmic.201400303; Qiao HF, 2014, J NEUROSCI, V34, P4801, DOI 10.1523/JNEUROSCI.4393-13.2014; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Rezabkova L, 2010, J STRUCT BIOL, V170, P451, DOI 10.1016/j.jsb.2010.03.009; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Squires KE, 2018, BRAIN STRUCT FUNCT, V223, P233, DOI 10.1007/s00429-017-1487-y; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	76	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14616	14631		10.1074/jbc.RA118.002816	http://dx.doi.org/10.1074/jbc.RA118.002816			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093406	Green Published, hybrid			2022-12-26	WOS:000446155000004
J	Meneses, G; Rosetti, M; Espinosa, A; Fiorentino, A; Bautista, M; Diaz, G; Olvera, G; Barcena, B; Fleury, A; Adalid-Peralta, L; Lamoyi, E; Fragoso, G; Sciutto, E				Meneses, Gabriela; Rosetti, Marcos; Espinosa, Alejandro; Fiorentino, Alejandra; Bautista, Marcel; Diaz, Georgina; Olvera, Guillermo; Barcena, Brandon; Fleury, Agnes; Adalid-Peralta, Laura; Lamoyi, Edmundo; Fragoso, Gladis; Sciutto, Edda			Recovery from an acute systemic and central LPS-inflammation challenge is affected by mouse sex and genetic background	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; LIPOPOLYSACCHARIDE; RECEPTORS; MODEL; NEUROINFLAMMATION; PATHWAY	Genetic and sexual factors influence the prevalence and the pathogenesis of many inflammatory disorders. In this study their relevance on the peripheral and central inflammatory status induced by a peripheral injection of lipopolysaccharide (LPS) was evaluated. BALB/c and CD-1 male and female mice were intraperitoneally injected with LPS. Spleens and brains were collected 2 and 72 hours later to study the levels of IL-6, TNF-alpha and IL-1 beta. Percentage of microglia and astrocytes was determined in the cortex and hippocampus. Locomotor activity was registered before and during the 72 hours after LPS-treatment. Two hours after LPS-injection, a peripheral increase of the three cytokines was found. In brains, LPS increased TNF-alpha only in males with higher levels in CD-1 than BALB/c. IL-1 beta increased only in CD-1 males. IL-6 increased in both strains with lower levels in BALB/c females. Peripheral and central levels of cytokines decline 72 hrs after LPS-treatment whilst a significantly increase of Iba-1 expression was detected. A dramatic drop of the locomotor activity was observed immediately after LPS injection. Our results show that acute systemic administration of LPS leads to peripheral and central increase of pro-inflammatory cytokines and microglia activation, in a strain and sex dependent manner.	[Meneses, Gabriela; Espinosa, Alejandro; Fiorentino, Alejandra; Bautista, Marcel; Diaz, Georgina; Olvera, Guillermo; Barcena, Brandon; Lamoyi, Edmundo; Fragoso, Gladis; Sciutto, Edda] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Ciudad De Mexico, Mexico; [Rosetti, Marcos] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Ciudad De Mexico, Mexico; [Fleury, Agnes] Univ Nacl Autonoma Mexico, Inst Nacl Neurol & Neurocirugia Dr Manuel Velasco, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental,Unidad Perifer, Ciudad De Mexico, Mexico; [Adalid-Peralta, Laura] Univ Nacl Autonoma Mexico, Inst Nacl Neurol & Neurocirugia Dr Manuel Velasco, Inst Invest Biomed, Unidad Perifer, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Sciutto, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Ciudad De Mexico, Mexico.	edda@unam.mx	Fleury, Agnès/AAD-2128-2021; Adalid, Laura/AAE-8509-2019	Adalid, Laura/0000-0002-1010-698X; Fleury, Agnes/0000-0002-8930-2202; Granados, Guillermo/0000-0003-0808-845X; Barcena, Brandon/0000-0002-7806-3218; Sciutto, Edda/0000-0001-5608-5355; Rosetti, Marcos/0000-0002-4607-8984	Direccion General de Personal Academico, UNAM (DGAPA-UNAM), Mexico [IN211917]; Institutional program "Programa de Investigacion para el Desarrollo y la Optimizacion de Vacunas, Inmunomoduladores y Metodos Diagnosticos del Instituto de Investigaciones Biomedicas" U.N.A.M.;  [CONACYT-SALUD-2015-C01-261455]	Direccion General de Personal Academico, UNAM (DGAPA-UNAM), Mexico; Institutional program "Programa de Investigacion para el Desarrollo y la Optimizacion de Vacunas, Inmunomoduladores y Metodos Diagnosticos del Instituto de Investigaciones Biomedicas" U.N.A.M.; 	This work was supported by Direccion General de Personal Academico, UNAM (DGAPA-UNAM, grant IN211917 to E.S.), Mexico. This study was also supported by the Institutional program "Programa de Investigacion para el Desarrollo y la Optimizacion de Vacunas, Inmunomoduladores y Metodos Diagnosticos del Instituto de Investigaciones Biomedicas" U.N.A.M., and by CONACYT-SALUD-2015-C01-261455 to L.A-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aomatsu M, 2013, BIOCHEM BIOPH RES CO, V441, P220, DOI 10.1016/j.bbrc.2013.10.042; Aravalli RN, 2007, J NEUROIMMUNE PHARM, V2, P297, DOI 10.1007/s11481-007-9071-5; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Bergquist M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-110; Bluthe RM, 2000, EUR J NEUROSCI, V12, P4447, DOI 10.1046/j.1460-9568.2000.01348.x; Chaudhuri A, 2013, IMMUNOL CELL BIOL, V91, P451, DOI 10.1038/icb.2013.27; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Ferguson JF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-63; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kostarnoy AV, 2013, J INTERF CYTOK RES, V33, P514, DOI 10.1089/jir.2012.0108; Kunda PE, 2014, NEUROSCIENCE, V280, P60, DOI 10.1016/j.neuroscience.2014.08.053; Lasselin J, 2016, BRAIN BEHAV IMMUN, V57, P30, DOI 10.1016/j.bbi.2016.01.003; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Meneses G, 2017, CLIN EXP IMMUNOL, V190, P304, DOI 10.1111/cei.13018; Michalikova S, 2010, BEHAV BRAIN RES, V207, P402, DOI 10.1016/j.bbr.2009.10.028; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Queen AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152289; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; R Core Team, 2018, R LANG ENV STAT COMP; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Thomas RC, 2014, PEPTIDES, V61, P56, DOI 10.1016/j.peptides.2014.08.009; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Vegeto E, 2004, J STEROID BIOCHEM, V91, P59, DOI 10.1016/j.jsbmb.2004.02.004; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Vegeto E, 2000, EXP GERONTOL, V35, P1309, DOI 10.1016/S0531-5565(00)00161-3; Voelker MT, 2014, CLIN EXP PHARMACOL P, V41, P844, DOI 10.1111/1440-1681.12283; Yoshino S, 1999, J IMMUNOL, V163, P3417; Yoshino S, 2000, BRIT J PHARMACOL, V129, P1309, DOI 10.1038/sj.bjp.0703166	37	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201375	10.1371/journal.pone.0201375	http://dx.doi.org/10.1371/journal.pone.0201375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133465	Green Submitted, Green Published, gold			2022-12-26	WOS:000442500400020
J	Woodman, T; Strunk, T; Patole, S; Hartmann, B; Simmer, K; Currie, A				Woodman, Tabitha; Strunk, Tobias; Patole, Sanjay; Hartmann, Benjamin; Simmer, Karen; Currie, Andrew			Effects of lactoferrin on neonatal pathogens and Bifidobacterium breve in human breast milk	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LATE-ONSET SEPSIS; PRETERM INFANTS; NECROTIZING ENTEROCOLITIS; BOVINE LACTOFERRIN; BACTERICIDAL ACTIVITY; IRON SATURATION; IN-VITRO; GROWTH; SUPPLEMENTATION	Supplementation with probiotics in preterm infants reduces necrotizing enterocolitis and sepsis. Bovine lactoferrin is a promising supplement that may further reduce disease burden, but its effects on probiotic bacteria in human breast milk has not been evaluated. We aimed to characterise the antimicrobial activity of bovine and human lactoferrin in human breast milk against probiotics and typical neonatal sepsis pathogens. Lactoferrin levels were determined by enzyme linked immunosorbent assay in fresh and pasteurised human breast milk. The neonatal pathogens Staphylococcus epidermidis and Escherichia coli, and the probiotic Bifidobacterium breve strain M-16V were cultured in human breast milk or infant formula in the presence or absence of clinically relevant doses of bovine or human lactoferrin. Standard microbiological methods were used to determine the effects of lactoferrin on bacterial growth. Unpasteurised human breast milk contained significantly higher lactoferrin levels and resulted in superior inhibition of pathogenic bacterial growth compared to infant formula and pasteurised human breast milk. Human lactoferrin was significantly more effective at inhibiting bacterial growth, when compared to bovine lactoferrin. Supplementation with human lactoferrin or high dose bovine lactoferrin inhibited growth of the probiotic strain B. breve M-16V in pasteurised human breast milk. Although unpasteurised human breast milk and human lactoferrin had the greatest antimicrobial activity against all bacterial species tested, higher doses of bovine lactoferrin also showed activity against B. breve and. S. epidermidis. This study suggests that simultaneous administration of lactoferrins and probiotics may affect colonisation with probiotic bacteria, warranting further investigations.	[Woodman, Tabitha; Currie, Andrew] Murdoch Univ, Med & Mol Sci, Perth, WA, Australia; [Strunk, Tobias; Patole, Sanjay; Simmer, Karen; Currie, Andrew] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Med, Perth, WA, Australia; [Strunk, Tobias; Patole, Sanjay; Simmer, Karen] King Edward Mem Hosp Women, Neonatal Directorate, Perth, WA, Australia; [Hartmann, Benjamin] King Edward Mem Hosp Women, Perron Rotary Express Milk Bank, Perth, WA, Australia	Murdoch University; University of Western Australia; King Edward Memorial Hospital; King Edward Memorial Hospital	Currie, A (corresponding author), Murdoch Univ, Med & Mol Sci, Perth, WA, Australia.; Currie, A (corresponding author), Univ Western Australia, Ctr Neonatal Res & Educ, Sch Med, Perth, WA, Australia.	a.currie@murdoch.edu.au	Currie, Andrew/C-2778-2015; Strunk, Tobias/AIE-3407-2022	Strunk, Tobias/0000-0001-7079-2339; Simmer, Karen/0000-0003-4777-9069; Currie, Andrew/0000-0002-5193-3404; Woodman, Tabitha/0000-0002-9214-8066	National and Medical Health Research Council of Australia, Centre of Research Excellence in Preterm Birth Outcomes	National and Medical Health Research Council of Australia, Centre of Research Excellence in Preterm Birth Outcomes	1. National and Medical Health Research Council of Australia, Centre of Research Excellence in Preterm Birth Outcomes. http://www.crepreterm.org.au/ 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe F., 2009, Bioscience and Microflora, V28, P7; Akinbi H, 2010, J PEDIATR GASTR NUTR, V51, P347, DOI 10.1097/MPG.0b013e3181e07f0a; ARNOLD RR, 1981, INFECT IMMUN, V32, P655, DOI 10.1128/IAI.32.2.655-660.1981; ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bokkhim H, 2013, FOOD CHEM, V141, P3007, DOI 10.1016/j.foodchem.2013.05.139; Bonsante F, 2013, AM J PERINAT, V30, P41, DOI 10.1055/s-0032-1321498; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Cossey V, 2014, BREASTFEED MED, V9, P79, DOI 10.1089/bfm.2012.0116; Drago-Serrano ME, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030501; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Embleton ND, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00014; Gregory Katherine E, 2013, Curr Pediatr Rep, V1, DOI 10.1007/s40124-013-0028-2; Griffiths EA, 2003, DIGEST DIS SCI, V48, P1324, DOI 10.1023/A:1024111310345; Hartmann BT, 2007, EARLY HUM DEV, V83, P667, DOI 10.1016/j.earlhumdev.2007.07.012; Hunter C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-142; Jacobs SE, 2013, PEDIATRICS, V132, P1055, DOI 10.1542/peds.2013-1339; Jakaitis Brett M, 2014, Pathophysiology, V21, P47, DOI 10.1016/j.pathophys.2013.11.012; Kim WS, 2004, BIOMETALS, V17, P279, DOI 10.1023/B:BIOM.0000027705.57430.f1; Kirkham Lea-Ann S, 2013, BMC Res Notes, V6, P522, DOI 10.1186/1756-0500-6-522; Kitajima H, 1997, ARCH DIS CHILD-FETAL, V76, pF101, DOI 10.1136/fn.76.2.F101; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Majka G, 2013, ANAL BIOANAL CHEM, V405, P5191, DOI 10.1007/s00216-013-6943-9; Manzoni P., 2009, Early Human Development, V85, pS94, DOI 10.1016/j.earlhumdev.2009.08.030; Manzoni P, 2014, EARLY HUM DEV, V90, pS60, DOI 10.1016/S0378-3782(14)70020-9; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; MillerCatchpole R, 1997, NUTR RES, V17, P205, DOI 10.1016/S0271-5317(96)00252-7; Moles L, 2015, J PEDIATR GASTR NUTR, V60, P120, DOI 10.1097/MPG.0000000000000560; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Patole S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089511; Patole SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150775; PAULSSON MA, 1993, J DAIRY SCI, V76, P3711, DOI 10.3168/jds.S0022-0302(93)77713-9; Petschow BW, 1999, J MED MICROBIOL, V48, P541, DOI 10.1099/00222615-48-6-541; Silvestre D, 2008, J HUM LACT, V24, P371, DOI 10.1177/0890334408319158; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Trend S, 2015, PLOS ONE, V10; Van Gysel M, 2012, EUR J PEDIATR, V171, P1231, DOI 10.1007/s00431-012-1750-4; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37	40	30	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201819	10.1371/journal.pone.0201819	http://dx.doi.org/10.1371/journal.pone.0201819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133470	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400038
J	Chen, ZL; Wang, XF; Wang, HJ				Chen, Zhulin; Wang, Xuefeng; Wang, Huaijing			Preliminary research on total nitrogen content prediction of sandalwood using the error-in-variable models based on digital image processing	PLOS ONE			English	Article							SPECTRAL REFLECTANCE; NUTRITION STATUS; RICE; COLOR; FERTIGATION; DIAGNOSIS; GROWTH; CAMERA; METER	This paper presents a method for predicting the total nitrogen content in sandalwood using digital image processing. The goal of this study is to provide a real-time, efficient, and highly automated nutritional diagnosis system for producers by analyzing images obtained in forests. Using images acquired from field servers, which were installed in six forest farms of different cities located in northern Hainan Province, we propose a new segmentation algorithm and define a new indicator named "growth status" (GS), which includes two varieties: GS(MER) (the ratio of sandalwood pixels to the minimum enclosing rectangle pixels) and GS(MCC) (the ratio of sandalwood pixels to minimum circumscribed circle pixels). We used the error-in-variable model by considering the errors that exist in independent variables. After comparison and analysis, the obtained results show that (1) The b and L channels in the Lab color system have complementary advantages. By combining this system with the Otsu method, median filtering and a morphological operation, sandalwood can be separated from the background. (2) The fitting degree of the models improves after adding the GS indicator and shows that GS(MCC) performs better than GS(MER). (3) After using the error-in-variable model to estimate the parameters, the accuracy and precision of the model improved compared to the results obtained using the least squares method. The optimal model for predicting the total nitrogen content is y = 237.374e(-(4.471L/L'+11.927a/a'+2.782b/b') + 26.248GS(MCC) - 4.274. This study demonstrates the use of Internet of Things technology in forestry and provides guidance for the nutritional diagnosis of the important sandalwood tree species.	[Chen, Zhulin; Wang, Xuefeng; Wang, Huaijing] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF	Wang, XF (corresponding author), Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China.	xuefeng@ifrit.ac.cn		Chen, zhulin/0000-0001-7280-2916	National Natural Science Foundation of China [31670642]; State Forestry Administration of the People's Republic of China [11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration of the People's Republic of China	This study is funded by National Natural Science Foundation of China (grant number "31670642" to X.W. and URL "http://www.nsfc.gov.cn/") and State Forestry Administration of the People's Republic of China (grant number "[2016] No.11" to X.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAETHGEN WE, 1989, AGRON J, V81, P120, DOI 10.2134/agronj1989.00021962008100010022x; Balasubramanian V, 1999, NUTR CYCL AGROECOSYS, V53, P59; Baresel JP, 2017, COMPUT ELECTRON AGR, V140, P25, DOI 10.1016/j.compag.2017.05.032; BLACKMER TM, 1995, J PROD AGRIC, V8, P56, DOI 10.2134/jpa1995.0056; BLINN C R, 1988, Southern Journal of Applied Forestry, V12, P270; Chen PF, 2015, REMOTE SENS-BASEL, V7, P4527, DOI 10.3390/rs70404527; Chen XP, 1999, SOILS FERTILIZERS, V2, P19; Confalonieri R, 2015, BIOSYST ENG, V135, P21, DOI 10.1016/j.biosystemseng.2015.04.013; Cui RX, 2016, SPECTROSC SPECT ANAL, V36, P1837, DOI 10.3964/j.issn.1000-0593(2016)06-1837-06; Fernandez CJ, 1996, CROP SCI, V36, P1224, DOI 10.2135/cropsci1996.0011183X003600050026x; Flowers M, 2003, AGRON J, V95, P167, DOI 10.2134/agronj2003.0167; Guo W, 2011, J AGR MECH RES, V10, P31; Intaravanne Y, 2015, COMPUT ELECTRON AGR, V116, P228, DOI 10.1016/j.compag.2015.07.005; Jia B, 2014, SCI WORLD J, DOI 10.1155/2014/602647; Jia LL, 2009, SPECTROSC SPECT ANAL, V29, P2176, DOI 10.3964/j.issn.1000-0593(2009)08-2176-04; Lee KJ, 2013, EUR J AGRON, V48, P57, DOI 10.1016/j.eja.2013.02.011; Li HongJun, 2011, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V19, P155, DOI 10.3724/SP.J.1011.2011.00155; [李岚涛 Li Lantao], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P259; [李朝东 LI Zhaodong], 2011, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V17, P767; Lin FF, 2010, COMPUT ELECTRON AGR, V71, pS60, DOI 10.1016/j.compag.2009.09.006; Liu XiaoJin, 2013, Scientia Silvae Sinicae, V49, P143; Mao HP, 2015, SCI HORTIC-AMSTERDAM, V184, P1, DOI 10.1016/j.scienta.2014.12.027; Noh H, 2012, COMPUT ELECTRON AGR, V83, P52, DOI 10.1016/j.compag.2012.01.014; Qu WeiQun, 2007, Acta Agronomica Sinica, V33, P1010; Romualdo LM, 2014, COMPUT ELECTRON AGR, V104, P63, DOI 10.1016/j.compag.2014.03.009; Scharf PC, 2002, AGRON J, V94, P435; Tang S Z, 2015, STAT BASIS BIOL MATH; Tang SZ, 2002, ECOL MODEL, V156, P225, DOI 10.1016/S0304-3800(02)00173-4; Tang SZ, 2001, ECOL MODEL, V142, P285, DOI 10.1016/S0304-3800(01)00326-X; Wang T, 2013, AGR RES APPL, V6, P56; [王晓静 WANG Xiaojing], 2007, [棉花学报, Cotton Science], V19, P106; Wang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147419; Wang YT, 2012, FOOD CONTROL, V28, P131, DOI 10.1016/j.foodcont.2012.04.037; [魏全全 Wei Quanquan], 2016, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V22, P1701; Xia TT, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070605; Zhang NN, 2006, PRACTICAL FORESTRY T, P14; [张培松 Zhang Peisong], 2015, [热带作物学报, Chinese Journal of Tropical Crops], V36, P2120; Zhao ManXing, 2005, Plant Nutrition and Fertilizer Science, V11, P461; Zhou ZJ, 2018, COMPUT ELECTRON AGR, V144, P154, DOI 10.1016/j.compag.2017.12.005; Zhou ZJ, 2017, EUR J AGRON, V87, P1, DOI 10.1016/j.eja.2017.04.002	41	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0202649	10.1371/journal.pone.0202649	http://dx.doi.org/10.1371/journal.pone.0202649			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130375	Green Published, Green Submitted, gold			2022-12-26	WOS:000442284500012
J	Simoons, M; Mulder, H; Doornbos, B; Schoevers, RA; van Roon, EN; Ruhe, HG				Simoons, Mirjam; Mulder, Hans; Doornbos, Bennard; Schoevers, Robert A.; van Roon, Eric N.; Ruhe, Henricus G.			Monitoring of somatic parameters at outpatient departments for mood and anxiety disorders	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; METABOLIC SYNDROME; BIPOLAR DISORDER; GUIDELINES; RISK; PEOPLE; SCHIZOPHRENIA; RECOMMENDATIONS; ANTIPSYCHOTICS; METAANALYSIS	Introduction Somatic complications account for the majority of the 13-30 years shortened life expectancy in psychiatric patients compared to the general population. The study aim was to assess to which extent patients visiting outpatient departments for mood and anxiety disorders were monitored for relevant somatic comorbidities and (adverse) effects of psychotropic drugs-more specifically a) metabolic parameters, b) lithium safety and c) ECGs-during their treatment. Methods We performed a retrospective clinical records review and cross-sectional analysis to assess the extent of somatic monitoring at four outpatient departments for mood and anxiety disorders in The Netherlands. We consecutively recruited adult patients visiting a participating outpatient department between March and November 2014. The primary outcome was percentage of patients without monitoring measurements. Secondary outcomes were number of measurements per parameter per patient per year and time from start of treatment to first measurement. Results We included 324 outpatients, of whom 60.2% were female. Most patients were treated for depressive disorders (39.8%), anxiety disorders (16.7%) or bipolar or related disorders (11.7%) and 198 patients (61.1%) used at least one psychotropic drug. For 186 patients (57.4%), no monitoring records were recorded (median treatment period 7.3 months, range 0-55.6). The median number of measurements per parameter per year since the start of outpatient treatment for patients with monitoring measurements was 0.31 (range 0.0-12.9). The median time to first monitoring measurement per parameter for patients with monitoring measurements was 3.8 months (range 0.0-50.7). Discussion Somatic monitoring in outpatients with mood and anxiety disorders is not routine clinical practice. Monitoring practices need to be improved to prevent psychiatric outpatients from undetected somatic complications.	[Simoons, Mirjam; Mulder, Hans] Wilhelmina Hosp Assen, Dept Clin Pharm, Assen, Netherlands; [Simoons, Mirjam; Schoevers, Robert A.; Ruhe, Henricus G.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Simoons, Mirjam; van Roon, Eric N.] Univ Groningen, Dept Pharmacotherapy Epidemiol & Econ, Dept Pharm, Groningen, Netherlands; [Mulder, Hans; Doornbos, Bennard] Mental Hlth Serv Drenthe, Assen, Netherlands; [van Roon, Eric N.] Med Ctr Leeuwarden, Dept Clin Pharm & Clin Pharmacol, Leeuwarden, Netherlands; [Ruhe, Henricus G.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England	University of Groningen; University of Groningen; Medical Center Leeuwarden; University of Oxford	Mulder, H (corresponding author), Wilhelmina Hosp Assen, Dept Clin Pharm, Assen, Netherlands.; Mulder, H (corresponding author), Mental Hlth Serv Drenthe, Assen, Netherlands.	hans.mulder@wza.nl	van Roon, Eric N/O-2112-2013; Ruhe, Henricus G/K-8764-2012	Ruhe, Henricus G/0000-0001-6072-0358; Schoevers, Robert A/0000-0003-0760-9866	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)/ZonMW VENI [016.126.059]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)/ZonMW VENI(Netherlands Organization for Scientific Research (NWO))	The author(s) received no specific funding for this work, but HGR is supported by a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)/ZonMW VENI-Grant (https://www.zonmw.nl/en/research-and-results/ fundamental-research/programmas/programme-detail/veni/), grant number #016.126.059. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094112; Collins N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-80; Correll CU, 2015, WORLD PSYCHIATRY, V14, P119, DOI 10.1002/wps.20204; De Hert M, 2011, BRIT J PSYCHIAT, V199, P99, DOI 10.1192/bjp.bp.110.084665; De Hert M, 2011, WORLD PSYCHIATRY, V10, P138; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Derijks HJ, 2008, EUR J CLIN PHARMACOL, V64, P531, DOI 10.1007/s00228-007-0441-y; Dhamane AD, 2013, J PSYCHIATR PRACT, V19, P360, DOI 10.1097/01.pra.0000435035.45308.03; Dodd S, 2012, CURR DRUG SAF, V7, P1, DOI 10.2174/157488612800492780; Dodd S, 2011, AUST NZ J PSYCHIAT, V45, P712, DOI 10.3109/00048674.2011.595686; Drye LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098426; Erlangsen A, 2017, LANCET PSYCHIAT, V4, P937, DOI 10.1016/S2215-0366(17)30429-7; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jennex A, 2008, CAN J PSYCHIAT, V53, P34, DOI 10.1177/070674370805300106; Katz MH, 2015, JAMA INT MED; Lai CL, 2015, PHARMACOPSYCHIATRY, V48, P25, DOI 10.1055/s-0034-1394396; Mangurian C, 2015, JAMA INTERN MED, P1; Mitchell AJ, 2012, PSYCHOL MED, V42, P125, DOI 10.1017/S003329171100105X; Morrato EH, 2010, ARCH GEN PSYCHIAT, V67, P17, DOI 10.1001/archgenpsychiatry.2009.179; Najim H, 2012, BRIT J PSYCHIAT, V201, P75, DOI 10.1192/bjp.201.1.75b; National Collaborating Centre for Mental Health (UK), 2006, AN NIC CLIN GUID; National Institute for Clinical Excellence, 2014, RIM SEC CAR CLIN GUI; Ng F, 2009, BIPOLAR DISORD, V11, P559, DOI 10.1111/j.1399-5618.2009.00737.x; Paton C, 2013, BIPOLAR DISORD, V15, P865, DOI 10.1111/bdi.12128; Romera I, 2010, J AFFECT DISORDERS, V127, P160, DOI 10.1016/j.jad.2010.05.009; Sheeler RD, 2012, MAYO CLIN PROC, V87, P1042, DOI 10.1016/j.mayocp.2012.07.009; Simon V, 2009, J CLIN PSYCHIAT, V70, P1041, DOI 10.4088/JCP.08r04392; Simoons M, 2016, J CLIN PSYCHIAT, V77, P1511, DOI 10.4088/JCP.15m10376; Sugawara N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086826; Tosh G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008298.pub2; Vaccarino AL, 2008, J AFFECT DISORDERS, V110, P270, DOI 10.1016/j.jad.2008.01.009; van Hasselt FM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-426; Vancampfort D, 2014, PSYCHOL MED, V44, P2017, DOI 10.1017/S0033291713002778; Vancampfort D, 2015, WORLD PSYCHIATRY, V14, P339, DOI 10.1002/wps.20252; Zivin K, 2013, AM J PSYCHIAT, V170, P642, DOI 10.1176/appi.ajp.2013.12030408; 2004, J CLIN PSYCHIAT, V65, P267	36	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0200520	10.1371/journal.pone.0200520	http://dx.doi.org/10.1371/journal.pone.0200520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR1HU	30130372	Green Published, Green Submitted, gold			2022-12-26	WOS:000442284500002
J	van Steensel, S; van den Hill, LCL; Schreinemacher, MHF; ten Broek, RPG; van Goor, H; Bouvy, ND				van Steensel, Sebastiaan; van den Hill, Leontine C. L.; Schreinemacher, Marc H. F.; ten Broek, Richard P. G.; van Goor, Harry; Bouvy, Nicole D.			Adhesion awareness in 2016: An update of the national survey of surgeons	PLOS ONE			English	Article							ABDOMINAL-SURGERY; POSTOPERATIVE ADHESIONS; PREVENTION	Background and aims Adhesions, that form in 60-80% of all abdominal operations, can cause complications such as chronic abdominal pain, small-bowel obstruction, female infertility, and the need for adhesiolysis in future surgeries. Our 2010 Adhesion Awareness survey demonstrated that despite the huge clinical impact of adhesions; adhesion-related complications were seldom mentioned in the informed consent. Six years later, a follow-up survey was conducted to assess the progress on awareness on adhesion-related complications in the Netherlands. Material and methods The 2010 Adhesion Awareness survey was repeated after a literature update. The knowledge regarding adhesions; the use of anti-adhesive agents and involvement in the informed consent process were assessed. Surgeons and surgical trainees were contacted by e-mail. The data was analysed using a Chi-square or Mann-Whitney U test and corrected for multiple testing. Results The response rate was 32.6%, similar to the survey in 2010 (34.4%). 88.1% agreed with the clinical relevance of adhesions, comparable to 2010 (89.8%). The score on the knowledge test was 38.8% (2010: 37.2%). Involvement of adhesion-related complications in the informed consent process increased, although 32.5% almost never mentions adhesions. In 2016, 42.4% reported a correct occurrence of bowel lesions during adhesiolysis, higher than in 2010 (P<0.001). Conclusions The adhesion awareness did not increase in six years, despite the efforts made. However, an increased awareness regarding adhesiolysis related complications was detected. Improvement of knowledge and behavior is essential to narrowing the gap between the impact of adhesions as a major complication of abdominal surgery and the limited adhesion awareness.	[van Steensel, Sebastiaan; van den Hill, Leontine C. L.; Bouvy, Nicole D.] Maastricht Univ, Dept Gen Surg, Med Ctr, Maastricht, Netherlands; [van Steensel, Sebastiaan; van den Hill, Leontine C. L.; Bouvy, Nicole D.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Schreinemacher, Marc H. F.] Acad Med Ctr, Dept Gen Surg, Amsterdam, Netherlands; [ten Broek, Richard P. G.; van Goor, Harry] Radboud Univ Nijmegen, Dept Gen Surg, Med Ctr, Nijmegen, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Bouvy, ND (corresponding author), Maastricht Univ, Dept Gen Surg, Med Ctr, Maastricht, Netherlands.; Bouvy, ND (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	n.bouvy@mumc.nl	Broek, Richard PG ten/M-9038-2016; Bouvy, Nicole/AAD-2844-2021	Broek, Richard PG ten/0000-0002-4012-7968; 				Andersen P, 2017, BJS OPEN, V1, P30, DOI 10.1002/bjs5.5; De Wilde RL, 2012, GYNECOL SURG, V9, P365, DOI 10.1007/s10397-012-0764-2; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Johnson P, 2004, DIS COLON RECTUM, V47, P1119, DOI 10.1007/s10350-004-0570-7; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; Meuleman T, 2013, EUR J OBSTET GYN R B, V169, P353, DOI 10.1016/j.ejogrb.2013.03.019; Parker MC, 2005, COLORECTAL DIS, V7, P551, DOI 10.1111/j.1463-1318.2005.00857.x; Parker MC, 2001, DIS COLON RECTUM, V44, P822, DOI 10.1007/BF02234701; Rajab TK, 2009, WORLD J SURG, V33, P748, DOI 10.1007/s00268-008-9917-x; Robb WB, 2014, DIS COLON RECTUM, V57, P1228, DOI 10.1097/DCR.0000000000000191; Schreinemacher MHF, 2010, WORLD J SURG, V34, P2805, DOI 10.1007/s00268-010-0778-8; Stommel MWJ, 2018, ANN SURG, V267, P743, DOI 10.1097/SLA.0000000000002175; ten Broek RPG, 2016, ANN SURG, V263, P12, DOI 10.1097/SLA.0000000000001286; ten Broek RPG, 2014, LANCET, V383, P48, DOI 10.1016/S0140-6736(13)61687-6; ten Broek RPG, 2013, ANN SURG, V258, P98, DOI 10.1097/SLA.0b013e31826f4969; Vogels RRM, 2017, HERNIA, V21, P667, DOI 10.1007/s10029-017-1605-z; Zinther NB, 2010, SURG ENDOSC, V24, P2681, DOI 10.1007/s00464-010-1119-6	17	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202418	10.1371/journal.pone.0202418	http://dx.doi.org/10.1371/journal.pone.0202418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118503	Green Published, Green Submitted, gold			2022-12-26	WOS:000442282700025
J	Bahbahani, H; Afana, A; Wragg, D				Bahbahani, Hussain; Afana, Arwa; Wragg, David			Genomic signatures of adaptive introgression and environmental adaptation in the Sheko cattle of southwest Ethiopia	PLOS ONE			English	Article							AFRICAN SHORTHORN ZEBU; POSITIVE SELECTION; ANCESTRAL ADMIXTURE; NATURAL-SELECTION; F-STATISTICS; FOOTPRINTS; BREEDS; MUTATIONS; PACKAGE	Although classified as an African taurine breed, the genomes of Sheko cattle are an admixture of Asian zebu and African taurine ancestries. They populate the humid Bench Maji zone in Sheko and Bench districts in the south-western part of Ethiopia and are considered as a trypanotolerant breed with high potential for dairy production. Here, we investigate the genome of Sheko cattle for candidate signatures of adaptive introgression and positive selection using medium density genome-wide SNP data. Following locus-ancestry deviation analysis, 15 and 72 genome regions show substantial excess and deficiency in Asian zebu ancestry, respectively. Nine and 23 regions show candidate signatures of positive selection following extended haplotype homozygosity (EHH)-based analyses (iHS and Rsb), respectively. The results support natural selection before admixture for one iHS, one Rsb and three zebu ancestry-deficient regions. Genes and/or QTL associated with bovine immunity, fertility, heat tolerance, trypanotolerance and lactation are present within candidate selected regions. The identification of candidate regions under selection in Sheko cattle warrants further investigation of a larger sample size using full genome sequence data to better characterise the underlying haplotypes. The results can then support informative genomic breeding programmes to sustainably enhance livestock productivity in East African trypanosomosis infested areas.	[Bahbahani, Hussain; Afana, Arwa] Kuwait Univ, Fac Sci, Dept Biol Sci, Kuwait, Kuwait; [Wragg, David] Roslin Inst, Ctr Trop Livestock Genet & Hlth, Edinburgh, Midlothian, Scotland	Kuwait University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Bahbahani, H (corresponding author), Kuwait Univ, Fac Sci, Dept Biol Sci, Kuwait, Kuwait.	hussain.bahbahani@ku.edu.kw		Wragg, David/0000-0002-4007-953X				Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bahbahani H., 2015, OIE SCI TECHNICAL RE, V34, P185; Bahbahani H, 2017, FRONT GENET, V8, P1, DOI DOI 10.3389/FGENE.2017.00001; Bahbahani H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190446; Bahbahani H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11729; Bayou E, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1340-9; Bayou E., 2014, LIVESTOCK RES RURAL, V26; Bonfiglio S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038601; Brisbin A, 2012, HUM BIOL, V84, P343, DOI 10.3378/027.084.0401; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; DAGRIS. Domestic Animal Genetic Resources Information System (DAGRIS), 2017, ADD AB; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Felius M., 1995, CATTLE BREEDS ENCY; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Getinet Mekuriaw, 2015, Online Journal of Animal and Feed Research (OJAFR), V5, P125; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hanotte O, 2003, P NATL ACAD SCI USA, V100, P7443, DOI 10.1073/pnas.1232392100; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Jin WF, 2012, GENOME RES, V22, P519, DOI 10.1101/gr.124784.111; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kemper KE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-246; Khayatzadeh N, 2016, ANIM GENET, V47, P637, DOI 10.1111/age.12470; Kim J, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1153-y; Lemecha H, 2006, VET PARASITOL, V141, P165, DOI 10.1016/j.vetpar.2006.04.035; Littlejohn MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6861; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mbole-Kariuki MN, 2014, HEREDITY, V113, P297, DOI 10.1038/hdy.2014.31; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Ohinata Y, 2002, BIOL REPROD, V67, P1824, DOI 10.1095/biolreprod.101.002550; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Or R, 1998, CYTOKINES CELL MOL T, V4, P287; Qanbari S, 2014, LIVEST SCI, V166, P133, DOI 10.1016/j.livsci.2014.05.003; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; R Development Core Team, 2012, R LANG ENV STAT COMP; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Rege J. E. O., 1999, Animal Genetic Resources Information, P1; Salim B, 2014, ANIM GENET, V45, P782, DOI 10.1111/age.12225; Sanchez-Correa B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00931; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Tang H, 2007, AM J HUM GENET, V81, P626, DOI 10.1086/520769; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Taye T, 2009, ETHIOPINA JOURNAL OF, V9; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202479	10.1371/journal.pone.0202479	http://dx.doi.org/10.1371/journal.pone.0202479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114214	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400073
J	Ouchene-Khelifi, NA; Lafri, M; Pompanon, F; Ouhrouch, A; Ouchene, N; Blanquet, V; Lenstra, JA; Benjelloun, B; Da Silva, A				Ouchene-Khelifi, Nadjet-Amina; Lafri, Mohamed; Pompanon, Francois; Ouhrouch, Abdessamad; Ouchene, Nassim; Blanquet, Veronique; Lenstra, Johannes A.; Benjelloun, Badr; Da Silva, Anne			Genetic homogeneity of North-African goats	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; INFERENCE; DIVERSITY; ADMIXTURE; PROGRAM	North Africa represents a rich and early reservoir of goat genetic diversity, from which the main African breeds have been derived. In this study, the genetic diversity of four indigenous Algerian goat breeds (i.e., Arabia, Makatia, M'Zabite and Kabyle, with n = 12 for each breed) has been investigated for the first time by genome-wide SNP genotyping; moreover in a broader context, genetic structuration of Algerian and Moroccan goats was explored (via FST, MDS, STRUCTURE, FineSTRUCTURE, BAPS, sPCA and DAPC analyses). At national level, the study revealed high level of genetic diversity and a significant phenomenon of admixture affecting all the Algerian breeds. At broader scale, clear global genetic homogeneity appeared considering both Algerian and Moroccan stocks. Indeed, genetic structuration was almost nonexistent among Arabia (from Algeria), Draa, Black and Nord (from Morocco), while the ancestral Kabyle and M'Zabite breeds, reared by Berber peoples, showed genetic distinctness. The study highlighted the threat to the Maghrebin stock, probably induced by unsupervised cross-breeding practices which have intensified in recent centuries. Moreover, it underlined the necessity to deepen our understanding of the genetic resources represented by the resilient North-African goat stock.	[Ouchene-Khelifi, Nadjet-Amina; Lafri, Mohamed; Ouchene, Nassim] Univ Blida, Sci Vet Inst, Blida, Algeria; [Ouchene-Khelifi, Nadjet-Amina; Lafri, Mohamed; Ouchene, Nassim] Univ Blida, Lab Biotechnol Related Anim Reprod LBRA, Blida, Algeria; [Pompanon, Francois; Benjelloun, Badr] Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, LECA, Grenoble, France; [Ouhrouch, Abdessamad; Benjelloun, Badr] Reg Ctr Agron Res, Natl Inst Agron Res INRA Maroc, Beni Mellal, Morocco; [Ouhrouch, Abdessamad] Univ Sultan Moulay Slimane, LBVRP, Beni Mellal, Morocco; [Blanquet, Veronique; Da Silva, Anne] Univ Limoges, INRA, EA7500, GAMAA USC1061, Limoges, France; [Lenstra, Johannes A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Universite Saad Dahlab de Blida; Universite Saad Dahlab de Blida; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Sultan Moulay Slimane University of Beni Mellal; INRAE; Universite de Limoges; Utrecht University	Da Silva, A (corresponding author), Univ Limoges, INRA, EA7500, GAMAA USC1061, Limoges, France.	anne.blondeau@unilim.fr	Khelifi, Nadjet Amina/AAU-7824-2021; Benjelloun, Badr/O-5559-2018; Pompanon, François/D-3459-2009	Benjelloun, Badr/0000-0003-4310-7281; Pompanon, François/0000-0003-4600-0172				Benjelloun B, 2011, SMALL RUMINANT RES, V98, P201, DOI 10.1016/j.smallrumres.2011.03.041; Benjelloun B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00107; Boujenane I., 2005, CHARACTERIZATION SMA, V2, P5; Chaker S, 1994, ENCY BERBERE, P1913; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Couput M., EXPOSITION UNIVERSEL; Couvreur G, 1968, REV GEOGRAPHIE MAROC, V13, P347; Davis SJM., 1993, DOMESTIC ANIMALS MES, V7, P1; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Delgado C, 1999, 28 IFPRA FOOD AGR EN; Djari MS, 1981, MEMOIRE FIN ETUDE IT; Dunne J, 2017, QUATERNARY INT; EPSTEIN H., 1953, East African Agricultural Journal, V18, P123; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eyraud E., 1934, PRODUCTION OVINE MAR; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gaouar SBS, 2017, HEREDITY, V118, P293, DOI 10.1038/hdy.2016.86; Gaouar SBS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122667; Hassan FA, 2000, CLIMATE CATTLE N AFR, P61; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hlal M, 1983, THESIS, P306; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kim ES, 2016, HEREDITY, V116, P255, DOI 10.1038/hdy.2015.94; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lewis P, 1999, GENETIC DATA ANAL CO; Madani T, 2003, ALG97G31 MATEGEFPNUD, P44; Manunza A, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0229-6; Mason I. L., 1996, WORLD DICT LIVESTOCK; Mason IL, 1969, A WORLD DICTIONARY O; Mason IL, 1984, EVOLUTION DOMESTICAT, P85; Miller SA, 1998, NUCLEIC ACIDS RES, V16, P12; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nazareno AG, 2017, MOL ECOL RESOUR, V17, P1136, DOI 10.1111/1755-0998.12654; Newman JL., 1995, PEOPLING AFRICA GEOG; Nicoloso L, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0140-6; Ouchene-Khelifi NA, 2015, TROP ANIM HEALTH PRO, V47, P1343, DOI 10.1007/s11250-015-0869-5; Pereira F, 2001, ENCY LIFE SCI ELS; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sagne J, 1950, ALGERIE PASTORALE SE; Sanson A, 1885, MOUTONS HIST NATUREL; SMITH AB, 1992, ANNU REV ANTHROPOL, V21, P125; Societe A imperiale zoologique d'acclimatation, 1857, B MENS SOC IMP ZOOL, V4; Stoyan D, 1986, BIOMETRICAL J, V28, P664, DOI [10.1002/bmj.4710280603, DOI 10.1002/BMJ.4710280603]; Van Dorp L, 2015, PLOS GENET, V11, P49; Velu H., 1934, DEUX ANS EXPT FERME; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeuner F. E., 1963	59	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202196	10.1371/journal.pone.0202196	http://dx.doi.org/10.1371/journal.pone.0202196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114267	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400048
J	Baik, LS; Recinos, Y; Chevez, JA; Holmes, TC				Baik, Lisa Soyeon; Recinos, Yocelyn; Chevez, Joshua A.; Holmes, Todd C.			Circadian modulation of light-evoked avoidance/attraction behavior in Drosophila	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; PACEMAKER NEURONS; CLOCK NEURONS; TEMPERATURE PREFERENCE; MEMBRANE EXCITABILITY; FUNCTIONAL-ANALYSIS; UV-LIGHT; CRYPTOCHROME; PHOTORECEPTOR; MELANOGASTER	Many insects show strong behavioral responses to short wavelength light. Drosophila melanogaster exhibit Cryptochrome-and Hyperkinetic-dependent blue and ultraviolet (UV) light avoidance responses that vary by time-of-day, suggesting that these key sensory behaviors are circadian regulated. Here we show mutant flies lacking core clock genes exhibit defects in both time-of-day responses and valence of UV light avoidance/attraction behavior. Non-genetic environmental disruption of the circadian clock by constant UV light exposure leads to complete loss of rhythmic UV light avoidance/attraction behavior. Flies with ablated or electrically silenced circadian lateral ventral neurons have attenuated avoidance response to UV light. We conclude that circadian clock proteins and the circadian lateral ventral neurons regulate both the timing and the valence of UV light avoidance/attraction. These results provide mechanistic support for Pittendrigh's "escape from light" hypothesis regarding the co-evolution of phototransduction and circadian systems.	[Baik, Lisa Soyeon; Recinos, Yocelyn; Chevez, Joshua A.; Holmes, Todd C.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine	Holmes, TC (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA.	tholmes@uci.edu		Recinos, Yocelyn/0000-0002-7377-8660; Chevez, Joshua/0000-0002-3790-0171; Baik, Lisa Soyeon/0000-0001-8184-2039	National Institute of Health [GM102965, GM107405, GM127102]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102965, R01GM107405] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health GM102965 to TCH (https://www.nih.gov/), National Institute of Health GM107405 to TCH (https://www.nih.gov/), National Institute of Health GM127102 to TCH (https://www.nih.gov/), and National Science Foundation Graduate Research Fellowship Program to LSB (https://www.nsfgrfp.org/) provided support for this work.	Baik LS, 2017, P NATL ACAD SCI USA, V114, P776, DOI 10.1073/pnas.1607989114; Barber AF, 2016, GENE DEV, V30, P2596, DOI 10.1101/gad.288258.116; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Chatterjee A, 2010, CURR BIOL, V20, P300, DOI 10.1016/j.cub.2009.12.055; DAAN S, 1976, J COMP PHYSIOL, V106, P267, DOI 10.1007/BF01417858; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134213; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; FORK RL, 1971, SCIENCE, V171, P907, DOI 10.1126/science.171.3974.907; Garbe DS, 2015, BIOL OPEN, V4, P1558, DOI 10.1242/bio.013011; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Guntur AR, 2015, P NATL ACAD SCI USA, V112, pE5753, DOI 10.1073/pnas.1514862112; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Kane EA, 2013, P NATL ACAD SCI USA, V110, pE3868, DOI 10.1073/pnas.1215295110; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Kaneko M, 1997, J NEUROSCI, V17, P6745; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Ni JD, 2017, NATURE, V545, P340, DOI 10.1038/nature22325; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Pan YP, 2008, J BIOL CHEM, V283, P8634, DOI 10.1074/jbc.M709304200; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pittendrigh CS, 1965, CIRCADIAN CLOCKS, P277; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Roberts L, 2015, CURR BIOL, V25, P858, DOI 10.1016/j.cub.2015.01.056; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011628; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; STEVENSON RD, 1985, AM NAT, V126, P362, DOI 10.1086/284423; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Weng J, 2006, J BIOL CHEM, V281, P15194, DOI 10.1074/jbc.M513809200; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201927	10.1371/journal.pone.0201927	http://dx.doi.org/10.1371/journal.pone.0201927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106957	gold, Green Submitted, Green Published			2022-12-26	WOS:000441662800017
J	Burger, IA; Lohmann, C; Messerli, M; Bengs, S; Becker, A; Maredziak, M; Treyer, V; Haider, A; Schwyzer, M; Benz, DC; Kudura, K; Fiechter, M; Giannopoulos, AA; Fuchs, TA; Grani, C; Pazhenkottil, AP; Gaemperli, O; Buechel, RR; Kaufmann, PA; Gebhard, C				Burger, Irene A.; Lohmann, Christine; Messerli, Michael; Bengs, Susan; Becker, Anton; Maredziak, Monika; Treyer, Valerie; Haider, Ahmed; Schwyzer, Moritz; Benz, Dominik C.; Kudura, Ken; Fiechter, Michael; Giannopoulos, Andreas A.; Fuchs, Tobias A.; Grani, Christoph; Pazhenkottil, Aju P.; Gaemperli, Oliver; Buechel, Ronny R.; Kaufmann, Philipp A.; Gebhard, Catherine			Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by F-18-DOPA PET imaging	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BLOOD-PRESSURE; GENDER-DIFFERENCES; NERVE ACTIVITY; HEART-DISEASE; WOMEN; RISK; ACTIVATION; GUIDELINES; STATEMENT	Background Sexual dimorphism in cardiac sympathetic outflow has recently gained attention in the context of Takotsubo cardiomyopathy. Previous studies suggest that there are sex- and age-dependent differences in peripheral autonomic control, however, data on cardiac-specific sympathetic activation in aged women and men are lacking. Methods and results Regional quantitative analysis of cardiac fluorine-18 (F-18)- Dihydroxyphenylalanine (DOPA) uptake was retrospectively performed in 133 patients (69 females, mean age 52.4 +/- 17.7 years) referred for assessment of neuroendocrine tumours (NET) by Positron-Emission-Tomography. Cardiac F-18-DOPA uptake was significantly higher in women as compared to men (1.33 +/- 0.21 vs. 1.18 +/- 0.24, p<0.001). This sex-difference was most pronounced in the apical region of the left ventricle (LV, 1.30 +/- 0.24 in women vs. 1.13 +/- 0.25 in men, p<0.001) and in individuals >55 years of age (1.39 +/- 0.25 in women vs. 1.09 +/- 0.24 in men, p<0.001). Women showed a prominent increase in myocardial F-18-DOPA uptake with age with the strongest increase seen in the LV apical region (r = 0.34, p = 0.004). Accordingly, sex and age were selected as significant predictors of LV apical F-18-DOPA uptake in a stepwise linear regression model. No age-dependent changes of cardiac F-18-DOPA uptake were observed in men or in the right ventricular region. Conclusion Our study suggests that aging is related to sex-specific changes in regional cardiac sympathetic activity. Future studies will have to assess whether the increase in LV apical F-18-DOPA uptake with age in women is of pathogenic relevance for the higher susceptibility of postmenopausal women to conditions associated with increased sympathetic activity.	[Burger, Irene A.; Lohmann, Christine; Messerli, Michael; Bengs, Susan; Treyer, Valerie; Haider, Ahmed; Schwyzer, Moritz; Benz, Dominik C.; Kudura, Ken; Fiechter, Michael; Giannopoulos, Andreas A.; Fuchs, Tobias A.; Grani, Christoph; Pazhenkottil, Aju P.; Gaemperli, Oliver; Buechel, Ronny R.; Kaufmann, Philipp A.; Gebhard, Catherine] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Becker, Anton; Maredziak, Monika] Univ Hosp Zurich, Dept Diagnost & Intervent Radiol, Zurich, Switzerland; [Gebhard, Catherine] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich	Gebhard, C (corresponding author), Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland.; Gebhard, C (corresponding author), Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland.	catherine.gebhard@usz.ch	Treyer, Valerie/G-6986-2018; Burger, Irene/AAG-1077-2020; Gebhard, Catherine/AAT-7060-2020; Haider, Ahmed/AAQ-6443-2020; Becker, Anton S./H-5416-2019; Haider, Ahmed/N-3834-2017	Treyer, Valerie/0000-0002-4584-3031; Gebhard, Catherine/0000-0001-7240-5822; Becker, Anton S./0000-0001-8372-6496; Grani, Christoph/0000-0001-6029-0597; Benz, Dominik Carlo/0000-0001-8627-726X; Haider, Ahmed/0000-0002-5204-4473; Buechel, Ronny Ralf/0000-0001-8064-8904; Giannopoulos, Andreas/0000-0002-0938-3170; Bengs, Susan/0000-0003-2424-3894; Pazhenkottil, Aju/0000-0002-8847-2154; Kaufmann, Philipp/0000-0002-9451-5210	Swiss National Science Foundation (SNSF); Olga Mayenfisch Foundation, Switzerland; OPO Foundation, Switzerland; Novartis Foundation, Switzerland; Swissheart Foundation; Helmut Horten Foundation, Switzerland	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Olga Mayenfisch Foundation, Switzerland; OPO Foundation, Switzerland; Novartis Foundation, Switzerland(Novartis); Swissheart Foundation; Helmut Horten Foundation, Switzerland	This work was supported by grants from the Swiss National Science Foundation (SNSF), the Olga Mayenfisch Foundation, Switzerland, the OPO Foundation, Switzerland, the Novartis Foundation, Switzerland, and the Swissheart Foundation. We declare that the authors received research grants from the Swiss National Science Foundation (SNSF), the Olga Mayenfisch Foundation, Switzerland, the OPO Foundation, Switzerland, the Novartis Foundation, Switzerland, the Helmut Horten Foundation, Switzerland, and the Swissheart Foundation (all to Catherine Gebhard). These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and provided financial support only in the form of salaries (CG, SB, AH, MM) and research materials.	Agostini D, 2008, EUR J NUCL MED MOL I, V35, P535, DOI 10.1007/s00259-007-0639-3; Ando Giuseppe, 2010, Acute Card Care, V12, P70, DOI 10.3109/17482941003732758; Baker SE, 2016, AM J PHYSIOL-REG I, V311, pR1271, DOI 10.1152/ajpregu.00288.2016; Baldassarre LA, 2016, JACC-CARDIOVASC IMAG, V9, P421, DOI 10.1016/j.jcmg.2016.01.004; Briant LJB, 2016, EXP PHYSIOL, V101, P219, DOI 10.1113/EP085368; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chondrogiannis S, 2014, PET CLIN, V9, P307, DOI 10.1016/j.cpet.2014.03.007; Chondrogiannis S, 2013, NUCL MED COMMUN, V34, P1141, DOI 10.1097/MNM.0000000000000008; Di Monaco A, 2010, J CARDIOVASC MED, V11, P151, DOI 10.2459/JCM.0b013e328330321d; Ellison D A, 2001, Am J Clin Pathol, V115 Suppl, pS46; ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278, DOI 10.1152/ajpregu.1995.268.1.R278; FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725; GANGULY PK, 1986, CIRC RES, V59, P684, DOI 10.1161/01.RES.59.6.684; Gebhard C, 2017, EUR HEART J-CARD IMG, V18, P990, DOI 10.1093/ehjci/jew142; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; Harvey RE, 2017, AM J PHYSIOL-HEART C, V312, pH340, DOI 10.1152/ajpheart.00447.2016; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hogarth AJ, 2009, EUR HEART J, V30, P1764, DOI 10.1093/eurheartj/ehp188; Incognito AV, 2018, AM J PHYSIOL-REG I, V314, pR114, DOI 10.1152/ajpregu.00266.2017; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; Ketchum ES, 2012, J NUCL CARDIOL, V19, P1007, DOI 10.1007/s12350-012-9603-0; Li SJ, 2013, HIGH BLOOD PRESS CAR, V20, P115, DOI 10.1007/s40292-013-0018-z; Li ST, 2003, J NUCL MED, V44, P1599; Liu CC, 2003, AM J PHYSIOL-HEART C, V285, pH2188, DOI 10.1152/ajpheart.00256.2003; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Matsukawa T, 1998, AM J PHYSIOL-REG I, V275, pR1600, DOI 10.1152/ajpregu.1998.275.5.R1600; Mieres JH, 2014, CIRCULATION, V130, P350, DOI 10.1161/CIR.0000000000000061; Mitoff PR, 2011, HEART, V97, P382, DOI 10.1136/hrt.2010.199760; Narkiewicz K, 2005, HYPERTENSION, V45, P522, DOI 10.1161/01.HYP.0000160318.46725.46; Pepine CJ, 2015, J AM COLL CARDIOL, V66, P1918, DOI 10.1016/j.jacc.2015.08.876; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Sakata K, 1998, J NUCL MED, V39, P1667; Taieb D, 2012, EUR J NUCL MED MOL I, V39, P1977, DOI 10.1007/s00259-012-2215-8; Takahashi TA, 2015, MED CLIN N AM, V99, P521, DOI 10.1016/j.mcna.2015.01.006; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Trio Olimpia, 2010, Ther Adv Cardiovasc Dis, V4, P105, DOI 10.1177/1753944709356013; TSUCHIMOCHI S, 1995, J NUCL MED, V36, P969; Ubrich R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186783; Vaccarino V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003630; Vongpatanasin W, 2001, CIRCULATION, V103, P2903, DOI 10.1161/01.CIR.103.24.2903; Wilmot KA, 2015, CIRCULATION, V132, P997, DOI 10.1161/CIRCULATIONAHA.115.015293	42	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202302	10.1371/journal.pone.0202302	http://dx.doi.org/10.1371/journal.pone.0202302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106984	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000441662800037
J	Blanke, J; Boke-Olen, N; Olin, S; Chang, JF; Sahlin, U; Lindeskog, M; Lehsten, V				Blanke, Jan; Boke-Olen, Niklas; Olin, Stefan; Chang, Jinfeng; Sahlin, Ullrika; Lindeskog, Mats; Lehsten, Veiko			Implications of accounting for management intensity on carbon and nitrogen balances of European grasslands	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; EARTH SYSTEM MODEL; LAND-USE; AGRICULTURE; PRODUCTIVITY; SCENARIOS; BIOMASS; WATER; BIOSPHERE; EMISSIONS	European managed grasslands are amongst the most productive in the world. Besides temperature and the amount and timing of precipitation, grass production is also highly controlled by applications of nitrogen fertilizers and land management to sustain a high productivity. Since management characteristics of pastures vary greatly across Europe, land-use intensity and their projections are critical input variables in earth system modeling when examining and predicting the effects of increasingly intensified agricultural and livestock systems on the environment. In this study, we aim to improve the representation of pastures in the dynamic global vegetation model LPJ-GUESS. This is done by incorporating daily carbon allocation for grasses as a foundation to further implement daily land management routines and land-use intensity data into the model to discriminate between intensively and extensively used regions. We further compare our new simulations with leaf area index observations, reported regional grassland productivity, and simulations conducted with the vegetation model ORCHIDEE-GM. Additionally, we analyze the implications of including pasture fertilization and daily management compared to the standard version of LPJ-GUESS. Our results demonstrate that grassland productivity cannot be adequately captured without including land-use intensity data in form of nitrogen applications. Using this type of information improved spatial patterns of grassland productivity significantly compared to standard LPJ-GUESS. In general, simulations for net primary productivity, net ecosystem carbon balance and nitrogen leaching were considerably increased in the extended version. Finally, the adapted version of LPJ-GUESS, driven with projections of climate and land-use intensity, simulated an increase in potential grassland productivity until 2050 for several agro-climatic regions, most notably for the Mediterranean North, the Mediterranean South, the Atlantic Central and the Atlantic South.	[Blanke, Jan; Boke-Olen, Niklas; Olin, Stefan; Lindeskog, Mats; Lehsten, Veiko] Lund Univ, Dept Phys Geog & Ecosyst Sci, Solvegatan 12, S-22362 Lund, Sweden; [Chang, Jinfeng] UVSQ, CNRS, UMR8212, CEA,Lab Sci Climat & Environm, Gif Sur Yvette, France; [Sahlin, Ullrika] Lund Univ, Ctr Environm & Climate Res, Solvegatan 37, S-22362 Lund, Sweden; [Lehsten, Veiko] Snow & Landscape Res WSL, Swiss Fed Inst Forest, Zurcherstr 11, CH-8903 Birmensdorf, Switzerland	Lund University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Lund University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Blanke, J (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Solvegatan 12, S-22362 Lund, Sweden.	blankejanh@gmail.com	CHANG, Jinfeng/A-4603-2019; Boke-Olen, Niklas/AAQ-8047-2020; Chang, Jinfeng/H-7884-2019	CHANG, Jinfeng/0000-0003-4463-7778; Boke-Olen, Niklas/0000-0003-2441-7153; Chang, Jinfeng/0000-0003-4463-7778; Olin, Stefan/0000-0002-8621-3300; Blanke, Jan Hendrik/0000-0001-9007-5097	ERA-Net BiodivERsA; FORMAS; Lund University Center for studies of Carbon Cycle and Climate Interactions (LUCCI); Lund University; University of Gothenburg Biodiversity and Ecosystem Services in a Changing Climate (BECC)	ERA-Net BiodivERsA; FORMAS(Swedish Research Council Formas); Lund University Center for studies of Carbon Cycle and Climate Interactions (LUCCI); Lund University; University of Gothenburg Biodiversity and Ecosystem Services in a Changing Climate (BECC)	JHB and VL are funded by the ERA-Net BiodivERsA, with the national funder FORMAS, part of the 2012 BiodivERsA call for research proposals via the EC21C project. NBO is supported by Lund University Center for studies of Carbon Cycle and Climate Interactions (LUCCI) and Lund University and University of Gothenburg Biodiversity and Ecosystem Services in a Changing Climate (BECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research, conducted within the projects EC21C, was funded by the ERA-Net BiodivERsA, with the national funder FORMAS, part of the 2012 BiodivERsA call for research proposals.	Ahlstrom A, 2013, BIOGEOSCIENCES, V10, P1517, DOI 10.5194/bg-10-1517-2013; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Bentsen M, 2013, GEOSCI MODEL DEV, V6, P687, DOI 10.5194/gmd-6-687-2013; Blanke JH, 2016, J GEOPHYS RES-BIOGEO, V121, P1352, DOI 10.1002/2015JG003216; Boke-Olen N, J ARID ENV; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Britz W, 2012, CAPRI MODEL DOCUMENT; Chang JF, 2013, GEOSCI MODEL DEV, V6, P2165, DOI 10.5194/gmd-6-2165-2013; Chang JF, 2017, CARBON BAL MANAGE, V12, DOI 10.1186/s13021-017-0079-8; Chang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127554; CORRALL AJ, 1988, INFORMATION B FAO EU, V1, P25; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Dusseux P, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083559; Erb KH, 2017, GLOBAL CHANGE BIOL, V23, P512, DOI 10.1111/gcb.13443; Foley JA, 2007, P NATL ACAD SCI USA, V104, P12585, DOI 10.1073/pnas.0705190104; Gent PR, 2010, CLIM DYNAM, V34, P819, DOI 10.1007/s00382-009-0614-8; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Griffies SM, 2011, J CLIMATE, V24, P3520, DOI 10.1175/2011JCLI3964.1; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hufkens K, 2016, NAT CLIM CHANGE, V6, P710, DOI [10.1038/nclimate2942, 10.1038/NCLIMATE2942]; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Iglesias A, 2012, CLIMATIC CHANGE, V112, P143, DOI 10.1007/s10584-011-0344-x; JOHNSON IR, 1983, PLANT CELL ENVIRON, V6, P721, DOI 10.1111/1365-3040.ep11588103_6_9; Kirschbaum MUF, 2015, SCI TOTAL ENVIRON, V512, P273, DOI 10.1016/j.scitotenv.2015.01.045; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Lautenbach S, 2017, ECOL INDIC, V73, P139, DOI 10.1016/j.ecolind.2016.09.035; Lehsten V, 2015, GLOBAL ECOL BIOGEOGR, V24, P653, DOI 10.1111/geb.12291; Leip A, 2008, BIOGEOSCIENCES, V5, P73, DOI 10.5194/bg-5-73-2008; Leip A, 2011, ENVIRON POLLUT, V159, P3243, DOI 10.1016/j.envpol.2011.01.040; Levers C, 2016, LAND USE POLICY, V58, P380, DOI 10.1016/j.landusepol.2016.08.013; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Lindeskog M, 2013, EARTH SYST DYNAM, V4, P385, DOI 10.5194/esd-4-385-2013; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Neumann K, 2011, AGR ECOSYST ENVIRON, V140, P88, DOI 10.1016/j.agee.2010.11.015; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Olin S, 2015, BIOGEOSCIENCES, V12, P2489, DOI 10.5194/bg-12-2489-2015; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Petersen SO, 1998, ATMOS ENVIRON, V32, P295, DOI 10.1016/S1352-2310(97)00043-5; Riedo M, 1998, ECOL MODEL, V105, P141, DOI 10.1016/S0304-3800(97)00110-5; Rolinski S, 2015, ADV ANIM BIOSCI, V6, P43, DOI [10.1017/S2040470014000521, DOI 10.1017/S2040470014000521]; Sannes RA, 2002, J DAIRY SCI, V85, P900, DOI 10.3168/jds.S0022-0302(02)74148-9; Schmidt GA, 2014, J ADV MODEL EARTH SY, V6, P141, DOI 10.1002/2013MS000265; Schulze E.D., 2000, CARBON NITROGEN CYCL; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Smith B, 2014, BIOGEOSCIENCES, V11, P2027, DOI 10.5194/bg-11-2027-2014; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Stevens B, 2013, J ADV MODEL EARTH SY, V5, P146, DOI 10.1002/jame.20015; Stocker BD, 2013, NAT CLIM CHANGE, V3, P666, DOI [10.1038/NCLIMATE1864, 10.1038/nclimate1864]; Sturck J, 2018, REG ENVIRON CHANGE, V18, P733, DOI 10.1007/s10113-015-0876-0; Temme A., 2010, AGR ECOSYST ENVIRON, V140, P46, DOI DOI 10.1016/J.AGEE.2010; Tenkorang F, 2009, NUTR CYCL AGROECOSYS, V83, P233, DOI 10.1007/s10705-008-9214-y; Thebault A, 2014, J ECOL, V102, P896, DOI 10.1111/1365-2745.12236; van Asselen S, 2012, GLOBAL CHANGE BIOL, V18, P3125, DOI 10.1111/j.1365-2486.2012.02759.x; Vuichard N, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002611; Waha K, 2012, GLOBAL ECOL BIOGEOGR, V21, P247, DOI 10.1111/j.1466-8238.2011.00678.x; Webber H, 2015, EUR J AGRON, V71, P123, DOI 10.1016/j.eja.2015.09.002; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1; Whitehead D.C., 1995, GRASSLAND NITROGEN; Willmott CJ, 2012, INT J CLIMATOL, V32, P2088, DOI 10.1002/joc.2419; Wint W., 2007, GRIDDED LIVESTOCK WO	63	7	8	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201058	10.1371/journal.pone.0201058	http://dx.doi.org/10.1371/journal.pone.0201058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102732	Green Submitted, Green Published, gold			2022-12-26	WOS:000441452200006
J	Hubert, JN; Zerjal, T; Hospital, F				Hubert, Jean-Noel; Zerjal, Tatiana; Hospital, Frederic			Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrish)	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; FACIAL TUMOR DISEASE; INTELLECTUAL DISABILITY; UBIQUITIN LIGASE; ADHESION-GPCRS; CELL-ADHESION; TRIM FAMILY; TOOL SET; POPULATION; TRANSMISSION	Devil Facial Tumor Disease (DFTD) is an aggressive cancer notorious for its rare etiology and its impact on Tasmanian devil populations. Two regions underlying an evolutionary response to this cancer were recently identified using genomic time-series pre- and post-DTFD arrival. Here, we support that DFTD shaped the genome of the Tasmanian devil in an even more extensive way than previously reported. We detected 97 signatures of selection, including 148 protein coding genes having a human orthologue, linked to DFTD. Most candidate genes are associated with cancer progression, and an important subset of candidate genes has additional influence on social behavior. This confirms the influence of cancer on the ecology and evolution of the Tasmanian devil. Our work also demonstrates the possibility to detect highly polygenic footprints of short-term selection in very small populations.	[Hubert, Jean-Noel; Zerjal, Tatiana; Hospital, Frederic] Univ Paris Saclay, AgroParisTech, GABI, INRA, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Hubert, JN (corresponding author), Univ Paris Saclay, AgroParisTech, GABI, INRA, Jouy En Josas, France.	jean-noel.hubert@inra.fr	zerjal, tatiana/AAO-9473-2020		French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	JNH was supported by the French Ministry of Higher Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageta-Ishihara N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10090; Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9; Bachiller S, 2015, CELL MOL LIFE SCI, V72, P2961, DOI 10.1007/s00018-015-1878-2; Belov K, 2012, BIOESSAYS, V34, P285, DOI 10.1002/bies.201100161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitenkamp AFS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095579; Cao ZF, 2015, IMMUNITY, V43, P715, DOI 10.1016/j.immuni.2015.10.005; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen SW, 2017, ONCOTARGET, V8, P22460, DOI 10.18632/oncotarget.13006; Chen Y, 2015, ONCOTARGET, V6, P23708, DOI 10.18632/oncotarget.4291; Cheng LP, 2003, J NEUROSCI, V23, P9961; Cowell JK, 2017, INT J CANCER, V141, P1822, DOI 10.1002/ijc.30848; Dai YD, 2017, ONCOTARGET, V8, P9783, DOI 10.18632/oncotarget.14189; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Detchokul S, 2014, BRIT J PHARMACOL, V171, P5462, DOI 10.1111/bph.12260; Epstein B, 2016, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.r60sv, DOI 10.5061/DRYAD.R60SV]; Epstein B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12684; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Hamede RK, 2013, J ANIM ECOL, V82, P182, DOI 10.1111/j.1365-2656.2012.02025.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hellsten SV, 2017, FEBS OPEN BIO, V7, P730, DOI 10.1002/2211-5463.12219; Helsmoortel C, 2015, CLIN GENET, V88, P140, DOI 10.1111/cge.12470; Hendricks S, 2017, CONSERV GENET, V18, P977, DOI 10.1007/s10592-017-0939-5; Hnoonual A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12317-3; Hollis F, 2017, CURR OPIN NEUROBIOL, V45, P178, DOI 10.1016/j.conb.2017.05.018; Ioannou MS, 2016, J BIOL CHEM, V291, P9929, DOI 10.1074/jbc.R116.715193; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Juang YL, 2016, MOL CARCINOGEN, V55, P2247, DOI 10.1002/mc.22465; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kaya N, 2016, J MED GENET, V53, P786, DOI 10.1136/jmedgenet-2015-103637; Klein-Goldberg A, 2014, CANCER LETT, V352, P54, DOI 10.1016/j.canlet.2013.08.029; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Lavi O, 2015, CANCER RES, V75, P808, DOI 10.1158/0008-5472.CAN-14-3256; Lee Y, 2013, CARCINOGENESIS, V34, P307, DOI 10.1093/carcin/bgs356; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Li HL, 2016, ONCOTARGET, V7, P66267, DOI [10.18632/oncotarget.11411, 10.18632/oncotarget.11728]; Li JC, 2016, MOL PSYCHIATR, V21, P298, DOI 10.1038/mp.2015.58; Liao ZH, 2019, CELL IMMUNOL, V343, DOI 10.1016/j.cellimm.2017.12.003; Little EC, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.45; Liu XC, 2017, J BIOMATER TISS ENG, V7, P1, DOI 10.1166/jbt.2017.1539; Lovero KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066171; Ma YN, 2015, AM J CANCER RES, V5, P663; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Metzger MJ, 2016, NATURE, V534, P705, DOI 10.1038/nature18599; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Nakata Takao, 2007, Sci STKE, V2007, ppe6, DOI 10.1126/stke.3722007pe6; Nijmeijer S, 2016, BIOCHEM PHARMACOL, V114, P88, DOI 10.1016/j.bcp.2016.04.013; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Orsmond GI, 2004, J AUTISM DEV DISORD, V34, P245, DOI 10.1023/B:JADD.0000029547.96610.df; Pagnamenta AT, 2011, J MED GENET, V48, P48, DOI 10.1136/jmg.2010.079426; Poot M, 2010, NEUROGENETICS, V11, P81, DOI 10.1007/s10048-009-0205-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pye RJ, 2016, VET PATHOL, V53, P726, DOI 10.1177/0300985815616444; Pye R, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0553; Rhein VF, 2016, J BIOL CHEM, V291, P14851, DOI 10.1074/jbc.M116.734970; Roche B, 2017, ECOLOGY EVOLUTION CA, P180; Russell T, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700146; Salvador Ellaine, 2016, Curr Pathobiol Rep, V4, P135; Samanta D, 2016, CANCER RES, V76, P4430, DOI 10.1158/0008-5472.CAN-16-0530; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Schiffman JD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0231; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Storfer A, 2017, CONSERV GENET, V18, P1287, DOI 10.1007/s10592-017-0980-4; Strub T, 2011, RES MELANOMA A GLIMP, DOI [10.5772/19769, DOI 10.5772/19769]; Syed V, 2016, J CELL BIOCHEM, V117, P1279, DOI 10.1002/jcb.25496; Taheri A, 2016, J INTELL DISABIL RES, V60, P435, DOI 10.1111/jir.12289; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tang PMK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14677; Thepot S, 2015, GENETICS, V199, P609, DOI 10.1534/genetics.114.169995; Tissot T, 2016, BIOESSAYS, V38, P276, DOI 10.1002/bies.201500163; Ujvari B, 2016, BIOESSAYS, V38, pS14, DOI 10.1002/bies.201670904; Ujvari B, 2014, EVOL APPL, V7, P260, DOI 10.1111/eva.12117; Utine GE, 2017, EUR J MED GENET, V60, P279, DOI 10.1016/j.ejmg.2017.03.007; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Veenbergen S, 2011, IMMUNOL LETT, V138, P129, DOI 10.1016/j.imlet.2011.03.010; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Vougiouklakis T, 2015, EPIGENOMICS-UK, V7, P863, DOI 10.2217/epi.15.32; Walton KM, 2013, J AUTISM DEV DISORD, V43, P594, DOI 10.1007/s10803-012-1601-1; Wells K, 2017, ECOL LETT, V20, P770, DOI 10.1111/ele.12776; Woodbury-Smith M, 2015, HUM GENET, V134, P191, DOI 10.1007/s00439-014-1513-6; Wu Z, 2012, TUMOR BIOL, V33, P1619, DOI 10.1007/s13277-012-0417-0; Yan Y, 2017, ONCOTARGET, V8, P35750, DOI 10.18632/oncotarget.16189; Yan Z, 2016, J NEUROSCI, V36, P11411, DOI 10.1523/JNEUROSCI.2360-16.2016; Yee NS, 2015, CANCERS, V7, P2134, DOI 10.3390/cancers7040882; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhang B, 2014, ONCOL LETT, V8, P1163, DOI 10.3892/ol.2014.2300; Zhang DH, 2016, ONCOL LETT, V12, P5136, DOI 10.3892/ol.2016.5341; Zhi XL, 2015, HEPATOLOGY, V61, P598, DOI 10.1002/hep.27558	101	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201838	10.1371/journal.pone.0201838	http://dx.doi.org/10.1371/journal.pone.0201838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102725	gold, Green Published, Green Submitted			2022-12-26	WOS:000441452200018
J	Jonas, JB; Wei, WB; Xu, L; Rietschel, M; Streit, F; Wang, YX				Jonas, Jost B.; Wei, Wen Bin; Xu, Liang; Rietschel, Marcella; Streit, Fabian; Wang, Ya Xing			Self-rated depression and eye diseases: The Beijing Eye Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DRY-EYE; TEAR FLUID; ANXIETY; PREVALENCE; SYMPTOMS; AGE; GLAUCOMA; ASSOCIATION; VALIDITY	Purpose To assess the prevalence of depression in the general population of Beijing and its association with ocular diseases. Methods The population-based Beijing Eye Study was conducted in a rural and an urban region of Greater Beijing. The study participants underwent a detailed ophthalmological examination and an interview including questions on the socioeconomic background. Depressive symptoms were evaluated using a Chinese depression scale adapted from Zung's self-rated depression scale. The total score of depression symptoms was 80. Depression was defined as having a depression score >44. Results Out of 3468 study participants, 3267 (94.2%) individuals (1419 men) with an age of 64.5 +/- 9.7 years (range: 50-93 years) participated in the interview and answered all questions on depression. The mean depression score was 25.0 +/- 5.9 (median: 23.3; range:20-64). Depression (depression score >44) was present in 66 individuals (2.0%; 95% confidence interval (CI): 1.5,2.5), and 5 individuals (0.2%; 95%CI: 0.02,0.3) had a depression score >= 59. In multivariate regression, analysis, a higher depression score was associated (regression coefficient r(2):0.22) with a higher number of days with dry eye feeling (P<0.001; standardized regression coefficient beta: 0.09; non-standardized regression coefficient B: 0.20; 95%CI: 0.12,0.29) and shorter corneal curvature radius (P = 0.03;beta:-0.04; B:1.01; 95%CI: -1.90,-0.12), after adjusting for age, gender, region of habitation, body mass index, cognitive function score, life quality score and blood concentration of triglycerides. Adding age-related macular degeneration (P = 0.10), glaucoma (P = 0.77), diabetic retinopathy (P = 0.77), nuclear cataract (P = 0.35), cortical cataract (P= 0.58) or posterior subcapsular cataract (P= 0.28) as single parameters to the model revealed no significant correlation with the depression score. Lower best corrected visual acuity showed a marginal significant association (P = 0.05; beta: 0.04; B: 1.56; 95%CI: -0.01, 3.13). Conclusions Dry eye feeling was the only common ocular disorder associated with an increased depression score, while the occurrence of age-related macular degeneration, any type of glaucoma, diabetic retinopathy, any type of cataract and keratoconus were not significantly associated with an increased depression score. Lower visual acuity was marginally associated. The prevalence of depression in the population aged 50+ years in Greater Beijing was 2.0% (96%CI: 1.5,2.5).	[Jonas, Jost B.; Xu, Liang; Wang, Ya Xing] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.; Xu, Liang; Wang, Ya Xing] Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Rietschel, Marcella; Streit, Fabian] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Wang, YX (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing, Peoples R China.; Wang, YX (corresponding author), Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China.	xlbio1@163.com	wei, wei/HHR-8613-2022; wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227	State Natural Sciences Fund [81041018]; Natural Sciences Fund of the Beijing Government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of the Beijing Government	This work is supported by the State Natural Sciences Fund (81041018 to W.B.W.) and the Natural Sciences Fund of the Beijing Government (7092021; 7112031 to W.B.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin A, 2007, INVEST OPHTH VIS SCI, V48, P1498, DOI 10.1167/iovs.06-0761; BIGGS JT, 1978, BRIT J PSYCHIAT, V132, P381, DOI 10.1192/bjp.132.4.381; Brody BL, 2001, OPHTHALMOLOGY, V108, P1893, DOI 10.1016/S0161-6420(01)00754-0; Cohen BE, 2015, AM J HYPERTENS, V28, P1295, DOI 10.1093/ajh/hpv047; Dawson SR, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-78; de Salamanca AE, 2005, INVEST OPHTH VIS SCI, V46, P504, DOI 10.1167/iovs.04-0665; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065356; Hallak JA, 2015, CORNEA, V34, P1545, DOI 10.1097/ICO.0000000000000641; Hilsenroth MJ, 2004, INT J PSYCHIAT CLIN, V8, P3, DOI 10.1080/13651500310004795; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Jivraj J, 2013, CAN J OPHTHALMOL, V48, P269, DOI 10.1016/j.jcjo.2013.03.007; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kim KW, 2011, INVEST OPHTH VIS SCI, V52, P7954, DOI 10.1167/iovs.11-8050; KITAMURA T, 1994, ACTA PSYCHIAT SCAND, V90, P446, DOI 10.1111/j.1600-0447.1994.tb01622.x; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; LEE HC, 1994, J GERIATR PSYCH NEUR, V7, P216, DOI 10.1177/089198879400700404; Lee WJ, 2013, ASIA-PAC J OPHTHALMO, V2, P23, DOI 10.1097/APO.0b013e31827be8b1; Lim NCS, 2016, J GLAUCOMA, V25, P605, DOI 10.1097/IJG.0000000000000393; Mabuchi F, 2008, J GLAUCOMA, V17, P552, DOI 10.1097/IJG.0b013e31816299d4; Martin J, 2017, PSYCHIAT GENET, V27, P187, DOI 10.1097/YPG.0000000000000182; Mrugacz M, 2017, ADV MED SCI-POLAND, V62, P338, DOI 10.1016/j.advms.2017.03.003; Munzer A, 2013, TOXINS, V5, P2227, DOI 10.3390/toxins5112227; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Popescu ML, 2012, INVEST OPHTH VIS SCI, V53, P2308, DOI 10.1167/iovs.11-9330; Qian Y, 2012, AM J OPHTHALMOL, V153, P370, DOI 10.1016/j.ajo.2011.06.028; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Shen MX, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012961; Skalicky S, 2008, J GLAUCOMA, V17, P546, DOI 10.1097/IJG.0b013e318163bdd1; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wan KH, 2016, EYE, V30, P1558, DOI 10.1038/eye.2016.186; Wang SG, 2012, TRAC-TREND ANAL CHEM, V39, P3, DOI 10.1016/j.trac.2012.07.010; Wang TJ, 2012, ACTA OPHTHALMOL, V90, P663, DOI 10.1111/j.1755-3768.2010.01993.x; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yan YN, 2015, OPHTHALMOLOGY, V122, P1873, DOI 10.1016/j.ophtha.2015.05.031; Yochim BP, 2012, J GLAUCOMA, V21, P250, DOI 10.1097/IJG.0b013e3182071b7e; Zhang XX, 2017, AM J OPHTHALMOL, V183, P37, DOI 10.1016/j.ajo.2017.07.021; Zhang XZ, 2013, JAMA OPHTHALMOL, V131, P573, DOI 10.1001/jamaophthalmol.2013.2597; Zheng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46453; Zhou CD, 2013, J PSYCHOSOM RES, V75, P75, DOI 10.1016/j.jpsychores.2013.03.005; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	47	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202132	10.1371/journal.pone.0202132	http://dx.doi.org/10.1371/journal.pone.0202132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096194	gold, Green Submitted, Green Published			2022-12-26	WOS:000441308500052
J	Shen, M				Shen, Menghan			The association between the end of court-ordered school desegregation and preterm births among Black women	PLOS ONE			English	Article							RACIAL DISPARITIES; YOUNG-ADULTS; RESIDENTIAL SEGREGATION; EDUCATIONAL-ATTAINMENT; WEIGHT; HEALTH; AGE; DISCRIMINATION; DELIVERY; STRESS	Racial segregation, and in particular school segregation, likely plays an important role in affecting health outcomes. To examine this connection, this paper explores the relationship between the end of court-ordered school desegregation and preterm births among Blacks using birth certificate information between 1992 and 2002 (n = 183,178). The end of court-ordered oversight has important implications for the level of racial segregation in schools: If residential segregation remains high, neighborhood-based student assignment plans would naturally increase school segregation. A rise in school segregation may lead to worse educational, labor, and health outcomes among Blacks. Using multiple difference-in-differences framework that exploits variation in exposure to schools that declared unitary status, it finds that school districts' release from court oversight is associated with a 0.8 percentage point increase in preterm births among Black mothers. This paper contributes to literature that finds that the end of court-ordered school desegregation in the 1990s have negative implications for Blacks. More research should be conducted to understand the causal relationship between school segregation and infant health.	[Shen, Menghan] Waseda Univ, Inst Adv Study, Shinjuku Ku, Tokyo, Japan	Waseda University	Shen, M (corresponding author), Waseda Univ, Inst Adv Study, Shinjuku Ku, Tokyo, Japan.	shenmenghan@waseda.aoni.jp		Shen, Menghan/0000-0001-6051-954X	Waseda University	Waseda University	An Individual Research Allowance from Waseda University was used to fund the proofreading process for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2016, JAMA-J AM MED ASSOC, V316, P1641, DOI 10.1001/jama.2016.14058; Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Allin M, 2006, J NEUROL NEUROSUR PS, V77, P495, DOI 10.1136/jnnp.2005.075465; Becker G. S., 1973, J POLITICAL EC, V8, P279, DOI DOI 10.1086/260166; Behrman RE, 2007, PRETERM BIRTH CAUSES; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Billings SB, 2014, Q J ECON, V129, P435, DOI 10.1093/qje/qjt026; Black LL, 2015, J RACIAL ETHN HEALTH, V2, P11, DOI 10.1007/s40615-014-0043-1; Buka SL, 2003, AM J EPIDEMIOL, V157, P1, DOI 10.1093/aje/kwf170; CARD D, 1992, J POLIT ECON, V100, P1, DOI 10.1086/261805; Clotfelter CT., 2006, AM LAW ECON REV, V8, P347, DOI [10.1093/aler/ahl002, DOI 10.1093/ALER/AHL002]; Crain RL, 1985, SCH DESEGREGATION BL; Culhane JF, 2005, AM J OBSTET GYNECOL, V192, pS22, DOI 10.1016/j.ajog.2005.01.071; Currie J, 2003, Q J ECON, V118, P1495, DOI 10.1162/003355303322552856; Gee GC, 2008, AM J PUBLIC HEALTH, V98, pS48, DOI 10.2105/AJPH.98.Supplement_1.S48; Glymour MM, 2008, J EPIDEMIOL COMMUN H, V62, P532, DOI 10.1136/jech.2006.059469; Guryan J, 2004, AM ECON REV, V94, P919, DOI 10.1257/0002828042002679; Hobel C, 2003, J NUTR, V133, p1709S, DOI 10.1093/jn/133.5.1709S; Johnson RC, 2011, LONG RUN IMPACTS SCH, P16664; KLEINMAN JC, 1987, NEW ENGL J MED, V317, P749, DOI 10.1056/NEJM198709173171207; Liebowitz DD, 2018, EDUC EVAL POLICY AN, V40, P103, DOI 10.3102/0162373717725804; Lindstrom K, 2007, PEDIATRICS, V120, P70, DOI 10.1542/peds.2006-3260; Lockwood CJ, 1999, AM J OBSTET GYNECOL, V180, pS264, DOI 10.1016/S0002-9378(99)70713-1; Lutz B, 2011, AM ECON J-ECON POLIC, V3, P130, DOI 10.1257/pol.3.2.130; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Misra DP, 2001, PAEDIATR PERINAT EP, V15, P110, DOI 10.1046/j.1365-3016.2001.00333.x; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; National Center for Health Statistics, 1992, VIT STAT NAT BIRTH D; O'Campo P, 2005, AM J OBSTET GYNECOL, V192, pS56, DOI 10.1016/j.ajog.2005.01.074; Osypuk TL, 2008, AM J EPIDEMIOL, V167, P1295, DOI 10.1093/aje/kwn043; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Polednak AP, 1996, AM J PUBLIC HEALTH, V86, P723, DOI 10.2105/AJPH.86.5.723; Rauh VA, 2001, AM J PUBLIC HEALTH, V91, P1815, DOI 10.2105/AJPH.91.11.1815; Reardon SF, 2012, J POLICY ANAL MANAG, V31, P876, DOI 10.1002/pam.21649; Reber SJ, 2010, J HUM RESOUR, V45, P893; Reber SJ, 2005, J HUM RESOUR, V40, P559; Rivkin StevenG., 2006, HDB EC ED, P1019; Roberts EM, 1997, AM J PUBLIC HEALTH, V87, P597, DOI 10.2105/AJPH.87.4.597; Sacerdote B, 2011, HBK ECON, V3, P249, DOI 10.1016/S0169-7218(11)03004-8; Shen MH, 2018, ECON HUM BIOL, V30, P104, DOI 10.1016/j.ehb.2018.06.002; Shen MH, 2018, ECON EDUC REV, V63, P31, DOI 10.1016/j.econedurev.2018.01.001; Slaughter-Acey JC, 2016, ANN EPIDEMIOL, V26, P7, DOI 10.1016/j.annepidem.2015.10.005; Steven R, 2010, INTEGRATED PUBLIC US, DOI [10.18128/D010.V7.0, DOI 10.18128/D010.V7.0]; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Valley CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123941; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Weisburd D, 2018, AM J COMMUN PSYCHOL, V61, P285, DOI 10.1002/ajcp.12232; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201372	10.1371/journal.pone.0201372	http://dx.doi.org/10.1371/journal.pone.0201372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR3NR	30133463	Green Published, Green Submitted, gold			2022-12-26	WOS:000442500400019
J	Nakano, R; Mason, AC				Nakano, Ryo; Mason, Andrew C.			Early erratic flight response of the lucerne moth to the quiet echolocation calls of distant bats	PLOS ONE			English	Article							BIG BROWN BATS; ULTRASONIC HEARING; EPTESICUS-FUSCUS; DEFENSIVE BEHAVIOR; AUDITORY SYSTEMS; PREDATOR; PREY; INSECTS; LEPIDOPTERA; SENSITIVITY	Nocturnal insects have evolved ultrasound-sensitive hearing in response to predation pressures from echolocating insectivorous bats. Flying tympanate moths take various evasive actions when they detect bat cries, including turning away, performing a steering/zigzagging flight and ceasing flight. In general, infrequent ultrasonic pulses with low sound intensities that are emitted by distant bats evoke slight turns, whereas frequent and loud ultrasonic pulses of nearby bats evoke erratic or rapid unpredictable changes in the flight path of a moth. Flight cessation, which is a freezing response that causes the moth to passively dive (drop) to the ground, is considered the ultimate last-ditch evasive behaviour against approaching bats where there is a high predation threat. Here, we found that the crambid moth Nomophila nearctica never performed passive dives in response to frequent and loud ultrasonic pulses of >60 dB sound pressure level (SPL) that simulated the attacking echolocation call sequence of the predominant sympatric insectivorous bat Eptesicus fuscus, but rather turned away or flew erratically, regardless of the temporal structure of the stimulus. Consequently, N. nearctica is likely to survive predation by bats by taking early evasive action even when it detects the echolocation calls of sympatric bats hunting other insects at a distance. Since aerially hawking bats can track and catch erratically flying moths after targeting their prey, this early escape strategy may be common among night-flying tympanate insects.	[Nakano, Ryo; Mason, Andrew C.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [Nakano, Ryo] Natl Agr & Food Res Org, Div Fruit Prod & Postharvest Sci, Inst Fruit Tree & Tea Sci, Tsukuba, Ibaraki, Japan	University of Toronto; University Toronto Scarborough; National Agriculture & Food Research Organization - Japan	Nakano, R (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.; Nakano, R (corresponding author), Natl Agr & Food Res Org, Div Fruit Prod & Postharvest Sci, Inst Fruit Tree & Tea Sci, Tsukuba, Ibaraki, Japan.	rnakano@affrc.go.jp		Nakano, Ryo/0000-0002-7983-9380	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad [26132]; Council for Science, Technology and Innovation (CSTI) Cross-Ministerial Strategic Innovation Promotion Program ('Technologies for creating next-generation agriculture, forestry and fisheries')	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science, Technology and Innovation (CSTI) Cross-Ministerial Strategic Innovation Promotion Program ('Technologies for creating next-generation agriculture, forestry and fisheries')	RN was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad 26132 (http://www.jsps.go.jp/english/index.html) and the Council for Science, Technology and Innovation (CSTI) Cross-Ministerial Strategic Innovation Promotion Program ('Technologies for creating next-generation agriculture, forestry and fisheries') (http://www8.cao.go.jp/cstp/panhu/sip_english/sip_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1999, CAN J ZOOL, V77, P27, DOI 10.1139/cjz-77-1-27; Barber JR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Clare EL, 2014, MOL ECOL, V23, P3633, DOI 10.1111/mec.12519; Clare EL, 2014, MOL ECOL, V23, P3618, DOI 10.1111/mec.12542; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; Corcoran AJ, 2016, J EXP BIOL, V219, P2704, DOI 10.1242/jeb.137638; Corcoran AJ, 2014, J COMP PHYSIOL A, V200, P811, DOI 10.1007/s00359-014-0924-0; Corcoran AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063609; Corcoran AJ, 2012, J EXP BIOL, V215, P4278, DOI 10.1242/jeb.076943; Dawson JW, 2004, J COMP PHYSIOL A, V190, P69, DOI 10.1007/s00359-003-0474-3; Dowdy NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152981; DUNNING DC, 1965, SCIENCE, V147, P173, DOI 10.1126/science.147.3654.173; FULLARD JH, 1982, CAN J ZOOL, V60, P2572, DOI 10.1139/z82-330; FULLARD JH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF00604990; FULLARD JH, 1994, J EXP BIOL, V194, P285; Fullard JH, 2001, P ROY SOC B-BIOL SCI, V268, P1375, DOI 10.1098/rspb.2001.1664; Ghose K, 2009, J EXP BIOL, V212, P693, DOI 10.1242/jeb.019380; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Jensen ME, 1999, BEHAV ECOL SOCIOBIOL, V47, P60, DOI 10.1007/s002650050650; Kawahara AY, 2015, P NATL ACAD SCI USA, V112, P6407, DOI 10.1073/pnas.1416679112; Krauel JJ, 2018, OECOLOGIA, V186, P49, DOI 10.1007/s00442-017-3995-0; LEWIS FP, 1993, CAN J ZOOL, V71, P1562, DOI 10.1139/z93-221; MILLER FD, 1991, GREAT LAKES ENTOMOL, V24, P281; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Minet Joel, 2003, Handbuch der Zoologie (Berlin), V4, P289; Moss CF, 2006, PLOS BIOL, V4, P615, DOI 10.1371/journal.pbio.0040079; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; Nakano R, 2017, BIOL J LINN SOC, V121, P174, DOI 10.1093/biolinnean/blw029; Nakano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02003; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; Ratcliffe JM, 2008, CAN J ZOOL, V86, P582, DOI 10.1139/Z08-024; Ratcliffe JM, 2009, BIOL LETTERS, V5, P368, DOI 10.1098/rsbl.2009.0079; Rodriguez RL, 2004, PHYSIOL ENTOMOL, V29, P159, DOI 10.1111/j.1365-3032.2004.00380.x; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; ROEDER KD, 1967, J INSECT PHYSIOL, V13, P873, DOI 10.1016/0022-1910(67)90051-0; ROEDER KD, 1964, J INSECT PHYSIOL, V10, P529, DOI 10.1016/0022-1910(64)90025-3; Rydell J, 1997, P ROY SOC B-BIOL SCI, V264, P83, DOI 10.1098/rspb.1997.0012; Rydell J, 1998, P ROY SOC B-BIOL SCI, V265, P1373, DOI 10.1098/rspb.1998.0444; Simmons J. A., 2001, Acoustics Research Letters Online, V2, P43, DOI 10.1121/1.1352717; Simmons JA, 2005, ACOUST RES LETT ONL, V6, P238, DOI 10.1121/1.1985957; Skals N, 2000, PHYSIOL ENTOMOL, V25, P354, DOI 10.1046/j.1365-3032.2000.00204.x; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59, DOI 10.1146/annurev.en.33.010188.000423; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; SURLYKKE A, 1984, J EXP BIOL, V113, P323; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Svensson GP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5901; ter Hofstede HM, 2016, J EXP BIOL, V219, P1589, DOI 10.1242/jeb.086686; Yack JE, 2007, J COMP PHYSIOL A, V193, P577, DOI 10.1007/s00359-007-0213-2; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051; Yager DD, 2012, CURR OPIN NEUROBIOL, V22, P201, DOI 10.1016/j.conb.2011.12.011; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	53	2	1	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202679	10.1371/journal.pone.0202679	http://dx.doi.org/10.1371/journal.pone.0202679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125318	Green Published, gold, Green Submitted			2022-12-26	WOS:000442202100042
J	Al-Eryani, L; Jenkins, SF; States, VA; Pan, JM; Malone, JC; Rai, SN; Galandiuk, S; Giri, AK; States, JC				Al-Eryani, Laila; Jenkins, Samantha F.; States, Vanessa A.; Pan, Jianmin; Malone, Janine C.; Rai, Shesh N.; Galandiuk, Susan; Giri, Ashok K.; States, J. Christopher			miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions	PLOS ONE			English	Article							DRINKING-WATER; OVARIAN-CANCER; WEST-BENGAL; MICRORNA; PROLIFERATION; PREVALENCE; CARCINOMA; EXPOSURE; MIR-433; MIR-184	Arsenic, a naturally occurring element, contaminates the drinking water of over 200 million people globally. Chronic arsenic exposure causes multiple cancers including those originating from skin, lung and bladder, and is associated with liver, kidney, and prostate cancers. Skin is the primary target organ for arsenic toxicity; chronic toxicity initially manifests as nonmalignant hyperkeratoses (HK) and subsequently advances to malignant lesions, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). In this study, we evaluate the miRNA expression profiles of premalignant (3 HK) and malignant (3 BCC and 3 SCC) skin lesions from individuals chronically exposed to high levels of arsenic (59 +/- 172 ppb) in their drinking water in West Bengal, India. The lesions were histologically complex requiring histopathologic identification of keratinocytes to be isolated for RNA analyses. Keratinocytes were harvested using Laser Capture Microdissection and miRNA expression profiles were determined using TaqMan (R) Array Human MiRNA A Card v2.0. Thirty-five miRNAs were differentially expressed among the three lesion types analyzed. Two miRNAs (miR-425-5p and miR-433) were induced in both BCC and SCC relative to HK indicating their association with malignancy. Two other miRNAs (miR-184 and miR-576-3p) were induced in SCC relative to both BCC and HK suggesting selective induction in tumors capable of metastasis. Six miRNAs (miR-29c, miR-381, miR-452, miR-487b, miR-494 and miR-590-5p) were selectively suppressed in BCC relative to both SCC and HK. In conclusion, the differential miRNA expression was both phenotype-and stage-related. These miRNAs are potential biomarkers and may serve as therapy targets for arsenic-induced internal tumors.	[Al-Eryani, Laila; Jenkins, Samantha F.; States, J. Christopher] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [States, Vanessa A.; Galandiuk, Susan] Univ Louisville, Price Inst Surg Res, Louisville, KY 40292 USA; [Pan, Jianmin; Rai, Shesh N.] Univ Louisville, James Graham Brown Canc Ctr, Biostat Shared Facil, Louisville, KY 40292 USA; [Malone, Janine C.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Rai, Shesh N.] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Giri, Ashok K.] CSIR Indian Inst Chem Biol, Mol Genet Div, Kolkata, India; [Al-Eryani, Laila] NCI, DNA Repair Sect, Lab Canc Biol & Genet, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	States, JC (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	jcstates@louisville.edu	States, J. Christopher/H-4246-2011	States, J. Christopher/0000-0003-4717-4422; Giri, Ashok/0000-0002-2646-4087	National Institute of Environmental Health Science grant [R21ES023627, R01ES027778, T35ES014559]; National Cancer Institute [R25CA134283]; University of Louisville Office of the Executive Vice President for Research and Innovation; Wendell Cherry Chair Endowment Funds; NATIONAL CANCER INSTITUTE [R25CA134283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027778, R21ES023627, T35ES014559] Funding Source: NIH RePORTER	National Institute of Environmental Health Science grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Louisville Office of the Executive Vice President for Research and Innovation; Wendell Cherry Chair Endowment Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Science grant R21ES023627, R01ES027778 to J.C.S., T35ES014559 to R.A. Prough (supported S.F.J.), National Cancer Institute grant R25CA134283 to D. W. Hein (supported V.A.S.); Competitive Enhancement Grant from the University of Louisville Office of the Executive Vice President for Research and Innovation to J.C.S.; Wendell Cherry Chair Endowment Funds to S.N.R. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Eryani L, 2017, TOXICOL APPL PHARM, V331, P130, DOI 10.1016/j.taap.2017.06.002; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; ATSDR, 2007, TOX PROF ARS; Bailey Kathryn A, 2014, Curr Environ Health Rep, V1, P22; Balci S, 2016, CLIN EXP DERMATOL, V41, P346, DOI 10.1111/ced.12736; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Camacho LM, 2011, CHEMOSPHERE, V83, P211, DOI 10.1016/j.chemosphere.2010.12.067; Centeno JA, 2002, ENVIRON HEALTH PERSP, V110, P883, DOI 10.1289/ehp.02110s5883; Chen CL, 2010, CANCER EPIDEM BIOMAR, V19, P101, DOI 10.1158/1055-9965.EPI-09-0333; Chowdhury TR, 1999, NATURE, V401, P545, DOI 10.1038/44056; Coskun E, 2013, LEUKEMIA RES, V37, P647, DOI 10.1016/j.leukres.2013.02.019; Cui QK, 2014, ASIAN PAC J TROP MED, V7, P776, DOI 10.1016/S1995-7645(14)60135-8; Flanagan SM, 2014, ARSENIC IRON LEAD MA; Fleming NH, 2015, CANCER-AM CANCER SOC, V121, P51, DOI 10.1002/cncr.28981; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Gao B, 2014, BIOMED PHARMACOTHER, V68, P143, DOI 10.1016/j.biopha.2013.09.005; Gribble MO, 2012, AM J EPIDEMIOL, V176, P865, DOI 10.1093/aje/kws153; Guo LH, 2013, INT J MOL SCI, V14, P14171, DOI 10.3390/ijms140714171; Haque R, 2003, EPIDEMIOLOGY, V14, P174, DOI 10.1097/00001648-200303000-00011; Hsu CM, 2012, TUMOR BIOL, V33, P1933, DOI 10.1007/s13277-012-0454-8; Hutchinson J, 1911, BRIT MED J, V1911, P976, DOI 10.1136/bmj.1.2626.976; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Liang Z, 2015, MOL CELLS, V38, P130, DOI 10.14348/molcells.2015.2146; Mazumder DNG, 2000, DIAGNOSIS TREATMENT; Nielsen MG, 2010, ASSESSMENT ARSENIC C; Park Su Jin, 2013, Arthritis Rheum, V65, P3141, DOI 10.1002/art.38188; Paul S, 2013, J EXPO SCI ENV EPID, V23, P156, DOI 10.1038/jes.2012.91; Polya DA, 2016, ARSENIC: EXPOSURE SOURCES, HEALTH RISKS, AND MECHANISMS OF TOXICITY, P23; Qin CZ, 2015, PHARMAZIE, V70, P668, DOI 10.1691/ph.2015.5577; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Sarma N, 2016, ARSENIC: EXPOSURE SOURCES, HEALTH RISKS, AND MECHANISMS OF TOXICITY, P127; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; States JC, 2015, BIOL TRACE ELEM RES, V166, P34, DOI 10.1007/s12011-015-0306-7; States JC, 2011, PERSPECTIVES CYTOLOG, V15, P13; Stern RS, 2010, ARCH DERMATOL, V146, P279, DOI 10.1001/archdermatol.2010.4; Su ZM, 2015, EXP THER MED, V9, P961, DOI 10.3892/etm.2015.2199; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Tseng CH, 2005, ENVIRON CARCIN ECO R, V23, P55, DOI [10.1081/GNC-200051860, DOI 10.1081/GNC-200051860]; Tsunetsugu-Yokota Y, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00108; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Weiner-Gorzel K, 2015, CANCER MED-US, V4, P745, DOI 10.1002/cam4.409; WHO WHO, 2008, GUID DRINK WAT QUA D, V1; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088796; Xu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.274; Zhang ZQ, 2015, EXP THER MED, V9, P1617, DOI 10.3892/etm.2015.2318	50	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202579	10.1371/journal.pone.0202579	http://dx.doi.org/10.1371/journal.pone.0202579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114287	Green Published, gold			2022-12-26	WOS:000441850400087
J	Kirkegard, J; Ladekarl, M; Fristrup, CW; Hansen, CP; Sall, M; Mortensen, FV				Kirkegard, Jakob; Ladekarl, Morten; Fristrup, Claus Wilki; Hansen, Carsten Palnaes; Sall, Mogens; Mortensen, Frank Viborg			Urban versus rural residency and pancreatic cancer survival: A Danish nationwide population-based cohort study	PLOS ONE			English	Article							MORTALITY; OUTCOMES; QUALITY; RESECTION; REGISTRY	It is unknown whether urban versus rural residency affects pancreatic cancer survival in a universal tax-financed healthcare system. We conducted a nationwide, population-based cohort study of all patients diagnosed with pancreatic cancer in Denmark from 2004-2015. We used nationwide registries to collect information on characteristics, comorbidity, cancerdirected treatment, and vital status. We followed the patients from pancreatic cancer diagnosis until death, emigration, or 1 October 2017, whichever occurred first. We truncated at five years of follow up. We stratified patients into calendar periods according to year of diagnosis (2004-2007, 2008-2011, and 2012- 2015). We used Cox proportional hazards model to compute hazard ratios (HRs) with associated 95% confidence intervals (CIs) of death, comparing patients in urban and rural areas. HRs were adjusted for age, sex, comorbidity, tumor stage, and localization. In a sub-analysis, we also adjusted for cancer-directed treatment. We included 10,594 patients diagnosed with pancreatic cancer. Median age was 71 years (inter-quartile range: 63-78 years), and half were men. The majority (61.7%) lived in an urban area at the time of diagnosis. When adjusting for potential confounders, we observed a better survival rate among pancreatic cancer patients residing in urban areas compared with rural areas (adjusted HR: 0.92; 95% CI: 0.87-0.98). When taking treatment into account, the association was unclear (adjusted HR: 0.96; 95% CI: 0.88-1.04). Pancreatic cancer patients residing in urban areas had a slightly better survival rate compared with patients in rural areas.	[Kirkegard, Jakob; Mortensen, Frank Viborg] Aarhus Univ Hosp, Dept Surg, HPB Sect, Aarhus, Denmark; [Ladekarl, Morten] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Fristrup, Claus Wilki] Odense Univ Hosp, Odense Pancreas Ctr OPAC, Dept Surg, Odense, Denmark; [Hansen, Carsten Palnaes] Rigshosp, Dept Surg Gastroenterol & Transplantat, Copenhagen, Denmark; [Sall, Mogens] Aalborg Univ Hosp, Dept Surg, Aaborg, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Aalborg University	Kirkegard, J (corresponding author), Aarhus Univ Hosp, Dept Surg, HPB Sect, Aarhus, Denmark.	jakob.kirkegaard@auh.rm.dk	Ladekarl, Morten/AAD-5654-2020; hansen, carsten palnæs/AAR-2988-2020; hansen, carsten p/HGE-3825-2022; Ladekarl, Morten/AAQ-1702-2020; Kirkegard, Jakob/D-4138-2014	Ladekarl, Morten/0000-0002-0182-1228; hansen, carsten palnæs/0000-0002-9256-2240; hansen, carsten p/0000-0002-9256-2240; Kirkegard, Jakob/0000-0002-6994-0637; Mortensen, Frank Viborg/0000-0001-7580-8037; Fristrup, Claus Wilki/0000-0003-2721-0967	Danish Cancer Society [R124-A7521]	Danish Cancer Society(Danish Cancer Society)	The work was supported by The Danish Cancer Society, (www.cancer.dk), R124-A7521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DET MOD CANC MET KVA; Are C, 2016, J SURG ONCOL, V114, P736, DOI 10.1002/jso.24410; Burmeister EA, 2016, PANCREATOLOGY, V16, P873, DOI 10.1016/j.pan.2016.06.010; Burmeister EA, 2016, MED J AUSTRALIA, V205, P459, DOI 10.5694/mja16.00567; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen KX, 2003, WORLD J GASTROENTERO, V9, P2557; Cheung R, 2013, ASIAN PAC J CANCER P, V14, P159, DOI 10.7314/APJCP.2013.14.1.159; Chu QYD, 2017, HPB, V19, P1046, DOI 10.1016/j.hpb.2017.04.017; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cronin-Fenton Deirdre P, 2011, Clin Epidemiol, V3 Suppl 1, P19, DOI 10.2147/CLEP.S20611; Eloubeidi MA, 2006, AM J SURG, V192, P322, DOI 10.1016/j.amjsurg.2006.02.017; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hagedoorn P, 2018, INT J CANCER, V142, P23, DOI 10.1002/ijc.31031; Kagedan DJ, 2016, CANCER-AM CANCER SOC, V122, P3175, DOI 10.1002/cncr.30148; Kuhn Y, 2010, EJSO-EUR J SURG ONC, V36, P496, DOI 10.1016/j.ejso.2009.08.006; Markossian TW, 2016, AUST J RURAL HEALTH, V24, P73, DOI 10.1111/ajr.12200; Martin HL, 2015, AUST J RURAL HEALTH, V23, P302, DOI 10.1111/ajr.12218; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Raju RS, 2015, CURR ONCOL, V22, pE478, DOI 10.3747/co.22.2653; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sathyamurthy A, 2016, SOUTH MED J, V109, P718, DOI 10.14423/SMJ.0000000000000553; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Storm HH, 1997, DAN MED BULL, V44, P535; Tas F, 2013, INT J CLIN ONCOL, V18, P839, DOI 10.1007/s10147-012-0474-9; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	27	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202486	10.1371/journal.pone.0202486	http://dx.doi.org/10.1371/journal.pone.0202486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114213	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400077
J	Vergara, M; Torres, M; Muller, A; Avello, V; Acevedo, C; Berrios, J; Reyes, JG; Valdez-Cruz, NA; Altamirano, C				Vergara, Mauricio; Torres, Mauro; Mueller, Andrea; Avello, Veronica; Acevedo, Cristian; Berrios, Julio; Reyes, Juan G.; Valdez-Cruz, Norma A.; Altamirano, Claudia			High glucose and low specific cell growth but not mild hypothermia improve specific r-protein productivity in chemostat culture of CHO cells	PLOS ONE			English	Article							HAMSTER OVARY CELLS; INTERFERON-GAMMA PRODUCTION; ANTIBODY-PRODUCTION; DILUTION RATE; TEMPERATURE REDUCTION; RECOMBINANT ANTIBODY; TRANSCRIPTION LEVEL; PROTEOMIC ANALYSIS; MAMMALIAN-CELLS; GENE-EXPRESSION	In the biopharmaceutical sector, Chinese hamster ovary (CHO) cells have become the host of choice to produce recombinant proteins (r-proteins) due to their capacity for correct protein folding, assembly, and posttranslational modification. However, the production of therapeutic r-proteins in CHO cells is expensive and presents insufficient production yields for certain proteins. Effective culture strategies to increase productivity (q(p)) include a high glucose concentration in the medium and mild hypothermia (28 +/- 34 degrees C), but these changes lead to a reduced specific growth rate. To study the individual and combined impacts of glucose concentration, specific growth rate and mild hypothermia on culture performance and cell metabolism, we analyzed chemostat cultures of recombinant human tissue plasminogen activator (rh-tPA)-producing CHO cell lines fed with three glucose concentrations in feeding media (20, 30 and 40 mM), at two dilution rates (0.01 and 0.018 1/h) and two temperatures (33 and 37 degrees C). The results indicated significant changes in cell growth, cell cycle distribution, metabolism, and rh-tPA productivity in response to the varying environmental culture conditions. High glucose feed led to constrained cell growth, increased specific rh-tPA productivity and a higher number of cells in the G2/M phase. Low specific growth rate and temperature (33 degrees C) reduced glucose consumption and lactate production rates. Our findings indicated that a reduced specific growth rate coupled with high feed glucose significantly improves r-protein productivity in CHO cells. We also observed that low temperature significantly reduced q(p), but not cell growth when dilution rate was manipulated, regardless of the glucose concentration or dilution rate. In contrast, we determined that feed glucose concentration and consumption rate were the dominant aspects of the growth and productivity in CHO cells by using multivariate analysis.	[Vergara, Mauricio; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Chem, Valparaiso, Chile; [Avello, Veronica; Acevedo, Cristian] Univ Tecn Federico Santa Maria, Ctr Biotechnol, Valparaiso, Chile; [Acevedo, Cristian] Univ Tecn Federico Santa Maria, Inst Phys, Valparaiso, Chile; [Valdez-Cruz, Norma A.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Ciudad De Mexico, Mexico; [Altamirano, Claudia] CONICYT REG, Reg Ctr Hlth Food Studies CREAS R17A10001, Gore Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria; Universidad Nacional Autonoma de Mexico	Altamirano, C (corresponding author), CONICYT REG, Reg Ctr Hlth Food Studies CREAS R17A10001, Gore Valparaiso, Chile.	claudia.altamirano@pucv.cl	Valdez-Cruz, Norma A./AAH-9584-2020; Acevedo, Cristian A./D-5133-2011	Valdez-Cruz, Norma A./0000-0002-8581-1173; Torres, Mauro/0000-0002-4054-4323; Altamirano, Claudia/0000-0002-6389-086X; Avello, Veronica/0000-0002-5292-8295; Berrios, Julio/0000-0002-6180-0023	Fondo Nacional de Desarrollo Cientifico y Tecnologico [3150373, 1161452]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the 3150373 Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) to MV, and 1161452 Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) to CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; Altamirano C, 2000, BIOTECHNOL PROGR, V16, P69, DOI 10.1021/bp990124j; Altamirano C, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue3-fulltext-2; Avello V, 2017, ELECTRON J BIOTECHN, V27, P55, DOI 10.1016/j.ejbt.2017.03.008; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Bandaranayake AD, 2014, FEBS LETT, V588, P253, DOI 10.1016/j.febslet.2013.11.035; Becerra S, 2012, BIOCHEM ENG J, V60, P1, DOI 10.1016/j.bej.2011.10.003; BEDOYALOPEZ A, 2016, PLOS ONE, V11, DOI DOI 10.1371/J0URNAL.P0NE.0151529; Berrios J, 2011, CHEM ENG SCI, V66, P2431, DOI 10.1016/j.ces.2011.03.011; Berrios J, 2009, BIOTECHNOL LETT, V31, P1493, DOI 10.1007/s10529-009-0050-1; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Burleigh SC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-95; Carvalhal AV, 2003, APPL MICROBIOL BIOT, V63, P164, DOI 10.1007/s00253-003-1385-5; Carvalhal AV, 2003, BIOTECHNOL PROGR, V19, P69, DOI 10.1021/bp0255917; Chen KQ, 2001, BIOTECHNOL BIOENG, V72, P55, DOI 10.1002/1097-0290(20010105)72:1<55::AID-BIT8>3.0.CO;2-4; Chen YH, 2007, ARCH BIOCHEM BIOPHYS, V465, P164, DOI 10.1016/j.abb.2007.05.010; Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D; Cruz HJ, 1999, APPL MICROBIOL BIOT, V51, P579, DOI 10.1007/s002530051435; Darja O, 2016, J BIOTECHNOL, V219, P98, DOI 10.1016/j.jbiotec.2015.12.013; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Fan Y, 2015, BIOTECHNOL BIOENG, V112, P521, DOI 10.1002/bit.25450; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Gowtham YK, 2017, BIOTECHNOL PROGR, V33, P771, DOI 10.1002/btpr.2462; Ha HJ, 2000, KIDNEY INT, V58, pS19, DOI 10.1046/j.1523-1755.2000.07704.x; Ha TK, 2015, PHARM BIOPROCESS, V3, P249, DOI 10.4155/PBP.15.6; Han JJ, 2015, GYNECOL ONCOL, V138, P668, DOI 10.1016/j.ygyno.2015.06.036; Han L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027074; Harwood SM, 2007, KIDNEY INT, V71, P655, DOI 10.1038/sj.ki.5002106; HAYTER PM, 1993, BIOTECHNOL BIOENG, V42, P1077, DOI 10.1002/bit.260420909; HAYTER PM, 1992, BIOTECHNOL BIOENG, V39, P327, DOI 10.1002/bit.260390311; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Huang CM, 2006, DIABETES, V55, P1826, DOI 10.2337/db05-1438; Jan DCH, 1997, BIOTECHNOL BIOENG, V54, P153, DOI 10.1002/(SICI)1097-0290(19970420)54:2<153::AID-BIT7>3.0.CO;2-K; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kochanowski N, 2008, BIOTECHNOL BIOENG, V100, P721, DOI 10.1002/bit.21816; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Krampe B, 2011, BIOTECHNOL BIOENG, V108, P1603, DOI 10.1002/bit.23100; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kumar N, 2007, CYTOTECHNOLOGY, V53, P33, DOI 10.1007/s10616-007-9047-6; Lattenmayer C, 2006, CYTOTECHNOLOGY, V51, P171, DOI 10.1007/s10616-006-9029-0; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee TY, 2015, J CARBOHYD CHEM, V34, P1, DOI 10.1080/07328303.2014.977908; Leelavatcharamas V, 1999, CYTOTECHNOLOGY, V30, P59, DOI 10.1023/A:1008055904642; Lin HH, 2017, J BIOSCI BIOENG, V124, P108, DOI 10.1016/j.jbiosc.2017.02.010; Liu B, 2014, J BIOTECHNOL, V170, P17, DOI 10.1016/j.jbiotec.2013.11.007; Liu ZK, 2015, BIOTECHNOL PROGR, V31, P1026, DOI 10.1002/btpr.2090; Lu SB, 2005, PROCESS BIOCHEM, V40, P1917, DOI 10.1016/j.procbio.2004.07.004; MARTENS DE, 1993, BIOTECHNOL BIOENG, V41, P429, DOI 10.1002/bit.260410406; Meijer J, 1995, J CELL PHYSL, P198; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Morrison J, 2004, PHYSIOL GENOMICS, V17, P271, DOI 10.1152/physiolgenomics.00031.2004; MULUKUTLA BC, 2015, PLOS ONE, V10, DOI DOI 10.1371/J0URNAL.P0NE.0121561; Nyberg GB, 1999, BIOTECHNOL BIOENG, V62, P324, DOI 10.1002/(SICI)1097-0290(19990205)62:3<324::AID-BIT9>3.3.CO;2-3; Omasa T, 2010, BIOPROC BIOSYST ENG, V33, P117, DOI 10.1007/s00449-009-0351-8; ORMEROD MG, 1987, CYTOMETRY, V8, P637, DOI 10.1002/cyto.990080617; Ozturk SS, 1997, BIOTECHNOL BIOENG, V53, P372, DOI 10.1002/(SICI)1097-0290(19970220)53:4<372::AID-BIT3>3.0.CO;2-K; R Core Team, 2014, R A LANGUAGE AND ENV; Reinhart D, 2015, APPL MICROBIOL BIOT, V99, P4645, DOI 10.1007/s00253-015-6514-4; ROBINSON DK, 1991, BIOTECHNOL BIOENG, V38, P972, DOI 10.1002/bit.260380903; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Seo JS, 2013, APPL MICROBIOL BIOT, V97, P5283, DOI 10.1007/s00253-013-4849-2; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Sonna L, 2002, J APPL PHYSIOL, V89, P1253, DOI DOI 10.1152/JAPPLPHYSIOL.00017.2004; Sou SN, 2015, BIOTECHNOL BIOENG, V112, P1165, DOI 10.1002/bit.25524; Szperalski Berthold, 2011, BMC Proc, V5 Suppl 8, pP107, DOI 10.1186/1753-6561-5-S8-P107; Tey BT, 2005, J BIOSCI BIOENG, V100, P303, DOI 10.1263/jbb.100.303; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; VERGARA M, 2014, PLOS ONE, V9, DOI DOI 10.1371/J0URNAL.P0NE.0093865; VERGARA M, 2015, PLOS ONE, V10, DOI DOI 10.1371/J0URNAL.P0NE.0144224; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; YALCIN A, 2014, CANCER METAB, V2, DOI DOI 10.1186/2049-3002-2-S1-05; Yoon SK, 2006, J BIOTECHNOL, V122, P463, DOI 10.1016/j.jbiotec.2005.09.010; Yoon SK, 2005, BIOTECHNOL BIOENG, V89, P345, DOI 10.1002/bit.20353; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Yoon SK, 2003, BIOTECHNOL PROGR, V19, P1383, DOI 10.1021/bp034051m; Yuk IH, 2011, BIOTECHNOL BIOENG, V108, P2600, DOI 10.1002/bit.23218; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; ZIELKE HR, 1984, FED PROC, V43, P121	85	8	8	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202098	10.1371/journal.pone.0202098	http://dx.doi.org/10.1371/journal.pone.0202098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114204	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400042
J	Ning, JF; Ai, SY; Cui, LH				Ning, Jianfeng; Ai, Shaoying; Cui, Lihua			Dicyandiamide has more inhibitory activities on nitrification than thiosulfate	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; 3,4-DIMETHYLPYRAZOLE PHOSPHATE DMPP; AMMONIUM THIOSULFATE; MICROBIAL COMMUNITIES; METHANE EMISSIONS; GRAZED GRASSLAND; UREASE INHIBITOR; CROPPING SYSTEM; CALCIUM CARBIDE; SOIL PROPERTIES	Dicyandiamide (DCD) and thiosulfates are two type of nitrification inhibitors (NIs) that have been widely used in agriculture to improve nitrogen (N) fertilizer use efficiency and mitigate negative effect of N on environment. Little information is available concerning the comparison of the efficacy of DCD and thiosulfate on N transformations in soil. The aim of this study was to compare the effects of DCD and thiosulfate (K2S2O3) on changes of NH4+-N, nitrification inhibition and N recovery in a latosolic red soil. An incubation experiment was conducted with four treatments of control (CK), N, N+DCD, and N+K2S2O3. Soil samples were collected periodically over 50 d to determine concentrations of mineral N, and the amoA gene abundance of ammonia monooxygenase (AMO) for ammonia-oxidizing bacteria (AOB) was estimated by qPCR after 10 d incubation. In the N treatment, 67.8% of the applied N as NH4+-N disappeared from the mineral N pool and only 2.7% and 30.8% of the applied N was accumulated as NO2--N and NO3--N, respectively. Addition of DCD and thiosulfate to the soil prevented NH4+-N disappearance by 63.0% and 13.6%, respectively. DCD suppressed the production of NO2--N by 97.41%, whereas thiosulfate increased accumulation of NO2--N by 14.6%. Application of N along with DCD and thiosulfate inhibited nitrification, respectively, by 72.6% and 33.1%, resulting in the delay of the nitrification process for 30 days and 10 days, respectively. Apparent N recovery in N treatment was 66.2%, which increased by 55.2% and 4.8% by DCD and thiosulfate, respectively. Numbers of AOB amoA gene copy was significantly inhibited by both DCD and thiosulfate, and the stronger inhibition induced by DCD than thiosulfate was recorded. Results indicated that both DCD and thiosulfate were effective inhibitors for NH4+-N oxidation, NO3--N production, mineral N losses and AOB growth. DCD showed a more pronounced effect on nitrification inhibition than thiosulfate.	[Ning, Jianfeng; Cui, Lihua] South China Agr Univ, Coll Nat Resource & Environm, Guangzhou, Guangdong, Peoples R China; [Ning, Jianfeng; Ai, Shaoying] Guangdong Acad Agr Sci, Inst Agr Resources & Environm, Key Lab Plant Nutr & Fertilizer South Reg, Minist Agr,Guangdong Key Lab Nutrient Cycling & F, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Cui, LH (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Guangzhou, Guangdong, Peoples R China.	136860345@qq.com			National Natural Science Foundation of China [41271245]; Engineering Research Center for Wastewater Ecological Treatment and Water-body Remediation of Guangdong Higher Education Institutes [2012gczxA1004]; Project of Science and Technology of Guangdong Province [2014B020206001]; Guangdong Special Fund of Applied Research and Development Project [2016B020240009]; Guangdong Hydraulic Technology Innovation [2015-15]; Project of Guangzhou Technological Innovation [201508020073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Engineering Research Center for Wastewater Ecological Treatment and Water-body Remediation of Guangdong Higher Education Institutes; Project of Science and Technology of Guangdong Province; Guangdong Special Fund of Applied Research and Development Project; Guangdong Hydraulic Technology Innovation; Project of Guangzhou Technological Innovation	This study was supported by the National Natural Science Foundation of China (No. 41271245), the Engineering Research Center for Wastewater Ecological Treatment and Water-body Remediation of Guangdong Higher Education Institutes (No. 2012gczxA1004), the Project of Science and Technology of Guangdong Province (No. 2014B020206001), Guangdong Special Fund of Applied Research and Development Project (No. 2016B020240009), the Guangdong Hydraulic Technology Innovation (No. 2015-15), and Project of Guangzhou Technological Innovation (No. 201508020073).	Abbasi MK, 2013, INT J ENVIRON SCI TE, V10, P961, DOI 10.1007/s13762-013-0225-0; Abbasi MK, 2011, CHEMOSPHERE, V82, P1629, DOI 10.1016/j.chemosphere.2010.11.044; Abbasi MK, 2000, BIOL FERT SOILS, V31, P38, DOI 10.1007/s003740050621; ABBES C, 1994, SOIL BIOL BIOCHEM, V26, P1041, DOI 10.1016/0038-0717(94)90119-8; AMBERGER A, 1989, COMMUN SOIL SCI PLAN, V20, P1933, DOI 10.1080/00103628909368195; Beeckman F, 2018, CURR OPIN BIOTECH, V50, P166, DOI 10.1016/j.copbio.2018.01.014; Cahalan E, 2015, AGR ECOSYST ENVIRON, V199, P339, DOI 10.1016/j.agee.2014.09.008; Cai ZJ, 2018, SCI TOTAL ENVIRON, V618, P243, DOI 10.1016/j.scitotenv.2017.10.274; Chaves B, 2006, BIOL FERT SOILS, V43, P62, DOI 10.1007/s00374-005-0061-6; Chen QH, 2015, APPL MICROBIOL BIOT, V99, P477, DOI 10.1007/s00253-014-6026-7; Cui M, 2011, J SOIL SEDIMENT, V11, P722, DOI 10.1007/s11368-011-0357-0; Di HJ, 2006, BIOL FERT SOILS, V42, P472, DOI 10.1007/s00374-005-0038-5; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2007, NUTR CYCL AGROECOSYS, V79, P281, DOI 10.1007/s10705-007-9115-5; Di HJ, 2016, J SOIL SEDIMENT, V16, P1401, DOI 10.1007/s11368-016-1403-8; Di HJ, 2011, J SOIL SEDIMENT, V11, P432, DOI [10.1007/s11368-011-0372-1, 10.1007/s11368-010-0318-z]; Dong D, 2018, SOIL TILL RES, V180, P82, DOI 10.1016/j.still.2018.02.010; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; FRENEY JR, 1992, FERT RES, V32, P1, DOI 10.1007/BF01054388; Gilsanz C, 2016, AGR ECOSYST ENVIRON, V216, P1, DOI 10.1016/j.agee.2015.09.030; GOOS RJ, 1985, SOIL SCI SOC AM J, V49, P232, DOI 10.2136/sssaj1985.03615995004900010047x; GOOS RJ, 1992, COMMUN SOIL SCI PLAN, V23, P1105, DOI 10.1080/00103629209368652; GOULD WD, 1973, PLANT SOIL, V38, P393, DOI 10.1007/BF00779021; GRAZIANO PL, 1990, FERT RES, V24, P111, DOI 10.1007/BF01073229; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Harris RH, 2013, NUTR CYCL AGROECOSYS, V95, P269, DOI 10.1007/s10705-013-9562-0; Isobe K, 2012, SOIL BIOL BIOCHEM, V52, P61, DOI 10.1016/j.soilbio.2012.04.006; JANZEN HH, 1986, SOIL SCI SOC AM J, V50, P803, DOI 10.2136/sssaj1986.03615995005000030047x; Kelliher FM, 2008, SOIL BIOL BIOCHEM, V40, P1878, DOI 10.1016/j.soilbio.2008.03.013; Kelling KA, 2011, AM J POTATO RES, V88, P459, DOI 10.1007/s12230-011-9212-5; Kumar U, 2000, BIOL FERT SOILS, V32, P474, DOI 10.1007/s003740000278; LEFAOU A, 1990, FEMS MICROBIOL LETT, V75, P351, DOI 10.1016/S0168-6445(05)80005-1; Li YY, 2018, SOIL BIOL BIOCHEM, V116, P290, DOI 10.1016/j.soilbio.2017.10.023; Liu G, 2016, ENVIRON SCI POLLUT R, V23, P17426, DOI 10.1007/s11356-016-6936-2; Luo J, 2015, BIOL FERT SOILS, V51, P453, DOI 10.1007/s00374-015-0993-4; Ma L, 2015, BIOL FERT SOILS, V51, P563, DOI 10.1007/s00374-015-1001-8; Macadam XMB, 2003, J PLANT PHYSIOL, V160, P1517, DOI 10.1078/0176-1617-01006; MAGALHAES AMT, 1987, FERT RES, V11, P161, DOI 10.1007/BF01051059; Mazzetto AM, 2015, NUTR CYCL AGROECOSYS, V101, P83, DOI 10.1007/s10705-014-9663-4; McCarty GW, 1999, BIOL FERT SOILS, V29, P1, DOI 10.1007/s003740050518; MCCARTY GW, 1990, FERT RES, V24, P135, DOI 10.1007/BF01073581; MCCARTY GW, 1989, BIOL FERT SOILS, V8, P204, DOI 10.1007/BF00266480; McGeough KL, 2016, SOIL BIOL BIOCHEM, V94, P222, DOI 10.1016/j.soilbio.2015.11.017; MINAMI K, 1981, SOIL SCI PLANT NUTR, V27, P541, DOI 10.1080/00380768.1981.10431309; O'Callaghan M, 2010, SOIL BIOL BIOCHEM, V42, P1425, DOI 10.1016/j.soilbio.2010.05.003; OSINAME O, 1983, TROP AGRIC, V60, P211; RAJBANSHI SS, 1992, NATURWISSENSCHAFTEN, V79, P26, DOI 10.1007/BF01132276; ROBERTSON LA, 1989, A VAN LEEUW J MICROB, V56, P301, DOI 10.1007/BF00443744; Saad OALO, 1996, BIOL FERT SOILS, V21, P152, DOI 10.1007/BF00335927; SALLADE YE, 1992, PLANT SOIL, V147, P283, DOI 10.1007/BF00029080; Sharma SN, 1996, FERT RES, V44, P169, DOI 10.1007/BF00750923; Shen QR, 2003, CHEMOSPHERE, V50, P747, DOI 10.1016/S0045-6535(02)00215-1; Shen TL, 2013, FEMS MICROBIOL LETT, V344, P121, DOI 10.1111/1574-6968.12164; Shi YF, 2015, ACTA AGR SCAND B-S P, V65, P271, DOI 10.1080/09064710.2015.1004357; Subbarao GV, 2006, CRIT REV PLANT SCI, V25, P303, DOI 10.1080/07352680600794232; Tian D, 2017, SCI TOTAL ENVIRON, V598, P87, DOI 10.1016/j.scitotenv.2017.03.220; TOUCHTON JT, 1985, J FERT ISSUES, V2, P32; VILSMEIER K, 1987, FERT RES, V12, P255, DOI 10.1007/BF01315109; Weiske A, 2001, NUTR CYCL AGROECOSYS, V60, P57, DOI 10.1023/A:1012669500547; Xu XK, 2001, BIOL FERT SOILS, V34, P286; ZACHERL B, 1990, FERT RES, V22, P37, DOI 10.1007/BF01054805; Zaman M, 2009, SOIL BIOL BIOCHEM, V41, P1270, DOI 10.1016/j.soilbio.2009.03.011; Zhong W, 2016, SOIL BIOL BIOCHEM, V41, P1270	63	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0200598	10.1371/journal.pone.0200598	http://dx.doi.org/10.1371/journal.pone.0200598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106965	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800001
J	White, AE; Lutz, DA; Howarth, RB; Soto, JR				White, Alisa E.; Lutz, David A.; Howarth, Richard B.; Soto, Jose R.			Small-scale forestry and carbon offset markets: An empirical study of Vermont Current Use forest landowner willingness to accept carbon credit programs	PLOS ONE			English	Article							CLIMATE-CHANGE	This study investigates the preferences of small forest landowners regarding forest carbon credit programs while documenting characteristics of potentially successful frameworks. We designed hypothetical carbon credit programs with aggregated carbon offset projects and requirements of existing voluntary and compliance protocols in mind. We administered a mail survey to 992 forest landowners in Vermont's Current Use Program utilizing best-worst choice, a novel preference elicitation technique, to elicit their preferences about these programs. We found that small forest landowners see revenue as the most important factor in a carbon credit program and the duration of the program as the least important factor. Landowners reported that shorter program duration, higher revenue, and lower withdrawal penalties positively impact their willingness to accept forest carbon credit programs. Notably, our study includes carbon credit program implementer as a key program attribute, allowing us to quantify landowners' tradeoffs between non-profit, for-profit, and government organizations. Overall, we found that landowners significantly prefer working with a non-profit organization. Based on monetary estimates of willingness-to-accept compensation, our results suggest that aggregated forest carbon offset projects incorporating small forest landowners could be piloted successfully in Vermont by non-profit organizations while maintaining relatively strict guidelines of existing carbon offset protocols.	[White, Alisa E.; Lutz, David A.; Howarth, Richard B.] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; [Soto, Jose R.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	Dartmouth College; University of Arizona	White, AE (corresponding author), Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA.	alise.e.white@gmail.com		Soto, Jose/0000-0001-8971-1623; Lutz, David/0000-0001-8780-7576	Dartmouth College; Dartmouth Outdoor Programs Office Northern Studies Grant; Nelson A. Rockefeller Center's Senior Honors Thesis Grant; Environmental Studies Program	Dartmouth College; Dartmouth Outdoor Programs Office Northern Studies Grant; Nelson A. Rockefeller Center's Senior Honors Thesis Grant; Environmental Studies Program	The funding for this study was provided entirely by Dartmouth College. The funding amount was $5,000 and came from four different funding sources within the College. The majority of the funding, $3,500, was provided by the Dartmouth Outdoor Programs Office Northern Studies Grant. The remaining funds were provided by the Nelson A. Rockefeller Center's Senior Honors Thesis Grant, Undergraduate Advising and Research, and the Environmental Studies Program. All funding was received by author Alisa E. White. The Northern Studies Grant website is here: http://outdoors.dartmouth.edu/doc/funding/northstudy.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Beane J, 2012, SELLING FOREST CARBO; Broussard SR, 2006, UNDERSTANDING YOUR P; Butler BJ, 2004, J FOREST, V102, P4; Caldwell BT, 2014, J FOREST, V112, P60, DOI 10.5849/jof.13-024; Cashore B, 2002, GOVERNANCE, V15, P503, DOI 10.1111/1468-0491.00199; Charnley S, 2010, SMALL-SCALE FOR, V9, P445, DOI 10.1007/s11842-010-9135-x; Climate Action Reserve, 2010, GUID AGGR FOR PROJ V; Coast J, 2006, BRIT J DERMATOL, V155, P387, DOI 10.1111/j.1365-2133.2006.07328.x; Department of Forests, 2017, PARKS R US VAL APPR; Diamant A, 2010, AGGREGATION GREENHOU; Dickinson BJ, 2012, J FOREST ECON, V18, P36, DOI 10.1016/j.jfe.2011.06.002; Dymond CC, 2016, BIOGEOSCIENCES, V13, P1933, DOI 10.5194/bg-13-1933-2016; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; FINN A, 1992, J PUBLIC POLICY MARK, V11, P12, DOI 10.1177/074391569201100202; Fletcher LS, 2009, FOREST LANDOWNERS WI; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Flynn TN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-76; Forest Products Laboratory, 2010, WOOD HDB WOOD ENG MA; Galik CS, 2009, FOREST ECOL MANAG, V257, P2209, DOI 10.1016/j.foreco.2009.03.017; Greene W.H., 2010, MODELING ORDERED CHO, DOI [10.1017/CBO9780511845062, DOI 10.1017/CBO9780511845062]; Habesland DE, 2016, FOREST POLICY ECON, V70, P30, DOI 10.1016/j.forpol.2016.05.017; Hess S., 2014, HDB CHOICE MODELLING; Jacobson MG, 2009, SOUTH J APPL FOR, V33, P7; Janota JJ, 2008, FOREST POLICY ECON, V10, P89, DOI 10.1016/j.forpol.2007.06.001; Jenkins D, 2015, FOR LANDOWNERS, V74, P37; Karsenty A, 2014, ENVIRON SCI POLICY, V35, P20, DOI 10.1016/j.envsci.2012.08.013; Kelly EC, 2016, GEOFORUM, V75, P99, DOI 10.1016/j.geoforum.2016.06.021; Kerchner CD, 2015, FOREST POLICY ECON, V50, P70, DOI 10.1016/j.forpol.2014.09.005; Kilgore MA, INFLUENCE FINANCIAL; Loureiro ML, 2012, J FOREST ECON, V18, P381, DOI 10.1016/j.jfe.2012.06.006; Louviere J.J., 2000, ANAL APPL, DOI [10.1002/jae.701, DOI 10.1002/JAE.701]; Louviere Jordan J, 2015, BEST WORST SCALING T; Ma Z, 2014, LAND USE POLICY, V36, P492, DOI 10.1016/j.landusepol.2013.09.016; Ma Z, 2012, LAND USE POLICY, V29, P53, DOI 10.1016/j.landusepol.2011.05.004; Markowski-Lindsay M, 2011, ECOL ECON, V71, P180, DOI 10.1016/j.ecolecon.2011.08.027; Merenlender AM, 2004, LAND TRUSTS CONSERVA, P65, DOI [10.1111/j.1523-1739.2004.00401.x, DOI 10.1111/J.1523-1739.2004.00401.X]; Miller KA, 2012, FOREST POLICY ECON, V25, P113, DOI 10.1016/j.forpol.2012.09.009; Morin R. S., 2012, FORESTS VERMONT NEW; Nunez F, 2006, ASSEMBLY BILL 32 GLO; Rao VR, 2014, THEORY DESIGN CONJOI, P37; Rodriguez G, 2003, STATA J, V3, P32, DOI 10.1177/1536867X0300300102; Ruseva T, 2017, J ENVIRON MANAGE, V198, P277, DOI 10.1016/j.jenvman.2017.04.082; Schmitz MB, 2016, GLOB ENV POLIT, V16; Simpson H, 2010, ENV CREDIT MARKETING; Smyth JoleneD., 2008, INTERNET MAIL MIXED; Soto JR, 2016, FOREST POLICY ECON, V63, P35, DOI 10.1016/j.forpol.2015.12.004; von Stein J, 2008, J CONFLICT RESOLUT, V52, P243, DOI 10.1177/0022002707313692; York AM, 2006, LAND USE POLICY, V23, P542, DOI 10.1016/j.landusepol.2005.04.001	48	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201967	10.1371/journal.pone.0201967	http://dx.doi.org/10.1371/journal.pone.0201967			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ4SC	30106977	gold, Green Published, Green Submitted			2022-12-26	WOS:000441662800020
J	Beier, RC; Harvey, RB; Hernandez, CA; Hume, ME; Andrews, K; Droleskey, RE; Davidson, MK; Bodeis-Jones, S; Young, S; Duke, SE; Anderson, RC; Crippen, TL; Poole, TL; Nisbet, DJ				Beier, Ross C.; Harvey, Roger B.; Hernandez, Charles A.; Hume, Michael E.; Andrews, Kathleen; Droleskey, Robert E.; Davidson, Maureen K.; Bodeis-Jones, Sonia; Young, Shenia; Duke, Sara E.; Anderson, Robin C.; Crippen, Tawni L.; Poole, Toni L.; Nisbet, David J.			Interactions of organic acids with Campylobacter coli from swine	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUSCEPTIBILITY PROFILES; JEJUNI; STRAINS; DISINFECTANT; PREVALENCE; RESISTANCE; PH; PATHOGENS; CARCASSES	Campylobacter coli is a bacterial species that is a major cause of diarrheal disease world-wide, and Campylobacter spp. are among the top 5 foodborne pathogens in the United States. During food production organic acids (OAs) are often used to remove bacteria from animal carcasses. The interactions of six OAs with 111 C. coli strains obtained from swine and retail pork chops were studied by determining the molar minimum inhibitory concentrations (MIC(M)s) of the C. coli strains, and the pH at the MIC(M)s. The Henderson-Hasselbalch equation was used to calculate the concentrations of the undissociated and dissociated OAs at the MIC(M)s of the C. coli strains. The results for the 111 different C. coli strains obtained from different locations were treated as a single group for each OA since many of the C. coli strains behaved similarly to each different OA. Inhibition of C. coli was not dependent on pH or on the undissociated OA species, but C. coli inhibition correlated with the dissociated OA species. Therefore, if the concentration of the dissociated OAs decreases from optimum, one may then expect that C. coli bacteria would escape disinfection. The concentration of the dissociated OA should be carefully controlled in a carcass wash. We suggest maintaining a concentration of the dissociated acetic, butyric, citric, formic, lactic and propionic acids at 29, 23,11,35,22 and 25 mM, respectively, when using a carcass wash with these OAs to remove C. coli bacteria. However, due to C. coli utilization of acetate, formate, lactate and propionate, these four OAs may not be the best choice to use for a carcass wash to remove C. coli contamination. Of the six OAs, citric acid was the most efficient at inhibiting C. coli.	[Beier, Ross C.; Harvey, Roger B.; Hernandez, Charles A.; Hume, Michael E.; Andrews, Kathleen; Droleskey, Robert E.; Duke, Sara E.; Anderson, Robin C.; Crippen, Tawni L.; Poole, Toni L.; Nisbet, David J.] ARS, USDA, Southern Plains Agr Res Ctr, Food & Feed Safety Res Unit, College Stn, TX 77840 USA; [Davidson, Maureen K.; Bodeis-Jones, Sonia; Young, Shenia] USDA, Off Res, Ctr Vet Med, Laurel, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Beier, RC (corresponding author), ARS, USDA, Southern Plains Agr Res Ctr, Food & Feed Safety Res Unit, College Stn, TX 77840 USA.	ross.beier@ars.usda.gov		Beier, Ross/0000-0002-3445-1008; Poole, Toni/0000-0003-0882-0209; Crippen, Tawni/0000-0001-5129-2371	USDA, Agricultural Research Service	USDA, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by the USDA, Agricultural Research Service.; This work was funded by the USDA, Agricultural Research Service. Mention of trade names, proprietary products or specific equipment is solely for the purpose of providing specific information and does not constitute a guarantee, warranty or endorsement by the U.S. Department of Agriculture or by the U.S. Food and Drug Administration and does not imply its approval to the exclusion of other products that may be suitable. Additionally, the views expressed in this article are those of the authors and do not necessarily reflect the official policy of the U.S. Department of Agriculture, the U.S. Food and Drug Administration or the U.S. Government.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; [Anonymous], CAMPYLOBACTER; [Anonymous], NARMS IS CAMP COL FD; [Anonymous], J FOOD CHEM NANOTECH; [Anonymous], HENDERSON HASSELBALC; Baer AA, 2013, COMPR REV FOOD SCI F, V12, P183, DOI 10.1111/1541-4337.12001; Bearson BL, 2009, MICROBIOL-SGM, V155, P805, DOI 10.1099/mic.0.022905-0; Beier RC, 2015, J APPL MICROBIOL, V118, P326, DOI 10.1111/jam.12707; Beier RC, 2016, J FOOD PROTECT, V79, P1355, DOI 10.4315/0362-028X.JFP-15-600; Beier RC, 2013, J FOOD PROTECT, V76, P6, DOI 10.4315/0362-028X.JFP-12-253; Blackburn CD, 2009, WOODHEAD PUBL FOOD S, P718, DOI 10.1533/9781845696337.2.718; BLOCHER JC, 1982, J FOOD SCI, V47, P2028, DOI 10.1111/j.1365-2621.1982.tb12938.x; Castillo A, 2001, J FOOD PROTECT, V64, P58, DOI 10.4315/0362-028X-64.1.58; CDC (Centers for Disease Control and Prevention), 2011, BURD FOODB ILLN FIND; CDC (Centers for Disease Control and Prevention), 2017, CAMP SALM LED BACT F; Clark M., 2013, FOODBORNE ILLNESS OU; Clinical and Laboratory Standards Institute (CLSI), 2010, M45A2 CLSI, V30, pM45; Departments of Pennsylvania State University Texas Tech University and Washington State University, 2005, ANT SPRAY TREATM RED; EFSA, 2016, EFSA J, V14, DOI [10.2903/j.efsa.2016.4375, 10.2903/j.efsa.2016.4584]; ELHARRIF Z, 1986, CURR MICROBIOL, V13, P117, DOI 10.1007/BF01568505; EPLING LK, 1993, J FOOD PROTECT, V56, P536, DOI 10.4315/0362-028X-56.6.536; Epps SVR, 2013, INT J ENV RES PUB HE, V10, P6292, DOI 10.3390/ijerph10126292; Gao C, 2012, J BACTERIOL, V194, P4751, DOI 10.1128/JB.00943-12; Gao C, 2012, J BACTERIOL, V194, P2687, DOI 10.1128/JB.06579-11; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Gillespie IA, 2009, EMERG INFECT DIS, V15, P2046, DOI 10.3201/eid1512.090280; Gorman R, 2004, LETT APPL MICROBIOL, V38, P306, DOI 10.1111/j.1472-765X.2004.01490.x; Harvey RB, 1999, ADV EXP MED BIOL, V473, P237; HEBERT GA, 1984, J CLIN MICROBIOL, V20, P138; Kempf I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00955; Large TM, 2005, APPL ENVIRON MICROB, V71, P2493, DOI 10.1128/AEM.71.5.2493-2500.2005; Leeson S., 2007, CAB REV PERSPECTIVES, V2; Mukherjee P, 2013, EMERG INFECT DIS, V19, P1155, DOI 10.3201/eid1907.121278; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773; Raftari M, 2009, Open Microbiol J, V3, P121, DOI 10.2174/1874285800903010121; Raftari M, 2011, AFR J MICROBIOL RES, V5, P3113; Ray B, 1992, FOOD BIOPRESERVATIVE, P103; Reynolds Jr AE, 2005, UTILIZATION SPRAY WA; Ronveaux O, 2000, ACTA CLIN BELG, V55, P307; ROOP RM, 1984, CAN J MICROBIOL, V30, P938, DOI 10.1139/m84-147; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schuppers ME, 2005, PREV VET MED, V69, P189, DOI 10.1016/j.prevetmed.2005.02.004; Shaheen BW, 2007, J FOOD SAFETY, V27, P326, DOI 10.1111/j.1745-4565.2007.00083.x; Sifre E, 2015, J MICROBIOL METH, V119, P206, DOI 10.1016/j.mimet.2015.10.018; SOFOS JN, 1981, J FOOD PROTECT, V44, P614, DOI 10.4315/0362-028X-44.8.614; Tam CC, 2003, J INFECTION, V47, P28, DOI 10.1016/S0163-4453(03)00042-2; Wachsmuth IK, 1997, FEMS IMMUNOL MED MIC, V18, P233, DOI 10.1016/S0928-8244(97)00053-9; Wagley S, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0262-y; Wardak S, 2008, EUROSURVEILLANCE, V13, P1; WHO, 2016, MED CTR CAMP FACT SH	53	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202100	10.1371/journal.pone.0202100	http://dx.doi.org/10.1371/journal.pone.0202100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096155	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500049
J	Hartmann-Boyce, J; Aveyard, P; Piernas, C; Koshiaris, C; Velardo, C; Salvi, D; Jebb, SA				Hartmann-Boyce, Jamie; Aveyard, Paul; Piernas, Carmen; Koshiaris, Constantinos; Velardo, Carmelo; Salvi, Dario; Jebb, Susan A.			Cognitive and behavioural strategies for weight management in overweight adults: Results from the Oxford Food and Activity Behaviours (OxFAB) cohort study	PLOS ONE			English	Article							CLINICAL EFFECTIVENESS; CONTROLLED-TRIALS; LOSS MAINTENANCE; METAANALYSIS; INTERVENTIONS; PROGRAMS; TAXONOMY; VALIDITY; DIET	Background Though many overweight and obese adults attempt to lose weight without formal support, little is known about the strategies used in self-directed weight loss attempts. We set out to assess cognitive and behavioural strategies for weight loss and their associations with weight change. Methods Prospective, web-based cohort study of overweight UK adults (BMI <= 25kg/m(2)) trying to lose weight through behaviour change. Strategy use was assessed using the OxFAB questionnaire and evaluated (1) at the domain level, (2) through exploratory factor analysis, and (3) in a model of strategies deemed a priori to be "essential" to weight management. Associations with weight change at 3 months were tested using linear regression. Results 486 participants answered all questions; 194 reported weight at baseline and at 3 months (mean weight change -3.3kg (SD 4.1)). Greater weight loss was significantly associated with the motivational support domain (-2.4kg, 95% CI -4.4 to -0.4), dietary impulse control (from factor analysis) (-0.6kg, 95% Cl -1.1 to -0.03), and weight loss planning and monitoring (from factor analysis) (-1.3kg, 95% Cl -2.0 to -0.5). Higher scores in the model of essential behavioural strategies were significantly associated with greater weight loss (compared to participants using 6 or fewer of the 9 strategies, using 7 or more of the 9 strategies was associated with a 2.13kg greater weight loss (SE 0.58, p<0.001)). Conclusions Despite heterogeneity in the strategies employed for weight loss, coherent patterns of behaviours emerged for individual participants, some of which were associated with greater weight loss, including strategies relating to dietary impulse control, weight loss planning and monitoring, motivational support, information seeking and self-monitoring. Trials could test the effect of promoting use of these patterns on weight loss.	[Hartmann-Boyce, Jamie; Aveyard, Paul; Piernas, Carmen; Koshiaris, Constantinos; Jebb, Susan A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Radcliffe Primary Care Bldg, Oxford, England; [Velardo, Carmelo; Salvi, Dario] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Old Rd Campus Res Bldg, Oxford, England	University of Oxford; University of Oxford	Hartmann-Boyce, J (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Radcliffe Primary Care Bldg, Oxford, England.	Jamie.hartmann-boyce@phc.ox.ac.uk	Koshiaris, Constantinos/R-1263-2019; Piernas, Carmen/AAT-8276-2020; Salvi, Dario/E-5754-2012	Piernas, Carmen/0000-0002-7536-922X; Salvi, Dario/0000-0002-9203-1124; Hartmann-Boyce, Jamie/0000-0001-9898-3049; Aveyard, Paul/0000-0002-1802-4217; Jebb, Susan/0000-0001-9190-2920	National Institute for Health Research School for Primary Care Research (NIHR SPCR); NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health NHS Foundation Trust (NIHR CLAHRC Oxford); NIHR SPCR; NIHR CLAHRC Oxford; NIHR Oxford Biomedical Research Centre (BRC); University of Oxford; UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Department of Health under UK Clinical Research Collaboration	National Institute for Health Research School for Primary Care Research (NIHR SPCR); NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health NHS Foundation Trust (NIHR CLAHRC Oxford); NIHR SPCR; NIHR CLAHRC Oxford; NIHR Oxford Biomedical Research Centre (BRC); University of Oxford; UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health under UK Clinical Research Collaboration	This research was funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR, https://www.spcr.nihr.ac.uk/) and NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health NHS Foundation Trust (NIHR CLAHRC Oxford, https://www.phc.ox.ac.uk/news/clarhc). The views expressed in this research are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. JHB received support from the NIHR SPCR. CP receives support from the NIHR CLAHRC Oxford. DS and CV receive funding from the NIHR Oxford Biomedical Research Centre (BRC). The University of Oxford also provided funding. PA is funded by The UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the Department of Health, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brown A., 2013, AM DESIRE SHED POUND; Butryn ML, 2007, OBESITY, V15, P3091, DOI 10.1038/oby.2007.368; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220; Hartmann-Boyce J, 2014, OBES REV, V15, P598, DOI 10.1111/obr.12165; Hartmann-Boyce J, 2016, OBESITY, V24, P314, DOI 10.1002/oby.21341; Hartmann-Boyce J, 2015, AM J PUBLIC HEALTH, V105, pE43, DOI 10.2105/AJPH.2014.302389; Harvey-Berino J, 2011, TELEMED E-HEALTH, V17, P696, DOI 10.1089/tmj.2011.0032; Johns DJ, 2014, J ACAD NUTR DIET, V114, P1557, DOI 10.1016/j.jand.2014.07.005; Kruger J, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-17; Lassale C, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2575; Loveman E, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15020; McGuire MT, 1999, OBES RES, V7, P334, DOI 10.1002/j.1550-8528.1999.tb00416.x; McGuire MT, 1998, INT J OBESITY, V22, P572, DOI 10.1038/sj.ijo.0800627; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Parretti HM, 2016, OBES REV, V17, P225, DOI 10.1111/obr.12366; Piernas C, 2016, INT J OBESITY, V40, P1754, DOI 10.1038/ijo.2016.141; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Santos I, 2017, OBES REV, V18, P32, DOI 10.1111/obr.12466; Stata, 2009, STAT STAT SOFTW REL; Stubbs J, 2011, OBES REV, V12, P688, DOI 10.1111/j.1467-789X.2011.00883.x; van Beurden S, 2016, HLTH PSYCHOL; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	28	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202072	10.1371/journal.pone.0202072	http://dx.doi.org/10.1371/journal.pone.0202072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ0KU	30096203	Green Submitted, gold, Green Published			2022-12-26	WOS:000441308500048
J	Massaquoi, TA; Burke, RM; Yang, G; Lakoh, S; Sevalie, S; Li, B; Jia, HJ; Huang, L; Deen, GF; Beynon, F; Sahr, F				Massaquoi, Thomas A.; Burke, Rachael M.; Yang, Guang; Lakoh, Suliaman; Sevalie, Stephen; Li, Bo; Jia, Hongjun; Huang, Lei; Deen, Gibrilla F.; Beynon, Fenella; Sahr, Foday			Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SURFACE-ANTIGEN; INFECTIONS; GAMBIA; HBC	Introduction Hepatitis B is a serious public health problem across sub-Saharan Africa. Sierra Leone has no national hepatitis B strategy plan or high quality estimates of prevalence. Healthcare workers are perceived as an at-risk group for hepatitis B. We assessed the prevalence of hepatitis B among healthcare workers at two hospital sites in Freetown, Sierra Leone. Methods In October 2017, healthcare workers were offered voluntary testing for hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), hepatitis B core antibody (antiHBc), hepatitis B e antigen (HBeAg) and hepatitis B e antibody (anti-HBe) using rapid lateral flow assay for all samples, followed by Enzyme Immunosorbent Assay to confirm positive results. Participants completed a questionnaire about knowledge, attitudes and practices concerning hepatitis B. HBsAg positive participants were invited to a clinic for further assessment. Results Overall, 447 participants were tested for hepatitis B. Most (90.6%, 405/447) participants were nurses, 72.3% (323/447) were female and 71.6% (320/447) were 30 years or older. The prevalence of chronic hepatitis B (HBsAg positivity) was 8.7% (39/447, 95% CI 6.311.7%). There was no significant difference in prevalence by sex, age group, site of work or type of job. None of the 66.7% (26/39) of participants with chronic hepatitis B who attended the clinic met the 2015 WHO criteria to start treatment for hepatitis B on the basis of cirrhosis. Most participants (96.9% 432 / 446) stated that they were worried about their risk of hepatitis B at work. Conclusions Hepatitis B is highly prevalent among healthcare workers in Sierra Leone. It is unclear whether this reflects high community prevalence or is due to occupational risk. No participants with chronic hepatitis B needed to start treatment. In order to achieve the WHO target of elimination of viral hepatitis by 2030, introduction of birth dose vaccine for infants and catch-up vaccines for healthcare workers and healthcare students, together with a national hepatitis B screen and treat programme is advisable for Sierra Leone.	[Massaquoi, Thomas A.; Sevalie, Stephen; Sahr, Foday] 34 Mil Hosp, Freetown, Sierra Leone; [Burke, Rachael M.; Beynon, Fenella] Kings Coll London, Fac Life Sci & Med, Ctr Global Hlth & Hlth Partnerships, London, England; [Burke, Rachael M.; Beynon, Fenella] Connaught Hosp, Kings Sierra Leone Partnership, Freetown, Sierra Leone; [Yang, Guang; Li, Bo; Jia, Hongjun; Huang, Lei] 302 Mil Hosp, Chinese Mil Med Expert Grp Sierra Leone, Beijing, Peoples R China; [Lakoh, Suliaman; Deen, Gibrilla F.] Univ Sierra Leone, Connaught Hosp, Teaching Hosp Complex, Freetown, Sierra Leone	University of London; King's College London; Connaught Hospital; Fifth Medical Center of Chinese PLA General Hospital; Connaught Hospital	Massaquoi, TA (corresponding author), 34 Mil Hosp, Freetown, Sierra Leone.; Huang, L (corresponding author), 302 Mil Hosp, Chinese Mil Med Expert Grp Sierra Leone, Beijing, Peoples R China.	thomassaq@gmail.com; huangleiwa@sina.com	lei, huang/AFS-7785-2022	Burke, Rachael/0000-0002-2156-5030; Li, Bo/0000-0002-5510-1912; Beynon, Fenella/0000-0002-4758-8847; Massaquoi, Thomas/0000-0002-7829-7620	National Nature Science Foundation China grant [81772185]; European and Developing Countries Clinical Trials Partnership (EDCTP) grant for research capacity building [EDCTP-CSA-Ebola-360]; EDCTP grant; National Nature Science Foundation China	National Nature Science Foundation China grant(National Natural Science Foundation of China (NSFC)); European and Developing Countries Clinical Trials Partnership (EDCTP) grant for research capacity building; EDCTP grant; National Nature Science Foundation China(National Natural Science Foundation of China (NSFC))	Hepatitis B test kits were provided by Chinese Military Medical Expert Group in Sierra Leone who are funded by National Nature Science Foundation China grant (81772185). RB is funded by a European and Developing Countries Clinical Trials Partnership (EDCTP) grant for research capacity building (EDCTP-CSA-Ebola-360), held by Kings College London. Some investigators time (for authors TAM, SS, GD and FB) was funded in part by the same EDCTP grant. The National Nature Science Foundation China was indirectly responsible for the decision concerning the brand of test kits used (test kits were funded "in-kind", based on what was available in Sierra Leone and in use for routine work in their laboratory). Other than this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdela Abdnur, 2016, BMC Res Notes, V9, P410, DOI 10.1186/s13104-016-2216-y; Aberra H, 2017, BMC INFECT DIS, P1; Allain JP, 2016, NAT REV GASTRO HEPAT, V13, P643, DOI 10.1038/nrgastro.2016.138; [Anonymous], 2017, WHO GLOB HEP REP 201; Ansumana Rashid, 2018, BMC Res Notes, V11, P113, DOI 10.1186/s13104-018-3218-8; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Desalegn H, 2017, LIVER INT, V37, P1461, DOI 10.1111/liv.13393; Garcia-Tardon N, 2017, LANCET, V390, P1485, DOI 10.1016/S0140-6736(17)32390-5; Gibney KB, 2008, J MED VIROL, V80, P1565, DOI 10.1002/jmv.21267; Grob P, 2000, J MED VIROL, V62, P450, DOI 10.1002/1096-9071(200012)62:4&lt;450::AID-JMV9&gt;3.0.CO;2-Y; Hodges M, 1998, West Afr J Med, V17, P36; Kang SY, 2010, J MED VIROL, V82, P1508, DOI 10.1002/jmv.21862; Lee R, 2009, J HOSP INFECT, V72, P285, DOI 10.1016/j.jhin.2009.03.016; Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9; Lewis JD, 2015, WORLD J HEPATOL, V7, P488, DOI 10.4254/wjh.v7.i3.488; Liu C, 2014, J VIROL METHODS, V196, P174, DOI 10.1016/j.jviromet.2013.10.039; Nayagam S, 2016, LANCET GLOB HEALTH, V4, pE568, DOI 10.1016/S2214-109X(16)30101-2; Rothe C, 2013, J HOSP INFECT, V85, P257, DOI 10.1016/j.jhin.2013.09.008; Sondlane TH, 2016, VACCINE, V34, P3835, DOI 10.1016/j.vaccine.2016.05.040; Spearman CW, 2017, LANCET GASTROENTEROL, V2, P900, DOI 10.1016/S2468-1253(17)30295-9; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Tramuto F, 2012, J COMMUN HEALTH, V37, P547, DOI 10.1007/s10900-011-9477-0; WHO, UNICEF VACC PREV DIS; Witt MD, 2013, CLIN INFECT DIS, V56, P606, DOI 10.1093/cid/cis908; Wurie IM, 2005, W AFRICAN J MED, V24, P1, DOI [10.4314/wajm.v24i1.28156, DOI 10.4314/WAJM.V24I1.28156]	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201820	10.1371/journal.pone.0201820	http://dx.doi.org/10.1371/journal.pone.0201820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096162	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500029
J	Yu, DY; Huang, P; Chen, Y; Lin, YW; Akutse, KS; Lan, YY; Wei, H				Yu, Deyi; Huang, Peng; Chen, Yong; Lin, Yongwen; Akutse, Komivi Senyo; Lan, Yanyang; Wei, Hui			Effects of flower thrips (Thysanoptera: Thripidae) on nutritional quality of banana (Zingiberales: Musaceae) buds	PLOS ONE			English	Article							RESISTANT CULTIVARS; INSECT; PLANT; STRESS; INJURY; PEST	The abundance of banana flower thrips (Thrips hawaiiensis Morgan) in a banana (Musa acuminata Colla "Williams" cultivar) plantation was investigated using yellow sticky traps (29.70 cm x 21.00 cm) in 2015. Banana flower thrips occurred throughout the year with monthly variation, and the maximum occurrence was observed in October and November during the bud burst (73.80 +/- 6.32 adults/trap) and young fruit (70.06 +/- 5.69 adults/trap) periods. The damage rates were as follows: interior flowers >3(rd)-layer flowers > 2(nd)-layer flowers > 1 (st)-layer flowers > young fruits. This result indicates that thrips migrated to lower bracts, young fruits, and other flower buds as bracts gradually opened. Results also showed that the reducing sugar, vitamin C, protein and ash contents in thrips-damaged flowers were all significantly lower than those in undamaged flowers, while there was no significant difference between damaged and undamaged young banana fruit. Our results indicated that the abundances of banana flower thrips were closely associated with the growing stage of banana. Thrips mainly infested flower buds and caused a reduction in nutrients for the host plant, especially the reducing sugar and vitamin C contents, which reduced the nutritional quality of banana fruits and the quality of flower bud by-products of banana.	[Yu, Deyi; Huang, Peng; Chen, Yong; Lin, Yongwen; Wei, Hui] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou, Fujian, Peoples R China; [Yu, Deyi; Huang, Peng; Chen, Yong; Wei, Hui] Fujian Key Lab Monitoring & Integrated Management, Fuzhou, Fujian, Peoples R China; [Lin, Yongwen] Fujian Agr & Forestry Univ, Plant Protect Coll, Fuzhou, Fujian, Peoples R China; [Akutse, Komivi Senyo] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Lan, Yanyang] Res & Dev Ctr Zhangzhou Natl Agr Sci & Technol Zo, Zhangzhou, Peoples R China	Fujian Academy of Agricultural Sciences; Fujian Agriculture & Forestry University; International Centre of Insect Physiology & Ecology (ICIPE)	Yu, DY; Wei, H (corresponding author), Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou, Fujian, Peoples R China.; Yu, DY; Wei, H (corresponding author), Fujian Key Lab Monitoring & Integrated Management, Fuzhou, Fujian, Peoples R China.	yudy_2004@126.com; weihui@faas.cn	Akutse, Komivi Senyo/I-8137-2019	Akutse, Komivi Senyo/0000-0002-2124-1626	Science and Technology Major Project of Fujian Province [2013NZ0002-4-7]; Basic R & D Special Fund Business of Fujian Province [2014R1024-1]; Scientific and Technological Innovation Team of Biological Control Resources of Fujian Academy of Agricultural Sciences [STIT2017-2-2]	Science and Technology Major Project of Fujian Province; Basic R & D Special Fund Business of Fujian Province; Scientific and Technological Innovation Team of Biological Control Resources of Fujian Academy of Agricultural Sciences	This research was supported by the Science and Technology Major Project of Fujian Province (2013NZ0002-4-7 to D.Y.), the Basic R & D Special Fund Business of Fujian Province (2014R1024-1 to D.Y.), and the Scientific and Technological Innovation Team of Biological Control Resources of Fujian Academy of Agricultural Sciences (STIT2017-2-2 to D.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, ANAL CHEM, DOI DOI 10.1016/B978-1-4832-3298-0.50008-4; BOYDEN S, 1972, MED J AUSTRALIA, V1, P1229, DOI 10.5694/j.1326-5377.1972.tb116528.x; Butler CD, 2007, BIOL CONTROL, V40, P339, DOI 10.1016/j.biocontrol.2006.12.005; Chen YG, 2014, BIOL CONTROL, V70, P9, DOI 10.1016/j.biocontrol.2013.12.002; Daryono BS, 2002, ACTA HORTIC, P321, DOI 10.17660/ActaHortic.2002.588.52; DINUZZO P, 1987, NUCL GEOPHYS, V1, P329; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gu G.Y., 2008, FOOD SCI, V71, P36; Haile FJ, 2003, ENVIRON ENTOMOL, V32, P433, DOI 10.1603/0046-225X-32.3.433; Harman JA, 2007, PEST MANAG SCI, V63, P210, DOI 10.1002/ps.1322; Harms HH, 2010, PEST MANAG SCI, V35, P277; Hu W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00742; Jamuna JB, 2014, NUTR METAB CARDIOVAS, V24, P623, DOI 10.1016/j.numecd.2013.12.003; Ju Rui-Ting, 2010, Acta Entomologica Sinica, V53, P1009; Kou J, 2014, ACTA ECOLOGICA SINIC, V34, P2459; [寇江涛 Kou Jiangtao], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P2459; Loomans AJM, 1995, DEV PLANT PATHOLOGY, V14, P244; Lou Yonggen, 1997, Acta Entomologica Sinica, V40, P320; Lu H, 2011, PLANT PROTECTION, V55, P21; de Castro MDL, 2010, J CHROMATOGR A, V1217, P2383, DOI 10.1016/j.chroma.2009.11.027; Murai T, 2001, B ENTOMOL RES, V91, P193; NANGJU D, 1979, FIELD CROP RES, V2, P373, DOI 10.1016/0378-4290(79)90035-2; Pearsall IA, 2000, J ECON ENTOMOL, V93, P264, DOI 10.1603/0022-0493-93.2.264; PETERSON HG, 1994, AQUAT TOXICOL, V28, P275, DOI 10.1016/0166-445X(94)90038-8; Roditakis E, 2006, PHYTOPARASITICA, V34, P488, DOI 10.1007/BF02981204; Russell GE, 1974, NATURE, V250, P272; Sezginturk MK, 2005, TALANTA, V65, P998, DOI 10.1016/j.talanta.2004.08.037; Sreedharan S, 2013, PLANT BIOTECHNOL J, V11, P942, DOI 10.1111/pbi.12086; Wu W, 2016, FOOD ANAL METHOD, V9, P3187, DOI 10.1007/s12161-016-0507-5; Yu De-yi, 2015, Fujian Nongye Xuebao, V30, P997; Yu De-Yi, 2013, Acta Entomologica Sinica, V56, P60; Zaffari GR, 2000, PLANT CELL TISS ORG, V63, P187, DOI 10.1023/A:1010611318932; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zhang Ying, 1998, Acta Entomologica Sinica, V41, P204	34	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202199	10.1371/journal.pone.0202199	http://dx.doi.org/10.1371/journal.pone.0202199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096210	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500058
J	Bosse, M; Heuwieser, A; Heinzel, A; Lukas, A; Oliveira, G; Mayer, B				Bosse, Magnus; Heuwieser, Alexander; Heinzel, Andreas; Lukas, Arno; Oliveira, Guilherme; Mayer, Bernd			Biomarker panels for characterizing microbial community biofilm formation as composite molecular process	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; DATABASE; PROTEIN	Microbial consortia execute collaborative molecular processes with contributions from individual species, on such basis enabling optimized molecular function. Such collaboration and synergies benefit metabolic flux specifically in extreme environmental conditions as seen in acid mine drainage, with biofilms as relevant microenvironment. However, knowledge about community species composition is not sufficient for deducing presence and efficiency of composite molecular function. For this task molecular resolution of the consortium interactome is to be retrieved, with molecular biomarkers particularly suited for characterizing composite molecular processes involved in biofilm formation and maintenance. A microbial species set identified in 18 copper environmental sites provides a data matrix for deriving a cross-species molecular process model of biofilm formation composed of 191 protein coding genes contributed from 25 microbial species. Computing degree and stress centrality of biofilm molecular process nodes allows selection of network hubs and central connectors, with the top ranking molecular features proposed as biomarker candidates for characterizing biofilm homeostasis. Functional classes represented in the biomarker panel include quorum sensing, chemotaxis, motility and extracellular polysaccharide biosynthesis, complemented by chaperones. Abundance of biomarker candidates identified in experimental data sets monitoring different biofilm conditions provides evidence for the selected biomarkers as sensitive and specific molecular process proxies for capturing biofilm microenvironments. Topological criteria of process networks covering an aggregate function of interest support the selection of biomarker candidates independent of specific community species composition. Such panels promise efficient screening of environmental samples for presence of microbial community composite molecular function.	[Bosse, Magnus; Heuwieser, Alexander; Heinzel, Andreas; Lukas, Arno; Mayer, Bernd] Emergentec Biodev GmbH, Vienna, Austria; [Oliveira, Guilherme] Vale Inst Technol, Belem, Para, Brazil	Emergentec Biodevelopment GmbH; Instituto Tecnologico Vale Desenvolvimento Sustentavel	Mayer, B (corresponding author), Emergentec Biodev GmbH, Vienna, Austria.	bernd.mayer@emergentec.com		Bosse, Magnus/0000-0002-3396-475X	Vale Institute of Technology, Brazil; Brazilian National Counsel of Technological and Scientific Development CNPq [309312/2012-4]; emergentec biodevelopment GmbH	Vale Institute of Technology, Brazil; Brazilian National Counsel of Technological and Scientific Development CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); emergentec biodevelopment GmbH	This work was made possible as part of the META-BASE project financially supported by Vale Institute of Technology (www.itv.org), Brazil (MB, AH). GO is a fellow of the Brazilian National Counsel of Technological and Scientific Development CNPq (309312/2012-4). The commercial entity emergentec biodevelopment GmbH (www.emergentec.com) provided support in the form of salaries for authors AH, AL and BM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Berbis MA, 2015, CURR MED CHEM, V22, P1687, DOI 10.2174/0929867322666150114151248; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Barreto M, 2005, APPL ENVIRON MICROB, V71, P2902, DOI 10.1128/AEM.71.6.2902-2909.2005; Bastian M., 2009, 3 INT ICWSM C; Belnap CP, 2010, ISME J, V4, P520, DOI 10.1038/ismej.2009.139; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Bosse M, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0054-4; Chen LX, 2015, ISME J, V9, P1579, DOI 10.1038/ismej.2014.245; Christel S, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02091-17; Cornforth DM, 2012, AM NAT, V180, P296, DOI 10.1086/667193; Donati ER, 2007, MICROBIAL PROCESSING; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Ghasemi M, 2014, CURR BIOINFORM, V9, P426, DOI 10.2174/15748936113086660013; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Hao T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060907; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Jiao YQ, 2010, APPL ENVIRON MICROB, V76, P2916, DOI 10.1128/AEM.02289-09; Karunakaran E, 2011, APPL MICROBIOL BIOT, V90, P1869, DOI 10.1007/s00253-011-3293-4; Kuang JL, 2016, ISME J, V10, P1527, DOI 10.1038/ismej.2015.201; Latorre M, 2016, BIORESOURCE TECHNOL, V218, P659, DOI 10.1016/j.biortech.2016.07.012; Lemos JA, 2007, J BACTERIOL, V189, P1582, DOI 10.1128/JB.01655-06; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moreno-Paz M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-404; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Noel N, 2010, HYDROMETALLURGY, V104, P370, DOI 10.1016/j.hydromet.2010.02.021; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Peng TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178008; Pritykin Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003243; Quatrini R, 2018, CURR OPIN MICROBIOL, V43, P139, DOI 10.1016/j.mib.2018.01.011; R Core Team, 2021, R LANGUAGE ENV STAT; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roume H, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.7; Ruiz LM, 2012, LETT APPL MICROBIOL, V54, P133, DOI 10.1111/j.1472-765X.2011.03180.x; Sachs JL, 2012, MBIO, V3, DOI 10.1128/mBio.00099-12; Sand W, 2006, RES MICROBIOL, V157, P49, DOI 10.1016/j.resmic.2005.07.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Teng WK, 2017, MINERALS-BASEL, V7, DOI 10.3390/min7060106; Tsuboi A., 2017, MAPPING BASED ALL RN, V4, P1, DOI [10.1101/159293, DOI 10.1101/159293]; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Uzureau S, 2010, J PROTEOME RES, V9, P3200, DOI 10.1021/pr100068p; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Vera M, 2013, PROTEOMICS, V13, P1133, DOI 10.1002/pmic.201200386; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Zarraonaindia I, 2013, BIOL PHILOS, V28, P261, DOI 10.1007/s10539-012-9357-8; Zhang X, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0330-4	48	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202032	10.1371/journal.pone.0202032	http://dx.doi.org/10.1371/journal.pone.0202032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092027	gold, Green Submitted, Green Published			2022-12-26	WOS:000441232600081
J	Rodrigues, AG; Mello, ACMP; Baskin, CC; Baskin, JM; Oliveira, DMT; Garcia, QS				Rodrigues-Junior, Ailton G.; Mello, Ana Caroline M. P.; Baskin, Carol C.; Baskin, Jerry M.; Oliveira, Denise M. T.; Garcia, Queila S.			Why large seeds with physical dormancy become nondormant earlier than small ones	PLOS ONE			English	Article							TRIFOLIUM-SUBTERRANEUM; COAT; SENSITIVITY; GERMINATION; BREAK; CLASSIFICATION; HARDSEEDEDNESS; MECHANISM; FEATURES; FABACEAE	Under natural conditions, large seeds with physical dormancy (PY) may become water permeable earlier than small ones. However, the mechanism for this difference has not been elucidated. Thus, our aim was to evaluate the traits associated with PY in seeds of Senna multijuga (Fabaceae) and to propose a mechanism for earlier dormancy-break in large than in small seeds. Two seedlots were collected and each separated into large and small seeds. Seed dry mass, water content, thickness of palisade layer in the hilar and distal regions and the ratio between palisade layer thickness (P) in the lens fissure and seed mass (M) were evaluated. Further, the correlation between seed mass and seed dimensions was investigated. Large seeds had higher dry mass and water content than small seeds. The absolute thickness of the palisade layer in the different regions did not show any trend with seed size; however, large seeds had a lower P:M ratio than small seeds. Seed mass correlated positively with all seed dimensions, providing evidence for a substantially higher volume in large seeds. Since wet, but not dry, high temperatures break PY in sensitive seeds of S. multijuga, the data support our prediction that internal pressure potential in the seed and palisade layer thickness in the water gap (lens), which is related to seed mass (i.e. P:M ratio), act together to modulate the second step (dormancy break) of the two-stage sensitivity cycling model for PY break. In which case, large seeds are predetermined to become water-permeable earlier than small ones.	[Rodrigues-Junior, Ailton G.; Mello, Ana Caroline M. P.; Oliveira, Denise M. T.; Garcia, Queila S.] Univ Fed Minas Gerais, ICB, Dept Bot, Belo Horizonte, MG, Brazil; [Rodrigues-Junior, Ailton G.; Baskin, Carol C.; Baskin, Jerry M.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Rodrigues-Junior, Ailton G.] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil	Universidade Federal de Minas Gerais; University of Kentucky; University of Kentucky; Universidade Federal de Uberlandia	Rodrigues, AG (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bot, Belo Horizonte, MG, Brazil.; Rodrigues, AG (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY USA.; Rodrigues, AG (corresponding author), Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil.	ailtongrodrigues@gmail.com	Garcia, Queila S/B-5429-2014; Oliveira, Denise MT/B-5050-2010; Oliveira, Denise Maria Trombert/N-8049-2019; Rodrigues-Junior, Ailton/N-3130-2013	Garcia, Queila S/0000-0002-7137-788X; Oliveira, Denise MT/0000-0003-1918-2433; Oliveira, Denise Maria Trombert/0000-0003-1918-2433; Rodrigues-Junior, Ailton/0000-0003-4350-8982	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CRA-APQ-02038-16]; Coordenacao de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308117/2014-0, 304387/2016-9]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (process CRA-APQ-02038-16 to AGR-J), the Coordenacao de Pessoal de Nivel Superior (CAPES) for the study grant awarded to AGR-J and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the research productivity grants awarded to DMTO (process 308117/2014-0) and QSG (process 304387/2016-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin CC, 2003, NEW PHYTOL, V158, P229, DOI 10.1046/j.1469-8137.2003.00751.x; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Gama-Arachchige NS, 2013, ANN BOT-LONDON, V112, P69, DOI 10.1093/aob/mct094; HALLORAN GM, 1974, ANN BOT-LONDON, V38, P1039, DOI 10.1093/oxfordjournals.aob.a084894; HANNA PJ, 1984, NEW PHYTOL, V96, P23, DOI 10.1111/j.1469-8137.1984.tb03539.x; Hyde EOC, 1954, ANN BOT, V18, P241, DOI DOI 10.1093/OXFORDJOURNALS.AOB.A083393; International Seed Testing Association (ISTA), 2004, INT RUL SEED TEST RU; Jaganathan GK, 2016, PLANT ECOL, V217, P71, DOI 10.1007/s11258-015-0560-y; Jayasuriya KMGG, 2008, ANN BOT-LONDON, V101, P341, DOI 10.1093/aob/mcm285; Jayasuriya KMGG, 2009, INT J PLANT SCI, V170, P429, DOI 10.1086/597270; Jayasuriya KMGG, 2009, SEED SCI RES, V19, P3, DOI 10.1017/S096025850818730X; Jayasuriya KMGG, 2009, ANN BOT-LONDON, V103, P433, DOI 10.1093/aob/mcn240; MCCOMB J A, 1974, Australian Journal of Experimental Agriculture and Animal Husbandry, V14, P68, DOI 10.1071/EA9740068; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; QUINLIVAN BJ, 1971, J AUST I AGR SCI, V37, P283; R Development Core Team, 2014, R LANG ENV STAT COMP; Rodrigues AG, 2018, PLANT BIOLOGY, V20, P698, DOI [10.1111/plb.12719, 10]; Rodrigues AG, 2014, SEED SCI RES, V24, P147, DOI 10.1017/S0960258514000087; Russi L., 1992, Seed Science Research, V2, P243; Schutte BJ, 2014, SEED SCI RES, V24, P119, DOI 10.1017/S0960258514000099; SERRATOVALENTI G, 1995, ANN BOT-LONDON, V75, P569, DOI 10.1006/anbo.1995.1060; Smith FP, 1996, AUST J AGR RES, V47, P775, DOI 10.1071/AR9960775; Taylor GB, 2005, AUST J AGR RES, V56, P645, DOI 10.1071/AR04284; TAYLOR GB, 1981, AUST J PLANT PHYSIOL, V8, P547, DOI 10.1071/PP9810547; TRAN VN, 1979, AUST J PLANT PHYSIOL, V6, P277; Venier P, 2012, S AFR J BOT, V79, P19, DOI 10.1016/j.sajb.2011.11.005; Venier P, 2012, FLORA, V207, P39, DOI 10.1016/j.flora.2011.07.017	29	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202038	10.1371/journal.pone.0202038	http://dx.doi.org/10.1371/journal.pone.0202038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092026	Green Submitted, gold, Green Published			2022-12-26	WOS:000441232600082
J	Skiles, MP; Curtis, SL; Angeles, G; Mullen, S; Senik, T				Skiles, Martha Priedeman; Curtis, Sian L.; Angeles, Gustavo; Mullen, Stephanie; Senik, Tatyana			Evaluating the impact of social support services on tuberculosis treatment default in Ukraine	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; PULMONARY TUBERCULOSIS; TB PATIENTS; PREDICTORS; REGIONS; RUSSIA; DEATH	Ukraine is among the top 20 highest drug-resistant tuberculosis burden countries in the world. Driving the high drug-resistant tuberculosis rates is an unchecked treatment default rate. This evaluation measures the effect of social support provided to tuberculosis patients at risk of defaulting on treatment during outpatient treatment. Five tuberculosis patient cohorts, served in three oblasts from 2011 and 2012, were constructed from medical records to compare risk factors for default, receipt of social services, and treatment outcome. Regression analyses were used to identify risk factors predictive of treatment default and to estimate the impact of the social support program on treatment default, controlling for risk, disease status, and demographics. In 2012, tuberculosis patients receiving social support in Ukraine reduced their probability of defaulting on continuation treatment by 10 percentage points compared to high-risk patients who did not receive social support in 2012 or 2011. Treatment success rates for the high-risk patients receiving social support were comparable to the low-risk cohorts and significantly improved over the high-risk comparison cohorts. Further research is recommended to quantify the costs and benefits for scaling-up social support services, evaluate social support program fidelity, identify which populations respond best to select services, and what barriers might still exist to achieve better adherence. With that information, tailoring programs to most effectively reach and serve clients in a patient-centered approach may reap substantial rewards for Ukraine.	[Skiles, Martha Priedeman; Curtis, Sian L.; Angeles, Gustavo] Univ North Carolina Chapel Hill, Carolina Populat Ctr, MEASURE Evaluat Project, Chapel Hill, NC USA; [Curtis, Sian L.; Angeles, Gustavo] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA; [Mullen, Stephanie] John Snow Inc, Rosslyn, VA USA; [Senik, Tatyana] Int Res Agcy IFAK Inst, Kiev, Ukraine; [Skiles, Martha Priedeman] Washington Dept Hlth, Off Family & Community Hlth Improvement, Olympia, WA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Skiles, MP (corresponding author), Univ North Carolina Chapel Hill, Carolina Populat Ctr, MEASURE Evaluat Project, Chapel Hill, NC USA.; Skiles, MP (corresponding author), Washington Dept Hlth, Off Family & Community Hlth Improvement, Olympia, WA USA.	mpskiles25@gmail.com			U.S. Agency for International Development (USAID) [GHA-A-00-08-00003-00]; USAID; Carolina Population Center [R24 HD050924]; F.H. Yanovskyi Institute of Phthisiology and Pulmonology, Academy of Medical Sciences of Ukraine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); Carolina Population Center; F.H. Yanovskyi Institute of Phthisiology and Pulmonology, Academy of Medical Sciences of Ukraine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	MEASURE Evaluation is funded by the U.S. Agency for International Development (USAID) under Cooperative Agreement GHA-A-00-08-00003-00 and is implemented by the Carolina Population Center at the University of North Carolina at Chapel Hill, in association with The Palladium Group, ICF International; John Snow, Inc.; Management Sciences for Health, and Tulane University. John Snow Inc. (JSI) is a public health consulting firm and did not fund this research. Funds provided by USAID under the Cooperative Agreement supported salaries for authors (MS, SC, GA, SM, TS) and research materials. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We are grateful for the Carolina Population Center (R24 HD050924) for general support. We also thank the F.H. Yanovskyi Institute of Phthisiology and Pulmonology, Academy of Medical Sciences of Ukraine for their support in conducting this study in Ukraine.	Akachi Y, 2012, J INFECT DIS; [Anonymous], 2015, STRENGTH TUB CONTR U; Bustamante-Montes LP, 2000, INT J TUBERC LUNG D, V4, P208; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Dubrovina I, 2008, INT J TUBERC LUNG D, V12, P756; Jakubowiak W, 2009, INT J INFECT DIS, V13, P362, DOI 10.1016/j.ijid.2008.07.015; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Jakubowiak WM, 2008, TUBERCULOSIS, V88, P495, DOI 10.1016/j.tube.2008.03.004; Jenkins HE, 2013, INT J TUBERC LUNG D, V17, P373, DOI 10.5588/ijtld.12.0464; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; Marx FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045724; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Ukraine Ministry of Health, 2010, NAT TUB PROGR DAT 20; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	19	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0199513	10.1371/journal.pone.0199513	http://dx.doi.org/10.1371/journal.pone.0199513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092037	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600003
J	Li, H; Tian, ZF; Qu, YP; Yang, Q; Guan, HX; Shi, BY; Ji, MJ; Hou, P				Li, Heng; Tian, Zhufang; Qu, Yiping; Yang, Qi; Guan, Haixia; Shi, Bingyin; Ji, Meiju; Hou, Peng			SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis	ONCOGENE			English	Article							CELL-LINES; CANCER; NICOTINAMIDE; EXPRESSION; CARCINOMA; APOPTOSIS; SURVIVAL; TARGET; MTOR; S6K1	SIRT7 is an NAD(+)-dependent histone/non-histone deacetylase, which is highly expressed in different types of cancer including thyroid cancer; however, its biological function in thyroid cancer is still undiscovered. In this study, we found that SIRT7 expression was elevated in papillary thyroid cancers (PTCs), and demonstrated that SIRT7 knockdown dramatically inhibited the proliferation, colony formation, migration and invasion of thyroid cancer cells, and induced thyroid cancer cell cycle arrest and apoptosis. Conversely, SIRT7 re-expression markedly enhanced thyroid cancer cell growth, invasiveness and tumorigenic potential in nude mice. Further studies revealed that SIRT7 exerted an oncogenic function in thyroid tumorigenesis by phosphorylation of Akt and p70S6K1. Mechanistically, SIRT7 binds to the promoter of deleted in breast cancer-1 (DBC1), an endogenous inhibitor of SIRT1, and represses its transcription via deacetylation of H3K18Ac. This results in enhanced interactions between SIRT1 and Akt or p70S6K1, thereby promoting deacetylation and subsequent phosphorylation of Akt and p70S6K1 through a SIRT1-dependent manner. Altogether, our results show that DBC1 is a downstream target of SIRT7, and first uncover that SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via the modulation of DBC1/SIRT1 axis.	[Li, Heng; Qu, Yiping; Yang, Qi; Shi, Bingyin; Hou, Peng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Shaanxi, Peoples R China; [Li, Heng; Tian, Zhufang] Xian Cent Hosp, Dept Endocrinol, Xian 710003, Shaanxi, Peoples R China; [Guan, Haixia] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang 110001, Liaoning, Peoples R China; [Shi, Bingyin; Hou, Peng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Tumor Precis Med Shaanxi Prov, Xian 710061, Shaanxi, Peoples R China; [Ji, Meiju] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University; China Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University	Hou, P (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Shaanxi, Peoples R China.; Hou, P (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Tumor Precis Med Shaanxi Prov, Xian 710061, Shaanxi, Peoples R China.; Ji, MJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, Xian 710061, Shaanxi, Peoples R China.	mjji0409@163.com; phou@xjtu.edu.cn			National Natural Science Foundation of China [81372217, 81572627, 81672645]; China International Medical Foundation [2016-N-07-12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Medical Foundation	We would like to thank Drs. Haixia Guan (The First Affiliated Hospital of China Medical University, Shenyang, China) and Lei Ye (Ruijin Hospital, Shanghai, China) for kindly providing human thyroid cancer cell lines. This work was supported by the National Natural Science Foundation of China (no. 81372217, 81572627 and 81672645), and the China International Medical Foundation (no. 2016-N-07-12).	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burns WR, 2010, SEMIN ONCOL, V37, P557, DOI 10.1053/j.seminoncol.2010.10.008; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Chen SF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10734; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; de Nigris F, 2002, BRIT J CANCER, V86, P917, DOI 10.1038/sj.bjc.6600156; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye R, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600635; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herranz D, 2013, ONCOGENE, V32, P4052, DOI 10.1038/onc.2012.407; Hong SK, 2014, J BIOL CHEM, V289, P13132, DOI 10.1074/jbc.M113.520734; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kim LC, 2017, ONCOGENE, V36, P2191, DOI 10.1038/onc.2016.363; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Petrulea MS, 2015, CANCER TREAT REV, V41, P707, DOI 10.1016/j.ctrv.2015.06.005; Qu N, 2017, INT J ONCOL, V50, P1683, DOI 10.3892/ijo.2017.3951; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shackelford R, 2013, ANTICANCER RES, V33, P3047; Shi J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.346; Shi J, 2015, ONCOTARGET, V6, P14344, DOI 10.18632/oncotarget.3852; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Toker A, 2008, MOL CELL, V31, P6, DOI 10.1016/j.molcel.2008.06.007; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Yu HY, 2014, CLIN CANCER RES, V20, P3434, DOI 10.1158/1078-0432.CCR-13-2952; Yu J, 2017, CELL REP, V18, P1229, DOI 10.1016/j.celrep.2017.01.009; Zhang PY, 2016, NUCLEIC ACIDS RES, V44, P3629, DOI 10.1093/nar/gkv1504; Zhang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09787; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	41	28	31	2	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					345	359		10.1038/s41388-018-0434-6	http://dx.doi.org/10.1038/s41388-018-0434-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30093629				2022-12-26	WOS:000455851200004
J	Whitcomb, EA; Tsai, YC; Basappa, J; Liu, K; Le Feuvre, AK; Weissman, AM; Taylor, A				Whitcomb, Elizabeth A.; Tsai, Yien Che; Basappa, Johnvesly; Liu, Ke; Le Feuvre, Aurelie K.; Weissman, Allan M.; Taylor, Allen			Stabilization of p27(Kip1)/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control	FASEB JOURNAL			English	Article						cell division; proteasome; ubiquitin-conjugating enzyme; CDKI	LENS EPITHELIAL-CELLS; CONJUGATING ENZYMES E2S; S-PHASE; PROTEASOME PATHWAY; ACTIVATING ENZYME; DAMAGED PROTEINS; NUCLEAR EXPORT; BREAST-CANCER; DEGRADATION; EXPRESSION	Ubiquitinylation drives many cellular processes by targeting proteins for proteasomal degradation. Ubiquitin conjugation enzymes promote ubiquitinylation and, thus, degradation of protein substrates. Ubiquitinylation is a well-known posttranslational modification controlling cell-cycle transitions and levels or/and activation levels of ubiquitin-conjugating enzymes change during development and cell cycle. Progression through the cell cycle is tightly controlled by CDK inhibitors such as p27(Kip1). Here we show that, in contrast to promoting its degradation, the ubiquitin-conjugating enzyme UBCH7/UBE2L3 specifically protects p27(Kip1) from degradation. Overexpression of UBCH7/UBE2L3 stabilizes p27(Kip1) and delays the G(1)-to-S transition, while depletion of UBCH7/UBE2L3 increases turnover of p27(Kip1). Levels of p21(Cip1/Waf1), p57(Kip2), cyclin A and cyclin E, all of which are also involved in regulating the G(1)/S transition are not affected by UBCH7/UBE2L3 depletion. The effect of UBCH7/UBE2L3 on p27(Kip1) is not due to alteration of the levels of any of the ubiquitin ligases known to ubiquitinylate p27(Kip1). Rather, UBCH7/UBE2L3 catalyzes the conjugation of heterotypic ubiquitin chains on p27(Kip1) that are proteolytically incompetent. These data reveal new controls and concepts about the ubiquitin proteasome system in which a ubiquitin-conjugating enzyme selectively inhibits and may even protect, rather than promote degradation of a crucial cell-cycle regulatory molecule.Whitcomb, E. A., Tsai, Y. C., Basappa, J., Liu, K., Le Feuvre, A. K., Weissman, A. M., Taylor, A. Stabilization of p27(Kip1)/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.	[Whitcomb, Elizabeth A.; Basappa, Johnvesly; Liu, Ke; Le Feuvre, Aurelie K.; Taylor, Allen] Tufts Univ, Lab Nutr & Vis Res, JM USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, Frederick, MD 21701 USA; [Basappa, Johnvesly] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Liu, Ke] Sichuan Univ, Key Lab Bioresource & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Le Feuvre, Aurelie K.] Mission Therapeut, Cambridge, England	Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fox Chase Cancer Center; Sichuan University	Whitcomb, EA; Taylor, A (corresponding author), Tufts Univ, JM USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	elizabeth.whitcomb@tufts.edu; allen.taylor@tufts.edu	Liu, Ke/D-3380-2015	Liu, Ke/0000-0002-4683-9325; Tsai, Yien Che/0000-0001-9624-1092	U.S. National Institutes of Health (NIH) National Eye Institute [RO1 EY 13250, RO1 EY21212, RO1 EY26979]; U.S. Department of Agriculture [1950-510000-060-03A]; NIH Center for Cancer Research-National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC010292] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY026979] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH Center for Cancer Research-National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by U.S. National Institutes of Health (NIH) National Eye Institute Grants RO1 EY 13250, RO1 EY21212, and RO1 EY26979, U.S. Department of Agriculture contract 1950-510000-060-03A (to A.T.), and the NIH Center for Cancer Research-National Cancer Institute Intramural Research Program (to Y.C.T. and A.M.W.). The authors thank E. Bejarano-Fernandez (Tufts University) for critical review and W. Yang (Brandeis University, Waltham, MA, USA) for expert technical assistance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Borel F, 2002, J CELL SCI, V115, P2829; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chiaroni-Clarke RC, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-53; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Craney A, 2013, CURR OPIN CELL BIOL, V25, P704, DOI 10.1016/j.ceb.2013.07.004; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Eliseeva E, 2001, CELL GROWTH DIFFER, V12, P427; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Grice GL, 2015, CELL REP, V12, P545, DOI 10.1016/j.celrep.2015.06.061; Guan XX, 2010, J CELL MOL MED, V14, P944, DOI 10.1111/j.1582-4934.2009.00730.x; Guo WM, 2004, INVEST OPHTH VIS SCI, V45, P1194, DOI 10.1167/iovs.03-0830; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iovine B, 2011, BIOCHIMIE, V93, P867, DOI 10.1016/j.biochi.2010.12.017; JAHNGEN JH, 1986, J BIOL CHEM, V261, P3760; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kullmann MK, 2013, CELL CYCLE, V12, P2625, DOI 10.4161/cc.25622; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu K, 2015, P NATL ACAD SCI USA, V112, P1071, DOI 10.1073/pnas.1404059112; Liu Q, 2004, EXP EYE RES, V78, P197, DOI 10.1016/j.exer.2003.11.009; Liu Q, 2006, INVEST OPHTH VIS SCI, V47, P1302, DOI 10.1167/iovs.05-0935; Liu Q, 2006, MOL VIS, V12, P931; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Lyu L, 2016, FASEB J, V30, P1087, DOI 10.1096/fj.15-278036; Ma XJ, 2017, ONCOTARGET, V8, P84193, DOI 10.18632/oncotarget.20449; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Ohtake F, 2018, P NATL ACAD SCI USA, V115, pE1401, DOI 10.1073/pnas.1716673115; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Park SH, 2011, CANCER LETT, V310, P232, DOI 10.1016/j.canlet.2011.07.009; Patel D, 2010, J VIROL, V84, P10956, DOI 10.1128/JVI.00259-10; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plafker KS, 2010, J BIOL CHEM, V285, P23062, DOI 10.1074/jbc.M110.121913; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reichard EL, 2016, J BIOL CHEM, V291, P18547, DOI 10.1074/jbc.M116.720151; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shang F, 2001, EXP EYE RES, V73, P827, DOI 10.1006/exer.2001.1091; Shi Q, 2015, DEV CELL, V35, P483, DOI 10.1016/j.devcel.2015.10.014; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Thomas JJ, 2016, CELL REP, V16, P3388, DOI 10.1016/j.celrep.2016.08.024; Topper LM, 2001, J CELL BIOL, V154, P707, DOI 10.1083/jcb.200104130; Tsuruta F, 2016, MOL CELL BIOL, V36, P2182, DOI 10.1128/MCB.00174-16; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Wagner M, 2001, EXP GERONTOL, V37, P41, DOI 10.1016/S0531-5565(01)00165-6; Wang Y, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0098-6; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	84	12	14	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1235	1247		10.1096/fj.201800960R	http://dx.doi.org/10.1096/fj.201800960R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30113882	Green Published			2022-12-26	WOS:000457401500098
J	Guo, LS; Carraro, M; Sartori, G; Minervini, G; Eriksson, O; Petronilli, V; Bernardi, P				Guo, Lishu; Carraro, Michela; Sartori, Geppo; Minervini, Giovanni; Eriksson, Ove; Petronilli, Valeria; Bernardi, Paolo			Arginine 107 of yeast ATP synthase subunit g mediates sensitivity of the mitochondrial permeability transition to phenylglyoxal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; mitochondria; mitochondrial permeability transition (MPT); calcium; bioenergetics	METHYLGLYOXAL METABOLISM; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CRISTAE MORPHOLOGY; PROTEIN GLYCATION; CHANNEL FORMATION; CA2+ RELEASE; CELL-DEATH; C-SUBUNIT; IN-SITU	Modification with arginine-specific glyoxals modulates the permeability transition (PT) of rat liver mitochondria, with inhibitory or inducing effects that depend on the net charge of the adduct(s). Here, we show that phenylglyoxal (PGO) affects the PT in a species-specific manner (inhibition in mouse and yeast, induction in human and Drosophila mitochondria). Following the hypotheses (i) that the effects are mediated by conserved arginine(s) and (ii) that the PT is mediated by the F-ATP synthase, we have narrowed the search to 60 arginines. Most of these residues are located in subunits alpha, beta, gamma, epsilon, a, and c and were excluded because PGO modification did not significantly affect enzyme catalysis. On the other hand, yeast mitochondria lacking subunit g or bearing a subunit g R107A mutation were totally resistant to PT inhibition by PGO. Thus, the effect of PGO on the PT is specifically mediated by Arg-107, the only subunit g arginine that has been conserved across species. These findings are evidence that the PT is mediated by F-ATP synthase.	[Guo, Lishu; Carraro, Michela; Sartori, Geppo; Minervini, Giovanni; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR, Inst Neurosci, I-35131 Padua, Italy; [Guo, Lishu; Carraro, Michela; Sartori, Geppo; Minervini, Giovanni; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Eriksson, Ove] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, FIN-00290 Helsinki, Finland	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Helsinki	Bernardi, P (corresponding author), Univ Padua, CNR, Inst Neurosci, I-35131 Padua, Italy.; Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.	bernardi@bio.unipd.it	Minervini, Giovanni/D-1200-2013; Bernardi, Paolo/C-3656-2008; Eriksson-Rosenberg, Ove/GVU-6692-2022; Petronilli, Valeria/C-3558-2015	Minervini, Giovanni/0000-0001-7013-5785; Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404	AIRC [IG17067]; Fondation Leducq [16CVD04]; China Scholarship Council	AIRC(Fondazione AIRC per la ricerca sul cancro); Fondation Leducq(Leducq Foundation); China Scholarship Council(China Scholarship Council)	This work was supported by AIRC Grant IG17067 (to P. B.) and Fondation Leducq Grant 16CVD04 (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the China Scholarship Council. This work is in partial fulfillment of the requirements for the Ph.D. for this author at the Department of Biomedical Sciences, University of Padova.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Antoniel M, 2018, EMBO REP, V19, P257, DOI 10.15252/embr.201744705; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Bernardi P, 2018, CURR OPIN PHYSIOL, V3, P1, DOI 10.1016/j.cophys.2017.12.006; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burstein SR, 2018, BBA-BIOENERGETICS, V1859, P423, DOI 10.1016/j.bbabio.2018.03.006; Carraro M, 2016, CELL CALCIUM, V60, P102, DOI 10.1016/j.ceca.2016.03.005; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Eriksson O, 1998, J BIOL CHEM, V273, P12669, DOI 10.1074/jbc.273.20.12669; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gomes RA, 2005, FEBS J, V272, P4521, DOI 10.1111/j.1742-4658.2005.04872.x; Gomes RA, 2008, FEMS YEAST RES, V8, P174, DOI 10.1111/j.1567-1364.2007.00337.x; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Johans M, 2005, J BIOL CHEM, V280, P12130, DOI 10.1074/jbc.M413454200; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laun P, 2012, SUBCELL BIOCHEM, V57, P207, DOI 10.1007/978-94-007-2561-4_10; Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495; Lindblom Runa, 2015, Rev Diabet Stud, V12, P134, DOI 10.1900/RDS.2015.12.134; Linder MD, 2002, J BIOL CHEM, V277, P937, DOI 10.1074/jbc.M107610200; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Maessen DEM, 2015, CLIN SCI, V128, P839, DOI 10.1042/CS20140683; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piovesan D, 2017, BIOINFORMATICS, V33, P1889, DOI 10.1093/bioinformatics/btx085; PRESCOTT M, 1994, BIOCHEM MOL BIOL INT, V34, P789; Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; UH M, 1990, J BIOL CHEM, V265, P19047; von Stockum S, 2015, J BIOL CHEM, V290, P4537, DOI 10.1074/jbc.C114.629766; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Zeng JM, 2005, CHEM RES TOXICOL, V18, P1232, DOI 10.1021/tx050074u	63	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14632	14645		10.1074/jbc.RA118.004495	http://dx.doi.org/10.1074/jbc.RA118.004495			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093404	Green Published, hybrid			2022-12-26	WOS:000446155000005
J	Scott, AJ; Walker, SA; Krank, JJ; Wilkinson, AS; Johnson, KM; Lewis, EM; Wilkinson, JC				Scott, Andrew J.; Walker, Sierra A.; Krank, Joshua J.; Wilkinson, Amanda S.; Johnson, Kaitlyn M.; Lewis, Eric M.; Wilkinson, John C.			AIF promotes a JNK1-mediated cadherin switch independently of respiratory chain stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; metabolism; oxidative stress; cancer; cell signaling; epithelial-mesenchymal transition (EMT); MAPK	APOPTOSIS-INDUCING-FACTOR; X-LINKED INHIBITOR; CELL-DEATH; OXIDATIVE-PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TUMOR PROGRESSION; DOWN-REGULATION; CANCER CELLS; MAP KINASES; MUTATION	Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein occasionally involved in cell death that primarily regulates mitochondrial energy metabolism under normal cellular conditions. AIF catalyzes the oxidation of NADH in vitro, yet the significance of this redox activity in cells remains unclear. Here, we show that through its enzymatic activity AIF is a critical factor for oxidative stress-induced activation of the mitogen-activated protein kinases JNK1 (c-Jun N-terminal kinase), p38, and ERK (extracellular signal-regulated kinase). AIF-dependent JNK1 signaling culminates in the cadherin switch, and genetic reversal of this switch leads to apoptosis when AIF is suppressed. Notably, this widespread ability of AIF to promote JNK signaling can be uncoupled from its more limited role in respiratory chain stabilization. Thus, AIF is a transmitter of extra-mitochondrial signaling cues with important implications for human development and disease.	[Scott, Andrew J.; Walker, Sierra A.; Krank, Joshua J.; Wilkinson, Amanda S.; Johnson, Kaitlyn M.; Wilkinson, John C.] North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Lewis, Eric M.] Clarion Univ Pennsylvania, Dept Chem Math & Phys, Clarion, PA 16214 USA	North Dakota State University Fargo; Pennsylvania State System of Higher Education (PASSHE); Clarion University of Pennsylvania	Wilkinson, JC (corresponding author), North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	john.wilkinson@ndsu.edu	Walker, Sierra A/AAU-3993-2020	Scott, Andrew/0000-0002-0835-4888; Walker, Sierra/0000-0002-9201-0833	North Dakota State University Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer under National Institutes of Health COBRE Program [1P20GM109024]; State of North Dakota Experimental Program to Stimulate Competitive Research Grant ND-EPSCoR Project [FAR0022246]; Department of Defense Prostate Cancer Research Program [W81XWH-08-1-0045]; American Cancer Society [RSG-09-166-01-CCG]; National Institutes of Health [1R15CA206067-01]; NATIONAL CANCER INSTITUTE [R15CA206067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109024] Funding Source: NIH RePORTER	North Dakota State University Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer under National Institutes of Health COBRE Program; State of North Dakota Experimental Program to Stimulate Competitive Research Grant ND-EPSCoR Project; Department of Defense Prostate Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by North Dakota State University Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer under National Institutes of Health COBRE Program Grant 1P20GM109024, State of North Dakota Experimental Program to Stimulate Competitive Research Grant ND-EPSCoR Project FAR0022246 (to J. C. W.), Grant W81XWH-08-1-0045 (to J. C. W.) from the Department of Defense Prostate Cancer Research Program, Grant RSG-09-166-01-CCG (to J. C. W.) from the American Cancer Society, and Grant 1R15CA206067-01 (to J. C. W.) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Berger I, 2011, MOL GENET METAB, V104, P517, DOI 10.1016/j.ymgme.2011.09.020; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dougherty JA, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00022; Fan TL, 2014, TUMOR BIOL, V35, P519, DOI 10.1007/s13277-013-1073-8; Galban S, 2009, BIOCHEM J, V417, P765, DOI 10.1042/BJ20081677; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Goel HL, 2013, J CELL PHYSIOL, V228, P1601, DOI 10.1002/jcp.24323; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jeong EG, 2006, APMIS, V114, P867, DOI 10.1111/j.1600-0463.2006.apm_502.x; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Krasnik V, 2017, NEOPLASMA, V64, P262, DOI 10.4149/neo_2017_213; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JW, 2006, PATHOL RES PRACT, V202, P497, DOI 10.1016/j.prp.2006.03.004; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lenhausen AM, 2016, BIOCHEMISTRY-US, V55, P3285, DOI 10.1021/acs.biochem.6b00306; Lewis EM, 2012, J BIOL CHEM, V287, P43862, DOI 10.1074/jbc.M112.407650; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Li SY, 2011, ARCH PATHOL LAB MED, V135, P903, DOI 10.1043/2010-0003-OAR1.1; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Milasta S, 2016, IMMUNITY, V44, P88, DOI 10.1016/j.immuni.2015.12.002; Millan A, 2009, J SURG RES, V151, P163, DOI 10.1016/j.jss.2007.05.020; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Rouget R, 2008, J BIOL CHEM, V283, P5533, DOI 10.1074/jbc.M706257200; Sancho P, 2017, NEUROGENETICS, V18, P245, DOI 10.1007/s10048-017-0524-6; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott AJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2320-3; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Skyrlas A, 2011, EXP DERMATOL, V20, P674, DOI 10.1111/j.1600-0625.2011.01249.x; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Su KH, 2016, NAT CELL BIOL, V18, P527, DOI 10.1038/ncb3335; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Turner RL, 2014, VIROLOGY, V456, P205, DOI 10.1016/j.virol.2014.03.010; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wilkinson JC, 2004, J BIOL CHEM, V279, P51091, DOI 10.1074/jbc.M409623200; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053	73	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14707	14722		10.1074/jbc.RA118.004022	http://dx.doi.org/10.1074/jbc.RA118.004022			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093403	hybrid, Green Published			2022-12-26	WOS:000446155000011
J	Zhang, T; Lu, HZ; Wang, L; Yin, MC; Yang, LK				Zhang, Tao; Lu, Hongzhao; Wang, Ling; Yin, Meichen; Yang, Likai			Specific expression pattern of IMP metabolism related-genes in chicken muscle between cage and free range conditions	PLOS ONE			English	Article							GARS-AIRS-GART; MEAT QUALITY TRAITS; CARCASS CHARACTERISTICS; BROILER-CHICKENS; YOU CHICKENS; ADSL; POLYMORPHISMS; BREEDS	Inosine monophosphate (IMP) is a key factor affecting the fleshy flavor of meat; meanwhile, the free-range mode is an efficient strategy to improve muscular IMP content. To assess expression differences in IMP metabolism-related genes under different feeding patterns, Illumina Nextseq 500 sequencing was used to catalog the global gene expression profiles of muscle samples from Lueyang black-bone chicken under free-range and caging conditions. A total of 15510 unigenes were assembled, with 13423 (86.54%) and 6088 (39.25%) unigenes correctly annotated in the GO and KOG databases, respectively. Next, the "purine metabolism" pathway in the "nucleotide metabolism group" was assessed in depth. Through Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, we retrieved 172 nucleotide- and 5 purine-metabolism related genes that were differentially expressed in muscle samples from free-range and caged chickens. At 60-day-old, AMPD1, NT5C1A and ENTPD8 showed higher levels in the free-range group, while only ENTPD8 was upregulated in 120-day-old chickens. In addition, GART, GARS and ADSL in free-range chickens showed higher levels compared with caged animals. Furthermore, IMPDH levels in free-range chicken were lower than those of caged chicken. Real-time quantitative polymerase chain reaction (qPCR) was used to validate the above findings. These results revealed a set of differentially expressed genes potentially related to IMP metabolism in chicken under different breeding modes, providing novel insights into controlling IMP levels in chicken meat.	[Zhang, Tao; Lu, Hongzhao; Wang, Ling; Yin, Meichen; Yang, Likai] Shaanxi Univ Technol, Sch Biosci & Engn, Hanzhong, Shaanxi, Peoples R China	Shaanxi University of Technology	Zhang, T (corresponding author), Shaanxi Univ Technol, Sch Biosci & Engn, Hanzhong, Shaanxi, Peoples R China.	zl780823@163.com			Shaanxi province agricultural science and technology innovation; Shaanxi University of Technology [SLGQD2017-09]; National Natural Science Foundation of China (NSFC) [31402071]; technological project [2016NY-084]	Shaanxi province agricultural science and technology innovation; Shaanxi University of Technology; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); technological project	This study was supported by the Shaanxi province agricultural science and technology innovation, Shaanxi University of Technology research project, SLGQD2017-09 and technological project (2016NY-084) and the National Natural Science Foundation of China (NSFC) (31402071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Coleto I, 2016, PLANT CELL ENVIRON, V39, P1767, DOI 10.1111/pce.12743; Corf NA, 2010, FEBS J, V191, P721; Detremmerie C, 2017, ACTA PHARM SIN B, V7, P401, DOI 10.1016/j.apsb.2017.06.003; Fanatico AC, 2007, POULTRY SCI, V86, P2441, DOI 10.3382/ps.2007-00092; Guan CG, 2018, TOXICOL APPL PHARM, V343, P1, DOI 10.1016/j.taap.2018.02.001; Guan RF, 2013, J ZHEJIANG UNIV-SC B, V14, P896, DOI 10.1631/jzus.B1300163; Hu J, 2015, GENE, V574, P204, DOI 10.1016/j.gene.2015.08.008; Jung S, 2013, POULTRY SCI, V92, P3275, DOI 10.3382/ps.2013-03441; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kobayashi H, 2013, ANIM SCI J, V84, P489, DOI 10.1111/asj.12021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HY, 2011, GENES GENOM, V33, P147, DOI 10.1007/s13258-010-0091-9; Lin Y, 2012, CONTEMP SYST THINK, P69, DOI 10.1007/978-1-4614-2311-9_4; Ma T, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0022-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perenlei G, 2014, ANIM SCI J, V85, P895, DOI 10.1111/asj.12221; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Ray SP, 2012, BIOCHEMISTRY-US, V51, P6701, DOI 10.1021/bi300796y; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Sarsenbek A, 2013, POULTRY SCI, V92, P2776, DOI 10.3382/ps.2012-02841; Shu JT, 2009, BRIT POULTRY SCI, V50, P680, DOI 10.1080/00071660903391709; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tsukihara H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163961; Wang AQ, 2015, INT J MOL SCI, V16, P22904, DOI 10.3390/ijms160922904; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wegelin I, 1996, COMP BIOCHEM PHYS A, V114, P99, DOI 10.1016/0300-9629(95)02098-5; Yan JS, 2018, POULTRY SCI, V97, P1229, DOI 10.3382/ps/pex415; Ye MH, 2010, BRIT POULTRY SCI, V51, P609, DOI 10.1080/00071668.2010.508486; Zanetti E, 2010, BRIT POULTRY SCI, V51, P629, DOI 10.1080/00071668.2010.521142; Zhang GQ, 2008, POULTRY SCI, V87, P1364, DOI 10.3382/ps.2007-00193; Zhang XD, 2015, GENET MOL RES, V14, P14823, DOI 10.4238/2015.November.18.47; Zhang XD, 2015, GENET MOL RES, V14, P2031, DOI 10.4238/2015.March.20.13	33	7	11	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201736	10.1371/journal.pone.0201736	http://dx.doi.org/10.1371/journal.pone.0201736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133460	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400033
J	Dussaq, AM; Kennell, T; Eustace, NJ; Anderson, JC; Almeida, JS; Willey, CD				Dussaq, Alex M.; Kennell, Timothy, Jr.; Eustace, Nicholas J.; Anderson, Joshua C.; Almeida, Jonas S.; Willey, Christopher D.			Kinomics toolbox-A web platform for analysis and viewing of kinomic peptide array data	PLOS ONE			English	Article							MICROARRAY EXPERIMENT MIAME; MINIMUM INFORMATION; CANCER; CHALLENGES; STRATEGIES	Kinomics is an emerging field of science that involves the study of global kinase activity. As kinases are essential players in virtually all cellular activities, kinomic testing can directly examine protein function, distinguishing kinomics from more remote, upstream components of the central dogma, such as genomics and transcriptomics. While there exist several different approaches for kinomic research, peptide microarrays are the most widely used and involve kinase activity assessment through measurement of phosphorylation of peptide substrates on the array. Unfortunately, bioinformatic tools for analyzing kinomic data are quite limited necessitating the development of accessible open access software in order to facilitate standardization and dissemination of kinomic data for scientific use. Here, we examine and present tools for data analysis for the popular PamChip (R) (PamGene International) kinomic peptide microarray. As a result, we propose (1) a procedural optimization of kinetic curve data capture, (2) new methods for background normalization, (3) guidelines for the detection of outliers during parameterization, and (4) a standardized data model to store array data at various analytical points. In order to utilize the new data model, we developed a series of tools to implement the new methods and to visualize the various data models. In the interest of accessibility, we developed this new toolbox as a series of JavaScript procedures that can be utilized as either server side resources (easily packaged as web services) or as client side scripts (web applications running in the browser). The aggregation of these tools within a Kinomics Toolbox provides an extensible web based analytic platform that researchers can engage directly and web programmers can extend. As a proof of concept, we developed three analytical tools, a technical reproducibility visualizer, an ANOVA based detector of differentially phosphorylated peptides, and a heatmap display with hierarchical clustering.	[Dussaq, Alex M.; Eustace, Nicholas J.; Anderson, Joshua C.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Kennell, Timothy, Jr.] Univ Alabama Birmingham, Dept Med, Informat Inst, Birmingham, AL 35294 USA; [Almeida, Jonas S.] SUNY Stony Brook, Sch Med, Dept Biomed Informat, Stony Brook, NY 11794 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Willey, CD (corresponding author), Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA.	cwilley@uabmc.edu		Eustace, Nicholas/0000-0002-2483-7863; Dussaq, Alex/0000-0001-9946-9551	NIGMS MSTP [T32GM008361]; American Cancer Society [RSG-14-071-01-TBG]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039] Funding Source: NIH RePORTER	NIGMS MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIGMS MSTP T32GM008361, https://www.nigms.nih.gov/Pages/default.aspx; Research Scholar Grant from the American Cancer Society (grant no. RSG-14-071-01-TBG), https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/research-scholar-grants.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116388; Anderson JC, 2014, RADIOTHER ONCOL, V111, P468, DOI 10.1016/j.radonc.2014.04.010; Arsenault R, 2011, PROTEOMICS, V11, P4595, DOI 10.1002/pmic.201100296; Baharani A, 2017, BIOCHEM SOC T, V45, P65, DOI 10.1042/BST20160163; Baker M, 2017, NATURE, V541, P269, DOI 10.1038/541269a; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Dussaq Alex, 2016, J Proteomics Bioinform, V9, P151; Gilbert AN, 2016, JOVE-J VIS EXP, DOI 10.3791/54026; Giorgianni F, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4040037; Hilhorst R, 2013, PEPTIDE MICROARRAYS, P259, DOI [10.1007/978-1-62703-284-1_21, DOI 10.1007/978-1-62703-284-1_21]; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P46, DOI 10.1159/000335914; Humphrey SJ, ALL RIGHTS RESERVED, V33, P990, DOI [10.1038/nbt.3327, DOI 10.1038/NBT.3327]; Isayeva T, 2015, MODERN PATHOL, V28, P631, DOI 10.1038/modpathol.2014.149; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Li Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002429; Naji F, 2013, BIONAVIGATOR SOFTWAR, P1; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Peppelenbosch MP, 2016, EXPERT REV PROTEOMIC, V13, P571, DOI 10.1080/14789450.2016.1187564; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Rohrbach TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140870; Rosenberger AFN, 2016, J ALZHEIMERS DIS, V49, P927, DOI 10.3233/JAD-150429; Thilakarathne PJ, 2011, BIOINFORMATICS, V27, P2859, DOI 10.1093/bioinformatics/btr475; Trost B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080837; Venerando A, 2017, FEBS J, V284, P1936, DOI 10.1111/febs.14014; Versele M, 2009, MOL CANCER THER, V8, P1846, DOI 10.1158/1535-7163.MCT-08-1029; Vyse S, 2017, IUCRJ, V4, P119, DOI 10.1107/S2052252516020546; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	29	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2018	13	8							e0202139	10.1371/journal.pone.0202139	http://dx.doi.org/10.1371/journal.pone.0202139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HU	30130366	Green Published, gold, Green Submitted			2022-12-26	WOS:000442284500008
J	Boivin-Jahns, V; Uhland, K; Holthoff, HP; Beyersdorf, N; Kocoski, V; Kerkau, T; Munch, G; Lohse, MJ; Ungerer, M; Jahns, R				Boivin-Jahns, Valerie; Uhland, Kerstin; Holthoff, Hans-Peter; Beyersdorf, Niklas; Kocoski, Vladimir; Kerkau, Thomas; Muench, Goetz; Lohse, Martin J.; Ungerer, Martin; Jahns, Roland			Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure	PLOS ONE			English	Article							BETA(1)-ADRENERGIC RECEPTORS; AUTOANTIBODIES; PATHOGENESIS; STIMULATION; LOOP	Rationale Despite advances in pharmacotherapy, heart failure still incurs significant morbidity and mortality. Stimulating antibodies directed against the secondextracellular loop of the human beta(1)-adrenergic receptor (anti-beta(1)EC2) cause myocyte damage and heart failure in rats. This receptor domain is 100% homologous between rats and humans. Objective beta(1)EC2-mimicking cyclopeptides (25-meric) markedly improved the development and/or course of anti-beta(1)EC2-mediated cardiomyopathy. Further developments should be investigated. Methods and results The shortened 18-meric cyclic peptide COR-1, in which one of the two disulphide bonds was removed to enable reproducible GMP production, can also be used to treat cardiomyopathic rats. Echocardiography, catheterization and histopathology of the rat hearts revealed that monthly intravenous administrations of COR-1 almost fully reversed the cardiomyopathic phenotype within 6 months at doses of 1 to 4 mg/kg body weight. Administration of COR-1 resulted in markedly reduced anti-beta(1)EC2-expressing memory B lymphocytes in the spleen despite continued antigenic boosts, but did not significantly decrease overall peripheral anti-beta(1)EC2 titers. COR-1 did not induce any anti-beta(1)EC2 or other immune response in naive rats (corresponding to findings in healthy human volunteers). It did not cause any toxic side effects in GLP studies in dogs, rats or mice, and the "no observed adverse effect level" (NOAEL) exceeded the therapeutic doses by 100-fold. Conclusion The second generation immunomodulating epitope-mimicking cyclopeptide COR-1 (also termed JNJ-5442840) offers promise to treat immune-mediated cardiac diseases.	[Boivin-Jahns, Valerie; Lohse, Martin J.; Jahns, Roland] Univ Wurzburg, Dept Pharmacol & Toxicol, CHFC, Univ Hosp Wurzburg, Wurzburg, Germany; [Uhland, Kerstin; Holthoff, Hans-Peter; Muench, Goetz; Ungerer, Martin] Procorde, Martinsried, Germany; [Beyersdorf, Niklas; Kocoski, Vladimir; Kerkau, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Jahns, Roland] CHFC, Interdisciplinary Bank Biomat & Data Wurzburg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Ungerer, M (corresponding author), Procorde, Martinsried, Germany.	ungerer@procorde.com	Kerkau, Thomas/ABE-8007-2020; Lohse, Martin J/A-7160-2012; Beyersdorf, Niklas/S-3845-2016	Lohse, Martin J/0000-0002-0599-3510; Beyersdorf, Niklas/0000-0002-9236-5415	Deutsche Forschungsgemeinschaft [Ja 706/4-1]; Bundesministerium fur Bildung und Forschung [GoBio 315031, 01ES0901]; Corimmun GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Corimmun GmbH	This work was funded by Deutsche Forschungsgemeinschaft (Ja 706/4-1 to Roland Jahns); Bundesministerium fur Bildung und Forschung (GoBio 315031 to Roland Jahns); Bundesministerium fur Bildung und Forschung (01ES0901 to Roland Jahns). Martin Ungerer is affiliated to Procorde. At the time of the study, Corimmun GmbH provided support in the form of salary for author MU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117589; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dandel M, 2012, IMMUNOBIOLOGY, V217, P511, DOI 10.1016/j.imbio.2011.07.012; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Freedman NJ, 2004, J CLIN INVEST, V113, P1379, DOI 10.1172/JCI200421748; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Haberland A, 2016, EUR J PHARMACOL, V789, P37, DOI 10.1016/j.ejphar.2016.06.061; Hebert TE, 2007, CARDIOVASC RES, V76, P5, DOI 10.1016/j.cardiores.2007.07.011; Holthoff HP, 2017, ENDOCRINOLOGY, V158, P2376, DOI 10.1210/en.2016-1845; Holthoff HP, 2012, CIRC RES, V111, P675, DOI 10.1161/CIRCRESAHA.112.272682; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Jahns R, 1996, EUR J PHARMACOL, V316, P111, DOI 10.1016/S0014-2999(96)00654-1; Jahns R, 2000, J AM COLL CARDIOL, V36, P1280, DOI 10.1016/S0735-1097(00)00881-0; Jahns R, 2006, TRENDS CARDIOVAS MED, V16, P20, DOI 10.1016/j.tcm.2005.11.002; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; MAGNUSSON Y, 1989, CLIN EXP IMMUNOL, V78, P42; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McConville P, 2005, AM J PHYSIOL-ENDOC M, V289, pE412, DOI 10.1152/ajpendo.00049.2004; Munch G, 2012, EUR J HEART FAIL, V14, P1230, DOI 10.1093/eurjhf/hfs118; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nnane IP, 2016, CLIN PHARMACOKINET, V55, P225, DOI 10.1007/s40262-015-0309-8; Staudt A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.027; Stork S, 2006, AM HEART J, V152, P697, DOI 10.1016/j.ahj.2006.05.004; Stork S, 2016, CARDIOVASC PHARM OPE, V5, P4, DOI DOI 10.4172/2329-6607.1000190; TZARTOS SJ, 1982, P NATL ACAD SCI-BIOL, V79, P188, DOI 10.1073/pnas.79.1.188; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wallukat G, 2002, NEW ENGL J MED, V347, P1806, DOI 10.1056/NEJM200211283472220; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; XIAO RP, 1993, CIRC RES, V73, P286, DOI 10.1161/01.RES.73.2.286; Yoshikawa T, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_B.8	37	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0201160	10.1371/journal.pone.0201160	http://dx.doi.org/10.1371/journal.pone.0201160			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125285	Green Published, gold			2022-12-26	WOS:000442202100004
J	Schneider, MP; Hilgers, KF; Schmid, M; Hubner, S; Nadal, J; Seitz, D; Busch, M; Haller, H; Kottgen, A; Kronenberg, F; Baid-Agrawal, S; Schlieper, G; Schultheiss, U; Sitter, T; Sommerer, C; Titze, S; Meiselbach, H; Wanner, C; Eckardt, KU				Schneider, Markus P.; Hilgers, Karl F.; Schmid, Matthias; Huebner, Silvia; Nadal, Jennifer; Seitz, David; Busch, Martin; Haller, Hermann; Koettgen, Anna; Kronenberg, Florian; Baid-Agrawal, Seema; Schlieper, Georg; Schultheiss, Ulla; Sitter, Thomas; Sommerer, Claudia; Titze, Stephanie; Meiselbach, Heike; Wanner, Christoph; Eckardt, Kai-Uwe		GCKD Study Investigators	Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study	PLOS ONE			English	Article							CHRONIC RENAL-INSUFFICIENCY; RESISTANT HYPERTENSION; DRUG ADHERENCE; TRIAL; CKD; POPULATION; MANAGEMENT; HEALTH	We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30 +/- 60 mL/min/1.73 m 2 or overt proteinuria in the presence of an eGFR> 60 mL/min/1.73 m 2. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 +/- 20.4 /79.3 +/- 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use.	[Schneider, Markus P.; Hilgers, Karl F.; Huebner, Silvia; Seitz, David; Titze, Stephanie; Meiselbach, Heike; Eckardt, Kai-Uwe] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Nephrol & Hypertens, Erlangen, Germany; [Schneider, Markus P.] Paracelsus Private Med Univ, Dept Nephrol & Hypertens, Klinikum Nurnberg, Nurnberg, Germany; [Schmid, Matthias; Nadal, Jennifer] Univ Bonn, Dept Med Biometry Informat & Epidemiol IMBIE, Bonn, Germany; [Busch, Martin] Friedrich Schiller Univ, Univ Hosp Jena, Dept Internal Med 3, Jena, Germany; [Haller, Hermann] Hannover Med Sch, Div Nephrol, Hannover, Germany; [Koettgen, Anna; Schultheiss, Ulla] Univ Freiburg, Div Genet Epidemiol, Inst Biometry & Stat, Fac Med, Freiburg, Germany; [Koettgen, Anna; Schultheiss, Ulla] Univ Freiburg, Med Ctr, Freiburg, Germany; [Kronenberg, Florian; Eckardt, Kai-Uwe] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Baid-Agrawal, Seema] Charite Univ Med Berlin, Dept Nephrol & Med Intens Care, Berlin, Germany; [Schlieper, Georg] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, Aachen, Germany; Univ Freiburg, Div Nephrol, Fac Med, Freiburg, Germany; [Sitter, Thomas] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nephrol, Munich, Germany; [Sommerer, Claudia] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Wanner, Christoph] Univ Hosp Wurzburg, Dept Med, Div Nephrol, Wurzburg, Germany	University of Erlangen Nuremberg; Klinikum Nurnberg Nord; University of Bonn; Friedrich Schiller University of Jena; Hannover Medical School; University of Freiburg; University of Freiburg; Medical University of Innsbruck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; University of Freiburg; University of Munich; Ruprecht Karls University Heidelberg; University of Wurzburg	Schneider, MP (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Nephrol & Hypertens, Erlangen, Germany.; Schneider, MP (corresponding author), Paracelsus Private Med Univ, Dept Nephrol & Hypertens, Klinikum Nurnberg, Nurnberg, Germany.	markus.schneider@uk-erlangen.de	Baid-Agrawal, Seema/HGB-9062-2022; Weissensteiner, Hansi/AAT-1789-2021; Kronenberg, Florian/B-1736-2008	Baid-Agrawal, Seema/0000-0001-8192-1079; Weissensteiner, Hansi/0000-0002-2871-8669; Kronenberg, Florian/0000-0003-2229-1120; Schmid, Matthias/0000-0002-0788-0317; Schneider, Markus/0000-0002-5265-8088; Schultheiss, Ulla T/0000-0002-7541-5310	German Ministry of Education and Research (BMBF) [01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821, 01ER 0122]; KfH Foundation for Preventive Medicine	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); KfH Foundation for Preventive Medicine	The GCKD study is funded by grants from the German Ministry of Education and Research (BMBF) (www.gesundheitsforschung-bmbf.de; grant numbers 01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821, and 01ER 0122) and the KfH Foundation for Preventive Medicine (http://www.kfh-stiftung-praeventivmedizin.de/) to K-UE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnier M, 2015, NEPHROL DIAL TRANSPL, V30, P39, DOI 10.1093/ndt/gfu015; Burnier M, 2013, HYPERTENSION, V62, P218, DOI 10.1161/HYPERTENSIONAHA.113.00687; Busse R, 2014, GERMANY HLTH SYST RE, V16, P1; Chertow GM, 2016, J AM SOC NEPHROL, V27, P40, DOI 10.1681/ASN.2015101125; Drawz P, 2016, CLIN J AM SOC NEPHRO, V11, P207, DOI 10.2215/CJN.03940415; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gorostidi M, 2013, AM J KIDNEY DIS, V62, P285, DOI 10.1053/j.ajkd.2013.03.025; Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286; KDIGO, 2012, KIDNEY INT, V2, DOI 10.1038/kisup.2012.46; Konta T, 2012, AM J HYPERTENS, V25, P342, DOI 10.1038/ajh.2011.217; Landray MJ, 2010, AM J KIDNEY DIS, V56, P1082, DOI 10.1053/j.ajkd.2010.07.016; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Marin R, 2006, J HYPERTENS, V24, P395, DOI 10.1097/01.hjh.0000202819.48577.a1; Martinez-Castelao A, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-53; Muntner P, 2010, AM J KIDNEY DIS, V56, P447, DOI 10.1053/j.ajkd.2010.02.348; Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Peralta CA, 2005, HYPERTENSION, V45, P1119, DOI 10.1161/01.HYP.0000164577.81087.70; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Rossignol P, 2015, LANCET, V386, P1588, DOI 10.1016/S0140-6736(15)00418-3; Sarafidis PA, 2008, AM J MED, V121, P332, DOI 10.1016/j.amjmed.2007.11.025; Schmitt KE, 2010, AM J NEPHROL, V32, P541, DOI 10.1159/000321688; Schneider MP, 2014, CURR OPIN NEPHROL HY, V23, P180, DOI 10.1097/01.mnh.0000441050.36783.ba; Sonawane KB, 2015, CLIN THER, V37, P188, DOI 10.1016/j.clinthera.2014.11.011; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Taler SJ, 2016, AM J KIDNEY DIS, V68, P15, DOI 10.1053/j.ajkd.2016.02.045; Thomas G, 2016, HYPERTENSION, V67, P387, DOI 10.1161/HYPERTENSIONAHA.115.06487; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294; Wheeler DC, 2013, KIDNEY INT, V83, P377, DOI 10.1038/ki.2012.425	35	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202604	10.1371/journal.pone.0202604	http://dx.doi.org/10.1371/journal.pone.0202604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125326	Green Published, gold, Green Submitted			2022-12-26	WOS:000442202100036
J	Arias-Orozco, P; Bastida-Gonzalez, F; Cruz, L; Villatoro, J; Espinoza, E; Zarate-Segura, PB; Recuenco, S				Arias-Orozco, Patricia; Bastida-Gonzalez, Fernando; Cruz, Lilian; Villatoro, Jacqueline; Espinoza, Eduardo; Berenice Zarate-Segura, Paola; Recuenco, Sergio			Spatiotemporal analysis of canine rabies in El Salvador: Violence and poverty as social factors of canine rabies	PLOS ONE			English	Article							DISEASE; ELIMINATION; MORTALITY	Background The incidence of canine rabies cases in El Salvador has decreased in the last decade since the establishment of intense control programs, such as massive vaccination campaigns implemented by the Ministry of Health. Socioeconomic crises in recent years have limited the access to certain areas across the country and have impacted surveillance and prevention campaigns, which places the country at risk for a resurgence of canine rabies.We aimedto describe the spatiotemporal patterns of canine rabies and its association with critical social factors in El Salvador from 2005 to 2014. Method We included 459 cases of canine rabies. Several socioeconomic, demographic, and surveillance variables were modeled using a Poisson regression to evaluate their associations with the incidence of canine rabies. Spatial scan statistics were adjusted or unadjusted with covariates and applied to identify statistically significant clusters of canine rabies. Finally, a canine rabies risk map was created. Results A positive association and higher risk of canine rabies were found for low poverty zones, where it is suspected that urban slums contribute to ongoing rabies transmission (RR = 7.74). Violence had a negative association with rabies (RR = 0.663), which is likely due to reporting bias. Significant clusters were identified in all five epidemiological regions, and the Eastern region had the highest risk (RR = 50.62). The influences of the selected variables in cluster detection were confirmed by the adjusted analysis. Higher-risk townships were distributed from the Western to the Eastern regions of the country. Conclusion Social factors are determinants of rabies in El Salvador and play a major role in national spatial patterns of the disease. There are high-risk areas for canine rabies across the country, and there were two persistent rabies foci during the study period. Examining the role of social factors can provide better insight into rabies in vulnerable countries, and socioeconomic factors can be key elements in developing better policies and interventions for rabies control.	[Arias-Orozco, Patricia; Bastida-Gonzalez, Fernando; Berenice Zarate-Segura, Paola] Inst Politecn Nacl, Escuela Super Med, Lab Med Traslac, Santo Tomas, Miguel Hidalgo, Mexico; [Bastida-Gonzalez, Fernando] Lab Estatal Salud Publ Estado Mexico, Lab Biol Mol, Paseo Tollocan S-N, Toluca, Mexico; [Cruz, Lilian; Villatoro, Jacqueline] Ministerio Salud, Lab Nacl Referencia, Unidad Zoonosis, San Salvador, El Salvador; [Espinoza, Eduardo] Ministerio Salud Salvador, San Salvador, El Salvador; [Recuenco, Sergio] INS, Ctr Nacl Salud Publ, Lima, Peru	Instituto Politecnico Nacional - Mexico; Instituto Nacional de Salud - Peru	Recuenco, S (corresponding author), INS, Ctr Nacl Salud Publ, Lima, Peru.	sergio.recuenco@gmail.com		Arias-Orozco, Patricia/0000-0002-0771-6373; Bastida, Fernando/0000-0002-1670-5879; Zarate-Segura, Paola Berenice/0000-0002-5639-9503	National Health Institute; National Center of Public Health in Peru	National Health Institute; National Center of Public Health in Peru	The authors thank to the National Reference Laboratory of the Ministry of Health in El Salvador and thank the health staff Dra. Lilian Cruz y Dra. Jacqueline Villatoro, for providing the surveillance information of canine rabies. We also thank to the National Health Institute and the National Center of Public Health in Peru for their support and training in the statistical analysis and Geographical Information Systems References.	Arias S, 2010, ATLAS POBREZA OPULEN; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Briggs DJ, 2003, RABIES, P401; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Cruz J., 2005, ESTUDIOS CENTROAMERI, V60, P1155, DOI [10.51378/eca.v60i685-686.5125, DOI 10.51378/ECA.V60I685-686.5125]; Department J, 2014, MED LEG HOM ORG JUD; DYGESTIC, 2007, CENS POBL VIV; Ferguson EA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18232; FLACSO MINEC PNUD, 2010, MAP POBR URB EXCL SO, V1; FLACSO PES, 2005, MAP POBR POL SOC FOC; Franka R, 2013, ANTIVIR RES, V100, P220, DOI 10.1016/j.antiviral.2013.07.004; FUNDAUNGO, 2013, ATL VIOL SALV 2009 2; GEOPORTAL-CNR, 2014, SERV GEOGR COB GEOGR; Haining R., 2003, SPATIAL DATA ANAL TH; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hume M, 2007, DEV PRACT, V17, P739, DOI 10.1080/09614520701628121; Knobel DL, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P591, DOI 10.1016/B978-0-12-396547-9.00017-1; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2009, SOFTWARE SPATIAL SPA; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; McCullagh P, 1989, GEN LINEAR MODELS; Meslin FX, 2013, ANTIVIR RES, V98, P291, DOI 10.1016/j.antiviral.2013.03.011; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Vigilato MAN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0143; Organization PAH, 2013, 14 M DIR NAT PROGR R; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; PAHO, 2004, EL RAB HUM TRANSM PE; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; POLJUVE I, 2009, VIOLENCIA JUVENIL MA; Recuenco S, 2008, PREV VET MED, V86, P30, DOI 10.1016/j.prevetmed.2008.03.001; Recuenco S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-14; Savenije W, 2007, DEFINICION CATEGORIZ; Schneider MC, 2007, CAD SAUDE PUBLICA, V23, P2049, DOI 10.1590/S0102-311X2007000900013; Schneider MC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000964; Statacorp, 2013, STAT 13 BAS REF MAN; StataCorp, 2013, STAT REL 13; Tenzin, 2012, PREV VET MED, V107, P21, DOI 10.1016/j.prevetmed.2012.05.003; Townsend SE, 2013, COMP IMMUNOL MICROB, V36, P249, DOI 10.1016/j.cimid.2012.10.008; United Nations Office on Drugs and Crime (UNODC), 2013, GLOB STUD HOM 2013; WHO, 2013, WHO EXP CONS RAB 2 R; WHO, 2011, SOC DET APPR PUBL HL; Yao HW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003502	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0201305	10.1371/journal.pone.0201305	http://dx.doi.org/10.1371/journal.pone.0201305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118490	gold, Green Published, Green Submitted			2022-12-26	WOS:000442282700008
J	Rooney, J; Oshida, K; Vasani, N; Vallanat, B; Ryan, N; Chorley, BN; Wang, XT; Bell, DA; Wu, KC; Aleksunes, LM; Klaassen, CD; Kensler, TW; Corton, JC				Rooney, John; Oshida, Keiyu; Vasani, Naresh; Vallanat, Beena; Ryan, Natalia; Chorley, Brian N.; Wang, Xuting; Bell, Douglas A.; Wu, Kai C.; Aleksunes, Lauren M.; Klaassen, Curtis D.; Kensler, Thomas W.; Corton, J. Christopher			Activation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor	PLOS ONE			English	Article							HEPATOCYTE-SPECIFIC DELETION; ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION PROFILES; OXIDATIVE STRESS; LIFE-SPAN; GENDER-DIFFERENCES; SIGNAL TRANSDUCER; SEX-DIFFERENCES; PPAR-ALPHA; PHASE-II	The transcription factor Nrf2 (encoded by Nfe2l2) induces expression of numerous detoxifying and antioxidant genes in response to oxidative stress. The cytoplasmic protein Keap1 interacts with and represses Nrf2 function. Computational approaches were developed to identify factors that modulate Nrf2 in a mouse liver gene expression compendium. Forty-eight Nrf2 biomarker genes were identified using profiles from the livers of mice in which Nrf2 was activated genetically in Keap1-null mice or chemically by a potent activator of Nrf2 signaling. The rank-based Running Fisher statistical test was used to determine the correlation between the Nrf2 biomarker genes and a test set of 81 profiles with known Nrf2 activation status demonstrating a balanced accuracy of 96%. For a large number of factors examined in the compendium, we found consistent relationships between activation of Nrf2 and feminization of the liver transcriptome through suppression of the male-specific growth hormone (GH)-regulated transcription factor STAT5b. The livers of female mice exhibited higher Nrf2 activation than male mice in untreated or chemical-treated conditions. In male mice, Nrf2 was activated by treatment with ethinyl estradiol, whereas in female mice, Nrf2 was suppressed by treatment with testosterone. Nrf2 was activated in 5 models of disrupted GH signaling containing mutations in Pit1, Prop1, Ghrh, Ghrhr, and Ghr. Out of 59 chemical treatments that activated Nrf2, 36 exhibited STAT5b suppression in the male liver. The Nrf2-STAT5b coupling was absent in in vitro comparisons of chemical treatments. Treatment of male and female mice with 11 chemicals that induce oxidative stress led to activation of Nrf2 to greater extents in females than males. The enhanced basal and inducible levels of Nrf2 activation in females relative to males provides a molecular explanation for the greater resistance often seen in females vs. males to age-dependent diseases and chemical-induced toxicity.	[Rooney, John; Oshida, Keiyu; Vasani, Naresh; Vallanat, Beena; Ryan, Natalia; Chorley, Brian N.; Corton, J. Christopher] US EPA, NHEERL, Res Triangle Pk, NC 27711 USA; [Wang, Xuting; Bell, Douglas A.] NIEHS, Immun Inflammat & Dis Lab, Res Triangle Pk, NC 27711 USA; [Wu, Kai C.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Aleksunes, Lauren M.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ USA; [Klaassen, Curtis D.] Univ Washington, Seattle, WA 98195 USA; [Kensler, Thomas W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Kensler, Thomas W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Oshida, Keiyu] Toray Industries Ltd, Kamakura, Kanagawa, Japan; [Wu, Kai C.] Janssen Pharmaceut, Spring House, PA USA	United States Environmental Protection Agency; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Kansas; University of Kansas Medical Center; Rutgers State University New Brunswick; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Toray Industries, Inc.; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Corton, JC (corresponding author), US EPA, NHEERL, Res Triangle Pk, NC 27711 USA.	corton.chris@epa.gov	Kensler, Thomas W/D-8686-2014; Vasani, Naresh B/K-9082-2019; Bell, Douglas A/C-7687-2019	Kensler, Thomas W/0000-0002-6676-261X; Bell, Douglas A/0000-0001-7700-0840; Vasani, Naresh/0000-0003-4814-3310; Aleksunes, Lauren/0000-0002-0032-1037	NIH [R35 CA197222]; U.S. Environmental Protection Agency; Toray Industries; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100475] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Environmental Protection Agency(United States Environmental Protection Agency); Toray Industries(Toray Industries, Inc.); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	TWK is supported by NIH grant R35 CA197222. The information in this document has been funded in part by the U.S. Environmental Protection Agency. Toray Industries provided support in the form of salary for KO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Axelsson AS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4477; Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bruns DR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732596; Budinsky RA, 2014, CRIT REV TOXICOL, V44, P83, DOI 10.3109/10408444.2013.835787; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Corton JC, 2018, ARCH TOXICOL, V92, P83, DOI 10.1007/s00204-017-2094-7; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Du K, 2014, TOXICOL APPL PHARM, V281, P58, DOI 10.1016/j.taap.2014.09.002; Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Frank SJ, 2001, GROWTH HORM IGF RES, V11, P201, DOI 10.1054/ghir.2001.0237; FUSE Y, 2017, MOLECULES, V22, DOI DOI 10.3390/M0LECULES22030436; Goetz ME, 2008, CANCER LETT, V266, P73, DOI 10.1016/j.canlet.2008.02.035; Guo Y, 2015, J BIOL CHEM, V290, P14754, DOI 10.1074/jbc.M115.642124; Harada H, 2001, J APPL PHYSIOL, V91, P2816, DOI 10.1152/jappl.2001.91.6.2816; HARTMAN ML, 1993, HORM RES, V40, P37, DOI 10.1159/000183766; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015, DOI 10.1152/ajpheart.2000.279.3.H1015; Kadekar S, 2012, TOXICOL PATHOL, V40, P1160, DOI 10.1177/0192623312446527; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lee CC, 2000, HEPATO-GASTROENTEROL, V47, P446; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu H, 2013, P NATL ACAD SCI USA, V110, P19065, DOI 10.1073/pnas.1318247110; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mazziotti G, 2013, NAT REV ENDOCRINOL, V9, P265, DOI 10.1038/nrendo.2013.5; Meinhardt UJ, 2007, ENDOCRIN METAB CLIN, V36, P57, DOI 10.1016/j.ecl.2006.11.009; Montano MM, 1997, P NATL ACAD SCI USA, V94, P2581, DOI 10.1073/pnas.94.6.2581; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148308; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150284; Oshida K, 2015, TOXICOLOGY, V336, P99, DOI 10.1016/j.tox.2015.07.005; Oshida Keiyu, 2015, Nucl Recept Signal, V13, pe002, DOI 10.1621/nrs.13002; Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Pohjanvirta R, 2012, TOXICOL APPL PHARM, V262, P167, DOI 10.1016/j.taap.2012.04.032; Pohjanvirta R, 2009, TOXICOL APPL PHARM, V236, P166, DOI 10.1016/j.taap.2009.01.005; Rohrer PR, 2014, DRUG METAB DISPOS, V42, P1663, DOI 10.1124/dmd.114.059006; Rooney JP, 2017, TOXICOL SCI, V160, P15, DOI 10.1093/toxsci/kfx153; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Roy D, 2007, J TOXICOL ENV HEAL B, V10, P235, DOI 10.1080/15287390600974924; Ryan N, 2016, TOXICOL SCI, V151, P88, DOI 10.1093/toxsci/kfw026; Shen GX, 2005, PHARM RES-DORDR, V22, P1805, DOI 10.1007/s11095-005-7546-8; Simon R, 2007, CANCER INFORM, V3, P11; Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496; Sumi D, 2009, J TOXICOL SCI, V34, P627, DOI 10.2131/jts.34.627; Sun LY, 2013, ELIFE, V2, DOI 10.7554/eLife.01098; Sun LY, 2011, FASEB J, V25, P398, DOI 10.1096/fj.10-164376; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vanhees K, 2013, FREE RADICAL BIO MED, V57, P154, DOI 10.1016/j.freeradbiomed.2012.12.021; Veldhuis J D, 2001, Growth Horm IGF Res, V11 Suppl A, pS25, DOI 10.1016/S1096-6374(01)80005-8; Vina J, 2011, CURR PHARM DESIGN, V17, P3959, DOI 10.2174/138161211798764942; Wang S, 2015, TOXICOL SCI, V144, P393, DOI 10.1093/toxsci/kfv006; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Wiegand Heike, 2009, Cancer Genomics & Proteomics, V6, P85; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Xu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044237; Yao YA, 2010, BREAST CANCER RES TR, V124, P585, DOI 10.1007/s10549-010-1023-8; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100	84	29	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0200004	10.1371/journal.pone.0200004	http://dx.doi.org/10.1371/journal.pone.0200004			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114225	gold, Green Published, Green Submitted			2022-12-26	WOS:000441850400004
J	Rueda-Contreras, MD; Romero-Arias, JR; Aragon, JL; Barrio, RA				Rueda-Contreras, Mara D.; Romero-Arias, Jose R.; Aragon, Jose L.; Barrio, Rafael A.			Curvature-driven spatial patterns in growing 3D domains: A mechanochemical model for phyllotaxis	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; MECHANICAL SIGNALS; PLANT DEVELOPMENT; TURING PATTERNS; AUXIN; GROWTH; MORPHOGENESIS; INSTABILITY; ELONGATION; EXPRESSION	Here we discuss the formation of phyllotactic patterns in the shoot apical meristem (SAM) of plants, where the spatial distribution of the phytohormone auxin determines phyllotaxis in a domain that is growing and changing in time. We assume that the concentration of auxin modifies the mechanical properties of the domain and that the mechanical stress field in the SAM orients the flux of auxin. To study this problem we propose a mechanism for pattern formation in growing domains with variable curvature. The dynamics of chemicals is modeled by a reaction-diffusion system that produces a three dimensional pattern of chemical concentrations that changes the stress field in the domain while growing. The growth process is modeled by a phase-field order parameter which determines the location of the boundaries of the domain. This field is coupled to the chemical concentration through a curvature term that affects the local mechanical stress in the domain. The local stress changes in turn modify the chemical patterns. Our model constitutes a useful and novel approach in theoretical biology, as many developmental processes in organisms seem to be affected by the changes of curvature, size, mechanical stress and other physical aspects. Several patterns seen in many plants are reproduced under certain conditions by our model.	[Rueda-Contreras, Mara D.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla 76230, Queretaro, Mexico; [Rueda-Contreras, Mara D.; Aragon, Jose L.] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Juriquilla 76230, Queretaro, Mexico; [Romero-Arias, Jose R.] Univ Michoacana, CONACYT, Inst Fis & Matemat, Ciudad Univ, Morelia 58040, Michoacan, Mexico; [Romero-Arias, Jose R.] Univ Nacl Autonoma Mexico, Inst Matemat, Campus Juriquilla, Juriquilla 76230, Queretaro, Mexico; [Barrio, Rafael A.] Univ Nacl Autonoma Mexico, Inst Fis, Ciudad De Mexico 01000, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Aragon, JL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Juriquilla 76230, Queretaro, Mexico.	jlaragon@unam.mx	BARRIO MARTÍN, ROCIO/L-1603-2014; Aragón, José L./S-5942-2019; Vera, José L Aragón/L-4421-2017; Romero-Arias, Jose Roberto/ABY-7195-2022	BARRIO MARTÍN, ROCIO/0000-0001-7662-0714; Aragón, José L./0000-0001-7719-2942; Vera, José L Aragón/0000-0001-7719-2942; Romero-Arias, Jose Roberto/0000-0002-3423-6455	Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (MX); PASPA; dgapa.unam.mx [2]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, DGAPA (PASPA) UNAM; Consejo Nacional de Ciencia y Tecnologia [371688];  [PAPIIT-IN110817]	Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (MX); PASPA; dgapa.unam.mx; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, DGAPA (PASPA) UNAM; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	This work was supported by Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (MX); PAPIIT-IN110817; PASPA; dgapa.unam.mx (JLA) 2, and Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, DGAPA (PASPA) UNAM for a sabbatical grant, RAB. Mara D Rueda-Contreras is a doctoral student from Programa de Doctorado en Ciencias Biomedicas in Instituto de Neurobiologia at Universidad Nacional Autonoma de Mexico, and received fellowship 371688 from Consejo Nacional de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; Barrio RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013523; Aragon JL, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026201; Aragon JL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051913; ARCURI P, 1986, J MATH BIOL, V24, P141; Barreira R, 2011, J MATH BIOL, V63, P1095, DOI 10.1007/s00285-011-0401-0; Barrio RA, 2018, MODELLING ELECT ACTI, P51; Barrio RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003026; Bernal R, 2007, J MECH MATER STRUCT, V2, P1157, DOI 10.2140/jomms.2007.2.1157; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Campelo F, 2007, EUR PHYS J-SPEC TOP, V143, P101, DOI 10.1140/epjst/e2007-00077-y; Campelo F, 2006, EUR PHYS J E, V20, P37, DOI 10.1140/epje/i2005-10079-5; CHAPLAIN MAJ, 1990, J THEOR BIOL, V146, P177, DOI 10.1016/S0022-5193(05)80134-1; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7, DOI 10.1007/s003440000003; Elliott CM, 2012, MILAN J MATH, V80, P469, DOI 10.1007/s00032-012-0195-6; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Gierer A, 1988, SYNERGETICS DYNAMIC, P151; Gjorgjeva J., 2007, DIS CONT DYN SYS  S, P436; Gjorgjieva J, 2006, THESIS; Green PB, 1996, SEMIN CELL DEV BIOL, V7, P903, DOI 10.1006/scdb.1996.0110; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2010, CURR OPIN GENET DEV, V20, P454, DOI 10.1016/j.gde.2010.04.009; Hamant O, 2010, NEW PHYTOL, V185, P369, DOI 10.1111/j.1469-8137.2009.03100.x; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; HEJNOWICZ Z, 1977, Z PFLANZENPHYSIOL, V81, P409, DOI 10.1016/S0044-328X(77)80176-1; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hernandez-Hernandez V, 2018, PHYS BIOL, V15, DOI 10.1088/1478-3975/aaac99; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kelly WJ, 2003, AM J BOT, V90, P1131, DOI 10.3732/ajb.90.8.1131; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kwiatkowska D, 2004, AM J BOT, V91, P1277, DOI 10.3732/ajb.91.9.1277; Landau L D, 1980, STAT PHYS, V5; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lazaro GR, 2015, CHEM PHYS LIPIDS, V185, P46, DOI 10.1016/j.chemphyslip.2014.08.001; Leppanen T, 2011, SPATIO TEMPORAL DYNA; Leppanen T, 2004, COMPUTATIONAL STUDIE; Lintilhac P, 1947, AM J BOT, V61, P135, DOI [10.1002/j.1537-2197.1974.tb06038.x, DOI 10.1002/J.1537-2197.1974.TB06038.X]; Lintilhac P, 1947, AM J BOT, V61, P230, DOI [10.1002/j.1537-2197.1974.tb10770.x, DOI 10.1002/J.1537-2197.1974.TB10770.X]; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Lynch TM, 1997, DEV BIOL, V181, P246, DOI 10.1006/dbio.1996.8462; Madzvamuse A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.043307; Madzvamuse A, 2009, NONLINEAR ANAL-THEOR, V71, pE2250, DOI 10.1016/j.na.2009.05.027; MARTYNOV LA, 1975, J THEOR BIOL, V52, P471, DOI 10.1016/0022-5193(75)90013-2; Mercker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082617; Mirabet V, 2011, ANNU REV PLANT BIOL, V62, P365, DOI 10.1146/annurev-arplant-042110-103852; Moulia B, 2006, AM J BOT, V93, P1477, DOI 10.3732/ajb.93.10.1477; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Nakayama N, 2012, CURR BIOL, V22, P1468, DOI 10.1016/j.cub.2012.06.050; Newell AC, 2008, J THEOR BIOL, V251, P421, DOI 10.1016/j.jtbi.2007.11.036; Niklas K.J., 2012, PLANT PHYS; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pennybacker M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.248104; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Plaza R., 2004, J DYN DIFFER EQU, V16, P1093, DOI DOI 10.1007/S10884-004-7834-8; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; RIVIER N, 1984, J PHYS-PARIS, V45, P49, DOI 10.1051/jphys:0198400450104900; Rivier N, 2016, EUR PHYS J E, V39, DOI 10.1140/epje/i2016-16007-8; Sampathkumar A, 2014, CURR BIOL, V24, pR475, DOI 10.1016/j.cub.2014.03.014; Saunders P T, 1992, COLLECTED WORKS AM T, V3; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Shani E, 2006, CURR OPIN PLANT BIOL, V9, P484, DOI 10.1016/j.pbi.2006.07.008; Shipman PD, 2005, J THEOR BIOL, V236, P154, DOI 10.1016/j.jtbi.2005.03.007; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Steele CR, 2000, J APPL MECH-T ASME, V67, P237, DOI 10.1115/1.1305333; Thompson D.W, 1917, GROWTH FORM; Traas J, 2013, DEVELOPMENT, V140, P249, DOI 10.1242/dev.074740; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Urdy S, 2012, BIOL REV, V87, P786, DOI 10.1111/j.1469-185X.2012.00221.x; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	79	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201746	10.1371/journal.pone.0201746	http://dx.doi.org/10.1371/journal.pone.0201746			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114231	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400025
J	Barbolosi, D; Crona, J; Serre, R; Pacak, K; Taieb, D				Barbolosi, Dominique; Crona, Joakim; Serre, Raphael; Pacak, Karel; Taieb, David			Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies	PLOS ONE			English	Article							FAMILIAL PHEOCHROMOCYTOMA; SUCCINATE-DEHYDROGENASE; MUTATIONS; GENE; PENETRANCE; TUMORIGENESIS; CANCER	Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL). Although truncation of the succinate dehydrogenase complex is thought to be the disease causing mechanism in both disorders, SDHB and SDHD patients exihibit different phenotypes. These phenotypic differences are currently unexplained by molecular genetics. The aim of this study is to compare disease dynamics in these two conditions via a Markov chain model based on 4 clinically-defined steady states. Our model corroborates at the population level phenotypic observations in SDHB and SDHD carriers and suggests potential explanations associated with the probabilities of disease maintenance and regression. In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00). However, when SDHB-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with SDHD counterparts (p = 0.17 vs 0.89). By constrast, almost all SDHD patients develop PGL (mainly head and neck) that persist throughout their lifetime. However, compared to SDHB, maintenance of metastatic lesions seems to be less effective for SDHD (p = 0.83 vs 0.11). These findings align with data suggesting that SDHD-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues. By contrast, the higher number of genetic abnormalities required for tumor initiation and maintenance in SDHB PPGL result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival. These proposed differences in disease progression dynamics between SDHB and SDHD diseases provide new cues for future exploration of SDHx PPGL behavior, offering considerations for future specific therapeutic and prevention strategies.	[Barbolosi, Dominique; Serre, Raphael] Aix Marseille Univ, Sch Pharm Marseille, SMARTc, Marseille, France; [Barbolosi, Dominique; Serre, Raphael; Taieb, David] Aix Marseille Univ, INSERM UMR U1068, CNRS UMR 7258, Canc Res Ctr Marseille, Marseille, France; [Crona, Joakim] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, NIH, Bethesda, MD USA; [Taieb, David] Aix Marseille Univ, Dept Nucl Med, La Timone Univ Hosp, European Ctr Res Med Imaging, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Barbolosi, D (corresponding author), Aix Marseille Univ, Sch Pharm Marseille, SMARTc, Marseille, France.; Barbolosi, D; Taieb, D (corresponding author), Aix Marseille Univ, INSERM UMR U1068, CNRS UMR 7258, Canc Res Ctr Marseille, Marseille, France.; Taieb, D (corresponding author), Aix Marseille Univ, Dept Nucl Med, La Timone Univ Hosp, European Ctr Res Med Imaging, Marseille, France.	dominique.barbolosi@univ-amu.fr; david.taieb@ap-hm.fr	Crona, Joakim/D-3474-2013; Taieb, Pr. David/M-5219-2017	Crona, Joakim/0000-0003-0677-4894; 	NIH [ZIAHD008735-18]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The paper has been supported partially by the NIH ZIAHD008735-18 (Pr Karel Pacak). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KA, 2018, J MED GENET, V55, P384, DOI 10.1136/jmedgenet-2017-105127; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bayoumi AM, 2000, JNCI-J NATL CANCER I, V92, P1731, DOI 10.1093/jnci/92.21.1731; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2006, J CLIN ENDOCR METAB, V91, P827, DOI 10.1210/jc.2005-1862; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cascon A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv053; Castro-Vega LJ, 2014, HUM MOL GENET, V23, P2440, DOI 10.1093/hmg/ddt639; Crona J, 2017, ENDOCR REV, V38, P489, DOI 10.1210/er.2017-00062; Crona J, 2015, CLIN CANCER RES, V21, P4451, DOI 10.1158/1078-0432.CCR-14-2854; Duffy S W, 1997, J Natl Cancer Inst Monogr, P93; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Garrigue P, 2017, J NUCL MED, V58, P1749, DOI 10.2967/jnumed.117.192674; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hes FJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-92; Hoekstra AS, 2017, ONCOTARGET, V8, P14525, DOI 10.18632/oncotarget.14649; Hoekstra AS, 2015, SEMIN CELL DEV BIOL, V43, P117, DOI 10.1016/j.semcdb.2015.05.011; Jochmanova I, 2013, JNCI-J NATL CANCER I, V105, P1270, DOI 10.1093/jnci/djt201; Kugelberg J, 2014, WORLD J SURG, V38, P724, DOI 10.1007/s00268-013-2373-2; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Lloyd RV, 2017, WHO CLASSIFICATION T, V4th; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Portschy PR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju160; Rijken JA, 2018, CLIN GENET, V93, P60, DOI 10.1111/cge.13055; Schiavi F, 2010, HUM MUTAT, V31, P761, DOI 10.1002/humu.21269; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Solis DC, 2009, CLIN GENET, V75, P354, DOI 10.1111/j.1399-0004.2009.01157.x; Timmers HJLM, 2012, J NATL CANCER I, V104, P700, DOI 10.1093/jnci/djs188; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201303	10.1371/journal.pone.0201303	http://dx.doi.org/10.1371/journal.pone.0201303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106970	Green Published, gold, Green Submitted			2022-12-26	WOS:000441662800006
J	Harper, KD; Quinn, C; Eccles, J; Ramsey, F; Rehman, S				Harper, Katharine D.; Quinn, Courtney; Eccles, Joshua; Ramsey, Frederick; Rehman, Saqib			Administration of intravenous antibiotics in patients with open fractures is dependent on emergency room triaging	PLOS ONE			English	Article							INFECTION; PROPHYLAXIS; MANAGEMENT; CLASSIFICATION; COMPLICATIONS; WOUNDS; TRAUMA; TIBIA; RISK	Background Recent literature has demonstrated that emergent administration of antibiotics is perhaps more critical than even emergent debridement. Most recent studies recommend patients receive antibiotics no later than 1 hour after injury to prevent infection. The objective of this study is to evaluate the time to antibiotic administration after patients with open fractures arrive to a trauma center depending on triaging team. Methods A retrospective study at a level 1 Trauma center from January 2013 to March 2015 where 117 patients with open fractures were evaluated. Patients who presented with open fractures of the extremities or pelvis were considered. Subjects were identified using Current Procedural Terminology (CPT) codes. Patients aged 18 and older were analyzed for Gustilo type, antibiotics administered in the emergency room (ER), presence of an antibiotic allergy, post-operative antibiotic regimen and number of debridements, among others. Additionally, whether a patient was triaged by ER doctors or trauma surgeons (and made a trauma activation) was evaluated. Outcome measurements included time to intravenous (IV) antibiotic administration and time to surgical debridement. Results Patients received IV cefazolin a median of 17 minutes after arrival. Eighty-five patients who were made trauma activations received cefazolin 14 minutes after arrival while 24 non-trauma patients received cefazolin 53 minutes after arrival (p = <0.0001). The median time to gentamicin administration for all patients was 180 minutes. Patients not upgraded to a trauma received gentamicin 263 minutes after arrival, while patients upgraded received gentamicin 176 minutes after arrival. There was no statistically significant difference between the timing to cefazolin or gentamicin based on Gustilo type. Conclusions Overall, patients that arrive at our institution with open fractures receive IV cefazolin significantly faster when trauma surgeons evaluate the patient. Additionally, delays in gentamicin administration are demonstrated in both triaging groups. This is due to the fact that cefazolin is stocked in the hospital ER, while gentamicin is commonly not due to weight-based dosing requirements precluding a standard dose. Improvements can be made to antibiotic administration of non-trauma patients and those requiring gentamicin via improved education and awareness of open fractures.	[Harper, Katharine D.; Quinn, Courtney; Rehman, Saqib] Temple Univ Hosp & Med Sch, Dept Orthopaed Surg & Sports Med, Philadelphia, PA 19140 USA; [Eccles, Joshua] Temple Univ, Sch Med, Lewis Katz Sch Med, Philadelphia, PA USA; [Ramsey, Frederick] Temple Univ, Sch Med, Dept Clin Sci, Lewis Katz Sch Med, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Harper, KD (corresponding author), Temple Univ Hosp & Med Sch, Dept Orthopaed Surg & Sports Med, Philadelphia, PA 19140 USA.	katharineharpermd@gmail.com		Harper, Katharine/0000-0003-2130-2414				Barton Cassie A, 2012, Int J Crit Illn Inj Sci, V2, P57, DOI 10.4103/2229-5151.97268; BRUMBACK RJ, 1994, J BONE JOINT SURG AM, V76A, P1162, DOI 10.2106/00004623-199408000-00006; Carver DC, 2017, ORTHOP CLIN N AM, V48, P137, DOI [10.1016/j.ocl.2016.12.005, 10.1016/j.oc1.2016.12.005]; Collinge CA, 2014, J ORTHOP TRAUMA, V28, P620, DOI 10.1097/BOT.0000000000000090; DELLINGER EP, 1988, ARCH SURG-CHICAGO, V123, P1320, DOI 10.1001/archsurg.1988.01400350034004; Dunkel N, 2013, BONE JOINT J, V95B, P831, DOI 10.1302/0301-620X.95B6.30114; Gosselin R A, 2004, Cochrane Database Syst Rev, pCD003764, DOI 10.1002/14651858.CD003764.pub2; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Harris AM, 2009, J ORTHOP TRAUMA, V23, P1, DOI 10.1097/BOT.0b013e31818e43dd; Hauser Carl J, 2006, Surg Infect (Larchmt), V7, P379; Hoff WS, 2011, J TRAUMA, V70, P751, DOI 10.1097/TA.0b013e31820930e5; Hull PD, 2014, BONE JOINT J, V96B, P379, DOI 10.1302/0301-620X.96B3.32380; Johnson JP, 2017, J ORTHOP TRAUMA, V31, P596, DOI 10.1097/BOT.0000000000000928; Lack WD, 2015, J ORTHOP TRAUMA, V29, P1, DOI [10.1097/BOT.0000000000000262, 10.1016/j.mporth.2014.12.008]; PATZAKIS MJ, 1989, CLIN ORTHOP RELAT R, P36; Patzakis MJ, 2000, J ORTHOP TRAUMA, V14, P529, DOI 10.1097/00005131-200011000-00002; Zalavras CG, 2007, J BONE JOINT SURG AM, V89A, P884, DOI 10.2106/00004623-200704000-00027	18	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							0202013	10.1371/journal.pone.0202013	http://dx.doi.org/10.1371/journal.pone.0202013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106964	gold, Green Published, Green Submitted			2022-12-26	WOS:000441662800022
J	Ntirampeba, D; Neema, I; Kazembe, L				Ntirampeba, D.; Neema, I.; Kazembe, L.			Modelling spatio-temporal patterns of disease for spatially misaligned data: An application on measles incidence data in Namibia from 2005-2014	PLOS ONE			English	Article								Background Making inferences about measles distribution patterns at small area level is vital for more focal targeted intervention. However, in statistical literature, the analysis of originally collected data on one resolution with the purpose to make inferences on a different level of spatial resolution is referred to as the misalignment problem. In Namibia the measles data were available in aggregated format at regional level for the period 2005 to 2014. This leads to a spatial misalignment problem if the purpose is to make decisions at constituency level. Moreover, although data on risk covariates of measles could be obtained at constituency level, they were not available each year between 2005 and 2014. Thus, assuming that covariates were constant through the study period would induce measurement errors which might have effects on the analysis results. This paper presents a spatio-temporal model through a multi-step approach in order to deal with misalignment and measurement error. Methods For the period 2005-2014, measles data from the Ministry of Health and Social Services (MoHSS) were analysed in two steps. First, a multi-step approach was applied to correct spatial misalignment in the data. Second, a classical measurement error model was fitted to account for measurement errors. The time effects were specified using a non-parametric formulation for the linear trend through first order random walk. An interaction between area and time was modelled through type I and type II interaction structures. Results The study showed that there was high variation in measles risk across constituencies and as well as over the study period (2005-2014). Furthermore, the risk of measles was found to be associated with (i) the number of people aged between 0 and 24 years, (ii) the percentages of women aged 15-49 with an educational level more than secondary, (iii) the percentages of children age 12-23 months who received measles vaccine, (iv) the percentages of malnourished children under 5 years, and (vi) the measles cases for each previous year. Conclusion The study showed some of the determinants of measles risk and revealed areas at high risk through disease mapping. Additionally, the study showed a non-linear temporal distribution of measles risk over the study period. Finally, it was shown that ignoring the measurement errors may yield misleading results. It was recommended that group and geographically targeted intervention, prevention and control strategies can be tailored on the basis these findings.	[Ntirampeba, D.] Polytech Namibia, Dept Math & Stat, Windhoek, Namibia; [Neema, I.] NSA, Windhoek, Namibia; [Kazembe, L.] Univ Namibia, Dept Stat & Populat Studies, Pionerspk, Windhoek, Namibia	Namibia University of Science & Technology; University of Namibia	Ntirampeba, D (corresponding author), Polytech Namibia, Dept Math & Stat, Windhoek, Namibia.	dntirampeba@nust.na			DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [Africa Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) programme] [107754/Z/15/Z-DELTAS]; UK government	DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [Africa Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) programme]; UK government	This work was supported through the DELTAS Africa Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant 107754/Z/15/Z-DELTAS Africa Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) programme] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government.	Adika VO, 2013, J RES NURSING MIDWIF, V2, P6; BESAG J, 1993, J ROY STAT SOC B MET, V55, P25; Beyene B. B., 2016, Journal of Public Health and Epidemiology, V8, P27; Bhella D, 2007, MEASLES VIRUS NUCLEO; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI [10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001]; Brownwright TK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4961-9; Buonaccorsi JP, 2010, INTERD STAT, P1, DOI 10.1201/9781420066586; Chiogna M, 2004, STAT METHODS APPL, V13, P55; Doungmo Goufo EF, 2014, ABSTR APPL ANAL, V2014, P22; Dwyer-Lindgren L, 2014, SPAT SPATIO-TEMPORAL, V11, P89, DOI 10.1016/j.sste.2014.09.002; Filia A, 2013, KOREA, V1, P4; Finley AO, 2014, METHODS ECOL EVOL, V5, P514, DOI 10.1111/2041-210X.12189; Gotway CA, 2002, J AM STAT ASSOC, V97, P632, DOI 10.1198/016214502760047140; Gustafson JP, 2004, MEASUREMENT ERROR MI; Heymann D., 2015, CONTROL COMMUNICABLE, V20th; Jasem J, 2012, INT J INFECT DIS, V16, pE166, DOI 10.1016/j.ijid.2011.11.002; Kumar V., 2003, HLTH POPULATION PERS, V26, P135; Lawson A B., 2009, HIERARCHICAL MODELLI; Ntirampeba D, 2017, CLIN EPIDEMIOL GLOB, V5, P190, DOI 10.1016/j.cegh.2017.01.002; Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325; Wattanasaruch P, 2012, SONGKLANAKARIN J SCI, V34; WHO, 2015, REP MEASL CAS INC RA; World Health Organization, 2014, WHO WARNS PROGR EL M; Zhu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079334	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201700	10.1371/journal.pone.0201700	http://dx.doi.org/10.1371/journal.pone.0201700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102712	Green Published, Green Submitted, gold			2022-12-26	WOS:000441452200016
J	Ralli, M; Greco, A; Boccassini, A; Altissimi, G; Di Paolo, C; Falasca, V; De Virgilio, A; Polimeni, A; Cianfrone, G; de Vincentiis, M				Ralli, Massimo; Greco, Antonio; Boccassini, Armando; Altissimi, Giancarlo; Di Paolo, Carlo; Falasca, Vincenzo; De Virgilio, Armando; Polimeni, Antonella; Cianfrone, Giancarlo; de Vincentiis, Marco			Subtyping patients with somatic tinnitus: Modulation of tinnitus and history for somatic dysfunction help identify tinnitus patients with temporomandibular joint disorders	PLOS ONE			English	Article							HEARING-LOSS; MUSCLE-CONTRACTIONS; COCHLEAR NUCLEUS; QUESTIONNAIRE; HYPERACUSIS; PREVALENCE; DEPRESSION; MANAGEMENT; NECK	Objective Determine in a cohort of patients with normal hearing and chronic tinnitus if self-reported history for temporomandibular joint (TMJ) dysfunction and a positive modulation of tinnitus in the TMJ region could be suggestive of an underlying TMJ disorder. Patients and methods The study included 226 patients presenting to the Head and Neck Service of our University Hospital. Following audiological and somatic tinnitus evaluation, patients were divided into two groups. The study group (n = 134) included subjects that met both the following criteria: A) a self-reported history for TMJ dysfunction and B) a positive modulation of tinnitus following somatic maneuvers in the TMJ region. The control group (n = 92) included patients with similar demographic and tinnitus characteristics that did not meet the proposed criteria for somatic tinnitus. Afterwards, patients underwent clinical TMJ evaluation in the Service of Clinical Gnathology of our University. Results One hundred thirty-one patients (57.9%) received a clinical diagnosis of TMJ disorder according to DC/TMD Axis I; 79.1% in the study group and 27.2% in the control group. Ninety-five (42.1%) patients were negative for TMJ disorders; 20.9% in the study group and 72.8% in the control group. A significantly higher number of TMJ disorders was found in patients in the study group compared to the control group (p<0.0001). Most patients had joint disorders (67.2%), followed by other (29.8%) and pain disorders (29%). Logistic regression analysis in the study group showed that female gender was more prevalent in patients with TMJ disorders. Conclusion Our findings in patients with chronic tinnitus and normal hearing suggest that self-reported history for somatic dysfunction and modulation of tinnitus, when occurring simultaneously in the TMJ region, can be useful to preliminarily identify patients with TMJ disorders.	[Ralli, Massimo; Boccassini, Armando; Di Paolo, Carlo; Polimeni, Antonella; de Vincentiis, Marco] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Rome, Italy; [Ralli, Massimo] Univ Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Greco, Antonio; Altissimi, Giancarlo; Falasca, Vincenzo; Cianfrone, Giancarlo] Sapienza Univ Rome, Dept Sense Organs, Rome, Italy; [De Virgilio, Armando] Humanitas Clin & Res Ctr, Otorhinolaryngol Unit, Rozzano, MI, Italy	Sapienza University Rome; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Sapienza University Rome; IRCCS Humanitas Research Hospital	Ralli, M (corresponding author), Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Rome, Italy.; Ralli, M (corresponding author), Univ Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA.	massimo.ralli@uniroma1.it	De Virgilio, Armando/G-8710-2012	De Virgilio, Armando/0000-0003-0738-8223; Ralli, Massimo/0000-0001-8776-0421				Abel MD, 2004, CRANIO, V22, P181, DOI 10.1179/crn.2004.024; [Anonymous], 1979, JAMA-J AM MED ASSOC, V241, P2055; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Bernhardt O, 2004, J ORAL REHABIL, V31, P311, DOI 10.1046/j.1365-2842.2003.01249.x; Bhatt J, 2015, OTOL NEUROTOL, V36, P1459, DOI 10.1097/MAO.0000000000000827; Buergers R, 2014, J PROSTHET DENT, V111, P222, DOI 10.1016/j.prosdent.2013.10.001; BUSH FM, 1987, J PROSTHET DENT, V58, P495, DOI 10.1016/0022-3913(87)90282-4; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; de Felicio CM, 2008, CRANIO, V26, P118; Saldanha ADD, 2012, CRANIO, V30, P166, DOI 10.1179/crn.2012.026; Ferendiuk E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/824684; Fernandes G, 2013, ARQ NEURO-PSIQUIAT, V71, P943, DOI 10.1590/0004-282X20130191; Fernandes G, 2013, J OROFAC PAIN, V27, P14, DOI 10.11607/jop.921; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Haider HF, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00207; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Lee CF, 2016, EUR ARCH OTO-RHINO-L, V273, P203, DOI 10.1007/s00405-015-3491-2; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Moller AR, 2011, TEXTBOOK OF TINNITUS, P29, DOI 10.1007/978-1-60761-145-5_5; Nelting M, 2002, LARYNGO RHINO OTOL, V81, P327, DOI 10.1055/s-2002-28342; Passi Stefania, 2008, Int Tinnitus J, V14, P26; Ralli M, 2014, ACTA OTORHINOLARYNGO, V34, P198; Ralli Massimo, 2017, Int Tinnitus J, V21, P112, DOI 10.5935/0946-5448.20170022; Ralli M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188255; Ralli M, 2017, J INT MED RES, V45, P1459, DOI 10.1177/0300060516672124; Ralli M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091035; Ralli M, 2017, J INT MED RES, V45, P933, DOI 10.1177/0300060517707673; Ralli M, 2016, AUDIOL NEURO-OTOL, V21, P372, DOI 10.1159/000452472; RUBINSTEIN B, 1990, Journal of Craniomandibular Disorders, V4, P186; RUBINSTEIN B, 1987, Cranio, V5, P254; Sanchez TG, 2007, ANN OTO RHINOL LARYN, V116, P30, DOI 10.1177/000348940711600106; Sanchez TG, 2011, CLINICS, V66, P1089, DOI 10.1590/S1807-59322011000600028; Sanchez TG, 2002, AUDIOL NEURO-OTOL, V7, P370, DOI 10.1159/000066155; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Sheppard A, 2014, ACTA OTORHINOLARYNGO, V34, P79; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Simmons Richard, 2008, Seminars in Hearing, V29, P361, DOI 10.1055/s-0028-1095895; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; Tullberg M, 2006, ACTA ODONTOL SCAND, V64, P89, DOI 10.1080/00016350500377842; Tuz HH, 2003, AM J ORTHOD DENTOFAC, V123, P620, DOI 10.1016/S0889-5406(03)00153-7; VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006; VERNON J, 1992, EUR ARCH OTO-RHINO-L, V249, P93; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Vielsmeier V, 2011, OTOLARYNG HEAD NECK, V145, P748, DOI 10.1177/0194599811413376; Ward J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126254; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Won JY, 2013, AUDIOL NEURO-OTOL, V18, P261, DOI 10.1159/000351685; Wright, 1997, Int Tinnitus J, V3, P55; Wu C, 2016, HEARING RES, V334, P20, DOI 10.1016/j.heares.2015.06.005	55	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202050	10.1371/journal.pone.0202050	http://dx.doi.org/10.1371/journal.pone.0202050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102717	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200029
J	Sanneh, B; Kebbeh, A; Jallow, HS; Camara, Y; Mwamakamba, LW; Ceesay, IF; Barrow, E; Sowe, FO; Sambou, SM; Baldeh, I; Jallow, A; Raul, MAJ; Andremont, A				Sanneh, Bakary; Kebbeh, Abou; Jallow, Haruna S.; Camara, Yaya; Mwamakamba, Lusubilo Witson; Ceesay, Ida Fatou; Barrow, Ebrima; Sowe, Fatou O.; Sambou, Sana M.; Baldeh, Ignatius; Jallow, Alpha; Raul, Matheu Alvarez Jorge; Andremont, Antoine			Prevalence and risk factors for faecal carriage of Extended Spectrum beta-lactamase producing Enterobacteriaceae among food handlers in lower basic schools in West Coast Region of The Gambia	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; COMMUNITY; EPIDEMIOLOGY; RESISTANCE; OUTBREAK; STRAINS; SENEGAL	Background The isolation of Extended spectrum beta lactamase (ESBLs) producing Enterobacteriaceae among food handlers and their implication as sources of food borne outbreaks are a public health concern. This study seeks to investigate the prevalence of faecal carriage of these bacteria among food handlers in the West Coast Region of The Gambia. Method This study enrolled 600 participants from 60 Lower Basic Schools in West Coast Region of the country. Stool samples collected from the participants were presumptively screened for the ESBLs producing Enterobacteriaceae, using Drigalski agar, supplemented with 2mg/L cefotaxime. The bacterial colonies that grew on each Drigalski agar were tested for ESBL production by the double disk synergy test as recommended by Clinical and Laboratory Standard Institute (CLSI-2015). The confirmatory analysis for ESBL was determined as the zone of inhibition of cefotaxime and/or ceftazidime to >= 5mm from that of cefotaxime /clavulanicacid and/or ceftazidime/clavulanic acid. The presumptive screening of isolates for AmpC phenotypes was done by testing the organism against cefoxitin. The prevalence of the ESBL carriage was presented in percentages. The association of risk factors to the faecal carriage of ESBLs producing Enterobacteriaceae was performed by Pearson Chisquared and Fishers Exact at (p <= 0.05). Result The prevalence of faecal carriage ESBL producing Enterobacteriaceae among food handlers was 5.0% (28/565). We found 50% (14/28) and 3.57% (1/28) ESBL producing bacteria were presumptive AmpC and carbapenemase resistance phenotype. The most abundant ESBL producing Enterobacteriaceae were Klebsiella spp 32.1% (9/28) and Escherichia spp 28.6% (8/28). The use of antibiotics in the last 3 months was found to be significantly associated (P = 0.012) with the faecal carriage of ESBLs producing Enterobacteriaceae. Conclusion The prevalence of faecal carriage of ESBLs producing Enterobacteriaceae among food handlers in the Gambia is low. The history to use of the antibiotics in the last three months was found to be significantly associated with this prevalence. Therefore, the institution of a robust antimicrobial surveillance and treatment of patients with such infections are necessary to curb the spread of these multidrug resistant bacteria in the country. Rational prescription and usage of the antibiotics especially cephalosporin should be advocated both in public and private health facilities.	[Sanneh, Bakary; Kebbeh, Abou; Jallow, Haruna S.; Ceesay, Ida Fatou; Baldeh, Ignatius] Minist Hlth & Social Welf, Natl Publ Hlth Labs, Kotu Layout, Kotu, Gambia; [Camara, Yaya; Sambou, Sana M.] Minist Hlth & Social Welf, Epidemiol & Dis Control Dept, Kotu Layout, Kotu, Gambia; [Mwamakamba, Lusubilo Witson] WHO, Intercountry Support Team, Ouagadougou, Burkina Faso; [Barrow, Ebrima] Edward Francis Small Teaching Hosp, Med Microbiol Lab, Banjul, Gambia; [Sowe, Fatou O.] Minist Hlth & Social Welf, Dept Hlth Promot & Educ, Kotu Layout, Kotu, Gambia; [Jallow, Alpha] WHO, CountryOff, Banjul, Gambia; [Raul, Matheu Alvarez Jorge] WHO, Food Safety & Zoonoses Dept, Geneva, Switzerland; [Andremont, Antoine] Univ Paris Diderot, Med Sch, Paris, France	World Health Organization; World Health Organization; World Health Organization; UDICE-French Research Universities; Universite Paris Cite	Sanneh, B (corresponding author), Minist Hlth & Social Welf, Natl Publ Hlth Labs, Kotu Layout, Kotu, Gambia.	sheikbakary@yahoo.com	KEBBEH, ABOU/AHC-1785-2022	KEBBEH, ABOU/0000-0003-4365-4680; Sanneh, Bakary/0000-0002-6188-9283	World Health Organization, Afro GFN/AGISAR PROJECT [SPHQ14-APW-3979]	World Health Organization, Afro GFN/AGISAR PROJECT	This study was supported by the World Health Organization, Afro GFN/AGISAR PROJECT with grant number SPHQ14-APW-3979, and the grant was received by Mr Bakary Sanneh.	[Anonymous], 2017, GAMB STAND TREATM GU; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bradbury RS, 2015, T ROY SOC TROP MED H, V109, P334, DOI 10.1093/trstmh/trv020; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Calbo E, 2011, CLIN INFECT DIS, V52, P743, DOI 10.1093/cid/ciq238; Chaw PS, 2017, GESUNDHEITSWESEN, V79, pV; Davis Gregg S, 2016, Curr Environ Health Rep, V3, P128, DOI 10.1007/s40572-016-0089-9; Dione MM, 2011, J INFECT DEV COUNTR, V5, P765, DOI 10.3855/jidc.1512; Nguyen DP, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8182096; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Jallow HS., 2017, INT J FOOD SCI BIOTE, V2, P1; Juma AO, 2018, THESIS; Kang CI, 2012, J CLIN MICROBIOL, V50, P312, DOI 10.1128/JCM.06002-11; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Kurz MSE, 2017, TROP MED INT HEALTH, V22, P210, DOI 10.1111/tmi.12824; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P1244, DOI 10.1093/jac/dkn093; Lewis JS, 2015, PERFORMANCE STANDARD; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Moremi N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184592; Nakane K, 2016, APPL ENVIRON MICROB, V82, P1818, DOI 10.1128/AEM.02929-15; Okomo UA, 2018, THESIS; Ouattara M. B., 2014, African Journal of Microbiology Research, V8, P2758; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P3135, DOI 10.1128/AAC.00139-09; Secka O, 2013, ANTIMICROB AGENTS CH, V57, P1231, DOI 10.1128/AAC.00517-12; Stewardson AJ, 2014, INFECT CONT HOSP EP, V35, P375, DOI 10.1086/675609; Sumareh Nyima, 2014, THESIS; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Woerther PL, 2013, ANTIMICROB AGENTS CH, V57, P5060, DOI 10.1128/AAC.00848-13; Yaici L, 2017, INT J FOOD MICROBIOL, V245, P66, DOI 10.1016/j.ijfoodmicro.2017.01.011	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0200894	10.1371/journal.pone.0200894	http://dx.doi.org/10.1371/journal.pone.0200894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102698	Green Published, Green Submitted			2022-12-26	WOS:000441452200004
J	Almeida, C; De Wreede, A; Lamaziere, A; Ayala-Sanmartin, J				Almeida, Claudia; De Wreede, Anaelle; Lamaziere, Antonin; Ayala-Sanmartin, Jesus			Cholesterol-pyrene as a probe for cholesterol distribution on ordered and disordered membranes: Determination of spectral wavelengths	PLOS ONE			English	Article							LIPID RAFTS; FLUORESCENCE SPECTROSCOPY; SPHINGOLIPID DOMAINS; LATERAL ORGANIZATION; BIOLOGICAL-MEMBRANES; PLASMA-MEMBRANES; GIANT VESICLES; CELL-MEMBRANES; PHASE; TEMPERATURE	Biological membranes contain a large variety of lipids species compartmentalized in different domains heterogeneous in size, composition and dynamics. Cholesterol induces membrane ordered domains thanks to its affinity for saturated lipids. Membrane domains had been studied with fluorescent probes either linked to phospholipids and proteins or as individual fluorophore. However, no efficient formulation of a cholesterol probe has been available so far. Herein, we described a cholesterol-pyrene probe behaviour in heterogeneous membranes. We characterised the pyrene fluorescence spectra in liquid-ordered (Lo) and liquid-disordered (Ld) membranes. Using statistical multivariate analysis, we found out the most appropriate wavelengths for membrane domains studies. 373 nm and 379 nm were the most discriminant wavelengths to follow the liquid-ordered and the liquid-disordered environments. Cholesterol clustering behaviour was quantified by the modulation of the cholesterol-pyrene excimers peak (474 nm). In liquid-ordered membranes at low temperature, cholesterol-pyrene was found as multimers and as monomers. At high temperature, the liquid-ordered status of the membrane decreases and cholesterol-pyrene tends to cluster. In liquid-disordered membranes, cholesterol-pyrene was present mostly as monomers and the small quantity of excimers increased with temperature. Cholesterol-pyrene was used to test the ceramide effect on membranes, and presented a behaviour in agreement with the cholesterol behaviour reported in the literature. Overall, the presented data show that cholesterol-pyrene is an efficient sensor to study liquid ordered and liquid disordered organisation in membranes.	[Almeida, Claudia; De Wreede, Anaelle; Lamaziere, Antonin; Ayala-Sanmartin, Jesus] PSL Univ, Sorbonne Univ, Hop St Antoine,LBM, AP HP,CNRS,Ecole Normale Super,INSERM,Lab Biomol, Paris, France	Arts et Metiers Institute of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Ayala-Sanmartin, J (corresponding author), PSL Univ, Sorbonne Univ, Hop St Antoine,LBM, AP HP,CNRS,Ecole Normale Super,INSERM,Lab Biomol, Paris, France.	jesus.ayala-sanmartin@upmc.fr	Lamaziere, Antonin/AAH-2285-2022; DE ALMEIDA, CARLOS CAETANO/K-4265-2016; Lamaziere, Antonin/AFM-0000-2022	DE ALMEIDA, CARLOS CAETANO/0000-0002-3215-5731; Ayala-Sanmartin, Jesus/0000-0002-1215-0159				Almeida C, 2016, BBA-BIOMEMBRANES, V1858, P2584, DOI 10.1016/j.bbamem.2016.07.012; Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Barenholz Y, 1996, J BIOL CHEM, V271, P3085, DOI 10.1074/jbc.271.6.3085; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brzustowicz MR, 2002, BIOCHEMISTRY-US, V41, P12509, DOI 10.1021/bi0262808; Busto JV, 2010, BIOPHYS J, V99, P1119, DOI 10.1016/j.bpj.2010.05.032; Chachaty C, 2005, BIOPHYS J, V88, P4032, DOI 10.1529/biophysj.104.054155; CHONG PLG, 1994, BIOPHYS J, V66, P2029, DOI 10.1016/S0006-3495(94)80996-8; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Goni FM, 2014, BBA-BIOMEMBRANES, V1838, P1467, DOI 10.1016/j.bbamem.2014.01.006; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Kim SD, 2002, MACROMOLECULES, V35, P5943, DOI 10.1021/ma0200322; Kinnun JJ, 2018, BIOPHYS J, V114, P380, DOI 10.1016/j.bpj.2017.11.023; Lagane B, 2002, BIOPHYS CHEM, V95, P7, DOI 10.1016/S0301-4622(01)00235-6; Lamaziere Antonin, 2009, Commun Integr Biol, V2, P223; Le Guyader L, 2007, BIOPHYS J, V93, P4462, DOI 10.1529/biophysj.107.112821; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; LIANOS P, 1979, PHOTOCHEM PHOTOBIOL, V30, P355, DOI 10.1111/j.1751-1097.1979.tb07368.x; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Lozano MM, 2013, J AM CHEM SOC, V135, P5620, DOI 10.1021/ja310831m; Maniti O, 2014, INT J BIOCHEM CELL B, V50, P73, DOI 10.1016/j.biocel.2014.02.017; Maniti O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015819; Molugu TR, 2017, CHEM REV, V117, P12087, DOI 10.1021/acs.chemrev.6b00619; PASENKIEWICZGIERULA M, 1991, BIOCHIMIE, V73, P1311, DOI 10.1016/0300-9084(91)90094-H; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pinto SN, 2013, BBA-BIOMEMBRANES, V1828, P2099, DOI 10.1016/j.bbamem.2013.05.011; Rosetti CM, 2017, BBA-BIOMEMBRANES, V1859, P789, DOI 10.1016/j.bbamem.2017.01.030; Schmid F, 2017, BBA-BIOMEMBRANES, V1859, P509, DOI 10.1016/j.bbamem.2016.10.021; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sezgin E, 2016, J LIPID RES, V57, P299, DOI 10.1194/jlr.M065326; Sezgin E, 2015, CHEMPHYSCHEM, V16, P1387, DOI 10.1002/cphc.201402794; Shaikh SR, 2002, BIOCHEMISTRY-US, V41, P10593, DOI 10.1021/bi025712b; Silva LC, 2009, BIOPHYS J, V96, P3210, DOI 10.1016/j.bpj.2008.12.3923; Staneva G, 2008, BBA-BIOMEMBRANES, V1778, P2727, DOI 10.1016/j.bbamem.2008.07.025; Taniguchi Y, 2006, BBA-BIOMEMBRANES, V1758, P145, DOI 10.1016/j.bbamem.2006.02.026; Tessier C, 2009, COLLOID SURFACE B, V74, P293, DOI 10.1016/j.colsurfb.2009.07.033; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; Wang Y, 2016, BBA-BIOMEMBRANES, V1858, P2846, DOI 10.1016/j.bbamem.2016.08.005; WARIS R, 1988, ANALYST, V113, P1465, DOI 10.1039/an9881301465; Wilson-Ashworth HA, 2006, BIOPHYS J, V91, P4091, DOI 10.1529/biophysj.106.090860; WINNIK FM, 1992, J PHYS CHEM-US, V96, P1967, DOI 10.1021/j100183a079; WINNIK FM, 1993, CHEM REV, V93, P587, DOI 10.1021/cr00018a001; Wustner D, 2016, CHEM PHYS LIPIDS, V199, P106, DOI 10.1016/j.chemphyslip.2016.03.003	51	6	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201373	10.1371/journal.pone.0201373	http://dx.doi.org/10.1371/journal.pone.0201373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096186	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500016
J	Huckstepp, RTR; Cardoza, KP; Henderson, LE; Feldman, JL				Huckstepp, Robert T. R.; Cardoza, Kathryn P.; Henderson, Lauren E.; Feldman, Jack L.			Distinct parafacial regions in control of breathing in adult rats	PLOS ONE			English	Article							RETROTRAPEZOID NUCLEUS NEURONS; BRAIN-STEM; OPTOGENETIC STIMULATION; PREINSPIRATORY NEURONS; PREBOTZINGER COMPLEX; ACTIVE EXPIRATION; RHYTHM GENERATION; BLOOD-PRESSURE; INSPIRATION; MEDULLA	Recently, based on functional differences, we subdivided neurons juxtaposed to the facial nucleus into two distinct populations, the parafacial ventral and lateral regions, i.e., pF(v) and pF(L). Little is known about the composition of these regions, i.e., are they homogenous or heterogeneous populations? Here, we manipulated their excitability in spontaneously breathing vagotomized urethane anesthetized adult rats to further characterize their role in breathing. In the pF(L), disinhibition or excitation decreased breathing frequency (f) with a concomitant increase of tidal volume (V-T), and induced active expiration; in contrast, reducing excitation had no effect. This result is congruent with pF(L) neurons constituting a conditional expiratory oscillator comprised of a functionally homogeneous set of excitatory neurons that are tonically suppressed at rest. In the pF(v), disinhibition increased fwith a presumptive reflexive decrease in V-T; excitation increased f, V(T)and sigh rate; reducing excitation decreased V-T with a presumptive reflexive increase in f. Therefore, the pF(v), has multiple functional roles that require further parcellation. Interestingly, while hyperpolarization of the pF(v) reduces ongoing expiratory activity, no perturbation of pF(v) excitability induced active expiration. Thus, while the pF(v) can affect ongoing expiratory activity, presumably generated by the pF(L), it does not appear capable of directly inducing active expiration. We conclude that the pF(L) contains neurons that can initiate, modulate, and sustain active expiration, whereas the pF(v) contains subpopulations of neurons that differentially affect various aspects of breathing pattern, including but not limited to modulation of ongoing expiratory activity.	[Huckstepp, Robert T. R.; Cardoza, Kathryn P.; Henderson, Lauren E.; Feldman, Jack L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Huckstepp, Robert T. R.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Warwick	Feldman, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	feldman@g.ucla.edu	feldman, jack/AAO-7505-2021; Huckstepp, Robert/L-2387-2018	feldman, jack/0000-0003-3692-9412; Huckstepp, Robert/0000-0003-4410-3397	NIH [NS72211, HL135779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH, NS72211 and HL135779, awarded to JLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2013, HYPERTENSION, V61, P835, DOI 10.1161/HYPERTENSIONAHA.111.00860; Abbott SBG, 2011, J NEUROSCI, V31, P16410, DOI 10.1523/JNEUROSCI.3280-11.2011; Abbott SBG, 2009, J PHYSIOL-LONDON, V587, P5613, DOI 10.1113/jphysiol.2009.177535; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Burke PGR, 2015, J APPL PHYSIOL, V118, P1491, DOI 10.1152/japplphysiol.00164.2015; Chamberlin NL, 2007, J PHYSIOL-LONDON, V579, P515, DOI 10.1113/jphysiol.2006.121889; Champagnat J, 2010, PROG BRAIN RES, V187, P39, DOI [10.1016/B978-0-444-53613-6.00003-4, 10.1016/S0079-6123(10)87003-7]; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; Cinelli E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00403; Cui Y, 2016, NEURON, V91, P602, DOI 10.1016/j.neuron.2016.07.003; de Britto AA, 2017, J PHYSIOL-LONDON, V595, P2043, DOI 10.1113/JP273335; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Huckstepp RTR, 2016, ELIFE, V5, DOI [10.7554/eLife14203, 10.7554/eLife.14203]; Huckstepp RTR, 2015, J NEUROSCI, V35, P1052, DOI 10.1523/JNEUROSCI.2953-14.2015; Iscoe S, 1998, PROG NEUROBIOL, V56, P433, DOI 10.1016/S0301-0082(98)00046-X; Janczewski WA, 2002, J PHYSIOL-LONDON, V545, P1017, DOI 10.1113/jphysiol.2002.023408; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Janczewski WA, 2006, J NEUROPHYSIOL, V96, P1, DOI 10.1152/jn.00246.2006; Li AH, 2006, J PHYSIOL-LONDON, V577, P307, DOI 10.1113/jphysiol.2006.114504; Li P, 2016, NATURE, V530, P293, DOI 10.1038/nature16964; LOEWY AD, 1978, J COMP NEUROL, V181, P421, DOI 10.1002/cne.901810211; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; Moreira TS, 2007, J NEUROPHYSIOL, V98, P3627, DOI 10.1152/jn.00675.2007; Morgado-Valle C, 2010, J NEUROSCI, V30, P3634, DOI 10.1523/JNEUROSCI.3040-09.2010; Mulkey DK, 2007, J NEUROSCI, V27, P14128, DOI 10.1523/JNEUROSCI.4167-07.2007; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Nattie E, 2001, RESP PHYSIOL, V124, P179, DOI 10.1016/S0034-5687(00)00212-7; Nattie E, 2000, RESP PHYSIOL, V122, P223, DOI 10.1016/S0034-5687(00)00161-4; NATTIE EE, 1994, J APPL PHYSIOL, V76, P760, DOI 10.1152/jappl.1994.76.2.760; Nattie EE, 2002, J APPL PHYSIOL, V92, P2119, DOI 10.1152/japplphysiol.01128.2001; Nattie EE, 2002, J PHYSIOL-LONDON, V544, P603, DOI 10.1113/jphysiol.2002.020032; NUNEZABADES PA, 1993, J AUTONOM NERV SYST, V42, P99, DOI 10.1016/0165-1838(93)90042-S; Oku Y, 2007, J PHYSIOL-LONDON, V585, P175, DOI 10.1113/jphysiol.2007.138180; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; PORTILLO F, 1992, BRAIN RES, V583, P349, DOI 10.1016/S0006-8993(10)80049-6; Ramanantsoa N, 2011, J NEUROSCI, V31, P12880, DOI 10.1523/JNEUROSCI.1721-11.2011; Rosin DL, 2006, J COMP NEUROL, V499, P64, DOI 10.1002/cne.21105; Schreihofer AM, 1999, J COMP NEUROL, V407, P583, DOI 10.1002/(SICI)1096-9861(19990517)407:4<583::AID-CNE8>3.0.CO;2-E; Silva JN, 2016, RESP PHYSIOL NEUROBI, V227, P9, DOI 10.1016/j.resp.2016.02.005; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111	44	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0201485	10.1371/journal.pone.0201485	http://dx.doi.org/10.1371/journal.pone.0201485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096151	Green Published, gold			2022-12-26	WOS:000441308500018
J	Krag, LA; Krafft, BA; Engas, A; Herrmann, B				Krag, Ludvig A.; Krafft, Bjorn A.; Engas, Arill; Herrmann, Bent			Collecting size-selectivity data for Antarctic krill (Euphausia superba) with a trawl independent towing rig	PLOS ONE			English	Article								For the development of efficient trawls to minimize catch loss, escape mortality and potential negative ecosystem impacts from the fishery, the understanding about trawl selectivity processes are crucial. Small crustaceans are regarded as being less motile than most fish species. Crustaceans also display low levels of active avoidance from trawl netting, which in turn may cause direct contact with netting on multiple occasions on their passage towards the codend increasing the probability for escapement. Full-scaled experiments to estimate gear selectivity are highly resource demanding and are highly technically challenging for several types of fisheries. In this study, we developed and tested a trawl-independent towed-rig construction designed to investigate size selectivity of Antarctic krill (Euphausia superba). The results indicate that valid selectivity estimates can be obtained using this method, but due to the small sample size, results are inconclusive. However, the findings of the current study show a potential for developing easier and more cost-effective ways of investigating and estimating size selectivity of Antarctic krill and other small crustacean species in trawls.	[Krag, Ludvig A.] Tech Univ Denmark, Hirtshals, Denmark; [Krafft, Bjorn A.; Engas, Arill] Inst Marine Res, Bergen, Norway; [Herrmann, Bent] SINTEF, Hirtshals, Denmark	Technical University of Denmark; Institute of Marine Research - Norway; SINTEF	Krag, LA (corresponding author), Tech Univ Denmark, Hirtshals, Denmark.	lak@aqua.dtu.dk		Krag, Ludvig Ahm/0000-0002-1531-1499; Herrmann, Bent/0000-0003-1325-6198	Research Council of Norway [243619, 222798]; Aker BioMarine AS	Research Council of Norway(Research Council of Norway); Aker BioMarine AS	The Research Council of Norway, grant number 243619 and 222798, funded travel costs and expedition equipment; grant number 243619 funded in addition salary and publication costs. The contribution by author BH, from SINTEF, was funded by the grant number 243619. Aker BioMarine AS sponsored shiptime and crew. Aker BioMarine AS provided valuable practical input regarding the framework needed for execution of the field experiments.	BEVERTON R. J. H., 1963, INT COMM NORTHWEST ATLANTIC FISH SPEC PUBLICATION, V5, P9; Bohl H, 1963, FURTHER INVESTIGATIO; Chernick M., 2007, WILEY SERIES PROBABI; He P., 2010, BEHAV MARINE FISHES, P375; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Hillis J.P., 1982, 1982B19 ICES CM, V1982, P19; Krafft BA, 2010, POLAR BIOL, V33, P957, DOI 10.1007/s00300-010-0774-3; Krafft BA, 2013, 8 I MAR RES, P26; Krafft BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162311; Krafft BA, 2015, FISH RES, V170, P102, DOI 10.1016/j.fishres.2015.05.019; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Larsen RB, 2018, FISH RES, V204, P441, DOI 10.1016/j.fishres.2018.03.023; Marr J, DISCOVERY REPORTS, V32; MILLAR RB, 1992, J AM STAT ASSOC, V87, P962, DOI 10.2307/2290632; Moore D.S., 2003, PRACTICE BUSINESS ST; Pitcher T. J., 1993, BEHAV TELEOST FISHES, P740, DOI 10.1007/978-94-011-1578-0; Polet H, 2000, FISH RES, V48, P167, DOI 10.1016/S0165-7836(00)00125-9; Sala A, 2015, FISH RES, V161, P182, DOI 10.1016/j.fishres.2014.07.011; Thorsteinsson G, 1981, ICES CM, V5; Wileman D., 1996, 215 ICES COOP RES, P126, DOI 10.17895/ices.pub.4628	21	4	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202027	10.1371/journal.pone.0202027	http://dx.doi.org/10.1371/journal.pone.0202027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096169	Green Published, gold, Green Accepted			2022-12-26	WOS:000441308500040
J	Garcia-Jimenez, A; Trejo-Tellez, LI; Guillen-Sanchez, D; Gomez-Merino, FC				Garcia-Jimenez, Atonaltzin; Iris Trejo-Tellez, Libia; Guillen-Sanchez, Dagoberto; Carlos Gomez-Merino, Fernando			Vanadium stimulates pepper plant growth and flowering, increases concentrations of amino acids, sugars and chlorophylls, and modifies nutrient concentrations	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; VANADATE; ACCUMULATION; METABOLISM; DAMAGE; SOILS; BIOSYNTHESIS; GENOTYPES; PATHWAYS; STRESS	Vanadium (V) can be absorbed by plants and regulate their growth and development, although contrasting effects have been reported among species and handling conditions. The objective of this work was to evaluate the beneficial effect of V on pepper plants (Capsicum annuum L.). The plants were grown in a hydroponic system with the application of four V concentrations (0, 5, 10, and 15 mu M NH4VO3). Four weeks after the beginning of the treatments, growth, flowering, biomass, chlorophyll concentration, total amino acids, total soluble sugars, and nutrients were determined in leaves, stems, and roots. The application of 5 pM V increased plant growth, induced floral bud development, and accelerated flowering. The chlorophyll concentration varied according to the type of plant part analyzed. The concentrations of amino acids and sugars in leaves and roots were higher with 5 mu M. With 10 and 15 mu M V, the plants were smaller and showed toxicity symptoms. The K concentration in leaves decreased as the V dose increased (0 to 15 mu M). However, 5 mu M V increased the concentrations of N, P, K, Ca, Mg, Cu, Mn, and B, exclusively in stems. The application of 15 mu M V decreased the concentrations of Mg and Mn in leaves, but increased those of P, Ca, Mg, Cu, and B in roots. We conclude that V has positive effects on pepper growth and development, as well as on the concentrations of amino acids and total sugars. V was antagonistic with K, Mg, and Mn in leaves, while in stems and roots, there was synergism with macro and micronutrients. Vanadium is a beneficial element with the potential to be used in biostimulation approaches of crops like pepper.	[Garcia-Jimenez, Atonaltzin; Carlos Gomez-Merino, Fernando] Colegio Postgrad, Dept Plant Physiol, Campus Montecillo, Texcoco, State Of Mexico, Mexico; [Iris Trejo-Tellez, Libia] Colegio Postgrad, Lab Plant Nutr, Dept Soil Sci, Campus Montecillo, Texcoco, State Of Mexico, Mexico; [Guillen-Sanchez, Dagoberto] Autonomous Univ State Morelos, Xalostoc Sch Higher Studies, Ayala, Morelos, Mexico	Colegio de Postgraduados - Mexico; Colegio de Postgraduados - Mexico	Gomez-Merino, FC (corresponding author), Colegio Postgrad, Dept Plant Physiol, Campus Montecillo, Texcoco, State Of Mexico, Mexico.	fernandg@colpos.mx	LIBIA, TREJO-TÉLLEZ/AAV-8118-2021; Gómez-Merino, Fernando Carlos/D-2224-2014; Gomez-Merino, Fernando Carlos/B-2423-2015	Gomez-Merino, Fernando Carlos/0000-0001-8496-2095	Mexico's National Science and Technology Council (CONACYT); Colegio de Postgraduados Campus CoArdoba and Montecillo	Mexico's National Science and Technology Council (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Colegio de Postgraduados Campus CoArdoba and Montecillo	The authors are grateful to Mexico's National Science and Technology Council (CONACYT) for the Dr. Sc. scholarship given to AGJ, the infrastructure and financial support provided by the Colegio de Postgraduados Campus CoArdoba and Montecillo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabayov SR, 2014, INORG CHIM ACTA, V420, P16, DOI 10.1016/j.ica.2014.02.010; Akoumianaki-Ioannidou A., 2016, Australian Journal of Crop Science, V10, P199; Akoumianaki-Ioannidou A., 2015, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Horticulture, V72, P295; Alcantar G. G., 1999, PUBLICACION ESPECIAL, V10; Aureliano M, 2008, INORG CHEM, V47, P5677, DOI 10.1021/ic702405d; Azofeifa A., 2005, Agronomia Costarricense, V29, P77; Baken S, 2012, EUR J SOIL SCI, V63, P839, DOI 10.1111/j.1365-2389.2012.01491.x; BASIOUNY FM, 1984, J PLANT NUTR, V7, P1059, DOI 10.1080/01904168409363265; Bertrand G., 1950, B AM MUS NAT HIST, V94, P409; Bishayee A, 2010, CANCER LETT, V294, P1, DOI 10.1016/j.canlet.2010.01.030; BODE HP, 1990, BIOCHIM BIOPHYS ACTA, V1022, P163, DOI 10.1016/0005-2736(90)90110-A; Bremner J.M., 1965, METHODS SOIL ANAL 2, P1149, DOI DOI 10.2134/AGRONMONOGR9.2.C32; Chen T, 2016, ENVIRON TOXICOL CHEM, V35, P695, DOI 10.1002/etc.3226; Chongkid B., 2007, KASETSART J NAT SCI, V41, P28; DELFERT DM, 1985, ARCH BIOCHEM BIOPHYS, V241, P665, DOI 10.1016/0003-9861(85)90593-4; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Domingo JL, 1996, REPROD TOXICOL, V10, P175, DOI 10.1016/0890-6238(96)00019-6; EMADIAN SF, 1989, J PLANT PHYSIOL, V134, P98, DOI 10.1016/S0176-1617(89)80209-3; Fargasova A, 1998, CHEMOSPHERE, V36, P1305, DOI 10.1016/S0045-6535(97)00375-5; Garau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141041; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; GIL J, 1995, J ENVIRON SCI HEAL A, V30, P73, DOI 10.1080/10934529509376186; Gresser MJ, 1990, VANADIUM BIOL SYSTEM, P63; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; HARLAND BF, 1994, J AM DIET ASSOC, V94, P891, DOI 10.1016/0002-8223(94)92371-X; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; Hu YL, 2012, DALTON T, V41, P1118, DOI 10.1039/c1dt11535a; Imtiaz M, 2017, ENVIRON EXP BOT, V134, P72, DOI 10.1016/j.envexpbot.2016.11.003; Imtiaz M, 2016, ENVIRON SCI POLLUT R, V23, P19787, DOI 10.1007/s11356-016-7192-1; Imtiaz M, 2015, PLANT SOIL, V390, P17, DOI 10.1007/s11104-014-2341-0; KAPLAN DI, 1990, WATER AIR SOIL POLL, V49, P81, DOI 10.1007/BF00279512; Larsson MA, 2013, ENVIRON TOXICOL CHEM, V32, P2266, DOI 10.1002/etc.2322; Lin CY, 2015, PHYSIOL PLANTARUM, V153, P137, DOI 10.1111/ppl.12229; Lin CY, 2013, PLANT PHYSIOL BIOCH, V66, P98, DOI 10.1016/j.plaphy.2013.02.007; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Marcano L, 2006, BIOCELL, V30, P259; MEISCH HU, 1975, ARCH MICROBIOL, V105, P77, DOI 10.1007/BF00447117; MOORE S, 1954, J BIOL CHEM, V211, P907; Mukherjee B, 2004, TOXICOL LETT, V150, P135, DOI 10.1016/j.toxlet.2004.01.009; Olness A, 2005, IND CROP PROD, V21, P165, DOI 10.1016/j.indcrop.2004.02.005; Pilbeam DJ, 2015, HDB PLANT NUTR, P711; Pilbeam DJ, 2007, HDB PLANT NUTR, P585; Pilon-Smits EAH, 2009, CURR OPIN PLANT BIOL, V12, P267, DOI 10.1016/j.pbi.2009.04.009; Popko M, 2018, MOLECULES, V23, DOI 10.3390/molecules23020470; Rehder D, 2015, METALLOMICS, V7, P730, DOI 10.1039/c4mt00304g; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Saco D, 2013, BIOL PLANTARUM, V57, P128, DOI 10.1007/s10535-012-0133-z; SAS/Stat, 2011, SAS STAT US GUID VER; SINGH B, 1969, PLANT PHYSIOL, V44, P1321, DOI 10.1104/pp.44.9.1321; SINGH BB, 1971, PLANT SOIL, V34, P209, DOI 10.1007/BF01372773; Smith PG, 2013, ARCH ENVIRON CON TOX, V64, P87, DOI 10.1007/s00244-012-9806-z; Soveid M, 2013, ARCH IRAN MED, V16, P408, DOI 013167/AIM.009; Sozudogru S, 2001, CIENCIA, V9, P88; Stemmler AJ, 2001, J BIOL INORG CHEM, V6, P100, DOI 10.1007/s007750000174; Tang YT, 2009, ENVIRON EXP BOT, V66, P126, DOI 10.1016/j.envexpbot.2008.12.016; Teixeira WF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00327; Thompson KH, 2006, J INORG BIOCHEM, V100, P1925, DOI 10.1016/j.jinorgbio.2006.08.016; Thompson KH, 1999, CHEM REV, V99, P2561, DOI 10.1021/cr980427c; Tian LY, 2015, ENVIRON SCI POLLUT R, V22, P9215, DOI 10.1007/s11356-014-4031-0; Vachirapatama N., 2011, Songklanakarin Journal of Science and Technology, V33, P255; Venkataraman B., 2005, ASIAN J EXP SCI, V19, P127; Vincent JB, 2012, NUTRITIONAL AND THERAPEUTIC INTERVENTIONS FOR DIABETES AND METABOLIC SYNDROME, P381, DOI 10.1016/B978-0-12-385083-6.00030-9; Wang HO, 2013, ENVIRON GEOCHEM HLTH, V35, P585, DOI 10.1007/s10653-013-9541-z; Wang JF, 1999, PLANT SOIL, V216, P47, DOI 10.1023/A:1004723509113; WELCH RM, 1973, PLANT PHYSIOL, V51, P828, DOI 10.1104/pp.51.5.828; Witz G., 1886, B SOC CHIM FR, V2, P309, DOI DOI 10.1017/CBO9781139923972.002; Yang JY, 2014, J HAZARD MATER, V264, P498, DOI 10.1016/j.jhazmat.2013.09.063; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	68	35	36	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201908	10.1371/journal.pone.0201908	http://dx.doi.org/10.1371/journal.pone.0201908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092079	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600067
J	Lee, MS; Wang, J; Yuan, HH; Jiao, HL; Tsai, TL; Squire, MW; Li, WJ				Lee, Ming-Song; Wang, Jesse; Yuan, Huihua; Jiao, Hongli; Tsai, Tsung-Lin; Squire, Matthew W.; Li, Wan-Ju			Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells	FASEB JOURNAL			English	Article						endothelin receptor; adipogenesis; osteogenesis; regenerative medicine	B RECEPTOR; STROMAL CELLS; EXPRESSION; TISSUE; ACTIVATION; LIPOLYSIS; BIOLOGY; CLONING; RESIDE	Blood vessels composed of endothelial cells (ECs) contact with mesenchymal stem cells (MSCs) in different tissues, suggesting possible interaction between these 2 types of cells. We hypothesized that endothelin-1 (ET1), a secreted paracrine factor of ECs, can differentially direct the lineages of adipose-derived stem cells (ASCs) and bone marrow-derived MSCs (BMSCs). Predifferentiated ASCs and BMSCs were treated with ET1 for 2 cell passages and then induced for multilineage differentiation. Our results showed that adipogenesis of ET1-pretreated ASCs and osteogenesis of ET1-pretreated BMSCs were increased compared to those of control cells. The effect of ET1 on enhancing adipogenesis of ASCs and osteogenesis of BMSCs was attenuated by blocking endothelin receptor type A (ETAR) and/or endothelin receptor type B (ETBR). Western blot analysis indicated that regulation by ET1 was mediated through activation of the protein kinase B and ERK1/2 signaling pathways. We analyzed subpopulations of ASCs and BMSCs with or without ETAR and/or ETBR, and we found that ETAR(+)/ETBR- and ETAR(-)/ETBR+ subpopulations of ASCs and those of BMSCs pretreated with ET1 were prone to turning into adipocytes and osteoblasts, respectively, after differentiation induction. Our findings provide insight into the differential regulation of MSC specification by ET1, which may help develop viable approaches for tissue regeneration.Lee, M.-S., Wang, J., Yuan, H., Jiao, H., Tsai, T.-L., Squire, M. W., Li, W.-J. Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells.	[Lee, Ming-Song; Wang, Jesse; Yuan, Huihua; Jiao, Hongli; Tsai, Tsung-Lin; Squire, Matthew W.; Li, Wan-Ju] Univ Wisconsin, Dept Orthoped & Rehabil, Lab Musculoskeletal Biol & Regenerat Med, Madison, WI USA; [Lee, Ming-Song; Wang, Jesse; Tsai, Tsung-Lin; Li, Wan-Ju] Univ Wisconsin, Dept Biomed Engn, 1111 Highland Ave,WIMR 5051, Madison, WI 53705 USA; [Yuan, Huihua] Donghua Univ, Coll Chem, Chem Engn & Biotechnol, Shanghai, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Donghua University	Li, WJ (corresponding author), Univ Wisconsin, Dept Biomed Engn, 1111 Highland Ave,WIMR 5051, Madison, WI 53705 USA.	li@ortho.wisc.edu	Li, Wan-Ju/B-4911-2011; Yuan, Huihua/G-8590-2012	Li, Wan-Ju/0000-0002-6579-8063; Yuan, Huihua/0000-0001-8657-984X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR064803]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064803] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank E.-L. Hsieh (Shih Chien University, Taipei, Taiwan), J. L. Michel (University of Wisconsin-La Crosse, WI, USA), and C. Ma (Wellesley College, MA, USA) for their help in this study. Research reported in this publication was partially supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR064803). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Brown PT, 2014, CELL TISSUE RES, V358, P149, DOI 10.1007/s00441-014-1926-5; Caplan AI, 2017, J ORTHOP RES, V35, P1151, DOI 10.1002/jor.23560; Chen S, 2015, GENES DIS, V2, P76, DOI 10.1016/j.gendis.2014.12.003; Cianfrocca R, 2010, CAN J PHYSIOL PHARM, V88, P796, DOI 10.1139/Y10-052; CLERK A, 1994, J BIOL CHEM, V269, P32848; Clines GA, 2011, J BONE MINER RES, V26, P2523, DOI 10.1002/jbmr.450; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dawson LA, 2004, BRIT J CANCER, V90, P1577, DOI 10.1038/sj.bjc.6601717; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dibra D, 2016, HEPATOLOGY, V63, P1000, DOI 10.1002/hep.28379; Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI 10.1089/ten.TEA.2009.0398; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Eriksson AKS, 2009, INT J OBESITY, V33, P67, DOI 10.1038/ijo.2008.212; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hiruma Y, 1998, AM J PHYSIOL-REG I, V275, pR1099, DOI 10.1152/ajpregu.1998.275.4.R1099; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Juan CC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1146, DOI 10.1152/ajpendo.00481.2004; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kwon A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23544; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Liao Han-Tsung, 2014, World J Stem Cells, V6, P288, DOI 10.4252/wjsc.v6.i3.288; Lin RZ, 2014, P NATL ACAD SCI USA, V111, P10137, DOI 10.1073/pnas.1405388111; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mundy AL, 2007, CARDIOVASC RES, V73, P368, DOI 10.1016/j.cardiores.2006.11.019; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Nassiri SM, 2014, STEM CELLS DEV, V23, P319, DOI 10.1089/scd.2013.0419; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nelson JB, 1999, UROLOGY, V53, P1063, DOI 10.1016/S0090-4295(98)00658-X; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Tanaka S, 2017, J ORAL MAX SURG MED, V29, P85, DOI 10.1016/j.ajoms.2016.09.002; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tsai TL, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0065-6; van Harmelen V, 2008, DIABETES, V57, P378, DOI 10.2337/db07-0893; Winter A, 2003, ARTHRITIS RHEUM-US, V48, P418, DOI 10.1002/art.10767; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yamaguchi T, 2003, EUR J BIOCHEM, V270, P1816, DOI 10.1046/j.1432-1033.2003.03544.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang JL, 2014, AM J PATHOL, V184, P1706, DOI 10.1016/j.ajpath.2014.02.027; Zhong Q, 2002, BIOCHEM BIOPH RES CO, V296, P383, DOI 10.1016/S0006-291X(02)00882-3	55	15	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					996	1007		10.1096/fj.201800614R	http://dx.doi.org/10.1096/fj.201800614R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30096039	Green Published			2022-12-26	WOS:000457401500078
J	Nakazono, A; Adachi, N; Takahashi, H; Seki, T; Hamada, D; Ueyama, T; Sakai, N; Saito, N				Nakazono, Aoi; Adachi, Naoko; Takahashi, Hideyuki; Seki, Takahiro; Hamada, Daizo; Ueyama, Takehiko; Sakai, Norio; Saito, Naoaki			Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKC gamma in spinocerebellar ataxia type 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase C (PKC); ataxia; heat shock protein (HSP); neurodegenerative disease; 70-kilodalton heat shock protein (Hsp70); heat shock protein 90 (Hsp90); Hsp40; PKC; SCA14; spinocerebellar ataxia; chaperone protein	KINASE-C-GAMMA; CULTURED PURKINJE-CELLS; CEREBELLAR-ATAXIA; MOLECULAR-MECHANISM; CELASTROL PROTECTS; SCA14 MUTATION; ENERGY CONTENT; AGGREGATION; HSP70; AUTOPHAGY	Amyloid and amyloid-like protein aggregations are hallmarks of multiple, varied neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. We previously reported that spinocerebellar ataxia type 14 (SCA14), a dominant-inherited neurodegenerative disease that affects cerebellar Purkinje cells, is characterized by the intracellular formation of neurotoxic amyloid-like aggregates of genetic variants of protein kinase C (PKC gamma). A number of protein chaperones, including heat shock protein 70 (Hsp70), promote the degradation and/or refolding of misfolded proteins and thereby prevent their aggregation. Here, we report that, in various SCA14-associated, aggregating PKC gamma variants, endogenous Hsp70 is incorporated into aggregates and that expression of these PKC gamma mutants up-regulates Hsp70 expression. We observed that PKC gamma binds Hsp70 and that this interaction is enhanced in the SCA14-associated variants, mediated by the kinase domain that is involved in amyloid-like fibril formation as well as the C2 domain of PKC gamma. Pharmacological up-regulation of Hsp70 by the Hsp90 inhibitors celastrol and herbimycin A attenuated the aggregation of mutant PKC gamma in primary cultured Purkinje cells. Up-regulation of Hsp70 diminished net PKC gamma aggregation by preventing aggregate formation, resulting in decreased levels of apoptotic cell death among primary cultured Purkinje cells expressing the PKC gamma variant. Of note, herbimycin A also ameliorated abnormal dendritic development. Extending our in vitro observations, administration of celastrol to mice up-regulated cerebellar Hsp70. Our findings identify heat shock proteins as important endogenous regulators of pathophysiological PKC gamma aggregation and point to Hsp90 inhibition as a potential therapeutic strategy in the treatment of SCA14.	[Nakazono, Aoi; Adachi, Naoko; Takahashi, Hideyuki; Ueyama, Takehiko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Seki, Takahiro] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Chemicopharmacol Sci, Kumamoto 8620973, Japan; [Hamada, Daizo] Kobe Univ, Grad Sch Engn, Chuo Ku, 7-1-48 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan; [Hamada, Daizo] Kobe Univ, CASS, 7-1-48 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan; [Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan; [Takahashi, Hideyuki] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Takahashi, Hideyuki] Yale Univ, Sch Med, Dept Neurobiol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA	Kobe University; Kumamoto University; Kobe University; Kobe University; Hiroshima University; Yale University; Yale University	Adachi, N; Saito, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	na@gold.kobe-u.ac.jp; naosaito@kobe-u.ac.jp	Sakai, Norio/AAM-5822-2021; Hamada, Daizo/N-1118-2016	Sakai, Norio/0000-0002-6648-8761; Hamada, Daizo/0000-0002-1799-5476; Adachi, Naoko/0000-0002-8797-0717; Seki, Takahiro/0000-0002-9894-4768	Joint Research Program of the Biosignal Research Center, Kobe University [281007]; JSPS KAKENHI [JP25293060, JP17H04032]	Joint Research Program of the Biosignal Research Center, Kobe University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Joint Research Program of the Biosignal Research Center, Kobe University Grant 281007, and by JSPS KAKENHI Grants JP25293060 and JP17H04032. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Asai H, 2009, HUM MOL GENET, V18, P3533, DOI 10.1093/hmg/ddp298; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Cascao R, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00069; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Deane CAS, 2016, CELL STRESS CHAPERON, V21, P837, DOI 10.1007/s12192-016-0708-2; Deng YN, 2013, NEUROCHEM INT, V63, P1, DOI 10.1016/j.neuint.2013.04.005; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Divya T, 2017, PULM PHARMACOL THER, V45, P47, DOI 10.1016/j.pupt.2017.04.003; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duncan RF, 2005, FEBS J, V272, P5244, DOI 10.1111/j.1742-4658.2005.04921.x; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Ganos C, 2014, CEREBELLUM, V13, P89, DOI 10.1007/s12311-013-0522-7; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Guo JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140745; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; Hamel L, 2000, CELL STRESS CHAPERON, V5, P121, DOI 10.1379/1466-1268(2000)005<0121:IOHSPB>2.0.CO;2; Hylander BL, 2000, BRAIN RES, V869, P49, DOI 10.1016/S0006-8993(00)02346-5; Isambert N, 2015, ANN ONCOL, V26, P1005, DOI 10.1093/annonc/mdv031; Jezierska J, 2014, J NEUROCHEM, V128, P741, DOI 10.1111/jnc.12491; Kalmar B, 2009, CELL MOL BIOL LETT, V14, P319, DOI 10.2478/s11658-009-0002-8; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Koht J, 2012, ACTA NEUROL SCAND, V125, P116, DOI 10.1111/j.1600-0404.2011.01504.x; KOSE A, 1988, J NEUROSCI, V8, P4262; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McFarland NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086048; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Ogawa K, 2013, BIOCHEM BIOPH RES CO, V440, P25, DOI 10.1016/j.bbrc.2013.09.013; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Sailer A, 2012, NEUROLOGY, V79, P127, DOI 10.1212/WNL.0b013e31825f048e; SAITO N, 1988, J NEUROSCI, V8, P369; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Seki T, 2011, J PHARMACOL SCI, V116, P239, DOI 10.1254/jphs.11R04CP; Seki T, 2010, J PHARMACOL SCI, V114, P206, DOI 10.1254/jphs.10170FP; Seki T, 2010, J BIOL CHEM, V285, P33252, DOI 10.1074/jbc.M110.146704; Seki T, 2009, NEUROBIOL DIS, V33, P260, DOI 10.1016/j.nbd.2008.10.013; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Shuvaev AN, 2011, J NEUROSCI, V31, P14324, DOI 10.1523/JNEUROSCI.5530-10.2011; Silva-Fernandes A, 2014, NEUROTHERAPEUTICS, V11, P433, DOI 10.1007/s13311-013-0255-9; Smeets CJLM, 2016, NEUROBIOL DIS, V88, P96, DOI 10.1016/j.nbd.2016.01.009; Sousa MC, 1998, BIOCHEMISTRY-US, V37, P15392, DOI 10.1021/bi981510x; Takahashi H, 2015, HUM MOL GENET, V24, P525, DOI 10.1093/hmg/ddu472; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Ueda T, 2013, J NEUROL, V260, P1664, DOI 10.1007/s00415-013-6916-0; van Gaalen J, 2013, MOVEMENT DISORD, V28, P1902, DOI 10.1002/mds.25572; Verbeek DS, 2005, BRAIN, V128, P436, DOI 10.1093/brain/awh378; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamamoto K, 2010, GENES CELLS, V15, P425, DOI 10.1111/j.1365-2443.2010.01395.x; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang YQ, 2007, J MOL MED-JMM, V85, P1421, DOI 10.1007/s00109-007-0251-9	68	10	11	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14758	14774		10.1074/jbc.RA118.002913	http://dx.doi.org/10.1074/jbc.RA118.002913			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093405	Green Published, hybrid			2022-12-26	WOS:000446155000014
J	Peng, KT; Tsai, MH; Lee, CW; Chiang, YC; Chen, PC; Chen, CC; Chang, CH; Shih, HN; Chang, PJ				Peng, Kuo-Ti; Tsai, Meng-Hsueh; Lee, Chiang-Wen; Chiang, Yao-Chang; Chen, Pei-Chun; Chen, Chun-Chieh; Chang, Chih-Hsiang; Shih, Hsin-Nung; Chang, Pey-Jium			Dysregulated expression of antioxidant enzymes in polyethylene particle-induced periprosthetic inflammation and osteolysis	PLOS ONE			English	Article							TOTAL HIP-REPLACEMENT; REACTIVE OXYGEN; IN-VITRO; OXIDATIVE STRESS; MOLECULAR-WEIGHT; BONE-RESORPTION; WEAR PARTICLES; FREE-RADICALS; MACROPHAGES; SIZE	Small wear particles (0.1 - 10 mu m) in total joint replacement are generally considered as the major causative agent leading to periprosthetic inflammation and osteolysis. However, little is known about the roles of larger wear particles (10 - 100 mu m) in periprosthetic inflammation and osteolysis. Additionally, although ample studies demonstrated that increased oxidative stress is critically involved in particle-induced inflammation and osteolysis, detailed changes in antioxidant enzymes expression in the disease development remain largely unclear. Herein, we used a rat knee prosthesis model to assess effects of polyethylene (PE) particles (20 - 60 mu m) on the levels of oxidative stress markers such as malondialdehyde (MDA) and total antioxidant capacity (TAC) in blood plasma, and on the expression profiles of antioxidant enzymes in knee joint tissues. In combination with a forced-exercise intervention for all surgical rats, we found that the rat groups treated with both artificial joint and PE particles exhibited higher MDA levels and lower TAC levels, together with lower levels of physical activity and higher levels of inflammatory markers, than the sham group and the groups receiving artificial joint or PE particles alone at weeks 20 - 24 post-operatively. Dose-response relationships between the exposure to PE particles and the induction of oxidative stress and inflammation were also observed in the artificial joint/PE groups. Under such conditions, we unexpectedly found that most of antioxidant enzymes displayed pronounced up-regulation, with concomitant induction of inflammatory and osteoclast-inducing factors (including IL-1 beta, NF-kappa B and RANKL), in the artificial joint/PE groups as compared to the sham, artificial joint only, or PE only group. Only a few antioxidant enzymes including SOD2 and GPx2 showed down-regulation. Collectively, our findings demonstrate that implantation of artificial joint along with large PE particles synergistically trigger the induction of oxidative stress; however, down-regulation of many antioxidant enzymes may not necessarily occur during the disease development.	[Peng, Kuo-Ti; Tsai, Meng-Hsueh; Chen, Pei-Chun] Chang Gung Mem Hosp, Dept Orthoped Surg, Chiayi, Taiwan; [Peng, Kuo-Ti] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Chiang-Wen] Chang Gung Inst Technol, Div Basic Med Sci, Dept Nursing, Chiayi, Taiwan; [Lee, Chiang-Wen] Chang Gung Inst Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Chiang, Yao-Chang] China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan; [Chen, Chun-Chieh; Chang, Chih-Hsiang; Shih, Hsin-Nung] Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan; [Chang, Pey-Jium] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Pey-Jium] Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Shih, HN (corresponding author), Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan.; Chang, PJ (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.; Chang, PJ (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan.	aronc@adm.cgmh.org.tw; peyjiumc@mail.cgu.edu.tw	Chang, Chih-Hsiang/G-8238-2016	Chang, Pey-Jium/0000-0002-6492-0346; Chiang, Yao-Chang/0000-0002-7619-1902	Chang-Gung Memorial Hospital, Taiwan [CMRPG3C1251, CMRPG3C1252, CMRPG6F0341]; Ministry of Science and Technology, Taiwan [NMRPG6F0111, NMRPG3C6051, NMRPG3C6052]	Chang-Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants CMRPG3C1251 (to HNS), CMRPG3C1252 (to HNS) and CMRPG6F0341 (to KTP) from the Chang-Gung Memorial Hospital, Taiwan (https://www.cgmh.org.tw/), and by grants NMRPG6F0111 (to KTP), NMRPG3C6051 (to HNS) and NMRPG3C6052 (to HNS) from the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2011, WORLD J ORTHOP, V2, P93, DOI 10.5312/wjo.v2.i10.93; Candas D, 2014, ANTIOXID REDOX SIGN, V20, P1599, DOI 10.1089/ars.2013.5305; Chen WS, 2015, CELL PHYSIOL BIOCHEM, V35, P1857, DOI 10.1159/000373996; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Goodman SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0962; Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9; Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Herberts P, 2000, ACTA ORTHOP SCAND, V71, P111, DOI 10.1080/000164700317413067; Ingham E, 2003, Hip Int, V13, P17, DOI 10.5301/HIP.2013.11458; Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054; Jay SM, 2010, J BIOMED MATER RES A, V93A, P189, DOI 10.1002/jbm.a.32513; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kinov P, 2006, J ORTHOP RES, V24, P55, DOI 10.1002/jor.20013; Krajewska M, 1996, AM J PATHOL, V149, P1449; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lubbeke A, 2011, J BONE JOINT SURG BR, V93B, P456, DOI 10.1302/0301-620X.93B4.25868; Luo GT, 2016, INFLAMMATION, V39, P775, DOI 10.1007/s10753-016-0306-6; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2; Nine MJ, 2014, MATERIALS, V7, P980, DOI 10.3390/ma7020980; Peng KT, 2011, J BONE JOINT SURG BR, V93B, P1201, DOI 10.1302/0301-620X.93B9.26736; Peng KT, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1131-7; Purdue P Edward, 2006, HSS J, V2, P102, DOI 10.1007/s11420-006-9003-6; Raghunathan VK, 2013, BIOMATERIALS, V34, P3559, DOI 10.1016/j.biomaterials.2013.01.085; Rigoni R, 2016, J EXP MED, V213, P355, DOI 10.1084/jem.20151116; Robertsson O, 2001, J BONE JOINT SURG BR, V83B, P45, DOI 10.1302/0301-620X.83B1.10871; Sheikh Z, 2015, MATERIALS, V8, P5671, DOI 10.3390/ma8095269; Shen LC, 2010, J ORAL PATHOL MED, V39, P242, DOI 10.1111/j.1600-0714.2009.00862.x; Sundfeldt M, 2002, ACTA ORTHOP SCAND, V73, P416, DOI 10.1080/00016470216314; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Tipper J L, 2000, J Mater Sci Mater Med, V11, P117, DOI 10.1023/A:1008901302646; Tsaryk R, 2013, BIOMATERIALS, V34, P8075, DOI 10.1016/j.biomaterials.2013.07.030; Wang ML, 2002, J ARTHROPLASTY, V17, P335, DOI 10.1054/arth.2002.30416; Yamada M, 2010, J DENT RES, V89, P411, DOI 10.1177/0022034510363243; Zolotarevova E, 2010, ACTA BIOMATER, V6, P3595, DOI 10.1016/j.actbio.2010.04.010	37	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202501	10.1371/journal.pone.0202501	http://dx.doi.org/10.1371/journal.pone.0202501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125327	Green Published, Green Submitted, gold			2022-12-26	WOS:000442202100031
J	Teo, AKJ; Tai, BC; Chio, MTW; La, HH				Teo, Alvin Kuo Jing; Tai, Bee Choo; Chio, Martin Tze-Wei; La, Hanh Hao			A mixed methods study of non-occupational post-exposure prophylaxis at an STI clinic in Singapore: Five-year retrospective analysis and providers' perspectives	PLOS ONE			English	Article							SEXUAL EXPOSURE; HIV; ADHERENCE; METAANALYSIS; PHYSICIANS	Background This mixed methods study aims to describe 1) characteristics of the population treated with non-occupational post-exposure prophylaxis (nPEP), 2) predictors of loss to follow-up (LTFU) and nPEP adherence, and 3) to evaluate the nPEP prescribing practices against current management guideline. Methods This study was conducted at the Department of Sexually Transmitted Infections Control Clinic in Singapore using clinical data from 2010 to 2016. Explanatory sequential mixed method design was adopted. Predictors of LTFU and nPEP adherence were assessed using modified Poisson regression with robust sandwich variance. Subsequently, nine in-depth interviews with healthcare providers were conducted to gain their insights into barriers and facilitators to nPEP implementation. Transcripts were coded and themes were explored using applied thematic analysis. Results Of 502 nPEP cases reviewed, 46% were LTFU, 42% were adherent to nPEP and 431 prescription decisions were made in accordance with the guideline. Tourists (aRR, 2.29 [1.90-2.74]; p<0.001) and men who have sex with men/bisexual men (aRR, 1.32 [1.09-1.59]; p=0.004) were significant predictors of LTFU. Absence of side effects (aRR, 1.14 [1.02-1.27]; p=0.024) and nPEP treatment with TDF/FTC/ATV/r (aRR, 1.15 [1.03-1.29]; p=0.017) were positively associated with nPEP adherence. Stigma, types of antiretroviral regimen, side effects, and patients' perception of risk and treatment benefits derived qualitatively further reinforced corresponding quantitative findings. Conclusion Tailored socio-behavioral interventions are needed to address inherent differences within heterogeneous populations requesting nPEP, stigma, and patients' perceptions of nPEP in order to improve follow-up and its adherence.	[Teo, Alvin Kuo Jing; Tai, Bee Choo; La, Hanh Hao] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Teo, Alvin Kuo Jing; Tai, Bee Choo; La, Hanh Hao] Natl Univ Hlth Syst, Singapore, Singapore; [Chio, Martin Tze-Wei] Natl Skin Ctr, Dept Sexually Transmitted Infect Control, Singapore, Singapore; [La, Hanh Hao] Univ Penn, Ctr High Impact Philanthropy, Philadelphia, PA 19104 USA; [La, Hanh Hao] Univ Penn, Ctr Publ Hlth Initiat, Philadelphia, PA 19104 USA	National University of Singapore; National University of Singapore; National Skin Centre; University of Pennsylvania; University of Pennsylvania	Teo, AKJ; La, HH (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Teo, AKJ; La, HH (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; La, HH (corresponding author), Univ Penn, Ctr High Impact Philanthropy, Philadelphia, PA 19104 USA.; La, HH (corresponding author), Univ Penn, Ctr Publ Hlth Initiat, Philadelphia, PA 19104 USA.	alvin.teo@aol.com; hanhla@pennmedicine.upenn.edu	Teo, Alvin/AAH-4516-2020	Teo, Alvin/0000-0002-0569-3518	Saw Swee Hock School of Public Health, National University of Singapore	Saw Swee Hock School of Public Health, National University of Singapore	This project was a Master of Public Health practicum supported by Saw Swee Hock School of Public Health, National University of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armishaw J, 2011, INT J STD AIDS, V22, P714, DOI 10.1258/ijsa.2011.011174; Bogoch II, 2014, CLIN INFECT DIS, V58, P1618, DOI 10.1093/cid/ciu118; Chio MTW., 2010, DERMATOL B, V21, P27; Chua AC, 2013, ANN ACAD MED SINGAP, V42, P350; Cresswell F, 2015, UK GUIDELINE USE HIV; Day S, 2006, SEX TRANSM INFECT, V82, P236, DOI 10.1136/sti.2005.017764; Donnell D, 2010, AIDS BEHAV, V14, P1182, DOI 10.1007/s10461-010-9712-1; Fletcher JB, 2013, J SEX TRANSM DIS, V2013, DOI 10.1155/2013/210403; Ford N, 2014, AIDS, V28, P2721, DOI 10.1097/QAD.0000000000000505; Gantner P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145440; Grusky O, 2005, AIDS PATIENT CARE ST, V19, P157, DOI 10.1089/apc.2005.19.157; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Gulholm T, 2013, SEX HEALTH, V10, P438, DOI 10.1071/SH13018; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Jain S, 2015, JAIDS-J ACQ IMM DEF, V68, P97, DOI 10.1097/QAI.0000000000000403; Joshi M, 2014, INT J STD AIDS, V25, P67, DOI 10.1177/0956462413491734; Laporte A, 2002, AIDS, V16, P397, DOI 10.1097/00002030-200202150-00011; Lee HL, 2007, STATEMENT PARLIAMENT; Malinverni S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153021; McDougal SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105030; Ministry of Health, 2016, UPD HIV AIDS SIT SIN; Oldenburg CE, 2014, AIDS BEHAV, V18, P217, DOI 10.1007/s10461-013-0567-0; Rey D, 2008, AIDS CARE, V20, P537, DOI 10.1080/09540120701867198; Shoptaw S, 2008, AIDS CARE, V20, P376, DOI 10.1080/09540120701660353; Tan HH, 2013, SEXUALLY TRANSMITTED; Thomas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142534; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1; World Health Organization (WHO), 2014, GUID POST PROPH HIV	28	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202267	10.1371/journal.pone.0202267	http://dx.doi.org/10.1371/journal.pone.0202267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR0JS	30125333	Green Published, gold, Green Submitted			2022-12-26	WOS:000442202100022
J	Hirschberg, CB				Hirschberg, Carlos B.			My journey in the discovery of nucleotide sugar transporters of the Golgi apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						glycobiology; glycoprotein; nucleotide; Golgi; glycoprotein biosynthesis	N-ACETYLGLUCOSAMINE TRANSPORTER; CMP-SIALIC ACID; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; RAT-LIVER; ENDOPLASMIC-RETICULUM; MUTANT DEFICIENT; UDP-GALACTOSE; TRANSLOCATION; PURIFICATION	Defects in protein glycosylation can have a dramatic impact on eukaryotic cells and is associated with mental and developmental pathologies in humans. The studies outlined below illustrate how a basic biochemical problem in the mechanisms of protein glycosylation, specifically substrate transporters of nucleotide sugars, including ATP and 3'-phosphoadenyl-5'-phosphosulfate (PAPS), in the membrane of the Golgi apparatus and endoplasmic reticulum, expanded into diverse biological systems from mammals, including humans, to yeast, roundworms, and protozoa. Using these diverse model systems allowed my colleagues and me to answer fundamental biological questions that enabled us to formulate far-reaching hypotheses and expanded our knowledge of human diseases caused by malfunctions in the metabolic processes involved.	[Hirschberg, Carlos B.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Hirschberg, Carlos B.] Univ Andres Bello, Dept Biol Sci, Santiago, Chile	Boston University; Universidad Andres Bello	Hirschberg, CB (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.; Hirschberg, CB (corresponding author), Univ Andres Bello, Dept Biol Sci, Santiago, Chile.	chirschb@bu.edu			NIH [GM 30365, GM 34396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030365, R01GM030365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am deeply indebted to my mentors, graduate students, postdocs, and collaborators. Without them, none of the above research could have been done. I was also fortunate to have NIGMS NIH program directors such as Lee van Lenten and Pam Marino, whose support was invaluable. Last, but not least, I am fortunate to have had the ongoing support and love of my wife, Lois Hirschberg. Most of the above research was supported by NIH Grants GM 30365 and GM 34396.	Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; Bredeston LM, 2005, J BIOL CHEM, V280, P32168, DOI 10.1074/jbc.M507035200; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; CAPASSO JM, 1989, J BIOL CHEM, V264, P5233; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; CAREY DJ, 1980, CELL, V19, P597, DOI 10.1016/S0092-8674(80)80036-5; CARTER HE, 1968, BIOCHEMISTRY-US, V7, P2296, DOI 10.1021/bi00846a036; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Hirschberg C. B., 2016, HIGH LEARN RES COMMU, V6, P4, DOI [10.18870/hlrc.v6i1.318, DOI 10.18870/HLRC.V6I1.318]; HIRSCHBERG CB, 1970, J BIOL CHEM, V245, P3084; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; HIRSCHBERG CB, 1974, VIROLOGY, V61, P602, DOI 10.1016/0042-6822(74)90295-5; HIRSCHBERG CB, 1976, BIOCHEMISTRY-US, V15, P3591, DOI 10.1021/bi00661a029; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Liu L, 2013, J BIOL CHEM, V288, P10599, DOI 10.1074/jbc.M113.453597; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; MILLA ME, 1989, P NATL ACAD SCI USA, V86, P1786, DOI 10.1073/pnas.86.6.1786; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Toma L, 1996, J BIOL CHEM, V271, P3897	29	5	5	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12653	12662		10.1074/jbc.X118.004819	http://dx.doi.org/10.1074/jbc.X118.004819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120148	hybrid, Green Published			2022-12-26	WOS:000442203500001
J	Christensen, DS; Flensborg-Madsen, T; Garde, E; Hansen, AM; Pedersen, JM; Mortensen, EL				Christensen, Dinne Skjaerlund; Flensborg-Madsen, Trine; Garde, Ellen; Hansen, Ase Marie; Pedersen, Jolene Masters; Mortensen, Erik Lykke			Early life predictors of midlife allostatic load: A prospective cohort study	PLOS ONE			English	Article							CHILDHOOD SOCIOECONOMIC-STATUS; CUMULATIVE BIOLOGICAL RISK; BIRTH-WEIGHT; GENDER-DIFFERENCES; SEX-DIFFERENCES; BLOOD-PRESSURE; HEALTH; ADULTHOOD; MORTALITY; ASSOCIATION	Background Allostatic load has been suggested as a pathway through which experiences become biologically embedded to influence health. Research on childhood predictors of allostatic load has focused on socioeconomic and psychosocial exposures, while few studies include prospective measures of biomedical exposures. Further, findings on sex differences in the association of childhood predictors with various health outcomes related to allostatic load are ambiguous. Aims To examine the influence of early life biomedical and social factors in the first year of life on midlife allostatic load, assessing potential sex differences. Methods This prospective cohort study includes early life information collected at birth and a one year examination for 1,648 members of the Copenhagen Perinatal Cohort who also participated in the Copenhagen Aging and Midlife Biobank study (aged 49-52 years, 56% women). Allostatic load based on 14 biomarkers was selected as a measure of midlife health status. Early life factors were categorized as predominantly biomedical or social, and their associations with midlife allostatic load were examined in domain-specific and combined sex-stratified multiple regression models. Results The biomedical factors model explained 6.6% of the variance in midlife allostatic load in men and 6.7% in women, while the social model explained 4.1% of the variance in men and 7.3% in women. For both sexes, parental socioeconomic position at one year and maternal BMI significantly predicted midlife allostatic load in a model containing all early life factors. For women, additional significant predictors were complications at birth, birth weight and not living with parents at one year. Conclusion The results confirm an association of lower childhood socioeconomic position with higher adult allostatic load while demonstrating the importance of other prenatal and early life exposures and highlighting potential sex differences.	[Christensen, Dinne Skjaerlund; Flensborg-Madsen, Trine; Garde, Ellen; Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Sect Environm Hlth, Copenhagen, Denmark; [Christensen, Dinne Skjaerlund; Flensborg-Madsen, Trine; Garde, Ellen; Pedersen, Jolene Masters; Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Garde, Ellen] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Hansen, Ase Marie; Pedersen, Jolene Masters] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Hansen, Ase Marie] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; National Research Centre for the Working Environment	Christensen, DS (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Environm Hlth, Copenhagen, Denmark.; Christensen, DS (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.	dinnesc@sund.ku.dk	Hansen, Åse/AAJ-1043-2020	Hansen, Åse/0000-0002-4075-3918; PEdersen, Jolene MAsters/0000-0002-7592-422X; Flensborg-Madsen, Trine/0000-0002-6753-335X; Christensen, Dinne S./0000-0002-3568-3556	Center of Healthy Aging, University of Copenhagen; VELUX FOUNDATION [VELUX26145, 31539]; VELUX FOUNDATION	Center of Healthy Aging, University of Copenhagen; VELUX FOUNDATION(Velux Fonden); VELUX FOUNDATION(Velux Fonden)	DS was supported by the Center of Healthy Aging, University of Copenhagen (www.healthyaging.ku.dk). The Copenhagen Aging and Midlife Biobank was funded by a generous grant from the VELUX FOUNDATION (VELUX26145 and 31539) (www.veluxfoundations.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the crucial role of A. L. Willumsen and B. Zachau-Christiansen in the establishment of the Copenhagen Perinatal Cohort and thank the Steering Committee for permission to conduct this study. The Copenhagen Aging and Midlife Biobank was funded by a generous grant from the VELUX FOUNDATION. This manuscript was prepared in collaboration with members of the CAMB steering committee. The list of the CAMB steering committee and those responsible for the collection of historical data can be found at http://www.camb.ku.dk/.	Aiken L. S., 1991, MULTIPLE REGRESSION; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Avlund K, 2014, J AGING HEALTH, V26, P5, DOI 10.1177/0898264313509277; Solis CB, 2016, SOC SCI MED, V165, P19, DOI 10.1016/j.socscimed.2016.07.031; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Christensen U, 2004, PSYCHOSOM MED, V66, P572, DOI 10.1097/01.psy.0000126206.35683.d1; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dasinger JH, 2016, CLIN SCI, V130, P337, DOI 10.1042/CS20150611; Dich N, 2015, ANXIETY STRESS COPIN, V28, P372, DOI 10.1080/10615806.2014.969720; Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Evans G. W., 2012, POVERTY GETS SKIN LI; Evans GW, 2010, ANN NY ACAD SCI, V1186, P174, DOI 10.1111/j.1749-6632.2009.05336.x; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Friedman EM, 2015, PSYCHOSOM MED, V77, P176, DOI 10.1097/PSY.0000000000000147; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Godfrey K M, 2001, Public Health Nutr, V4, P611; Graffar M., 1956, COURRIER, V6, P455; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Gustafsson PE, 2012, ANN BEHAV MED, V43, P117, DOI 10.1007/s12160-011-9309-6; Gustafsson PE, 2011, J EPIDEMIOL COMMUN H, V65, P986, DOI 10.1136/jech.2010.108332; Hamil-Luker J, 2007, DEMOGRAPHY, V44, P137, DOI 10.1353/dem.2007.0004; Hansen AM, 2014, J AGING HEALTH, V26, P72, DOI 10.1177/0898264313508187; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Janicki-Deverts D, 2012, PSYCHOSOM MED, V74, P728, DOI 10.1097/PSY.0b013e31825e32e8; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Khlat M, 2009, SOC SCI MED, V68, P1692, DOI 10.1016/j.socscimed.2009.02.024; Kochanska G, 2010, J CHILD PSYCHOL PSYC, V51, P998, DOI 10.1111/j.1469-7610.2010.02238.x; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076; Kuh D., 2004, LIFE COURSE APPROACH, DOI DOI 10.1093/ACPROF:OSO/9780198578154.003.0017; Langenberg C, 2006, AM J PUBLIC HEALTH, V96, P2216, DOI 10.2105/AJPH.2004.049429; Lawlor DA, 2006, ANN EPIDEMIOL, V16, P19, DOI 10.1016/j.annepidem.2005.04.006; Lawlor DA, 2002, AM J EPIDEMIOL, V156, P1100, DOI 10.1093/aje/kwf154; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lund R, 2016, INT J EPIDEMIOL, V45, P1044, DOI 10.1093/ije/dyv149; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Na-Ek N, 2017, J EPIDEMIOL COMMUN H, V71, P253, DOI 10.1136/jech-2016-207394; Osler M, 2006, INT J EPIDEMIOL, V35, P541, DOI 10.1093/ije/dyi300; Pengpid S, 2015, GENDER BEHAV, V13, P6576; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Petrovic D, 2016, PSYCHONEUROENDOCRINO, V67, P76, DOI 10.1016/j.psyneuen.2016.02.003; Power C, 2005, AM J PUBLIC HEALTH, V95, P1396, DOI 10.2105/AJPH.2004.047340; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Seplaki CL, 2005, EXP GERONTOL, V40, P438, DOI 10.1016/j.exger.2005.03.002; Seplaki CL, 2004, J GERONTOL A-BIOL, V59, P201; Shalev I, 2014, PEDIATRICS, V134, pE1315, DOI 10.1542/peds.2014-1669; Singer B, 1999, ANN NY ACAD SCI, V896, P96, DOI 10.1111/j.1749-6632.1999.tb08108.x; Solis CB, 2015, P NATL ACAD SCI USA, V112, pE738, DOI 10.1073/pnas.1417325112; Turner RJ, 2016, SOC SCI MED, V156, P114, DOI 10.1016/j.socscimed.2016.02.026; Voigt M, 2006, EUR J PEDIATR, V165, P757, DOI 10.1007/s00431-006-0169-1; Westerlund H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035967; Yang JJ, 2014, DIABETIC MED, V31, P1399, DOI 10.1111/dme.12525; Zachau-Christiansen B., 1975, BABIES STUDY HUMAN D	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202395	10.1371/journal.pone.0202395	http://dx.doi.org/10.1371/journal.pone.0202395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ6RF	30114237	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400067
J	Manus, MB; Bloomfield, GS; Leonardo, AS; Guidera, LN; Samson, DR; Nunn, CL				Manus, Melissa B.; Bloomfield, Gerald S.; Leonardo, Ashley Sobel; Guidera, Laura N.; Samson, David R.; Nunn, Charles L.			High prevalence of hypertension in an agricultural village in Madagascar	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; RISK-FACTORS; GLOBAL BURDEN; ASSOCIATION; POPULATION; DISEASE; COMMUNITY; AWARENESS; AFRICA	Elevated blood pressure presents a global health threat, with rates of hypertension increasing in low and middle-income countries. Lifestyle changes may be an important driver of these increases in blood pressure. Hypertension is particularly prevalent in African countries, though the majority of studies have focused on mainland Africa. We collected demographic and health data from 513 adults living in a community in rural Madagascar. We used generalized linear mixed models to assess body mass index (BMI), age, sex, and attributes related to household composition and lifestyle as predictors of blood pressure and hypertension. The prevalence of hypertension in this cohort was 49.1% (both sexes combined: N = 513; females: 50.3%, N = 290; males: 47.5%, N = 223). Blood pressure, as well as hypertensive state, was positively associated with age and BMI. Lifestyle and household factors had no significant relationships with blood pressure. The prevalence of hypertension was similar to that found in urban centers of other African countries, yet almost double what has been previously found in Madagascar. Future research should investigate the drivers of hypertension in rural communities worldwide, as well as the lifestyle, cultural, and genetic factors that underlie variation in hypertension across space and time.	[Manus, Melissa B.; Bloomfield, Gerald S.; Nunn, Charles L.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Manus, Melissa B.; Nunn, Charles L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Bloomfield, Gerald S.] Duke Univ, Dept Med, Durham, NC USA; [Bloomfield, Gerald S.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Leonardo, Ashley Sobel; Guidera, Laura N.] Duke Univ, Dept Biol, Durham, NC USA; [Samson, David R.] Univ Toronto, Dept Anthropol, Mississauga, ON, Canada	Duke University; Duke University; Duke University; Duke University; Duke University; University of Toronto; University Toronto Mississauga	Manus, MB (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Manus, MB (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	mmanus09@gmail.com			Bass Connections at Duke University; Duke Global Health Institute; Bass Connections; Bass Connections "Shining Evolutionary Light on Global Health Challenges" research team	Bass Connections at Duke University; Duke Global Health Institute; Bass Connections; Bass Connections "Shining Evolutionary Light on Global Health Challenges" research team	This work was supported by Bass Connections at Duke University (https:// bassconnections.duke.edu/): awarded to CLN; Duke Global Health Institute (https://globalhealth.duke.edu/): awarded to MBM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the people of Mandena for their warmth and willingness to participate. We also thank the Duke Lemur Center SAVA Conservation staff and affiliates, including Lanto Andrianandrasana, Marina Blanco, Desire A Razafimatratra, Prisca Raharimalala, Guy Irenel Raoloniaina and Henri Lahady, Bona Theogene, Mboty Cynthia, and Nono Romain, as well as the Madagascar Institute for the Conservation of Tropical Environments (MICET) for logistical support. We thank Bass Connections and the Duke Global Health Institute for financial support. Finally, we thank the Bass Connections "Shining Evolutionary Light on Global Health Challenges" research team for their support in planning and executing this work, and James Herrera and Caroline Amoroso for their assistance with data analysis and visualization.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Alberts M, 2005, EUR J CARDIOV PREV R, V12, P347, DOI 10.1097/01.hjr.0000174792.24188.8e; Amoah AGB, 2003, ETHNIC DIS, V13, P310; [Anonymous], 2000, WHO TECHN REP SER; Bakris GL, 2009, J CLIN HYPERTENS, V11, P144, DOI 10.1111/j.1751-7176.2009.00092.x; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bushara SO, 2015, RENAL FAILURE, V37, P1022, DOI 10.3109/0886022X.2015.1052951; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cooper R, 1997, AM J HYPERTENS, V10, P804, DOI 10.1016/S0895-7061(97)00211-2; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; de Vijver SV, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.38.3100; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; FOLSOM AR, 1994, J CLIN EPIDEMIOL, V47, P173, DOI 10.1016/0895-4356(94)90022-1; Fuentes R, 2000, J HYPERTENS, V18, P521, DOI 10.1097/00004872-200018050-00003; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Jackson F., 1991, HYPERTENSION S1, V17; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kamar HH, 2000, J HLTH TRANSLATIONAL; Kulkarni S, 1998, WMJ, V97, P34; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Noor SK, 2016, RENAL FAILURE, V38, P352, DOI 10.3109/0886022X.2015.1128839; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Pierron D, 2017, PNAS; Ratovoson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137408; Stearns SC, 2016, EVOLUTIONARY MED; Team RC, 2015, R LANG ENV STAT COMP; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tibazarwa KB, 2014, CAN J CARDIOL, V30, P527, DOI 10.1016/j.cjca.2014.02.020; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wassmer SC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00121; Wells JCK, 2017, LANCET, V390, P500, DOI 10.1016/S0140-6736(17)30572-X; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, WHODCOWHD20132; ZIMMERMAN RS, 1990, J HYPERTENS, V8, pS103	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201616	10.1371/journal.pone.0201616	http://dx.doi.org/10.1371/journal.pone.0201616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114223	Green Published, gold			2022-12-26	WOS:000441850400018
J	Muradas, TC; Abbadi, BL; Villela, AD; Macchi, FS; Bergo, PF; de Freitas, TF; Sperotto, NDM; Timmers, LFSM; de Souza, ON; Picada, JN; Fachini, J; da Silva, JB; de Albuquerque, NCP; Habenschus, MD; Carrao, DB; Rocha, BA; Barbosa, F; de Oliveira, ARM; Mascarello, A; Neuenfeldf, P; Nunes, RJ; Morbidoni, HR; Campos, MM; Basso, LA; Rodrigues, VS				Muradas, Thais C.; Abbadi, Bruno L.; Villela, Anne D.; Macchi, Fernanda S.; Bergo, Pedro F.; de Freitas, Talita F.; Sperotto, Nathalia D. M.; Timmers, Luis F. S. M.; de Souza, Osmar Norberto; Picada, Jaqueline N.; Fachini, Jean; da Silva, Juliana Bondan; de Albuquerque, Nayara C. P.; Habenschus, Maisa D.; Carrao, Daniel B.; Rocha, Bruno A.; Barbosa Junior, Fernando; de Oliveira, Anderson R. M.; Mascarello, Alessandra; Neuenfeldf, Patricia; Nunes, Ricardo J.; Morbidoni, Hector R.; Campos, Maria M.; Basso, Luiz A.; Rodrigues-Junior, Valnes S.			Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CYTOCHROME-P450 ENZYMES; CELLS; DERIVATIVES; CHEMISTRY; DISCOVERY; APOPTOSIS; AGENTS; ASSAY	New effective compounds for tuberculosis treatment are needed. This study evaluated the effects of a series of quinoxaline-derived chalcones against laboratorial strains and clinical isolates of M. tuberculosis. Six molecules, namely N5, N9, N10, N15, N16, and N23 inhibited the growth of the M. tuberculosis H37Rv laboratorial strain. The three compounds (N9, N15 and N23) with the lowest MIC values were further tested against clinical isolates and laboratory strains with mutations in katG or inhA genes. From these data, N9 was selected as the lead compound for further investigation. Importantly, this chalcone displayed a synergistic effect when combined with moxifloxacin. Noteworthy, the anti-tubercular effects of N9 did not rely on inhibition of mycolic acids synthesis, circumventing important mechanisms of resistance. Interactions with cytochrome P450 isoforms and toxic effects were assessed in silico and in vitro. The chalcone N9 was not predicted to elicit any mutagenic, genotoxic, irritant, or reproductive effects, according to in silico analysis. Additionally, N9 did not cause mutagenicity or genotoxicity, as revealed by Salmonella/ microsome and alkaline comet assays, respectively. Moreover, N9 did not inhibit the cytochrome P450 isoforms CYP3A4/5, CYP2C9, and CYP2C19. N9 can be considered a potential lead molecule for development of a new anti-tubercular therapeutic agent.	[Muradas, Thais C.; Abbadi, Bruno L.; Villela, Anne D.; Macchi, Fernanda S.; Bergo, Pedro F.; de Freitas, Talita F.; Sperotto, Nathalia D. M.; Campos, Maria M.; Basso, Luiz A.; Rodrigues-Junior, Valnes S.] Pontificia Univ Catolica Rio Grande do Sul PUCRS, CPBMF, Porto Alegre, RS, Brazil; [Muradas, Thais C.; Abbadi, Bruno L.; Villela, Anne D.; Macchi, Fernanda S.; Bergo, Pedro F.; de Freitas, Talita F.; Sperotto, Nathalia D. M.; Campos, Maria M.; Basso, Luiz A.; Rodrigues-Junior, Valnes S.] Pontificia Univ Catolica Rio Grande do Sul PUCRS, INCT TB, Porto Alegre, RS, Brazil; [Muradas, Thais C.; de Freitas, Talita F.; Sperotto, Nathalia D. M.; Campos, Maria M.; Basso, Luiz A.] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil; [Abbadi, Bruno L.; Macchi, Fernanda S.; Basso, Luiz A.] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Timmers, Luis F. S. M.; de Souza, Osmar Norberto] Pontificia Univ Catolica Rio Grande do Sul, Lab Bioinformat Modelagem & Simulacao Biossistema, Porto Alegre, RS, Brazil; [Picada, Jaqueline N.; Fachini, Jean; da Silva, Juliana Bondan] Lutheran Univ Brazil ULBRA, Lab Toxicol Genet, Canoas, Brazil; [de Albuquerque, Nayara C. P.; Habenschus, Maisa D.; Carrao, Daniel B.; de Oliveira, Anderson R. M.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, Brazil; [Rocha, Bruno A.; Barbosa Junior, Fernando] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Lab Toxicol & Essencialidade Met, Ribeirao Preto, Brazil; [Mascarello, Alessandra; Neuenfeldf, Patricia; Nunes, Ricardo J.] Univ Fed Santa Catarina, Dept Quim, Florianopolis, SC, Brazil; [Morbidoni, Hector R.] UNR, Fac Ciencias Med, Lab Microbiol Mol, Rosario, Sante Fe, Argentina; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Ctr Pesquisa Toxicol & Farmacol, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Luterana do Brasil; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC); National University of Rosario; Pontificia Universidade Catolica Do Rio Grande Do Sul	Campos, MM; Rodrigues, VS (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUCRS, CPBMF, Porto Alegre, RS, Brazil.; Campos, MM; Rodrigues, VS (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUCRS, INCT TB, Porto Alegre, RS, Brazil.; Campos, MM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil.; Campos, MM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Ctr Pesquisa Toxicol & Farmacol, Porto Alegre, RS, Brazil.	maria.campos@pucrs.br; valnes.junior@pucrs.br	Sperotto, Nathalia D. M./L-3313-2015; Rocha, Bruno A./C-6123-2012; Barbosa, Fernando/C-6929-2012; Abbadi, Bruno/AAR-8866-2020; Carrão, Daniel Blascke/N-9299-2019; Picada, Jaqueline Nascimento/B-2480-2014; Carrão, Daniel/G-3197-2012; Rocha, Bruno Alves/M-9774-2019; de Souza, Osmar Norberto/B-7328-2013; Campos, Maria Martha M/J-8829-2015; de Oliveira, Anderson R. M./AAM-4707-2021; Habenschus, Maísa D/P-1597-2016; de Oliveira, Anderson R. M./E-6427-2012	Sperotto, Nathalia D. M./0000-0002-0095-4504; Rocha, Bruno A./0000-0001-7893-758X; Barbosa, Fernando/0000-0002-2498-0619; Abbadi, Bruno/0000-0002-4336-1282; Carrão, Daniel Blascke/0000-0002-0599-912X; Picada, Jaqueline Nascimento/0000-0003-2360-1557; Rocha, Bruno Alves/0000-0001-7893-758X; de Souza, Osmar Norberto/0000-0002-4602-1208; Campos, Maria Martha M/0000-0002-1153-3633; de Oliveira, Anderson R. M./0000-0002-5305-8957; Habenschus, Maísa D/0000-0002-1732-1316; de Oliveira, Anderson R. M./0000-0002-5305-8957; Souza Macchi Hopf, Fernanda/0000-0002-0936-4527; Cristina Muradas, Thais/0000-0002-6169-550X; Campos, Maria/0000-0001-7738-9892; Perez de Albuquerque, Nayara Cristina/0000-0003-1823-1184; S. Rodrigues-Junior, Valnes/0000-0002-4849-2249; Fernandes Bergo, Pedro Henrique/0000-0003-0667-0075	Banco Nacional de Desenvolvimento Economico e Social (BNDES) [14.2.0914.1]; National Institute of Science and Technology on Tuberculosis (Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES); FINEP [research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" - PUCRSINFRA] [01.11.0014-00]; National Council for Scientific and Technological Development of Brazil (CNPq) [441720/2014-5, 404440/2016-9]	Banco Nacional de Desenvolvimento Economico e Social (BNDES); National Institute of Science and Technology on Tuberculosis (Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES); FINEP [research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" - PUCRSINFRA]; National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Banco Nacional de Desenvolvimento Economico e Social (BNDES) [grant number 14.2.0914.1], National Institute of Science and Technology on Tuberculosis (Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES), FINEP [research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" - PUCRSINFRA - #01.11.0014-00], and National Council for Scientific and Technological Development of Brazil (CNPq) [grant number 441720/2014-5 to A.D.V., and grant number 404440/2016-9 to V.S.R.-J.]. L.A.B. and M.M.C. are research career awardees of the CNPq. H.R.M. is Principal Investigator of CIUNR (Consejo de Investigaciones de la Universidad Nacional de Rosario, Argentina).	Abbadi BL, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02222-17; Amorim CF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190294; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; Desai V, 2017, BIOORG MED CHEM LETT, V27, P2174, DOI 10.1016/j.bmcl.2017.03.059; Giacobbo BC, 2017, EUR J MED CHEM, V126, P491, DOI 10.1016/j.ejmech.2016.11.048; Gomes MN, 2017, EUR J MED CHEM, V137, P126, DOI 10.1016/j.ejmech.2017.05.026; Gomes MN, 2017, BIOORG MED CHEM LETT, V27, P2459, DOI 10.1016/j.bmcl.2017.04.010; Habenschus MD, 2017, PLANTA MED, V83, P727, DOI 10.1055/s-0042-124615; Jaso A, 2003, EUR J MED CHEM, V38, P791, DOI 10.1016/S0223-5234(03)00137-5; Kuo YF, 2010, FREE RADICAL BIO MED, V49, P214, DOI 10.1016/j.freeradbiomed.2010.04.005; Lang JX, 2017, XENOBIOTICA, V47, P849, DOI 10.1080/00498254.2016.1257171; Lin YM, 2002, BIOORGAN MED CHEM, V10, P2795, DOI 10.1016/S0968-0896(02)00094-9; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Mielcke TR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16199-3; Mielcke TR, 2012, EUR J MED CHEM, V48, P255, DOI 10.1016/j.ejmech.2011.12.023; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Orlikova B, 2011, GENES NUTR, V6, P125, DOI 10.1007/s12263-011-0210-5; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Rodrigues VS, 2012, INT J ANTIMICROB AG, V40, P182, DOI 10.1016/j.ijantimicag.2012.04.019; Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j; Spaggiari D, 2014, J PHARMACEUT BIOMED, V101, P221, DOI 10.1016/j.jpba.2014.03.018; Szliszka E, 2012, INT J MOL SCI, V13, P15343, DOI 10.3390/ijms131115343; U.S.Food and Drug Administration. FDA, 2016, CTR DRUG EV RES GUID; WHO, 2017, GLOB TUB REP; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Zanger UM, 2014, CLIN PHARMACOL THER, V95, P258, DOI 10.1038/clpt.2013.220; Zhuang CL, 2017, CHEM REV, V117, P7762, DOI 10.1021/acs.chemrev.7b00020	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0202568	10.1371/journal.pone.0202568	http://dx.doi.org/10.1371/journal.pone.0202568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114296	Green Published, gold, Green Submitted			2022-12-26	WOS:000441850400085
J	Arroyo-Lambaer, D; Chapman, H; Hale, M; Blackburn, D				Arroyo-Lambaer, Denise; Chapman, Hazel; Hale, Marie; Blackburn, David			Conservation genetics of two threatened frogs from the Mambilla highlands, Nigeria	PLOS ONE			English	Article							AMPHIBIAN POPULATION DECLINES; MULTILOCUS GENOTYPE DATA; METAPOPULATION DYNAMICS; MICROSATELLITE MARKERS; LANDSCAPE GENETICS; FOREST FRAGMENTS; DIVERSITY; AFLP; FLOW; HABITAT	Amphibians are the vertebrate group with the highest number of species threatened with extinction, and habitat loss and fragmentation are considered to be among the leading causes of their declines and extinctions. Little is known of the population biology of amphibian species inhabiting montane forests in Central and West Africa, where anthropogenic activities such as farming and cattle raising are major threats to native biodiversity. We used Amplified Fragment Length Polymorphisms (AFLPs) to assess the population genetic structure of two poorly known species, Cardioglossa schioetzi and Leptodactylodon bicolor (both in the Arthroleptidae), in and around Ngel Nyaki Forest Reserve on the Mambilla Plateau in eastern Nigeria. The landscape comprises continuous forest on steep slopes and small riparian forest fragments in a grassland matrix. While increased fragmentation is well documented for these and other forests in the mountains of Cameroon and Nigeria over the past century, there are no previous assessments of the impact of forest fragmentation on montane amphibian populations in this region. Our estimates of genetic diversity are similar across populations within each species with levels of heterozygosity values consistent with local population declines. Except for a pair of populations (C. schioetzi) we did not observe genetic differentiation between forest and riparian forest fragment populations, nor across sites within continuous forest (L. bicolor). Our results demonstrate recent gene flow between forest fragments and the adjacent protected forests and suggest that small forest corridors connecting these may lessen the genetic consequences of at least 30 years of intense and severe fragmentation in Ngel Nyaki.	[Arroyo-Lambaer, Denise] Univ Nacl Autonoma Mexico, Inst Biol, Ciudad Univ, Ciudad De Mexico, Mexico; [Chapman, Hazel; Hale, Marie] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Blackburn, David] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Universidad Nacional Autonoma de Mexico; University of Canterbury; State University System of Florida; University of Florida	Chapman, H (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	hazel.chapman@canterbury.ac.nz	Blackburn, David/L-3812-2019; Arroyo-Lambaer, Denise/G-7446-2019	Blackburn, David/0000-0002-1810-9886; Arroyo-Lambaer, Denise/0000-0002-6739-2390	US National Science Foundation [1202609]; Chester Zoo (UK); CNOOC Nexen Nigeria; A. G. Leventis Foundation; School of Biological Sciences, University of Canterbury, New Zealand	US National Science Foundation(National Science Foundation (NSF)); Chester Zoo (UK); CNOOC Nexen Nigeria; A. G. Leventis Foundation; School of Biological Sciences, University of Canterbury, New Zealand	Portions of fieldwork were supported by US National Science Foundation grant DEB #1202609 to DCB. Other financial support came from Chester Zoo (UK, http://www.chesterzoo.org) (HC), CNOOC Nexen Nigeria (http://www.nexencnoocltd.com) (HC), the A. G. Leventis Foundation (http://www.leventisfoundation.org) (HC) and the School of Biological Sciences, University of Canterbury, New Zealand (http://www.biol.canterbury.ac.nz) (DA-L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06747-2; Allentoft Morten E., 2010, Diversity, V2, P47; Amiet J.-L., 1971, Annales Fac Sci Univ fed Cameroun, VNo. 7-8,1971, P141; AMIET JL, 1981, ANN FS YAOUNDE, V28, P117; Andersen LW, 2004, P ROY SOC B-BIOL SCI, V271, P1293, DOI 10.1098/rspb.2004.2720; Angelone S, 2011, ECOGRAPHY, V34, P714, DOI 10.1111/j.1600-0587.2010.06494.x; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Arroyo-Lambaer D, 2015, CONSERVING AMPHIBIAN; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Bawden M.G., 1966, LAND RESOURCES SO SA; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Blackburn David C., 2006, Herpetological Review, V37, P486; Blackburn DC, 2010, HERPETOLOGICA, V66, P335, DOI 10.1655/HERPETOLOGICA-D-10-00015.1; Blackburn DC, 2010, AFR J HERPETOL, V59, P33, DOI 10.1080/04416651003742160; Blouin MS, 2010, CONSERV GENET, V11, P2179, DOI 10.1007/s10592-010-0104-x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Channing A., 2012, TADPOLES AFRICA BIOL; Chapman HM, 2004, ORYX, V38, P282, DOI 10.1017/S0030605304000511; Chapman J.D., 2001, FORESTS TARABA ADAMA; Cheek M., 2004, PLANTS KUPE MWANENGU; Cheek M, 2000, PLANTS MOUNT OKU IJI; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Deruelle B, 1991, MAGMATISM EXTENSIONA, P275, DOI DOI 10.1007/978-3-642-73966)8_12; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fagan ME, 2016, ECOL APPL, V26, P1456, DOI 10.1890/14-2188; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Garoia F, 2007, MOL ECOL, V16, P1377, DOI 10.1111/j.1365-294X.2007.03247.x; Gartshore M.E., 1986, P204; Gaudeul M, 2004, HEREDITY, V92, P508, DOI 10.1038/sj.hdy.6800443; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; HANSKI I, 1997, METAPOPULATION BIOL; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Hillers A, 2008, CONSERV BIOL, V22, P762, DOI 10.1111/j.1523-1739.2008.00920.x; Hirschfeld M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155129; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2013, IUCN RED LIST THREAT; Jehle R, 2002, HERPETOL J, V12, P1; Kraaijeveld-Smit FJL, 2005, MOL ECOL, V14, P3307, DOI 10.1111/j.1365-294X.2005.02614.x; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; LACY RC, 1995, BIOL CONSERV, V73, P131, DOI 10.1016/0006-3207(95)91940-Y; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lucas LK, 2009, J HERPETOL, V43, P220, DOI 10.1670/0022-1511-43.2.220; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Makowsky R, 2009, GENETICA, V135, P169, DOI 10.1007/s10709-008-9267-5; Mapouyat L, 2014, ZOOTAXA, V 3765, P29, DOI 10.11646/zootaxa.3765.1.2; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; McLennan MR, 2012, TROP CONSERV SCI, V5, P79, DOI 10.1177/194008291200500108; Measey GJ, 2007, CONSERV GENET, V8, P1177, DOI 10.1007/s10592-006-9272-0; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; Monsen KJ, 2004, CONSERV GENET, V5, P827, DOI 10.1007/s10592-004-1981-z; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rogell B, 2010, CONSERV GENET, V11, P173, DOI 10.1007/s10592-009-0021-z; Sandberger L, 2010, AFR J HERPETOL, V59, P79, DOI 10.1080/04416651003788619; Seiferling IS, 2012, CONSERV BIOL, V26, P610, DOI 10.1111/j.1523-1739.2011.01674.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Stolting KN, 2011, MOL ECOL RESOUR, V11, P494, DOI 10.1111/j.1755-0998.2010.02957.x; Storfer A, 2003, DIVERS DISTRIB, V9, P151, DOI 10.1046/j.1472-4642.2003.00014.x; Storfer A, 2009, BIOSCIENCE, V59, P559, DOI 10.1525/bio.2009.59.7.7; Stuart S. N., 1986, CONSERVATION CAMEROO; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waldman B, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P394; Weising K., 1995, DNA FINGERPRINTING P; White F., 1983, VEGETATION AFRICA DE; Wright S, 1943, GENETICS, V28, P114; Zancolli G, 2014, MOL ECOL, V23, P4989, DOI 10.1111/mec.12921	93	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202010	10.1371/journal.pone.0202010	http://dx.doi.org/10.1371/journal.pone.0202010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110399	gold, Green Published, Green Submitted			2022-12-26	WOS:000441738000047
J	Cullingsworth, ZE; Kelly, BB; Deebel, NA; Colhoun, AF; Nagle, AS; Klausner, AP; Speich, JE				Cullingsworth, Zachary E.; Kelly, Brooks B.; Deebel, Nicholas A.; Colhoun, Andrew F.; Nagle, Anna S.; Klausner, Adam P.; Speich, John E.			Automated quantification of low amplitude rhythmic contractions (LARC) during real-world urodynamics identifies a potential detrusor overactivity subgroup	PLOS ONE			English	Article							URINARY-BLADDER; SMOOTH-MUSCLE; RAT; TONE; PIG	Objectives Detrusor overactivity (DO) is characterized by non-voiding detrusor smooth muscle contrac-tions during the bladder filling phase and often contributes to overactive bladder. In some patients DO is observed as isolated or sporadic contractions, while in others DO is mani-fested as low amplitude rhythmic contractions (LARC). The aim of this study was to develop an objective method to quantify LARC frequencies and amplitudes in urodynamic studies (UDS) and identify a subgroup DO of patients with LARC. Methods An automated Fast Fourier Transform (FFT) algorithm was developed to analyze a 205-second region of interest of retrospectively collected "real-world" UDS ending 30 seconds before voiding. The algorithm was designed to identify the three largest rhythmic amplitude peaks in vesical pressure (P-ves) in the 1.75-6 cycle/minute frequency range. These peak eves amplitudes were analyzed to determine whether they were 1) significant (above base-line P-ves activity) and 2) independent (distinct from any in abdominal pressure (P-abd) rhythm). Results 95 UDS met criteria for inclusion and were analyzed with the FFT algorithm. During a blinded visual analysis, a neurourologist/urodynamicist identified 52/95 (55%) patients as having DO. The FFT algorithm identified significant and independent (S&I) LARC in 14/52 (27%) patients with DO and 0/43 patients (0%) without DO, resulting in 100% specificity and a significant association (Fischer's exact test, p<0.0001). The average slowest S&I LARC frequency in this DO subgroup was 3.20 +/- 0.34 cycles/min with an amplitude of 8.40 +/- 1.30 cm-H2O. This algorithm can analyze individual UDS in under 5 seconds, allowing real-time interpretation. Conclusions An FFT algorithm can be applied to "real-world" UDS to automatically characterize the frequency and amplitude of underlying LARC. This algorithm identified a potential subgroup of DO patients with LARC.	[Cullingsworth, Zachary E.; Nagle, Anna S.; Speich, John E.] Virginia Commonwealth Univ, Sch Engn, Dept Mech & Nucl Engn, Richmond, VA 23284 USA; [Kelly, Brooks B.; Deebel, Nicholas A.; Colhoun, Andrew F.; Klausner, Adam P.] Virginia Commonwealth Univ, Sch Med, Div Urol, Dept Surg, Richmond, VA USA; [Klausner, Adam P.] Hunter Holmes McGuire Vet Affairs Med Ctr, Div Urol, Dept Surg, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Speich, JE (corresponding author), Virginia Commonwealth Univ, Sch Engn, Dept Mech & Nucl Engn, Richmond, VA 23284 USA.	jespeich@vcu.edu	Speich, John/F-6246-2011	Speich, John/0000-0002-8824-4098	National Institutes of Health [R01DK101719]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant number R01DK101719 from the National Institutes of Health (https://www.niddk.nih.gov/) awarded to APK and JES. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Brading AF, 1997, UROLOGY, V50, P8; Byrne MD, 2013, J UROLOGY, V190, P334, DOI 10.1016/j.juro.2013.02.071; Clavica F, 2015, NEUROUROL URODYNAM, V34, P794, DOI 10.1002/nau.22664; Colhoun AF, 2017, WORLD J UROL, V35, P1255, DOI 10.1007/s00345-016-1994-0; Collins C, 2009, J CELL MOL MED, V13, P3236, DOI 10.1111/j.1582-4934.2009.00714.x; Drake MJ, 2005, BJU INT, V95, P1002, DOI 10.1111/j.1464-410X.2005.05455.x; Gillespie JI, 2015, N-S ARCH PHARMACOL, V388, P709, DOI 10.1007/s00210-015-1131-4; Hulls CM, 2017, AM J PHYSIOL-RENAL, V313, pF687, DOI 10.1152/ajprenal.00156.2017; KINDER RB, 1987, BRIT J UROL, V60, P509, DOI 10.1111/j.1464-410X.1987.tb05031.x; Klausner AP, 2014, WORLD J UROL, V32, P85, DOI 10.1007/s00345-013-1084-5; Komari SO, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.168; Lentle RG, 2015, BJU INT, V116, P973, DOI 10.1111/bju.13132; McCarthy CJ, 2009, J UROLOGY, V181, P1459, DOI 10.1016/j.juro.2008.10.139; Niederhauser T, 2018, NEUROUROL URODYNAM, V37, P823, DOI 10.1002/nau.23357; Parsons BA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00052; Ratz PH, 2003, AM J PHYSIOL-REG I, V284, pR1063, DOI 10.1152/ajpregu.00596.2002; Shenfeld OZ, 1999, UROL RES, V27, P386, DOI 10.1007/s002400050168; Smith PP, 2015, BJU INT, V115, P322, DOI 10.1111/bju.12669; Streng T, 2006, BJU INT, V97, P1094, DOI 10.1111/j.1464-410X.2006.06137.x; Szell EA, 2003, AM J PHYSIOL-REG I, V285, pR809, DOI 10.1152/ajpregu.00641.2002; Vince R, 2018, NEUROUROL URODYNAM, V37, P642, DOI 10.1002/nau.23362	24	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201594	10.1371/journal.pone.0201594	http://dx.doi.org/10.1371/journal.pone.0201594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110353	Green Published, gold, Green Submitted			2022-12-26	WOS:000441738000035
J	Frey, WD; Sharma, K; Cain, TL; Nishimori, K; Teruyama, R; Kim, J				Frey, Wesley D.; Sharma, Kaustubh; Cain, Terri L.; Nishimori, Katsuhiko; Teruyama, Ryoichi; Kim, Joomyeong			Oxytocin receptor is regulated by Peg3	PLOS ONE			English	Article							IMPRINTED GENE; EXPRESSION; NEURONS; SYSTEM; MICE	Mouse Peg3 encodes a DNA-binding protein involved in the milk letdown process. In the current study, we tested whether PEG3 controls the expression of the oxytocin receptor gene. According to the results, PEG3 directly binds to a genomic region within the 3rd exon of Oxtr, which contains a DNA-binding motif for PEG3. In nursing female mice, removal of PEG3 resulted in the increased expression of Oxtr in mammary epithelial cells and also in the hypothalamus. This suggests a repressor role of PEG3 in the expression of Oxtr in these tissues. Overall, this study suggests that Peg3 may function as a direct transcriptional regulator for Oxtr expression that acts to moderate the milk letdown process.	[Frey, Wesley D.; Sharma, Kaustubh; Cain, Terri L.; Teruyama, Ryoichi; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Nishimori, Katsuhiko] Tohoku Univ, Dept Mol & Cell Biol, Grad Sch Agr Sci, Sendai, Miyagi, Japan	Louisiana State University System; Louisiana State University; Tohoku University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526; Frey, Wesley/0000-0003-0392-5714	NIH (National Institute of General Medical Sciences) [R01-GM066225, R01-GM097074]	NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH (National Institute of General Medical Sciences; R01-GM066225 and R01-GM097074 to J.K.). A part of this research was carried out under the Strategic Research Program for Brain Sciences from Japan (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretz CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197069; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Denizot AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006053; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; He H, 2016, PLOS ONE, V11; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145531; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Perera BPU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119493; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Welch MG, 2009, J COMP NEUROL, V512, P256, DOI 10.1002/cne.21872; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Ye A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178363; Ye A, 2016, EPIGENETICS-US, V11, P889, DOI 10.1080/15592294.2016.1255385; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202476	10.1371/journal.pone.0202476	http://dx.doi.org/10.1371/journal.pone.0202476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106994	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800046
J	Hawlitschek, O; Fernandez-Gonzalez, A; Balmori-de la Puente, A; Castresana, J				Hawlitschek, Oliver; Fernandez-Gonzalez, Angel; Balmori-de la Puente, Alfonso; Castresana, Jose			A pipeline for metabarcoding and diet analysis from fecal samples developed for a small semi- aquatic mammal	PLOS ONE			English	Article							DESMAN GALEMYS-PYRENAICUS; PYRENEAN DESMAN; BIOLOGICAL IDENTIFICATIONS; BIODIVERSITY ASSESSMENT; DNA; GENERATION; PREY; AMPLIFICATION; INSIGHTS; BARCODE	Metabarcoding allows the genetic analysis of pooled samples of various sources. It is becoming popular in the study of animal diet, especially because it allows the analysis of the composition of feces without the need of handling animals. In this work, we studied the diet of the Pyrenean desman (Galemys pyrenaicus), a small semi-aquatic mammal endemic to the Iberian Peninsula and the Pyrenees, by sequencing COI minibarcodes from feces using next-generation sequencing techniques. For the identification of assembled sequences, we employed a tree-based identification method that used a reference tree of sequences of freshwater organisms. The comparison of freshly collected fecal samples and older samples showed that fresh samples produced significantly more sequencing reads. They also rendered more operational taxonomical units (OTUs), but not significantly. Our analyses of 41 samples identified 224 OTUs corresponding to species of the reference tree. Ephemeroptera, Diptera excl. Chironomidae, and Chironomidae were the most highly represented groups in terms of reads as well as samples. Other groups of freshwater organisms detected were Plecoptera, Trichoptera, Neuropteroida, Coleoptera, Crustacea, and Annelida. Our results are largely in line with previous morphological and genetic studies on the diet of the Pyrenean desman, but allowed the identification of a higher diversity of OTUs in each sample. Additionally, the bioinformatic pipeline we developed for deep sequencing of fecal samples will enable the quantitative analysis of the diet of this and other species, which can be highly useful to determine their ecological requirements.	[Hawlitschek, Oliver; Balmori-de la Puente, Alfonso; Castresana, Jose] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain; [Hawlitschek, Oliver] ZSM, SNSB, Munich, Germany; [Fernandez-Gonzalez, Angel] Biosfera Consultoria Medioambiental SL, Calle Candamo, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Hawlitschek, O (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain.; Hawlitschek, O (corresponding author), ZSM, SNSB, Munich, Germany.	oliver.hawlitschek@gmx.de	Castresana, Jose/K-3437-2014; Balmori-de la Puente, Alfonso/AIF-4863-2022	Castresana, Jose/0000-0002-9391-8050; Balmori-de la Puente, Alfonso/0000-0001-9070-6709; Hawlitschek, Oliver/0000-0001-8010-4157; Fernandez-Gonzalez, Angel/0000-0001-5016-4626	"Plan Nacional I+D+I del Ministerio de Economia y Competitividad" (Spain) [GL2014-53968-P]; FEDER funds; ADIF; FPI predoctoral contract of the "Ministerio de EconomoAa y Competitividad" [BES-2015-074119]; DFG [HA7255/1-1]; Biosfera Consultoria Medioambiental S.L.	"Plan Nacional I+D+I del Ministerio de Economia y Competitividad" (Spain); FEDER funds(European Commission); ADIF; FPI predoctoral contract of the "Ministerio de EconomoAa y Competitividad"; DFG(German Research Foundation (DFG)); Biosfera Consultoria Medioambiental S.L.	This work was financially supported by the research Project CGL2014-53968-P of the "Plan Nacional I+D+I del Ministerio de Economia y Competitividad" (Spain) to J.C., cofinanced with FEDER funds. Work with the Pyrenean desman in Zamora was financed by ADIF. ABdlP was supported by FPI predoctoral contract BES-2015-074119 of the "Ministerio de EconomoAa y Competitividad". O.H. was funded by DFG postdoctoral grant HA7255/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biosfera Consultoria Medioambiental S.L. provided support in the form of salary for AFG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Arrendal J, 2007, CONSERV GENET, V8, P1097, DOI 10.1007/s10592-006-9266-y; Aymerich P., 2001, ORSIS, V16, P93; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Bao E, 2011, BIOINFORMATICS, V27, P2502, DOI 10.1093/bioinformatics/btr447; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Biffi M, 2017, MAMM BIOL, V87, P176, DOI 10.1016/j.mambio.2017.09.001; Biffi M, 2017, J MAMMAL, V98, P1497, DOI 10.1093/jmammal/gyx070; Castien E, 1995, NETH J ZOOL, V45, P422; Charbonnel A, 2015, BIOL CONSERV, V184, P182, DOI 10.1016/j.biocon.2015.01.019; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Fernandes M, 2008, IUCN RED LIST THREAT; Fernandez-Salvador R, 1998, EUR MAMM C SANT COMP; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gillet F, 2015, MAMM BIOL, V80, P505, DOI 10.1016/j.mambio.2015.08.002; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hawlitschek O, 2017, MOL ECOL RESOUR, V17, P1037, DOI 10.1111/1755-0998.12638; Hawlitschek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073368; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Igea J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-115; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Locey KJ, 2016, P NATL ACAD SCI USA, V113, P5970, DOI 10.1073/pnas.1521291113; Matsen FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031009; Melero Y, 2012, EUR J WILDLIFE RES, V58, P185, DOI 10.1007/s10344-011-0561-7; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Moriniere J, 2017, MOL ECOL RESOUR, V17, P1293, DOI 10.1111/1755-0998.12683; Moriniere J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155497; Nagy ZT, 2013, DNA BARCODING PRACTI; Nemoz Melanie, 2011, Galemys, V23, P47; Papadopoulou A, 2015, MOL ECOL RESOUR, V15, P136, DOI 10.1111/1755-0998.12256; Paula DP, 2015, MOL ECOL RESOUR, V15, P880, DOI 10.1111/1755-0998.12364; Pawluczyk M, 2015, ANAL BIOANAL CHEM, V407, P1841, DOI 10.1007/s00216-014-8435-y; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SANTAMARINA J, 1993, HYDROBIOLOGIA, V252, P175, DOI 10.1007/BF00008154; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Srivathsan A, 2015, MOL ECOL RESOUR, V15, P250, DOI 10.1111/1755-0998.12302; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strayer DL, 2006, J N AM BENTHOL SOC, V25, P271, DOI 10.1899/0887-3593(2006)25[271:CFFIC]2.0.CO;2; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Thomas AC, 2016, MOL ECOL RESOUR, V16, P714, DOI 10.1111/1755-0998.12490; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	65	17	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201763	10.1371/journal.pone.0201763	http://dx.doi.org/10.1371/journal.pone.0201763			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106960	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800013
J	Cardoso, YP; Rosso, JJ; Mabragana, E; Gonzalez-Castro, M; Delpiani, M; Avigliano, E; Bogan, S; Covain, R; Schenone, NF; de Astarloa, JMD				Cardoso, Yamila P.; Rosso, Juan J.; Mabragana, Ezequiel; Gonzalez-Castro, Mariano; Delpiani, Matias; Avigliano, Esteban; Bogan, Sergio; Covain, Raphael; Schenone, Nahuel F.; Diaz de Astarloa, Juan M.			A continental-wide molecular approach unraveling mtDNA diversity and geographic distribution of the Neotropical genus Hoplias	PLOS ONE			English	Article							FRESH-WATER FISHES; MALABARICUS CHARACIFORMES ERYTHRINIDAE; SPECIES COMPLEX CHARACIFORMES; GENUS HYPOSTOMUS SILURIFORMES; RIVER-BASIN; GENETIC DIFFERENTIATION; ALLOPATRIC POPULATIONS; BARCODE DIVERGENCE; KARYOTYPIC FORMS; BIOGEOGRAPHY	With an estimate of around 9,000 species, the Neotropical region hosts the greatest diversity of freshwater fishes of the world. Genetic surveys have the potential to unravel isolated and unique lineages and may result in the identification of undescribed species, accelerating the cataloguing of extant biodiversity. In this paper, molecular diversity within the valuable and widespread Neotropical genus Hoplias was assessed by means of DNA Barcoding. The geographic coverage spanned 40 degrees of latitude from French Guiana to Argentina. Our analyses revealed 22 mitochondrial lineages fully supported by means of Barcode Index Number, Automatic Barcode Gap Discovery and phylogenetic analyses. This mtDNA survey revealed the existence of 15 fully supported mitochondrial lineages within the once considered to be the continentally distributed H. malabaricus. Only four of them are currently described as valid species however, leaving 11 mitochondrial lineages currently "masked" within this species complex. Mean genetic divergence was 13.1%. Barcoding gap analysis discriminated 20 out of the 22 lineages tested. Phylogenetic analyses showed that all taxonomically recognized species form monophyletic groups. Hoplias malabaricus sensu stricto clustered within a large Glade, excluding the representatives of the La Plata River Basin. In the H. lacerdae group, all species but H. curupira showed a cohesive match between taxonomic and molecular identification. Two different genetic lineages were recovered for H. aimara. Given the unexpected hidden mitochondrial diversity within H. malabaricus, the COI sequence composition of specimens from Suriname (the type locality), identified as H. malebaricus sensu stricto, is of major importance.	[Cardoso, Yamila P.] Univ Nacl La Plata, Lab Sistemat & Biol Evolut, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina; [Cardoso, Yamila P.; Rosso, Juan J.; Mabragana, Ezequiel; Gonzalez-Castro, Mariano; Delpiani, Matias; Avigliano, Esteban; Diaz de Astarloa, Juan M.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rosso, Juan J.; Mabragana, Ezequiel; Gonzalez-Castro, Mariano; Delpiani, Matias; Diaz de Astarloa, Juan M.] Univ Nacl Mar del Plata, Grp Biotaxon Morfol & Mol Peces, Inst Invest Marinas & Costeras, Mar Del Plata, Buenos Aires, Argentina; [Rosso, Juan J.; Mabragana, Ezequiel; Avigliano, Esteban] Fdn Bosques Nat Argentinos Biodiversidad, Buenos Aires, DF, Argentina; [Avigliano, Esteban] Univ Buenos Aires, Fac Ciencias Vet, Inst Invest Prod & Anim, Buenos Aires, DF, Argentina; [Bogan, Sergio] Univ Maimonides, Fdn Hist Nat Felix de Azara, Dept Ciencias Nat & Antropol, Buenos Aires, DF, Argentina; [Covain, Raphael] Museum Nat Hist, Dept Herpetol & Ichthyol, Geneva, Switzerland; [Schenone, Nahuel F.] Ctr Invest Antonia Ramos, Campo Ramon, Misiones, Argentina	National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Buenos Aires	Rosso, JJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Rosso, JJ (corresponding author), Univ Nacl Mar del Plata, Grp Biotaxon Morfol & Mol Peces, Inst Invest Marinas & Costeras, Mar Del Plata, Buenos Aires, Argentina.; Rosso, JJ (corresponding author), Fdn Bosques Nat Argentinos Biodiversidad, Buenos Aires, DF, Argentina.	plurosso@yahoo.com.ar	Covain, Raphael/H-2411-2018; Rosso, Juan Jose/ABC-5504-2020; de Astarloa, Juan Diaz/F-5395-2012; Mabragaña, Ezequiel/J-9057-2019; González-Castro, Mariano/AAG-8103-2019	Covain, Raphael/0000-0002-8186-8914; Gonzalez-Castro, Mariano/0000-0003-2403-3168; Cardoso, Yamila P./0000-0003-3497-4359; Rosso, Juan Jose/0000-0001-6730-9385; Avigliano, Esteban/0000-0002-3620-2291; Mabragana, Ezequiel/0000-0002-4089-9888	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220130100339 CO]; Consejo Nacional de Investigaciones Cientificas y Tecnicas I-Bol Grant; Universidad Nacional de Mar del Plata (AR) [15/E619 EXA669/14]; Fondo para la Investigacion Cientifica y Tecnologica [PICT2014-0580, PICT 2014-0665]; Fundacion Bosques Nativos Argentinos para la Biodiversidad; International Development Research Centre	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas I-Bol Grant; Universidad Nacional de Mar del Plata (AR); Fondo para la Investigacion Cientifica y Tecnologica; Fundacion Bosques Nativos Argentinos para la Biodiversidad; International Development Research Centre	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas: PIP 11220130100339 CO to MGC, Consejo Nacional de Investigaciones Cientificas y Tecnicas I-Bol Grant to JMDA, Universidad Nacional de Mar del Plata (AR) 15/E619 EXA669/14 to JMDA, Fondo para la Investigacion Cientifica y Tecnologica, PICT2014-0580 to YPC and PICT 2014-0665 to JMDA, Fundacion Bosques Nativos Argentinos para la Biodiversidad to EA, and the International Development Research Centre to JJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Alonso F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196261; Amaral CRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074397; Andrade MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170053; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Azpelicueta M. de las Mercedes, 2015, Acta Zoologica Lilloana, V59, P71; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Barker D., 2002, GUIDE ACCEPTABLE PRO; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Barros-Garcia D, 2016, ZOOL SCR, V45, P263, DOI 10.1111/zsc.12154; Benine RC, 2009, NEOTROP ICHTHYOL, V7, P161, DOI 10.1590/S1679-62252009000200005; Bertollo L., 1979, BRAZ J GENET, V2, P17; Bertollo LAC, 2000, CHROMOSOME RES, V8, P603, DOI 10.1023/A:1009233907558; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blanco DR, 2010, NEOTROP ICHTHYOL, V8, P361, DOI 10.1590/S1679-62252010000200015; Born G. G., 2006, Braz. J. Biol., V66, P205, DOI 10.1590/S1519-69842006000200004; Cardoso YP, 2016, ICHTHYOL EXPLOR FRES, V27, P9; Cardoso YP, 2012, ZOOTAXA, P69; Cardoso YP, 2009, MOL ECOL, V18, P947, DOI 10.1111/j.1365-294X.2008.04068.x; Carvalho TP, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P193; Paz FPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098603; Cerutti-Pereyra F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036479; Cioffi MB, 2009, CYTOGENET GENOME RES, V125, P132, DOI 10.1159/000227838; Cioffi MB, 2012, RECENT TRENDS CYTOGE, P125; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Covain R, 2012, CYBIUM, V36, P115; Da Rosa R, 2009, BIOL RES, V42, P289, DOI [10.4067/S0716-97602009000300003, /S0716-97602009000300003]; de Carvalho Daniel C, 2011, Mitochondrial DNA, V22 Suppl 1, P80, DOI 10.3109/19401736.2011.588214; Dergam JA, 1998, GENET MOL BIOL, V21, P493, DOI 10.1590/S1415-47571998000400015; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157419; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Durand JD, 2017, REV FISH BIOL FISHER, V27, P233, DOI 10.1007/s11160-016-9457-7; Eschmeyer W.N., 2017, CATALOG FISHES GENER; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisch-Muller S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189789; Fisch-Muller S, 2012, CYBIUM, V36, P163; Frantine-Silva W, 2015, MOL ECOL RESOUR, V15, P1226, DOI 10.1111/1755-0998.12385; Garcia Aurea, 2014, Folia Amazonica, V23, P95; Gommon M, 2014, AQUA INT J ICHTHYOL, V20, P219; Goulding M., 1980, FISHES FOREST EXPLOR; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Hubert N, 2007, MOL ECOL, V16, P2488, DOI 10.1111/j.1365-294X.2007.03338.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCNInternational Union for Conservation of Nature, 2001, SPEC SURV COMM INT U; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Iwaszkiw Juan Miguel, 2011, Rev. Mus. Argent. Cienc. Nat., V13, P21; Joppa LN, 2016, CONSERV BIOL, V30, P362, DOI 10.1111/cobi.12591; Kartavtsev YP, 2011, MITOCHONDR DNA, V22, P55, DOI 10.3109/19401736.2011.588215; Knebelsberger T, 2014, ZOOL J LINN SOC-LOND, V172, P831, DOI 10.1111/zoj.12189; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lemos PMM, 2002, CARYOLOGIA, V55, P193, DOI 10.1080/00087114.2002.10589277; Li J, 2017, BIODIVERS CONSERV, V26, P653, DOI 10.1007/s10531-016-1263-y; Lopes PA, 1998, COPEIA, P485; Lovejoy NR, 2000, MOL ECOL, V9, P259, DOI 10.1046/j.1365-294x.2000.00845.x; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Marques DF, 2013, NEOTROP ICHTHYOL, V11, P459, DOI 10.1590/S1679-62252013000200015; De Astarloa JMD, 2008, ZOOTAXA, P35, DOI 10.11646/zootaxa.1921.1.3; Mattox GMT, 2006, COPEIA, P516; Mattox GMT, 2014, NEOTROP ICHTHYOL, V12, P343, DOI 10.1590/1982-0224-20130174; Mayr E., 1942, P1; Melo BF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00107; Melo BF, 2016, ZOOL SCR, V45, P650, DOI 10.1111/zsc.12178; Miller M.A., 2010, P GAT COMP ENV WORKS; Mol JH, 2012, CYBIUM, V36, P263; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Oyakawa O. T., 2003, CHECK LIST FRESHWATE, P238; Oyakawa OT, 2009, NEOTROP ICHTHYOL, V7, P117, DOI 10.1590/S1679-62252009000200001; Oyakawa OT, 1990, REVISAO SISTEMATICA; Paepke H.-J, 1999, THESIS ZOOLOGICAE; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Pazza Rubens, 2003, Cytologia (Tokyo), V68, P159, DOI 10.1508/cytologia.68.159; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pereira TL, 2013, J BIOGEOGR, V40, P905, DOI 10.1111/jbi.12044; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Puncher GN, 2015, REV FISH BIOL FISHER, V25, P485, DOI 10.1007/s11160-015-9390-1; R Core Team, 2020, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reis R. E., 2013, International Zoo Yearbook, V47, P65, DOI 10.1111/izy.12000; Reis RE., 2003, CLOFFSCA CHECK LIST; RENNO JF, 1990, J FISH BIOL, V36, P85, DOI 10.1111/j.1095-8649.1990.tb03522.x; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Rossini BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167203; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Rosso JJ, 2018, ICHTHYOL EXPLOR FRES, V28, P235, DOI 10.23788/IEF-1076; Rosso JJ, 2016, CYBIUM, V40, P199; Roxo FF, 2012, ZOOTAXA, V21, P5326; Ruocco NL, 2012, ZOOL STUD, V51, P862; Santos U, 2009, J FISH BIOL, V75, P2326, DOI 10.1111/j.1095-8649.2009.02489.x; Scavone Marcia D. P., 1994, Cytobios, V80, P223; Silva GSC, 2011, ZOOTAXA, P50; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tordecilla-Petro Glenys, 2005, Rev.MVZ Cordoba, V10, P623; Torres Rodrigo Augusto, 2005, Neotrop. ichthyol., V3, P277, DOI 10.1590/S1679-62252005000200005; Utsunomia R, 2014, J FISH BIOL, V85, P1682, DOI 10.1111/jfb.12526; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vari Richard P., 1998, P1; Vicari MR, 2005, GENET MOL BIOL, V28, P103, DOI 10.1590/S1415-47572005000100018; Vitorino CA, 2011, J FISH BIOL, V78, P1239, DOI 10.1111/j.1095-8649.2011.02930.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Willis SC, 2007, MOL PHYLOGENET EVOL, V44, P291, DOI 10.1016/j.ympev.2006.12.014	111	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202024	10.1371/journal.pone.0202024	http://dx.doi.org/10.1371/journal.pone.0202024			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102742	Green Published, gold			2022-12-26	WOS:000441452200028
J	Hara, T; Nishimura, S; Yamamoto, T; Kajimoto, Y; Kusumoto, K; Kanagawa, R; Ikeda, S; Nishimoto, T				Hara, Tomoya; Nishimura, Satoshi; Yamamoto, Toshihiro; Kajimoto, Yumiko; Kusumoto, Keiji; Kanagawa, Ray; Ikeda, Shota; Nishimoto, Tomoyuki			TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; SARCOPLASMIC-RETICULUM; BLOOD-PRESSURE; RECEPTOR ANTAGONIST; CALCIUM-RELEASE; TRANSGENIC MICE; ALISKIREN; RATS; CALSEQUESTRIN	The renin-angiotensin system (RAS), which plays an important role in the progression of heart failure, is efficiently blocked by the inhibition of renin, the rate-limiting enzyme in the RAS cascade. In the present study, we investigated the cardioprotective effects of TAK-272 (SCO-272, imarikiren), a novel, orally effective direct renin inhibitor (DRI), and compared its efficacy with that of aliskiren, a DRI that is already available in the market. TAK-272 was administered to calsequestrin transgenic (CSQ-tg) heart failure mouse model that show severe symptoms and high mortality. The CSQ-tg mice treated with 300 mg/kg, the highest dose tested, of TAK-272 showed significantly reduced plasma renin activity (PRA), cardiac hypertrophy, and lung congestion. Further, TAK-272 reduced cardiomyocyte injury accompanied by an attenuation of the increase in NADPH oxidase 4 and nitric oxide synthase 3 expressions. TAK-272 also prolonged the survival of CSQ-tg mice in a dose-dependent manner (30 mg/kg: P=0.42, 100 mg/kg: P=0.12, 300 mg/kg: P<0.01). Additionally, when compared at the same dose level (300 mg/kg), TAK-272 showed strong and sustained PRA inhibition and reduced the heart weight and plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration, a heart failure biomarker, while aliskiren showed a significant weaker PRA inhibition and failed to demonstrate any cardioprotective effects. Our results showed that TAK-272 is an orally active and persistent renin inhibitor, which reduced the mortality of CSQ-tg mice and conferred protection against cardiac hypertrophy and injury. Thus, TAK-272 treatment could provide a new therapeutic approach for heart failure.	[Hara, Tomoya; Nishimura, Satoshi; Yamamoto, Toshihiro; Kajimoto, Yumiko; Kusumoto, Keiji; Kanagawa, Ray; Ikeda, Shota; Nishimoto, Tomoyuki] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Nishimoto, T (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Fujisawa, Kanagawa, Japan.	tomoyuki.nishimoto@takeda.com		Ikeda, Shota/0000-0003-1358-524X	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. The authors as employees of Takeda played their roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Avery CL, 2012, J AM COLL CARDIOL, V60, P1640, DOI 10.1016/j.jacc.2012.07.022; Bai F, 2016, LIFE SCI, V153, P141, DOI 10.1016/j.lfs.2016.04.013; Buczko W, 2008, PHARMACOL REP, V60, P623; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; CHRISTEN Y, 1991, CIRCULATION, V83, P1333, DOI 10.1161/01.CIR.83.4.1333; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Ferrario CM, 2010, LIFE SCI, V86, P289, DOI 10.1016/j.lfs.2009.11.020; Fisher NDL, 2005, J AM SOC NEPHROL, V16, P592, DOI 10.1681/ASN.2004100874; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1461, DOI 10.1001/jama.2013.3309; Gunther S, 2010, N-S ARCH PHARMACOL, V382, P265, DOI 10.1007/s00210-010-0544-3; IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033; IKEMOTO N, 1991, BIOCHEMISTRY-US, V30, P5230, DOI 10.1021/bi00235a017; Imaeda Y, 2016, ACS MED CHEM LETT, V7, P933, DOI 10.1021/acsmedchemlett.6b00251; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Kaneko M, 2016, BIOMARKERS, P1; KAWASAKI T, 1994, BIOCHEM BIOPH RES CO, V199, P1120, DOI 10.1006/bbrc.1994.1347; Li JJ, 2014, J MOL CELL CARDIOL, V76, P73, DOI 10.1016/j.yjmcc.2014.08.006; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Matsumoto R, 2004, CIRC J, V68, P376, DOI 10.1253/circj.68.376; McMurray JJV, 2008, CIRC-HEART FAIL, V1, P17, DOI 10.1161/CIRCHEARTFAILURE.107.740704; McMurray JJV, 2016, NEW ENGL J MED, V374, P1521, DOI 10.1056/NEJMoa1514859; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Oh BH, 2007, J AM COLL CARDIOL, V49, P1157, DOI 10.1016/j.jacc.2006.11.032; Parodi-Rullan R, 2012, CELL PHYSIOL BIOCHEM, V29, P841, DOI 10.1159/000178526; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pilz B, 2005, HYPERTENSION, V46, P569, DOI 10.1161/01.HYP.0000179573.91016.3f; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Rashikh A, 2012, BIOMED PHARMACOTHER, V66, P138, DOI 10.1016/j.biopha.2011.11.020; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Stanton A, 2003, J RENIN-ANGIO-ALDO S, V4, P6, DOI 10.3317/jraas.2003.008; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Vaidyanathan S, 2008, CLIN PHARMACOKINET, V47, P515, DOI 10.2165/00003088-200847080-00002; Weng LQ, 2014, ACTA PHARMACOL SIN, V35, P1005, DOI 10.1038/aps.2014.45; Westermann D, 2008, HYPERTENSION, V52, P1068, DOI 10.1161/HYPERTENSIONAHA.108.116350; WONG PC, 1990, HYPERTENSION, V15, P823, DOI 10.1161/01.HYP.15.6.823; Wood J M, 1987, J Enzyme Inhib, V1, P169, DOI 10.3109/14756368709020115; Zhi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081612; Zhuo JL, 2002, HYPERTENSION, V39, P634, DOI 10.1161/hy0202.103417	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202176	10.1371/journal.pone.0202176	http://dx.doi.org/10.1371/journal.pone.0202176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092100	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600097
J	Xu, CC; Zhang, D; Hann, DR; Xie, ZP; Staehelin, C				Xu, Chang-Chao; Zhang, Di; Hann, Dagmar R.; Xie, Zhi-Ping; Staehelin, Christian			Biochemical properties and in planta effects of NopM, a rhizobial E3 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; E3 ubiquitin ligase; phosphorylation; type III secretion system (T3SS); symbiosis; effector protein; ubiquitination	ACTIVATED-PROTEIN-KINASE; NODULATION OUTER PROTEINS; SP STRAIN NGR234; TRIGGERED IMMUNITY; TYPE-3 EFFECTOR; SHIGELLA EFFECTOR; SECRETION SYSTEM; LOTUS-JAPONICUS; IPAH FAMILY; DEGRADATION	Nodulation outer protein M (NopM) is an IpaH family type three (T3) effector secreted by the nitrogen-fixing nodule bacterium Sinorhizobium sp. strain NGR234. Previous work indicated that NopM is an E3 ubiquitin ligase required for an optimal symbiosis between NGR234 and the host legume Lablab purpureus. Here, we continued to analyze the function of NopM. Recombinant NopM was biochemically characterized using an in vitro ubiquitination system with Arabidopsis thaliana proteins. In this assay, NopM forms unanchored polyubiquitin chains and possesses auto-ubiquitination activity. In a NopM variant lacking any lysine residues, auto-ubiquitination was not completely abolished, indicating noncanonical auto-ubiquitination of the protein. In addition, we could show intermolecular ubiquitin transfer from NopM to C338A (enzymatically inactive NopM form) in vitro. Bimolecular fluorescence complementation analysis provided clues about NopM-NopM interactions at plasma membranes in planta. NopM, but not C338A, expressed in tobacco cells induced cell death, suggesting that E3 ubiquitin ligase activity of NopM induced effector-triggered immunity responses. Likewise, expression of NopM in Lotus japonicus caused reduced nodule formation, whereas expression of C338A showed no obvious effects on symbiosis. Further experiments indicated that serine residue 26 of NopM is phosphorylated in planta and that NopM can be phosphorylated in vitro by salicylic acid-induced protein kinase (NtSIPK), a mitogen-activated protein kinase (MAPK) of tobacco. Hence, NopM is a phosphorylated T3 effector that can interact with itself, with ubiquitin, and with MAPKs.	[Xu, Chang-Chao; Zhang, Di; Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, East Campus, Guangzhou 510006, Guangdong, Peoples R China; [Xu, Chang-Chao; Zhang, Di; Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, East Campus, Guangzhou 510006, Guangdong, Peoples R China; [Hann, Dagmar R.] Ludwig Maximilians Univ Munchen, Inst Genet, D-82152 Martinsried, Germany; [Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, Shenzhen Res & Dev Ctr, State Key Lab Biocontrol, Shenzhen 518057, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Munich; Sun Yat Sen University	Xie, ZP; Staehelin, C (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, East Campus, Guangzhou 510006, Guangdong, Peoples R China.; Xie, ZP; Staehelin, C (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Shenzhen Res & Dev Ctr, State Key Lab Biocontrol, Shenzhen 518057, Peoples R China.	xiezping@mail.sysu.edu.cn; cst@mail.sysu.edu.cn	Hann, Dagmar/GYA-4366-2022		National Natural Science Foundation of China [31470197]; Department of Science and Technology of Guangdong Province, China [2013B051000043, 2017B030311005]; Science Foundation of the State Key Laboratory of Biocontrol Grants [SKLBC32-2017-A09, SKLBC32-2018-A10]; Guangdong Key Laboratory of Plant Resources Grant [2014B030301026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guangdong Province, China; Science Foundation of the State Key Laboratory of Biocontrol Grants; Guangdong Key Laboratory of Plant Resources Grant	This work was supported by the National Natural Science Foundation of China Grant 31470197; by the Department of Science and Technology of Guangdong Province, China, Grants 2013B051000043 and 2017B030311005; by the Science Foundation of the State Key Laboratory of Biocontrol Grants SKLBC32-2017-A09 and SKLBC32-2018-A10; and by the Guangdong Key Laboratory of Plant Resources Grant 2014B030301026. The authors declare that they have no conflicts of interest with the contents of this article.	Ashida H, 2016, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00100; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Buttner D, 2016, FEMS MICROBIOL REV, V40, P894, DOI 10.1093/femsre/fuw026; Chen M., 2016, Recent trends in PGPR research for sustainable crop productivity. 4th Asian PGPR Conference Proceedings, Hanoi, Vietnam, 3-6 May, 2015, P174; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Fotiadis CT, 2012, FEMS MICROBIOL LETT, V327, P66, DOI 10.1111/j.1574-6968.2011.02466.x; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; GAMBORG OL, 1970, PLANT PHYSIOL, V45, P372, DOI 10.1104/pp.45.4.372; Ge YY, 2016, J EXP BOT, V67, P2483, DOI 10.1093/jxb/erw065; Gilkerson J, 2015, PLANT PHYSIOL, V168, P708, DOI 10.1104/pp.15.00402; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Lopez-Baena FJ, 2009, MOL PLANT MICROBE IN, V22, P1445, DOI 10.1094/MPMI-22-11-1445; Kambara K, 2009, MOL MICROBIOL, V71, P92, DOI 10.1111/j.1365-2958.2008.06507.x; Keszei AFA, 2017, P NATL ACAD SCI USA, V114, P1311, DOI 10.1073/pnas.1611595114; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumagai H, 2003, MOL PLANT MICROBE IN, V16, P663, DOI 10.1094/MPMI.2003.16.8.663; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Marin M, 2013, PLANT CELL, V25, P3153, DOI 10.1105/tpc.113.116319; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Nakano M, 2017, MICROBIOL-SGM, V163, P992, DOI 10.1099/mic.0.000495; Nelson MS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00491; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Okazaki S, 2013, P NATL ACAD SCI USA, V110, P17131, DOI 10.1073/pnas.1302360110; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rodrigues JA, 2007, J PROTEOME RES, V6, P1029, DOI 10.1021/pr060519f; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Seyedarabi A, 2010, FEBS LETT, V584, P4163, DOI 10.1016/j.febslet.2010.09.006; Singer AU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003121; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Staehelin C, 2015, BIOCHEM J, V470, P263, DOI 10.1042/BJ20150518; Toyotome T, 2001, J BIOL CHEM, V276, P32071, DOI 10.1074/jbc.M101882200; Valkevich EM, 2014, BIOCHEMISTRY-US, V53, P4979, DOI 10.1021/bi5006305; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xin DW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002707; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yasuda M, 2016, PLANT CELL PHYSIOL, V57, P1791, DOI 10.1093/pcp/pcw104; Zhang L, 2011, J BIOL CHEM, V286, P32178, DOI 10.1074/jbc.M111.265942; Zhang SQ, 2001, PLANT CELL, V13, P1877, DOI 10.1105/tpc.13.8.1877; Zhao QZ, 2013, PLANT J, V74, P524, DOI 10.1111/tpj.12127; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517; Zouhir S, 2014, BIOCHEM J, V464, P135, DOI 10.1042/BJ20140587	58	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15304	15315		10.1074/jbc.RA118.004444	http://dx.doi.org/10.1074/jbc.RA118.004444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30120198	Green Published, hybrid			2022-12-26	WOS:000445998400029
J	White, EJ; Gyulay, G; Lhotak, S; Szewczyk, MM; Chong, T; Fuller, MT; Dadoo, O; Fox-Robichaud, AE; Austin, RC; Trigatti, BL; Igdoura, SA				White, Elizabeth J.; Gyulay, Gabriel; Lhotak, Sarka; Szewczyk, Magdalena M.; Chong, Taryne; Fuller, Mark T.; Dadoo, Omid; Fox-Robichaud, Alison E.; Austin, Richard C.; Trigatti, Bernardo L.; Igdoura, Suleiman A.			Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein metabolism; monocyte; sialidase; atherosclerosis; glycosylation inhibitor; sialic acid; gene knockout; apolipoprotein E (ApoE); bone marrow; transplantation; Hyaluronic acid; P-selectin	LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; LYSOSOMAL SIALIDASE; ACID CONTENT; 2-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID; PLASMA-MEMBRANE; HUMAN MONOCYTES; EXPRESSION; CELLS; MOUSE	Atherosclerosis is a complex disease that involves alterations in lipoprotein metabolism and inflammation. Protein and lipid glycosylation events, such as sialylation, contribute to the development of atherosclerosis and are regulated by specific glycosidases, including sialidases. To evaluate the effect of the sialidase neuraminidase 1 (NEU1) on atherogenesis, here we generated apolipoprotein E (ApoE)-deficient mice that express hypomorphic levels of NEU1 (Neu1(hypo)Apoe(-/-)). We found that the hypomorphic NEU1 expression in male Apoe(-/-) mice reduces serum levels of very-low-density lipoprotein (VLDL) and LDL cholesterol, diminishes infiltration of inflammatory cells into lesions, and decreases aortic sinus atherosclerosis. Transplantation of Apoe(-/-) bone marrow (BM) into Neu1(hypo)Apoe(-/-) mice significantly increased atherosclerotic lesion development and had no effect on serum lipoprotein levels. Moreover, Neu1(hypo)Apoe(-/-) mice exhibited a reduction in circulating monocyte and neutrophil levels and had reduced hyaluronic acid and P-selectin adhesion capability on monocytes/neutrophils and T cells. Consistent with these findings, administration of a sialidase inhibitor, 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, had a significant anti-atherogenic effect in the Apoe(-/-) mice. In summary, the reduction in NEU1 expression or function decreases atherosclerosis in mice via its significant effects on lipid metabolism and inflammatory processes. We conclude that NEU1 may represent a promising target for managing atherosclerosis.	[White, Elizabeth J.; Gyulay, Gabriel; Szewczyk, Magdalena M.; Chong, Taryne; Igdoura, Suleiman A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Fuller, Mark T.; Dadoo, Omid; Trigatti, Bernardo L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Igdoura, Suleiman A.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada; [Fuller, Mark T.; Dadoo, Omid; Fox-Robichaud, Alison E.; Austin, Richard C.; Trigatti, Bernardo L.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8S 4K1, Canada; [Lhotak, Sarka; Fox-Robichaud, Alison E.; Austin, Richard C.] McMaster Univ, St Josephs Healthcare, Div Nephrol, Dept Med, Hamilton, ON L8N 4A6, Canada; [Lhotak, Sarka; Fox-Robichaud, Alison E.; Austin, Richard C.] Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Igdoura, SA (corresponding author), McMaster Univ, 1280 Main St W LSB 335, Hamilton, ON L8S 4K1, Canada.	igdoura@mcmaster.ca		Trigatti, Bernardo (Dino) L./0000-0002-4556-119X	Heart & Stroke Foundation of Canada (HSF) grants; Canadian Institutes of Health Research (CIHR) postdoctoral fellowship; CIHR studentship	Heart & Stroke Foundation of Canada (HSF) grants(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); CIHR studentship(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart & Stroke Foundation of Canada (HSF) grants (to S. A. I.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canadian Institutes of Health Research (CIHR) postdoctoral fellowship.; Recipient of a CIHR studentship.	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Bonnet P, 2004, PROTEIN SCI, V13, P946, DOI 10.1110/ps.03129704; Carrillo MB, 1997, GLYCOBIOLOGY, V7, P975; Champigny MJ, 2009, MOL GENET METAB, V97, P43, DOI 10.1016/j.ymgme.2009.01.004; Champigny MJ, 2005, EXP CELL RES, V311, P157, DOI 10.1016/j.yexcr.2005.08.023; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Cross AS, 2012, J BIOL CHEM, V287, P15966, DOI 10.1074/jbc.M112.346817; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; FILIPOVIC I, 1979, EUR J BIOCHEM, V93, P51, DOI 10.1111/j.1432-1033.1979.tb12793.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox-Robichaud A, 2000, HEPATOLOGY, V31, P1123, DOI 10.1053/he.2000.6961; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gayral S, 2014, CARDIOVASC RES, V102, P118, DOI 10.1093/cvr/cvt336; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Igdoura SA, 1998, HUM MOL GENET, V7, P115, DOI 10.1093/hmg/7.1.115; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Li XH, 1996, J LIPID RES, V37, P210; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; MALMENDIER CL, 1980, ATHEROSCLEROSIS, V37, P277, DOI 10.1016/0021-9150(80)90013-1; MEINDL P, 1974, VIROLOGY, V58, P457, DOI 10.1016/0042-6822(74)90080-4; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Millar JS, 2001, ATHEROSCLEROSIS, V154, P1, DOI 10.1016/S0021-9150(00)00697-3; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; OREKHOV AN, 1992, J LIPID RES, V33, P805; OREKHOV AN, 1991, ATHEROSCLEROSIS, V86, P153, DOI 10.1016/0021-9150(91)90211-K; Pappu BP, 2004, J IMMUNOL, V173, P275, DOI 10.4049/jimmunol.173.1.275; POTIER M, 1979, FEBS LETT, V108, P345, DOI 10.1016/0014-5793(79)80560-8; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; RUELLAND A, 1993, CLIN CHIM ACTA, V221, P127, DOI 10.1016/0009-8981(93)90027-2; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; SPRAGUE EA, 1988, J CELL PHYSIOL, V137, P251, DOI 10.1002/jcp.1041370207; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yang A, 2012, J LIPID RES, V53, P2573, DOI 10.1194/jlr.M027300; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	51	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14689	14706		10.1074/jbc.RA118.004589	http://dx.doi.org/10.1074/jbc.RA118.004589			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30097518	Green Published, hybrid			2022-12-26	WOS:000446155000010
J	Bertin, A; Beraud, A; Lansade, L; Blache, MC; Diot, A; Mulot, B; Arnould, C				Bertin, Aline; Beraud, Arielle; Lansade, Lea; Blache, Marie-Claire; Diot, Amandine; Mulot, Baptiste; Arnould, Cecile			Facial display and blushing: Means of visual communication in blue-and-yellow macaws (Ara Ararauna)?	PLOS ONE			English	Article							PLUMAGE COLORATION; PARROTS; EVOLUTION; BIRDS; MUSCULATURE; EXPRESSION; SIGNALS; THREAT; GAZE; SKIN	Mainly recognized for their cognitive performance, the visual communication system and, particularly, the potential function of facial displays in parrots remain thus far unexplored. Here, we provide the first descriptive study of facial display use in captive blue-and-yellow macaws. We observed the feather position (sleeked or ruffled) on the crown, nape and cheek at the group level during the macaws' daily routine and individually while interacting with a familiar animal caretaker. In the latter context, blushing was also assessed on the bare skin of the cheek. Group level observations showed that crown, nape and cheek feathers ruffling was more frequent in activities requiring no locomotion than in activities requiring locomotion. With the animal caretaker, crown ruffling was significantly more frequent when the caretaker was actively engaging with the parrot than during a control phase with no mutual interaction. In addition, a significantly higher proportion of naive observers judged blushing as being present on photographs taken during the mutual interaction phase than during the control phase. We thus showed significant variations in facial displays and bare skin colour based on the birds' social context and activity. Our results broaden the scope for further studies to determine whether parrots' faces provide visual social signals.	[Bertin, Aline; Beraud, Arielle; Lansade, Lea; Blache, Marie-Claire; Arnould, Cecile] Univ Tours, INRA, IFCE, CNRS,PRC, Nouzilly, France; [Beraud, Arielle; Diot, Amandine; Mulot, Baptiste] ZooParc Beauval & Beauval Nat, St Aignan, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours	Bertin, A (corresponding author), Univ Tours, INRA, IFCE, CNRS,PRC, Nouzilly, France.	aline.bertin@inra.fr			Association Beauval Nature pour la Recherche et la Conservation; Zooparc de Beauval	Association Beauval Nature pour la Recherche et la Conservation; Zooparc de Beauval	The Association Beauval Nature pour la Recherche et la Conservation and the Zooparc de Beauval provided financial support to Arielle Beraud.; We are grateful to the Association Beauval Nature pour la Recherche et la Conservation and the Zooparc de Beauval who provided access to the birds and financial support. We are very grateful to Amandine Diot who trained the birds and kindly agreed to participate in this experiment. We thank all the caretakers of the Zoo Parc de Beauval Saint Aignan for the care provided to the birds. We thank our panel of blind observers including Frederic Levy. We thank the statistical consulting agency Anastats (http://www.anastats.fr).	Anderson PK, 2014, ANTHROZOOS, V27, P371, DOI 10.2752/175303714X13903827488006; Andrew R. J., 1961, IBIS               A, V103, P315, DOI [10.1111/j.1474-919X.1961.tb02464.x, DOI 10.1111/J.1474-919X.1961.TB02464.X]; Bamford AJ, 2010, ETHOLOGY, V116, P1163, DOI 10.1111/j.1439-0310.2010.01834.x; Bellegarde LGA, 2017, APPL ANIM BEHAV SCI, V193, P51, DOI 10.1016/j.applanim.2017.03.014; Berg ML, 2010, EMU, V110, P10, DOI 10.1071/MU09076; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Brown L. H., 1968, EAGLES HAWKS FALCONS; Crozier WR, 2016, J THEOR SOC BEHAV, V46, P502, DOI 10.1111/jtsb.12105; Cuthill IC, 2017, SCIENCE, V357, DOI 10.1126/science.aan0221; Darwin C., 1872, EXPRESSION EMOTIONS; de Jong PJ, 2013, SOC PERSONAL PSYCHOL, V7, P13, DOI 10.1111/spc3.12009; Diogo R, 2008, J ANAT, V213, P391, DOI 10.1111/j.1469-7580.2008.00953.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Finlayson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166446; Forshaw J, 1989, PARROTS WORLD; Goodwin D., 1956, Ibis, V98, P186, DOI 10.1111/j.1474-919X.1956.tb03040.x; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Homberger DG, 2003, J EXP ZOOL PART B, V298B, P123, DOI 10.1002/jez.b.00030; Ingels J, 2011, NEOTROPICAL BIRDING, P71; Kaplan G, 2015, BIRD MINDS: COGNITION AND BEHAVIOUR OF AUSTRALIAN NATIVE BIRDS, P1; Kinkaid HYM, 2013, AVIAN BIOL RES, V6, P289, DOI 10.3184/175815513X13803574144572; Kumar Anil, 2010, Journal of Threatened Taxa, V2, P919; Lange H, 2003, ANIM BEHAV, V65, P573, DOI 10.1006/anbe.2003.2088; Masello JF, 2003, EMU, V103, P149, DOI 10.1071/MU02036; McGraw KJ, 2003, OIKOS, V102, P402; McGraw KJ, 2004, COMP BIOCHEM PHYS B, V138, P229, DOI 10.1016/j.cbpc.2004.03.011; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; MORRIS D., 1956, BEHAVIOUR, V9, P75, DOI 10.1163/156853956X00264; MOYNIHAN M, 1954, BEHAVIOUR, V7, P33; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Negro JJ, 2006, COMP BIOCHEM PHYS A, V143, P78, DOI 10.1016/j.cbpa.2005.10.028; Nikolic M, 2016, EMOTION, V16, P475, DOI 10.1037/emo0000131; Olkowicz S, 2016, P NATL ACAD SCI USA, V113, P7255, DOI 10.1073/pnas.1517131113; Parr LA, 2006, SOC COGN AFFECT NEUR, V1, P221, DOI 10.1093/scan/nsl031; Pepperberg I.M, 2009, ALEX STUDIES COGNITI; Pepperberg IM, 1996, J COMP PSYCHOL, V110, P286, DOI 10.1037/0735-7036.110.3.286; Rakotonirina H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15393-7; Renton K, 2004, CONDOR, V106, P354, DOI 10.1650/7388; Ruiz-Rodriguez M, 2017, J AVIAN BIOL, V48, P1425, DOI 10.1111/jav.01402; Scheider L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151733; SERPELL JA, 1982, ANIM BEHAV, V30, P1244, DOI 10.1016/S0003-3472(82)80217-0; van Dongen WFD, 2007, BEHAV ECOL SOCIOBIOL, V62, P77, DOI 10.1007/s00265-007-0440-0; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Waller BM, 2013, EMOT REV, V5, P54, DOI 10.1177/1754073912451503	46	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201762	10.1371/journal.pone.0201762	http://dx.doi.org/10.1371/journal.pone.0201762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR3NR	30133471	Green Published, gold			2022-12-26	WOS:000442500400037
J	Bastos, DB; Sarafim-Silva, BAM; Sundefeld, MLMM; Ribeiro, AA; Brandao, JDP; Biasoli, ER; Miyahara, GI; Casarini, DE; Bernabe, DG				Bastos, Daniela B.; Sarafim-Silva, Bruna A. M.; Sundefeld, Maria Lucia M. M.; Ribeiro, Amanda A.; Brandao, Juliana D. P.; Biasoli, Eder R.; Miyahara, Glauco, I; Casarini, Dulce E.; Bernabe, Daniel G.			Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; QUALITY-OF-LIFE; OVARIAN-CANCER; BREAST-CANCER; PSYCHOLOGICAL DISTRESS; TUMOR NOREPINEPHRINE; SLEEP DISTURBANCE; URINARY-EXCRETION; NERVOUS-SYSTEM; CELL-LINES	Studies have shown that stress-related catecholamines may affect cancer progression. However, little is known about catecholamine secretion profiles in head and neck cancer patients. The present study investigated plasma norepinephrine and epinephrine levels in head and neck squamous cell carcinoma (HNSCC) patients and patients with oral leukoplakia, as well as their association with clinicopathological and biobehavioral variables and anxiety symptoms. A total of 93 patients with HNSCC and 32 patients with oral leukoplakia were included. Plasma norepinephrine and epinephrine levels were measured by high performance liquid chromatography with electrochemical detection (HPLC-ED), and psychological anxiety levels were measured by the Beck Anxiety Inventory (BAI). Plasma norepinephrine and epinephrine concentrations were significantly higher in patients with oral and oropharyngeal squamous cell carcinoma (SCC) compared to non-cancer patients. Oral SCC patients displayed plasma norepinephrine levels about six times higher than oropharyngeal SCC patients, and nine times higher than oral leukoplakia patients (p <.001). Plasma epinephrine levels in oral SCC patients were higher compared to the oropharyngeal SCC (p =.0097) and leukoplakia (p <.0001) patients. Oropharyngeal SCC patients had higher plasma norepinephrine (p =.0382) and epinephrine levels (p =.045) than patients with oral leukoplakia. Multiple regression analyses showed that a history of high alcohol consumption was predictive for reduced plasma norepinephrine levels in the oral SCC group (p <.001). Anxiety symptom of "hand tremor" measured by the BAI was an independent predictor for higher plasma norepinephrine levels in HNSCC patients (beta = 157.5, p =.0377), while the "heart pounding/racing" symptom was independently associated with higher plasma epinephrine levels in the oropharyngeal SCC group (beta = 15.8, p =.0441). In oral leukoplakia patients, sleep deprivation and worse sleep quality were independent predictors for higher plasma norepinephrine levels, while severe tobacco consumption and higher anxiety levels were factors for higher plasma epinephrine levels. These findings suggest that head and neck cancer patients display sympathetic nervous system hyperactivity, and that changes in circulating catecholamines may be associated with alcohol consumption, as well as withdrawal-related anxiety symptoms.	[Bastos, Daniela B.; Sarafim-Silva, Bruna A. M.; Sundefeld, Maria Lucia M. M.; Biasoli, Eder R.; Miyahara, Glauco, I; Bernabe, Daniel G.] Sao Paulo State Univ UNESP, Psychosomat Res Ctr, Sch Dent, Aracatuba, SP, Brazil; [Bastos, Daniela B.; Sarafim-Silva, Bruna A. M.; Sundefeld, Maria Lucia M. M.; Biasoli, Eder R.; Miyahara, Glauco, I; Bernabe, Daniel G.] Sao Paulo State Univ UNESP, Oral Oncol Ctr, Sch Dent, Aracatuba, SP, Brazil; [Ribeiro, Amanda A.; Brandao, Juliana D. P.; Casarini, Dulce E.] Fed Univ Sao Paulo UNIFESP, Dept Med, Nephrol Div, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Bernabe, DG (corresponding author), Sao Paulo State Univ UNESP, Psychosomat Res Ctr, Sch Dent, Aracatuba, SP, Brazil.; Bernabe, DG (corresponding author), Sao Paulo State Univ UNESP, Oral Oncol Ctr, Sch Dent, Aracatuba, SP, Brazil.	danielbernabe@foa.unesp.br	Casarini, Dulce E/D-4091-2012; Sarafim-Silva, Bruna AM/T-8576-2018; miyahara, glauco/D-8544-2012; Bastos, Daniela/C-1722-2018	miyahara, glauco/0000-0002-5748-9412; Bastos, Daniela/0000-0002-2389-0646; Perez Brandao, Juliana Dineia/0000-0003-2482-1412; Casarini, Dulce/0000-0003-1912-4292; Sarafim-Silva, Bruna/0000-0002-5705-9877; Bernabe, Daniel/0000-0002-1225-7749	Sao Paulo State Research Foundation (FAPESP); FAPESP [2015/12485-4, 2010/51904-9, 2016/25255-0]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo State Research Foundation (FAPESP). FAPESP grant 2015/12485-4 supported Daniela B Bastos in her master-degree research. FAPESP grant 2010/51904-9 designated to Dulce E Casarini supported the experiments in her lab and FAPESP grant 2016/25255-0 designated to Daniel G BernabeA supported Psychosomatic Research Center's studies, www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Armaiz-Pena GN, 2009, BRAIN BEHAV IMMUN, V23, P10, DOI 10.1016/j.bbi.2008.06.007; Becker HC, 2012, ALCOHOL RES-CURR REV, V34, P448; Bernabe DG, 2011, BRAIN BEHAV IMMUN, V25, P574, DOI 10.1016/j.bbi.2010.12.012; Bernabe DG, 2012, J CLIN PATHOL, V65, P934, DOI 10.1136/jclinpath-2012-200695; Boyd AD, 2012, SCI WORLD J, DOI 10.1100/2012/650707; Carlson LE, 2007, J BEHAV MED, V30, P45, DOI 10.1007/s10865-006-9082-3; Chauhan A, 2012, AUTON NEUROSCI-BASIC, V166, P93, DOI 10.1016/j.autneu.2011.09.006; Clevenger L, 2013, CANCER-AM CANCER SOC, V119, P3234, DOI 10.1002/cncr.28188; Cohen L, 2001, PSYCHOSOM MED, V63, P951, DOI 10.1097/00006842-200111000-00014; Cordes MC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-731; Costanzo ES, 2011, IMMUNOL ALLERGY CLIN, V31, P109, DOI 10.1016/j.iac.2010.09.001; Davis LZ, 2015, CANCER-AM CANCER SOC, V121, P3543, DOI 10.1002/cncr.29516; Di Marco GS, 2003, J CELL BIOCHEM, V89, P144, DOI 10.1002/jcb.10485; DROTT C, 1988, ANN SURG, V208, P645, DOI 10.1097/00000658-198811000-00017; Ehrenreich H, 1997, ALCOHOL CLIN EXP RES, V21, P1285, DOI 10.1097/00000374-199710000-00019; ELGEROT A, 1978, J CLIN PSYCHOL, V34, P759, DOI 10.1002/1097-4679(197807)34:3<759::AID-JCLP2270340338>3.0.CO;2-Y; Fitzgerald Paul J, 2012, Clin Epidemiol, V4, P151, DOI 10.2147/CLEP.S33695; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Heinz A, 1999, PSYCHIAT RES, V89, P97, DOI 10.1016/S0165-1781(99)00099-2; Kovacs GL, 2002, EUR J PHARMACOL, V448, P151, DOI 10.1016/S0014-2999(02)01939-8; KRAMER I R H, 1978, Oral Surgery Oral Medicine Oral Pathology, V46, P518; Lindell G, SCAND J GASTROENTERO; Liu JX, 2017, PSYCHO-ONCOLOGY, V26, P1347, DOI 10.1002/pon.4305; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Lutgendorf SK, 2015, AM PSYCHOL, V70, P186, DOI 10.1037/a0035730; Lutgendorf SK, 2011, BRAIN BEHAV IMMUN, V25, P250, DOI 10.1016/j.bbi.2010.10.012; Madden KS, 2003, BRAIN BEHAV IMMUN, V17, pS5; Mausbach BT, 2006, SLEEP, V29, P1347, DOI 10.1093/sleep/29.10.1347; Mazzacoratti M.G.Naffah, 1992, ARQ BRAS ENDOCRINOL, V36, P119; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Moye J, 2014, PSYCHO-ONCOLOGY, V23, P237, DOI 10.1002/pon.3381; Osman A, 1997, J CLIN PSYCHOL, V53, P7, DOI 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S; Parlesak A, 2004, SCAND J GASTROENTERO, V39, P60, DOI 10.1080/00365520310007738; Partecke LI, 2016, PANCREATOLOGY, V16, P423, DOI 10.1016/j.pan.2016.03.005; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579; Shang ZJ, 2009, J ORAL PATHOL MED, V38, P371, DOI 10.1111/j.1600-0714.2008.00691.x; Shiraz F, 2014, BRIT J ORAL MAX SURG, V52, P513, DOI 10.1016/j.bjoms.2014.03.019; Singh B, 1997, LARYNGOSCOPE, V107, P1469, DOI 10.1097/00005537-199711000-00009; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Thornton LM, 2010, HEALTH PSYCHOL, V29, P333, DOI 10.1037/a0018836; Valente VB, 2018, PSYCHONEUROENDOCRINO, V89, P229, DOI 10.1016/j.psyneuen.2017.11.001; Vgontzas AN, 1998, J PSYCHOSOM RES, V45, P21, DOI 10.1016/S0022-3999(97)00302-4; WARD KD, 1991, PHARMACOL BIOCHEM BE, V40, P937, DOI 10.1016/0091-3057(91)90109-F; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wu YS, 2016, NEUROPSYCH DIS TREAT, V12, P1029, DOI 10.2147/NDT.S103203; Xie HX, 2015, ORAL ONCOL, V51, P991, DOI 10.1016/j.oraloncology.2015.08.007; Xie HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099179; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; ZUSPAN FP, 1979, AM J OBSTET GYNECOL, V135, P1012, DOI 10.1016/0002-9378(79)90727-0	55	14	14	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202515	10.1371/journal.pone.0202515	http://dx.doi.org/10.1371/journal.pone.0202515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR0JS	30125310	gold, Green Published, Green Submitted			2022-12-26	WOS:000442202100033
J	Masse, M; Maton, M; Genay, S; Blanchemain, N; Barthelemy, C; Decaudin, B; Odon, P				Masse, Morgane; Maton, Mickael; Genay, Stephanie; Blanchemain, Nicolas; Barthelemy, Christine; Decaudin, Bertrand; Odon, Pascal			In vitro assessment of the influence of intravenous extension set materials on insulin aspart drug delivery	PLOS ONE			English	Article							QUANTITATIVE ANALYTICAL PROCEDURES; PHYSICOCHEMICAL PROPERTIES; LIQUID-CHROMATOGRAPHY; SFSTP PROPOSAL; ADSORPTION; STABILITY; HARMONIZATION; PLASTICIZERS; DEGRADATION; VALIDATION	Insulin is a frequently prescribed drug in hospitals and is usually administered by syringe pumps with an extension line which can be made of various materials. Two insulin solutions were studied: an insulin analogue, Novorapid (R) which contains insulin aspart and two phenolic preservatives (e.g. phenol and metacresol) and Umuline rapide (R) with human insulin and metacresol as preservative. Some studies have indicated interactions between insulin, polyvinyl chloride (PVC) and polyethylene (PE). The aim of this work was to study such interactions between Novorapid (R) or Umuline rapide (R) and infusion extension line materials (PVC, PE and coextruded (PE/PVC)). Insulin solution at 1 IU/mL was infused at 2 mL/h over 24 hours with 16 different extension lines (8 in PVC, 3 in PE and 5 in PE/PVC). Ultra-Fast Liquid Chromatography with diode array detection (UFLC-DAD) was performed to quantify insulin (human and aspart) and preservatives (metacresol and phenol). Limited human insulin sorption was observed thirty minutes after the onset of infusion: 24.3 +/- 12.9%, 3.1 +/- 1.6% and 18.6 +/- 10.0% for PVC, PE and PE/PVC respectively. With insulin aspart, sorption of about 5% was observed at the onset of infusion for all materials. However, there were interactions between phenol and especially metacresol with PVC, but no interactions with PE and PE/PVC. This study shows that insulin interacts with PVC, PE and PE/PVC at the onset of infusion. It also demonstrates that insulin preservatives interact with PVC, which may result in problems of insulin conservation and conformation. Some more studies are required to understand the clinical impact of the latter during infusion.	[Masse, Morgane; Genay, Stephanie; Barthelemy, Christine; Decaudin, Bertrand; Odon, Pascal] Univ Lille, EA 7365, GRITA, Lille, France; [Masse, Morgane; Genay, Stephanie; Decaudin, Bertrand; Odon, Pascal] CHU Lille, Inst Pharm, Lille, France; [Maton, Mickael; Blanchemain, Nicolas] Univ Lille, Controlled Drug Delivery Syst & Biomat U1008, Inserm, CHU Lille, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Genay, S (corresponding author), Univ Lille, EA 7365, GRITA, Lille, France.; Genay, S (corresponding author), CHU Lille, Inst Pharm, Lille, France.	stephanie.genay@univ-lille.fr	masse, morgane/AAF-2140-2020; Nicolas, Blanchemain/GWV-3651-2022; Decaudin, Bertrand/E-5828-2010	masse, morgane/0000-0002-6761-9444; Decaudin, Bertrand/0000-0001-8267-5594				Al Salloum H, 2015, INT J PHARMACEUT, V496, P664, DOI 10.1016/j.ijpharm.2015.11.004; Berchtold H, 1999, BIOPOLYMERS, V51, P165, DOI 10.1002/(SICI)1097-0282(1999)51:2<165::AID-BIP6>3.3.CO;2-O; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J., 1987, RASMUSSEN GALENICS O; Fuloria M, 1998, PEDIATRICS, V102, P1401, DOI 10.1542/peds.102.6.1401; Genay S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0298-x; Havelund S, 2015, PHARM RES-DORDR, V32, P2250, DOI 10.1007/s11095-014-1614-x; Hewson MP, 2000, J PAEDIATR CHILD H, V36, P216, DOI 10.1046/j.1440-1754.2000.00488.x; Hubert P, 2004, J PHARMACEUT BIOMED, V36, P579, DOI 10.1016/j.jpba.2004.07.027; Hubert P, 2007, J PHARMACEUT BIOMED, V45, P82, DOI 10.1016/j.jpba.2007.06.032; ICH, HARM TRIP GUID STAB; Jakobsson Therese, 2009, J Diabetes Sci Technol, V3, P213; KANG S, 1991, DIABETES CARE, V14, P942, DOI 10.2337/diacare.14.11.942; Kerr David, 2013, J Diabetes Sci Technol, V7, P1595; Ling J, 1999, DIABETES EDUCATOR, V25, P237; Lisi GP, 2014, BIOCHEMISTRY-US, V53, P3576, DOI 10.1021/bi401678n; Masse M, 2017, TALANTA, V162, P187, DOI 10.1016/j.talanta.2016.10.029; MELBERG SG, 1988, DIABETIC MED, V5, P243, DOI 10.1111/j.1464-5491.1988.tb00977.x; Mollmann SH, 2006, EUR J PHARM SCI, V27, P194, DOI 10.1016/j.ejps.2005.09.010; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Poulsen C, 2008, PHARM RES-DORDR, V25, P2534, DOI 10.1007/s11095-008-9670-8; Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806; Teska BM, 2015, J PHARM SCI-US, V104, P1555, DOI 10.1002/jps.24330; Teska BM, 2014, J PHARM SCI-US, V103, P2255, DOI 10.1002/jps.24039; Weber C, 2015, TOXICOL REP, V2, P194, DOI 10.1016/j.toxrep.2014.11.019; Xu XL, 2006, J PHARMACEUT BIOMED, V41, P266, DOI 10.1016/j.jpba.2005.10.016; Zahid Najam, 2008, Diabetes Res Clin Pract, V80, pe11, DOI 10.1016/j.diabres.2008.02.013	27	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201623	10.1371/journal.pone.0201623	http://dx.doi.org/10.1371/journal.pone.0201623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114258	Green Published, Green Submitted, gold			2022-12-26	WOS:000441850400019
J	Shimmon, G; Kotecha, A; Rene, JS; Astor, AS; Newman, J; Berryman, S; Cottam, EM; Gold, S; Tuthil, TJ; King, DP; Brocchi, E; King, AMQ; Owens, R; Fry, EE; Stuart, DI; Burman, A; Jackson, T				Shimmon, Gareth; Kotecha, Abhay; Rene, Jingshan; Astor, Amin S.; Newman, Joseph; Berryman, Stephen; Cottam, Eleanor M.; Gold, Sarah; Tuthil, Toby J.; King, Donald P.; Brocchi, Emiliana; King, Andrew M. Q.; Owens, Ray; Fry, Elizabeth E.; Stuart, David, I; Burman, Alison; Jackson, Terry			Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays	PLOS ONE			English	Article							FOOT-AND-MOUTH; LINKED-IMMUNOSORBENT-ASSAY; LATERAL FLOW DEVICE; 4 ANTIGENIC SITES; DISEASE-VIRUS; MONOCLONAL-ANTIBODIES; INTEGRIN ALPHA(V)BETA(3); NEUTRALIZING EPITOPES; HYPERVARIABLE REGIONS; STRUCTURAL REPERTOIRE	Foot-and-mouth disease (FMD) affects economically important livestock and is one of the most contagious viral diseases. The most commonly used FMD diagnostic assay is a sandwich ELISA. However, the main disadvantage of this ELISA is that it requires anti-FMD virus (FMDV) serotype-specific antibodies raised in small animals. This problem can be, in part, overcome by using anti-FMDV monoclonal antibodies (MAbs) as detecting reagents. However, the long-term use of MAbs may be problematic and they may need to be replaced. Here we have constructed chimeric antibodies (mouse/rabbit D9) and Fabs (fragment anti-gen-binding) (mouse/cattle D9) using the Fv (fragment variable) regions of a mouse MAb, D9 (MAb D9), which recognises type O FMDV. The mouse/rabbit D9 chimeric antibody retained the FMDV serotype-specificity of MAb D9 and performed well in a FMDV detection ELISA as well as in routine laboratory assays. Cryo-electron microscopy analysis confirmed engagement with antigenic site 1 and peptide competition studies identified the aspartic acid at residue VP1 147 as a novel component of the D9 epitope. This chimeric expression approach is a simple but effective way to preserve valuable FMDV antibodies, and has the potential for unlimited generation of antibodies and antibody fragments in recombinant systems with the concomitant positive impacts on the 3Rs (Replacement, Reduction and Refinement) principles.	[Shimmon, Gareth; Astor, Amin S.; Newman, Joseph; Berryman, Stephen; Cottam, Eleanor M.; Gold, Sarah; Tuthil, Toby J.; King, Donald P.; King, Andrew M. Q.; Burman, Alison; Jackson, Terry] Pirbright Inst, Pirbright, Surrey, England; [Kotecha, Abhay; Rene, Jingshan; Owens, Ray; Fry, Elizabeth E.; Stuart, David, I] Univ Oxford, Div Struct Biol, Oxford, England; [Brocchi, Emiliana] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Stuart, David, I] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Cottam, Eleanor M.] Reading Enterprise Ctr, Gen Bioinformat, Reading, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; IZS Lombardia e Emilia; Diamond Light Source	Shimmon, G (corresponding author), Pirbright Inst, Pirbright, Surrey, England.; Fry, EE (corresponding author), Univ Oxford, Div Struct Biol, Oxford, England.	gareth.shimmon@pirbrigh.ac.uk; liz@strubi.ox.ac.uk	Brocchi, Emiliana/G-1810-2019; Ren, Jingshan/AAT-7729-2021	Brocchi, Emiliana/0000-0003-1864-080X; Ren, Jingshan/0000-0003-4015-1404; King, Donald/0000-0002-6959-2708; Newman, Joseph/0000-0003-0717-8672; Stuart, David/0000-0002-3426-4210; Kotecha, Abhay/0000-0002-4480-5439	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001716, BB/N007298/1, BB/K003801/1, BBS/E/I/00001980, BBS/E/I/00007034, BB/L004828/1]; United Kingdom Department for Environment, Food and Rural Affairs [SE1127, SE1128, SE1129]; Medical Research Council [MR/N00065X/1]; Wellcome Trust [101122/Z/13/Z]; BBSRC [BB/K003801/1, BBS/E/I/00001980, BBS/E/I/00007034, BB/N007298/1, BBS/E/I/00001716, BB/L004828/1] Funding Source: UKRI; MRC [MR/N00065X/1, MR/K018779/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, projects BBS/E/I/00001716, BB/N007298/1 and BB/K003801/1 to TJ, projects BBS/E/I/00001980 and BBS/E/I/00007034 to TJT, project BB/L004828/1 to DPK, http://www.bbsrc.ac.uk/, and the United Kingdom Department for Environment, Food and Rural Affairs, projects SE1127, SE1128 and SE1129 to DPK, https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs, and the Medical Research Council, project MR/N00065X/1 to DIS, https://mrc.ukri.org/ and the Wellcome Trust, project 101122/Z/13/Z to DIS, https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; Adams JJ, 2014, CURR OPIN STRUC BIOL, V24, P1, DOI 10.1016/j.sbi.2013.11.003; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Asfor AS, 2014, J GEN VIROL, V95, P1104, DOI 10.1099/vir.0.060939-0; BARNETT PV, 1989, J GEN VIROL, V70, P1483, DOI 10.1099/0022-1317-70-6-1483; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; BAXT B, 1990, Virus Genes, V4, P73, DOI 10.1007/BF00308567; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Berryman S, 2005, J VIROL, V79, P8519, DOI 10.1128/JVI.79.13.8519-8534.2005; BOLWELL C, 1989, J GEN VIROL, V70, P59, DOI 10.1099/0022-1317-70-1-59; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; Brocchi EC A., 1983, ATTI SOC ITALIANA SC, V36, P576; BROOKSBY J B, 1958, Adv Virus Res, V5, P1, DOI 10.1016/S0065-3527(08)60670-3; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1986, SCIENCE, V233, P755, DOI 10.1126/science.3090684; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; CHUCK AS, 1992, BIOTECHNOL BIOENG, V39, P354, DOI 10.1002/bit.260390315; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; COUTURE ML, 1995, BIOTECHNOL BIOENG, V47, P270, DOI 10.1002/bit.260470219; CROWTHER JR, 1993, J GEN VIROL, V74, P1547, DOI 10.1099/0022-1317-74-8-1547; DE CASTRO M. P., 1964, ARQ INST BIOL [SAO PAULO], V31, P63; DiCara D, 2008, J VIROL, V82, P1537, DOI 10.1128/JVI.01480-07; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; Dunbar J, 2016, NUCLEIC ACIDS RES, V44, pW474, DOI 10.1093/nar/gkw361; Ferris N, 2001, VET REC, V148, P823; Ferris NP, 2011, J VIROL METHODS, V175, P253, DOI 10.1016/j.jviromet.2011.05.026; Ferris NP, 2010, J VIROL METHODS, V163, P474, DOI 10.1016/j.jviromet.2009.09.022; Ferris NP, 2009, J VIROL METHODS, V155, P10, DOI 10.1016/j.jviromet.2008.09.009; FERRIS NP, 1988, VET MICROBIOL, V16, P201, DOI 10.1016/0378-1135(88)90024-7; Ferris NP, 2005, J VIROL METHODS, V127, P69, DOI 10.1016/j.jviromet.2005.02.014; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Goller KV, 2018, TRANSBOUND EMERG DIS, V65, P578, DOI 10.1111/tbed.12744; Hewat EA, 1997, EMBO J, V16, P1492, DOI 10.1093/emboj/16.7.1492; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Howson ELA, 2018, TRANSBOUND EMERG DIS, V65, P221, DOI 10.1111/tbed.12684; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2003, VIRUS RES, V91, P33, DOI 10.1016/S0168-1702(02)00258-7; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; Jamal SM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-116; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kabat E. A., 1991, SEQUENCES PROTEINS I, V1; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Knight-Jones TJD, 2016, TRANSBOUND EMERG DIS, V63, P42, DOI 10.1111/tbed.12523; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Kotecha A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15408; Kotecha A, 2015, NAT STRUCT MOL BIOL, V22, P788, DOI 10.1038/nsmb.3096; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Martin ACR, 1996, J MOL BIOL, V263, P800, DOI 10.1006/jmbi.1996.0617; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MATEU MG, 1990, J GEN VIROL, V71, P629, DOI 10.1099/0022-1317-71-3-629; MATEU MG, 1989, P NATL ACAD SCI USA, V86, P5883, DOI 10.1073/pnas.86.15.5883; MATEU MG, 1987, VIRUS RES, V8, P261, DOI 10.1016/0168-1702(87)90020-7; MCCAHON D, 1989, J GEN VIROL, V70, P639, DOI 10.1099/0022-1317-70-3-639; MCCULLOUGH KC, 1987, VIROLOGY, V157, P516, DOI 10.1016/0042-6822(87)90294-7; MERRITT SE, 1993, BIOTECHNOL BIOENG, V42, P247, DOI 10.1002/bit.260420213; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; Nettleship JE, 2008, PROTEIN EXPRES PURIF, V62, P83, DOI 10.1016/j.pep.2008.06.017; Nettleship JE, 2012, METHODS MOL BIOL, V801, P137, DOI 10.1007/978-1-61779-352-3_10; NEUBERGER MS, 1985, NATURE, V314, P268, DOI 10.1038/314268a0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; PFAFF E, 1988, J VIROL, V62, P2033, DOI 10.1128/JVI.62.6.2033-2040.1988; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Reid SM, 2001, J VIROL METHODS, V96, P189, DOI 10.1016/S0166-0934(01)00334-2; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rodriguez LL, 2011, EXPERT REV VACCINES, V10, P377, DOI [10.1586/erv.11.4, 10.1586/ERV.11.4]; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; ROWLANDS D, 1994, ARCH VIROL, P51; ROWLANDS DJ, 1969, J GEN VIROL, V4, P479, DOI 10.1099/0022-1317-4-4-479; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shimmon G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160696; STAVE JW, 1988, VIROLOGY, V162, P21, DOI 10.1016/0042-6822(88)90390-X; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; TALBOT P, 1972, J GEN VIROL, V15, P163, DOI 10.1099/0022-1317-15-2-163; THOMAS AAM, 1988, J VIROL, V62, P2782, DOI 10.1128/JVI.62.8.2782-2789.1988; TOMLINSON IM, 1995, EMBO J, V14, P4628, DOI 10.1002/j.1460-2075.1995.tb00142.x; TRAMONTANO A, 1989, PROTEINS, V6, P382, DOI 10.1002/prot.340060405; TRAMONTANO A, 1990, J MOL BIOL, V215, P175, DOI 10.1016/S0022-2836(05)80102-0; VERDAGUER N, 1995, EMBO J, V14, P1690, DOI 10.1002/j.1460-2075.1995.tb07158.x; WU S, 1993, J MOL BIOL, V229, P597, DOI 10.1006/jmbi.1993.1065; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; XIE QC, 1987, J GEN VIROL, V68, P1637, DOI 10.1099/0022-1317-68-6-1637; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	95	3	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201853	10.1371/journal.pone.0201853	http://dx.doi.org/10.1371/journal.pone.0201853			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114227	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400031
J	Ren, FY; Liu, Y; Cao, JL; He, RX; Fu, Y; Zhou, YJ; Liu, H				Ren, Fengyu; Liu, Yang; Cao, Jianli; He, Rongxing; Fu, Yu; Zhou, Yanjun; Liu, Huan			Prediction of the caved rock zones' scope induced by caving mining method	PLOS ONE			English	Article							FAILURE; COLLAPSE; MINES; SLOPE; FLOW	Critical medium column theory has typically been used to predict the scope of caved rock zone (CRZ) caused by caving mining method. It is essential to understand the distribution laws of lateral pressure induced by caving mining method with different dipping angles. In this study, a self-designed scaled physical model was used to investigate the distribution laws with angles ranging from 80 degrees to 90 degrees, and ore drawing was employed in experiments to simulate caving mining method. The experimental results indicated that the distribution laws were divided into the reductive region and the extensive region during ore drawing. The reductive region was close to the drawing hole, and its scope was smaller than the other part. Moreover, decreasing the dipping angle was an effective way of controlling the maximum reduction rates and the scope of reductive region. By varying laws of lateral pressure, the predictive model of CRZs' scope was established. Additionally, the rock mass located outside the predictive CRZs' scope did not rupture based on the monitoring of Digital Optical Televiewing (OPTV), which was verified by the field test in Dabeishan Iron Mine, China. The results of the field test demonstrated that the prediction method used in this study was valid and could be used in practice.	[Ren, Fengyu; Liu, Yang; Cao, Jianli; He, Rongxing; Fu, Yu; Zhou, Yanjun; Liu, Huan] Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China	Northeastern University - China	Liu, Y (corresponding author), Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China.	liuyang1510448@163.com			National Natural Science Foundation of China [51534003]; National Basic Research Program of China [2016YFC0801601]; Fundamental Research Funds for the Central Universities [N150104006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (No. 51534003 to F.R.), the National Basic Research Program of China (No. 2016YFC0801601 to F.R.), and the Fundamental Research Funds for the Central Universities (No. N150104006 to R.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady B., 2006, ROCK MECH UNDERGROUN, V3, P165; Brown R. L., 1965, RHEOL ACTA, V4, P153, DOI [DOI 10.1007/BF01969251, 10.1007/BF01969251]; Castro R, 2007, INT J ROCK MECH MIN, V44, P860, DOI 10.1016/j.ijrmms.2007.01.001; Eremenko VA, 2015, J MIN SCI+, V51, P1113, DOI 10.1134/S106273911506037X; He Zhong-ming, 2009, Journal of Central South University (Science and Technology), V40, P1066; Hubbard B, 2013, ANN GLACIOL, V54, P83, DOI 10.3189/2013AoG64A201; Hubbard B, 2012, ANN GLACIOL, V53, P137, DOI 10.3189/2012AoG60A045; Hubbard B, 2008, J GLACIOL, V54, P823, DOI 10.3189/002214308787779988; JOHANSON JR, 1972, POWDER TECHNOL, V5, P93, DOI 10.1016/0032-5910(72)80006-8; LEFEUVRE F, 1993, GEOPHYSICS, V58, P818, DOI 10.1190/1.1443467; Li DY, 2017, ENG GEOL, V228, P270, DOI 10.1016/j.enggeo.2017.08.006; [李海英 Li Haiying], 2015, [东北大学学报. 自然科学版, Journal of Northeastern University. Natural Science], V36, P419; Li LC, 2014, B ENG GEOL ENVIRON, V73, P1165, DOI 10.1007/s10064-014-0656-y; Li LC, 2010, ROCK SOIL MECH, V31, P3537; Liu Yang, 2018, Journal of Northeastern University (Natural Science), V39, P416, DOI 10.12068/j.issn.1005-3026.2018.03.022; Lu CY, 2014, ENG GEOL, V183, P14, DOI 10.1016/j.enggeo.2014.09.007; Lupo JF, 1997, INT J ROCK MECH MIN, V34, P684; O'Keefe JMK, 2013, INT J COAL GEOL, V118, P58, DOI 10.1016/j.coal.2013.08.007; Oparin VN, 2008, J MIN SCI+, V44, P569, DOI 10.1007/s10913-008-0064-4; Sammaljarvi J, 2016, ENG GEOL, V210, P70, DOI 10.1016/j.enggeo.2016.06.003; Szwedzicki T, 2001, INT J ROCK MECH MIN, V38, P957, DOI 10.1016/S1365-1609(01)00062-4; Villegas T, 2011, ENG GEOL, V121, P18, DOI 10.1016/j.enggeo.2011.04.010; Vyazmensky A, 2010, ROCK MECH ROCK ENG, V43, P21, DOI 10.1007/s00603-009-0035-3; Willam K, 2006, J ENG MECH, V132, P1400; Wong TF, 2006, MECH MATER, V38, P664, DOI 10.1016/j.mechmat.2005.12.002; Wu JH, 2004, INT J ROCK MECH MIN, V41, P731, DOI 10.1016/j.ijrmms.2004.01.010; Wu JH, 2018, ENG GEOL, V242, P92, DOI 10.1016/j.enggeo.2018.05.018; Xu S, 2017, GRANUL MATTER, V19, DOI 10.1007/s10035-017-0748-z; Zhang FF, 2014, J HAZARD MATER, V279, P562, DOI 10.1016/j.jhazmat.2014.07.047; Zhang XF, 2018, INT J ROCK MECH MIN, V103, P179, DOI 10.1016/j.ijrmms.2018.01.039; Zingoni A, 2009, INT J NUMER METH ENG, V79, P253, DOI 10.1002/nme.2576	31	10	11	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202221	10.1371/journal.pone.0202221	http://dx.doi.org/10.1371/journal.pone.0202221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110372	Green Submitted, Green Published, gold			2022-12-26	WOS:000441738000055
J	Schiavon, E; Smalley, JL; Newton, S; Greig, NH; Forsythe, ID				Schiavon, Emanuele; Smalley, Joshua L.; Newton, Sherylanne; Greig, Nigel H.; Forsythe, Ian D.			Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model	PLOS ONE			English	Article							JAUNDICED GUNN-RATS; AUDITORY BRAIN-STEM; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; NEURODEGENERATIVE DISEASES; PNEUMOCOCCAL MENINGITIS; IN-VIVO; HYPERBILIRUBINEMIA; DAMAGE; INFLAMMATION	Hyperbilirubinemia (jaundice) is caused by raised levels of unconjugated bilirubin in the blood. When severe, susceptible brain regions including the cerebellum and auditory brainstem are damaged causing neurological sequelae such as ataxia, hearing loss and kernicterus. The mechanism(s) by which bilirubin exerts its toxic effect have not been completely understood to date. In this study we investigated the acute mechanisms by which bilirubin causes the neurotoxicity that contributes to hearing loss. We developed a novel mouse model that exhibits the neurological features seen in human Bilirubin-Induced Neurological Dysfunction (BIND) syndrome that we assessed with a behavioural score and auditory brainstem responses (ABR). Guided by initial experiments applying bilirubin to cultured cells in vitro, we performed whole genome gene expression measurements on mouse brain tissue (cerebellum and auditory brainstem) following bilirubin exposure to gain mechanistic insights into biochemical processes affected, and investigated further using immunoblotting. We then compared the gene changes induced by bilirubin to bacterial lipopolysaccharide (LPS), a well characterized inducer of neuroinflammation, to assess the degree of similarity between them. Finally, we examined the extent to which genetic perturbation of inflammation and both known and novel anti-inflammatory drugs could protect hearing from bilirubin-induced toxicity. The in vitro results indicated that bilirubin induces changes in gene expression consistent with endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR). These gene changes were similar to the gene expression signature of thapsigargin-a known ER stress inducer. It also induced gene expression changes associated with inflammation and NF-kappa B activation. The in vivo model showed behavioural impairment and a raised auditory threshold. Whole genome gene expression analysis confirmed inflammation as a key mechanism of bilirubin neurotoxicity in the auditory pathway and shared gene expression hallmarks induced by exposure to bacterial lipopolysaccharide (LPS) a well-characterized inducer of neuroinflammation. Interestingly, bilirubin caused more severe damage to the auditory system than LPS in this model, but consistent with our hypothesis of neuroinflammation being a primary part of bilirubin toxicity, the hearing loss was protected by perturbing the inflammatory response. This was carried out genetically using lipocalin- 2 (LCN2)-null mice, which is an inflammatory cytokine highly upregulated in response to bilirubin. Finally, we tested known and novel anti-inflammatory compounds (interfering with NF-kappa B and TNF alpha signalling), and also demonstrated protection of the auditory system from bilirubin toxicity. We have developed a novel, reversible, model for jaundice that shows movement impairment and auditory loss consistent with human symptoms. We used this model to establish ER-stress and inflammation as major contributors to bilirubin toxicity. Because of the rapid and reversible onset of toxicity in this novel model it represents a system to screen therapeutic compounds. We have demonstrated this by targeting inflammation genetically and with anti-inflammatory small molecules that offered protection against bilirubin toxicity. This also suggests that anti-inflammatory drugs could be of therapeutic use in hyperbilirubinemia.	[Schiavon, Emanuele; Smalley, Joshua L.; Newton, Sherylanne; Forsythe, Ian D.] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England; [Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Schiavon, Emanuele] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Insubria, Italy; [Smalley, Joshua L.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA	University of Leicester; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Insubria; Tufts University	Forsythe, ID (corresponding author), Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England.	idf@le.ac.uk	Smalley, Joshua L./ABF-8150-2020	Schiavon, Emanuele/0000-0002-4592-6961; Forsythe, Ian/0000-0001-8216-0419; Newton, Sherylanne/0000-0002-8210-3526; Smalley, Joshua/0000-0002-7437-6655	Action on Hearing Loss (AoHL); MRC (UK); Stoneygate Trust (UK); Rosetrees Trust (UK); Intramural Research Program of the National Institute on Aging (NIH, USA); NATIONAL INSTITUTE ON AGING [ZIAAG000994] Funding Source: NIH RePORTER	Action on Hearing Loss (AoHL); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stoneygate Trust (UK); Rosetrees Trust (UK)(Rosetrees Trust); Intramural Research Program of the National Institute on Aging (NIH, USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from Action on Hearing Loss (AoHL, https://www. actiononhearingloss.org.uk/), MRC (UK, https://mrc.ukri.org/), Stoneygate Trust (UK) and Rosetrees Trust (http://www.rosetreestrust.co.uk/, UK). NHG is supported by the Intramural Research Program of the National Institute on Aging (NIH, USA, https://irp.nih.gov/about-us/our-programs/ nia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Barateiro A, 2016, MOL PHARMACOL, V89, P84, DOI 10.1124/mol.115.098228; Barateiro A, 2013, MOL NEUROBIOL, V47, P632, DOI 10.1007/s12035-012-8364-8; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bortolussi G, 2014, DIS MODEL MECH, V7, P1057, DOI 10.1242/dmm.016535; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Bradford RD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004774; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Calligaris R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-543; Conlee JW, 1997, ACTA NEUROPATHOL, V93, P450, DOI 10.1007/s004010050639; Crisafulli SG, 2018, MOL NEUROBIOL, V55, P2789, DOI 10.1007/s12035-017-0532-4; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gant TW, 2009, CURR OPIN DRUG DISC, V12, P72; Gao XL, 2011, TOXICOL MECH METHOD, V21, P383, DOI 10.3109/15376516.2010.546815; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gkoltsiou K, 2008, EARLY HUM DEV, V84, P829, DOI 10.1016/j.earlhumdev.2008.09.008; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Han GY, 2015, CNS NEUROSCI THER, V21, P262, DOI 10.1111/cns.12355; Han Y, 2012, GENE, V499, P318, DOI 10.1016/j.gene.2012.02.042; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haustein MD, 2010, J PHYSIOL-LONDON, V588, P4683, DOI 10.1113/jphysiol.2010.199778; Heckenberg SGB, 2012, CLIN MICROBIOL INFEC, V18, P849, DOI 10.1111/j.1469-0691.2011.03668.x; Hokkanen L, 2014, PEERJ, V2, DOI 10.7717/peerj.294; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; JEW JY, 1979, ARCH NEUROL-CHICAGO, V36, P149, DOI 10.1001/archneur.1979.00500390067007; Jin Myungwon, 2014, Exp Neurobiol, V23, P155, DOI 10.5607/en.2014.23.2.155; KURIYAMA M, 1990, BIOL NEONATE, V58, P32; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee CL, 2012, J BIOL CHEM, V287, P36999, DOI 10.1074/jbc.M112.385336; Liang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00275-9; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Memon N, 2016, PEDIATR RES, V79, P378, DOI 10.1038/pr.2015.247; Mesquita SD, 2014, CELL DEATH DIFFER, V21, P1588, DOI 10.1038/cdd.2014.68; Min HS, 2014, KIDNEY RES CLIN PRAC, V33, P33, DOI 10.1016/j.krcp.2013.11.002; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Oh GS, 2011, J IMMUNOL, V186, P1140, DOI 10.4049/jimmunol.1002183; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Perny M, 2016, J NEUROSCI, V36, P7740, DOI 10.1523/JNEUROSCI.0554-16.2016; Pilati N, 2016, J PHYSIOL-LONDON, V594, P3683, DOI 10.1113/JP271929; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; SCHUTTA HS, 1967, J NEUROPATH EXP NEUR, V26, P377, DOI 10.1097/00005072-196707000-00003; SCHUTTA HS, 1971, LAB INVEST, V24, P82; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Shaia WT, 2005, LARYNGOSCOPE, V115, P2167, DOI 10.1097/01.MLG.0000181501.80291.05; SHAPIRO SM, 1988, DEV BRAIN RES, V41, P147, DOI 10.1016/0165-3806(88)90178-2; SHAPIRO SM, 1988, PEDIATR RES, V23, P306, DOI 10.1203/00006450-198803000-00015; Shapiro SM, 2006, CLIN PERINATOL, V33, P387, DOI 10.1016/j.clp.2006.03.010; SISSON TRC, 1974, PEDIATR RES, V8, P647, DOI 10.1203/00006450-197406000-00005; Smalley JL, 2016, J MOL MED, V94, P235, DOI 10.1007/s00109-015-1344-5; Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Tan WJT, 2016, HISTOCHEM CELL BIOL, V146, P219, DOI 10.1007/s00418-016-1436-5; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Varadarajan S, 2015, CELL DEATH DIFFER, V22, P1388, DOI 10.1038/cdd.2015.1; Varadarajan S, 2012, CELL DEATH DIFFER, V19, P1896, DOI 10.1038/cdd.2012.108; Varadarajan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056603; Vodret S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0838-1; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; Xiang R, 2017, MOL MED REP, V16, P2830, DOI 10.3892/mmr.2017.6926; Xu Joshua, 2010, Hum Genomics, V4, P428; Ye HB, 2012, J NEUROSCI RES, V90, P2201, DOI 10.1002/jnr.23107; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang J, 2014, IMMUNOL LETT, V162, P101, DOI 10.1016/j.imlet.2014.07.013; Zuo WQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0300-1	68	18	20	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0201022	10.1371/journal.pone.0201022	http://dx.doi.org/10.1371/journal.pone.0201022			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106954	Green Published, gold, Green Submitted			2022-12-26	WOS:000441662800003
J	Gomard, Y; Cornuault, J; Licciardi, S; Lagadec, E; Belqat, B; Dsouli, N; Mavingui, P; Tortosa, P				Gomard, Yann; Cornuault, Josselin; Licciardi, Severine; Lagadec, Erwan; Belqat, Boutaina; Dsouli, Najla; Mavingui, Patrick; Tortosa, Pablo			Evidence of multiple colonizations as a driver of black fly diversification in an oceanic island	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DIPTERA-SIMULIIDAE; FLIES DIPTERA; MOLECULAR-IDENTIFICATION; DNA; RADIATION; DIVERSITY; EVOLUTION; PATTERNS; PHYLOGEOGRAPHY	True oceanic islands typically host reduced species diversity together with high levels of endemism, which make these environmental set-ups ideal for the exploration of species diversification drivers. In the present study, we used black fly species (Diptera: Simuliidae) from Reunion Island as a model to highlight the main drivers of insect species diversification in this young and remote volcanic island located in the Southwestern Indian Ocean. Using local and regional (Comoros and Seychelles archipelagos) samples as well as specimens from continental Africa, we tested the likelihood of two distinct scenarios, i.e. multiple colonizations vs. in-situ diversification. For this, posterior odds were used to test whether species from Reunion did form a monophyletic group and we estimated divergence times between species. Three out of the four previously described Reunion black fly species could be sampled, namely Simulium ruficorne, Simulium borbonense and Simulium triplex. The phylogenies based on nuclear and mitochondrial markers showed that S. ruficorne and S. borbonense are the most closely related species. Interestingly, we report a probable mitochondrial introgression between these two species although they diverged almost six million years ago. Finally, we showed that the three Reunion species did not form a monophyletic group, and, combined with the molecular datation, the results indicated that Reunion black fly diversity resulted from multiple colonization events. Thus, multiple colonizations, rather than in-situ diversification, are likely responsible for an important part of black fly diversity found on this young Darwinian island.	[Gomard, Yann; Lagadec, Erwan; Mavingui, Patrick; Tortosa, Pablo] Univ La Reunion, UMR PIMIT Proc Infectieux Milieu Insulaire Trop, INSERM 1187, CNRS 9192,IRD 249,Plateforme Technol CYROI, St Clotilde, La Reunion, France; [Cornuault, Josselin] CSIC, RJB, Dept Biodivers & Conservat, Madrid, Spain; [Licciardi, Severine] CIRAD, UMR ASTRE, St Clotilde, La Reunion, France; [Licciardi, Severine] Univ Montpellier, ASTRE, CIRAD, INRA, Montpellier, France; [Licciardi, Severine] Grp Interet Publ Cyclotron Reunion Ocean Indien G, St Clotilde, La Reunion, France; [Belqat, Boutaina] Univ Abdelmalek Essaadi, Fac Sci, Dept Biol, Tetouan, Morocco; [Dsouli, Najla] Ctr Rech & Veille Malad Emergentes Ocean Indien C, Plateforme Technol CYROI, St Clotilde, La Reunion, France; [Mavingui, Patrick] Univ Lyon, Lyon, France; [Mavingui, Patrick] Univ Lyon 1, Villeurbanne, France; [Mavingui, Patrick] CNRS, UMR 5557, Ecol Microbienne, Villeurbanne, France; [Mavingui, Patrick] INRA, UMR1418, Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; CIRAD; CIRAD; INRAE; Universite de Montpellier; Abdelmalek Essaadi University of Tetouan; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; INRAE	Gomard, Y (corresponding author), Univ La Reunion, UMR PIMIT Proc Infectieux Milieu Insulaire Trop, INSERM 1187, CNRS 9192,IRD 249,Plateforme Technol CYROI, St Clotilde, La Reunion, France.	yann.gomard@gmail.com		Tortosa, Pablo/0000-0002-7928-7264; Megchiche, Dylia/0000-0002-7749-0306	FEDER Reunion, Programme Operationnel de Cooperation Territoriale Pathogenes associes a la Faune Sauvage Ocean Indien [31189]	FEDER Reunion, Programme Operationnel de Cooperation Territoriale Pathogenes associes a la Faune Sauvage Ocean Indien	This work was supported by FEDER Reunion, Programme Operationnel de Cooperation Territoriale (2007-2013) Pathogenes associes a la Faune Sauvage Ocean Indien #31189. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedraabo S, 1993, B SOC ENTOMOLOGIQUE, V98; Adler P. H., 2017, WORLD BLACKFLIES DIP; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler PH, 2005, J BIOGEOGR, V32, P211, DOI 10.1111/j.1365-2699.2004.01156.x; Adler PH, 2004, BLACK FLIES SIMULIID; Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Anbalagan Sankarappan, 2011, Acta Hydrobiologica Sinica, V35, P688; [Anonymous], 1996, MOL BIOL EVOL, V13, P244; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Bergsten J, 2013, SYST BIOL, V62, P660, DOI 10.1093/sysbio/syt029; Borge T, 2005, J EVOLUTION BIOL, V18, P1416, DOI 10.1111/j.1420-9101.2005.00964.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BROCKHOUSE CL, 1993, BIOCHEM BIOPH RES CO, V194, P628, DOI 10.1006/bbrc.1993.1867; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bruun HH, 2006, OIKOS, V113, P185, DOI 10.1111/j.0030-1299.2001.14174.x; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Conflitti IM, 2010, MOL PHYLOGENET EVOL, V57, P245, DOI 10.1016/j.ympev.2010.06.024; Cornuault J, 2013, AM NAT, V182, P820, DOI 10.1086/673724; Cornuault J, 2012, MOL ECOL, V21, P1438, DOI 10.1111/j.1365-294X.2012.05483.x; Craig DA, 2001, J BIOGEOGR, V28, P1101, DOI 10.1046/j.1365-2699.2001.00619.x; Crosskey R.W., 1990, NATURAL HIST BLACKFL; Croucher PJP, 2007, EVOLUTION, V61, P1622, DOI 10.1111/j.1558-5646.2007.00146.x; Currie DC, 2008, HYDROBIOLOGIA, V595, P469, DOI 10.1007/s10750-007-9114-1; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freeman P, 1953, SIMULIIDAE ETHIOPIAN; Gibon FM, 1996, COLLOQ SEMI, P507; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Giudicelli J, 2008, EPHEMERA, V9, P33; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Harmon LJ, 2008, SYST BIOL, V57, P562, DOI 10.1080/10635150802304779; Hellgren O, 2008, MOL ECOL, V17, P1605, DOI 10.1111/j.1365-294X.2007.03680.x; Hembry DH, 2016, J BIOGEOGR, V43, P1372, DOI 10.1111/jbi.12723; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Johnson KP, 2000, EVOLUTION, V54, P387; Joy DA, 2007, HEREDITY, V99, P452, DOI 10.1038/sj.hdy.6801023; Joy DA, 2001, SYST BIOL, V50, P18, DOI 10.1080/106351501750107431; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kraus FB, 2007, HEREDITY, V99, P233, DOI 10.1038/sj.hdy.6800988; Krueger A, 2006, MOL PHYLOGENET EVOL, V39, P83, DOI 10.1016/j.ympev.2005.11.007; Kruger A, 2000, INSECT MOL BIOL, V9, P101, DOI 10.1046/j.1365-2583.2000.00163.x; LaRue B, 2009, MOL PHYLOGENET EVOL, V53, P749, DOI 10.1016/j.ympev.2009.07.032; Lautenschlager M, 2005, LIMNOLOGICA, V35, P262, DOI 10.1016/j.limno.2005.04.003; Le Pechon T, 2010, ANN BOT-LONDON, V106, P343, DOI 10.1093/aob/mcq116; Levin II, 2011, INT J PARASITOL, V41, P1019, DOI 10.1016/j.ijpara.2011.03.014; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Malmqvist B, 2004, ECOSCIENCE, V11, P187, DOI 10.1080/11956860.2004.11682824; Malmqvist B, 2001, OIKOS, V92, P35, DOI 10.1034/j.1600-0706.2001.920105.x; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pramual P, 2012, ENTOMOL SCI, V15, P202, DOI 10.1111/j.1479-8298.2011.00491.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; Roger M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003045; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Sato A, 1999, P NATL ACAD SCI USA, V96, P5101, DOI 10.1073/pnas.96.9.5101; Shaw KL, 2016, P NATL ACAD SCI USA, V113, P7986, DOI 10.1073/pnas.1601078113; Smith Stephen A., 1996, Seminars in Avian and Exotic Pet Medicine, V5, P97, DOI 10.1016/S1055-937X(96)80022-3; Spironello M, 2003, J BIOGEOGR, V30, P1563, DOI 10.1046/j.1365-2699.2003.00945.x; Sriphirom P, 2014, GENOME, V57, P45, DOI 10.1139/gen-2013-0145; Tang JM, 1996, MOL BIOL EVOL, V13, P244, DOI 10.1093/oxfordjournals.molbev.a025561; Thebaud C, 2009, ENCY ISLANDS, P612; Thiollay JM, 1999, BIOL CONSERV, V87, P191, DOI 10.1016/S0006-3207(98)00062-7; Venkatasamy S, 2006, BOT J LINN SOC, V150, P307, DOI 10.1111/j.1095-8339.2006.00474.x; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Warren BH, 2005, BIOL J LINN SOC, V85, P271, DOI 10.1111/j.1095-8312.2005.00492.x; Warren DL, 2017, MOL BIOL EVOL, V34, P1016, DOI 10.1093/molbev/msw279; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	79	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202015	10.1371/journal.pone.0202015	http://dx.doi.org/10.1371/journal.pone.0202015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096163	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500039
J	Motwalli, O; Essack, M; Salhi, A; Hanks, J; Mijakovic, I; Bajic, VB				Motwalli, Olaa; Essack, Magbubah; Salhi, Adil; Hanks, John; Mijakovic, Ivan; Bajic, Vladimir B.			Online dietary intake assessment using a graphical food frequency app (eNutri): Usability metrics from the EatWellUK study	PLOS ONE			English	Article							FATTY-ACID PRODUCTION; CYANOBACTERIA; FRAMEWORK; GENOME; MICROALGAE; PLATFORM; STRAIN	Background With widespread use of the internet, lifestyle and dietary data collection can now be facilitated using online questionnaires as opposed to paper versions. We have developed a graphical food frequency assessment app (eNutri), which is able to assess dietary intake using a validated food frequency questionnaire (FFQ) and provide personalised nutrition advice. FFQ user acceptance and evaluation have not been investigated extensively and only a few studies involving user acceptance of nutrition assessment and advice apps by older adults are published. Methods A formative study with 20 participants (including n = 10 <= 60 years) assessed the suitability of this app for adults and investigated improvements to its usability. The outcomes of this formative study were applied to the final version of the application, which was deployed in an online study (EatWellUK) with 324 participants (including n = 53 <= 60 years) in the UK, using different devices (smartphones, tablets and laptops/desktops). Completion times were based on browser timestamps and usability was measured using the System Usability Scale (SUS), scoring between 0 and 100. Products with a SUS score higher than 70 are considered to be good. Results In the EatWellUK study, SUS score median (n = 322) was 77.5 (IQR 15.0). Out of the 322 SUS questionnaire completions, 321 device screen sizes were detected by the app. Grouped by device screen size, small (n = 92), medium (n = 38) and large (n = 191) screens received median SUS scores of 77.5 (IQR 15.0), 75.0 (IQR 19.4) and 77.5 (IQR 16.25), respectively. The median SUS scores from younger (n = 268) and older participants (n = 53) were the same. The FFQ contained 157 food items, and the mean completion time was 13.1 minutes (95% Cl 12.6-13.7 minutes). Small, medium and large screen devices resulted in completion times of 11.7 minutes (95% Cl 10.9-12.6 minutes), 14.4 minutes (95% Cl 12.9-15.9 minutes) and 13.6 minutes (95% Cl 12.8-14.3 minutes), respectively. Conclusions The overall median SUS score of 77.5 and overall mean completion time of 13.3 minutes indicate good overall usability, and equally, comparable SUS scores and completion times across small, medium and large screen sizes indicates good usability across devices. This work is a step toward the promotion of wider uptake of online apps that can provide online dietary intake assessment at-scale, with the aim of addressing pressing epidemiological challenges.	[Motwalli, Olaa; Essack, Magbubah; Salhi, Adil; Hanks, John; Bajic, Vladimir B.] KAUST, CBRC, Thuwal, Saudi Arabia; [Motwalli, Olaa] SEU, Coll Comp & Informat, Madinah, Saudi Arabia; [Mijakovic, Ivan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Syst & Synthet Biol, Gothenburg, Sweden; [Mijakovic, Ivan] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark	King Abdullah University of Science & Technology; Chalmers University of Technology; Technical University of Denmark	Bajic, VB (corresponding author), KAUST, CBRC, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Essack, Magbubah/R-2773-2019	Zenun Franco, Rodrigo/0000-0002-1998-4367; Fallaize, Rosalind/0000-0003-3734-6489	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) [URF/1/1976-02, FCS/1/2911-01-01]	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR)	This publication is based upon work supported by the King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) under Awards No URF/1/1976-02 and FCS/1/2911-01-01.	Alam I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082210; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1998, MATLAB, P382; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer K., 2008, COMMON FRAGRANCE FLA; Baumgart M, 2013, APPL ENVIRON MICROB, V79, P6006, DOI 10.1128/AEM.01634-13; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Coursolle D, 2015, MOL BIOSYST, V11, P2464, DOI 10.1039/c5mb00268k; Dhillon BK, 2015, NUCLEIC ACIDS RES; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Kaiser BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058307; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d; Liu H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-41; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; Morimoto T, 2008, DNA RES, V15, P73, DOI 10.1093/dnares/dsn002; Motwalli O, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3389-4; Nakao M, 2009, NUCLEIC ACIDS RES; Nakayama T, 2014, P NATL ACAD SCI USA, V111, P11407, DOI 10.1073/pnas.1405222111; OHLROGGE JB, 1994, PLANT PHYSIOL, V104, P821, DOI 10.1104/pp.104.3.821; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reddy T. B. K, 2014, NUCLEIC ACIDS RES; Ruffing Anne M, 2014, Front Bioeng Biotechnol, V2, P17, DOI 10.3389/fbioe.2014.00017; Ruffing AM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-113; Ruffing AM, 2012, BIOTECHNOL BIOENG, V109, P2190, DOI 10.1002/bit.24509; Sasaki NV, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap025; Savakis P, 2015, CURR OPIN BIOTECH, V33, P8, DOI 10.1016/j.copbio.2014.09.007; Selvan BK, 2013, INDIAN J EXP BIOL, V51, P262; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, P3872, DOI 10.1093/nar/gkv278; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; WU J, 2007, BMC GENOMICS, V8, P1, DOI DOI 10.1186/1471-2164-8-104; Yao L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-94; Zhou YJ, 2016, NATURE COMMUNICATION, V7; Zhou Yongjin J, 2014, Front Bioeng Biotechnol, V2, P32, DOI 10.3389/fbioe.2014.00032	47	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202006	10.1371/journal.pone.0202006	http://dx.doi.org/10.1371/journal.pone.0202006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096211	Green Published, gold, Green Submitted			2022-12-26	WOS:000441308500037
J	Brandt, S; Fachinger, S; Tohge, T; Fernie, AR; Braun, HP; Hildebrandt, TM				Brandt, Saskia; Fachinger, Sara; Tohge, Takayuki; Fernie, Alisdair R.; Braun, Hans-Peter; Hildebrandt, Tatjana M.			Extended darkness induces internal turnover of glucosinolates in Arabidopsis thaliana leaves	PLOS ONE			English	Article							EPITHIOSPECIFIER PROTEIN; BRASSICA-NAPUS; MYROSINASE; SULFUR; BIOSYNTHESIS; DEFENSE; GROWTH; IDENTIFICATION; METABOLOMICS; INTEGRATION	Prolonged darkness leads to carbohydrate starvation, and as a consequence plants degrade proteins and lipids to oxidize amino acids and fatty acids as alternative substrates for mitochondrial ATP production. We investigated, whether the internal breakdown of glucosinolates, a major class of sulfur-containing secondary metabolites, might be an additional component of the carbohydrate starvation response in Arabidopsis thaliana (A. thaliana). The glucosinolate content of A. thaliana leaves was strongly reduced after seven days of darkness. We also detected a significant increase in the activity of myrosinase, the enzyme catalyzing the initial step in glucosinolate breakdown, coinciding with a strong induction of the main leaf myrosinase isoforms TGG1 and TGG2. In addition, nitrilase activity was increased suggesting a turnover via nitriles and carboxylic acids. Internal degradation of glucosinolates might also be involved in diurnal or developmental adaptations of the glucosinolate profile. We observed a diurnal rhythm for myrosinase activity in two-week-old plants. Furthermore, leaf myrosinase activity and protein abundance of TGG2 varied during plant development, whereas leaf protein abundance of TGG1 remained stable indicating regulation at the transcriptional as well as post-translational level.	[Brandt, Saskia; Fachinger, Sara; Braun, Hans-Peter; Hildebrandt, Tatjana M.] Leibniz Univ Hannover, Inst Pflanzengenet, Hannover, Germany; [Tohge, Takayuki; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Tohge, Takayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan	Leibniz University Hannover; Max Planck Society; Nara Institute of Science & Technology	Hildebrandt, TM (corresponding author), Leibniz Univ Hannover, Inst Pflanzengenet, Hannover, Germany.	hildebrandt@genetik.uni-hannover.de	Tohge, Takayuki/G-7924-2017; Braun, Hans-Peter/E-7149-2011	Tohge, Takayuki/0000-0001-5555-5650; Braun, Hans-Peter/0000-0002-4459-9727; Hildebrandt, Tatjana/0000-0002-3562-5241	Hannover School for Biomolecular Drug Research (HSBDR)	Hannover School for Biomolecular Drug Research (HSBDR)	The funding of Saskia Brandt was provided by the Hannover School for Biomolecular Drug Research (HSBDR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Andersen TG, 2013, PLANT CELL, V25, P3133, DOI 10.1105/tpc.113.110890; Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Brown PD, 1997, ADV AGRON, V61, P167, DOI 10.1016/S0065-2113(08)60664-1; Burow M, 2009, PLANT PHYSIOL, V149, P561, DOI 10.1104/pp.108.130732; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Burow M, 2017, CURR OPIN PLANT BIOL, V38, P142, DOI 10.1016/j.pbi.2017.04.009; Burow M, 2009, PHYTOCHEM REV, V8, P87, DOI 10.1007/s11101-008-9113-5; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Chung WC, 2005, BIOCONTROL SCI TECHN, V15, P455, DOI 10.1080/09583150500086607; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; Das S, 2000, CURR SCI INDIA, V79, P1665; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Goodspeed D, 2013, CURR BIOL, V23, P1235, DOI 10.1016/j.cub.2013.05.034; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Hecht SS, 1999, J NUTR, V129, p768S, DOI 10.1093/jn/129.3.768S; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Howden AJM, 2009, MICROB BIOTECHNOL, V2, P441, DOI 10.1111/j.1751-7915.2009.00111.x; Huseby S, 2013, J EXP BOT, V64, P1039, DOI 10.1093/jxb/ers378; Izumi M, 2013, PLANT PHYSIOL, V161, P1682, DOI 10.1104/pp.113.215632; JAMES DC, 1991, PHYSIOL PLANTARUM, V82, P163; Janowitz T, 2009, PHYTOCHEMISTRY, V70, P1680, DOI 10.1016/j.phytochem.2009.07.028; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kong WW, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01202, 10.3389/fpls.2016.01292]; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Koroleva OA, 2011, METHODS, V54, P413, DOI 10.1016/j.ymeth.2011.06.005; Kutz A, 2002, PLANT J, V30, P95, DOI 10.1046/j.1365-313X.2002.01271.x; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Liu JD, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0474-9; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; MATILE P, 1980, BIOCHEM PHYSIOL PFL, V175, P722, DOI 10.1016/S0015-3796(80)80059-X; Nakabayashi R, 2009, PHYTOCHEMISTRY, V70, P1017, DOI 10.1016/j.phytochem.2009.03.021; Nakano RT, 2017, PLANT J, V89, P204, DOI 10.1111/tpj.13377; Nakano RT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00073; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Ogasawara K, 2009, PLANT CELL PHYSIOL, V50, P480, DOI 10.1093/pcp/pcp007; PALMIERI S, 1982, ANAL BIOCHEM, V123, P320, DOI 10.1016/0003-2697(82)90452-3; Peng C, 2015, PLANT PHYSIOL, V169, P1807, DOI 10.1104/pp.15.00461; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; ROSA EAS, 1994, J SCI FOOD AGR, V66, P457, DOI 10.1002/jsfa.2740660406; Rosa EAS, 1997, J SCI FOOD AGR, V73, P364, DOI 10.1002/(SICI)1097-0010(199703)73:3&lt;364::AID-JSFA742&gt;3.0.CO;2-O; Schonhof I, 2007, J PLANT NUTR SOIL SC, V170, P65, DOI 10.1002/jpln.200620639; Tohge T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12399; Tohge T, 2010, NAT PROTOC, V5, P1210, DOI 10.1038/nprot.2010.82; Ueda H, 2006, PLANT CELL PHYSIOL, V47, P164, DOI 10.1093/pcp/pci232; Van Slyke DD, 1933, J BIOL CHEM, V102, P499; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yamada K, 2009, PLANT SIGNAL BEHAV, V4, P849, DOI 10.4161/psb.4.9.9377; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; ZHAO FJ, 1994, J SCI FOOD AGR, V64, P295, DOI 10.1002/jsfa.2740640309	64	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202153	10.1371/journal.pone.0202153	http://dx.doi.org/10.1371/journal.pone.0202153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092103	Green Submitted, Green Published, gold			2022-12-26	WOS:000441232600095
J	Ejigu, Y; Tadesse, B				Ejigu, Yohannes; Tadesse, Biniyam			HIV testing during pregnancy for prevention of mother-to-child transmission of HIV in Ethiopia	PLOS ONE			English	Article							ANTENATAL CARE; WOMEN; ACCEPTABILITY; SETTINGS; KENYA; PMTCT	Introduction HIV testing during pregnancy provides an entry point to prevention of mother-to-child transmission of HIV and to access treatment for HIV positive women. The study aimed to assess the uptake of HIV testing during pregnancy and associated factors among Ethiopian women. Methods We analyzed the 2016 Ethiopian Demographic and Health Survey dataset. Women who gave birth within one year prior to the survey were included in the analysis. Uptake of HIV testing during pregnancy is defined as receiving HIV testing service during pregnancy and/ or at the time of delivery and knew the test results. Adjusted odds ratios (AORs) and 95% confidence intervals (95% Cls) were calculated by using step-wise backward logistic regression analyses to identify factors associated with HIV testing during pregnancy. Results A total of 2114 women who were pregnant in the last one year prior to the survey were included in the analysis. Of these, only 35.1% were tested for HIV and received the test results during pregnancy. About one third of women who had antenatal care follow-up missed the opportunity to be tested for HIV. Compared to women who had no formal education, those who had primary level education (AOR = 1.55; 95% CI: 1.12-2.15), secondary level education (AOR = 2.56 95%CI: 1.36-3.82), or higher education (AOR = 3.95, 95`)/X1: 1.31-11.95) were more likely to be tested for HIV during pregnancy. Similarly, having awareness about mother-to-child transmission of HIV (AOR = 2.03, 95%CI: 1.48-2.78), and living in urban areas (AOR = 3.30, 95`)/X1: 1.39-7.85) were positively and independently associated with uptake of HIV during pregnancy. Women who have stigmatizing attitude towards HIV positive people were less likely to be tested for HIV (AOR = 0.57, 95`)/X1: 0.40-0.79). Conclusion Uptake of HIV testing during pregnancy is low. Missed opportunity among women who had antenatal care visits was very high. Integrating HIV testing with antenatal care services, improving HIV testing service quality and access are essential to increase uptake of HIV testing during pregnancy and reach the goal of eliminating MTCT.	[Ejigu, Yohannes; Tadesse, Biniyam] Jimma Univ, Coll Hlth Sci, Dept Hlth Econ Management & Policy, Jimma, Ethiopia; [Ejigu, Yohannes; Tadesse, Biniyam] Jimma Univ, ICHME, Jimma, Ethiopia	Jimma University; Jimma University	Ejigu, Y (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Hlth Econ Management & Policy, Jimma, Ethiopia.; Ejigu, Y (corresponding author), Jimma Univ, ICHME, Jimma, Ethiopia.	yohannesejigu@yahoo.com		Tsehay, Yohannes Ejigu/0000-0001-5504-5335				Abtew Solomon, 2015, BMC Res Notes, V8, P661, DOI 10.1186/s13104-015-1652-4; Alemu YM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1389-2; [Anonymous], 2014, GLOBAL GUIDANCE CRIT; Bert F, 2018, INT J HEALTH PLAN M, V33, P31, DOI 10.1002/hpm.2418; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Chowers M, 2017, SEX TRANSM INFECT, V93, P112, DOI 10.1136/sextrans-2015-052497; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Demographic and Health Survey, US DAT AN; Deressa W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-328; El Bcheraoui C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082760; Federal HIV Prevention and Control Office of Ethiopia, 2014, HIV AIDS STRAT PLAN; Federal Ministry of Health, 2017, GUID COMPR HIV PREV; FHAPCO, 2007, GUID HIV COUNS TEST; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Gartland MG, 2013, AIDS, V27, P1253, DOI 10.1097/QAD.0b013e32835e3937; Ghoma-Linguissi Laure Stella, 2015, BMC Res Notes, V8, P652, DOI 10.1186/s13104-015-1651-5; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; ICF International, 2011, DEM HLTH SURV METH Q; Ishikawa N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21212; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, AMB TREATM TARG HELP; Kohler PK, 2014, AIDS PATIENT CARE ST, V28, P643, DOI 10.1089/apc.2014.0171; Kohler PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110110; Larsson EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037590; Li CR, 2014, CHINESE MED J-PEKING, V127, P3423, DOI 10.3760/cma.j.issn.0366-6999.20140465; Malaju MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-226; Qiao S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192327; Ruducha J, 2017, LANCET GLOB HEALTH, V5, pE1142, DOI 10.1016/S2214-109X(17)30331-5; Sirengo M, 2014, JAIDS-J ACQ IMM DEF, V66, pS66, DOI 10.1097/QAI.0000000000000115; Domingues RMSM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0837-8; UNAIDS, 2016, AIDS BY THE NUMB; UNAIDS, 2017, HIV TEST SERV NEW OP; UNAIDS, 2018, UNAIDS DAT 2017; WHO, 2015, CONSOLIDATED GUIDELI; Workagegn F, 2015, HIV AIDS-RES PALLIAT, V7, P215, DOI 10.2147/HIV.S82000; World Health Organization, 2016, CONS GUID US ANT DRU	36	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0201886	10.1371/journal.pone.0201886	http://dx.doi.org/10.1371/journal.pone.0201886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092104	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600064
J	Frey, R; Gabrielova, B; Gladilin, E				Frey, Robert; Gabrielova, Barbora; Gladilin, Evgeny			A combined planning approach for improved functional and esthetic outcome of bimaxillary rotation advancement for treatment of obstructive sleep apnea using 3D biomechanical modeling	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; FINITE-ELEMENT MODEL; UPPER AIRWAY; MAXILLOMANDIBULAR ADVANCEMENT; FLOW; VELOPHARYNX; SIMULATION; PATTERNS; EFFICACY; DISEASE	In recent years, bimaxillary rotation advancement (BRA) has become the method of choice for surgical treatment of obstructive sleep apnea (OSA). As dislocation of the jaw bones affects both, airways and facial contours, surgeons are facing the challenge of finding an optimal jaw position that allows for the reestablishment of normal airway ventilation and esthetic surgical outcome. Owing to the complexity of the facial anatomy and its mechanical behavior, individual planning of surgical OSA treatment under consideration of functional and esthetic aspects presents a challenge that surgeons typically approach in a non-quantitative manner using subjective evaluation and clinical experience. This paper describes a framework for individual planning of OSA treatment using bimaxillary rotation advancement, which relies on computational modeling of hard and soft tissue mechanics. The described framework for simulation of functional and esthetic post-surgery outcome was used in 10 OSA patients. Comparison of the simulation results with post-surgery data reveals that bio-mechanical simulation provides a reliable estimate for post-surgery facial tissue behavior and antero-posterior airway extension, but fails to accurately describe a surprisingly large lateral stretch of the velopharyngeal region. This discrepancy is traced back to anisotropic effects of pharyngeal muscles. Possible approaches to improving the accuracy of model predictions and defining sharp criteria for optimizing combined OSA planning are discussed.	[Frey, Robert] Seegartenklin, Dept Oral & Maxillofacial Surg, Adenauerpl 4-1, D-69115 Heidelberg, Germany; [Gabrielova, Barbora; Gladilin, Evgeny] Heidelberg Univ, BioQuant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] German Canc Res Ctr, Div Theoret Bioinformat, Berliner Str 41, D-69120 Heidelberg, Germany; [Gladilin, Evgeny] Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Seeland, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Frey, R (corresponding author), Seegartenklin, Dept Oral & Maxillofacial Surg, Adenauerpl 4-1, D-69115 Heidelberg, Germany.	dr.robfrey@gmail.com		Frey, Robert/0000-0002-1622-1102	Department of Oral and Maxillofacial Surgery, Seegartenklinik GmbH	Department of Oral and Maxillofacial Surgery, Seegartenklinik GmbH	The funder 'Department of Oral and Maxillofacial Surgery, Seegartenklinik GmbH' provided support in the form of salary for R.F. The specific roles of this author are articulated in the 'author contributions' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatoury J, 2016, J APPL PHYSIOL, V120, P743, DOI 10.1152/japplphysiol.00820.2015; Ayappa I, 2003, SLEEP MED REV, V7, P9, DOI 10.1053/smrv.2002.0238; Aytekin E, 2015, J PHYS THER SCI, V27, P2951, DOI 10.1589/jpts.27.2951; Chabanas M, 2003, MED IMAGE ANAL, V7, P131, DOI 10.1016/S1361-8415(02)00108-1; Cheng GC, 2014, MATH COMPUT SIMULAT, V106, P44, DOI 10.1016/j.matcom.2012.11.008; Chouly F, 2008, J FLUID STRUCT, V24, P250, DOI 10.1016/j.jfluidstructs.2007.08.004; Cisonni J, 2013, J BIOMECH, V46, P2504, DOI 10.1016/j.jbiomech.2013.07.007; Garvey JF, 2015, J THORAC DIS, V7, P920, DOI 10.3978/j.issn.2072-1439.2015.04.52; Gladilin E, 2009, COMPUT METHOD BIOMEC, V12, P305, DOI 10.1080/10255840802529925; Gupta MA, 2015, J CLIN SLEEP MED, V11, P165, DOI 10.5664/jcsm.4466; Huang QR, 2008, J CLIN SLEEP MED, V4, P543; Huang YQ, 2005, CHEST, V128, P1324, DOI 10.1378/chest.128.3.1324; ISONO S, 1993, J APPL PHYSIOL, V75, P148, DOI 10.1152/jappl.1993.75.1.148; Jeong SJ, 2007, MED ENG PHYS, V29, P637, DOI 10.1016/j.medengphy.2006.08.017; Li KK, 2002, J ORAL MAXIL SURG, V60, P526, DOI 10.1053/joms.2002.31849; Lucey AD, 2010, IEEE T BIO-MED ENG, V57, P2535, DOI 10.1109/TBME.2010.2052808; Mihaescu M, 2011, J BIOMECH, V44, P2221, DOI 10.1016/j.jbiomech.2011.06.006; Monahan K, 2011, CURR OPIN CARDIOL, V26, P541, DOI 10.1097/HCO.0b013e32834b806a; Pirnar J, 2015, J BIOMECH, V48, P3685, DOI 10.1016/j.jbiomech.2015.08.017; Powell NB, 2011, SLEEP MED, V12, P966, DOI 10.1016/j.sleep.2011.08.004; Rasani MR, 2011, MOD SIMUL ENG, V2011, DOI 10.1155/2011/510472; Ravesloot MJL, 2011, SLEEP, V34, P105, DOI 10.1093/sleep/34.1.105; Schendel S, 2011, J ORAL MAXIL SURG, V69, P663, DOI 10.1016/j.joms.2010.11.010; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Sittitavornwong S, 2013, J ORAL MAXIL SURG, V71, P1397, DOI 10.1016/j.joms.2013.02.022; Skorin L, 2016, J AM OSTEOPATH ASSOC, V116, P522, DOI 10.7556/jaoa.2016.105; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Sung SJ, 2006, ANGLE ORTHOD, V76, P791, DOI 10.2319/071305-231; Swanson CM, 2015, J BONE MINER RES, V30, P199, DOI 10.1002/jbmr.2446; Uppgaard-Penaz R, 2015, OPERATIVE TECHNIQUES, V26, P197, DOI [10.1016/j.otot.2015.08.004, DOI 10.1016/J.OTOT.2015.08.004]; Yu CC, 2012, J CRANIOFAC SURG, V23, P401, DOI 10.1097/SCS.0b013e318240feed; Zinser MJ, 2013, INT J ORAL MAX SURG, V42, P569, DOI 10.1016/j.ijom.2012.08.002	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0199956	10.1371/journal.pone.0199956	http://dx.doi.org/10.1371/journal.pone.0199956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092020	Green Published, Green Submitted, gold			2022-12-26	WOS:000441232600005
J	Schneider, F; Martin, J; Schneider, G; Schulz, CM				Schneider, Frederick; Martin, Jan; Schneider, Gerhard; Schulz, Christian M.			The impact of the patient's initial NACA score on subjective and physiological indicators of workload during pre-hospital emergency care	PLOS ONE			English	Article							ANESTHETISTS WORKLOAD; HEART-RATE; EXPERIENCE; SEVERITY; PROVIDERS; QUALITY; STRESS; STRAIN	Background Excessive workload may impair patient safety. However, little is known about emergency care providers' workload during the treatment of life-threatening cases including cardiopulmonary resuscitation (CPR). Therefore, we tested the hypothesis that subjective and physiological indicators of workload are associated with the patient's initial NACA score and that workload is particularly high during CPR. Methods NASA task load index (NASA-tlx) and alarm codes were obtained for 216 sorties of pre-hospital emergency medical care. Furthermore, initial NACA scores of 140 patients were extracted from the physicians' protocols. The physiological workload indicators mean heart rate (HR) and permutation entropy (PeEn) were calculated for 51 sorties of primary care. General linear mixed models were used to analyze the association of NACA scores with subjective (NASA-tlx) and physiological (mean HR, PeEn) measures of workload. Results In contrast to the physiological variables PeEn (p = 0.10) and HR (p = 0.19), the mental (p<0.001) and temporal demands (p<0.001) as well as the effort (p<0.001) and frustration (p = 0.04) subscale of the NASA-tlx were significantly associated with initial NACA scores. Compared to NACA = I, an initial NACA score of VI (representing CPR) increased workload by a mean of 389.5% (p = 0.001) in the mental and 345.9% (p<0.001) in the temporal demands, effort by a mean of 446,8% (p = 0.002) and frustration by 190.0% (p = 0.03). In line with the increase in NASA-tlx, PeEn increased by 20.6% (p = 0.01) and HR by 6.4% (p = 0.57). Conclusions Patients' initial NACA scores are associated with subjective workload. Workload was highest during CPR.	[Schneider, Frederick; Martin, Jan; Schneider, Gerhard; Schulz, Christian M.] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Anesthesiol, Munich, Germany	Technical University of Munich	Schneider, F (corresponding author), Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Anesthesiol, Munich, Germany.	frederick.schneider@tum.de		Schneider, Frederick/0000-0002-1952-0124; Schneider, Gerhard/0000-0002-4903-0118				Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Alessandrini H, 2012, NOTFALL RETTUNGSMED, V15, P42, DOI 10.1007/s10049-010-1386-8; [Anonymous], 2005, NOTF RETT; Arztetag B., 2017, WEITERBILDUNGSORDNUN; Bernhardt M, 2012, PRAKLINISCHES TRAUMA; Bjorkli CA, 2012, APPL ERGON, V43, P799, DOI 10.1016/j.apergo.2011.11.015; BONATTI J, 1995, RESUSCITATION, V30, P133, DOI 10.1016/0300-9572(95)00883-U; Byrne AJ, 2013, ANAESTHESIA, V68, P1266, DOI 10.1111/anae.12455; Cinaz B, 2013, PERS UBIQUIT COMPUT, V17, P229, DOI 10.1007/s00779-011-0466-1; DEANDA A, 1991, ANESTH ANALG, V72, P308; Estryn-Behar M, 2011, EMERG MED J, V28, P397, DOI 10.1136/emj.2009.082594; GABA DM, 1994, ANESTHESIOLOGY, V81, P488, DOI 10.1097/00000542-199408000-00028; HART S G, 1988, P139; Hart SG, 1988, NASA TLX PAPER PENCI, DOI [10.1007/s00420-013-0847-z, DOI 10.1007/S00420-013-0847-Z]; Havel C, 2008, RESUSCITATION, V77, P81, DOI 10.1016/j.resuscitation.2007.09.010; Henelius Andreas, 2009, Annu Int Conf IEEE Eng Med Biol Soc, V2009, P1836, DOI 10.1109/IEMBS.2009.5332602; Huber S, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0252-1; Karhula K, 2014, CHRONOBIOL INT, V31, P1179, DOI 10.3109/07420528.2014.957294; Knapp J, 2008, ANAESTHESIST, V57, P1069, DOI 10.1007/s00101-008-1454-3; Leary M, 2008, RESUSCITATION, V77, P1, DOI 10.1016/j.resuscitation.2008.02.005; Leedal JM, 2005, BRIT J ANAESTH, V94, P702, DOI 10.1093/bja/aei131; Martin J, 2016, BRIT J ANAESTH, V117, P767, DOI 10.1093/bja/aew342; Mazur LM, 2012, INT J RADIAT ONCOL, V83, pE571, DOI 10.1016/j.ijrobp.2012.01.063; McNeer RR, 2016, ANESTH ANALG, V122, P512, DOI 10.1213/ANE.0000000000001067; Parsons SE, 2012, J TRAUMA ACUTE CARE, V73, P1267, DOI 10.1097/Ta.0b013e318265d15a; Pitts S, 2004, LANCET, V364, P313, DOI 10.1016/S0140-6736(04)16740-8; Prytz Erik G, 2016, J Emerg Manag, V14, P289, DOI 10.5055/jem.2016.0294; Raatiniemi L, 2017, ACTA ANAESTH SCAND, V61, P557, DOI 10.1111/aas.12881; Raatiniemi L, 2013, ACTA ANAESTH SCAND, V57, P1253, DOI 10.1111/aas.12208; Rieger A, 2014, INT ARCH OCC ENV HEA, V87, P165, DOI 10.1007/s00420-013-0847-z; Schneider F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188635; Schoenenberger S, 2014, INT J OCCUP SAF ERGO, V20, P551, DOI 10.1080/10803548.2014.11077071; Schulz CM, 2011, BRIT J ANAESTH, V106, P44, DOI 10.1093/bja/aeq307; Tur FC, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0225-4; Wallace SK, 2013, CIRCULATION, V127, P1591, DOI 10.1161/CIRCULATIONAHA.113.002058; Weinger MB, 2004, ANESTH ANALG, V98, P1419, DOI 10.1213/01.ANE.0000106838.66901.D2; WEINGER MB, 1994, ANESTHESIOLOGY, V80, P77, DOI 10.1097/00000542-199401000-00015; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030; Wheelock A, 2015, ANN SURG, V261, P1079, DOI 10.1097/SLA.0000000000001051	39	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2018	13	8							e0202215	10.1371/journal.pone.0202215	http://dx.doi.org/10.1371/journal.pone.0202215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP9JF	30092090	Green Published, gold, Green Submitted			2022-12-26	WOS:000441232600102
J	Patel, Y; Soni, M; Awgulewitsch, A; Kern, MJ; Liu, S; Shah, N; Singh, UP; Chen, H				Patel, Y.; Soni, M.; Awgulewitsch, A.; Kern, M. J.; Liu, S.; Shah, N.; Singh, U. P.; Chen, H.			Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis	ONCOGENE			English	Article							STEM-CELLS; BREAST-CANCER; GLAND; MAINTENANCE; QUIESCENT	Although it has been demonstrated that transformed progenitor cell population can contribute to tumor initiation, factors contributing to this malignant transformation are poorly known. Using in vitro and xenograft-based models, previous studies demonstrated that miR-489 acts as a tumor suppressor miRNA by targeting various oncogenic pathways. It has been demonstrated that miR-489 directly targets HER2 and inhibits the HER2 signaling pathway; however, its role in mammary gland development and HER2-induced tumor initiation hasn't been studied. To dissect the role of miR-489, we sorted different populations of mammary epithelial cells and determined that miR-489 was highly expressed in mammary stem cells. MMTV-miR-489 mice that overexpressed miR-489 in mammary epithelial cells were developed and these mice exhibited an inhibition of mammary gland development in early ages with a specific impact on highly proliferative cells. Double transgenic MMTV-Her2-miR489 mice were then generated to observe how miR-489 overexpression affects HER2-induced tumorigenesis. miR-489 overexpression delayed HER2-induced tumor initiation significantly. Moreover, miR-489 overexpression inhibited tumor growth and lung metastasis. miR-489 overexpression reduced mammary progenitor cell population significantly in preneoplastic mammary glands of MMTV-Her2 mice which showed a putative transformed population in HER2-induced tumorigenesis. The miR-489 overexpression reduced CD49f(hi)CD61(hi) populations in tumors that have stem-like properties, and miR-489 overexpression altered the HER2 signaling pathway in mammary tumors. Altogether, these data indicate that the inhibition of HER2-induced tumorigenesis by miR-489 overexpression was due to altering progenitor cell populations while decreasing tumor growth and metastasis via influencing tumor promoting genes DEK and SHP2.	[Patel, Y.; Soni, M.; Liu, S.; Shah, N.; Chen, H.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Patel, Y.; Soni, M.; Liu, S.; Shah, N.; Chen, H.] Univ South Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Awgulewitsch, A.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Awgulewitsch, A.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Transgen & Genome Editing Core, Charleston, SC 29425 USA; [Kern, M. J.] Med Univ South Carolina, Gene Funct Core, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Singh, U. P.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chen, H (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.; Chen, H (corresponding author), Univ South Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA.	hchen@biol.sc.edu	chen, hexin/F-1714-2011	Chen, Hexin/0000-0001-9300-0859; Singh, Udai/0000-0002-7048-4325	NIH [4R01 CA178386-04, 4P30 GM103342-05]; USC ASPIRE-1 grant; USC SPARC graduate research grant; NATIONAL CANCER INSTITUTE [R01CA178386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC ASPIRE-1 grant; USC SPARC graduate research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Gene Function and Transgenic and Genome Editing (TGE) Cores of the Medical University of South Carolina (MUSC) for their assistance with the generation of transgenic MMTV-miR-489 mice. This work was supported by the NIH grants (4R01 CA178386-04 and 4P30 GM103342-05) and the USC ASPIRE-1 grant to H.C., and the USC SPARC graduate research grant to M.S.	Boras-Granic K, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0487-6; Cai S, 2017, CELL STEM CELL, V20, P247, DOI 10.1016/j.stem.2016.11.007; Celia-Terrassa T, 2017, NAT CELL BIOL, V19, P711, DOI 10.1038/ncb3533; Chang THT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3593; Chen H, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0754-0; Chen X, 2016, J PATHOL, V239, P459, DOI 10.1002/path.4743; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cho Andrew, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1911s42; Elsarraj HS, 2013, J CELL SCI, V126, P2446, DOI 10.1242/jcs.119214; Fu NY, 2017, NAT CELL BIOL, V19, P164, DOI 10.1038/ncb3471; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Jiang L, 2014, FEBS LETT, V588, P2009, DOI 10.1016/j.febslet.2014.04.024; Ke J, 2015, ONCOTARGET, V6, P3709, DOI 10.18632/oncotarget.2888; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kim JC, 2016, CANCER RES, V76, P6424, DOI 10.1158/0008-5472.CAN-16-1571; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Martinez-Ruiz H, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf5402; Patel Y, 2016, ONCOTARGET, V7, P18295, DOI 10.18632/oncotarget.7577; Phua YW, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0593-0; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Rodriguez-Barrueco R, 2017, GENE DEV, V31, P553, DOI 10.1101/gad.292318.116; Soady KJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0539-6; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Tiede BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008035; Vaillant F, 2007, STEM CELL REV, V3, P114, DOI 10.1007/s12015-007-0018-2; Vinnedge LMP, 2015, ONCOGENE, V34, P2325, DOI 10.1038/onc.2014.173; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Yallowitz AR, 2014, CELL DEATH DIFFER, V21, P645, DOI 10.1038/cdd.2013.199; Yoo KH, 2014, DEV BIOL, V395, P245, DOI 10.1016/j.ydbio.2014.09.012; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	34	13	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2019	38	3					445	453		10.1038/s41388-018-0439-1	http://dx.doi.org/10.1038/s41388-018-0439-1			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HH6OP	30104710	Green Accepted			2022-12-26	WOS:000455851200010
J	Canniffe, DP; Thweatt, JL; Chew, AGM; Hunter, CN; Bryant, DA				Canniffe, Daniel P.; Thweatt, Jennifer L.; Chew, Aline Gomez Maqueo; Hunter, C. Neil; Bryant, Donald A.			A paralog of a bacteriochlorophyll biosynthesis enzyme catalyzes the formation of 1,2-dihydrocarotenoids in green sulfur bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; photosynthetic pigment; carotenoid; bacterial genetics; energy metabolism; Blastochloris viridis; Chlorobaculum tepidum; green sulfur bacterium; Rhodobacter sphaeroides	PHOTOSYNTHETIC REACTION-CENTER; RHODOBACTER-SPHAEROIDES; CHLOROBIUM-TEPIDUM; RHODOPSEUDOMONAS-VIRIDIS; GERANYLGERANYL REDUCTASE; CHLOROPHYLL BIOSYNTHESIS; ENGINEERED BIOSYNTHESIS; NATURAL TRANSFORMATION; FUNCTIONAL ASSIGNMENT; GENE INACTIVATION	Chlorobaculum tepidum, a green sulfur bacterium, utilizes chlorobactene as its major carotenoid, and this organism also accumulates a reduced form of this monocyclic pigment, 1,2-dihydrochlorobactene. The protein catalyzing this reduction is the last unidentified enzyme in the biosynthetic pathways for all of the green sulfur bacterial pigments used for photosynthesis. The genome of C. tepidum contains two paralogous genes encoding members of the FixC family of flavoproteins: bchP, which has been shown to encode an enzyme of bacteriochlorophyll biosynthesis; and bchO, for which a function has not been assigned. Here we demonstrate that a bchO mutant is unable to synthesize 1,2-dihydrochlorobactene, and when bchO is heterologously expressed in a neurosporene-producing mutant of the purple bacterium, Rhodobacter sphaeroides, the encoded protein is able to catalyze the formation of 1,2-dihydroneurosporene, the major carotenoid of the only other organism reported to synthesize 1,2-dihydrocarotenoids, Blastochloris viridis. Identification of this enzyme completes the pathways for the synthesis of photosynthetic pigments in Chlorobiaceae, and accordingly and consistent with its role in carotenoid biosynthesis, we propose to rename the gene cruI. Notably, the absence of cruI in B. viridis indicates that a second 1,2-carotenoid reductase, which is structurally unrelated to CruI (BchO), must exist in nature. The evolution of this carotenoid reductase in green sulfur bacteria is discussed herein.	[Canniffe, Daniel P.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Canniffe, Daniel P.; Thweatt, Jennifer L.; Chew, Aline Gomez Maqueo; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Chew, Aline Gomez Maqueo] Univ Valle Mexico, Hermosillo 83165, Sonora, Mexico	University of Sheffield; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Canniffe, DP (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.; Canniffe, DP; Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Bryant, DA (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	d.canniffe@sheffield.ac.uk; dab14@psu.edu		Canniffe, Daniel/0000-0002-5022-0437	European Commission Marie Sklodowska-Curie Global Fellowship [660652]; Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-94ER20137]; Biotechnology and Biological Sciences Research Council [BB/M000265/1]; European Research Council [338895]; BBSRC [BB/M000265/1] Funding Source: UKRI	European Commission Marie Sklodowska-Curie Global Fellowship; Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by European Commission Marie Sklodowska-Curie Global Fellowship 660652 (to D. P. C.), by Grant DE-FG02-94ER20137 from the Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to D. A. B.), by Biotechnology and Biological Sciences Research Council Grant BB/M000265/1 (to C. N. H.), and Advanced Award 338895 from the European Research Council (to C. N. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Addlesee HA, 1999, J BACTERIOL, V181, P7248, DOI 10.1128/JB.181.23.7248-7255.1999; Addlesee HA, 1996, FEBS LETT, V389, P126, DOI 10.1016/0014-5793(96)00549-2; Armstrong G., 1999, COMPREHENSIVE NATURA, P321; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aa9c3c; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Canniffe DP, 2014, BBA-BIOENERGETICS, V1837, P1611, DOI 10.1016/j.bbabio.2014.07.011; Canniffe DP, 2014, BIOCHEM J, V462, P433, DOI 10.1042/BJ20140163; Chen GE, 2016, J BACTERIOL, V198, P2056, DOI 10.1128/JB.00121-16; Chew AGM, 2008, J BACTERIOL, V190, P747, DOI 10.1128/JB.01430-07; Chi SC, 2015, BBA-BIOENERGETICS, V1847, P189, DOI 10.1016/j.bbabio.2014.10.004; Claus D., 1977, GERMAN COLLECTION MI, P279; DREWS G, 1966, ARCH MIKROBIOL, V53, P255, DOI 10.1007/BF00446672; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Frigaard NU, 2004, METH MOL B, V274, P325; Frigaard NU, 2004, J BACTERIOL, V186, P5210, DOI 10.1128/JB.186.16.5210-5220.2004; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GIBSON J, 1984, ARCH MICROBIOL, V138, P96, DOI 10.1007/BF00413007; Gisriel C, 2017, SCIENCE, V357, P1021, DOI 10.1126/science.aan5611; Gong LM, 1996, MICROBIOL-UK, V142, P2057, DOI 10.1099/13500872-142-8-2057; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Hirabayashi H, 2004, PHOTOCHEM PHOTOBIOL, V79, P280, DOI 10.1562/WB-03-11.1; Hitchcock A, 2016, ACS SYNTH BIOL, V5, P948, DOI 10.1021/acssynbio.6b00069; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1471; Klimov VV, 2003, PHOTOSYNTH RES, V76, P247, DOI 10.1023/A:1024990408747; Kumka JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2162-4; Liu L. N., 2016, GENOME ANNOUNCEMENTS, V4; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Magdaong NCM, 2016, J PHYS CHEM B, V120, P5159, DOI 10.1021/acs.jpcb.6b04307; MALHOTRA HC, 1970, J CHEM SOC CHEM COMM, P127, DOI 10.1039/c29700000127; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Maresca JA, 2006, J BACTERIOL, V188, P6217, DOI 10.1128/JB.00766-06; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Ortega-Ramos M, 2018, BBA-BIOENERGETICS, V1859, P501, DOI 10.1016/j.bbabio.2018.02.006; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Paulsen H, 1999, ADV PHOTOSYNTH, V8, P123; Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824; Qian P, 2018, NATURE, V556, P203, DOI 10.1038/s41586-018-0014-5; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHEER H, 1974, J AM CHEM SOC, V96, P3714, DOI 10.1021/ja00818a092; Shpilyov AV, 2005, BBA-BIOENERGETICS, V1706, P195, DOI 10.1016/j.bbabio.2004.11.001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Takaichi S, 1997, ARCH MICROBIOL, V168, P270, DOI 10.1007/s002030050498; Takaichi S, 1999, PLANT CELL PHYSIOL, V40, P691, DOI 10.1093/oxfordjournals.pcp.a029594; Thweatt JL, 2017, J BIOL CHEM, V292, P1361, DOI 10.1074/jbc.M116.767665; Tikh IB, 2014, APPL MICROBIOL BIOT, V98, P3111, DOI 10.1007/s00253-014-5527-8; Van Gemerden H, 1995, ANOXYGENIC PHOTOSYNT, P49; WAHLUND TM, 1995, J BACTERIOL, V177, P2583, DOI 10.1128/jb.177.9.2583-2588.1995; Yabuzaki J, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax004; Zeng Y, 2017, MODERN TOPICS PHOTOT, P163, DOI [DOI 10.1007/978-3-319-46261-5_5, 10.1007/978-3-319-46261-5_5]; Zeng YH, 2015, INT J SYST EVOL MICR, V65, P2410, DOI 10.1099/ijs.0.000272; Zeng YH, 2014, P NATL ACAD SCI USA, V111, P7795, DOI 10.1073/pnas.1400295111	60	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15233	15242		10.1074/jbc.RA118.004672	http://dx.doi.org/10.1074/jbc.RA118.004672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30126840	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000445998400023
J	Yu, SY; Hsiao, CT; Izawa, M; Yusa, A; Ishida, H; Nakamura, S; Yagi, H; Kannagi, R; Khoo, KH				Yu, Shin-Yi; Hsiao, Cheng-Te; Izawa, Mineko; Yusa, Akiko; Ishida, Hiroji; Nakamura, Shigeo; Yagi, Hirokazu; Kannagi, Reiji; Khoo, Kay-Hooi			Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); glycobiology; glycomics; analytical chemistry; colorectal cancer; CHST; GlcNAc-6-O-sulfotransferase; MECA-79; sulfoglycomics	HIGH ENDOTHELIAL VENULES; L-SELECTIN LIGAND; SIALYL-LEWIS-X; MUCINOUS ADENOCARCINOMA; PERMETHYLATED GLYCANS; ECTOPIC EXPRESSION; COLORECTAL-CANCER; MOLECULAR-CLONING; SULFATED GLYCANS; O-GLYCANS	Sulfated glycans are known to be involved in several glycan-mediated cell adhesion and recognition pathways. Our mRNA transcript analyses on the genes involved in synthesizing GlcNAc-6-O-sulfated glycans in human colon cancer tissues indicated that GlcNAc6ST-2 (CHST4) is preferentially expressed in cancer cells compared with nonmalignant epithelial cells among the three known major GlcNAc-6-O-sulfotransferases. On the contrary, GlcNAc6ST-3 (CHST5) was only expressed in nonmalignant epithelial cells, whereas GlcNAc6ST-1 (CHST2) was expressed equally in both cancerous and nonmalignant epithelial cells. These results suggest that 6-O-sulfated glycans that are synthesized only by GlcNAc6ST-2 may be highly colon cancer-specific, as supported by immunohistochemical staining of cancer cells using the MECA-79 antibody known to be relatively specific to the enzymatic reaction products of GlcNAc6ST-2. By more precise MS-based sulfoglycomic analyses, we sought to further infer the substrate specificities of GlcNAc6STs via a definitive mapping of various sulfo-glycotopes and O-glycan structures expressed in response to overexpression of transfected GlcNAc6STs in the SW480 colon cancer cell line. By detailed MS/MS sequencing, GlcNAc6ST-3 was shown to preferentially add sulfate onto core 2-based O-glycan structures, but it does not act on extended core 1 structures, whereas GlcNAc6ST-1 prefers core 2-based O-glycans to extended core 1 structures. In contrast, GlcNAc6ST-2 could efficiently add sulfate onto both extended core 1- and core 2-based O-glycans, leading to the production of unique sulfated extended core 1 structures such as R-GlcNAc(6-SO3-)1-3Gal1-4GlcNAc(6-SO3-)1-3Gal1-3GalNAc, which are good candidates to be targeted as cancer-specific glycans.	[Yu, Shin-Yi; Hsiao, Cheng-Te; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Yu, Shin-Yi; Kannagi, Reiji] Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 115, Taiwan; [Izawa, Mineko; Yusa, Akiko; Kannagi, Reiji] Aichi Canc Ctr, Dept Mol Pathol, Nagoya, Aichi 4648681, Japan; [Ishida, Hiroji; Nakamura, Shigeo; Kannagi, Reiji] Aichi Canc Ctr, Lab Clin Pathol, Nagoya, Aichi 4648681, Japan; [Yagi, Hirokazu; Kannagi, Reiji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Aichi Cancer Center; Aichi Cancer Center; Nagoya City University	Kannagi, R (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.; Khoo, KH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	rkannagi@ibms.sinica.edu.tw; kkhoo@gate.sinica.edu.tw	Yagi, Hirokazu/ABH-6151-2020; Kannagi, Reiji/Q-6459-2018; Khoo, Kay-Hooi/E-1989-2019	Kannagi, Reiji/0000-0003-4202-2921; Khoo, Kay-Hooi/0000-0003-2906-406X; Yagi, Hirokazu/0000-0001-9296-0225; YU, Shin-Yi/0000-0003-0197-9575	Taiwan National Core Facility Program for Biotechnology [NSC 100-2325-B-001-029]	Taiwan National Core Facility Program for Biotechnology	The MALDI- MS and MS/MS data were acquired at the previous Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC 100-2325-B-001-029. We further acknowledge the use of Academia Sinica Common Mass Spectrometry Facilities at Institute of Biological Chemistry and technical assistance of Ming-Chieh Tsai and Dr. Shu-Yu Lin for nanoLC-MS/MS analysis. The synthetic sulfated glycan standards were generously provided by Prof. Chun-Hung Lin (Institute of Biological Chemistry, Academia Sinica) and Prof. James C. Paulson (Scripps Research Institute).	Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Akama TO, 2002, J BIOL CHEM, V277, P42505, DOI 10.1074/jbc.M207412200; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bowman KG, 2001, BIOCHEMISTRY-US, V40, P5382, DOI 10.1021/bi001750o; Broad Institute TCGA Genome Data Analysis Center, 2016, AN READ STAND TCGA D, DOI [10.7908/C11G0KM9, DOI 10.7908/C11G0KM9]; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Chandrasekaran EV, 2004, J BIOL CHEM, V279, P10032, DOI 10.1074/jbc.M311989200; Chandrasekaran EV, 1997, GLYCOBIOLOGY, V7, P753, DOI 10.1093/glycob/7.6.753; Chandrasekaran EV, 1999, GLYCOCONJUGATE J, V16, P523, DOI 10.1023/A:1007074005371; Cheng CW, 2015, ANAL CHEM, V87, P6380, DOI 10.1021/acs.analchem.5b01409; Cheng PF, 2013, ANAL BIOANAL CHEM, V405, P6683, DOI 10.1007/s00216-013-7128-2; FILIPE MI, 1969, GUT, V10, P577, DOI 10.1136/gut.10.7.577; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; FUKUSHIMA K, 1995, GLYCOBIOLOGY, V5, P105, DOI 10.1093/glycob/5.1.105; Grunwell JR, 2002, BIOCHEMISTRY-US, V41, P13117, DOI 10.1021/bi020507h; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Hsiao CT, 2017, MOL CELL PROTEOMICS, V16, P2268, DOI 10.1074/mcp.TIR117.000156; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Izawa M, 2000, CANCER RES, V60, P1410; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima H, 2006, BIOL PHARM BULL, V29, P2343, DOI 10.1248/bpb.29.2343; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kletter D, 2013, MOL CELL PROTEOMICS, V12, P1026, DOI 10.1074/mcp.M112.026641; Kobayashi M, 2011, J PATHOL, V224, P67, DOI 10.1002/path.2851; Kobayashi M, 2009, BIOL PHARM BULL, V32, P774, DOI 10.1248/bpb.32.774; KUHNS W, 1995, GLYCOBIOLOGY, V5, P689, DOI 10.1093/glycob/5.7.689; Lee JK, 2003, GLYCOBIOLOGY, V13, P245, DOI 10.1093/glycob/cwg018; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Okayama H, 2011, CANCER SCI, V102, P1088, DOI 10.1111/j.1349-7006.2011.01895.x; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Patnode ML, 2013, GLYCOBIOLOGY, V23, P381, DOI 10.1093/glycob/cws166; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Seko A, 2000, GLYCOBIOLOGY, V10, P919, DOI 10.1093/glycob/10.9.919; Seko A, 2005, BIOCHEM J, V391, P77, DOI 10.1042/BJ20050362; Seko A, 2002, JPN J CANCER RES, V93, P507, DOI 10.1111/j.1349-7006.2002.tb01285.x; Seko A, 2002, GLYCOBIOLOGY, V12, P379, DOI 10.1093/glycob/12.6.379; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Tu ZJ, 2013, CHEM-ASIAN J, V8, P1536, DOI 10.1002/asia.201201204; Uchimura K, 2000, BIOCHEM BIOPH RES CO, V274, P291, DOI 10.1006/bbrc.2000.3141; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; YAMORI T, 1987, CANCER RES, V47, P2741; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3; Yu SY, 2009, GLYCOBIOLOGY, V19, P1136, DOI 10.1093/glycob/cwp113	57	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15163	15177		10.1074/jbc.RA118.001937	http://dx.doi.org/10.1074/jbc.RA118.001937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30093410	Green Published, hybrid			2022-12-26	WOS:000445998400018
J	Di Girolamo, C; Walters, S; Gildea, C; Majano, SB; Rachet, B; Morris, M				Di Girolamo, Chiara; Walters, Sarah; Gildea, Carolynn; Majano, Sara Benitez; Rachet, Bernard; Morris, Melanie			Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013	PLOS ONE			English	Article							LONGER DIAGNOSTIC INTERVALS; COLORECTAL-CANCER; BREAST-CANCER; PRIMARY-CARE; LUNG-CANCER; REFERRAL PATHWAY; PROSTATE-CANCER; TREATMENT DELAY; 2-WEEK RULE; STAGE	Background Cancer Waiting Time targets have been integrated into successive cancer strategies as indicators of cancer care quality in England. These targets are reported in national statistics for all cancers combined, but there is mixed evidence of their benefits and it is unclear if meeting Cancer Waiting Time targets, as currently defined and published, is associated with improved survival for individual patients, and thus if survival is a good metric for judging the utility of the targets. Methods and findings We used individually-linked data from the National Cancer Waiting Times Monitoring Dataset (CWT), the cancer registry and other routinely collected datasets. The study population consisted of all adult patients diagnosed in England (2009 +/- 2013) with colorectal (164,890), lung (171,208) or ovarian (24,545) cancer, of whom 82%, 76%, and 77%, respectively, had a CWT matching record. The main outcome was one-year net survival for all matched patients by target attainment ('met/not met'). The time to each type of treatment for the 31-day and 62-day targets was estimated using multivariable analyses, adjusting for age, sex, tumour stage and deprivation. The two-week wait (TWW) from GP referral to specialist consultation and 31-day target from decision to treat to start of treatment were met for more than 95% of patients, but the 62-day target from GP referral to start of treatment was missed more often. There was little evidence of an association between meeting the TWW target and one-year net survival, but for the 31-day and 62-day targets, survival was worse for those for whom the targets were met (e.g. colorectal cancer: survival 89.1% (95% CI 88.9 +/- 89.4) for patients with 31-day target met, 96.9% (95% CI 96.1 +/- 91.7) for patients for whom it was not met). Time-to-treatment analyses showed that treatments recorded as palliative were given earlier in time, than treatments with potentially curative intent. There are possible limitations in the accuracy of the categorisation of treatment variables which do not allow for fully distinguishing, for example, between curative and palliative intent; and it is difficult in these data to assess the appropriateness of treatment by stage. These limitations in the nature of the data do not affect the survival estimates found, but do mean that it is not possible to separate those patients for whom the times between referral, decision to treat and start of treatment could actually have an impact on the clinical outcomes. This means that the use of these survival measures to evaluate the targets would be misleading. Conclusions Based on these individually-linked data, and for the cancers we looked at, we did not find that Cancer Waiting Time targets being met translates into improved one-year survival. Patients may benefit psychologically from limited waits which encourage timely treatment, but one-year survival is not a useful measure for evaluating Trust performance with regards to Cancer Waiting Time targets, which are not currently stratified by stage or treatment type. As such, the current composition of the data means target compliance needs further evaluation before being used for the assessment of clinical outcomes.	[Di Girolamo, Chiara; Walters, Sarah; Majano, Sara Benitez; Rachet, Bernard; Morris, Melanie] London Sch Hyg & Trop Med, Canc Survival Grp, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England; [Di Girolamo, Chiara] Univ Bologna, Alma Mater Studorium, Dept Med & Surg Sci, Bologna, Italy; [Gildea, Carolynn] Publ Hlth England, Natl Canc Registrat & Anal Serv, Vulcan House Steel, Sheffield, S Yorkshire, England	University of London; London School of Hygiene & Tropical Medicine; University of Bologna; Public Health England	Morris, M (corresponding author), London Sch Hyg & Trop Med, Canc Survival Grp, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England.	melanie.morris@lshtm.ac.uk	Di Girolamo, Chiara/AAB-9735-2019	Rachet, Bernard/0000-0001-5837-7773; Morris, Melanie/0000-0003-3819-8107; Di Girolamo, Chiara/0000-0002-6031-1009; Benitez Majano, Sara/0000-0001-8032-9794	Cancer Research UK [C7923/A18348]	Cancer Research UK(Cancer Research UK)	This work was supported by a grant from Cancer Research UK (https://www.cancerresearchuk.org/), award number C7923/A18348, held by BR as principal investigator. The funding body collaborated in the design of the study but had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. The researchers are independent of the funding body.	Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108; Benitez-Majano S, 2016, BRIT J CANCER, V115, P391, DOI 10.1038/bjc.2016.177; Bleicher RJ, 2016, JAMA ONCOL, V2, P330, DOI 10.1001/jamaoncol.2015.4508; Cancer Waiting Times Team, 2016, CANC WAIT TIM COMM T; Cancer Waiting Times Team, 2015, NAT CANC WAIT TIM MO; Crawford SC, 2002, BRIT MED J, V325, P196, DOI 10.1136/bmj.325.7357.196; Department for Communities and Local Government, 2008, ENGLISH INDICES DEPR; Department of Health, 2000, NHS CANC PLAN PLAN I; Department of Health, 2011, REV CANC WAIT TIM ST, DOI [10.1002/cncr.25644, DOI 10.1002/CNCR.25644]; Department of Health, 2011, IMPR OUTC STRAT CANC, DOI [10.1002/cncr.26280, DOI 10.1002/CNCR.26280]; Department of Health, 2007, CANC REF STRAT; Di Girolamo C, 2018, BRIT J CANCER, V118, P733, DOI 10.1038/bjc.2017.452; Elit LM, 2014, J CLIN ONCOL, V32, P27, DOI 10.1200/JCO.2013.51.3671; Forrest LF, 2014, BRIT J CANCER, V111, P1843, DOI 10.1038/bjc.2014.472; Giobbie-Hurder A, 2013, J CLIN ONCOL, V31, P2963, DOI 10.1200/JCO.2013.49.5283; Gray R, 2016, CANC RES UK SCI  JUL; Gray RE, 1999, CANCER PRACT, V7, P130, DOI 10.1046/j.1523-5394.1999.07308.x; Independent Cancer Taskforce, 2015, ACH WORLD CLASS CANC; JONES RVH, 1994, BRIT J GEN PRACT, V44, P370; King's Fund, 2014, UK PRIV HLTH MARK; Klein R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5104; Leiva A, 2017, CANCER EPIDEMIOL, V47, P48, DOI 10.1016/j.canep.2016.10.021; Li RR, 2014, CANCER EPIDEMIOL, V38, P314, DOI 10.1016/j.canep.2014.02.013; Mckie C, 2008, ORAL ONCOL, V44, P851, DOI 10.1016/j.oraloncology.2007.10.010; Moller H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5102; Murchie P, 2014, BRIT J CANCER, V111, P461, DOI 10.1038/bjc.2014.352; Myrdal G, 2004, THORAX, V59, P45; National Cancer Intelligence Network Data Briefing, 2016, TRENDS CANC WAIT TIM; NHS England, CANC WAIT TIM 2015; NHS Executive, 1998, BREAST CANC WAIT TIM; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Potter S, 2007, BMJ-BRIT MED J, V335, P288, DOI 10.1136/bmj.39258.688553.55; Probst HB, 2012, HEALTH POLICY, V105, P65, DOI 10.1016/j.healthpol.2011.11.001; Redaniel MT, 2013, BRIT J CANCER, V109, P42, DOI 10.1038/bjc.2013.317; Samuels M, 2016, WAITING TIMES SUSPEC; Seklehner S, 2013, SCAND J UROL, V47, P101, DOI 10.3109/00365599.2012.700946; Sharpe D, 2010, EJSO-EUR J SURG ONC, V36, P977, DOI 10.1016/j.ejso.2010.07.002; Sobin L, 2009, TNM CLASSIFICATION M; Spika D, CANC SURVIVAL GROUP; Spurgeon P, 2000, BRIT MED J, V320, P838, DOI 10.1136/bmj.320.7238.838; Thorne K, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-43; Torring ML, 2017, BRIT J CANCER, V117, P888, DOI 10.1038/bjc.2017.236; Torring ML, 2011, BRIT J CANCER, V104, P934, DOI 10.1038/bjc.2011.60; Torring ML, 2013, EUR J CANCER, V49, P2187, DOI 10.1016/j.ejca.2013.01.025; van Harten MC, 2014, ORAL ONCOL, V50, P282, DOI 10.1016/j.oraloncology.2013.12.018; Visser E, 2016, ANN SURG ONCOL, V23, P2679, DOI 10.1245/s10434-016-5191-6	46	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201288	10.1371/journal.pone.0201288	http://dx.doi.org/10.1371/journal.pone.0201288			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133466	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000442500400018
J	Opgenorth, D; Stelfox, HT; Gilfoyle, E; Gibney, RTN; Meier, M; Boucher, P; McKinley, D; McIntosh, CNJ; Wang, XM; Zygun, DA; Bagshaw, SM				Opgenorth, Dawn; Stelfox, Henry T.; Gilfoyle, Elaine; Gibney, R. T. Noel; Meier, Michael; Boucher, Paul; McKinley, David; McIntosh, Christiane N. Job; Wang, Xiaoming; Zygun, David A.; Bagshaw, Sean M.			Perspectives on strained intensive care unit capacity: A survey of critical care professionals	PLOS ONE			English	Article							FAMILY SATISFACTION; ICU; PERCEPTIONS; MORTALITY; TIME	Background Strained intensive care unit (ICU) capacity represents a supply-demand mismatch in ICU care. Limited data have explored health care worker (HCW) perceptions of strain. Methods Cross-sectional survey of HCW across 16 Alberta ICUs. A web-based questionnaire captured data on demographics, strain definition, and sources, impact and strategies for management. Results 658 HCW responded (33%; 95% CI, 32 +/- 36%), of which 452 were nurses (69%), 128 allied health (19%), 45 physicians (7%) and 33 administrators (5%). Participants (agreed/strongly agreed: 94%) reported that strain was best defined as a time-varying imbalance between the supply of available beds, staff and/or resources and the demand to provide high-quality care for patients who may become or who are critically ill"; while some recommended defining high-quality care", integrating safety", and families in the definition. Participants reported significant contributors to strain were: inability to discharge ICU patients due to lack of available ward beds" (97%); increases in the volume" (89%); and acuity and complexity of patients requiring ICU support" (88%). Strain was perceived to increase stress levels in health care providers" (98%); and burnout in health care providers" (96%). The highest ranked strategies were: have more consistent and better goals-of-care conversations with patients/families outside of ICU" (95%); and increase non-acute care beds" (92%). Interpretation Strain is perceived as common. HCW believe precipitants represent a mix of patient-related and operational factors. Strain is thought to have negative implications for quality of care, HCW well-being and workplace environment. Most indicated strategies outside" of ICU settings were priorities for managing strain.	[Opgenorth, Dawn; Gibney, R. T. Noel; Meier, Michael; McKinley, David; Zygun, David A.; Bagshaw, Sean M.] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada; [Stelfox, Henry T.; Boucher, Paul] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Henry T.; Gilfoyle, Elaine; Meier, Michael; Boucher, Paul; McIntosh, Christiane N. Job; Zygun, David A.; Bagshaw, Sean M.] Alberta Hlth Serv, Crit Care Strateg Clin Network, Edmonton, AB, Canada; [Stelfox, Henry T.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Gilfoyle, Elaine] Univ Calgary, Cumming Sch Med, Dept Pediat, Sect Crit Care, Calgary, AB, Canada; [Wang, Xiaoming] Alberta Hlth Serv, Analyt DIMR, Res Facilitat, Edmonton, AB, Canada	University of Alberta; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS)	Bagshaw, SM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada.; Bagshaw, SM (corresponding author), Alberta Hlth Serv, Crit Care Strateg Clin Network, Edmonton, AB, Canada.	bagshaw@ualberta.ca		Stelfox, Henry/0000-0003-1231-1490; Opgenorth, Dawn/0000-0003-3571-3871	Alberta Innovates - Health Solutions [AIHS PRIHS 201300476]; Canada Research Chair in Critical Care Nephrology; AI Population Health Investigator Award; CIHR Embedded Clinician Researcher Award	Alberta Innovates - Health Solutions; Canada Research Chair in Critical Care Nephrology; AI Population Health Investigator Award; CIHR Embedded Clinician Researcher Award	This work was supported by a grant from Alberta Innovates - Health Solutions (AIHS PRIHS 201300476) received by Dr. Sean M Bagshaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Bagshaw is supported by a Canada Research Chair in Critical Care Nephrology. Dr. Stelfox is supported by an AI Population Health Investigator Award and CIHR Embedded Clinician Researcher Award.	Bagshaw SM, 2017, CRIT CARE MED, V45, pE347, DOI 10.1097/CCM.0000000000002093; Brown SES, 2014, AM J RESP CRIT CARE, V190, P831, DOI 10.1164/rccm.201406-1127LE; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Chrusch CA, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/2516765; Daud-Gallotti RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052342; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Dhillon NK, 2017, JAMA SURG, V152, P1015, DOI 10.1001/jamasurg.2017.2165; Dodek PM, 2016, J CRIT CARE, V31, P178, DOI 10.1016/j.jcrc.2015.10.011; Fowler RA, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0852-6; Gabler NB, 2013, AM J RESP CRIT CARE, V188, P800, DOI 10.1164/rccm.201304-0622OC; Gardner Jane K, 2007, Nephrol Nurs J, V34, P271; Gardner JK, 2007, NEPHROL NURS J, V34, P282; Garland A, 2013, AM J CRIT CARE, V22, P390, DOI 10.4037/ajcc2013973; Hefter Y, 2016, CRIT CARE MED, V44, P1482, DOI 10.1097/CCM.0000000000001719; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Heyland DK, 2001, J CRIT CARE, V16, P142, DOI 10.1053/jcrc.2001.30163; Holodinsky JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145408; Hua M, 2016, INTENSIVE CARE MED; Johnson-Coyle Leah, 2016, Can J Crit Care Nurs, V27, P27; Kerlin Meeta Prasad, 2014, Ann Am Thorac Soc, V11, P167, DOI 10.1513/AnnalsATS.201306-141OC; Lane D, 2013, CRIT CARE MED, V41, P2015, DOI 10.1097/CCM.0b013e31828a435f; Levin PD, 2003, J CRIT CARE, V18, P206, DOI 10.1016/j.jcrc.2003.10.003; Morrison A L, 2001, Aust Crit Care, V14, P116, DOI 10.1016/S1036-7314(01)80028-X; Neuraz A, 2015, CRIT CARE MED, V43, P1587, DOI 10.1097/CCM.0000000000001015; Rewa OG, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1975-3; Stelfox HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140141; van Mol MMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136955; Wagner J, 2013, ANN INTERN MED, V159, P447, DOI 10.7326/0003-4819-159-7-201310010-00004; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; Wall RJ, 2007, CRIT CARE MED, V35, P271, DOI 10.1097/01.CCM.0000251122.15053.50; Weissman GE, 2015, J CRIT CARE, V30, P1303, DOI 10.1016/j.jcrc.2015.08.015; Whitehead PB, 2015, J NURS SCHOLARSHIP, V47, P117, DOI 10.1111/jnu.12115; You JJ, 2015, JAMA INTERN MED, V175, P549, DOI 10.1001/jamainternmed.2014.7732	33	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2018	13	8							e0201524	10.1371/journal.pone.0201524	http://dx.doi.org/10.1371/journal.pone.0201524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3NR	30133479	Green Published, gold, Green Submitted			2022-12-26	WOS:000442500400023
J	Hamano, S; Nishibori, Y; Hada, I; Mikami, N; Ito-Nitta, N; Fukuhara, D; Kudo, A; Xiao, ZJ; Nukui, M; Patrakka, J; Tryggvason, K; Yan, K				Hamano, Sho; Nishibori, Yukino; Hada, Ichiro; Mikami, Naoaki; Ito-Nitta, Noriko; Fukuhara, Daisuke; Kudo, Akihiko; Xiao, Zhijie; Nukui, Masatoshi; Patrakka, Jaakko; Tryggvason, Karl; Yan, Kunimasa			Association of crumbs homolog-2 with mTORC1 in developing podocyte	PLOS ONE			English	Article							CELL POLARITY; SIGNALING PATHWAY; MAMMALIAN TARGET; EPITHELIAL-CELLS; DISCS LOST; PROTEIN; COMPLEX; ACTIVATION; DROSOPHILA; RAPAMYCIN	The evidence that gene mutations in the polarity determinant Crumbs homologs-2 (CRB2) cause congenital nephrotic syndrome suggests the functional importance of this gene product in podocyte development. Because another isoform, CRB3, was reported to repress the mechanistic/mammalian target of the rapamycin complex 1 (mTORC1) pathway, we examined the role of CRB2 function in developing podocytes in relation to mTORC1. In HEK-293 and MDCK cells constitutively expressing CRB2, we found that the protein localized to the apicolateral side of the cell plasma membrane and that this plasma membrane assembly required N-glycosylation. Confocal microscopy of the neonate mouse kidney revealed that both the tyrosine-phosphorylated form and non-phosphorylated form of CRB2 commence at the S-shaped body stage at the apicolateral side of podocyte precursor cells and move to foot processes in a capillary tuft pattern. The pattern of phosphorylated mTOR in developing podocytes was similar to that of CRB2 tyrosine phosphorylation. Additionally, the lack of a tyrosine phosphorylation site on CRB2 led to the reduced sensitivity of mTORC1 activation in response to energy starvation. CRB2 may play an important role in the mechanistic pathway of developing podocytes through tyrosine phosphorylation by associating with mTORC1 activation.	[Hamano, Sho; Nishibori, Yukino; Hada, Ichiro; Mikami, Naoaki; Ito-Nitta, Noriko; Fukuhara, Daisuke; Yan, Kunimasa] Kyorin Univ, Dept Pediat, Sch Med, Mitaka, Tokyo, Japan; [Kudo, Akihiko] Kyorin Univ, Dept Anat, Dept Pediat, Sch Med, Mitaka, Tokyo, Japan; [Xiao, Zhijie; Nukui, Masatoshi; Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden; [Patrakka, Jaakko] Karolinska Univ Hosp Huddinge, KI AZ Integrated CardioMetab Ctr, Karolinska Inst, Dept Lab Med, Huddinge, Sweden	Kyorin University; Kyorin University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Yan, K (corresponding author), Kyorin Univ, Dept Pediat, Sch Med, Mitaka, Tokyo, Japan.	kuniyan@ks.kyorin-u.ac.jp	Patrakka, Jaakko/AAG-8796-2019; Kudo, Akihiko/ACZ-3340-2022	Kudo, Akihiko/0000-0002-2630-5991; Fukuhara, Daisuke/0000-0003-1932-4841				Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Ebarasi L, 2015, AM J HUM GENET, V96, P153, DOI 10.1016/j.ajhg.2014.11.014; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Hara M, 2012, DIABETOLOGIA, V55, P2913, DOI 10.1007/s00125-012-2661-7; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hartleben B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036705; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kriz W, 2007, NEPHRON EXP NEPHROL, V106, pE44, DOI 10.1159/000101792; Kurayama R, 2011, LAB INVEST, V91, P992, DOI 10.1038/labinvest.2011.43; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; Mao JH, 2014, AM J PHYSIOL-RENAL, V307, pF1023, DOI 10.1152/ajprenal.00018.2014; Massey-Harroche D, 2007, HUM MOL GENET, V16, P529, DOI 10.1093/hmg/ddl485; McMahon GM, 2012, BIOCHEM BIOPH RES CO, V425, P244, DOI 10.1016/j.bbrc.2012.07.075; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; MUNDEL P, 1991, J HISTOCHEM CYTOCHEM, V39, P1047, DOI 10.1177/39.8.1856454; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Sekine Y, 2009, J AM SOC NEPHROL, V20, P1586, DOI 10.1681/ASN.2008070809; Slavotinek A, 2015, AM J HUM GENET, V96, P162, DOI 10.1016/j.ajhg.2014.11.013; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Takagi H, 2017, AM J PHYSIOL-RENAL, V312, pF702, DOI 10.1152/ajprenal.00197.2016; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wei ZY, 2015, J BIOL CHEM, V290, P11384, DOI 10.1074/jbc.M115.643791; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Yan K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013297.11876.5B	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2018	13	8							e0202400	10.1371/journal.pone.0202400	http://dx.doi.org/10.1371/journal.pone.0202400			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR0JS	30125302	gold, Green Published, Green Submitted			2022-12-26	WOS:000442202100026
J	Dzodzomenyo, M; Ghansah, A; Ensaw, N; Dovie, B; Bimi, L; Quansah, R; Gyan, B; Gyakobo, M; Amoani, B				Dzodzomenyo, Mawuli; Ghansah, Anita; Ensaw, Nana; Dovie, Benjamin; Bimi, Langbong; Quansah, Reginald; Gyan, Ben A.; Gyakobo, Mawuli; Amoani, Benjamin			Inducible nitric oxide synthase 2 promoter polymorphism and malaria disease severity in children in Southern Ghana	PLOS ONE			English	Article							TANZANIAN CHILDREN; TYPE-2 EXPRESSION; CEREBRAL MALARIA; PROTECTION; ASSOCIATION; CELL	Objective We assessed the association of mutant allele frequencies of nitric oxide synthase 2 (NOS2) gene at two SNPs (-954 and -1173) with malaria disease severity in children from a malaria endemic area in Southern Ghana. Method Using children recruited at the hospital, assigned into clinical subgroups of uncomplicated and severe malaria and matching with their "healthy control" counterparts, we designed a case control study. Genomic DNA was extracted and genotyping using Restriction Fragment Polymorphism was done. Result A total of 123 malaria cases (91 uncomplicated, 32 severe) and 100 controls were sampled. Their corresponding mean Hbs were 9.6, 9.3 and 11.2g/di and geometric mean parasite densities of 32097, 193252 and 0 parasites/ml respectively. Variant allele frequencies varied from 0.09 through 0.03 to 0.12 for G-954C and 0.06 through 0.03 to 0.07 for C-1173T in the uncomplicated, severe and healthy control groups respectively. There was a strong linkage disequilibrium between the two alleles (p<0.001). For the -954 position, the odds of developing severe malaria was found to be 2.5 times lower with the carriage of a C allele compared to those without severe malaria (chi(2); p< 0.05) though this isn't the case with -1173. Conclusion The carriage of a mutant allele in the -954 NOS2 gene may have a protective effect on malaria among Southern Ghanaian children.	[Dzodzomenyo, Mawuli; Quansah, Reginald] Univ Ghana, Sch Publ Hlth, Dept Biol Environm & Occupat Hlth Sci, Legon, Ghana; [Ghansah, Anita; Gyan, Ben A.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Ensaw, Nana] St Dominics Hosp, Akwatia, Ghana; [Dovie, Benjamin] Univ Ghana, Dept Geog, Legon, Ghana; [Bimi, Langbong] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana; [Gyakobo, Mawuli] Tetteh Quarshie Mem Hosp, Mampong Akwapim, Ghana; [Amoani, Benjamin] Univ Cape Coast, Coll Hlth & Allied Sci, Dept Biomed Sci, Cape Coast, Ghana	University of Ghana; University of Ghana; University of Ghana; University of Ghana; University of Cape Coast	Dzodzomenyo, M (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Biol Environm & Occupat Hlth Sci, Legon, Ghana.	mdzodzomenyo@ug.edu.gh	Quansah, Reginald/AAZ-4015-2020; Amoani, Benjamin/AAB-8772-2020	Quansah, Reginald/0000-0002-7318-4192; Amoani, Benjamin/0000-0002-4086-3033; Dzodzomenyo, Mawuli/0000-0002-4709-3182; BIMI, Langbong/0000-0002-8536-4828	WHO/TDR [A50984]	WHO/TDR(World Health Organization)	This study received financial support from the WHO/TDR Grant No. A50984 for MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the immense contribution of the staff of St. Dominic Hospital, Akwatia, in particular Mr. Shaibu (Laboratory Manager) and the parents of the children who participated in the study, the staff of the Department of Parasitology of the NMIMR, where the laboratory studies was carried out for their various roles. This work was supported by WHO/TDR, grant ID #: A50984 awarded to Mawuli Dzodzomenyo.	Anstey NM, 1999, AM J TROP MED HYG, V61, P253, DOI 10.4269/ajtmh.1999.61.253; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Boutlis CS, 2003, INFECT IMMUN, V71, P3682, DOI 10.1128/IAI.71.7.3682-3689.2003; Burgner D, 2003, GENES IMMUN, V4, P506, DOI 10.1038/sj.gene.6364022; Burgner D, 1998, LANCET, V352, P1193, DOI 10.1016/S0140-6736(05)60531-4; Cramer JP, 2004, TROP MED INT HEALTH, V9, P1074, DOI 10.1111/j.1365-3156.2004.01312.x; Dzodzomenyo M, 2005, TOKYO WOMENS MED U J, V75, P34; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Gyan B, 2002, ACTA TROP, V83, P133, DOI 10.1016/S0001-706X(02)00109-2; Hobbs MR, 2002, LANCET, V360, P1468, DOI 10.1016/S0140-6736(02)11474-7; Kumar A, 2018, REDOX BIOL, V15, P192, DOI 10.1016/j.redox.2017.12.005; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; Kun JFJ, 1998, LANCET, V351, P265, DOI 10.1016/S0140-6736(05)78273-8; Levesque MC, 1999, J INFECT DIS, V180, P1994, DOI 10.1086/315140; Luoni G, 2001, GENES IMMUN, V2, P411, DOI 10.1038/sj.gene.6363797; Lwanira CN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1970-1; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Ohashi J, 2002, J INFECT DIS, V186, P578, DOI 10.1086/341779; Parikh S, 2004, AM J TROP MED HYG, V71, P750, DOI 10.4269/ajtmh.2004.71.750; Perkins DJ, 1999, INFECT IMMUN, V67, P4977, DOI 10.1128/IAI.67.9.4977-4981.1999; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; Ubalee R, 2001, TISSUE ANTIGENS, V58, P407, DOI 10.1034/j.1399-0039.2001.580610.x; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	28	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2018	13	8							e0202218	10.1371/journal.pone.0202218	http://dx.doi.org/10.1371/journal.pone.0202218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR1HG	30118498	Green Submitted, Green Published, gold			2022-12-26	WOS:000442282700018
J	Diallo, AO; Chevalier, V; Cappelle, J; Duong, V; Fontenille, D; Duboz, R				Diallo, Alpha Oumar, II; Chevalier, Veronique; Cappelle, Julien; Duong, Veasna; Fontenille, Didier; Duboz, Raphael			How much does direct transmission between pigs contribute to Japanese Encephalitis virus circulation? A modelling approach in Cambodia	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; INFECTION; DYNAMICS; EPIDEMIOLOGY; VACCINATION; ECOLOGY; SWINE; INDIA	Japanese Encephalitis (JE) is the most important cause of human encephalitis throughout Asia and the Pacific. Although JE is a vector-borne disease, it has been demonstrated experimentally that transmission between pigs can occur through direct contact. Whether pig-to-pig transmission plays a role in the natural epidemiological cycle of JE remains unknown. To assess whether direct transmission between pigs may occur under field conditions, we built two mathematical models of JE transmission incorporating vector-borne transmission alone or a combination of vector-borne and direct transmission. We used Markov Chain Monte Carlo (MCMC) techniques to estimate the parameters of the models. We fitted the models to (i) two serological datasets collected longitudinally from two pig cohorts (C1 and C2) during two periods of four months on a farm on the outskirts of Phnom-Penh, Cambodia and to (ii) a cross-sectional (CS) serological survey dataset collected from 505 swine coming from eight different provinces of Cambodia. In both cases, the model incorporating both vector-borne and direct transmission better explained the data. We computed the value of the basic reproduction number R-0 (2.93 for C1, 2.66 for C2 and 2.27 for CS), as well as the vector-borne reproduction number R-pv and the direct transmission reproduction number R-pp. We then determined the contribution of direct transmission on R-0 (11.90% for C1, 11.62% for C2 and 7.51% for CS). According to our results, the existence of pig-to-pig transmission is consistent with our swine serological data. Thus, direct transmission may contribute to the epidemiological cycle of JE in Cambodia. These results need to be confirmed in other eco-climatic settings, in particular in temperate areas where pig-to-pig transmission may facilitate the persistence of JE virus (JEV) during cold seasons when there are no or few mosquitoes.	[Diallo, Alpha Oumar, II; Chevalier, Veronique; Cappelle, Julien; Duboz, Raphael] UMR ASTRE, CIRAD, Phnom Penh, Cambodia; [Diallo, Alpha Oumar, II; Chevalier, Veronique; Cappelle, Julien; Duboz, Raphael] Univ Montpellier, INRA, CIRAD, ASTRE, Montpellier, France; [Diallo, Alpha Oumar, II; Chevalier, Veronique; Duboz, Raphael] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Cappelle, Julien] INRA, VetAgrosup, UMR EpiA, Marcy Letoile, France; [Duong, Veasna] IPC, Virol Unit, Phnom Penh, Cambodia; [Fontenille, Didier] IPC, Phnom Penh, Cambodia	CIRAD; CIRAD; INRAE; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; INRAE; VetAgro Sup	Chevalier, V (corresponding author), UMR ASTRE, CIRAD, Phnom Penh, Cambodia.; Chevalier, V (corresponding author), Univ Montpellier, INRA, CIRAD, ASTRE, Montpellier, France.; Chevalier, V (corresponding author), Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia.	chevalier@cirad.fr	Veasna, Duong/I-9684-2014	Veasna, Duong/0000-0003-0353-1678; FONTENILLE, didier/0000-0002-0544-3885; Cappelle, Julien/0000-0001-7668-1971	CIRAD, Institut Pasteur de Paris, ComAcross project; Institut Pasteur du Cambodge; ComAcross; SEAe project; CIRAD; Institut Pasteur de Paris; ComAcross project	CIRAD, Institut Pasteur de Paris, ComAcross project; Institut Pasteur du Cambodge; ComAcross; SEAe project; CIRAD; Institut Pasteur de Paris; ComAcross project	This work was funded by CIRAD, Institut Pasteur de Paris, ComAcross project (www.onehealthsea.org/comacross) and Institut Pasteur du Cambodge. The salary of our PhD student, AO Diallo, was granted half by CIRAD, half by Institut Pasteur de Paris. Other costs were funded by ComAcross and Institut Pasteur du Cambodge (www.onehealthsea.org/comacross) project. SEAe project https://www.grease-network.org/main-projects/on-going/seae) funded the collection of pig incidence data (published in Cappelle et al). The specific roles of these authors are articulated in the 'author contributions' section.; This work was funded by CIRAD, Institut Pasteur de Paris, and ComAcross (www.onehealthsea.org/comacross) project. We also gratefully thank Dr M. Morters for her support on English editing, and her valuable suggestions.	Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Andreasen V, 2011, B MATH BIOL, V73, P2305, DOI 10.1007/s11538-010-9623-3; [Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 2014, R LANG ENV STAT COMP; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; BIRLEY MH, 1981, J MED ENTOMOL, V18, P181, DOI 10.1093/jmedent/18.3.181; Brauer Fred, 2017, Infect Dis Model, V2, P12, DOI 10.1016/j.idm.2016.12.001; Brookmeyer R., 2015, WILEY STATSREF STAT, P1, DOI [10.1002/9781118445112., DOI 10.1002/9781118445112]; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P678, DOI 10.4269/ajtmh.1959.8.678; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P651, DOI 10.4269/ajtmh.1959.8.651; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Cappelle J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005149; Chowell G, 2009, MATH STAT ESTIMATION, P130, DOI [10.1007/978-90-481-2313-1, DOI 10.1007/978-90-481-2313-1]; Cleton NB, 2014, AM J TROP MED HYG, V90, P242, DOI 10.4269/ajtmh.13-0161; Cruz-Pacheco G, 2005, B MATH BIOL, V67, P1157, DOI 10.1016/j.bulm.2004.11.008; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dietze K., 2011, PIGS PROSPERITY ROME; Duong V, 2011, ACTA TROP, V120, P146, DOI 10.1016/j.actatropica.2011.07.008; Dutta P, 2011, AM J TROP MED HYG, V84, P466, DOI 10.4269/ajtmh.2011.10-0270; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Faivre R., 2013, ANAL SENSIBILITE EXP; Gajanana A, 1997, J MED ENTOMOL, V34, P651, DOI 10.1093/jmedent/34.6.651; Gamerman D, 2006, MARKOV CHAIN MONTE C; Ghosh AK, 1999, IMA J MATH APPL MED, V16, P1; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; HETHCOTE H W, 1976, Mathematical Biosciences, V28, P335, DOI 10.1016/0025-5564(76)90132-2; HSU ST, 1972, B WORLD HEALTH ORGAN, V46, P465; Huynh TTT, 2006, ASIAN J AGRIC DEV, V3, P69; Impoinvil DE, 2013, CURR TOP MICROBIOL, V365, P205, DOI 10.1007/82_2012_243; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Khan SU, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003166; Lindahl J, 2012, JAPANESE ENCEPHALITI; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; Lord JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004074; Martcheva M., 2015, INTRO MATH EPIDEMIOL, DOI [10.1007/978-1-4899-7612-3, DOI 10.1007/978-1-4899-7612-3]; Miller E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080279; Mukhopadhyay B.B., 1994, INT J MATH MATH SCI, V17, P347; MUKHOPADHYAY BB, 1993, MATH COMPUT MODEL, V17, P99, DOI 10.1016/0895-7177(93)90157-T; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Naresh R, 2009, APPL APPL MATH, V4, P155; Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022; Panja P, 2018, COMPUT APPL MATH, V37, P1330, DOI 10.1007/s40314-016-0400-2; Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832; RODRIGUES FM, 1981, T ROY SOC TROP MED H, V75, P258, DOI 10.1016/0035-9203(81)90330-8; Samuel P, 2000, INDIAN COUNCIL MED R, P4; SASAKI O, 1982, ANTIVIR RES, V2, P355, DOI 10.1016/0166-3542(82)90005-5; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; SOMAN RS, 1977, INDIAN J MED RES, V66, P709; TAPASWI PK, 1995, ECOL MODEL, V83, P295, DOI 10.1016/0304-3800(94)00102-X; Tarantola A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002533; Tian HY, 2015, ENVIRON INT, V79, P17, DOI 10.1016/j.envint.2015.03.002; Touch S, 2009, TROP MED INT HEALTH, V14, P1365, DOI 10.1111/j.1365-3156.2009.02380.x; Turner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053128; UNDESA, 2018, STESASERA420 UNDESA, DOI [10.4054/demres.2005.12.9, DOI 10.4054/DEMRES.2005.12.9]; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087	59	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2018	13	8							e0201209	10.1371/journal.pone.0201209	http://dx.doi.org/10.1371/journal.pone.0201209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ6RF	30114197	Green Submitted, Green Published, gold			2022-12-26	WOS:000441850400011
J	Rodriguez-Fernandez, A; Sanchez-Sanchez, J; Ramirez-Campillo, R; Rodriguez-Marroyo, JA; Vicente, JGV; Nakamura, FY				Rodriguez-Fernandez, Alejandro; Sanchez-Sanchez, Javier; Ramirez-Campillo, Rodrigo; Antonio Rodriguez-Marroyo, Jose; Villa Vicente, Jose Gerardo; Yuzo Nakamura, Fabio			Effects of short-term in-season break detraining on repeated-sprint ability and intermittent endurance according to initial performance of soccer player	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; PROFESSIONAL SOCCER; MATCH PERFORMANCE; TRAINING LOADS; RECOVERY TEST; FOOTBALL; VALIDITY; FATIGUE; RELIABILITY; RESPONSES	To better understand the detraining effects in soccer, the purpose of the study was to analyse if performance level of soccer players modulate repeated-sprint ability (RSA) and intermittent endurance changes during 2-weeks of detraining (i.e., in-season break). Seventeen professional and sixteen young elite soccer players of two different teams performed, before and after 2-weeks of detraining, the RSA test and the Yo-Yo Intermittent Recovery Test, level 1 (YYIR1). Before detraining, professional players perform better (p < 0.05) RSA best time (RSA(best)) than young players. A decrease (p < 0.05) in RSA(best), RSA total time (RSA(total)) and mean time (RSA(mean)) performance was observed in both teams, without changes in RSA fatigue index (Sdec). No significant changes in distance covered during YYIR1 was observed in any team. Before detraining, faster players from both teams (FG) (following the median split technique, soccer players with RSA(best) <= 3.95 s) performed better (p < 0.01) in RSA(total), RSA(mean) and RSA(best), but worse (p < 0.01) in Sdec. Although FG and the slower players (SG, RSA(best) > 3.95 s) showed a worse (p < 0.05) RSA(total), RSA(best) and RSA(mean) performance after detraining (ES = 1.5, 1.4 and 2.9; ES = 0.6, 1.2 and 0.6; for FG and SG, respectively), the deterioration was greater in the FG for RSA(best) (p < 0.05) and RSA(total) (ES = 1.46). After detraining, FG improved (p <0.05) Sdec performance. In conclusion, a 2-week in-season break (detraining) period induced a worse RSA, with no effect on intermittent endurance in professional and elite young soccer players, with greater detrimental effects on RSA(total) and RSA(best) in FG. In addition, Sdec does not seem to be sensitive to changes in RSA after a 2-week in-season break.	[Rodriguez-Fernandez, Alejandro; Sanchez-Sanchez, Javier; Antonio Rodriguez-Marroyo, Jose; Villa Vicente, Jose Gerardo] Univ Leon, Inst Biomed IBIOMED, Dept Phys Educ & Sports, Leon, Spain; [Rodriguez-Fernandez, Alejandro] Univ Isabel I, Fac Phys Act Sci & Sports, Burgos, Spain; [Rodriguez-Fernandez, Alejandro; Sanchez-Sanchez, Javier; Ramirez-Campillo, Rodrigo; Villa Vicente, Jose Gerardo; Yuzo Nakamura, Fabio] Pontifical Univ Salamanca, Fac Educ, Unit Assessment & Planning Sports Training, Salamanca, Spain; [Ramirez-Campillo, Rodrigo] Univ Los Lagos, Dept Phys Act Sci, Osorno, Chile; [Yuzo Nakamura, Fabio] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy; [Yuzo Nakamura, Fabio] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia	Universidad de Leon; Pontifical University of Salamanca; Universidad de Los Lagos; G d'Annunzio University of Chieti-Pescara; James Cook University	Nakamura, FY (corresponding author), Pontifical Univ Salamanca, Fac Educ, Unit Assessment & Planning Sports Training, Salamanca, Spain.; Nakamura, FY (corresponding author), G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy.; Nakamura, FY (corresponding author), James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia.	fabioy_nakamura@yahoo.com.br	Vicente, Jose Gerardo Villa/C-1123-2011; Ramirez-Campillo, Rodrigo/M-1258-2016; Rodríguez-Marroyo, Jose A./AAA-5609-2019; Rodríguez-Fernández, Alejandro/AAL-1749-2020; Nakamura, Fábio Yuzo/AAC-3069-2020; Sanchez-Sanchez, Javier/N-1712-2016	Vicente, Jose Gerardo Villa/0000-0002-6640-4521; Ramirez-Campillo, Rodrigo/0000-0003-2035-3279; Rodríguez-Marroyo, Jose A./0000-0002-9157-1532; Rodríguez-Fernández, Alejandro/0000-0002-0893-7573; Nakamura, Fábio Yuzo/0000-0002-5336-3652; Sanchez-Sanchez, Javier/0000-0003-4585-247X				BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bangsbo Jens, 1994, Journal of Sports Sciences, V12, pS5; Bradley PS, 2013, HUM MOVEMENT SCI, V32, P808, DOI 10.1016/j.humov.2013.06.002; Buchheit M, 2012, INT J SPORTS MED, V33, P230, DOI 10.1055/s-0031-1291364; Buchheit M, 2015, INT J SPORT PHYSIOL, V10, P120, DOI 10.1123/ijspp.2014-0082; Buchheit M, 2012, SPORTS MED, V42, P165, DOI 10.2165/11598220-000000000-00000; Buchheit M, 2010, J STRENGTH COND RES, V24, P2715, DOI 10.1519/JSC.0b013e3181bf0223; Campos-Vazquez MA, 2015, J STRENGTH COND RES, V29, P744, DOI 10.1519/JSC.0000000000000700; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2663, DOI [10.1519/JSC.0b013e3181e347f4, 10.1519/JSC.0b013e3181d65071]; Christensen PM, 2011, MED SCI SPORT EXER, V43, P1716, DOI 10.1249/MSS.0b013e318211c01a; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2008, INTJ SPORT PHYSIOL, V3, P107, DOI 10.1123/ijspp.3.1.107; Glaister M, 2008, J STRENGTH COND RES, V22, P1597, DOI 10.1519/JSC.0b013e318181ab80; GREENHAFF PL, 1994, J PHYSIOL-LONDON, V478, P149, DOI 10.1113/jphysiol.1994.sp020238; Iaia FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171462; Iaia FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138096; Iaia FM, 2009, INTJ SPORT PHYSIOL, V4, P291, DOI 10.1123/ijspp.4.3.291; Impellizzeri FM, 2008, INT J SPORTS MED, V29, P899, DOI 10.1055/s-2008-1038491; Joo CH, 2016, J EXERC REHABIL, V12, P54, DOI 10.12965/jer.160280; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; KUZON WM, 1990, INT J SPORTS MED, V11, P99, DOI 10.1055/s-2007-1024770; Melchiorri G, 2014, J SPORT MED PHYS FIT, V54, P27; Mendez-Villanueva A, 2007, MED SCI SPORT EXER, V39, P2219, DOI 10.1249/mss.0b013e31815669dc; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Mujika I, 2001, MED SCI SPORT EXER, V33, P1297, DOI 10.1097/00005768-200108000-00009; Mujika I, 2009, J SPORT SCI, V27, P1581, DOI 10.1080/02640410903350281; Nakamura D, 2012, J STRENGTH COND RES, V26, P3392, DOI 10.1519/JSC.0b013e3182474356; Nakamura FY, 2016, J STRENGTH COND RES, V30, P1553, DOI 10.1519/JSC.0000000000001257; Oliver JL, 2009, J SCI MED SPORT, V12, P238, DOI 10.1016/j.jsams.2007.09.006; Owen AL, 2012, J STRENGTH COND RES, V26, P2748, DOI 10.1519/JSC.0b013e318242d2d1; Rampinini E, 2007, INT J SPORTS MED, V28, P228, DOI 10.1055/s-2006-924340; Ratel S, 2006, INT J SPORTS MED, V27, P1, DOI 10.1055/s-2005-837501; Reilly T, 2003, J SPORT SCI, V21, P693, DOI 10.1080/0264041031000102105; Rodriguez-Fernandez A, 2017, J SPORT MED PHYS FIT, V57, P529, DOI 10.23736/S0022-4707.16.06263-0; Thomassen M, 2010, J APPL PHYSIOL, V108, P898, DOI 10.1152/japplphysiol.01015.2009	39	23	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0201111	10.1371/journal.pone.0201111	http://dx.doi.org/10.1371/journal.pone.0201111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110374	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000441738000014
J	Sheweita, SA; Almasmari, AA; El-Banna, SG				Sheweita, Salah A.; Almasmari, Ainour A.; El-Banna, Sabah G.			Tramadol-induced hepato- and nephrotoxicity in rats: Role of Curcumin and Gallic acid as antioxidants	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; OXIDATIVE STRESS; NITRIC-OXIDE; DNA-ADDUCTS; PHASE-I; LIVER; PHARMACOLOGY; EXTRACTS; CANCER; MICE	Tramadol is an analgesic used to treat moderate to severe pain caused by cancer, osteoarthritis, and other musculoskeletal diseases. Cytochrome P450 system metabolizes tramadol and induces oxidative stress in different organs. Therefore, the present study aims at investigating the changes in the activities and the protein expressions of CYPs isozymes (2E1, 3A4, 2B1/2), antioxidants status, free radicals levels after pretreatment of rats with Curcumin and/or Gallic as single- and/or repeated-doses before administration of tramadol. In repeated-dose treatments of rats with tramadol, the activities of cytochrome P450, cytochrome b(5), and NADPH-cytochrome-c-reductase, and the antioxidant enzymes including glutathione reductase, glutathione peroxidase, glutathione S-transferase, catalase, super-oxide dismutase, and levels of glutathione were inhibited in the liver and the kidney of rats. Interestingly, such changes caused by tramadol restored to their normal levels after pretreatment of rats with either Curcumin and/or Gallic acid. On the other hand, repeated-dose treatment of rats with tramadol increased the activities of both dimethylnitrosamine N-demethylase I (DMN-dl), and aryl hydrocarbon hydroxylase (AHH) compared to the control group. However, pretreatment of rats with Curcumin and/or Gallic acid prior to administration of tramadol restored the inhibited DMN-dl activity and its protein expression (CYP 2E1) to their normal levels. On the other hand, tramadol inhibited the activity of ethoxycoumarin O-deethylase (ECOD) and suppressed its protein marker expression (CYP2B1/2), whereas Curcumin, Gallic acid and/or their mixture restored such changes to their normal levels. In conclusion, Curcumin and/or Gallic acid alleviated the adverse effects caused by tramadol. In addition, patients should be advice to take Curcumin and/or Gallic acid prior to tramadol treatment to alleviate the hepatic and renal toxicities caused by tramadol.	[Sheweita, Salah A.; Almasmari, Ainour A.] Alexandria Univ, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt; [El-Banna, Sabah G.] Alexandria Univ, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Sheweita, SA (corresponding author), Alexandria Univ, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt.	ssheweita@yahoo.com	Sheweita, Salah A/AFU-1622-2022	Sheweita, Salah A/0000-0001-8113-4403				Abdel-Zaher AO, 2011, NEUROTOXICOLOGY, V32, P725, DOI 10.1016/j.neuro.2011.08.001; Ahmed MA, 2014, CLIN EXP PHARMACOL P, V41, P317, DOI 10.1111/1440-1681.12213; Ahmed-Farid OAH, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0373-5; ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1989, J CLIN CHEM, V1, P130; Arafa MH, 2018, TOXICOL APPL PHARM, V346, P37, DOI 10.1016/j.taap.2018.03.019; Argolo ACC, 2004, BIORESOURCE TECHNOL, V95, P229, DOI 10.1016/j.biortech.2003.12.014; ASSMANN G, 1984, CLIN CHIM ACTA, V140, P77, DOI 10.1016/0009-8981(84)90153-0; Balbaa M, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0293-7; Batton C. J., 1977, ANAL CHEM, V49, P464, DOI [10.1021/ac50011a034, DOI 10.1021/AC50011A034]; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bouterfas K., 2016, Annales Pharmaceutiques Francaises, V74, P453, DOI 10.1016/j.pharma.2016.07.002; BOWERS LD, 1980, CLIN CHEM, V26, P555; Buja LM, 2010, CARDIOVASC PATHOL, V19, P29, DOI 10.1016/j.carpath.2008.10.001; Ceconi C, 2003, ARCH BIOCHEM BIOPHYS, V420, P217, DOI 10.1016/j.abb.2003.06.002; Cerny D, 2011, FITOTERAPIA, V82, P786, DOI 10.1016/j.fitote.2011.04.003; CHIU DTY, 1976, BIOCHIM BIOPHYS ACTA, V445, P558, DOI 10.1016/0005-2744(76)90110-8; Cho YA, 2012, PHARMAZIE, V67, P124, DOI 10.1691/ph.2012.1099; Choi H, 2008, CANCER SCI, V99, P2518, DOI 10.1111/j.1349-7006.2008.00984.x; Ciolino HP, 1998, BIOCHEM PHARMACOL, V56, P197, DOI 10.1016/S0006-2952(98)00143-9; DALVI RR, 1992, TOXICOL LETT, V60, P299, DOI 10.1016/0378-4274(92)90288-U; Dean L., 2012, MEDICAL GENETICS SUM; Drury AR., 1980, CARLETONS HISTOLOGIC, V5; El-Gaafarawi II., 2006, J HOSP MED, V23, P353; El-Hosseiny L S, 2016, Int J Biomed Sci, V12, P71; El-Wessemy A.M., 2008, EGYPT J ZOOL, V50, P423; Elyajzi N.R., 2013, IUG J NAT ENG STUD, V21, P51; Firozi PF, 1996, CHEM-BIOL INTERACT, V100, P41, DOI 10.1016/0009-2797(95)03684-9; Garg R, 2008, CARCINOGENESIS, V29, P1022, DOI 10.1093/carcin/bgn064; Gillman PK, 2005, BRIT J ANAESTH, V95, P434, DOI 10.1093/bja/aei210; GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596; Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004; Haorah J, 2001, J AGR FOOD CHEM, V49, P6068, DOI 10.1021/jf010602h; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Kim SB, 2015, PHARMACOGN MAG, V11, pS580, DOI 10.4103/0973-1296.172965; Kini AS, 2004, AM J CARDIOL, V93, P18, DOI 10.1016/j.amjcard.2003.09.006; LEE CY, 1981, J BIOL CHEM, V256, P8110; Loughrey MB, 2003, FORENSIC SCI INT, V134, P232, DOI 10.1016/S0379-0738(03)00132-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mansouri MT, 2013, PHARMACOL BIOCHEM BE, V111, P90, DOI 10.1016/j.pbb.2013.09.002; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Miotto K, 2017, ANESTH ANALG, V124, P44, DOI 10.1213/ANE.0000000000001683; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mitacek EJ, 1999, CARCINOGENESIS, V20, P133, DOI 10.1093/carcin/20.1.133; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MORSE MA, 1993, CANCER LETT, V72, P103, DOI 10.1016/0304-3835(93)90018-5; Nabavi SF, 2013, IND CROP PROD, V44, P50, DOI 10.1016/j.indcrop.2012.10.024; Naksuriya O, 2015, DRUG DISCOV THER, V9, P136, DOI 10.5582/ddt.2015.01013; Nishinaka T, 2007, TOXICOL LETT, V170, P238, DOI 10.1016/j.toxlet.2007.03.011; OMURA T, 1964, J BIOL CHEM, V239, P2370; Park J, 2010, WORLD J GASTRO ONCOL, V2, P169, DOI 10.4251/wjgo.v2.i4.169; Penttila I, 2000, CLIN CHEM LAB MED, V38, P187, DOI 10.1515/CCLM.2000.027; Raffa RB, 2008, J CLIN PHARM THER, V33, P101, DOI 10.1111/j.1365-2710.2008.00897.x; Rafieian-Kopaei M, 2013, J RENAL INJ PREV, V2, P63, DOI 10.12861/jrip.2013.21; Rajalakshmi D., 1996, V71, P65; REDDY ACP, 1994, FOOD CHEM TOXICOL, V32, P279, DOI 10.1016/0278-6915(94)90201-1; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Saygin M, 2016, ENVIRON TOXICOL, V31, P1771, DOI 10.1002/tox.22179; Sheweita SA, 2017, ENVIRON TOXICOL, V32, P2212, DOI 10.1002/tox.22436; Sheweita S A, 2011, Int J Biomed Sci, V7, P238; Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117; Sheweita SA, 2003, CURR DRUG METAB, V4, P45, DOI 10.2174/1389200033336919; Sheweita SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165667; SUOJANEN JN, 1980, BIOCHIM BIOPHYS ACTA, V630, P485, DOI 10.1016/0304-4165(80)90003-3; SZASZ G, 1974, Z KLIN CHEM KLIN BIO, V12, P228; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P333, DOI 10.1016/0003-9861(59)90259-0; Thapliyal R, 2002, CANCER LETT, V175, P79, DOI 10.1016/S0304-3835(01)00675-9; VENKATESAN N, 1968, LIFE SCI PT 1 PHYSI, V7, P1111, DOI 10.1016/0024-3205(68)90217-8; Watson WA, 2004, AM J EMERG MED, V22, P335, DOI 10.1016/j.ajem.2004.06.001; WIEBEL FJ, 1975, BIOCHEM PHARMACOL, V24, P1511, DOI 10.1016/0006-2952(75)90028-3; Wright JS, 2002, J MOL STRUC-THEOCHEM, V591, P207, DOI 10.1016/S0166-1280(02)00242-7; Yan XF, 2013, PHYTOTHER RES, V27, P1597, DOI 10.1002/ptr.4899; YANG CS, 1990, DRUG METAB REV, V22, P147, DOI 10.3109/03602539009041082; Yilmaz MZ, 2015, TURK J MED SCI, V45, P438, DOI 10.3906/sag-1401-168; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005; Zhang HY, 2002, BIOORG MED CHEM LETT, V12, P225, DOI 10.1016/S0960-894X(01)00724-7	76	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2018	13	8							e0202110	10.1371/journal.pone.0202110	http://dx.doi.org/10.1371/journal.pone.0202110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ5PD	30110401	Green Submitted, gold, Green Published			2022-12-26	WOS:000441738000050
J	Manzoor, MAP; Singh, B; Agrawal, AK; Arun, AB; Mujeeburahiman, M; Rekha, PD				Manzoor, Muhammed A. P.; Singh, Balwant; Agrawal, Ashish K.; Arun, Ananthapadmanabha Bhagwath; Mujeeburahiman, M.; Rekha, Punchappady-Devasya			Morphological and micro-tomographic study on evolution of struvite in synthetic urine infected with bacteria and investigation of its pathological biomineralization	PLOS ONE			English	Article							GROWTH-INHIBITION; PROTEUS-MIRABILIS; ARTIFICIAL URINE; CRYSTALLIZATION; STONES; CRYSTALS	Pathological biomineralization in the urinary system leads to urolithiasis. Formation of kidney stones involves a series of events during which they undergo morphological and mineralogical changes. We investigated the mineralization of biogenic struvite (in vitro) and examined the transformation of distinct interior and exterior structure of struvite. In vitro crystallization of struvite was performed in the presence of two bacteria that were originally isolated from the kidney stone patients. Morphological evaluation was carried out using SR-mu CT as well as FESEM, XRD and FT-IR. Characteristic internal 3-D morphology and porosity of the stones were studied. For comparison, patient derived struvite stones were used. From the results obtained, we report that the presence of bacteria enhances the crystallization process of struvite in vitro. A series of time-resolved experiments revealed that struvite crystals experienced a significant morphologic evolution from pin pointed structure to X-shaped and tabular morphologies. These X-shaped and unusual tabular habits of struvite resembled biogenic morphologies of struvite. SR-mu CT showed similarities between the patient derived and the in vitro derived struvite crystals. In conclusion, these experiments revealed that the bacteria play a major role in the specific morphogenesis of struvite and can able to control the nucleation, modulate crystalline phases, and shape of the growing crystal.	[Manzoor, Muhammed A. P.; Arun, Ananthapadmanabha Bhagwath; Rekha, Punchappady-Devasya] Yenepoya Deemed Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India; [Manzoor, Muhammed A. P.; Mujeeburahiman, M.] Yenepoya Deemed Univ, Yenepoya Med Coll, Dept Urol, Mangalore, Karnataka, India; [Singh, Balwant; Agrawal, Ashish K.] Bhabha Atom Res Ctr, Tech Phys Div, Indore, Madhya Pradesh, India	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University); Bhabha Atomic Research Center (BARC)	Rekha, PD (corresponding author), Yenepoya Deemed Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India.; Mujeeburahiman, M (corresponding author), Yenepoya Deemed Univ, Yenepoya Med Coll, Dept Urol, Mangalore, Karnataka, India.	mujeeburahiman@gmail.com; rekhapd@hotmail.com	Bhagwath, Arun Ananthapadmanabha/X-7604-2019	Bhagwath, Arun Ananthapadmanabha/0000-0003-3140-9266; Rekha, PD/0000-0002-9187-6395; Agrawal, Ashish/0000-0002-8503-751X	Yenepoya	Yenepoya	The author MAP acknowledges Yenepoya (Deemed to be University) for Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The author MAP acknowledges Yenepoya ( Deemed to be University) for Research Fellowship. The authors are thankful to Raja Ramanna Centre for advanced technology for providing an opportunity to carry out experiments at their facility and their active support during data acquisition and analysis.	Agrawal AK, 2015, J SYNCHROTRON RADIAT, V22, P1531, DOI 10.1107/S1600577515016276; Bazin D, 2012, UROLOGY, V79, P786, DOI 10.1016/j.urology.2011.08.054; Bichler KH, 2002, INT J ANTIMICROB AG, V19, P488, DOI 10.1016/S0924-8579(02)00088-2; Carpentier X, 2009, UROLOGY, V73, P968, DOI 10.1016/j.urology.2008.12.049; Chauhan CK, 2008, UROL RES, V36, P265, DOI 10.1007/s00240-008-0154-4; Chauhan CK, 2013, J CRYST GROWTH, V362, P330, DOI 10.1016/j.jcrysgro.2011.11.008; Chen L, 2009, CRYST GROWTH DES, V9, P743, DOI 10.1021/cg800224s; CLAPHAM L, 1990, J CRYST GROWTH, V104, P475, DOI 10.1016/0022-0248(90)90150-J; Cohen TD, 1996, SEMIN NEPHROL, V16, P425; Flannigan R, 2014, NAT REV UROL, V11, P333, DOI 10.1038/nrurol.2014.99; GRIFFITH DP, 1982, KIDNEY INT, V21, P422, DOI 10.1038/ki.1982.40; GRIFFITH DP, 1976, INVEST UROL, V13, P346; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Iqbal MW, 2016, J ENDOUROL, V30, DOI 10.1089/end.2013.0257; Kaiser J, 2011, UROL RES, V39, P259, DOI 10.1007/s00240-010-0343-9; Kofina AN, 2005, CRYST GROWTH DES, V5, P489, DOI 10.1021/cg049803e; Lange Dirk, 2015, ROLE BACTERIA UROLOG; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep07718; Limaye A, 2012, PROC SPIE, V8506, DOI 10.1117/12.935640; Manzoor MA, 2017, TSQA MED INT, V4, P26, DOI DOI 10.4103/ami.ami_24_17; Manzoor MAP, 2018, INT BRAZ J UROL, V44, P1234, DOI [10.1590/S1677-5538.IBJU.2017.0656, 10.1590/s1677-5538.ibju.2017.0656]; Manzoor Muhammed A P, 2019, Urolithiasis, V47, P137, DOI 10.1007/s00240-018-1052-z; Prywer J, 2010, CRYST RES TECHNOL, V45, P1283, DOI 10.1002/crat.201000344; Prywer J, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/862794; Prywer J, 2012, UROL RES, V40, P699, DOI 10.1007/s00240-012-0501-3; Prywer J, 2009, CRYST GROWTH DES, V9, P3538, DOI 10.1021/cg900281g; Torzewska A, 2003, J MED MICROBIOL, V52, P471, DOI 10.1099/jmm.0.05161-0; Yao QZ, 2012, EUR J MINERAL, V24, P519, DOI 10.1127/0935-1221/2012/0024-2186; Zhu H, 2012, BJU INT, V110	29	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202306	10.1371/journal.pone.0202306	http://dx.doi.org/10.1371/journal.pone.0202306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106992	Green Published, gold, Green Submitted			2022-12-26	WOS:000441662800038
J	McDonald, M; Trost, B; Napper, S				McDonald, Megan; Trost, Brett; Napper, Scott			Conservation of kinase-phosphorylation site pairings: Evidence for an evolutionarily dynamic phosphoproteome	PLOS ONE			English	Article							SLEEP PHASE SYNDROME; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN; PHOSPHOSITEPLUS; HOMOLOGY; GENOME	Kinase-mediated protein phosphorylation is a central mechanism for regulation of cellular responses and phenotypes. While considerable information is available regarding the evolutionary relationships within the kinase family, as well as the evolutionary conservation of phosphorylation sites, each aspect of this partnership is typically considered in isolation, despite their clear functional relationship. Here, to offer a more holistic perspective on the evolution of protein phosphorylation, the conservation of protein phosphorylation sites is considered in the context of the conservation of the corresponding modifying kinases. Specifically, conservation of defined kinase-phosphorylation site pairings (KPSPs), as well as of each of the component parts (the kinase and the phosphorylation site), were examined across a range of species. As expected, greater evolutionary distance between species was generally associated with lower probability of KPSP conservation, and only a small fraction of KPSPs were maintained across all species, with the vast majority of KPSP losses due to the absence of the phosphorylation site. This supports a model in which a relatively stable kinome promotes the emergence of functional substrates from an evolutionarily malleable phosphoproteome.	[McDonald, Megan; Trost, Brett; Napper, Scott] Univ Saskatchewan, Vaccine & Infect Dis Org, Int Vaccine Res Ctr, Saskatoon, SK, Canada; [McDonald, Megan; Napper, Scott] Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada; [Trost, Brett] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Napper, S (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Int Vaccine Res Ctr, Saskatoon, SK, Canada.; Napper, S (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada.	scott.napper@usask.ca	Trost, Brett/K-4127-2016	Trost, Brett/0000-0003-4863-7273; Napper, Scott/0000-0003-1948-4538	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Freschi L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004062; Gentile S, 2008, P NATL ACAD SCI USA, V105, P14704, DOI 10.1073/pnas.0802250105; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gray VE, 2011, MOL BIOL EVOL, V28, P1565, DOI 10.1093/molbev/msr013; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Kaduk M, 2017, NUCLEIC ACIDS RES, V45, pD687, DOI 10.1093/nar/gkw923; Landry CR, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00245; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Levy ED, 2012, PHILOS T R SOC B, V367, P2594, DOI 10.1098/rstb.2012.0078; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Moses AM, 2010, TRENDS GENET, V26, P462, DOI 10.1016/j.tig.2010.08.002; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Schreiber F, 2013, J MOL BIOL, V425, P2072, DOI 10.1016/j.jmb.2013.02.018; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Trost B, 2015, BRIEF BIOINFORM, V16, P820, DOI 10.1093/bib/bbu040; Trost B, 2013, BIOINFORMATICS, V29, P1693, DOI 10.1093/bioinformatics/btt265; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2018	13	8							e0202036	10.1371/journal.pone.0202036	http://dx.doi.org/10.1371/journal.pone.0202036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ4SC	30106995	Green Published, Green Submitted, gold			2022-12-26	WOS:000441662800025
J	Lamarche, C; Da Silva, C; Demol, G; Dague, E; Rols, MP; Pillet, F				Lamarche, Camille; Da Silva, Charlotte; Demol, Gauthier; Dague, Etienne; Rols, Marie-Pierre; Pillet, Flavien			Electrical discharges in water induce spores' DNA damage	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPORES; HYDROGEN-PEROXIDE; DISINFECTION; INACTIVATION; RESISTANCE; RADIATION; PROTEINS; BINDING; DIMERS	Bacterial spores are one of the most resilient life forms on earth and are involved in many human diseases, such as infectious diarrhea, fatal paralytic illnesses and respiratory infections. Here, we investigated the mechanisms involved in the death of Bacillus pumilus spores after exposure to electric arcs in water. Cutting-edge microscopies at the nanoscale did not reveal any structural disorganization of spores exposed to electric arcs. This result suggested the absence of physical destruction by a propagating shock wave or an exposure to an electric field. However, Pulsed-Field Gel Electrophoresis (PFGE) revealed genomic DNA damage induced by UV radiation and Reactive Oxygen Species (ROS). UV induced single-strand DNA breaks and thymine dimers while ROS were mainly involved in base excision. Our findings revealed a correlation between DNA damage and the treatment of spores with electrical discharges.	[Lamarche, Camille; Demol, Gauthier] ITHPP Alcen, Hameau de Drele, Thegra, France; [Lamarche, Camille; Da Silva, Charlotte; Rols, Marie-Pierre; Pillet, Flavien] Univ Toulouse, CNRS, UPS, IPBS, Toulouse, France; [Dague, Etienne] Univ Toulouse, CNRS, LAAS, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Rols, MP; Pillet, F (corresponding author), Univ Toulouse, CNRS, UPS, IPBS, Toulouse, France.	rols@ipbs.fr; pillet@ipbs.fr	ROLS, Marie-Pierre/GLV-6546-2022; Dague, Etienne/C-6454-2008; rols, marie-pierre/AAU-8093-2021	Dague, Etienne/0000-0003-3290-9166; rols, marie-pierre/0000-0003-3100-6272				Bjorn L. O., 2007, PHOTOBIOLOGY SCI LIF; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Ching WK, 2001, ENVIRON SCI TECHNOL, V35, P4139, DOI 10.1021/es010643u; Chopinet L, 2013, MICRON, V48, P26, DOI 10.1016/j.micron.2013.02.003; Cleghorn DA, 2002, J APPL MICROBIOL, V93, P937, DOI 10.1046/j.1365-2672.2002.01777.x; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dors M., 2008, INT J PLASMA ENV SCI, V2, P34, DOI [DOI 10.34343/IJPEST.2008.02.01.034, 10.34343/ijpest.2008.02.01.034]; Douki T, 2005, PHOTOCHEM PHOTOBIOL, V81, P163, DOI 10.1562/2004-08-18-RA-278.1; Driks A, 2000, MORPHOGENESIS PROPER, P191, DOI 10.1128/9781555818166.ch9; EDEBO L, 1969, APPL MICROBIOL, V17, P48, DOI 10.1128/AEM.17.1.48-53.1969; ENTICKNAP JB, 1968, BRIT J IND MED, V25, P72; Erickson MC, 2003, J FOOD PROTECT, V66, P691, DOI 10.4315/0362-028X-66.4.691; Formosa C, 2012, NANOMED-NANOTECHNOL, V8, P12, DOI 10.1016/j.nano.2011.09.009; GEIGL EM, 1991, CURR GENET, V20, P33, DOI 10.1007/BF00312762; Graham R, 1922, AM J PUBLIC HEALTH, V12, P659, DOI 10.2105/AJPH.12.8.659-a; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; Jeong J, 2006, ENVIRON SCI TECHNOL, V40, P6117, DOI 10.1021/es0604313; Leighs JA, 2014, J PHYS CONF SER, V500, DOI 10.1088/1742-6596/500/18/182026; Loffler F., 1887, ZENTRALANTIQUARIAT D; LUNDBECK H, 1963, BIOTECHNOL BIOENG, V5, P167, DOI 10.1002/bit.260050302; Ma WJ, 2009, MOL CELL BIOL, V29, P1212, DOI 10.1128/MCB.01499-08; Marjanovic I, 2013, BIOELECTROCHEMISTRY, V94, P79, DOI 10.1016/j.bioelechem.2013.09.001; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Melly E, 2002, J APPL MICROBIOL, V93, P316, DOI 10.1046/j.1365-2672.2002.01687.x; Otlewska A, 2013, ELECTROPHORESIS, V34, P3023, DOI 10.1002/elps.201300246; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Pillet F, 2016, SCI REP-UK, V6, DOI 10.1038/srep19778; Pillet F, 2014, BBA-GEN SUBJECTS, V1840, P1028, DOI 10.1016/j.bbagen.2013.11.019; Plomp M, 2005, LANGMUIR, V21, P10710, DOI 10.1021/la0517437; Roth CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15063; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SETLOW B, 1993, APPL ENVIRON MICROB, V59, P3418, DOI 10.1128/AEM.59.10.3418-3423.1993; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; SETLOW P, 1992, MOL MICROBIOL, V6, P563, DOI 10.1111/j.1365-2958.1992.tb01501.x; Slieman TA, 2000, APPL ENVIRON MICROB, V66, P199, DOI 10.1128/AEM.66.1.199-205.2000; Stringer SC, 2011, FOOD MICROBIOL, V28, P228, DOI 10.1016/j.fm.2010.03.003; Troxell B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084625; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Winward GP, 2008, WATER RES, V42, P483, DOI 10.1016/j.watres.2007.07.042; 1995, US PHARMACOPEIA, P1976	41	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201448	10.1371/journal.pone.0201448	http://dx.doi.org/10.1371/journal.pone.0201448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102709	Green Published, gold, Green Submitted			2022-12-26	WOS:000441452200010
J	Lewis, SA; Takimoto, T; Mehrvar, S; Higuchi, H; Doebley, AL; Stokes, G; Sheibani, N; Ikeda, S; Ranji, M; Ikeda, A				Lewis, Sarah Aileen; Takimoto, Tetsuya; Mehrvar, Shima; Higuchi, Hitoshi; Doebley, Anna-Lisa; Stokes, Giangela; Sheibani, Nader; Ikeda, Sakae; Ranji, Mahsa; Ikeda, Akihiro			The effect of Tmem135 overexpression on the mouse heart	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LARGE GENE LISTS; MITOCHONDRIAL FISSION; EXPRESSION; REPERFUSION; DYSFUNCTION; ISCHEMIA; DYNAMICS; INSULIN; FUSION	Tissues with high-energy demand including the heart are rich in the energy-producing organelles, mitochondria, and sensitive to mitochondrial dysfunction. While alterations in mitochondrial function are increasingly recognized in cardiovascular diseases, the molecular mechanisms through which changes in mitochondria lead to heart abnormalities have not been fully elucidated. Here, we report that transgenic mice overexpressing a novel regulator of mitochondrial dynamics, transmembrane protein 135 (Tmem135), exhibit increased fragmentation of mitochondria and disease phenotypes in the heart including collagen accumulation and hypertrophy. The gene expression analysis showed that genes associated with ER stress and unfolded protein response, and especially the pathway involving activating transcription factor 4, are upregulated in the heart of Tmem135transgenic mice. It also showed that gene expression changes in the heart of Tmem135transgenic mice significantly overlap with those of aged mice in addition to the similarity in cardiac phenotypes, suggesting that changes in mitochondrial dynamics may be involved in the development of heart abnormalities associated with aging. Our study revealed the pathological consequence of overexpression of Tmem135, and suggested downstream molecular changes that may underlie those disease pathologies.	[Lewis, Sarah Aileen; Takimoto, Tetsuya; Higuchi, Hitoshi; Doebley, Anna-Lisa; Stokes, Giangela; Ikeda, Sakae; Ikeda, Akihiro] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Takimoto, Tetsuya] Ajinomoto Co Inc, Inst Innovat, Tokyo, Japan; [Mehrvar, Shima; Ranji, Mahsa] Univ Wisconsin, Biophoton Lab, Dept Elect Engn, Milwaukee, WI 53201 USA; [Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Biomed Engn & Cell & Regenerat Biol, Madison, WI USA; [Sheibani, Nader; Ikeda, Sakae; Ikeda, Akihiro] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA; [Higuchi, Hitoshi] Okayama Univ Hosp, Dept Dent Anesthesiol, Okayama, Japan; [Doebley, Anna-Lisa] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; Ajinomoto Co Inc; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Okayama University; University of Washington; University of Washington Seattle	Ikeda, A (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.; Ikeda, A (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA.	aikeda@wisc.edu	Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217; Ikeda, Akihiro/0000-0001-8440-3891; Doebley, Anna-Lisa/0000-0002-3371-3352; Lewis, Sarah/0000-0002-5568-955X	National Institutes of Health (NIH) [R01 EY022086]; Ajinomoto Co., Inc.; Retina Research Foundation (Walter H. Helmerich Research Chair); Timothy William Trout Professorship in Eye Research; National Eye Institute Core Grant for Vision Research [P30 EY016665]; National Science Foundation Graduate Research Fellowship [4034030513, 403-4030513]; UWM Research Growth Initiative (RGI) [101x290]; Research to Prevent Blindness; NIH [EY026078]; Retina Research Foundation; Environmental Protection Agency (EPA) [83573701]; Stein RPB Innovation Award; National Institutes of Health [NIH R01 EY022086]; Core Grant for Vision Research [P30 EY016665]; UWM RGI [101x290]; Research to Prevent Blindness [EY026078, EPA 83573701]; NATIONAL EYE INSTITUTE [R01EY022086, P30EY016665, R01EY026078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Co., Inc.; Retina Research Foundation (Walter H. Helmerich Research Chair); Timothy William Trout Professorship in Eye Research; National Eye Institute Core Grant for Vision Research; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); UWM Research Growth Initiative (RGI); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Stein RPB Innovation Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; UWM RGI; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research herein was funded by the National Institutes of Health (NIH) (R01 EY022086; https://www.nih.gov/) to AI, a research agreement with Ajinomoto Co., Inc. (https://www.ajinomoto.com/en/) to AI, a professorship from the Retina Research Foundation (Walter H. Helmerich Research Chair; https://retinaresearchfnd.org/) to AI, the Timothy William Trout Professorship in Eye Research to AI, the National Eye Institute Core Grant for Vision Research (P30 EY016665; https://nei.nih.gov/), a National Science Foundation Graduate Research Fellowship (grant No. 4034030513; https://www.nsfgrfp.org/) to SAL, UWM Research Growth Initiative (RGI) 101x290 to MR (http://uwm.edu/), an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences (https://www.rpbusa.org/), NIH (EY026078; https://www.nih.gov/) to NS, Retina Research Foundation (https://retinaresearchfnd.org/) to NS, Environmental Protection Agency (EPA) (83573701; https://www.epa.gov/) to NS, and Stein RPB Innovation Award to NS (https://www.rpbusa.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, Ajinomoto Co., Inc., provided support in the form of salary for an author [TT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.; The authors thank Satoshi Kinoshita for generation of frozen sections and the University of Wisconsin Medical School Electron Microscopy Facility and Ben August for technical support and use of the facility equipment. This work was supported by a grant from the National Institutes of Health (NIH R01 EY022086), a research agreement with Ajinomoto Co., Inc., a professorship from the Retina Research Foundation (Walter H. Helmerich Research Chair) and Timothy William Trout Professorship in Eye Research to AI, Core Grant for Vision Research (P30 EY016665), the National Science Foundation Graduate Research Fellowship under Grant No. 403-4030513 to SL, and UWM RGI 101x290 to MR. The work in NS laboratory is supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, EY026078, EPA 83573701, and Stein RPB Innovation Award.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Cagalinec M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002511; Chance B, 1979, J BIOL CHEM; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Coughlan MT, 2016, DIABETES, V65, P1085, DOI 10.2337/db15-0864; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Exil VJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014228; FastQC, QUAL CONTR TOOL HIGH; Filippi BM, 2017, CELL REP, V18, P2301, DOI 10.1016/j.celrep.2017.02.035; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Haile Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0788-z; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hoppel CL, 2017, ADV EXP MED BIOL, V982, P451, DOI 10.1007/978-3-319-55330-6_24; Horn MA, 2016, J MOL CELL CARDIOL, V93, P175, DOI 10.1016/j.yjmcc.2015.11.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; la Cour MF, 2017, BIOMED OPT EXPRESS, V8, P4419, DOI 10.1364/BOE.8.004419; la Cour MF, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.1.016011; Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee MS, 2015, ANN NY ACAD SCI, V1350, P61, DOI 10.1111/nyas.12822; Lee WH, 2016, ELIFE, V5, DOI 10.7554/eLife.19264; Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2015, J MOL CELL CARDIOL, V86, P62, DOI 10.1016/j.yjmcc.2015.07.010; Liu ZH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.258; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; Montaigne David, 2015, Card Electrophysiol Clin, V7, P293, DOI 10.1016/j.ccep.2015.03.008; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; NUUTINEN EM, 1984, BASIC RES CARDIOL, V79, P49, DOI 10.1007/BF01935806; PAGE E, 1973, AM J CARDIOL, V31, P172, DOI 10.1016/0002-9149(73)91030-8; Pasternak JJ, 2004, INTRO HUMAN MOL GENE; Ranji M, 2016, IEEE J TRANSL ENG HE, V4, DOI 10.1109/JTEHM.2016.2570219; Rozpedek W., 2016, CURR MOL MED; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Tanjore H, 2013, BBA-MOL BASIS DIS, V1832, P940, DOI 10.1016/j.bbadis.2012.11.011; Tilton SC, 2013, CHEM RES TOXICOL, V26, P1034, DOI 10.1021/tx400078b; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	60	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0201986	10.1371/journal.pone.0201986	http://dx.doi.org/10.1371/journal.pone.0201986			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ2CL	30102730	gold, Green Submitted, Green Published			2022-12-26	WOS:000441452200025
J	Park, SH; Lee, PJ; Jeong, JH				Park, Sang Hee; Lee, Pyoung Jik; Jeong, Jeong Ho			Emotions evoked by exposure to footstep noise in residential buildings	PLOS ONE			English	Article							FLOOR IMPACT NOISE; PHYSIOLOGICAL-RESPONSES; INDIVIDUAL-DIFFERENCES; ANNOYANCE; SENSITIVITY; PERCEPTION; ATTENTION; SYMPATHY; EMPATHY; HEALTH	In the present study, the effect of footstep noise on emotions was investigated. This study used noise stimulus of human footsteps throughout the study. First, Korean emotion lexicons were collected from narratives of residents living in multi-family housing buildings. The lexicons were then classified into four emotion clusters, with three expressing negative emotions (anger, dislike, and pain) and the fourth depicting empathy. Since self-reported annoyance has long been investigated as one of the major non-auditory responses to noise, annoyance was measured along with affective responses in a laboratory experiment with varying noise levels. The findings revealed that the emotion and noise annoyance experienced by the participants were significantly affected by noise levels. All clusters expressing negative emotions showed strong correlations with noise annoyance, whereas that representing empathy showed the weakest correlation. Noise sensitivity and attitudes to the noise source were observed as possible moderators in emotional responses and annoyance ratings.	[Park, Sang Hee; Lee, Pyoung Jik] Univ Liverpool, Sch Architecture, Acoust Res Unit, Liverpool, Merseyside, England; [Jeong, Jeong Ho] Fire Insurers Labs Korea, Fire Safety & Bldg Environm Syst Res Team, Yeoju Si, Gyeonggi Do, South Korea	University of Liverpool	Lee, PJ (corresponding author), Univ Liverpool, Sch Architecture, Acoust Res Unit, Liverpool, Merseyside, England.	P.J.Lee@liverpool.ac.uk	Park, Sang Hee/V-2081-2019	Park, Sang Hee/0000-0002-1476-2378; Lee, Pyoung Jik/0000-0002-0328-9175; Jeong, Jeongho/0000-0002-9935-6140	Residential Environment Research Program - Ministry of Land, Infrastructure and Transport of Korean Government [18RERP-B082204-05]	Residential Environment Research Program - Ministry of Land, Infrastructure and Transport of Korean Government	This research was supported by a grant (18RERP-B082204-05) from Residential Environment Research Program funded by Ministry of Land, Infrastructure and Transport of Korean Government (https://www.kaia.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S.-H., 1993, KOREAN J SOCIAL PERS, V7, P107; Bentley M., 1928, FEELINGS EMOTIONS WI; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; Churchmann, 2002, HDB ENV PSYCHOL, P499; CLORE GL, 1987, J PERS SOC PSYCHOL, V53, P751, DOI 10.1037/0022-3514.53.4.751; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Darwell S, 1998, PHILOS STUD, V89, P261, DOI 10.1023/A:1004289113917; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Ekman P., 1971, UNIVERSALS CULTURAL; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FEHR B, 1984, J EXP PSYCHOL GEN, V113, P464, DOI 10.1037/0096-3445.113.3.464; Gilam G, 2016, NEUROSCI BIOBEHAV R, V68, P590, DOI 10.1016/j.neubiorev.2016.06.027; Gomez P, 2004, INT J PSYCHOPHYSIOL, V53, P91, DOI 10.1016/j.ijpsycho.2004.02.002; Greenwald M. K., 1989, J PSYCHOPHYSIOL, V3, P51; Grimwood CJ., 1993, 2293 BRE; Grossmann I, 2012, J EXP PSYCHOL GEN, V141, P31, DOI 10.1037/a0023817; Guite HF, 2006, PUBLIC HEALTH, V120, P1117, DOI 10.1016/j.puhe.2006.10.005; Guski R, 1999, J SOUND VIB, V223, P513, DOI 10.1006/jsvi.1998.2173; Guski Rainer, 1999, Noise Health, V1, P45; Han D. W., 2000, KOREAN J PSYCHOL, V19, P63; Hari R, 2015, NEURON, V88, P181, DOI 10.1016/j.neuron.2015.09.022; Harmon-Jones E., 2016, HDB EMOTIONS, V4th ed., P774; Hume K, 2013, APPL ACOUST, V74, P275, DOI 10.1016/j.apacoust.2011.10.009; Jeon JY, 2010, J ACOUST SOC AM, V127, P1357, DOI 10.1121/1.3298437; Ju Sohn Sun, 2012, [Science of Emotion & Sensibility, 감성과학], V15, P105; Keen S, 2006, NARRATIVE, V14, P207, DOI 10.1353/nar.2006.0015; Larsen R.J., 1992, EMOTION, P25; Lazarus R.S., 1991, EMOTION ADAPTATION; Lewis M., 1993, RAGE POWER AGGRESSIO, P148; Maschke C, 2007, NOISE CONTROL ENG J, V55, P348, DOI 10.3397/1.2741308; Matsumoto D., 2008, HDB EMOTIONS, V3, P211, DOI DOI 10.1016/J.BRAT.2006.05.004; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; 박인조, 2005, [Korean Journal of Social and Personality Psychology, 한국심리학회지: 사회및성격], V19, P109; Morgan CT, 1979, INTRO PSYCHOL; Namba S., 1991, Journal of the Acoustical Society of Japan (E), V12, P19, DOI 10.1250/ast.12.19; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Ohrstrom E, 2007, J ACOUST SOC AM, V122, P2642, DOI 10.1121/1.2785809; ORTONY A, 1987, COGNITIVE SCI, V11, P341, DOI 10.1207/s15516709cog1103_4; Park SH, 2018, BUILD ENVIRON, V136, P302, DOI 10.1016/j.buildenv.2018.03.061; Park SH, 2017, BUILD ENVIRON, V116, P173, DOI 10.1016/j.buildenv.2017.02.005; Park SH, 2017, APPL ACOUST, V120, P148, DOI 10.1016/j.apacoust.2017.01.012; Park SH, 2016, ACTA ACUST UNITED AC, V102, P902, DOI 10.3813/AAA.919004; Park SH, 2016, J ACOUST SOC AM, V139, P1158, DOI 10.1121/1.4944034; Pedersen E, 2007, OCCUP ENVIRON MED, V64, P480, DOI 10.1136/oem.2006.031039; RAW GJ, 1991, APPL ACOUST, V32, P215, DOI 10.1016/0003-682X(91)90004-X; ROSEMAN IJ, 1991, COGNITION EMOTION, V5, P161, DOI 10.1080/02699939108411034; ROSEMAN IJ, 1990, J PERS SOC PSYCHOL, V59, P899, DOI 10.1037/0022-3514.59.5.899; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Ryu JK, 2011, APPL ACOUST, V72, P336, DOI 10.1016/j.apacoust.2010.12.005; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Schmidt B, 2018, J INDIVID DIFFER, V39, P142, DOI 10.1027/1614-0001/a000258; SCHULTZ TJ, 1978, J ACOUST SOC AM, V64, P377, DOI 10.1121/1.382013; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Stansfeld S, 2000, Rev Environ Health, V15, P43; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; Stokoe E, 2005, DISCOURSE SOC, V16, P647, DOI 10.1177/0957926505054940; Tajadura-Jimenez A, 2010, EMOTION, V10, P416, DOI 10.1037/a0018423; Tajadura-Jimenez A, 2010, EMOTION, V10, P216, DOI 10.1037/a0018422; Turchet L, 2016, APPL ACOUST, V111, P77, DOI 10.1016/j.apacoust.2016.04.007; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WATSON D, 1984, J PERS SOC PSYCHOL, V47, P127, DOI 10.1037/0022-3514.47.1.127; WEINSTEIN ND, 1978, J APPL PSYCHOL, V63, P458, DOI 10.1037/0021-9010.63.4.458; WISPE L, 1986, J PERS SOC PSYCHOL, V50, P314, DOI 10.1037/0022-3514.50.2.314; Zaki J., 2016, HDB EMOTIONS, V4th edn, P871; 박광현, 2015, [InHa Law Review, 법학연구], V18, P297	67	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2018	13	8							e0202058	10.1371/journal.pone.0202058	http://dx.doi.org/10.1371/journal.pone.0202058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GQ2CL	30102721	Green Published, Green Submitted			2022-12-26	WOS:000441452200030
J	Welch, D; Buonanno, M; Shuryak, I; Randers-Pehrson, G; Spotnitz, HM; Brenner, DJ				Welch, David; Buonanno, Manuela; Shuryak, Igor; Randers-Pehrson, Gerhard; Spotnitz, Henry M.; Brenner, David J.			Effect of far ultraviolet light emitted from an optical diffuser on methicillin-resistant Staphylococcus aureus in vitro	PLOS ONE			English	Article							CLINICAL-OUTCOMES; INFECTIONS; RADIATION; IMPACT; EXPOSURE; COSTS; FILM	Drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are a target for new antimicrobial technologies. Far-UVC technology is an emerging disinfection method that directly kills microorganisms using light. In contrast with conventional UV sterilization, far-UVC light has antimicrobial capabilities without apparent harm to mammalian cells. This study examines the application of 224 nm far-UVC light delivered from a laser using an optical diffuser towards the goal of protecting against bacterial invasion around skin penetrating devices. Delivery of far-UVC using a laser and optical fibers enables exposure to unique geometries that would otherwise be shielded when using a lamp. Testing of the bactericidal potential of diffusing the far-UVC laser output over a large area was tested and yielded qualitative area killing results. The killing of MRSA using this method was also examined using an in vitro survival assay. Results followed a classic log-linear disinfection model with a rate constant of k = 0.51 cm(2)/mJ, which corresponds to an inactivation cross section of D-90 = 4.5 mJ/cm(2). This study establishes far-UVC delivered from a laser through an optical diffuser as a viable solution for disinfection of susceptible regions such as around catheters, drivelines, or other skin penetrating medical devices.	[Welch, David; Buonanno, Manuela; Shuryak, Igor; Randers-Pehrson, Gerhard; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Irving Med Ctr, New York, NY 10032 USA; [Spotnitz, Henry M.] Columbia Univ, Dept Surg, Irving Med Ctr, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Welch, D (corresponding author), Columbia Univ, Ctr Radiol Res, Irving Med Ctr, New York, NY 10032 USA.	dw2600@columbia.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	Shostack Foundation; Columbia-Coulter Translational Research Partnership	Shostack Foundation; Columbia-Coulter Translational Research Partnership	This work has been supported the Shostack Foundation and by the Columbia-Coulter Translational Research Partnership 9/1/15 - 8/31/16 "Ultraviolet Laser Sleeve" grant to Drs. Spotnitz and Andreas Hielscher.	BUDOWSKY EI, 1981, ARCH VIROL, V68, P239, DOI 10.1007/BF01314577; Buonanno M, 2017, RADIAT RES, V187, P483, DOI 10.1667/RR0010CC.1; Buonanno M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138418; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; Crnich CJ, 2012, INFECT DIS CLIN N AM, V26, P143, DOI 10.1016/j.idc.2011.09.007; Drobny J. G, 2010, RAD TECHNOLOGY POLYM, P215; Goldstein DJ, 2012, J HEART LUNG TRANSPL, V31, P1151, DOI 10.1016/j.healun.2012.05.004; Gross M, 2013, CURR BIOL, V23, pR1063, DOI 10.1016/j.cub.2013.11.057; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Koval CE, 2014, J HEART LUNG TRANSPL, V33, P1164, DOI 10.1016/j.healun.2014.05.011; Kowalski W, 2009, ULTRAVIOLET GERMICIDAL IRRADIATION HANDBOOK, P1, DOI 10.1007/978-3-642-01999-9; Krins A, 2000, RADIAT PROT DOSIM, V87, P261, DOI 10.1093/oxfordjournals.rpd.a033006; Lessa FC, 2012, CLIN INFECT DIS, V55, P232, DOI 10.1093/cid/cis408; Macedo-Vinas M, 2013, J HOSP INFECT, V84, P132, DOI 10.1016/j.jhin.2013.02.015; Mendez I, 2014, MED PHYS, V41, DOI 10.1118/1.4845095; Narita K, 2018, J PHOTOCH PHOTOBIO B, V178, P10, DOI 10.1016/j.jphotobiol.2017.10.030; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Smeeton T, 2017, PHOTONIC SPECTRA, V51, P40; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Trevisan A, 2006, PHOTOCHEM PHOTOBIOL, V82, P1077, DOI 10.1562/2005-10-27-RA-728; Welch D, 2017, RADIAT PROT DOSIM, V176, P341, DOI 10.1093/rpd/ncx016; Welch D, 2017, PHOTOCHEM PHOTOBIOL, V93, P1509, DOI 10.1111/php.12798; Zaffina S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1001, DOI 10.1111/j.1751-1097.2012.01151.x; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	26	9	9	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2018	13	8							e0202275	10.1371/journal.pone.0202275	http://dx.doi.org/10.1371/journal.pone.0202275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ0KU	30096188	Green Published, Green Submitted, gold			2022-12-26	WOS:000441308500062
